OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	incomplete_evidence

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC1533075	6/1998	S9-PMC1533075	['mothers also took individual Micronutrient supplements (e.g., Vitamin C tablets), but most mothers who took these also took multivitamins, making it IMPOSSIBLE to determine POTENTIAL independent EFFECTS of these Micronutrients.']	[('DIFFICULT_TASK', 149), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 195)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 29, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin C'), ('PR_000004900', 'complement C3', 70, 'C'), ('CHEBI_33839', 'macromolecule', 212, 'micronutrients')]
PMC555773	9/2004	S218-PMC555773	['IN GENERAL, it IS REPORTED that patients with UNCONTROLLED ESSENTIAL hypertension have elevated concentrations of Superoxide Anion (o2−⋅), H2O2, Lipid Peroxides, endothelin, and transforming Growth Factor-Beta (Tgf-Beta) with a simultaneous decrease in Endothelial No (eno), sod, Vitamin E, and Long-Chain polyunsaturated Fatty Acids (lcpufas).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 59)]	5	[('CHEBI_62945', 'thromboxane anion', 114, 'superoxide anion'), ('CHEBI_16240', 'hydrogen peroxide', 139, 'H2O2'), ('CHEBI_48155', 'tetrahydrofurancarboxylic acid', 145, 'lipid peroxides'), ('PR_000008020', 'glucocorticoid-induced transcript 1 protein', 191, 'growth factor-beta'), ('PR_000000046', 'TGF-beta', 211, 'TGF-beta'), ('UBERON_0001986', 'endothelium', 253, 'endothelial'), ('CHEBI_16382', 'iodide', 265, 'NO'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin E'), ('CHEBI_28911', 'cob(III)alamin', 295, 'long-chain'), ('CHEBI_33250', 'atom', 322, 'fatty'), ('CHEBI_37527', 'acid', 328, 'acids')]
PMC1168874	7/2005	S66-PMC1168874	['among Oestrogens and Retinol (Vitamin A), ONLY high dose treatments are CONSIDERED.']	[('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 72)]	3	[('CHEBI_50905', 'teratogenic agent', 6, 'oestrogens'), ('CHEBI_26536', 'retinoic acid', 21, 'retinol'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin A')]
PMC1168874	7/2005	S68-PMC1168874	['OUR FINDING is IN AGREEMENT with the CONCLUSION of the european network of the teratology information services, whose data set DID NOT PROVIDE EVIDENCE for an INCREASED RISK of major cas ASSOCIATED with high Vitamin A intake (10,000 iu per day or more) during the Organogenetic period of Embryo26.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 127), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 187)]	6	[('CHEBI_27300', 'vitamin D', 208, 'vitamin A'), ('GO_0048513', 'animal organ development', 264, 'organogenetic'), ('UBERON_0000922', 'embryo', 288, 'embryo26')]
PMC1281283	10/2005	S153-PMC1281283	['HOWEVER, fish also contain Nutrients such as iron, Vitamin E, Selenium, and Long-Chain N-3 polyunsaturated Fatty Acids that MAY benefit Brain development (clarkson and strain 2003;national research council 2000;neuringer et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 124)]	2	[('CHEBI_33284', 'nutrient', 27, 'nutrients'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 62, 'selenium'), ('CHEBI_32805', 'cis-aconitic acid', 76, 'long-chain n-3'), ('CHEBI_35366', 'fatty acid', 107, 'fatty acids'), ('UBERON_0000955', 'brain', 136, 'brain')]
PMC1361787	12/2005	S11-PMC1361787	['maternal Intake of Carbohydrates and protein [3], Fatty Acids [4], and Micronutrients such as zinc [5-7], iron [2], magnesium [8-10], Calcium [11], riboflavin [4], and Vitamin C [12]MAY also have IMPORTANT EFFECTS on fetal growth and Perinatal outcomes.']	[('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 196), ('SUPERFICIAL_RELATIONSHIP', 206)]	3	[('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_16646', 'carbohydrate', 19, 'carbohydrates'), ('CHEBI_35366', 'fatty acid', 50, 'fatty acids'), ('CHEBI_33839', 'macromolecule', 71, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 134, 'calcium'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin C'), ('GO_0036268', 'swimming', 234, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 234, 'perinatal')]
PMC1448690	4/2006	S296-PMC1448690	['the dietary factors INVOLVED include Eating at fast food outlets, as well as lower intake of milk, vegetables, fibre and Foods rich in Vitamin E. dietary Vitamin E was REPORTED to inhibit Ige responses to allergic stimuli in a random sample of 2633 Adults [174].']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 168)]	2	[('GO_0051318', 'G1 phase', 37, 'eating'), ('CHEBI_33290', 'food', 121, 'foods'), ('CHEBI_28384', 'vitamin K', 135, 'Vitamin E'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin E'), ('GO_0007630', 'jump response', 188, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 188, 'IgE'), ('UBERON_0007023', 'adult organism', 249, 'adults')]
PMC1448690	4/2006	S301-PMC1448690	['in an investigation of WHETHER reduction in childhood infections OR change in diet COULD explain increases in asthma and atopic disease, seaton and devereux [178] FOUND that low intake of Vitamin C was ASSOCIATED with a sevenfold increase in the risk of bronchial hyper-reactivity; by CONTRAST, those with the lowest intake of saturated fats had a tenfold lower risk.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 202), ('ANOMALY_CURIOUS_FINDING', 285)]	5	[('CHEBI_27300', 'vitamin D', 188, 'vitamin C')]
PMC1481554	4/2006	S98-PMC1481554	['THUS, with lower Vitamin C content than pregvit®, IT IS POSSIBLE that the systemic absorption of Iron of materna®MAY BE subtherapeutic14.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 113)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin C'), ('PR_000004900', 'complement C3', 25, 'C'), ('CHEBI_24870', 'ion', 97, 'iron')]
PMC4155147	4/2007	S79-PMC4155147	['the recommended dosage originally on the package was one tablet “every three hours.” HOWEVER, it was RECENTLY changed to add “up to three times per day as NECESSARY,” BECAUSE the 15,000 units of Vitamin A from three tablets is enough to cause POSSIBLE Liver damage, dizziness, and blurred Vision.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 155), ('PROBABLE_UNDERSTANDING', 167), ('INCOMPLETE_EVIDENCE', 243)]	5	[('CHEBI_27300', 'vitamin D', 195, 'vitamin A'), ('UBERON_0002107', 'liver', 252, 'liver'), ('GO_0007601', 'visual perception', 289, 'vision')]
PMC1888711	5/2007	S46-PMC1888711	['beneficial EFFECTS on Birth weight and the risk of Postpartum endometritis were SEEN for high-risk women" [22].moderatedietary Vitamin A deficiencyvitamin a supplementation"further EVIDENCE on biologically PLAUSIBLE mechanisms of morbidity reduction such as reduced incidence of sepsis and/or reduced MARKERS of inflammation ARE NEEDED" [60].lowdietary Micronutrient deficienciesmultiple Micronutrient supplementationone trial in tanzania showed no additional effect on markers of infection (C-Reactive Protein) compared with Iron and Folic Acid [15].lowanemia p. falciparum infectionanti-malarial Drugs"Drugs given routinely for malaria during Pregnancy reduce SEVERE Antenatal anaemia in the mother, and are ASSOCIATED with higher Birth weight in the baby and PROBABLY fewer Perinatal deaths.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 181), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 301), ('FUTURE_WORK', 325), ('IMPORTANT_CONSIDERATION', 662), ('SUPERFICIAL_RELATIONSHIP', 710), ('PROBABLE_UNDERSTANDING', 762)]	9	[('GO_0007567', 'parturition', 22, 'birth'), ('GO_0007565', 'female pregnancy', 51, 'postpartum'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 353, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 388, 'micronutrient'), ('PR_000005890', 'crooked neck-like protein 1', 492, 'C-reactive protein'), ('CHEBI_24870', 'ion', 526, 'iron'), ('CHEBI_30751', 'formic acid', 535, 'folic acid'), ('CHEBI_23888', 'drug', 598, 'drugs'), ('CHEBI_23888', 'drug', 604, 'Drugs'), ('GO_0007565', 'female pregnancy', 645, 'pregnancy'), ('GO_0007567', 'parturition', 669, 'antenatal'), ('GO_0007567', 'parturition', 733, 'birth'), ('GO_0036268', 'swimming', 777, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 777, 'perinatal')]
PMC1888711	5/2007	S48-PMC1888711	['routine daily or weekly Antenatal iron or iron plus Folic Acid supplementation MAY BE of benefit, especially where pre-Gestational iron deficiency and anaemia are prevalent" [26].moderatedietary Vitamin A deficiencyvitamin A supplementation"FURTHER EVIDENCE on the effectiveness of adding Vitamin A to Iron and Folic Acid for treatment of anaemia IS NEEDED" [60].']	[('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 241), ('FUTURE_WORK', 347)]	3	[('GO_0007567', 'parturition', 24, 'antenatal'), ('CHEBI_30751', 'formic acid', 52, 'folic acid'), ('GO_0007565', 'female pregnancy', 119, 'gestational'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 223, 'A'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin A'), ('CHEBI_24870', 'ion', 302, 'iron'), ('CHEBI_30751', 'formic acid', 311, 'folic acid')]
PMC1888711	5/2007	S107-PMC1888711	['supplementation with Vitamins C and E HAS BEEN SHOWN to have no effect on eclampsia, ALBEIT among well-nourished women [34,35].']	[('INCOMPLETE_EVIDENCE', 38), ('ANOMALY_CURIOUS_FINDING', 85)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamins C'), ('PR_000004900', 'complement C3', 30, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 36, 'E')]
PMC1888711	5/2007	S123-PMC1888711	['Albendazole HAS BEEN SHOWN to reduce the decline in haemoglobin during Pregnancy, but there is NO CONCLUSIVE EVIDENCE for an EFFECT of Vitamin A or other Micronutrients on anemia during Pregnancy, PARTICULARLY when compared with Iron and Folate supplementation [60,61].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 125), ('ANOMALY_CURIOUS_FINDING', 197)]	4	[('CHEBI_16664', 'albendazole', 0, 'Albendazole'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_33839', 'macromolecule', 154, 'micronutrients'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_24870', 'ion', 229, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 238, 'folate')]
PMC2606998	6/2007	S12-PMC2606998	['in the industrialized countries, Intake of Folate, Vitamin\u2009D and iron, all with a SUGGESTED IMPACT on Pregnancy outcome, HAS BEEN REPORTED to be low in Pregnant women3–5.']	[('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 121)]	3	[('GO_0007631', 'feeding behavior', 33, 'intake'), ('CHEBI_30863', '5-azaorotic acid', 43, 'folate'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 152, 'pregnant')]
PMC2606998	6/2007	S14-PMC2606998	['maternal Vitamin\u2009D deficiency is SUGGESTED to cause POOR foetal and infant Skeletal growth and mineralization8with consequences for future bone mass9.']	[('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 52)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0004288', 'skeleton', 75, 'skeletal')]
PMC2606998	6/2007	S84-PMC2606998	['from this perspective, the most STRIKING result from THIS STUDY was the CONSIDERABLY lower than RECOMMENDED intakes of Folate and Vitamin\u2009D, both before and during Pregnancy, EVEN when PROBABLE UNDERREPORTING was taken INTO ACCOUNT.']	[('ANOMALY_CURIOUS_FINDING', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('ANOMALY_CURIOUS_FINDING', 72), ('FUTURE_WORK', 96), ('ANOMALY_CURIOUS_FINDING', 175), ('PROBABLE_UNDERSTANDING', 185), ('PROBLEM_COMPLICATION', 194), ('INCOMPLETE_EVIDENCE', 219)]	8	[('CHEBI_30863', '5-azaorotic acid', 119, 'folate'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 164, 'pregnancy')]
PMC2606998	6/2007	S86-PMC2606998	['both Folate and Vitamin\u2009D are CONSIDERED to have PROFOUND EFFECTS on Pregnancy outcome, as well as on maternal health.6,7.']	[('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 49), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('CHEBI_30863', '5-azaorotic acid', 5, 'folate'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy')]
PMC2606998	6/2007	S120-PMC2606998	['ACCORDING TO the PRESENT STUDY there is a NEED to expand this FOCUS and include Selenium, Folate and Vitamin\u2009D too.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('FUTURE_WORK', 42), ('IMPORTANT_CONSIDERATION', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 62)]	5	[('CHEBI_27568', 'selenium atom', 80, 'selenium'), ('CHEBI_30863', '5-azaorotic acid', 90, 'folate'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC2151954	10/2007	S171-PMC2151954	['with respect to seasonally-fluctuating exposures that MAY UNDERLIE THESE FINDINGS, we SPECULATE that low Prenatal Vitamin D is a CANDIDATE that WARRANTS closer inspection [4].']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 129), ('FUTURE_WORK', 144)]	6	[('GO_0007565', 'female pregnancy', 105, 'prenatal'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC2151954	10/2007	S172-PMC2151954	['firstly, there is ROBUST EVIDENCE that Vitamin D levels fluctuate over the seasons and also across latitudes [26].']	[('INCOMPLETE_EVIDENCE', 18)]	1	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC2151954	10/2007	S173-PMC2151954	['secondly, a nonlinear exposure-risk RELATIONSHIP between maternal Vitamin D levels and neonatal anthropometry HAS BEEN FOUND [22].']	[('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 119)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC2151954	10/2007	S175-PMC2151954	['for example, low maternal Vitamin D levels HAVE BEEN ASSOCIATED with altered Birth anthropometry, with SOME STUDIES FINDING an ASSOCIATION between Vitamin D deficiency and larger Birth weight and length [29], WHILE others HAVE SHOWN an ASSOCIATION between lower maternal Vitamin D levels and shorter Gestation and smaller Knee-Heel length (a component of Birth length) [22].']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 209), ('INCOMPLETE_EVIDENCE', 222), ('SUPERFICIAL_RELATIONSHIP', 236)]	8	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 77, 'birth'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 179, 'birth'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0007565', 'female pregnancy', 300, 'gestation'), ('UBERON_0001485', 'knee joint', 322, 'knee-heel'), ('GO_0007567', 'parturition', 355, 'birth')]
PMC2265059	3/2008	S37-PMC2265059	['for example, in australia,mcgrath and colleagues (2005b)SUGGESTED that Prenatal Vitamin D ASSOCIATED with maternal exposure to sunlight is ASSOCIATED with the seasonal variation in Birth weight.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 90), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('GO_0007565', 'female pregnancy', 71, 'prenatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007567', 'parturition', 181, 'birth')]
PMC2330139	3/2008	S98-PMC2330139	['the FINDINGS that the most commonly used ds by teens were multivitamins (16%) and Vitamin C (6%) IS REASSURING in terms of POTENTIAL health RISKS.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 100), ('INCOMPLETE_EVIDENCE', 123), ('IMPORTANT_CONSIDERATION', 140)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin C')]
PMC2290997	4/2008	S14-PMC2290997	['the BEST-KNOWN benefit of sunlight is its ability to boost the body’s Vitamin D supply; MOST cases of Vitamin D deficiency are DUE TO lack of outdoor sun exposure.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 88), ('PROBLEM_COMPLICATION', 127)]	4	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC2290997	4/2008	S16-PMC2290997	['ALTHOUGH most of the health-promoting benefits of sun exposure are THOUGHT TO occur through Vitamin D Photosynthesis, there MAY BE OTHER health benefits that have gone largely OVERLOOKED in the DEBATE over HOW much sun is NEEDED for good health [see “other sun-dependent pathways,” p. a165].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('EXPLICIT_QUESTION', 206), ('IMPORTANT_CONSIDERATION', 222)]	8	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 102, 'photosynthesis')]
PMC2290997	4/2008	S26-PMC2290997	['more RECENTLY, there HAS BEEN a GROWING APPRECIATION for Vitamin D’s IMPACT on bone health in Adults.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 40), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0007023', 'adult organism', 94, 'adults')]
PMC2290997	4/2008	S45-PMC2290997	['NEVERTHELESS, a meta-analysis published in the february 2008 international journal of epidemiology FOUND that high Vitamin D levels reduce the RISK of active tb (i.e., tb showing clinical symptoms) by 32%.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 143)]	3	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC2290997	4/2008	S71-PMC2290997	['other health LINKS\nVARIOUS STUDIES have LINKED low 25(Oh)D levels to diseases other than cancer, raising the POSSIBILITY that Vitamin D insufficiency is CONTRIBUTING to many major illnesses.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 153)]	5	[('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 57, 'D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC2290997	4/2008	S72-PMC2290997	['for example, there is substantial THOUGH not DEFINITIVE EVIDENCE that high levels of Vitamin D EITHER from diet or from uvr exposure MAY decrease the risk of developing multiple sclerosis (ms).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 133)]	5	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC2290997	4/2008	S74-PMC2290997	['STILL to be resolved, HOWEVER, is the QUESTION of WHAT levels of Vitamin D are OPTIMAL for preventing the disease—and WHETHER the statistical ASSOCIATIONS REFLECT DIFFERENT Gene pools RATHER than DIFFERENT levels of 25(Oh)D. (INTERESTINGLY, holick REPORTED in the august 1988 issue of the journal of clinical endocrinology & Metabolism that no previtamin d3formed when Human skin was exposed to sunlight on cloudless days in boston, at 42.2°n, from november through february or in edmonton, at 52°n, from october through march.)']	[('IMPORTANT_CONSIDERATION', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('EXPLICIT_QUESTION', 38), ('EXPLICIT_QUESTION', 50), ('IMPORTANT_CONSIDERATION', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('EXPLICIT_QUESTION', 118), ('SUPERFICIAL_RELATIONSHIP', 142), ('SUPERFICIAL_RELATIONSHIP', 155), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('ANOMALY_CURIOUS_FINDING', 226), ('INCOMPLETE_EVIDENCE', 248)]	14	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('SO_0000704', 'gene', 173, 'gene'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('GO_0008152', 'metabolic process', 325, 'Metabolism'), ('NCBITaxon_9606', 'Homo sapiens', 369, 'human')]
PMC2290997	4/2008	S75-PMC2290997	['“SCIENTIFIC EVIDENCE on specific EFFECTS of Vitamin D in preventing ms or slowing its progression is not SUFFICIENT,” says alberto ascherio, a nutritional epidemiologist at the harvard school of public health.']	[('INCOMPLETE_EVIDENCE', 1), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 105)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC2290997	4/2008	S77-PMC2290997	['a swedish epidemiologic study published in the december 2006 issue of diabetologia FOUND that sufficient Vitamin D status in early Life was ASSOCIATED with a lower risk of developing type 1 diabetes.']	[('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 140)]	2	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0000104', 'life cycle', 131, 'life')]
PMC2290997	4/2008	S79-PMC2290997	['and a finnish study published 3 november 2001 in the lancet SHOWED that children who received 2,000 iu Vitamin D per day from 1 year of age on had an 80% decreased risk of developing type 1 diabetes later in Life, WHEREAS children who were Vitamin D deficient had a fourfold increased risk.']	[('INCOMPLETE_EVIDENCE', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0000104', 'life cycle', 208, 'life'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC2290997	4/2008	S80-PMC2290997	['researchers are now seeking to understand HOW much uvr/Vitamin D is NEEDED to lower the risk of diabetes and WHETHER this is a FACTOR ONLY in high-risk groups.']	[('EXPLICIT_QUESTION', 42), ('FUTURE_WORK', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('EXPLICIT_QUESTION', 109), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 134)]	6	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC2290997	4/2008	S83-PMC2290997	['SOME STUDIES have DEMONSTRATED high prevalence of low Vitamin D levels in People with type 2 diabetes, ALTHOUGH it is NOT CLEAR WHETHER this is a cause of the disease or an EFFECT of another causative FACTOR—for example, lower levels of physical activity (in this case, outdoor activity in particular).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('ANOMALY_CURIOUS_FINDING', 103), ('FULL_UNKNOWN', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('SUPERFICIAL_RELATIONSHIP', 173), ('SUPERFICIAL_RELATIONSHIP', 201)]	7	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 74, 'people')]
PMC2290997	4/2008	S84-PMC2290997	['People living at higher latitudes throughout the world are at higher RISK of hypertension, and patients with Cardiovascular disease are OFTEN found to be deficient in Vitamin D, ACCORDING TO research by harvard medical school professor thomas j. wang and colleagues in the 29 january 2008 issue of circulation .']	[('IMPORTANT_CONSIDERATION', 69), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 178)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'People'), ('UBERON_0004535', 'cardiovascular system', 109, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC2290997	4/2008	S86-PMC2290997	['“moreover, there is an inflammatory component to atherosclerosis, and Vascular Smooth Muscle Cells have a Vitamin D receptor and relax in the presence of 1,25(Oh)D, SUGGESTING a multitude of mechanisms by which Vitamin D MAY BE cardioprotective.”\nTO DETERMINE the POTENTIAL LINK betwen sun exposure and the PROTECTIVE effect in preventing hypertension, rolfdieter krause of the free university of berlin department of natural medicine and colleagues exposed a group of hypertensive Adults to a Tanning Bed that emitted full-spectrum uvr similar to summer sunlight.']	[('INCOMPLETE_EVIDENCE', 165), ('INCOMPLETE_EVIDENCE', 221), ('QUESTION_ANSWERED_BY_THIS_WORK', 247), ('INCOMPLETE_EVIDENCE', 264), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 307)]	6	[('CL_0000359', 'vascular associated smooth muscle cell', 70, 'vascular smooth muscle cells'), ('UBERON_0004237', 'blood vessel smooth muscle', 70, 'vascular smooth muscle'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 158, '(OH)D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('UBERON_0007023', 'adult organism', 482, 'adults'), ('UBERON_0002544', 'digit', 494, 'tanning'), ('UBERON_0002531', 'paired fin bud', 502, 'bed')]
PMC2290997	4/2008	S95-PMC2290997	['in addition, 25(Oh)D levels are inversely ASSOCIATED with the clinical status of ra patients, and greater intake of Vitamin D HAS BEEN LINKED with lower ra RISK, AS REPORTED in january 2004 in arthritis & rheumatism .']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 156), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 165)]	6	[('CHEBI_71657', 'versiconol acetate', 13, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC2290997	4/2008	S101-PMC2290997	['NEVERTHELESS, given the epidemiologic backdrop DESCRIBED above, there are now CALLS to rethink sun exposure policy OR to promote Vitamin D supplementation in HIGHER-RISK populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 78), ('IMPORTANT_CONSIDERATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC2290997	4/2008	S107-PMC2290997	['studies by bruce hollis, director of pediatric nutritional sciences at the medical university of south carolina, and colleagues SUGGEST that a maternal Vitamin D3Intake of 4,000 iu per day is SAFE and sufficient to ensure adequate Vitamin D status for both mother and nursing infant.']	[('INCOMPLETE_EVIDENCE', 128), ('IMPORTANT_CONSIDERATION', 192)]	2	[('CHEBI_63635', 'valganciclovir', 152, 'vitamin D3intake'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
PMC2290997	4/2008	S108-PMC2290997	['THESE days, MOST EXPERTS DEFINE Vitamin D deficiency AS a Serum 25(Oh)D level of less than 20 ng/ml.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 12), ('PROBABLE_UNDERSTANDING', 17), ('PROBABLE_UNDERSTANDING', 25), ('PROBABLE_UNDERSTANDING', 25), ('PROBABLE_UNDERSTANDING', 53)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001977', 'blood serum', 58, 'serum'), ('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 64, '25 ... OH ... D')]
PMC2290997	4/2008	S109-PMC2290997	['holick and others ASSERT that levels of 29 ng/ml or lower CAN be considered to INDICATE a relative insufficiency of Vitamin D. using this scale and considering VARIOUS epidemiologic STUDIES, an ESTIMATED 1 billion People worldwide have Vitamin D deficiency or insufficiency, says holick, who adds, “ACCORDING TO SEVERAL STUDIES, SOME forty to one hundred percent of the u.s. and european elderly men and women STILL living in the community [that is, not in nursing homes] are Vitamin D DEFICIENT.” holick ASSERTS that a large NUMBER of infants, children, adolescents, and Postmenopausal women also are Vitamin D INSUFFICIENT.']	[('INCOMPLETE_EVIDENCE', 18), ('PROBABLE_UNDERSTANDING', 18), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 299), ('INCOMPLETE_EVIDENCE', 312), ('INCOMPLETE_EVIDENCE', 329), ('IMPORTANT_CONSIDERATION', 410), ('IMPORTANT_CONSIDERATION', 486), ('INCOMPLETE_EVIDENCE', 505), ('INCOMPLETE_EVIDENCE', 526), ('IMPORTANT_CONSIDERATION', 612)]	14	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 214, 'people'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 476, 'vitamin D'), ('GO_0007595', 'lactation', 572, 'postmenopausal'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D')]
PMC2290997	4/2008	S111-PMC2290997	['in the context of INADEQUATE sunlight or Vitamin D insufficiency, SOME scientists WORRY that the EMPHASIS on preventing skin cancers tends to obscure the much larger mortality BURDEN posed by more Life-threatening cancers such as Lung, Colon, and Breast cancers.']	[('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 66), ('IMPORTANT_CONSIDERATION', 82), ('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 176)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0000104', 'life cycle', 197, 'life'), ('UBERON_0002048', 'lung', 230, 'lung'), ('UBERON_0001155', 'colon', 236, 'colon'), ('UBERON_0000310', 'breast', 247, 'breast')]
PMC2290997	4/2008	S115-PMC2290997	['so when you ESTIMATE the number of deaths LIKELY to be attributable to uv light or Vitamin D, it does is not APPEAR TO BE the BEST policy to ADVISE People to simply keep out of the sun just to prevent skin cancer.”\nto maximize protection against cancer, grant RECOMMENDS raising 25(Oh)D levels to between 40 and 60 ng/ml.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 42), ('ANOMALY_CURIOUS_FINDING', 109), ('IMPORTANT_CONSIDERATION', 126), ('FUTURE_WORK', 141), ('FUTURE_WORK', 260)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 148, 'people'), ('CHEBI_71657', 'versiconol acetate', 279, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 279, '25(OH ... D')]
PMC2290997	4/2008	S131-PMC2290997	['gilchrest says the american academy of dermatology and MOST dermatologists currently SUGGEST sun protection in combination with Vitamin D supplementation AS a means of minimizing the RISK of both skin cancer and internal cancers.']	[('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 154), ('IMPORTANT_CONSIDERATION', 183)]	4	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC2290997	4/2008	S136-PMC2290997	['in the near FUTURE, Vitamin D and health GUIDELINES regarding sun exposure MAY NEED TO BE revised.']	[('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 41), ('INCOMPLETE_EVIDENCE', 75), ('FUTURE_WORK', 79)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC2290997	4/2008	S138-PMC2290997	['“current OBSERVATIONS of widespread Vitamin D insufficiency SHOULD NOT BE ATTRIBUTED ONLY to sun protection STRATEGIES,” says lucas.']	[('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 85), ('FUTURE_WORK', 108)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC2290997	4/2008	S160-PMC2290997	['OTHER sun-dependent pathways\nthe sun MAY BE BEST KNOWN for boosting Production Of Vitamin D, BUT there are many OTHER uvr-MEDIATED EFFECTS independent of this pathway.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 131)]	8	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 68, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC2290997	4/2008	S193-PMC2290997	['NONETHELESS, says lucas, “there are DRAWBACKS to INFERRING that a RELATIONSHIP with any PROXY for the exposure of interest is a RELATIONSHIP with personal uv dose or Vitamin D status.” on the bright side, she adds, our ability to ACCURATELY gauge an Individual’s uv dose history HAS BEEN ENHANCED with the use of silicone rubber casts of the Back of subjects’ Hands.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 36), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 230), ('INCOMPLETE_EVIDENCE', 279), ('FUTURE_WORK', 288)]	9	[('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('NCBITaxon_1', 'root', 250, 'individual'), ('UBERON_0001137', 'dorsum', 342, 'back'), ('UBERON_0002398', 'manus', 360, 'hands')]
PMC2405769	5/2008	S13-PMC2405769	['background\nmultivitamin-Mineral supplementation is RECOMMENDED before and during Pregnancy to ensure adequate intake of several KEY Nutrients including Folate, iron, and more RECENTLY Vitamin D – all of which have IMPORTANCE among Pregnant women, women of Childbearing age, and during Fetal Development [1-6].']	[('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 128), ('INCOMPLETE_EVIDENCE', 175), ('IMPORTANT_CONSIDERATION', 214)]	4	[('CHEBI_46662', 'mineral', 24, 'mineral'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('CHEBI_33284', 'nutrient', 132, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 152, 'folate'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 231, 'pregnant'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 256, 'childbearing'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 285, 'fetal development')]
PMC2396486	6/2008	S0-PMC2396486	['Protein Expression in the Nucleus accumbens of Rats exposed to developmental Vitamin D deficiency\n\nabstract\n\nintroduction\ndevelopmental Vitamin D (Dvd) deficiency is a CANDIDATE risk factor for schizophrenia.']	[('INCOMPLETE_EVIDENCE', 168)]	1	[('GO_0045053', 'protein retention in Golgi apparatus', 0, 'Protein Expression'), ('GO_0005634', 'nucleus', 26, 'Nucleus'), ('NCBITaxon_10088', 'Mus <genus>', 47, 'Rats'), ('CHEBI_28384', 'vitamin K', 77, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 77, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 147, 'DVD')]
PMC2396486	6/2008	S2-PMC2396486	['because the Nucleus Accumbens HAS BEEN IMPLICATED in neuropsychiatric disorders, in THE CURRENT STUDY we EXAMINED protein Expression in this region in Adult Rats exposed to Dvd deficiency\n\nmethods\nfemale sprague dawley Rats were maintained on a Vitamin D deficient diet for 6 weeks, Mated and allowed to Give Birth, after which a diet containing Vitamin D was reintroduced.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 84), ('QUESTION_ANSWERED_BY_THIS_WORK', 105)]	4	[('UBERON_0001882', 'nucleus accumbens', 12, 'nucleus accumbens'), ('GO_0010467', 'gene expression', 122, 'expression'), ('UBERON_0007023', 'adult organism', 151, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 157, 'rats'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 173, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 219, 'rats'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('GO_0007618', 'mating', 283, 'mated'), ('GO_0007631', 'feeding behavior', 304, 'give'), ('GO_0007567', 'parturition', 309, 'birth'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]
PMC2396486	6/2008	S11-PMC2396486	['disruptions in pathways RELATED to calcium-binding proteins and Mitochondrial function MAY underlie SOME of the behavioural features ASSOCIATED with Animal MODELS of developmental Vitamin D deficiency\n\nintroduction\nbased on CLUES from epidemiology, we have PROPOSED that low Prenatal Vitamin D MAY BE a risk factor for later development of schizophrenia[1].']	[('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 133), ('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 257), ('INCOMPLETE_EVIDENCE', 294)]	8	[('GO_0005739', 'mitochondrion', 64, 'mitochondrial'), ('NCBITaxon_33208', 'Metazoa', 149, 'animal'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0007565', 'female pregnancy', 275, 'prenatal'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC2396486	6/2008	S13-PMC2396486	['given that Vitamin D levels in the population fluctuate across the seasons and decrease across higher latitude[4], low Prenatal Vitamin D ‘FITS’ these key environmental features and is THEREFORE a PLAUSIBLE CANDIDATE risk factor for this disease.']	[('SUPERFICIAL_RELATIONSHIP', 139), ('PROBABLE_UNDERSTANDING', 185), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 207)]	4	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'prenatal'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC2396486	6/2008	S15-PMC2396486	['Rats exposed to low Prenatal Vitamin D have a broad range of neurobiological outcomes that are INFORMATIVE for schizophrenia research.']	[('INCOMPLETE_EVIDENCE', 95)]	1	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('GO_0007565', 'female pregnancy', 20, 'prenatal'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC2396486	6/2008	S102-PMC2396486	['Calbindin is strongly induced by Vitamin D[29], and THUS it is FEASIBLE that the reduction in this protein MAY BE a consequence of the Early Life reduction in Vitamin D. the POTENTIAL LINKS between Vitamin D and Neuronal calcium binding proteins HAS BEEN NOTED in a recent review article[30]\ntwo members of the dynamin family (Dynamin 1 and Dynamin 1-Like proteins) were also significantly down-regulated.']	[('PROBABLE_UNDERSTANDING', 52), ('PROBABLE_UNDERSTANDING', 63), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 184), ('ANOMALY_CURIOUS_FINDING', 246)]	6	[('PR_000004967', 'calbindin', 0, 'Calbindin'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001847', 'lobule of pinna', 135, 'early life'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('CL_0000540', 'neuron', 212, 'neuronal'), ('PR_000006501', 'dickkopf-related protein 3', 327, 'dynamin 1'), ('PR_000006609', 'DNA (cytosine-5)-methyltransferase 3-like', 341, 'dynamin 1-like')]
PMC2396486	6/2008	S133-PMC2396486	['combined with OTHER experimental findings, THE CURRENT STUDY LENDS FURTHER CREDIBILITY to the NOTION that developmental Vitamin D deficiency IMPACTS adversely on normal Brain Development[30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007420', 'brain development', 169, 'brain development'), ('UBERON_0000955', 'brain', 169, 'brain')]
BMJ_2008_Nov_7_337_a2001	11/2008	S180-BMJ_2008_Nov_7_337_a2001	['the Vitamin C in the multiple Micronutrient supplements MIGHT have enhanced the absorption of iron and also CONTRIBUTED TO reducing the difference in the absolute amount of iron absorbed.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 108)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin C'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 30, 'micronutrient')]
PMC2581757	11/2008	S6-PMC2581757	['a significant reduction in the incidence of Preeclampsia was FOUND in women AT RISK who were taking Vitamins C and E supplements [1].']	[('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 76)]	2	[('GO_0007128', 'meiotic prophase I', 44, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 100, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 115, 'E')]
PMC2581757	11/2008	S10-PMC2581757	['the functional consequence and the POSSIBLE ROLE of the decrease in Plasma Vitamin C reserves in Preeclampsia (pe) are CONSISTENT with the fact that women who Ingested less Vitamin C than the recommended daily allowance (8.5\xa0mg) were at a 2-fold INCREASED risk of developing pe [7].']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 119), ('IMPORTANT_CONSIDERATION', 246)]	4	[('UBERON_0001969', 'blood plasma', 68, 'plasma'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin C'), ('GO_0007128', 'meiotic prophase I', 97, 'preeclampsia'), ('GO_0007631', 'feeding behavior', 159, 'ingested'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin C')]
PMC2581757	11/2008	S13-PMC2581757	['HOWEVER, in a recent review, antioxidant therapy HAS BEEN SUGGESTED and that the prophylactic supplementation of Vitamins C and E to Pregnant women is ASSOCIATED with reduced incidence of preeclampsia and decreased Placental and Endothelial dysfunction [9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 151)]	3	[('CHEBI_27300', 'vitamin D', 113, 'vitamins C'), ('PR_000004900', 'complement C3', 122, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 128, 'E'), ('GO_0007565', 'female pregnancy', 133, 'pregnant'), ('UBERON_0001987', 'placenta', 215, 'placental'), ('UBERON_0001986', 'endothelium', 229, 'endothelial')]
PMC2581757	11/2008	S14-PMC2581757	['in preeclampsia, an inverse CORRELATION between Vitamin E levels and Lipid peroxidation HAS BEEN FOUND [10] SUGGESTING that Vitamin E content in Plasma MAY BE used as a prognostic MARKER of the LIKELY development of Preeclampsia [11].']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 180), ('PROBABLE_UNDERSTANDING', 194)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin E'), ('CHEBI_18059', 'lipid', 69, 'lipid'), ('GO_0006266', 'DNA ligation', 69, 'lipid'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 145, 'plasma'), ('GO_0007128', 'meiotic prophase I', 216, 'preeclampsia')]
PMC2581757	11/2008	S15-PMC2581757	['in addition, there was a RELATIONSHIP FOUND between the extent of Vitamin E deficiency and increased Lipid Peroxidation with enhanced diastolic Blood pressure [12].']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 38)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin E'), ('CHEBI_18059', 'lipid', 101, 'lipid'), ('GO_0032622', 'interleukin-19 production', 101, 'lipid peroxidation'), ('UBERON_0000178', 'blood', 144, 'blood')]
PMC2581757	11/2008	S16-PMC2581757	['THUS, decreased Plasma levels of Vitamin E COULD BE a CONTRIBUTORY FACTOR of hypertension in preeclampsia, BUT OTHER STUDIES have not demonstrated significant differences in Plasma Vitamin E levels between normal and Preeclamptic women [13].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 117)]	7	[('UBERON_0001969', 'blood plasma', 16, 'plasma'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 174, 'plasma'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin E'), ('GO_0007565', 'female pregnancy', 217, 'preeclamptic')]
PMC2581757	11/2008	S17-PMC2581757	['moreover, SOME results are at VARIANCE with the PREVAILING OPINION, SINCE increased Plasma levels of Vitamin E among women with Preeclampsia as compared to those in normotensive pregnant women HAVE BEEN REPORTED [14].']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('INCOMPLETE_EVIDENCE', 59), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 193)]	8	[('UBERON_0001969', 'blood plasma', 84, 'plasma'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin E'), ('GO_0007128', 'meiotic prophase I', 128, 'preeclampsia')]
PMC2581757	11/2008	S18-PMC2581757	['the latter study does not SUPPORT the HYPOTHESIS of a causal RELATIONSHIP between decreased dietary Vitamin E consumption and Plasma levels and the development of Preeclampsia.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_27300', 'vitamin D', 100, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 126, 'plasma'), ('GO_0007128', 'meiotic prophase I', 163, 'preeclampsia')]
PMC2581757	11/2008	S36-PMC2581757	['in VIEW of the CONTRADICTORY REPORTS and the SERIOUSNESS of preeclampsia, the PRESENT STUDY included the determination of the activities of catalase, sod, Gpx and Grx in the Blood of normal and Preeclamptic women with and without vitamin treatment, along-with the contents of mda, Gsh, gssg, gssg/Gsh, no and Uric Acid, TO collectively EVALUATE the ROLES of Vitamins C and e in the Regulation of these factors.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 320), ('QUESTION_ANSWERED_BY_THIS_WORK', 336), ('SUPERFICIAL_RELATIONSHIP', 349)]	8	[('PR_000008210', 'glutathione peroxidase 1', 155, 'GPx'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 163, 'GRx'), ('UBERON_0000178', 'blood', 174, 'blood'), ('GO_0007565', 'female pregnancy', 194, 'preeclamptic'), ('CHEBI_16856', 'glutathione', 281, 'GSH'), ('CHEBI_16856', 'glutathione', 297, 'GSH'), ('CHEBI_27226', 'uric acid', 309, 'uric acid'), ('CHEBI_27300', 'vitamin D', 358, 'vitamins C'), ('GO_0065007', 'biological regulation', 382, 'regulation')]
PMC2581757	11/2008	S130-PMC2581757	['those who consumed Vitamin E and C during the Gestational period from the second Trimester of Pregnancy to Delivery DEMONSTRATED an insignificant ( p \xa0=\xa00.5395) fall in Grx activities.']	[('INCOMPLETE_EVIDENCE', 116)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin E'), ('CHEBI_18245', 'carboxylato group', 33, 'C'), ('GO_0007565', 'female pregnancy', 46, 'gestational'), ('GO_0009294', 'DNA mediated transformation', 81, 'trimester'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy'), ('GO_0007567', 'parturition', 107, 'delivery'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 169, 'GRx')]
PMC2581757	11/2008	S150-PMC2581757	['this SHOWS the effectiveness of Vitamins C and e in restricting the elevation of Lipid peroxidation.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamins C'), ('CHEBI_18059', 'lipid', 81, 'lipid'), ('GO_0006266', 'DNA ligation', 81, 'lipid')]
PMC2581757	11/2008	S179-PMC2581757	['a comparison of these two groups REVEALED a significant difference (22–29%), which SHOWS that Vitamins C and E consumption PREVENTED the fall in Grx activity.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('CHEBI_27300', 'vitamin D', 94, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 109, 'E'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 145, 'GRx')]
PMC2581757	11/2008	S187-PMC2581757	['[1] HAVE REPORTED that a significant reduction in the incidence of Preeclampsia was FOUND in women AT RISK who were taking a Vitamins C and E supplements.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 84), ('IMPORTANT_CONSIDERATION', 99)]	3	[('GO_0007128', 'meiotic prophase I', 67, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 125, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 140, 'E')]
PMC2581757	11/2008	S191-PMC2581757	['[7] HAVE REPORTED a 2-fold increased risk of developing Preeclampsia in women taking lower Vitamin C doses.']	[('INCOMPLETE_EVIDENCE', 4)]	1	[('GO_0007128', 'meiotic prophase I', 56, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin C')]
PMC2581757	11/2008	S193-PMC2581757	['[9] SUGGEST the prophylactic use of Vitamins C and E before the 20th.']	[('INCOMPLETE_EVIDENCE', 4)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamins C'), ('PR_000004900', 'complement C3', 45, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 51, 'E')]
PMC2581757	11/2008	S195-PMC2581757	['we FOUND that the patients supplemented with Vitamin C 1000\xa0mg plus Vitamin E 400\xa0iu daily from the second Trimester of Pregnancy until Delivery showed improvements in certain biochemical indices during the Development Of Preeclampsia.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 45, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin E'), ('GO_0009294', 'DNA mediated transformation', 107, 'trimester'), ('GO_0007565', 'female pregnancy', 120, 'pregnancy'), ('GO_0007567', 'parturition', 136, 'delivery'), ('GO_0070483', 'detection of hypoxia', 207, 'development of preeclampsia')]
PMC2582131	11/2008	S0-PMC2582131	['Maternal Plasma 25-Hydroxyvitamin D concentrations and the risk for Gestational diabetes mellitus\n\nabstract\n\nbackground\nEVIDENCE is ACCUMULATING for a ROLE of Vitamin D in maintaining normal Glucose Homeostasis.']	[('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 151)]	3	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001969', 'blood plasma', 9, 'Plasma'), ('CHEBI_27844', "2',3'-cyclic AMP", 16, '25-Hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 68, 'Gestational'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_17234', 'glucose', 191, 'glucose'), ('GO_0042593', 'glucose homeostasis', 191, 'glucose homeostasis')]
PMC2582131	11/2008	S8-PMC2582131	['APPROXIMATELY 33% of gdm cases, COMPARED with 14% of controls ( p<0.001), had maternal Plasma 25-[Oh] D concentrations consistent with a pre-specified diagnosis of Vitamin D deficiency (<20 ng/ml).']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 32)]	2	[('UBERON_0001969', 'blood plasma', 87, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 94, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC2582131	11/2008	S12-PMC2582131	['conclusions\nFINDINGS from the PRESENT STUDY SUGGEST that maternal Vitamin D deficiency in early Pregnancy is significantly ASSOCIATED with an elevated RISK for gdm.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 151)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy')]
PMC2582131	11/2008	S14-PMC2582131	['HOWEVER, the ubiquitous distribution of Intracellular Vitamin D Receptor across diverse Tissues[1]and the EMERGING epidemiological EVIDENCE DOCUMENTING INCREASED RISKS of hypertension[2],[3], Cardiovascular disease[4]–[7], and selected cancers[1],[8]ASSOCIATED with Vitamin D deficiency underscore the pleiotropic actions of Vitamin D. evidence is also accumulating for a ROLE of Vitamin D in maintaining normal Glucose Homeostasis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 372)]	6	[('GO_0005622', 'intracellular anatomical structure', 40, 'intracellular'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 54, 'vitamin D receptor'), ('UBERON_0000479', 'tissue', 88, 'tissues'), ('UBERON_0004535', 'cardiovascular system', 192, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_17234', 'glucose', 412, 'glucose'), ('GO_0042593', 'glucose homeostasis', 412, 'glucose homeostasis')]
PMC2582131	11/2008	S17-PMC2582131	['moreover, a significant and strong ASSOCIATION between Vitamin D deficiency and Ss-Cell dysfunction HAS BEEN REPORTED in healthy, non-diabetic, or diabetic populations[13]–[15].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 99)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CL_0000623', 'natural killer cell', 80, 'ß-cell')]
PMC2582131	11/2008	S19-PMC2582131	['it HAS long BEEN KNOWN that Vitamin D deficiency is PREVALENT among Pregnant women[20]–[22].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 52)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnant')]
PMC2582131	11/2008	S20-PMC2582131	['for instance, RECENT DATA among Pregnant women in northern united states INDICATED that Vitamin D deficiency occurred in 29.2% of black women and 5% of white women[23].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 73)]	2	[('GO_0007565', 'female pregnancy', 32, 'pregnant'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC2582131	11/2008	S21-PMC2582131	['data on the ROLE of Vitamin D in Glucose Homeostasis during Pregnancy and the development of Gestational Diabetes Mellitus (gdm) are SCANT and findings are INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_17234', 'glucose', 33, 'glucose'), ('GO_0042593', 'glucose homeostasis', 33, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('GO_0035193', 'larval central nervous system remodeling', 93, 'gestational diabetes mellitus')]
PMC2582131	11/2008	S54-PMC2582131	['we categorized Plasma 25-[Oh] D concentrations according to PREVIOUSLY published criteria for Vitamin D sufficiency (≥30 ng/ml), insufficiency (20–29 ng/ml) and deficiency (<20 ng/ml)[1].']	[('INCOMPLETE_EVIDENCE', 60)]	1	[('UBERON_0001969', 'blood plasma', 15, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 22, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC2582131	11/2008	S68-PMC2582131	['APPROXIMATELY 33% of gdm cases, COMPARED with 14% of controls ( p<0.001), had Plasma 25-[Oh] D concentrations CONSISTENT with a diagnosis of Vitamin D deficiency (<20 ng/ml))[1](table 2) .']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 32), ('INCOMPLETE_EVIDENCE', 110)]	3	[('UBERON_0001969', 'blood plasma', 78, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 85, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC2582131	11/2008	S79-PMC2582131	['the risk for gdm was highest for overweight women who were classified as being deficient for Vitamin D (25-[Oh] D<20 ng/ml in Pregnancy); they experienced an APPROXIMATELY 5-fold increased risk as compared with lean women of higher Plasma 25-[Oh] D levels (adjusted or\u200a=\u200a4.93, 95% ci 1.63–14.9) ( table 3 ).10.1371/journal.pone.0003753.t003\n\ncaption (table-wrap): table 3\nodds ratios (or) and 95% confidence intervals (ci) for Gestational diabetes (gdm) according to both maternal Plasma 25-Hydroxyvitamin D deficient status and pre-Pregnancy overweight status.Vitamin D deficiency*overweight**gdm casescontrolsunadjusted or (95% ci)adjusted1or (95% ci)(n\u200a=\u200a57)(n\u200a=\u200a114)nono22751.00 (referent)1.00 (referent)yesno792.65 (0.89–7.93)2.36 (0.75–7.43)noyes16232.37 (1.07–5.25)2.24 (0.99–5.08)yesyes1275.84 (2.05–16.6)4.93 (1.63–14.9) p value for interaction term0.930.93\nVitamin D deficiency is DEFINED as maternal Plasma 25-Hydroxyvitamin D concentrations <20 ng/ml (holick mf,[reference 1]).']	[('INCOMPLETE_EVIDENCE', 158), ('PROBABLE_UNDERSTANDING', 891)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_34300', '2-naphthoyl-CoA', 104, '25-[OH] D'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('UBERON_0001969', 'blood plasma', 232, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 239, '25-[OH] D'), ('GO_0007565', 'female pregnancy', 427, 'gestational'), ('UBERON_0001969', 'blood plasma', 481, 'plasma'), ('CHEBI_27844', "2',3'-cyclic AMP", 488, '25-Hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 533, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 561, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 867, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 911, 'plasma'), ('CHEBI_27844', "2',3'-cyclic AMP", 918, '25-Hydroxyvitamin D')]
PMC2582131	11/2008	S88-PMC2582131	['several mechanisms MAY EXPLAIN the OBSERVED ASSOCIATION between Vitamin D deficiency and gdm risk.']	[('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 23), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC2582131	11/2008	S89-PMC2582131	['first, Vitamin D MAY directly OR indirectly Modulate Pancreatic Β-Cell function and secretion by binding its circulating active form, 1,25-[Oh]D, to Β-Cell Vitamin D receptor and Regulating the balance between the Extracellular and Intracellular Β-Cell calcium pools[12],[30].']	[('INCOMPLETE_EVIDENCE', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30)]	2	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('GO_0065007', 'biological regulation', 44, 'modulate'), ('CL_0000173', 'pancreatic D cell', 53, 'pancreatic β-cell'), ('UBERON_0001264', 'pancreas', 53, 'pancreatic'), ('CHEBI_84441', '13(S)-HOTrE', 134, '1,25-[OH]D'), ('CL_0000623', 'natural killer cell', 149, 'β-cell'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0065007', 'biological regulation', 179, 'regulating'), ('GO_0005576', 'extracellular region', 214, 'extracellular'), ('GO_0005622', 'intracellular anatomical structure', 232, 'intracellular'), ('CL_0000623', 'natural killer cell', 246, 'β-cell')]
PMC2582131	11/2008	S90-PMC2582131	['second, Vitamin D CAN promote Insulin sensitivity by stimulating the Expression of Insulin receptors and enhancing Insulin responsiveness for Glucose transport.']	[('INCOMPLETE_EVIDENCE', 18)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('PR_000045358', 'insulin family protein', 30, 'insulin'), ('GO_0010467', 'gene expression', 69, 'expression'), ('PR_000045358', 'insulin family protein', 83, 'insulin'), ('PR_000045358', 'insulin family protein', 115, 'insulin'), ('CHEBI_17234', 'glucose', 142, 'glucose')]
PMC2582131	11/2008	S92-PMC2582131	['lastly, IT IS POSSIBLE that the OBSERVED inverse ASSOCIATION of Plasma 25-[Oh] D with gdm risk REFLECTS the IMPACT of other components of major endogenous and exogenous sources of Vitamin D on Glucose Homeostasis through OTHER pathways.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 95), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	6	[('UBERON_0001969', 'blood plasma', 64, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 71, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_17234', 'glucose', 193, 'glucose'), ('GO_0042593', 'glucose homeostasis', 193, 'glucose homeostasis')]
PMC2582131	11/2008	S95-PMC2582131	['data relating Vitamin D to the risk for gdm are SPARSE.']	[('INCOMPLETE_EVIDENCE', 48)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
PMC2582131	11/2008	S100-PMC2582131	['OUR FINDINGS are also GENERALLY CONSISTENT with a relatively large body of LITERATURE documenting a significant and inverse ASSOCIATION of circulating Vitamin D concentrations with measurements of glycemia or presence of type 2 dm among non-Pregnant women, ALTHOUGH the majority of THESE FINDINGS are based ON cross-sectional/RETROSPECTIVE data.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 22), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 124), ('ANOMALY_CURIOUS_FINDING', 257), ('INCOMPLETE_EVIDENCE', 282), ('ANOMALY_CURIOUS_FINDING', 307), ('INCOMPLETE_EVIDENCE', 326)]	9	[('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnant')]
PMC2582131	11/2008	S118-PMC2582131	['HOWEVER, DUE TO the PREDISPOSITION of asian, black, and hispanic women for Insulin resistance and Vitamin D deficiency, IT IS POSSIBLE that adequate Vitamin D status MAY BE even more IMPORTANT in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 166), ('IMPORTANT_CONSIDERATION', 183)]	6	[('PR_000045358', 'insulin family protein', 75, 'insulin'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC2582131	11/2008	S119-PMC2582131	['in CONCLUSION, OUR STUDY provides data INDICATING that maternal Vitamin D deficiency in early Pregnancy (i.e.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 39)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC2582131	11/2008	S121-PMC2582131	['such EVIDENCE is valuable in view of the LIMITED prospective DATA on the RELATION of circulating Vitamin D status to impaired Glucose tolerance in either Pregnant or non-Pregnant Individuals.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_17234', 'glucose', 126, 'glucose'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('GO_0007565', 'female pregnancy', 170, 'pregnant'), ('NCBITaxon_1', 'root', 179, 'individuals')]
PMC2582131	11/2008	S123-PMC2582131	['circulating Vitamin D CAN be modified by Food Consumption (e.g.']	[('INCOMPLETE_EVIDENCE', 22)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_33290', 'food', 41, 'food'), ('GO_0007631', 'feeding behavior', 41, 'food consumption')]
PMC2582131	11/2008	S125-PMC2582131	['intervention studies[14],[40]–[44]assessing the EFFECT of Vitamin D and Calcium supplements on Glucose Metabolism among non-Pregnant Individuals have yielded MIXED results, which is AT LEAST PARTLY DUE TO VARIATIONS in the dose of supplementation and the duration of follow up.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('PROBABLE_UNDERSTANDING', 182), ('INCOMPLETE_EVIDENCE', 191), ('PROBLEM_COMPLICATION', 198), ('DIFFICULT_TASK', 205)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 72, 'calcium'), ('CHEBI_17234', 'glucose', 95, 'glucose'), ('GO_0006006', 'glucose metabolic process', 95, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'pregnant'), ('NCBITaxon_1', 'root', 133, 'individuals')]
PMC2582131	11/2008	S127-PMC2582131	['IF CONFIRMED, our data RAISE the POSSIBILITY that treating Vitamin D deficiency in Pregnancy, via supplementation OR lifestyle measures, CAN CONTRIBUTE to the PREVENTION of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 3), ('EXPLICIT_QUESTION', 23), ('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 159)]	8	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC2722583	1/2009	S117-PMC2722583	['iron deficiency is an IMPORTANT RISK FACTOR for increased maternal mortality, low Birth weight and Preterm Delivery (brabin et al 2001) and the availability of calcium, Iodine, Folate and Vitamins A and D MAY Modulate fetal development (bartley et al 2005).']	[('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 205)]	3	[('GO_0007567', 'parturition', 82, 'birth'), ('GO_0007565', 'female pregnancy', 99, 'preterm'), ('GO_0007567', 'parturition', 107, 'delivery'), ('CHEBI_24859', 'iodine atom', 169, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 177, 'folate'), ('CHEBI_27300', 'vitamin D', 188, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 203, 'D'), ('GO_0065007', 'biological regulation', 209, 'modulate')]
PMC2722583	1/2009	S122-PMC2722583	['for example, the fact that Prenatal Folate supplementation substantially reduces the risk of Neural Tube defect ONLY IF it is taken Preconceptually is WELL KNOWN BUT improving Vitamin A status before Pregnancy HAS also BEEN SHOWN to have a dramatic and AS YET UNEXPLAINED EFFECT on maternal morbidity and mortality (west et al 1999).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 253), ('INCOMPLETE_EVIDENCE', 260), ('SUPERFICIAL_RELATIONSHIP', 272)]	8	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 36, 'folate'), ('UBERON_0001049', 'neural tube', 93, 'neural tube'), ('GO_0007608', 'sensory perception of smell', 132, 'preconceptually'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin A'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy')]
PMC2644268	3/2009	S96-PMC2644268	['EVIDENCE was provided that Sympathetic Nervous activity in Vitamin E-deficient Rats was greater than in control Animals (51).']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('UBERON_0000429', 'enteric plexus', 27, 'sympathetic nervous'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin E'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 79, 'rats'), ('NCBITaxon_33208', 'Metazoa', 112, 'animals')]
PMC2644268	3/2009	S98-PMC2644268	['another Rat study SUGGESTED that the Sympathetic Nervous System in Spleen and Heart were stimulated by Vitamin A deficiency (54).']	[('INCOMPLETE_EVIDENCE', 18)]	1	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 8, 'rat'), ('UBERON_0000013', 'sympathetic nervous system', 37, 'sympathetic nervous system'), ('UBERON_0002106', 'spleen', 67, 'spleen'), ('UBERON_0000948', 'heart', 78, 'heart'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin A')]
PMC2646054	3/2009	S185-PMC2646054	['experiments in hypercholesterolemic Rabbits HAVE SHOWN that administration of the antioxidant Vitamin E during Pregnancy resulted in reduced atherosclerotic lesions in the offspring (16,17), INDICATING that maternal oxidative stress LIKELY plays a ROLE in maternal programming for atherosclerosis.']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 191), ('PROBABLE_UNDERSTANDING', 233), ('SUPERFICIAL_RELATIONSHIP', 248)]	4	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 36, 'rabbits'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin E'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy')]
PMC2999828	3/2009	S235-PMC2999828	['numerous individual Nutrients consumed by the mother during Pregnancy HAVE BEEN SUGGESTED as being preventive for development of atopic diseases in the child; these include apples or fish,[80] Vitamin D,[107] Vitamin E,[108] and various Probiotics, the latter HAVING BEEN SHOWN to be effective in Mouse MODELS [109] and Human studies [110].']	[('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 260), ('INCOMPLETE_EVIDENCE', 303)]	4	[('CHEBI_33284', 'nutrient', 20, 'nutrients'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin E'), ('CHEBI_26346', 'prostaglandins J', 237, 'probiotics'), ('NCBITaxon_10088', 'Mus <genus>', 297, 'mouse'), ('NCBITaxon_9606', 'Homo sapiens', 320, 'human')]
PMC2777012	4/2009	S59-PMC2777012	['children with multiple Food allergies HAVE BEEN FOUND TO BE shorter than those with one Food allergy and to have less than adequate intakes of Calcium, Vitamin D, and Vitamin E [14].']	[('INCOMPLETE_EVIDENCE', 38), ('ANOMALY_CURIOUS_FINDING', 48)]	2	[('CHEBI_33290', 'food', 23, 'food'), ('CHEBI_33290', 'food', 88, 'food'), ('CHEBI_22313', 'alkaline earth metal atom', 143, 'calcium'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin E')]
PMC2679409	5/2009	S477-PMC2679409	['given the POTENTIAL Teratogenic EFFECT and toxicity of high-dose Vitamin A, a variety of Vitamin A INTERVENTIONS (daily supplementation with either low-dose Vitamin A or Β-Carotene) HAVE BEEN evaluated with assessment of SAFETY and IMPACT on maternal, newborn and infant outcomes.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 99), ('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 221), ('SUPERFICIAL_RELATIONSHIP', 232)]	6	[('CHEBI_50905', 'teratogenic agent', 20, 'teratogenic'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 170, 'β-carotene')]
PMC2679409	5/2009	S483-PMC2679409	['[96] performed a cochrane review of 5 trials of women who had received Vitamin A in Pregnancy (n = 23,426), but ONLY one study [101], REPORTED Perinatal mortality [loe: 1+] (additional file12).']	[('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 134)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin A'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('GO_0036268', 'swimming', 143, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 143, 'perinatal')]
PMC2679409	5/2009	S488-PMC2679409	['[87] yielded SIMILAR FINDINGS on the risk of stillbirth ASSOCIATED with Vitamin A supplementation (rr = 1.26, 95% ci: 0.53, 3.01) [loe: 1++] (additional file13).']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('CHEBI_27300', 'vitamin D', 72, 'vitamin A')]
PMC2679409	5/2009	S497-PMC2679409	['conclusion\nthe existence of a cochrane review on the subject and several strong rcts allow us to rate the level of evidence as grade c [96], BUT the AVAILABLE EVIDENCE SUGGESTS no ROLE of Vitamin A in PREVENTING stillbirths.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 180), ('SUPERFICIAL_RELATIONSHIP', 201)]	5	[('CHEBI_27300', 'vitamin D', 188, 'vitamin A')]
PMC2679409	5/2009	S499-PMC2679409	['the largest rct reporting the IMPACT of Vitamin A on stillbirths [101] also INDICATES no benefit of vitamin a for fetal or early infant survival, ALTHOUGH vitamin a does APPEAR TO BE of benefit to maternal health and survival, and Vitamin A deficiencies are KNOWN to CO-exist with iron deficiency [98].']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 76), ('ANOMALY_CURIOUS_FINDING', 146), ('ANOMALY_CURIOUS_FINDING', 170), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin A')]
PMC2685863	5/2009	S1-PMC2685863	['dietary Vitamin D intake HAS BEEN ASSOCIATED with lower ms risk, and Vitamin D deficiency HAS BEEN ASSOCIATED with INCREASED RISK, BUT direct LINKS between Vitamin D and ms have NOT BEEN IDENTIFIED.']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 99), ('IMPORTANT_CONSIDERATION', 115), ('ANOMALY_CURIOUS_FINDING', 131), ('SUPERFICIAL_RELATIONSHIP', 142), ('FULL_UNKNOWN', 178)]	8	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC2685863	5/2009	S2-PMC2685863	['a team of canadian and british researchers has now REPORTED EVIDENCE that Vitamin D INTERACTS with a variant form of the Hla-Drb1 Gene, which HAS BEEN ASSOCIATED with ms.\nas REPORTED in the 6 february 2009 issue of the online journal plos genetics , study leader george ebers, a clinical neurologist at the university of oxford, united kingdom, and colleagues examined cells with two copies of the Hla-Drb*15 form of Hla-Drb1 .']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151), ('INCOMPLETE_EVIDENCE', 174)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 121, 'HLA-DRB1'), ('SO_0000704', 'gene', 130, 'gene'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 398, 'HLA-DRB'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 417, 'HLA-DRB1')]
PMC2685863	5/2009	S3-PMC2685863	['they IDENTIFIED a Vitamin D response element (vdre)—a short stretch of dna that is a signature of Genes Regulated by Vitamin D—next to the Gene.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('SO_0000704', 'gene', 98, 'genes'), ('GO_0065007', 'biological regulation', 104, 'regulated'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('SO_0000704', 'gene', 139, 'gene')]
PMC2685863	5/2009	S5-PMC2685863	['the researchers also SHOWED that the vdre sequence FOUND in People with Hla-Drb1*15 could bind to the Vitamin D receptor, and that the hla-Drb1 Gene responded more strongly to Vitamin D in cells with the Hla-Drb1*15 vdre sequence than in cells without it.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 51)]	2	[('NCBITaxon_10088', 'Mus <genus>', 60, 'people'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 72, 'HLA-DRB1'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 139, 'DRB1'), ('SO_0000704', 'gene', 144, 'gene'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 204, 'HLA-DRB1')]
PMC2685863	5/2009	S6-PMC2685863	['“this is the FIRST DIRECT EVIDENCE that Vitamin D Regulates the Gene,” says ebers.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0065007', 'biological regulation', 50, 'regulates'), ('SO_0000704', 'gene', 64, 'gene')]
PMC2685863	5/2009	S8-PMC2685863	['the next step is determining HOW Vitamin D and Hla-Drb1*15 MIGHT INTERACT to Modulate the Autoimmune nature of ms. epidemiologic and Animal studies of ms POINT TO involvement of the Thymus Gland early in development.']	[('EXPLICIT_QUESTION', 29), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 154)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 47, 'HLA-DRB1'), ('GO_0065007', 'biological regulation', 77, 'modulate'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('NCBITaxon_33208', 'Metazoa', 133, 'animal'), ('UBERON_0002370', 'thymus', 182, 'thymus gland')]
PMC2685863	5/2009	S12-PMC2685863	['the researchers REASON that a lack of Vitamin D in the Thymus in early Life COULD limit this process, THUS enabling “self-directed” T Cells to survive and trigger an Autoimmune response to the Myelin Sheath on Nerve Fibers—a classic feature of ms.']	[('PROBABLE_UNDERSTANDING', 16), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 102)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0002370', 'thymus', 55, 'thymus'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('CL_0000084', 'T cell', 132, 'T cells'), ('UBERON_0001442', 'skeleton of manus', 166, 'autoimmune'), ('UBERON_0000347', 'entire myelin sheath', 193, 'myelin sheath'), ('UBERON_0006134', 'nerve fiber', 210, 'nerve fibers')]
PMC2685863	5/2009	S13-PMC2685863	['the authors PROPOSE that Vitamin D supplementation at CRITICAL periods during Pregnancy and early childhood MIGHT reduce the RISK for developing ms—a VIEW endorsed by bruce hollis, a nutritional biochemist and professor of pediatrics at the medical university of south carolina.']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 54), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 125), ('INCOMPLETE_EVIDENCE', 150)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy')]
PMC2685863	5/2009	S14-PMC2685863	['WHEREAS the institute of medicine RECOMMENDS 200 international units of Vitamin D per day (iu/day) for People under age 50, including Pregnant and Lactating women and infants, hollis wrote in the december 2007 issue of the journal of bone and Mineral research that as much as 6,000 iu/day MIGHT be NEEDED to maintain adequate Blood levels of the Vitamin in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 34), ('INCOMPLETE_EVIDENCE', 289), ('FUTURE_WORK', 298), ('IMPORTANT_CONSIDERATION', 298)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 103, 'people'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('GO_0007594', 'puparial adhesion', 147, 'lactating'), ('CHEBI_46662', 'mineral', 243, 'Mineral'), ('UBERON_0000178', 'blood', 326, 'blood'), ('CHEBI_33229', 'vitamin (role)', 346, 'vitamin')]
PMC2716336	7/2009	S64-PMC2716336	['currently, the ear cut-offs that are based on the chinese nutrition society dietary reference intakes (dris) CAN be used to assess the prevalence of inadequate Nutrient intakes of zinc, selenium, Vitamin A, Vitamin D, Thiamine, riboflavin, Vitamin C and Folate.']	[('INCOMPLETE_EVIDENCE', 109)]	1	[('CHEBI_33284', 'nutrient', 160, 'nutrient'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('CHEBI_26948', 'vitamin B1', 218, 'thiamine'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin C'), ('CHEBI_30863', '5-azaorotic acid', 254, 'folate')]
PMC2716336	7/2009	S129-PMC2716336	['furthermore, SOME calculated Nutrient intakes, such as Selenium, Folate, and Vitamin C MAY BE less stable and altered by different Food preservation, processing and cooking methods used in different parts of china [34].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 87)]	2	[('CHEBI_33284', 'nutrient', 29, 'nutrient'), ('CHEBI_27568', 'selenium atom', 55, 'selenium'), ('CHEBI_30863', '5-azaorotic acid', 65, 'folate'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin C'), ('CHEBI_33290', 'food', 131, 'food')]
PMC2716336	7/2009	S135-PMC2716336	['HOWEVER, the study population Consumed less Retinol, total Vitamin E and zinc, SOME of which MAY BE EXPLAINED by the lower intake of meat.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 100)]	4	[('GO_0007631', 'feeding behavior', 30, 'consumed'), ('CHEBI_26536', 'retinoic acid', 44, 'retinol'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin E')]
PMC2716336	7/2009	S161-PMC2716336	['we FOUND that 34% of our subjects failed to meet the ear for Vitamin C, UNLIKE the relatively high percentage of inadequate intake of OTHER Nutrients such as riboflavin, Folate.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin C'), ('CHEBI_33284', 'nutrient', 140, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 170, 'folate')]
PMC2716336	7/2009	S166-PMC2716336	['HOWEVER, significant differences were FOUND in calcium, iron, zinc, riboflavin and Vitamin C intakes across the various subgroups of household wealth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 38)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin C')]
PMC2716336	7/2009	S169-PMC2716336	['we FOUND seasonal variations in the Intake of energy, protein, calcium, riboflavin and Vitamin C by Pregnant women.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('GO_0007631', 'feeding behavior', 36, 'intake'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin C'), ('GO_0007565', 'female pregnancy', 100, 'pregnant')]
PMC4516488	9/2009	S187-PMC4516488	['Pea-15 is also on the list of about 50 differentially Expressed Genes in the Mouse Brain REVEALED by two-dimensional gel electrophoresis in a MODEL of developmental Vitamin D deficiency [44].']	[('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 142)]	2	[('PR_000001904', 'platelet endothelial cell adhesion molecule', 0, 'PEA-15'), ('GO_0010467', 'gene expression', 54, 'expressed'), ('SO_0000704', 'gene', 64, 'genes'), ('NCBITaxon_10088', 'Mus <genus>', 77, 'mouse'), ('UBERON_0000955', 'brain', 83, 'brain'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
PMC4516488	9/2009	S188-PMC4516488	['ALTHOUGH this FINDING WAS NOT discussed or followed-up, it is IN LINE WITH the Vitamin D dependency of Pea-15 OUTLINED in OUR STUDY.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 110), ('QUESTION_ANSWERED_BY_THIS_WORK', 122)]	6	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_39015', 'apolipoprotein', 103, 'PEA'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 103, 'PEA-15')]
PMC2779500	11/2009	S42-PMC2779500	['for example, ALTHOUGH reduced mortality HAS BEEN SHOWN in hiv-positive children receiving Vitamin A supplementation [30], the administration of Vitamin A supplements to women has BEEN IMPLICATED in increased Vaginal Viral shedding (no effect on risk was observed from Vitamins B, C, and E) [31], a heightened risk of Mother-To-Child Hiv Transmission [32], and hastened progression of child mortality [30].']	[('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 40), ('ANOMALY_CURIOUS_FINDING', 179), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin A'), ('UBERON_0001987', 'placenta', 208, 'vaginal'), ('NCBITaxon_1', 'root', 216, 'viral'), ('CHEBI_27300', 'vitamin D', 268, 'vitamins B'), ('PR_000000037', 'BMP receptor type-2', 277, 'B'), ('CHEBI_18245', 'carboxylato group', 280, 'C'), ('PR_000004900', 'complement C3', 280, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 287, 'E'), ('GO_0048870', 'cell motility', 317, 'mother-to-child'), ('GO_0007228', 'positive regulation of hh target transcription factor activity', 333, 'HIV transmission')]
PMC2779500	11/2009	S43-PMC2779500	['in addition, high doses of Vitamin C supplementation HAVE BEEN SHOWN to reduce the bioavailability of the protease Inhibitor, Indinavir [33].']	[('INCOMPLETE_EVIDENCE', 53)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin C'), ('CHEBI_35222', 'inhibitor', 115, 'inhibitor'), ('CHEBI_44032', 'indinavir', 126, 'indinavir')]
PMC2779500	11/2009	S44-PMC2779500	['THESE FINDINGS, among others, UNDOUBTEDLY necessitate CONCERN, and have led authors to QUESTION the benefits of universal Vitamin A supplementation for women in hiv-endemic areas [30,31].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 30), ('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 54), ('EXPLICIT_QUESTION', 87)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
PMC2779500	11/2009	S46-PMC2779500	['[31] maintain that Prenatal supplementation of Vitamins B, C, and e SHOULD BE continued DUE TO their MANY REPORTED positive EFFECTS on maternal and fetal health.']	[('FUTURE_WORK', 68), ('PROBABLE_UNDERSTANDING', 88), ('PROBLEM_COMPLICATION', 88), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('GO_0007565', 'female pregnancy', 19, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamins B'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 47, 'vitamins B'), ('CHEBI_18245', 'carboxylato group', 59, 'C'), ('PR_000004900', 'complement C3', 59, 'C')]
PMC2779500	11/2009	S58-PMC2779500	['lower Serum concentrations of Vitamin A, compared with hiv-negative idus, HAVE also BEEN OBSERVED [35].']	[('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 89)]	2	[('UBERON_0001977', 'blood serum', 6, 'serum'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin A')]
PMC2779500	11/2009	S63-PMC2779500	['after six consecutive months of treatment, it was FOUND that patients in groups hiv(-) and hiv(+)P had significantly lower Blood Plasma concentrations of Vitamins A, c and e than the control group, while Individuals in the hiv(+)v group had levels characteristic of the control group.']	[('INCOMPLETE_EVIDENCE', 50)]	1	[('CHEBI_53758', 'PAP', 97, 'P'), ('UBERON_0000178', 'blood', 123, 'blood'), ('UBERON_0001969', 'blood plasma', 129, 'plasma'), ('CHEBI_27300', 'vitamin D', 154, 'vitamins A'), ('NCBITaxon_1', 'root', 204, 'individuals')]
PMC2779500	11/2009	S118-PMC2779500	['moreover, SINCE Ascorbic Acid (Vitamin C) HAS BEEN cited as a KEY H2O2Scavenging antioxidant [40], we use it as our antioxidant for the purpose of parameter estimation.']	[('PROBLEM_COMPLICATION', 10), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 62)]	3	[('CHEBI_22652', 'ascorbic acid', 16, 'ascorbic acid'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin C'), ('CHEBI_74359', 'L-alpha-aminobutyrate zwitterion', 66, 'H2O2scavenging')]
PMC2779500	11/2009	S127-PMC2779500	['literature ESTIMATES forand λa\nit HAS BEEN RECOMMENDED that dietary Vitamin C intake for all Individuals exceed 200 mg per day [41].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 34), ('FUTURE_WORK', 43)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin C'), ('NCBITaxon_1', 'root', 93, 'individuals')]
PMC2779500	11/2009	S130-PMC2779500	['IN ORDER TO account for the fact that injection Drug users (idus) MAY have a smaller Vitamin C intake, we set the amount of dietary Vitamin C absorbed in groups hiv(-), hiv(+)p and hiv(+)v to be 80 mg/day which yields λa= 2.74 × 1013molecules μ l-1day-1.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 66)]	2	[('CHEBI_23888', 'drug', 48, 'drug'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin C')]
PMC2779500	11/2009	S175-PMC2779500	['we include the unstable equilibrium point of the hiv(+)v group at a total Vitamin C supplementation level of APPROXIMATELY 116 mg/day.']	[('INCOMPLETE_EVIDENCE', 109)]	1	[('CHEBI_27300', 'vitamin D', 74, 'vitamin C')]
PMC2779500	11/2009	S327-PMC2779500	['this outcome is ANECDOTAL and highly DEPENDENT upon the amount of Vitamin C absorbed; HOWEVER, it ILLUSTRATES the POTENTIAL sensitivity of clinical results to the details of measurement timing.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 114)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin C')]
PMC2831604	1/2010	S79-PMC2831604	["the POTENTIAL for adverse events on medium to high dose ics is USUALLY LIMITED to a small reduction in growth velocity of approximately 1 cm in the first year of treatment which is not progressive over time and can be measured by a stadiometer.20,21\nin children who are REQUIRED to receive high dose Corticosteroids, age appropriate dietary Intake of Calcium and Vitamin D SHOULD BE reviewed with the child's care givers (evidence d) and slit lamp Eye examination and bone densitometry SHOULD BE CONSIDERED (evidence d)."]	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 270), ('FUTURE_WORK', 373), ('FUTURE_WORK', 486), ('IMPORTANT_CONSIDERATION', 486), ('FUTURE_WORK', 496)]	8	[('CHEBI_50850', 'etabonate ester', 300, 'corticosteroids'), ('GO_0007631', 'feeding behavior', 341, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 351, 'calcium'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('UBERON_0000970', 'eye', 448, 'eye')]
PMC4188019	1/2010	S2-PMC4188019	['OBJECTIVES : THIS was a PRELIMINARY EXPLORATION of the Vitamin D status in Pregnant women visiting the Antenatal clinic in the antwerp university hospital.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 36)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnant'), ('GO_0007567', 'parturition', 103, 'antenatal'), ('UBERON_0001760', 'frontal sinus', 103, 'antenatal')]
PMC4188019	1/2010	S20-PMC4188019	['in vitro studies have SUGGESTED a PROTECTIVE EFFECT of 25-Oh Vitamin D against malignancies such as Breastcancer and cancer of the Colon.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 55, '25-OH'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0000110', 'neurula stage', 100, 'breastcancer'), ('UBERON_0001155', 'colon', 131, 'colon')]
PMC4188019	1/2010	S61-PMC4188019	['when we ONLY compare covered versus non-covered groups, there are significantly more covered than non-covered women with a concentration of Vitamin D lower than 30\u2008ng/ml (odds ratio 6,2; 95% ci: 1,8-21,7; p\u2008<\u20080,05).']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4188019	1/2010	S63-PMC4188019	['this SUGGESTS a widespread SHORTAGE of Vitamin D in our population, 1,75% was suffering from SEVERE deficiency, 9,9% had moderate deficiency and 18,1% had mild deficiency.']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 93)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4188019	1/2010	S66-PMC4188019	['with NEW date on the ROLE of Vitamin D besides bone Metabolism, SOME authors are PLEADING for higher cut-off values to determine deficiency (norman et al., 2007; sachan et al., 2005; wagner et al., 2008).']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 81), ('IMPORTANT_CONSIDERATION', 81)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0008152', 'metabolic process', 52, 'metabolism')]
PMC4188019	1/2010	S72-PMC4188019	['this fact is CONFIRMED in our pilot study: no significant difference in Vitamin D levels between women taking Supplements and those who did not.']	[('INCOMPLETE_EVIDENCE', 13)]	1	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 110, 'supplements')]
PMC4188019	1/2010	S78-PMC4188019	['HENCE, their lower Vitamin D levels MIGHT not be only ATTRIBUTABLE to wearing Head/body cover but also to poor dietary Intake.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 36), ('PROBABLE_UNDERSTANDING', 54)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0000033', 'head', 78, 'head'), ('GO_0007631', 'feeding behavior', 119, 'intake')]
PMC4188019	1/2010	S80-PMC4188019	['AS this was a pilot STUDY, we ONLY measured 25-Oh Vitamin D. in the FUTURE, we will start including other RELEVANT parameters such as medical history, Serum levels of calcium and Parathyroid hormone.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 44, '25-OH'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0001977', 'blood serum', 151, 'serum'), ('UBERON_0001132', 'parathyroid gland', 179, 'parathyroid')]
PMC4188019	1/2010	S81-PMC4188019	['conclusion\nlow Vitamin D levels are frequently FOUND in Pregnancy but the optimal Serum concentration REMAINS UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 47), ('FULL_UNKNOWN', 102)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnancy'), ('UBERON_0001977', 'blood serum', 82, 'serum')]
PMC4188019	1/2010	S83-PMC4188019	['in THIS PILOT STUDY, we FOUND that low Vitamin D levels in the antwerp population are frequent and that there is an EFFECT of the seasonal moment of the year and degree of sun exposure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 116)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC2821652	2/2010	S19-PMC2821652	['at the time of Birth, Cord Blood AS a direct reflection of fetal Vitamin D status will contain APPROXIMATELY 50–60% of the maternal circulating levels of 25(Oh)D. this RELATIONSHIP APPEARS TO BE linear EVEN at Pharmacological intakes of Vitamin D [12].']	[('PROBABLE_UNDERSTANDING', 33), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 181), ('ANOMALY_CURIOUS_FINDING', 202)]	5	[('GO_0007567', 'parturition', 15, 'birth'), ('UBERON_0009472', 'axilla', 22, 'cord blood'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D'), ('CHEBI_52217', 'pharmaceutical', 210, 'pharmacological'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC2821652	2/2010	S20-PMC2821652	['with respect to the more Polar Metabolites of Vitamin D, a SIMILAR (BUT lesser) RELATIONSHIP is OBSERVED between mother and fetus [11].']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 96)]	5	[('CHEBI_37173', 'silanol', 25, 'polar'), ('CHEBI_25212', 'metabolite', 31, 'metabolites'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC2821652	2/2010	S21-PMC2821652	['INTERESTINGLY, there APPEARS TO BE LITTLE, if ANY, RELATIONSHIP with respect to the parent Vitamin, Vitamin D [11].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 35), ('IMPORTANT_CONSIDERATION', 46), ('SUPERFICIAL_RELATIONSHIP', 51)]	5	[('CHEBI_33229', 'vitamin (role)', 91, 'vitamin'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC2821652	2/2010	S22-PMC2821652	['this lack of Placental transfer of the parent Vitamin D from mother to fetus also HAS BEEN observed in a Porcine experimental Animal MODEL [13].']	[('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 133)]	2	[('UBERON_0001987', 'placenta', 13, 'placental'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 105, 'porcine'), ('NCBITaxon_33208', 'Metazoa', 126, 'animal')]
PMC2821652	2/2010	S29-PMC2821652	['DESPITE an expanding Intravascular volume during Pregnancy, maternal Vitamin D status SHOWS seasonal variation but beyond the typical FACTORS that INFLUENCE Vitamin D status in Adults (such as sunlight exposure and bmi), Vitamin D status does not fluctuate during Pregnancy and once supplemented, maternal Blood levels reach steady-state within 2 months [15].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 134), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('GO_0005622', 'intracellular anatomical structure', 21, 'intravascular'), ('GO_0007565', 'female pregnancy', 49, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('UBERON_0007023', 'adult organism', 177, 'adults'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 264, 'pregnancy'), ('UBERON_0000178', 'blood', 306, 'blood')]
PMC2821652	2/2010	S30-PMC2821652	['these aspects of Calcium and Vitamin D Metabolism are IMPORTANT in the understanding of Vitamin D sufficiency during Pregnancy and the PREMISE that the REQUIREMENTS of Vitamin D are stable throughout Gestation.']	[('IMPORTANT_CONSIDERATION', 54), ('INCOMPLETE_EVIDENCE', 135), ('IMPORTANT_CONSIDERATION', 152)]	3	[('GO_0051216', 'cartilage development', 17, 'calcium ...'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 29, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007565', 'female pregnancy', 200, 'gestation')]
PMC2821652	2/2010	S31-PMC2821652	['EXISTING guidelines RECOMMEND that Pregnant women receive 400\u2009iu of Vitamin D per day via an oral supplement [17,18].']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 20)]	2	[('GO_0007565', 'female pregnancy', 35, 'pregnant'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC2821652	2/2010	S34-PMC2821652	['WHILE rickets HAS BEEN traditionally THOUGHT TO be the main sequelae of Vitamin D deficiency, numerous OTHER long-latency disease states (such as multiple sclerosis [23–25], rheumatoid arthritis [26–29], type 1 and 2 diabetes [30–34], Cardiovascular disease [35,36], various cancers [37–43], and systemic lupus erythematosus [44], to name BUT a few) as well as acute infections such as Upper Respiratory illnesses [45] and tuberculosis [46,47] are now LINKED with Vitamin D deficiency that are EXPLAINED by alterations in Immune function [47–49].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 339), ('SUPERFICIAL_RELATIONSHIP', 452), ('PROBABLE_UNDERSTANDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 235, 'cardiovascular'), ('UBERON_0001154', 'vermiform appendix', 386, 'upper respiratory'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0002405', 'immune system', 522, 'immune')]
PMC2821652	2/2010	S36-PMC2821652	['studies are currently UNDERWAY to determine the optimum supplementation dose of Vitamin D among Pregnant women (clinicaltrials.gov: nct00412087 and nct00292591).']	[('INCOMPLETE_EVIDENCE', 22)]	1	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnant')]
PMC2821652	2/2010	S74-PMC2821652	['WHILE there is a MODEL in existence which calculates the predicted change in Serum 25(Oh)D for different doses of Vitamin D supplement, this model was developed using data from men [64], and its applicability to a population of Pregnant females is debatable.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17)]	2	[('UBERON_0001977', 'blood serum', 77, 'serum'), ('CHEBI_71657', 'versiconol acetate', 83, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 83, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 228, 'pregnant')]
PMC2821652	2/2010	S77-PMC2821652	["in developing a definition of adherence by Serum 25(Oh)D levels, SEVERAL ASSUMPTIONS were made a priori about WHAT types of PATTERNS of 25(Oh)D levels would be exhibited by adherent and nonadherent patients BASED ON CURRENT KNOWLEDGE about the Metabolism Of Vitamin D.\nassumption 1\nBASED ON KNOWN pharmacokinetics of Vitamin D [64], adherent patients' 25(Oh)D levels would be expected to rise over time, eventually reaching a steady state after 2 months of therapy; nonadherent patients' 25(Oh)D levels would be expected to be erratic and to exhibit variable PATTERNS that would differ significantly from adherent patients' 25(Oh)D levels over the same dosing interval."]	[('INCOMPLETE_EVIDENCE', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('EXPLICIT_QUESTION', 110), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 207), ('PROBABLE_UNDERSTANDING', 207), ('SUPERFICIAL_RELATIONSHIP', 207), ('INCOMPLETE_EVIDENCE', 216), ('PROBABLE_UNDERSTANDING', 282), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 291), ('SUPERFICIAL_RELATIONSHIP', 559)]	12	[('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 49, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 142, 'D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 244, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 317, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 325, 'D'), ('CHEBI_71657', 'versiconol acetate', 352, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 358, 'D'), ('CHEBI_71657', 'versiconol acetate', 488, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 488, '25'), ('PR_000011614', 'opioid growth factor receptor', 491, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 494, 'D'), ('CHEBI_71657', 'versiconol acetate', 624, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 624, '25(OH ... D')]
PMC2841444	2/2010	S11-PMC2841444	['the following are SUPPORTED by moderate- to high-quality evidence and STRONGLY RECOMMENDED for lmics:\n• two INTERVENTIONS PREVENT Preterm Births—smoking cessation and Progesterone\n• eight INTERVENTIONS PREVENT stillbirths—balanced protein energy supplementation, screening and treatment of syphilis, intermittant presumptive treatment for malaria during Pregnancy, Insecticide-treated mosquito nets, Birth preparedness, emergency obstetric care, cesarean section for breech presentation, and elective induction for post-term Delivery\n• eleven INTERVENTIONS improve survival of Preterm newborns—prophylactic Steroids in Preterm labor, Antibiotics for prom, Vitamin K supplementation at Delivery, case management of neonatal sepsis and pneumonia, delayed Cord clamping, room air (vs. 100% oxygen) for resuscitation, hospital-based kangaroo mother care, early breastfeeding, thermal care, and Surfactant therapy and application of continued distending pressure to the Lungs for Respiratory Distress syndrome\n\nconclusion\nthe research paradigm for discovery science and intervention development MUST BE BALANCED to address PREVENTION as well as improve morbidity and mortality in all settings.']	[('INCOMPLETE_EVIDENCE', 18), ('PROBABLE_UNDERSTANDING', 70), ('FUTURE_WORK', 79), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 543), ('IMPORTANT_CONSIDERATION', 1090), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1098), ('SUPERFICIAL_RELATIONSHIP', 1118)]	11	[('GO_0007565', 'female pregnancy', 130, 'preterm births'), ('CHEBI_17026', 'progesterone', 167, 'progesterone'), ('GO_0007565', 'female pregnancy', 354, 'pregnancy'), ('CHEBI_24852', 'insecticide', 365, 'insecticide'), ('GO_0007567', 'parturition', 400, 'birth'), ('GO_0007567', 'parturition', 525, 'delivery'), ('GO_0007565', 'female pregnancy', 577, 'preterm'), ('CHEBI_35341', 'steroid', 607, 'steroids'), ('GO_0007565', 'female pregnancy', 619, 'preterm'), ('CHEBI_33282', 'antibacterial agent', 634, 'antibiotics'), ('CHEBI_27300', 'vitamin D', 656, 'vitamin K'), ('GO_0007567', 'parturition', 685, 'delivery'), ('UBERON_0002240', 'spinal cord', 753, 'cord'), ('CHEBI_35195', 'surfactant', 890, 'surfactant'), ('UBERON_0002048', 'lung', 965, 'lungs'), ('UBERON_0003495', 'respiratory system arteriole', 975, 'respiratory distress')]
PMC2841444	2/2010	S484-PMC2841444	['the RECENT lancet nutrition series IDENTIFIED neonatal Vitamin A supplementation in south asia were ASSOCIATED with a significant reduction in infant mortality at 6 months [245].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 100)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin A')]
PMC2841444	2/2010	S485-PMC2841444	['from these RECENT trials of neonatal Vitamin A supplementation, it was possible to obtain separate data for preterm infants from three rcts [246-248].']	[('INCOMPLETE_EVIDENCE', 11)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A')]
PMC2841444	2/2010	S499-PMC2841444	['although the quality of the trials is variable and FURTHER STUDIES ARE NEEDED, these data SUGGEST a POSSIBLE ROLE for Antenatal maternal Vitamin K administration as a means of reducing RISKS of pvh and mortality in preterm infants.']	[('FUTURE_WORK', 51), ('FUTURE_WORK', 59), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 185)]	6	[('GO_0007567', 'parturition', 118, 'antenatal'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin K')]
PMC2841444	2/2010	S500-PMC2841444	['EVIDENCE SUPPORTING the use of injectable Vitamin K (Phytomenadione) shortly after Birth to prevent hemorrhage-RELATED morbidity and mortality was accumulated before rcts were widely adopted, being based on observational studies.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin K'), ('CHEBI_71323', 'alpha-D-GlcpNAc-(1->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc', 53, 'phytomenadione'), ('GO_0007567', 'parturition', 83, 'birth')]
PMC2841444	2/2010	S501-PMC2841444	['the STRONGEST EVIDENCE from high-income countries comes from periods in which CONCERNS about the SAFETY of Vitamin K led to its reduced use in newborns; these periods were followed by increased incidence of hemorrhagic disorders [252].']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 78), ('IMPORTANT_CONSIDERATION', 97)]	3	[('CHEBI_27300', 'vitamin D', 107, 'vitamin K')]
PMC2841444	2/2010	S503-PMC2841444	['DUE TO ethical REASONS RECENT RCTS DID NOT include a placebo group, but compared DIFFERENT treatment modes, using Vitamin K status as the primary outcome.']	[('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin K')]
PMC3257641	3/2010	S0-PMC3257641	['Vitamin D status during Pregnancy and aspects of offspring health\n\nabstract\nlow maternal Vitamin D levels during Pregnancy HAVE BEEN LINKED to various health outcomes in the offspring, ranging from periconceptional EFFECTS to diseases of Adult onset.']	[('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 133), ('SUPERFICIAL_RELATIONSHIP', 215)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 24, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('UBERON_0007023', 'adult organism', 238, 'adult')]
PMC3257641	3/2010	S4-PMC3257641	['the EVIDENCE to date SUPPORTS that women SHOULD BE monitored and treated for Vitamin D deficiency during Pregnancy BUT OPTIMAL and upper limit Serum 25(Oh)D levels during Pregnancy are NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('IMPORTANT_CONSIDERATION', 119), ('FULL_UNKNOWN', 185)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'pregnancy'), ('UBERON_0001977', 'blood serum', 143, 'serum'), ('CHEBI_71657', 'versiconol acetate', 149, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 149, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
PMC3257641	3/2010	S5-PMC3257641	['1. review\nthe high PREVALENCE of Vitamin D insufficiency during Pregnancy is increasingly RECOGNIZED, amid GROWING EVIDENCE that the Intrauterine environment CAN have both immediate and long-lasting EFFECTS on health of the offspring.']	[('IMPORTANT_CONSIDERATION', 19), ('PROBABLE_UNDERSTANDING', 90), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 199)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('UBERON_0022293', 'reproductive gland secretion', 133, 'intrauterine')]
PMC3257641	3/2010	S6-PMC3257641	['in THIS REVIEW, we OUTLINE the RESEARCH EVIDENCE TO DATE RELATING to Vitamin D status and Pregnancy, including a range of POSSIBLE health outcomes from pre-Conception to later Life (figure 1).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 122)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007620', 'copulation', 156, 'conception'), ('UBERON_0000104', 'life cycle', 176, 'life')]
PMC3257641	3/2010	S8-PMC3257641	['caption (fig): figure 1\n\nmanifestation of reviewed POSSIBLE major outcomes RELATED to Vitamin D status at different Life Stages.']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000104', 'life cycle', 116, 'life stages')]
PMC3257641	3/2010	S13-PMC3257641	['dietary Vitamin D MAY BE in the form of Vitamin D2(Ergocalciferol), derived from Plants, OR Vitamin D3, sourced from fatty fish such as salmon, Sardines and mackerel and, to a certain extent, Egg Yolks [3].']	[('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_28934', 'vitamin D2', 40, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 40, 'vitamin D2'), ('CHEBI_4910', 'etomidate', 51, 'ergocalciferol'), ('NCBITaxon_10088', 'Mus <genus>', 81, 'plants'), ('CHEBI_33279', 'vitamin D5', 92, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 92, 'vitamin D3'), ('UBERON_2000442', 'supraneural bone', 144, 'sardines'), ('UBERON_0005079', 'eggshell', 192, 'egg yolks')]
PMC3257641	3/2010	S41-PMC3257641	['for any uv-b level, Vitamin D synthesis is then DEPENDENT on the amount of skin exposed, skin pigmentation, use of sun protection such as shade, sunscreen and POSSIBLY other physical or host-related FACTORS [29,30].']	[('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC3257641	3/2010	S42-PMC3257641	['as for OTHER population groups, Pregnant women living at high latitude and low altitude, with dark skin pigmentation or skin USUALLY covered by clothing will be at increased risk of Vitamin D deficiency [31,32], UNLESS dietary intake is high (table 1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 212)]	3	[('GO_0007565', 'female pregnancy', 32, 'pregnant'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC3257641	3/2010	S43-PMC3257641	['furthermore, SINCE 25(Oh)D is stored in Adipose Tissue, there is SOME EVIDENCE that obesity is a FURTHER RISK FACTOR for Vitamin D insufficiency.nutrients-02-00389-t001_table 1\n\ncaption (table-wrap): table 1\n\nrisk factors for Vitamin D deficiency.low ambient uvr level high latitude locationwinter season inadequate sun exposure built or indoor environmentextensive clothing cover (e.g., veiled)excess sun avoidance – (shade, sunscreen) host factors dark skin pigmentationold ageobesitymalabsorptive syndromes (e.g., inflammatory Bowel disease)\nMANY STUDIES HAVE REPORTED on the Vitamin D status of Pregnant women, in a range of environments (summarized intable 2, including studies from 1997–2006).']	[('PROBLEM_COMPLICATION', 13), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 545), ('INCOMPLETE_EVIDENCE', 558)]	6	[('CHEBI_71657', 'versiconol acetate', 19, '25(OH)D'), ('UBERON_0001013', 'adipose tissue', 40, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0000160', 'intestine', 530, 'bowel'), ('CHEBI_27300', 'vitamin D', 579, 'vitamin D'), ('GO_0007565', 'female pregnancy', 599, 'pregnant')]
PMC3257641	3/2010	S44-PMC3257641	['AS EXPECTED, Vitamin D deficiency is PARTICULARLY common in darkly Pigmented mothers, PARTICULARLY among those who have migrated to regions with lower ambient uvr than their evolutionary heritage.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 37), ('ANOMALY_CURIOUS_FINDING', 86)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 67, 'pigmented')]
PMC3257641	3/2010	S48-PMC3257641	['a NUMBER OF STUDIES within non-Pregnant Adult populations have examined 25(Oh)D levels in RELATION to DIFFERENT dosages, preparations or dosing intervals of oral Vitamin D (reviewed in[33]).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	3	[('GO_0007565', 'female pregnancy', 31, 'pregnant'), ('UBERON_0007023', 'adult organism', 40, 'adult'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 72, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC3257641	3/2010	S49-PMC3257641	['recent RECOMMENDATIONS SUGGEST that the lower level of Vitamin D adequacy SHOULD BE a Serum 25(Oh)D level of 75–80 nmol/l.']	[('FUTURE_WORK', 7), ('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 74)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 92, '25(OH ... D')]
PMC3257641	3/2010	S51-PMC3257641	['FEW STUDIES to date have examined Vitamin D supplementation during Pregnancy, and optimal 25(Oh)D levels have not yet been defined [35,36].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 90, '25(OH)D')]
PMC3257641	3/2010	S56-PMC3257641	['a RECENT meta-analysis of Vitamin D supplementation in RELATION to bone health in Adults, SHOWED that for every 1 iu increase in oral Vitamin D3, the 25(Oh)D level COULD BE expected to increase by 0.016 nmol/l, with a relatively linear RELATIONSHIP AT LEAST up to 2000 iu/day [45].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 236), ('PROBABLE_UNDERSTANDING', 249)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0007023', 'adult organism', 82, 'adults'), ('CHEBI_33279', 'vitamin D5', 134, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 134, 'vitamin D3'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D')]
PMC3257641	3/2010	S60-PMC3257641	['Conception\nSOME older STUDIES SHOWED that Vitamin D deficient Rats had reduced fertility and litter size, ASSOCIATED with impaired Ovarian function and Spermatogenesis.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 106)]	4	[('GO_0006936', 'muscle contraction', 0, 'Conception'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 62, 'rats'), ('UBERON_0000992', 'ovary', 131, 'ovarian'), ('GO_0007283', 'spermatogenesis', 152, 'spermatogenesis')]
PMC3257641	3/2010	S63-PMC3257641	['HOWEVER, the ASSOCIATION between Vitamin D deficiency and defective Reproduction MAY BE the result of hypocalcaemia RATHER than a Vitamin D EFFECT per se , AS the infertile female Vdr null Mice developed normal fertility when Fed a Calcium rich diet [48].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('SUPERFICIAL_RELATIONSHIP', 140), ('PROBABLE_UNDERSTANDING', 156)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0000003', 'reproduction', 68, 'reproduction'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 180, 'VDR'), ('NCBITaxon_10088', 'Mus <genus>', 189, 'mice'), ('GO_0007631', 'feeding behavior', 226, 'fed'), ('CHEBI_22313', 'alkaline earth metal atom', 232, 'calcium')]
PMC3257641	3/2010	S75-PMC3257641	['ONGOING RESEARCH is examining the ROLE of 1,25(Oh)2D in decreasing the risk of infections during Pregnancy and WHETHER Vitamin D status alters the risk of developing adverse outcomes following such infections.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111)]	3	[('CHEBI_82784', 'PVP38-Ag NP', 42, '1,25(OH)2D'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3257641	3/2010	S79-PMC3257641	['Human STUDIES ARE NEEDED AS inter-species variation in Vitamin D REQUIREMENTS and Metabolism MAY occur [55].']	[('FUTURE_WORK', 6), ('PROBABLE_UNDERSTANDING', 25), ('IMPORTANT_CONSIDERATION', 65), ('INCOMPLETE_EVIDENCE', 93)]	4	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0008152', 'metabolic process', 82, 'metabolism')]
PMC3257641	3/2010	S80-PMC3257641	['among Vitamin D deficient Pregnant women, fetal ultrasound revealed splaying of the Distal Metaphysis Of the fetal Femur as early as 19 weeks, with the APPEARANCE being very SIMILAR TO that SEEN in childhood (Vitamin D-deficient) rickets [56].']	[('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 190)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0007565', 'female pregnancy', 26, 'pregnant'), ('UBERON_0001389', 'soleus muscle', 84, 'distal'), ('UBERON_0006865', 'metaphysis of femur', 91, 'metaphysis of ... femur'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC3257641	3/2010	S89-PMC3257641	['mode of Birth\nRECENT DATA SUGGEST an ASSOCIATION between Vitamin D deficiency and caesarean section.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 37)]	3	[('GO_0007567', 'parturition', 8, 'Birth'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC3257641	3/2010	S92-PMC3257641	['Birth weight\nOBSERVATIONAL STUDIES of Vitamin D status during Pregnancy and physical characteristics of the offspring are FEW and provide CONFLICTING results.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138)]	3	[('GO_0007567', 'parturition', 0, 'Birth'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy')]
PMC3257641	3/2010	S93-PMC3257641	['ONE STUDY FOUND Pregnancies of mothers with low Vitamin D status were shorter (by 0.7 week; 95% ci −1.3, −0.1) [60], and the babies had poorer Intrauterine long bone growth [60], WHILE in OTHER studies, offspring had lower Birth weight [61,62,63].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188)]	4	[('GO_0007565', 'female pregnancy', 16, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0022293', 'reproductive gland secretion', 143, 'intrauterine'), ('GO_0007567', 'parturition', 223, 'birth')]
PMC3257641	3/2010	S94-PMC3257641	['HOWEVER ANOTHER STUDY FOUND THE OPPOSITE, with babies of Vitamin D deficient mothers being both heavier and longer, compared to the offspring of Vitamin D-sufficient mothers [64].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC3257641	3/2010	S98-PMC3257641	['the media REPORTED on a reduction in both Preterm Birth and small-for-dates babies, with Vitamin D supplementation [41], BUT formal publication of the FINDINGS had not occurred at the time of writing this review, THUS these reports cannot BE formally evaluated.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('INCOMPLETE_EVIDENCE', 151), ('PROBABLE_UNDERSTANDING', 213), ('ANOMALY_CURIOUS_FINDING', 239)]	5	[('GO_0007565', 'female pregnancy', 42, 'preterm'), ('GO_0007567', 'parturition', 50, 'birth'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3257641	3/2010	S103-PMC3257641	['low maternal Vitamin D status MAY slow neonatal Cardiac Development [69] and alter Brain morphology [70,71], with changes in the latter persisting into Adulthood [72].']	[('INCOMPLETE_EVIDENCE', 30)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007507', 'heart development', 48, 'cardiac development'), ('UBERON_0000948', 'heart', 48, 'cardiac'), ('UBERON_0000955', 'brain', 83, 'brain'), ('UBERON_0000113', 'post-juvenile adult stage', 152, 'adulthood')]
PMC3257641	3/2010	S104-PMC3257641	['excess Vitamin D administration during Pregnancy COULD also POTENTIALLY be of CONCERN.']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 60), ('PROBLEM_COMPLICATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy')]
PMC3257641	3/2010	S105-PMC3257641	['Rats receiving very high-dose Vitamin D during Gestation and early development (CONSIDERABLY higher than would be administered to Humans) had adverse changes in elastin content and organization in the Aorta CONSISTENT with increased later risk of hypertension or aneurysm [73].']	[('ANOMALY_CURIOUS_FINDING', 80), ('INCOMPLETE_EVIDENCE', 207)]	2	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'gestation'), ('NCBITaxon_9606', 'Homo sapiens', 130, 'humans'), ('UBERON_0000947', 'aorta', 201, 'aorta')]
PMC3257641	3/2010	S106-PMC3257641	['NEVERTHELESS, in two studies in Pigs, Vitamin D administration to two sows at doses that achieved Serum 25(Oh)D levels, APPROXIMATING RECOMMENDED Human levels, was ASSOCIATED with Coronary lesions in offspring at six weeks [74,75].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 120), ('FUTURE_WORK', 134), ('SUPERFICIAL_RELATIONSHIP', 164)]	4	[('NCBITaxon_10088', 'Mus <genus>', 32, 'pigs'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('NCBITaxon_9606', 'Homo sapiens', 146, 'human'), ('UBERON_0005985', 'coronary vessel', 180, 'coronary')]
PMC3257641	3/2010	S118-PMC3257641	['the diabetes autoimmunity study in the young (daisy) cohort has OBSERVED that Maternal Intake of Vitamin D via Food, recorded at Birth, was significantly ASSOCIATED with a decreased risk of Islet autoimmunity in offspring during the first four years of Life [88].']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 154)]	2	[('GO_0007618', 'mating', 78, 'maternal'), ('GO_0007631', 'feeding behavior', 87, 'intake'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_33290', 'food', 111, 'food'), ('GO_0007567', 'parturition', 129, 'birth'), ('CL_0000214', 'synovial cell', 190, 'islet'), ('UBERON_0002533', 'post-anal tail bud', 190, 'islet'), ('UBERON_0000104', 'life cycle', 253, 'life')]
PMC3257641	3/2010	S119-PMC3257641	['a norwegian case control study FOUND cod Liver oil use during Pregnancy was ASSOCIATED with lower risk of type 1 diabetes in the offspring, INDICATING Vitamin D or the N-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid in the cod Liver oil, or both, MAY have a PROTECTIVE EFFECT against type i diabetes [89].']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 262), ('SUPERFICIAL_RELATIONSHIP', 273), ('SUPERFICIAL_RELATIONSHIP', 284)]	6	[('UBERON_0002107', 'liver', 41, 'liver'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_35418', 'N-acetylneuraminate', 168, 'n-3 fatty acids'), ('CHEBI_36003', 'decenoic acid', 184, 'eicosapentaenoic acid'), ('CHEBI_36003', 'decenoic acid', 210, 'docosahexaenoic acid'), ('UBERON_0002107', 'liver', 242, 'liver')]
PMC3257641	3/2010	S120-PMC3257641	['THESE FINDINGS are also CONSISTENT with the FINDING of an inverse ASSOCIATION between Postnatal Vitamin D supplementation in early Life and type 1 diabetes risk [90,91].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 66)]	4	[('GO_0007567', 'parturition', 86, 'postnatal'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0000104', 'life cycle', 131, 'life')]
PMC3257641	3/2010	S121-PMC3257641	['low Vitamin D intake during Pregnancy HAS BEEN ASSOCIATED with an increased risk of asthma, eczema or hay fever [92,93], WHILE winter Birth was ASSOCIATED with higher Ige levels and lower Il-10 than summer Birth [57].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 144)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('GO_0007567', 'parturition', 134, 'birth'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 167, 'IgE'), ('PR_000001470', 'interleukin-28B', 188, 'IL-10'), ('GO_0007567', 'parturition', 206, 'birth')]
PMC3257641	3/2010	S122-PMC3257641	['as Il-10 is IMPORTANT in the development of tolerance to exogenous Antigens and inhibition of Mast Cell Degranulation [57], these FINDINGS are CONSISTENT with the notion of low Vitamin D levels at Birth increasing the risk of an allergic propensity.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 143)]	3	[('PR_000001470', 'interleukin-28B', 3, 'IL-10'), ('CHEBI_59132', 'antigen', 67, 'antigens'), ('CL_0000097', 'mast cell', 94, 'mast cell'), ('GO_0030154', 'cell differentiation', 99, 'cell degranulation'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'birth')]
PMC3257641	3/2010	S129-PMC3257641	['Genes of the Vitamin D pathway (25 Hydroxylase, 1Α Hydroxylase and 24 Hydroxylase) and vdr are Expressed in Rat Brain Cells [99] and the distribution of Vdr and 1Α hydroxylase IS THOUGHT TO be SIMILAR in Rat and Human Brains [100].']	[('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 193)]	3	[('SO_0000704', 'gene', 0, 'Genes'), ('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 32, '25 hydroxylase'), ('PR_000003753', 'adenylate cyclase type 2', 48, '1α hydroxylase'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 67, '24 hydroxylase'), ('GO_0010467', 'gene expression', 95, 'expressed'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 108, 'rat'), ('CL_0000312', 'keratinocyte', 112, 'brain cells'), ('UBERON_0000955', 'brain', 112, 'brain'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 153, 'VDR'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 161, '1α'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 204, 'rat'), ('NCBITaxon_9606', 'Homo sapiens', 212, 'human'), ('UBERON_0000955', 'brain', 218, 'brains')]
PMC3257641	3/2010	S131-PMC3257641	['seasonal and population level PATTERNS of schizophrenia incidence INDICATE the POSSIBLE ROLE of low Intrauterine Vitamin D in increasing later schizophrenia risk.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 88)]	4	[('UBERON_0022293', 'reproductive gland secretion', 100, 'intrauterine'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC3257641	3/2010	S134-PMC3257641	['OBSERVATIONAL studies provide INDIRECT EVIDENCE that low Vitamin D status during early Life MAY increase the RISK of multiple sclerosis [107,108].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0000104', 'life cycle', 87, 'life')]
PMC3257641	3/2010	S136-PMC3257641	['using Prenatal ambient uvr levels as an instrumental variable for Vitamin D levels in Pregnancy [113], an inverse ASSOCIATION between maternal ambient uvr exposure during the late first trimester and ms risk was OBSERVED [110].']	[('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 212)]	2	[('GO_0007565', 'female pregnancy', 6, 'prenatal'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy')]
PMC3257641	3/2010	S139-PMC3257641	['OTHER CANDIDATE diseases that REQUIRE FURTHER RESEARCH with regard to the POTENTIAL ROLE of Prenatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 30), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 84)]	7	[('GO_0007565', 'female pregnancy', 92, 'prenatal'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3257641	3/2010	S140-PMC3257641	['seasonal PATTERNS of Birth in Adults [114] and children [115] with Brain tumors and epilepsy [116] HAVE BEEN NOTED and COULD BE evidence of an EFFECT of low Vitamin D status, BUT this is far from CONCLUSIVE.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 99), ('ANOMALY_CURIOUS_FINDING', 109), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196)]	7	[('GO_0007567', 'parturition', 21, 'birth'), ('UBERON_0007023', 'adult organism', 30, 'adults'), ('UBERON_0000955', 'brain', 67, 'brain'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC3257641	3/2010	S141-PMC3257641	['a TENTATIVE LINK between Vitamin D status and autism HAS BEEN POSTULATED, arising MAINLY from the FINDINGS of population level studies [117,118].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 62), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 98)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC3257641	3/2010	S143-PMC3257641	['in Adult ecological and observational studies there is considerable EVIDENCE that Vitamin D status MAY BE RELATED to risk or prognosis of a number of cancers, including of the Prostate [121] and Breast [122].']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 106)]	3	[('UBERON_0007023', 'adult organism', 3, 'adult'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 176, 'prostate'), ('UBERON_0000310', 'breast', 195, 'breast')]
PMC3257641	3/2010	S144-PMC3257641	['one Animal STUDY HAS SHOWN that maternal Antenatal Vitamin D supplementation was ASSOCIATED with greater mean Prostatic weight and a histologically more differentiated Prostatic architecture in offspring in Adulthood [123].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('NCBITaxon_33208', 'Metazoa', 4, 'animal'), ('GO_0007567', 'parturition', 41, 'antenatal'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0000054', 'macula', 110, 'prostatic'), ('UBERON_0000054', 'macula', 168, 'prostatic'), ('UBERON_0000113', 'post-juvenile adult stage', 207, 'adulthood')]
PMC3257641	3/2010	S147-PMC3257641	['overview\nIN SUMMARY, we have reviewed the EXISTING EVIDENCE for a range of POSSIBLE adverse offspring health outcomes resulting from low maternal Vitamin D status in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 75)]	3	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy')]
PMC3257641	3/2010	S150-PMC3257641	['EVEN with these trials (mostly of high risk women, many years ago) being systematically reviewed, it APPEARS that there is NOT ENOUGH EVIDENCE to evaluate the EFFECTS of Vitamin D supplementation in Pregnancy [124].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 101), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 159)]	4	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC3257641	3/2010	S152-PMC3257641	['the MERIT of achieving a relatively high Vitamin D status (>100 nmol/l) has NOT BEEN FULLY ESTABLISHED, particularly in RELATION to offspring Cardiovascular or atopic disease development.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 120)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 142, 'cardiovascular')]
PMC3257641	3/2010	S153-PMC3257641	['HOWEVER, the MAJORITY of POTENTIAL adverse offspring health outcomes pertain to low Prenatal Vitamin D status and the EVOLVING EVIDENCE has provided greater IMPETUS for PUBLIC HEALTH EFFORTS to ensure mothers are not frankly Vitamin D deficient (<25 nmol/l) in Pregnancy, ALTHOUGH the value of treating relative Vitamin D insufficiency in Pregnancy is NOT clearly ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 169), ('FUTURE_WORK', 183), ('ANOMALY_CURIOUS_FINDING', 272), ('FULL_UNKNOWN', 352)]	9	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D'), ('GO_0007565', 'female pregnancy', 339, 'pregnancy')]
PMC3257641	3/2010	S158-PMC3257641	['CARE IS also NEEDED at the trial design and implementation stages to reduce the POSSIBILITY of POTENTIAL contamination of the placebo or lower dose Vitamin D group by additional subject-initiated Vitamin D supplementation or increased uvr exposure.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 5), ('FUTURE_WORK', 13), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 95)]	5	[('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC3257641	3/2010	S160-PMC3257641	['to examine the POTENTIAL long term EFFECTS of low Vitamin D on offspring health, randomized controlled trials STUDIES MAY NOT BE feasible, particularly for RARE diseases with later onset such as schizophrenia.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 35), ('FUTURE_WORK', 110), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 122), ('INCOMPLETE_EVIDENCE', 156)]	6	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3257641	3/2010	S161-PMC3257641	['for these studies, observational studies will NEED to include seasonal variation in Vitamin D status, POTENTIALLY CONFOUNDING by other seasonal factors such as infection, and also deseasonalized interpersonal variation in Ingested Vitamin D or uvr-derived Vitamin D. with regard to these deaseasonalized MARKERS of Vitamin D status, it is highly LIKELY that Vitamin d status in Pregnancy will be CORRELATED with Ingested or uvr-derived Vitamin D exposure for mothers preceding Pregnancy and offspring after Pregnancy.']	[('FUTURE_WORK', 46), ('INCOMPLETE_EVIDENCE', 102), ('PROBLEM_COMPLICATION', 114), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 346), ('SUPERFICIAL_RELATIONSHIP', 396)]	6	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007631', 'feeding behavior', 222, 'ingested'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 315, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 358, 'vitamin'), ('GO_0007565', 'female pregnancy', 378, 'pregnancy'), ('GO_0007631', 'feeding behavior', 412, 'ingested'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('GO_0007565', 'female pregnancy', 477, 'pregnancy'), ('GO_0007565', 'female pregnancy', 507, 'pregnancy')]
BMJ_2010_Apr_29_340_c1640	4/2010	S17-BMJ_2010_Apr_29_340_c1640	['this latitudinal gradient SEEMS environmentally RELATED BECAUSE the risk ASSOCIATED with latitude alters if People move after Birth.45a strong environmental CANDIDATE is the level of ambient regional ultraviolet radiation, acting EITHER directly OR through the generation of Vitamin D.6higher exposure to ultraviolet radiation,7higher Vitamin D intake,8and also higher Serum Vitamin D concentrations9seem to be ASSOCIATED with a reduced risk of onset of multiple sclerosis.']	[('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 73), ('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230), ('SUPERFICIAL_RELATIONSHIP', 411)]	7	[('NCBITaxon_10088', 'Mus <genus>', 108, 'people'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 335, 'vitamin D'), ('UBERON_0001977', 'blood serum', 369, 'serum'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
BMJ_2010_Apr_29_340_c1640	4/2010	S85-BMJ_2010_Apr_29_340_c1640	['this PROXY has some LIMITATIONS in that it DOES NOT take into account individual personal behaviour, concurrent dietary Vitamin D intake, or skin pigmentation.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 20), ('ANOMALY_CURIOUS_FINDING', 43)]	3	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S87-BMJ_2010_Apr_29_340_c1640	['RECENT work by sayers et al also INDICATES that ambient erythemal ultraviolet radiation levels during Pregnancy, EVEN in a single location, CAN be used to INDICATE Vitamin D status.29further work COULD CONFIRM the timing of the OBSERVED EFFECT of Prenatal ultraviolet radiation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 33), ('ANOMALY_CURIOUS_FINDING', 113), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 237)]	9	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 247, 'prenatal')]
BMJ_2010_Apr_29_340_c1640	4/2010	S94-BMJ_2010_Apr_29_340_c1640	['in this setting, there is STRONG a priori EVIDENCE that sun exposure or Vitamin D, or both, is LIKELY to be the central exposure6and LITTLE a priori evidence for any other strong DETERMINANT of multiple sclerosis LIKELY to be LINKED to maternal ambient Ultraviolet radiation exposure during the first Trimester.']	[('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 42), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 179), ('PROBABLE_UNDERSTANDING', 213), ('SUPERFICIAL_RELATIONSHIP', 226)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 253, 'ultraviolet'), ('GO_0009294', 'DNA mediated transformation', 301, 'trimester')]
BMJ_2010_Apr_29_340_c1640	4/2010	S95-BMJ_2010_Apr_29_340_c1640	['maternal exposure and health of offspring\nthis report adds to other work SHOWING that maternal exposure to ambient ultraviolet radiation during Pregnancy MIGHT INFLUENCE subsequent health in the offspring.30313233in a new zealand Birth cohort, infants whose mothers were exposed to peak sunshine during the first Trimester were significantly heavier at Birth than infants whose mothers experienced trough levels of sunshine during the same trimester.30in the united kingdom, maternal ambient Ultraviolet B exposure in the third trimester HAS BEEN positively RELATED to bone Mineral density and content at age 9 in offspring.34there is now GROWING INTEREST in the ROLE of maternal Vitamin D deficiency in Pregnancy and the Development of Central Nervous System and Immune disorders, PARTICULARLY schizophrenia,33type 1 diabetes, and other disorders.35ALTHOUGH active Vitamin D3Concentrations in the mother increase substantially during Pregnancy, early fetal supplies are lower36and directly DEPENDENT on the mother.']	[('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 538), ('SUPERFICIAL_RELATIONSHIP', 558), ('INCOMPLETE_EVIDENCE', 639), ('SUPERFICIAL_RELATIONSHIP', 663), ('IMPORTANT_CONSIDERATION', 782), ('ANOMALY_CURIOUS_FINDING', 848), ('SUPERFICIAL_RELATIONSHIP', 991)]	10	[('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0007567', 'parturition', 230, 'birth'), ('GO_0009294', 'DNA mediated transformation', 313, 'trimester'), ('GO_0007567', 'parturition', 353, 'birth'), ('CHEBI_72754', 'bisphenol AF', 492, 'ultraviolet B'), ('CHEBI_46662', 'mineral', 574, 'mineral'), ('CHEBI_27300', 'vitamin D', 680, 'vitamin D'), ('GO_0007565', 'female pregnancy', 704, 'pregnancy'), ('GO_0008289', 'lipid binding', 722, 'development'), ('GO_0022412', 'cellular process involved in reproduction in multicellular organism', 737, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 737, 'central nervous system'), ('UBERON_0002405', 'immune system', 764, 'immune'), ('PR_000017350', 'serine/threonine-protein kinase VRK2', 866, 'vitamin D3concentrations'), ('GO_0007565', 'female pregnancy', 935, 'pregnancy')]
BMJ_2010_Apr_29_340_c1640	4/2010	S96-BMJ_2010_Apr_29_340_c1640	['by the time of Delivery, maternal and infant Cord Serum 25-Hydroxyvitamin d3concentrations are highly CORRELATED.37UNFORTUNATELY, much REMAINS UNKNOWN, leading to large international variations in maternal Vitamin D monitoring and supplementation during Pregnancy.353839\na maternal EFFECT operating Antenatally would also be CONSISTENT with the stronger maternal than paternal “parent of origin” EFFECT in familial multiple sclerosis.1340it HAS BEEN PREVIOUSLY PROPOSED14THAT maternal Vitamin D deficiency, a PROBLEM for SOME dark skinned women migrating to regions with low ambient ultraviolet radiation, such as the uk, MIGHT EXPLAIN the increase in incidence of disease SEEN among second generation migrants in such locations.41our FINDINGS are CONSISTENT with this EXPLANATION.']	[('SUPERFICIAL_RELATIONSHIP', 102), ('ANOMALY_CURIOUS_FINDING', 113), ('ANOMALY_CURIOUS_FINDING', 113), ('FULL_UNKNOWN', 135), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 325), ('SUPERFICIAL_RELATIONSHIP', 396), ('INCOMPLETE_EVIDENCE', 441), ('INCOMPLETE_EVIDENCE', 450), ('INCOMPLETE_EVIDENCE', 461), ('IMPORTANT_CONSIDERATION', 509), ('INCOMPLETE_EVIDENCE', 521), ('INCOMPLETE_EVIDENCE', 622), ('PROBABLE_UNDERSTANDING', 628), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 735), ('INCOMPLETE_EVIDENCE', 748), ('PROBABLE_UNDERSTANDING', 769)]	18	[('GO_0007567', 'parturition', 15, 'delivery'), ('UBERON_0002240', 'spinal cord', 45, 'cord'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 56, '25-hydroxyvitamin'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy'), ('GO_0007288', 'sperm axoneme assembly', 299, 'antenatally'), ('CHEBI_27300', 'vitamin D', 485, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S99-BMJ_2010_Apr_29_340_c1640	['ultraviolet radiation exposure during the first trimester would be expected to specifically INFLUENCE Vitamin D concentrations up to early in the second trimester, given that Vitamin D has a half life of one to two months.45in RECENT australian work, higher levels of ambient ultraviolet radiation were ASSOCIATED with higher Vitamin D concentrations at the population level with a lag of one and a half months.46\n\nPOSSIBLE mechanisms\nfirst trimester Vitamin D concentrations MIGHT be particularly IMPORTANT in the development of the Central Nervous System BECAUSE during Early Embryonic Development, Vitamin D receptors are Expressed in the Neuroepithelium and later in the Subventricular Zone.15myelination occurs later; EVEN in mid-Gestation (19-24 weeks) Cortical Axonal tracts are not yet myelinated,47with major myelination of several areas occurring as late as 29-39 weeks.48in addition, the in utero Development Of Immune central Tolerance occurs in the first trimester and Vitamin D has immunomodulating properties.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 303), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 476), ('IMPORTANT_CONSIDERATION', 498), ('PROBABLE_UNDERSTANDING', 557), ('ANOMALY_CURIOUS_FINDING', 723)]	8	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 326, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 534, 'central nervous system'), ('UBERON_0019248', 'early embryo', 572, 'early embryonic'), ('GO_0009790', 'embryo development', 578, 'embryonic development'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0010467', 'gene expression', 625, 'expressed'), ('UBERON_0034705', 'developing neuroepithelium', 642, 'neuroepithelium'), ('UBERON_0004922', 'postnatal subventricular zone', 675, 'subventricular zone'), ('GO_0007565', 'female pregnancy', 735, 'gestation'), ('UBERON_0001851', 'cortex', 759, 'cortical'), ('GO_0030424', 'axon', 768, 'axonal'), ('GO_0034102', 'erythrocyte clearance', 908, 'development of ... tolerance'), ('UBERON_0002405', 'immune system', 923, 'immune'), ('CHEBI_27300', 'vitamin D', 982, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S100-BMJ_2010_Apr_29_340_c1640	['the first trimester is also a sensitive period with regard to Prenatal Thymocyte differentiation, with Animal STUDIES SHOWING that chemicals such as Dioxin CAN alter this process, disrupt the development of central tolerance, and LEAD TO increased auto-reactive Peripheral T Cells.49FURTHERMORE, indirect EFFECTS of Vitamin D SHOULD BE CONSIDERED.']	[('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 230), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('SUPERFICIAL_RELATIONSHIP', 305), ('FUTURE_WORK', 326), ('FUTURE_WORK', 336)]	8	[('GO_0007565', 'female pregnancy', 62, 'prenatal'), ('CL_0000893', 'thymocyte', 71, 'thymocyte'), ('NCBITaxon_33208', 'Metazoa', 103, 'animal'), ('CHEBI_4553', 'dihydroanhydropodorhizol', 149, 'dioxin'), ('CL_0000111', 'peripheral neuron', 262, 'peripheral T cells'), ('CHEBI_27300', 'vitamin D', 316, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S101-BMJ_2010_Apr_29_340_c1640	['for example, Vitamin D can down-regulate Interleukin 6, an IMPORTANT mediator of the adverse EFFECT of maternal infection during Pregnancy on neural development in the fetus.505152\n\nPrenatal and Postnatal timing\nour results do not INDICATE that the POSSIBLE beneficial EFFECT of Ultraviolet radiation exposure is confined ONLY to the Prenatal period.']	[('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 269), ('INCOMPLETE_EVIDENCE', 322)]	6	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('PR_000008988', 'interleukin-1 family member 5', 41, 'interleukin 6'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007565', 'female pregnancy', 182, 'Prenatal'), ('GO_0007567', 'parturition', 195, 'postnatal'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 279, 'ultraviolet'), ('GO_0007565', 'female pregnancy', 334, 'prenatal')]
BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]
PMC2872349	4/2010	S29-PMC2872349	['the Proliferation Of the Chondrocytes HAS BEEN SHOWN to be INFLUENCED by Parathyroid Hormone Related peptide (pthrp) [14], cytokines of the igf axis [15], activated Vitamin D [16] and Triodothryronine [17].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('GO_0002901', 'mature B cell apoptotic process', 4, 'proliferation of ... chondrocytes'), ('CL_0000138', 'chondrocyte', 25, 'chondrocytes'), ('PR_000013393', 'proteasome activator complex subunit 2', 73, 'parathyroid hormone related'), ('UBERON_0001132', 'parathyroid gland', 73, 'parathyroid'), ('CHEBI_33280', 'molecular messenger', 85, 'hormone'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('CHEBI_26982', 'threo-3-methylmalic acid', 184, 'triodothryronine')]
PMC2872349	4/2010	S34-PMC2872349	['rickets has served as a longstanding example of an adverse Early Life environment, in the form of Vitamin D deficiency, disrupting the process of Bone Development and untreated CAN LEAD TO persistent changes in the child’s bone structure.']	[('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 181)]	2	[('UBERON_0001847', 'lobule of pinna', 59, 'early life'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0048539', 'bone marrow development', 146, 'bone development')]
PMC2872349	4/2010	S42-PMC2872349	['the RELATIONSHIPS REMAINED after adjustment for KNOWN Genetic markers of osteoporosis risk, such as polymorphisms in the Gene for the Vitamin D Receptor (vdr), and after adjustment for lifestyle characteristics in Adulthood that MIGHT have INFLUENCED bone mass (physical activity, dietary calcium intake, cigarette smoking, and alcohol consumption).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 229), ('SUPERFICIAL_RELATIONSHIP', 240)]	5	[('SO_0000704', 'gene', 54, 'genetic'), ('SO_0000704', 'gene', 121, 'gene'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 134, 'vitamin D receptor'), ('UBERON_0000113', 'post-juvenile adult stage', 214, 'adulthood')]
PMC2872349	4/2010	S87-PMC2872349	['Calcium and Vitamin D, being key Nutrients in the process of bone formation, are prime CANDIDATES for INVESTIGATION.']	[('INCOMPLETE_EVIDENCE', 87), ('FUTURE_WORK', 102)]	2	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_33284', 'nutrient', 33, 'nutrients')]
PMC2872349	4/2010	S93-PMC2872349	['ADDITIONAL EVIDENCE SUPPORTING a ROLE for maternal Vitamin D status was obtained in the southampton women’s survey, when maternal Vitamin D concentrations again CORRELATED with neonatal bone mass [41].']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 161)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC2872349	4/2010	S124-PMC2872349	['in summary Maternal behavior, in the form of activities such as smoking, dietary choices including Calcium and Vitamin D intake, and alterations in the Endocrine pathways especially in early Life, HAVE BEEN SHOWN to CORRELATE with offspring bone health [48,50,54,55].']	[('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 216)]	2	[('GO_0007618', 'mating', 11, 'maternal'), ('CHEBI_22313', 'alkaline earth metal atom', 99, 'calcium'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0006397', 'mRNA processing', 152, 'endocrine'), ('UBERON_0000104', 'life cycle', 191, 'life')]
PMC2872349	4/2010	S143-PMC2872349	['this SUPPORTS the general NEED for a programme of interventional research aimed at improving general dietary quality among women before Conception and during Pregnancy, in addition to studies that EVALUATE the TARGETING of specific Micronutrients such as Vitamin D and Calcium.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 26), ('INCOMPLETE_EVIDENCE', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 197), ('QUESTION_ANSWERED_BY_THIS_WORK', 197), ('FUTURE_WORK', 210)]	6	[('GO_0007620', 'copulation', 136, 'conception'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('CHEBI_33839', 'macromolecule', 232, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 269, 'calcium')]
PMC2872349	4/2010	S145-PMC2872349	['the STUDY AIMS TO TEST the HYPOTHESIS that Vitamin D supplementation of Pregnant women who have low levels of Vitamin D will result in improved neonatal bone Mineral content.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 27)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_46662', 'mineral', 158, 'mineral')]
PMC2872349	4/2010	S146-PMC2872349	['this is an IDEAL platform on which TO INVESTIGATE epigenetic Modulation Of Placental Calcium Transport, PARTICULARLY the ROLE of Vitamin D. this SHOULD improve our understanding of the processes INVOLVED in developing osteoporosis, and POTENTIALLY provide a focus for interventions to avert DETRIMENTAL processes by INFLUENCING maternal dietary habits.']	[('IMPORTANT_CONSIDERATION', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('IMPORTANT_CONSIDERATION', 104), ('SUPERFICIAL_RELATIONSHIP', 121), ('FUTURE_WORK', 145), ('SUPERFICIAL_RELATIONSHIP', 195), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 291), ('SUPERFICIAL_RELATIONSHIP', 316)]	9	[('GO_0061724', 'lipophagy', 61, 'modulation of'), ('GO_0006813', 'potassium ion transport', 75, 'placental calcium transport'), ('UBERON_0001987', 'placenta', 75, 'placental'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC2873552	4/2010	S128-PMC2873552	["caption (table-wrap): table 2\n\nfunctions and diseases related to both ceu and yri Signaturesceuyri diabetes 1.70e-172.70e-20 Coronary Artery disease 3.78e-173.12e-13 Genetic disorder 1.09e-144.53e-14 Cardiovascular disease 1.34e-144.78e-11 non-Insulin-dependent diabetes mellitus 1.03e-128.66e-15 Endocrine System disorder 1.91e-121.25e-18 hypertension 2.13e-122.83e-11 Neurological disorder 2.49e-123.27e-12 crohn's disease 7.59e-127.25e-09 bipolar affective disease 3.50e-115.24e-09 Metabolic disorder 5.66e-119.83e-16 inflammatory disorder 2.56e-091.08e-08 Digestive System disorder 2.66e-091.31e-07 Skeletal and muscular disorder 1.49e-081.58e-08 progressive motor neuropathy 2.53e-085.59e-12 Autoimmune disease 7.28e-081.09e-12 immunological disorder 2.46e-073.66e-13 rheumatoid arthritis 3.78e-072.54e-07 shape change of Epithelial Cells 8.86e-07 alzheimer's disease 3.60e-062.27e-07 parkinson's disease 7.24e-065.29e-06 shape change of Dermal Cells 9.33e-06 Insulin-dependent diabetes mellitus 3.76e-15 neuropathy 5.38e-12 amyotrophic lateral sclerosis 1.36e-09 arthritis 1.44e-07\n\nVitamin D HYPOTHESIS\nan INTERESTING HYPOTHESIS HAS BEEN PROPOSED by mcgrace [28] claiming that low Prenatal Vitamin D increases the risk of a wide range of diseases such as multiple sclerosis, diabetes, schizophrenia, Prostate cancer, Breast cancer and Colorectal cancer because of its versatile function in normal development."]	[('INCOMPLETE_EVIDENCE', 1099), ('ANOMALY_CURIOUS_FINDING', 1113), ('INCOMPLETE_EVIDENCE', 1125), ('INCOMPLETE_EVIDENCE', 1136), ('INCOMPLETE_EVIDENCE', 1145)]	5	[('GO_0036367', 'light adaption', 82, 'signaturesCEUYRI'), ('UBERON_0001621', 'coronary artery', 125, 'Coronary artery'), ('SO_0000704', 'gene', 166, 'Genetic'), ('UBERON_0004535', 'cardiovascular system', 200, 'Cardiovascular'), ('PR_000045358', 'insulin family protein', 244, 'insulin'), ('UBERON_0000949', 'endocrine system', 297, 'Endocrine system'), ('UBERON_0001016', 'nervous system', 370, 'Neurological'), ('GO_0008152', 'metabolic process', 485, 'Metabolic'), ('UBERON_0004854', 'gastrointestinal system mesentery', 560, 'Digestive system'), ('UBERON_0004288', 'skeleton', 603, 'Skeletal'), ('UBERON_0005445', 'segment of pes', 697, 'Autoimmune'), ('CL_0000066', 'epithelial cell', 827, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 827, 'epithelial'), ('CL_0000346', 'hair follicle dermal papilla cell', 943, 'dermal cells'), ('PR_000045358', 'insulin family protein', 965, 'Insulin'), ('CHEBI_28384', 'vitamin K', 1089, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1188, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1197, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 1307, 'prostate'), ('UBERON_0000310', 'breast', 1324, 'breast'), ('UBERON_0012652', 'colorectum', 1342, 'colorectal')]
PMC2873552	4/2010	S129-PMC2873552	['additional CIRCUMSTANTIAL EVIDENCE encouraged us to integrate this "Vitamin D HYPOTHESIS" and population-specific selection.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 78)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC2873552	4/2010	S130-PMC2873552	['first, the ASSUMED prime function of pigmentation, one of the MOST CONVINCING AS a recent selection target differentiating ceu and yri populations, is to control Vitamin D synthesis from Ultra Violet exposure [17,29].']	[('PROBABLE_UNDERSTANDING', 11), ('PROBABLE_UNDERSTANDING', 62), ('INCOMPLETE_EVIDENCE', 67), ('PROBABLE_UNDERSTANDING', 67), ('PROBABLE_UNDERSTANDING', 78)]	5	[('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 187, 'ultra violet')]
PMC2873552	4/2010	S131-PMC2873552	["second, in addition to mcgrace's list of diseases, Animal MODEL studies and epidemiological surveys have FURTHER LINKED Vitamin D insufficiency to Cardiovascular disease and Inflammatory Bowel disease [17,30,31], as well as abnormal Brain Development [31]."]	[('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('NCBITaxon_33208', 'Metazoa', 51, 'animal'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 147, 'cardiovascular'), ('UBERON_0001782', 'pigmented layer of retina', 174, 'inflammatory bowel'), ('GO_0007420', 'brain development', 233, 'brain development'), ('UBERON_0000955', 'brain', 233, 'brain')]
PMC2873552	4/2010	S133-PMC2873552	['TO ASSESS this POSSIBILITY, we looked into the entropy of the vdr Gene, a Vitamin D receptor.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 15)]	2	[('SO_0000704', 'gene', 66, 'gene'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC2873552	4/2010	S137-PMC2873552	['these results are SUGGESTIVE that Vitamin D MIGHT have been INVOLVED in the alteration of risk of disease and abnormal development and CONSEQUENTLY in the Genetic adaptation of modern Humans, BUT validation from FURTHER STUDY IS NECESSARY.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('FUTURE_WORK', 212), ('FUTURE_WORK', 226), ('FUTURE_WORK', 229)]	8	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0000704', 'gene', 155, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 184, 'humans')]
PMC2889879	5/2010	S0-PMC2889879	['dietary Intake of fish, Omega-3, Omega-6 polyunsaturated Fatty Acids and Vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33 000 women from the general population\n\nabstract\n\nbackground\nlow intake of fish, polyunsaturated Fatty Acids (pufa) and Vitamin D deficiency HAS BEEN SUGGESTED to play a ROLE in the development of schizophrenia.']	[('INCOMPLETE_EVIDENCE', 287), ('SUPERFICIAL_RELATIONSHIP', 316)]	2	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_79370', 'ibho#10', 24, 'omega-3'), ('CHEBI_79370', 'ibho#10', 33, 'omega-6'), ('CHEBI_35366', 'fatty acid', 57, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_35366', 'fatty acid', 243, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D')]
PMC2889879	5/2010	S14-PMC2889879	['conclusion\nOUR FINDINGS RAISE a POSSIBILITY that Adult women with a high Intake of fish, Omega-3 or Omega-6 Pufa and Vitamin D have a lower rate of psychotic-like symptoms.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('EXPLICIT_QUESTION', 24), ('INCOMPLETE_EVIDENCE', 32)]	3	[('UBERON_0007023', 'adult organism', 49, 'adult'), ('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_79370', 'ibho#10', 89, 'omega-3'), ('CHEBI_79370', 'ibho#10', 100, 'omega-6'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 108, 'PUFA'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC2889879	5/2010	S26-PMC2889879	['fatty fish is a rich dietary source of essential Fatty Acids and Vitamin D, both of which COULD BE IMPLICATED in the development of schizophrenia.']	[('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('CHEBI_35366', 'fatty acid', 49, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC2889879	5/2010	S35-PMC2889879	['furthermore, it HAS BEEN HYPOTHESIZED that Prenatal Vitamin D deficiency is a risk factor for schizophrenia, SUPPORTED by the ROLE of this Vitamin in Cell Growth and differentiation, the excess of winter births in schizophrenia (a period when Vitamin D levels are low), and increased Births of pre-schizophrenic subjects in urban areas, where Vitamin D deficiency is higher [12,18].']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 139, 'vitamin'), ('GO_0016049', 'cell growth', 150, 'cell growth'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('GO_0007567', 'parturition', 284, 'births'), ('CHEBI_27300', 'vitamin D', 343, 'vitamin D')]
PMC2889879	5/2010	S95-PMC2889879	['we DECIDED not to include dietary Vitamin D ESTIMATES in the final multivariate MODELS AS fish is a rich source of Vitamin D and COULD account for SOME of the EFFECT of fish on our outcome.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 159)]	7	[('CHEBI_28384', 'vitamin K', 34, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC2889879	5/2010	S125-PMC2889879	['HOWEVER, NONE of these covariates change the ESTIMATES substantially, and was THEREFORE not included in the final multivariate MODEL\ncsum of Eicosapentaenoic Acid (Epa), Docosahexaenoic Acid (Dha) and Docosapentaenoic Acid\ndadjusted for age, total energy intake and dietary intake of Vitamin B12, Alcohol and dietary intake of fat other than Eicosapentaenoic Acid, Docosahexaenoic Acid and Docosapentaenoic Acid\nesum of Arachidonic And Linoleic Acids\nfadjusted for age, total energy intake and dietary intake of Vitamin B12, Alcohol and dietary intake of other than Omega-6 Fatty Acids\ngsum of Eicosapentaenoic Acid (Epa), Docosahexaenoic Acid (Dha), Docosapentaenoic Acid and Α-Linolenic Acid\nhadjusted for age, total energy intake and dietary Intake of Vitamin B12, Alcohol and dietary intake of other than Omega-3 Fatty Acids\nthe intake of Vitamin D was significantly ASSOCIATED with a decreased relative risk of both the middle and high levels of psychotic-like symptoms (table4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 78), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 871)]	6	[('CHEBI_36003', 'decenoic acid', 141, 'eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 164, 'EPA'), ('CHEBI_36003', 'decenoic acid', 170, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 192, 'DHA'), ('CHEBI_61205', 'docosatetraenoic acid', 201, 'docosapentaenoic acid'), ('CHEBI_33279', 'vitamin D5', 284, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 284, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 297, 'alcohol'), ('CHEBI_36003', 'decenoic acid', 342, 'eicosapentaenoic acid'), ('CHEBI_36003', 'decenoic acid', 365, 'docosahexaenoic acid'), ('CHEBI_61205', 'docosatetraenoic acid', 390, 'docosapentaenoic acid'), ('CHEBI_36431', 'angelic acid', 420, 'arachidonic and'), ('CHEBI_25048', 'linolenic acid', 436, 'linoleic acids'), ('CHEBI_33279', 'vitamin D5', 512, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 512, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 525, 'alcohol'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 566, 'omega-6 fatty acids'), ('CHEBI_36003', 'decenoic acid', 594, 'eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 617, 'EPA'), ('CHEBI_36003', 'decenoic acid', 623, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 645, 'DHA'), ('CHEBI_61205', 'docosatetraenoic acid', 651, 'docosapentaenoic acid'), ('CHEBI_86354', '2-hydroxyacrylic acid', 677, 'α-linolenic acid'), ('GO_0007631', 'feeding behavior', 745, 'intake'), ('CHEBI_33279', 'vitamin D5', 755, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 755, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 768, 'alcohol'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 809, 'omega-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 843, 'vitamin D')]
PMC2889879	5/2010	S127-PMC2889879	['caption (table-wrap): table 4\n\nrelative risk of positive psychotic-like symptoms in relation to estimated dietary intake of vitamin Ddietary intake g/day·mjpositive psychotic-like symptomsamedianinterquintile rangelow level groupmiddle level grouphigh level group energy adjustedmultivariatebenergy adjustedmultivariatebvitamin dno.no.rr95% cirr95% cino.rr95% cirr95% ci 0.4(0.01-0.5)4132ref.36682400.6(0.5-0.6)447634620.870.82-0.930.88a0.82-0.931850.710.58-0.860.72a0.59-0.880.7(0.6-0.8)459033930.840.79-0.890.84a0.79-0.901710.640.53-0.790.65a0.52-0.800.9(0.8-4.0)462033430.830.78-0.880.82a0.77-0.881750.660.54-0.810.63a0.50-0.78\naadjusted for age, total energy intake, country of Birth, bmi and dietary intake of Vitamin B12\n\ndiscussion\nwe report HERE results from the FIRST STUDY that has evaluated the dietary Intake of Fish, Pufa and Vitamin D in RELATION to the experience of positive psychotic-like symptoms in a large cohort of over 30 000 swedish women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 749), ('INCOMPLETE_EVIDENCE', 771), ('SUPERFICIAL_RELATIONSHIP', 852)]	3	[('GO_0051215', 'RNAi-mediated antiviral immunity against DNA virus', 132, 'DDietary'), ('GO_0007567', 'parturition', 682, 'birth'), ('CHEBI_33279', 'vitamin D5', 715, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 715, 'vitamin B12'), ('GO_0007631', 'feeding behavior', 814, 'intake'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 824, 'fish'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 830, 'PUFA'), ('CHEBI_27300', 'vitamin D', 839, 'vitamin D')]
PMC2889879	5/2010	S128-PMC2889879	['we FOUND SUPPORT for a PROTECTIVE EFFECT regarding the risk of positive psychotic-like symptoms with high dietary Intake of fish, Omega-3 and omega-6 Pufa, as well as of Vitamin D. the ASSOCIATIONS were j-shaped with the strongest reduced risk for an intermediate intake of Fish or Pufa.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 185)]	5	[('GO_0007631', 'feeding behavior', 114, 'intake'), ('CHEBI_30823', 'oleate', 130, 'omega'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 150, 'PUFA'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 274, 'fish'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 282, 'PUFA')]
PMC2889879	5/2010	S135-PMC2889879	['OUR FINDINGS INDICATED a PROTECTIVE EFFECT of Vitamin D for the risk of psychotic-like symptoms.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 36)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC2889879	5/2010	S136-PMC2889879	['Prenatal Vitamin D deficiency has been PROPOSED to be a risk factor for the development of schizophrenia [12].']	[('INCOMPLETE_EVIDENCE', 39)]	1	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC2889879	5/2010	S137-PMC2889879	['results from the northern finland 1966 Birth cohort SHOWED that Vitamin D supplementation during the first year of Life was ASSOCIATED with a reduced risk of schizophrenia in males, BUT NOT in women [32].']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 124), ('FULL_UNKNOWN', 182)]	3	[('GO_0007567', 'parturition', 39, 'Birth'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000104', 'life cycle', 115, 'life')]
PMC2889879	5/2010	S138-PMC2889879	['HOWEVER, a SMALL pilot STUDY of maternal Vitamin D levels in archived Prenatal Sera, SHOWED no decrease in Prenatal Vitamin D in subjects who later developed schizophrenia [33].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 85)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'prenatal'), ('UBERON_0001977', 'blood serum', 79, 'sera'), ('GO_0007565', 'female pregnancy', 107, 'prenatal'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC2889879	5/2010	S139-PMC2889879	['it HAS BEEN HYPOTHESISED that Vitamin D INSUFFICIENCY COULD account for SOME of the increased risk of schizophrenia OBSERVED among dark-skinned immigrants moving to countries with less sun exposure [12].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 116)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC2889879	5/2010	S141-PMC2889879	['our results of a PROTECTIVE EFFECT of Vitamin D intake MUST BE CONSIDERED AS ROUGH, SINCE we ONLY measure the dietary intake of Vitamin D. a more complete picture of the Vitamin D status COULD have been supplied through Vitamin D levels in Blood; HOWEVER, NO biological samples are AVAILABLE.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 63), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 77), ('PROBLEM_COMPLICATION', 84), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 187), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('FULL_UNKNOWN', 256)]	11	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('UBERON_0000178', 'blood', 240, 'blood')]
PMC2889879	5/2010	S143-PMC2889879	['THUS, the CORRELATION between Vitamin D intake and Serum levels MAY VARY.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 64), ('DIFFICULT_TASK', 68)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 51, 'serum')]
PMC2889879	5/2010	S146-PMC2889879	['our results of the PROTECTIVE EFFECT of fatty fish COULD IN PART be due to the content of Vitamin D. WHILE the epidemiological EVIDENCE LINKING low Prenatal Vitamin D and schizophrenia REMAINS INCONCLUSIVE, Rodent MODELS have provided COMPELLING EVIDENCE about the ROLE of Vitamin D deficiency for Brain Development like larger lateral volumes [36], subtle Memory dysfunction and altered attention processing [37] which have IMPLICATIONS for neuropsychiatric disorders.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('INCOMPLETE_EVIDENCE', 235), ('SUPERFICIAL_RELATIONSHIP', 265), ('IMPORTANT_CONSIDERATION', 425)]	13	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'prenatal'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 207, 'rodent'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('GO_0007420', 'brain development', 298, 'brain development'), ('UBERON_0000955', 'brain', 298, 'brain'), ('GO_0007613', 'memory', 357, 'memory')]
PMC2889879	5/2010	S181-PMC2889879	['the dietary intake of Vitamin D in this cohort is COMPARABLE to several other european populations [58].']	[('INCOMPLETE_EVIDENCE', 50)]	1	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC2889879	5/2010	S197-PMC2889879	['BUT, adjustment for multivitamin supplement intake, containing Vitamin D, did not change the ESTIMATES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 93)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC2889879	5/2010	S207-PMC2889879	['INTERESTINGLY, we FOUND a lower rate of psychotic-like symptoms with increasing Vitamin D intake.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18)]	2	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC2898025	5/2010	S4-PMC2898025	['THIS PAPER reviews the PLAUSIBILITY of evidence FOCUSING on the seasonal INTERRELATION of farming, allergies, Viruses, Vitamin D, diet, Birth weight, and handedness.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('SUPERFICIAL_RELATIONSHIP', 73)]	4	[('NCBITaxon_1', 'root', 110, 'viruses'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007567', 'parturition', 136, 'birth')]
PMC2898025	5/2010	S36-PMC2898025	['thus far, the major evidence in SUPPORT of a seasonal EFFECT involves farming, allergies/immunity, Viruses, and Vitamin D. other POSSIBLE factors RELATED to Seasonal Birth are diet, Birth weight, and handedness.']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 146)]	4	[('NCBITaxon_1', 'root', 99, 'viruses'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 157, 'seasonal'), ('GO_0007567', 'parturition', 166, 'birth'), ('GO_0007567', 'parturition', 182, 'birth')]
PMC2898025	5/2010	S112-PMC2898025	['children who live in polluted, inner city environments and who are deprived of regular sunlight exposure HAVE BEEN SHOWN to suffer a higher prevalence of rickets (due to Vitamin D deficiency) than children in rural areas [148].']	[('INCOMPLETE_EVIDENCE', 105)]	1	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC2898025	5/2010	S113-PMC2898025	['seasonal variation in Vitamin D levels also HAS BEEN SUGGESTED as a factor differentially AFFECTING newborn Growth Plate width, and this MAY explain WHY babies Born in australia around october (spring) are relatively heavier than those Born at other times [156].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 137), ('EXPLICIT_QUESTION', 149)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002516', 'epiphyseal plate', 108, 'growth plate'), ('GO_0007567', 'parturition', 160, 'born'), ('GO_0007567', 'parturition', 236, 'born')]
PMC3032617	5/2010	S8-PMC3032617	['conclusion\nthe results of THIS STUDY SUGGEST including Vitamin C in the GUIDELINES of multivitamin PREVENTION for Pregnant women, ESPECIALLY in developing countries where seasonal availability of fruits and Vegetables COULD result in adverse clinical outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 72), ('PROBABLE_UNDERSTANDING', 72), ('SUPERFICIAL_RELATIONSHIP', 99), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 218)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin C'), ('GO_0007565', 'female pregnancy', 114, 'pregnant'), ('CHEBI_33267', 'elemental nitrogen', 207, 'vegetables')]
PMC3032617	5/2010	S15-PMC3032617	['kallner et al., have DEMONSTRATED that at Tissue saturation, whole body Vitamin C content is approximately 20mg/kg, or 1500mg, and that during depletion its loss is at a rate of 3% of whole-body content per day [4].']	[('INCOMPLETE_EVIDENCE', 21)]	1	[('UBERON_0000479', 'tissue', 42, 'tissue'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin C')]
PMC3032617	5/2010	S29-PMC3032617	['the book HIGHLIGHTS the benefit in decreasing the incidence of common cold by a continuous and mega-dose Vitamin C intake (>1g/day).']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 105, 'vitamin C')]
PMC3032617	5/2010	S30-PMC3032617	['SEVERAL randomized placebo controlled STUDIES have ATTEMPTED to repeat pauling’s experience with INCONSISTENT and variable results which to date can not provide a definite conclusion around the real extent of overall health BENEFIT brought in by Vitamin C high daily intake [16-18].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 38), ('DIFFICULT_TASK', 51), ('INCOMPLETE_EVIDENCE', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('IMPORTANT_CONSIDERATION', 224)]	6	[('CHEBI_27300', 'vitamin D', 246, 'vitamin C')]
PMC3032617	5/2010	S60-PMC3032617	['we HYPOTHESIZED to record at least 30% of women not hospitalized during Pregnancy in the control group in consideration of the fact they were supplemented regularly throughout their Pregnancy with Ferrous, Folic Acid and b-Complex for anemia prevention, also followed-up every month, ON THE OTHER SIDE at least a 50% of women not hospitalized in the group of women supplemented with Vitamin C in a 1:1 randomized ratio.']	[('INCOMPLETE_EVIDENCE', 3), ('DIFFICULT_TASK', 223), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 284)]	3	[('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy'), ('CHEBI_15378', 'hydron', 197, 'ferrous'), ('CHEBI_30751', 'formic acid', 206, 'folic acid'), ('CHEBI_34652', 'compactin diol lactone', 223, 'complex'), ('GO_0032991', 'protein-containing complex', 223, 'complex'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin C')]
PMC3032617	5/2010	S82-PMC3032617	['child low Birth weight was FOUND in 29 women in the Vitamin C group and in 47 women among the control group, this difference was considered significant ( results are summarized intable 2).']	[('INCOMPLETE_EVIDENCE', 27)]	1	[('GO_0007567', 'parturition', 10, 'birth'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin C')]
PMC3032617	5/2010	S88-PMC3032617	['seemingly, in both groups a linear CORRELATION was FOUND between the hospitalization rate and the Delivery body mass index (Vitamin C group (r=0.59), cl 0.49-0.68; control group (r=0.43), cl 0.3-0.54; p=0.0001).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 51)]	2	[('GO_0007567', 'parturition', 98, 'delivery'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin C')]
PMC3032617	5/2010	S94-PMC3032617	['AS a CONFIRMATION of this data, EVEN when women in the two groups were stratified for overall number of times hospitalized, the Vitamin C group was shown to achieve significantly better results.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 32)]	3	[('CHEBI_27300', 'vitamin D', 128, 'vitamin C')]
PMC3032617	5/2010	S99-PMC3032617	['in the case of children Born with a body weight lower than 2500g, the significant difference FOUND among groups in favor of the Vitamin C women is INTRIGUING as it CAN be INTERPRETED as more and better energy supply to child during Gestation.']	[('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 147), ('INCOMPLETE_EVIDENCE', 164), ('PROBABLE_UNDERSTANDING', 171)]	4	[('GO_0007567', 'parturition', 24, 'born'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin C'), ('GO_0007565', 'female pregnancy', 232, 'gestation')]
PMC3032617	5/2010	S102-PMC3032617	['INTERESTINGLY, ALTHOUGH the average weight gain was normal in the two groups during Pregnancy without any significant statistical difference, this was FOUND lower in the Vitamin C group COMPARED TO controls, and this COULD SUGGEST the POSSIBILITY of a better Fatty Acid Catabolism provided by high dose Vitamin C intake which IS KNOWN to enhance Carnitine synthesis, a fundamental long chain Fatty Acid transporter to the Mitochondrial site for energy production in form of atp, also, Ascorbic Acid is INVOLVED in the biosynthetic pathway of Thyroid hormones which are known regulators of the basal Metabolism.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 186), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 235), ('INCOMPLETE_EVIDENCE', 326), ('SUPERFICIAL_RELATIONSHIP', 502)]	9	[('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin C'), ('CHEBI_35366', 'fatty acid', 259, 'fatty acid'), ('GO_0009062', 'fatty acid catabolic process', 259, 'fatty acid catabolism'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin C'), ('CHEBI_17126', 'carnitine', 346, 'carnitine'), ('GO_0015915', 'fatty-acyl group transport', 392, 'fatty acid'), ('GO_0005739', 'mitochondrion', 422, 'mitochondrial'), ('CHEBI_22652', 'ascorbic acid', 485, 'ascorbic acid'), ('CHEBI_9437', 'temoporfin', 542, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 542, 'thyroid'), ('GO_0008152', 'metabolic process', 599, 'metabolism')]
PMC3032617	5/2010	S107-PMC3032617	['considering the IMPORTANCE of systolic Blood pressure during Pregnancy which is a direct reflex of mother’s Blood output and THEREFORE child Nutrient provision, we compared in each group the difference from baseline to end of Pregnancy and a significant average increase was FOUND in both groups from baseline, with a higher increase in the Vitamin C group.']	[('IMPORTANT_CONSIDERATION', 16), ('PROBABLE_UNDERSTANDING', 125), ('INCOMPLETE_EVIDENCE', 275)]	3	[('UBERON_0000178', 'blood', 39, 'blood'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('UBERON_0000178', 'blood', 108, 'blood'), ('CHEBI_33284', 'nutrient', 141, 'nutrient'), ('GO_0007565', 'female pregnancy', 226, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 341, 'vitamin C')]
PMC3032617	5/2010	S108-PMC3032617	['this data SUGGEST AT LEAST two considerations; first of all regular iron, Folic Acid and Vitamin B-Complex PROTECTED women from Blood and energy loss by stimulating Red Blood Cells and THEREFORE Hemoglobin Formation.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 107), ('PROBABLE_UNDERSTANDING', 185)]	4	[('CHEBI_30751', 'formic acid', 74, 'folic acid'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin B'), ('GO_0032991', 'protein-containing complex', 99, 'complex'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CL_0000232', 'erythrocyte', 165, 'red blood cells'), ('GO_0030154', 'cell differentiation', 165, 'red blood cells'), ('UBERON_0000178', 'blood', 169, 'blood'), ('GO_0042541', 'hemoglobin biosynthetic process', 195, 'hemoglobin formation')]
PMC3032617	5/2010	S109-PMC3032617	['in second place , the higher increase achieved with the Vitamin C supplementation (8mmhg vs. 4.5mmhg), with a TREND towards SIGNIFICANCE, can be INTERPRETED in two ways; as an increased Gastric absorption of iron in the presence of Ascorbic Acid that HAS BEEN DEMONSTRATED in SEVERAL STUDIES [1,3,9,22] and also, the Red Blood Cell protection from oxidation in the presence of high amounts of Ascorbic Acid which HAS BEEN DEMONSTRATED to be an Electron Donor of Glutathione, a vital antioxidant of Red Blood Cells [1,3,24].']	[('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 124), ('FULL_UNKNOWN', 145), ('INCOMPLETE_EVIDENCE', 251), ('INCOMPLETE_EVIDENCE', 260), ('INCOMPLETE_EVIDENCE', 276), ('INCOMPLETE_EVIDENCE', 413)]	7	[('CHEBI_27300', 'vitamin D', 56, 'vitamin C'), ('UBERON_0001844', 'cochlea', 186, 'gastric'), ('CHEBI_22652', 'ascorbic acid', 232, 'ascorbic acid'), ('CL_0000232', 'erythrocyte', 317, 'red blood cell'), ('UBERON_0000178', 'blood', 321, 'blood'), ('CHEBI_22652', 'ascorbic acid', 393, 'ascorbic acid'), ('CHEBI_10545', 'electron', 444, 'electron'), ('CHEBI_13193', 'hydrogen acceptor', 453, 'donor'), ('CHEBI_16856', 'glutathione', 462, 'glutathione'), ('CL_0000232', 'erythrocyte', 498, 'red blood cells'), ('UBERON_0000178', 'blood', 502, 'blood')]
PMC3032617	5/2010	S112-PMC3032617	['the choice of dosing the Vitamin C supplement 400mg daily matured after reviewing the medical literature were it was HIGHLIGHTED that at doses exceeding 1g daily the PROBABILITY of side-effects such as diarrhea and Renal colic increased greatly [1,3,13,14] on the OTHER side doses up to 500 mg daily are advised by the official statement of the linus pauling’s institute to the general population, this led us to choose this dose as the SAFEST.']	[('INCOMPLETE_EVIDENCE', 117), ('PROBABLE_UNDERSTANDING', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('IMPORTANT_CONSIDERATION', 437)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin C'), ('UBERON_0002113', 'kidney', 215, 'renal')]
PMC3032617	5/2010	S117-PMC3032617	['ALTHOUGH we DID not achieve the expected 50% of patients not hospitalized in the Vitamin C group, the difference between the Vitamin C group and controls, 42% vs. 28% was FOUND significant, also is to note the higher amount of drop-outs in the Vitamin C group which MIGHT have INFLUENCED the results (13 vs. 3).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 266), ('SUPERFICIAL_RELATIONSHIP', 277)]	5	[('CHEBI_27300', 'vitamin D', 81, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin C')]
PMC3032617	5/2010	S128-PMC3032617	['our results INDICATE the benefit of adding Vitamin C in the guidelines of multivitamin supplementation to Pregnant women.']	[('INCOMPLETE_EVIDENCE', 12)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin C'), ('GO_0007565', 'female pregnancy', 106, 'pregnant')]
PMC2874518	6/2010	S111-PMC2874518	['women in our cohort were receiving adequate amounts of these Micronutrients from their diet alone, as assessed by the 24-hour dietary Recall (table 2), confirming the inverse Supplement HYPOTHESIS, that women who least NEED Supplements are most LIKELY to take them.22\nOTHER STUDIES have SUGGESTED POTENTIAL adverse EFFECTS of SOME Supplements, specifically those containing antioxidant Vitamins such as Vitamins C and E, on Pregnancy outcome when taken by women with adequate dietary Micronutrient intake.']	[('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 219), ('PROBABLE_UNDERSTANDING', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 268), ('INCOMPLETE_EVIDENCE', 268), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('SUPERFICIAL_RELATIONSHIP', 315), ('INCOMPLETE_EVIDENCE', 326)]	9	[('CHEBI_33839', 'macromolecule', 61, 'micronutrients'), ('GO_0060033', 'anatomical structure regression', 134, 'recall'), ('CHEBI_16158', 'steroid sulfate', 175, 'supplement'), ('CHEBI_33341', 'titanium atom', 224, 'supplements'), ('CHEBI_33341', 'titanium atom', 331, 'supplements'), ('CHEBI_33277', 'gamma-tocotrienol', 386, 'vitamins'), ('CHEBI_27300', 'vitamin D', 403, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 418, 'E'), ('GO_0007565', 'female pregnancy', 424, 'pregnancy'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 484, 'micronutrient')]
PMC2874518	6/2010	S113-PMC2874518	[',23in a case–control study of offspring with congenital Heart disease, FOUND that periconceptual use of Vitamin E supplements with high dietary intake of the same Vitamin was ASSOCIATED with up to nine-fold increase in the risk of congenital Heart disease.']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 175)]	2	[('UBERON_0000948', 'heart', 56, 'heart'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin E'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin'), ('UBERON_0000948', 'heart', 242, 'heart')]
PMC2874518	6/2010	S114-PMC2874518	['ANOTHER STUDY FOUND that use of supplements for Vitamins C and E was ASSOCIATED with an INCREASED RISK of premature rupture of membranes.24unfortunately, this information was NOT RECORDED in our study.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 88), ('FULL_UNKNOWN', 175)]	5	[('CHEBI_27300', 'vitamin D', 48, 'vitamins C'), ('PR_000004900', 'complement C3', 57, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 63, 'E')]
PMC2874518	6/2010	S117-PMC2874518	['a RECENT-meta-analysis of seven studies CONCLUDED that combined Vitamin C and e supplementation had no potential benefit in the improvement of maternal and neonatal outcome and increased the risk of Gestational Hypertension in women at risk of pre-eclampsia.26\nit is WELL ESTABLISHED that there are significant INTERACTIONS between Micronutrients and their Metabolism.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 267), ('PROBABLE_UNDERSTANDING', 267), ('SUPERFICIAL_RELATIONSHIP', 311)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin C'), ('GO_0007549', 'dosage compensation', 199, 'gestational hypertension'), ('CHEBI_33839', 'macromolecule', 332, 'micronutrients'), ('GO_0008152', 'metabolic process', 357, 'metabolism')]
PMC3075531	7/2010	S8-PMC3075531	['also, OUR STUDY SHOWED significant DISCREPANCY between the two groups ACCORDING TO the rate of deficiency, insufficiency and normal range of Vitamin D categories (p=0.021).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3075531	7/2010	S9-PMC3075531	['conclusions:\nwe FOUND the same results as those studies carried out in europe and north america; i.e., lower Serum Vitamin D level in ms patients than that in normal population, IN SPITE of sufficient sun exposure in isfahan region.']	[('INCOMPLETE_EVIDENCE', 16), ('ANOMALY_CURIOUS_FINDING', 178)]	2	[('UBERON_0001977', 'blood serum', 109, 'serum'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]
PMC3075531	7/2010	S11-PMC3075531	['SHOWED that sun exposure in Childhood period PREVENTS from ms.16third, it SEEMS low risk of ms in white population is ASSOCIATED with high Serum level of vitamin d or high oral Intake via supplements or oily fish in SOME STUDIES.217–19fourth, it HAVE BEEN SHOWN that Vitamin D CAN be a PROTECTIVE agent against experimental Autoimmune encephalitis in Mice (like ms in Humans).48finally, some scientists administered 100-1700 iu/day Vitamin D supplements in ms patients and OBSERVED the reduction of relapses.20–22the CANDIDATE for estimating Serum level of Vitamin D is 25-Hydroxy Vitamin D, BECAUSE of its prolonged half-Life.823–25it is used to assess an Individual’s overall Vitamin D nutritional status, BECAUSE its formation, UNLIKE that of 1, 25-Dihydroxy Vitamin D, is not tightly Regulated and it has a relatively long half-life (20-60 days).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 277), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 473), ('INCOMPLETE_EVIDENCE', 517), ('PROBABLE_UNDERSTANDING', 592), ('PROBABLE_UNDERSTANDING', 708), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 731)]	13	[('UBERON_0013628', 'pollical pad', 28, 'childhood'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 324, 'autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 351, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 368, 'humans'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D'), ('UBERON_0001977', 'blood serum', 542, 'serum'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 570, '25-hydroxy vitamin D'), ('UBERON_0000104', 'life cycle', 622, 'life'), ('NCBITaxon_1', 'root', 657, 'individual'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_43176', 'hydroxy group', 752, 'dihydroxy'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0065007', 'biological regulation', 788, 'regulated')]
PMC3075531	7/2010	S12-PMC3075531	['there are DIFFERENCES in OPTIMAL level of 25-Hydroxy Vitamin D BUT nowadays internationally ACCEPTED normal range is between 75 nmol/l and 200 nmol/l, and we CONSIDER Serum level below 75 nmol/l and below 2 nmol/l as insufficiency and deficiency, respectively.42325even it SEEMS to achieve the prevention of Autoimmune diseases, the Serum level of Vitamin D MUST BE higher than the level required to reduce osteoporosis (higher than 75 nmol/l).4in attention to high prevalence of ms in iran and especially in isfahan which is ABOUT 43.5/100,0002627and GIVEN that iran is located in an latitude of 32° 50’ and longitude of 51° 43’ with enough sun exposure and BECAUSE nobody INVESTIGATED the RELATIONSHIP between Vitamin D, AS an environmental agent, and ms disease in iran before, we DECIDED to compare the Serum level of 25-Hydroxy Vitamin D in ms patients and healthy control group in isfahan region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 158), ('ANOMALY_CURIOUS_FINDING', 273), ('IMPORTANT_CONSIDERATION', 358), ('INCOMPLETE_EVIDENCE', 526), ('PROBABLE_UNDERSTANDING', 552), ('PROBABLE_UNDERSTANDING', 659), ('QUESTION_ANSWERED_BY_THIS_WORK', 674), ('SUPERFICIAL_RELATIONSHIP', 691), ('PROBABLE_UNDERSTANDING', 723), ('QUESTION_ANSWERED_BY_THIS_WORK', 784)]	14	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 42, '25-hydroxy vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum'), ('UBERON_0001442', 'skeleton of manus', 308, 'autoimmune'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 712, 'vitamin D'), ('UBERON_0001977', 'blood serum', 807, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 822, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 841, 'D')]
PMC3075531	7/2010	S32-PMC3075531	['the mean level of 25-Hydroxy Vitamin D in case and control groups were 48 and 62 nmol/l, respec-tively, and it SHOWED a significant difference between them (p=0.036).there was not any significant relationship between age and Serum level of Vitamin D in both groups (p=0.83).']	[('INCOMPLETE_EVIDENCE', 111)]	1	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 18, '25-hydroxy vitamin D'), ('UBERON_0001977', 'blood serum', 225, 'serum'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC3075531	7/2010	S35-PMC3075531	['this study SHOWED a significant RELATIONSHIP between Serum levels of Vitamin D between the two groups (p=0.021).']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('UBERON_0001977', 'blood serum', 53, 'serum'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3075531	7/2010	S40-PMC3075531	['discussion\nwe FOUND the same results as studies in europe and north america, which IMPLICATES lower Serum Vitamin D level in ms patients than in normal population, IN SPITE of sufficient sun exposure in isfahan region.23815the HYPOTHESIS that Vitamin D deficiency is a RISK FACTOR for ms was first PROPOSED over 30 years ago4and GAINED CREDIBILITY after the discovery of the immunomodulatory EFFECTS of Vitamin D.5moreover, in the past few years, the epidemiological EVIDENCE of an increased ms risk among Individuals with low Vitamin D concentrations has ACHIEVED SUBSTANTIAL STRENGTH.']	[('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 83), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 269), ('INCOMPLETE_EVIDENCE', 298), ('PROBABLE_UNDERSTANDING', 329), ('SUPERFICIAL_RELATIONSHIP', 392), ('INCOMPLETE_EVIDENCE', 467), ('PROBABLE_UNDERSTANDING', 556)]	10	[('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 403, 'vitamin D'), ('NCBITaxon_1', 'root', 506, 'individuals'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D')]
PMC3075531	7/2010	S43-PMC3075531	['relative to sun exposure, diet is a POOR source of Colecalciferol, providing ONLY 40-400 iu per Food serving,12WHEREAS whole-body uvb exposure for 20 min for a light-skinned Person during the summer months will produce AT LEAST 10,000 iu.713HOWEVER, increased skin pigmentation, age, use of sunscreen, built environment, and environmental FACTORS that reduce the strength of uvb reaching the earth’s surface (e.g., winter season, high latitude, pollution, cloud cover, and Ozone levels) all CONTRIBUTE to reduce skin Colecalciferol production to the point at which diet MIGHT become the primary source.7–14BECAUSE Melanin Pigment in Human skin absorbs uvb,28black People have lower 25 Hydroxyvitamin D concentrations than white People, and are OFTEN Vitamin D deficient.21HOWEVER, the risk of ms in black People is lower than in white People (BECAUSE of Genetic differences).28analyses of the RELATION between Vitamin D status and ms risk are THEREFORE BETTER done separately within each race/ethnic group.']	[('IMPORTANT_CONSIDERATION', 36), ('ANOMALY_CURIOUS_FINDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('PROBABLE_UNDERSTANDING', 219), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241), ('SUPERFICIAL_RELATIONSHIP', 339), ('SUPERFICIAL_RELATIONSHIP', 491), ('INCOMPLETE_EVIDENCE', 570), ('PROBABLE_UNDERSTANDING', 606), ('PROBABLE_UNDERSTANDING', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 772), ('PROBABLE_UNDERSTANDING', 843), ('SUPERFICIAL_RELATIONSHIP', 893), ('PROBABLE_UNDERSTANDING', 943), ('IMPORTANT_CONSIDERATION', 953)]	15	[('CHEBI_50553', 'mancude carbobicyclic parent', 51, 'colecalciferol'), ('CHEBI_33290', 'food', 96, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 174, 'person'), ('CHEBI_25812', 'ozone', 473, 'ozone'), ('CHEBI_50553', 'mancude carbobicyclic parent', 517, 'colecalciferol'), ('CHEBI_25179', 'melanins', 614, 'melanin'), ('CHEBI_26130', 'biological pigment', 622, 'pigment'), ('NCBITaxon_9606', 'Homo sapiens', 633, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 664, 'people'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 682, '25 hydroxyvitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 728, 'people'), ('CHEBI_27300', 'vitamin D', 750, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 805, 'people'), ('NCBITaxon_10088', 'Mus <genus>', 835, 'people'), ('SO_0000704', 'gene', 854, 'genetic'), ('CHEBI_27300', 'vitamin D', 910, 'vitamin D')]
PMC3075531	7/2010	S46-PMC3075531	['the REASONS WHY Vitamin D deficiency is THOUGHT TO be a RISK FACTOR for ms are as follows: first, ms frequency increases with increasing latitude, which is strongly inversely CORRELATED with duration and intensity of uvb from sunlight and Vitamin D concentrations.2830–35second, prevalence of ms is lower than EXPECTED at high latitudes in populations with high Consumption of Vitamin-D-rich Fatty fish43536.']	[('PROBABLE_UNDERSTANDING', 4), ('EXPLICIT_QUESTION', 12), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 175), ('ANOMALY_CURIOUS_FINDING', 310)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('GO_0007631', 'feeding behavior', 362, 'consumption'), ('CHEBI_83326', 'tedizolid phosphate', 377, 'vitamin-D'), ('CHEBI_33250', 'atom', 392, 'fatty')]
PMC3075531	7/2010	S48-PMC3075531	['the ONLY study satisfying this condition used a nested case-control design to sample an underlying prospective cohort comprising over 7 million Individuals who served in the us military and had at least two Serum samples stored in the us department of defense Serum repository.18the study CONCLUDED that Serum concentration of 25 Hydroxyvitamin D in healthy young white Adults is an IMPORTANT PREDICTOR of their risk of developing ms, INDEPENDENTLY from their place of Birth and latitude of residence during childhood.18in a prospective investigation comprising approximately 200,000 women in the usa, Vitamin D intake was measured every 4 years by a comprehensive semi-quantitative Food frequency questionnaire.37the incidence of ms during the 30-year follow-up decreased with increasing Vitamin D intake (p=0.03 for trend) and was 33% lower among women in the highest quintile of Vitamin D intake versus those in the lowest quintile.17furthermore, ms incidence was 41% lower among women taking 400 iu per day or more from Supplements compared with non-users.17ATTEMPTS to RELATE Vitamin D intake to ms risk HAVE also BEEN made in casecontrol studies.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 289), ('IMPORTANT_CONSIDERATION', 383), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 435), ('INCOMPLETE_EVIDENCE', 1062), ('SUPERFICIAL_RELATIONSHIP', 1074), ('INCOMPLETE_EVIDENCE', 1109)]	8	[('NCBITaxon_1', 'root', 144, 'individuals'), ('UBERON_0001977', 'blood serum', 207, 'serum'), ('UBERON_0001977', 'blood serum', 260, 'Serum'), ('UBERON_0001977', 'blood serum', 304, 'serum'), ('CHEBI_37972', 'phosphorus-32 atom', 327, '25'), ('CHEBI_67825', '17beta,21beta-epoxyhopan-3-one', 330, 'hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 370, 'adults'), ('GO_0007567', 'parturition', 469, 'birth'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_33290', 'food', 683, 'food'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 882, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 1024, 'supplements'), ('CHEBI_27300', 'vitamin D', 1081, 'vitamin D')]
PMC3075531	7/2010	S49-PMC3075531	['in norway, a study comprising 119 ms cases and 251 controls living above the arctic circle, where Fatty Fish is a MAJOR CONTRIBUTOR to Vitamin D intake, REPORTED a lower risk of ms for Individuals who Ate fish three or more times per week at 16–20 years of age compared with those with a lower Consumption (odds ratio=0.57 [95%ci 0.33-0.93]; p=0.024).19supplementation with codliver oil was also ASSOCIATED with lower risk of ms, BUT ONLY among Individuals with low summer outdoor activity.']	[('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 396), ('ANOMALY_CURIOUS_FINDING', 430)]	5	[('CHEBI_38677', 'famphur', 98, 'fatty fish'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_1', 'root', 185, 'individuals'), ('GO_0009636', 'response to toxic substance', 201, 'ate'), ('GO_0007631', 'feeding behavior', 294, 'consumption'), ('NCBITaxon_1', 'root', 445, 'individuals')]
PMC3075531	7/2010	S53-PMC3075531	['THUS, if Vitamin D was PROTECTIVE, these cancers WOULD BE EXPECTED to be RARE among Individuals with ms.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('FUTURE_PREDICTION', 49), ('INCOMPLETE_EVIDENCE', 73)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('NCBITaxon_1', 'root', 84, 'individuals')]
PMC3075531	7/2010	S55-PMC3075531	['in a pooled analysis of data from canada, uk, denmark, and sweden including more than 40,000 Individuals with ms, significantly fewer (8.5%) People with ms were Born in november and significantly more (9.1%) were Born in may.39THIS FINDING SUGGESTS that Prenatal exposures or exposures in the first months of Life COULD BE IMPORTANT in ms etiology, BUT the LINK to Vitamin D is UNCLEAR.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 314), ('IMPORTANT_CONSIDERATION', 323), ('ANOMALY_CURIOUS_FINDING', 349), ('SUPERFICIAL_RELATIONSHIP', 357), ('FULL_UNKNOWN', 378)]	8	[('NCBITaxon_1', 'root', 93, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 141, 'people'), ('GO_0007567', 'parturition', 161, 'born'), ('GO_0007567', 'parturition', 213, 'born'), ('GO_0007565', 'female pregnancy', 254, 'prenatal'), ('UBERON_0000104', 'life cycle', 309, 'life'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
PMC3075531	7/2010	S56-PMC3075531	['Genes also CAN AFFECT Vitamin D Metabolism, skin color, and behavior, all of which CAN INFLUENCE circulating 25-Hydroxyvitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 87)]	4	[('SO_0000704', 'gene', 0, 'Genes'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 22, 'vitamin D metabolism'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 109, '25-hydroxyvitamin D')]
PMC3075531	7/2010	S57-PMC3075531	['furthermore, Genetic variations in Vitamin-D-related and other Genes MIGHT INFLUENCE the EFFECTS of Vitamin D on the Immune System.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 89)]	3	[('SO_0000704', 'gene', 13, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 35, 'vitamin-D'), ('SO_0000704', 'gene', 63, 'genes'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0002405', 'immune system', 117, 'immune system')]
PMC3075531	7/2010	S58-PMC3075531	['THEREFORE, Genetic variations in Vitamin-D-related Genes MIGHT also AFFECT ms risk, EITHER directly OR by modifying the EFFECTS of Vitamin D.40\nour IMPLICATIONS for FUTURE RESEARCH and ms prevention and ACCORDING TO the basis of the results of the ONLY longitudinal study of Serum 25-Hydroxyvitamin D and ms onset,18and ASSUM-ING that these results are unbiased and Vitamin D is TRULY PROTECTIVE against ms, over 70% of ms cases in the usa and europe COULD BE PREVENTED by increasing the Serum 25-Hydroxyvitamin D concentration of adolescents and young Adults to above 100 nmol/l.4142these concentrations are commonly FOUND ONLY in Individuals with outdoor lifestyles in sunny regions, BUT COULD BE reached in MOST People by taking 1000-4000 iu Colecalciferol daily.8254344ALTHOUGH these doses are LARGELY CONSIDERED SAFE and POTENTIALLY beneficial for other outcomes,819CONFIRMATION of SAFETY and efficacy in a LARGE randomized TRIAL is NEEDED before making general RECOMMENDATIONS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 148), ('FUTURE_WORK', 165), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 320), ('PROBABLE_UNDERSTANDING', 379), ('SUPERFICIAL_RELATIONSHIP', 385), ('INCOMPLETE_EVIDENCE', 451), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 618), ('ANOMALY_CURIOUS_FINDING', 624), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 686), ('INCOMPLETE_EVIDENCE', 690), ('PROBABLE_UNDERSTANDING', 710), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 773), ('INCOMPLETE_EVIDENCE', 798), ('INCOMPLETE_EVIDENCE', 806), ('IMPORTANT_CONSIDERATION', 817), ('INCOMPLETE_EVIDENCE', 826), ('INCOMPLETE_EVIDENCE', 871), ('IMPORTANT_CONSIDERATION', 887), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 938), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 11, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 33, 'vitamin-D'), ('SO_0000704', 'gene', 51, 'genes'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 275, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 281, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D'), ('UBERON_0001977', 'blood serum', 488, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 494, '25-hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 553, 'adults'), ('NCBITaxon_1', 'root', 632, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 715, 'people'), ('CHEBI_50553', 'mancude carbobicyclic parent', 745, 'colecalciferol')]
PMC3075531	7/2010	S59-PMC3075531	['one option WOULD BE a national or multinational study based on randomization of school districts or other suitable units in regions of low sunlight intensity, PERHAPS including multiple outcomes that MIGHT be AFFECTED by Vitamin D, such as diabetes, obesity, Respiratory infections, and asthma.4546ALTERNATIVELY, high-risk first-degree relatives of individu-als with ms COULD BE targeted in a smaller trial,47ALTHOUGH randomization and compliance COULD BE more CHALLENGING.']	[('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('FUTURE_WORK', 370), ('ANOMALY_CURIOUS_FINDING', 409), ('FUTURE_WORK', 447), ('DIFFICULT_TASK', 461)]	9	[('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 259, 'respiratory')]
PMC3075531	7/2010	S61-PMC3075531	['conclusions\nin conclusion, THIS STUDY SHOWED that Serum Vitamin D deficiency MIGHT be a POTENTIAL environmental predisposing FACTOR for developing multiple sclerosis in our region, and NEED to follow FACTORS that cause THIS PROBLEM including dietary, Genetic, and other ones.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 125), ('IMPORTANT_CONSIDERATION', 185), ('SUPERFICIAL_RELATIONSHIP', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 219), ('IMPORTANT_CONSIDERATION', 224)]	9	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('SO_0000704', 'gene', 251, 'genetic')]
PMC3075531	7/2010	S62-PMC3075531	['WHEREAS FUTURE observational epidemiological studies and Genetic and molecular INVESTIGATIONS WILL be useful to strengthen and refine the HYPOTHESIS, it MIGHT be NECESSARY to do a LARGE randomized TRIAL to establish the SAFETY and efficacy NEEDED to promote large-scale Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 79), ('FUTURE_PREDICTION', 94), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 153), ('IMPORTANT_CONSIDERATION', 162), ('FUTURE_WORK', 180), ('IMPORTANT_CONSIDERATION', 220), ('FUTURE_WORK', 240)]	10	[('SO_0000704', 'gene', 57, 'genetic'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3075531	7/2010	S63-PMC3075531	['a test of the HYPOTHESIS that Vitamin D COULD reduce ms risk WILL REQUIRE the administration of relatively high doses of Vitamin D to hundreds of thousands of young adults for several years, and careful monitoring for UNFORESEEN ADVERSE EFFECTS is MANDATORY.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 40), ('FUTURE_PREDICTION', 61), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 218), ('IMPORTANT_CONSIDERATION', 248)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC3075531	7/2010	S65-PMC3075531	['furthermore, screening of Serum 25-Hydroxyvitamin D concentrations is LIKELY to identify a large proportion of patients who are Vitamin D deficient or insufficient, and who MIGHT BENEFIT from Vitamin D supplementation for PREVENTION of osteoporosis and other complications, especially multiple sclerosis.']	[('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 173), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 222)]	4	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 32, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC2913107	8/2010	S0-PMC2913107	['on the aetiology of autism\ni have SUGGESTED that the primary environmental TRIGGER for autism is not vaccinations, Toxins or infections, BUT Gestational and early childhood Vitamin D deficiency (1,2).']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	3	[('CHEBI_27026', 'toxin', 115, 'toxins'), ('GO_0007565', 'female pregnancy', 141, 'gestational'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC2913107	8/2010	S1-PMC2913107	['subsequently, the title of an article in scientific american RECENTLY ASKED, ‘WHAT IF Vitamin D deficiency is a cause of autism?’ (3) since then, an ARTICLE on Vitamin D and autism in acta paediatrica (4) and the accompanying COMMENTARY (5) have added to the ACCELERATING SUSPICION that Vitamin D deficiency – EITHER during Pregnancy OR early childhood – MAY BE an environmental TRIGGER for the Genetic disease of autism.']	[('INCOMPLETE_EVIDENCE', 61), ('EXPLICIT_QUESTION', 70), ('EXPLICIT_QUESTION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('EXPLICIT_QUESTION', 127), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 226), ('IMPORTANT_CONSIDERATION', 259), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 272), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 310), ('INCOMPLETE_EVIDENCE', 355), ('SUPERFICIAL_RELATIONSHIP', 379)]	12	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('SO_0000704', 'gene', 395, 'genetic')]
PMC2913107	8/2010	S5-PMC2913107	['SIMULTANEOUS with the above two acta paediatrica publications, a PAPER elsewhere REPORTED that among 117 Adult psychiatric outpatients is sweden with various diagnoses, the 10 patients with autism had the lowest Vitamin D levels of any of the groups studied, a mean of 12 ng/ml (31 nm), approaching the osteomalacic range for Adults and the Rachitic range for children (6).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 81)]	3	[('UBERON_0007023', 'adult organism', 105, 'adult'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('UBERON_0007023', 'adult organism', 326, 'adults'), ('UBERON_0000387', 'meniscus', 341, 'rachitic')]
PMC2913107	8/2010	S6-PMC2913107	['even more INTERESTING, SOME of the patients SEEMED to IMPROVE when treated with an average dose of ABOUT 4000 iu of Vitamin D/day.']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 44), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 99)]	5	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC2913107	8/2010	S8-PMC2913107	['a 2008 REVIEW DETAILED the DEVASTATING EFFECT Gestational Vitamin D deficiency has on developing Mammalian Brains (7).']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 27), ('SUPERFICIAL_RELATIONSHIP', 39)]	4	[('GO_0007565', 'female pregnancy', 46, 'gestational'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('NCBITaxon_40674', 'Mammalia', 97, 'mammalian'), ('UBERON_0000955', 'brain', 107, 'brains')]
PMC2913107	8/2010	S10-PMC2913107	['FOR THIS REASON, in 2007, the canadian paediatric society CAUTIONED Pregnant women they MAY REQUIRE NOT 400 iu/day BUT 2000 iu/day, or more, to PREVENT Gestational Vitamin D deficiency (9).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 58), ('INCOMPLETE_EVIDENCE', 88), ('IMPORTANT_CONSIDERATION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('SUPERFICIAL_RELATIONSHIP', 144)]	6	[('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('GO_0007565', 'female pregnancy', 152, 'gestational'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC2913107	8/2010	S15-PMC2913107	['even more INTRIGUING, BOTH PAPERS REPORT that the mental condition in rickets IMPROVED with Vitamin D.\nANOTHER of the MYSTERIES of autism is the APPARENT INCREASED INCIDENCE of autism in the children of richer college-educated parents, ESPECIALLY women, a FINDING announced a few months ago (12).']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FULL_UNKNOWN', 118), ('ANOMALY_CURIOUS_FINDING', 145), ('IMPORTANT_CONSIDERATION', 154), ('ANOMALY_CURIOUS_FINDING', 236), ('INCOMPLETE_EVIDENCE', 256)]	11	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC2913107	8/2010	S19-PMC2913107	['IF the Vitamin D THEORY is TRUE, autism SHOULD BE MORE COMMON in richer well-educated mothers, who are more LIKELY THAN other mothers to practice sun avoidance and use sunblock (1,2).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 27), ('FUTURE_PREDICTION', 40), ('PROBABLE_UNDERSTANDING', 50), ('PROBABLE_UNDERSTANDING', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	7	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D')]
PMC2913107	8/2010	S37-PMC2913107	['WHILE the Omega-3 and mercury content of fish is WELL KNOWN, LESS WELL KNOWN is THE FACT THAT fish is one of the few Foods with SIGNIFICANT amounts of Vitamin D, which, as referenced earlier, PROTECTS the Genome from damage by Toxins.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 61), ('ANOMALY_CURIOUS_FINDING', 80), ('IMPORTANT_CONSIDERATION', 128), ('SUPERFICIAL_RELATIONSHIP', 192)]	6	[('CHEBI_79370', 'ibho#10', 10, 'omega-3'), ('CHEBI_33290', 'food', 117, 'foods'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('SO_0001026', 'genome', 205, 'genome'), ('CHEBI_27026', 'toxin', 227, 'toxins')]
PMC2913107	8/2010	S41-PMC2913107	['a comment to the authors (20) DETAILED the EVIDENCE that Antiepileptic Drugs are one of the few classes of Drugs that CONSISTENTLY and SIGNIFICANTLY INTERFERE with Vitamin D Metabolism, lowering 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 43), ('PROBABLE_UNDERSTANDING', 118), ('IMPORTANT_CONSIDERATION', 135), ('SUPERFICIAL_RELATIONSHIP', 149)]	5	[('CHEBI_35218', 'anthocyanin cation', 57, 'antiepileptic'), ('CHEBI_23888', 'drug', 71, 'drugs'), ('CHEBI_23888', 'drug', 107, 'drugs'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0008152', 'metabolic process', 174, 'metabolism'), ('CHEBI_71657', 'versiconol acetate', 195, '25(OH)D')]
PMC2913107	8/2010	S42-PMC2913107	['i AGREE WITH dr eyles’ comment that the Vitamin D THEORY is ‘HIGHLY PARSIMONIOUS.’ indeed, it was love of parsimony that led me to first HYPOTHESIZE that Vitamin D is intimately INVOLVED in the pathology and epidemiology of both autism and influenza (21).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 178)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC2913107	8/2010	S45-PMC2913107	['the Vitamin D THEORY of autism DOES NOT DIMINISH Genetic CONTRIBUTIONS to autism occurrence.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('SO_0000704', 'gene', 49, 'genetic')]
PMC2913107	8/2010	S48-PMC2913107	['IF this THEORY is TRUE, the PATH TOWARDS EFFECTIVE PREVENTION – and PERHAPS a treatment EFFECT IF ADEQUATE physiological doses of Vitamin D are given – is so SIMPLE, so SAFE, so INEXPENSIVE, so READILY AVAILABLE and so easy, that it DEFIES IMAGINATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 95), ('IMPORTANT_CONSIDERATION', 98), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 169), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 194), ('ANOMALY_CURIOUS_FINDING', 233)]	15	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC2913107	8/2010	S49-PMC2913107	['seventeen Vitamin D EXPERTS RECENTLY STATED, ‘IN OUR OPINION, children with chronic illnesses such as autism, diabetes and/or frequent infections SHOULD BE supplemented with higher doses of sunshine or Vitamin D3, doses ADEQUATE to maintain their 25(Oh)D levels in the mid-normal of the reference range [65 ng/ml (162 nmol/l)] – and SHOULD BE so supplemented year round.’ (22)\nfinally, IF TRUE, a DARKER SIDE of the THEORY EMERGES.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 146), ('IMPORTANT_CONSIDERATION', 220), ('IMPORTANT_CONSIDERATION', 333), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 386), ('PROBABLE_UNDERSTANDING', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 397), ('INCOMPLETE_EVIDENCE', 416), ('INCOMPLETE_EVIDENCE', 423)]	12	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 202, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 202, 'vitamin D3'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D')]
PMC2963768	10/2010	S0-PMC2963768	['Vitamin D status of infants in northeastern rural bangladesh: preliminary observations and a review of potential determinants\n\nabstract\nVitamin D deficiency is a GLOBAL PUBLIC-HEALTH CONCERN, EVEN in tropical regions where the risk of deficiency was PREVIOUSLY ASSUMED to be low due to cutaneous Vitamin D Synthesis stimulated by exposure to sun.']	[('IMPORTANT_CONSIDERATION', 162), ('ANOMALY_CURIOUS_FINDING', 192), ('INCOMPLETE_EVIDENCE', 250), ('PROBABLE_UNDERSTANDING', 261)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 136, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 296, 'vitamin D synthesis')]
PMC2963768	10/2010	S1-PMC2963768	['POOR Vitamin D status, INDICATED by low Serum concentrations of 25-Hydroxyvitamin D [25(Oh)D], HAS BEEN observed in south asian populations.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('UBERON_0001977', 'blood serum', 40, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 64, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D')]
PMC2963768	10/2010	S2-PMC2963768	['HOWEVER, LIMITED INFORMATION is available on the Vitamin D status of young infants in this region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC2963768	10/2010	S3-PMC2963768	['THEREFORE, to gain PRELIMINARY INSIGHTS into the Vitamin D status of infants in rural bangladesh, 25(Oh)D was ASSESSED in a group of community-sampled control participants in a pneumonia case-control study in rural sylhet, bangladesh (25°n) during the winter dry season (january-february).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 110)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D')]
PMC2963768	10/2010	S10-PMC2963768	['in conclusion, the Vitamin D status in young infants in rural sylhet, bangladesh, was poorer than MIGHT be expected based on geographic CONSIDERATIONS.']	[('INCOMPLETE_EVIDENCE', 98), ('IMPORTANT_CONSIDERATION', 136)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC2963768	10/2010	S13-PMC2963768	['HOWEVER, SINCE Vitamin D status has become READILY estimable BASED on Serum/Plasma 25-Hydroxyvitamin D concentration [25(Oh)D] (2), epidemiologic RESEARCH aimed at identifying PREVIOUSLY-UNCHARACTERIZED AT-risk populations and characterizing NOVEL disease ASSOCIATIONS with Vitamin D status HAS BEEN greatly facilitated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('PROBABLE_UNDERSTANDING', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('FUTURE_WORK', 146), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 203), ('FULL_UNKNOWN', 242), ('SUPERFICIAL_RELATIONSHIP', 256), ('INCOMPLETE_EVIDENCE', 291)]	11	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 83, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC2963768	10/2010	S16-PMC2963768	['FEW STUDIES on Vitamin D status in infancy HAVE BEEN conducted in south asia (table 1).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 43)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC2963768	10/2010	S19-PMC2963768	["summary of studies of Vitamin D status of infants and children aged 1 month to <5 years in bangladesh, pakistan, and indiastudyparticipantslocationlatitudeseasonno.mean 25(Oh)d (nmol/l)categorical descriptions of Vitamin D statuscombs et al ., 2008 (9)aged 1-5 years; no clinical signs of ricketschakaria subdistrict, cox's bazar, bangladesh21°nunknown15868.3\n25(Oh)D <25 nmol/l in 6% (10/158)\n25(Oh)D <37.5 nmol/l in 21% (33/158)fischer et al ., 1999 (10)cases in case-control study of rickets; aged 10-120 monthschakaria subdistrict, bangladesh21°nunknown1450\nrange 17.5-162.5 nmol/l\n25(Oh)D <35 nmol/l in 2/14 (14%).controlschakaria subdistrict, bangladesh21°nunknown1362.5\nrange 55-87.5 nmol/l\nnone with 25(Oh)D <35 nmol/latiq et al ., 1998 (11)aged 6 weeks-11 months; immunization clinickarachi, pakistan25°nnovember-march2324.5\n25(Oh)D <25 nmol/l in 52% (throughout the year)april-october4840.7agarwal et al ., 2002 (12)aged 9-24 months; high-pollution areamorigate, delhi, india28°nmarch-april2631\n25(oh)d <30 nmol/l in 35%aged 9-24 months; low-pollution areagurgaon, delhi, india28°nmarch-april3168\n25(Oh)D <30 nmol/l in 0%bhalala et al ., 2007 (13)healthy breastfed infants aged 3 monthsmumbai, india18°nthroughout the year3545.5\n25(Oh)D <62.5 nmol/l in 80%tiwari and puliyel, 2004 (14)aged 9-30 months living in impoverished neighbourhoodssundernagari, delhi, india28°njanuary4796.3\n25(Oh)D <35 nmol/l in 2%rajiv colony, delhi, india28°nfebruary4923.8\n25(Oh)D <35nmol/l in 82.9%rajiv colony, delhi, india28°naugust4817.8\n25(Oh)D <35 nmol/l in 84.0%gurgaon, delhi, india28°naugust5219.2\n25(Oh)D <35 nmol/l in 82.0%wayse et al ., 2004 (15)healthy controls in case-control study; aged <5 yearsindapur, india17°nmay-june7038.4\n25(Oh)D <22.5 nmol/l in 31%\n25(Oh)D <50 nmol/l in 61%\nknowledge of the Vitamin D status of young children and infants IS NEEDED to DESIGN STUDIES targeting the aetiologic mechanisms and POTENTIAL health IMPLICATIONS of deficiency."]	[('FUTURE_WORK', 1851), ('FUTURE_WORK', 1864), ('INCOMPLETE_EVIDENCE', 1919), ('IMPORTANT_CONSIDERATION', 1936)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_37972', 'phosphorus-32 atom', 169, '25'), ('CHEBI_17792', 'organohalogen compound', 172, 'OH'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 360, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 394, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 588, '(OH)D'), ('CHEBI_71657', 'versiconol acetate', 708, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 711, 'OH ... D'), ('CHEBI_71657', 'versiconol acetate', 834, '25(OH)D'), ('PR_000006880', 'extracellular matrix protein 2', 834, '25 ... OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 1110, 'OH)D'), ('CHEBI_71657', 'versiconol acetate', 1239, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1393, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1399, 'D'), ('CHEBI_71657', 'versiconol acetate', 1462, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1531, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1596, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1733, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1761, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1804, 'vitamin D')]
PMC2963768	10/2010	S20-PMC2963768	['a case-control study on the ASSOCIATION between acute Lower Respiratory Tract infection (alri) and Vitamin D status in infants and young children conducted in zakiganj subdistrict of sylhet district in bangladesh, during january-february 2008, provided an OPPORTUNITY to gain PRELIMINARY INSIGHTS into the Vitamin D status of infants in northeastern rural bangladesh (4).']	[('SUPERFICIAL_RELATIONSHIP', 28), ('FUTURE_WORK', 256), ('INCOMPLETE_EVIDENCE', 276), ('INCOMPLETE_EVIDENCE', 288)]	4	[('UBERON_0004905', 'articulation', 54, 'lower respiratory tract'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
PMC2963768	10/2010	S21-PMC2963768	['HERE, we AIMED to describe the Vitamin D status of the source population and briefly review the POTENTIAL DETERMINANTS of low infant 25(Oh)D in this setting.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 133, '25 ... OH ... D')]
PMC2963768	10/2010	S33-PMC2963768	['collection of data\ncaregivers (mothers) of participants were administered a questionnaire that addressed selected infant, maternal and household characteristics POTENTIALLY associated with Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 161)]	1	[('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
PMC2963768	10/2010	S34-PMC2963768	['maternal Intake of Foods from Animal sources, which included POTENTIAL sources of Vitamin D and rich sources of Calcium, was ASSESSED based on the reported frequency of consumption of Food items/categories over the seven days preceding enrollment.']	[('INCOMPLETE_EVIDENCE', 61), ('QUESTION_ANSWERED_BY_THIS_WORK', 125)]	2	[('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_33290', 'food', 19, 'foods'), ('NCBITaxon_33208', 'Metazoa', 30, 'animal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 112, 'calcium'), ('CHEBI_33290', 'food', 184, 'food')]
PMC2963768	10/2010	S45-PMC2963768	['as a secondary exploratory analysis, observations relating to infant, maternal or household FACTORS that POTENTIALLY INFLUENCED Vitamin D status were drawn from the complete sample of 74 participants (cases and controls) in whom 25(Oh)D was measured.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 117)]	3	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 229, '25(OH)D')]
PMC2963768	10/2010	S51-PMC2963768	['given that the DETERMINANTS of Vitamin D status MAY DIFFER across age-groups, associational analyses were repeated among participants aged less than six months.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC2963768	10/2010	S76-PMC2963768	['results of analyses of ASSOCIATIONS of Vitamin D status with POTENTIAL RISK FACTORS were SIMILAR when repeated in a group restricted to participants aged less than six months (data not shown).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC2963768	10/2010	S83-PMC2963768	["cement, brick, or tin)\xa0\xa0floor03 (6)0.221\xa0\xa0walls6 (25)16 (32)0.537\xa0\xa0roof20 (83)45 (90)0.411child is/was usually swaddled during the first 6 months of Life24 (100)46 (92)0.154child was deliberately exposed to sunlight before Learning to crawl/walk18 (75)36 (72)0.786mother's clothing practices when outdoors\xa0\xa0head usually covered23 (96)50 (100)0.146\xa0\xa0Face usually covered00-\xa0\xa0Arms usually covered24 (100)48 (96)0.321\xa0\xa0usually wears burka in public21 (91)47 (94)0.672number of meals at which mother reportedly Consumed Food items from Animal source during the past week (median±iqr)any type of fish13.0±514.5±120.158\xa0\xa0small fish with Bones6.0±76±80.561\xa0\xa0milk0±00±70.119\xa0\xa0meat0±0.50±20.415\xa0\xa0Eggs0±1.50±20.247\xa0\xa0Liver0±00±00.324\nfigures in parentheses indicate percentages;\niqr=interquartile range;\nsd=standard deviation\n\ndiscussion\nTHIS PRELIMINARY STUDY in sylhet during the winter dry season REVEALED that the Vitamin d status of young infants in rural bangladesh MIGHT be POOR enough to put many AT RISK of rickets and other POTENTIAL Vitamin D-RELATED health consequences."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 827), ('QUESTION_ANSWERED_BY_THIS_WORK', 832), ('QUESTION_ANSWERED_BY_THIS_WORK', 832), ('INCOMPLETE_EVIDENCE', 889), ('INCOMPLETE_EVIDENCE', 961), ('IMPORTANT_CONSIDERATION', 970), ('IMPORTANT_CONSIDERATION', 994), ('INCOMPLETE_EVIDENCE', 1023), ('SUPERFICIAL_RELATIONSHIP', 1043)]	9	[('UBERON_0008878', 'palmar part of manus', 149, 'life24'), ('GO_0007612', 'learning', 223, 'learning'), ('UBERON_0001456', 'face', 349, 'Face'), ('UBERON_0001460', 'arm', 374, 'Arms'), ('GO_0007631', 'feeding behavior', 507, 'consumed'), ('CHEBI_33290', 'food', 516, 'food'), ('NCBITaxon_33208', 'Metazoa', 532, 'animal'), ('UBERON_0001474', 'bone element', 631, 'bones6'), ('CL_0000059', 'ameloblast', 687, 'Eggs0'), ('UBERON_0001773', 'sclera', 706, 'Liver0'), ('CHEBI_33229', 'vitamin (role)', 907, 'vitamin'), ('CHEBI_27300', 'vitamin D', 1033, 'vitamin D')]
PMC2963768	10/2010	S84-PMC2963768	['applying a very CONSERVATIVE definition of Vitamin D deficiency [25(Oh)D <25 nmol/l], we ESTIMATED that ABOUT one-third of infants aged 1-6 months MAY BE Vitamin D-deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 147)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 65, '25'), ('PR_000006444', 'diacylglycerol kinase delta', 71, 'D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC2963768	10/2010	S85-PMC2963768	['TO OUR KNOWLEDGE, THIS is the FIRST report of Vitamin D status in young infants in bangladesh.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC2963768	10/2010	S87-PMC2963768	['to put these FINDINGS in a global context, it is first useful to draw a comparison with WHAT is PERHAPS the ONLY young infant ‘reference’ group studied at the equator where Vitamin D status would be expected to be optimal throughout the year in the absence of dietary supplementation or fortification.']	[('INCOMPLETE_EVIDENCE', 13), ('EXPLICIT_QUESTION', 88), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 108)]	4	[('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC2963768	10/2010	S99-PMC2963768	['THEREFORE, these data from rural bangladesh, in combination with EARLIER FINDINGS from infants in urban pakistan, india, and uae, have DEMONSTRATED that the Vitamin D status of young infants in south asia and the middle east MAY BE no better than that of unsupplemented infants at much higher northern latitudes in north america, where GUIDELINES SUPPORT the provision of routine Vitamin D supplementation to all breastfed infants (21,22).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 225), ('PROBABLE_UNDERSTANDING', 336), ('INCOMPLETE_EVIDENCE', 347)]	7	[('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D')]
PMC2963768	10/2010	S102-PMC2963768	['IN FACT, a seasonal differential in Vitamin D status was OBSERVED among pakistani infants (11).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 57)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC2963768	10/2010	S103-PMC2963768	['THEREFORE, the representativeness of our data is LIMITED because they REFLECT Vitamin D status during the winter, when ultraviolet radiation exposure is at its nadir, and when cutaneous Vitamin D Synthesis would be expected to be relatively minimal (24).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 186, 'vitamin D synthesis')]
PMC2963768	10/2010	S104-PMC2963768	['moreover, in the bengal region, the attenuation of actual summer-time ultraviolet radiation exposure due to monsoon cloud-cover (24) MAY prevent sufficient endowment of Vitamin D stores during the summer and, thus, further increase the risk of deficiency during the winter.']	[('INCOMPLETE_EVIDENCE', 133)]	1	[('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC2963768	10/2010	S106-PMC2963768	['HOWEVER, these age-DEPENDENT DIFFERENCES MAY HAVE BEEN CONFOUNDED by seasonal timing of Gestation—a younger age IMPLIED that the third trimester COINCIDED with the expected seasonal nadir of Vitamin D Synthesis, when maternal Vitamin D stores MIGHT be relatively depleted and, THUS, when transfer of Vitamin D Metabolites to the foetus MAY have been minimized.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 45), ('DIFFICULT_TASK', 55), ('SUPERFICIAL_RELATIONSHIP', 112), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 243), ('PROBABLE_UNDERSTANDING', 277), ('INCOMPLETE_EVIDENCE', 336)]	11	[('GO_0007565', 'female pregnancy', 88, 'gestation'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 191, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D'), ('CHEBI_25212', 'metabolite', 310, 'metabolites')]
PMC2963768	10/2010	S107-PMC2963768	['to FURTHER EXPLAIN the APPARENT ‘Vitamin D paradox’ in south asia (3), a range of hypothetical mechanisms CAN BE PROPOSED (table 3).']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 11), ('ANOMALY_CURIOUS_FINDING', 23), ('FUTURE_WORK', 106), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC2963768	10/2010	S108-PMC2963768	['young infants DEPEND ALMOST ENTIRELY on the transplacental transfer of Vitamin D and 25(Oh)D, which EXPLAINS the CONSISTENT ASSOCIATION between maternal and Cord-blood 25(Oh)D (25) and the observation that maternal Antenatal Vitamin D supplementation augments both maternal and Cord-Blood 25(Oh)D (26).']	[('SUPERFICIAL_RELATIONSHIP', 14), ('PROBABLE_UNDERSTANDING', 21), ('PROBABLE_UNDERSTANDING', 100), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 157, 'cord'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 168, '25(OH ... D'), ('GO_0007567', 'parturition', 215, 'antenatal'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 278, 'cord'), ('UBERON_0000178', 'blood', 283, 'blood'), ('CHEBI_71657', 'versiconol acetate', 289, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 289, '25 ... OH ... D')]
PMC2963768	10/2010	S109-PMC2963768	['THEREFORE, the MAJOR REASON that bangladeshi infants start Life with POOR Vitamin D stores is low maternal Antenatal 25(Oh)D, which HAS BEEN DOCUMENTED in urban and rural bangladeshi women of Reproductive age (27).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 15), ('PROBABLE_UNDERSTANDING', 21), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 141)]	6	[('UBERON_0000104', 'life cycle', 59, 'life'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007567', 'parturition', 107, 'antenatal'), ('CHEBI_71657', 'versiconol acetate', 117, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 123, 'D'), ('GO_0000003', 'reproduction', 192, 'reproductive')]
PMC2963768	10/2010	S111-PMC2963768	['RECENTLY STUDIED female workers in a garment factory in dhaka and SPECULATED that their long day-time hours in indoors, brief exposure to low-intensity sunlight in the early morning, outdoor air pollution, and widespread sunscreen use, in combination with darkly-Pigmented skin, MAY CONTRIBUTE to their POOR Vitamin D status (mean 25(Oh)D of 37 nmol/l, and 15% of the participants had 25(Oh)D <25 nmol/l) (28).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 279), ('SUPERFICIAL_RELATIONSHIP', 283), ('IMPORTANT_CONSIDERATION', 303)]	5	[('CHEBI_26130', 'biological pigment', 263, 'pigmented'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 331, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 385, '25(OH)D')]
PMC2963768	10/2010	S112-PMC2963768	['conservative dress, including almost complete skin coverage by traditional veils or cloaks, HAS BEEN EMPHASIZED as a contributor to Vitamin D deficits in muslim women in south asia and the middle east because it limits cutaneous Vitamin D Synthesis REGARDLESS OF the intensity of ambient ultraviolet b (29).']	[('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 101), ('INCOMPLETE_EVIDENCE', 249)]	3	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 229, 'vitamin D synthesis')]
PMC2963768	10/2010	S113-PMC2963768	['inferences regarding the DETERMINANTS of infant/toddlers’ Vitamin D status in THIS STUDY were LIMITED, largely BECAUSE of the SMALL sample-size and substantial uniformity with respect to selected maternal clothing and dietary practices.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 94), ('PROBLEM_COMPLICATION', 111), ('INCOMPLETE_EVIDENCE', 126)]	5	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC2963768	10/2010	S116-PMC2963768	['the amount of Vitamin D in the local diet is UNKNOWN but low calcium intake (or reduced absorption of Calcium due to high Phytate intake), typical of low-income diets in bangladesh (30,31), MAY accelerate 25(Oh)D use, leading to relatively-increased Vitamin D demands (32).']	[('FULL_UNKNOWN', 45), ('INCOMPLETE_EVIDENCE', 190)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 102, 'calcium'), ('CHEBI_15361', 'pyruvate', 122, 'phytate'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D')]
PMC2963768	10/2010	S117-PMC2963768	['SINCE the concentration of Vitamin D Metabolites in Breastmilk is determined by maternal Vitamin D status, maternal Vitamin D deficiency during Lactation MAY cause ongoing deficits in Postnatal infants’ Vitamin D intake (42); YET, maternal FACTORS CANNOT ENTIRELY ACCOUNT for the persistence of low 25(Oh)D among toddlers (table 1) who experience direct exposure to sun and should BE unaffected by the conservative clothing practices of their mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226), ('ANOMALY_CURIOUS_FINDING', 226), ('SUPERFICIAL_RELATIONSHIP', 240), ('INCOMPLETE_EVIDENCE', 248), ('IMPORTANT_CONSIDERATION', 264), ('ANOMALY_CURIOUS_FINDING', 381)]	9	[('CHEBI_26871', 'terpene alkaloid', 27, 'vitamin D metabolites'), ('UBERON_0001348', 'brown adipose tissue', 52, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007595', 'lactation', 144, 'lactation'), ('GO_0007567', 'parturition', 184, 'postnatal'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 299, '25(OH)D')]
PMC2963768	10/2010	S120-PMC2963768	['hypothetical mechanisms that MAY CONTRIBUTE to risk of maternal-infant Vitamin D deficiency in south asiageneral mechanismexamples of specific HYPOTHESIZED mechanismsendogenous cutaneous Vitamin D Production\nconservative clothing practices (33)\nlimited time spent outdoors\ndark skin pigmentation (34)\ncloud-cover and outdoor air pollution (12)\ngeographic/Genetic/dietary factors that alter Epidermal 7-Dehydrocholesterol composition or concentrationdietary Vitamin D intake\ninadequate intake of Liver, eggs, fish, or fish oils, or fortified dairy products\ndiminished natural Vitamin d content of farmed fish (35)\nreduction in Vitamin D content of fish due to Cooking (e.g.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 143)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 187, 'vitamin D production'), ('PR_000006444', 'diacylglycerol kinase delta', 195, 'D'), ('SO_0000704', 'gene', 355, 'genetic'), ('UBERON_0007376', 'outer epithelium', 390, 'epidermal'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 400, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 457, 'vitamin D'), ('UBERON_0002107', 'liver', 495, 'liver'), ('CHEBI_33229', 'vitamin (role)', 575, 'vitamin'), ('CHEBI_27300', 'vitamin D', 626, 'vitamin D'), ('GO_0065007', 'biological regulation', 659, 'cooking')]
PMC2963768	10/2010	S125-PMC2963768	['Vitamin D Receptor, 24-hydroxylase\nDESPITE the current enthusiasm for Vitamin D supplementation in the usa (22), the EFFECTS of Vitamin D deficits during early infancy are STILL NOT FULLY UNDERSTOOD, and meaningful inflection points in 25(Oh)D-outcome RELATIONSHIPS have NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('ANOMALY_CURIOUS_FINDING', 35), ('SUPERFICIAL_RELATIONSHIP', 117), ('FULL_UNKNOWN', 172), ('IMPORTANT_CONSIDERATION', 172), ('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 252), ('FULL_UNKNOWN', 271), ('ANOMALY_CURIOUS_FINDING', 275)]	9	[('CHEBI_27300', 'vitamin D', 0, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 0, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 236, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 236, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 239, 'OH ... D')]
PMC2963768	10/2010	S127-PMC2963768	['young infants with SEVERE congenital Vitamin D deficiency MAY present with hypocalcaemic tetany or seizures, with absent or subtle Skeletal pathology (43–45).']	[('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 58)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0004288', 'skeleton', 131, 'skeletal')]
PMC2963768	10/2010	S129-PMC2963768	['ALTHOUGH 25(Oh)D <25 nmol/l is typical of clinically-apparent rickets, early stages of the disease MAY occur at higher 25(Oh)D (∼40 nmol/l) (47), with declines in 25(Oh)D occurring as the disease progresses and Vitamin D stores are depleted.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 99)]	2	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 122, 'OH)D'), ('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC2963768	10/2010	S134-PMC2963768	['SOME investigators have played down the ROLE of Vitamin D in rickets in bangladesh (10,52), INSTEAD blaming dietary calcium deficits or OTHER Mineral deficiencies or excesses, e.g.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_46662', 'mineral', 142, 'mineral')]
PMC2963768	10/2010	S137-PMC2963768	["a PLAUSIBLE HYPOTHESIS is that Vitamin D deficiency ACTS SYNERGISTICALLY with OTHER causes of INADEQUATE bone mineralization and that an Individual's 25(Oh)D concentration below which clinical signs emerge DEPENDS ON the severity and multiplicity of OTHER Genetic and environmental FACTORS."]	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 250), ('SUPERFICIAL_RELATIONSHIP', 282)]	9	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_1', 'root', 137, 'individual'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 150, '25 ... OH ... D'), ('SO_0000704', 'gene', 256, 'genetic')]
PMC2963768	10/2010	S138-PMC2963768	['beyond rickets, SPECULATION abounds regarding the POTENTIAL Extra-Skeletal CONSEQUENCES of suboptimal Vitamin D status during Foetal Development and infancy.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 50), ('PROBLEM_COMPLICATION', 75)]	3	[('UBERON_0005614', 'lens anterior epithelium', 60, 'extra'), ('UBERON_0004288', 'skeleton', 66, 'skeletal'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0060324', 'face development', 126, 'foetal development')]
PMC2963768	10/2010	S139-PMC2963768	['the Vitamin D receptor HAS BEEN FOUND within VIRTUALLY every Organ-System (55), and the active Metabolite of Vitamin D is WELL-DESCRIBED as a potent mediator of Cell Proliferation and Differentiation, PARTICULARLY NOTED for its range of EFFECTS on Immune function in laboratory MODELS (56).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 45), ('PROBABLE_UNDERSTANDING', 122), ('ANOMALY_CURIOUS_FINDING', 201), ('ANOMALY_CURIOUS_FINDING', 214), ('SUPERFICIAL_RELATIONSHIP', 237), ('INCOMPLETE_EVIDENCE', 278)]	8	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0000062', 'organ', 61, 'organ'), ('UBERON_0000467', 'anatomical system', 67, 'system'), ('CHEBI_39382', 'flufenoxuron', 95, 'metabolite'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 117, 'D'), ('GO_0030154', 'cell differentiation', 161, 'cell proliferation ... differentiation'), ('UBERON_0002405', 'immune system', 248, 'immune')]
PMC2963768	10/2010	S141-PMC2963768	['if Vitamin D deficiency is CONFIRMED AS a RISK FACTOR for pneumonia, INTERVENTIONS to improve maternal-infant Vitamin D status COULD reduce THE GLOBAL BURDEN of alri, the single most IMPORTANT cause of early childhood death in the world (58).']	[('INCOMPLETE_EVIDENCE', 27), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('FUTURE_WORK', 69), ('INCOMPLETE_EVIDENCE', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 140), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 183)]	8	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC2963768	10/2010	S142-PMC2963768	['OTHER POSTULATED CONSEQUENCES of Antenatal or infant Vitamin D deficiency include growth faltering (59,60), type 1 diabetes (61), and asthma (62).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('PROBLEM_COMPLICATION', 17)]	3	[('GO_0007567', 'parturition', 33, 'antenatal'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC2963768	10/2010	S143-PMC2963768	['HOWEVER, rigorous studies of the broad health benefits of interventions to improve the Antenatal or Postnatal Vitamin D status in south asian mothers and infants have YET to be REPORTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 167), ('INCOMPLETE_EVIDENCE', 177)]	3	[('GO_0007567', 'parturition', 87, 'antenatal'), ('GO_0007567', 'parturition', 100, 'postnatal'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC2963768	10/2010	S152-PMC2963768	['conclusions\nTHIS STUDY provides initial OBSERVATIONS on the Vitamin D status of young infants in northeastern rural bangladesh.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 40)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC2996405	11/2010	S0-PMC2996405	['schizophrenia and Vitamin D RELATED Genes COULD have been subject to latitude-driven adaptation\n\nabstract\n\nbackground\nmany natural phenomena are directly OR indirectly RELATED to latitude.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154), ('SUPERFICIAL_RELATIONSHIP', 168)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('SO_0000704', 'gene', 36, 'genes')]
PMC2996405	11/2010	S9-PMC2996405	['in an ATTEMPT to try to EXPLAIN this POSSIBLE LINK between latitude and schizophrenia, we INVESTIGATED their ASSOCIATIONS with Vitamin D. we FOUND in a set of vitamin d related Genes a significant enrichment of both lrgs and of Genes INVOLVED in schizophrenia.']	[('DIFFICULT_TASK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('PROBABLE_UNDERSTANDING', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 234)]	9	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('SO_0000704', 'gene', 177, 'genes'), ('SO_0000704', 'gene', 228, 'genes')]
PMC2996405	11/2010	S10-PMC2996405	['conclusions\nour results SUGGEST a latitude-driven adaptation for both schizophrenia and Vitamin D RELATED Genes.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 98)]	2	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('SO_0000704', 'gene', 106, 'genes')]
PMC2996405	11/2010	S11-PMC2996405	['in addition we CONFIRM, at a molecular level, the LINK between schizophrenia and Vitamin D. finally, we discuss a MODEL in which schizophrenia is, at LEAST PARTLY, a maladaptive by-product of latitude DEPENDENT adaptive changes in Vitamin D Metabolism.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 114), ('PROBABLE_UNDERSTANDING', 150), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 201)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 231, 'vitamin D metabolism')]
PMC2996405	11/2010	S50-PMC2996405	['AS most Individuals do not develop cancer until they are past their Reproductive age, from an evolutionary POINT OF VIEW, skin cancer REPRESENTS a less powerful selective force than Vitamin D availability in Serum [21].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('NCBITaxon_1', 'root', 8, 'individuals'), ('GO_0000003', 'reproduction', 68, 'reproductive'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('UBERON_0001977', 'blood serum', 208, 'serum')]
PMC2996405	11/2010	S59-PMC2996405	['in an ATTEMPT to try to EXPLAIN this POSSIBLE LINK between latitude and schizophrenia, we INVESTIGATED their ASSOCIATION with Vitamin D, which had been PREVIOUSLY ASSOCIATED, separately, to both of them.']	[('DIFFICULT_TASK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('PROBABLE_UNDERSTANDING', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 163)]	9	[('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC2996405	11/2010	S60-PMC2996405	['OUR FINDINGS SUGGEST a molecular LINK among latitude, schizophrenia and Vitamin D.\n\nresults\na set of Snps showing high levels of latitude-DEPENDENT population differentiation was selected by using a two-step approach.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 138)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('SO_0000694', 'SNP', 101, 'SNPs')]
PMC2996405	11/2010	S103-PMC2996405	['an IMPORTANT factor HYPOTHESIZED to be both latitude DEPENDENT and Neural Development-RELATED is Vitamin D. we checked for an enrichment of lrgs in Vitamin D related (vdr) Genes by manually creating a list of 943 Genes that broadly comprised the most IMPORTANT processes in which it is INVOLVED, since a comprehensive list is not yet present in the literature (additional file4).']	[('IMPORTANT_CONSIDERATION', 3), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 251), ('SUPERFICIAL_RELATIONSHIP', 286)]	6	[('GO_0007399', 'nervous system development', 67, 'neural development'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 148, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 148, 'Vitamin'), ('SO_0000704', 'gene', 172, 'genes'), ('SO_0000704', 'gene', 213, 'genes')]
PMC2996405	11/2010	S109-PMC2996405	['we checked WHETHER OR NOT in these 9 Genes belonged Snps, selected by our procedure, that were PREVIOUSLY studied in RELATIONSHIP to either schizophrenia or Vitamin D RELATED phenotypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 167)]	4	[('SO_0000704', 'gene', 37, 'genes'), ('SO_0000694', 'SNP', 52, 'SNPs'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC2996405	11/2010	S147-PMC2996405	['searching for a mechanism that COULD CONNECT latitude and schizophrenia at a molecular level, we reasoned that a well-known phenomenon separately LINKED to both of them is Vitamin D. indeed, Vitamin D is ESSENTIAL for normal growth, calcium absorption and Skeletal Development.']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 146), ('IMPORTANT_CONSIDERATION', 204)]	4	[('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0001501', 'skeletal system development', 256, 'skeletal development'), ('UBERON_0004288', 'skeleton', 256, 'skeletal')]
PMC2996405	11/2010	S149-PMC2996405	['with the same dietary Intake, the most IMPORTANT DETERMINANT for Vitamin D levels IS CONSIDERED to be where Individuals live, because of the DEPENDENCE on geographical location of the availability of uv radiation for Vitamin D synthesis.']	[('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 141)]	4	[('GO_0007631', 'feeding behavior', 22, 'intake'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('NCBITaxon_1', 'root', 108, 'individuals'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC2996405	11/2010	S152-PMC2996405	['this adaptation process was compulsory, SINCE Pelvic deformities due to Vitamin D deficiency COULD PREVENT normal Childbirth, BUT it is REASONABLE to SUGGEST that also OTHER molecular mechanisms apart from depigmentation COULD HAVE been subject to selective pressure in order to increase the levels of Vitamin D in the body.']	[('PROBABLE_UNDERSTANDING', 40), ('PROBLEM_COMPLICATION', 40), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 168), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 227)]	10	[('UBERON_0002108', 'small intestine', 46, 'pelvic'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 114, 'childbirth'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC2996405	11/2010	S155-PMC2996405	['this result MAY SUGGEST that Vitamin D related Genes COULD have been subject, AT LEAST IN PART, to a latitude-DEPENDENT adaptation, SUPPORTING the HYPOTHESIS that selection also ACTED on OTHER mechanisms different from depigmentation.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 53), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187)]	9	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('SO_0000704', 'gene', 47, 'genes')]
PMC2996405	11/2010	S156-PMC2996405	['ON THE OTHER HAND, the RELATIONSHIP between Vitamin D and schizophrenia is WELL ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 80)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC2996405	11/2010	S157-PMC2996405	['Vitamin D receptors were FOUND in most Tissues OTHER than those classically INVOLVED in the Vitamin D action (bone, Gut, Kidney, etc.).']	[('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000479', 'tissue', 39, 'tissues'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 116, 'gut'), ('UBERON_0002113', 'kidney', 121, 'kidney')]
PMC2996405	11/2010	S158-PMC2996405	['in particular, receptors for Vitamin D are widely distributed in the Nervous System and Vitamin D HAS BEEN RECENTLY IMPLICATED in Brain function [51].']	[('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0001016', 'nervous system', 69, 'nervous system'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0000955', 'brain', 130, 'brain')]
PMC2996405	11/2010	S159-PMC2996405	['there is GROWING EVIDENCE that low Vitamin D levels adversely IMPACT on Brain Development [52].']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 62)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007420', 'brain development', 72, 'brain development'), ('UBERON_0000955', 'brain', 72, 'brain')]
PMC2996405	11/2010	S160-PMC2996405	['in Mice, it HAS BEEN SUGGESTED that changes in Brain Development induced by Prenatal Vitamin D deficiency LEAD TO specific functional alterations in hippocampal Synaptic plasticity [53].']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 106)]	2	[('NCBITaxon_10088', 'Mus <genus>', 3, 'mice'), ('GO_0007420', 'brain development', 47, 'brain development'), ('UBERON_0000955', 'brain', 47, 'brain'), ('GO_0007565', 'female pregnancy', 76, 'prenatal'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0045202', 'synapse', 161, 'synaptic')]
PMC2996405	11/2010	S161-PMC2996405	['also in Humans, maternal Vitamin D insufficiency HAS BEEN ASSOCIATED with childhood rickets and longer term problems including schizophrenia [54].']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('NCBITaxon_9606', 'Homo sapiens', 8, 'humans'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC2996405	11/2010	S162-PMC2996405	['in addition, epidemiological data SUGGEST that Vitamin D deficiency MAY BE ASSOCIATED with INCREASED RISKS of mental health disorders such as schizophrenia [55].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 75), ('IMPORTANT_CONSIDERATION', 91)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC2996405	11/2010	S164-PMC2996405	['we FOUND a significant overlap of 70 Genes between schizophrenia and Vitamin D RELATED Genes (figure1and additional file3).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 79)]	2	[('SO_0000704', 'gene', 37, 'genes'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('SO_0000704', 'gene', 87, 'genes')]
PMC2996405	11/2010	S167-PMC2996405	['it is THEREFORE POSSIBLE that the same Genes COULD BE Regulated by Vitamin D levels also in Neurons during Brain Development that, in turn, HAVE BEEN ASSOCIATED to schizophrenia [47].']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 150)]	5	[('SO_0000704', 'gene', 39, 'genes'), ('GO_0065007', 'biological regulation', 54, 'regulated'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CL_0000540', 'neuron', 92, 'neurons'), ('GO_0007420', 'brain development', 107, 'brain development'), ('UBERON_0000955', 'brain', 107, 'brain')]
PMC2996405	11/2010	S168-PMC2996405	['ACCORDING TO our HYPOTHESIS that Vitamin D COULD BE the LINK between latitude and schizophrenia, we FOCUSED on the 9 lrgs present in both the lists of Vitamin D and schizophrenia RELATED Genes (figure1).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('SUPERFICIAL_RELATIONSHIP', 179)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('SO_0000704', 'gene', 187, 'genes')]
PMC2996405	11/2010	S192-PMC2996405	['winac MAY rearrange the Nucleosome array around the positive and negative Vitamin D responsive elements (vdres), thereby facilitating the Coregulatory Complexes access for further transcription Control.']	[('INCOMPLETE_EVIDENCE', 6)]	1	[('GO_0000786', 'nucleosome', 24, 'nucleosome'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0065007', 'biological regulation', 138, 'coregulatory'), ('GO_0032991', 'protein-containing complex', 151, 'complexes'), ('GO_0065007', 'biological regulation', 194, 'control')]
PMC2996405	11/2010	S204-PMC2996405	['IT IS POSSIBLE to SPECULATE that a selective pressure COULD have favoured a Haplotype containing the t Allele in an environment with low Vitamin D availability, for its positive EFFECT on the bone phenotype.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('SO_0001024', 'haplotype', 76, 'haplotype'), ('SO_0001023', 'allele', 103, 'allele'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC2996405	11/2010	S212-PMC2996405	['as STATED, latitude acts directly OR indirectly, on a WIDE VARIETY of phenomena, THEREFORE it is expected that its EFFECTS are not limited just to Vitamin D and Neural Development.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54), ('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 115)]	5	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007399', 'nervous system development', 161, 'neural development')]
PMC2996405	11/2010	S249-PMC2996405	['conclusions\nwe FOUND that frequencies of Genetic variants INVOLVED in Brain Development, schizophrenia and Vitamin D-RELATED processes significantly vary with latitude.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 58), ('SUPERFICIAL_RELATIONSHIP', 117)]	3	[('SO_0000704', 'gene', 41, 'genetic'), ('GO_0007420', 'brain development', 70, 'brain development'), ('UBERON_0000955', 'brain', 70, 'brain'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC2996405	11/2010	S250-PMC2996405	['we also FOUND a molecular RELATIONSHIP of schizophrenia with both latitude and Vitamin D. AT LEAST in one case, our results SUGGEST that schizophrenia COULD BE a maladaptive by-product of latitude DEPENDENT adaptive changes in Vitamin D Metabolism.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 26), ('PROBABLE_UNDERSTANDING', 90), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 151), ('SUPERFICIAL_RELATIONSHIP', 197)]	6	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 227, 'vitamin D metabolism')]
PMC2996405	11/2010	S269-PMC2996405	['finally, CANDIDATE transcriptional target Genes of Vitamin D were obtained from a set of Genes differentially Expressed in scc25 cells treated with 1,25(Oh)2D3By a Genome-wide microarray analysis [56].']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('SO_0000704', 'gene', 42, 'genes'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('SO_0000704', 'gene', 89, 'genes'), ('GO_0010467', 'gene expression', 110, 'expressed'), ('CHEBI_79988', 'Sobetirome', 148, '1,25(OH)2D3by'), ('SO_0001026', 'genome', 164, 'genome')]
PMC2798111	12/2010	S16-PMC2798111	["Human Milk's total Vitamin D or its antirachitic activity obtained from mothers receiving 400\u2009iu/day TYPICALLY contains 33–68\u2009iu/l, far below the ESTIMATED daily infant REQUIREMENT of 400\u2009iu/l [3–5], the NECESSARY level for the PREVENTION of rickets [1]."]	[('PROBABLE_UNDERSTANDING', 101), ('INCOMPLETE_EVIDENCE', 146), ('IMPORTANT_CONSIDERATION', 169), ('IMPORTANT_CONSIDERATION', 204), ('SUPERFICIAL_RELATIONSHIP', 228)]	5	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('UBERON_0001913', 'milk', 6, 'milk'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC2798111	12/2010	S17-PMC2798111	['THEREFORE, Oral supplementation or sufficient sun exposure is NECESSARY to ensure adequate Vitamin D status for proper calcium absorption and bone mineralization [3–6].RECENT RESEARCH has also LINKED Vitamin D to Innate Immunity [7–9].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 193)]	4	[('UBERON_0000165', 'mouth', 11, 'oral'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('GO_0045087', 'innate immune response', 213, 'innate immunity')]
PMC2798111	12/2010	S18-PMC2798111	["furthermore, Vitamin D deficiency HAS BEEN ASSOCIATED with a NUMBER OF disease states including but certainly not limited to rheumatoid arthritis [10], multiple sclerosis [11–14], type i and ii diabetes [15–19], crohn's disease [20], Cardiovascular disease [21,22], and a NUMBER of cancers [23,24]."]	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 272)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 234, 'cardiovascular')]
PMC2798111	12/2010	S22-PMC2798111	['during recent years, Vitamin D-only preparations have become available, SOME of which are Aqueous and others which are oil-based preparations.']	[('INCOMPLETE_EVIDENCE', 72)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_15377', 'water', 90, 'aqueous')]
PMC2798111	12/2010	S25-PMC2798111	['while the parent randomized clinical trial will not be completed until 2011, it is ESSENTIAL to report PRELIMINARY DATA on the EFFECTIVENESS of one drop per day dosing of Vitamin D to aid clinicians in their decision-making process concerning Vitamin D preparations for infants.']	[('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC2798111	12/2010	S43-PMC2798111	['use of formula\nbecause of the POTENTIAL CONFOUNDER of proprietary formulas that contain 400\u2009iu/l Vitamin D, each mother was given up to six 4-oz bottles per month of Vitamin D-free formula with the instructions to avoid use of any formula but if there was a need to supplement, the Vitamin D-free formula prepared by mead-johnson, evansville, in was used.']	[('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 40)]	2	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC2798111	12/2010	S90-PMC2798111	['discussion\nbecause the PRELIMINARY results of this arm of the trial are IMPORTANT for decision-making in the current clinical environment, we report HERE the interim results of an ONGOING Vitamin D supplementation TRIAL of Lactating women and their infants.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 72), ('QUESTION_ANSWERED_BY_THIS_WORK', 149), ('IMPORTANT_CONSIDERATION', 180), ('INCOMPLETE_EVIDENCE', 214)]	5	[('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 223, 'lactating')]
PMC2798111	12/2010	S95-PMC2798111	['WHILE not powered to assess SAFETY at this juncture, it is IMPORTANT TO NOTE that, thus FAR, there HAVE BEEN no increased rates of infection in the infants or adverse health EFFECTS that COULD BE ATTRIBUTED to Vitamin D supplementation in this cohort.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 59), ('ANOMALY_CURIOUS_FINDING', 88), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 196)]	8	[('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC2798111	12/2010	S99-PMC2798111	['THUS, OUR FINDINGS in THIS STUDY and our earlier studies [4,32] SUPPORT the RECENT aap RECOMMENDATION of starting Vitamin D supplementation in all breastfed infants within the first few days after Delivery [26].']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 76), ('FUTURE_WORK', 87)]	6	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'delivery')]
PMC2798111	12/2010	S104-PMC2798111	['OUR FINDINGS SUPPORT the PREMISE that an oil emulsion delivered as a single drop is well-tolerated and absorbed with a CONSISTENT increase in circulating 25(Oh)d on the Vitamin D supplementation during a three-month interval that was sustained during the next three-month interval.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 119)]	4	[('CHEBI_30778', 'gallic acid', 154, '25(OH)'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC2798111	12/2010	S114-PMC2798111	['the direct effect of the Vitamin D supplementation is SUPPORTED by the following: in this trial, of the mothers who were randomized to receive 2400\u2009iu Vitamin D/day, there was insufficient transfer of Vitamin D in their Milk and 31% of those breastfed infants required open label Vitamin D supplementation at the 4th month visit compared with 6% in the control group and 5% in the 6400\u2009iu Vitamin D supplementation group.']	[('INCOMPLETE_EVIDENCE', 54)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('UBERON_0001913', 'milk', 220, 'milk'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D')]
PMC2798111	12/2010	S117-PMC2798111	['IN SUMMARY, a single drop oil emulsion Vitamin D preparation APPEARS TO BE an effective method to deliver Vitamin D3To a breastfed infant.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 61)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_33706', 'beta-amino acid', 106, 'vitamin D3to'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 106, 'vitamin D3to')]
PMC3004407	12/2010	S12-PMC3004407	['THESE FINDINGS RAISE the ISSUE of adequacy of current Vitamin D RECOMMENDATIONS for Pregnant women.']	[('INCOMPLETE_EVIDENCE', 0), ('EXPLICIT_QUESTION', 15), ('PROBLEM_COMPLICATION', 25), ('FUTURE_WORK', 64)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnant')]
PMC3004407	12/2010	S14-PMC3004407	['introduction\nmuch has happened in the world of Vitamin D RESEARCH since the 2002 centers for disease control report of the WIDESPREAD deficiency in african-american women in their Childbearing years [1].']	[('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 123)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 180, 'childbearing')]
PMC3004407	12/2010	S17-PMC3004407	["STUDIES to SUPPORT this PREMISE have increased significantly in number during the past five years [13–30], and with frequent lay press articles and featured news items about Vitamin D, PUBLIC UNDERSTANDING of Vitamin D's IMPORTANCE in maintaining health has increased."]	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 185), ('IMPORTANT_CONSIDERATION', 221)]	5	[('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC3004407	12/2010	S20-PMC3004407	['EARLIER REPORTS of Vitamin D deficiency during Pregnancy have focused on women living in northern europe (latitude 50–55°n), which DID NOT include women of diverse racial/ethnic backgrounds living in a sun-rich environment [5,31,32].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 131)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy')]
PMC3004407	12/2010	S21-PMC3004407	['THEORETICALLY, women at lower latitudes, DESPITE darker pigmentation, SHOULD have less Vitamin D deficiency because of the greater LIKELIHOOD of effective sunlight exposure to induce endogenous Vitamin d synthesis [33].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 41), ('FUTURE_WORK', 70), ('PROBABLE_UNDERSTANDING', 131)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]
PMC3004407	12/2010	S22-PMC3004407	['AS a result of the CONCERN regarding the prevalence of Vitamin D deficiency among Pregnant women receiving care at community health centers, and TO CLARIFY earlier scientific STUDIES which REPORTED that a majority of african-american and hispanic women are Vitamin D deficient [34–40], a cross-sectional study of Pregnant women presenting at a community health center network in south carolina at latitude 32°n was designed and implemented.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 19), ('PROBLEM_COMPLICATION', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 145), ('FUTURE_WORK', 148), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('GO_0007565', 'female pregnancy', 313, 'pregnant')]
PMC3004407	12/2010	S24-PMC3004407	["it was HYPOTHESIZED that DESPITE south carolina's lower latitude and abundance of sunlight, given modern-day lifestyles that OFTEN PRECLUDE sunlight exposure, the majority of the women presenting for obstetrical care at this community health center network would have Vitamin D insufficiency and a significant number would have outright Vitamin D deficiency."]	[('INCOMPLETE_EVIDENCE', 7), ('ANOMALY_CURIOUS_FINDING', 25), ('PROBABLE_UNDERSTANDING', 125), ('DIFFICULT_TASK', 131)]	4	[('CHEBI_27300', 'vitamin D', 268, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 337, 'vitamin D')]
PMC3004407	12/2010	S86-PMC3004407	['a small percentage (5.2%) of the women reported dietary restrictions that MAY have INFLUENCED their Vitamin D status; 3% reported such restrictions for health reasons such as type 2 diabetes, 0.9% for religious reasons (vegetarian), and 1.3% gave no reason.']	[('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3004407	12/2010	S91-PMC3004407	['in univariate logistic regression models, african-american women had APPROXIMATELY 8 times the odds of Vitamin D deficiency of hispanic women, and 20 times the odds of Vitamin D deficiency of caucasian women ( p< .001 for both comparisons).']	[('INCOMPLETE_EVIDENCE', 69)]	1	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC3004407	12/2010	S103-PMC3004407	['specifically, obesity and race DEMONSTRATED a significant ASSOCIATION with Vitamin D category, and obesity retained a significant RELATIONSHIP with Vitamin D category after controlling for race ( p = .01).']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 58), ('SUPERFICIAL_RELATIONSHIP', 130)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC3004407	12/2010	S146-PMC3004407	['using both circulating 25(Oh)D and pth as MARKERS of Vitamin D deficiency, THESE FINDINGS UNDERSCORE RECENT REPORTS of widespread Vitamin D deficiency among Pregnant women, EVEN in areas of the world with ample sunlight.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 108), ('ANOMALY_CURIOUS_FINDING', 173)]	6	[('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnant')]
PMC3004407	12/2010	S152-PMC3004407	['the STRENGTHS of the study are that a large and diverse group of women at various stages of Pregnancy were studied to: (1) ascertain their Vitamin D status at the time of presentation to a community health center and (2) find WHAT FACTORS were most PREDICTIVE of that status in a sun-rich environment where THEORETICALLY there are no LIMITATIONS to achieving an adequate Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 4), ('EXPLICIT_QUESTION', 226), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 249), ('INCOMPLETE_EVIDENCE', 307), ('INCOMPLETE_EVIDENCE', 334)]	6	[('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin D')]
PMC3004407	12/2010	S153-PMC3004407	['POTENTIAL LIMITATIONS of this study include that the active form of Vitamin D, 1,25(Oh)2D, WAS NOT MEASURED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 91)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 81, '25(OH)2D')]
PMC3004407	12/2010	S156-PMC3004407	['given RECENT DISCOVERIES that LINK Vitamin D with the innate Immune System [6], it is not UNREASONABLE to predict that deficiencies during fetal development COULD have lasting sequelae on the child, NOT ONLY in terms of bone mineralization, BUT ALSO in terms of Immune Development that becomes the basis for later derangements SEEN with long-latency diseases such as multiple sclerosis, rheumatoid arthritis, diabetes, and certain cancers [59].']	[('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 157), ('ANOMALY_CURIOUS_FINDING', 199), ('ANOMALY_CURIOUS_FINDING', 241), ('INCOMPLETE_EVIDENCE', 327)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007566', 'embryo implantation', 61, 'immune'), ('UBERON_0002405', 'immune system', 61, 'immune system'), ('GO_0001822', 'kidney development', 262, 'immune development'), ('UBERON_0002405', 'immune system', 262, 'immune')]
PMC3004407	12/2010	S158-PMC3004407	['studies TO EXAMINE the BENEFIT of higher doses of Vitamin D during Pregnancy SUGGEST that the dose of Vitamin D FOUND in MOST Prenatal Vitamins—400\u2009iu—is INADEQUATE to meet the NEEDS of the Pregnant woman and her growing fetus [11,32,34,39,60–67].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 112), ('PROBABLE_UNDERSTANDING', 121), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 177)]	7	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 135, 'vitamins'), ('GO_0007565', 'female pregnancy', 190, 'pregnant')]
PMC3004407	12/2010	S159-PMC3004407	["TAKING INTO account Vitamin D's EMERGING ROLE in Immune maintenance throughout the body and the MOUNTING EVIDENCE TO SUPPORT the IMPORTANCE of Vitamin D in maintaining good health, at the very LEAST, women who are deficient in Vitamin D SHOULD BE counseled regarding the risks of Vitamin D deficiency for themselves and their offspring and RECOMMENDED a therapy to ensure Vitamin D adequacy [60–62,68–70]."]	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 7), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 129), ('PROBABLE_UNDERSTANDING', 193), ('FUTURE_WORK', 237), ('FUTURE_WORK', 340)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0002405', 'immune system', 49, 'immune'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 372, 'vitamin D')]
PMC3034879	12/2010	S1-PMC3034879	['Postnatal Vitamin D supplementation improved Vitamin D status BUT ONLY PARTLY eliminated the differences in bone variables induced by maternal Vitamin D status during the fetal period.']	[('ANOMALY_CURIOUS_FINDING', 62), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 71)]	4	[('GO_0007567', 'parturition', 0, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC3034879	12/2010	S8-PMC3034879	['FINDINGS were compared with maternal Vitamin D status during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
PMC3034879	12/2010	S14-PMC3034879	['conclusions\nPostnatal Vitamin D supplementation improved Vitamin D status BUT ONLY PARTLY eliminated the differences in bone variables induced by maternal Vitamin D status during the fetal period.']	[('ANOMALY_CURIOUS_FINDING', 74), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 83)]	3	[('GO_0007567', 'parturition', 12, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC3034879	12/2010	S18-PMC3034879	['Vitamin D is a seco Sterol that modifies various biological functions in the body [5], and researchers have IDENTIFIED 37 target Organs for Vitamin D [5].']	[('INCOMPLETE_EVIDENCE', 108)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_15889', 'sterol', 20, 'sterol'), ('UBERON_0000062', 'organ', 129, 'organs'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC3034879	12/2010	S26-PMC3034879	['PREVIOUSLY the authors of the current study have REPORTED that during the Pregnancy, 69% of the women and 37% of the newborns at Birth were Vitamin D deficient (defined in women AS S-25-Ohd <50\xa0nmol/l [18,19] and in the newborn AS <37.5\xa0nmol/l [20]).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 178), ('PROBABLE_UNDERSTANDING', 228)]	4	[('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007567', 'parturition', 129, 'birth'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_16786', 'vestitone', 181, 'S-'), ('CHEBI_72765', 'verruculogen', 183, '25-OHD'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 183, '25')]
PMC3034879	12/2010	S28-PMC3034879	['BASED ON these results, it was CONCLUDED that maternal Vitamin D status AFFECTS bone Mineral accrual and INFLUENCES bone size during the Intrauterine Period [10].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 72), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_46662', 'mineral', 85, 'mineral'), ('UBERON_0006351', 'principal vein of forelimb', 137, 'intrauterine period')]
PMC3034879	12/2010	S145-PMC3034879	['we CONSIDER this as a random finding because it is UNLIKELY that higher maternal Vitamin D status would contribute to this and SEVERAL STUDIES have witnessed that Vitamin D deficiency is RELATED to delayed age of walking [24,25].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 187)]	4	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3034879	12/2010	S153-PMC3034879	['Tibia csa REMAINED SOMEWHAT larger in infants whose mothers had better Vitamin D status during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 19)]	2	[('UBERON_0000979', 'tibia', 0, 'Tibia'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy')]
PMC3034879	12/2010	S167-PMC3034879	['SOME STUDIES have witnessed that insufficient Vitamin D status during Pregnancy is RELATED to lower bone Mineral status in the newborn [9,10,28].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_46662', 'mineral', 105, 'mineral')]
PMC3034879	12/2010	S178-PMC3034879	['in the present study, 85% of infants had total Vitamin D intake that was IN LINE WITH the nordic RECOMMENDATION [23].']	[('INCOMPLETE_EVIDENCE', 73), ('FUTURE_WORK', 97)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC3034879	12/2010	S179-PMC3034879	['INTERESTINGLY, the use of d3supplements was ASSOCIATED with improved Vitamin D status to a greater extent than use of d2supplements, which is IN LINE WITH FINDINGS of houghton and vieth [38].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 155)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3034879	12/2010	S185-PMC3034879	['the study SHOWS that fetal Vitamin D status, RATHER than Postnatal Vitamin D status, AFFECTS bone growth during the first year.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007567', 'parturition', 57, 'postnatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC3034879	12/2010	S187-PMC3034879	['∆S-25-Ohd CORRELATED positively with ∆s-tracp and inversely with δbalp SUGGESTING that Vitamin D AFFECTS bone turnover [42].']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_52260', 'rhod-2 dye', 1, 'S'), ('CHEBI_72765', 'verruculogen', 3, '25-OHD'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC3034879	12/2010	S191-PMC3034879	['given that more than 20% of the infants had S-25-Ohd below 50 nmol/l, DESPITE compliance with supplementation, higher intake of vitamin D is RECOMMENDED in order to obtain all the POTENTIAL health benefits of Vitamin D [43,44].']	[('ANOMALY_CURIOUS_FINDING', 70), ('FUTURE_WORK', 141), ('INCOMPLETE_EVIDENCE', 180)]	3	[('CHEBI_86929', 'S b G-5,5-G b S A CH2', 44, 'S-25-OHD'), ('PR_000001900', 'neuropilin-1', 44, 'S-25-OHD'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 136, 'D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC3034879	12/2010	S192-PMC3034879	['optimally, Vitamin D sufficiency SHOULD BE guaranteed during fetal Life AS the FINDINGS of the PRESENT STUDY SUGGEST that the CONSEQUENCES of POOR Vitamin D status during the fetal period cannot be totally reverted by Postnatal Vitamin D supplementation.']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 33), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 126), ('IMPORTANT_CONSIDERATION', 142)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 218, 'postnatal'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC3034879	12/2010	S199-PMC3034879	['it CAN BE concluded that Postnatal Vitamin D supplementation improved Vitamin D status in infants and PARTLY eliminated the differences in bone variables that had resulted from maternal Vitamin D status during the fetal period.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 102)]	2	[('GO_0007567', 'parturition', 25, 'postnatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC3034879	12/2010	S202-PMC3034879	['based ON these OBSERVATIONS, ADDITIONAL EFFORTS SHOULD BE MADE to improve Vitamin D status during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 6), ('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 15), ('FUTURE_WORK', 29), ('FUTURE_WORK', 40), ('FUTURE_WORK', 48)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy')]
PMC3355895	1/2011	S3-PMC3355895	['physiological systems include Vitamin D, Parathyroid hormone, leptin, gh/Igf-1; finally the POTENTIAL ROLE of epigenetic processes in the underlying mechanisms will be explored.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 102)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 41, 'parathyroid'), ('PR_000008929', 'interferon-related developmental regulator 1', 73, 'IGF-1')]
PMC3355895	1/2011	S50-PMC3355895	['the Regulation of this process is AS YET UNKNOWN, but at least one of the Isoforms of Pmca HAS BEEN shown to be Regulated by 1,25(Oh)-Vitamin D (kip and strehler,2004), and in SOME Animals, BUT NOT OTHERS, 1,25(Oh)2-Vitamin D APPEARS necessary for maintenance of the maternofetal calcium gradient (lester,1986).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 34), ('FULL_UNKNOWN', 37), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('ANOMALY_CURIOUS_FINDING', 226)]	7	[('GO_0065007', 'biological regulation', 4, 'regulation'), ('SO_0001060', 'sequence_variant', 74, 'isoforms'), ('PR_000012924', 'bifunctional polynucleotide phosphatase/kinase', 86, 'PMCA'), ('GO_0065007', 'biological regulation', 112, 'regulated'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 130, 'OH)-'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 181, 'animals'), ('CHEBI_75874', 'para-terphenyl', 206, '1,25(OH)2-'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC3355895	1/2011	S52-PMC3355895	['these OBSERVATIONS MAY SUGGEST a POSSIBLE mechanism for the INFLUENCE of maternal Vitamin D status on Placental Calcium Transport and Intrauterine bone Mineral accrual.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 60)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'placental'), ('UBERON_0001987', 'placenta', 102, 'placental'), ('GO_0006816', 'calcium ion transport', 112, 'calcium transport'), ('UBERON_0022293', 'reproductive gland secretion', 134, 'intrauterine'), ('CHEBI_46662', 'mineral', 152, 'mineral')]
PMC3355895	1/2011	S80-PMC3355895	['Calcium and Vitamin D, being key Nutrients in Bone Development, are prime CANDIDATES FOR INVESTIGATION.']	[('INCOMPLETE_EVIDENCE', 74), ('FUTURE_WORK', 85)]	2	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_33284', 'nutrient', 33, 'nutrients'), ('GO_0048539', 'bone marrow development', 46, 'bone development')]
PMC3355895	1/2011	S86-PMC3355895	["adjunctive EVIDENCE SUPPORTING a ROLE for maternal Vitamin D status was obtained in the southampton women's survey, where maternal Vitamin D concentrations again CORRELATED with neonatal bone mass (harvey et al.,2008)."]	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 162)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3355895	1/2011	S87-PMC3355895	['FINDINGS from the avon longitudinal study of parents and children (sayers and tobias,2009) FURTHER REINFORCED the IMPORTANCE of maternal 25(Oh)-Vitamin D levels, DEMONSTRATING a positive ASSOCIATION between ambient ultraviolet b radiation in Pregnancy and offspring bmc at 9 years old.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 187)]	6	[('CHEBI_63056', 'zinc cation', 137, '25(OH'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy')]
PMC3355895	1/2011	S171-PMC3355895	['1,25(oh)-Vitamin D HAS BEEN SHOWN to Regulate OTHER Pmca Isoforms (kip and strehler,2004) and is THEREFORE a POTENTIAL CANDIDATE.']	[('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 119)]	5	[('CHEBI_37958', 'dye', 0, '1,'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0065007', 'biological regulation', 37, 'regulate'), ('PR_000012924', 'bifunctional polynucleotide phosphatase/kinase', 52, 'PMCA'), ('SO_0001060', 'sequence_variant', 57, 'isoforms')]
PMC3061267	2/2011	S2-PMC3061267	['adequate Vitamin D and Calcium nutrition throughout Life MAY reduce the RISK of osteoporosis, and Calcium supplementation during Pregnancy MAY reduce Preeclampsia and low Birth weight.']	[('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 139)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 23, 'calcium'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('CHEBI_22313', 'alkaline earth metal atom', 98, 'calcium'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 150, 'preeclampsia'), ('GO_0007567', 'parturition', 171, 'birth')]
PMC3061267	2/2011	S40-PMC3061267	['WHILE DEFICIENCIES of several Nutrients besides iron CAN cause anemia, and SOME Nutrients like Vitamin A are OFTEN LINKED to iron status, a RECENT review FOUND no greater IMPACT of a multimicronutrient supplement on iron status THAN supplementing with iron alone [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 171), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	10	[('CHEBI_33284', 'nutrient', 30, 'nutrients'), ('CHEBI_33284', 'nutrient', 80, 'nutrients'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin A')]
PMC3061267	2/2011	S49-PMC3061267	['one TRIAL in nepal FOUND that giving Pregnant women frequent small doses of Vitamin A reduced maternal mortality by 44% [22].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 19)]	2	[('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin A')]
PMC3061267	2/2011	S50-PMC3061267	['LATER trials within less Vitamin A deficient populations in bangladesh [23] and ghana [24] FAILED TO FIND any IMPACT.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 91), ('DIFFICULT_TASK', 91), ('SUPERFICIAL_RELATIONSHIP', 110)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A')]
PMC3103150	3/2011	S1-PMC3103150	['the data on Vitamin D status of healthy term breastfed indian infants and mothers are SCANT.']	[('INCOMPLETE_EVIDENCE', 86)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC3103150	3/2011	S18-PMC3103150	['rickets and hypocalcemic seizures due to Vitamin D deficiency in exclusively Breastfed young infants HAVE BEEN RECENTLY REPORTED from southern india78.']	[('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 120)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007567', 'parturition', 77, 'breastfed')]
PMC3103150	3/2011	S19-PMC3103150	['there are a FEW REPORTS of Vitamin D deficiency among Pregnant women and Cord Blood of their newborns910and Breastfed young infants from india1112.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 16)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnant'), ('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('GO_0007567', 'parturition', 108, 'breastfed')]
PMC3103150	3/2011	S42-PMC3103150	['the cut-off for elevated pth was taken as 46 pg/ml BASED ON RECENT STUDIES in Vitamin D replete subjects17.']	[('INCOMPLETE_EVIDENCE', 51), ('PROBABLE_UNDERSTANDING', 51), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 60)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3103150	3/2011	S51-PMC3103150	['for Vitamin D deficiency in infants Born to mothers with Vitamin D deficiency was REPORTED.']	[('INCOMPLETE_EVIDENCE', 82)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007567', 'parturition', 36, 'born'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC3103150	3/2011	S102-PMC3103150	['discussion\nwe FOUND a high prevalence of Vitamin D deficiency in term, appropriate for Gestational age breastfed infants and their mothers.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 87, 'gestational')]
PMC3103150	3/2011	S105-PMC3103150	['in a RECENT STUDY of schoolgirls from india, 90.8 per cent were FOUND to have Vitamin D deficiency25.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 64)]	2	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3103150	3/2011	S112-PMC3103150	['we FOUND no seasonal variation in the Vitamin D levels of the infants EVEN THOUGH there was a significant difference in the mothers’ levels.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 70)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC3103150	3/2011	S126-PMC3103150	['in the united states, the CURRENTLY RECOMMENDED adequate intake for Vitamin D during Pregnancy as well as Lactation is 200 iu/day34.']	[('INCOMPLETE_EVIDENCE', 26), ('FUTURE_WORK', 36)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('GO_0007595', 'lactation', 106, 'lactation')]
PMC3103150	3/2011	S128-PMC3103150	['in CONCLUSION, the PRESENT STUDY FOUND a very high prevalence of Vitamin D deficiency in healthy term Born infants at the age of 3 months and their mothers in winter as well as summer.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('INCOMPLETE_EVIDENCE', 33)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'born')]
PMC3103150	3/2011	S131-PMC3103150	['LARGER STUDIES and meta-analysis SHOULD BE conducted to CONFIRM the FINDINGS of the PRESENT study and develop RECOMMENDATIONS for Vitamin D supplementation for Pregnant and Lactating women and young infants.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 33), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 68), ('QUESTION_ANSWERED_BY_THIS_WORK', 84), ('FUTURE_WORK', 110)]	6	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnant'), ('GO_0007594', 'puparial adhesion', 173, 'lactating')]
PMC3107676	4/2011	S37-PMC3107676	['PREVIOUS STUDIES have NOT REPORTED prevalence of Vitamin C supplementation among women who took Drugs classified as Nitrosatable or INDICATED the EFFECTS of Vitamin C intake on any ASSOCIATIONS between Nitrosatable Drug use and adverse Pregnancy outcomes.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 181)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin C'), ('CHEBI_23888', 'drug', 96, 'drugs'), ('CHEBI_7587', 'nitroalkane', 116, 'nitrosatable'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin C'), ('CHEBI_75872', '(R)-sarin', 202, 'nitrosatable drug'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]
PMC3107676	4/2011	S38-PMC3107676	['accounting for Vitamin C use when assessing the EFFECTS of Nitrosatable Drugs on Pregnancy outcomes MAY prove to be CRITICALLY IMPORTANT.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 116), ('IMPORTANT_CONSIDERATION', 127)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin C'), ('CHEBI_7496', 'nelfinavir', 59, 'nitrosatable drugs'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC3107676	4/2011	S105-PMC3107676	['among women who took Nitrosatable Drugs, <40% reported daily use of a supplement with Vitamin C during the first month of Pregnancy (table 3), ALTHOUGH APPROXIMATELY 80% took such a Supplement daily by the third month.']	[('ANOMALY_CURIOUS_FINDING', 143), ('INCOMPLETE_EVIDENCE', 152)]	2	[('CHEBI_7496', 'nelfinavir', 21, 'nitrosatable drugs'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin C'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 182, 'supplement')]
PMC3107676	4/2011	S115-PMC3107676	['by the third month of Pregnancy, APPROXIMATELY 80% reported taking Supplements that MOST LIKELY contained Vitamin C.\ncompared with prevalence ESTIMATES in PREVIOUSLY PUBLISHED STUDIES, the PRESENT STUDY has the highest REPORTED prevalence of Nitrosatable Drug use during early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 84), ('PROBABLE_UNDERSTANDING', 89), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 155), ('QUESTION_ANSWERED_BY_THIS_WORK', 189), ('INCOMPLETE_EVIDENCE', 219)]	7	[('GO_0007565', 'female pregnancy', 22, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 67, 'supplements'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin C'), ('CHEBI_75872', '(R)-sarin', 242, 'nitrosatable drug'), ('GO_0007565', 'female pregnancy', 277, 'pregnancy')]
PMC3231909	4/2011	S151-PMC3231909	['list also does NOT TAKE account of the mode of Delivery and the fact that Delivery of SOME interventions like Antenatal Care or vaccination establishes a platform that CAN serve for adding other interventions, like itn or Vitamin A distribution.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 168)]	3	[('GO_0007567', 'parturition', 47, 'delivery'), ('GO_0007567', 'parturition', 74, 'delivery'), ('GO_0007608', 'sensory perception of smell', 110, 'antenatal care'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin A')]
PMC3099599	5/2011	S4-PMC3099599	['subdural hematoma MAY also be the result of common Birth trauma, COMPLICATED by Prenatal Vitamin D deficiency, which also CONTRIBUTES to the appearance of Long Bone fractures commonly ASSOCIATED with child abuse.']	[('INCOMPLETE_EVIDENCE', 18), ('DIFFICULT_TASK', 65), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('GO_0007567', 'parturition', 51, 'birth'), ('GO_0007565', 'female pregnancy', 80, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0002495', 'long bone', 155, 'long bone')]
PMC3099599	5/2011	S211-PMC3099599	['HOWEVER, Vitamin D deficiency (vdd) and its bony manifestation, rickets, CAN lead to deformation of the weakened Skull during Birth resulting in psdh, and CONTRIBUTE to bony FINDINGS that SEEMINGLY CONFIRM the child abuse etiology.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 174), ('ANOMALY_CURIOUS_FINDING', 188), ('INCOMPLETE_EVIDENCE', 198)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0003129', 'skull', 113, 'skull'), ('GO_0007567', 'parturition', 126, 'birth')]
PMC3099599	5/2011	S217-PMC3099599	['the radiographic findings are transient (figure 9) but MAY NEVERTHELESS be interpreted as abusive, without clinical correlation, Vitamin D testing, meaningful differential diagnosis or corroborative history of violence.64\n\nconfusion between Central Nervous System infection and Shaken baby syndrome\nfever, irritability, Meningeal signs, elevated white counts and tense fontanelles suggest central Nervous System infection.']	[('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59)]	2	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 241, 'Central Nervous System'), ('PR_000014863', 'single Ig IL-1-related receptor', 278, 'Shaken'), ('UBERON_0002360', 'meninx', 320, 'meningeal'), ('UBERON_0001016', 'nervous system', 397, 'nervous system')]
PMC3309463	6/2011	S43-PMC3309463	['it HAS BEEN PROPOSED that developmental Vitamin D deficiency MAY CONTRIBUTE to the increased risk of schizophrenia in dark-skinned migrants and those living in crowded urban settings.28both dark skin and urban residence are ASSOCIATED with an INCREASED risk of hypovitaminosis D.29developmental Vitamin D deficiency MAY also UNDERLIE the well-replicated season of birth EFFECT FOUND in schizophrenia (those Born in winter and spring have a small but significant increased risk of schizophrenia).30vitamin D is a potent pro-differentiation agent and CAN INFLUENCE Brain functioning via many DIFFERENT pathways.31the Vitamin D receptor and the enzyme required for the manufacture of the hormonally active form of Vitamin D have BEEN IDENTIFIED in the Human Brain,32AND THERE IS EVIDENCE from Rodent MODELS DEMONSTRATING that transient Prenatal Vitamin D deficiency results in persistent changes in Adult Brain structure, neurochemistry and behavior.33our species has evolved in settings where Vitamin D is abundant, and migration to colder climates and urban-related lifestyle factors have left modern Humans at increased risk of hypovitaminosis D.\ninspired by the conceptual framework described above, we PROPOSE that the absence of adequate Vitamin D levels during development deprives the Organism of expected instructions from the environment.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 224), ('IMPORTANT_CONSIDERATION', 243), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 325), ('SUPERFICIAL_RELATIONSHIP', 370), ('INCOMPLETE_EVIDENCE', 377), ('INCOMPLETE_EVIDENCE', 549), ('SUPERFICIAL_RELATIONSHIP', 553), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 590), ('ANOMALY_CURIOUS_FINDING', 726), ('INCOMPLETE_EVIDENCE', 731), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 761), ('INCOMPLETE_EVIDENCE', 767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 797), ('INCOMPLETE_EVIDENCE', 797), ('INCOMPLETE_EVIDENCE', 804), ('INCOMPLETE_EVIDENCE', 1204)]	21	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D'), ('GO_0007567', 'parturition', 407, 'born'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 505, 'D'), ('UBERON_0000955', 'brain', 563, 'brain'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 711, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'human'), ('UBERON_0000955', 'brain', 755, 'brain'), ('NCBITaxon_33208', 'Metazoa', 790, 'rodent'), ('GO_0007565', 'female pregnancy', 833, 'prenatal'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin D'), ('UBERON_0007023', 'adult organism', 896, 'adult'), ('UBERON_0000955', 'brain', 902, 'brain'), ('CHEBI_27300', 'vitamin D', 991, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1100, 'humans'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1144, 'D'), ('CHEBI_27300', 'vitamin D', 1241, 'vitamin D'), ('NCBITaxon_1', 'root', 1290, 'organism')]
PMC3309463	6/2011	S44-PMC3309463	['we SPECULATE that (a) developmental Vitamin D deficiency MAY underlie KEY features of the epidemiology of schizophrenia, (b) the Vitamin D deficiency during development decanalizes Brain Development and (c) schizophrenia is a behavioral phenotype ASSOCIATED with increased variance ASSOCIATED with this decanalization of Brain Development.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 70), ('SUPERFICIAL_RELATIONSHIP', 247), ('SUPERFICIAL_RELATIONSHIP', 282)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007420', 'brain development', 181, 'brain development'), ('UBERON_0000955', 'brain', 181, 'brain'), ('GO_0007420', 'brain development', 321, 'brain development'), ('UBERON_0000955', 'brain', 321, 'brain')]
PMC3309463	6/2011	S45-PMC3309463	['we SPECULATE that Prenatal Vitamin D deficiency would be one of many DIFFERENT exposures that COULD decanalize Brain Development and lead TO an increased susceptibility to schizophrenia.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('INCOMPLETE_EVIDENCE', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 138)]	4	[('GO_0007565', 'female pregnancy', 18, 'prenatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007420', 'brain development', 111, 'brain development'), ('UBERON_0000955', 'brain', 111, 'brain')]
PMC3309463	6/2011	S89-PMC3309463	['with respect to the epidemiology of schizophrenia, we OUTLINE HOW one CANDIDATE environmental RISK FACTOR, low Prenatal Vitamin D, CAN result in environmental editing of Brain Development.']	[('INCOMPLETE_EVIDENCE', 54), ('EXPLICIT_QUESTION', 62), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 131)]	5	[('GO_0007565', 'female pregnancy', 111, 'prenatal'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 128, 'D'), ('GO_0007420', 'brain development', 170, 'brain development'), ('UBERON_0000955', 'brain', 170, 'brain')]
PMC3120197	7/2011	S78-PMC3120197	['AS EXPECTED, higher nonheme iron intake was ASSOCIATED with higher intake of fruits, vegetables, fiber, and Vitamin C.\n\ncaption (table-wrap): table 1\n\nparticipants’ characteristics according to quartiles of dietary Heme and nonheme iron intake, seattle and tacoma, wa, omega cohort studycharacteristicdietary Heme iron (mg per day)dietary nonheme iron (mg per day)cohortquintile 1quintile 2quintile 3quintile 4 p for trendquintile 1quintile 2quintile 3quintile 4 p for trend n 3,158806765793794787790791790interval—<0.480.48–0.750.76–1.11≥1.12<9.109.10–12.1612.17–15.97≥12.98median—0.300.610.931.43<0.0017.1610.6513.8119.60<0.001maternal age (years)32.732.632.732.633.00.1032.432.932.932.70.11prepregnancy bmi (kg/m2)23.522.623.223.524.6<0.00123.623.623.423.20.04non-hispanic white (%)87.787.689.588.884.80.0880.987.689.992.2<0.001<12 years of education (%)3.13.72.23.43.00.723.63.03.22.70.35not married (%)10.011.08.19.311.50.6211.49.98.410.30.30nullipara (%)62.267.063.562.256.1<0.00160.261.863.663.20.17smoked during Pregnancy (%)5.45.14.45.46.70.117.14.74.85.10.10prenatal Vitamin use (%)97.697.897.398.197.40.8797.598.497.197.60.72iron deficiency anemia (%)2.33.12.41.81.80.0512.32.01.63.00.43physically inactive in Pregnancy (%)12.111.811.113.112.50.4411.913.911.511.10.35history of hypertension (%)4.23.53.73.56.20.024.35.14.33.20.19family history of hypertension (%)49.245.949.248.952.80.0152.548.248.347.70.08family history of diabetes (%)13.512.313.713.614.40.2614.613.812.812.80.23total energy intake (kcal)1,7171,4201,5631,7862,096<0.0011,1851,6061,8572,216<0.001calories from Carbohydrate (%)53.057.154.452.048.4<0.00151.352.253.555.0<0.001calories from protein (%)17.415.917.117.818.8<0.00117.517.317.517.20.28calories from total fat (%)31.529.330.532.034.1<0.00132.732.331.029.9<0.001calories from Saturated fat (%)11.210.610.911.412.0<0.00111.711.511.110.6<0.001calories from trans fat (%)1.110.971.051.151.25<0.0011.161.141.081.05<0.001calories from polyunsaturated fat (%)6.56.26.36.56.9<0.0016.76.66.46.3<0.001calories from N-3 Fatty Acids (%)0.760.710.750.770.82<0.0010.820.780.730.71<0.001dietary Cholesterol (mg)*271222247269315<0.001298287274249<0.001dietary Vitamin C (mg)*136148142138123<0.001118129129151<0.001dietary Vitamin E (mg)*15.716.416.215.615.00.0019.311.413.722.2<0.001total dietary fiber (g)*20.922.721.820.919.2<0.00116.719.220.923.4<0.001dietary calcium (g)*1.411.541.491.421.27<0.0011.321.321.381.51<0.001dietary total iron (mg)*16.216.716.616.116.00.0029.312.415.222.0<0.001fruits and vegetables (servings per day)4.44.14.24.64.9<0.0013.24.34.75.5<0.001whole grains (servings per day)0.630.580.590.670.68<0.0010.400.530.710.88<0.001red and processed meats (servings per day)0.660.190.470.731.24<0.0010.500.650.720.76<0.001poultry meats (servings per day)0.230.090.190.260.37<0.0010.180.220.240.27<0.001fish meats (servings per day)0.200.110.180.220.28<0.0010.150.180.200.25<0.001\ndata are means or percentages.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 108, 'vitamin C'), ('CHEBI_30413', 'heme', 215, 'heme'), ('CHEBI_30413', 'heme', 309, 'heme'), ('GO_0007565', 'female pregnancy', 1020, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 1077, 'vitamin'), ('GO_0007565', 'female pregnancy', 1221, 'pregnancy'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 1589, 'carbohydrate'), ('CHEBI_51247', 'texas red', 1813, 'saturated'), ('CHEBI_30256', 'thiocarbonyl group', 2043, 'n-3'), ('CHEBI_35366', 'fatty acid', 2047, 'fatty acids'), ('CHEBI_16113', 'cholesterol', 2118, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 2182, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 2244, 'vitamin E')]
PMC3366289	7/2011	S17-PMC3366289	['DEFICIENCY of Thiamine and Vitamin A as well as a high prevalence of anemia HAS BEEN DOCUMENTED in Pregnant and Postpartum women in this population [8–10].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 85)]	3	[('CHEBI_26948', 'vitamin B1', 14, 'thiamine'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin A'), ('GO_0007565', 'female pregnancy', 99, 'pregnant'), ('GO_0007565', 'female pregnancy', 112, 'postpartum')]
PMC3366289	7/2011	S122-PMC3366289	['Ascorbic Acid and Vitamin A in the flour MIGHT have been RESPONSIBLE for effective iron absorption [24,25].']	[('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 57)]	2	[('CHEBI_2874', 'Asimicin', 0, 'Ascorbic acid'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin A')]
PMC3366289	7/2011	S139-PMC3366289	['on the basis of Serum Retinol (6%\xa0<\xa01.05\xa0μmol/l) and of fat adjusted milk Retinol (5 and 16%\xa0≤\xa028\xa0μmol/kg fat), there is LITTLE EVIDENCE of SEVERE Vitamin A deficiency among Lactating mothers from maela camp.']	[('INCOMPLETE_EVIDENCE', 121), ('IMPORTANT_CONSIDERATION', 140)]	2	[('UBERON_0001977', 'blood serum', 16, 'serum'), ('CHEBI_26536', 'retinoic acid', 22, 'retinol'), ('CHEBI_26536', 'retinoic acid', 74, 'retinol'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin A'), ('GO_0007594', 'puparial adhesion', 174, 'lactating')]
PMC3169551	9/2011	S129-PMC3169551	['the cost of coverage with weekly Iron-Folic Acid is COMPARABLE to program ESTIMATES for distribution of other Nutritional Supplements such as twice-yearly Vitamin A, and zinc.']	[('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 74)]	2	[('CHEBI_24870', 'ion', 33, 'iron'), ('CHEBI_30751', 'formic acid', 38, 'folic acid'), ('CHEBI_7495', 'nefazodone hydrochloride', 110, 'nutritional'), ('CHEBI_33341', 'titanium atom', 122, 'supplements'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 163, 'A')]
PMC3169551	9/2011	S130-PMC3169551	['a RECENT survey[25]of the cost of Micronutrient supplementation programs (both published and “grey” literature) IDENTIFIED 43 STUDIES, of which 31 were for Vitamin A, and the rest for iron (7), Iodine (4) and zinc (1).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 126)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 34, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 194, 'iodine')]
PMC3169551	9/2011	S131-PMC3169551	['mean cost per beneficiary were calculated as usd1.95 (Vitamin A), usd3.64 (Iodine), usd0.52 (zinc – ONLY 1 program), BUT WAS NOT calculated for iron.']	[('INCOMPLETE_EVIDENCE', 100), ('PROBLEM_COMPLICATION', 117), ('INCOMPLETE_EVIDENCE', 121)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 75, 'iodine')]
PMC3169551	9/2011	S132-PMC3169551	['mean cost per person-year of “useful” coverage was ESTIMATED as usd8.53 (Vitamin A) and usd0.74 (Iodine) but NOT AVAILABLE for iron or zinc.']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 109)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 97, 'iodine')]
PMC3169551	9/2011	S134-PMC3169551	['this MAY REFLECT lower coverage with volunteer health workers and lower population densities in africa, where most costing STUDIES of Vitamin A were done.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 9), ('INCOMPLETE_EVIDENCE', 123)]	3	[('CHEBI_27300', 'vitamin D', 134, 'vitamin A')]
PMC3171895	9/2011	S3-PMC3171895	['the PRESENT PAPER summarises the CURRENT understanding of selected Micronutrient antioxidants Selenium, copper, zinc, manganese, and Vitamins C and e in Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 33)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('CHEBI_27568', 'selenium atom', 94, 'selenium'), ('CHEBI_27300', 'vitamin D', 133, 'vitamins C'), ('PR_000004900', 'complement C3', 142, 'C'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy')]
PMC3171895	9/2011	S36-PMC3171895	['methods\na number of Micronutrients and Vitamins are KNOWN to serve as antioxidants or be essential Cofactors for antioxidant enzymes; these include Selenium, copper, zinc, manganese, and Vitamins C and e. THE PRESENT PAPER summarises CURRENT UNDERSTANDING of the IMPORTANCE of these Micronutrient antioxidants in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 52), ('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('INCOMPLETE_EVIDENCE', 234), ('IMPORTANT_CONSIDERATION', 263)]	5	[('CHEBI_33839', 'macromolecule', 20, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 39, 'vitamins'), ('CHEBI_23357', 'cofactor', 99, 'cofactors'), ('CHEBI_27568', 'selenium atom', 148, 'selenium'), ('CHEBI_27300', 'vitamin D', 187, 'vitamins C'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 283, 'micronutrient'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy')]
PMC3171895	9/2011	S44-PMC3171895	['most of these values have been determined from the intake believed necessary to maximise the activity of the antioxidant Glutathione peroxidase in Plasma [49,50] and Selenium, like Vitamins C and e which have received much ATTENTION in RECENT YEARS.']	[('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 236)]	2	[('CHEBI_16856', 'glutathione', 121, 'glutathione'), ('UBERON_0001969', 'blood plasma', 147, 'plasma'), ('CHEBI_27568', 'selenium atom', 166, 'selenium'), ('CHEBI_27300', 'vitamin D', 181, 'vitamins C'), ('PR_000004900', 'complement C3', 190, 'C')]
PMC3171895	9/2011	S141-PMC3171895	['vitamin c is commonly included in low doses (<200\u2009mg/day) within multivitamin preparations for Pregnancy but HAS also BEEN given in higher doses (up to 1000\u2009mg/day) as a supplement, alone or in combination with Vitamin E [127].']	[('INCOMPLETE_EVIDENCE', 109)]	1	[('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin E')]
PMC3171895	9/2011	S142-PMC3171895	['smoking HAS BEEN SHOWN to increase oxidative stress and Metabolic turnover of Vitamin C, thus the REQUIREMENT for smokers is increased by 35\u2009mg/day [79].']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 98)]	2	[('GO_0008152', 'metabolic process', 56, 'metabolic'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin C')]
PMC3171895	9/2011	S145-PMC3171895	['a CONSIDERABLE INTEREST exists regarding PREVENTION of Maternal and Perinatal Morbidity with Vitamins C and E. HOWEVER, the most RECENT meta-analysis of ten trials (6533 women) published in 2008 of antioxidant supplementation (including Vitamin C and e but also OTHER supplements such as Lycopene) SHOWED no difference in the relative risk (rr) of Preeclampsia (rr 0.73, 95% ci 0.51 to 1.06), Preterm Birth (before 37 weeks) (rr 1.10, 95% ci 0.99 to 1.22), sga infants (rr 0.83, 95% ci 0.62 to 1.11), or any baby death (rr 1.12, 95% ci 0.81 to 1.53) [7].']	[('ANOMALY_CURIOUS_FINDING', 2), ('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 262), ('INCOMPLETE_EVIDENCE', 298)]	8	[('GO_0007618', 'mating', 55, 'maternal ...'), ('GO_0019230', 'proprioception', 68, 'perinatal morbidity'), ('UBERON_0012101', 'perinatal stage', 68, 'perinatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamins C'), ('PR_000004900', 'complement C3', 102, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 108, 'E'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin C'), ('CHEBI_15948', 'lycopene', 288, 'lycopene'), ('GO_0007128', 'meiotic prophase I', 348, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 393, 'preterm'), ('GO_0007567', 'parturition', 401, 'birth')]
PMC3171895	9/2011	S147-PMC3171895	['a couple of subsequent RECENT multicentre double-blinded randomised trials of a combination of Vitamin C and E [130,131] also FOUND that supplementation did not reduce the rate of Preeclampsia or Gestational hypertension and, like the Vitamins in Preeclampsia trial in 2006 [132], increased the risk of fetal loss or Perinatal death and preterm prelabour rupture of Membranes.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 126)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 109, 'E'), ('GO_0007128', 'meiotic prophase I', 180, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 196, 'gestational'), ('CHEBI_28371', 'vitamin K epoxide', 235, 'Vitamins'), ('GO_0007128', 'meiotic prophase I', 247, 'Preeclampsia'), ('GO_0036268', 'swimming', 317, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 317, 'perinatal'), ('UBERON_0000922', 'embryo', 366, 'membranes')]
PMC3171895	9/2011	S148-PMC3171895	['ANOTHER RECENT multicentre placebo-controlled TRIAL of Vitamin C and E in women with type-1 diabetes in Pregnancy (Dapit) also REPORTED no differences in the rates of Preeclampsia between supplemented or placebo groups [133].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 127)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 69, 'E'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('CHEBI_73285', "3-iodo-4-aminobenzyl-5'-N-methylcarboxamidoadenosine", 115, 'DAPIT'), ('GO_0007128', 'meiotic prophase I', 167, 'preeclampsia')]
PMC3171895	9/2011	S149-PMC3171895	['FURTHER INVESTIGATIONS are REQUIRED AS the concentrations of these Vitamins REMAIN significantly reduced in women with Preeclampsia, but in the absence OF FURTHER EVIDENCE, routine supplementation with higher dose Vitamin C and E is not RECOMMENDED AS they CAN be POTENTIALLY dangerous in high concentrations.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('IMPORTANT_CONSIDERATION', 27), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 76), ('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 155), ('FUTURE_WORK', 237), ('PROBABLE_UNDERSTANDING', 249), ('INCOMPLETE_EVIDENCE', 257), ('INCOMPLETE_EVIDENCE', 264)]	11	[('CHEBI_33277', 'gamma-tocotrienol', 67, 'vitamins'), ('GO_0007128', 'meiotic prophase I', 119, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 228, 'E')]
PMC3235789	12/2011	S22-PMC3235789	['ONE us cohort STUDY has EXAMINED the ASSOCIATION between maternal Vitamin D status and bv in Pregnancy, FINDING a dose-response RELATIONSHIP between the mean unadjusted Serum 25-Oh-D concentration and the prevalence of Bv per gram stain of Vaginal smears obtained in early Pregnancy [29].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 128)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('UBERON_0001977', 'blood serum', 169, 'serum'), ('CHEBI_65350', 'lorcaserin hydrochloride', 177, '-OH-D'), ('PR_000004696', 'apoptosis facilitator Bcl-2-like protein 14', 219, 'BV'), ('UBERON_0001987', 'placenta', 240, 'vaginal'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
PMC3235789	12/2011	S23-PMC3235789	['national health and nutrition examination survey (nhanes) data from 2001–2004 REVEAL that Vitamin D deficiency is ASSOCIATED with bv in Pregnant, but not nonpregnant, women (aor 2.87, 95% ci: 1.13–7.28) [30].']	[('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 114)]	2	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'pregnant')]
PMC3235789	12/2011	S24-PMC3235789	['another us cohort study among nonpregnant women FOUND an ASSOCIATION between bv and the high total dietary intake of fat (aor 1.5, 95% ci: 1.1–2.4) and the low dietary Intake of Folate (aor 0.4, 95% ci: 0.2–0.8), Vitamin E (aor 0.4, 95% ci: 0.2–0.8), and Calcium (aor 0.4, 95% ci: 0.3–0.7), WHEREAS no relationship with dietary Vitamin D intake was observed [31].']	[('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 291)]	3	[('GO_0007631', 'feeding behavior', 168, 'intake'), ('CHEBI_30863', '5-azaorotic acid', 178, 'folate'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin E'), ('CHEBI_22313', 'alkaline earth metal atom', 255, 'calcium'), ('CHEBI_27300', 'vitamin D', 328, 'vitamin D')]
PMC3235789	12/2011	S25-PMC3235789	['a cohort study of low-income, Pregnant african-american women FOUND no association between bv and dietary Intake of protein and Vitamins A and C [32].']	[('INCOMPLETE_EVIDENCE', 62)]	1	[('GO_0007565', 'female pregnancy', 30, 'pregnant'), ('GO_0007631', 'feeding behavior', 106, 'intake'), ('CHEBI_27300', 'vitamin D', 128, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 137, 'A'), ('CHEBI_18245', 'carboxylato group', 143, 'C'), ('PR_000004900', 'complement C3', 143, 'C')]
PMC3235789	12/2011	S66-PMC3235789	['IN ACCORDANCE WITH a RECENT REVIEW of data by a committee of the institute of medicine, the following Serum concentrations of 25-Oh-D were considered in the analyses: <12\u2009ng/ml (Vitamin D deficient), 12–20\u2009ng/ml (Vitamin D insufficient), ≥20\u2009ng/ml (referrent category, CONSIDERED adequate for bone and overall health in healthy Individuals) [36].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 269)]	3	[('UBERON_0001977', 'blood serum', 102, 'serum'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 126, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('NCBITaxon_1', 'root', 328, 'individuals')]
PMC3235789	12/2011	S99-PMC3235789	['in the case of Vitamin D deficiency, OUR FINDINGS are CONSISTENT with a RECENT cohort of Pregnant women, which FOUND a dose-response RELATIONSHIP between 25-Oh-D and the PREVALENCE of Bv during Pregnancy [29], and a nationally representative cross-sectional study of women in the united states, which found that 25-Oh-D <30\u2009ng/ml significantly increased the odds of bv during Pregnancy (aor 2.87, 95% ci: 1.13–7.28) [30].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 133), ('IMPORTANT_CONSIDERATION', 170)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant'), ('CHEBI_17808', 'IDP', 157, 'OH-D'), ('PR_000004696', 'apoptosis facilitator Bcl-2-like protein 14', 184, 'BV'), ('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 312, '25-OH-D'), ('GO_0007565', 'female pregnancy', 376, 'pregnancy')]
PMC3235789	12/2011	S103-PMC3235789	['the active form of Vitamin D (1,25-Dihydroxyvitamin D3) is a key modulator of the Immune Response, and Vitamin D is KNOWN to be a potent regulator of Placental Immunity, stimulating Antimicrobial Responses while suppressing inflammation [39].']	[('INCOMPLETE_EVIDENCE', 116)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_63912', '19-hydroxyprostaglandin H2', 30, '1,25-dihydroxyvitamin D3'), ('GO_0006955', 'immune response', 82, 'immune response'), ('UBERON_0002405', 'immune system', 82, 'immune'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0001987', 'placenta', 150, 'placental'), ('GO_0007566', 'embryo implantation', 160, 'immunity'), ('CHEBI_65381', 'albizoside C', 182, 'antimicrobial'), ('GO_0051607', 'defense response to virus', 182, 'antimicrobial responses')]
PMC3235789	12/2011	S104-PMC3235789	['there is EMERGING EVIDENCE that Vitamin D Regulates a KEY Antimicrobial peptide with broad Antimicrobial properties against gram-negative and gram-positive bacteria [40].']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 54)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 42, 'regulates'), ('CHEBI_65381', 'albizoside C', 58, 'antimicrobial'), ('CHEBI_65381', 'albizoside C', 91, 'antimicrobial')]
PMC3235789	12/2011	S105-PMC3235789	['adequate Vitamin D status MAY offer protection against bv by induction of Cathelicidin [41].']	[('INCOMPLETE_EVIDENCE', 26)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 74, 'cathelicidin')]
PMC3235789	12/2011	S107-PMC3235789	['studies in the us DEMONSTRATE a higher prevalence of deficiencies of Vitamin D and Folate among black compared with white women.']	[('INCOMPLETE_EVIDENCE', 18)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 83, 'folate')]
PMC3235789	12/2011	S115-PMC3235789	['THUS, in addition to the myriad OTHER health REASONS for addressing the POOR UNDERLYING Vitamin D and Folate status of us women [48,49], decreasing the susceptibility of women of Reproductive age to bv MAY provide further RATIONALE.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('PROBABLE_UNDERSTANDING', 45), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 222)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 102, 'folate'), ('GO_0000003', 'reproduction', 179, 'reproductive')]
PMC3235789	12/2011	S129-PMC3235789	['conclusions\nthis case-control study FOUND a significant ASSOCIATION between maternal Plasma 25-Hydroxy-Vitamin D <12\u2009ng/ml and Folate <5\u2009ug/ml and bv during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('UBERON_0001969', 'blood plasma', 85, 'plasma'), ('CHEBI_70487', '(-)-sanguinolignan C', 92, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 127, 'folate'), ('GO_0007565', 'female pregnancy', 157, 'pregnancy')]
PMC3272870	12/2011	S45-PMC3272870	['moreover, the usual RECOMMENDATIONS to avoid sun exposure reduces dermal Synthesis Of Vitamin D3Although Vitamin D is UNDOUBTEDLY IMPORTANT for foetal Bone Development, we KNOW that it plays a much wider ROLE in health and disease prevention.']	[('FUTURE_WORK', 20), ('ANOMALY_CURIOUS_FINDING', 96), ('PROBABLE_UNDERSTANDING', 118), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 204)]	6	[('GO_0030474', 'spindle pole body duplication', 73, 'synthesis of ... D3Although'), ('CHEBI_83701', '8-PAHSA(1-)', 86, 'vitamin D3Although'), ('PR_000027594', 'histone H3', 86, 'vitamin D3Although'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0048539', 'bone marrow development', 151, 'bone development')]
PMC3274449	12/2011	S39-PMC3274449	['ACCORDING TO the national policy, children from 6-59 mo SHOULD BE supplemented with Vitamin A every 6 months and mothers SHOULD receive a Vitamin A dose within 2 months after delivary.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 56), ('FUTURE_WORK', 121)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A')]
PMC3277098	12/2011	S1-PMC3277098	['abstract\na ROLE for Vitamin D in the Regulation Of Immune function was FIRST PROPOSED after the identification of Vitamin D receptors in Lymphocytes.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 77)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0006883', 'cellular sodium ion homeostasis', 37, 'regulation of immune'), ('UBERON_0002405', 'immune system', 51, 'immune'), ('CHEBI_28384', 'vitamin K', 114, 'Vitamin D'), ('CL_0000542', 'lymphocyte', 137, 'lymphocytes')]
PMC3277098	12/2011	S3-PMC3277098	['there is a GROWING BODY of LITERATURE LINKING Vitamin D (Serum 25(Oh)D, Oral Intake and SURROGATE indicators such as latitude) to various immune-RELATED conditions, including allergy, ALTHOUGH the nature of this RELATIONSHIP is STILL UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 145), ('ANOMALY_CURIOUS_FINDING', 184), ('SUPERFICIAL_RELATIONSHIP', 212), ('FULL_UNKNOWN', 228)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001977', 'blood serum', 57, 'serum'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 63, '25 ... OH ... D'), ('UBERON_0000165', 'mouth', 72, 'oral'), ('GO_0007631', 'feeding behavior', 77, 'intake')]
PMC3277098	12/2011	S4-PMC3277098	['THIS REVIEW explores the FINDINGS of epidemiological, clinical and laboratory research, and the POTENTIAL ROLE of Vitamin D in promoting the inappropriate Immune Responses which UNDERPIN the rise in a broad range of Immune diseases.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 178)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006955', 'immune response', 155, 'immune responses'), ('UBERON_0002405', 'immune system', 155, 'immune'), ('UBERON_0002405', 'immune system', 216, 'immune')]
PMC3277098	12/2011	S8-PMC3277098	['we now KNOW that all Tissues in the body posses receptors for the active form of Vitamin D, 1,25-Dihydroxyvitamin D (1α,25(Oh)2D3) and it HAS RECENTLY BEEN DISCOVERED that there are Extrarenal Tissues capable of converting 25(Oh)D to the active Metabolite, including certain Immune Cells [1,2].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 156)]	3	[('UBERON_0000479', 'tissue', 21, 'tissues'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 92, '1,25-dihydroxyvitamin D'), ('CHEBI_34898', 'OM-174', 123, 'OH)2D3'), ('UBERON_0005292', 'extraembryonic tissue', 182, 'extrarenal tissues'), ('CHEBI_71657', 'versiconol acetate', 223, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 245, 'metabolite'), ('CL_0000738', 'leukocyte', 275, 'immune cells'), ('UBERON_0002405', 'immune system', 275, 'immune')]
PMC3277098	12/2011	S9-PMC3277098	['aside from Skeletal health, Vitamin D HAS BEEN ASSOCIATED with various cancers and Autoimmune disorders [1] with EVIDENCE FOR a ROLE in development and maintenance of Lung structure and function [3,4,5].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('UBERON_0004288', 'skeleton', 11, 'skeletal'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 83, 'autoimmune'), ('UBERON_0002048', 'lung', 167, 'lung')]
PMC3277098	12/2011	S10-PMC3277098	['it is this ASSOCIATION with Immune and Airway function that provides the basis for the HYPOTHESIS that Vitamin D MAY have direct LINKS with asthma and allergic disease [6,7].']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 129)]	4	[('UBERON_0002405', 'immune system', 28, 'immune'), ('UBERON_0001005', 'respiratory airway', 39, 'airway'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC3277098	12/2011	S11-PMC3277098	['we AIM to review the CURRENT EVIDENCE on Vitamin D in RELATION to Immune mechanisms and FOCUS on the EFFECT of Pregnancy and Early Life exposure on Allergy Development.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0002405', 'immune system', 66, 'immune'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('UBERON_0001847', 'lobule of pinna', 125, 'early life'), ('GO_0060021', 'roof of mouth development', 148, 'allergy development')]
PMC3277098	12/2011	S20-PMC3277098	['more RECENTLY variations in Vitamin D status and intake HAS BEEN IMPLICATED in Allergy Development and CONSIDERED AS one of a NUMBER OF EXPLANATIONS for epidemiological and immunological ASSOCIATIONS.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 103), ('PROBABLE_UNDERSTANDING', 114), ('INCOMPLETE_EVIDENCE', 126), ('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 187)]	9	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 79, 'allergy development')]
PMC3277098	12/2011	S29-PMC3277098	['such populations are THEREFORE reliant on dietary or supplemental sources of Vitamin D; a FACTOR that MAY BE playing a ROLE in the current allergy epidemic [16,17].']	[('PROBABLE_UNDERSTANDING', 21), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC3277098	12/2011	S31-PMC3277098	['this ASSOCIATION persists after adjusting for physical activity and dietary intake SUGGESTING obesity is an INDEPENDENT risk factor for reduced Serum 25(Oh)D and SUPPORTS the notion that Vitamin D deficiency MAY follow from modern lifestyle change.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 162), ('INCOMPLETE_EVIDENCE', 208)]	5	[('UBERON_0001977', 'blood serum', 144, 'serum'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 150, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC3277098	12/2011	S38-PMC3277098	['Immune Cell Differentiation and Proliferation\nthe ROLE of Vitamin D in Regulation Of the Immune System was FIRST RECOGNIZED through the identification of Vitamin D receptors on Peripheral Blood Mononuclear cells (Lymphocytes) [2].']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 107), ('PROBABLE_UNDERSTANDING', 113)]	3	[('CL_0000902', 'induced T-regulatory cell', 0, 'Immune Cell'), ('GO_0002121', 'inter-male aggressive behavior', 0, 'Immune Cell Differentiation ... Proliferation'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007093', 'mitotic cell cycle checkpoint signaling', 71, 'regulation of ... immune system'), ('UBERON_0002405', 'immune system', 89, 'immune system'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('UBERON_0012101', 'perinatal stage', 177, 'peripheral blood'), ('CL_0000100', 'motor neuron', 194, 'mononuclear'), ('GO_0031097', 'medial cortex', 194, 'mononuclear'), ('CL_0000542', 'lymphocyte', 213, 'lymphocytes')]
PMC3277098	12/2011	S42-PMC3277098	['the resulting th2 relative dominance HAS BEEN used as an explanation for the earlier OBSERVATION (1990’s) that the rise in allergic disease COINCIDED with the introduction of routine Vitamin D fortification in high latitude regions [16,17].']	[('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 85), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC3277098	12/2011	S43-PMC3277098	['HOWEVER, just as with the epidemiological ASSOCIATIONS, the EFFECTS of Vitamin D on Th2 Cells HAVE also BEEN CONTRADICTORY, with REPORTS of both enhancement and inhibition [29,30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 94), ('ANOMALY_CURIOUS_FINDING', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('INCOMPLETE_EVIDENCE', 129)]	7	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CL_0000546', 'T-helper 2 cell', 84, 'Th2 cells')]
PMC3277098	12/2011	S44-PMC3277098	['in Animal MODELS, an increased th2 response to Vitamin D HAS BEEN ACCOMPANIED by increase in anti-inflammatory Il-10 response [30].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 111, 'IL-10')]
PMC3277098	12/2011	S45-PMC3277098	['in Human studies there is SOME EVIDENCE of a non-linear response to Vitamin D, in that both high and low levels HAVE BEEN ASSOCIATED with increased th2 activity, but also EVIDENCE of an increased Regulatory response.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 122), ('INCOMPLETE_EVIDENCE', 171)]	4	[('NCBITaxon_9606', 'Homo sapiens', 3, 'human'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0065007', 'biological regulation', 196, 'regulatory')]
PMC3277098	12/2011	S46-PMC3277098	['ACCORDINGLY, there is INCREASING EVIDENCE that the immunomodulatory effect of Vitamin D MAY act not ONLY through Modulation of Helper T Cell function, but also through induction of Cd4+Cd25+ Regulatory T Cells (Tregs) [29].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 100)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0065007', 'biological regulation', 113, 'modulation'), ('CL_0000912', 'helper T cell', 127, 'helper T cell'), ('GO_0006283', 'transcription-coupled nucleotide-excision repair', 134, 'T cell'), ('PR_000001204', 'C-C chemokine receptor type 8', 181, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 185, 'CD25'), ('CL_0000815', 'regulatory T cell', 191, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 191, 'regulatory'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 211, 'Tregs')]
PMC3277098	12/2011	S47-PMC3277098	['this MAY BE one POSSIBLE EXPLANATION for the epidemiological LINKS between both Autoimmune disease and allergy with Vitamin D deficiency [31].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 61)]	4	[('UBERON_0001442', 'skeleton of manus', 80, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC3277098	12/2011	S50-PMC3277098	['to date, the MAJORITY of research HAS BEEN conducted using cells sourced from peripheral Blood; HOWEVER SOME authors have PROPOSED that Gut-associated lymphoid Tissue MAY be of RELEVANCE, particularly in regard to oral Vitamin D Intake and Food Allergen sensitization [33].']	[('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 122), ('INCOMPLETE_EVIDENCE', 167), ('IMPORTANT_CONSIDERATION', 177)]	7	[('UBERON_0000178', 'blood', 89, 'blood'), ('UBERON_0001555', 'digestive tract', 136, 'gut'), ('UBERON_0000479', 'tissue', 160, 'tissue'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('GO_0007631', 'feeding behavior', 229, 'intake'), ('CHEBI_33290', 'food', 240, 'food'), ('CHEBI_50904', 'allergen', 245, 'allergen')]
PMC3277098	12/2011	S56-PMC3277098	['given that B and T Cells are INFLUENCED by Vitamin D (section 4.1), there is SPECULATION that Orally Ingested Vitamin D COULD have the POTENTIAL to directly Modulate the function of Lymphocytes in the local Gut micro-environment.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 135)]	4	[('CL_0000969', 'regulatory B cell', 11, 'B ...'), ('CL_0000084', 'T cell', 17, 'T cells'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 94, 'orally'), ('GO_0007631', 'feeding behavior', 101, 'ingested'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0065007', 'biological regulation', 157, 'modulate'), ('CL_0000542', 'lymphocyte', 182, 'lymphocytes'), ('UBERON_0001555', 'digestive tract', 207, 'gut')]
PMC3277098	12/2011	S57-PMC3277098	['weiss [33] PROPOSES in his editorial on Vitamin D and the Gut microbiome that Vitamin D COULD POTENTIALLY INTERACT directly with both the galt and the microflora, to INFLUENCE Immune function and allergy outcomes, a THEORY also explored by vassallo and camargo [35].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 216)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 58, 'gut'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002405', 'immune system', 176, 'immune')]
PMC3277098	12/2011	S59-PMC3277098	['the “Vitamin D/microbiome HYPOTHESIS” has PROPONENTS on BOTH SIDES, with vassallo and camargo [35] ARGUING that deficiency is causative, WHILE wjst [17] SUGGESTS that the introduction of Vitamin D supplementation COINCIDES with the rise in allergic disease.']	[('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 213)]	7	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC3277098	12/2011	S60-PMC3277098	['this line of argument HIGHLIGHTS that the potency and pharmacokinetics of endogenous and exogenous Vitamin D MAY BE DIFFERENT and that Serum 25(Oh)D, sun exposure and oral Intake SHOULD BE CONSIDERED INDEPENDENTLY of one another.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('FUTURE_WORK', 179), ('FUTURE_WORK', 189), ('SUPERFICIAL_RELATIONSHIP', 200)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 141, '25(OH ... D'), ('GO_0007631', 'feeding behavior', 172, 'intake')]
PMC3277098	12/2011	S63-PMC3277098	['[4] FOUND that Vitamin D deficiency in Mice is significantly ASSOCIATED with decreased Lung volume, Tissue volume and increased Airway resistance.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 61)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 39, 'mice'), ('UBERON_0002048', 'lung', 87, 'lung'), ('UBERON_0000479', 'tissue', 100, 'tissue'), ('UBERON_0001005', 'respiratory airway', 128, 'airway')]
PMC3277098	12/2011	S64-PMC3277098	['they PROPOSED that, as reduced Lung volume is a RISK FACTOR for Lung function and Respiratory illness in Humans, Vitamin D deficiency COULD increase the risk of these conditions through EFFECTS on Lung Tissue growth.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 134), ('SUPERFICIAL_RELATIONSHIP', 186)]	4	[('UBERON_0002048', 'lung', 31, 'lung'), ('UBERON_0002048', 'lung', 64, 'lung'), ('UBERON_0001004', 'respiratory system', 82, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 105, 'humans'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0002048', 'lung', 197, 'lung'), ('UBERON_0000479', 'tissue', 202, 'tissue')]
PMC3277098	12/2011	S65-PMC3277098	['there is SOME SUPPORT for this in Human studies LINKING Vitamin D deficiency with reduced Lung function [3,5].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('NCBITaxon_9606', 'Homo sapiens', 34, 'human'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0002048', 'lung', 90, 'lung')]
PMC3277098	12/2011	S68-PMC3277098	['the latter study FOUND a high prevalence of Vitamin D deficiency in patients, with 88.9% of having Serum 25(Oh)D <50 nmol/l.']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0001977', 'blood serum', 99, 'serum'), ('CHEBI_71657', 'versiconol acetate', 105, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 105, '25(OH)D')]
PMC3277098	12/2011	S70-PMC3277098	['the exact physiological mechanisms behind these OBSERVATIONS REMAINS unanswered, however there is GROWING EVIDENCE of Genetic variability that Modulates sensitivity to, and EFFECTS of, Vitamin D exposure.']	[('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('SO_0000704', 'gene', 118, 'genetic'), ('GO_0065007', 'biological regulation', 143, 'modulates'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3277098	12/2011	S101-PMC3277098	['functional consequences of vdr polymorphisms MAY, THEREFORE, vary with the availability of Vitamin D to Tissues and become apparent, OR exaggerated, in an environment of Vitamin d deficiency, such as observed in the case of several infectious diseases [45,46].']	[('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('UBERON_0000479', 'tissue', 104, 'tissues'), ('CHEBI_33229', 'vitamin (role)', 170, 'vitamin')]
PMC3277098	12/2011	S109-PMC3277098	['FOUND Vitamin D to BE inversely ASSOCIATED with wheeze in japanese children aged 16–24 months, an ASSOCIATION that was no longer significant when adjusted for Docosahexaenoic Acid Intake [51].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 19), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_36003', 'decenoic acid', 159, 'docosahexaenoic acid'), ('GO_0007631', 'feeding behavior', 180, 'intake')]
PMC3277098	12/2011	S113-PMC3277098	['WHILE Vitamin D MAY BE ASSOCIATED with the development of wheeze through OTHER mechanisms (seesection 4.3) these REPORTS of wheeze are NOT NECESSARILY RELATED to a true th2-dominant allergic response.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 151)]	7	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC3277098	12/2011	S118-PMC3277098	['for each 2.5 µg/day (100 iu) incremental increase in Vitamin D intake the authors FOUND a 10% decrease risk of wheeze and 13% decrease risk of recurrent wheeze at 2 years (or 0.90; 95% ci, 0.83–0.97 and or 0.87; 95% ci, 0.77–0.97, respectively) and SIMILAR risk of recurrent wheeze at 3 years of age (or 0.80; 95% ci 0.72–0.90), adjusted for multiple factors.']	[('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 249)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC3277098	12/2011	S119-PMC3277098	['the ASSOCIATION REMAINED significant after adjusting for several predisposing risk factors and dietary components such as Calcium, Vitamin E, fish and vegetable intake.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 16)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 122, 'calcium'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin E')]
PMC3277098	12/2011	S122-PMC3277098	['[6] who FOUND lower rates of both allergic rhinitis (or 0.85; 95% ci 0.75–0.96, p< 0.01) and asthma (or 0.80; 95% ci 0.65–0.98, p< 0.05) in 5 year old children with higher maternal Vitamin D intake in Pregnancy, with no relationship to eczema (or 0.95; 95% ci 0.86–1.05, p> 0.05).']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('GO_0007565', 'female pregnancy', 201, 'pregnancy')]
PMC3277098	12/2011	S132-PMC3277098	['RECORDED Serum 25(Oh)D in addition to dietary and supplemental Vitamin D intake and ESTIMATED uv exposure in 466 Pregnant women in the uk [55].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 84)]	2	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_71657', 'versiconol acetate', 15, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 15, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnant')]
PMC3277098	12/2011	S140-PMC3277098	['Cord Blood (Cb) HAS BEEN used as a measure of fetal Vitamin D status at Birth in the investigation of Immune function and allergic outcomes.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 12, 'CB'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007567', 'parturition', 72, 'birth'), ('UBERON_0002405', 'immune system', 102, 'immune')]
PMC3277098	12/2011	S179-PMC3277098	['FEWER STUDIES have investigated Vitamin D status and Food allergy outcomes.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_33290', 'food', 53, 'food')]
PMC3277098	12/2011	S181-PMC3277098	['[64] FOUND that lower Serum 25(Oh)D (of ≤37.5 nmol/l) was ASSOCIATED with both Peanut (or 2.39; 95% ci 1.29–4.45, p = 0.005) and shrimp (or 3.08; 95% ci 1.16–8.19, p = 0.02) sensitization, HOWEVER, OTHER studies of Food allergy are LARGELY LIMITED TO epidemiological data without serological measures of Vitamin D [69,70,71,72].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 189), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 240)]	6	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_71657', 'versiconol acetate', 28, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 28, '25(OH)D'), ('NCBITaxon_10088', 'Mus <genus>', 79, 'peanut'), ('CHEBI_33290', 'food', 215, 'food'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D')]
PMC3277098	12/2011	S183-PMC3277098	['a NUMBER OF longitudinal OBSERVATIONAL studies have specifically examined infant Vitamin D supplementation in the context of allergic disease.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 25)]	2	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC3277098	12/2011	S184-PMC3277098	['this data has the advantage of focussing on the Early Life Period and MAY THEREFORE provide INSIGHT into the aetiological ROLE of Vitamin D. DESPITE the OBSERVED PROTECTIVE ASSOCIATION of Serum 25(Oh)D and allergy, it has been NOTED that the widespread practice of supplementation COINCIDED with the rise in allergic disease [35].']	[('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('ANOMALY_CURIOUS_FINDING', 141), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 173), ('ANOMALY_CURIOUS_FINDING', 227), ('SUPERFICIAL_RELATIONSHIP', 281)]	11	[('UBERON_0019248', 'early embryo', 48, 'early life period'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('UBERON_0001977', 'blood serum', 188, 'serum'), ('CHEBI_71657', 'versiconol acetate', 194, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 194, '25(OH)D')]
PMC3277098	12/2011	S185-PMC3277098	['SUPPORTING this observation are SEVERAL STUDIES which FOUND Vitamin D supplementation to be ASSOCIATED with an INCREASED RISK of atopic dermatitis [73], allergic rhinitis [35,74], asthma, sensitisation [69,74] and Food allergy [70], HOWEVER NONE of these papers are SUPPORTED by biological measures of Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 233), ('INCOMPLETE_EVIDENCE', 241), ('INCOMPLETE_EVIDENCE', 266)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_33290', 'food', 214, 'food'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC3277098	12/2011	S189-PMC3277098	['HOWEVER, OTHER authors investigating infant Intakes in this lower dose range (closer to aap recommendations) HAVE ALSO SHOWN that atopic manifestations (particularly atopic dermatitis) were more prevalent in children with “high” (>13.1 μg/day) versus “low” (≤13.1 μg/day) intake of Vitamin D [73].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 114)]	4	[('GO_0007631', 'feeding behavior', 44, 'intakes'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC3277098	12/2011	S194-PMC3277098	['there is also SOME EVIDENCE that the EFFECT of supplementation MAY depend ON WHETHER Vitamin D is administered in a fat- OR Water-soluble form.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 63), ('ANOMALY_CURIOUS_FINDING', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_15377', 'water', 124, 'water')]
PMC3277098	12/2011	S196-PMC3277098	['[70] DEMONSTRATED that children given Vitamin D (400 iu) in Water-soluble form during the first year of Life had an almost two-fold increase in asthma (or 2.18; 95% ci 1.45–3.28), Food allergy (or 1.89; 95% ci 1.33–2.65), and sensitization (or 1.88; 95% ci 1.34–2.64) at 4 years of age compared with children having received the same Vitamins in peanut oil (ALTHOUGH there was no difference in the risk of allergic rhinitis or eczema).']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 358)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_15377', 'water', 60, 'water'), ('UBERON_0000104', 'life cycle', 104, 'life'), ('CHEBI_33290', 'food', 180, 'food'), ('CHEBI_33277', 'gamma-tocotrienol', 334, 'vitamins')]
PMC3277098	12/2011	S197-PMC3277098	['these CONTRASTING results HIGHLIGHT THE NEED for randomised controlled trials (rct) to provide clearer picture of ROLE of Vitamin D during infancy in Regulation of Allergic disease, including uptake, Metabolism and Immunomodulation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 150)]	6	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0065007', 'biological regulation', 150, 'regulation'), ('GO_0040011', 'locomotion', 164, 'allergic'), ('GO_0008152', 'metabolic process', 200, 'metabolism'), ('GO_0050900', 'leukocyte migration', 215, 'immunomodulation')]
PMC3277098	12/2011	S198-PMC3277098	['IN SUMMARY, the CONTRARY epidemiological OBSERVATIONS between Serum status (GENERALLY PROTECTIVE) and Oral exposure (supplementation increasing allergy risk in MANY STUDIES) HIGHLIGHT the uncertainty surrounding Vitamin D in Allergy Development and precludes population RECOMMENDATIONS.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 76), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 174), ('FUTURE_WORK', 270)]	8	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('UBERON_0000165', 'mouth', 102, 'oral'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 225, 'allergy development')]
PMC3277098	12/2011	S199-PMC3277098	['most of these OBSERVATIONAL studies DID NOT have direct serological measures of 25(Oh)D levels to ACCURATELY CONFIRM Vitamin D status and cross sectional study designs involving older children and Adults fail TO provide EVIDENCE on aetiological FACTORS.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 109), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('UBERON_0007023', 'adult organism', 197, 'adults')]
PMC3277098	12/2011	S204-PMC3277098	['there is MUCH EVIDENCE to SHOW Vitamin D AFFECTS Differentiation and Proliferation Of Immune Cells [2,24,25] and that Genetic polymorphisms, including of vdr and Vdbp , MAY CONTRIBUTE to disease susceptibility [42,78,79,80,81].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0030254', 'protein secretion by the type III secretion system', 49, 'differentiation ...'), ('GO_0008283', 'cell proliferation', 69, 'proliferation of ... cells'), ('CL_0000738', 'leukocyte', 86, 'immune cells'), ('UBERON_0002405', 'immune system', 86, 'immune'), ('SO_0000704', 'gene', 118, 'genetic'), ('PR_000017279', 'testis-specific basic protein Y 1', 162, 'VDBP')]
PMC3277098	12/2011	S207-PMC3277098	['RANDOMIZED control TRIALS are ultimately REQUIRED to determine the EFFECTS of Vitamin D supplementation on the developing Immune System, and any POTENTIAL ROLE in preventing allergic disease.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 19), ('FUTURE_WORK', 41), ('IMPORTANT_CONSIDERATION', 41), ('SUPERFICIAL_RELATIONSHIP', 67), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 155)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune system')]
PMC3271033	1/2012	S13-PMC3271033	['REMARKABLY, FEW DATA have LOOKED AT modern techniques of assessing bone Mineral status and compared it to Vitamin D levels and supplementation in this population [5].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 26)]	3	[('CHEBI_46662', 'mineral', 72, 'mineral'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC3271033	1/2012	S14-PMC3271033	['Serum 25-Hydroxyvitamin D (25(Oh)D) is ACCEPTED as the BEST MARKER of Vitamin D status ALTHOUGH it MAY serve PRIMARILY as a MARKER of exposure RATHER than clinical outcomes [2].there are FEW DATA that CORRELATE Serum 25(Oh)D levels with functional outcomes in newborns and small infants.']	[('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('INCOMPLETE_EVIDENCE', 99), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 201)]	10	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0001977', 'blood serum', 211, 'serum'), ('CHEBI_71657', 'versiconol acetate', 217, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 217, '25(OH)D')]
PMC3271033	1/2012	S20-PMC3271033	['HOWEVER, the RELATIONSHIP between Vitamin D status and bone-related outcomes in supplemented infants provides INFORMATION about the EFFECTS of these Cord levels and Vitamin D supplementation in early Infancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 132)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 149, 'cord'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('UBERON_0000023', 'wing', 200, 'infancy')]
PMC3271033	1/2012	S21-PMC3271033	['furthermore, FEW DATA have EVALUATED hispanic infants who MAY BE at high-risk for low Vitamin D status DUE TO POOR maternal Vitamin D intake [4].']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 58), ('PROBABLE_UNDERSTANDING', 103), ('PROBLEM_COMPLICATION', 110)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC3271033	1/2012	S116-PMC3271033	['these extremely low values are NOT COMMONLY reported in the united states, ALTHOUGH we SPECULATE that an increasing NUMBER OF cases MAY BE reported in the FUTURE DUE TO INCREASED AWARENESS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 75), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 132), ('FUTURE_PREDICTION', 155), ('PROBABLE_UNDERSTANDING', 162), ('IMPORTANT_CONSIDERATION', 169)]	8	[('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC3271033	1/2012	S127-PMC3271033	['regardless, Serum calcium in the Cord Blood and in the first days of Life is LIKELY Controlled by a VARIETY of FACTORS, of which Vitamin D is ONLY one FACTOR.']	[('PROBABLE_UNDERSTANDING', 77), ('DIFFICULT_TASK', 100), ('SUPERFICIAL_RELATIONSHIP', 111), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	5	[('UBERON_0001977', 'blood serum', 12, 'serum'), ('UBERON_0002240', 'spinal cord', 33, 'cord'), ('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0000104', 'life cycle', 69, 'life'), ('GO_0065007', 'biological regulation', 84, 'controlled'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3271033	1/2012	S131-PMC3271033	['it HAS BEEN SUGGESTED BUT is NOT PROVEN that early Life calcium absorption is PRIMARILY non-Vitamin D DEPENDENT [2].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 102)]	5	[('UBERON_0000104', 'life cycle', 51, 'life'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3271033	1/2012	S134-PMC3271033	['greer et al [16] FOUND an increase in 25(Oh)D from 24 to 39 ng/ml at three months of age with the provision of 400 iu/day of Vitamin D to Breast-Fed infants.']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_71657', 'versiconol acetate', 38, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 38, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('GO_0007567', 'parturition', 138, 'breast'), ('UBERON_0000310', 'breast', 138, 'breast'), ('GO_0007631', 'feeding behavior', 145, 'fed')]
PMC3271033	1/2012	S140-PMC3271033	['HOWEVER, it APPEARS that, AT LEAST in a southern us setting, 400 iu/day is adequate for infants REGARDLESS OF Vitamin D status at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 96)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007567', 'parturition', 130, 'birth')]
PMC3271033	1/2012	S141-PMC3271033	['we CANNOT RULE OUT the POSSIBILITY that a SMALL NUMBER OF infants WILL be hypocalcemic in the first weeks of Life with this approach, BUT, this APPEARS TO BE UNCOMMON and MAY BE more RELATED to pth function than Vitamin D. further RESEARCH IS NEEDED relative to the etiology of symptomatic hypocalcemia in the first weeks of life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 48), ('FUTURE_PREDICTION', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('ANOMALY_CURIOUS_FINDING', 144), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 183), ('FUTURE_WORK', 231)]	11	[('UBERON_0000104', 'life cycle', 109, 'life'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC3271033	1/2012	S146-PMC3271033	['HOWEVER, the FINDINGS in OUR STUDY APPEAR MEANINGFUL in that the provision of Vitamin D at a dose of 400 iu/day LED TO mean values that were above 30 ng/ml REGARDLESS OF starting value or ethnicity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ANOMALY_CURIOUS_FINDING', 35), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 156)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3271033	1/2012	S148-PMC3271033	['the EFFECTS of maternal Vitamin D deficiency are COMPLEX and MAY EXTEND beyond bone health EFFECTS in infants.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('DIFFICULT_TASK', 49), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC3271033	1/2012	S159-PMC3271033	['OUR FINDINGS SUPPORT current GUIDELINES to begin Vitamin D supplementation of 400 iu/day to all Breast-Fed infants in the first week of Life and to FURTHER ENCOURAGE the provision of adequate Vitamin D to Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 29), ('FUTURE_WORK', 148), ('FUTURE_WORK', 156)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'breast'), ('UBERON_0000310', 'breast', 96, 'breast'), ('GO_0007631', 'feeding behavior', 103, 'fed'), ('UBERON_0000104', 'life cycle', 136, 'life'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('GO_0007565', 'female pregnancy', 205, 'pregnant')]
PMC3278486	1/2012	S137-PMC3278486	["comparison with other studies\nour finding of no benefit, BUT a POSSIBLE adverse EFFECT from Folic Acid supplementation on cancer incidence is IN LINE WITH REPORTED results of studies on other Nutrient supplements, including Vitamin E, Β-Carotene (Vitamin-A precursor) or Selenium; all SHOWING no or an adverse EFFECT of supplementation in controlled clinical trials on cancer development.4243a RECENT meta-analysis of Folic Acid supplements by clarke and coworkers, in the ‘b-Vitamin treatment trialists' collaboration’3with individual patient data, FOUND no increased cancer risk in any subgroups."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 285), ('SUPERFICIAL_RELATIONSHIP', 310), ('INCOMPLETE_EVIDENCE', 394), ('INCOMPLETE_EVIDENCE', 550)]	9	[('CHEBI_30751', 'formic acid', 92, 'folic acid'), ('CHEBI_33284', 'nutrient', 192, 'nutrient'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin E'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 235, 'β-carotene'), ('CHEBI_83326', 'tedizolid phosphate', 247, 'vitamin-A'), ('CHEBI_27568', 'selenium atom', 271, 'selenium'), ('CHEBI_30751', 'formic acid', 418, 'folic acid'), ('CHEBI_33229', 'vitamin (role)', 476, 'Vitamin')]
PMC3296991	2/2012	S0-PMC3296991	['EVIDENCE of ASSOCIATIONS between feto-maternal Vitamin D status, Cord Parathyroid Hormone and bone-specific alkaline phosphatase, and newborn Whole body bone Mineral content\n\nabstract\nin SPITE of a high prevalence of Vitamin D inadequacy in Pregnant women and neonates, RELATIONSHIPS among Vitamin D status (25(Oh)D), Parathyroid hormone (pth), bone specific alkaline phosphatase (balp), and Whole body bone Mineral content (wbbmc) in the newborn are POORLY characterized.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 12), ('ANOMALY_CURIOUS_FINDING', 187), ('SUPERFICIAL_RELATIONSHIP', 270), ('PROBLEM_COMPLICATION', 451)]	5	[('CHEBI_28384', 'vitamin K', 47, 'Vitamin D'), ('UBERON_0000948', 'heart', 65, 'Cord'), ('UBERON_0001132', 'parathyroid gland', 70, 'Parathyroid'), ('CHEBI_5762', 'hordatine A', 82, 'Hormone'), ('UBERON_0004043', 'semicircular canal ampulla', 142, 'Whole'), ('CHEBI_46662', 'mineral', 158, 'Mineral'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnant'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 308, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 318, 'parathyroid'), ('UBERON_0007688', 'anlage', 392, 'whole'), ('CHEBI_46662', 'mineral', 408, 'mineral')]
PMC3296991	2/2012	S17-PMC3296991	['bone BIOMARKERS including balp increase during Pregnancy REGARDLESS OF Vitamin D status and attain higher values in Umbilical Cord Blood than maternal Blood [14], POSSIBLY reflecting higher rates of bone turnover.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 163)]	3	[('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 116, 'umbilical cord'), ('UBERON_0000178', 'blood', 131, 'blood'), ('UBERON_0000178', 'blood', 151, 'blood')]
PMC3296991	2/2012	S19-PMC3296991	['DEMONSTRATED that maternal Vitamin D status CAN INFLUENCE Fetal Femoral Development as early as 19 weeks Gestation [15].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007631', 'feeding behavior', 58, 'fetal'), ('GO_0009556', 'microsporogenesis', 64, 'femoral development'), ('UBERON_0000981', 'femur', 64, 'femoral'), ('GO_0007565', 'female pregnancy', 105, 'gestation')]
PMC3296991	2/2012	S67-PMC3296991	['Cord Serum 25(Oh)D was significantly higher, and maternal Serum 25(Oh)D marginally higher, in women whose total daily Vitamin D intake was ESTIMATED to be >600 iu/day ( n = 50, p = 0.0015 and p = 0.06 for Cord and maternal values, respectively).']	[('INCOMPLETE_EVIDENCE', 139)]	1	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0001977', 'blood serum', 5, 'serum'), ('CHEBI_71657', 'versiconol acetate', 11, '25(OH)D'), ('UBERON_0001977', 'blood serum', 58, 'serum'), ('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 205, 'cord')]
PMC3296991	2/2012	S83-PMC3296991	['polymorphisms in the Vitamin D Receptor Gene MAY CONTRIBUTE to racial DISPARITIES in fetal growth and bone mineralization [20,21], although ADDITIONAL RESEARCH IS WARRANTED in this area.']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 70), ('FUTURE_WORK', 140), ('FUTURE_WORK', 151)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 21, 'vitamin D receptor'), ('SO_0000704', 'gene', 40, 'gene')]
PMC3296991	2/2012	S85-PMC3296991	['in the PRESENT STUDY, total maternal daily Vitamin D intake >600 iu/day was ASSOCIATED with significantly higher Cord, and a TREND towards higher maternal, Serum 25(Oh)D at Delivery.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 125)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 113, 'cord'), ('UBERON_0001977', 'blood serum', 156, 'serum'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 162, '25(OH ... D'), ('GO_0007567', 'parturition', 173, 'delivery')]
PMC3296991	2/2012	S95-PMC3296991	['it is LIKELY that the elevation in balp OBSERVED in Vitamin D deficiency is due to increased release from Osteoblasts accumulated in unmineralized bone Matrix.']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 40)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CL_0000062', 'osteoblast', 106, 'osteoblasts'), ('GO_0031012', 'extracellular matrix', 152, 'matrix')]
PMC3296991	2/2012	S98-PMC3296991	['FURTHER RESEARCH is NECESSARY to CONSIDER the behavior of OTHER BIOMARKERS in RELATIONSHIP to Vitamin D status and their POTENTIAL CONTRIBUTION to PREDICTION of neonatal wbbmc.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('SUPERFICIAL_RELATIONSHIP', 64), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 147)]	9	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3296991	2/2012	S100-PMC3296991	['conclusion\nTHIS STUDY PROVIDES EVIDENCE of ASSOCIATIONS between feto-maternal Vitamin D status, cord pth and balp, and neonatal wbbmc, THOUGH neither Cord nor maternal 25(Oh)D were directly CORRELATED with wbbmc.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 22), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 135), ('SUPERFICIAL_RELATIONSHIP', 190)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 150, 'cord'), ('CHEBI_33010', 'chromide(1-)', 170, '(OH)D')]
PMC3385441	2/2012	S269-PMC3385441	['caption (table-wrap): table 3\n\nchallenges to developing comprehensive fish Consumption ADVICE.viewpoint and challengesexamplestoxicological hazards: fish contaminants (e.g., mehg, Pcbs, Pesticides)multiple co-occurring contaminantssynergistic adverse EFFECTS on Neurodevelopment with Joint mehg and pcb exposureadvisories for single contaminantfarmed salmon low in mehg but can be high in pcbstoxicant levels vary within and across speciestilefish Mehg: high in gulf of mexico but low in atlanticvariable susceptibility to toxicitiesprenatal exposure: increased susceptibility to Mehg neurotoxicityconfounding by nutritional BENEFITSUNDERESTIMATION of hazard from mehg if CONFOUNDED by n‑3 lcpufasnutritional BENEFITS: fish Nutrients (e.g., n‑3 lcpufas, Vitamin D, Iodine, Selenium)multiple co-occurring nutrientsfor Neurodevelopment, fish intake more CONSISTENTLY beneficial than n‑3 lcpufa supplementsanutrient levels vary within and across specieshealth benefits associated with high n‑3 lcpufa fishaconfounding by contaminant riskunderestimation of benefit from n‑3 lcpufas if CONFOUNDED by Mehgincreased fish intake (for most populations) RECOMMENDED by nutrition GUIDELINESAVAILABLE fish insufficient to meet demand EVEN without greater intakeenvironmental sustainability: overfishing, habitat destruction, aquaculturemodern harvesting can deplete fish stocks, other aquatic wildlife, and habitatsfishing trawls plough the Seafloor, removing most, if not all, aquatic Life and structures in their pathwild fish stocks insufficient to meet projected GLOBAL demandapproximately 90% of large predatory fish stocks (e.g., bluefin Tuna, atlantic salmon) are already depletedaquaculture CAN adversely AFFECT wild fish and ecosystems; CONTAMINANTSFARMED salmon can escape and outcompete wild fish and MAY have higher Pcb levelseconomic INFLUENCES: consumer choice, industry stakeholders, fisheries managementeconomic ASSUMPTION of improved consumer welfare with more information not necessarily TRUE for fish choiceu.s.']	[('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 625), ('DIFFICULT_TASK', 672), ('IMPORTANT_CONSIDERATION', 709), ('PROBABLE_UNDERSTANDING', 852), ('DIFFICULT_TASK', 1081), ('FUTURE_WORK', 1144), ('PROBABLE_UNDERSTANDING', 1169), ('ANOMALY_CURIOUS_FINDING', 1222), ('IMPORTANT_CONSIDERATION', 1555), ('INCOMPLETE_EVIDENCE', 1687), ('SUPERFICIAL_RELATIONSHIP', 1701), ('IMPORTANT_CONSIDERATION', 1734), ('INCOMPLETE_EVIDENCE', 1800), ('SUPERFICIAL_RELATIONSHIP', 1835), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1916), ('PROBABLE_UNDERSTANDING', 1994)]	18	[('GO_0007631', 'feeding behavior', 75, 'consumption'), ('CHEBI_26199', 'polyprenol', 180, 'PCBs'), ('CHEBI_35392', 'glucarate(1-)', 186, 'pesticides'), ('GO_0007399', 'nervous system development', 262, 'neurodevelopment'), ('UBERON_0004905', 'articulation', 284, 'joint'), ('CHEBI_82056', 'Mebenil', 448, 'MeHg'), ('CHEBI_82056', 'Mebenil', 580, 'MeHg'), ('CHEBI_33284', 'nutrient', 724, 'nutrients'), ('CHEBI_27300', 'vitamin D', 754, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 765, 'iodine'), ('CHEBI_27568', 'selenium atom', 773, 'selenium'), ('GO_0007399', 'nervous system development', 817, 'neurodevelopment'), ('CHEBI_82492', 'N-Methylolacrylamide', 1095, 'MeHgIncreased'), ('UBERON_0001273', 'ilium', 1429, 'seafloor'), ('UBERON_0000104', 'life cycle', 1474, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 1632, 'tuna'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 1816, 'PCB')]
PMC3513049	2/2012	S3-PMC3513049	['Prenatal Vitamin D inadequacy HAS BEEN HYPOTHESIZED as a risk factor for pediatric atopy and asthma.']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 39)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC3513049	2/2012	S4-PMC3513049	['methods\nTO INVESTIGATE POTENTIAL RELATIONSHIPS between household pet exposure and Cord Blood Vitamin D concentrations, we analyzed information from a large, geographically-based, general risk birth cohort.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('UBERON_0002240', 'spinal cord', 82, 'cord'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC3313761	3/2012	S18-PMC3313761	['hypocalcemia HAS also BEEN shown to occur in exclusively Breast Fed babies not exposed to sunlight and in infants whose mothers are deficient in Vitamin D.[1] symptoms of hypocalcemia in children include lethargy, recurrent Respiratory Tract infections, focal clonic seizures, jitteriness, carpopedal spasm and RARELY stridor DUE TO laryngospasm.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 311), ('PROBLEM_COMPLICATION', 326)]	3	[('GO_0007567', 'parturition', 57, 'breast'), ('UBERON_0000310', 'breast', 57, 'breast'), ('GO_0007631', 'feeding behavior', 64, 'fed'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 224, 'respiratory tract')]
PMC3347028	3/2012	S2-PMC3347028	['there are clear indicators from in vitro and Animal in vivo studies that POINT to Vitamin D’s INDISPUTABLE ROLE in both Innate and Adaptive Immunity; HOWEVER, the translation of THESE FINDINGS to clinical practice, including the Care of the Pregnant woman, has not occurred.']	[('INCOMPLETE_EVIDENCE', 73), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 178)]	5	[('NCBITaxon_33208', 'Metazoa', 45, 'animal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007631', 'feeding behavior', 120, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 131, 'adaptive immunity'), ('GO_0007567', 'parturition', 229, 'care'), ('GO_0007565', 'female pregnancy', 241, 'pregnant')]
PMC3347028	3/2012	S3-PMC3347028	['until RECENTLY, there HAS BEEN a PAUCITY of data from randomized controlled trials to establish clear cut beneficial EFFECTS of Vitamin D supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'pregnancy')]
PMC3347028	3/2012	S17-PMC3347028	['in the sections ahead, we will FOCUS on one Micronutrient—Vitamin D—and will discuss WHAT we KNOW and what we surely do NOT KNOW in the context of the Pregnant woman and her developing fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('EXPLICIT_QUESTION', 85), ('INCOMPLETE_EVIDENCE', 93), ('FULL_UNKNOWN', 120)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 44, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnant')]
PMC3347028	3/2012	S31-PMC3347028	['without this reaction, Humans are DEPENDENT on dietary Intake of Vitamin D, which MAY BE in the form of either Vitamin D2Or D3.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 82)]	2	[('NCBITaxon_9606', 'Homo sapiens', 23, 'humans'), ('GO_0007631', 'feeding behavior', 55, 'intake'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27329', 'xanthosine phosphate', 111, 'vitamin D2or'), ('PR_000017050', 'UDP-glucuronosyltransferase 1A3', 111, 'vitamin D2or D3')]
PMC3347028	3/2012	S46-PMC3347028	['BEST KNOWN is the processing of 25(Oh)D by the Kidney where 25(Oh)D Complexed with Vdbp and Megalin is taken up by the Epithelial Cells of the Proximal Tubules and converted to the active hormonal form of Vitamin D—Di-Hydroxy-Vitamin D (1,25(Oh)2d or Calcitriol)—by the action of the Mitochondrial enzyme 1-α-hydroxylase.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('UBERON_0002113', 'kidney', 47, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('GO_0032991', 'protein-containing complex', 68, 'complexed'), ('PR_000017279', 'testis-specific basic protein Y 1', 83, 'VDBP'), ('PR_000010409', 'midnolin', 92, 'megalin'), ('CL_0000066', 'epithelial cell', 119, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 119, 'epithelial'), ('UBERON_0004134', 'proximal tubule', 143, 'proximal tubules'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_67723', 'Anhydrofurospongin-1', 215, 'di-hydroxy-'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('CHEBI_87140', '3-oxochola-4,22-dien-24-oyl-CoA', 237, '1,25(OH)'), ('CHEBI_17823', 'calcitriol', 251, 'calcitriol'), ('GO_0005739', 'mitochondrion', 284, 'mitochondrial')]
PMC3347028	3/2012	S58-PMC3347028	['DESPITE these OBSERVATIONS, it was CONCLUDED that the condition of Vitamin D deficiency LED TO weakness and malnutrition and was not a direct EFFECT of Vitamin D on the Immune System.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('UBERON_0002405', 'immune system', 169, 'immune system')]
PMC3347028	3/2012	S63-PMC3347028	['vdre are found ONLY in the Ll-37 Gene Promoters of Primates, SUGGESTING that the ability of Vitamin D to promote Ll-37 antibacterial action is a relatively recent event in evolution.']	[('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 61)]	3	[('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 27, 'LL-37'), ('SO_0000704', 'gene', 33, 'gene'), ('SO_0000167', 'promoter', 38, 'promoters'), ('NCBITaxon_33208', 'Metazoa', 51, 'primates'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 113, 'LL-37')]
PMC3347028	3/2012	S65-PMC3347028	['significant SUPPORT for the ROLE of Vitamin D in Immune Processes and function came in 2006 when liu et al.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0002252', 'immune effector process', 49, 'immune processes'), ('UBERON_0002405', 'immune system', 49, 'immune')]
PMC3347028	3/2012	S70-PMC3347028	['[23], SHOWED that Ifn-Γ-mediated Antimicrobial activity of Human Macrophages, especially IMPORTANT in hiv and tuberculosis patients, is DEPENDENT on Vitamin D. BOTH STUDY findings have IMPLICATIONS for the Pregnant woman and her developing fetus, BUT our understanding of such processes following maternal exposure to a pathogen or maternal infection REMAINS SCANT.']	[('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 185), ('ANOMALY_CURIOUS_FINDING', 247), ('INCOMPLETE_EVIDENCE', 351), ('INCOMPLETE_EVIDENCE', 359)]	8	[('PR_000008920', 'interferon alpha-7', 18, 'IFN-γ'), ('CHEBI_65381', 'albizoside C', 33, 'antimicrobial'), ('NCBITaxon_9606', 'Homo sapiens', 59, 'human'), ('CL_0000235', 'macrophage', 65, 'macrophages'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 206, 'pregnant')]
PMC3347028	3/2012	S78-PMC3347028	['these in vitro FINDINGS HELP to EXPLAIN the significant ASSOCIATION between Vitamin D deficiency and Autoimmune diseases, such as systemic lupus erythematosus [25], multiple sclerosis [26,27,28,29,30,31,32,33,34,35], rheumatoid arthritis [31,36,37], diabetes—both types 1 [31,38,39,40,41,42] and 2 [43,44,45], and certain cancers, such as Colon [46,47,48,49], Breast [50,51,52,53,54,55], and Prostate [55,56,57,58,59].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 24), ('PROBABLE_UNDERSTANDING', 32), ('SUPERFICIAL_RELATIONSHIP', 56)]	4	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 101, 'autoimmune'), ('UBERON_0001155', 'colon', 339, 'colon'), ('UBERON_0000310', 'breast', 360, 'breast'), ('UBERON_0002367', 'prostate gland', 392, 'prostate')]
PMC3347028	3/2012	S79-PMC3347028	['additionally, the ROLE of Vitamin D in Immune function intensifies the NEED to establish Vitamin D sufficiency during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 71)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0002405', 'immune system', 39, 'immune'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
PMC3347028	3/2012	S87-PMC3347028	['it IS NOT SURPRISING, then that during Pregnancy pth as a MARKER of Vitamin D status is a LESS RELIABLE PREDICTOR than in nonpregnant Adults [60,61,62].']	[('PROBABLE_UNDERSTANDING', 3), ('PROBABLE_UNDERSTANDING', 6), ('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 104)]	7	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adults')]
PMC3347028	3/2012	S97-PMC3347028	['WHILE okonofua, et al, SUGGEST that normalization of maternal calcium and pth would be useful endpoints in determining the success of Vitamin D supplementation during Pregnancy, more RECENT STUDIES SUGGEST that BECAUSE pth threshold ESTIMATES cannot be precisely defined, total circulating 25(Oh)D ALONE is a BETTER measure of maternal Vitamin D status [60,64,65].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 198), ('PROBLEM_COMPLICATION', 211), ('INCOMPLETE_EVIDENCE', 233), ('ANOMALY_CURIOUS_FINDING', 298), ('INCOMPLETE_EVIDENCE', 298), ('INCOMPLETE_EVIDENCE', 309)]	9	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 290, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D')]
PMC3347028	3/2012	S107-PMC3347028	['beyond childhood, SEVERE Vitamin D deficiency CAN occur in young women, including those who are Pregnant, with higher RISK with advancing age in a woman’s Lifecycle.']	[('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 118)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('GO_0006266', 'DNA ligation', 155, 'lifecycle')]
PMC3347028	3/2012	S115-PMC3347028	['using the RECENTLY revised institute of medicine’s (iom) 2010 criterion for Vitamin D deficiency of total circulating 25(Oh)D < 20 ng/ml (50 nmol/l) [72], approximately 70% of the african american COMPARED TO 35% of caucasian women in the rhode island study had evidence of Vitamin D deficiency during winter, with slight improvement during summer months compared to winter months in both groups.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC3347028	3/2012	S123-PMC3347028	['a GLOBAL PERSPECTIVE on Vitamin D status of women during Pregnancy\nwith improved laboratory techniques for the measurement of Vitamin D developed in the early 1980’s [73], investigators began to measure the Vitamin D status of Pregnant women.']	[('IMPORTANT_CONSIDERATION', 2), ('INCOMPLETE_EVIDENCE', 9)]	2	[('CHEBI_28384', 'vitamin K', 24, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('GO_0007565', 'female pregnancy', 227, 'pregnant')]
PMC3347028	3/2012	S125-PMC3347028	['YET, it was THOUGHT for the MOST PART that Vitamin D deficiency was RARE and COULD BE avoided through some sunlight exposure and a daily Vitamin D intake of 200 iu (5 μg) [80].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 28), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77)]	7	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3347028	3/2012	S126-PMC3347028	['THEREFORE, it came AS quite a SURPRISE when the FIRST REPORT of widespread Vitamin D deficiency in u.s. women of Childbearing age was REPORTED by the center for disease control (cdc) in 2002 [81].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 19), ('ANOMALY_CURIOUS_FINDING', 30), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 134)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 113, 'childbearing')]
PMC3347028	3/2012	S145-PMC3347028	['with SEVERE maternal Vitamin D deficiency, the fetus rarely MAY develop rickets in utero with manifestation at Birth [96].']	[('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 60)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007567', 'parturition', 111, 'birth')]
PMC3347028	3/2012	S149-PMC3347028	['[100], comparing growth parameters in newborn infants with the maternal Intakes of milk and Vitamin D during Pregnancy, FOUND an ASSOCIATION between Vitamin D intake during Pregnancy and Birth weight.']	[('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 129)]	2	[('GO_0007631', 'feeding behavior', 72, 'intakes'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('GO_0007567', 'parturition', 187, 'birth')]
PMC3347028	3/2012	S153-PMC3347028	['FOUND significantly wider posterior Fontanelle diameter in neonates of mothers with Vitamin D deficiency (AS defined by a 25(Oh)D level <34.9 nmol/l or ~14 ng/ml) compared to neonates whose mothers were not deficient [102].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 106)]	2	[('UBERON_0002221', 'fontanelle', 36, 'fontanelle'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D')]
PMC3347028	3/2012	S154-PMC3347028	['beyond growth, RECENT REPORTS of neonates followed prospectively for acute Viral infections and bronchiolitis from Respiratory syncytial Virus (Rsv) SUPPORT the PREMISE that these states of deficiency do IMPACT on the health of the young infant and SUGGEST a greater ROLE of Vitamin D beyond bone health [103,104,105].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 161), ('SUPERFICIAL_RELATIONSHIP', 204), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 267)]	7	[('NCBITaxon_1', 'root', 75, 'viral'), ('UBERON_0001004', 'respiratory system', 115, 'respiratory'), ('NCBITaxon_1', 'root', 137, 'virus'), ('NCBITaxon_10088', 'Mus <genus>', 144, 'RSV'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3347028	3/2012	S156-PMC3347028	['BECAUSE Vitamin D status has not been a consistent CONCERN during Pregnancy, long-term DATA are SPARSE.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 87)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy')]
PMC3347028	3/2012	S157-PMC3347028	['the FEW STUDIES that HAVE BEEN conducted have FOCUSED more on discernible neonatal EFFECTS of Vitamin D during Pregnancy, RATHER than the long-latency and later health EFFECTS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 168)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy')]
PMC3347028	3/2012	S158-PMC3347028	['reports of neonatal seizures due to SEVERE hypocalcemia or rickets in utero that is manifested at Birth from SEVERE maternal and THUS fetal Vitamin D deficiency are RARE and do not further our understanding of POTENTIAL epigenetic EFFECTS of Vitamin D [122,123].']	[('IMPORTANT_CONSIDERATION', 36), ('IMPORTANT_CONSIDERATION', 109), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 165), ('INCOMPLETE_EVIDENCE', 210), ('SUPERFICIAL_RELATIONSHIP', 231)]	6	[('GO_0007567', 'parturition', 98, 'birth'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D')]
PMC3347028	3/2012	S161-PMC3347028	['WHILE there are numerous epidemiological studies that bear EVIDENCE of the ASSOCIATION between Vitamin D deficiency and altered health, definitive proof in terms of randomized controlled trials is often LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 75), ('FULL_UNKNOWN', 203)]	4	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3347028	3/2012	S163-PMC3347028	['WHILE we await the results of numerous clinical trials now underway TO determine IF there is a discernible EFFECT of Vitamin D in altering RISK for various disease states to understand the ROLE of Vitamin D in health, it is IMPORTANT not TO discount the MOUNTING EVIDENCE from laboratory studies and prospective observation trials [103,104,105] that Vitamin D—as a preprohormone—is ESSENTIAL in maintaining the Immune System with PROFOUND IMPLICATIONS [19,138,139,140].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 139), ('SUPERFICIAL_RELATIONSHIP', 189), ('IMPORTANT_CONSIDERATION', 224), ('QUESTION_ANSWERED_BY_THIS_WORK', 238), ('INCOMPLETE_EVIDENCE', 254), ('IMPORTANT_CONSIDERATION', 382), ('IMPORTANT_CONSIDERATION', 430), ('IMPORTANT_CONSIDERATION', 439)]	12	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('UBERON_0002405', 'immune system', 411, 'immune system')]
PMC3347028	3/2012	S166-PMC3347028	['GIVES INVALUABLE INSIGHT into Vitamin D status of darker Pigmented Individuals living in a sun-rich environment in eastern africa [141].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 17)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 57, 'pigmented'), ('NCBITaxon_1', 'root', 67, 'individuals')]
PMC3347028	3/2012	S179-PMC3347028	['a large proportion of the younger Adult population MAY follow these guidelines, which MAY increase the RISK of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 103)]	3	[('UBERON_0007023', 'adult organism', 34, 'adult'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC3347028	3/2012	S182-PMC3347028	['effectiveness of Vitamin D supplementation during Pregnancy\nthere HAS BEEN a PAUCITY OF studies evaluating the REQUIREMENTS and EFFECTS of Vitamin D supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 111), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_28384', 'vitamin K', 17, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 172, 'pregnancy')]
PMC3347028	3/2012	S183-PMC3347028	['the studies that were available in a cochrane review more than a decade ago INDICATED that the adequate intake (Ai) for Vitamin D during Pregnancy of 400 iu/day is grossly INADEQUATE, especially with ethnic minorities [147].']	[('INCOMPLETE_EVIDENCE', 76), ('PROBLEM_COMPLICATION', 172)]	2	[('CHEBI_28741', 'sodium fluoride', 112, 'AI'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy')]
PMC3347028	3/2012	S184-PMC3347028	['AS PREDICTED by Vitamin D pharmacokinetics, supplements of 1000 iu/day of Vitamin D to Pregnant women result in a 12.5 to 15.0 nmol/l increase in circulating 25(Oh)D concentrations in both maternal and Cord Serum compared with nonsupplemented controls [75,76,77].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 3)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 87, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 158, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 158, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 202, 'cord'), ('UBERON_0001977', 'blood serum', 207, 'serum')]
PMC3347028	3/2012	S185-PMC3347028	['this PREMISE is SUPPORTED by our two randomized clinical trials involving Vitamin D supplementation of Pregnant women [6,148].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 16)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnant')]
PMC3347028	3/2012	S187-PMC3347028	['results of two RECENT randomized controlled trials during Pregnancy\nin our RECENTLY completed nichd Vitamin D supplementation trial involving a diverse group of Pregnant women less than 16 weeks of Gestation, 4000 iu (100 μg) Vitamin D3/day was SUPERIOR to 400 (control)- or 2000 iu/day in achieving circulating 25(Oh)d of at least 40 ng/ml (100 nmol/l), the point at which 1,25(Oh)2D begins to be optimized (seefigure 2) [6].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 245)]	3	[('GO_0007565', 'female pregnancy', 58, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'pregnant'), ('GO_0007565', 'female pregnancy', 198, 'gestation'), ('CHEBI_33279', 'vitamin D5', 226, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 226, 'vitamin D3'), ('CHEBI_63056', 'zinc cation', 312, '25(OH'), ('CHEBI_82784', 'PVP38-Ag NP', 374, '1,25(OH)2D')]
PMC3347028	3/2012	S191-PMC3347028	['EVEN in the latter trial where women were randomized to either 2000 iu (50 μg) or 4000 iu (100 μg) Vitamin D3/day, there were no safety ISSUES surrounding Vitamin D supplementation and there was a TREND where specific health COMPLICATIONS of Pregnancy such as Preterm Birth, Preterm Labor, hypertensive orders of Pregnancy, Gestational diabetes, and infection were higher in the 400 iu-compared with the 4000 iu-group, but did not reach statistical significance [149].']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 136), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 197), ('IMPORTANT_CONSIDERATION', 225), ('PROBLEM_COMPLICATION', 225)]	6	[('CHEBI_33279', 'vitamin D5', 99, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 99, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 260, 'preterm birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 275, 'preterm labor'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy'), ('GO_0007565', 'female pregnancy', 324, 'gestational')]
PMC3347028	3/2012	S196-PMC3347028	['secondary analysis INDICATED that Preterm Birth and labor were inversely RELATED to pre-Delivery Vitamin D status (Preterm Birth or = 0.50 per 10 ng/ml, p = 0.002; Preterm Labor or Birth or = 0.72 per 10 ng/ml, p = 0.012), an EFFECT that PERSISTED EVEN after controlling for race.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 226), ('INCOMPLETE_EVIDENCE', 238), ('ANOMALY_CURIOUS_FINDING', 248)]	5	[('GO_0007565', 'female pregnancy', 34, 'preterm'), ('GO_0007567', 'parturition', 42, 'birth'), ('GO_0007567', 'parturition', 88, 'delivery'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'preterm'), ('GO_0007567', 'parturition', 123, 'birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 164, 'preterm labor'), ('GO_0007567', 'parturition', 181, 'birth')]
PMC3347028	3/2012	S217-PMC3347028	['studies specifically designed and powered to answer the QUESTION of WHETHER OR NOT Vitamin D supplementation LEADS TO improved health outcomes—lower RISK of Preterm Birth, preeclampsia, and infection REMAIN to be done.']	[('EXPLICIT_QUESTION', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 149), ('INCOMPLETE_EVIDENCE', 200)]	5	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'preterm birth')]
PMC3347028	3/2012	S224-PMC3347028	['it is INTERESTING that epidemiological studies involving Pregnant women with Preeclampsia—a clinical picture of inflammation and vasculitis—Vitamin D deficiency HAS BEEN IMPLICATED [152,153,154].']	[('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 161), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('GO_0007128', 'meiotic prophase I', 77, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC3347028	3/2012	S225-PMC3347028	['MORE WORK IS WARRANTED in this AREA to understand the POSSIBLE ROLE of Vitamin D deficiency in preeclampsia.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 31), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3347028	3/2012	S226-PMC3347028	['the health effects data from Vitamin D supplementation trials THUS FAR, WHILE TANTALIZING, are NOT CONCLUSIVE in SHOWING definitive “proof” for Vitamin D AS a POTENTIAL CANDIDATE in the reduction of comorbidities of Pregnancy, YET one CANNOT DISMISS the strong CORRELATION between reduced RISK with increased Serum 25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 113), ('PROBABLE_UNDERSTANDING', 154), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('ANOMALY_CURIOUS_FINDING', 227), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('SUPERFICIAL_RELATIONSHIP', 261), ('IMPORTANT_CONSIDERATION', 289)]	13	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy'), ('UBERON_0001977', 'blood serum', 309, 'serum'), ('CHEBI_71657', 'versiconol acetate', 315, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 315, '25(OH)D')]
PMC3347028	3/2012	S233-PMC3347028	['looking carefully at the INCREASING NUMBER OF epidemiological STUDIES involving women with Preeclampsia: is there a LINK with Vitamin D deficiency where PERHAPS in certain women, there is loss of the Vitamin D-mediated Suppression Of T Cells that leads to a profound inflammatory reaction REMINISCENT of graft- vs. -host disease?']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 153), ('ANOMALY_CURIOUS_FINDING', 289), ('EXPLICIT_QUESTION', 328)]	6	[('GO_0007128', 'meiotic prophase I', 91, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('GO_0048469', 'cell maturation', 219, 'suppression of T cells'), ('CL_0000084', 'T cell', 234, 'T cells')]
PMC3347028	3/2012	S234-PMC3347028	['in those women with a specific Genetic repertoire—affinity for Vitamin D and receptor processing—Vitamin D deficiency MAY very well be the LOST KEY to stopping the Cascade of Events.']	[('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 139), ('IMPORTANT_CONSIDERATION', 144)]	3	[('SO_0000704', 'gene', 31, 'genetic'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0055097', 'high density lipoprotein particle mediated signaling', 164, 'cascade'), ('GO_0006897', 'endocytosis', 175, 'events')]
PMC3347028	3/2012	S237-PMC3347028	['conclusions\nthe ROLE of Vitamin D during Pregnancy and its EFFECT on maternal and fetal health is just BEGINNING TO BE understood.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 103)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy')]
PMC3347028	3/2012	S240-PMC3347028	['WHILE there REMAINS much to be DISCOVERED and learned about Vitamin D’s EFFECT on the mother and her developing fetus, there is enough EVIDENCE TO SUPPORT the PREMISE that deficiency is not healthful for either the mother or fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 159)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3347028	3/2012	S242-PMC3347028	['a RECENT randomized controlled TRIAL with 350 women of diverse racial and ethnic backgrounds SHOWED that 4000 iu Vitamin D/day is MOST EFFECTIVE in improving the Vitamin D status of Pregnant women, attaining circulating levels of at least 40 ng/ml (100 nmol/l) for 25(Oh)D, and was NECESSARY to achieve OPTIMAL 1,25(Oh)2D production.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 130), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 282), ('IMPORTANT_CONSIDERATION', 303)]	6	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 265, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 267, '(OH ... D'), ('CHEBI_37983', 'sulfur-35 atom', 311, '1'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 313, '25(OH)2D')]
PMC3319623	4/2012	S59-PMC3319623	['INTERESTINGLY, SEVERAL LINES OF EVIDENCE now SUPPORT a ROLE for Vitamin D deficiency in the pathogenesis of psychiatric conditions, in particular schizophrenia[25].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 55)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC3319623	4/2012	S60-PMC3319623	['Animal MODELS of Gestational Vitamin D deficiency HIGHLIGHT the IMPORTANT ROLE of Vitamin D for correct Neurodevelopment[25].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 64), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('GO_0007565', 'female pregnancy', 17, 'gestational'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007399', 'nervous system development', 104, 'neurodevelopment')]
PMC3319623	4/2012	S63-PMC3319623	['SIMILAR mechanisms MAY apply to bad and rdd, BUT the EVIDENCE for Vitamin D in these disorders is much LESS STRONG and OTHER FACTORS such as maternal infections and fluctuations in diet MAY also play an IMPORTANT ROLE.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 125), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 203), ('SUPERFICIAL_RELATIONSHIP', 213)]	11	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3338544	4/2012	S10-PMC3338544	['introduction\nan INCREASING body of epidemiological EVIDENCE SUPPORTS the HYPOTHESIS that maternal Vitamin D deficiency is a risk-modifying factor for schizophrenia[1],[2].']	[('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 73)]	4	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3338544	4/2012	S11-PMC3338544	['in a RECENT case-control STUDY, those with low levels of Vitamin D at Birth had a two-fold increase in the risk of developing schizophrenia in later Life[3].']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007567', 'parturition', 70, 'birth'), ('UBERON_0000104', 'life cycle', 149, 'life')]
PMC3338544	4/2012	S12-PMC3338544	['moreover, there is now CONVINCING EXPERIMENTAL EVIDENCE BASED ON a MODEL in sprague-dawley Rats that developmental Vitamin D (Dvd) deficiency is ASSOCIATED with a range of schizophrenia-related neurochemical, neuroanatomical, and behavioural phenotypes[4],[5].']	[('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 23), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 56), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 145)]	7	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 91, 'rats'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 126, 'DVD')]
PMC3338544	4/2012	S161-PMC3338544	['there are AS YET no epidemiological studies DEMONSTRATING a direct ASSOCIATION between autistic spectrum disorders and developmental Vitamin D levels, YET there are EFFECTS of season of Birth, latitude of Birth, and migrant status that MAY INDICATE a POSSIBLE ASSOCIATION (for review,[39]).']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 67), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 251), ('SUPERFICIAL_RELATIONSHIP', 260)]	9	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007567', 'parturition', 186, 'birth'), ('GO_0007567', 'parturition', 205, 'birth')]
PMC3338544	4/2012	S162-PMC3338544	['if FURTHER EVIDENCE CONTINUES to SUPPORT this ASSOCIATION, the Dvd-deficient Mouse MODEL MAY BE utilized to FURTHER EXAMINE the ROLE Vitamin D plays in Brain Development with RELEVANCE to autism.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 108), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 175)]	9	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 63, 'DVD'), ('NCBITaxon_10088', 'Mus <genus>', 77, 'mouse'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007420', 'brain development', 152, 'brain development'), ('UBERON_0000955', 'brain', 152, 'brain')]
PMC3338544	4/2012	S169-PMC3338544	['dvd deficiency has BEEN examined in one outbred Rat strain and two inbred Mouse strains, and PERHAPS the two strains chosen (c57bl/6j and 129x1/svj) MAY BE largely unresponsive to changes in Vitamin D levels.']	[('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 149)]	3	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 48, 'rat'), ('NCBITaxon_10088', 'Mus <genus>', 74, 'mouse'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC3338544	4/2012	S170-PMC3338544	['such DIFFERENCES HIGHLIGHT the IMPORTANCE of species and strain selection in studies of altered Vitamin D Signalling and Brain Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 31)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0048371', 'lateral mesodermal cell differentiation', 96, 'vitamin D signalling'), ('GO_0007420', 'brain development', 121, 'brain development'), ('UBERON_0000955', 'brain', 121, 'brain')]
PMC3338544	4/2012	S171-PMC3338544	['taken together these findings INDICATE that attentional processing is largely intact in a c57bl/6 Mouse MODEL of Prenatal Vitamin D deficiency, SUGGESTING that Dvd deficiency has LITTLE TO NO effect on the systems Governing attention in the Mouse.']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 144), ('FULL_UNKNOWN', 179)]	4	[('NCBITaxon_10088', 'Mus <genus>', 98, 'mouse'), ('GO_0007565', 'female pregnancy', 113, 'prenatal'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 160, 'DVD'), ('GO_0065007', 'biological regulation', 214, 'governing'), ('NCBITaxon_10088', 'Mus <genus>', 241, 'mouse')]
PMC3347007	4/2012	S1-PMC3347007	['the AIMS of the PRESENT STUDY were to ESTIMATE the intake and sources of Vitamin D in danish Pregnant women and TO EXAMINE POTENTIAL DETERMINANTS of Vitamin D intake of the recommended level (10 µg per day).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 133)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnant'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC3347007	4/2012	S6-PMC3347007	['we PROPOSE that clinicians ENCOURAGE Vitamin D supplementation among Pregnant women, with SPECIAL FOCUS on vulnerable groups such as the young, smokers and multiparous women, in order to improve maternal and fetal health both during and after Pregnancy.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 27), ('IMPORTANT_CONSIDERATION', 90), ('IMPORTANT_CONSIDERATION', 98)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('GO_0007565', 'female pregnancy', 243, 'pregnancy')]
PMC3347007	4/2012	S9-PMC3347007	['the need for Vitamin D CAN be fulfilled by exposing skin to sunlight; however, in northern latitudes the sun exposure only synthesizes Vitamin D from april to october [1] and Vitamin D MUST BE obtained from OTHER sources during the winter period.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 207)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC3347007	4/2012	S10-PMC3347007	['sun exposure MAY also increase the risk of skin cancer and it MAY THEREFORE be problematic to ENCOURAGE sun exposure as the only source of Vitamin D [2].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 62), ('PROBABLE_UNDERSTANDING', 66), ('FUTURE_WORK', 94)]	4	[('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC3347007	4/2012	S11-PMC3347007	['dietary Vitamin D intake is very LIMITED and THEREFORE supplementation is NEEDED to avoid Vitamin D deficiency during sun-deprived periods.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 45), ('FUTURE_WORK', 74)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3347007	4/2012	S14-PMC3347007	['this SUGGESTS that Vitamin D deficiency in Pregnancy will LEAD TO more children being Born deficient [5].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('GO_0007567', 'parturition', 86, 'born')]
PMC3347007	4/2012	S16-PMC3347007	['studies have SUGGESTED that children Born to women with low Vitamin D status have lower scores in terms of Birth weight, Birth length, and bone Mineral content [4].']	[('INCOMPLETE_EVIDENCE', 13)]	1	[('GO_0007567', 'parturition', 37, 'born'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007567', 'parturition', 107, 'birth'), ('GO_0007567', 'parturition', 121, 'birth'), ('CHEBI_46662', 'mineral', 144, 'mineral')]
PMC3347007	4/2012	S17-PMC3347007	['other STUDIES PROPOSE an ASSOCIATION between Vitamin D deficiency and pre-eclampsia [8].']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3347007	4/2012	S18-PMC3347007	['studies have also SUGGESTED that Vitamin D sufficiency has a PROTECTIVE EFFECT against pre-term Delivery and Gestational diabetes mellitus through its immunomodulatory and anti-inflammatory properties [9].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 72)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'delivery'), ('GO_0007565', 'female pregnancy', 109, 'gestational')]
PMC3347007	4/2012	S19-PMC3347007	['Animal studies SHOW a POSSIBLE ASSOCIATION between maternal Vitamin D status and Brain Development in pups, which COULD POSSIBLY play a ROLE in Cognitive and Neurological Development [4].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 136)]	6	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007420', 'brain development', 81, 'brain development'), ('UBERON_0000955', 'brain', 81, 'brain'), ('GO_0050890', 'cognition', 144, 'cognitive ...'), ('GO_0007399', 'nervous system development', 158, 'neurological development'), ('UBERON_0001016', 'nervous system', 158, 'neurological')]
PMC3347007	4/2012	S20-PMC3347007	['OTHER SUGGESTED CONSEQUENCES of Vitamin D deficiency during Pregnancy are increased risks of: schizophrenia, type 1 diabetes, multiple sclerosis, Heart disease, cancer, and small for Gestational age diagnosis [10,11,12,13].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('PROBLEM_COMPLICATION', 16)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('UBERON_0000948', 'heart', 146, 'heart'), ('GO_0007565', 'female pregnancy', 183, 'gestational')]
PMC3347007	4/2012	S21-PMC3347007	['the definition of optimal Vitamin D status and optimal intake level of Vitamin D HAVE BEEN subject to much DEBATE, and RECOMMENDATIONS VARY between countries.']	[('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('FUTURE_WORK', 119), ('DIFFICULT_TASK', 135)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3347007	4/2012	S25-PMC3347007	['SEVERAL STUDIES have REPORTED that Vitamin D intake among Pregnant women is lower than recommended.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnant')]
PMC3347007	4/2012	S27-PMC3347007	['the danish national Birth cohort (dnbc) offers information on Vitamin D intake in danish Pregnant women as well as information on socio-demographic and lifestyle factors, and is THEREBY an excellent OPPORTUNITY TO investigate POTENTIAL DETERMINANTS of Vitamin D intake.']	[('PROBABLE_UNDERSTANDING', 178), ('FUTURE_WORK', 199), ('QUESTION_ANSWERED_BY_THIS_WORK', 211), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 236)]	5	[('GO_0007567', 'parturition', 20, 'Birth'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D')]
PMC3347007	4/2012	S28-PMC3347007	['this information CAN HELP identify women AT RISK of insufficient Vitamin D intake and POTENTIALLY Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 21), ('IMPORTANT_CONSIDERATION', 41), ('INCOMPLETE_EVIDENCE', 86)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3347007	4/2012	S30-PMC3347007	['the AIMS of the PRESENT STUDY, conducted within the danish national Birth cohort, were: (1) to ESTIMATE the Vitamin D intake among danish Pregnant women; (2) TO INVESTIGATE the sources of Vitamin D; and (3) TO EXAMINE POTENTIAL DETERMINANTS of sufficient total Vitamin D intake among danish Pregnant women, including Gestational, lifestyle, and dietary factors.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('QUESTION_ANSWERED_BY_THIS_WORK', 207), ('INCOMPLETE_EVIDENCE', 218), ('SUPERFICIAL_RELATIONSHIP', 228)]	7	[('GO_0007567', 'parturition', 68, 'Birth'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'pregnant'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('GO_0007565', 'female pregnancy', 291, 'pregnant'), ('GO_0007565', 'female pregnancy', 317, 'gestational')]
PMC3347007	4/2012	S57-PMC3347007	['the database is NOT VALIDATED but validation of a similar database from the norwegian Birth cohort (moba) SHOWED good agreement between supplementary Vitamin D measured by ffq and 25(Oh)D-levels [24].']	[('FULL_UNKNOWN', 16), ('INCOMPLETE_EVIDENCE', 106)]	2	[('GO_0007567', 'parturition', 86, 'birth'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_73376', 'Ala-Met-Ser-Arg', 180, '25(OH)D-')]
PMC3347007	4/2012	S63-PMC3347007	['the following FACTORS were regarded as POTENTIAL DETERMINANTS of Vitamin D intake and included in the analyses: maternal age (<20, 20–25, 25–30, 30–35, 35–40, ≥40), pre-Pregnancy bmi (≤18.5, 18.5–25, 25–30, 30–35, 35–40, >40), energy intake, parity (0, 1, 2, 3+), civil status (single, coupled/married), socio-occupational status (high, medium, skilled, student, unskilled, unemployed), physical activity level (inactive, light, moderate, high), smoking during Pregnancy (non-smoker, occasional smoker, <15 cigarettes per day, ≥15 cigarettes per day), Alcohol Consumption during Pregnancy (yes, no), season of filling out the ffq, and planned Pregnancy (planned, partly planned, not planned).']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy'), ('GO_0007565', 'female pregnancy', 461, 'pregnancy'), ('CHEBI_30879', 'alcohol', 552, 'alcohol'), ('GO_0007631', 'feeding behavior', 560, 'consumption'), ('GO_0007565', 'female pregnancy', 579, 'pregnancy'), ('GO_0007565', 'female pregnancy', 643, 'pregnancy')]
PMC3347007	4/2012	S82-PMC3347007	['in Gestational week 20 to 25 (the period also covered by the ffq), the proportion of women reporting use of Vitamin D supplements ≥10 µg per day was APPROXIMATELY 30%.']	[('INCOMPLETE_EVIDENCE', 149)]	1	[('GO_0007565', 'female pregnancy', 3, 'gestational'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC3347007	4/2012	S86-PMC3347007	['the sources were ranked according to their contribution to total Vitamin D intake (table 2), and we FOUND that supplements were the primary source of Vitamin D for the two higher quartiles and diet was for the two lower quartiles.']	[('INCOMPLETE_EVIDENCE', 100)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC3347007	4/2012	S90-PMC3347007	['intakes below 0.1 µg MIGHT be subject to uncertainty and THEREFORE these were NOT CONSIDERED to be contributing to dietary Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 21), ('PROBABLE_UNDERSTANDING', 57), ('INCOMPLETE_EVIDENCE', 78)]	3	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC3347007	4/2012	S134-PMC3347007	['when the study was conducted there were no formal RECOMMENDATIONS from the danish national board of health on use of Vitamin D supplements during Pregnancy, and both the number of users and the supplement dose MAY THEREFORE be higher today.']	[('FUTURE_WORK', 50), ('INCOMPLETE_EVIDENCE', 210), ('PROBABLE_UNDERSTANDING', 214)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy')]
PMC3347007	4/2012	S137-PMC3347007	['the most common doses of Vitamin D in supplements were 10 µg and 5 µg, INDICATING that the available supplements in denmark all have doses of 5 and 10 µg Vitamin D. low dose supplements make it DIFFICULT for the women to obtain the RECOMMENDED dose of Vitamin D. all Vitamin D supplements aimed at Pregnant women SHOULD THEREFORE contain 10 µg.']	[('INCOMPLETE_EVIDENCE', 71), ('DIFFICULT_TASK', 194), ('FUTURE_WORK', 232), ('FUTURE_WORK', 313), ('PROBABLE_UNDERSTANDING', 320)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('GO_0007565', 'female pregnancy', 298, 'pregnant')]
PMC3347007	4/2012	S138-PMC3347007	['when looking at the total Vitamin D intake in the dnbc we FOUND that as many as 55.6% had insufficient intakes EVEN THOUGH 67.6% REPORT use of Vitamin D supplements in SOME dose.']	[('INCOMPLETE_EVIDENCE', 58), ('ANOMALY_CURIOUS_FINDING', 111), ('ANOMALY_CURIOUS_FINDING', 116), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 168)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC3347007	4/2012	S144-PMC3347007	['this SUGGESTS that the women who have Vitamin D-containing diets are also the ones who use high dose supplements.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC3347007	4/2012	S145-PMC3347007	['we FOUND Supplements to contribute substantially to Vitamin D intake, but a large group of women STILL did not reach the RECOMMENDED level of intake.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 97), ('FUTURE_WORK', 121)]	3	[('CHEBI_33341', 'titanium atom', 9, 'supplements'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC3347007	4/2012	S147-PMC3347007	['we FOUND a lower LIKELIHOOD of sufficient total Vitamin D intake among young, smoking, multiparous women.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 17)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC3347007	4/2012	S148-PMC3347007	['in OTHER studies, maternal age was also FOUND TO BE inversely ASSOCIATED with Vitamin D intake and the use of Supplements, SUGGESTING that younger Individuals MAY BE less conscious about health matters [17,18,27,28,29].']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 40), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 159)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 110, 'supplements'), ('NCBITaxon_1', 'root', 147, 'individuals')]
PMC3347007	4/2012	S154-PMC3347007	['we FOUND that smoking was inversely ASSOCIATED with Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC3347007	4/2012	S155-PMC3347007	['OTHER STUDIES also FOUND that non-smokers had higher intakes of Vitamin D [19,29] and that non-smokers were more LIKELY to use vitamin D supplements [17,27].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 113)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 135, 'D')]
PMC3347007	4/2012	S156-PMC3347007	['smokers MIGHT be overall less health conscious and THEREFORE not aware of the IMPORTANCE of using Vitamin D supplements in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy')]
PMC3347007	4/2012	S157-PMC3347007	['in OTHER studies, overweight women HAVE BEEN FOUND to be less LIKELY to have sufficient Vitamin D intake and to use supplements [17,27,29].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 62)]	3	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC3347007	4/2012	S159-PMC3347007	['high socio-economic status and education was found TO BE directly ASSOCIATED with Vitamin D intake and supplement use in OTHER studies [17,18,27,28,29].']	[('ANOMALY_CURIOUS_FINDING', 51), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 121)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC3347007	4/2012	S161-PMC3347007	['AS EXPECTED, Pregnancy-planners were more LIKELY to have sufficient total Vitamin D intake, PROBABLY BECAUSE they were more conscious about their Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 42), ('PROBABLE_UNDERSTANDING', 92), ('PROBABLE_UNDERSTANDING', 101)]	4	[('GO_0007565', 'female pregnancy', 13, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy')]
PMC3347007	4/2012	S163-PMC3347007	['we also FOUND civil status to be non-significantly ASSOCIATED with Vitamin D intake, with single women being less LIKELY to have sufficient total Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBABLE_UNDERSTANDING', 114)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC3347007	4/2012	S169-PMC3347007	['TOGETHER, these results SUGGEST that women who use Vitamin D supplements or have sufficient total Vitamin D intake MIGHT have a healthier diet than women with insufficient Vitamin D Intake or who do not use supplements.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 115)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('GO_0007631', 'feeding behavior', 182, 'intake')]
PMC3347007	4/2012	S170-PMC3347007	['EVEN THOUGH the differences in diet between women with sufficient vs. women with insufficient total Vitamin D intake are statistically significant, IT IS POSSIBLE that the differences are clinically trivial, since the ESTIMATES in absolute numbers ONLY differ very LITTLE.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 218), ('ANOMALY_CURIOUS_FINDING', 248), ('INCOMPLETE_EVIDENCE', 248), ('INCOMPLETE_EVIDENCE', 265)]	6	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3347007	4/2012	S171-PMC3347007	['a database of all known Supplements in denmark has been developed in order to ESTIMATE Vitamin D intake from Supplements.']	[('INCOMPLETE_EVIDENCE', 78)]	1	[('CHEBI_33341', 'titanium atom', 24, 'supplements'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 109, 'supplements')]
PMC3347007	4/2012	S173-PMC3347007	['SOME analytical data SUGGEST that actual levels of Nutrients exceed labeled levels but ACCORDING TO the us department of agriculture, the INFORMATION on Vitamin D deviation from labels has NOT YET BEEN ESTIMATED [30,31].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 138), ('FULL_UNKNOWN', 189), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 202)]	7	[('CHEBI_33284', 'nutrient', 51, 'nutrients'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3347007	4/2012	S175-PMC3347007	['also, VALIDATION of a similar database from the norwegian Birth cohort moba SHOWED good agreement between supplementary Vitamin D measured by ffq and 25(Oh)D levels [24].']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 76)]	2	[('GO_0007567', 'parturition', 58, 'birth'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 150, '25(OH ... D')]
PMC3347007	4/2012	S178-PMC3347007	['IT IS POSSIBLE that null value IMPUTATION has caused an UNDERESTIMATION of Vitamin D supplementation, BUT since the ESTIMATED use of Vitamin D supplements is SIMILAR TO the one SEEN in norway [17], and lower than the one in finland [27], we do not think this ISSUE is RELEVANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('PROBLEM_COMPLICATION', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 177), ('PROBLEM_COMPLICATION', 259), ('IMPORTANT_CONSIDERATION', 268)]	9	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC3347007	4/2012	S183-PMC3347007	['HOWEVER, we BELIEVE that the DETERMINANTS of Vitamin D intake SEEN in THIS STUDY MAY adequately reflect the ones of the background population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('INCOMPLETE_EVIDENCE', 81)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3347007	4/2012	S184-PMC3347007	['determinants of Vitamin D insufficiency MUST BE TAKEN INTO CONSIDERATION in making RECOMMENDATIONS on Vitamin D intake in Pregnancy, to include more vulnerable groups that MAY BE at higher risk of deficiency.']	[('IMPORTANT_CONSIDERATION', 40), ('IMPORTANT_CONSIDERATION', 48), ('FUTURE_WORK', 83), ('INCOMPLETE_EVIDENCE', 172)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC3347007	4/2012	S187-PMC3347007	['we FOUND supplements to CONTRIBUTE substantially to Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 24)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC3347007	4/2012	S190-PMC3347007	['we PROPOSE that clinicians SHOULD ENCOURAGE Vitamin D supplementation among Pregnant women, with a SPECIAL FOCUS on vulnerable groups, such as younger, smoking and multiparous women, IN ORDER to improve maternal and fetal health both during and after Pregnancy.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 27), ('FUTURE_WORK', 34), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 107), ('QUESTION_ANSWERED_BY_THIS_WORK', 183)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnant'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]
PMC3348565	4/2012	S0-PMC3348565	['EFFECT on the incidence of pneumonia of Vitamin D supplementation by quarterly bolus dose to infants in kabul: a randomised controlled superiority trial\n\nabstractsummary\n\nbackground\nVitamin D has a ROLE in Regulating Immune function, and its deficiency is a SUGGESTED risk factor for childhood pneumonia.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 198), ('INCOMPLETE_EVIDENCE', 258)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 182, 'Vitamin D'), ('GO_0065007', 'biological regulation', 206, 'regulating'), ('UBERON_0002405', 'immune system', 217, 'immune')]
PMC3348565	4/2012	S15-PMC3348565	['two hospital-based case-control studies in ethiopia1and india2SUGGEST that Vitamin D deficiency MIGHT substantially increase the risk of SEVERE pneumonia in children.']	[('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 96), ('IMPORTANT_CONSIDERATION', 137)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3348565	4/2012	S18-PMC3348565	['HOWEVER, the risk of repeated pneumonia in the subsequent 3 months was 13% (relative risk [rr] 0·78, 95% ci 0·64–0·94; p=0·01) lower in the Vitamin D3Compared with the placebo group.3OTHER more RECENT STUDIES assessing different outcomes in children or Adults have CONFLICTING findings on the effectiveness of Vitamin D.\nthere is GROWING EVIDENCE of the Vitamin D parancrine system enhancing Innate Immunity:4the activation of toll-like receptors on Monocytes and Macrophages by Microbial pathogens results in increased Expression of Cyp27B1 and Vitamin D Receptor ( vdr ) Genes within these cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183), ('INCOMPLETE_EVIDENCE', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('INCOMPLETE_EVIDENCE', 330)]	6	[('CHEBI_59884', 'XDP(3-)', 140, 'vitamin D3compared'), ('UBERON_0007023', 'adult organism', 253, 'adults'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin D'), ('GO_0045087', 'innate immune response', 392, 'innate immunity'), ('CL_0000576', 'monocyte', 450, 'monocytes'), ('CL_0000235', 'macrophage', 464, 'macrophages'), ('NCBITaxon_10088', 'Mus <genus>', 479, 'microbial'), ('GO_0010467', 'gene expression', 520, 'expression'), ('PR_000006101', 'cytochrome P450 1A1', 534, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 546, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 546, 'vitamin D receptor'), ('SO_0000704', 'gene', 573, 'genes')]
PMC3348565	4/2012	S21-PMC3348565	['it HAS BEEN SUGGESTED that Vitamin D MIGHT be used in the treatment of opportunistic and Antibiotic-resistant infections.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 37)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_33282', 'antibacterial agent', 89, 'antibiotic')]
PMC3348565	4/2012	S23-PMC3348565	['in children, Serum Calcifediol concentrations SHOULD BE maintained at 50 nmol/l (20 ng/ml) or greater for Skeletal benefits.6vitamin D deficiency rickets in children younger than 5 years is an endemic PROBLEM in developing countries, ranging from 5–45%, EVEN where sunlight is abundant,1,2,7,8and has also re-emerged in SOME developed countries.7,9\nin People, the main source of Vitamin D is through the action of ultraviolet b radiation on 7-Dehydrocholesterol in the skin, with small amounts derived from dietary sources.']	[('FUTURE_WORK', 46), ('PROBLEM_COMPLICATION', 201), ('ANOMALY_CURIOUS_FINDING', 254), ('INCOMPLETE_EVIDENCE', 320)]	4	[('UBERON_0001977', 'blood serum', 13, 'serum'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 19, 'calcifediol'), ('UBERON_0004288', 'skeleton', 106, 'skeletal'), ('PR_000006444', 'diacylglycerol kinase delta', 133, 'D'), ('NCBITaxon_10088', 'Mus <genus>', 352, 'people'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 441, '7-dehydrocholesterol')]
PMC3348565	4/2012	S26-PMC3348565	['furthermore, the common practice of swaddling infants MIGHT reduce exposure to sunlight.2THUS young children are at a high risk of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 89)]	2	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3348565	4/2012	S27-PMC3348565	['a cross-sectional survey during the high-risk winter months in 2005 SHOWED that greater than 95% of children younger than 5 years in a socioeconomically deprived part of kabul had Serum Calcifediol levels of less than 37·5 nmol/l.12\nON THE BASIS OF findings that Vitamin D is an immunomodulator, that deficiency is a risk factor for pneumonia, and that quarterly supplementation had better compliance than daily or weekly supplementation,13,14we AIMED TO TEST the HYPOTHESIS that quarterly 100\u2008000 iu Vitamin D supplementation WOULD reduce the incidence of radiologically confirmed pneumonia by 35% in our study population.']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 233), ('QUESTION_ANSWERED_BY_THIS_WORK', 446), ('QUESTION_ANSWERED_BY_THIS_WORK', 452), ('INCOMPLETE_EVIDENCE', 464), ('FUTURE_PREDICTION', 527)]	6	[('UBERON_0001977', 'blood serum', 180, 'serum'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 186, 'calcifediol'), ('CHEBI_27300', 'vitamin D', 263, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 501, 'vitamin D')]
PMC3348565	4/2012	S47-PMC3348565	['procedures\nwe chose a quarterly supplementation regimen because in routine programme conditions a quarterly regimen is LIKELY to have better adherence than a daily regimen,13,14and HAS BEEN shown to be effective at maintaining the Serum Vitamin D concentration within normal ranges for 2–3 months in a french high-risk infant population.16the syringes containing Vitamin D or placebo were stored in conditions recommended by the manufacturer—a dry cool environment—between 2 and 24 weeks before administration.']	[('PROBABLE_UNDERSTANDING', 119), ('INCOMPLETE_EVIDENCE', 181)]	2	[('UBERON_0001977', 'blood serum', 231, 'serum'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D')]
PMC3348565	4/2012	S67-PMC3348565	['given that 73% of children had Vitamin D deficiency in the study region in 2005,12and that the incidence of pneumonia was ten-times higher in vitamin d deficient children than in children without a deficiency in case-control studies1,2we POSTULATED that there WOULD BE AT LEAST a 35% reduction in pneumonia incidence in the Vitamin D compared with the placebo group.']	[('INCOMPLETE_EVIDENCE', 238), ('FUTURE_PREDICTION', 260), ('PROBABLE_UNDERSTANDING', 269)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 324, 'vitamin D')]
PMC3348565	4/2012	S110-PMC3348565	['THUS the LACK OF a PROTECTIVE EFFECT of Vitamin D against pneumonia is PROBABLY not due to MISCLASSIFICATION of outcomes or INADEQUATE supplementation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 71), ('PROBLEM_COMPLICATION', 91), ('PROBLEM_COMPLICATION', 124)]	7	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC3348565	4/2012	S114-PMC3348565	['genotyping, which was NOT PRACTICAL in our study setting, MIGHT have aided the INTERPRETATION of our findings, AS SHOWN in a Vitamin D supplementation trial for tuberculosis.20\nwe accounted for nutritional factors through a diet questionnaire, weight at recruitment, and growth comparison at the end of our study—any nutritional deficiencies WOULD HAVE BEEN equally balanced between the two groups.']	[('DIFFICULT_TASK', 22), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 111), ('FUTURE_PREDICTION', 342), ('INCOMPLETE_EVIDENCE', 348)]	6	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3348565	4/2012	S115-PMC3348565	['AS WITH OTHER STUDIES, dietary calcium deficiency MIGHT have led to so-called wastage of body stores of Vitamin D in both groups, AFFECTING the maintenance of EVEN higher Vitamin D levels in the intervention group.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 130), ('ANOMALY_CURIOUS_FINDING', 159)]	4	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC3348565	4/2012	S119-PMC3348565	['our sample testing SUGGEST that the Vitamin D group maintained above mean adequate Vitamin D concetrations verses CONSISTENTLY low concentrations in the placebo group.']	[('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 114)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC3348565	4/2012	S120-PMC3348565	['it can be ARGUED that a steady-state adequate Vitamin D concentration was not reached in SOME children BECAUSE of fluctuations in Serum concentrations DUE TO our study regimen.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 89), ('PROBLEM_COMPLICATION', 103), ('PROBLEM_COMPLICATION', 151)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001977', 'blood serum', 130, 'serum')]
PMC3348565	4/2012	S121-PMC3348565	['ALTHOUGH this is PROBABLY TRUE, a sufficient Serum concentrations for the immunological EFFECTS of Vitamin D is UNKNOWN and COULD BE higher or lower than that of the Skeletal system accepted concentrations.6THE NEED for a steady state is currently highly SPECULATIVE and RELATES to Vitamin D2Supplementation for negative cancer22and bone outcomes.23\nour findings are AT ODDS with SMALLER case-control hospital STUDIES that show an enhanced rate of Vitamin D deficiency or rickets in children with pneumonia and the INCREASING EVIDENCE SUGGESTING that Calcitriol, the biologically active Metabolite of Vitamin D, has an IMPORTANT ROLE in the Human Immune System.4a systematic review of the ROLE of Vitamin D supplementation in infectious diseases had MIXED findings, CONCLUDING that more rigorously designed clinical trials ARE NEEDED (panel).25NO STUDIES report the EFFECT of Vitamin D on radiologically confirmed pneumonias.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 17), ('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 112), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('INCOMPLETE_EVIDENCE', 380), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 619), ('SUPERFICIAL_RELATIONSHIP', 629), ('SUPERFICIAL_RELATIONSHIP', 689), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('PROBABLE_UNDERSTANDING', 766), ('FUTURE_WORK', 823), ('INCOMPLETE_EVIDENCE', 844), ('SUPERFICIAL_RELATIONSHIP', 866)]	21	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0004288', 'skeleton', 166, 'skeletal'), ('CHEBI_52910', 'delta-lactam ring', 282, 'vitamin D2supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 282, 'vitamin D2supplementation'), ('CHEBI_27300', 'vitamin D', 448, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 551, 'calcitriol'), ('CHEBI_39382', 'flufenoxuron', 587, 'metabolite'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 641, 'human'), ('UBERON_0002405', 'immune system', 647, 'immune system'), ('CHEBI_27300', 'vitamin D', 697, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 876, 'vitamin D')]
PMC3348565	4/2012	S127-PMC3348565	['AS IN our studies, these INCONSISTENT findings POINT to the existence of COMPLICATED pathways for the function of Vitamin D in disease processes, or simply that the correct effective dose of Vitamin D supplementation NEEDS to be BETTER defined.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('INCOMPLETE_EVIDENCE', 47), ('DIFFICULT_TASK', 73), ('FUTURE_WORK', 217), ('INCOMPLETE_EVIDENCE', 229)]	6	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC3348565	4/2012	S129-PMC3348565	['an ASSOCIATED ISSUE is that, after the start of our trial, SPECULATIONS arose that high fluctuations of natural or supplemented Vitamin D intake MIGHT be LINKED to negative outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('PROBLEM_COMPLICATION', 14), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 154)]	5	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC3348565	4/2012	S130-PMC3348565	['these SPECULATIONS RELATE two studies in which supplementation of a single large dose (300\u200800033or 500\u200800023iu) of Vitamin D for reducing fractures in elderly women led to an increase in fractures, plus similar DISCREPANCIES in Prostate cancer research with Vitamin D.22our findings and particularly the slightly higher repeat episodes of pneumonia in the vitamin d group COULD BE DUE TO such fluctuations IF the HYPOTHESIS is TRUE.']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('INCOMPLETE_EVIDENCE', 372), ('PROBLEM_COMPLICATION', 381), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 406), ('INCOMPLETE_EVIDENCE', 413), ('PROBABLE_UNDERSTANDING', 427)]	8	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 228, 'prostate'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC3348565	4/2012	S133-PMC3348565	['FURTHER QUESTIONS arise with respect to the previous treatment trial in the same region of kabul, which showed that a single high-dose supplementation with 100\u2008000 iu Vitamin D3Given orally to young children, along with Antibiotic treatment at the time of diagnosis, reduced repeat episodes of pneumonia in the subsequent 3 months.3the INCONSISTENT results COULD BE RELATED to the evidence that stimulation of toll-like receptors on Macrophages and Monocytes by Bacterial Antigens is IMPORTANT in up-regulation of Cyp27B1 and the Vitamin D receptor,5which are CRUCIAL in Production Of Cathelicidins in Vitamin-D-depleted Individuals.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 336), ('INCOMPLETE_EVIDENCE', 357), ('SUPERFICIAL_RELATIONSHIP', 366), ('IMPORTANT_CONSIDERATION', 484), ('IMPORTANT_CONSIDERATION', 560)]	6	[('CHEBI_67916', '2alpha,3beta,23-trihydroxylup-20(29)-en-28-oic acid', 167, 'vitamin D3given'), ('PR_000001177', 'D(2) dopamine receptor', 175, 'D3given'), ('CHEBI_33282', 'antibacterial agent', 220, 'antibiotic'), ('CL_0000235', 'macrophage', 433, 'macrophages'), ('CL_0000576', 'monocyte', 449, 'monocytes'), ('CHEBI_22695', 'base', 462, 'bacterial'), ('CHEBI_59132', 'antigen', 472, 'antigens'), ('PR_000006101', 'cytochrome P450 1A1', 514, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0030154', 'cell differentiation', 571, 'production of cathelicidins'), ('CHEBI_83326', 'tedizolid phosphate', 602, 'vitamin-D'), ('NCBITaxon_1', 'root', 621, 'individuals')]
PMC3348565	4/2012	S134-PMC3348565	['in other words, this system MIGHT not be effective unless there is existing infection with pathogens when Vitamin D supplementation is given.']	[('INCOMPLETE_EVIDENCE', 28)]	1	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC3348565	4/2012	S136-PMC3348565	['AS WITH the trials in the older children, giving higher doses of Vitamin D,25,34we too did not record any adverse effects associated with Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC3348565	4/2012	S138-PMC3348565	['ALTHOUGH Vitamin D overload is a theoretical POSSIBILITY, 100\u2008000 iu of Vitamin D3Has BEEN shown to provide the best protection against Vitamin D deficiency without overload or side-effects in high-risk infants aged 0–9 months with normal baseline ranges of Vitamin D.16furthermore, single intramuscular injection of three times this dose (300\u2008000 iu) was safe in treating nutritional rickets in 6–30-month-old children residing in lower socioeconomic regions of sunny istanbul.35higher than RECOMMENDED doses of daily supplementation of Vitamin D (500–1000 iu per day, adding up to 120\u2008000 iu over 3 months) plus additional milk fortified with Vitamin D, HAS BEEN shown not to induce an overload,13including in infants starting with normal ranges of Vitamin D, EVEN when supplementation continued during the summer (in france) and when mothers had Antenatal Vitamin D supplementation.36it is IMPORTANT to note that in our study, where community supplementation was in a population with known high rates of Vitamin D deficiency, 1% of children tested had a Calcifediol concentration greater than 375 nmol/l—THOUGHT UNDESIRABLY high.6ALTHOUGH these did not produce any clinical signs and symptoms, these measurements raise a NEED for CAUTION with doses for population supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 82), ('FUTURE_WORK', 492), ('INCOMPLETE_EVIDENCE', 656), ('ANOMALY_CURIOUS_FINDING', 762), ('IMPORTANT_CONSIDERATION', 893), ('INCOMPLETE_EVIDENCE', 1107), ('PROBLEM_COMPLICATION', 1115), ('ANOMALY_CURIOUS_FINDING', 1133), ('FUTURE_WORK', 1224), ('IMPORTANT_CONSIDERATION', 1233)]	12	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_35646', 'galanthan', 72, 'vitamin D3has'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 72, 'vitamin D3has'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 538, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 645, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 751, 'vitamin D'), ('GO_0007567', 'parturition', 849, 'antenatal'), ('CHEBI_27300', 'vitamin D', 859, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1007, 'vitamin D'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 1057, 'calcifediol')]
PMC3348565	4/2012	S139-PMC3348565	['the SPECULATIVE negative ROLE of fluctuations is Vitamin D NEEDS to be CONSIDERED with CAUTION UNTIL FURTHER EVIDENCE is available.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 25), ('FUTURE_WORK', 59), ('FUTURE_WORK', 71), ('INCOMPLETE_EVIDENCE', 87), ('FUTURE_WORK', 95), ('INCOMPLETE_EVIDENCE', 101)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3348565	4/2012	S140-PMC3348565	['we HAVE SHOWN that a quarterly 100\u2008000 iu supplementation of Vitamin D3Did not reduce the incidence of pneumonias in children living in regions with high Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_75970', "2'-phospho-cyclic ADP-ribose(3-)", 61, 'vitamin D3did'), ('PR_000006287', 'deleted in azoospermia protein 4', 69, 'D3did'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC3356951	4/2012	S1-PMC3356951	['an ESTIMATED 1 billion People worldwide, across all ethnicities and age groups, have a Vitamin D deficiency (vdd).']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('NCBITaxon_10088', 'Mus <genus>', 23, 'people'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC3356951	4/2012	S4-PMC3356951	['CURRENT STUDIES SUGGEST that we MAY NEED more Vitamin D than presently RECOMMENDED to prevent chronic disease.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 71)]	5	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3356951	4/2012	S7-PMC3356951	['AS few Foods contain Vitamin D, guidelines RECOMMENDED supplementation at SUGGESTED daily Intake and tolerable upper limit levels.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 43), ('INCOMPLETE_EVIDENCE', 74)]	3	[('CHEBI_33290', 'food', 7, 'foods'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007631', 'feeding behavior', 90, 'intake')]
PMC3356951	4/2012	S10-PMC3356951	['a meta-analysis published in 2007 SHOWED that Vitamin D supplementation was ASSOCIATED with significantly reduced mortality.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC3356951	4/2012	S13-PMC3356951	['[1] an ESTIMATED 1 billion People worldwide, across all ethnicities and age groups, have a Vitamin D deficiency (vdd).']	[('INCOMPLETE_EVIDENCE', 7)]	1	[('NCBITaxon_10088', 'Mus <genus>', 27, 'people'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC3356951	4/2012	S14-PMC3356951	['[1–3] this PANDEMIC of hypovitaminosis d CAN MAINLY be ATTRIBUTED to lifestyle and environmental FACTORS that reduce exposure to sunlight, which is REQUIRED for ultraviolet-b (uvb)-induced Vitamin D Production in the skin.']	[('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 97), ('IMPORTANT_CONSIDERATION', 148)]	6	[('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0006272', 'leading strand elongation', 197, 'D production')]
PMC3356951	4/2012	S16-PMC3356951	['[5] emerging RESEARCH SUPPORTS the POSSIBLE ROLE of Vitamin D against cancer, Heart disease, fractures and falls, Autoimmune diseases, influenza, type-2 diabetes, and depression.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0000948', 'heart', 78, 'heart'), ('UBERON_0001442', 'skeleton of manus', 114, 'autoimmune')]
PMC3356951	4/2012	S18-PMC3356951	['[6] a meta-analysis published in 2007 SHOWED that Vitamin D supplementation was ASSOCIATED with significantly reduced mortality.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3356951	4/2012	S28-PMC3356951	['[12] without Vitamin D, only 10–15% of dietary calcium and ABOUT 60% of Phosphorus are absorbed.']	[('INCOMPLETE_EVIDENCE', 59)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_35885', 'secondary phosphine', 72, 'phosphorus')]
PMC3356951	4/2012	S32-PMC3356951	['[614–16] the local Production Of 1,25(Oh)2D MAY BE responsible for Regulating up to 200 Genes[17] that MAY facilitate MANY of the pleiotropic health benefits that HAVE BEEN REPORTED for Vitamin D.[38914]\n\nVitamin D deficiency: prevalence\nvdd HAS BEEN historically defined and RECENTLY RECOMMENDED by the institute of medicine (iom) AS a 25(Oh)D of less than 0.8 iu.']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 276), ('FUTURE_WORK', 285), ('PROBABLE_UNDERSTANDING', 332)]	8	[('GO_0008283', 'cell proliferation', 19, 'production of ... )2D'), ('CHEBI_37958', 'dye', 33, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 35, '25(OH)2D'), ('GO_0065007', 'biological regulation', 67, 'regulating'), ('SO_0000704', 'gene', 88, 'genes'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 205, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 337, '25(OH)D')]
PMC3356951	4/2012	S54-PMC3356951	['dietary supplements MIGHT be REQUIRED to meet the daily need for Vitamin D in SOME group of People.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 29), ('INCOMPLETE_EVIDENCE', 78)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 92, 'people')]
PMC3356951	4/2012	S56-PMC3356951	["[52] Vitamin D content of Human Milk is RELATED to the mother's Vitamin D status; THEREFORE mothers who supplement with high doses of Vitamin D MAY have high levels of Vitamin D in their milk."]	[('SUPERFICIAL_RELATIONSHIP', 40), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 144)]	3	[('CHEBI_28384', 'vitamin K', 5, 'Vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 26, 'human'), ('UBERON_0001913', 'milk', 32, 'milk'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC3356951	4/2012	S59-PMC3356951	['their skin cannot synthesize Vitamin D as efficiently, they are LIKELY to spend more time indoors, and they MAY have INADEQUATE intakes of the Vitamin.']	[('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 117)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 143, 'vitamin')]
PMC3356951	4/2012	S61-PMC3356951	['[5455] the SIGNIFICANCE of the ROLE that sunscreen MAY play in reducing Vitamin D Synthesis is STILL UNCLEAR.']	[('IMPORTANT_CONSIDERATION', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 51), ('FULL_UNKNOWN', 95)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 72, 'vitamin D synthesis')]
PMC3356951	4/2012	S67-PMC3356951	['individuals with reduced ability to absorb dietary fat MIGHT REQUIRE Vitamin D supplements.']	[('INCOMPLETE_EVIDENCE', 55), ('IMPORTANT_CONSIDERATION', 61)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3356951	4/2012	S70-PMC3356951	['obese People MAY NEED larger than usual intakes of Vitamin D to achieve 25(Oh)D levels COMPARABLE to those of normal weight.']	[('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 17), ('INCOMPLETE_EVIDENCE', 87)]	3	[('NCBITaxon_10088', 'Mus <genus>', 6, 'people'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D')]
PMC3356951	4/2012	S72-PMC3356951	['individuals who have undergone Gastric bypass surgery MAY become Vitamin D deficient over time without a sufficient Intake of Vitamin D from Food or supplements; moreover part of the upper Small Intestine where Vitamin D is absorbed is bypassed.']	[('INCOMPLETE_EVIDENCE', 54)]	1	[('UBERON_0001844', 'cochlea', 31, 'gastric'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007631', 'feeding behavior', 116, 'intake'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_33290', 'food', 141, 'food'), ('UBERON_0002108', 'small intestine', 189, 'small intestine'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC3356951	4/2012	S74-PMC3356951	['[1293360] Vitamin D produced in the skin MAY last AT LEAST twice as long in the Blood compared with Ingested Vitamin D.[61] when an Adult wearing a bathing suit is exposed to one minimal erythemal dose of uv radiation (a slight pinkness to the skin 24 h after exposure), the amount of vitamin d produced is equivalent to Ingesting between 10,000 and 25,000 iu.']	[('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 50)]	2	[('CHEBI_28384', 'vitamin K', 10, 'Vitamin D'), ('UBERON_0000178', 'blood', 80, 'blood'), ('GO_0007631', 'feeding behavior', 100, 'ingested'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0007023', 'adult organism', 132, 'adult'), ('GO_0007567', 'parturition', 321, 'ingesting')]
PMC3356951	4/2012	S81-PMC3356951	['Calcitriol (1,25-Dihydroxyvitamin D3), the active form of Vitamin D, has a half-life of about 15 h, while Calcidiol (25-hydroxyvitamin D3) has a half-life of ABOUT 15 days.']	[('INCOMPLETE_EVIDENCE', 158)]	1	[('CHEBI_17823', 'calcitriol', 0, 'Calcitriol'), ('CHEBI_63912', '19-hydroxyprostaglandin H2', 12, '1,25-dihydroxyvitamin D3'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_17933', 'calcidiol', 106, 'calcidiol'), ('PR_000001177', 'D(2) dopamine receptor', 135, 'D3')]
PMC3356951	4/2012	S88-PMC3356951	['[68] another example of Extrarenal Regulation of 1α-hydroxylase is that the increased Production Of 1,25(Oh)2D by Keratinocytes in wounds[69] THEREFORE provides a good ESTIMATE of Vitamin D status, BUT Regulation of 1α-hydroxylase activity SHOULD also BE CONSIDERED.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 142), ('INCOMPLETE_EVIDENCE', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('FUTURE_WORK', 240), ('ANOMALY_CURIOUS_FINDING', 252), ('FUTURE_WORK', 255)]	7	[('UBERON_0001691', 'external ear', 24, 'extrarenal'), ('GO_0065007', 'biological regulation', 35, 'regulation'), ('GO_0034205', 'amyloid-beta formation', 86, 'production of ... 2D'), ('CHEBI_82784', 'PVP38-Ag NP', 100, '1,25(OH)2D'), ('CL_0000312', 'keratinocyte', 114, 'keratinocytes'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0065007', 'biological regulation', 202, 'regulation')]
PMC3356951	4/2012	S92-PMC3356951	['[9] SINCE Vitamin D is fat soluble, orlistat and Cholestyramine CAN reduce its absorption and SHOULD BE taken several hours apart from it.']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 64), ('FUTURE_WORK', 94)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_3647', 'chlorpromazine', 49, 'Cholestyramine')]
PMC3356951	4/2012	S95-PMC3356951	['traditional multivitamins contain ABOUT 400 iu of Vitamin D, but many multivitamins now contain 800 to 1000 iu.']	[('INCOMPLETE_EVIDENCE', 34)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 58, 'D')]
PMC3356951	4/2012	S99-PMC3356951	['[7172] MANY STUDIES have SUGGESTED a LINK between low Vitamin D levels and an INCREASED RISK of cancer, with the STRONGEST EVIDENCE for Colorectal cancer.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 37), ('IMPORTANT_CONSIDERATION', 78), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0012652', 'colorectum', 136, 'colorectal')]
PMC3356951	4/2012	S101-PMC3356951	['[71] a definitive conclusion cannot yet be made about the ASSOCIATION between Vitamin D concentration and cancer RISK, BUT results from MANY STUDIES are promising.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('INCOMPLETE_EVIDENCE', 136)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3356951	4/2012	S102-PMC3356951	['there is SOME EVIDENCE LINKING higher Vitamin D intake to a lower RISK for Breast cancer.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 23), ('IMPORTANT_CONSIDERATION', 66)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000310', 'breast', 75, 'breast')]
PMC3356951	4/2012	S104-PMC3356951	['Heart disease\nSEVERAL STUDIES are PROVIDING EVIDENCE that the PROTECTIVE EFFECT of Vitamin D on the Heart COULD BE via the Renin–angiotensin hormone system, through the suppression of inflammation, or directly on the cells of the Heart and Blood-Vessel Walls.']	[('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 34), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 73), ('INCOMPLETE_EVIDENCE', 106)]	6	[('UBERON_0000948', 'heart', 0, 'Heart'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0000948', 'heart', 100, 'heart'), ('PR_000014368', 'RuvB-like 1', 123, 'renin'), ('UBERON_0000948', 'heart', 230, 'heart'), ('UBERON_0003512', 'lung blood vessel', 240, 'blood-vessel walls')]
PMC3356951	4/2012	S106-PMC3356951	['[17] in ANOTHER STUDY, which followed men and women for 4 years, patients with low Vitamin D concentrations (<15 ng/ml) were three times more LIKELY to be diagnosed with hypertension than those with high concentrations (>30 ng/ml).']	[('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 142)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC3356951	4/2012	S111-PMC3356951	['[85]\n\nobesity\nlow concentrations of circulating Vitamin D are common with obesity and MAY represent a POTENTIAL mechanism EXPLAINING the elevated risk of certain cancers and Cardiovascular outcomes.']	[('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 122)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 174, 'cardiovascular')]
PMC3356951	4/2012	S115-PMC3356951	['[89]\n\ntype 2 diabetes\na trial of nondiabetic patients aged 65 years and older FOUND that those who received 700 iu of Vitamin D (plus calcium) had a smaller rise in fasting Plasma Glucose over 3 years versus those who received placebo.']	[('INCOMPLETE_EVIDENCE', 78)]	1	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 173, 'plasma'), ('CHEBI_17234', 'glucose', 180, 'glucose')]
PMC3356951	4/2012	S116-PMC3356951	['[90] a CORRELATION between Vitamin D and the risk diabetes CAN be RULED in from the results.']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3356951	4/2012	S117-PMC3356951	['depression\na norwegian trial of overweight subjects SHOWED that those receiving a high dose of Vitamin D (20,000 or 40,000 iu weekly) had a significant improvement in depressive symptom scale scores after 1 year versus those receiving placebo.']	[('INCOMPLETE_EVIDENCE', 52)]	1	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3356951	4/2012	S123-PMC3356951	["RECENTLY, it HAS BEEN SUGGESTED that chronically INADEQUATE Vitamin D intake MAY play a significant ROLE in the pathogenesis of parkinson's disease."]	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3356951	4/2012	S124-PMC3356951	["a cohort study based on the mini-finland health survey DEMONSTRATED that low Vitamin D levels MAY PREDICT the development of parkinson's disease."]	[('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 98)]	3	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC3356951	4/2012	S127-PMC3356951	['[94] it is THEORIZED that Vitamin D MAY increase muscle strength, thereby PREVENTING falls.']	[('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC3356951	4/2012	S128-PMC3356951	['[6] MANY STUDIES HAVE SHOWN an ASSOCIATION between low Vitamin D concentrations and an INCREASED RISK of fractures and falls in older Adults.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 87)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adults')]
PMC3356951	4/2012	S129-PMC3356951	['a combined analysis of 12 fracture-prevention trials FOUND that supplementation with ABOUT 800 iu of Vitamin D per day reduced Hip and Nonspinal fractures by ABOUT 20%, and that supplementation with ABOUT 400 iu per day showed no benefit.']	[('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 199)]	4	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0001464', 'hip', 127, 'hip'), ('UBERON_0001707', 'nasal cavity', 135, 'nonspinal')]
PMC3356951	4/2012	S130-PMC3356951	['[95] researchers at the jean mayer usda Human nutrition research center on Aging at tufts university have EXAMINED the best trials of Vitamin D versus placebo for falls.']	[('INCOMPLETE_EVIDENCE', 106)]	1	[('NCBITaxon_10088', 'Mus <genus>', 40, 'Human'), ('GO_0007568', 'aging', 75, 'Aging'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3356951	4/2012	S132-PMC3356951	['[96]\na prospective study of white subjects FOUND that those with the highest Vitamin D concentrations had a 62% lower risk of developing ms versus those with the lowest concentrations.']	[('INCOMPLETE_EVIDENCE', 43)]	1	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC3356951	4/2012	S146-PMC3356951	["[103]\n\nrecommended dietary intakes of Vitamin D\nescp SUGGESTS that obese children and Adults on Anticonvulsant medications, Glucocorticoids, antifungals such as Ketoconazole, and medications for aids SHOULD BE given at least two to three times more Vitamin D for their age group to satisfy their body's Vitamin D REQUIREMENT[table 1]."]	[('INCOMPLETE_EVIDENCE', 53), ('FUTURE_WORK', 200), ('IMPORTANT_CONSIDERATION', 200), ('IMPORTANT_CONSIDERATION', 313)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 86, 'adults'), ('CHEBI_35624', 'azaspiro compound', 96, 'anticonvulsant'), ('CHEBI_36597', 'phthalazine', 124, 'glucocorticoids'), ('CHEBI_47519', 'ketoconazole', 161, 'ketoconazole'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
PMC3356951	4/2012	S147-PMC3356951	['caption (table-wrap): table 1\n\nrecommended dietary intakes of Vitamin D for patients AT RISK for Vitamin D deficiency[103]\nescp SUGGESTS that the maintenance tolerable upper limits (ul) of Vitamin D, which is not to BE exceeded without medical supervision, SHOULD BE 1000 iu/d for infants up to 6 months, 1500 iu/d for infants from 6 months to 1 year, AT LEAST 2500 iu/d for children aged 1–3 years, 3000 iu/d for children aged 4–8 years, and 4000 iu/d for everyone over 8 years.']	[('IMPORTANT_CONSIDERATION', 85), ('INCOMPLETE_EVIDENCE', 128), ('ANOMALY_CURIOUS_FINDING', 216), ('FUTURE_WORK', 257), ('PROBABLE_UNDERSTANDING', 352)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
PMC3356951	4/2012	S150-PMC3356951	['in patients with Extrarenal Production of 1,25(Oh)2D, serial monitoring of 25(Oh)D levels and Serum calcium levels during treatment with Vitamin D to prevent hypercalcemia is SUGGESTED [table 2].']	[('INCOMPLETE_EVIDENCE', 175)]	1	[('UBERON_0001691', 'external ear', 17, 'extrarenal'), ('GO_0007128', 'meiotic prophase I', 28, 'production'), ('CHEBI_82784', 'PVP38-Ag NP', 42, '1,25(OH)2D'), ('CHEBI_71657', 'versiconol acetate', 75, '25(OH)D'), ('UBERON_0001977', 'blood serum', 94, 'serum'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3356951	4/2012	S160-PMC3356951	['synthetic analogs of Vitamin D\n\nmaxacalcitol (22-Oxacalcitriol or oct) is the FIRST analog FOUND to have a wider therapeutic window than 1,25(Oh)2d3.']	[('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 91)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_37090', '1-anthrol', 46, '22-oxacalcitriol'), ('CHEBI_63056', 'zinc cation', 139, '25(OH')]
PMC3356951	4/2012	S161-PMC3356951	['[104]\ncalcipotriol is derived from Calcitriol was FIRST DISCOVERED during trials involving the use of Vitamin D for treating osteoporosis.']	[('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 56)]	2	[('CHEBI_17823', 'calcitriol', 35, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC3356951	4/2012	S162-PMC3356951	['Dihydrotachysterol (Dht) is a synthetic form of Vitamin D that many CONSIDER SUPERIOR to natural d2and d3.']	[('INCOMPLETE_EVIDENCE', 68), ('IMPORTANT_CONSIDERATION', 77)]	2	[('CHEBI_4553', 'dihydroanhydropodorhizol', 0, 'Dihydrotachysterol'), ('CHEBI_18320', '1,4-dithiothreitol', 20, 'DHT'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 56, 'D')]
PMC3356951	4/2012	S165-PMC3356951	['it is the FIRST of the new Vitamin D analogs to be approved for secondary hyperparathyroidism and DIFFERS from Calcitriol in that it lacks the exocyclic carbon 19 and has a Vitamin D2Side Chain INSTEAD of a Vitamin D3Side Chain.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 111, 'calcitriol'), ('CHEBI_66361', 'Viridamide A', 173, 'vitamin D2side chain'), ('CHEBI_66361', 'Viridamide A', 207, 'vitamin D3side chain')]
PMC3366611	4/2012	S155-PMC3366611	['a modest negative ASSOCIATION between maternal bmi and diet quality HAS BEEN IDENTIFIED [131], and obesity is ASSOCIATED with lower levels of Vitamin D [132] and Folic Acid levels during the Childbearing years [133], which MAY increase the risk of Insulin resistance and Neural Tube defects, respectively [134].']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 223)]	5	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_30751', 'formic acid', 162, 'folic acid'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 191, 'childbearing'), ('PR_000045358', 'insulin family protein', 248, 'insulin'), ('UBERON_0001049', 'neural tube', 271, 'neural tube')]
PMC3427192	4/2012	S3-PMC3427192	['additionally, a GROWING body of LITERATURE SUGGESTS that there is a RELATIONSHIP between Vitamin D status and Respiratory symptoms, PRESUMABLY through immunomodulatory EFFECTS of Vitamin D. this review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on Human studies.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 132), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 228), ('QUESTION_ANSWERED_BY_THIS_WORK', 278)]	8	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 110, 'respiratory'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 287, 'human')]
PMC3427192	4/2012	S9-PMC3427192	['indeed, numerous dietary hypotheses HAVE BEEN PROPOSED.13-15among the Nutrients and antioxidants included in this HYPOTHESIS, Vitamin D is of particular INTEREST SINCE Vitamin D concentrations decrease with increased time spent indoors, decreased exposure to sunlight, less exercise, obesity, and inadequate Calcium intake.16additionally, a GROWING BODY of literature SUGGESTS that there is a RELATIONSHIP between Vitamin D status and asthma-RELATED Respiratory symptoms,17-22PRESUMABLY through the immunomodulatory EFFECTS of Vitamin D.23,24this brief review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on EMERGING Human STUDIES over the past decade.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 153), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 341), ('INCOMPLETE_EVIDENCE', 368), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 442), ('ANOMALY_CURIOUS_FINDING', 474), ('SUPERFICIAL_RELATIONSHIP', 516), ('SUPERFICIAL_RELATIONSHIP', 586), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 645)]	14	[('CHEBI_33284', 'nutrient', 70, 'nutrients'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 308, 'calcium'), ('CHEBI_27300', 'vitamin D', 414, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 450, 'respiratory'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 570, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 654, 'human')]
PMC3427192	4/2012	S15-PMC3427192	['vdrs are Expressed on a variety of Airway Immune Cells, where they function as classic Nuclear Steroid Hormone receptors and ultimately Regulate the transcription of numerous Genes associated with inflammation and Immunomodulation.27vitamin d also plays an IMPORTANT ROLE in Respiratory infection by facilitating Toll-Like Receptor Signaling through increased Synthesis of Human Cathelicidin Antimicrobial peptide,28-30which is cleaved to generate the active Cationic peptide, Ll-37.31,32vitamin D also exerts direct EFFECTS on target cells independent of Gene transcription33and MAY THEREFORE be of relevance to Airway inflammatory disorders.34while Vitamin D can suppress il-1735and Il-4-mediated Expression of Il-13,35,36it CAN also shift the th1/th2 balance toward th2 dominance.37THESE CONTRADICTORY actions MAY BE DUE to the direct actions of Vitamin D on cd4+T Cells to promote an Il-10-secreting T-Regulatory population.38\n\nBiosynthesis Of Vitamin D\nBiosynthesis Of Vitamin D begins PRIMARILY with absorption of solar ultravoilet-b (uvb) radiation and secondarily via Consumption of Vitamin D-rich and fortified foods, such as oily fish, fortified grains and dairy products.26following exposure to uvb radiation, 7-Dehydrocholesterol within the skin is converted to Previtamin D3( fig.']	[('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267), ('SUPERFICIAL_RELATIONSHIP', 517), ('INCOMPLETE_EVIDENCE', 580), ('PROBABLE_UNDERSTANDING', 584), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 783), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 791), ('INCOMPLETE_EVIDENCE', 813), ('IMPORTANT_CONSIDERATION', 820), ('PROBABLE_UNDERSTANDING', 991)]	11	[('GO_0010467', 'gene expression', 9, 'expressed'), ('UBERON_0001005', 'respiratory airway', 35, 'airway'), ('CL_0000738', 'leukocyte', 42, 'immune cells'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('GO_0005634', 'nucleus', 87, 'nuclear'), ('CHEBI_26764', 'steroid hormone', 95, 'steroid hormone'), ('GO_0065007', 'biological regulation', 136, 'regulate'), ('SO_0000704', 'gene', 175, 'genes'), ('GO_0050900', 'leukocyte migration', 214, 'immunomodulation'), ('UBERON_0001004', 'respiratory system', 275, 'respiratory'), ('GO_0002770', 'T cell inhibitory signaling pathway', 313, 'Toll-like receptor signaling'), ('GO_0009057', 'macromolecule catabolic process', 360, 'synthesis'), ('NCBITaxon_9606', 'Homo sapiens', 373, 'human'), ('PR_000006009', 'alpha-catulin', 379, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 392, 'antimicrobial'), ('CHEBI_36916', 'cation', 459, 'cationic'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 477, 'LL-37'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 496, 'D'), ('SO_0000704', 'gene', 556, 'gene'), ('UBERON_0001005', 'respiratory airway', 613, 'airway'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 685, 'IL-4'), ('GO_0010467', 'gene expression', 699, 'expression'), ('PR_000001470', 'interleukin-28B', 713, 'IL-13'), ('CHEBI_27300', 'vitamin D', 849, 'vitamin D'), ('CL_0000084', 'T cell', 866, 'T cells'), ('PR_000001470', 'interleukin-28B', 888, 'IL-10'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 904, 'T'), ('CL_0000232', 'erythrocyte', 906, 'regulatory'), ('GO_0065007', 'biological regulation', 906, 'regulatory'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 932, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 948, 'vitamin D'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 958, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 974, 'vitamin D'), ('GO_0007631', 'feeding behavior', 1076, 'consumption'), ('CHEBI_27300', 'vitamin D', 1091, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 1221, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 1274, 'previtamin D3')]
PMC3427192	4/2012	S18-PMC3427192	['1,25(Oh)2D3, also referred to as Calcitriol, is then transported throughout the body via the Blood to various cells types that Express vdrs, where Gene Expression is induced.24,39BECAUSE the MAJORITY of Vitamin D Metabolism occurs in this skin, several FACTORS ARE THOUGHT TO INFLUENCE Vitamin D skin Metabolism, including age, body fat, the level of skin Melanin, and OTHER variables such as latitude, the amount and degree of sun exposure, and use of sunscreen products with uv protection.40these FACTORS HAVE BEEN PREVIOUSLY ASSOCIATED with Vitamin D deficiency in epidemiologic studies.41-43\n\ncaption (fig): figure 2.']	[('PROBABLE_UNDERSTANDING', 177), ('PROBABLE_UNDERSTANDING', 191), ('SUPERFICIAL_RELATIONSHIP', 253), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 276), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 369), ('SUPERFICIAL_RELATIONSHIP', 499), ('INCOMPLETE_EVIDENCE', 507), ('INCOMPLETE_EVIDENCE', 517), ('SUPERFICIAL_RELATIONSHIP', 528)]	11	[('CHEBI_37958', 'dye', 0, '1,'), ('CHEBI_73394', 'Ala-Ser', 2, '25(OH)2D3'), ('CHEBI_17823', 'calcitriol', 33, 'calcitriol'), ('UBERON_0000178', 'blood', 93, 'blood'), ('GO_0010467', 'gene expression', 127, 'express'), ('GO_0010467', 'gene expression', 147, 'gene expression'), ('SO_0000704', 'gene', 147, 'gene'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 203, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0008152', 'metabolic process', 301, 'metabolism'), ('CHEBI_25179', 'melanins', 356, 'melanin'), ('CHEBI_27300', 'vitamin D', 544, 'vitamin D')]
PMC3427192	4/2012	S19-PMC3427192	['Biosynthesis Of Vitamin D.\n\nVitamin D THRESHOLDS\nSerum concentrations of 25(Oh)D are CONSIDERED to be a BIOMARKER and INDICATOR of Vitamin D status.44,45ALTHOUGH Vitamin D insufficiency HAS TRADITIONALLY BEEN defined as a Serum 25(Oh)D concentration of 20 to 29 ng/ml,46a panel of experts from the institute of medicine RECENTLY SUGGESTED that Vitamin D INSUFFICIENCY be redefined AS a Serum 25(Oh)D concentration less than 20 ng/ml.47this RECOMMENDATION was based ON INCONCLUSIVE evidence for the threshold of 29 ng/ml and EVIDENCE for adverse Skeletal EFFECTS at thresholds less than 20 ng/ml.47HOWEVER, this revised definition of Vitamin D insufficiency has generated significant CONTROVERSY48,49AND THUS there is presently NO universally ACCEPTED definition for “optimal” 25(Oh)d concentrations INDEPENDENT of Musculoskeletal health.']	[('PROBABLE_UNDERSTANDING', 38), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 118), ('ANOMALY_CURIOUS_FINDING', 151), ('IMPORTANT_CONSIDERATION', 186), ('INCOMPLETE_EVIDENCE', 190), ('PROBABLE_UNDERSTANDING', 190), ('INCOMPLETE_EVIDENCE', 320), ('INCOMPLETE_EVIDENCE', 329), ('IMPORTANT_CONSIDERATION', 354), ('PROBABLE_UNDERSTANDING', 381), ('FUTURE_WORK', 440), ('ANOMALY_CURIOUS_FINDING', 465), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 524), ('SUPERFICIAL_RELATIONSHIP', 554), ('ANOMALY_CURIOUS_FINDING', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 683), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 697), ('PROBABLE_UNDERSTANDING', 703), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 742), ('INCOMPLETE_EVIDENCE', 742), ('SUPERFICIAL_RELATIONSHIP', 799)]	25	[('GO_0033593', 'BRCA2-MAGE-D1 complex', 0, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 49, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 228, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D'), ('UBERON_0001977', 'blood serum', 386, 'serum'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 392, '25(OH)D'), ('UBERON_0004288', 'skeleton', 545, 'skeletal'), ('CHEBI_27300', 'vitamin D', 633, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 776, '25(OH)'), ('UBERON_0002204', 'musculoskeletal system', 814, 'musculoskeletal')]
PMC3427192	4/2012	S21-PMC3427192	['INSTEAD, a number of environmental exposures MAY also alter the rate of Asthma Development.50-54of these modifiable environmental exposures, the ROLE of diet in asthma is of PARTICULAR INTEREST13,55since RECENT STUDIES SUGGEST that the Development Of Asthma in children MAY BE DUE to in utero exposure to Nutrients from the mother’s diet.56given the ROLE of Vitamin D in inflammation and Immunomodulation, SEVERAL STUDIES have focused on in utero Vitamin D exposure and subsequent asthma in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 145), ('ANOMALY_CURIOUS_FINDING', 174), ('ANOMALY_CURIOUS_FINDING', 185), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 219), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 277), ('SUPERFICIAL_RELATIONSHIP', 350), ('INCOMPLETE_EVIDENCE', 406)]	11	[('GO_0035801', 'adrenal cortex development', 72, 'asthma development'), ('GO_0009602', 'detection of symbiont', 236, 'development of asthma'), ('CHEBI_33284', 'nutrient', 305, 'nutrients'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0050900', 'leukocyte migration', 388, 'immunomodulation'), ('CHEBI_27300', 'vitamin D', 447, 'vitamin D')]
PMC3427192	4/2012	S22-PMC3427192	['WHILE SOME STUDIES quantified maternal dietary Intake of Vitamin D during the final Trimester of Pregnancy, others measured Vitamin D levels within the Plasma and whole Blood of Pregnant women (table 1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6)]	2	[('GO_0007631', 'feeding behavior', 47, 'intake'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 84, 'trimester'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 152, 'plasma'), ('UBERON_0000178', 'blood', 169, 'blood'), ('GO_0007565', 'female pregnancy', 178, 'pregnant')]
PMC3427192	4/2012	S23-PMC3427192	['SEVERAL of THESE STUDIES NOTED an inverse RELATIONSHIP between maternal Vitamin D intake and the RISK of subsequent wheezing in young infants and preschool children.58,61,62,64HOWEVER, Vitamin D intakes varied CONSIDERABLY between geographic locations, from 548 iu/day in the united states58and 260 iu/day in finland62to 248 and 137 iu/day in japan64and scotland,61respectively.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 25), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('ANOMALY_CURIOUS_FINDING', 210)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3427192	4/2012	S26-PMC3427192	['similarly, in a finnish Birth cohort, infants supplemented with Vitamin D during the first year of Life were not more LIKELY to have asthma in early Adulthood.67rather, in that STUDY67AND another,68the prevalence of allergic sensitization was greater at age 6 and age 31 y in those subjects who received regular Vitamin D supplementation during infancy.']	[('PROBABLE_UNDERSTANDING', 118), ('INCOMPLETE_EVIDENCE', 177)]	2	[('GO_0007567', 'parturition', 24, 'birth'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000104', 'life cycle', 99, 'life'), ('UBERON_0000113', 'post-juvenile adult stage', 149, 'adulthood'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D')]
PMC3427192	4/2012	S28-PMC3427192	['studies of Vitamin D exposure in early Life and Respiratory outcomesauthoryearcountrystudy designsample sizeage of children at assessmentdetermination of Vitamin D statusassociation between Vitamin D and Respiratory outcomesbelderbos572011netherlandsprospective cohort156 neonatesbirth to 1 ymaternal Food-frequency questionnaire and Cord Blood 25(Oh)Dlower 25(Oh)D concentrations ASSOCIATED with an increased risk of Respiratory syncytial Virus infectioncamargo582007united statesprospective cohort1194 mother-child dyads3 ymaternal Food-frequency questionnairehighest quartile of Vitamin D intake during Pregnancy ASSOCIATED with a lower risk of recurrent wheezingcamargo592011new zealandprospective cohort922 newbornsbirth to 5 ycord Blood 25(Oh)Dhigher 25(Oh)D ASSOCIATED with a decreased risk of Respiratory infection and wheezing BUT NO associations with childhood asthma NOTEDCARROLL602011CANADACROSS-sectional340 mother-infant dyads5–29 weeksmaternal whole Blood 25(Oh)Dincreasing maternal 25(Oh)D ASSOCIATED with decreased odds of asthma in mothers BUT no associations with infantile wheezing noteddevereux612007scotlandprospective cohort2000 Pregnant women, 1212 children5 ymaternal Food-frequency questionnairehighest and lowest maternal Vitamin D intakes ASSOCIATED with lower risk of wheezingerkkola622009finlandprospective cohort1669 mother-child dyads5 ymaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with lower risk of asthma and allergic rhinitisgale632008ukprospective cohort466 mothers and 178 children9 mo and 9 ymaternal Serum 25(Oh)Dmaternal Vitamin D levels > 75 nmol/l ASSOCIATED with increased risk of atopic dermatitis and asthmamiyake642010japanprospective cohort763 mother-child dyads16–24 momaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with a decreased risk of wheeze and atopic dermatitismorales652012spainprospective cohort1724 children12 mo, 4–6 ymaternal plasma 25(Oh)Dincreased maternal 25(Oh)D ASSOCIATED with a decreased risk of lower Respiratory infections BUT NOT wheezing or asthmarothers662011united statesprospective cohort219 childrenbirth to 5 ycord Blood 25(Oh)Dboth low and high Cord Blood 25(Oh)D ASSOCIATED with increased Aeroallergen sensitization BUT NOT with allergic rhinitis or asthma\nin other Birth cohort studies where 25(Oh)D concentrations were measured in the Plasma and whole Blood of Pregnant women, median 25(Oh)D concentrations ranged from APPROXIMATELY 20 to 29.5 ng/ml.60,63,65a 50% decrease in the odds of maternal asthma was FURTHER OBSERVED with every 35 nmol/l increase in 25(Oh)D levels, SUGGESTING a POSSIBLE LINK between Vitamin D status and asthma during Pregnancy.60HOWEVER, similar to the studies of maternal Vitamin D intake, NO CONSISTENT RELATIONSHIPS between 25(Oh)D concentrations and Respiratory symptoms during childhood HAVE BEEN observed.']	[('SUPERFICIAL_RELATIONSHIP', 381), ('SUPERFICIAL_RELATIONSHIP', 616), ('SUPERFICIAL_RELATIONSHIP', 765), ('ANOMALY_CURIOUS_FINDING', 836), ('ANOMALY_CURIOUS_FINDING', 878), ('SUPERFICIAL_RELATIONSHIP', 1006), ('ANOMALY_CURIOUS_FINDING', 1058), ('SUPERFICIAL_RELATIONSHIP', 1267), ('SUPERFICIAL_RELATIONSHIP', 1439), ('SUPERFICIAL_RELATIONSHIP', 1627), ('SUPERFICIAL_RELATIONSHIP', 1824), ('SUPERFICIAL_RELATIONSHIP', 1999), ('ANOMALY_CURIOUS_FINDING', 2064), ('SUPERFICIAL_RELATIONSHIP', 2213), ('ANOMALY_CURIOUS_FINDING', 2266), ('INCOMPLETE_EVIDENCE', 2471), ('INCOMPLETE_EVIDENCE', 2560), ('INCOMPLETE_EVIDENCE', 2568), ('INCOMPLETE_EVIDENCE', 2626), ('INCOMPLETE_EVIDENCE', 2639), ('SUPERFICIAL_RELATIONSHIP', 2648), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2706), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2770), ('SUPERFICIAL_RELATIONSHIP', 2784), ('INCOMPLETE_EVIDENCE', 2871)]	25	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 39, 'life'), ('UBERON_0001004', 'respiratory system', 48, 'respiratory'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 204, 'respiratory'), ('CHEBI_33290', 'food', 301, 'food'), ('UBERON_0002240', 'spinal cord', 334, 'cord'), ('UBERON_0000178', 'blood', 339, 'blood'), ('CHEBI_78858', '(R)-2-methylpyrrolidine', 345, '25(OH)DLower'), ('CHEBI_71657', 'versiconol acetate', 358, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 418, 'respiratory'), ('NCBITaxon_1', 'root', 440, 'virus'), ('CHEBI_33290', 'food', 534, 'food'), ('CHEBI_27300', 'vitamin D', 582, 'vitamin D'), ('GO_0007565', 'female pregnancy', 606, 'pregnancy'), ('UBERON_0000178', 'blood', 737, 'blood'), ('CHEBI_72842', '9-oxo-ODE', 743, '25(OH)DHigher'), ('CHEBI_71657', 'versiconol acetate', 757, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 801, 'respiratory'), ('UBERON_0000178', 'blood', 965, 'blood'), ('CHEBI_74350', 'N-diazoacetylnorleucine methyl ester', 971, '25(OH)DIncreasing'), ('PR_000011614', 'opioid growth factor receptor', 974, 'OH'), ('PR_000006449', 'diacylglycerol kinase kappa', 977, 'DIncreasing'), ('CHEBI_71657', 'versiconol acetate', 998, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 998, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 1152, 'pregnant'), ('CHEBI_33290', 'food', 1193, 'food'), ('CHEBI_27300', 'vitamin D', 1249, 'vitamin D'), ('CHEBI_33290', 'food', 1378, 'food'), ('CHEBI_27300', 'vitamin D', 1422, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1576, 'serum'), ('CHEBI_51469', 'butyllithium', 1582, '25(OH)DMaternal'), ('CHEBI_27300', 'vitamin D', 1598, 'vitamin D'), ('CHEBI_33290', 'food', 1763, 'food'), ('CHEBI_27300', 'vitamin D', 1807, 'vitamin D'), ('CHEBI_86378', '(25R)-3beta-hydroxycholest-5-en-26-oic acid', 1965, '25(OH)DIncreased'), ('PR_000011040', 'nuclear receptor coactivator 1', 1967, '(OH'), ('CHEBI_71657', 'versiconol acetate', 1991, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1991, '25(OH ... D'), ('UBERON_0001004', 'respiratory system', 2041, 'respiratory'), ('UBERON_0000178', 'blood', 2163, 'blood'), ('CHEBI_73803', 'Ala-Asp', 2169, '25(OH)DBoth'), ('UBERON_0002240', 'spinal cord', 2194, 'cord'), ('UBERON_0000178', 'blood', 2199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 2205, '25(OH)D'), ('CHEBI_2500', 'Aescin', 2239, 'aeroallergen'), ('GO_0007567', 'parturition', 2316, 'birth'), ('CHEBI_71657', 'versiconol acetate', 2343, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 2387, 'plasma'), ('UBERON_0000178', 'blood', 2404, 'blood'), ('GO_0007565', 'female pregnancy', 2413, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 2436, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 2610, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 2616, 'D'), ('CHEBI_27300', 'vitamin D', 2661, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2696, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2752, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 2806, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 2833, 'respiratory')]
PMC3427192	4/2012	S32-PMC3427192	['HOWEVER, in THESE STUDIES, there were no associations between Cord-Blood 25(Oh)D concentrations and subsequent asthma at 5 y of age.59,66\ncollectively, these studies SUGGEST that the benefits of Vitamin D during early Life MAY BE LIMITED to its EFFECTS on Respiratory infections and Viral-induced wheezing and not asthma per se.17HOWEVER, ALTHOUGH Vitamin D MAY have IMPORTANT ROLES in Immune Regulation during early Life, excessive Vitamin D exposure MAY also be ASSOCIATED with adverse health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 230), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 328), ('ANOMALY_CURIOUS_FINDING', 339), ('INCOMPLETE_EVIDENCE', 358), ('IMPORTANT_CONSIDERATION', 367), ('SUPERFICIAL_RELATIONSHIP', 377), ('INCOMPLETE_EVIDENCE', 452), ('SUPERFICIAL_RELATIONSHIP', 464)]	13	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('UBERON_0000104', 'life cycle', 218, 'life'), ('UBERON_0001004', 'respiratory system', 256, 'respiratory'), ('NCBITaxon_1', 'root', 283, 'viral'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0002521', 'leukocyte differentiation', 386, 'immune regulation'), ('UBERON_0002405', 'immune system', 386, 'immune'), ('UBERON_0000104', 'life cycle', 417, 'life'), ('CHEBI_27300', 'vitamin D', 433, 'vitamin D')]
PMC3427192	4/2012	S34-PMC3427192	['this finding is SIMILAR TO OTHER STUDIES where an INCREASED risk of allergic sensitization was NOTED in infants who received Vitamin D supplementation.67,68likewise, gale et al.63NOTED that maternal 25(Oh)D concentrations greater than 75\u2009nmol/l (30 ng/ml) were ASSOCIATED with 5-fold increased odds of asthma at 9 y of age in the exposed children.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 50), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 261)]	6	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 199, '25(OH)D')]
PMC3427192	4/2012	S35-PMC3427192	['HOWEVER, it is IMPORTANT TO NOTE that a large percentage of children were lost to follow-up, and THUS the resulting sample of mothers had higher concentrations of 25(Oh)D and were older, less LIKELY to smoke during Pregnancy, and more educated.63therefore WHILE there MAY BE therapeutic window for vitamin D supplementation in early Life, FURTHER STUDIES ARE NEEDED to more clearly understand the RISKS of high Vitamin D intake and bioavailability during the early childhood years.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 15), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 192), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 268), ('FUTURE_WORK', 339), ('FUTURE_WORK', 347), ('IMPORTANT_CONSIDERATION', 397)]	9	[('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 306, 'D'), ('UBERON_0000104', 'life cycle', 333, 'life'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D')]
PMC3427192	4/2012	S36-PMC3427192	['Vitamin D in school-aged children with asthma\nseveral RECENT STUDIES HAVE SHOWN ASSOCIATIONS between Vitamin D status and asthma outcomes in school-age children (table 2), ALTHOUGH there is considerable variation between the study populations.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 80), ('ANOMALY_CURIOUS_FINDING', 172)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3427192	4/2012	S37-PMC3427192	['OF PARTICULAR INTEREST is the FINDING of racial DISPARITIES in Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 48)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC3427192	4/2012	S38-PMC3427192	['due to higher levels of Melanin, african americans have the highest prevalence of Vitamin D deficiency, with the highest prevalence in those living in urban environments.43,76at the same time, asthma is also more PREVALENT in african american children.10,11only ONE STUDY TO DATE has FOCUSED on Vitamin D status in school-aged african american asthmatic children.']	[('IMPORTANT_CONSIDERATION', 213), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 272), ('QUESTION_ANSWERED_BY_THIS_WORK', 284)]	4	[('CHEBI_25179', 'melanins', 24, 'melanin'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC3427192	4/2012	S40-PMC3427192	['HOWEVER, 25(Oh)D concentrations in the non-asthmatic group were significantly higher than PREVIOUSLY-REPORTED average values in african american children.21the childhood asthma management program study, which consisted of a racially diverse population, also FOUND that 24% of Vitamin D deficient subjects were african american, compared with only 7% in the Vitamin D sufficient group.69the FACTORS responsible for the racial DISPARITY in Vitamin D status are UNCLEAR and WARRANT FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 425), ('FULL_UNKNOWN', 459), ('FUTURE_WORK', 471), ('FUTURE_WORK', 479)]	10	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 357, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 438, 'vitamin D')]
PMC3427192	4/2012	S45-PMC3427192	['WHILE these studies SHOW INTRIGUING ASSOCIATIONS between Vitamin D insufficiency (or deficiency) and asthma Control, the cross-sectional nature of the 25(Oh)D measurement and outcome assessment prevents causal INTERPRETATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('ANOMALY_CURIOUS_FINDING', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 210)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0065007', 'biological regulation', 108, 'control'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D')]
PMC3427192	4/2012	S47-PMC3427192	['given the LIMITATIONS ASSOCIATED with these epidemiologic studies, randomized controlled TRIALS of Vitamin D ARE NEEDED in children to BETTER UNDERSTAND the causal RELATIONSHIP between Vitamin D status and Respiratory outcomes such as asthma Control in this population.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 22), ('FUTURE_WORK', 89), ('FUTURE_WORK', 109), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 164)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 206, 'respiratory'), ('GO_0065007', 'biological regulation', 242, 'control')]
PMC3427192	4/2012	S52-PMC3427192	['in these sub-analyses, Vitamin D3Supplementation was ASSOCIATED with a decreased risk of exacerbations compared with Placebo, with a relative risk of 0.17.75similarly, in a more RECENT randomized, double-blind 6-mo trial where 800 µg of inhaled Budesonide was administered daily to a small group of 48 children with asthma in the presence or absence of 500 iu/day of Vitamin D3, children receiving supplemental Vitamin D did not have a reduction in 25(Oh)D during the winter months and also had a reduced risk of asthma exacerbations triggered by acute Respiratory Viral infections.73these INITIAL FINDINGS SUGGEST that Vitamin D supplementation MAY have therapeutic benefit children with asthma, ALTHOUGH ADDITIONAL randomized, double-blind, placebo-controlled STUDIES ARE NEEDED.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 590), ('INCOMPLETE_EVIDENCE', 607), ('INCOMPLETE_EVIDENCE', 646), ('ANOMALY_CURIOUS_FINDING', 697), ('FUTURE_WORK', 706), ('FUTURE_WORK', 762)]	8	[('CHEBI_52915', 'phosphatediyl group', 23, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 23, 'vitamin D3supplementation'), ('CHEBI_26130', 'biological pigment', 117, 'placebo'), ('CHEBI_3219', 'bupropion', 245, 'budesonide'), ('CHEBI_33279', 'vitamin D5', 367, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 367, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 449, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 455, 'D'), ('UBERON_0001004', 'respiratory system', 553, 'respiratory'), ('NCBITaxon_1', 'root', 565, 'viral'), ('CHEBI_27300', 'vitamin D', 620, 'vitamin D')]
PMC3427192	4/2012	S53-PMC3427192	['Vitamin D in Adults with asthma\nin Adults, the RECOMMENDED dietary intake for Vitamin D ranges from 600 to 800 iu daily.47HOWEVER, DESPITE the large variety of Foods supplemented with Vitamin D, a large proportion of the Adult population remains Vitamin D deficient,77,78perhaps DUE IN PART to INADEQUATE sun exposure and the rising PREVALENCE of obesity which CAN LEAD TO decreased Vitamin D bioavailability.79SIMILAR to the studies in school age children, a NUMBER OF cross-sectional studies in Adults have also DEMONSTRATED ASSOCIATIONS between Vitamin D status and asthma Control (table 3).']	[('FUTURE_WORK', 47), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 279), ('INCOMPLETE_EVIDENCE', 283), ('IMPORTANT_CONSIDERATION', 294), ('IMPORTANT_CONSIDERATION', 333), ('INCOMPLETE_EVIDENCE', 361), ('SUPERFICIAL_RELATIONSHIP', 365), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 460), ('INCOMPLETE_EVIDENCE', 514), ('SUPERFICIAL_RELATIONSHIP', 527)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 13, 'Adults'), ('UBERON_0007023', 'adult organism', 35, 'adults'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33290', 'food', 160, 'foods'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0007023', 'adult organism', 221, 'adult'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('UBERON_0007023', 'adult organism', 497, 'adults'), ('CHEBI_27300', 'vitamin D', 548, 'vitamin D'), ('GO_0065007', 'biological regulation', 576, 'control')]
PMC3427192	4/2012	S55-PMC3427192	['furthermore, in those subjects with current asthma, lower 25(Oh)D concentrations were ASSOCIATED with increased odds of asthma exacerbations and healthcare utilization in the preceding year.81OTHER STUDIES have also NOTED ASSOCIATIONS between decreased Serum 25(Oh)D concentrations and decreased Lung function, increased Airway hyperresponsiveness to Methacholine, and blunted Glucocorticoid responsiveness.80,82,84HOWEVER, in a RECENT case-control STUDY of obese subjects with and without asthma, no associations between Vitamin D status and asthma prevalence were NOTED.83the cross-sectional nature of these studies SHOULD again BE EMPHASIZED SINCE causation CANNOT BE determined DUE TO potential CONFOUNDING of the study results.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 190), ('ANOMALY_CURIOUS_FINDING', 216), ('SUPERFICIAL_RELATIONSHIP', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('INCOMPLETE_EVIDENCE', 429), ('ANOMALY_CURIOUS_FINDING', 566), ('FUTURE_WORK', 618), ('ANOMALY_CURIOUS_FINDING', 631), ('IMPORTANT_CONSIDERATION', 634), ('PROBLEM_COMPLICATION', 645), ('DIFFICULT_TASK', 661), ('PROBLEM_COMPLICATION', 682), ('PROBLEM_COMPLICATION', 699)]	14	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('UBERON_0001977', 'blood serum', 253, 'serum'), ('CHEBI_71657', 'versiconol acetate', 259, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 259, '25 ... OH ... D'), ('UBERON_0002048', 'lung', 296, 'lung'), ('UBERON_0001005', 'respiratory airway', 321, 'airway'), ('CHEBI_6805', 'methacycline', 351, 'methacholine'), ('CHEBI_24261', 'glucocorticoid', 377, 'glucocorticoid'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D')]
PMC3427192	4/2012	S57-PMC3427192	['in the FIRST KNOWN clinical TRIAL focused on the ROLE of Vitamin D in allergic disease, rappaport et al.85found that supplementation with 60,000 to 30,000 iu of Vitamin D2Per day resulted in significant relief of asthma and hay fever symptoms in more than 96% of patients suffering from asthma and seasonal allergies.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_63635', 'valganciclovir', 161, 'vitamin D2per'), ('PR_000001177', 'D(2) dopamine receptor', 169, 'D2per')]
PMC3427192	4/2012	S58-PMC3427192	['THUS, Vitamin D MAY have therapeutic EFFECTIVENESS in Adults with asthma, but MORE STUDIES ARE CLEARLY NEEDED.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('ANOMALY_CURIOUS_FINDING', 78), ('FUTURE_WORK', 83)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adults')]
PMC3427192	4/2012	S60-PMC3427192	['studies of Vitamin D status in Adults with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsblack80200514,091 (55)> 20 ycross-sectionalgeneral us populationlung functionhigher Serum 25(Oh)D ASSOCIATED with increased Lung functionkeet8120116857 (49)23.6cross-sectionalgeneral us populationwheeze, history of asthma, and asthma exacerbationhigher serum 25(Oh)D ASSOCIATED with decreased odds of current wheezing and asthma as well as emergency visits for asthma and asthma exacerbationsli822011435 (38)48.57cross-sectionalnewly diagnosed asthmaticslung function, total Serum igehigher 25(Oh)D ASSOCIATED with greater Lung function with no associations NOTED for igeoren832008290 (26)43cross-sectionalobese patientsasthma and allergic rhinitis25(Oh)D deficiency (< 25 ng/ml) ASSOCIATED with increased odds of atopic dermatitis BUT no associations with asthmasutherland84201054 (43)38.3cross-sectionalpersistent asthmalung function, Airway hyper-responsiveness, Glucocorticoid responsivenessdecreased 25(Oh)D ASSOCIATED with decreased Lung function, increased Airway hyperresponsiveness, and reduced Glucocorticoid responses\n\ngenetics of Vitamin D and asthma\nSOME STUDIES have FOCUSED on Genetic ASSOCIATIONS between Vitamin D and asthma in larger populations.']	[('SUPERFICIAL_RELATIONSHIP', 219), ('SUPERFICIAL_RELATIONSHIP', 388), ('SUPERFICIAL_RELATIONSHIP', 620), ('ANOMALY_CURIOUS_FINDING', 679), ('SUPERFICIAL_RELATIONSHIP', 801), ('ANOMALY_CURIOUS_FINDING', 853), ('SUPERFICIAL_RELATIONSHIP', 1034), ('INCOMPLETE_EVIDENCE', 1184), ('QUESTION_ANSWERED_BY_THIS_WORK', 1202), ('SUPERFICIAL_RELATIONSHIP', 1221)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0007023', 'adult organism', 31, 'adults'), ('UBERON_0001977', 'blood serum', 205, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 211, '25(OH)D'), ('UBERON_0002048', 'lung', 245, 'lung'), ('CHEBI_71657', 'versiconol acetate', 380, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 380, '25(OH)D'), ('UBERON_0001977', 'blood serum', 596, 'serum'), ('CHEBI_71657', 'versiconol acetate', 612, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 612, '25(OH)D'), ('UBERON_0002048', 'lung', 644, 'lung'), ('CHEBI_33010', 'chromide(1-)', 771, '(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 775, 'D'), ('UBERON_0001005', 'respiratory airway', 958, 'airway'), ('CHEBI_24261', 'glucocorticoid', 987, 'glucocorticoid'), ('CHEBI_71657', 'versiconol acetate', 1026, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 1029, 'OH ... D'), ('UBERON_0002048', 'lung', 1060, 'lung'), ('UBERON_0001005', 'respiratory airway', 1085, 'airway'), ('CHEBI_24261', 'glucocorticoid', 1125, 'glucocorticoid'), ('CHEBI_28384', 'vitamin K', 1163, 'Vitamin D'), ('SO_0000704', 'gene', 1213, 'genetic'), ('CHEBI_27300', 'vitamin D', 1242, 'vitamin D')]
PMC3427192	4/2012	S64-PMC3427192	['Genetic studies of Vitamin D and asthmaauthoryearnlocation/ populationoutcome measuresfindingsbossé8620091,064québec, canada/ french-canadian familiesgenotype of Genes INVOLVED in the Vitamin D pathwaysnps in Il10, Cyp24A1, Cyp2R1, Il1Rl1 and Cd86 were ASSOCIATED with asthma and atopypoon8720041,139quebecvdr Genetic variants in family-based cohortssix Allelic varients were ASSOCIATED with asthma, while four varients were ASSOCIATED with atopyraby882004582united states/ multi-centertwenty-eight loci in 7 positional candidates were genotypedvdr polymorphism DEMONSTRATED significant transmission distortionsaadi8920091,090jinan china/ han Populationsnps in the vdronly one marker showed a significant ASSOCIATION with asthma.']	[('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 253), ('SUPERFICIAL_RELATIONSHIP', 376), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 562), ('SUPERFICIAL_RELATIONSHIP', 705)]	6	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('SO_0000704', 'gene', 162, 'genes'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007601', 'visual perception', 184, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 209, 'IL10'), ('PR_000006101', 'cytochrome P450 1A1', 215, 'CYP24A1'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 224, 'CYP2R1'), ('PR_000008998', 'interleukin-21 receptor', 232, 'IL1RL1'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 243, 'CD86'), ('SO_0000704', 'gene', 310, 'genetic'), ('SO_0001023', 'allele', 354, 'allelic'), ('SO_0000751', 'proviral_location', 643, 'populationSNPs')]
PMC3427192	4/2012	S65-PMC3427192	['Haplotype analysis of the vdr polymorphisms SHOWED a significant ASSOCIATION with asthmavollmert90200432munich, germany/ germansnps in the vdr and Integrin Β7None of the Snps were ASSOCIATED with asthmawjst912005951munich, germany/ germany and sweden13 Snps in the vdrin unaffected siblings, Allele in the 5′ region was undertransmitted while two other Alleles in the 3′ terminal region were overtransmittedwjst922006947munich, germany/ germany and swedenserum levels of Vitamin D and genotyping of dna Single Base variantsat least one positive Snp with a transmission disequilibrium of for asthma or total Ige and Vitamin D was FOUND in several Genes\nONLY a HANDFUL OF STUDIES have evaluated the LINK between asthma and polymorphisms in other Genes INVOLVED in Vitamin d synthesis, bioavailability and Metabolism.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 180), ('INCOMPLETE_EVIDENCE', 629), ('INCOMPLETE_EVIDENCE', 652), ('INCOMPLETE_EVIDENCE', 659), ('SUPERFICIAL_RELATIONSHIP', 697), ('SUPERFICIAL_RELATIONSHIP', 750)]	8	[('SO_0001024', 'haplotype', 0, 'Haplotype'), ('PR_000009070', 'integrator complex subunit 3', 147, 'integrin β7None'), ('SO_0000694', 'SNP', 170, 'SNPs'), ('SO_0000694', 'SNP', 253, 'SNPs'), ('SO_0001023', 'allele', 292, 'allele'), ('SO_0001023', 'allele', 353, 'alleles'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D'), ('SO_0000984', 'single', 503, 'single base'), ('SO_0000694', 'SNP', 545, 'SNP'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 607, 'IgE'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('SO_0000704', 'gene', 646, 'genes'), ('SO_0000704', 'gene', 744, 'genes'), ('CHEBI_33229', 'vitamin (role)', 762, 'vitamin'), ('GO_0008152', 'metabolic process', 803, 'metabolism')]
PMC3427192	4/2012	S66-PMC3427192	['in ONE STUDY, modest ASSOCIATIONS were NOTED between several Genes in the Vitamin D pathway and asthma and allergic sensitization in populations enriched for subjects with current asthma.86a separate study of asthmatics also FOUND Haplotype ASSOCIATIONS for Cyp24A1 , the primary enzyme ASSOCIATED with Calcidiol Metabolism, where a 5-point Haplotype was ASSOCIATED with asthma, allergic sensitization, and Vitamin D Metabolites in asthmatic subjects.92while these PRELIMINARY results SUGGEST that Genetic components MAY account for Vitamin D status in subjects with asthma, OTHER STUDIES ARE NEEDED to determine tease out the Genetic vs. environmental UNDERPINNINGS of Vitamin D status in this population.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 39), ('INCOMPLETE_EVIDENCE', 225), ('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 287), ('SUPERFICIAL_RELATIONSHIP', 355), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 485), ('INCOMPLETE_EVIDENCE', 517), ('FUTURE_WORK', 575), ('FUTURE_WORK', 581), ('SUPERFICIAL_RELATIONSHIP', 653)]	13	[('SO_0000704', 'gene', 61, 'genes'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('SO_0001024', 'haplotype', 231, 'haplotype'), ('PR_000006101', 'cytochrome P450 1A1', 258, 'CYP24A1'), ('CHEBI_17933', 'calcidiol', 303, 'calcidiol'), ('GO_0008152', 'metabolic process', 313, 'metabolism'), ('SO_0001024', 'haplotype', 341, 'haplotype'), ('CHEBI_27300', 'vitamin D', 407, 'vitamin D'), ('CHEBI_25212', 'metabolite', 417, 'metabolites'), ('SO_0000704', 'gene', 498, 'genetic'), ('CHEBI_27300', 'vitamin D', 533, 'vitamin D'), ('SO_0000704', 'gene', 627, 'genetic'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D')]
PMC3427192	4/2012	S67-PMC3427192	['conclusion\nthere is a GROWING INTEREST in the ROLE of Vitamin D in asthma and Respiratory disorders across the Lifespan.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 78, 'respiratory'), ('UBERON_0000104', 'life cycle', 111, 'lifespan')]
PMC3427192	4/2012	S68-PMC3427192	['WHILE several observational STUDIES and a handful of SMALL clinical trials SUGGEST that Vitamin D MAY BE beneficial in asthma and wheezing disorders resulting from Respiratory Viral infections, findings are NOT CONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 207), ('INCOMPLETE_EVIDENCE', 211)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 164, 'respiratory'), ('NCBITaxon_1', 'root', 176, 'viral')]
PMC3427192	4/2012	S70-PMC3427192	['BECAUSE of the LIMITATIONS of OBSERVATIONAL studies which include CONFOUNDING by indication, definitive RECOMMENDATIONS for Vitamin D in subjects with asthma across the Lifespan cannot be made.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 66), ('FUTURE_WORK', 104)]	5	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0000104', 'life cycle', 169, 'lifespan')]
PMC3475131	6/2012	S108-PMC3475131	['use of different Supplements (n\u2009=\u20097 reviews)\n\nlaboratory outcomes\nseven systematic reviews (four of high quality) investigated the EFFECTS of Micronutrients other than iron and Folic Acid [16,18-23] and FOUND NO EVIDENCE TO SUPPORT the use of Vitamin B12, Vitamin C, calcium or zinc to prevent anaemia during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 209)]	3	[('CHEBI_33341', 'titanium atom', 17, 'supplements'), ('CHEBI_33839', 'macromolecule', 142, 'micronutrients'), ('CHEBI_30751', 'formic acid', 177, 'folic acid'), ('CHEBI_33279', 'vitamin D5', 243, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin C'), ('GO_0007565', 'female pregnancy', 309, 'pregnancy')]
PMC3475131	6/2012	S110-PMC3475131	['four of the seven systematic reviews assessed the ROLE of Vitamin A [16,17,20,21], although ONLY one was of high quality.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 92)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin A')]
PMC3475131	6/2012	S111-PMC3475131	['[21] all included a single rct (suharno 1993 [40]) which DEMONSTRATED higher mean haemoglobin concentrations and lower prevalence of anaemia at Birth for women who had received a combination of Vitamin A and Iron, COMPARED TO women who received Vitamin A or iron alone.']	[('INCOMPLETE_EVIDENCE', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214)]	2	[('GO_0007567', 'parturition', 144, 'birth'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin A'), ('CHEBI_24870', 'ion', 208, 'iron'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin A')]
PMC3475131	6/2012	S168-PMC3475131	['there was LIMITED EVIDENCE to demonstrate that riboflavin, Folic Acid, Vitamin A and the use of Erythropoietin COULD enhance a response to iron.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 111)]	2	[('CHEBI_30751', 'formic acid', 59, 'folic acid'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin A'), ('CHEBI_24009', 'eumelanin', 96, 'erythropoietin')]
PMC3395583	7/2012	S0-PMC3395583	['month of Birth, Vitamin D and risk of Immune-mediated disease: a case control study\n\nabstract\n\nbackground\na season of Birth EFFECT in Immune-mediated diseases (id) such as multiple sclerosis and type 1 diabetes HAS BEEN CONSISTENTLY REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 211), ('PROBABLE_UNDERSTANDING', 220), ('INCOMPLETE_EVIDENCE', 233)]	4	[('GO_0007567', 'parturition', 9, 'birth'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0002405', 'immune system', 38, 'immune'), ('GO_0007567', 'parturition', 118, 'birth'), ('UBERON_0002405', 'immune system', 134, 'immune')]
PMC3395583	7/2012	S8-PMC3395583	['Gestational uvb and Vitamin D exposure MAY BE IMPLICATED in the aetiology of id.']	[('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC3395583	7/2012	S21-PMC3395583	['DESPITE these DIFFERENCES, an abnormal Activation Of the Immune System is a common thread LINKING these conditions and several OBSERVATIONS INDICATE that similar Genetic pathways and environmental agents, such as Vitamin D deficiency, smoking behaviour and various infections, are INVOLVED in the pathogenesis of these disorders [18-20,22-25].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 281)]	7	[('GO_0000103', 'sulfate assimilation', 39, 'activation of ... immune system'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('SO_0000704', 'gene', 162, 'genetic'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC3395583	7/2012	S24-PMC3395583	['since all these conditions HAVE BEEN LINKED to Vitamin D deficiency [23,24], we also TESTED WHETHER the risk of disease by month of Birth follows the same seasonal distribution of predicted ultraviolet b (uvb) light radiation and 25-Hydroxyvitamin D (25-Oh-D) levels during Gestation.']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 37), ('QUESTION_ANSWERED_BY_THIS_WORK', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007567', 'parturition', 132, 'birth'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 230, '25-hydroxyvitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 251, '25-OH-D'), ('GO_0007565', 'female pregnancy', 274, 'gestation')]
PMC3395583	7/2012	S85-PMC3395583	['furthermore, the seasonal variation of 25-Oh-D levels WAS NOT INVESTIGATED AND NO other STUDIES have tried to answer the same QUESTION in id OTHER than ms. we FOUND that the risk of id was inversely ASSOCIATED with PREDICTED second trimester Uvb exposure and third trimester Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 54), ('FULL_UNKNOWN', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('EXPLICIT_QUESTION', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 215)]	8	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 39, '25-OH-D'), ('CHEBI_37043', "pyrimidine 2'-deoxyribonucleoside 5'-triphosphate", 242, 'UVB'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3395583	7/2012	S86-PMC3395583	['THESE FINDINGS are INTERESTING since SEVERAL LINES OF EVIDENCE now SUPPORT a ROLE for Vitamin D deficiency in the pathogenesis of id [23,24].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 77)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3395583	7/2012	S89-PMC3395583	['furthermore, in utero Vitamin D deficiency has a significant EFFECT on the developing Immune System and our group has RECENTLY SHOWN that Genes ASSOCIATED with ms, ra, cd, sle and t1d are significantly enriched for Vitamin D receptor Binding Sites [44-46].']	[('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 86, 'immune system'), ('SO_0000704', 'gene', 138, 'genes'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 223, 'D'), ('SO_0000409', 'binding_site', 234, 'binding sites')]
PMC3395583	7/2012	S91-PMC3395583	['it MAY BE that in utero Vitamin D deficiency, in conjunction with individual Genetic variation and subsequent exposure to other environmental agents, MAY then LEAD TO disease specificity.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('SO_0000704', 'gene', 77, 'genetic')]
PMC3395583	7/2012	S92-PMC3395583	['NOTABLY, schizophrenia is also INFLUENCED by the season of Birth and a RECENT STUDY HAS SHOWN that neonatal Vitamin D levels are significantly ASSOCIATED with risk of schizophrenia later in Life [49,50].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 143)]	5	[('GO_0007567', 'parturition', 59, 'birth'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000104', 'life cycle', 190, 'life')]
PMC3395583	7/2012	S100-PMC3395583	['we were LIMITED to using average uvb radiation and general population Vitamin D measures, which MAY differ from the individual maternal exposures.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 96)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC3395583	7/2012	S101-PMC3395583	['it is IMPORTANT TO NOTE that our uvb and Vitamin D CORRELATION analysis DOES NOT prove causation and that, ALTHOUGH the Vitamin D HYPOTHESIS is SUPPORTED by both epidemiological and functional OBSERVATIONS, seasonality dominates many features of the global environment and OTHER seasonal factors MAY play a ROLE in determining the risk of id.']	[('IMPORTANT_CONSIDERATION', 6), ('SUPERFICIAL_RELATIONSHIP', 51), ('ANOMALY_CURIOUS_FINDING', 72), ('ANOMALY_CURIOUS_FINDING', 107), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 273), ('INCOMPLETE_EVIDENCE', 296), ('SUPERFICIAL_RELATIONSHIP', 307)]	10	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3395583	7/2012	S105-PMC3395583	['Gestational Vitamin D deficiency APPEARS TO BE a PLAUSIBLE causative agent.']	[('ANOMALY_CURIOUS_FINDING', 33), ('INCOMPLETE_EVIDENCE', 49)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC3407995	7/2012	S1-PMC3407995	['purpose: to highlight the POTENTIAL BENEFITS of maternal supplementation with Docosahexaenoic Acid (Dha) and other IMPORTANT complimentary Nutrients, including Vitamin D, Folic Acid and Iodine during Pregnancy and/or Breast feeding for Foetal and/or infant Brain Development and/or function.']	[('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 36), ('IMPORTANT_CONSIDERATION', 115)]	3	[('CHEBI_36003', 'decenoic acid', 78, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 100, 'DHA'), ('CHEBI_33284', 'nutrient', 139, 'nutrients'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_30751', 'formic acid', 171, 'folic acid'), ('CHEBI_24859', 'iodine atom', 186, 'iodine'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy'), ('UBERON_0000310', 'breast', 217, 'breast'), ('GO_0000009', 'alpha-1,6-mannosyltransferase activity', 236, 'foetal ...'), ('GO_0007420', 'brain development', 257, 'brain development'), ('UBERON_0000955', 'brain', 257, 'brain')]
PMC3407995	7/2012	S11-PMC3407995	['RECENT RESEARCH HAS SHOWN that maternal dietary deficiencies of Docosahexaenoic Acid (Dha), Vitamin D, Folic Acid and Iodine are ASSOCIATED with a variety of poor foetal and/or infant health outcomes MOSTLY IMPACTING Brain Development and/or function in infancy and OFTEN throughout Life.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 129), ('PROBABLE_UNDERSTANDING', 200), ('SUPERFICIAL_RELATIONSHIP', 207), ('PROBABLE_UNDERSTANDING', 266)]	6	[('CHEBI_36003', 'decenoic acid', 64, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 86, 'DHA'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_30751', 'formic acid', 103, 'folic acid'), ('CHEBI_24859', 'iodine atom', 118, 'iodine'), ('GO_0007420', 'brain development', 217, 'brain development'), ('UBERON_0000955', 'brain', 217, 'brain'), ('UBERON_0000104', 'life cycle', 283, 'life')]
PMC3407995	7/2012	S13-PMC3407995	['a review of current literature was UNDERTAKEN to summarize the POTENTIAL benefits of maternal supplementation with Dha, Vitamin D, Folic Acid and Iodine during Pregnancy and/or Breast feeding for Foetal and/or infant Brain Development and/or function.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('INCOMPLETE_EVIDENCE', 63)]	2	[('CHEBI_17874', 'dihydrozeatin', 115, 'DHA'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_30751', 'formic acid', 131, 'folic acid'), ('CHEBI_24859', 'iodine atom', 146, 'iodine'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy'), ('UBERON_0000310', 'breast', 177, 'breast'), ('GO_0000009', 'alpha-1,6-mannosyltransferase activity', 196, 'foetal ...'), ('GO_0007420', 'brain development', 217, 'brain development'), ('UBERON_0000955', 'brain', 217, 'brain')]
PMC3407995	7/2012	S18-PMC3407995	['data was reviewed and summarized to discuss the RELEVANCE of dietary Dha, Vitamin D, Folic Acid and Iodine to Foetal and infant Brain Development and function, to PRESENT EVIDENCE DEMONSTRATING dietary deficiency of these Nutrients in many populations, to highlight the POTENTIAL benefits of maternal supplementation during Pregnancy and/or Lactation on foetal and/or infant outcomes and to include SAFE Intake RECOMMENDATIONS.']	[('IMPORTANT_CONSIDERATION', 48), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 180), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 399), ('FUTURE_WORK', 411)]	6	[('CHEBI_17874', 'dihydrozeatin', 69, 'DHA'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_30751', 'formic acid', 85, 'folic acid'), ('CHEBI_24859', 'iodine atom', 100, 'iodine'), ('GO_0000009', 'alpha-1,6-mannosyltransferase activity', 110, 'foetal ...'), ('GO_0007420', 'brain development', 128, 'brain development'), ('UBERON_0000955', 'brain', 128, 'brain'), ('CHEBI_33284', 'nutrient', 222, 'nutrients'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('GO_0007595', 'lactation', 341, 'lactation'), ('GO_0007631', 'feeding behavior', 404, 'intake')]
PMC3407995	7/2012	S78-PMC3407995	['THERE IS EVIDENCE of widespread sub-clinical Vitamin D deficiency [44] that is aggravated by long hours of work indoors and avoidance of sunshine aimed at reducing skin cancer risk [45].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3407995	7/2012	S84-PMC3407995	['the only OTHER useful sources are Eggs, fortified Margarines (REQUIRED in some countries by law to contain Vitamin D) and SOME fortified yoghurts and breakfast cereals.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 122)]	3	[('CL_0000025', 'egg cell', 34, 'eggs'), ('CHEBI_25140', 'maltodextrin', 50, 'margarines'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC3407995	7/2012	S85-PMC3407995	['HOWEVER, a recent global review of Vitamin D status HAS SHOWN that its Intake is OFTEN TOO low TO sustain healthy circulating 25(Oh)D in countries without mandatory staple Food fortification and is EVEN too low in countries that do fortify due to low Milk Consumption, vegetarianism, non-supplement use and low fish Intake [46].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 81), ('DIFFICULT_TASK', 87), ('ANOMALY_CURIOUS_FINDING', 198)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007631', 'feeding behavior', 71, 'intake'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 126, '25(OH ... D'), ('CHEBI_33290', 'food', 172, 'food'), ('UBERON_0001913', 'milk', 251, 'milk'), ('GO_0007631', 'feeding behavior', 256, 'consumption'), ('GO_0007631', 'feeding behavior', 316, 'intake')]
PMC3407995	7/2012	S87-PMC3407995	['as REPORTED in 2005, the average dietary intake of Vitamin D was in the range of 3 μg/day in most countries and did not exceed 9 μg/day in any of the countries surveyed including the united states, canada, the united kingdom, ireland, scotland, australia, europe, japan and various other countries.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3407995	7/2012	S89-PMC3407995	['approximately one billion People worldwide are ESTIMATED to be Vitamin D deficient with People living in europe, the middle east, china and japan AT PARTICULAR RISK [47,48].']	[('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 146), ('IMPORTANT_CONSIDERATION', 149)]	3	[('NCBITaxon_10088', 'Mus <genus>', 26, 'people'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 88, 'people')]
PMC3407995	7/2012	S94-PMC3407995	['Vitamin D insufficiency HAS BEEN ASSOCIATED with reduction in bone Mineral content of the offspring [51] and Perinatal growth restriction [52].']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_27300', 'vitamin D', 0, 'vitamin D'), ('CHEBI_46662', 'mineral', 67, 'mineral'), ('GO_0036268', 'swimming', 109, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 109, 'perinatal')]
PMC3407995	7/2012	S98-PMC3407995	['promote normal Brain Development—PRELIMINARY RESEARCH SUGGESTS that Gestational Vitamin D insufficiency HAS BEEN LINKED to altered Brain Development and Adult mental health [49], in particular schizophrenia [54].']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('GO_0007420', 'brain development', 15, 'brain development'), ('UBERON_0000955', 'brain', 15, 'brain'), ('GO_0007565', 'female pregnancy', 68, 'gestational'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007420', 'brain development', 131, 'brain development'), ('UBERON_0000955', 'brain', 131, 'brain'), ('UBERON_0007023', 'adult organism', 153, 'adult')]
PMC3407995	7/2012	S99-PMC3407995	['there is also evidence from observational studies SUGGESTING that adequate Vitamin D during early Life MAY PREVENT development of Immunological Diseases in the offspring later in Life such as type 1 diabetes [55], allergic diseases [53] and Lower Respiratory Tract infections, wheezing and asthma [56].']	[('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0000104', 'life cycle', 98, 'life'), ('GO_0007567', 'parturition', 130, 'immunological diseases'), ('UBERON_0003222', 'flexor digitorum superficialis', 130, 'immunological'), ('UBERON_0000104', 'life cycle', 179, 'life'), ('UBERON_0004905', 'articulation', 241, 'lower respiratory tract')]
PMC3407995	7/2012	S100-PMC3407995	['THEREFORE at its worst, Vitamin D deficiency CAN be Life threatening to the newborn, WHILE lesser deficiency CAN weaken Skull Bones risking Brain injury during Birth and can CONTRIBUTE to a multitude of future health PROBLEMS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 174), ('IMPORTANT_CONSIDERATION', 217)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('UBERON_0003215', 'alveolus', 120, 'skull bones'), ('UBERON_0000955', 'brain', 140, 'brain'), ('GO_0007567', 'parturition', 160, 'birth')]
PMC3407995	7/2012	S249-PMC3407995	['evidence of the POTENTIAL benefits of maternal Vitamin D supplementation for foetal/infant Brain health\npublished placebo-controlled intervention trials studying the IMPACT of Vitamin D supplementation in mothers with low Serum 25(Oh)D are RARE [45] because such trials are deemed UNACCEPTABLE by ethics committees.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 240), ('IMPORTANT_CONSIDERATION', 281)]	4	[('CHEBI_28384', 'vitamin K', 47, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 47, 'Vitamin D'), ('UBERON_0000955', 'brain', 91, 'Brain'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 228, '25(OH)D')]
PMC3407995	7/2012	S250-PMC3407995	['THEREFORE, results of epidemiological studies provide MOST OF the EVIDENCE SUGGESTING the IMPORTANCE of Vitamin D for foetal/infant Brain health.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 54), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 90)]	5	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0000955', 'brain', 132, 'brain')]
PMC3407995	7/2012	S253-PMC3407995	['a STUDY in black and white Pregnant women residing in the northern united states FOUND that approximately 29% of black Pregnant women and 5% of white Pregnant women had Vitamin D deficiency (Serum 25(Oh)D less than 37.5 nmol/l); WHEREAS 54% of black women and 47% of white women had Vitamin D insufficiency (defined as Serum 25(Oh)D levels 37.5 to 80 nmol/l) [122].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 229)]	3	[('GO_0007565', 'female pregnancy', 27, 'pregnant'), ('GO_0007565', 'female pregnancy', 119, 'pregnant'), ('GO_0007565', 'female pregnancy', 150, 'pregnant'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('UBERON_0001977', 'blood serum', 191, 'serum'), ('CHEBI_71657', 'versiconol acetate', 197, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 197, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('UBERON_0001977', 'blood serum', 319, 'serum'), ('CHEBI_71657', 'versiconol acetate', 325, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 325, '25 ... OH ... D')]
PMC3407995	7/2012	S254-PMC3407995	['RECENT STUDIES in white Pregnant women also SHOW high prevalence of Vitamin D deficiency in the uk [123] and ireland [124].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 44)]	2	[('GO_0007565', 'female pregnancy', 24, 'pregnant'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC3407995	7/2012	S257-PMC3407995	['differences in latitude HAVE also BEEN SHOWN to INFLUENCE the concentration of Vitamin D in a majority of Pregnant women [140].']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnant')]
PMC3407995	7/2012	S258-PMC3407995	['a recent review of studies LINKING maternal Vitamin D status during Pregnancy with maternal, foetal and Postnatal outcomes SUPPORTS a ROLE of maternal Vitamin D status, PARTICULARLY early in Pregnancy, in Modulating the risk of Pregnancy complications and in sustaining foetal growth, body composition, Skeletal Development, Immune Maturation and Respiratory health [141].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 169)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('GO_0065007', 'biological regulation', 205, 'modulating'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0001501', 'skeletal system development', 303, 'skeletal development'), ('UBERON_0004288', 'skeleton', 303, 'skeletal'), ('GO_0050900', 'leukocyte migration', 325, 'immune maturation'), ('UBERON_0002405', 'immune system', 325, 'immune'), ('UBERON_0001004', 'respiratory system', 347, 'respiratory')]
PMC3407995	7/2012	S259-PMC3407995	['SEVERAL STUDIES have DEMONSTRATED an ASSOCIATION between POOR maternal Vitamin D status and SEVERE Preeclampsia that CAN result in Miscarriage [141].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 37), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 92), ('INCOMPLETE_EVIDENCE', 117)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 99, 'preeclampsia'), ('GO_0046660', 'female sex differentiation', 131, 'miscarriage')]
PMC3407995	7/2012	S260-PMC3407995	['Miscarriages CAN also result from an increased rate of bacterial vaginosis in the 1st Trimester of Pregnancy that is ASSOCIATED with low Vitamin D status [49].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 117)]	2	[('GO_0042700', 'luteinizing hormone signaling pathway', 0, 'Miscarriages'), ('GO_0009294', 'DNA mediated transformation', 86, 'trimester'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3407995	7/2012	S261-PMC3407995	['maternal Vitamin D status early in Pregnancy was ASSOCIATED with risk of low Birth weight and small-for-Gestational age infants in ONE STUDY, WHEREAS another study FOUND this RELATION ONLY among white women [141].']	[('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 175), ('ANOMALY_CURIOUS_FINDING', 184), ('INCOMPLETE_EVIDENCE', 184)]	7	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('GO_0007567', 'parturition', 77, 'birth'), ('GO_0007565', 'female pregnancy', 104, 'gestational')]
PMC3407995	7/2012	S262-PMC3407995	['polymorphisms in the Vitamin D Receptor Gene MAY CONTRIBUTE to Vitamin D-RELATED DISPARITIES in foetal growth [141].']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 81)]	4	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 21, 'vitamin D receptor'), ('SO_0000704', 'gene', 40, 'gene'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC3407995	7/2012	S263-PMC3407995	['evidence from RECENT STUDIES SUGGESTS an early Prenatal INFLUENCE of maternal Vitamin D status on foetal Skeletal Development, with lasting Postnatal EFFECTS [141].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0001501', 'skeletal system development', 105, 'skeletal development'), ('UBERON_0004288', 'skeleton', 105, 'skeletal'), ('GO_0007567', 'parturition', 140, 'postnatal')]
PMC3407995	7/2012	S264-PMC3407995	['in addition, one STUDY has SUGGESTED that supplementation during Pregnancy MAY BE NECESSARY to assure adequate concentration of Vitamin D in Breast Milk during Lactation [142].']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 82)]	4	[('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 141, 'breast milk'), ('GO_0007595', 'lactation', 160, 'lactation')]
PMC3407995	7/2012	S268-PMC3407995	['in a study completed by a coalition of scientists formed to optimize Vitamin D fortification in the northern european countries, the average dietary intake of Vitamin D in young women was ONLY around 80 iu (2 μg) per day [144].']	[('ANOMALY_CURIOUS_FINDING', 188), ('INCOMPLETE_EVIDENCE', 188)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC3407995	7/2012	S278-PMC3407995	['DESPITE abundant sunshine and latitude CONSISTENT with year-long Vitamin D Synthesis, 65.5% of a largely low-risk Antenatal population in rural victoria, australia had insufficient Vitamin D. over 5.0% of women had Vitamin D levels that pose a significant neonatal and Adult health RISK [135].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 282)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 65, 'vitamin D synthesis'), ('GO_0007567', 'parturition', 114, 'antenatal'), ('UBERON_0001760', 'frontal sinus', 114, 'antenatal'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('UBERON_0007023', 'adult organism', 269, 'adult')]
PMC3407995	7/2012	S283-PMC3407995	['the authors CONCLUDED that Vitamin D deficiency is high among Pregnant urban pakistani women and their newborns and is a PUBLIC HEALTH PROBLEM that NEEDS URGENT ATTENTION [137].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 121), ('IMPORTANT_CONSIDERATION', 135), ('FUTURE_WORK', 148), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 154), ('FUTURE_WORK', 161)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnant')]
PMC3407995	7/2012	S287-PMC3407995	['in addition, there was an increase in late (5–10 days of age) and late-late (2–12 weeks of age) neonatal hypocalcaemia presenting predominantly with seizures, DEMONSTRATING the INVOLVEMENT of Vitamin D in Brain function [50].']	[('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 177)]	2	[('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('UBERON_0000955', 'brain', 205, 'brain')]
PMC3407995	7/2012	S289-PMC3407995	['Pregnancy maintenance\na cohort study of 23,423 nulliparous Pregnant women taking part in the norwegian mother and child cohort study FOUND a 27% reduction in risk of Preeclampsia in women taking Vitamin D supplements relative to those who did not take Supplements [145].']	[('INCOMPLETE_EVIDENCE', 133)]	1	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('GO_0007128', 'meiotic prophase I', 166, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 252, 'supplements')]
PMC3407995	7/2012	S293-PMC3407995	['THERE IS EVIDENCE that Vitamin D during Pregnancy is INVOLVED in foetal Brain Development and that maternal Vitamin D deficiency during Pregnancy CAN alter the structure and function of the Brain resulting in Life long behavioural changes in the offspring [146,147,148].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 146)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0007420', 'brain development', 72, 'brain development'), ('UBERON_0000955', 'brain', 72, 'brain'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'pregnancy'), ('UBERON_0000955', 'brain', 190, 'brain'), ('UBERON_0000104', 'life cycle', 209, 'life')]
PMC3407995	7/2012	S302-PMC3407995	['the authors CONCLUDED that Prenatal Vitamin D supplements in women AT RISK of deficiency COULD reduce the risk of schizophrenia in their offspring [149].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 67), ('INCOMPLETE_EVIDENCE', 89)]	3	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3407995	7/2012	S303-PMC3407995	['HOWEVER, one SHOULD CONSIDER the COMPLEX nature of Vitamin D EFFECTS SINCE EITHER deficiency OR excess MAY BE harmful [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('FUTURE_WORK', 20), ('DIFFICULT_TASK', 33), ('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 103)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3407995	7/2012	S306-PMC3407995	['studies SHOWING CORRELATION between maternal and foetal Vitamin D status\nfive hundred and six Pregnant women were given 400 iu (10μg) of Vitamin D per day from about the 12th week of Pregnancy until Delivery [150].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 16)]	2	[('CHEBI_28384', 'vitamin K', 56, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnant'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'pregnancy'), ('GO_0007567', 'parturition', 199, 'delivery')]
PMC3407995	7/2012	S312-PMC3407995	['these results SUGGEST that Vitamin D supplementation during Pregnancy would be beneficial for mothers, whose intake from diet and skin Synthesis is APPRECIABLY less than 500 iu of vitamin d daily.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 148)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('GO_0009057', 'macromolecule catabolic process', 135, 'synthesis')]
PMC3407995	7/2012	S434-PMC3407995	['in 2011, the us Endocrine task force on Vitamin D STATED that 15 μg (600 iu) daily MAY not be enough to correct Vitamin D deficiency in Pregnant and Lactating women.']	[('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 83)]	2	[('UBERON_0005063', 'left ventricular compact myocardium', 16, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'pregnant'), ('GO_0007594', 'puparial adhesion', 149, 'lactating')]
PMC3407995	7/2012	S436-PMC3407995	['a RECENT cochrane review ASSESSED the EFFECTS and SAFETY of Vitamin D supplementation in Pregnancy and EXAMINED WHETHER supplementation with Vitamin D alone OR in combination with Calcium and other Vitamins and Minerals given to women during Pregnancy COULD SAFELY improve Pregnancy outcomes [175].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 38), ('IMPORTANT_CONSIDERATION', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 252), ('IMPORTANT_CONSIDERATION', 258)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 180, 'calcium'), ('CHEBI_33277', 'gamma-tocotrienol', 198, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 211, 'minerals'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
PMC3407995	7/2012	S438-PMC3407995	['data from four trials involving 414 women CONSISTENTLY SHOWED that women who received Vitamin D supplements during Pregnancy had higher concentrations of Vitamin D in Serum at term than those women who received no intervention or a placebo; HOWEVER the magnitude of the response was highly heterogenous.']	[('PROBABLE_UNDERSTANDING', 42), ('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum')]
PMC3407995	7/2012	S439-PMC3407995	['data from three trials SUGGESTED that Vitamin D supplemented women had babies with Birth weights below 2500 g less frequently than those women receiving no treatment or placebo.']	[('INCOMPLETE_EVIDENCE', 23)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007567', 'parturition', 83, 'birth')]
PMC3407995	7/2012	S442-PMC3407995	['the authors CONCLUDED that Vitamin D supplementation in a single or continued dose during Pregnancy increases Serum Vitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 12)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('UBERON_0001977', 'blood serum', 110, 'serum'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC3407995	7/2012	S444-PMC3407995	['there HAS BEEN little toxicity REPORTED in Adults taking doses of Vitamin D as high as 10,000 iu/day (250 µg/day) of Vitamin d [176,177,178] ALTHOUGH toxicity becomes GENERALLY present at 20,000 iu/day (500 µg/day).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 141), ('PROBABLE_UNDERSTANDING', 167)]	4	[('UBERON_0007023', 'adult organism', 43, 'adults'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 117, 'vitamin')]
PMC3407995	7/2012	S445-PMC3407995	['RECENTLY, a randomized, controlled trial, including 350 women with a singleton Pregnancy at 12 to 16 weeks’ Gestation supplemented with 400 (10 μg), 2000 (50 μg), or 4000 iu (100 μg) of Vitamin D per day until Delivery.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('GO_0007565', 'female pregnancy', 108, 'gestation'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0007567', 'parturition', 210, 'delivery')]
PMC3407995	7/2012	S449-PMC3407995	['the authors CONCLUDED that Vitamin D supplementation of 4000 iu/day for Pregnant women is SAFE and MOST EFFECTIVE in achieving sufficiency in all women and their neonates regardless of race, WHEREAS the current ESTIMATED average REQUIREMENT is comparatively ineffective at achieving adequate circulating 25(Oh)D concentrations, especially in african americans [179].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 99), ('SUPERFICIAL_RELATIONSHIP', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 229)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 304, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 304, '25(OH)D')]
PMC3407995	7/2012	S480-PMC3407995	['HOWEVER, common dietary DEFICIENCIES within many populations of particular Nutrients including dha, Vitamin D, Folic Acid, and Iodine, that all play CRITICAL ROLES at various developmental stages, HAVE BEEN SHOWN to CONTRIBUTE to functional abnormalities, many of which have lasting EFFECTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 24), ('IMPORTANT_CONSIDERATION', 149), ('SUPERFICIAL_RELATIONSHIP', 158), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 216), ('SUPERFICIAL_RELATIONSHIP', 283)]	7	[('CHEBI_33284', 'nutrient', 75, 'nutrients'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_30751', 'formic acid', 111, 'folic acid'), ('CHEBI_24859', 'iodine atom', 127, 'iodine')]
PMC3407995	7/2012	S485-PMC3407995	['PRECLINICAL studies in offspring Born to Vitamin D deficient mothers HAVE REPORTED gross morphological changes in Brain structure that persist into Adulthood resulting in impaired Attention processing, sensitivity to Agents that induce psychosis and abnormal movement patterns.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 69)]	2	[('GO_0007567', 'parturition', 33, 'born'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0000955', 'brain', 114, 'brain'), ('UBERON_0000113', 'post-juvenile adult stage', 148, 'adulthood'), ('GO_0006915', 'apoptotic process', 180, 'attention'), ('CHEBI_33250', 'atom', 217, 'agents')]
PMC3407995	7/2012	S486-PMC3407995	['epidemiological studies have LINKED low maternal Vitamin D status to SEVERE Preeclampsia resulting in Miscarriage, risk of low Birth weight and small-for-Gestational age infants, neonatal hypocalcaemia with seizures and POSSIBLE INVOLVEMENT in the development of schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 229)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 76, 'preeclampsia'), ('GO_0046660', 'female sex differentiation', 102, 'miscarriage'), ('GO_0007567', 'parturition', 127, 'birth'), ('GO_0007565', 'female pregnancy', 154, 'gestational')]
PMC3407995	7/2012	S492-PMC3407995	['maternal supplementation with Dha, Vitamin D, Folic Acid and Iodine within RECOMMENDED SAFE intake quantities in a large segment of the population that is currently DEFICIENT in these Nutrients, COULD significantly prevent many Brain and Central Nervous System malfunctions and EVEN enhance Brain Development and function in future generations.']	[('FUTURE_WORK', 75), ('IMPORTANT_CONSIDERATION', 87), ('IMPORTANT_CONSIDERATION', 165), ('INCOMPLETE_EVIDENCE', 195), ('ANOMALY_CURIOUS_FINDING', 278)]	5	[('CHEBI_17874', 'dihydrozeatin', 30, 'DHA'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_30751', 'formic acid', 46, 'folic acid'), ('CHEBI_24859', 'iodine atom', 61, 'iodine'), ('CHEBI_33284', 'nutrient', 184, 'nutrients'), ('UBERON_0000955', 'brain', 228, 'brain'), ('UBERON_0001017', 'central nervous system', 238, 'central nervous system'), ('GO_0007420', 'brain development', 291, 'brain development'), ('UBERON_0000955', 'brain', 291, 'brain')]
PMC3409554	7/2012	S42-PMC3409554	['calf and pork Liver have a high content of Iron with a good bioavailability, but the danish health authorities ADVISE Pregnant women not to consume pork Liver and pork Liver paté due to the high content of Vitamin A, which POSSIBLY MAY cause malformations in the fetus [18].']	[('FUTURE_WORK', 111), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 232)]	3	[('UBERON_0002107', 'liver', 14, 'liver'), ('CHEBI_24870', 'ion', 43, 'iron'), ('GO_0007565', 'female pregnancy', 118, 'pregnant'), ('UBERON_0002107', 'liver', 153, 'liver'), ('UBERON_0002107', 'liver', 168, 'liver'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin A')]
PMC3415261	7/2012	S38-PMC3415261	['for example, the selection of the Animal model for studying Vitamin A supplementation is CRUCIAL because the Carotenoids are very differently absorbed DEPENDING ON the selected MODEL [7].']	[('IMPORTANT_CONSIDERATION', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 177)]	3	[('NCBITaxon_33208', 'Metazoa', 34, 'animal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('CHEBI_50815', 'norgestimate', 109, 'carotenoids')]
PMC3417531	7/2012	S66-PMC3417531	["(91)childreninfectious diseasehigh rate of simkania negevensis among canadian inuit infants hospitalized with Lower Respiratory Tract infections (92)childrennutritioniron deficiency and anaemia prevalence and ASSOCIATED etiologic RISK FACTORS in first nations and inuit communities in northern ontario and nunavut (93)childrennutritionfood insecurity among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (59)childrennutritionvitamin D status of inuit preschoolers reflects season and Vitamin D intake (56)childrenenvironment/environmental exposures; infectious diseaseeffect of Prenatal exposure to Polychlorinated Biphenyls on incidence of acute Respiratory infections in preschool inuit children (25)childrenchronic disease; interventions/programmingthe benefits of sound field amplification in classrooms of inuit students of nunavik: a pilot project (73)childrensocial DETERMINANTS of health; tobaccocultural, socioeconomic, and health indicators among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (9)childreninfectious disease; tobaccoindoor air quality and the risk of Lower Respiratory Tract infections in young canadian inuit children (41)childreninfectious disease; interventions/programmingheat recovery ventilators prevent Respiratory disorders in inuit children (40)childrengenetics; nutritionadaptation of inuit children to a low-calcium diet (83)childreninfectious disease; health care, policy, Human resourcesbronchiolitis in inuit children from a canadian central arctic community, 1995–1996 (69)youthchronic diseasecauses and CONTRIBUTIONS to differences in Life expectancy for inuit nunangat and canada, 1994–2003 (82)youthinfectious diseaseotitis media and Hearing loss among 12–16 year-old inuit of inukjuak, quebec, canada (35)youthinjuryinjury mortality risk assessment and targeting the subpopulations for prevention in the northwest territories, canada (86)youthnutritionage differences in Vitamin A intake among canadian inuit (55)youthmental health and wellbeingcompleted suicides among the inuit of northern quebec, 1982–1996: a case-control study (77)youthmental health and wellbeing; social determinants of healthsuicidality in a sample of arctic households (76)youthinfectious disease; interventions/programminghiv testing experiences of aboriginal youth in canada: service IMPLICATIONS (74)youthinfections disease; social determinants of healthdeterminants of Sexually Transmitted infections among canadian inuit adolescent populations (30)youthinfections disease; mental health and wellbeingyouth sexual health in nunavut: a needs-based survey of knowledge, attitudes and behaviour (31)maternalbirth outcomesreclaiming Birth, health, and community: midwifery in the inuit villages of nunavik, canada (68)maternalenvironment/environmental exposuresorganochlorine levels in maternal and Umbilical Cord Blood Plasma in arctic canada (49)maternalenvironment/environmental exposuresexposure of the inuit population of nunavik (arctic quebec) to lead and mercury (48)maternalnutritiondietary assessment of indigenous canadian arctic women with a focus on Pregnancy and Lactation (54)maternalnutritioncontribution of selected traditional and market Foods to the diet of nunavik inuit women (57)maternalbirth outcomes; tobaccomaternal smoking at first Prenatal visit as a MARKER of risk for adverse Pregnancy outcomes in the qikiqtaaluk (baffin) region (8)maternalnutrition; environment/environmental exposuresfish Consumption and Blood Lipids in 3 ethnic groups of quebec (canada) (51)maternalhealth care, policy, Human resources; Birth outcomesconverging epistemologies: CRITICAL ISSUES in canadian inuit Childbirth and Pregnancy (65)maternalenvironment/environmental exposures; nutritiondeterminants of Polychlorinated Biphenyls and Methylmercury exposure in inuit women of Childbearing age (50)maternalhealth care, policy, Human resources; interventions/programmingthe outcome of Perinatal Care in inukjuak, nunavik, canada 1998–2002 (70)maternalhealth care, policy, Human resources; Birth outcomesthe inuulitsivik maternities: culturally appropriate midwifery and epistemological accommodation (66)maternalinfectious disease; interventions/programmingoncogenic human papillomavirus infection and Cervical lesions in aboriginal women in nunavut, canada (94)maternalchronic disease; social determinants of health; tobacco; mental health and Wellbeingthe health of cree, inuit and southern quebec women: similarities and differences (79)maternalnutrition; social DETERMINANTS of health; environment/environmental exposuresfood insecurity among inuit women exacerbated by socioeconomic stresses and climate change (60)children; youthchronic diseasethe RELATIONSHIP between socio-economic and geographic factors and asthma among canada's aboriginal populations (81)children; youthinfectious diseasehospitalization due to pneumonia among innu, inuit and non-aboriginal communities, newfoundland and labrador, canada (24)children; maternalbirth outcomesheart defects and other malformations in the inuit in canada: a baseline study (62)children; maternalbirth outcomesbirth outcomes in the inuit-inhabited areas of canada (95)children; maternalbirth outcomesdegree of rural isolation and Birth outcomes (63)children; maternalbirth outcomesrisks of adverse Pregnancy outcomes among inuit and north american indian women in quebec, 1985–97 (64)children; maternalenvironment/environmental exposuresprenatal exposure to Methylmercury and Pcbs AFFECTS distinct stages of information processing: an event-related POTENTIAL study with inuit children (44)children; maternalenvironment/environmental exposuresthe RELATION of lead neurotoxicity to the event-related potential p3b component in inuit children from arctic quebec (47)children; maternalenvironment/environmental exposuresthyroid hormone levels of Pregnant inuit women and their infants exposed to environmental contaminants (96)children; maternalenvironment/environmental exposuresneuromotor functions in inuit preschool children exposed to Pb, Pcbs, and hg (43)children; maternalenvironment/environmental exposuresbeneficial EFFECTS of a polyunsaturated Fatty Acid on infant development: EVIDENCE from the inuit of arctic quebec (52)children; maternalenvironment/environmental exposuresthe RELATION of environmental contaminants exposure to behavioural indicators in inuit preschoolers in arctic quebec (46)children; maternalinfectious diseaseneonatal Vitamin A deficiency and its IMPACT on acute Respiratory infections among preschool inuit children (33)children; maternalnutritionanaemia and iron status in inuit infants from northern quebec (97)children; maternalbirth outcomes; nutritioncongenital Heart defects in canadian inuit: is more Folic Acid making a difference?"]	[('SUPERFICIAL_RELATIONSHIP', 209), ('SUPERFICIAL_RELATIONSHIP', 230), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1581), ('IMPORTANT_CONSIDERATION', 2342), ('SUPERFICIAL_RELATIONSHIP', 3334), ('IMPORTANT_CONSIDERATION', 3635), ('IMPORTANT_CONSIDERATION', 3644), ('SUPERFICIAL_RELATIONSHIP', 4527), ('SUPERFICIAL_RELATIONSHIP', 4715), ('SUPERFICIAL_RELATIONSHIP', 5499), ('INCOMPLETE_EVIDENCE', 5567), ('SUPERFICIAL_RELATIONSHIP', 5664), ('SUPERFICIAL_RELATIONSHIP', 6139), ('INCOMPLETE_EVIDENCE', 6202), ('SUPERFICIAL_RELATIONSHIP', 6304), ('SUPERFICIAL_RELATIONSHIP', 6495), ('EXPLICIT_QUESTION', 6787)]	18	[('UBERON_0004905', 'articulation', 110, 'lower respiratory tract'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 451, 'D'), ('CHEBI_27300', 'vitamin D', 502, 'vitamin D'), ('GO_0007565', 'female pregnancy', 596, 'prenatal'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 617, 'polychlorinated biphenyls'), ('UBERON_0001004', 'respiratory system', 665, 'respiratory'), ('UBERON_0004905', 'articulation', 1113, 'lower respiratory tract'), ('UBERON_0001004', 'respiratory system', 1272, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 1447, 'human'), ('UBERON_0000104', 'life cycle', 1613, 'life'), ('GO_0007605', 'sensory perception of sound', 1714, 'hearing'), ('CHEBI_27300', 'vitamin D', 1952, 'vitamin A'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 2429, 'sexually transmitted'), ('GO_0007567', 'parturition', 2689, 'birth'), ('UBERON_0002331', 'umbilical cord', 2855, 'umbilical cord'), ('UBERON_0000178', 'blood', 2870, 'blood'), ('UBERON_0001969', 'blood plasma', 2876, 'plasma'), ('GO_0007565', 'female pregnancy', 3119, 'pregnancy'), ('GO_0007595', 'lactation', 3133, 'lactation'), ('CHEBI_33290', 'food', 3212, 'foods'), ('GO_0007565', 'female pregnancy', 3314, 'prenatal'), ('GO_0007565', 'female pregnancy', 3361, 'pregnancy'), ('GO_0007631', 'feeding behavior', 3477, 'consumption'), ('UBERON_0000178', 'blood', 3493, 'blood'), ('CHEBI_18059', 'lipid', 3499, 'lipids'), ('NCBITaxon_9606', 'Homo sapiens', 3577, 'human'), ('GO_0007567', 'parturition', 3594, 'birth'), ('GO_0007623', 'circadian rhythm', 3669, 'childbirth'), ('GO_0007565', 'female pregnancy', 3684, 'pregnancy'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 3768, 'polychlorinated biphenyls'), ('CHEBI_33963', 'metallocene', 3798, 'methylmercury'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 3839, 'childbearing'), ('NCBITaxon_9606', 'Homo sapiens', 3889, 'human'), ('GO_0036356', 'cyclic 2,3-diphosphoglycerate synthetase activity', 3946, 'perinatal care'), ('UBERON_0012101', 'perinatal stage', 3946, 'perinatal'), ('NCBITaxon_9606', 'Homo sapiens', 4033, 'human'), ('GO_0007567', 'parturition', 4050, 'birth'), ('UBERON_0005434', 'cervical region', 4263, 'cervical'), ('GO_0035706', 'T-helper 1 cell chemotaxis', 4406, 'wellbeingThe'), ('GO_0007567', 'parturition', 5248, 'birth'), ('GO_0007565', 'female pregnancy', 5316, 'pregnancy'), ('CHEBI_33963', 'metallocene', 5476, 'methylmercury'), ('CHEBI_26199', 'polyprenol', 5494, 'PCBs'), ('GO_0007565', 'female pregnancy', 5860, 'pregnant'), ('CHEBI_37983', 'sulfur-35 atom', 6054, 'Pb'), ('CHEBI_26199', 'polyprenol', 6058, 'PCBs'), ('CHEBI_35366', 'fatty acid', 6168, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 6466, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 6511, 'respiratory'), ('UBERON_0000948', 'heart', 6716, 'heart'), ('CHEBI_30751', 'formic acid', 6757, 'folic acid')]
PMC3417531	7/2012	S87-PMC3417531	['more RECENTLY, FACTORS that HAVE BEEN ASSOCIATED with lrtis among inuit children are place of residence, lack of breast-feeding (39), reduced ventilation (40,41), neonatal Vitamin A deficiency (33) and above average levels of Organochlorines (42), and Pcbs (25).']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 38)]	4	[('CHEBI_27300', 'vitamin D', 172, 'vitamin A'), ('CHEBI_25805', 'oxygen atom', 226, 'organochlorines'), ('CHEBI_26199', 'polyprenol', 252, 'PCBs')]
PMC3417531	7/2012	S177-PMC3417531	['the FIRST FOUND that while inuit children had a low intake of Calcium per day, calcium absorption APPEARED TO BE more efficient in children with a bb Vitamin D receptor genotype.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 10), ('ANOMALY_CURIOUS_FINDING', 98)]	3	[('CHEBI_22313', 'alkaline earth metal atom', 62, 'calcium'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC3411795	8/2012	S13-PMC3411795	['in particular those Animal MODELS that HAVE BEEN developed specifically to address KNOWN epidemiological risk factors for schizophrenia, such as Prenatal Vitamin D deficiency or Prenatal infection, reveal very early changes in Da Development[9],[10],[11],[12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 83)]	4	[('NCBITaxon_33208', 'Metazoa', 20, 'animal'), ('GO_0007565', 'female pregnancy', 145, 'prenatal'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'prenatal'), ('GO_0060539', 'diaphragm development', 227, 'DA development')]
PMC3424155	8/2012	S10-PMC3424155	['conclusion\nTHESE FINDINGS DEMONSTRATE that maternal Vitamin D deficiency accompanies changes in the Renal Expression of IMPORTANT FACTORS that MAY retard the Maturation Of Glomeruli by EXTENDING the period of Nephrogenesis.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('IMPORTANT_CONSIDERATION', 120), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 185)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002113', 'kidney', 100, 'renal'), ('GO_0010467', 'gene expression', 106, 'expression'), ('GO_0009902', 'chloroplast relocation', 158, 'maturation of glomeruli'), ('UBERON_0000074', 'renal glomerulus', 172, 'glomeruli'), ('GO_0001822', 'kidney development', 209, 'nephrogenesis')]
PMC3424155	8/2012	S16-PMC3424155	['HOWEVER, NEW EVIDENCE SUGGESTS that Vitamin D COULD BE VITAL to normal fetal Development and that Vitamin D restriction in this period MAY AFFECT chronic disease susceptibility post-Natal Life[8].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 139)]	7	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0008289', 'lipid binding', 77, 'development'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007567', 'parturition', 182, 'natal'), ('UBERON_0000104', 'life cycle', 188, 'life')]
PMC3424155	8/2012	S166-PMC3424155	['a RECENT STUDY of Pregnant women in europe REPORTED that ONLY 12% had an OPTIMAL level of Vitamin D[20].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 57), ('IMPORTANT_CONSIDERATION', 73)]	4	[('GO_0007565', 'female pregnancy', 18, 'pregnant'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3424155	8/2012	S171-PMC3424155	['PREVIOUS STUDIES in rodents HAVE SHOWN that the restriction of Vitamin D for a period of six weeks prior to Mating assures Vitamin D deficiency during Pregnancy[13],[22].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007618', 'mating', 108, 'mating'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy')]
PMC3424155	8/2012	S172-PMC3424155	['Vitamin D deficiency during the third Trimester of Pregnancy in Humans HAS BEEN ASSOCIATED with Cardiovascular disease, diabetes and obesity in offspring[23], which COULD BE LINKED to the POTENTIAL ROLE of Vitamin D in the Regulation Of Adiposity[24],[25].']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 165), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 188), ('SUPERFICIAL_RELATIONSHIP', 198), ('SUPERFICIAL_RELATIONSHIP', 223)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0009294', 'DNA mediated transformation', 38, 'trimester'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 64, 'humans'), ('UBERON_0004535', 'cardiovascular system', 96, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0045752', 'positive regulation of Toll signaling pathway', 223, 'regulation of adiposity')]
PMC3424155	8/2012	S173-PMC3424155	['maternal Nutrient restriction causes adiposity in offspring[26], and RECENT DATA SUGGEST that maternal Vitamin D deficiency AFFECTS adiposity, ALTHOUGH the mechanisms are NOT yet FULLY UNDERSTOOD[23].']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 124), ('ANOMALY_CURIOUS_FINDING', 143), ('INCOMPLETE_EVIDENCE', 171)]	5	[('CHEBI_33284', 'nutrient', 9, 'nutrient'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC3424155	8/2012	S179-PMC3424155	['in Rats, it has been OBSERVED that maternal Vitamin D deficiency LEADS to a significant increase in the number of Glomeruli, which is a UNIQUE and IMPORTANT EFFECT of Vitamin D restriction during fetal development[13].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 65), ('ANOMALY_CURIOUS_FINDING', 136), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 114, 'glomeruli'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC3424155	8/2012	S183-PMC3424155	['research SUGGESTS that Vitamin D is IMPORTANT for differentiation and maturation during Cell Proliferation[9]and that it down-regulates Renin Gene Expression in the Kidneys[13].']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 36)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0008283', 'cell proliferation', 88, 'cell proliferation'), ('PR_000014368', 'RuvB-like 1', 136, 'renin'), ('GO_0010467', 'gene expression', 142, 'gene expression'), ('SO_0000704', 'gene', 142, 'gene'), ('UBERON_0002113', 'kidney', 165, 'kidneys')]
PMC3424155	8/2012	S189-PMC3424155	['maternal Vitamin D deficiency MAY also have CONTRIBUTED to an increased number of Glomeruli, THUS producing smaller Glomeruli than in Animals Fed sc.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 44), ('PROBABLE_UNDERSTANDING', 93)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 82, 'glomeruli'), ('UBERON_0000074', 'renal glomerulus', 116, 'glomeruli'), ('NCBITaxon_33208', 'Metazoa', 134, 'animals'), ('GO_0007631', 'feeding behavior', 142, 'fed')]
PMC3424155	8/2012	S208-PMC3424155	['the MAJOR AIM of the study was TO INVESTIGATE Glomerular Development and Renal structure at Birth, 10 days and Adulthood in Mice Born to mothers Fed a diet restricted in Vitamin D. ALTHOUGH, we EXAMINED OTHER variables, such as body mass and 24 h Urine, the PRESENT STUDY was NOT DESIGNED TO investigate Renal functional and Metabolic CONSEQUENCES BUT RATHER was DESIGNED TO answer the QUESTION of WHETHER there were structural, Glomerular alterations or transgenerational EFFECTS.']	[('IMPORTANT_CONSIDERATION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 203), ('QUESTION_ANSWERED_BY_THIS_WORK', 258), ('INCOMPLETE_EVIDENCE', 276), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('QUESTION_ANSWERED_BY_THIS_WORK', 363), ('EXPLICIT_QUESTION', 386), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 398), ('SUPERFICIAL_RELATIONSHIP', 473)]	15	[('GO_0032835', 'glomerulus development', 46, 'glomerular development'), ('UBERON_0000074', 'renal glomerulus', 46, 'glomerular'), ('UBERON_0002113', 'kidney', 73, 'renal'), ('GO_0007567', 'parturition', 92, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 111, 'adulthood'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'mice'), ('GO_0007567', 'parturition', 129, 'born'), ('GO_0007631', 'feeding behavior', 145, 'fed'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('UBERON_0001088', 'urine', 247, 'urine'), ('UBERON_0002113', 'kidney', 304, 'renal'), ('GO_0008152', 'metabolic process', 325, 'metabolic'), ('UBERON_0000074', 'renal glomerulus', 429, 'glomerular')]
PMC3424155	8/2012	S210-PMC3424155	['furthermore, the literature SHOWS SOME RELATIONSHIP between Vitamin D deficiency and Adipose Tissue Development, and OTHER STUDIES SHOULD evaluate such EFFECTS, and the transgenerational EFFECTS.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 39), ('FUTURE_WORK', 117), ('FUTURE_WORK', 131), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 187)]	7	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 85, 'adipose tissue development'), ('UBERON_0001013', 'adipose tissue', 85, 'adipose tissue')]
PMC3424155	8/2012	S211-PMC3424155	['in conclusion, the present FINDINGS provide INSIGHT into the RELATIONSHIP between maternal Vitamin D deficiency and the occurrence of a greater number of Glomeruli in offspring.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 154, 'glomeruli')]
PMC3427250	8/2012	S0-PMC3427250	['high prevalence of Vitamin D deficiency in Pregnant women: a national cross-sectional survey\n\nabstract\nan increasing NUMBER OF STUDIES SUGGEST that Vitamin D deficiency during Pregnancy is ASSOCIATED with multiple adverse health outcomes in mothers, neonates and children.']	[('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 189)]	3	[('CHEBI_28384', 'vitamin K', 19, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 19, 'Vitamin'), ('GO_0007565', 'female pregnancy', 43, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('GO_0007565', 'female pregnancy', 176, 'pregnancy')]
PMC3427250	8/2012	S15-PMC3427250	['the ubiquitous presence of Vitamin D receptors in most Tissues, including the Placenta, SUGGESTS that Vitamin D MAY have OTHER ROLES as well.']	[('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0000479', 'tissue', 55, 'tissues'), ('UBERON_0001987', 'placenta', 78, 'placenta'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC3427250	8/2012	S17-PMC3427250	['in addition, an increasing NUMBER OF STUDIES SUGGEST that Vitamin D deficiency during Pregnancy is ASSOCIATED with multiple adverse health outcomes in mothers (Gestational diabetes and pre-eclampsia), in neonates (wheezing) and children (low bone Mineral density, type-1 diabetes, eczema)[16]–[22].']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('GO_0007565', 'female pregnancy', 160, 'gestational'), ('CHEBI_46662', 'mineral', 247, 'mineral')]
PMC3427250	8/2012	S18-PMC3427250	['HOWEVER there is so far NO CONCLUSIVE EVIDENCE about the causality of these RELATIONSHIPS, as NO randomised controlled TRIALS of Vitamin D supplementation with an appropriate assessment of a VARIETY of health outcomes have been carried out to date[21].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 76), ('FULL_UNKNOWN', 94), ('DIFFICULT_TASK', 191)]	5	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3427250	8/2012	S22-PMC3427250	['due to its longer half-life, 25-(Oh)D IS CONSIDERED the best bio-marker of Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 38)]	1	[('CHEBI_72657', '19,20-DiHDPA', 29, '25-(OH)D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3427250	8/2012	S27-PMC3427250	['the cut-off points used to define Vitamin D insufficiency and deficiency are NOT WELL ESTABLISHED and REMAIN CONTROVERSIAL.']	[('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC3427250	8/2012	S31-PMC3427250	['there is a GROWING CONCERN about the health CONSEQUENCES of the high prevalence of Vitamin D deficiency worldwide among the general population, including Pregnant women.']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 19), ('PROBLEM_COMPLICATION', 44)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant')]
PMC3427250	8/2012	S33-PMC3427250	['ALTHOUGH previous small surveys SUGGEST that Vitamin D deficiency among Pregnant women is common in europe[29],[30], there are NO RELIABLE country-wide estimates of Vitamin D status of Pregnant women in european countries.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 127)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 185, 'pregnant')]
PMC3427250	8/2012	S34-PMC3427250	['THEREFORE the AIM of THIS STUDY was to carry out the FIRST national representative random sample survey on Vitamin D status in Pregnant women in a european country and TO ASSESS the determinants of Vitamin D status in the first and third Trimester of Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 168)]	5	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnant'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 238, 'trimester'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]
PMC3427250	8/2012	S95-PMC3427250	['a previous small study in brussels SUGGESTED that the prevalence of Vitamin D deficiency was high among the Adult population and that immigrants were at greater risk of Vitamin D deficiency[32].']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0007023', 'adult organism', 108, 'adult'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC3427250	8/2012	S96-PMC3427250	['other SMALL-SCALE STUDIES in belgium showed a high prevalence of Vitamin D deficiency among belgian Postmenopausal osteoporotic women[33]and elderly[34].']	[('INCOMPLETE_EVIDENCE', 6)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007595', 'lactation', 100, 'postmenopausal')]
PMC3427250	8/2012	S97-PMC3427250	['however, the PRESENT STUDY is the FIRST national survey on Vitamin D status among Pregnant women in belgium.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 34)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant')]
PMC3427250	8/2012	S98-PMC3427250	['the high prevalence of Vitamin D deficiency in belgium stems from the fact that the contribution of dietary sources to the Vitamin D status is negligible as was shown by the flemish Food Consumption survey among preschoolers which ESTIMATED the mean Vitamin D intake at ONLY 2 µg/day[35].']	[('INCOMPLETE_EVIDENCE', 231), ('ANOMALY_CURIOUS_FINDING', 270)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_33290', 'food', 182, 'food'), ('GO_0007631', 'feeding behavior', 182, 'food consumption'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D')]
PMC3427250	8/2012	S99-PMC3427250	['the prevalence of vitamin deficiency (25-(Oh)D <20 ng/ml) is high in many european countries[36]–[43]and SOME STUDIES SUGGEST that Pregnant women in europe are also at high risk of Vitamin D deficiency[29],[30].']	[('INCOMPLETE_EVIDENCE', 105), ('INCOMPLETE_EVIDENCE', 118)]	2	[('CHEBI_72657', '19,20-DiHDPA', 38, '25-(OH)D'), ('GO_0007565', 'female pregnancy', 131, 'pregnant'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC3427250	8/2012	S102-PMC3427250	['the ASSOCIATION of Vitamin D status with bmi HAS BEEN ATTRIBUTED to an excessive Storage Of Vitamin D in fat Tissue decreasing thereby Serum concentrations[47].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0030730', 'sequestering of triglyceride', 81, 'storage of vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('UBERON_0000479', 'tissue', 109, 'tissue'), ('UBERON_0001977', 'blood serum', 135, 'serum')]
PMC3427250	8/2012	S103-PMC3427250	['ethnicity was also a major DETERMINANT of Vitamin D status in the PRESENT STUDY, as PREVIOUSLY reported in the Adult population[32]and in Pregnant women[29],[48],[49].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 66), ('INCOMPLETE_EVIDENCE', 84)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 138, 'pregnant')]
PMC3427250	8/2012	S111-PMC3427250	['sunscreen Lotions prevent uv radiation from reaching the skin and MIGHT THEREFORE reduce the skin’s Vitamin D production[56].']	[('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 72)]	2	[('CHEBI_75702', 'dU5', 10, 'lotions'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3427250	8/2012	S117-PMC3427250	['SOME studies SUGGEST that the dietary requirement during Pregnancy and Lactation MAY BE as high as 6000 iu/d[59]and recognize that AT LEAST 1500–2000 iu/d of Vitamin D MAY BE NEEDED in order to maintain a Blood level of 25(Oh)D above 30 ng/ml[24].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 81), ('PROBABLE_UNDERSTANDING', 131), ('INCOMPLETE_EVIDENCE', 168), ('FUTURE_WORK', 175)]	6	[('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('GO_0007595', 'lactation', 71, 'lactation'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0000178', 'blood', 205, 'blood'), ('CHEBI_71657', 'versiconol acetate', 220, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25(OH)D')]
PMC3427250	8/2012	S118-PMC3427250	['as those authors recognize that the EVIDENCE to propose such Intakes IS SCARCE and as long as the health benefits of having Serum 25(Oh)D levels higher than 30 ng/ml are NOT clearly ESTABLISHED particularly in Pregnant women, the belgian superior health council STILL RECOMMENDS a Vitamin D supplement of 20 µg/day or 800 iu during Pregnancy[58].']	[('INCOMPLETE_EVIDENCE', 36), ('FULL_UNKNOWN', 170), ('IMPORTANT_CONSIDERATION', 262), ('FUTURE_WORK', 268)]	4	[('GO_0007631', 'feeding behavior', 61, 'intakes'), ('UBERON_0001977', 'blood serum', 124, 'serum'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 132, '(OH ... D'), ('GO_0007565', 'female pregnancy', 210, 'pregnant'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('GO_0007565', 'female pregnancy', 332, 'pregnancy')]
PMC3427250	8/2012	S119-PMC3427250	['HOWEVER, the Vitamin D content of multivitamins for Pregnant women in belgium is ONLY 400 iu INDICATING EVEN this RECOMMENDATION is not followed as Pregnant women only take one Multivitamin pill a day.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 81), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 104), ('FUTURE_WORK', 114)]	5	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant'), ('GO_0007565', 'female pregnancy', 148, 'pregnant'), ('CHEBI_7025', 'mupirocin', 177, 'multivitamin')]
PMC3427250	8/2012	S122-PMC3427250	['in addition to the UNCERTAINTY CONCERNING the optimal Vitamin D intakes preventing Vitamin D deficiency, there exists also a LACK OF RECOMMENDATIONS to treat Vitamin D deficient Pregnant women.']	[('FULL_UNKNOWN', 19), ('PROBLEM_COMPLICATION', 31), ('INCOMPLETE_EVIDENCE', 125), ('FUTURE_WORK', 133)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnant')]
PMC3427250	8/2012	S123-PMC3427250	['EVEN in the last published guidelines the treatment of Vitamin D deficient women is NOT SPECIFICALLY discussed[24].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 84)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3427250	8/2012	S124-PMC3427250	['the UNCOVERING of the magnitude of Vitamin D deficiency in Pregnant women in belgium (and western europe) SHOULD BE translated into NEW RESEARCH in order to fill the huge KNOWLEDGE GAP CONCERNING the adequate amount of Vitamin D to prevent and treat Vitamin D deficient Pregnant women.']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_WORK', 106), ('INCOMPLETE_EVIDENCE', 132), ('FULL_UNKNOWN', 171), ('PROBLEM_COMPLICATION', 185)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('GO_0007565', 'female pregnancy', 270, 'pregnant')]
PMC3427250	8/2012	S125-PMC3427250	['in addition, an increasing NUMBER OF STUDIES SUGGEST that Gestational Vitamin D deficiency is ASSOCIATED with multiple adverse health outcomes in mothers and children[16]–[22].']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('GO_0007565', 'female pregnancy', 58, 'gestational'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC3427250	8/2012	S129-PMC3427250	['UNTIL the adequate treatment of Vitamin D deficient Pregnant women is established, a safe approach MAY BE to correct Vitamin D deficiency by TARGETING Pregnant women at high risk of severe Vitamin D deficiency.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 99), ('FUTURE_WORK', 141)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnant'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
PMC3427250	8/2012	S133-PMC3427250	['WHILE several observational studies POINT to CORRELATIONS between Vitamin D insufficiency and maternal and neonatal ill health, EXPERIMENTAL EVIDENCE from supplementation clinical trials IS NEEDED to inform health policy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 128), ('FUTURE_WORK', 187)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3432839	8/2012	S24-PMC3432839	['HOWEVER, they MAY BE an INDICATOR of increased risk of arthritis in Adulthood, SINCE it HAS BEEN SHOWN that children with Limb pains are more LIKELY to have parents and/or grandparents with a history of arthritis COMPARED TO the general population.1among SMALL STUDIES of selected groups of children, recurrent Limb pains HAVE BEEN REPORTED to be PARTICULARLY PREVALENT in obese children,4and in those with some Vitamin D deficiency,5THOUGH this WAS NOT FOUND in a SMALL STUDY in new mexico.6other POSSIBILITIES HAVE BEEN summarised by evans and scutter.7\nAdult arthritis HAS long BEEN CONSIDERED to be a condition that COULD BE ameliorated or prevented by dietary manipulation, with SUGGESTIONS of different components of the diet being IMPORTANT—particularly Ω-3 Fatty Acids.8TO OUR KNOWLEDGE the ONLY specific dietary factor that has BEEN CONSIDERED in regard to childhood Limb pain concerns a study of 532 greek children aged 4–12.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 79), ('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 322), ('INCOMPLETE_EVIDENCE', 332), ('ANOMALY_CURIOUS_FINDING', 347), ('IMPORTANT_CONSIDERATION', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 433), ('INCOMPLETE_EVIDENCE', 446), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 454), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 572), ('INCOMPLETE_EVIDENCE', 586), ('INCOMPLETE_EVIDENCE', 620), ('INCOMPLETE_EVIDENCE', 684), ('IMPORTANT_CONSIDERATION', 738), ('PROBABLE_UNDERSTANDING', 777), ('INCOMPLETE_EVIDENCE', 799), ('ANOMALY_CURIOUS_FINDING', 837), ('INCOMPLETE_EVIDENCE', 842)]	27	[('UBERON_0000113', 'post-juvenile adult stage', 68, 'adulthood'), ('UBERON_0002101', 'limb', 122, 'limb'), ('UBERON_0002101', 'limb', 311, 'limb'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin D'), ('UBERON_0007023', 'adult organism', 556, 'Adult'), ('CHEBI_18320', '1,4-dithiothreitol', 761, 'ω-3'), ('CHEBI_35366', 'fatty acid', 765, 'fatty acids'), ('UBERON_0002101', 'limb', 876, 'limb')]
PMC3472720	8/2012	S0-PMC3472720	['Prenatal Vitamin D deficiency INDUCES an early and more SEVERE experimental Autoimmune encephalomyelitis in the second generation\n\nabstract\nin a PREVIOUS STUDY, we DEMONSTRATED that Mouse Adult f1offspring, exposed to a Vitamin D deficiency during Pregnancy, developed a less SEVERE and delayed experimental Autoimmune encephalomyelitis (eae), when compared with control offspring.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 56), ('INCOMPLETE_EVIDENCE', 145), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 276)]	5	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0005445', 'segment of pes', 76, 'Autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 182, 'mouse'), ('UBERON_0007023', 'adult organism', 188, 'adult'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy'), ('UBERON_0005445', 'segment of pes', 308, 'Autoimmune')]
PMC3472720	8/2012	S3-PMC3472720	['UNEXPECTEDLY, we OBSERVED that the Vitamin D deficiency AFFECTING the f0pregnant Mice induced a precocious and more SEVERE eae in the f2generation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 116)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 81, 'mice')]
PMC3472720	8/2012	S5-PMC3472720	['using the refgensep database for ms trios (the patient and his/her parents), we collected the parents’ dates of Birth and assessed a potential season of Birth EFFECT that COULD POTENTIALLY be indicative of the Vitamin D status of the Pregnant grandmothers.']	[('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 177)]	3	[('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007567', 'parturition', 153, 'birth'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007565', 'female pregnancy', 234, 'pregnant')]
PMC3472720	8/2012	S11-PMC3472720	['this season of Birth EFFECT, combined with an OBSERVED latitude gradient in incidence (higher risk at higher latitude) [10], SUGGEST that an environmental FACTOR, POSSIBLY Vitamin D exposure, MAY BE IMPORTANT in PREDICTING ms risk.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 192), ('IMPORTANT_CONSIDERATION', 199), ('SUPERFICIAL_RELATIONSHIP', 212)]	8	[('GO_0007567', 'parturition', 15, 'birth'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC3472720	8/2012	S12-PMC3472720	['IN ORDER TO TEST the HYPOTHESIS that low Vitamin D status during Gestation is a RISK FACTOR for ms, we explored a well-DESCRIBED developmental Vitamin D (dvd) deficiency Rodent MODEL, [11,12].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 177)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestation'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 170, 'rodent')]
PMC3472720	8/2012	S13-PMC3472720	['in this MODEL, the Vitamin D deficiency experienced by the offspring is restored by the 1st week of Life, therefore the MODEL is not associated with any abnormal Bone Development and calcium and pth levels in the Adult offspring are normal [13].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 120)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('GO_0048539', 'bone marrow development', 162, 'bone development'), ('UBERON_0007023', 'adult organism', 213, 'adult')]
PMC3472720	8/2012	S19-PMC3472720	['CURIOUSLY, deluca and plum [16] have DEMONSTRATED that prolonged Vitamin D deficiency, maintained for two generations, also diminished the severity and delayed the onset of eae in b10pl Mice.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 37)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 186, 'mice')]
PMC3472720	8/2012	S29-PMC3472720	['PARADOXICALLY, we OBSERVED that the Vitamin D deficiency AFFECTING the f0pregnant Mice induced a precocious and more SEVERE eae in the f2generation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 117)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 82, 'mice')]
PMC3472720	8/2012	S31-PMC3472720	['the QUESTION we have ADDRESSED was WHETHER one’s parents’ season of Birth (AS a PROXY-measure of developmental Vitamin D status) COULD BE an additional RISK FACTOR for ms patients?']	[('EXPLICIT_QUESTION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('EXPLICIT_QUESTION', 35), ('PROBABLE_UNDERSTANDING', 75), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 152), ('EXPLICIT_QUESTION', 179)]	9	[('GO_0007567', 'parturition', 68, 'birth'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 119, 'D')]
PMC3472720	8/2012	S32-PMC3472720	['using the refgensep database for ms trios (the patient and his/her parents), we collected the parents’ dates of Birth and assessed a potential season of Birth EFFECT that COULD POTENTIALLY be indicative of the Vitamin D status of the Pregnant grandmothers.']	[('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 177)]	3	[('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007567', 'parturition', 153, 'birth'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007565', 'female pregnancy', 234, 'pregnant')]
PMC3472720	8/2012	S41-PMC3472720	['in a PREVIOUS experiment, we DEMONSTRATED that a Prenatal Vitamin D deficiency induces a milder and delayed eae in the f1generation [14].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 29)]	2	[('GO_0007565', 'female pregnancy', 49, 'prenatal'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC3472720	8/2012	S52-PMC3472720	['among the current CANDIDATES, we can cite mir-22 that is induced by Vitamin D and acts as an antiproliferative and antimigratory agent in cancer cells [21] or mir-125B that Regulates the Expression of Human Vitamin D receptor and abolishes the anti-proliferative action of Calcitriol [22].']	[('INCOMPLETE_EVIDENCE', 18)]	1	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('PR_000000035', 'BMP receptor type-1A', 162, '-125b'), ('GO_0065007', 'biological regulation', 173, 'regulates'), ('GO_0010467', 'gene expression', 187, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 201, 'human'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 215, 'D'), ('CHEBI_17823', 'calcitriol', 273, 'calcitriol')]
PMC3472720	8/2012	S53-PMC3472720	['NONETHELESS, to date, NOT a single study has yet DEMONSTRATED a Pirna- or a Mirna-ASSOCIATED action of Vitamin D on the Immune or the Nervous system.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('SO_0001035', 'piRNA', 64, 'piRNA'), ('SO_0000276', 'miRNA', 76, 'miRNA'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('UBERON_0001016', 'nervous system', 134, 'nervous')]
PMC3472720	8/2012	S54-PMC3472720	['we PREVIOUSLY DEMONSTRATED that a Postnatal Vitamin D supplementation reduced the severity of eae and delayed the onset of symptoms [15].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 14)]	2	[('GO_0007567', 'parturition', 34, 'postnatal'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC3472720	8/2012	S69-PMC3472720	['it is THEREFORE LIKELY that his/her Immune and Nervous Systems BENEFITED from Vitamin D’s WELL-DESCRIBED anti-inflammatory actions [23].']	[('PROBABLE_UNDERSTANDING', 6), ('PROBABLE_UNDERSTANDING', 16), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 90), ('INCOMPLETE_EVIDENCE', 95)]	5	[('UBERON_0002405', 'immune system', 36, 'immune'), ('UBERON_0001016', 'nervous system', 47, 'nervous systems'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3472720	8/2012	S105-PMC3472720	['conclusions\nwe SHOW HERE for the FIRST TIME that a maternal Vitamin D deficiency induces inverted transgenerational EFFECTS on the Immune System of offspring: the f2generation is more sensitive to Myelin peptide immunization WHILE, as PREVIOUSLY DEMONSTRATED, the f1generation is less sensitive.']	[('INCOMPLETE_EVIDENCE', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('INCOMPLETE_EVIDENCE', 235)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002405', 'immune system', 131, 'immune system'), ('UBERON_0000345', 'myelin', 197, 'myelin')]
PMC3472720	8/2012	S110-PMC3472720	['IN LINE WITH our Animal study, we predicted that parents developing in a Vitamin D poor environment during the third Trimester of Pregnancy, in other words those born in spring, will be at higher risk of Giving Birth to ms Individuals.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('NCBITaxon_33208', 'Metazoa', 17, 'animal'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 117, 'trimester'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('GO_0040007', 'growth', 204, 'giving'), ('GO_0007567', 'parturition', 211, 'birth'), ('NCBITaxon_1', 'root', 223, 'individuals')]
PMC3472720	8/2012	S112-PMC3472720	['HOWEVER, we FOUND that parents developing in a supposedly Vitamin D rich environment ( i.e.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC3476426	8/2012	S0-PMC3476426	['reduced Serum concentrations of 25-Hydroxy Vitamin D in children with autism: RELATION to autoimmunity\n\nabstract\n\nbackground\naside from the Skeletal health affection, Vitamin D deficiency has BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering for SOME Autoimmune disorders.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('ANOMALY_CURIOUS_FINDING', 192), ('SUPERFICIAL_RELATIONSHIP', 197), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 237), ('INCOMPLETE_EVIDENCE', 259)]	6	[('UBERON_0001977', 'blood serum', 8, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 32, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0004288', 'skeleton', 140, 'skeletal'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 264, 'autoimmune')]
PMC3476426	8/2012	S2-PMC3476426	['immunomodulatory EFFECTS of Vitamin D MAY act NOT ONLY through Modulation of T-Helper Cell function, BUT ALSO through induction of Cd4+Cd25Highregulatory T-Cells.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 38), ('ANOMALY_CURIOUS_FINDING', 46), ('ANOMALY_CURIOUS_FINDING', 101)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0065007', 'biological regulation', 63, 'modulation'), ('CL_0000912', 'helper T cell', 77, 'T-helper cell'), ('PR_000001204', 'C-C chemokine receptor type 8', 131, 'CD4'), ('PR_000005166', 'CMRF35-like molecule 7', 135, 'CD25highregulatory'), ('CL_0000084', 'T cell', 154, 'T-cells')]
PMC3476426	8/2012	S11-PMC3476426	['HOWEVER, FUTURE STUDIES looking at a POTENTIAL ROLE of Vitamin D in the pathophysiology and treatment of autism ARE WARRANTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_WORK', 112)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3476426	8/2012	S19-PMC3476426	['a ROLE for Vitamin D in the Regulation Of Immune function was FIRST PROPOSED after the identification of Vitamin D receptors in Lymphocytes.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 68)]	4	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0006883', 'cellular sodium ion homeostasis', 28, 'regulation of immune'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CL_0000542', 'lymphocyte', 128, 'lymphocytes')]
PMC3476426	8/2012	S21-PMC3476426	['there is a GROWING BODY of LITERATURE LINKING Vitamin D to various Immune-related conditions, including allergy and autoimmunity [4].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002405', 'immune system', 67, 'immune')]
PMC3476426	8/2012	S22-PMC3476426	['RECENTLY, Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders, including multiple sclerosis (ms) and systemic lupus erythematosus (sle) [5-7].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 103, 'autoimmune')]
PMC3476426	8/2012	S50-PMC3476426	['ACCORDING TO current recommendations, Serum 25-Hydroxy Vitamin D levels < 30 and < 10 ng/ml were DEFINED AS Vitamin D insufficiency and Vitamin D deficiency, respectively, WHILE levels > 30 ng/ml were defined as Vitamin D sufficiency [25].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	4	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 44, '25-hydroxy vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC3476426	8/2012	S91-PMC3476426	['RECENTLY, Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders [5,6].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 103, 'autoimmune')]
PMC3476426	8/2012	S95-PMC3476426	['SOME investigators REPORTED reduced Serum 25-Hydrox Vitamin D in autistic children.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19)]	2	[('UBERON_0001977', 'blood serum', 36, 'serum'), ('CHEBI_38264', '2-amino-3-methylpentanoic acid', 42, '25-hydrox'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC3476426	8/2012	S96-PMC3476426	['THESE STUDIES COULD classify them as being ‘Vitamin D INADEQUATE’, which LENDS SUPPORT to the HYPOTHESIS that autism is a Vitamin D deficiency disorder [31,32].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 54), ('PROBABLE_UNDERSTANDING', 73), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 94)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC3476426	8/2012	S99-PMC3476426	['Genetic polymorphisms of Cytochrome P450 enzymes HAVE also BEEN LINKED to autism, specifically Cyp27B1 that is ESSENTIAL for proper Vitamin D Metabolism.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 64), ('IMPORTANT_CONSIDERATION', 111)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_38557', 'cytochrome c2', 25, 'cytochrome P450'), ('PR_000006101', 'cytochrome P450 1A1', 95, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 132, 'vitamin D metabolism')]
PMC3476426	8/2012	S100-PMC3476426	['three NOVEL structural variants of the Vitamin D Receptor were REPORTED in psychiatric disease [33].']	[('FULL_UNKNOWN', 6), ('INCOMPLETE_EVIDENCE', 63)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 39, 'vitamin D receptor')]
PMC3476426	8/2012	S102-PMC3476426	['in the PRESENT WORK, Serum 25-Hydroxy Vitamin D levels had significant negative CORRELATIONS with cars ( p< 0.001) which signifies the POSSIBLE LINK between the extent of Vitamin D deficiency and the degree of the severity of autism.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 144)]	4	[('UBERON_0001977', 'blood serum', 21, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 27, '25-hydroxy vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC3476426	8/2012	S106-PMC3476426	['THUS, Vitamin D deficiency MAY CONTRIBUTE to higher mutation rates and impaired Repair Of Dna [35] AS a result of increased oxidative stress which was REPORTED in some autistic children [22].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('PROBABLE_UNDERSTANDING', 99), ('INCOMPLETE_EVIDENCE', 151)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0006281', 'DNA repair', 80, 'repair of DNA')]
PMC3476426	8/2012	S108-PMC3476426	['maternal Vitamin D deficiency MAY BE a risk factor for autism, POSSIBLY by AFFECTING fetal Brain Development as well as by AFFECTING maternal Immune System status during Pregnancy [37,38].']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 123)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007420', 'brain development', 91, 'brain development'), ('UBERON_0000955', 'brain', 91, 'brain'), ('UBERON_0002405', 'immune system', 142, 'immune system'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC3476426	8/2012	S115-PMC3476426	['THUS, the results of OUR STUDY DID NOT signify the reduced duration of sun exposure AS a causal factor of 25 Hydroxy Vitamin D deficiency in autistic children.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 31), ('PROBABLE_UNDERSTANDING', 84)]	4	[('CHEBI_45557', 'sec-butyl group', 106, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3476426	8/2012	S128-PMC3476426	['Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders SUGGESTING that Vitamin D MIGHT play a ROLE in Regulating auto-Antibody production [5,6].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 153)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001442', 'skeleton of manus', 93, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0065007', 'biological regulation', 161, 'regulating'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'antibody')]
PMC3476426	8/2012	S131-PMC3476426	['we could NOT trace data in the literature concerning the POSSIBLE contributing ROLE of 25-Hydroxy Vitamin D deficiency in the induction of the production of Brain-specific auto-Antibodies in SOME autistic children to compare our results.']	[('ANOMALY_CURIOUS_FINDING', 9), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 191)]	4	[('CHEBI_43141', '3-hydroxypropoxy group', 87, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0000955', 'brain', 157, 'brain'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'antibodies')]
PMC3476426	8/2012	S133-PMC3476426	['in Animal MODELS, an increased th2 response to Vitamin D HAS BEEN ACCOMPANIED by increase in anti-inflammatory Il-10 response [43].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 111, 'IL-10')]
PMC3476426	8/2012	S134-PMC3476426	['immunomodulatory effect of Vitamin D MAY act NOT ONLY through Modulation of Helper T Cell function, BUT ALSO through induction of Cd4+Cd25Highregulatory T-Cells (Tregs) [44].']	[('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 45), ('ANOMALY_CURIOUS_FINDING', 100)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'modulation'), ('CL_0000912', 'helper T cell', 76, 'helper T cell'), ('PR_000001204', 'C-C chemokine receptor type 8', 130, 'CD4'), ('PR_000005166', 'CMRF35-like molecule 7', 134, 'CD25highregulatory'), ('CL_0000084', 'T cell', 153, 'T-cells'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 162, 'Tregs')]
PMC3476426	8/2012	S138-PMC3476426	['THUS, Vitamin D deficiency MAY BE a CONTRIBUTING FACTOR to the production of Brain-specific auto-Antibodies AS a result of deficiency of Tregs in some autistic children.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 36), ('PROBABLE_UNDERSTANDING', 108)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0000955', 'brain', 77, 'brain'), ('GO_0042571', 'immunoglobulin complex, circulating', 97, 'antibodies'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 137, 'Tregs')]
PMC3476426	8/2012	S141-PMC3476426	['the Vitamin D THEORY of autism DOES NOT DIMINISH Genetic CONTRIBUTIONS to autism occurrence.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('SO_0000704', 'gene', 49, 'genetic')]
PMC3476426	8/2012	S142-PMC3476426	['indeed, without the Genetic TENDENCY for autism, SEVERE maternal or early childhood Vitamin D deficiency MAY cause bone abnormalities with no EVIDENCE autism.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 105), ('INCOMPLETE_EVIDENCE', 142)]	4	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC3476426	8/2012	S143-PMC3476426	['maternal and early childhood Vitamin D deficiency MAY allow the Genetic TENDENCY for autism to Express itself.']	[('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('SO_0000704', 'gene', 64, 'genetic'), ('GO_0010467', 'gene expression', 95, 'express')]
PMC3476426	8/2012	S145-PMC3476426	['basic, Genetic, and epidemiological studies INDICATE a POTENTIAL ROLE of Vitamin D in the PREVENTION of Autoimmune diseases, BUT randomized and controlled TRIALS ARE NECESSARY to establish the clinical efficacy of Vitamin D supplementation in ill or at-RISK subjects [48].']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125), ('FUTURE_WORK', 155), ('FUTURE_WORK', 166), ('IMPORTANT_CONSIDERATION', 166), ('IMPORTANT_CONSIDERATION', 253)]	9	[('SO_0000704', 'gene', 7, 'genetic'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 104, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3476426	8/2012	S150-PMC3476426	['HOWEVER, FUTURE STUDIES looking at a POTENTIAL ROLE of Vitamin D in the pathophysiology and treatment of autism ARE WARRANTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_WORK', 112)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3458940	9/2012	S20-PMC3458940	['EVEN mild Gestational Vitamin A deficiency LEADS to a deficit in Nephron number, which MAY predispose the Kidney to abnormal development or function when ASSOCIATED with other morbidities[8].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 154)]	4	[('GO_0007565', 'female pregnancy', 10, 'gestational'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('UBERON_0001285', 'nephron', 65, 'nephron'), ('UBERON_0002113', 'kidney', 106, 'kidney')]
PMC3458940	9/2012	S159-PMC3458940	['moreover, post-Natal Vitamin A deficiency HAS BEEN ASSOCIATED with Renal anomalies, including increased incidence of pyelonephritis, Kidney inflammation and fibrosis, polyuria and Dysregulated Urinary Ion/solute content, urolithiasis, and delayed Tissue Repair[7],[41],[42],[43],[44].']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('GO_0007567', 'parturition', 15, 'natal'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('UBERON_0002113', 'kidney', 67, 'renal'), ('UBERON_0002113', 'kidney', 133, 'kidney'), ('GO_0060203', 'clathrin-sculpted glutamate transport vesicle membrane', 180, 'dysregulated'), ('UBERON_0001088', 'urine', 193, 'urinary'), ('CHEBI_24870', 'ion', 201, 'ion'), ('UBERON_0000479', 'tissue', 247, 'tissue'), ('GO_0006281', 'DNA repair', 254, 'repair')]
PMC3458940	9/2012	S160-PMC3458940	['THUS, the ROLES for the tra/rar target Genes IDENTIFIED in THIS STUDY in the aforementioned Renal anomalies ASSOCIATED to post-Natal Vitamin A deficiency DESERVE FURTHER studies.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('SUPERFICIAL_RELATIONSHIP', 108), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 154), ('FUTURE_WORK', 162)]	8	[('SO_0000704', 'gene', 39, 'genes'), ('UBERON_0002113', 'kidney', 92, 'renal'), ('GO_0007567', 'parturition', 127, 'natal'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A')]
PMC3470091	9/2012	S15-PMC3470091	['these changes occur ACCORDING TO the needs for the mineralization of the fetus Bones as well as adequate secretion of Vitamin D in mother’s Milk.1\nDUE TO rapid fetal development, PARTICULARLY bone Calcification at the terminal stages of Pregnancy, there is a POSSIBILITY of Vitamin D deficiency to occur in mothers.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('PROBABLE_UNDERSTANDING', 147), ('IMPORTANT_CONSIDERATION', 179), ('INCOMPLETE_EVIDENCE', 259)]	4	[('UBERON_0001474', 'bone element', 79, 'bones'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0001913', 'milk', 140, 'milk'), ('GO_0051301', 'cell division', 197, 'calcification'), ('GO_0007565', 'female pregnancy', 237, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC3470091	9/2012	S17-PMC3470091	['studies have INDICATED that during Pregnancy Vitamin D deficiency varies from 18% to 84%, which varies with the region under the study and type of clothing.2,3vitamin d deficiency among Breast-Fed children in the regions with heavy sunshine such as the middle east is high.3-5this hypovitaminosis which is DUE TO limited exposure to sun of mothers’ and their babies as well as low Vitamin D intake by mothers.']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 306)]	2	[('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007567', 'parturition', 186, 'breast'), ('UBERON_0000310', 'breast', 186, 'breast'), ('GO_0007631', 'feeding behavior', 193, 'fed'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D')]
PMC3470091	9/2012	S18-PMC3470091	['these CAN cause Vitamin D deficiency in mothers’ Milk as the only source of Vitamin D for babies.6\nthere are EVIDENCES SHOWING the ROLE of Vitamin D in keeping normal Glucose Homeostasis.7-10resistance to Insulin and destruction of Insulin secretion in Human and Animal MODELS has CONSIDERABLY been RELATED to Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 270), ('ANOMALY_CURIOUS_FINDING', 281), ('SUPERFICIAL_RELATIONSHIP', 299)]	7	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001913', 'milk', 49, 'milk'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_17234', 'glucose', 167, 'glucose'), ('GO_0042593', 'glucose homeostasis', 167, 'glucose homeostasis'), ('PR_000045358', 'insulin family protein', 205, 'insulin'), ('PR_000045358', 'insulin family protein', 232, 'insulin'), ('NCBITaxon_9606', 'Homo sapiens', 253, 'human'), ('NCBITaxon_33208', 'Metazoa', 263, 'animal'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D')]
PMC3470091	9/2012	S19-PMC3470091	['such a RELATION HAS BEEN ATTRIBUTED to special receptors for Vitamin D in Pancreatic Betacells.9moreover, Vitamin D WAS SHOWN to have positive EFFECTS on Insulin sensitivity, and its deficiency to have negative EFFECTS on the function of Betacells.11IN AGREEMENT with this, cohort studies REVEALED that Vitamin D had a PROTECTIVE EFFECT against diabetes type Ii.8,11also, Serum concentration of Vitamin D during 24-29thweek of Pregnancy in women suffering from Gestational diabetes mellitus (gdm) was lower than that in women without the disease.12\nthe study of Vitamin D status and improving it in the Lactating mothers with previous gdm is of CONSPICUOUS VALUE.4,13\ndue to the limited exposure to sunshine and inadequate Intake, the level of Vitamin D is reduced in the milk of Lactating mothers.']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 143), ('SUPERFICIAL_RELATIONSHIP', 211), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 289), ('SUPERFICIAL_RELATIONSHIP', 319), ('SUPERFICIAL_RELATIONSHIP', 330), ('IMPORTANT_CONSIDERATION', 645)]	11	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CL_0000169', 'type B pancreatic cell', 74, 'pancreatic betacells'), ('UBERON_0001264', 'pancreas', 74, 'pancreatic'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('PR_000045358', 'insulin family protein', 154, 'insulin'), ('CL_0000365', 'animal zygote', 238, 'betacells'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CL_0002212', 'type II muscle cell', 359, 'II'), ('UBERON_0001977', 'blood serum', 372, 'serum'), ('CHEBI_27300', 'vitamin D', 395, 'vitamin D'), ('GO_0007565', 'female pregnancy', 427, 'pregnancy'), ('GO_0007565', 'female pregnancy', 461, 'gestational'), ('CHEBI_27300', 'vitamin D', 562, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 603, 'lactating'), ('GO_0007631', 'feeding behavior', 723, 'intake'), ('CHEBI_27300', 'vitamin D', 744, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 780, 'lactating')]
PMC3470091	9/2012	S20-PMC3470091	['THEREFORE, Vitamin D supplementation in high doses HAS BEEN RECOMMENDED, and oral doses of 20000 or 40000 iu were ASSOCIATED with positive outcomes.6,14moreover, higher oral dose of (6400 iu per day) to Lactating mothers significantly increased Vitamin D status in mothers as well as the Vitamin D content and antirachitic activity of their Milk.14THEREFORE, high doses of Vitamin D, EITHER orally OR through injection, HAS RECENTLY BEEN RECOMMENDED.15-24\na single dose of Vitamin D, administered parenterally, WOULD BE more EFFECTIVE, BECAUSE it is not associated with the NONCOMPLIANCE ASSOCIATED with an oral dose.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 51), ('FUTURE_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 384), ('INCOMPLETE_EVIDENCE', 420), ('FUTURE_WORK', 438), ('FUTURE_PREDICTION', 511), ('SUPERFICIAL_RELATIONSHIP', 525), ('PROBLEM_COMPLICATION', 536), ('PROBLEM_COMPLICATION', 574), ('SUPERFICIAL_RELATIONSHIP', 588)]	13	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 203, 'lactating'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin D'), ('UBERON_0001913', 'milk', 341, 'milk'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D')]
PMC3470091	9/2012	S67-PMC3470091	['caption (table-wrap): table 3:\n\nthe number and (percentage) frequency distribution of Vitamin D status in the intervention group (ig) and control group (cg) before and after interventiongroupsvitamin D status (nmol/l)igcgbeforeafterbeforeaftersevere deficient (<12.5)0000moderate deficient (12.5-24.9)15(62.5%)09(42.9%)10(47.6%)mild deficient (25-34.9)4(16.7%)1(4.2%)7(33.3%)3(14.3%)optimal (>35)5(20.8%)23(95.8%)4(19%)6(28.6%)\n\ndiscussion\nif Vitamin D deficiency is DEFINED as Serum concentration of 25(Oh) Vitamin D3 lower than 35 nmol/l,12ABOUT 80% of the mothers with gdm in the present study were suffering to some degrees from Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 467), ('INCOMPLETE_EVIDENCE', 542)]	2	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 200, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 200, 'D'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D'), ('UBERON_0001977', 'blood serum', 478, 'serum'), ('CHEBI_30778', 'gallic acid', 501, '25(OH)'), ('CHEBI_33279', 'vitamin D5', 508, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 508, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 633, 'vitamin D')]
PMC3470091	9/2012	S69-PMC3470091	['this INDICATES the efficacy of THIS procedure in dramatic improvement of Vitamin D status in the mothers, especially in the region with high Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 31)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3470091	9/2012	S72-PMC3470091	['in this study, the median concentration of the Serum Vitamin D in the ig raised from 24.25 to 62.10 nmol/l, which is IN LINE WITH a recent survey carried out by restorff et al.26on 33 rheumatoid arthritic patients.']	[('INCOMPLETE_EVIDENCE', 117)]	1	[('UBERON_0001977', 'blood serum', 47, 'serum'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC3470091	9/2012	S73-PMC3470091	['they SHOWED that supplementation with an oral dose of 300,000 iu of Vitamin D and 500-1000 mg daily of Calcium LED TO an increase in the concentration of Serum Vitamin D from 15 to 81.4 nmol/l.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 111)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 103, 'calcium'), ('UBERON_0001977', 'blood serum', 154, 'serum'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC3470091	9/2012	S77-PMC3470091	['such a change results in the inhibition of pth secretion from Parathyroid Cells.27\nthe increase of Serum calcium in the ig in the PRESENT STUDY is SIMILAR TO that REPORTED in the OTHER STUDIES.15,17-20,22-25,27,28the mechanism of increasing Serum Calcium by Vitamin D is that Vitamin D attaches optionally to receptors X Of Retinoic Acid (rxr), and composes a heteromeric Complex with a certain sequence on the dna, known as reacting elements to Vitamin D. this LEADS to the transcription of a special mrna, which results in the Translation Of several Proteins such as Epithelial calcium channels and the proteins attached to calcium.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 130), ('INCOMPLETE_EVIDENCE', 147), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 462)]	5	[('CL_0000512', 'paracrine cell', 62, 'parathyroid cells'), ('UBERON_0001132', 'parathyroid gland', 62, 'parathyroid'), ('UBERON_0001977', 'blood serum', 99, 'serum'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 247, 'calcium'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('CHEBI_30341', 'silver monochloride', 319, 'X of'), ('GO_0000805', 'X chromosome', 319, 'X'), ('CHEBI_26536', 'retinoic acid', 324, 'retinoic acid'), ('GO_0032991', 'protein-containing complex', 372, 'complex'), ('CHEBI_27300', 'vitamin D', 446, 'vitamin D'), ('GO_0006415', 'translational termination', 529, 'translation of ... proteins'), ('UBERON_0000483', 'epithelium', 569, 'epithelial')]
PMC3470091	9/2012	S78-PMC3470091	['this results in the increase of calcium absorption from the Intestine.27\nPREVIOUS STUDIES,17,27of intramuscular injection of 600,000 unit of Vitamin D was ASSOCIATED with significant increases of Serum Vitamin D at 1.5, 3, and 6 months, BUT NOT significant at 9 and 12 months later.']	[('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 155), ('ANOMALY_CURIOUS_FINDING', 237)]	3	[('UBERON_0000160', 'intestine', 60, 'intestine'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('UBERON_0001977', 'blood serum', 196, 'serum'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC3470091	9/2012	S80-PMC3470091	['in ANOTHER STUDY,15administration of 600,000 iu of Vitamin D was ASSOCIATED with a significant increase in Serum Vitamin D, a significant decrease in Serum pth, and hypercalcemia occurring in 4% of the subjects during 4 and 12 months of intervention.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0001977', 'blood serum', 107, 'serum'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0001977', 'blood serum', 150, 'serum')]
PMC3470091	9/2012	S82-PMC3470091	['a RECENT STUDY,21has INDICATED that administrating a high dose of Vitamin D every two months was an easy and comfortable treatment.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 21)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3470091	9/2012	S84-PMC3470091	['OUR STUDY REVEALED that a single high dose injection of Vitamin D is more economic and effective PARTICULARLY in Lactating mothers who refrain from Consuming oral daily doses due to Postpartum care, unwillingness or depression.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('ANOMALY_CURIOUS_FINDING', 97)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 113, 'lactating'), ('GO_0007631', 'feeding behavior', 148, 'consuming'), ('GO_0007565', 'female pregnancy', 182, 'postpartum')]
PMC3470091	9/2012	S85-PMC3470091	['witham et al.24SHOWED that single doses of 100,000 and 200,000 iu of Vitamin D in diabetic type ii patients increased Serum Vitamin D from 41 to 63 and from 48 to79 nmol./l respectively.']	[('INCOMPLETE_EVIDENCE', 15)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0001977', 'blood serum', 118, 'serum'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC3470091	9/2012	S87-PMC3470091	['moreover, ANOTHER STUDY,18SHOWED that a single dose of 200,000 iu of Vitamin D in the healthy youths was ASSOCIATED with a peak in Vitamin D concentration after two weeks of treatment, BUT lower than that of OUR STUDY at three months after treatment.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 208)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3470091	9/2012	S91-PMC3470091	['moreover, Serum Vitamin D was measured by elisa kit, which is of LOWER ACCURACY compared with hplc and ria methods.']	[('INCOMPLETE_EVIDENCE', 65)]	1	[('UBERON_0001977', 'blood serum', 10, 'serum'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC3470091	9/2012	S94-PMC3470091	['conclusion\nthe FINDINGS of the study INDICATE that intramuscular administration of a single dose of 300,000 iu of Vitamin D is EFFECTIVE and SAFE to improve Vitamin D status, and to ameliorate the FACTORS RELATED to the health of mothers and infants, PARTICULARLY in the regions with SEVERE Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 127), ('IMPORTANT_CONSIDERATION', 141), ('SUPERFICIAL_RELATIONSHIP', 197), ('SUPERFICIAL_RELATIONSHIP', 205), ('ANOMALY_CURIOUS_FINDING', 251), ('IMPORTANT_CONSIDERATION', 284)]	8	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D')]
PMC3465343	10/2012	S13-PMC3465343	['the decreases of Raldhs and Rars mrna Expression induced by Vitamin A deprivation SUGGEST that vertebral Birth defects MAY BE caused by a defect in ra signaling pathway during Somitogenesis.']	[('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 119)]	2	[('PR_000013739', 'retinoic acid receptor responder protein 1', 17, 'RALDHs'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 28, 'RARs'), ('GO_0010467', 'gene expression', 38, 'expression'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('GO_0007567', 'parturition', 105, 'birth'), ('GO_0001755', 'neural crest cell migration', 176, 'somitogenesis')]
PMC3465343	10/2012	S32-PMC3465343	['epidemiologic evidence has SUGGESTED that Vitamin A deficiency (vad) is not uncommon among Pregnant women and children in developing countries[20].']	[('INCOMPLETE_EVIDENCE', 27)]	1	[('CHEBI_27300', 'vitamin D', 42, 'vitamin A'), ('GO_0007565', 'female pregnancy', 91, 'pregnant')]
PMC3465343	10/2012	S38-PMC3465343	['excess dietary Vitamin A, ON THE OTHER HAND, HAS BEEN SHOWN to cause Teratogenesis, but toxicity from Food sources is RARE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 118)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin A'), ('GO_0031649', 'heat generation', 69, 'teratogenesis'), ('CHEBI_33290', 'food', 102, 'food')]
PMC3465343	10/2012	S40-PMC3465343	['ra is a derivative of Vitamin A and is REQUIRED for synchronous left-right Development Of Somites, either maternal vad during Pregnancy or an Embryonic defect in Metabolism from Vitamin A to ra MIGHT be ASSOCIATED with increased risk of Human vertebral defects.']	[('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 194), ('SUPERFICIAL_RELATIONSHIP', 203)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('GO_0042461', 'photoreceptor cell development', 75, 'development of somites'), ('UBERON_0002329', 'somite', 90, 'somites'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('UBERON_0000922', 'embryo', 142, 'embryonic'), ('GO_0008152', 'metabolic process', 162, 'metabolism'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('NCBITaxon_9606', 'Homo sapiens', 237, 'human')]
PMC3465343	10/2012	S126-PMC3465343	['the phenomenon that Gestational Vitamin A deficiency disrupts Embryonic Development HAS BEEN KNOWN for over 80 years.']	[('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 93)]	2	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin A'), ('GO_0009790', 'embryo development', 62, 'embryonic development'), ('UBERON_0000922', 'embryo', 62, 'embryonic')]
PMC3465343	10/2012	S139-PMC3465343	['excess dietary Vitamin A, ON THE OTHER HAND, HAS BEEN SHOWN to also cause Teratogenesis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 45)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin A'), ('GO_0031649', 'heat generation', 74, 'teratogenesis')]
PMC3465343	10/2012	S141-PMC3465343	['however, toxicity of Vitamin A excess from Food sources is RARE.']	[('INCOMPLETE_EVIDENCE', 59)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('CHEBI_33290', 'food', 43, 'food')]
PMC3465343	10/2012	S177-PMC3465343	['GIVEN that vad is STILL a SERIOUS and PREVALENT PUBLIC HEALTH PROBLEM in the world especially among Pregnant women and children and dietary Vitamin A is ONLY available from limited sources, including vegetables in the form of Β-Carotene or meat as Retinyl Esters, vad MAY BE an IMPORTANT cause of Human congenital Spinal deformities[43].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 18), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 38), ('IMPORTANT_CONSIDERATION', 48), ('PROBLEM_COMPLICATION', 62), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 268), ('IMPORTANT_CONSIDERATION', 278)]	9	[('GO_0007565', 'female pregnancy', 100, 'pregnant'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 226, 'β-carotene'), ('CHEBI_26523', 'reactive oxygen species', 248, 'retinyl esters'), ('NCBITaxon_9606', 'Homo sapiens', 297, 'human'), ('UBERON_0001130', 'vertebral column', 314, 'spinal')]
PMC3471827	10/2012	S15-PMC3471827	['PREVIOUSLY, we utilized the Zebrafish MODEL to separate the maternal and Embryonic REQUIREMENTS, and to characterize the molecular defect of Embryonic Vitamin E deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 83)]	3	[('NCBITaxon_7955', 'Danio rerio', 28, 'zebrafish'), ('UBERON_0000922', 'embryo', 73, 'embryonic'), ('UBERON_0000922', 'embryo', 141, 'embryonic'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin E')]
PMC3471827	10/2012	S18-PMC3471827	['after DEMONSTRATING the Embryonic requirement for Vitamin E we next queried HOW Α-Tocopherol is transferred into the Embryo during development.']	[('INCOMPLETE_EVIDENCE', 6), ('EXPLICIT_QUESTION', 76)]	2	[('UBERON_0000922', 'embryo', 24, 'embryonic'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin E'), ('CHEBI_27725', 'butin', 80, 'α-tocopherol'), ('UBERON_0000922', 'embryo', 117, 'embryo')]
PMC3471827	10/2012	S105-PMC3471827	['the phenotype, especially impaired Brain Formation in ttp knockdown Zebrafish Embryos RAISES the INTRIGUING POSSIBILITY that low Vitamin E status has adverse events in early Central Nervous System development in other Animals, including Humans.']	[('EXPLICIT_QUESTION', 86), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 108)]	3	[('GO_0001503', 'ossification', 35, 'brain formation'), ('UBERON_0000955', 'brain', 35, 'brain'), ('NCBITaxon_7955', 'Danio rerio', 68, 'zebrafish'), ('UBERON_0000922', 'embryo', 78, 'embryos'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin E'), ('GO_0022412', 'cellular process involved in reproduction in multicellular organism', 174, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 174, 'central nervous system'), ('NCBITaxon_33208', 'Metazoa', 218, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 237, 'humans')]
PMC3471827	10/2012	S107-PMC3471827	['in the case of Ttp knockout Mouse MODELS, mothers are infertile unless supplemented with high doses of Vitamin E[4].']	[('INCOMPLETE_EVIDENCE', 34)]	1	[('PR_000016850', 'tyrosine-protein kinase TXK', 15, 'TTP'), ('NCBITaxon_10088', 'Mus <genus>', 28, 'mouse'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E')]
PMC3471827	10/2012	S111-PMC3471827	['in SUPPORT of this NOTION, PREVIOUS STUDIES HAVE SHOWN a clear ASSOCIATION between maternal Vitamin E status during Gestation and Cognitive function of the offspring[21]–[23].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin E'), ('GO_0007565', 'female pregnancy', 116, 'gestation'), ('GO_0050890', 'cognition', 130, 'cognitive')]
PMC3471827	10/2012	S113-PMC3471827	['Fetal Resorption and Placental failure HAVE BEEN noted in ttp knockout Mice[4],[24], which are SIMILAR TO outcomes observed upon diet-induced Vitamin E deficiency[1],[25],[26].']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 95)]	2	[('GO_0001555', 'oocyte growth', 0, 'Fetal resorption'), ('UBERON_0001987', 'placenta', 21, 'placental'), ('NCBITaxon_10088', 'Mus <genus>', 71, 'mice'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin E')]
PMC3471827	10/2012	S116-PMC3471827	['the Mammalian maternal Vitamin E REQUIREMENTS occur prior to the developmental stage in which ttp is REQUIRED in the Zebrafish, creating a BARRIER to the study of ttp in Placental MODELS.']	[('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 101), ('DIFFICULT_TASK', 139), ('INCOMPLETE_EVIDENCE', 180)]	4	[('NCBITaxon_40674', 'Mammalia', 4, 'mammalian'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin E'), ('NCBITaxon_7955', 'Danio rerio', 117, 'zebrafish'), ('UBERON_0001987', 'placenta', 170, 'placental')]
PMC3471827	10/2012	S129-PMC3471827	['we PREVIOUSLY DEMONSTRATED the REQUIREMENT of Vitamin E during Zebrafish development using diet-induced Vitamin E deficient Embryos[7].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 31)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin E'), ('NCBITaxon_7955', 'Danio rerio', 63, 'zebrafish'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin E'), ('UBERON_0000922', 'embryo', 124, 'embryos')]
PMC3471827	10/2012	S132-PMC3471827	['loss of ttp, HOWEVER, precludes the specific trafficking and localization of Vitamin E, mimicking an absolute deficient state REGARDLESS OF the ubiquitous Yolk Sac supply.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 126)]	2	[('CHEBI_27300', 'vitamin D', 77, 'vitamin E'), ('UBERON_0001040', 'yolk sac', 155, 'yolk sac')]
PMC3471827	10/2012	S133-PMC3471827	['furthermore, in our PREVIOUS STUDIES Vitamin E deficiency was imposed by parental diet, WHILE ttp knockdown was performed using Embryos from fish Fed commercial lab diets.']	[('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin E'), ('UBERON_0000922', 'embryo', 128, 'embryos'), ('GO_0007631', 'feeding behavior', 146, 'fed')]
PMC3485340	10/2012	S0-PMC3485340	['maternal vitamin c deficiency during Pregnancy persistently impairs hippocampal Neurogenesis in offspring of guinea pigs\n\nabstract\nwhile having the highest Vitamin C (vitc) concentrations in the body, specific functions of Vitc in the Brain HAVE ONLY RECENTLY BEEN acknowledged.']	[('IMPORTANT_CONSIDERATION', 241), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 251)]	3	[('GO_0007565', 'female pregnancy', 37, 'Pregnancy'), ('GO_0001822', 'kidney development', 80, 'Neurogenesis'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin C'), ('PR_000017299', 'VIP peptides', 223, 'VitC'), ('UBERON_0000955', 'brain', 235, 'brain')]
PMC3485340	10/2012	S147-PMC3485340	['these results INDICATE that Prenatal vitc deficiency negatively AFFECTS the Migration Of newborn Cells into the Gl.10.1371/journal.pone.0048488.g004\n\ncaption (fig): figure 4\nPrenatal Vitamin C deficiency causes sustained reduction in Postnatal Migration Of newborn Cells into the granule layer.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('GO_0007565', 'female pregnancy', 28, 'prenatal'), ('GO_0016477', 'cell migration', 76, 'migration of ... cells'), ('UBERON_0001792', 'ganglionic layer of retina', 112, 'GL'), ('GO_0007565', 'female pregnancy', 174, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin C'), ('GO_0007567', 'parturition', 234, 'postnatal'), ('GO_0016477', 'cell migration', 244, 'migration of ... cells')]
PMC3485340	10/2012	S205-PMC3485340	['marginal Vitamin C deficiency is far from uncommon in Humans, and MAY AFFECT large subpopulations including mothers-to-be and young children[52].']	[('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('NCBITaxon_9606', 'Homo sapiens', 54, 'humans')]
PMC3488410	10/2012	S5-PMC3488410	['we will specifically discuss the Vitamin D deficiency MODEL, the poly i:c MODEL, the Ketamine MODEL, and the Postnatal Ventral Hippocampal lesion MODEL, all of which REFLECT core Neurodevelopmental ISSUES UNDERLYING schizophrenia onset.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 166), ('IMPORTANT_CONSIDERATION', 198), ('PROBLEM_COMPLICATION', 198), ('SUPERFICIAL_RELATIONSHIP', 205)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_6121', 'ketamine', 85, 'ketamine'), ('GO_0007567', 'parturition', 109, 'postnatal'), ('UBERON_0000218', 'vertebral arch of axis', 119, 'ventral hippocampal'), ('GO_0007399', 'nervous system development', 179, 'neurodevelopmental')]
PMC3488410	10/2012	S113-PMC3488410	['the Vitamin D deficiency MODEL APPEARS TO BE useful to study the IMPACT of Brain disturbances during Embryonic/fetal Development [127,128].']	[('INCOMPLETE_EVIDENCE', 25), ('ANOMALY_CURIOUS_FINDING', 31), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0000955', 'brain', 75, 'brain'), ('GO_0009790', 'embryo development', 101, 'embryonic ... development'), ('UBERON_0000922', 'embryo', 101, 'embryonic')]
PMC3488410	10/2012	S114-PMC3488410	['INTERESTINGLY, SOME of the Vitamin D deficiency EFFECTS COULD BE RELATED to later Gestational periods THUS POSSIBLY expanding the HAZARDOUS time window for the neurobiological development of schizophrenia [129].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 107), ('IMPORTANT_CONSIDERATION', 130)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'gestational')]
PMC3488410	10/2012	S116-PMC3488410	['the Vitamin D deficiency MODEL is one of the most commonly explored and used also in our lab [29,132].']	[('INCOMPLETE_EVIDENCE', 25)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC3488410	10/2012	S136-PMC3488410	['AS hippocampal Neurogenesis plays an IMPORTANT ROLE in Learning and Memory processes [74], we SPECULATE that the PREVIOUSLY DEMONSTRATED normalization of a Vitamin D deficiency-induced Habituation deficit in the hole board by Haloperidol [136] COULD result from an AT LEAST partially restored mitotic activity.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 244), ('PROBABLE_UNDERSTANDING', 265)]	8	[('GO_0022008', 'neurogenesis', 15, 'neurogenesis'), ('GO_0007612', 'learning', 55, 'learning'), ('GO_0007613', 'memory', 68, 'memory'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0046959', 'habituation', 185, 'habituation'), ('CHEBI_5613', 'haloperidol', 226, 'haloperidol')]
PMC3488410	10/2012	S137-PMC3488410	['this IDEA is SUPPORTED by FINDINGS that Vitamin D depletion depressed Promitotic Genes [131,137].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 26)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0006508', 'proteolysis', 70, 'promitotic'), ('SO_0000704', 'gene', 81, 'genes')]
PMC3488410	10/2012	S138-PMC3488410	['it is also PLAUSIBLE that there is SOME kind of exhaustion of the mitotic cell potency DUE TO the overshooting activity in young Animals, as it was DEMONSTRATED for the Vitamin D deficiency MODEL [131] and the nos knock-out MODEL [138].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 35), ('PROBLEM_COMPLICATION', 87), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 224)]	6	[('NCBITaxon_33208', 'Metazoa', 129, 'animals'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC3534399	10/2012	S169-PMC3534399	['a single trial (in hiv-infected mothers) has investigated a LIMITED range of T-Cell subsets in Pregnancy, but not in the offspring, and FOUND that limited mmn supplementation (Vitamins B, c and e), BUT NOT Vitamin A alone, increased cd4+ and cd8+ counts [25].']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('ANOMALY_CURIOUS_FINDING', 202)]	4	[('CL_0000084', 'T cell', 77, 'T-cell'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 176, 'vitamins B'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin A')]
PMC3501517	11/2012	S2-PMC3501517	['since Treg Cells are IMPORTANT in acute Lung injury resolution, we HYPOTHESIZED that Vitamin D deficiency increases the severity of injury and delays injury resolution in Lipopolysaccharide (Lps) induced acute Lung injury.']	[('IMPORTANT_CONSIDERATION', 21), ('INCOMPLETE_EVIDENCE', 67)]	2	[('CL_0000960', 'T3 B cell', 6, 'Treg cells'), ('UBERON_0002048', 'lung', 40, 'lung'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 171, 'lipopolysaccharide'), ('CHEBI_16412', 'lipopolysaccharide', 191, 'LPS'), ('UBERON_0002048', 'lung', 210, 'lung')]
PMC3501517	11/2012	S16-PMC3501517	['the POTENTIAL ROLE of Vitamin D on Immune function HAS BEEN explored in the last decade.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 51)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 35, 'immune')]
PMC3501517	11/2012	S17-PMC3501517	['Autoimmune diseases such as type 1 diabetes[10], multiple sclerosis[11]and asthma[12],[13]HAVE BEEN ASSOCIATED with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 100)]	2	[('UBERON_0005445', 'segment of pes', 0, 'Autoimmune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC3501517	11/2012	S18-PMC3501517	["this is LARGELY THOUGHT TO be due to the EFFECTS of Vitamin D on T-Regulatory (Treg) Cell function and Vitamin D's ability to stimulate Treg populations and enhance tolerance[14],[15],[16]."]	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 41)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CL_0000098', 'sensory epithelial cell', 65, 'T-regulatory ...'), ('GO_0007265', 'Ras protein signal transduction', 65, 'T-regulatory'), ('CL_0000960', 'T3 B cell', 79, 'Treg ... cell'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CL_0000901', 'Tr1 cell', 136, 'Treg')]
PMC3501517	11/2012	S19-PMC3501517	['the EFFECTS of Vitamin D on Macrophage function HAVE BEEN WELL STUDIED in mycobacterium tuberculosis (mtb) , and clinical tuberculosis is ASSOCIATED with Vitamin D deficiency[17],[18].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 138)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CL_0000235', 'macrophage', 28, 'macrophage'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC3501517	11/2012	S22-PMC3501517	['these data SUGGEST that Vitamin D levels MAY Modulate Pulmonary Inflammatory Responses and/or resolution of inflammation in response to infectious stimuli.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 41)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 45, 'modulate'), ('GO_0006925', 'inflammatory cell apoptotic process', 54, 'pulmonary inflammatory responses'), ('UBERON_0002048', 'lung', 54, 'pulmonary')]
PMC3501517	11/2012	S23-PMC3501517	['MULTIPLE STUDIES have IDENTIFIED a CORRELATION between SEVERE Vitamin D deficiency in children and Lower Respiratory Tract infections such as influenza[23],[24],[25],[26],[27].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 35), ('IMPORTANT_CONSIDERATION', 55)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0004905', 'articulation', 99, 'lower respiratory tract')]
PMC3501517	11/2012	S24-PMC3501517	['RECENT STUDIES have also CORRELATED low Cord-Blood Vitamin D levels with infant wheezing[28]and RISK for Rsv infection[29].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('IMPORTANT_CONSIDERATION', 96)]	3	[('UBERON_0002240', 'spinal cord', 40, 'cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 105, 'RSV')]
PMC3501517	11/2012	S25-PMC3501517	['relatively FEW Animal STUDIES to date have evaluated the RELATIONSHIP between Vitamin D and acute Lung injury (ali), and those that HAVE BEEN published examine the EFFECT of Vitamin D supplementation above normal dietary intake[30],[31],[32].']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 164)]	4	[('NCBITaxon_33208', 'Metazoa', 15, 'animal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002048', 'lung', 98, 'lung'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC3501517	11/2012	S29-PMC3501517	['we HYPOTHESIZED that Vitamin D level would INFLUENCE Lps-induced Lung inflammation and injury, and its resolution.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 43)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 53, 'LPS'), ('UBERON_0002048', 'lung', 65, 'lung')]
PMC3501517	11/2012	S30-PMC3501517	['TO TEST THIS HYPOTHESIS, we developed a Murine MODEL of Vitamin D deficiency through diet modification to compare the temporal pattern of inflammation and resolution in response to Lps exposure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 47)]	4	[('NCBITaxon_39107', 'Murinae', 40, 'murine'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 181, 'LPS')]
PMC3501517	11/2012	S31-PMC3501517	['we FOUND that Vitamin D alters Neutrophil Chemotaxis ex vivo but does not significantly affect the extent of Lps-induced Lung injury or its resolution in vivo .']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CL_0000775', 'neutrophil', 31, 'neutrophil'), ('GO_0007567', 'parturition', 31, 'neutrophil'), ('GO_0006935', 'chemotaxis', 42, 'chemotaxis'), ('CHEBI_16412', 'lipopolysaccharide', 109, 'LPS'), ('UBERON_0002048', 'lung', 121, 'lung')]
PMC3501517	11/2012	S92-PMC3501517	['results\n\nbaseline characteristics of Vitamin D sufficient and deficient Mice\nvitamin D deficiency (vdd) and sufficiency (vds) was CONFIRMED in 6-week old Mice.']	[('INCOMPLETE_EVIDENCE', 130)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'mice'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 85, 'D'), ('NCBITaxon_10088', 'Mus <genus>', 154, 'mice')]
PMC3501517	11/2012	S175-PMC3501517	['because these data SUGGESTED that Neutrophils from Vitamin D deficient Mice had impaired Chemotaxis to selected chemoattractants, we assessed Surface Expression of Cxcr2, the receptor for Kc/Cxcl1, by flow cytometry, on Bone Marrow-derived Neutrophils isolated from vds and vdd Mice.']	[('INCOMPLETE_EVIDENCE', 19)]	1	[('CL_0000775', 'neutrophil', 34, 'neutrophils'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 71, 'mice'), ('GO_0006935', 'chemotaxis', 89, 'chemotaxis'), ('GO_0009986', 'cell surface', 142, 'surface'), ('GO_0010467', 'gene expression', 150, 'expression'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 164, 'CXCR2'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 188, 'KC'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 191, 'CXCL1'), ('UBERON_0002371', 'bone marrow', 220, 'bone marrow'), ('CL_0000775', 'neutrophil', 240, 'neutrophils'), ('NCBITaxon_10088', 'Mus <genus>', 278, 'mice')]
PMC3501517	11/2012	S178-PMC3501517	['TOGETHER, these data SUGGEST that Vitamin D does not affect Neutrophil Chemotaxis to Kc/Cxcl1 through Modulation of Cxcr2 Expression.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CL_0000775', 'neutrophil', 60, 'neutrophil'), ('GO_0007567', 'parturition', 60, 'neutrophil'), ('GO_0006935', 'chemotaxis', 71, 'chemotaxis'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 85, 'KC'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 88, 'CXCL1'), ('GO_0065007', 'biological regulation', 102, 'modulation'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 116, 'CXCR2'), ('GO_0010467', 'gene expression', 122, 'expression')]
PMC3501517	11/2012	S180-PMC3501517	['we HYPOTHESIZED that both the severity of Lung injury and resolution of injury would be impaired in Vitamin D deficient Mice exposed to Lps.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('UBERON_0002048', 'lung', 42, 'lung'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 120, 'mice'), ('CHEBI_16412', 'lipopolysaccharide', 136, 'LPS')]
PMC3501517	11/2012	S190-PMC3501517	['these data CONTRAST WITH OTHER published STUDIES that demonstrate a POSSIBLE PROTECTIVE ROLE of Vitamin D supplementation during Lung injury.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 88)]	6	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0002048', 'lung', 129, 'lung')]
PMC3501517	11/2012	S194-PMC3501517	['these data SUGGEST that SOME PROTECTIVE BENEFIT MAY BE derived from Vitamin D supplementation in the setting of radiation-induced Lung injury; HOWEVER, the POTENTIAL physiological relevance of these differences is DIFFICULT to ascertain given the absence of systematic sampling or the LACK OF DATA on the magnitude of the differences.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 156), ('DIFFICULT_TASK', 214), ('INCOMPLETE_EVIDENCE', 285)]	9	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002048', 'lung', 130, 'lung')]
PMC3501517	11/2012	S197-PMC3501517	['Il-8 Production MAY BE suppressed by Vitamin D, DEPENDING ON the cell type[39],[40].']	[('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48)]	2	[('GO_0032637', 'interleukin-8 production', 0, 'IL-8 production'), ('PR_000001470', 'interleukin-28B', 0, 'IL-8'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC3501517	11/2012	S198-PMC3501517	['shih and co-authors REPORTED that Vitamin D supplementation reduced Lung injury as determined by wet/dry Lung weight ratios and semi-quantitative histological analysis in a Rat model of Hind Limb ischemia and reperfusion[30].']	[('INCOMPLETE_EVIDENCE', 20)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0002048', 'lung', 68, 'lung'), ('UBERON_0002048', 'lung', 105, 'lung'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 173, 'rat'), ('UBERON_0002103', 'hindlimb', 186, 'hind limb')]
PMC3501517	11/2012	S200-PMC3501517	['INTERESTINGLY, shih REPORTED that Serum cytokine levels were reduced in this MODEL with Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 77)]	3	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC3501517	11/2012	S201-PMC3501517	['ALTERNATIVELY, DIFFERENCES MAY again reflect the DIFFERENCE of supplementation above a normal level VERSUS chronic Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('INCOMPLETE_EVIDENCE', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100)]	5	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3501517	11/2012	S209-PMC3501517	['one POSSIBLE EXPLANATION for altered Kc/Cxcl1 responsiveness in vdd Mice in the absence of reduced Expression of Cxcr2 MAY BE Vitamin D-dependent post-Translational modifications to Cxcr2.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 119)]	3	[('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 37, 'KC'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 40, 'CXCL1'), ('NCBITaxon_10088', 'Mus <genus>', 68, 'mice'), ('GO_0010467', 'gene expression', 99, 'expression'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 113, 'CXCR2'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0006412', 'translation', 151, 'translational'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 182, 'CXCR2')]
PMC3501517	11/2012	S211-PMC3501517	['these data INDICATE that chronic Vitamin D deficiency has minimal IMPACT on the acute inflammatory response to Lps or in resolution of Lps-induced Lung injury.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 111, 'LPS'), ('CHEBI_16412', 'lipopolysaccharide', 135, 'LPS'), ('UBERON_0002048', 'lung', 147, 'lung')]
PMC3501517	11/2012	S212-PMC3501517	['THESE FINDINGS FURTHER SUGGEST that acute Vitamin D replacement therapy for patients with underlying Vitamin D deficiency MAY have LIMITED clinical BENEFIT in the setting of acute Lung injury from noninfectious causes.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 122), ('INCOMPLETE_EVIDENCE', 131), ('IMPORTANT_CONSIDERATION', 148)]	6	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0002048', 'lung', 180, 'lung')]
PMC3501517	11/2012	S214-PMC3501517	['we chose this MODEL because we were primarily interested in HOW Vitamin D level AFFECTED inflammatory response and resolution of inflammation RATHER than bacterial or Viral clearance.']	[('INCOMPLETE_EVIDENCE', 14), ('EXPLICIT_QUESTION', 60), ('SUPERFICIAL_RELATIONSHIP', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_1', 'root', 167, 'viral')]
PMC3501517	11/2012	S216-PMC3501517	['epidemiological data SUGGEST that Vitamin D level is ASSOCIATED with severity of illness with community-acquired pneumonia[42],[43].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC3501517	11/2012	S217-PMC3501517	['THEREFORE, WHILE Vitamin D MAY not play a ROLE in the acute inflammatory Response or resolution of inflammation, it MAY STILL be IMPORTANT in Controlling infections in the Lung.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 116), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 129)]	7	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0060033', 'anatomical structure regression', 73, 'response'), ('GO_0065007', 'biological regulation', 142, 'controlling'), ('UBERON_0002048', 'lung', 172, 'lung')]
PMC3501517	11/2012	S220-PMC3501517	['IN CONTRAST, a RECENT STUDY REPORTED that balb/c Vitamin D deficient Mice had smaller Lung volumes than Vitamin D sufficient Mice as well as higher elastance[44].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 69, 'mice'), ('UBERON_0002048', 'lung', 86, 'lung'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 125, 'mice')]
PMC3501517	11/2012	S223-PMC3501517	['the DIFFERENCES that the OTHER group saw MAY BE more the result of maternal and early Gestational Vitamin D deficiency and its EFFECTS on Fetal Lung Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('GO_0007565', 'female pregnancy', 86, 'gestational'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007631', 'feeding behavior', 138, 'fetal'), ('GO_0030324', 'lung development', 144, 'lung development'), ('UBERON_0002048', 'lung', 144, 'lung')]
PMC3501517	11/2012	S224-PMC3501517	['this is SUPPORTED by Human data SUGGESTING that maternal Vitamin D MAY AFFECT fetal Lung Development[28].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 71)]	4	[('NCBITaxon_9606', 'Homo sapiens', 21, 'human'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0030324', 'lung development', 84, 'lung development'), ('UBERON_0002048', 'lung', 84, 'lung')]
PMC3501517	11/2012	S225-PMC3501517	['a LIMITATION of THIS STUDY is that normal levels of Vitamin D in Mice are not well established.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 65, 'mice')]
PMC3501517	11/2012	S226-PMC3501517	['THEREFORE, an UNANSWERED QUESTION is IF Vitamin D augmentation CAN be PROTECTIVE in our Lps MODEL for ali.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('EXPLICIT_QUESTION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 92)]	9	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 88, 'LPS')]
PMC3501517	11/2012	S228-PMC3501517	['Mice do utilize uv exposure to produce Vitamin D3[45], but IT IS POSSIBLE that Vitamin D MAY BE more RELEVANT and active in Humans.']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 101)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mice'), ('CHEBI_33279', 'vitamin D5', 39, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 39, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 124, 'humans')]
PMC3501517	11/2012	S229-PMC3501517	['IN SUMMARY, Vitamin D deficiency, established through dietary restriction, has minimal IMPACT on the acute inflammatory response to Lps in the Lung or resolution of inflammation.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 87)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 132, 'LPS'), ('UBERON_0002048', 'lung', 143, 'lung')]
PMC3501517	11/2012	S233-PMC3501517	['the data SUGGEST that Vitamin D supplementation is UNLIKELY to be an effective therapy for acute Lung injury.']	[('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 51)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002048', 'lung', 97, 'lung')]
PMC3504157	11/2012	S23-PMC3504157	['MANY health providers NOW RECOMMEND nhps including Prenatal Vitamins, iron supplementation, calcium, and Vitamin D for a range of RECOGNIZED indications including deficiency states such as rickets and anemia, as well as illnesses such as multiple sclerosis.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 22), ('FUTURE_WORK', 26), ('PROBABLE_UNDERSTANDING', 130)]	4	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 60, 'vitamins'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC3509518	11/2012	S3-PMC3509518	['the main RELATIONSHIPS with allergic outcomes were SEEN with dietary Vitamin C and copper.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 51)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin C')]
PMC3509518	11/2012	S11-PMC3509518	['IN SUMMARY, THIS STUDY SUGGESTS that maternal diet of fresh Foods rich in Vitamin C is ASSOCIATED with reduced risk of infant wheeze, and that copper intake is ASSOCIATED with reduced RISK of several allergic outcomes.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 87), ('SUPERFICIAL_RELATIONSHIP', 160), ('IMPORTANT_CONSIDERATION', 184)]	6	[('CHEBI_33290', 'food', 60, 'foods'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin C')]
PMC3509518	11/2012	S22-PMC3509518	['a LIMITED NUMBER OF Birth cohort STUDIES have SUGGESTED beneficial ASSOCIATIONS between higher maternal intakes of Antioxidants such as Vitamin E [9,10,11] and zinc [9] and the development of early childhood wheeze, and asthma [12].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 67)]	3	[('GO_0007567', 'parturition', 20, 'birth'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 115, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]
PMC3509518	11/2012	S100-PMC3509518	['IN SUMMARY, there were no statistically significant associations OBSERVED between total intake of specific antioxidants (Β-Carotene, Vitamin C, e, zinc and copper) in Pregnancy and the risk of developing eczema, Food allergy, wheeze, sensitisation or any allergic disease neither in the crude nor adjusted analyses (data not shown).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 65)]	2	[('CHEBI_28064', 'cyanidin 3-O-rutinoside', 121, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin C'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy'), ('CHEBI_33290', 'food', 212, 'food')]
PMC3509518	11/2012	S103-PMC3509518	['discussion\nin this study, there were SOME inverse (“PROTECTIVE”) RELATIONSHIPS between antioxidant intakes in Pregnancy and infant allergic outcomes, but this was ONLY evident for selected antioxidant factors (Vitamin C and copper) and ONLY SEEN in RELATION to dietary Nutrients and not for dietary supplements per se .']	[('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 249)]	7	[('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin C'), ('CHEBI_33284', 'nutrient', 269, 'nutrients')]
PMC3509518	11/2012	S106-PMC3509518	['as INDICATED, there were no associations between allergic outcomes and total intakes of copper, Vitamin C or any other antioxidants when we also took maternal Vitamin and mineral supplementation into account.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 96, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 159, 'vitamin')]
PMC3509518	11/2012	S116-PMC3509518	['the POTENTIAL PROTECTIVE EFFECTS of Vitamin C and antioxidant rich foods on allergic disease HAVE BEEN NOTED in a NUMBER OF PREVIOUS STUDIES, including LINKS between higher intakes of antioxidant rich Foods, better Pulmonary function and reduced risk of wheeze [21].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 103), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 152)]	8	[('CHEBI_27300', 'vitamin D', 36, 'vitamin C'), ('CHEBI_33290', 'food', 201, 'foods'), ('UBERON_0002048', 'lung', 215, 'pulmonary')]
PMC3509518	11/2012	S117-PMC3509518	['this is CONSISTENT with the FINDINGS in the PRESENT STUDY that SUGGEST a reduced risk of wheeze with higher maternal dietary Vitamin C intake, ALTHOUGH the inverse linear trend fell short of the significance level.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('INCOMPLETE_EVIDENCE', 63), ('ANOMALY_CURIOUS_FINDING', 143)]	5	[('CHEBI_27300', 'vitamin D', 125, 'vitamin C')]
PMC3509518	11/2012	S120-PMC3509518	['[22] DEMONSTRATED that Plasma concentrations increased steeply above Intakes of 30 mg daily and that the steep portion of the Plasma concentration curve occurred with a daily dose of Vitamin C of between 30 and 100 mg.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('UBERON_0001969', 'blood plasma', 23, 'plasma'), ('GO_0007631', 'feeding behavior', 69, 'intakes'), ('UBERON_0001969', 'blood plasma', 126, 'plasma'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin C'), ('PR_000004900', 'complement C3', 191, 'C')]
PMC3509518	11/2012	S127-PMC3509518	['with a more LIMITED DATASET available, a meta-analysis on two published Birth cohort studies [9,10] OBSERVED no association between maternal Vitamin C intake in Pregnancy and wheeze at 2 years of age [23].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 100)]	2	[('GO_0007567', 'parturition', 72, 'birth'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin C'), ('GO_0007565', 'female pregnancy', 161, 'pregnancy')]
PMC3509518	11/2012	S128-PMC3509518	['there is a PAUCITY of intervention studies with Vitamin C in Pregnancy for PREVENTION of allergic disease.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin C'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
PMC3509518	11/2012	S131-PMC3509518	['we could not confirm PREVIOUS FINDINGS that reduced maternal Vitamin E intakes were ASSOCIATED with increased risk of developing childhood wheeze [9,10,11,12] DESPITE the fact that almost 50% of Pregnant mothers did not meet the rdi when intakes from diet alone were TAKEN INTO ACCOUNT, and 20% of the mothers did not meet the rdi when total Vitamin E intakes were analysed [18].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('ANOMALY_CURIOUS_FINDING', 159), ('IMPORTANT_CONSIDERATION', 267)]	6	[('CHEBI_27300', 'vitamin D', 61, 'vitamin E'), ('GO_0007565', 'female pregnancy', 195, 'pregnant'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin E')]
PMC3509518	11/2012	S148-PMC3509518	['conclusions\nIN SUMMARY, THIS STUDY SUGGESTS an ASSOCIATION between Maternal Consumption of Foods rich in SOME antioxidant factors, namely Vitamin C and copper, and reduced risk of allergic outcomes in infancy in a population PREDISPOSED to allergic disease.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 225)]	6	[('GO_0007618', 'mating', 67, 'maternal'), ('GO_0007631', 'feeding behavior', 76, 'consumption'), ('CHEBI_33290', 'food', 91, 'foods'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin C')]
PMC3509518	11/2012	S150-PMC3509518	['the PROTECTIVE EFFECTS of fresh Foods rich in Vitamin C on wheeze is CONSISTENT with PREVIOUS STUDIES, and it is notable that we DID NOT observe any effect of Vitamin supplements on any allergic outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 129)]	5	[('CHEBI_33290', 'food', 32, 'foods'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 159, 'vitamin')]
PMC3515887	11/2012	S218-PMC3515887	['Ascorbic Acid\nthe RATIONALE for Ascorbic Acid (Vitamin C) supplementation in large doses is that it blocks binding to da receptors and POSSIBLY corrects redox balance, leading to correction of Metabolic stress that MAY CONTRIBUTE to autism symptoms.']	[('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 219)]	5	[('CHEBI_2878', 'Aspecioside', 0, 'Ascorbic Acid'), ('CHEBI_22652', 'ascorbic acid', 32, 'ascorbic acid'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin C'), ('GO_0008152', 'metabolic process', 193, 'metabolic')]
PMC3532199	11/2012	S25-PMC3532199	['a NUMBER OF SUBSEQUENT STUDIES reviewed by czeizel [9] and munger [10] have CONTINUED to SUGGEST that Folic Acid and/or OTHER Micronutrients or vitamins, including Vitamin A and Vitamin B6, MAY BE IMPORTANT in the etiology of clefts as well.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('FUTURE_WORK', 76), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120), ('INCOMPLETE_EVIDENCE', 190), ('IMPORTANT_CONSIDERATION', 197)]	7	[('CHEBI_30751', 'formic acid', 102, 'folic acid'), ('CHEBI_33839', 'macromolecule', 126, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A'), ('CHEBI_33237', 'vitamin D4', 178, 'vitamin B6')]
PMC3515553	12/2012	S6-PMC3515553	['the expected EFFECT of maternal Vitamin B-12 on offspring iq, GIVEN the RELATIONSHIPS between Snps and Vitamin B-12, and Snps and iq was consistent with the OBSERVATIONAL result.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBABLE_UNDERSTANDING', 62), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 157)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 32, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 42, '12'), ('SO_0000694', 'SNP', 94, 'SNPs'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 103, 'vitamin B-12'), ('SO_0000694', 'SNP', 121, 'SNPs')]
PMC3515553	12/2012	S7-PMC3515553	['OUR FINDINGS SUGGEST that maternal Vitamin B-12 MAY not have an IMPORTANT EFFECT on offspring Cognitive ability.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 64), ('SUPERFICIAL_RELATIONSHIP', 74)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin B'), ('PR_000004770', 'Polycomb complex protein BMI-1', 43, 'B-12'), ('GO_0050890', 'cognition', 94, 'cognitive')]
PMC3515553	12/2012	S14-PMC3515553	['BECAUSE of the transfer from mother to offspring of Vitamin B-12 during Pregnancy and Lactation, maternal REQUIREMENTS during these periods are increased and deficiency CAN occur[5].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 106), ('INCOMPLETE_EVIDENCE', 169)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 52, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0007595', 'lactation', 86, 'lactation')]
PMC3515553	12/2012	S18-PMC3515553	['ONE WAY to avoid PROBLEMS of residual CONFOUNDING in OBSERVATIONAL epidemiology is to use Genetic variants that are KNOWN to be reliably RELATED to the modifiable risk factor of interest (here maternal Vitamin B-12) as PROXIES IN ORDER TO determine the causal EFFECT of the risk factor[9],[10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 17), ('PROBLEM_COMPLICATION', 38), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 219), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 236), ('SUPERFICIAL_RELATIONSHIP', 260)]	10	[('SO_0000704', 'gene', 90, 'genetic'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 202, 'vitamin B-12')]
PMC3515553	12/2012	S20-PMC3515553	['additionally, non-synonymous polymorphisms in the tcn2 Gene (rs1801198, 776c>g, p259r; rs9606756, 67a>g, i23v), that codes for the Transcobalamin Ii protein, HAVE BEEN ASSOCIATED with differences in the holotranscobalamin and total transcobalamin fractions of Vitamin B-12 and total Hcy concentration[3],[13]–[16], ALTHOUGH their EFFECTS are not fully established[16].']	[('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 315), ('SUPERFICIAL_RELATIONSHIP', 330)]	4	[('SO_0000704', 'gene', 55, 'gene'), ('PR_000016009', 'tumor-associated calcium signal transducer 2', 131, 'transcobalamin II'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 260, 'vitamin B-12'), ('CHEBI_37958', 'dye', 283, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 283, 'Hcy')]
PMC3515553	12/2012	S21-PMC3515553	['the AIM of THIS STUDY was TO EXAMINE the ASSOCIATION of maternal dietary Intake of Vitamin B-12 and also of Snps in Fut2 and tcn2 with offspring iq assessed at age 8 in a population of european origin.figure 1shows the framework for the HYPOTHESIS that we have EXAMINED HERE concerning the LINKS between maternal Vitamin B-12 during Pregnancy with offspring iq.10.1371/journal.pone.0051084.g001\n\ncaption (fig): figure 1\ndiagram showing the framework of the mendelian randomization approach used in this study.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 237), ('QUESTION_ANSWERED_BY_THIS_WORK', 261), ('QUESTION_ANSWERED_BY_THIS_WORK', 270), ('SUPERFICIAL_RELATIONSHIP', 290)]	8	[('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 83, 'vitamin B-12'), ('SO_0000694', 'SNP', 108, 'SNPs'), ('PR_000007719', 'frizzled-2', 116, 'FUT2'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin B'), ('GO_0007565', 'female pregnancy', 333, 'pregnancy')]
PMC3515553	12/2012	S49-PMC3515553	['potential confounders and mediators\nwe TESTED for the ASSOCIATION of POTENTIAL CONFOUNDERS with offspring iq, maternal dietary Vitamin B-12 intake and genotypes of Vitamin B-12 RELATED variants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 69), ('PROBLEM_COMPLICATION', 79), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('CHEBI_85855', 'diacylglycerol 46:7', 127, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 127, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 164, 'vitamin B-12')]
PMC3515553	12/2012	S53-PMC3515553	['in the observational analyses of maternal dietary Vitamin B-12 in Pregnancy, we also EXAMINED POSSIBLE MEDIATION by Gestational age, Birth-weight and breastfeeding (obtained from repeat Postnatal maternal completed questionnaires and derived as no breastfeeding, breastfeeding for <3 months, for 3 to 5 months, for ≥6 months).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 85), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 50, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007565', 'female pregnancy', 116, 'gestational'), ('GO_0007567', 'parturition', 133, 'birth'), ('GO_0007567', 'parturition', 186, 'postnatal')]
PMC3515553	12/2012	S60-PMC3515553	['Haplotypes consisting of both tcn2 Snps were evaluated AS POTENTIAL instrumental variables that MAY EXPLAIN better than genotypes part of the variation in circulating Vitamin B-12.']	[('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 96), ('PROBABLE_UNDERSTANDING', 100)]	4	[('SO_0001024', 'haplotype', 0, 'Haplotypes'), ('SO_0000694', 'SNP', 35, 'SNPs'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 167, 'vitamin B-12')]
PMC3515553	12/2012	S65-PMC3515553	['we INVESTIGATED the ASSOCIATION of POTENTIAL CONFOUNDING FACTORS with maternal Vitamin B-12 intake, offspring iq, and maternal and offspring genotype using linear regression and chi square tests.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 35), ('PROBLEM_COMPLICATION', 45)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 79, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 89, '12')]
PMC3515553	12/2012	S75-PMC3515553	['AS offspring genotype MAY INFLUENCE Cognitive ability per se , we adjusted for offspring genotype to estimate the EFFECT of maternal Vitamin B-12 status during Pregnancy on offspring iq.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 114)]	4	[('GO_0050890', 'cognition', 36, 'cognitive'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 133, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 143, '12'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy')]
PMC3515553	12/2012	S80-PMC3515553	['for example, POOR absorption COULD BE more RELEVANT for Individuals with reduced Vitamin B-12 intake.']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 43), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('NCBITaxon_1', 'root', 56, 'individuals'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 81, 'vitamin B-12')]
PMC3515553	12/2012	S87-PMC3515553	['subsequent adjustment for POTENTIAL CONFOUNDERS attenuated the ASSOCIATION by 65% (model 2), such that in this model offspring iq was on average 0.7 (95%ci −0.04, 1.4; p\u200a=\u200a0.06) points greater per doubling of maternal Vitamin B-12.']	[('INCOMPLETE_EVIDENCE', 26), ('PROBLEM_COMPLICATION', 36), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('CHEBI_27300', 'vitamin D', 218, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 218, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 228, '12')]
PMC3515553	12/2012	S94-PMC3515553	['all three maternal Snps SHOWED a SIMILAR magnitude of EFFECT on Cord Blood Vitamin B-12 concentration, but statistical EVIDENCE for the EFFECT of the Fut2 Snp and tcn2 rs9606756 was absent in this SMALL sample (table 3).']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 197)]	6	[('SO_0000694', 'SNP', 19, 'SNPs'), ('UBERON_0002240', 'spinal cord', 64, 'cord'), ('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 75, 'vitamin B-12'), ('PR_000007719', 'frizzled-2', 150, 'FUT2'), ('SO_0000694', 'SNP', 155, 'SNP')]
PMC3515553	12/2012	S95-PMC3515553	['analysis of offspring genotypes and Cord Blood Vitamin B-12 REVEALED a strong ASSOCIATION with the Fut2 variant BUT no association with tcn2 rs1801198 and a marginal effect of tcn2 rs9606756 (table s3).']	[('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 78), ('ANOMALY_CURIOUS_FINDING', 112)]	3	[('UBERON_0002240', 'spinal cord', 36, 'cord'), ('UBERON_0000178', 'blood', 41, 'blood'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 47, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 57, '12'), ('PR_000007719', 'frizzled-2', 99, 'FUT2')]
PMC3515553	12/2012	S96-PMC3515553	['Maternal rs9606756/rs1801198 Haplotypes carrying at least one PUTATIVE Vitamin B-12 increasing Allele showed higher Cord Blood Vitamin B-12 compared to the Haplotype carrying both Alleles PREVIOUSLY ASSOCIATED with elevated Hcy and lower Vitamin B-12 concentrations (ag, i.e.']	[('PROBABLE_UNDERSTANDING', 62), ('INCOMPLETE_EVIDENCE', 188), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('SO_0001024', 'haplotype', 29, 'haplotypes'), ('CHEBI_85855', 'diacylglycerol 46:7', 71, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 71, 'vitamin B-12'), ('SO_0001023', 'allele', 95, 'allele'), ('UBERON_0009472', 'axilla', 116, 'cord blood'), ('CHEBI_85855', 'diacylglycerol 46:7', 127, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 127, 'vitamin B-12'), ('SO_0001024', 'haplotype', 156, 'haplotype'), ('SO_0001023', 'allele', 180, 'alleles'), ('CHEBI_37958', 'dye', 224, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 224, 'Hcy'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 238, 'vitamin B-12')]
PMC3515553	12/2012	S119-PMC3515553	['maternal dietary intake of Vitamin B-12 was ASSOCIATED with the MAJORITY (7 out of 11 (64%)) of POTENTIAL CONFOUNDERS and with two of the three Mediators tested (table s7).']	[('SUPERFICIAL_RELATIONSHIP', 44), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 96), ('PROBLEM_COMPLICATION', 106)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 27, 'vitamin B-12'), ('CHEBI_35222', 'inhibitor', 144, 'mediators')]
PMC3515553	12/2012	S124-PMC3515553	['frequencies of the Vitamin B-12 Alleles were SIMILAR in the mothers and their offspring, and COMPARABLE to those FOUND in the hapmap european population (ceu) (rs492602 c Allele: 0.50 in alspac, 0.53 in ceu; rs1801198 c Allele: 0.55 in alspac, 0.55 in ceu; rs9606756 g Allele: 0.13 in alspac, 0.10 in ceu).']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 113)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 19, 'vitamin B-12'), ('SO_0001023', 'allele', 32, 'alleles'), ('SO_0001023', 'allele', 171, 'allele'), ('SO_0001023', 'allele', 220, 'allele'), ('SO_0001023', 'allele', 269, 'allele')]
PMC3515553	12/2012	S127-PMC3515553	['discussion\n\nmain findings\nTO THE BEST OF OUR KNOWLEDGE THIS is the FIRST STUDY to EXAMINE the IMPACT of differential concentrations of circulating Vitamin B-12 on offspring iq through the use of records of Maternal Pregnancy Vitamin B-12 intake, as well as Vitamin B-12 RELATED Genetic variants.']	[('PROBABLE_UNDERSTANDING', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 67), ('QUESTION_ANSWERED_BY_THIS_WORK', 73), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 270)]	7	[('CHEBI_27300', 'vitamin D', 147, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 147, 'vitamin B-12'), ('GO_0007618', 'mating', 206, 'maternal'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 225, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 235, '12'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 257, 'vitamin B-12'), ('SO_0000704', 'gene', 278, 'genetic')]
PMC3515553	12/2012	S133-PMC3515553	['the effect size of this ASSOCIATION between genotypic variation and iq was of a magnitude expected given the RELATIONSHIPS between Genetic variation and Vitamin B-12 and the RELATIONSHIPS between Vitamin B-12 and iq OBSERVATIONALLY.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 216)]	4	[('SO_0000704', 'gene', 131, 'genetic'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 153, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 196, 'vitamin B-12')]
PMC3515553	12/2012	S134-PMC3515553	['conditioning on offspring genotype made this ASSOCIATION SOMEWHAT stronger, giving SUPPORT to the HYPOTHESIS that offspring iq score MAY BE INFLUENCED by maternal Vitamin B-12 status during the Intra-Uterine or Perinatal Period RATHER than REFLECT post-Natal offspring exposure to dietary Vitamin B-12.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('SUPERFICIAL_RELATIONSHIP', 240)]	8	[('CHEBI_27300', 'vitamin D', 163, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 163, 'vitamin B-12'), ('UBERON_0001273', 'ilium', 194, 'intra'), ('UBERON_0000995', 'uterus', 200, 'uterine'), ('GO_0036268', 'swimming', 211, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 211, 'perinatal period'), ('GO_0007567', 'parturition', 253, 'natal'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 289, 'vitamin B-12')]
PMC3515553	12/2012	S135-PMC3515553	['FINDINGS in the context of existing literature\ntcn2 rs1801198 was ASSOCIATED with maternal Vitamin B-12 Consumption, with heterozygotes showing a higher intake than both homozygotes, ALTHOUGH this COULD WELL be a chance FINDING SINCE this Snp’s PUTATIVE action has not been RELATED to Intake[13].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 220), ('PROBLEM_COMPLICATION', 228), ('PROBABLE_UNDERSTANDING', 245), ('SUPERFICIAL_RELATIONSHIP', 274)]	8	[('CHEBI_27300', 'vitamin D', 91, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 91, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 104, 'consumption'), ('SO_0000694', 'SNP', 239, 'SNP'), ('GO_0007631', 'feeding behavior', 285, 'intake')]
PMC3515553	12/2012	S136-PMC3515553	['rs1801198 is a non-synonymous polymorphism (p259r) that HAS BEEN REPORTED to decrease transcription and the cellular and Plasma concentration of holo-transcobalamin, which is the biologically active fraction of Vitamin B-12 delivered to Tissues[13],[29].']	[('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 65)]	2	[('UBERON_0001969', 'blood plasma', 121, 'plasma'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 211, 'vitamin B-12'), ('UBERON_0000479', 'tissue', 237, 'tissues')]
PMC3515553	12/2012	S137-PMC3515553	['tcn2 rs9606756 is also a non-synonymous variant (i23v) that MAY facilitate the binding of cobalamin[30]and HAS BEEN ASSOCIATED with a higher proportion of Vitamin B-12 bound to transcobalamin[14], and lower Plasma total Hcy[15].']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('CHEBI_27300', 'vitamin D', 155, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 155, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 207, 'plasma'), ('CHEBI_37958', 'dye', 220, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 220, 'Hcy')]
PMC3515553	12/2012	S141-PMC3515553	['SINCE h. pylori infection MAY cause Malabsorption of Vitamin B-12, non-secretors are HYPOTHESIZED to have better absorption and HENCE higher Plasma concentrations of vitamin B-12 than secretors[33].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 128)]	5	[('GO_0046693', 'sperm storage', 36, 'malabsorption'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 53, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('PR_000004770', 'Polycomb complex protein BMI-1', 174, 'B-12')]
PMC3515553	12/2012	S142-PMC3515553	['CONSISTENT with this HYPOTHESIS, we FOUND that homozygotes for the rs492602 c Allele (in strong ld with rs601338 null Allele) exhibited higher Cord Blood Vitamin B-12 than tt/tc Individuals [geometric mean (95% ci), 322 (277, 374) vs 284 (263, 307), p\u200a=\u200a0.15].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 36)]	3	[('SO_0001023', 'allele', 78, 'allele'), ('SO_0001023', 'allele', 118, 'allele'), ('UBERON_0002240', 'spinal cord', 143, 'cord'), ('UBERON_0000178', 'blood', 148, 'blood'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin B'), ('NCBITaxon_1', 'root', 178, 'individuals')]
PMC3515553	12/2012	S143-PMC3515553	['PREVIOUS STUDIES of the EFFECT of Plasma Vitamin B-12 on Neurological Development in children SUGGEST that cobalamin deficiency has an adverse EFFECT on children’s Cognitive ability and motor skills.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 143)]	4	[('UBERON_0001969', 'blood plasma', 34, 'plasma'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 41, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 51, '12'), ('GO_0007399', 'nervous system development', 57, 'neurological development'), ('UBERON_0001016', 'nervous system', 57, 'neurological'), ('GO_0050890', 'cognition', 164, 'cognitive')]
PMC3515553	12/2012	S150-PMC3515553	['we DID NOT uncover any association between child’s genotype at Vitamin B-12 related variants and iq DESPITE FINDING an ASSOCIATION between offspring genotype and Cord Blood Vitamin B-12 concentration.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 100), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 63, 'vitamin B-12'), ('UBERON_0002240', 'spinal cord', 162, 'cord'), ('UBERON_0000178', 'blood', 167, 'blood'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 173, 'vitamin B-12')]
PMC3515553	12/2012	S152-PMC3515553	['it is also LIKELY that we DID NOT have enough statistical power in our analysis to identify an EFFECT of Vitamin B-12 on iq in children.']	[('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 105, 'vitamin B-12')]
PMC3515553	12/2012	S153-PMC3515553	['it HAS been PREVIOUSLY SHOWN that maternal cobalamin status is a strong PREDICTOR of Vitamin B-12 in breastfed infants up to AT LEAST 6 months of age[35].']	[('IMPORTANT_CONSIDERATION', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 72), ('PROBABLE_UNDERSTANDING', 125)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 85, 'vitamin B-12')]
PMC3515553	12/2012	S154-PMC3515553	['YET, LITTLE IS KNOWN about the INFLUENCE that low Plasma Vitamin B-12 during Pregnancy MAY have on the Cognitive ability of children later in Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 5), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 87)]	4	[('UBERON_0001969', 'blood plasma', 50, 'plasma'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 57, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0050890', 'cognition', 103, 'cognitive'), ('UBERON_0000104', 'life cycle', 142, 'life')]
PMC3515553	12/2012	S155-PMC3515553	['in mexico, a study that assessed maternal diet during the first Trimester of Pregnancy and offspring Neurodevelopment REPORTED a decrease in Cognition test scores among children of mothers with a deficient intake of Vitamin B-12 (<2 µg/day)[7].']	[('INCOMPLETE_EVIDENCE', 118)]	1	[('GO_0009294', 'DNA mediated transformation', 64, 'trimester'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007399', 'nervous system development', 101, 'neurodevelopment'), ('GO_0050890', 'cognition', 141, 'cognition'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 216, 'vitamin B-12')]
PMC3515553	12/2012	S156-PMC3515553	['two studies conducted in india, that measured Vitamin B-12 concentration, REPORTED CONTRADICTORY results, POSSIBLY DUE TO DIFFERING levels of Vitamin B-12 deficiency between the populations[6],[8].']	[('INCOMPLETE_EVIDENCE', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('INCOMPLETE_EVIDENCE', 106), ('PROBABLE_UNDERSTANDING', 115), ('PROBLEM_COMPLICATION', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 46, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 142, 'vitamin B-12')]
PMC3515553	12/2012	S158-PMC3515553	['limitations\nwith respect to dietary data the use of a ffq to estimate Vitamin B-12 dietary intake without taking into account Vitamin B-12 bioavailability can be CONSIDERED a LIMITATION.']	[('INCOMPLETE_EVIDENCE', 162), ('INCOMPLETE_EVIDENCE', 175)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 70, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 126, 'vitamin B-12')]
PMC3515553	12/2012	S159-PMC3515553	['RECENT work HAS SHOWN that different Foods CAN yield very different Blood concentrations of Vitamin B-12[38].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 43)]	3	[('CHEBI_33290', 'food', 37, 'foods'), ('UBERON_0000178', 'blood', 68, 'blood'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 92, 'vitamin B-12')]
PMC3515553	12/2012	S164-PMC3515553	['additionally, the Snps that we have used HERE as PROXIES for the unconfounded ASSOCIATION of maternal Vitamin B-12 with offspring iq explain ONLY a small proportion of the variance of Plasma Vitamin B-12[11],[39].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 141)]	4	[('SO_0000694', 'SNP', 18, 'SNPs'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 102, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 112, '12'), ('UBERON_0001969', 'blood plasma', 184, 'plasma'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 191, 'vitamin B-12')]
PMC3515553	12/2012	S167-PMC3515553	['because we used smaller subsets of samples from the original alspac study to assess ASSOCIATIONS of Snps with Cord Blood Vitamin B-12 and iq, there is always the POSSIBILITY of these subsets not being representative of the population under study.']	[('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 162)]	2	[('SO_0000694', 'SNP', 100, 'SNPs'), ('UBERON_0009472', 'axilla', 110, 'cord blood'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 121, 'vitamin B-12')]
PMC3515553	12/2012	S169-PMC3515553	['the differences in CONFOUNDERS between sample subsets and the overall alspac sample are UNLIKELY to AFFECT the ASSOCIATION between genotypes and Cord Blood Vitamin B-12 or genotypes and iq because, as EXPECTED, there was no association between genotypes and POTENTIAL CONFOUNDERS, OTHER than what MAY have arisen by chance DUE TO performing a large number of tests on the data.']	[('PROBLEM_COMPLICATION', 19), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 100), ('SUPERFICIAL_RELATIONSHIP', 111), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 258), ('PROBLEM_COMPLICATION', 268), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('INCOMPLETE_EVIDENCE', 297), ('PROBLEM_COMPLICATION', 323)]	10	[('UBERON_0002240', 'spinal cord', 145, 'cord'), ('UBERON_0000178', 'blood', 150, 'blood'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 156, 'vitamin B-12')]
PMC3515553	12/2012	S170-PMC3515553	['conclusions\nIN SUMMARY, we have FOUND that children Born to mothers with a higher dietary intake of Vitamin B-12 had a slightly higher iq than OTHER children, and that those with mothers carrying PUTATIVE Vitamin B-12-increasing Alleles were more LIKELY to have a higher iq than those Born to mothers without these Alleles.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('PROBABLE_UNDERSTANDING', 196), ('PROBABLE_UNDERSTANDING', 247)]	5	[('GO_0007567', 'parturition', 52, 'born'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 100, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 205, 'vitamin B-12'), ('SO_0001023', 'allele', 229, 'alleles'), ('GO_0007567', 'parturition', 285, 'born'), ('SO_0001023', 'allele', 315, 'alleles')]
PMC3515553	12/2012	S171-PMC3515553	['NONETHELESS, the fact that our OBSERVATIONAL ASSOCIATION of maternal dietary Intake attenuated NOTICEABLY with adjustment for CONFOUNDING FACTORS and that the Genetic ASSOCIATIONS are not very strong SUGGESTS that maternal Vitamin B-12 MAY not have an IMPORTANT causal EFFECT on offspring iq.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 95), ('PROBLEM_COMPLICATION', 126), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 200), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 252), ('SUPERFICIAL_RELATIONSHIP', 269)]	10	[('GO_0007631', 'feeding behavior', 77, 'intake'), ('SO_0000704', 'gene', 159, 'genetic'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 223, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 233, '12')]
PMC3521768	12/2012	S27-PMC3521768	['pertaining Vitamin A, a meta-analysis CONCLUDED that Prenatal Vitamin A supplementation does not significantly reduce RISK of lbw[16].']	[('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 118)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin A'), ('GO_0007565', 'female pregnancy', 53, 'prenatal'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin A')]
PMC3521768	12/2012	S32-PMC3521768	['DESPITE the existence of MANY rcts and OBSERVATIONAL studies which evaluated the EFFECT of Prenatal zinc and Vitamin A status on Birthweight, THE CURRENT STUDY is WORTH documentable as it HAS BEEN conducted in area with high prevalence of zinc and Vitamin A deficiencies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 142), ('ANOMALY_CURIOUS_FINDING', 163), ('INCOMPLETE_EVIDENCE', 188)]	8	[('GO_0007565', 'female pregnancy', 91, 'prenatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin A'), ('GO_0007596', 'blood coagulation', 129, 'birthweight'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin A')]
PMC3521768	12/2012	S57-PMC3521768	['HENCE the AVAILABLE sample size consisting of 228 Vitamin A deficient and 347 non-deficient and 316 zinc deficient and 259 non-deficient subjects was judged to be adequate.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin A')]
PMC3521768	12/2012	S143-PMC3521768	['IN ORDER TO INVESTIGATE the POSSIBILITY of synergetic INTERACTION of the two deficiencies in causing lbw, the study subjects were categorized into four groups based on Vitamin A and zinc deficiency statuses and analyzed accordingly (table 3).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 54)]	3	[('CHEBI_27300', 'vitamin D', 168, 'vitamin A')]
PMC3521768	12/2012	S169-PMC3521768	['OBSERVATIONAL studies on the RELATIONSHIP between maternal Vitamin A and Birthweight in apparently health subjects concluded DIVERGENTLY.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 67, 'A'), ('GO_0007596', 'blood coagulation', 73, 'birthweight')]
PMC3534321	12/2012	S65-PMC3534321	['MANY STUDIES about PREVENTION of pe are BASED on primary INTERVENTIONS, when applied to whole population\u2009:\u2009bed rest, restriction of activity or regular exercise, nutritional measures as Reduced Salt intake, and antioxidants such as Vitamins C and e, garlic, marine oil.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_26567', 'N-ribosyl-N(6)-isopentenyladenine', 186, 'reduced salt'), ('CHEBI_27300', 'vitamin D', 232, 'vitamins C')]
PMC3552819	12/2012	S0-PMC3552819	['pharmacokinetics of a single oral dose of Vitamin D3 (70,000 iu) in Pregnant and non-Pregnant women\n\nabstract\n\nbackground\nimprovements in Antenatal Vitamin D status MAY have maternal-infant health benefits.']	[('INCOMPLETE_EVIDENCE', 165)]	1	[('CHEBI_33279', 'vitamin D5', 42, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 42, 'vitamin D3'), ('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('GO_0007565', 'female pregnancy', 85, 'pregnant'), ('GO_0007567', 'parturition', 138, 'antenatal'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC3552819	12/2012	S10-PMC3552819	['these PRELIMINARY DATA SUPPORT the FURTHER INVESTIGATION of Antenatal Vitamin D3 regimens involving doses of ≤70,000 iu in regions where maternal-infant Vitamin D deficiency is common.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 35), ('INCOMPLETE_EVIDENCE', 35)]	4	[('GO_0007567', 'parturition', 60, 'antenatal'), ('CHEBI_33279', 'vitamin D5', 70, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 70, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3552819	12/2012	S12-PMC3552819	['there is considerable SPECULATION regarding the POTENTIAL EFFECTS of Vitamin D on both Skeletal and Extra-Skeletal aspects of Reproductive physiology and Fetal Development, YET it REMAINS UNKNOWN WHETHER there are benefits to improving maternal Antenatal Vitamin D status beyond the correction of SEVERE deficiency [2,3].']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 173), ('FULL_UNKNOWN', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 297)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0004288', 'skeleton', 87, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 100, 'extra-skeletal'), ('GO_0000003', 'reproduction', 126, 'reproductive'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 154, 'fetal development'), ('GO_0007567', 'parturition', 245, 'antenatal'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
PMC3552819	12/2012	S14-PMC3552819	['HOWEVER, VERY FEW STUDIES have rigorously addressed Vitamin D supplementation during Pregnancy, and the single-dose Vitamin D3 Pregnancy trials published to date have provided LITTLE insight into pharmacokinetics or SAFETY [5,6].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 9), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 176), ('IMPORTANT_CONSIDERATION', 216)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('CHEBI_33279', 'vitamin D5', 116, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 116, 'vitamin D3'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy')]
PMC3552819	12/2012	S18-PMC3552819	['the AIM was to generate PRELIMINARY pharmacokinetic (pk) and safety data to inform the design of supplementation regimens for use in FUTURE larger-scale TRIALS of Antenatal Vitamin D supplementation in bangladesh.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 24), ('FUTURE_WORK', 133)]	3	[('GO_0007567', 'parturition', 163, 'antenatal'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC3552819	12/2012	S20-PMC3552819	['reasons for exclusion were a known medical condition, SELF-REPORTED current use of any dietary supplements containing Vitamin D, use of anti-convulsant or anti-Mycobacterial medications, severe anemia (hemoglobin concentration <70 g/l), or hypertension at enrollment (systolic Blood pressure ≥140 mmhg or diastolic Blood pressure ≥90 mmhg on at least two measurements).']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 59)]	2	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 160, 'mycobacterial'), ('UBERON_0000178', 'blood', 277, 'blood'), ('UBERON_0000178', 'blood', 315, 'blood')]
PMC3552819	12/2012	S54-PMC3552819	['participants in the “weekly dose” groups were similarly randomized to one of two schedules (c or d); HOWEVER, the analysis of single-dose pharmacokinetics ONLY included those specimens collected up to and including day 7, preceding administration of the 2nd Vitamin D dose.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 155)]	2	[('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC3552819	12/2012	S113-PMC3552819	['the Stillbirth and newborn deaths were explained by medical problems, and there was NO EVIDENCE that either was RELATED to the Vitamin D supplementation, given their timing (i.e., did not occur at peak [25(Oh)D]) and the absence of biochemical EVIDENCE of Vitamin D toxicity in the mother (table\u20093).']	[('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 244)]	3	[('GO_0001966', 'thigmotaxis', 4, 'stillbirth'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 203, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC3552819	12/2012	S134-PMC3552819	['caption (table-wrap): table 4\n\nPregnancy and newborn outcomes for Pregnant participants who received only a single dose of 70,000 iu Vitamin D at enrollment and were followed up to Deliveryn13Gestational age at Birth , weeks (by lmp)amean (±sd)38.8 (±1.8)range35.7 – 42.0 Preterm, n (%)2 (15%) Birth weightb(g)\xa0mean (±sd)c2441 (±354)range (g)1890 – 3005n/n (%) low Birth weight6/12 (50%) Delivery mode , n/n (%) cesarean sectiond8/13 (62%) sex , n (%) female5 (38%) live Birthse12/13 alive at 1 month of agef11/13\na.in a sample of 113 Deliveries at the study site (october 2009 to january 2010) for which there was a recalled first day of last Menstrual period, the mean Gestational age at Birth was ESTIMATED to be 39.7 weeks (±2.2).']	[('INCOMPLETE_EVIDENCE', 700)]	1	[('GO_0007565', 'female pregnancy', 31, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 66, 'pregnant'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0042742', 'defense response to bacterium', 181, 'deliveryN13Gestational'), ('GO_0007567', 'parturition', 211, 'birth'), ('GO_0007128', 'meiotic prophase I', 272, 'Preterm'), ('GO_0007567', 'parturition', 294, 'Birth'), ('GO_0007567', 'parturition', 365, 'Birth'), ('GO_0007586', 'digestion', 388, 'Delivery'), ('GO_0007596', 'blood coagulation', 471, 'birthse12'), ('GO_0007567', 'parturition', 535, 'deliveries'), ('GO_0007613', 'memory', 644, 'menstrual'), ('UBERON_0001347', 'white adipose tissue', 644, 'menstrual'), ('GO_0007565', 'female pregnancy', 671, 'gestational'), ('GO_0007567', 'parturition', 690, 'birth')]
PMC3552819	12/2012	S189-PMC3552819	['MANY participants DEMONSTRATED a rapid rise in [25(Oh)D] during the first week, which is SIMILAR TO the response to an acute dose of ultraviolet radiation exposure [25]; BUT distinct from the more gradual EFFECTS of OTHER forms of exogenous Vitamin D Intake (e.g., oral D2 Ingestion [10]).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216)]	6	[('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 48, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0007631', 'feeding behavior', 251, 'intake'), ('CHEBI_37987', 'Cy3 dye', 270, 'D2'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 270, 'D2'), ('GO_0007631', 'feeding behavior', 273, 'ingestion')]
PMC3552819	12/2012	S192-PMC3552819	['higher concentrations of Vitamin D-binding protein during Pregnancy [[26] MAY have efficiently buffered the absorbed Vitamin D3 and slowed its Transport To the Liver where it undergoes 25-hydroxylation [27]].']	[('INCOMPLETE_EVIDENCE', 74)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_33279', 'vitamin D5', 117, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 117, 'vitamin D3'), ('GO_0006301', 'postreplication repair', 143, 'transport to ... liver'), ('UBERON_0002107', 'liver', 160, 'liver')]
PMC3552819	12/2012	S201-PMC3552819	['we SPECULATE that the massive dose administered in that study (600,000 iu) saturated the Hepatic 25-hydroxylase system, resulting in the engagement of subsidiary Vitamin D Catabolic pathways which reduced the 25(Oh)D yield.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('UBERON_0002107', 'liver', 89, 'hepatic'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0006281', 'DNA repair', 170, 'D catabolic'), ('CHEBI_71657', 'versiconol acetate', 209, '25(OH)D')]
PMC3552819	12/2012	S202-PMC3552819	['the single Vitamin D3 dose of 70,000 iu did not provoke hypercalcemia or hypercalciuria in non-Pregnant or Pregnant participants, and available data INDICATED that adverse Perinatal events were neither temporally nor mechanistically linked to Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 149)]	1	[('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('GO_0007565', 'female pregnancy', 107, 'pregnant'), ('GO_0036268', 'swimming', 172, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 172, 'perinatal'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC3552819	12/2012	S218-PMC3552819	['these erratic PATTERNS COULD NOT EASILY BE EXPLAINED on THE BASIS OF KNOWN Vitamin D pharmacokinetics, but were MOST LIKELY ATTRIBUTABLE TO small-sample ARTIFACTS, biological variability in the absorption and Metabolism Of Vitamin D, and inherent imprecision in the laboratory assessment of [25(Oh)D].']	[('SUPERFICIAL_RELATIONSHIP', 14), ('DIFFICULT_TASK', 23), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 43), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 137), ('PROBLEM_COMPLICATION', 153)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 209, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 292, '25(OH)D')]
PMC3552819	12/2012	S221-PMC3552819	['LIKEWISE, we DID NOT document any NOTABLE Pregnancy-related hypersensitivity to a Vitamin D dose of 70,000 iu in terms of its EFFECTS on calcium Homeostasis.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 34), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0042592', 'homeostatic process', 145, 'homeostasis')]
PMC3552819	12/2012	S222-PMC3552819	['HOWEVER, the unpredictability of the 25(Oh)D response at the individual level, PREVIOUS REPORTS of adverse EFFECTS of large single doses [23], and the THEORETICAL DISADVANTAGES of excessive fluctuations in Vitamin D status [29] SUGGEST that the use of large single or infrequent intermittent doses of Vitamin D3 MAY BE physiologically DISADVANTAGEOUS DESPITE its practical APPEAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 151), ('IMPORTANT_CONSIDERATION', 163), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 312), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 351), ('ANOMALY_CURIOUS_FINDING', 351), ('IMPORTANT_CONSIDERATION', 373)]	12	[('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 301, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 301, 'vitamin D3')]
PMC3820434	12/2012	S377-PMC3820434	['a POSSIBLE EXPLANATION MAY BE that upon Oral Consumption, circulating and Intracellular levels of Resveratrol in Humans are much lower than that of OTHER IMPORTANT Antioxidants, such as Vitamin C, Uric Acid, Vitamin E, and Glutathione.']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('IMPORTANT_CONSIDERATION', 154)]	5	[('UBERON_0000165', 'mouth', 40, 'oral'), ('GO_0007631', 'feeding behavior', 45, 'consumption'), ('GO_0005622', 'intracellular anatomical structure', 74, 'intracellular'), ('CHEBI_27881', 'resveratrol', 98, 'resveratrol'), ('NCBITaxon_9606', 'Homo sapiens', 113, 'humans'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 164, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin C'), ('CHEBI_27226', 'uric acid', 197, 'uric acid'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin E'), ('CHEBI_16856', 'glutathione', 223, 'glutathione')]
PMC3820434	12/2012	S379-PMC3820434	['THEREFORE, it was HYPOTHESIZED that a Mixture of dietary products (Resveratrol, green tea extract, Α -Tocopherol, Vitamin C, N-3 ( ω -3) polyunsaturated Fatty Acids, and tomato extract) selected for their EVIDENCE-BASED antioxidant and anti-inflammatory EFFECTS MAY yield more healthy EFFECTS than any single Molecule.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 254), ('INCOMPLETE_EVIDENCE', 262), ('SUPERFICIAL_RELATIONSHIP', 285)]	6	[('CHEBI_60004', 'mixture', 38, 'mixture'), ('CHEBI_27881', 'resveratrol', 67, 'resveratrol'), ('CHEBI_27725', 'butin', 99, 'α -tocopherol'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin C'), ('CHEBI_30256', 'thiocarbonyl group', 125, 'n-3'), ('CHEBI_35366', 'fatty acid', 153, 'fatty acids'), ('CHEBI_36357', 'polyatomic entity', 309, 'molecule')]
PMC3888066	12/2012	S0-PMC3888066	['monitoring maternal Beta Carotene and Retinol consumption MAY decrease the incidence of Neurodevelopmental disorders in offspring\n\nabstract\nRetinoic Acids (13-Cis and 13-trans) are known Teratogens, and their precursor is Retinol, a form of Vitamin A.']	[('INCOMPLETE_EVIDENCE', 58)]	1	[('CHEBI_50102', 'N-methyl-N-nitrosourea', 20, 'Beta Carotene'), ('CHEBI_27810', 'resorcinol', 38, 'Retinol'), ('GO_0007285', 'primary spermatocyte growth', 88, 'Neurodevelopmental'), ('CHEBI_26536', 'retinoic acid', 140, 'Retinoic acids'), ('CHEBI_33804', 'gluconates', 156, '13-cis'), ('CHEBI_50114', 'estrogen', 187, 'teratogens'), ('CHEBI_26536', 'retinoic acid', 222, 'retinol'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin A')]
PMC3888066	12/2012	S1-PMC3888066	['in 1995, rothman et al DEMONSTRATED an ASSOCIATION between excessive Vitamin A, >10,000 iu/day, during the first Trimester of Pregnancy and Teratogenic EFFECTS, particularly in the Central Nervous System.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 152)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A'), ('GO_0009294', 'DNA mediated transformation', 113, 'trimester'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('CHEBI_50905', 'teratogenic agent', 140, 'teratogenic'), ('UBERON_0001017', 'central nervous system', 181, 'central nervous system')]
PMC3888066	12/2012	S2-PMC3888066	['HOWEVER, Vitamin A deficiency HAS long BEEN KNOWN to be deleterious to the mother and fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 44)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A')]
PMC3888066	12/2012	S3-PMC3888066	['THEREFORE, there MAY BE a narrow therapeutic ratio for Vitamin A during Pregnancy that has not PREVIOUSLY been fully appreciated.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin A'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy')]
PMC3888066	12/2012	S12-PMC3888066	['this NOTION is BASED ON the KNOWN Teratogenic EFFECTS of Retinoic Acids on the Central Nervous System,1–3the CALCULATED dose of Retinol and Beta Carotene Ingested by the mother during early Pregnancy, and STRONG EVIDENCE that the fetus Metabolizes Beta Carotene to Retinoids and has LIMITED ability to store Beta Carotene in Fat Cells.4–7\nin 1995, rothman et al DEMONSTRATED that high maternal dietary intake of Vitamin A in the form of Retinol, ie, >10,000 iu/day, particularly in the first Trimester, MAY BE ASSOCIATED with Cranial-Neural-Crest Birth defects.8using a smooth regression curve, THIS study of 22,748 Pregnant women and their offspring IDENTIFIED 1 infant in 57 with malformations that COULD BE ATTRIBUTED to the intake of supplements of Preformed Vitamin A at a dose >10,000 iu/day.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 15), ('ANOMALY_CURIOUS_FINDING', 21), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 205), ('INCOMPLETE_EVIDENCE', 283), ('INCOMPLETE_EVIDENCE', 362), ('INCOMPLETE_EVIDENCE', 503), ('SUPERFICIAL_RELATIONSHIP', 510), ('QUESTION_ANSWERED_BY_THIS_WORK', 595), ('INCOMPLETE_EVIDENCE', 651), ('INCOMPLETE_EVIDENCE', 701), ('SUPERFICIAL_RELATIONSHIP', 710)]	16	[('CHEBI_50905', 'teratogenic agent', 34, 'teratogenic'), ('CHEBI_26536', 'retinoic acid', 57, 'retinoic acids'), ('UBERON_0001017', 'central nervous system', 79, 'central nervous system'), ('CHEBI_26536', 'retinoic acid', 128, 'retinol'), ('CHEBI_51438', 'D-isoascorbic acid', 140, 'beta carotene'), ('GO_0007631', 'feeding behavior', 154, 'ingested'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0008152', 'metabolic process', 236, 'metabolizes'), ('CHEBI_51438', 'D-isoascorbic acid', 248, 'beta carotene'), ('CHEBI_26537', 'retinoid', 265, 'retinoids'), ('CHEBI_51438', 'D-isoascorbic acid', 308, 'beta carotene'), ('CL_0000136', 'fat cell', 325, 'fat cells'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 437, 'retinol'), ('GO_0009294', 'DNA mediated transformation', 492, 'trimester'), ('UBERON_0001456', 'face', 526, 'cranial'), ('UBERON_0002342', 'neural crest', 534, 'neural-crest'), ('GO_0007567', 'parturition', 547, 'birth'), ('GO_0007565', 'female pregnancy', 616, 'pregnant'), ('GO_0007565', 'female pregnancy', 753, 'preformed'), ('CHEBI_27300', 'vitamin D', 763, 'vitamin A')]
PMC3888066	12/2012	S14-PMC3888066	['methodologies used in this study HAVE BEEN CRITICIZED, including aggregating Heart defects as Neural Crest defects, ESTIMATING missing information on Retinol supplementation and DEMONSTRATING the Vitamin A threshold of >10,000 iu/day.9SUBSEQUENT STUDIES have DISPUTED the 10,000 iu/day THRESHOLD BASED ON Non-Human Primate STUDIES and SMALL clinical trials in Humans.10\n\nEVIDENCE to SUPPORT the NOTION that a Toxin is responsible for SOME Neurodevelopmental disorders\na Toxin that MAY cause Neurodevelopmental disorders MUST BE able to cross NOT ONLY the Placenta, BUT ALSO the Blood Brain Barrier (bbb).']	[('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 259), ('PROBABLE_UNDERSTANDING', 286), ('INCOMPLETE_EVIDENCE', 296), ('PROBABLE_UNDERSTANDING', 296), ('INCOMPLETE_EVIDENCE', 323), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 371), ('INCOMPLETE_EVIDENCE', 383), ('INCOMPLETE_EVIDENCE', 395), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 481), ('IMPORTANT_CONSIDERATION', 520), ('ANOMALY_CURIOUS_FINDING', 542)]	19	[('UBERON_0000948', 'heart', 77, 'heart'), ('UBERON_0002342', 'neural crest', 94, 'neural crest'), ('CHEBI_26536', 'retinoic acid', 150, 'retinol'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 305, 'non'), ('NCBITaxon_9606', 'Homo sapiens', 309, 'human'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 315, 'primate'), ('NCBITaxon_9606', 'Homo sapiens', 360, 'humans'), ('CHEBI_27026', 'toxin', 409, 'toxin'), ('GO_0007399', 'nervous system development', 439, 'neurodevelopmental'), ('CHEBI_27026', 'toxin', 470, 'toxin'), ('GO_0007399', 'nervous system development', 491, 'neurodevelopmental'), ('UBERON_0001987', 'placenta', 555, 'placenta'), ('UBERON_0000120', 'blood brain barrier', 578, 'blood brain barrier')]
PMC3888066	12/2012	S19-PMC3888066	['finally, neonatal levels of 13-Cis Retinoic Acid are proportionately higher than All-Trans Retinoic Acid levels when compared to maternal levels, SUGGESTING that, in newborns, the equilibrium of cis and trans isomers is shifted toward the more Teratogenic 13-cis Isomer.12this is an IMPORTANT FINDING and POINTS to a deficit in studies that DO NOT demonstrate an association between excess Vitamin A and Birth defects, AS most DO NOT measure levels of Retinoic Acid Isomers in the fetus or newborn.']	[('INCOMPLETE_EVIDENCE', 146), ('IMPORTANT_CONSIDERATION', 283), ('INCOMPLETE_EVIDENCE', 293), ('INCOMPLETE_EVIDENCE', 305), ('INCOMPLETE_EVIDENCE', 341), ('PROBABLE_UNDERSTANDING', 419), ('INCOMPLETE_EVIDENCE', 427)]	7	[('CHEBI_61206', '2-hexenoic acid', 28, '13-cis retinoic acid'), ('CHEBI_16553', 'UDP-4-dehydro-6-deoxy-D-glucose', 81, 'all-trans retinoic acid'), ('CHEBI_50905', 'teratogenic agent', 244, 'teratogenic'), ('GO_0031649', 'heat generation', 244, 'teratogenic'), ('SO_0001017', 'silent_mutation', 263, 'isomer'), ('CHEBI_27300', 'vitamin D', 390, 'vitamin A'), ('GO_0007567', 'parturition', 404, 'birth'), ('CHEBI_26536', 'retinoic acid', 452, 'retinoic acid'), ('SO_0001060', 'sequence_variant', 466, 'isomers')]
PMC3888066	12/2012	S28-PMC3888066	['in addition, studying fetal Mice with knock out lesions for Comi and Retinol Binding Protein, kim et al “demonstrate UNEQUIVOCALLY that Beta Carotene CAN serve as an alternative Vitamin A source for the in situ Synthesis Of Retinoids in developing Tissues by the action of cmoi.”4\nthe equation for isomerization with 13-Trans Retinoic Acid as the energy-favored conformation is:isomerase13-cis\u2009Retinoic\u2009Acid↔13-Trans\u2009Retinoic\u2009Acid\nclearly, an increase in the concentration of 13-Trans Retinoic Acid will shift the equilibrium to the left, increasing Production Of Teratogenic 13-Cis Retinoic Acid.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('INCOMPLETE_EVIDENCE', 150)]	2	[('NCBITaxon_10088', 'Mus <genus>', 28, 'mice'), ('PR_000003266', 'collagen type II alpha chain', 60, 'COMI'), ('CHEBI_26536', 'retinoic acid', 69, 'retinol'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 69, 'retinol binding protein'), ('CHEBI_51438', 'D-isoascorbic acid', 136, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('GO_0010198', 'synergid death', 211, 'synthesis of retinoids'), ('CHEBI_26537', 'retinoid', 224, 'retinoids'), ('UBERON_0000479', 'tissue', 248, 'tissues'), ('CHEBI_38356', 'trans-hex-4-enoic acid', 317, '13-trans retinoic acid'), ('CHEBI_26536', 'retinoic acid', 394, 'retinoic acid'), ('CHEBI_38356', 'trans-hex-4-enoic acid', 408, '13-trans retinoic acid'), ('CHEBI_37983', 'sulfur-35 atom', 476, '13-'), ('CHEBI_64330', 'wybutoxosine', 479, 'trans retinoic acid'), ('GO_0007565', 'female pregnancy', 550, 'production of'), ('CHEBI_50905', 'teratogenic agent', 564, 'teratogenic'), ('GO_0006572', 'tyrosine catabolic process', 564, 'teratogenic ... retinoic acid'), ('CHEBI_61206', '2-hexenoic acid', 576, '13-cis retinoic acid')]
PMC3888066	12/2012	S42-PMC3888066	['ON THE OTHER HAND, the amount of Vitamin A in free-range beef is 7 times greater than in grain-Fed Animals.36thus, IF free-range beef is Eaten on a regular basis in combination with other foods, Vitamins, and Beta Carotene, significant increases in Retinoic Acid COULD result.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 263)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('GO_0007631', 'feeding behavior', 95, 'fed'), ('NCBITaxon_33208', 'Metazoa', 99, 'animals'), ('GO_0036268', 'swimming', 137, 'eaten'), ('CHEBI_33277', 'gamma-tocotrienol', 195, 'vitamins'), ('CHEBI_51438', 'D-isoascorbic acid', 209, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 249, 'retinoic acid')]
PMC3888066	12/2012	S45-PMC3888066	['examples of non-fortified Foods that are high in Vitamin A or beta Carotene are listed intable 5.37\n\ncalculation of Vitamin A and beta Carotene intake during Pregnancy\nthe absorption, Metabolism, storage, and Excretion Of Beta Carotene and Retinol in the mother are NOT COMPLETELY UNDERSTOOD; HOWEVER, most investigators agree that consumption of these forms of Vitamin A is RELATED to maternal Serum levels.38–40in ONE STUDY, maternal diet INFLUENCED Cord levels of Beta Carotene, but not Vitamin A.41absorption Of Beta Carotene from raw carrots and a low fat diet is very low compared to carrot juice.42according to current literature, 6 μg of Ingested Beta Carotene convert to 1 Retinol equivalent, or 1 μg Retinol, but ratios have ranged from 3.3:1 to 26:1.43,44\nbased on the discussion above, it MAY BE apparent that Maternal Ingestion of non-Beta Carotene sources of Vitamin A in foods + fortified foods + nutritional supplements would not LIKELY elevate Retinoic Acid levels in the fetus to Teratogenic levels.']	[('INCOMPLETE_EVIDENCE', 266), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 293), ('SUPERFICIAL_RELATIONSHIP', 375), ('INCOMPLETE_EVIDENCE', 416), ('SUPERFICIAL_RELATIONSHIP', 441), ('INCOMPLETE_EVIDENCE', 801), ('PROBABLE_UNDERSTANDING', 946)]	7	[('CHEBI_33290', 'food', 26, 'foods'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('CHEBI_23042', 'carotene', 67, 'carotene'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin A'), ('CHEBI_23042', 'carotene', 135, 'carotene'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('GO_0008152', 'metabolic process', 184, 'metabolism'), ('GO_0007530', 'sex determination', 209, 'excretion of ... carotene'), ('CHEBI_51438', 'D-isoascorbic acid', 222, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 240, 'retinol'), ('GO_0060033', 'anatomical structure regression', 240, 'retinol'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin A'), ('UBERON_0001977', 'blood serum', 395, 'serum'), ('UBERON_0002240', 'spinal cord', 452, 'cord'), ('CHEBI_51438', 'D-isoascorbic acid', 467, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 490, 'vitamin A'), ('GO_0046311', 'prenylcysteine biosynthetic process', 513, 'of ... carotene'), ('CHEBI_51438', 'D-isoascorbic acid', 516, 'beta carotene'), ('GO_0007631', 'feeding behavior', 646, 'ingested'), ('CHEBI_51438', 'D-isoascorbic acid', 655, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 682, 'retinol'), ('CHEBI_26536', 'retinoic acid', 710, 'retinol'), ('GO_0007618', 'mating', 822, 'maternal'), ('GO_0007631', 'feeding behavior', 831, 'ingestion'), ('CHEBI_51438', 'D-isoascorbic acid', 848, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 961, 'retinoic acid'), ('CHEBI_50905', 'teratogenic agent', 998, 'teratogenic'), ('GO_0031649', 'heat generation', 998, 'teratogenic')]
PMC3888066	12/2012	S52-PMC3888066	['conclusion and implications for care\nhigh levels of fetal Retinoic Acid, a Metabolite of Vitamin A, are KNOWN to be Teratogenic and MAY BE ASSOCIATED with developmental defects of the Central Nervous System, PARTICULARLY involving the Cerebellum, resulting in Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 139), ('IMPORTANT_CONSIDERATION', 208)]	4	[('CHEBI_26536', 'retinoic acid', 58, 'retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 75, 'metabolite'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_50905', 'teratogenic agent', 116, 'teratogenic'), ('UBERON_0001017', 'central nervous system', 184, 'central nervous system'), ('UBERON_0002037', 'cerebellum', 235, 'cerebellum'), ('GO_0007399', 'nervous system development', 260, 'neurodevelopmental')]
PMC3888066	12/2012	S58-PMC3888066	['this author BELIEVES that AWARENESS and simple monitoring of all POTENTIAL sources of Retinoic Acid during the first Trimester of Pregnancy, including nutritional supplements, dietary Vitamin A from Animal sources, and Beta Carotene, MAY decrease the incidence of Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 26), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 234)]	4	[('CHEBI_26536', 'retinoic acid', 86, 'retinoic acid'), ('GO_0009294', 'DNA mediated transformation', 117, 'trimester'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 199, 'animal'), ('CHEBI_86157', 'cadmium sulfate hydrate', 219, 'beta'), ('CHEBI_23042', 'carotene', 224, 'carotene'), ('GO_0007399', 'nervous system development', 264, 'neurodevelopmental')]
PMC3585741	1/2013	S135-PMC3585741	['finally, all the other Nutrients listed (except Vitamin D and zinc) SHOWED an overall nonsignificant TREND for those Consuming below rda levels to be more LIKELY to have epds ≥10 (see table\xa02).']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 101), ('PROBABLE_UNDERSTANDING', 155)]	3	[('CHEBI_33284', 'nutrient', 23, 'nutrients'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007631', 'feeding behavior', 117, 'consuming')]
PMC3599191	1/2013	S200-PMC3599191	['high levels of maternal Vitamin D CAN reduce the RISK of asthma and wheezing in children by up to 60% [108,109].']	[('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 49)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC3599191	1/2013	S201-PMC3599191	['the average dose of Vitamin D to be taken is ABOUT 600 ui/day [110], but MANY STUDIES INDICATE that a higher dose of Vitamin D during Pregnancy and Lactation, up to 1000 ui/day, is NECESSARY to achieve a good level of Vitamin D assets [111].']	[('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 181)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('GO_0007595', 'lactation', 148, 'lactation'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC3659910	1/2013	S2-PMC3659910	['RESEARCH INDICATES that adequate Vitamin D intake in Pregnancy is OPTIMAL for maternal, fetal and child health.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 66)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 53, 'pregnancy')]
PMC3659910	1/2013	S8-PMC3659910	['the CURRENTLY RECOMMENDED supplementation amount of Vitamin D is NOT SUFFICIENT to maintain a value of 25 Hydroxy Vitamin D above 30 ng/ml, during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_WORK', 14), ('IMPORTANT_CONSIDERATION', 65)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_45557', 'sec-butyl group', 103, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 122, 'D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
PMC3659910	1/2013	S9-PMC3659910	['STUDIES ARE UNDERWAY to establish the RECOMMENDED daily doses of Vitamin D in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 38)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnant')]
PMC3659910	1/2013	S16-PMC3659910	['[1] the QUESTION scientists HAVE BEEN working on for almost a decade is WHY and HOW Vitamin D is AFFECTING Conception, Pregnancy and the health of the newborn.']	[('EXPLICIT_QUESTION', 8), ('INCOMPLETE_EVIDENCE', 28), ('EXPLICIT_QUESTION', 72), ('EXPLICIT_QUESTION', 80), ('SUPERFICIAL_RELATIONSHIP', 97)]	5	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007620', 'copulation', 107, 'conception'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy')]
PMC3659910	1/2013	S19-PMC3659910	['[2] there are increasing STUDIES worldwide reporting POOR Vitamin D status, including those in tropical countries.']	[('INCOMPLETE_EVIDENCE', 25), ('IMPORTANT_CONSIDERATION', 53)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC3659910	1/2013	S20-PMC3659910	['the PREVALENCE of Vitamin D deficiency has been REPORTED to range from 15% to 80%.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 48)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC3659910	1/2013	S55-PMC3659910	['[12] Vitamin D deficiency CAN result in lower bone Mineral density and an INCREASED RISK of bone loss (osteoporosis) or bone fracture BECAUSE a lack of Vitamin D alters Mineral Metabolism in the body.']	[('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 74), ('PROBABLE_UNDERSTANDING', 134)]	3	[('CHEBI_28384', 'vitamin K', 5, 'Vitamin D'), ('CHEBI_46662', 'mineral', 51, 'mineral'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_46662', 'mineral', 169, 'mineral'), ('GO_0008152', 'metabolic process', 177, 'metabolism')]
PMC3659910	1/2013	S61-PMC3659910	['in the united states staple Foods like milk, breakfast cereals and margarines are artificially fortified with Vitamin D.[14] AT PRESENT, the number and variety of Vitamin D fortified foods available on the market DIFFERS significantly between countries and is ATTRIBUTED to the country-specific policies on Food fortification which are NOT YET unified.']	[('INCOMPLETE_EVIDENCE', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('SUPERFICIAL_RELATIONSHIP', 260), ('FUTURE_WORK', 336)]	4	[('CHEBI_33290', 'food', 28, 'foods'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_33290', 'food', 307, 'food')]
PMC3659910	1/2013	S65-PMC3659910	['methods are CURRENTLY available to quantify the CONTRIBUTION of Endogenous Vitamin D Synthesis resulting from sun exposure, BUT SERIOUS LIMITATIONS REMAIN in ACCURATELY ESTIMATING dietary Vitamin D intake BECAUSE of the INCOMPLETENESS of Nutrient databases for both Vitamin D-fortified Food and Vitamin D supplements.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBLEM_COMPLICATION', 124), ('IMPORTANT_CONSIDERATION', 128), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 158), ('INCOMPLETE_EVIDENCE', 169), ('PROBLEM_COMPLICATION', 205), ('INCOMPLETE_EVIDENCE', 220)]	10	[('GO_0009790', 'embryo development', 64, 'endogenous'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 75, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_33284', 'nutrient', 238, 'nutrient'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_33290', 'food', 286, 'food'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC3659910	1/2013	S78-PMC3659910	['[17] NEW RESEARCH SUGGESTS that women who take high doses of Vitamin D during Pregnancy have a greatly reduced RISK of COMPLICATIONS, including Gestational diabetes, preterm Birth, and infection.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 111), ('IMPORTANT_CONSIDERATION', 119)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0007565', 'female pregnancy', 144, 'gestational'), ('GO_0007567', 'parturition', 174, 'birth')]
PMC3659910	1/2013	S79-PMC3659910	['[18] this RECOMMENDATION MAY BE CONTROVERSIAL BECAUSE very high doses of Vitamin D HAVE long BEEN BELIEVED to cause Birth defects.']	[('FUTURE_WORK', 10), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('PROBABLE_UNDERSTANDING', 46), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007567', 'parturition', 116, 'birth')]
PMC3659910	1/2013	S85-PMC3659910	['VARIOUS Human STUDIES are done SO FAR involving Pharmacological doses of Vitamin D during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31)]	2	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('CHEBI_52217', 'pharmaceutical', 48, 'pharmacological'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy')]
PMC3659910	1/2013	S88-PMC3659910	['REPORTED that as hypoparathyroid patients have completed many Pregnancies while receiving Ergocalciferol,[21] it is UNLIKELY that material Vitamin D, 25(Oh) D, or 24,25(Oh) 2D per se are Teratogens.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 116)]	2	[('GO_0007565', 'female pregnancy', 62, 'pregnancies'), ('CHEBI_4910', 'etomidate', 90, 'ergocalciferol'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH) D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 166, '25(OH) 2D'), ('CHEBI_50114', 'estrogen', 187, 'teratogens')]
PMC3659910	1/2013	S97-PMC3659910	['RECENT work EMPHASIZES the IMPORTANCE of NON-CLASSICAL ROLES of Vitamin D in Pregnancy and the Placenta.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 12), ('IMPORTANT_CONSIDERATION', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 55)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('UBERON_0001987', 'placenta', 95, 'placenta')]
PMC3659910	1/2013	S99-PMC3659910	['women who have Vitamin D deficiency do not USUALLY feel any different BUT in SOME MAY have muscle weakness and weakened Bones.']	[('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 70), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 82)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001474', 'bone element', 120, 'bones')]
PMC3659910	1/2013	S101-PMC3659910	['a NEW STUDY FINDS that women who develop SEVERE Preeclampsia TEND to have lower Blood levels of Vitamin D than healthy Pregnant women raising the POSSIBILITY that the vitamin plays a ROLE in the COMPLICATION.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 41), ('PROBABLE_UNDERSTANDING', 61), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 183), ('IMPORTANT_CONSIDERATION', 195)]	7	[('GO_0007128', 'meiotic prophase I', 48, 'preeclampsia'), ('UBERON_0000178', 'blood', 80, 'blood'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnant')]
PMC3659910	1/2013	S105-PMC3659910	['STUDIES by other groups HAVE REPORTED abnormal Expression of 1α-hydroxylase, a Vitamin D—activating enzyme in Preeclamptic Pregnancies, REVEALING a POTENTIAL ROLE for 1,25(Oh) 2D3 as a REGULATOR of Placentation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 158), ('SUPERFICIAL_RELATIONSHIP', 185)]	6	[('GO_0010467', 'gene expression', 47, 'expression'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'preeclamptic'), ('GO_0007565', 'female pregnancy', 123, 'pregnancies'), ('CHEBI_73394', 'Ala-Ser', 169, '25(OH) 2D3'), ('PR_000010977', 'nucleosome assembly protein 1-like 3', 169, '25(OH) 2D3'), ('GO_0001890', 'placenta development', 198, 'placentation')]
PMC3659910	1/2013	S106-PMC3659910	['induction of the 1α-hydroxylase in early Gestation MIGHT provide a mechanism by which environmental or dietary Vitamin D CAN INFLUENCE fetal-Placental Development.']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 125)]	3	[('GO_0007565', 'female pregnancy', 41, 'gestation'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0001890', 'placenta development', 141, 'placental development'), ('UBERON_0001987', 'placenta', 141, 'placental')]
PMC3659910	1/2013	S107-PMC3659910	['two clinical trials SUPPORT a POTENTIAL ROLE of Vitamin D in the PREVENTION of Preeclampsia, ALTHOUGH neither of these treated with Vitamin D supplements alone.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 40), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 93)]	5	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 79, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3659910	1/2013	S118-PMC3659910	['nutritional Vitamin D status has very RECENTLY been LINKED to the Human innate Immune System and its ability to contain mycobacterium tuberculosis.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 66, 'human'), ('GO_0007566', 'embryo implantation', 79, 'immune'), ('UBERON_0002405', 'immune system', 79, 'immune system')]
PMC3659910	1/2013	S122-PMC3659910	['CONVERSELY, Vitamin D deficiency results in proximal muscle weakness and decreased Lower Extremity muscle function PERHAPS CONTRIBUTING TO the RISK for cesarean section.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 143)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0002103', 'hindlimb', 83, 'lower extremity')]
PMC3659910	1/2013	S124-PMC3659910	['the cochrane review CONCLUDED that there is NOT ENOUGH EVIDENCE TO EVALUATE the REQUIREMENTS and EFFECTS of Vitamin D supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 55), ('FUTURE_WORK', 64), ('IMPORTANT_CONSIDERATION', 80), ('SUPERFICIAL_RELATIONSHIP', 97)]	6	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnancy')]
PMC3659910	1/2013	S125-PMC3659910	['data from three trials involving 463 women SHOW a TREND for women who receive Vitamin D supplementation during Pregnancy to more frequently have a baby with a Birth weight below 2500 grams than those women receiving no treatment or placebo, ALTHOUGH the statistical significance was borderline.']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 50), ('PROBLEM_COMPLICATION', 241)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('GO_0007567', 'parturition', 159, 'birth')]
PMC3659910	1/2013	S126-PMC3659910	['Animal MODELS of Vitamin D deficiency HAVE SHOWN just how IMPORTANT adequate nutritional intakes of Vitamin D are to Skeletal, Cardiovascular, and Neurologic Development in experimental Animals.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 58)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0001501', 'skeletal system development', 117, 'skeletal ...'), ('UBERON_0001442', 'skeleton of manus', 117, 'skeletal ...'), ('GO_0002026', 'regulation of the force of heart contraction', 127, 'cardiovascular ...'), ('UBERON_0004535', 'cardiovascular system', 127, 'cardiovascular'), ('GO_0007399', 'nervous system development', 147, 'neurologic development'), ('UBERON_0001016', 'nervous system', 147, 'neurologic'), ('NCBITaxon_33208', 'Metazoa', 186, 'animals')]
PMC3659910	1/2013	S127-PMC3659910	['[27] weishaar and simpson[28] SHOWED that lengthy periods of Vitamin D deficiency in Rats are ASSOCIATED with PROFOUND changes in Cardiovascular function, including increases in Cardiac and vascular muscle Contractile function.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 94), ('IMPORTANT_CONSIDERATION', 110)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 85, 'rats'), ('UBERON_0004535', 'cardiovascular system', 130, 'cardiovascular'), ('UBERON_0000948', 'heart', 178, 'cardiac'), ('GO_0006936', 'muscle contraction', 206, 'contractile')]
PMC3659910	1/2013	S128-PMC3659910	['a RECENT STUDY provides EVIDENCE with reference to the CONSEQUENCES of Vitamin D deficiency on the Neurodevelopment Of the Fetus during Pregnancy in a Rat MODEL.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 155)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0001503', 'ossification', 99, 'neurodevelopment of ... fetus'), ('GO_0007565', 'female pregnancy', 136, 'pregnancy'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 151, 'rat')]
PMC3659910	1/2013	S129-PMC3659910	['[28] a study on rodents SHOWED that hypovitaminosis D Trabecular Bone loss, and CONCLUDED that Vitamin D is INDISPENSABLE for normal bone mineralization during the Reproductive period in Rats.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 80), ('IMPORTANT_CONSIDERATION', 108)]	3	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 52, 'D'), ('UBERON_0002483', 'trabecular bone tissue', 54, 'trabecular bone'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0000003', 'reproduction', 164, 'reproductive'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 187, 'rats')]
PMC3659910	1/2013	S131-PMC3659910	['RESEARCH has FOUND direct CONNECTIONS between Vitamin D and the Genes KNOWN to be INVOLVED in ms, BUT exact pathology and WHETHER Vitamin D supplements during Pregnancy OR childhood can lessen the likelihood of the child developing ms later in Life is NOT KNOWN.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 82), ('ANOMALY_CURIOUS_FINDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('FULL_UNKNOWN', 252)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('SO_0000704', 'gene', 64, 'genes'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy'), ('UBERON_0000104', 'life cycle', 244, 'life')]
PMC3659910	1/2013	S132-PMC3659910	['while there is INTEREST in the ROLE of Vitamin D in the PREVENTION of multiple sclerosis, following epidemiological STUDIES DEMONSTRATING an ASSOCIATION between Vitamin D supplementation and reduced PREVALENCE of the disease, FUTURE RESEARCH, including randomized controlled trials in Pregnant or nonpregnant Individuals, is AWAITED TO CONFIRM OR REFUTE such BENEFIT.']	[('IMPORTANT_CONSIDERATION', 15), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 141), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 226), ('FUTURE_WORK', 325), ('FUTURE_WORK', 333), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 344), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('IMPORTANT_CONSIDERATION', 359)]	13	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 285, 'pregnant'), ('NCBITaxon_1', 'root', 309, 'individuals')]
PMC3659910	1/2013	S133-PMC3659910	['BECAUSE the POOR Vitamin D stores of the mother MAY impair Vitamin D state in the infant, it is IMPORTANT to know WHETHER rickets can be PREVENTED in breast Fed infants by supplementation of the mother.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 96), ('EXPLICIT_QUESTION', 114), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007631', 'feeding behavior', 157, 'fed')]
PMC3659910	1/2013	S136-PMC3659910	['a sufficient supply of Vitamin D to the Breast Fed infant is achieved ONLY by increasing the maternal supplementation up to 2000 iu/day.']	[('INCOMPLETE_EVIDENCE', 70)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007567', 'parturition', 40, 'breast fed'), ('UBERON_0000310', 'breast', 40, 'breast')]
PMC3659910	1/2013	S138-PMC3659910	['OTHER SUGGESTS Vitamin D supplementation of 400 iu/day to Breast Fed infants is the MOST secure way of PREVENTING rickets in infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 103)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007567', 'parturition', 58, 'breast fed')]
PMC3659910	1/2013	S141-PMC3659910	['Vitamin D-deficiency in mothers have significantly INCREASED RISK of infantile rickets DUE TO INADEQUATE Maternal–fetal transfer of 25-Hydroxyvitamin D.[32] RECENT retrospective STUDIES FOUND a significant and PREVIOUSLY UNDETECTED ASSOCIATION of maternal Vitamin D deficiency with rickets-ASSOCIATED infant Heart Failure and with acute Lower Respiratory Tract infection,[33] a SERIOUS COMPLICATION OFTEN ASSOCIATED with sepsis without clinical signs of rickets.']	[('IMPORTANT_CONSIDERATION', 51), ('PROBABLE_UNDERSTANDING', 87), ('IMPORTANT_CONSIDERATION', 94), ('INCOMPLETE_EVIDENCE', 157), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 186), ('INCOMPLETE_EVIDENCE', 210), ('ANOMALY_CURIOUS_FINDING', 221), ('SUPERFICIAL_RELATIONSHIP', 232), ('SUPERFICIAL_RELATIONSHIP', 290), ('IMPORTANT_CONSIDERATION', 378), ('IMPORTANT_CONSIDERATION', 386), ('PROBABLE_UNDERSTANDING', 399), ('SUPERFICIAL_RELATIONSHIP', 405)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007618', 'mating', 105, 'maternal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 132, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0002081', 'cardiac atrium', 308, 'heart failure'), ('UBERON_0004905', 'articulation', 337, 'lower respiratory tract')]
PMC3659910	1/2013	S142-PMC3659910	['while Vitamin D supplementation in Pregnancy has PREVIOUSLY been ASSOCIATED with reduced RISK of wheezing and type 1 diabetes.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 89)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy')]
PMC3659910	1/2013	S149-PMC3659910	['women of indian origin, ESPECIALLY Pregnant women, are KNOWN to have a high PREVALENCE of Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 55), ('IMPORTANT_CONSIDERATION', 76)]	3	[('GO_0007565', 'female pregnancy', 35, 'pregnant'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3659910	1/2013	S154-PMC3659910	['AT PRESENT, Vitamin D supplementation is not a part of Antenatal Care programs in india.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 55, 'antenatal care')]
PMC3659910	1/2013	S160-PMC3659910	['[43] IF electing to test Vitamin D status, Serum 25-Hydroxyvitamin D is the ACCEPTED BIOMARKER to be offered early in Pregnancy.']	[('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 49, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
PMC3659910	1/2013	S163-PMC3659910	['a large laboratory (quest diagnostics) RECENTLY REPORTED the POSSIBILITY of thousands of INCORRECT Vitamin D level results.']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 61), ('PROBLEM_COMPLICATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC3659910	1/2013	S166-PMC3659910	['[44] CONTROVERSY exists regarding the optimum concentration of Serum 25-Hydroxyvitamin D for DEFINING Vitamin D deficiency, ESPECIALLY in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 93), ('IMPORTANT_CONSIDERATION', 124)]	3	[('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 69, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy')]
PMC3659910	1/2013	S169-PMC3659910	['as was RECENTLY POINTED out in a cochrane review, the topic of maternal Vitamin D REQUIREMENTS during Pregnancy HAS BEEN POORLY studied.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 112), ('PROBLEM_COMPLICATION', 121)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy')]
PMC3659910	1/2013	S172-PMC3659910	['there is NO dietary RECOMMENDED intake (dri) for Vitamin D. what IS KNOWN today is that for a Pregnant woman, the adequate intake for Vitamin D is 200 iu per day.']	[('FULL_UNKNOWN', 9), ('FUTURE_WORK', 20), ('INCOMPLETE_EVIDENCE', 65)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnant'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3659910	1/2013	S173-PMC3659910	['HOWEVER this RECOMMENDED level, which was LARGELY ARBITRARILY set, SEEMS TO BE LESS HELPFUL to improve the nutritional Vitamin D status of Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('ANOMALY_CURIOUS_FINDING', 67), ('FUTURE_PREDICTION', 73), ('IMPORTANT_CONSIDERATION', 79)]	7	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'pregnant')]
PMC3659910	1/2013	S175-PMC3659910	['a RECENT systematic review CONCLUDED that Antenatal Vitamin D supplementation is EFFECTIVE in improving the Vitamin D status of asian and white women, improves growth in the first year of Life in south asian babies and THEREFORE MAY CONTRIBUTE to reducing the incidence of rickets in this latter group, without evidence of harm.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 81), ('PROBABLE_UNDERSTANDING', 219), ('FUTURE_PREDICTION', 229), ('SUPERFICIAL_RELATIONSHIP', 233)]	6	[('GO_0007567', 'parturition', 42, 'antenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000104', 'life cycle', 188, 'life')]
PMC3659910	1/2013	S177-PMC3659910	["current nice GUIDANCE STATES clearly that Pregnant women are informed, at their first Antenatal booking, of the IMPORTANCE of adequate Vitamin D during Pregnancy and after, to maintain their own and their baby's health."]	[('FUTURE_WORK', 13), ('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 112)]	3	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('GO_0007567', 'parturition', 86, 'antenatal'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy')]
PMC3659910	1/2013	S185-PMC3659910	['HOWEVER, getting 25(Oh) D levels consistently above 75 nmol/l (30 ng/ml) MAY REQUIRE AT LEAST 1500-2000 iu/day of Vitamin D. if a mother is Vitamin D deficient, Breast Milk is not a good source of Vitamin D, so infants need to be given Vitamin D supplementation until they are weaned.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 73), ('FUTURE_WORK', 77), ('PROBABLE_UNDERSTANDING', 85)]	4	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 24, 'D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('UBERON_0000310', 'breast', 161, 'breast'), ('UBERON_0001913', 'milk', 168, 'milk'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
PMC3659910	1/2013	S187-PMC3659910	['it was RECENTLY SHOWN that a maternal supplementation of 2100 iu Vitamin D/day was NEEDED, when administered during the period of Lactation, in order to observe an increase in Serum levels of 25(Oh) D in the Breast-Fed infants comparable to that observed in children given 400 iu/day.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 83)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007595', 'lactation', 130, 'lactation'), ('UBERON_0001977', 'blood serum', 176, 'serum'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH) D'), ('PR_000010220', 'mannose-binding protein C', 194, '('), ('PR_000006444', 'diacylglycerol kinase delta', 199, 'D'), ('GO_0007567', 'parturition', 208, 'breast'), ('UBERON_0000310', 'breast', 208, 'breast'), ('GO_0007631', 'feeding behavior', 215, 'fed')]
PMC3659910	1/2013	S189-PMC3659910	['the current LACK OF EVIDENCE of benefit for women at lower RISK of Vitamin D deficiency points to the NEED FOR FURTHER RESEARCH into Vitamin D supplementation in Pregnant women with clinical neonatal and infant end-points under SCRUTINY.']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 59), ('FUTURE_WORK', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007565', 'female pregnancy', 162, 'pregnant')]
PMC3809191	1/2013	S17-PMC3809191	['Serum 25 (Oh) D levels ≤20 ng/ml are ACCEPTED AS the cutoff level for Vitamin D deficiency SINCE this level was the highest level to maintain the Serum pth levels below 45 pg/ml.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 46), ('PROBABLE_UNDERSTANDING', 91)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25 (OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 6, '25 (OH) D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0001977', 'blood serum', 146, 'serum')]
PMC3809191	1/2013	S18-PMC3809191	['Pregnant women with history of Pregestational diabetes, multiple Pregnancies, fetal abnormality, chronic Renal or Liver failure and history of Consumption of Calcium supplements or Vitamin D were EXCLUDED from the study.']	[('INCOMPLETE_EVIDENCE', 196)]	1	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0007565', 'female pregnancy', 31, 'pregestational'), ('GO_0007565', 'female pregnancy', 65, 'pregnancies'), ('UBERON_0002113', 'kidney', 105, 'renal'), ('UBERON_0002107', 'liver', 114, 'liver'), ('GO_0007631', 'feeding behavior', 143, 'consumption'), ('CHEBI_22313', 'alkaline earth metal atom', 158, 'calcium'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC3809191	1/2013	S49-PMC3809191	['Dental problems and muscle cramps were SEEN more frequent in Vitamin D deficient Pregnant women COMPARED TO non-Vitamin D deficient Pregnant women (fig.']	[('INCOMPLETE_EVIDENCE', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96)]	2	[('UBERON_0001091', 'calcareous tooth', 0, 'Dental'), ('CHEBI_28384', 'vitamin K', 61, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'pregnant')]
PMC3809191	1/2013	S53-PMC3809191	['THIS EVIDENCE is CONSISTENT with low Vitamin D levels in either Pregnant or non-Pregnant Individuals in our country as in the rest of the world.11,12HOWEVER we did not FIND significant association of low levels of Serum 25 (Oh) D with elevated RISK for gdm EVEN after adjustment for conventional risk FACTORS for diabetes.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 168), ('IMPORTANT_CONSIDERATION', 244), ('ANOMALY_CURIOUS_FINDING', 257), ('SUPERFICIAL_RELATIONSHIP', 301)]	8	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('GO_0007565', 'female pregnancy', 80, 'pregnant'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('UBERON_0001977', 'blood serum', 214, 'serum'), ('CHEBI_71657', 'versiconol acetate', 220, '25 (OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25 (OH) D')]
PMC3809191	1/2013	S54-PMC3809191	['data RELATING Vitamin D status to gdm RISK are INCONSISTENT and LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('IMPORTANT_CONSIDERATION', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 64)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
PMC3809191	1/2013	S55-PMC3809191	['in ONE cross-sectional STUDY, Serum 25(Oh) D levels during 24-28 weeks of Gestation were lower in gdm women than in nondiabetic Pregnant women.9in ANOTHER STUDY, maternal Serum 25 (Oh) D concentrations measured at the time of gdm screening test were significantly and inversely ASSOCIATED with fasting glucose, ALTHOUGH the ASSOCIATION of Vitamin D with gdm risk was not statistically significant.8our FINDINGS are also CONSISTENT with a study in an indian population, SHOWING no significant ASSOCIATION between 25 (Oh) D concentrations (at 30 weeks of Gestation) and gdm risk.6\ndeficiency of Vitamin D was shown to be ASSOCIATED with fetal and Brain growth deficiency and type 1 diabetes in children.13significantly reduced risk of type 1 Diabetes Mellitus Development was FOUND when high doses of Vitamin D supplementation (up to 2000 iu/d) were given during infancy in a Birth-cohort study.14\nVitamin D deficiency was also ASSOCIATED with INCREASED risk for Pregnancy complications and SERIOUS health PROBLEMS in the offspring.5,15-17higher risks of Preeclampsia and cesarean section ratios were shown in Pregnants with low levels of Vitamin D.16,17moreover supplementation of Vitamin D HAS BEEN DEMONSTRATED to decrease the RISK of Preeclampsia by 27% in a STUDY.18\n\ncaption (fig): fig.1\n\nthe correlation between Serum Vitamin D and pth levels\n\ncaption (fig): fig.2\n\nSerum Vitamin D levels in veiled and nonveiled Pregnant\n\ncaption (fig): fig.3\n\nVitamin D levels and the frequency of muscle cramps (x²=3.57, p=0.05).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 278), ('ANOMALY_CURIOUS_FINDING', 311), ('SUPERFICIAL_RELATIONSHIP', 324), ('INCOMPLETE_EVIDENCE', 402), ('INCOMPLETE_EVIDENCE', 420), ('INCOMPLETE_EVIDENCE', 469), ('SUPERFICIAL_RELATIONSHIP', 492), ('SUPERFICIAL_RELATIONSHIP', 619), ('INCOMPLETE_EVIDENCE', 774), ('SUPERFICIAL_RELATIONSHIP', 926), ('IMPORTANT_CONSIDERATION', 942), ('IMPORTANT_CONSIDERATION', 989), ('IMPORTANT_CONSIDERATION', 1004), ('INCOMPLETE_EVIDENCE', 1190), ('IMPORTANT_CONSIDERATION', 1228), ('INCOMPLETE_EVIDENCE', 1261)]	19	[('UBERON_0001977', 'blood serum', 30, 'serum'), ('CHEBI_71657', 'versiconol acetate', 36, '25(OH) D'), ('PR_000008838', 'serine protease HTRA1', 36, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('GO_0007565', 'female pregnancy', 128, 'pregnant'), ('UBERON_0001977', 'blood serum', 171, 'serum'), ('CHEBI_71657', 'versiconol acetate', 177, '25 (OH) D'), ('PR_000009880', 'Lon protease, mitochondrial', 177, '25 ... OH ... D'), ('CHEBI_28384', 'vitamin K', 339, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 339, 'Vitamin'), ('CHEBI_71657', 'versiconol acetate', 512, '25 (OH) D'), ('GO_0007565', 'female pregnancy', 553, 'gestation'), ('CHEBI_27300', 'vitamin D', 593, 'vitamin D'), ('UBERON_0000955', 'brain', 645, 'brain'), ('GO_1903709', 'uterine gland development', 740, 'diabetes mellitus development'), ('CHEBI_27300', 'vitamin D', 799, 'vitamin D'), ('GO_0007567', 'parturition', 874, 'birth'), ('CHEBI_28384', 'vitamin K', 896, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 961, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 1053, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 1108, 'pregnants'), ('CHEBI_28384', 'vitamin K', 1137, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 1180, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 1236, 'preeclampsia'), ('UBERON_0001977', 'blood serum', 1317, 'serum'), ('CHEBI_28384', 'vitamin K', 1323, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1323, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 1371, 'Serum'), ('CHEBI_28384', 'vitamin K', 1377, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1377, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1418, 'pregnant'), ('CHEBI_28384', 'vitamin K', 1450, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1450, 'Vitamin D')]
PMC3809191	1/2013	S60-PMC3809191	['first, Serum 25 (Oh) D concentrations determined in late trimester MAY not show the status of maternal Vitamin D during the whole Pregnancy Period and HENCE to IDENTIFY the ASSOCIATION of Gdm Development and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 67), ('PROBABLE_UNDERSTANDING', 151), ('QUESTION_ANSWERED_BY_THIS_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('UBERON_0001977', 'blood serum', 7, 'serum'), ('CHEBI_71657', 'versiconol acetate', 13, '25 (OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 21, 'D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('UBERON_0018298', 'stylocone', 130, 'pregnancy period'), ('GO_0072147', 'glomerular parietal epithelial cell fate commitment', 188, 'GDM development'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D')]
PMC3809191	1/2013	S64-PMC3809191	['ALTHOUGH there is NO CONSENSUS for routine Vitamin D screening in Pregnancy, being ALERT about the vitamin\xa0d deficiency and its symptoms and optimising when NECESSARY by replacement and/or through taking lifestyle measures MAY BE RECOMMENDED to prevent the Birth of Vitamin D-deficient infants from Vitamin D-deficient mothers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 157), ('INCOMPLETE_EVIDENCE', 223), ('FUTURE_WORK', 230)]	7	[('CHEBI_28384', 'vitamin K', 43, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007567', 'parturition', 257, 'birth'), ('CHEBI_28384', 'vitamin K', 266, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 266, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC3901983	1/2013	S95-PMC3901983	['SEVERAL STUDIES have presented an INCREASED RISK of bronchopulmonary dysplasia (bpd) in preterm infants with insufficient Vitamin A status [17].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 34)]	2	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
PMC3901983	1/2013	S97-PMC3901983	['it HAS BEEN SUGGESTED that the Vitamin A status of Pregnant women CAN INFLUENCE Vitamin A stores in the fetus Liver [20].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin A'), ('GO_0007565', 'female pregnancy', 51, 'pregnant'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('UBERON_0002107', 'liver', 110, 'liver')]
PMC3901983	1/2013	S103-PMC3901983	['there are no reports now on the NUMBER of Pregnant women presenting this disturbance, BUT it is NOTABLE that Vitamin K has already limited Placental Transfer during normal Pregnancy.']	[('INCOMPLETE_EVIDENCE', 32), ('ANOMALY_CURIOUS_FINDING', 86), ('ANOMALY_CURIOUS_FINDING', 96)]	3	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin K'), ('GO_0001966', 'thigmotaxis', 139, 'placental transfer'), ('UBERON_0001987', 'placenta', 139, 'placental'), ('GO_0007565', 'female pregnancy', 172, 'pregnancy')]
PMC3901983	1/2013	S104-PMC3901983	['the excessive vomiting or fat malabsorbtion, AFFECTING Pregnant women after bariatric surgery, MAY lead to a higher risk of Vitamin K-deficient bleeding disorders of the neonates of these mothers.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 95)]	2	[('GO_0007565', 'female pregnancy', 55, 'pregnant'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin K')]
PMC3901983	1/2013	S107-PMC3901983	['it is the FIRST well-DOCUMENTED REPORT RELATING to maternal Vitamin K deficiency and following COMPLICATIONS.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 95)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin K')]
PMC3901983	1/2013	S128-PMC3901983	['antioxidants, such as Vitamin C, Vitamin E, Selenium, and Lycopene, COULD neutralize Free Radicals.']	[('INCOMPLETE_EVIDENCE', 68)]	1	[('CHEBI_27300', 'vitamin D', 22, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 44, 'selenium'), ('CHEBI_15948', 'lycopene', 58, 'lycopene'), ('CHEBI_26519', 'radical', 85, 'free radicals')]
PMC3901983	1/2013	S162-PMC3901983	['it is ESSENTIAL to maintain Micronutrients supplementation also after Delivery and during breastfeeding, to ensure appropriate Vitamins and Minerals intake to neonate and to prevent Vitamin B deficiency, which CAN INDICATE SEVERE COMPLICATIONS including failure in thriving, megaloblastic anemia, and development delays [3,14].']	[('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 214), ('IMPORTANT_CONSIDERATION', 223), ('PROBLEM_COMPLICATION', 230)]	5	[('CHEBI_33839', 'macromolecule', 28, 'micronutrients'), ('GO_0007567', 'parturition', 70, 'delivery'), ('CHEBI_33277', 'gamma-tocotrienol', 127, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 140, 'minerals'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin B')]
PMC3901983	1/2013	S163-PMC3901983	['it was REPORTED that after adequate Vitamin B supplementation improvements in growth, development and reversal of anemia are OBSERVED [7].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 125)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin B')]
PMC3582478	2/2013	S10-PMC3582478	['changes in Fatty Acid composition during Pregnancy quickly return to the normal range following Parturition HOWEVER, an increase in the Omega-6/3 ratio increases the risk of Ppd11,12low maternal Omega-3 Polyunsaturated Fatty Acid Intake is SUGGESTED to CONTRIBUTE to decreased maternal and fetal health, INTERACTING with the Serotonin transporter Alleles to CONTRIBUTE TO ppd.13\ndecreased Pregnancy Vitamin D ASSOCIATES with many RISK FACTORS for ppd, including Preeclampsia,14SUGGESTING that it will indirectly Modulate ppd susceptibility.']	[('ANOMALY_CURIOUS_FINDING', 108), ('INCOMPLETE_EVIDENCE', 240), ('SUPERFICIAL_RELATIONSHIP', 253), ('SUPERFICIAL_RELATIONSHIP', 304), ('SUPERFICIAL_RELATIONSHIP', 358), ('SUPERFICIAL_RELATIONSHIP', 409), ('SUPERFICIAL_RELATIONSHIP', 430), ('INCOMPLETE_EVIDENCE', 475)]	8	[('CHEBI_35366', 'fatty acid', 11, 'fatty acid'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('GO_0019230', 'proprioception', 96, 'parturition'), ('CHEBI_30823', 'oleate', 136, 'omega'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 174, 'PPD11'), ('CHEBI_79370', 'ibho#10', 195, 'omega-3'), ('GO_0033576', 'protein glycosylation in cytosol', 203, 'polyunsaturated fatty acid intake'), ('CHEBI_35366', 'fatty acid', 219, 'fatty acid'), ('CHEBI_28790', 'serotonin', 325, 'serotonin'), ('SO_0001023', 'allele', 347, 'alleles'), ('GO_0007565', 'female pregnancy', 389, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 462, 'preeclampsia'), ('GO_0065007', 'biological regulation', 512, 'modulate')]
PMC3586494	2/2013	S120-PMC3586494	['in comparing Vitamin levels in term and preterm infants, term babies had significantly higher levels of Vitamins A, C, and e. the authors concluded that for Vitamins A and E, neonatal levels are DEPENDENT on maternal levels and that preterm babies have fewer Lipid-soluble antioxidant Vitamins in their Serum compared to term infants THUS MAY BE more susceptible to oxidative stress [52].']	[('SUPERFICIAL_RELATIONSHIP', 195), ('PROBABLE_UNDERSTANDING', 334), ('INCOMPLETE_EVIDENCE', 339)]	3	[('CHEBI_33229', 'vitamin (role)', 13, 'vitamin'), ('CHEBI_27300', 'vitamin D', 104, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 104, 'vitamins A'), ('PR_000004900', 'complement C3', 116, 'C'), ('CHEBI_27300', 'vitamin D', 157, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 166, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 172, 'E'), ('CHEBI_18059', 'lipid', 259, 'lipid'), ('CHEBI_33277', 'gamma-tocotrienol', 285, 'vitamins'), ('UBERON_0001977', 'blood serum', 303, 'serum')]
PMC3586494	2/2013	S179-PMC3586494	['female a/a Mice Fed a methyl-supplemented diet with extra Folate, Vitamin B-12,Choline, and betaine 2 weeks prior to Mating with male Avy/ a agouti Mice and throughout Pregnancy and Lactation passed along the agouti Gene to their offspring intact, YET DEMONSTRATED a shift in distribution towards having more offspring with the pseudoagouti phenotype [76].']	[('ANOMALY_CURIOUS_FINDING', 248), ('INCOMPLETE_EVIDENCE', 252)]	2	[('NCBITaxon_10088', 'Mus <genus>', 11, 'mice'), ('GO_0007631', 'feeding behavior', 16, 'fed'), ('CHEBI_30863', '5-azaorotic acid', 58, 'folate'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 66, 'vitamin B-12'), ('CHEBI_15354', 'choline', 79, 'choline'), ('GO_0007618', 'mating', 117, 'mating'), ('PR_000004155', 'apolipoprotein E', 134, 'Avy'), ('NCBITaxon_10088', 'Mus <genus>', 148, 'mice'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy'), ('GO_0007595', 'lactation', 182, 'lactation'), ('SO_0000704', 'gene', 216, 'gene')]
PMC3586494	2/2013	S258-PMC3586494	['in RELATING maternal Micronutrient Intake with fetal Glucocorticoid exposure, a Mouse MODEL of maternal dietary restriction of copper, zinc, and Vitamin E DEMONSTRATED reduced activity level of Placental 11 Β -Hydroxysteroid dehydrogenase-2, an enzyme that PROTECTS the fetus from overexposure to maternal Glucocorticoids [113].']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 257)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 21, 'micronutrient'), ('GO_0007631', 'feeding behavior', 35, 'intake'), ('CHEBI_24261', 'glucocorticoid', 53, 'glucocorticoid'), ('NCBITaxon_10088', 'Mus <genus>', 80, 'mouse'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin E'), ('UBERON_0001987', 'placenta', 194, 'placental'), ('CHEBI_36844', '7-hydroxy steroid', 207, 'β -hydroxysteroid'), ('CHEBI_36597', 'phthalazine', 306, 'glucocorticoids')]
PMC3586494	2/2013	S261-PMC3586494	['as discussed in the section on epigenetics, experimental studies on the IMPACT of methyl-supplemented diets containing added Folate and Vitamin B-12 REVEALED the POTENTIAL ROLE of these Micronutrients in inducing major changes in offspring phenotype, including the ability to IMPACT the development of chronic diseases.']	[('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 172), ('SUPERFICIAL_RELATIONSHIP', 276)]	5	[('CHEBI_30863', '5-azaorotic acid', 125, 'folate'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 136, 'vitamin B-12'), ('CHEBI_33839', 'macromolecule', 186, 'micronutrients')]
PMC3613945	2/2013	S5-PMC3613945	['indeed, dbp and Vitamin D MAY JOINTLY OR INDEPENDENTLY CONTRIBUTE to a variety of adverse health outcomes unrelated to classical notions of their function in bone and Mineral Metabolism.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 55)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_46662', 'mineral', 167, 'mineral'), ('GO_0008152', 'metabolic process', 175, 'metabolism')]
PMC3613945	2/2013	S8-PMC3613945	['in VIEW of the HEIGHTENED INTEREST in Vitamin D as a PUBLIC HEALTH TARGET, well-DESIGNED STUDIES that look simultaneously at Vitamin D and its carrier in RELATION to genotypes and adverse health outcome SHOULD BE ENCOURAGED.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 15), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 53), ('FUTURE_WORK', 67), ('FUTURE_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 154), ('FUTURE_WORK', 203), ('FUTURE_WORK', 213)]	9	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3613945	2/2013	S29-PMC3613945	['Genotype-phenotype ASSOCIATIONS and Vitamin D Metabolism\nmature Serum dbp concentration is a quantitative trait with a significant hereditable component (66%), AS ESTABLISHED by twin studies published AT LEAST a decade ago30,31.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('PROBABLE_UNDERSTANDING', 160), ('INCOMPLETE_EVIDENCE', 163), ('PROBABLE_UNDERSTANDING', 201)]	4	[('SO_0001026', 'genome', 0, 'Genotype'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 36, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 64, 'serum')]
PMC3613945	2/2013	S50-PMC3613945	['WHILE these common polymorphisms are ASSOCIATED with dbp status, others have DEMONSTRATED ASSOCIATION between genotype and Serum Vitamin D Metabolite levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 90)]	4	[('UBERON_0001977', 'blood serum', 123, 'serum'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 139, 'metabolite')]
PMC3613945	2/2013	S55-PMC3613945	['similarly, in a study population of 98 healthy Adult women, we FOUND that the 436kk homozygotes exhibited reduced baseline Vitamin D Serum levels44.']	[('INCOMPLETE_EVIDENCE', 63)]	1	[('UBERON_0007023', 'adult organism', 47, 'adult'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('UBERON_0001977', 'blood serum', 133, 'serum')]
PMC3613945	2/2013	S56-PMC3613945	['OF more immediate clinical INTEREST, PERHAPS, was our OBSERVATION that this Allele was also CORRELATED with the response of Serum 25(Oh)D levels to long-term Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 27), ('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('SO_0001023', 'allele', 76, 'allele'), ('UBERON_0001977', 'blood serum', 124, 'serum'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 130, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC3613945	2/2013	S57-PMC3613945	['the subjects with 436kk genotype SHOWED the largest proportional increase in response to a Vitamin D supplement.']	[('INCOMPLETE_EVIDENCE', 33)]	1	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC3613945	2/2013	S58-PMC3613945	['the population-wide IMPLICATIONS of these FINDINGS for Vitamin D in PUBLIC HEALTH are substantial, given that the 436\u2009k Allele is less PREVALENT in africans (15%) than in caucasians (23%), hispanics (20%) or asians (29%)45.']	[('IMPORTANT_CONSIDERATION', 20), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 68), ('IMPORTANT_CONSIDERATION', 135)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('SO_0001023', 'allele', 120, 'allele')]
PMC3613945	2/2013	S60-PMC3613945	['Vitamin D, dbp and Innate Immunity – an EMERGING theme\nthe ROLE of dbp in the biology of Vitamin D as it RELATES to the Endocrine status of bone and Mineral Metabolism is well established and the reader is referred to reviews47,48, monographs49and authoritative web sites50.']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 105)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0045087', 'innate immune response', 19, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0006397', 'mRNA processing', 120, 'endocrine'), ('CHEBI_46662', 'mineral', 149, 'mineral'), ('GO_0008152', 'metabolic process', 157, 'metabolism')]
PMC3613945	2/2013	S63-PMC3613945	['IN CONTRAST, the ROLE of Vitamin D and dbp in Innate Immunity HAS BEEN appreciated ONLY more RECENTLY, EITHER through its INVOLVEMENT in the Vitamin D transport pathway OR by independent mechanisms51.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('SUPERFICIAL_RELATIONSHIP', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	8	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0045087', 'innate immune response', 46, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3613945	2/2013	S121-PMC3613945	['AS SUCH, polymorphisms in the dbp Gene MIGHT provide INSIGHT into the ROLE of Vitamin D and diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('SO_0000704', 'gene', 34, 'gene'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3613945	2/2013	S163-PMC3613945	['a RECENT prospective STUDY examining more than 6100 elderly caucasians FOUND no association between dbp phenotype and osteoporosis; HOWEVER, a 33% increased risk of fracture was detected in gc1s carriers homozygous for polymorphisms in the 3′ Untranslated Region (Utr) of the Vitamin D Receptor ( vdr ) in haploblock 5 compared with non-carriers ( p \u2009=\u20090.005)88.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ANOMALY_CURIOUS_FINDING', 132)]	4	[('SO_0000205', 'three_prime_UTR', 240, '3′ untranslated region'), ('GO_0006309', 'apoptotic DNA fragmentation', 243, 'untranslated'), ('SO_0000203', 'UTR', 264, 'UTR'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 276, 'vitamin D receptor')]
PMC3613945	2/2013	S184-PMC3613945	['ecological studies INDICATE that Vitamin D deficiency is ASSOCIATED with asthma and asthma RELATED phenotypes101–105, BUT SOME STUDIES CONTRADICT these FINDINGS reporting a positive ASSOCIATION106,107, WHEREAS others SHOW no association108.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('INCOMPLETE_EVIDENCE', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('INCOMPLETE_EVIDENCE', 217)]	11	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3613945	2/2013	S185-PMC3613945	['FURTHER EVIDENCE SUGGESTING an inverse CORRELATION between Vitamin D and asthma is provided by Genetic109,110and epidemiologic (geospatial and solar radiation) STUDIES111.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 160)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('SO_0000704', 'gene', 95, 'genetic109')]
PMC3613945	2/2013	S187-PMC3613945	['REPORTED no association between ultraviolet radiation (uvr) or Vitamin D Serum levels; YET, cod Liver oil supplementation earlier in Life was ASSOCIATED with an INCREASED risk of asthma112.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 87), ('SUPERFICIAL_RELATIONSHIP', 142), ('IMPORTANT_CONSIDERATION', 161)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001977', 'blood serum', 73, 'serum'), ('UBERON_0002107', 'liver', 96, 'liver'), ('UBERON_0000104', 'life cycle', 133, 'life')]
PMC3613945	2/2013	S188-PMC3613945	['overall EVIDENCE SUGGESTS that Vitamin D PROTECTS against asthma, BUT the precise nature of this RELATIONSHIP is AMBIGUOUS and INCONSISTENT findings are LIKELY a function of epidemiological context.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('SUPERFICIAL_RELATIONSHIP', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('PROBABLE_UNDERSTANDING', 153)]	8	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC3613945	2/2013	S189-PMC3613945	['a molecular mechanism by which Vitamin D MAY AFFECT asthma is UNKNOWN and its RELATIONSHIP to atopy is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 45), ('FULL_UNKNOWN', 62), ('SUPERFICIAL_RELATIONSHIP', 78), ('FULL_UNKNOWN', 103)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC3613945	2/2013	S207-PMC3613945	['cancer\nseveral OBSERVATIONAL STUDIES have DEMONSTRATED an inverse RELATIONSHIP between uvb irradiance (REQUIRED for the cutaneous Synthesis Of Vitamin D) or Vitamin D status [Serum 25(Oh)D concentrations] and the incidence of mortality from Endometrial126, Lung127,128, Breast127,129–133, Prostate134–137, Ovarian138,139and Colorectal cancer140–149.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 103)]	4	[('GO_0030474', 'spindle pole body duplication', 130, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('UBERON_0001977', 'blood serum', 175, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 184, 'OH)D'), ('UBERON_0004167', 'orbitofrontal cortex', 241, 'endometrial126'), ('UBERON_0002048', 'lung', 257, 'lung127'), ('UBERON_0013550', 'Brodmann (1909) area 19', 270, 'breast127'), ('UBERON_0003820', 'prostate bud', 289, 'prostate134'), ('UBERON_0008231', 'dorsal thoracic segment of trunk', 306, 'ovarian138'), ('UBERON_0012652', 'colorectum', 324, 'colorectal')]
PMC3613945	2/2013	S208-PMC3613945	['the UNDERLYING mechanism by which Vitamin D status AFFECTS cancer RISK is UNKNOWN, HOWEVER, 1,25(Oh)2D3Has BEEN SHOWN to Modulate Cell Proliferation and Differentiation Of both normal and malignant Cells.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 51), ('IMPORTANT_CONSIDERATION', 66), ('FULL_UNKNOWN', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 107)]	7	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_76957', 'N-2-hydroxytetracosenoylsphingosine', 92, '1,25(OH)2D3has'), ('GO_0065007', 'biological regulation', 121, 'modulate'), ('GO_0008283', 'cell proliferation', 130, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 153, 'differentiation of ... cells')]
PMC3613945	2/2013	S210-PMC3613945	['Breast cancer\necological case-control studies INDICATE an inverse CORRELATION between Vitamin D status and Breast cancer RISK, HOWEVER, the RELATIONSHIP is LESS CLEAR in longitudinal studies150,151.']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('SUPERFICIAL_RELATIONSHIP', 140), ('FULL_UNKNOWN', 156)]	7	[('UBERON_0000310', 'breast', 0, 'Breast'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000310', 'breast', 107, 'breast')]
PMC3613945	2/2013	S211-PMC3613945	['MUCH work HAS BEEN done to elucidate a Vitamin D-RELATED mechanistic ROLE in Breast cancer.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 69)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0000310', 'breast', 77, 'breast')]
PMC3613945	2/2013	S214-PMC3613945	['ALTERNATIVELY, the active Metabolite of Vitamin D, Calcitriol, HAS BEEN SHOWN to inhibit Cell Proliferation and Differentiation and promote Apoptosis of Breast tumor Tissue155–158.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 63)]	2	[('CHEBI_39382', 'flufenoxuron', 26, 'metabolite'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 51, 'calcitriol'), ('GO_0030154', 'cell differentiation', 89, 'cell proliferation ... differentiation'), ('GO_0006915', 'apoptotic process', 140, 'apoptosis'), ('UBERON_0000310', 'breast', 153, 'breast'), ('UBERON_0003605', 'eye skin gland', 166, 'tissue155')]
PMC3613945	2/2013	S218-PMC3613945	['both THESE STUDIES ARGUE AGAINST a ROLE for gc-maf or Vitamin D in Breast cancer pathogenesis.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0000310', 'breast', 67, 'breast')]
PMC3613945	2/2013	S221-PMC3613945	['Prostate cancer\nstudies HAVE SHOWN that Vitamin D CAN inhibit Proliferation and Differentiation Of Human Prostatic Cells in vitro 162and 1,25(Oh)2D3Has marked anti-tumor EFFECTS in Animal MODELS163.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 188)]	4	[('UBERON_0002367', 'prostate gland', 0, 'Prostate'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 80, 'differentiation of ... cells'), ('NCBITaxon_9606', 'Homo sapiens', 99, 'human'), ('CL_0002492', 'strial marginal cell', 105, 'prostatic cells'), ('UBERON_0000054', 'macula', 105, 'prostatic'), ('CHEBI_17996', 'chloride', 138, ','), ('CHEBI_73376', 'Ala-Met-Ser-Arg', 139, '25(OH)2D3has'), ('NCBITaxon_33208', 'Metazoa', 181, 'animal')]
PMC3613945	2/2013	S227-PMC3613945	['explored PREVIOUS epidemiological EVIDENCE SUGGESTING a reduced risk ASSOCIATED with Vitamin D. NO EVIDENCE for ASSOCIATION between dbp genotype and risk of Colorectal cancer was FOUND, ALTHOUGH ASSOCIATIONS between dbp Snps and microsatellite-unstable Colorectal cancer were REPORTED168.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 186), ('SUPERFICIAL_RELATIONSHIP', 195), ('INCOMPLETE_EVIDENCE', 276)]	10	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0012652', 'colorectum', 157, 'colorectal'), ('SO_0000694', 'SNP', 220, 'SNPs'), ('UBERON_0012652', 'colorectum', 253, 'colorectal')]
PMC3613945	2/2013	S238-PMC3613945	['moreover, SEVERAL STUDIES HAVE SHOWN an inverse CORRELATION between Serum levels of Vitamin D and ms173,174, SUGGESTING that polymorphisms INFLUENCING Vitamin D status MIGHT CONTRIBUTE to the initiation or progression of disease.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 139), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 174)]	7	[('UBERON_0001977', 'blood serum', 68, 'serum'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
PMC3613945	2/2013	S243-PMC3613945	['ongoing interventional trials with Vitamin D and ASSOCIATION studies with larger cohorts MAY offer FURTHER OPPORTUNITY to explore an INTERACTIVE ROLE of dbp Snps with Vitamin D in ms.\n\namyotrophic lateral sclerosis\namyotrophic lateral sclerosis (als) is another neuropathy of UNKNOWN etiology that is characterized by the progressive loss of Motor Neurons in the Brain and spinal Cord, leading to debilitating, USUALLY fatal, muscle atrophy180.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 133), ('SUPERFICIAL_RELATIONSHIP', 145), ('FULL_UNKNOWN', 276), ('INCOMPLETE_EVIDENCE', 411)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('SO_0000694', 'SNP', 157, 'SNPs'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CL_0000100', 'motor neuron', 342, 'motor neurons'), ('UBERON_0000955', 'brain', 363, 'brain'), ('UBERON_0002240', 'spinal cord', 380, 'cord')]
PMC3613945	2/2013	S249-PMC3613945	['schizophrenia\na NUMBER OF HYPOTHESES HAVE BEEN put FORTH to explain the etiology of schizophrenia, BUT several lines of OBSERVATIONAL EVIDENCE SUGGEST that Vitamin D MAY BE a risk Factor183.']	[('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 166)]	9	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('PR_000007391', 'F-box only protein 17', 180, 'factor183')]
PMC3613945	2/2013	S279-PMC3613945	['a significant advance in our understanding of Innate Immunity against Tuberculosis came with a seminal report SHOWING convergence of the Vitamin D Metabolic Pathway with the toll-like receptor (Tlr2/1) signaling cascade resulting in the induction of Cathelicidin, a potent Antimicrobial peptide in the Innate Immunity pathway54,55.']	[('INCOMPLETE_EVIDENCE', 110)]	1	[('GO_0045087', 'innate immune response', 46, 'innate immunity'), ('GO_0035683', 'memory T cell extravasation', 70, 'tuberculosis'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007135', 'meiosis II', 147, 'metabolic pathway'), ('PR_000001155', 'Toll-like receptor 4', 194, 'TLR2'), ('PR_000006009', 'alpha-catulin', 250, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 273, 'antimicrobial'), ('GO_0045087', 'innate immune response', 302, 'innate immunity')]
PMC3613945	2/2013	S314-PMC3613945	['conclusion\nthere is GROWING EVIDENCE that dbp plays a ROLE in Immune modulation, EITHER directly through gc-maf, OR indirectly by INFLUENCING Serum levels of Vitamin D. it is TEMPTING to SPECULATE that dbp operates as a molecular switch between pro- and anti-inflammation and intervention STRATEGIES designed to modify this switch MAY be IMPORTANT in the Control and prevention Of chronic and Infectious Diseases.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 187), ('FUTURE_WORK', 289), ('INCOMPLETE_EVIDENCE', 331), ('IMPORTANT_CONSIDERATION', 338)]	9	[('UBERON_0002405', 'immune system', 62, 'immune'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0001715', 'ectodermal cell fate specification', 355, 'control ... of ... infectious diseases')]
PMC3662163	3/2013	S56-PMC3662163	['when Prenatal Vitamins were REPORTED, we considered them as multivitamins designed for Pregnant women containing more and/or other Vitamins than Folic Acid and Vitamin D. because Prenatal Vitamins are not actively advised by midwifes in the netherlands during Pregnancy, we considered them as Otc-medication.']	[('INCOMPLETE_EVIDENCE', 28)]	1	[('GO_0007565', 'female pregnancy', 5, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 14, 'vitamins'), ('GO_0007565', 'female pregnancy', 87, 'pregnant'), ('CHEBI_33277', 'gamma-tocotrienol', 131, 'vitamins'), ('CHEBI_30751', 'formic acid', 145, 'folic acid'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 179, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 188, 'vitamins'), ('GO_0007565', 'female pregnancy', 260, 'pregnancy'), ('CHEBI_74959', 'O(4)-phospho-D-tyrosine', 293, 'OTC')]
PMC3705320	3/2013	S14-PMC3705320	['HOWEVER, observational studies have SUGGESTED ASSOCIATIONS between Vitamin D status during Pregnancy and Postnatal infant health outcomes [3,4,5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('GO_0007567', 'parturition', 105, 'postnatal')]
PMC3705320	3/2013	S15-PMC3705320	['Serum 25-Hydroxyvitamin D concentration ([25(Oh)D]) ≥ 50 nmol/l is ASSOCIATED with Skeletal health benefits [1], BUT SOME data SUGGEST that IMPROVING Vitamin D status to attain Serum [25(Oh)D] ≥ 80 nmol/l MAY enhance a range of Vitamin D-related functions [6,7,8].']	[('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 140), ('INCOMPLETE_EVIDENCE', 205)]	6	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 42, '25(OH)D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('UBERON_0001977', 'blood serum', 177, 'serum'), ('CHEBI_71657', 'versiconol acetate', 184, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC3705320	3/2013	S17-PMC3705320	['the POSSIBLE ASSOCIATION between maternal-fetal Vitamin D status and infant health outcomes MAY be particularly relevant to south asian countries such as bangladesh, where adverse Perinatal outcomes and infant mortality are PUBLIC HEALTH PRIORITIES [10], and where Vitamin D deficiency HAS BEEN observed among women of Reproductive age [11] and young infants [12].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 224), ('IMPORTANT_CONSIDERATION', 238), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0036268', 'swimming', 180, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 180, 'perinatal'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0000003', 'reproduction', 319, 'reproductive')]
PMC3705320	3/2013	S114-PMC3705320	['there was substantial inter-subject variability in the response to Vitamin D supplementation, with one pl participant demonstrating ONLY a 7 nmol/l final increase in [25(Oh)D] above her baseline.']	[('INCOMPLETE_EVIDENCE', 132)]	1	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 167, '25(OH)D'), ('PR_000011614', 'opioid growth factor receptor', 170, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 173, 'D')]
PMC3705320	3/2013	S157-PMC3705320	['among bangladeshi women with a mean [25(Oh)D] of 33 nmol/l, 70,000 iu followed by 35,000 iu/week of Vitamin D3 until Delivery yielded an average [25(Oh)D] that was ABOUT 20 nmol/l higher than an Antenatal dose of 14,000 iu/week (the iom Vitamin D upper limit at the time the study was conducted).']	[('INCOMPLETE_EVIDENCE', 164)]	1	[('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 37, '25(OH ... D'), ('CHEBI_33279', 'vitamin D5', 100, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 100, 'vitamin D3'), ('GO_0007567', 'parturition', 117, 'delivery'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 152, 'D'), ('GO_0007567', 'parturition', 195, 'antenatal'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC3705320	3/2013	S173-PMC3705320	['(2008) [24], as well the RECENT iom REPORT (2010) [1], have DEMONSTRATED that the ∆[25(Oh)D] per mcg is a curvilinear inverse FUNCTION of Vitamin D Intake at doses <50 mcg/day, but nearly proportional to Intake at >50 mcg/day [24], which MAY EXPLAIN the greater OBSERVED efficiency of the lower dose.']	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 126), ('INCOMPLETE_EVIDENCE', 238), ('PROBABLE_UNDERSTANDING', 242), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_71657', 'versiconol acetate', 84, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007631', 'feeding behavior', 148, 'intake'), ('GO_0007631', 'feeding behavior', 204, 'intake')]
PMC3705320	3/2013	S178-PMC3705320	['in Pregnant participants, the higher-dose Vitamin D regimen had a significant suppressive EFFECT on maternal pth secretion, relative to the lower dose, as INDICATED by the change in average Pth concentrations from baseline to delivery, SIMILAR TO PREVIOUS OBSERVATIONS by wagner et al.']	[('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 256)]	5	[('GO_0007565', 'female pregnancy', 3, 'pregnant'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 190, 'PTH')]
PMC3705320	3/2013	S189-PMC3705320	['SIMILAR TO the participants who received only a single dose of 70,000 iu [13], maternal Serum calcium values in the weekly-dose participants were all below the threshold for defining hypercalcemia used by the iom in setting the 1997 dietary reference intakes (dris) for Vitamin D (2.75 mmol/l) [35] and in the revised dris in 2010 (2.63 mmol/l) [1].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('UBERON_0001977', 'blood serum', 88, 'serum'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3705320	3/2013	S193-PMC3705320	['first, precision of ESTIMATES of Pharmacokinetic parameters and between-group comparisons, as well as the generalizability of inferences regarding maternal-fetal SAFETY of high-dose Vitamin D supplementation, were LIMITED by the SMALL number of participants, stringent inclusion/exclusion criteria, and enrolment of Pregnant and non-Pregnant participants at one clinic site.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 162), ('INCOMPLETE_EVIDENCE', 214), ('INCOMPLETE_EVIDENCE', 229)]	4	[('CHEBI_87163', 'dihydroisopentenyldehydrorhodopin', 33, 'pharmacokinetic'), ('GO_0006909', 'phagocytosis', 33, 'pharmacokinetic'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0007565', 'female pregnancy', 316, 'pregnant'), ('GO_0007565', 'female pregnancy', 333, 'pregnant')]
PMC3705320	3/2013	S201-PMC3705320	['NONETHELESS, increases in the mean calcium concentration (within the normal range) and suppression of pth secretion among Pregnant women receiving the higher-dose regimen (70,000 iu initial dose followed by weekly doses of 35,000 iu) HIGHLIGHTED the physiological IMPACT of the intervention and the NEED to cautiously address POTENTIAL Pregnancy-specific sensitivities to Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 234), ('SUPERFICIAL_RELATIONSHIP', 264), ('FUTURE_WORK', 299), ('INCOMPLETE_EVIDENCE', 299), ('INCOMPLETE_EVIDENCE', 326)]	7	[('GO_0007565', 'female pregnancy', 122, 'pregnant'), ('GO_0007565', 'female pregnancy', 336, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 372, 'vitamin D')]
PMC3705320	3/2013	S204-PMC3705320	['the most direct application of the present OBSERVATIONS is to guide the design of FUTURE TRIALS of Vitamin D3 (at doses up to 35,000 iu per week) AIMED at CONFIRMING SAFETY and establishing the health benefits of Antenatal Vitamin D supplementation in south asia, where many POTENTIALLY Vitamin D-responsive outcomes (e.g., infant growth and infectious disease morbidity) are MAJOR PUBLIC HEALTH PRIORITIES.']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 146), ('PROBABLE_UNDERSTANDING', 155), ('IMPORTANT_CONSIDERATION', 166), ('INCOMPLETE_EVIDENCE', 275), ('IMPORTANT_CONSIDERATION', 376), ('IMPORTANT_CONSIDERATION', 382), ('IMPORTANT_CONSIDERATION', 396)]	9	[('CHEBI_33279', 'vitamin D5', 99, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 99, 'vitamin D3'), ('GO_0007567', 'parturition', 213, 'antenatal'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D')]
PMC3616124	4/2013	S13-PMC3616124	['hp phenotype does not influence Preeclampsia RISK, or identify a subset of women who MAY BENEFIT from Vitamin C and E supplementation to prevent Preeclampsia.']	[('IMPORTANT_CONSIDERATION', 45), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 89)]	3	[('GO_0007128', 'meiotic prophase I', 32, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 116, 'E'), ('GO_0007128', 'meiotic prophase I', 145, 'preeclampsia')]
PMC3616124	4/2013	S139-PMC3616124	['hp phenotype, Prenatal/multivitamin use at randomization, and Plasma Ascorbate\nhp phenotype INFLUENCES Plasma Ascorbate concentration[35], PROVIDING a POTENTIAL mechanism by which hp phenotype MIGHT INFLUENCE treatment response to Vitamin C and E. we EXAMINED the RELATIONSHIP between hp phenotype and Plasma Ascorbate in a pre-planned analysis.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('PROBABLE_UNDERSTANDING', 139), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 199), ('QUESTION_ANSWERED_BY_THIS_WORK', 251), ('SUPERFICIAL_RELATIONSHIP', 264)]	7	[('GO_0007565', 'female pregnancy', 14, 'Prenatal'), ('UBERON_0001969', 'blood plasma', 62, 'Plasma'), ('CHEBI_2874', 'Asimicin', 69, 'Ascorbate'), ('UBERON_0001969', 'blood plasma', 103, 'plasma'), ('CHEBI_22651', 'ascorbate', 110, 'ascorbate'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 245, 'E'), ('UBERON_0001969', 'blood plasma', 302, 'plasma'), ('CHEBI_22651', 'ascorbate', 309, 'ascorbate')]
PMC3616124	4/2013	S173-PMC3616124	['THEREFORE, we EXAMINED the POTENTIAL for hp phenotype to INFLUENCE the effectiveness of Vitamin C and E in preventing Preeclampsia and SERIOUS COMPLICATIONS of pah.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 143)]	6	[('CHEBI_27300', 'vitamin D', 88, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 102, 'E'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia')]
PMC3616124	4/2013	S186-PMC3616124	['first, Cardiovascular disease studies SUGGEST that Vitamin E alone has DIFFERENT EFFECTS from Vitamin C and E combined[18],[19],[27].']	[('INCOMPLETE_EVIDENCE', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('UBERON_0004535', 'cardiovascular system', 7, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 108, 'E')]
PMC3616124	4/2013	S189-PMC3616124	['HOWEVER, the pro-oxidant EFFECTS of Vitamin C[28]combined with the reduced antioxidant capacity of Hp 2-2 MAY have CONTRIBUTED to accelerated Coronary Artery narrowing in diabetic Hp 2-2 post-menopausal women taking Vitamins C and E[21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 115)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin C'), ('PR_000008793', 'heat shock factor protein 4', 99, 'Hp 2-2'), ('UBERON_0005985', 'coronary vessel', 142, 'coronary'), ('UBERON_0001637', 'artery', 151, 'artery'), ('PR_000008443', 'huntingtin-associated protein 1', 180, 'Hp 2'), ('CHEBI_27300', 'vitamin D', 216, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 231, 'E')]
PMC3616124	4/2013	S191-PMC3616124	['in PARTIAL SUPPORT of this HYPOTHESIS, we OBSERVED a 3-fold increase in Preeclampsia risk in hp 2-2 hispanic women receiving Vitamin C and E. the original rct combined Vitamins C and E, an approach used in Cardiovascular disease prevention trials[47],[48],[49]that was successful in SMALL clinical trials.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 283)]	5	[('GO_0007128', 'meiotic prophase I', 72, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 139, 'E'), ('CHEBI_27300', 'vitamin D', 168, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 183, 'E'), ('UBERON_0004535', 'cardiovascular system', 206, 'cardiovascular')]
PMC3616124	4/2013	S196-PMC3616124	['the MOST EXTENSIVELY STUDIED mechanism by which Vitamin E reduces Cardiovascular disease risk in type 2 diabetes is by preventing the hdl dysfunction caused by cross-linking with glycosylated hemoglobin[28].']	[('INCOMPLETE_EVIDENCE', 4)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin E'), ('UBERON_0004535', 'cardiovascular system', 66, 'cardiovascular')]
PMC3616124	4/2013	S203-PMC3616124	['conclusions\nIN CONTRAST TO our HYPOTHESIS, our secondary analysis of a large rct INDICATES that hp phenotype does not influence preeclampsia risk, or identify a subset of nulligravidas for whom Vitamins C and E would reduce Preeclampsia RISK in white, black or hispanic women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 81), ('IMPORTANT_CONSIDERATION', 237)]	4	[('CHEBI_27300', 'vitamin D', 194, 'vitamins C'), ('PR_000004900', 'complement C3', 203, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 209, 'E'), ('GO_0007128', 'meiotic prophase I', 224, 'preeclampsia')]
PMC3629265	4/2013	S1-PMC3629265	['DESPITE this long history, Vitamin D deficiency REMAINS a significant health CONCERN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 77)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3629265	4/2013	S2-PMC3629265	['CURRENTLY, Vitamin D supplementation is RECOMMENDED in canada for Breast Fed infants.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 40)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007567', 'parturition', 66, 'breast'), ('UBERON_0000310', 'breast', 66, 'breast'), ('GO_0007631', 'feeding behavior', 73, 'fed')]
PMC3629265	4/2013	S8-PMC3629265	["while these infants had several RISK FACTORS for Vitamin D deficiency, they were all receiving Cow's milk based formula supplemented with 400 iu/l of vitamin D.\n\nconclusion\nTHIS report SUGGESTS that CURRENT practice with regards to Vitamin D supplementation MAY BE INADEQUATE, especially for high-risk infants."]	[('SUPERFICIAL_RELATIONSHIP', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 173), ('INCOMPLETE_EVIDENCE', 185), ('INCOMPLETE_EVIDENCE', 199), ('INCOMPLETE_EVIDENCE', 258), ('IMPORTANT_CONSIDERATION', 265), ('PROBLEM_COMPLICATION', 265)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 95, 'cow'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC3629265	4/2013	S18-PMC3629265	['the canadian paediatric surveillance program (cpsp) RECENTLY included Vitamin D deficiency rickets in its national surveillance program (13).']	[('INCOMPLETE_EVIDENCE', 52)]	1	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC3629265	4/2013	S46-PMC3629265	['discussion\nwithin a relatively short time period, we HAVE SEEN 6 cases of severe Vitamin D deficiency presenting with hypocalcaemic seizures in formula-Fed first nation infants less than 2 months of age.']	[('INCOMPLETE_EVIDENCE', 53)]	1	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007631', 'feeding behavior', 152, 'fed')]
PMC3629265	4/2013	S47-PMC3629265	['all had multiple RISK FACTORS for Vitamin D deficiency including darker skin pigmentation, limited cutaneous sun exposure, residence at a northern latitude of 54°, and confirmed or SUSPECTED Vitamin D deficiency in their mothers.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 181)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC3629265	4/2013	S58-PMC3629265	['there HAVE BEEN several recent REPORTS of SEVERE Vitamin D deficiency presenting with hypocalcaemic seizures in Breast Fed infants.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 42)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 112, 'breast fed'), ('UBERON_0000310', 'breast', 112, 'breast')]
PMC3629265	4/2013	S62-PMC3629265	['these infants were PRESUMED to be Vitamin D deficient though Vitamin D levels were NOT CONSISTENTLY available.']	[('PROBABLE_UNDERSTANDING', 19), ('INCOMPLETE_EVIDENCE', 83)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC3629265	4/2013	S67-PMC3629265	['the canadian paediatric society statement does not clearly differentiate Breast-Fed vs. formula-Fed infants but does SUGGEST that infant formulas SHOULD BE an adequate source of Vitamin D as long as the infant consumes “adequate quantity” (23).']	[('INCOMPLETE_EVIDENCE', 117), ('FUTURE_WORK', 146)]	2	[('GO_0007567', 'parturition', 73, 'breast-'), ('UBERON_0000310', 'breast', 73, 'breast'), ('GO_0007631', 'feeding behavior', 80, 'fed'), ('GO_0007631', 'feeding behavior', 96, 'fed'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC3629265	4/2013	S71-PMC3629265	['a RECENT telephone survey of mothers of full-term infants in montreal IDENTIFIED that infants Consuming mixed Feedings (Breast and formula) and those exclusively formula-Fed were at high risk of not meeting recommended Vitamin D intake in the first 6 months of Life (25).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 70)]	2	[('GO_0007631', 'feeding behavior', 94, 'consuming'), ('GO_0007631', 'feeding behavior', 110, 'feedings'), ('UBERON_0000310', 'breast', 120, 'breast'), ('GO_0007631', 'feeding behavior', 170, 'fed'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('UBERON_0000104', 'life cycle', 261, 'life')]
PMC3629265	4/2013	S75-PMC3629265	['maternal Vitamin D deficiency REMAINS a common CONCERN (27).']	[('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 47)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC3629265	4/2013	S79-PMC3629265	['in addition, aboriginal women from manitoba HAVE BEEN SHOWN to have lower Vitamin D levels than caucasian women EVEN THOUGH Vitamin D intake did not differ between the groups.']	[('INCOMPLETE_EVIDENCE', 44), ('ANOMALY_CURIOUS_FINDING', 112)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC3629265	4/2013	S86-PMC3629265	['WHILE our 6 infants had numerous RISK FACTORS for Vitamin D deficiency, they were not Breast Fed, which was the most CONSISTENT FINDING in PREVIOUS reports (13,15–19).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 139)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007567', 'parturition', 86, 'breast'), ('GO_0007631', 'feeding behavior', 93, 'fed')]
PMC3629265	4/2013	S92-PMC3629265	['conclusion\nwe SUGGEST that the amount of Vitamin D supplementation NEEDED to prevent deficiency in infants residing in communities in the temperate region SHOULD BE REVISITED, PARTICULARLY for those at high risk for Prenatal deficiency.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 67), ('IMPORTANT_CONSIDERATION', 67), ('FUTURE_WORK', 155), ('FUTURE_WORK', 165), ('IMPORTANT_CONSIDERATION', 176)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'prenatal')]
PMC3635901	4/2013	S33-PMC3635901	['it HAS BEEN SHOWN that a LINK exists between the mycobacterium, ads, and, SURPRISINGLY, another component of the puzzle, namely, Vitamin D [18].']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 25), ('ANOMALY_CURIOUS_FINDING', 74)]	3	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3635901	4/2013	S35-PMC3635901	['this ROLE of Vitamin D SEEMS to be so IMPORTANT that ads show seasonality (due TO DIFFERENT levels of uv exposure), and EVEN the month of Birth MAY INFLUENCE the risk of onset of an ad, as SHOWN by disanto et al .']	[('SUPERFICIAL_RELATIONSHIP', 5), ('ANOMALY_CURIOUS_FINDING', 23), ('IMPORTANT_CONSIDERATION', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 189)]	9	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007567', 'parturition', 138, 'birth')]
PMC3635901	4/2013	S39-PMC3635901	['THE NEED to provide Vitamin D supplementation for patients with Autoimmune diseases, including ss, is clear.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune')]
PMC3641012	4/2013	S0-PMC3641012	['randomized placebo-controlled trial of high-dose Prenatal third-Trimester Vitamin D3 supplementation in bangladesh: the avidd trial\n\nabstract\n\nbackground\nantenatal Vitamin D status MAY be ASSOCIATED with the RISK of adverse Pregnancy and neonatal outcomes; HOWEVER, the benefits of Vitamin D supplementation during Pregnancy remain UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 188), ('IMPORTANT_CONSIDERATION', 208), ('ANOMALY_CURIOUS_FINDING', 257), ('FULL_UNKNOWN', 332)]	5	[('GO_0007565', 'female pregnancy', 49, 'prenatal'), ('GO_0009294', 'DNA mediated transformation', 64, 'trimester'), ('CHEBI_33279', 'vitamin D5', 74, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 74, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D'), ('GO_0007565', 'female pregnancy', 315, 'pregnancy')]
PMC3641012	4/2013	S14-PMC3641012	['CURRENTLY, there is INSUFFICIENT EVIDENCE to EITHER SUPPORT OR REFUTE the benefits of any given supplemental Vitamin D dose during Pregnancy [8,9].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63)]	5	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy')]
PMC3641012	4/2013	S18-PMC3641012	['uncertainty surrounding Vitamin D REQUIREMENTS in Pregnancy has LED TO DIVERGENT dose RECOMMENDATIONS; for example, the unicef Antenatal Micronutrient formulation contains 200\xa0iu/day [11], the canadian paediatric society has SUGGESTED 2000\xa0iu/day [12], and hollis et al.']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('FUTURE_WORK', 86), ('INCOMPLETE_EVIDENCE', 225)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0007567', 'parturition', 127, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 137, 'micronutrient')]
PMC3641012	4/2013	S20-PMC3641012	['SIMILARLY, the 25(Oh)D THRESHOLD to define Vitamin D sufficiency is DEBATED; the iom set 50\xa0nmol/l as a lower limit of sufficiency [7], YET OTHER expert bodies such as the american academy of pediatrics have SUGGESTED that Pregnant women attain Serum 25(Oh)D >80\xa0nmol/l [14].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('ANOMALY_CURIOUS_FINDING', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140), ('INCOMPLETE_EVIDENCE', 208)]	7	[('CHEBI_71657', 'versiconol acetate', 15, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnant'), ('UBERON_0001977', 'blood serum', 245, 'serum'), ('CHEBI_71657', 'versiconol acetate', 251, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 251, '25(OH)D')]
PMC3641012	4/2013	S21-PMC3641012	['determination of the Vitamin D intake level (and corresponding Serum 25(Oh)D concentration) that SAFELY optimizes Vitamin D-responsive maternal-infant health outcomes would have GLOBAL IMPLICATIONS, but MAY be particularly RELEVANT to resource-poor communities in south asia, where a relatively low Prenatal Vitamin D status OVERLAPS with a HIGH BURDEN of morbidity and mortality ASSOCIATED with adverse Birth and early infant health outcomes [15].']	[('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 185), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 223), ('SUPERFICIAL_RELATIONSHIP', 325), ('IMPORTANT_CONSIDERATION', 341), ('SUPERFICIAL_RELATIONSHIP', 380)]	8	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 69, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 299, 'prenatal'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('GO_0007567', 'parturition', 404, 'birth')]
PMC3641012	4/2013	S25-PMC3641012	['these data MAY serve to design larger rcts to measure the EFFECTS of Antenatal Vitamin D supplementation on functional outcomes of clinical and PUBLIC HEALTH IMPORTANCE.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 158)]	4	[('GO_0007567', 'parturition', 69, 'antenatal'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3641012	4/2013	S76-PMC3641012	['this definition was used BECAUSE isolated values slightly above the upper limit of the reference range were not considered to be CONSISTENT with Vitamin D toxicity.']	[('PROBLEM_COMPLICATION', 25), ('INCOMPLETE_EVIDENCE', 129)]	2	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC3641012	4/2013	S132-PMC3641012	['AS EVIDENCE that this plateau was not an artifact of diminishing supplement adherence over time, a sensitivity analysis in which 25(Oh)D was MODELED as a function of cumulative Vitamin D dose REVEALED the same PATTERN (figure\xa03), and fit the data well (table\xa05).']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 192), ('SUPERFICIAL_RELATIONSHIP', 210)]	6	[('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC3641012	4/2013	S161-PMC3641012	['given the substantial inter-Individual VARIABILITY in the response to Vitamin D supplementation (figure\xa03), we EXPLORED the ROLE of the following POTENTIAL MODIFIERS of the magnitude of the change in 25(Oh)D (δ25(Oh)D) from baseline to Delivery (selected a priori ): maternal weight at baseline, maternal age, Gestational age, maternal body mass index at baseline (bmi), gravidity, parity, baseline Pth status, season and baseline Vitamin D status.']	[('DIFFICULT_TASK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 111), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 156)]	5	[('NCBITaxon_1', 'root', 28, 'individual'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 206, 'D'), ('CHEBI_33010', 'chromide(1-)', 212, '(OH)D'), ('GO_0007567', 'parturition', 236, 'delivery'), ('GO_0007565', 'female pregnancy', 310, 'gestational'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 399, 'PTH'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D')]
PMC3641012	4/2013	S163-PMC3641012	['ALTHOUGH δ25(Oh)D was inversely ASSOCIATED with baseline Vitamin D status, and ABOUT 24% of the variance in δ25(Oh)D in the Vitamin D group was EXPLAINED by baseline 25(Oh)D, this ASSOCIATION APPEARED TO BE due to regression to the mean, SINCE similar TRENDS were observed in both the Vitamin D and placebo groups.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 79), ('PROBABLE_UNDERSTANDING', 144), ('SUPERFICIAL_RELATIONSHIP', 180), ('ANOMALY_CURIOUS_FINDING', 192), ('PROBABLE_UNDERSTANDING', 238), ('SUPERFICIAL_RELATIONSHIP', 252)]	8	[('CHEBI_33010', 'chromide(1-)', 12, '(OH)D'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 111, '(OH)D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 166, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 166, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D')]
PMC3641012	4/2013	S165-PMC3641012	['NOTABLY, variation in Cord 25(Oh)D within the Vitamin D group was not associated with duration of supplementation (p\u2009=\u20090.86) or cumulative Vitamin D supplement dose administered (p\u2009=\u20090.93), INDICATING that the maternal-fetal Vitamin D equilibrium was achieved rapidly.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 190)]	2	[('UBERON_0002240', 'spinal cord', 22, 'cord'), ('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 27, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC3641012	4/2013	S200-PMC3641012	['in particular, the overall proportion of encounters in which there was at least one symptom POSSIBLY suggestive of hypercalcemia was SIMILAR for the Placebo and Vitamin D groups (54% vs. 53%, p \u2009=\u20090.71; analysis accounted for repeated events within the same participants).']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 133)]	2	[('CHEBI_26130', 'biological pigment', 149, 'placebo'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC3641012	4/2013	S222-PMC3641012	['this is CONSISTENT with the HYPOTHESIZED constraint in Hepatic Vitamin D–To–25(Oh)D Conversion that occurs at a 25(Oh)D concentration of ABOUT 80–90\xa0nmol/l [28].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 137)]	3	[('UBERON_0002107', 'liver', 55, 'hepatic'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0019073', 'viral DNA genome packaging', 63, 'vitamin D–to ... OH)D conversion'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D')]
PMC3641012	4/2013	S226-PMC3641012	['in comparison to the lc-ms/ms method used HERE, the immunoassay used in the pilot study (diasorin liaison total) MAY have UNDER-estimated 25(Oh)D because of raised dbp concentrations in Pregnancy [29] OR relative imprecision at the higher 25(Oh)D range attained in the Vitamin D group [30,31].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('INCOMPLETE_EVIDENCE', 113), ('IMPORTANT_CONSIDERATION', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201)]	4	[('CHEBI_71657', 'versiconol acetate', 138, '25(OH)D'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 239, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC3641012	4/2013	S234-PMC3641012	['CONCLUDED from their trial findings “that the current Vitamin D ear and rda for Pregnant women issued in 2010 by the iom SHOULD BE raised to 4000\xa0iu of Vitamin D per day” [13].']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 121)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnant'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 160, 'D')]
PMC3641012	4/2013	S237-PMC3641012	['HOWEVER, like hollis et al., we did not encounter any EVIDENCE of Vitamin D toxicity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 54)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3641012	4/2013	S238-PMC3641012	['Vitamin D DID NOT affect average Urinary Calcium Excretion, YET we did see a SMALL but significant increase in the mean adj-ca in the Vitamin D group COMPARED TO the placebo group.']	[('INCOMPLETE_EVIDENCE', 10), ('ANOMALY_CURIOUS_FINDING', 60), ('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001088', 'urine', 33, 'urinary'), ('CHEBI_22313', 'alkaline earth metal atom', 41, 'calcium'), ('GO_0036161', 'calcitonin secretion', 41, 'calcium excretion'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3641012	4/2013	S242-PMC3641012	['this SUGGESTED a Homeostatic Adjustment to the altered Vitamin D status, with no further increase in Serum calcium after a steady-state 25(Oh)D was reached.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('GO_0044809', 'chemokine (C-C motif) ligand 17 production', 17, 'homeostatic adjustment'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0001977', 'blood serum', 101, 'serum'), ('CHEBI_71657', 'versiconol acetate', 136, '25(OH)D')]
PMC3641012	4/2013	S243-PMC3641012	['third, a positive ASSOCIATION between adj-ca and 25(Oh)D was apparent in the range of 25(Oh)D below 100\xa0nmol/l BUT not above 100\xa0nmol/l; evidence of POSSIBLE harm would be more CONSISTENT with the OPPOSITE FINDING of a Serum calcium that was tightly Controlled (i.e., unassociated with 25(Oh)D) within the lower range of 25(Oh)D, but deflected upward at higher 25(Oh)D. all maternal uncorrected and adj-ca values were below the threshold for hypercalcemia used by the iom in the 1997 Vitamin D dris (2.75\xa0mmol/l) [10] and the 2010 revision (2.63\xa0mmol/l) [7].']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('INCOMPLETE_EVIDENCE', 206)]	6	[('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('UBERON_0001977', 'blood serum', 219, 'serum'), ('GO_0065007', 'biological regulation', 250, 'controlled'), ('CHEBI_71657', 'versiconol acetate', 286, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 321, '25(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 364, 'OH)D'), ('CHEBI_27300', 'vitamin D', 484, 'vitamin D')]
PMC3641012	4/2013	S249-PMC3641012	['because of the high dose of Vitamin D not previously studied in Pregnancy, enrolment was LIMITED to healthy women at low risk of Pregnancy complications, and who were most LIKELY to adhere to the protocol; as such, generalizability of the findings MAY BE LIMITED.']	[('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 172), ('INCOMPLETE_EVIDENCE', 248), ('INCOMPLETE_EVIDENCE', 255)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC3641012	4/2013	S252-PMC3641012	['as well, we DID NOT calculate total intake of Vitamin D DUE TO the LACK OF adequate information regarding Vitamin D content in the bangladeshi Food supply.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBLEM_COMPLICATION', 56), ('PROBLEM_COMPLICATION', 67), ('ANOMALY_CURIOUS_FINDING', 72)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_33290', 'food', 143, 'food')]
PMC3773018	4/2013	S0-PMC3773018	['the longitudinal trajectory of Vitamin D status from Birth to early childhood on the development of Food sensitization\n\nabstract\n\nbackground\nINCREASING EVIDENCE SUPPORTS the immunomodulatory EFFECT of Vitamin D on Allergic diseases.']	[('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 161), ('SUPERFICIAL_RELATIONSHIP', 191)]	3	[('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('GO_0007567', 'parturition', 53, 'Birth'), ('CHEBI_33290', 'food', 100, 'Food'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0040011', 'locomotion', 214, 'allergic')]
PMC3773018	4/2013	S1-PMC3773018	['the combined ROLE of Prenatal and Postnatal Vitamin D status in the development of Food Sensitization (fs) and Food Allergy REMAINS under-STUDIED.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 137)]	3	[('GO_0007565', 'female pregnancy', 21, 'prenatal'), ('GO_0007567', 'parturition', 34, 'postnatal'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_33290', 'food', 83, 'food'), ('GO_0031318', 'detection of folic acid', 83, 'food sensitization'), ('CHEBI_33290', 'food', 111, 'food'), ('GO_0007631', 'feeding behavior', 111, 'food allergy')]
PMC3773018	4/2013	S9-PMC3773018	['the Vitamin D HYPOTHESIS, one of several HYPOTHESES on the development Of Food Allergy, was first SUGGESTED in 2007(2), and the POTENTIAL mechanisms were later PROPOSED in detail by vassallo et al.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 160)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0042067', 'establishment of ommatidial planar polarity', 71, 'of food allergy'), ('CHEBI_33290', 'food', 74, 'food')]
PMC3773018	4/2013	S12-PMC3773018	['PREVIOUS STUDIES (11–15) INDICATE that the immunomodulatory EFFECTS of Vitamin D, including its CONTRIBUTION to the development of allergic diseases, begin in utero .']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 60), ('SUPERFICIAL_RELATIONSHIP', 96)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3773018	4/2013	S13-PMC3773018	['to date, ONLY three birth cohort studies have examined the EFFECT of Prenatal Vitamin D exposure on allergic phenotypes using Cord Blood 25(Oh)D concentrations, an objective measure of Vitamin D status reflecting both dietary intake and sun exposure.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('GO_0007565', 'female pregnancy', 69, 'prenatal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 126, 'cord'), ('UBERON_0000178', 'blood', 131, 'blood'), ('CHEBI_71657', 'versiconol acetate', 137, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 137, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3773018	4/2013	S17-PMC3773018	['(17) REPORTED that both higher (>40ng/ml) and lower (<20 ng/ml) Vitamin D levels were ASSOCIATED with high total Ige and detectable inhalant allergen-specific Ige; high Vitamin D was also ASSOCIATED with positive allergy skin tests.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 188)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 113, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 159, 'IgE'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC3773018	4/2013	S18-PMC3773018	['our study, conducted primarily in african american children in the u.s., was the FIRST to SHOW that Genetic polymorphisms MIGHT modify the EFFECTS of Vitamin D deficiency on the risk of fs (18).']	[('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 139)]	4	[('SO_0000704', 'gene', 100, 'genetic'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC3773018	4/2013	S19-PMC3773018	['HOWEVER, FINDINGS regarding the combined EFFECTS of Prenatal and Postnatal Vitamin D status on fs, two of the most CRITICAL periods for Immune System Development (19,20), are UNCLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 175)]	5	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('GO_0007567', 'parturition', 65, 'postnatal'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0002520', 'immune system development', 136, 'immune system development'), ('UBERON_0002405', 'immune system', 136, 'immune system')]
PMC3773018	4/2013	S21-PMC3773018	['THIS STUDY FURTHER extends and strengthens our PREVIOUS work by EXAMINING the risk of fs in RELATION to the longitudinal trajectory of Vitamin D status from Birth to early childhood in the same Birth cohort.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 64), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007567', 'parturition', 157, 'birth'), ('GO_0007567', 'parturition', 194, 'birth')]
PMC3773018	4/2013	S35-PMC3773018	['we grouped the children according to longitudinal trajectory of 25(Oh)D based on if a child had: 1) low Vitamin D status at Birth (< 11ng/ml) AS SUGGESTED by the institute of medicine (26) or 2) low Postnatal Vitamin D status (< 30ng/ml) ACCORDING TO the Endocrine society clinical practice guidelines on Vitamin D insufficiency (27,28).']	[('PROBABLE_UNDERSTANDING', 142), ('INCOMPLETE_EVIDENCE', 145), ('INCOMPLETE_EVIDENCE', 238)]	3	[('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 64, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007567', 'parturition', 124, 'birth'), ('GO_0007567', 'parturition', 199, 'postnatal'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 255, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 305, 'Vitamin D')]
PMC3773018	4/2013	S54-PMC3773018	['SIMILAR ASSOCIATION PATTERNS between persistently low Vitamin D and high risk of fs were SEEN among children with 25(Oh)D measurements within 1 year of age and 1–3 years of age; among children Born in winter and non-winter; among children Born Preterm (< 37 weeks of Gestation) and children born term (>= 37 weeks) (data not shown).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 8), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 89)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 114, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 114, '25(OH ... D'), ('GO_0007567', 'parturition', 193, 'born'), ('GO_0007567', 'parturition', 239, 'born'), ('GO_0007565', 'female pregnancy', 244, 'preterm'), ('GO_0007565', 'female pregnancy', 267, 'gestation')]
PMC3773018	4/2013	S56-PMC3773018	['DUE TO SMALL sample size after stratification, the significant ASSOCIATION between persistently low Vitamin D and risk of fs was ONLY observed in children with 25(Oh)d measurements within 1 year of age (or=2.99, 95%ci: 1.05–8.52).']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 129)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 160, '25(OH)')]
PMC3773018	4/2013	S57-PMC3773018	['finally, we OBSERVED an INTERACTION EFFECT between rs2243250 and persistently low Vitamin D status on the risk of fs (pinteraction= 0.02).']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC3773018	4/2013	S61-PMC3773018	['discussion\nTHIS is the FIRST STUDY TO EXAMINE the EFFECTS of longitudinal trajectory Vitamin D status, by measurement of Plasma 25(Oh)D concentrations from Birth to early childhood, on the development of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 50)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 121, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 128, '25(OH ... D'), ('GO_0007567', 'parturition', 156, 'birth')]
PMC3773018	4/2013	S62-PMC3773018	['we FOUND that persistently low Vitamin D status from Birth to early childhood was ASSOCIATED with fs in the bbc.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007567', 'parturition', 53, 'birth')]
PMC3773018	4/2013	S63-PMC3773018	['OUR FINDINGS SUGGEST that both Prenatal and early Postnatal Vitamin D levels APPEAR TO play an IMPORTANT ROLE in the development of fs, ESPECIALLY among those with specific genotypes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 77), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 136)]	6	[('GO_0007565', 'female pregnancy', 31, 'prenatal'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3773018	4/2013	S67-PMC3773018	['we also FOUND high proportions of children with low Vitamin D status (i.e., <30ng.ml) during the first year of Life, 1–2 years, and 2–3 years (i.e., 29%, 36%, and 40%).']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0000104', 'life cycle', 111, 'life')]
PMC3773018	4/2013	S69-PMC3773018	['AS SUCH, IT IS POSSIBLE that SOME of the children in this study did not consume 1,000 ml Vitamin D-fortified formula per day, and were not Fed additional Vitamin D supplements to meet the RECOMMENDED intake of 400 iu/day for infants, children, and adolescents (30).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('FUTURE_WORK', 188)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007631', 'feeding behavior', 139, 'fed'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC3773018	4/2013	S72-PMC3773018	['we PREVIOUSLY reported the qualitative INTERACTIONS between Vitamin D deficiency, assessed from Cord Blood and a Genetic variant in the Gene Il4 (rs2243250), and fs in the same birth cohort (18).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 96, 'cord'), ('UBERON_0000178', 'blood', 101, 'blood'), ('SO_0000704', 'gene', 113, 'genetic'), ('SO_0000704', 'gene', 136, 'gene'), ('PR_000008989', 'interleukin-1 family member 7', 141, 'IL4')]
PMC3773018	4/2013	S74-PMC3773018	['the FINDINGS from THIS extended STUDY EMPHASIZE the IMPORTANT ROLE of Postnatal Vitamin D status in the development of fs.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('IMPORTANT_CONSIDERATION', 38), ('IMPORTANT_CONSIDERATION', 52), ('SUPERFICIAL_RELATIONSHIP', 62)]	6	[('GO_0007567', 'parturition', 70, 'postnatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC3773018	4/2013	S79-PMC3773018	['furthermore, OUR FINDINGS REMAINED SIMILAR after controlling for season of Birth or stratification by season of Birth, INDICATING that Birth season is UNLIKELY to MEDIATE the ASSOCIATIONS between persistently low Vitamin D and risk of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 151), ('SUPERFICIAL_RELATIONSHIP', 163), ('SUPERFICIAL_RELATIONSHIP', 175)]	8	[('GO_0007567', 'parturition', 75, 'birth'), ('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007567', 'parturition', 135, 'birth'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC3773018	4/2013	S82-PMC3773018	['OF NOTE, OUR FINDINGS from the stratified analyses SUGGESTED stronger ASSOCIATIONS between low Vitamin D status and high RISK of fs among children Born Preterm, which NEEDS to be FURTHER explored in a larger sample.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('IMPORTANT_CONSIDERATION', 121), ('IMPORTANT_CONSIDERATION', 167), ('FUTURE_WORK', 179), ('INCOMPLETE_EVIDENCE', 179)]	8	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007567', 'parturition', 147, 'born'), ('GO_0007565', 'female pregnancy', 152, 'preterm')]
PMC3773018	4/2013	S83-PMC3773018	['furthermore, we OBSERVED significant INTERACTION EFFECTS between the Il4 Gene polymorphism and persistently low Vitamin D status on fs in this SMALLER sized study sample.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 143)]	4	[('PR_000008989', 'interleukin-1 family member 7', 69, 'IL4'), ('SO_0000704', 'gene', 73, 'gene'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC3773018	4/2013	S85-PMC3773018	['among those carrying the tt genotype, post-Natal sufficient Vitamin D status EVEN SHOWED a decreased risk of fs.']	[('ANOMALY_CURIOUS_FINDING', 77), ('INCOMPLETE_EVIDENCE', 82)]	2	[('GO_0007567', 'parturition', 43, 'natal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3773018	4/2013	S86-PMC3773018	['it SHOULD BE NOTED that four Snps SHOWED significant INTERACTION EFFECTS with Vitamin D deficiency at Birth on fs in our PREVIOUS report (18).']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 121)]	6	[('SO_0000694', 'SNP', 29, 'SNPs'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'birth')]
PMC3773018	4/2013	S87-PMC3773018	['for this subset study, we have ONLY presented findings for the Il4 Promoter polymorphism given that rs2243250 HAS BEEN commonly studied and has already been shown to have the most significant Gene-Vitamin D deficiency INTERACTION on fs (18).']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 218)]	3	[('PR_000008989', 'interleukin-1 family member 7', 63, 'IL4'), ('SO_0000167', 'promoter', 67, 'promoter'), ('SO_0000704', 'gene', 192, 'gene'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC3773018	4/2013	S98-PMC3773018	['NEVERTHELESS, our data are valuable to the field given that there is a LACK OF longitudinal data on Vitamin D and allergic outcomes in early childhood.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 71)]	2	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3773018	4/2013	S103-PMC3773018	['FUTURE laboratory STUDIES also SHOULD BE SERIOUSLY CONSIDERED to help BETTER UNDERSTAND the molecular basis UNDERLYING HOW the immunomodulatory EFFECT of Vitamin D and Regulatory EFFECT of the Il4 Gene on Ige Production JOINTLY INFLUENCE the risk of fs.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 108), ('EXPLICIT_QUESTION', 119), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 220), ('SUPERFICIAL_RELATIONSHIP', 228)]	12	[('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0065007', 'biological regulation', 168, 'regulatory'), ('PR_000008989', 'interleukin-1 family member 7', 193, 'IL4'), ('SO_0000704', 'gene', 197, 'gene'), ('GO_0032631', 'interleukin-27 production', 205, 'IgE production'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 205, 'IgE')]
PMC3773018	4/2013	S104-PMC3773018	['IF THESE FINDINGS are REPLICATED in OTHER independent studies, then more ATTENTION to Vitamin D nutrition SHOULD BE given to very young children in the toddler age range, and particularly to those with very low Cord Blood Vitamin D measures and specific genotypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('FUTURE_WORK', 73), ('FUTURE_WORK', 106)]	6	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0009472', 'axilla', 211, 'cord blood'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC3773018	4/2013	S105-PMC3773018	['overall, THIS STUDY UNDERSCORES THE NEED to simultaneously CONSIDER both Cord Blood and Postnatal Vitamin D levels, along with Genetic susceptibility, in the development of fs and Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 32), ('FUTURE_WORK', 36), ('FUTURE_WORK', 59), ('IMPORTANT_CONSIDERATION', 59)]	6	[('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('GO_0007567', 'parturition', 88, 'postnatal'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic'), ('CHEBI_33290', 'food', 180, 'food')]
PMC3773018	4/2013	S106-PMC3773018	['the extent of Vitamin D insufficiency in this process MAY BE UNDERESTIMATED by a static, single value, and emphasizes that longer term exposure to a Vitamin D deficient state MIGHT have profound health consequences in a specific Genetic environment.']	[('INCOMPLETE_EVIDENCE', 54), ('PROBLEM_COMPLICATION', 61), ('INCOMPLETE_EVIDENCE', 175)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('SO_0000704', 'gene', 229, 'genetic')]
PMC3821254	4/2013	S70-PMC3821254	['[12] vitamin p ENHANCES the action of Vitamin C and for this REASON they SHOULD BE taken together.']	[('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 61), ('FUTURE_WORK', 73)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin C')]
PMC3651971	5/2013	S13-PMC3651971	['Animal studies have SUGGESTED that early Vitamin A deficiency CAN permanently impair Cognitive and motor function.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 62)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('GO_0050890', 'cognition', 85, 'cognitive')]
PMC3651971	5/2013	S14-PMC3651971	['we HYPOTHESISED that children Born to women in the Placebo group would have poorer scores on unit and mabc than their counterparts in the Vitamin A group.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('GO_0007567', 'parturition', 30, 'born'), ('CHEBI_26130', 'biological pigment', 51, 'placebo'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A')]
PMC3651971	5/2013	S15-PMC3651971	['our results provide NO EVIDENCE that early Vitamin A supplementation improves Cognitive or motor skills in 10-year-old to 13-year-old-children in rural nepal.']	[('INCOMPLETE_EVIDENCE', 20)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin A'), ('GO_0050890', 'cognition', 78, 'cognitive')]
PMC3651971	5/2013	S17-PMC3651971	["DEFICIENCY of essential Nutrients CAN harm the fetus; NO RESEARCH to date has examined the long-term EFFECT of early Vitamin A deficiency on children's cognitive or motor skills."]	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 101)]	4	[('CHEBI_33284', 'nutrient', 24, 'nutrients'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A')]
PMC3651971	5/2013	S18-PMC3651971	['THIS STUDY SUGGESTS no benefit of maternal Vitamin A supplementation on Cognitive or motor skills in 10-year-old to 13-year-old offspring.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin A'), ('GO_0050890', 'cognition', 72, 'cognitive')]
PMC3651971	5/2013	S19-PMC3651971	['this research SUGGESTS that Central Nervous System Development MAY BE PROTECTED in Vitamin A deficiency, POSSIBLY BECAUSE Vitamin A is preferentially allocated to the developing fetus.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 105), ('PROBABLE_UNDERSTANDING', 114)]	5	[('GO_0003204', 'cardiac skeleton development', 28, 'central nervous system development'), ('UBERON_0001017', 'central nervous system', 28, 'central nervous system'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]
PMC3651971	5/2013	S25-PMC3651971	['there are SUGGESTIONS from SPARSE Human data that fetal Vitamin A deficiency MAY adversely AFFECT childhood development.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 91)]	4	[('NCBITaxon_9606', 'Homo sapiens', 34, 'human'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin A')]
PMC3651971	5/2013	S26-PMC3651971	['in a study of healthy chinese mothers and newborns, a positive RELATIONSHIP was OBSERVED between Cord Blood Retinol level and motor skill achievements by age 2.17in indonesia, newborn Vitamin A supplementation resulted in modest improvement in Motor Development scores after 3\u2005years,18while Vitamin A supplementation to hiv-positive tanzanian women exerted no detectable changes in infant Psychomotor Development.19there REMAINS, HOWEVER, a NEED FOR ADDITIONAL causal data on early Life Vitamin A exposure and Neurocognitive and motor function.']	[('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 421), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 430), ('FUTURE_WORK', 441)]	5	[('UBERON_0002240', 'spinal cord', 97, 'cord'), ('UBERON_0000178', 'blood', 102, 'blood'), ('CHEBI_26536', 'retinoic acid', 108, 'retinol'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 244, 'motor development'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin A'), ('GO_0030324', 'lung development', 389, 'psychomotor development'), ('UBERON_0000104', 'life cycle', 482, 'life'), ('CHEBI_27300', 'vitamin D', 487, 'vitamin A'), ('GO_0050905', 'neuromuscular process', 510, 'neurocognitive')]
PMC3651971	5/2013	S27-PMC3651971	['THIS STUDY is the FIRST TO EXAMINE EFFECTS of routine, maternal Vitamin A supplementation before, during and following Pregnancy, provided via a randomised, placebo-controlled trial, on child Cognitive and motor ability.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 35)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin A'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('GO_0050890', 'cognition', 192, 'cognitive')]
PMC3651971	5/2013	S28-PMC3651971	['the trial was conducted in a chronically undernourished population where supplementation with Vitamin A or Β-Carotene reduced maternal mortality,20biochemical Vitamin A deficiency,21night blindness22and morbidity,23but had no overall effect on infant mortality.24in the long term, at 9–13\u2005years of age, the intervention HAS BEEN SHOWN to have improved Lung size25and innate aspects of Immunity,26but has not affected biomarker risk factors for Cardiovascular diseases.27\n\nmethods\n\nselection and description of sample\nthis study followed a sample of Children Born to women who participated in a cluster-randomised, placebo-controlled trial of Vitamin A or Β-Carotene supplementation before, during and after Pregnancy.']	[('INCOMPLETE_EVIDENCE', 320)]	1	[('CHEBI_27300', 'vitamin D', 94, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 107, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin A'), ('UBERON_0002048', 'lung', 352, 'lung'), ('GO_0007566', 'embryo implantation', 385, 'immunity'), ('UBERON_0004535', 'cardiovascular system', 444, 'cardiovascular'), ('GO_0050890', 'cognition', 549, 'children'), ('GO_0007567', 'parturition', 558, 'born'), ('CHEBI_27300', 'vitamin D', 642, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 655, 'β-carotene'), ('GO_0007565', 'female pregnancy', 707, 'pregnancy')]
PMC3651971	5/2013	S38-PMC3651971	['objective and outcomes\nTHIS STUDY HYPOTHESISED that, by school age, children Born to mothers routinely supplemented with Vitamin A would perform better on tests of Cognitive and motor ability than children Born to Placebo-supplemented women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('INCOMPLETE_EVIDENCE', 34), ('QUESTION_ANSWERED_BY_THIS_WORK', 34)]	3	[('GO_0007567', 'parturition', 77, 'born'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin A'), ('GO_0050890', 'cognition', 164, 'cognitive'), ('GO_0007567', 'parturition', 206, 'born'), ('CHEBI_26130', 'biological pigment', 214, 'placebo')]
PMC3651971	5/2013	S54-PMC3651971	['we HYPOTHESISED that Early Life Vitamin A supplementation COULD yield differences of 40% of an sd based on standardised distributions obtainable from unit and mabc, with 80% power, and arbitrarily assumed a design effect associated with ward randomisation of 2 and a 5% refusal rate.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 58)]	2	[('UBERON_0001847', 'lobule of pinna', 21, 'early life'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin A')]
PMC3651971	5/2013	S73-PMC3651971	['an unpaired, two-sided test statistic that accounted for clustering was calculated using the formula described by moulton and hayes36:where cpis the number of clusters in the Placebo group, cvathe number of clusters in the Vitamin A group,36and s can be calculated as the square-root of the variance, s2:where xijis the jth cluster mean of the i group, and xithe mean of all six of the i group clusters.36a ci for the difference in means was computed using the formula:where tv,0.025is the 2.5% of a t distribution with v=cpl\u2009+\u2009cva\u2009−\u20092 degrees of freedom.36\na two-step variation of this technique was used to estimate the treatment effect in an adjusted model that controlled for INFLUENCES of POTENTIAL CONFOUNDERS that were unevenly distributed between the two groups.']	[('SUPERFICIAL_RELATIONSHIP', 680), ('INCOMPLETE_EVIDENCE', 694), ('PROBLEM_COMPLICATION', 704)]	3	[('CHEBI_26130', 'biological pigment', 175, 'placebo'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin A')]
PMC3651971	5/2013	S80-PMC3651971	["further, children whose mother's histories of Gestational night blindness during the trial were missing (n=31) were excluded from the sampling frame because night blindness is an INDICATOR of Vitamin A deficiency and was CONSIDERED an ESSENTIAL exposure of interest for other research questions in this study."]	[('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 235)]	3	[('GO_0007565', 'female pregnancy', 46, 'gestational'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin A')]
PMC3651971	5/2013	S88-PMC3651971	['this TREND, HOWEVER, was ONLY evident in the Vitamin A group (among whom the percentages were 84.6 vs 52.9, respectively, p<0.01; data not shown).']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 25)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin A')]
PMC3651971	5/2013	S100-PMC3651971	['fifty-five per cent of children in both groups were stunted, SUGGESTING comparable levels of chronic undernutrition, ALTHOUGH children Born to mothers in the placebo group had a lower prevalence of anaemia (26% vs 36.6%, p=0.03) and lower exposure to adequately Iodised Salt in their home, BASED ON tested concentrations of ≥30\u2005ppm (78% vs 85.7%, p=0.05), than in the Vitamin A group.']	[('INCOMPLETE_EVIDENCE', 61), ('ANOMALY_CURIOUS_FINDING', 117), ('PROBABLE_UNDERSTANDING', 290)]	3	[('GO_0007567', 'parturition', 135, 'born'), ('CHEBI_24859', 'iodine atom', 262, 'iodised salt'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin A')]
PMC3651971	5/2013	S139-PMC3651971	['the lack of EFFECT is UNLIKELY to be DUE TO a lack of Vitamin A deficiency among Pregnant women; ∼20% of mothers were NOTED to have a Serum Retinol concentration below 0.70\u2005µmol/l, a prevalence that fell to ∼3% with supplementation.20gestational night blindness of ∼10% also responded to Vitamin A supplementation,37and the risk of Maternal death was reduced by ∼40% through supplementation.20there was no lack of Cognitive or motor effect, which is LIKELY to be OWING TO the POOR response to supplementation among the offspring; infants Born to supplemented women had a higher Serum Retinol than infants Born to Placebo mothers by 3\u2005months of age.24the children Born to supplemented women also had better Lung function (as measured by the forced Expiratory volume at 1\u2005s and forced vital capacity)25and raised natural Antibody levels26in childhood, FURTHER EVIDENCE of a physiological EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('PROBABLE_UNDERSTANDING', 22), ('PROBLEM_COMPLICATION', 37), ('ANOMALY_CURIOUS_FINDING', 118), ('PROBABLE_UNDERSTANDING', 450), ('PROBLEM_COMPLICATION', 463), ('PROBLEM_COMPLICATION', 476), ('INCOMPLETE_EVIDENCE', 850), ('SUPERFICIAL_RELATIONSHIP', 886)]	9	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('UBERON_0001977', 'blood serum', 134, 'serum'), ('CHEBI_26536', 'retinoic acid', 140, 'retinol'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin A'), ('GO_0007618', 'mating', 332, 'maternal'), ('GO_0050890', 'cognition', 414, 'cognitive'), ('GO_0007567', 'parturition', 538, 'born'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_26536', 'retinoic acid', 584, 'retinol'), ('GO_0007567', 'parturition', 605, 'born'), ('CHEBI_26130', 'biological pigment', 613, 'placebo'), ('GO_0007567', 'parturition', 663, 'born'), ('UBERON_0002048', 'lung', 706, 'lung'), ('GO_0010467', 'gene expression', 747, 'expiratory'), ('GO_0042571', 'immunoglobulin complex, circulating', 819, 'antibody')]
PMC3651971	5/2013	S140-PMC3651971	['the HYPOTHESISED EFFECT of Gestational Vitamin A supplementation on Cognition and Motor Development is BASED ON sound THEORY.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 103), ('SUPERFICIAL_RELATIONSHIP', 103), ('INCOMPLETE_EVIDENCE', 118)]	5	[('GO_0007565', 'female pregnancy', 27, 'gestational'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('GO_0050890', 'cognition', 68, 'cognition'), ('GO_0009653', 'anatomical structure morphogenesis', 82, 'motor development')]
PMC3651971	5/2013	S142-PMC3651971	['the Human studies that have SUGGESTED a ROLE for Vitamin A in Cognitive and Motor Development are LIMITED to much younger children.1718another POSSIBLE EXPLANATION for our results is that differences between groups were attenuated by routine supplementation from the national Vitamin A programme started in 1995.30given the wide cis for experimental measures of Cognitive and motor development, and the POTENTIAL for Brain plasticity, the supplementation programme MIGHT have attenuated a treatment EFFECT, allowing placebo group children to regain the nutritional losses of their early Life.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 143), ('PROBABLE_UNDERSTANDING', 152), ('INCOMPLETE_EVIDENCE', 403), ('INCOMPLETE_EVIDENCE', 465), ('SUPERFICIAL_RELATIONSHIP', 499)]	8	[('NCBITaxon_9606', 'Homo sapiens', 4, 'human'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('GO_0050890', 'cognition', 62, 'cognitive ...'), ('GO_0009653', 'anatomical structure morphogenesis', 76, 'motor development'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin A'), ('GO_0050890', 'cognition', 362, 'cognitive'), ('UBERON_0000955', 'brain', 417, 'brain'), ('UBERON_0000104', 'life cycle', 587, 'life')]
PMC3651971	5/2013	S143-PMC3651971	['there are also a host of OTHER nutritional INFLUENCES on Cognitive Development, SOME of which MIGHT obscure the RELATIONSHIP between early Vitamin A deficiency and developmental outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 112)]	5	[('GO_0050787', 'detoxification of mercury ion', 57, 'cognitive development'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin A')]
PMC3651971	5/2013	S149-PMC3651971	['we FOUND that Vitamin A group children in the sampling frame were from more affluent families than their counterparts in the placebo group, as indicated by measures of wealth collected during the nnips-2 trial.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A')]
PMC3651971	5/2013	S151-PMC3651971	['ANOTHER POSSIBLE EXPLANATION for the LACK OF difference between groups is that unit and mabc are INSUFFICIENTLY PRECISE to pick up on subtle differences in Vitamin A nutriture.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 17), ('INCOMPLETE_EVIDENCE', 37), ('PROBLEM_COMPLICATION', 97)]	5	[('CHEBI_27300', 'vitamin D', 156, 'vitamin A')]
PMC3651971	5/2013	S157-PMC3651971	['the post hoc analyses REPORTED in THIS PAPER HINTED AT differences in motor skills after in utero Vitamin A supplementation, but did so ONLY after excluding children who never attended school and those who repeated a grade.']	[('INCOMPLETE_EVIDENCE', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('INCOMPLETE_EVIDENCE', 45), ('ANOMALY_CURIOUS_FINDING', 136), ('INCOMPLETE_EVIDENCE', 136)]	5	[('CHEBI_27300', 'vitamin D', 98, 'vitamin A')]
PMC3660281	5/2013	S27-PMC3660281	['regarding to Vitamin D, both an excess and a deficiency HAVE BEEN ASSOCIATED with an INCREASED RISK of asthma.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 85)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC3660294	5/2013	S198-PMC3660294	['WHILE more than 20% of breastfeeding mothers in this study did not provide Vitamin D supplements to their infants, ABOUT half of exclusively breastfeeding mothers in another national survey gave their infants Vitamin D supplements [24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 115)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC3668200	5/2013	S0-PMC3668200	['comparison of the Serum Vitamin D level between breastfed and formula-Fed infants: several FACTORS which CAN AFFECT Serum Vitamin D concentration\nit is COMMON KNOWLEDGE among pediatricians that exclusively breastfed infants SHOULD BE supplemented with Vitamin D (400 iu/day) BECAUSE Human Breast Milk contains an INADEQUATE amount of Vitamin D. accordingly, choi et al.1)REPORTED a vitamin deficiency in early infants in a comparative study between Breastfed and formula-Fed infants in this issue.']	[('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 152), ('FUTURE_WORK', 159), ('FUTURE_WORK', 224), ('PROBABLE_UNDERSTANDING', 275), ('IMPORTANT_CONSIDERATION', 313), ('INCOMPLETE_EVIDENCE', 371)]	9	[('UBERON_0001977', 'blood serum', 18, 'serum'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007631', 'feeding behavior', 70, 'fed'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 283, 'human'), ('UBERON_0001348', 'brown adipose tissue', 289, 'breast milk'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D'), ('GO_0007567', 'parturition', 449, 'breastfed'), ('GO_0007631', 'feeding behavior', 471, 'fed')]
PMC3668200	5/2013	S1-PMC3668200	['ALTHOUGH the authors STATED SOME exclusion criteria, the study lacks SOME guidelines for CONSIDERATIONS in the evaluation of Vitamin D deficiency, especially those pertaining to FACTORS that can AFFECT the Vitamin concentration in the body.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 69), ('FUTURE_WORK', 89), ('IMPORTANT_CONSIDERATION', 89), ('SUPERFICIAL_RELATIONSHIP', 178), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 206, 'vitamin')]
PMC3668200	5/2013	S10-PMC3668200	['HOWEVER, measuring 1,25-Oh2-D levels AS a PREDICTOR of Vitamin D status CAN LEAD TO ERRONEOUS CONCLUSIONS BECAUSE, compared with 25(Oh)D levels, 1,25-Oh2-D levels CAN be normal or EVEN elevated DESPITE Vitamin D deficiency due to secondary hyperparathyroidism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 72), ('PROBABLE_UNDERSTANDING', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 194)]	14	[('CHEBI_78731', '9(R)-HPETE', 21, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 129, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 135, 'D'), ('CHEBI_78731', '9(R)-HPETE', 147, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC3668200	5/2013	S12-PMC3668200	['a study performed among Pregnant women DEMONSTRATED that fetal growth, expressed as Femur length, was reduced when the mother had low Vitamin D levels during the winter in a high-latitude area5).']	[('INCOMPLETE_EVIDENCE', 39)]	1	[('GO_0007565', 'female pregnancy', 24, 'pregnant'), ('UBERON_0000981', 'femur', 84, 'femur'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3668200	5/2013	S15-PMC3668200	['a light skin color MAY BE REQUIRED in women to produce relatively high amounts of Vitamin D NECESSARY for Pregnancy and Lactation8).']	[('INCOMPLETE_EVIDENCE', 19), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 92)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('GO_0007595', 'lactation', 120, 'lactation8')]
PMC3668200	5/2013	S27-PMC3668200	['THEREFORE, IT IS POSSIBLE that EVEN formula-Fed young infants are Vitamin D deficient.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 31)]	3	[('GO_0007631', 'feeding behavior', 44, 'fed'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3668200	5/2013	S28-PMC3668200	['Breast Milk ALONE can meet the Nutrient REQUIREMENT during the first 6 months of Life, with the POSSIBLE EXCEPTION of Vitamin D. the Vitamin A and Vitamin E contents of the Breast Milk are CORRELATED with the amount of the Vitamins in the dietary intake of Lactating mothers.']	[('ANOMALY_CURIOUS_FINDING', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 96), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 189)]	5	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breast milk'), ('CHEBI_33284', 'nutrient', 31, 'nutrient'), ('UBERON_0000104', 'life cycle', 81, 'life'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin E'), ('UBERON_0001348', 'brown adipose tissue', 173, 'breast milk'), ('CHEBI_33277', 'gamma-tocotrienol', 223, 'vitamins'), ('GO_0007594', 'puparial adhesion', 257, 'lactating')]
PMC3668200	5/2013	S31-PMC3668200	['the american academy of pediatrics (aap) PREVIOUSLY RECOMMENDED a daily Vitamin D intake of 200 iu for exclusively Breast-Fed infants.']	[('INCOMPLETE_EVIDENCE', 41), ('FUTURE_WORK', 52)]	2	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007567', 'parturition', 115, 'breast'), ('UBERON_0000310', 'breast', 115, 'breast'), ('GO_0007631', 'feeding behavior', 122, 'fed')]
PMC3668200	5/2013	S33-PMC3668200	['RECENTLY, aap RECOMMENDATION of 400 iu/day for Vitamin D supplementation was DOCUMENTED to maintain a 25(Oh)D Serum concentration higher than 50 nmol/l in exclusively Breast-Fed infants15).']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 14), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 102, '25(OH)D'), ('UBERON_0001977', 'blood serum', 110, 'serum'), ('GO_0007567', 'parturition', 167, 'breast'), ('UBERON_0000310', 'breast', 167, 'breast'), ('GO_0007631', 'feeding behavior', 174, 'fed')]
PMC3668200	5/2013	S36-PMC3668200	['THESE FINDINGS SUGGEST that a neonate Born to a mother with Vitamin D deficiency CAN be expected to be also deficient of the vitamin16).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 81)]	3	[('GO_0007567', 'parturition', 38, 'born'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3668200	5/2013	S37-PMC3668200	['in addition, women with increased skin pigmentation or those with little sunlight exposure are AT RISK of Vitamin D deficiency and MAY NEED additional Vitamin D supplementation, especially during Pregnancy and Lactation.']	[('IMPORTANT_CONSIDERATION', 95), ('INCOMPLETE_EVIDENCE', 131), ('IMPORTANT_CONSIDERATION', 135)]	3	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy'), ('GO_0007595', 'lactation', 210, 'lactation')]
PMC3668200	5/2013	S39-PMC3668200	['DESPITE SEVERE maternal Vitamin D deficiency, fetal rickets MAY RARELY develop.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 8), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 64)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC3668200	5/2013	S41-PMC3668200	['THEREFORE, daily supplementation with 400 iu of Vitamin D during the last Trimester of Pregnancy HAS BEEN practiced, ALBEIT with MINIMAL EFFECT on circulating 25(Oh)D concentrations in the mother and infant at term.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('ANOMALY_CURIOUS_FINDING', 117), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 74, 'trimester'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 159, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 165, 'D')]
PMC3668200	5/2013	S43-PMC3668200	['a canadian study that evaluated Serum Vitamin D and Mineral levels among infants REPORTED that newborns whose mothers had adequate intakes of milk and Vitamin D during Pregnancy showed increased Birth weight BUT NOT Head circumference or length at Birth17).']	[('INCOMPLETE_EVIDENCE', 81), ('ANOMALY_CURIOUS_FINDING', 208)]	2	[('UBERON_0001977', 'blood serum', 32, 'serum'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_46662', 'mineral', 52, 'mineral'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy'), ('GO_0007567', 'parturition', 195, 'birth'), ('UBERON_0000033', 'head', 216, 'head'), ('GO_0007567', 'parturition', 248, 'birth17')]
PMC3668200	5/2013	S45-PMC3668200	['the authors DID NOT TAKE into CONSIDERATION the height profiles of the newborns EVEN IF Minerals and Vitamin D are key FACTORS of bony growth.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 30), ('ANOMALY_CURIOUS_FINDING', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 119)]	5	[('CHEBI_46751', 'quinolizidine', 88, 'minerals'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3668200	5/2013	S51-PMC3668200	['MANY RESEARCH REPORTS on Vitamin D, which is IMPORTANT for Bony Metabolism and immunity, and has beneficial EFFECTS on diverse Organs, HAVE BEEN published RECENTLY.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 45), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0001461', 'elbow', 59, 'bony'), ('GO_0008152', 'metabolic process', 64, 'metabolism'), ('UBERON_0000062', 'organ', 127, 'organs')]
PMC3668200	5/2013	S52-PMC3668200	['Vitamin D concentration is AFFECTED by many Genetic, dietary, and environmental FACTORS; THEREFORE, it is RECOMMENDED that researchers CONSIDER the relative and EFFECTIVE FACTORS when performing STUDIES concerning Vitamin D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 80), ('PROBABLE_UNDERSTANDING', 89), ('FUTURE_WORK', 106), ('FUTURE_WORK', 135), ('SUPERFICIAL_RELATIONSHIP', 161), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 195)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('SO_0000704', 'gene', 44, 'genetic'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3672018	5/2013	S0-PMC3672018	['the INFLUENCE of early exposure to Vitamin D for development of Diseases later in Life\n\nabstract\n\nbackground\nVitamin D deficiency is common among otherwise healthy Pregnant women and MAY have CONSEQUENCES for them as well as the early Development and long-term health Of their Children.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 183), ('IMPORTANT_CONSIDERATION', 192)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007586', 'digestion', 64, 'diseases'), ('UBERON_0000104', 'life cycle', 82, 'life'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 164, 'pregnant'), ('GO_0001709', 'cell fate determination', 235, 'development ... - ... of ... children')]
PMC3672018	5/2013	S7-PMC3672018	['discussion\nthe results of the study will contribute to our CURRENT understanding of the SIGNIFICANCE of supplementation with Vitamin D. more specifically, they will enable new RESEARCH in related fields, including interventional research designed to assess supplementation NEEDS for different subgroups of Pregnant women.']	[('INCOMPLETE_EVIDENCE', 59), ('IMPORTANT_CONSIDERATION', 88), ('FUTURE_WORK', 176), ('IMPORTANT_CONSIDERATION', 273)]	4	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('GO_0007565', 'female pregnancy', 306, 'pregnant')]
PMC3672018	5/2013	S16-PMC3672018	['a RECENT STUDY reported identification of as many as 2,776 sites of Vitamin D receptor binding and 229 Genes whose Expression was directly LINKED to changes in Vitamin d levels [2].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 139)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('SO_0000704', 'gene', 103, 'genes'), ('GO_0010467', 'gene expression', 115, 'expression'), ('CHEBI_33229', 'vitamin (role)', 160, 'vitamin')]
PMC3672018	5/2013	S19-PMC3672018	['furthermore, as PROPOSED in 2001, a CRITICAL window MAY exist during which Vitamin D levels have a persisting IMPACT on health outcomes [5].']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 36), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3672018	5/2013	S20-PMC3672018	['low Vitamin D during Gestation and in early Life MAY THEREFORE play an IMPORTANT ROLE for susceptibility to bone fragility, obesity and Autoimmune diseases later in Life [6].']	[('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 53), ('IMPORTANT_CONSIDERATION', 71), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 21, 'gestation'), ('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0001442', 'skeleton of manus', 136, 'autoimmune'), ('UBERON_0000104', 'life cycle', 165, 'life')]
PMC3672018	5/2013	S23-PMC3672018	['Animal Tissues consumed as Food provide additional sources of this hormone-like vitamin, WHILE Plant foods MAY provide the less potent form of Vitamin D: Ergocalciferol (Vitamin D2) [7].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('INCOMPLETE_EVIDENCE', 107)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('UBERON_0000479', 'tissue', 7, 'tissues'), ('CHEBI_33290', 'food', 27, 'food'), ('NCBITaxon_33208', 'Metazoa', 95, 'plant'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_4910', 'etomidate', 154, 'ergocalciferol'), ('CHEBI_28934', 'vitamin D2', 170, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 170, 'vitamin D2')]
PMC3672018	5/2013	S28-PMC3672018	['it is ESTIMATED that one in seven, or ABOUT 860 million People around the world, have Vitamin D deficiency or insufficiency [9].']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 38)]	2	[('NCBITaxon_10088', 'Mus <genus>', 56, 'people'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3672018	5/2013	S34-PMC3672018	['adverse health EFFECTS of low Vitamin D MAY THEREFORE be MOST evident in Organs or Tissues whose development occurs in these trimesters, e.g.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 57)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000062', 'organ', 73, 'organs'), ('UBERON_0000479', 'tissue', 83, 'tissues')]
PMC3672018	5/2013	S35-PMC3672018	['obesity MAY BE PARTICULARLY ASSOCIATED with low Vitamin D during the third Trimester when Adipose Tissue is formed; fractures MAY BE PARTICULARLY ASSOCIATED with low Vitamin D during the third and/or second trimester [13]; and t1d with low Vitamin D during the first trimester.']	[('INCOMPLETE_EVIDENCE', 8), ('ANOMALY_CURIOUS_FINDING', 15), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 126), ('ANOMALY_CURIOUS_FINDING', 133), ('SUPERFICIAL_RELATIONSHIP', 146)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 75, 'trimester'), ('UBERON_0001013', 'adipose tissue', 90, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC3672018	5/2013	S37-PMC3672018	['a FEW STUDIES SUGGEST that low fetal Vitamin D MAY reduce bone Mineral content, CONSEQUENTLY leading to fragility fractures [14].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 47), ('PROBABLE_UNDERSTANDING', 80)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_46662', 'mineral', 63, 'mineral')]
PMC3672018	5/2013	S39-PMC3672018	['SOME STUDIES have FOUND that Adult obesity varies as a function of month of Birth and that subjects Born from winter to spring become more obese, POSSIBLY due to low Vitamin D levels from restricted maternal sun exposure during the third Trimester of Pregnancy [16].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 146)]	3	[('UBERON_0007023', 'adult organism', 29, 'adult'), ('GO_0007567', 'parturition', 76, 'birth'), ('GO_0007567', 'parturition', 100, 'born'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 238, 'trimester'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]
PMC3672018	5/2013	S40-PMC3672018	['furthermore, a RECENT STUDY REPORTED that a low level of maternal Vitamin D during Pregnancy was RELATED to high fat and low muscle in offspring at ages 5–9 [15].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC3672018	5/2013	S41-PMC3672018	['ALTHOUGH mechanisms RELATING low Perinatal Vitamin D to later obesity are NOT WELL KNOWN, PROPOSED mediators include epigenetic changes leading to initiation of Adipogenesis, or induction of permanent functional changes in Hypothalamic Appetite Regulation [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 78), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('GO_0036268', 'swimming', 33, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 33, 'perinatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 161, 'adipogenesis'), ('UBERON_0001898', 'hypothalamus', 223, 'hypothalamic'), ('GO_0034205', 'amyloid-beta formation', 236, 'appetite regulation')]
PMC3672018	5/2013	S42-PMC3672018	['furthermore, there are studies SHOWING that low fetal Vitamin D MAY lead to persistent changes in the Immune System, THUS POSSIBLY INFLUENCING the risk of developing Autoimmune diseases such as t1d [14,19,20].']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 64), ('PROBABLE_UNDERSTANDING', 117), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002405', 'immune system', 102, 'immune system'), ('UBERON_0001442', 'skeleton of manus', 166, 'autoimmune')]
PMC3672018	5/2013	S44-PMC3672018	['BOTH STUDIES SUGGEST that Prenatal malnutrition strongly IMPACTS Adult health, ALTHOUGH neither INDICATES specific EFFECTS from the lack of Vitamin D. the EFFECT of Vitamin D levels during Gestation, THUS, has never previously been followed in large populations.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 57), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 155), ('PROBABLE_UNDERSTANDING', 200)]	8	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('UBERON_0007023', 'adult organism', 65, 'adult'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'gestation')]
PMC3672018	5/2013	S48-PMC3672018	['objectives and HYPOTHESIS\nthe PRESENT STUDY relies on a unique societal experiment in which all Margarine and low fat Milk products Consumed by the danish population were fortified with vitamin D, during two distinct time periods: in 1961–1985 fortifying Margarine with Vitamin D was mandatory in denmark and in 1972–1976 low fat milk fortification was allowed.']	[('INCOMPLETE_EVIDENCE', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30)]	2	[('CHEBI_6784', 'mestranol', 96, 'margarine'), ('UBERON_0001913', 'milk', 118, 'milk'), ('GO_0007631', 'feeding behavior', 132, 'consumed'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 194, 'D'), ('CHEBI_6784', 'mestranol', 255, 'margarine'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3672018	5/2013	S54-PMC3672018	['the main HYPOTHESIS is that low levels of Vitamin D during CRITICAL phases of development have adverse EFFECTS on the long term risk of developing the above mentioned disease outcomes, and that exposure to extra Vitamin D from Food fortification has beneficial EFFECTS PREVENTING the mentioned diseases.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 269)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_33290', 'food', 227, 'food')]
PMC3672018	5/2013	S56-PMC3672018	['the Vitamin D fortification of low fat milk was not mandatory and THEREFORE not all low fat Milk distributed in denmark in the time period was fortified with Vitamin D. UNFORTUNATELY, there are no national statistics INDICATING the proportion of Milk Consumed that was fortified with Vitamin D. NEVERTHELESS, the two well-defined time periods of Vitamin D fortification provide a natural framework for comparing the EFFECTS of early exposure to Vitamin D on the Development Of Diseases later in Life amongst exposed and non-exposed adjacent Birth cohorts (figure\xa01).']	[('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 169), ('INCOMPLETE_EVIDENCE', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('SUPERFICIAL_RELATIONSHIP', 416)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0001913', 'milk', 92, 'milk'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001913', 'milk', 246, 'milk'), ('GO_0007631', 'feeding behavior', 251, 'consumed'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0009603', 'detection of symbiotic fungus', 462, 'development of diseases'), ('UBERON_0000104', 'life cycle', 495, 'life'), ('GO_0007567', 'parturition', 541, 'birth')]
PMC3672018	5/2013	S94-PMC3672018	['the HYPOTHESIS is that Individuals Born 1–2\u2009years after commencement of mandatory fortification (1961) and thus exposed to extra Vitamin D during Fetal Development and for the next 24–25\u2009years until 1985 (where fortification was ended), ALTHOUGH unexposed thereafter, will have a lower lifetime risk of developing the aforementioned disease entities COMPARED TO Individuals Born 1\u2009–2\u2009years before fortification.']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 237), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 350)]	3	[('NCBITaxon_1', 'root', 23, 'individuals'), ('GO_0007567', 'parturition', 35, 'born'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 146, 'fetal development'), ('NCBITaxon_1', 'root', 362, 'individuals'), ('GO_0007567', 'parturition', 374, 'born')]
PMC3672018	5/2013	S101-PMC3672018	['for instance, INFLUENCE of low Vitamin D on obesity and Adipose Tissues MAY BE particularly IMPORTANT for children whose third Gestation periods occur during winter, WHILE INFLUENCE of low Vitamin D on Autoimmune diseases MAY BE particularly IMPORTANT for children whose first Gestational trimester occurs during winter.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 72), ('IMPORTANT_CONSIDERATION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('SUPERFICIAL_RELATIONSHIP', 172), ('INCOMPLETE_EVIDENCE', 222), ('IMPORTANT_CONSIDERATION', 242)]	7	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 56, 'adipose tissues'), ('GO_0007565', 'female pregnancy', 127, 'gestation'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 202, 'autoimmune'), ('GO_0007565', 'female pregnancy', 277, 'gestational')]
PMC3672018	5/2013	S107-PMC3672018	['25(Oh)D3 level from dbs cards\nBECAUSE the 25(Oh)D3 levels in the newborn Blood REFLECTS the Vitamin D status of the newborn as well as the mother at the end of Pregnancy [29], measurement of 25(Oh)D3 levels in dbs will serve as VALIDATION for the EFFECT of fortification for incident cases.']	[('PROBABLE_UNDERSTANDING', 30), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 247)]	4	[('CHEBI_62946', 'ammonium sulfate', 0, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 0, '25(OH)D3'), ('CHEBI_62946', 'ammonium sulfate', 42, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 42, '25(OH)D3'), ('UBERON_0000178', 'blood', 73, 'blood'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy'), ('CHEBI_62946', 'ammonium sulfate', 191, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 191, '25(OH)D3')]
PMC3672018	5/2013	S145-PMC3672018	['fortification supplied 15% of Vitamin D intake on average, which MAY BE CONSIDERED low, PARTICULARLY when the sun exposure is not ample.']	[('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 88)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC3672018	5/2013	S148-PMC3672018	['the use of 50,000-100,000 Individuals from adjacent Birth years in the general population studies of events like fractures and diagnosis of t1d, a pivotal strength of THIS STUDY, makes it possible to detect EVEN minor EFFECTS of Vitamin D.\nFood disappearance statistics SHOW that Margarine Intake decreased and low fat milk slightly increased during the period covered.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('ANOMALY_CURIOUS_FINDING', 207), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 270)]	4	[('NCBITaxon_1', 'root', 26, 'individuals'), ('GO_0007567', 'parturition', 52, 'birth'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_33290', 'food', 240, 'Food'), ('CHEBI_6784', 'mestranol', 280, 'margarine'), ('GO_0007631', 'feeding behavior', 290, 'intake')]
PMC3672018	5/2013	S155-PMC3672018	['neither CONFOUNDING from external or internal factors, nor the LACK OF individual data on Vitamin D intake, is a prerequisite for the study, AS the INFLUENCES of lifestyle differences (e.g.']	[('PROBLEM_COMPLICATION', 8), ('INCOMPLETE_EVIDENCE', 63), ('PROBABLE_UNDERSTANDING', 141), ('SUPERFICIAL_RELATIONSHIP', 148)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3672018	5/2013	S160-PMC3672018	['moreover, there MIGHT be regional and urban/rural DIFFERENCES in Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC3672018	5/2013	S162-PMC3672018	['AS diet is USUALLY different between families with higher socioeconomic status and those with lower status [31], maternal socioeconomic status MAY have AFFECTED Margarine/milk Intake and THUS exposure to Vitamin D. information on socioeconomic position, education and ethnicity is available from statistics denmark and can be controlled for.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 152), ('PROBABLE_UNDERSTANDING', 187)]	5	[('CHEBI_6784', 'mestranol', 161, 'margarine'), ('GO_0007631', 'feeding behavior', 176, 'intake'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 212, 'D')]
PMC3672018	5/2013	S164-PMC3672018	['finally, the uncertainties RELATED to lack of knowledge about real Vitamin D status in mother and offspring MAY BE eliminated by assessing the measurement of infant Blood Vitamin D levels in those developing the three disease entities and comparing to time and gender-matched controls to examine actual exposure differences at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 108)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000178', 'blood', 165, 'blood'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007567', 'parturition', 327, 'birth')]
PMC3672018	5/2013	S165-PMC3672018	['implications\nUNLIKE many OTHER nutritional deficiencies, low Vitamin D status is PREVALENT among industrialized populations, and, ACCORDING TO danish health authorities, about half of all adults have Vitamin D insufficiency (below 50\u2009nmol/l) [32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('IMPORTANT_CONSIDERATION', 81), ('INCOMPLETE_EVIDENCE', 130)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC3672018	5/2013	S175-PMC3672018	['Growth and Pubertal Development, POSSIBILITY RELATED to Vitamin D exposures in early Life, PERHAPS EVEN before Conception, in addition to the outcomes studied.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 91), ('ANOMALY_CURIOUS_FINDING', 99)]	4	[('GO_0040007', 'growth', 0, 'growth ...'), ('GO_0060021', 'roof of mouth development', 11, 'pubertal development'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0000104', 'life cycle', 85, 'life'), ('GO_0007620', 'copulation', 111, 'conception')]
PMC3672018	5/2013	S180-PMC3672018	['besides IMPLICATIONS for research in the field, it MAY also inform the current DEBATE in denmark on WHETHER to resume Vitamin D Food fortification.']	[('IMPORTANT_CONSIDERATION', 8), ('INCOMPLETE_EVIDENCE', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('EXPLICIT_QUESTION', 100)]	5	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 128, 'food')]
PMC3705146	5/2013	S26-PMC3705146	['nowhere has lack of Photic input EXERTED more EFFECTS on Humans over time than in the high latitude country of ireland, where comparatively low dietary Vitamin D and the lack of sunlight-induced Vitamin D selected for the fairest skin type in the world, as REPORTED in dermatological surveys (gibson et al.,1997).']	[('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 257)]	3	[('GO_0036367', 'light adaption', 20, 'photic'), ('NCBITaxon_9606', 'Homo sapiens', 57, 'humans'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC3705146	5/2013	S30-PMC3705146	['mcgrath and welham (1999) have PROPOSED that Vitamin D availability MAY Modulate the eventual development of schizophrenia, and kinney et al.']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 68)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0065007', 'biological regulation', 72, 'modulate')]
PMC3705146	5/2013	S31-PMC3705146	['(2009) have EXTENDED that THEORY to PROPOSE the risk for schizophrenia around the world is RELATED to levels of Vitamin D from fish in their current diet.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC3705146	5/2013	S37-PMC3705146	['clearly, the relative lack of sunlight had an evolutionary IMPACT on Genes AFFECTING Vitamin D generation from sunlight, BUT WHAT EVIDENCE is there that it MIGHT also have selected for a change in the prevalence of a disease such as schizophrenia?']	[('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('EXPLICIT_QUESTION', 125), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 156), ('EXPLICIT_QUESTION', 246)]	7	[('SO_0000704', 'gene', 69, 'genes'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3705146	5/2013	S160-PMC3705146	['furthermore, a RECENT report DEMONSTRATES an equivalently strong season-of-Birth EFFECT in multiple sclerosis with peaks in april and may and in PARALLEL with schizophrenia (torrey et al.,1997; davies et al.,2003), deficits in births of future multiple sclerosis patients during october and november (dobson et al.,2013), a FINDING the authors ATTRIBUTE to VARIATIONS in sunlight during Gestation and to the resulting variations in Vitamin D availability.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 81), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 324), ('SUPERFICIAL_RELATIONSHIP', 344), ('DIFFICULT_TASK', 357)]	7	[('GO_0007567', 'parturition', 75, 'birth'), ('GO_0007565', 'female pregnancy', 387, 'gestation'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D')]
PMC3705146	5/2013	S195-PMC3705146	['ALTHOUGH sunlight-induced Vitamin D is not an IMPORTANT source of Vitamin D for lower Animals, it HAS BEEN SHOWN that Prenatal dietary Vitamin D in sprague-dawley Rats has significant EFFECTS on Postnatal anxiety and social behaviors (pan et al.,2013).']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 86, 'animals'), ('GO_0007565', 'female pregnancy', 118, 'prenatal'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 163, 'rats'), ('GO_0007567', 'parturition', 195, 'postnatal')]
PMC3705146	5/2013	S208-PMC3705146	['with respect to the POSSIBLE ROLE of sunlight intensity in behavioral phenotypes, it HAS BEEN PROPOSED that cutaneous Vitamin D generation MAY BE INVOLVED in Gestational EFFECTS that Modulate the eventual development of schizophrenia (mcgrath and welham,1999).']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 170)]	7	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'gestational'), ('GO_0065007', 'biological regulation', 183, 'modulate')]
PMC3705146	5/2013	S217-PMC3705146	['the need for Vitamin D MAY have played an IMPORTANT ROLE in selecting for polymorphisms in a variety of light-responsive Genes, including the melanotropins.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 42), ('SUPERFICIAL_RELATIONSHIP', 52)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('SO_0000704', 'gene', 121, 'genes')]
PMC3705146	5/2013	S219-PMC3705146	['it is WELL KNOWN that a lack of Vitamin D causes rickets, which would have had a negative IMPACT the ability to perform the physical work NECESSARY to survive in historical times, BUT more IMPORTANTLY, frequently caused fatal outcomes during Delivery BECAUSE of the improper configuration of Pelvis in SEVERE rickets (harrison,1966; cruickshank,1967; konje and ladipo,2000).']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 90), ('IMPORTANT_CONSIDERATION', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 189), ('PROBLEM_COMPLICATION', 251), ('IMPORTANT_CONSIDERATION', 302)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 242, 'delivery'), ('UBERON_0002355', 'pelvic region of trunk', 292, 'pelvis')]
PMC3705146	5/2013	S221-PMC3705146	['in such a manner, certain polymorphisms in melanotropin Genes MAY have become more prevalent in low-light environments IF they positively AFFECTED the natural Synthesis Of Vitamin D by reducing the Synthesis and Sequestration Of Melanin (valverde et al.,1995).']	[('INCOMPLETE_EVIDENCE', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('SO_0000704', 'gene', 56, 'genes'), ('GO_0030474', 'spindle pole body duplication', 159, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 198, 'synthesis'), ('GO_0098725', 'symmetric cell division', 212, 'sequestration of melanin'), ('CHEBI_25179', 'melanins', 229, 'melanin')]
PMC3705146	5/2013	S223-PMC3705146	['ALTHOUGH no Genetic associations between Vitamin-D receptors or enzymes INVOLVED in its formation or degradation HAVE yet BEEN IDENTIFIED for schizophrenia, that outcome does not NECESSARILY mean that Vitamin D is without effect in modifying the phenotypic plasticity that is obviously present in the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 179)]	6	[('SO_0000704', 'gene', 12, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 41, 'vitamin-D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'vitamin-D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC3705146	5/2013	S224-PMC3705146	['an INTERACTION between Vitamin D and the melanotropin system during development HAS BEEN DEMONSTRATED by eyles et al.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 80)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC3705146	5/2013	S225-PMC3705146	['(2007) who FOUND that Prenatal Vitamin D deficiency in rodents LEADS to elevations in the functional antagonist of alpha-msh , the melanotropic peptide mch .']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('GO_0007565', 'female pregnancy', 22, 'prenatal'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC3705146	5/2013	S226-PMC3705146	['HOWEVER, mcgrath and colleagues have ALSO SHOWN that the RELATIONSHIP between Vitamin D in Gestation and subsequent schizophrenia MAY BE COMPLEX, in that those with low maternal vitamin d are at INCREASED RISK of bearing offspring who become schizophrenic as are those with overly high Vitamin D (mcgrath et al.,2010a).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 130), ('DIFFICULT_TASK', 137), ('IMPORTANT_CONSIDERATION', 195)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'gestation'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D')]
PMC3705146	5/2013	S262-PMC3705146	['the need for Vitamin D MAY have AFFECTED NOT ONLY Gene frequencies of relevance to schizophrenia BUT MAY ALSO have Modulated Gene-environment INTERACTIONS that CAN occur in differing light regimes.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 32), ('ANOMALY_CURIOUS_FINDING', 41), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 101), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 160)]	8	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('SO_0000704', 'gene', 50, 'gene'), ('GO_0065007', 'biological regulation', 115, 'modulated'), ('SO_0000704', 'gene', 125, 'gene')]
PMC3717170	5/2013	S0-PMC3717170	['Vitamin D: beyond bone\n\nabstract\nin RECENT YEARS, Vitamin D HAS BEEN received INCREASED ATTENTION due TO the resurgence of Vitamin D deficiency and rickets in developed countries and the IDENTIFICATION of Extraskeletal EFFECTS of Vitamin D, SUGGESTING UNEXPECTED benefits of Vitamin D in health and disease, beyond bone health.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 219), ('INCOMPLETE_EVIDENCE', 241), ('ANOMALY_CURIOUS_FINDING', 252)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 205, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3717170	5/2013	S1-PMC3717170	['the POSSIBILITY of Extraskeletal EFFECTS of Vitamin D was FIRST NOTED with the discovery of the Vitamin D Receptor (vdr) in Tissues and cells that are not involved in maintaining Mineral Homeostasis and bone health, including skin, Placenta, Pancreas, Breast, Prostate and Colon cancer cells, and Activated T Cells.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 58), ('ANOMALY_CURIOUS_FINDING', 64)]	4	[('UBERON_0001431', 'distal carpal bone 2', 19, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 96, 'vitamin D receptor'), ('UBERON_0000479', 'tissue', 124, 'tissues'), ('CHEBI_46662', 'mineral', 179, 'mineral'), ('GO_0055085', 'transmembrane transport', 179, 'mineral homeostasis'), ('UBERON_0001987', 'placenta', 232, 'placenta'), ('UBERON_0001264', 'pancreas', 242, 'pancreas'), ('UBERON_0000310', 'breast', 252, 'breast'), ('UBERON_0002367', 'prostate gland', 260, 'prostate'), ('UBERON_0001155', 'colon', 273, 'colon'), ('CL_0002129', 'regular atrial cardiac myocyte', 297, 'activated T cells')]
PMC3717170	5/2013	S3-PMC3717170	['THIS REPORT summarizes RECENT RESEARCH on the ROLES for Vitamin D in cancer, Immunity and Autoimmune diseases, Cardiovascular and Respiratory health, Pregnancy, obesity, Erythropoiesis, diabetes, muscle function, and Aging.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007566', 'embryo implantation', 77, 'immunity'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 111, 'cardiovascular'), ('UBERON_0001004', 'respiratory system', 130, 'respiratory'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0030218', 'erythrocyte differentiation', 170, 'erythropoiesis'), ('GO_0007568', 'aging', 217, 'aging')]
PMC3717170	5/2013	S4-PMC3717170	['introduction\ntraditionally, Vitamin D HAS BEEN CONSIDERED almost exclusively in the context of its ROLE in Calcium Homeostasis.']	[('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 107, 'calcium homeostasis')]
PMC3717170	5/2013	S10-PMC3717170	['WHILE it was LONG HELD that Vitamin D ACTED only at the Intestine, Kidney, and Skeleton, and that its function was LIMITED to calcium Homeostasis, the POSSIBILITY of Extraskeletal EFFECTS HAS BEEN CONSIDERED for decades AS a result of the discovery of the vdr in Tissues that have no involvement in Calcium Homeostasis (e.g., skin, Placenta, Pancreas, Breast, Prostate and Colon cancer cells, and Activated T Cells).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 151), ('SUPERFICIAL_RELATIONSHIP', 180), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('PROBABLE_UNDERSTANDING', 220)]	10	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0000160', 'intestine', 56, 'intestine'), ('UBERON_0002113', 'kidney', 67, 'kidney'), ('UBERON_0004288', 'skeleton', 79, 'skeleton'), ('GO_0042592', 'homeostatic process', 134, 'homeostasis'), ('UBERON_0001431', 'distal carpal bone 2', 166, 'extraskeletal'), ('UBERON_0000479', 'tissue', 263, 'tissues'), ('GO_0055073', 'cadmium ion homeostasis', 299, 'calcium homeostasis'), ('UBERON_0001987', 'placenta', 332, 'placenta'), ('UBERON_0001264', 'pancreas', 342, 'pancreas'), ('UBERON_0000310', 'breast', 352, 'breast'), ('UBERON_0002367', 'prostate gland', 360, 'prostate'), ('UBERON_0001155', 'colon', 373, 'colon'), ('CL_0002129', 'regular atrial cardiac myocyte', 397, 'activated T cells')]
PMC3717170	5/2013	S13-PMC3717170	['nonclassical EFFECTS of Vitamin D\n\nVitamin D: beyond bone\nsylvia christakos (umdnj-new jersey medical school) began the meeting by summarizing the Metabolism and activity of Vitamin D and introducing the EMERGING AWARENESS of ROLES for Vitamin D beyond Calcium Homeostasis and Bone Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 204), ('IMPORTANT_CONSIDERATION', 213), ('SUPERFICIAL_RELATIONSHIP', 226)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 35, 'Vitamin D'), ('GO_0008152', 'metabolic process', 147, 'metabolism'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 253, 'calcium homeostasis'), ('GO_0006768', 'biotin metabolic process', 277, 'bone metabolism')]
PMC3717170	5/2013	S18-PMC3717170	['IN ORDER TO DETERMINE mechanisms INVOLVED in inhibition of Breast tumor growth, christakos’ lab SHOWED that C/Ebpα, a transcription factor that HAS BEEN SHOWN to play a CRITICAL ROLE in growth arrest of other cell types, is induced by 1,25(Oh)2D3In mcf-7 Human Breast cancer cells.2c/Ebpα was found to induce transcription of the Vitamin D receptor in mcf-7 cells.2since the levels of the vdr CORRELATE with the antiproliferative effects of 1,25(Oh)2D3, and since it HAS BEEN SUGGESTED that C/Ebpα CAN be considered a POTENTIAL tumor suppressor, these FINDINGS SUGGEST mechanisms whereby 1,25(Oh)2D3May act to inhibit Growth Of Breast cancer Cells.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 144), ('IMPORTANT_CONSIDERATION', 169), ('SUPERFICIAL_RELATIONSHIP', 178), ('SUPERFICIAL_RELATIONSHIP', 393), ('INCOMPLETE_EVIDENCE', 467), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 518), ('INCOMPLETE_EVIDENCE', 552), ('INCOMPLETE_EVIDENCE', 561)]	13	[('UBERON_0000310', 'breast', 59, 'breast'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 108, 'C/EBPα'), ('CHEBI_37958', 'dye', 235, '1,'), ('CHEBI_45409', 'ritonavir', 237, '25(OH)2D3in'), ('NCBITaxon_9606', 'Homo sapiens', 255, 'human'), ('UBERON_0000310', 'breast', 261, 'breast'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 284, 'EBPα'), ('CHEBI_27300', 'vitamin D', 330, 'vitamin D'), ('CHEBI_37983', 'sulfur-35 atom', 441, '1'), ('CHEBI_17996', 'chloride', 442, ','), ('CHEBI_73394', 'Ala-Ser', 443, '25(OH)2D3'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 491, 'C/EBPα'), ('CHEBI_37958', 'dye', 588, '1,'), ('CHEBI_83462', 'metolachlor OXA', 590, '25(OH)2D3may'), ('GO_0048468', 'cell development', 618, 'growth of ... cells'), ('UBERON_0000310', 'breast', 628, 'breast')]
PMC3717170	5/2013	S20-PMC3717170	['the mechanism of 1,25(Oh)2D3Suppression of Il-17 was found to be transcriptional and to involve blocking of Nuclear factor for Activated T Cells (Nfat, which is IMPORTANT for T Cell receptor–mediated transcriptional Regulation of Il-17), recruitment of Histone deacetylase to the Il-17 Promoter, and Sequestration of Runt-Related Transcription Factor 1 (runx1) by the vdr.31,25(Oh)2D3Was also FOUND to have a direct EFFECT on the induction of Foxp3, a transcription factor that ASSOCIATES with Nfat and runx1 for transcriptional repression.3THESE results DESCRIBE NOVEL mechanisms and new CONCEPTS with regard to Vitamin D and the Immune System and SUGGEST THERAPEUTIC TARGETS for the Control of Autoimmune diseases.']	[('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 393), ('SUPERFICIAL_RELATIONSHIP', 416), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 540), ('INCOMPLETE_EVIDENCE', 555), ('FULL_UNKNOWN', 564), ('INCOMPLETE_EVIDENCE', 589), ('FUTURE_WORK', 649), ('INCOMPLETE_EVIDENCE', 649), ('FUTURE_WORK', 657), ('FUTURE_WORK', 669)]	12	[('CHEBI_42976', 'L-glycero-alpha-D-manno-heptopyranose', 17, '1,25(OH)2D3suppression'), ('PR_000001470', 'interleukin-28B', 43, 'IL-17'), ('GO_0005634', 'nucleus', 108, 'nuclear'), ('CL_0002129', 'regular atrial cardiac myocyte', 127, 'activated T cells'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 146, 'NFAT'), ('CL_0000084', 'T cell', 175, 'T cell'), ('GO_0065007', 'biological regulation', 216, 'regulation'), ('PR_000001470', 'interleukin-28B', 230, 'IL-17'), ('CHEBI_15358', 'histone', 253, 'histone'), ('PR_000043452', 'core histone', 253, 'histone'), ('PR_000001470', 'interleukin-28B', 280, 'IL-17'), ('SO_0000167', 'promoter', 286, 'promoter'), ('GO_0051235', 'maintenance of location', 300, 'sequestration'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 317, 'Runt-related transcription factor 1'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 375, '25(OH)2D3was'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 443, 'Foxp3'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 494, 'NFAT'), ('CHEBI_27300', 'vitamin D', 613, 'vitamin D'), ('UBERON_0002405', 'immune system', 631, 'immune system'), ('GO_0065007', 'biological regulation', 685, 'control'), ('UBERON_0001442', 'skeleton of manus', 696, 'autoimmune')]
PMC3717170	5/2013	S32-PMC3717170	['with permission from christakos.60\n\nVitamin D in Immune function and disease PREVENTION\nmartin hewison (the david geffen school of medicine, university of california) detailed one of the most prominent of the SO-called nonclassical EFFECTS of Vitamin D: its ability to act as a potent modulator of Human Immune Responses.']	[('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 209), ('SUPERFICIAL_RELATIONSHIP', 232)]	3	[('CHEBI_28384', 'vitamin K', 36, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 36, 'Vitamin D'), ('UBERON_0002405', 'immune system', 49, 'immune'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 298, 'human'), ('GO_0006955', 'immune response', 304, 'immune responses'), ('UBERON_0002405', 'immune system', 304, 'immune')]
PMC3717170	5/2013	S40-PMC3717170	['HOWEVER, it is IMPORTANT TO RECOGNIZE that similar antibacterial responses to Vitamin D HAVE also BEEN REPORTED for OTHER cell types within Tissues, such as the skin, Lungs, Gi Tract, and Placenta, that MAY broadly be termed barrier sites .']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 203)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000479', 'tissue', 140, 'tissues'), ('UBERON_0002048', 'lung', 167, 'lungs'), ('UBERON_0000993', 'oviduct', 174, 'GI tract'), ('UBERON_0001987', 'placenta', 188, 'placenta')]
PMC3717170	5/2013	S41-PMC3717170	['THUS, IT IS POSSIBLE that Vitamin D deficiency has a generalized DETRIMENTAL IMPACT on antibacterial responses and MAY THEREFORE play a ROLE in many types of infectious diseases.5an IMPORTANT NOTE by hewison is that current data SUGGEST that this particular Immune Response to Vitamin D is restricted to Primates, UNDERLINING a POTENTIAL ROLE for Vitamin D in the evolution of Primate Immunity, BUT also LIMITING the scope of FURTHER in vivo STUDIES to explore this activity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 229), ('PROBABLE_UNDERSTANDING', 314), ('INCOMPLETE_EVIDENCE', 328), ('SUPERFICIAL_RELATIONSHIP', 338), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 395), ('INCOMPLETE_EVIDENCE', 404), ('FUTURE_WORK', 426)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0006955', 'immune response', 258, 'immune response'), ('UBERON_0002405', 'immune system', 258, 'immune'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 304, 'primates'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 377, 'primate'), ('GO_0007566', 'embryo implantation', 385, 'immunity')]
PMC3717170	5/2013	S44-PMC3717170	['as with antibacterial Responses to infection, it HAS BEEN PROPOSED that Adaptive Immune Responses MAY BE compromised in patients with low Serum concentrations of 25(Oh)D3, and ASSOCIATION studies HAVE SHOWN LINKS between Autoimmune disease and Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 207)]	6	[('GO_0060033', 'anatomical structure regression', 22, 'responses'), ('GO_0051866', 'general adaptation syndrome', 72, 'adaptive immune responses'), ('UBERON_0002405', 'immune system', 81, 'immune'), ('UBERON_0001977', 'blood serum', 138, 'serum'), ('CHEBI_62946', 'ammonium sulfate', 162, '25(OH)D3'), ('UBERON_0001442', 'skeleton of manus', 221, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D')]
PMC3717170	5/2013	S46-PMC3717170	['hewison STATED that it will be IMPORTANT to define WHETHER enhanced Vitamin D–mediated immunity prevents Immune disease OR WHETHER it CAN be used as therapy for these diseases.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('INCOMPLETE_EVIDENCE', 134)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002405', 'immune system', 105, 'immune')]
PMC3717170	5/2013	S47-PMC3717170	['moreover, IT IS POSSIBLE that SOME diseases, such as leprosy and hiv infection, MAY BE ASSOCIATED with dysregulation of the core Vitamin D intracrine Immune mechanism, and MAY THEREFORE require higher circulating levels of 25(Oh)D3To reestablish normal Immune Responses.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 172), ('PROBABLE_UNDERSTANDING', 176)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0002405', 'immune system', 150, 'immune'), ('CHEBI_63755', 'o-nitrophenyl group', 223, '25(OH)D3to'), ('GO_0006955', 'immune response', 253, 'immune responses'), ('UBERON_0002405', 'immune system', 253, 'immune')]
PMC3717170	5/2013	S49-PMC3717170	['Vitamin D in the Heart and Vascular System\ndavid g. gardner (university of california, san francisco) expanded the discussion of nonclassical EFFECTS of Vitamin D to include EVIDENCE of a significant ROLE for Vitamin D in the Cardiovascular System.']	[('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 200)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000948', 'heart', 17, 'heart'), ('UBERON_0007798', 'vascular system', 27, 'vascular system'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 226, 'cardiovascular system')]
PMC3717170	5/2013	S50-PMC3717170	['WHILE the Heart and Vasculature have ONLY RECENTLY been identified as POTENTIAL targets of Vitamin D action, a GROWING body of EVIDENCE SUGGESTS that the activated vdr plays an IMPORTANT ROLE in Regulating Cardiovascular function.8first, the vdr and the ligand-generating 25-Hydroxyvitamin D31-α-hydroxylase HAVE BEEN SHOWN to be present in Cardiac Myocytes, Cardiac Fibroblasts, Vascular Smooth Muscle Cells, and Vascular Endothelial Cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 136), ('IMPORTANT_CONSIDERATION', 177), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 308)]	9	[('UBERON_0000948', 'heart', 10, 'heart'), ('UBERON_0002049', 'vasculature', 20, 'vasculature'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 195, 'regulating'), ('UBERON_0004535', 'cardiovascular system', 206, 'cardiovascular'), ('CHEBI_67376', 'dihydrooroxylin A', 272, '25-hydroxyvitamin'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 290, 'D31'), ('CL_0000746', 'cardiac muscle cell', 341, 'cardiac myocytes'), ('UBERON_0000948', 'heart', 341, 'cardiac'), ('CL_0002548', 'fibroblast of cardiac tissue', 359, 'cardiac fibroblasts'), ('UBERON_0000948', 'heart', 359, 'cardiac'), ('CL_0000359', 'vascular associated smooth muscle cell', 380, 'vascular smooth muscle cells'), ('UBERON_0001135', 'smooth muscle tissue', 389, 'smooth muscle'), ('CL_0000071', 'blood vessel endothelial cell', 414, 'vascular endothelial cells'), ('UBERON_0001986', 'endothelium', 423, 'endothelial')]
PMC3717170	5/2013	S51-PMC3717170	['second, Vitamin D deficiency in rodents HAS BEEN SHOWN to elicit increases in Blood pressure and Cardiac hypertrophy.']	[('INCOMPLETE_EVIDENCE', 40)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0000178', 'blood', 78, 'blood'), ('UBERON_0000948', 'heart', 97, 'cardiac')]
PMC3717170	5/2013	S63-PMC3717170	['in SOME cases, treatment of these disorders with exogenous Vitamin D or Vitamin D Metabolites HAS BEEN SHOWN to restore Endothelial function.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 94)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_26871', 'terpene alkaloid', 72, 'vitamin D metabolites'), ('UBERON_0001986', 'endothelium', 120, 'endothelial')]
PMC3717170	5/2013	S66-PMC3717170	['collectively, these data DEMONSTRATE that the Vitamin D system—specifically, the ligand-bound vdr—plays an IMPORTANT ROLE in the maintenance of Cardiovascular health and SUGGEST that Vitamin D repletion MAY have IMPORTANT PUBLIC HEALTH IMPLICATIONS in Controlling the prevalence of, and morbidity ASSOCIATED with, Cardiovascular disease.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('IMPORTANT_CONSIDERATION', 107), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 203), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 222), ('SUPERFICIAL_RELATIONSHIP', 297)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 144, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0065007', 'biological regulation', 252, 'controlling'), ('UBERON_0004535', 'cardiovascular system', 314, 'cardiovascular')]
PMC3717170	5/2013	S67-PMC3717170	['of equivalent IMPORTANCE, therapy with high potency Vitamin D Metabolites or their analogs MAY subserve an IMPORTANT ROLE in the management of these diseases.']	[('IMPORTANT_CONSIDERATION', 14), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 107), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_25212', 'metabolite', 62, 'metabolites')]
PMC3717170	5/2013	S68-PMC3717170	['Vitamin D during Pregnancy and Lactation\nVitamin D as a preprohormone has EFFECTS that extend beyond Calcium Metabolism and Homeostasis throughout Life but which are most vivid during Pregnancy when Vitamin D Metabolism is disengaged from its usual constraints.12at no other time during the Lifecycle is 25(Oh)D3Linked directly to 1,25(Oh)2d3production, the latter rising more than 2.5 times above nonpregnant levels.12this elevation of 1,25(oh)2d3likely serves the purpose of Immune Regulation, THOUGH there HAVE BEEN ONLY a FEW STUDIES that have evaluated the EFFECT of Vitamin D status on Immune function during Pregnancy to SUPPORT THIS HYPOTHESIS.']	[('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 484), ('ANOMALY_CURIOUS_FINDING', 496), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 628), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 641)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('GO_0007595', 'lactation', 31, 'lactation'), ('CHEBI_28384', 'vitamin K', 41, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 101, 'calcium metabolism'), ('GO_0042592', 'homeostatic process', 124, 'homeostasis'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 199, 'vitamin D metabolism'), ('UBERON_0000104', 'life cycle', 291, 'lifecycle'), ('CHEBI_77914', '3-methylbut-1-ene', 304, '25(OH)D3linked'), ('CHEBI_63056', 'zinc cation', 333, '25(OH'), ('CHEBI_17996', 'chloride', 438, ','), ('GO_0002521', 'leukocyte differentiation', 477, 'immune regulation'), ('UBERON_0002405', 'immune system', 477, 'immune'), ('CHEBI_27300', 'vitamin D', 572, 'vitamin D'), ('UBERON_0002405', 'immune system', 592, 'immune'), ('GO_0007565', 'female pregnancy', 615, 'pregnancy')]
PMC3717170	5/2013	S69-PMC3717170	["in addition, FEW randomized controlled trials HAVE BEEN conducted in Pregnant women to determine optimal Vitamin D status.13–15\ncarol l. wagner (medical university of south carolina) DISCUSSED two RECENT STUDIES performed by her group in collaboration with bruce hollis's group—the national institute of child health and Human development (nichd) Vitamin D Pregnancy trial12and the thrasher research fund Vitamin D community-based supplementation trial16—that INDICATE that 400 iu Vitamin D, the amount found in MOST Prenatal Vitamins, is INADEQUATE and that 4000 iu/day is NECESSARY to optimize 1,25(Oh)2D3Production, achieved when total circulating 25(Oh)d3is at least 40 ng/ml (fig."]	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 460), ('PROBABLE_UNDERSTANDING', 512), ('IMPORTANT_CONSIDERATION', 539), ('PROBLEM_COMPLICATION', 539), ('IMPORTANT_CONSIDERATION', 574)]	9	[('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 321, 'Human'), ('CHEBI_28384', 'vitamin K', 347, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 357, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 405, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 405, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 481, 'vitamin D'), ('GO_0007565', 'female pregnancy', 517, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 526, 'vitamins'), ('CHEBI_37983', 'sulfur-35 atom', 596, '1'), ('CHEBI_74151', 'S-palmitoyl-L-cysteine residue', 597, ',25(OH)2D3production'), ('PR_000029121', 'leucine-rich repeat and guanylate kinase domain-containing protein', 604, '2D3production'), ('CHEBI_33310', 'neon atom', 653, '(OH)')]
PMC3717170	5/2013	S73-PMC3717170	['YET, before such FINDINGS are fully EMBRACED, the mechanism(s) of action of Vitamin D and its PROTECTIVE EFFECT during Pregnancy MUST BE BETTER delineated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 105), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 137)]	8	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy')]
PMC3717170	5/2013	S76-PMC3717170	['it WAS THOUGHT for decades that Human Milk was minimally sufficient in Vitamin D;17yet, PRELIMINARY results of the RECENTLY COMPLETED nichd Vitamin D supplementation trial during Lactation SHOW that when a mother is Vitamin D replete, with an Intake of 6400 iu Vitamin D3/day, Breast Milk is replete and a breastfeeding infant has excellent Vitamin D status without infant supplementation that is COMPARABLE to combined maternal and infant supplementation of 400 iu Vitamin D3/day.18the IMPLICATIONS of SAFELY achieving vitamin d SUFFICIENCY for both mother and breastfeeding infant solely through maternal supplementation is just BEGINNING TO BE UNDERSTOOD and will LIKELY CHALLENGE researchers for decades to come.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 397), ('IMPORTANT_CONSIDERATION', 487), ('IMPORTANT_CONSIDERATION', 503), ('IMPORTANT_CONSIDERATION', 530), ('INCOMPLETE_EVIDENCE', 631), ('PROBABLE_UNDERSTANDING', 667), ('DIFFICULT_TASK', 674)]	12	[('NCBITaxon_9606', 'Homo sapiens', 32, 'human'), ('UBERON_0001913', 'milk', 38, 'milk'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007595', 'lactation', 179, 'lactation'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0007631', 'feeding behavior', 243, 'intake'), ('CHEBI_33279', 'vitamin D5', 261, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 261, 'vitamin D3'), ('UBERON_0000310', 'breast', 277, 'breast'), ('UBERON_0001913', 'milk', 284, 'milk'), ('CHEBI_27300', 'vitamin D', 341, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 466, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 466, 'vitamin D3')]
PMC3717170	5/2013	S77-PMC3717170	['Vitamin D and obesity\nigor n. sergeev (south dakota state university) DISCUSSED the POSSIBILITY of integrating Vitamin D supplementation with current STRATEGIES in the PREVENTION and treatment of obesity.']	[('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 84), ('FUTURE_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 168)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC3717170	5/2013	S82-PMC3717170	['the EFFECTS of the hormonal form of Vitamin D, 1,25(Oh)2D3, on Apoptotic Cell Death are MEDIATED via multiple signaling pathways that involve common regulators and Effectors CONVERGING on cellular Ca2+.19,21sergeev and colleagues HAVE SHOWN that the CRITICAL characteristic of the apoptotic Ca2+signal is a sustained increase in the concentration of Intracellular Ca2+, reaching elevated BUT NOT cytotoxic levels.22HOWEVER, 1,25(Oh)2D3-Regulated, Ca2+-dependent apoptotic molecular targets HAVE NOT BEEN IDENTIFIED in Adipose Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 230), ('IMPORTANT_CONSIDERATION', 250), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('ANOMALY_CURIOUS_FINDING', 392), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('FULL_UNKNOWN', 490)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 47, '1,25(OH)2D3'), ('CL_0000445', 'apoptosis fated cell', 63, 'apoptotic cell'), ('GO_0006915', 'apoptotic process', 63, 'apoptotic cell death'), ('CHEBI_35224', 'effector', 164, 'effectors'), ('CHEBI_29108', 'calcium(2+)', 197, 'Ca2+.'), ('CHEBI_29108', 'calcium(2+)', 291, 'Ca2+'), ('GO_0005622', 'intracellular anatomical structure', 350, 'intracellular'), ('CHEBI_3312', 'calcium dichloride', 364, 'Ca2+,'), ('CHEBI_17996', 'chloride', 425, ','), ('CHEBI_73394', 'Ala-Ser', 426, '25(OH)2D3'), ('GO_0065007', 'biological regulation', 436, 'regulated'), ('CHEBI_81233', 'Schizonepetoside B', 447, 'Ca2+-'), ('UBERON_0001013', 'adipose tissue', 518, 'adipose tissue')]
PMC3717170	5/2013	S85-PMC3717170	['the 1,25(Oh)2D3-induced increase in cellular Ca2+is also ASSOCIATED with reduced Lipid accumulation in mature Adipocytes.23in prelimary BUT ongoing STUDIES, a Murine diet-induced obesity (dio) MODEL is being used to evaluate the ROLE of Vitamin D in adiposity.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 229)]	5	[('CHEBI_72779', '11-trans-LTE4', 4, '1,25(OH)2D3'), ('CHEBI_29108', 'calcium(2+)', 45, 'Ca2+'), ('CHEBI_18059', 'lipid', 81, 'lipid'), ('CL_0000136', 'fat cell', 110, 'adipocytes'), ('NCBITaxon_39107', 'Murinae', 159, 'murine'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC3717170	5/2013	S90-PMC3717170	['the PRELIMINARY results also SUGGEST that high Vitamin D and Calcium intake decreases body and fat weight gain in diet-induced obesity, and that the POTENTIAL mechanism of these effects involves activation of a Ca2+-mediated apoptotic Pathway in Adipose Tissue (specifically, normalization of the activities of apoptotic proteases Ca2+-dependent calpain and Ca2+/calpain-dependent Caspase-12 that are reduced in obesity).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 149)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 61, 'calcium'), ('CHEBI_81233', 'Schizonepetoside B', 211, 'Ca2+-'), ('GO_0051324', 'prophase', 235, 'pathway'), ('UBERON_0001013', 'adipose tissue', 246, 'adipose tissue'), ('CHEBI_81233', 'Schizonepetoside B', 331, 'Ca2+-'), ('CHEBI_32588', 'potassium chloride', 358, 'Ca2'), ('PR_000002319', 'catenin beta-1 isoform 1', 381, 'caspase-12')]
PMC3717170	5/2013	S91-PMC3717170	['targeting Ca2+Signaling and the Vitamin D/Ca2+–dependent calpains and caspases in Adipocytes with Vitamin D supplementation MAY THEREFORE be an effective and affordable approach for chemoprevention and treatment of obesity.']	[('INCOMPLETE_EVIDENCE', 124), ('PROBABLE_UNDERSTANDING', 128)]	2	[('CHEBI_29108', 'calcium(2+)', 10, 'Ca2+'), ('GO_0016215', 'acyl-CoA desaturase activity', 10, 'Ca2'), ('GO_0023051', 'regulation of signaling', 14, 'signaling'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_51231', 'DAPI', 42, 'Ca2+–'), ('CL_0000136', 'fat cell', 82, 'adipocytes'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3717170	5/2013	S92-PMC3717170	['ADDITIONAL STUDIES ARE WARRANTED to evaluate this approach from a safety POINT OF VIEW and to identify the OPTIMAL levels of Calcium and Vitamin D intakes in obesity.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 73), ('IMPORTANT_CONSIDERATION', 107)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 125, 'calcium'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3717170	5/2013	S102-PMC3717170	['in RELATION to the systemic pathology of copd the ROLE of Vitamin D has generated interest, AS Vitamin D deficiency is OFTEN present in patients with copd,24dependent on the severity of copd.25indeed, the prevalence of Vitamin D deficiency, defined as Plasma 25(Oh) D3Concentrations below 20 ng/ml (50 nmol/l), was 58% in a cross-sectional study of 151 copd patients entering Pulmonary rehabilitation during summer.26in the bergen copd cohort study, the prevalence of Vitamin D deficiency was INDEED higher in the copd patients than in the control subjects, INDEPENDENT of season, age, smoking, comorbidity, and body mass index.27several POTENTIAL EXPLANATIONS for the increased risk of Vitamin D deficiency in patients with copd include poor diet, less outdoor activity and THUS less exposure to sunlight, accelerated Skin Aging due to smoking, Renal dysfunction, and treatment with Corticosteroids.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('SUPERFICIAL_RELATIONSHIP', 50), ('PROBABLE_UNDERSTANDING', 92), ('PROBABLE_UNDERSTANDING', 119), ('ANOMALY_CURIOUS_FINDING', 493), ('SUPERFICIAL_RELATIONSHIP', 558), ('INCOMPLETE_EVIDENCE', 638), ('PROBABLE_UNDERSTANDING', 648), ('PROBABLE_UNDERSTANDING', 775)]	9	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 252, 'plasma'), ('CHEBI_73735', 'gadoterate', 259, '25(OH) D3concentrations'), ('PR_000016555', 'thymocyte selection-associated high mobility group box protein TOX', 259, '25(OH) D3concentrations'), ('UBERON_0002048', 'lung', 376, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 468, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 687, 'vitamin D'), ('GO_0036331', 'avascular cornea development in camera-type eye', 819, 'skin'), ('GO_0007568', 'aging', 824, 'aging'), ('UBERON_0002113', 'kidney', 846, 'renal'), ('CHEBI_50850', 'etabonate ester', 884, 'corticosteroids')]
PMC3717170	5/2013	S103-PMC3717170	['Vitamin D is RELATED to Skeletal health in patients with copd, and Vitamin D deficiency is ASSOCIATED with low bone Mineral density.26,28additionally, low vitamin d HAS BEEN RELATED to decreased exercise performance26,29and exacerbation rate30in copd patients.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 165), ('SUPERFICIAL_RELATIONSHIP', 174)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0004288', 'skeleton', 24, 'skeletal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_46662', 'mineral', 116, 'mineral')]
PMC3717170	5/2013	S104-PMC3717170	['and WHILE Vitamin D concentration HAS BEEN RELATED to Lung function in the general population, the RELATION between Lung function and Vitamin D concentration has YET to be investigated in copd patients ONLY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 99), ('ANOMALY_CURIOUS_FINDING', 162), ('INCOMPLETE_EVIDENCE', 202)]	6	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0002048', 'lung', 54, 'lung'), ('UBERON_0002048', 'lung', 116, 'lung'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3717170	5/2013	S108-PMC3717170	['pearson correlation coefficient SHOWED significant CORRELATIONS between Plasma Vitamin D concentration and fev1 ( r = 0.31, p< 0.01), fvc ( r = 0.29, p< 0.01) and dlco ( r = 0.20, p = 0.01).']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('UBERON_0001969', 'blood plasma', 72, 'plasma'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3717170	5/2013	S109-PMC3717170	['after stratification for Vitamin D deficiency, the CORRELATIONS PERSISTED ONLY in the patients with Vitamin D deficiency: fev1 ( r = 0.37, p< 0.01;fig.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 64), ('ANOMALY_CURIOUS_FINDING', 74), ('INCOMPLETE_EVIDENCE', 74)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3717170	5/2013	S111-PMC3717170	['multivariate regression analyses REVEALED that, after correction for age, gender, and bmi, Vitamin D concentration REMAINED INDEPENDENTLY ASSOCIATED with fev1 ( β = 0.26, p< 0.01) and dlco ( β = 0.25, p< 0.01), and there was a TREND for fvc ( β = 0.15, p< 0.08) in the subjects with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 124), ('SUPERFICIAL_RELATIONSHIP', 138), ('INCOMPLETE_EVIDENCE', 227)]	5	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC3717170	5/2013	S112-PMC3717170	['from their unpublished secondary analysis, rutten and colleagues conclude that THERE IS EVIDENCE SUGGESTING that Vitamin D plays a ROLE in the Lung pathology of patients with copd, which requires FURTHER INVESTIGATION.']	[('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 131), ('FUTURE_WORK', 196)]	4	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0002048', 'lung', 143, 'lung')]
PMC3717170	5/2013	S125-PMC3717170	['they have INITIATED a randomized controlled trial of 25(Oh)D3Repletion in Vitamin D–deficient hemodialysis patients TO EVALUATE efficacy and SAFETY and the EFFECTS on inflammation and esa REQUIREMENTS.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 116), ('IMPORTANT_CONSIDERATION', 141), ('SUPERFICIAL_RELATIONSHIP', 156), ('IMPORTANT_CONSIDERATION', 188)]	5	[('CHEBI_76706', 'EC 6.1.* (C-O bond-forming ligase) inhibitor', 53, '25(OH)D3repletion'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 53, '25(OH'), ('PR_000006494', 'disrupted in schizophrenia 1 protein', 59, 'D3repletion'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3717170	5/2013	S132-PMC3717170	['translating epidemiological data into policy and clinical applications\n\nVitamin D for diabetes\nanastassios g. pittas (tufts medical center) HIGHLIGHTED the POTENTIALLY IMPORTANT ROLE of Vitamin D in a variety of non-Skeletal medical conditions, including type 2 diabetes.']	[('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 156), ('IMPORTANT_CONSIDERATION', 168), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('CHEBI_28384', 'vitamin K', 72, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('UBERON_0004288', 'skeleton', 216, 'skeletal')]
PMC3717170	5/2013	S133-PMC3717170	['to systemically appraise the AVAILABLE EVIDENCE on the ROLE of Vitamin D in diabetes, pittas reviewed the original bradford hill criteria, which have been subsequently modified to include three general categories (mechanistic STUDIES, direct EVIDENCE, and parallel evidence),34and then applied these criteria to the AVAILABLE evidence.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 226), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 316)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC3717170	5/2013	S134-PMC3717170	['from a biological perspective, the HYPOTHESIS that Vitamin D MAY BE a DETERMINANT of diabetes risk is PLAUSIBLE, AS both impaired Insulin secretion and action HAVE BEEN reported with Vitamin D insufficiency.']	[('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 113), ('INCOMPLETE_EVIDENCE', 159)]	6	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('PR_000045358', 'insulin family protein', 130, 'insulin'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC3717170	5/2013	S135-PMC3717170	['the EFFECT of Vitamin D MAY BE direct, as SUPPORTED by the Expression of the vdr and the local Production Of 1,25(Oh)2D3In Pancreatic Β Cells, OR indirect via its ROLE in Regulating Calcium Homeostasis and calcium Flux through Cell Membranes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('SUPERFICIAL_RELATIONSHIP', 163)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0010467', 'gene expression', 59, 'expression'), ('GO_0008283', 'cell proliferation', 95, 'production of ...'), ('CHEBI_84175', '2-methylhexadecanoate', 109, '1,25(OH)2D3in'), ('GO_0006306', 'DNA methylation', 117, '2D3in'), ('UBERON_0001264', 'pancreas', 123, 'pancreatic'), ('CL_0000015', 'male germ cell', 134, 'β cells'), ('GO_0065007', 'biological regulation', 171, 'regulating'), ('GO_0055073', 'cadmium ion homeostasis', 182, 'calcium homeostasis'), ('GO_0006457', 'protein folding', 214, 'flux'), ('GO_0005886', 'plasma membrane', 227, 'cell membranes'), ('GO_0007613', 'memory', 232, 'membranes')]
PMC3717170	5/2013	S136-PMC3717170	['in Humans, the ROLE of Vitamin D in type 2 diabetes is SUGGESTED by a large NUMBER OF cross-sectional STUDIES that have CONSISTENTLY FOUND an inverse ASSOCIATION between Vitamin D status and prevalent hyperglycemia, including a REPORTED seasonal variation in the Control Of Glycemia in patients with diabetes, being worse in the winter when hypovitaminosis d is more prevalent.35in the MAJORITY of longitudinal OBSERVATIONAL studies, lower Vitamin D status is also ASSOCIATED with INCREASED RISK of incident type 2 diabetes.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 120), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 150), ('INCOMPLETE_EVIDENCE', 228), ('PROBABLE_UNDERSTANDING', 386), ('INCOMPLETE_EVIDENCE', 411), ('SUPERFICIAL_RELATIONSHIP', 465), ('IMPORTANT_CONSIDERATION', 481)]	11	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0006936', 'muscle contraction', 263, 'control of glycemia'), ('CHEBI_27300', 'vitamin D', 440, 'vitamin D')]
PMC3717170	5/2013	S139-PMC3717170	['HOWEVER, pittas CAUTIONED that one SHOULD RESIST making inferences on the basis of OBSERVATIONAL studies BECAUSE of the POSSIBILITY of CONFOUNDING ISSUES, which MAY BE especially TRUE when assessing Vitamin D status, BECAUSE WHILE 25(Oh)D3Concentration is an excellent MARKER of good health many of the VARIABLES that CONTRIBUTE to 25(Oh)d3concentration (e.g., skin pigmentation, physical inactivity, Aging, unhealthy dietary patterns) are also RISK FACTORS for the development of diabetes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 83), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 120), ('PROBLEM_COMPLICATION', 135), ('PROBLEM_COMPLICATION', 147), ('INCOMPLETE_EVIDENCE', 161), ('PROBABLE_UNDERSTANDING', 179), ('PROBABLE_UNDERSTANDING', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 303), ('SUPERFICIAL_RELATIONSHIP', 318), ('SUPERFICIAL_RELATIONSHIP', 445)]	18	[('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 231, '25(OH)D3concentration'), ('CHEBI_30778', 'gallic acid', 332, '25(OH)'), ('GO_0007568', 'aging', 401, 'aging')]
PMC3717170	5/2013	S140-PMC3717170	['THEREFORE, EVIDENCE from intervention studies—which is the most DIRECT EVIDENCE—is CRITICALLY IMPORTANT before one can conclude that Vitamin D has a ROLE in the prevention or treatment of diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 149)]	7	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC3717170	5/2013	S141-PMC3717170	['the results from SMALL clinical trials and post hoc analyses of larger trials on the EFFECT of Vitamin D supplementation on diabetes-related parameters HAVE BEEN INCONCLUSIVE, although Vitamin D APPEARS to have beneficial EFFECTS in Persons AT RISK for diabetes.36–39HOWEVER, no firm conclusions can be drawn from the available intervention studies BECAUSE of several LIMITATIONS: (1) NEARLY ALL studies were UNDERPOWERED; (2) the MINORITY of studies were designed specifically for Glycemic outcomes; (3) MOST STUDIES DID NOT REPORT use of diabetes medications at baseline or during the study; (4) SOME TRIALS used large infrequent doses of Vitamin D, which MAY BE Metabolized DIFFERENTLY compared to daily doses and MAY provide EITHER no benefit OR result in an UNFAVORABLE benefit/risk ratio.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('ANOMALY_CURIOUS_FINDING', 195), ('SUPERFICIAL_RELATIONSHIP', 222), ('IMPORTANT_CONSIDERATION', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('PROBLEM_COMPLICATION', 349), ('INCOMPLETE_EVIDENCE', 368), ('PROBLEM_COMPLICATION', 368), ('PROBABLE_UNDERSTANDING', 385), ('PROBLEM_COMPLICATION', 409), ('INCOMPLETE_EVIDENCE', 431), ('INCOMPLETE_EVIDENCE', 505), ('INCOMPLETE_EVIDENCE', 518), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 658), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 677), ('INCOMPLETE_EVIDENCE', 717), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 729), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 747), ('IMPORTANT_CONSIDERATION', 763)]	23	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'persons'), ('GO_0006096', 'glycolytic process', 482, 'glycemic'), ('CHEBI_27300', 'vitamin D', 641, 'vitamin D'), ('GO_0008152', 'metabolic process', 665, 'metabolized')]
PMC3717170	5/2013	S142-PMC3717170	['pittas CONCLUDED that ALTHOUGH the OBSERVATION studies STRONGLY SUGGEST an IMPORTANT ROLE for Vitamin D in type 2 diabetes, and such a ROLE is biologically PLAUSIBLE, there is LACK OF EVIDENCE from intervention studies to SUPPORT the CONTENTION that type 2 diabetes CAN be improved or PREVENTED by raising 25(Oh)D3Concentration.']	[('INCOMPLETE_EVIDENCE', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 85), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 266), ('SUPERFICIAL_RELATIONSHIP', 285)]	16	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 306, '25(OH)D3concentration'), ('PR_000005058', 'extracellular calcium-sensing receptor', 306, '25(OH ... D3concentration')]
PMC3717170	5/2013	S144-PMC3717170	['THEREFORE, CONFIRMATION of a POTENTIAL beneficial EFFECT of Vitamin D in type 2 diabetes IS NEEDED in trials conducted in well-defined populations (e.g., pre-diabetes and early diabetes) SPECIFICALLY DESIGNED TO TEST the COMPELLING BUT YET UNPROVEN HYPOTHESIS that Vitamin D status is a direct CONTRIBUTOR to the pathogenesis of type 2 diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 50), ('FUTURE_WORK', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('ANOMALY_CURIOUS_FINDING', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 294)]	14	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC3717170	5/2013	S155-PMC3717170	['alterations in these mechanisms during Vitamin D deficiency states MAY account for Skeletal muscle weakness, in VIEW of the KEY ROLE that Ca2+plays in the Regulation of Contractility.']	[('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 112), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_29108', 'calcium(2+)', 138, 'Ca2+'), ('GO_0065007', 'biological regulation', 155, 'regulation'), ('GO_0006936', 'muscle contraction', 169, 'contractility')]
PMC3717170	5/2013	S162-PMC3717170	['Vitamin D and physical and Cognitive function in older persons\nluigi ferrucci (national institute on Aging) DISCUSSED RECENT EVIDENCE LINKING Vitamin D deficiency to the pathogenesis and clinical Progression Of chronic Diseases highly prevalent in older Persons.']	[('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0050890', 'cognition', 27, 'cognitive'), ('GO_0007568', 'aging', 101, 'Aging'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 196, 'progression of ... diseases'), ('NCBITaxon_10088', 'Mus <genus>', 254, 'persons')]
PMC3717170	5/2013	S163-PMC3717170	['in large population-based studies, low levels of Vitamin D PREDICT loss of mobility and disability in Basic activities Of daily living, independent of age and other POTENTIAL CONFOUNDERS.47BASED on THESE FINDINGS, SOME gerontologists CLAIM that Vitamin D has antiaging EFFECTS.']	[('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 165), ('PROBLEM_COMPLICATION', 175), ('PROBABLE_UNDERSTANDING', 187), ('PROBABLE_UNDERSTANDING', 187), ('INCOMPLETE_EVIDENCE', 198), ('INCOMPLETE_EVIDENCE', 214), ('INCOMPLETE_EVIDENCE', 234), ('SUPERFICIAL_RELATIONSHIP', 269)]	9	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'basic'), ('UBERON_0002828', 'ventral cochlear nucleus', 119, 'of'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC3717170	5/2013	S171-PMC3717170	['there is STRONG EVIDENCE that obesity is ASSOCIATED with POOR Vitamin D status due to fat sequestration.48in fact, compared with the non-obese, higher doses of Vitamin D are REQUIRED in obese Individuals.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('NCBITaxon_1', 'root', 192, 'individuals')]
PMC3717170	5/2013	S173-PMC3717170	['HOWEVER, some recent DATA SUGGEST that low Vitamin D PREDICTS an accelerated increase in fat mass and incident obesity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC3717170	5/2013	S174-PMC3717170	['the IMPORTANCE of Vitamin D for muscle HAS BEEN discussed at length.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 39)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC3717170	5/2013	S176-PMC3717170	['CONSISTENTLY, in the longitudinal Aging study amsterdam, low Vitamin D and high Parathyroid hormone were strong, INDEPENDENT RISK FACTORS for loss of muscle strength and muscle mass (sarcopenia).49low Vitamin D levels also APPEAR TO BE CORRELATED with collagen deposition and are RELATED to Arterial stiffness.50the ROLE of Vitamin D in energetics has BEEN LESS THOROUGHLY INVESTIGATED.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 113), ('SUPERFICIAL_RELATIONSHIP', 125), ('ANOMALY_CURIOUS_FINDING', 223), ('SUPERFICIAL_RELATIONSHIP', 236), ('SUPERFICIAL_RELATIONSHIP', 280), ('SUPERFICIAL_RELATIONSHIP', 316), ('ANOMALY_CURIOUS_FINDING', 352), ('INCOMPLETE_EVIDENCE', 357)]	9	[('GO_0007568', 'aging', 34, 'Aging'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 80, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('UBERON_0001637', 'artery', 291, 'arterial'), ('CHEBI_27300', 'vitamin D', 324, 'vitamin D')]
PMC3717170	5/2013	S177-PMC3717170	['a RECENT STUDY DEMONSTRATED that Vitamin D level CORRELATES with maximal oxygen consumption, and that supplementation of Vitamin D increases fitness in athletes.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC3717170	5/2013	S178-PMC3717170	['INTERESTINGLY, a RECENT STUDY FOUND that vdrs are highly concentrated in the Cristae of the Mitochondria Inner Membrane.51the ROLE of Vitamin D in Homeostatic Signaling is COMPLEX and pervasive.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 126), ('DIFFICULT_TASK', 172)]	5	[('UBERON_0004721', 'crista ampullaris', 77, 'cristae'), ('GO_0005743', 'mitochondrial inner membrane', 92, 'mitochondria inner membrane'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0038128', 'ERBB2 signaling pathway', 147, 'homeostatic signaling')]
PMC3717170	5/2013	S180-PMC3717170	['the ROLE of Vitamin D in Neurologic function and pathology HAS BEEN studied from multiple perspectives.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 59)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0001016', 'nervous system', 25, 'neurologic')]
PMC3717170	5/2013	S182-PMC3717170	["low Vitamin D levels HAVE BEEN ASSOCIATED with accelerated Cognitive decline in epidemiological studies, and low Vitamin D dietary intake is ASSOCIATED with INCREASED risk of alzheimer's disease and depression.53,54mechanisms SUGGESTED for this ASSOCIATION include β-Amyloid formation/aggregation, Dysregulation of Gabaergic activity and nmda receptor, and increased calcium Entry Into Neurons."]	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 141), ('IMPORTANT_CONSIDERATION', 157), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 245)]	6	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0050890', 'cognition', 59, 'cognitive'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_60425', 'amyloid fibril', 267, 'amyloid'), ('GO_0060233', 'oenocyte delamination', 298, 'dysregulation'), ('CHEBI_86629', 'G b H', 315, 'GABAergic'), ('GO_0046897', 'N-terminal peptidyl-tyrosine methylation', 375, 'entry into neurons'), ('CL_0000540', 'neuron', 386, 'neurons')]
PMC3717170	5/2013	S184-PMC3717170	['WHETHER Vitamin D supplementation MAY positively IMPACT the Aging process REMAINS UNKNOWN and will REQUIRE FURTHER long-term intervention STUDIES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 49), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 99), ('FUTURE_WORK', 107)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007568', 'aging', 60, 'aging')]
PMC3717170	5/2013	S185-PMC3717170	['Vitamin D dietary reference intakes\ndaniel bikle (university of california and va medical center, san francisco) addressed the RECENT institute of medicine (iom) RECOMMENDATIONS for dietary Intake of Vitamin D and EVALUATED WHETHER they were sufficient in the context of EMERGING DATA about the ROLES of Vitamin D and the prevalence of deficiency.']	[('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 162), ('QUESTION_ANSWERED_BY_THIS_WORK', 214), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 190, 'intake'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D')]
PMC3717170	5/2013	S191-PMC3717170	['the iom EXPERT panel CONCLUDED that MOST americans (97.5%) had adequate levels of Vitamin D, BASED ON their CONCLUSION that a 25(Oh)d3of 20 ng/ml or greater was sufficient, RAISING the QUESTION of WHETHER supplementation was EVEN NEEDED.']	[('PROBABLE_UNDERSTANDING', 8), ('INCOMPLETE_EVIDENCE', 21), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 93), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 173), ('EXPLICIT_QUESTION', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('EXPLICIT_QUESTION', 197), ('ANOMALY_CURIOUS_FINDING', 225), ('IMPORTANT_CONSIDERATION', 230)]	12	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 126, '25(OH)')]
PMC3717170	5/2013	S192-PMC3717170	['this CONCLUSION was based on data from the 2001–2004 nhanes survey57that primarily sampled caucasians, with LIMITED sampling in northern latitudes during the winter, the time and region that People would MOST LIKELY have lower Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 108), ('PROBABLE_UNDERSTANDING', 204), ('PROBABLE_UNDERSTANDING', 209)]	4	[('NCBITaxon_10088', 'Mus <genus>', 191, 'people'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC3717170	5/2013	S195-PMC3717170	['moreover, a NUMBER OF STUDIES HAVE SHOWN that prevailing levels of 25(Oh)D3, especially in older subjects, the institutionalized, and in most other countries, are well below those DOCUMENTED in the nhanes survey.58as parts of the Aging Process, the skin becomes less able to make Vitamin D for a given amount of uvb exposure, the Kidneys become less able to produce the active Metabolite 1,25(Oh2)D3, and the Intestine becomes less able to respond to the 1,25(Oh2)D3With respect to calcium absorption.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 180)]	3	[('CHEBI_62946', 'ammonium sulfate', 67, '25(OH)D3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 67, '25(OH'), ('PR_000001177', 'D(2) dopamine receptor', 73, 'D3'), ('GO_0006915', 'apoptotic process', 230, 'aging process'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('UBERON_0002113', 'kidney', 330, 'kidneys'), ('CHEBI_39382', 'flufenoxuron', 377, 'metabolite'), ('CHEBI_37958', 'dye', 388, '1,'), ('CHEBI_72639', '13-HODE', 390, '25(OH2)D3'), ('UBERON_0000160', 'intestine', 409, 'intestine'), ('CHEBI_37958', 'dye', 455, '1,'), ('CHEBI_86970', 'N-[(15Z)-tetracosenoyl]-tetradecasphing-4-enine-1-phosphoethanolamine', 457, '25(OH2)D3with')]
PMC3717170	5/2013	S206-PMC3717170	['conclusions\nthe conference “Vitamin D: beyond bone” explo-red a considerable range of functions for Vitamin D and POTENTIAL therapeutic IMPLICATIONS outside of Calcium Homeostasis and bone health, HIGHLIGHTING the INCREASED UNDERSTANDING of Vitamin D, as well as HOW much is yet to be Learned.']	[('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 136), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 214), ('EXPLICIT_QUESTION', 263)]	5	[('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 28, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 160, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0007612', 'learning', 285, 'learned')]
PMC3717170	5/2013	S207-PMC3717170	['the scope of Vitamin D research and its therapeutic POSSIBILITIES, as presented by researchers across many different disciplines, generated enthusiasm TEMPERED with SOME SKEPTICISM.']	[('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 165), ('IMPORTANT_CONSIDERATION', 170)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC3717170	5/2013	S208-PMC3717170	['CONTINUING RESEARCH IS NEEDED to BETTER UNDERSTAND the RELATIONSHIPS between Vitamin D and Extraskeletal health and to determine the OPTIMAL dose of Vitamin D for Individuals BASED ON age, health conditions, and other FACTORS.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 133), ('SUPERFICIAL_RELATIONSHIP', 175), ('SUPERFICIAL_RELATIONSHIP', 218)]	8	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 91, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('NCBITaxon_1', 'root', 163, 'individuals')]
PMC3970319	5/2013	S164-PMC3970319	['in the second nepalese trial REPORTED above, the control group (Vitamin A supplements only) had a higher risk of Urinary microalbuminuria (microalbumin:creatinine ratio ≥3.4 mg/mmol) compared with Individuals whose mothers received Folic Acid or Folic Acid, iron, and zinc in addition to Vitamin A (11).']	[('INCOMPLETE_EVIDENCE', 29)]	1	[('CHEBI_27300', 'vitamin D', 64, 'vitamin A'), ('UBERON_0001088', 'urine', 113, 'urinary'), ('NCBITaxon_1', 'root', 197, 'individuals'), ('CHEBI_30751', 'formic acid', 232, 'folic acid'), ('CHEBI_30751', 'formic acid', 246, 'folic acid'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin A')]
PMC3679329	6/2013	S7-PMC3679329	['among Pregnant women, the proportion of women with an Intake of Vitamin C (from diet alone) below the ESTIMATED average REQUIREMENTS (ear) was lower among supplement users [users (44%) vs. non-users (68%)], and the proportion of Lactating women with intakes of iron (from diet alone) below the ear was lower among Supplement users [usesr (17%) vs. non-users (38%)].']	[('INCOMPLETE_EVIDENCE', 102), ('IMPORTANT_CONSIDERATION', 120)]	2	[('GO_0007565', 'female pregnancy', 6, 'pregnant'), ('GO_0007631', 'feeding behavior', 54, 'intake'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin C'), ('GO_0007594', 'puparial adhesion', 229, 'lactating'), ('CHEBI_16158', 'steroid sulfate', 314, 'supplement')]
PMC3679329	6/2013	S8-PMC3679329	['these results SUGGEST that among Pregnant and Lactating women, those who do not use dietary supplements TEND to have a lower intake of healthy Foods, such as beans and vegetables, as well as a lower intake of dietary fiber and Β-Carotene, which are abundant in these Foods, and non-users are more LIKELY than users to have INADEQUATE Intake of micro-Nutrient such as Vitamin C and iron.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 104), ('PROBABLE_UNDERSTANDING', 297), ('IMPORTANT_CONSIDERATION', 323), ('PROBLEM_COMPLICATION', 323)]	5	[('GO_0007565', 'female pregnancy', 33, 'pregnant'), ('GO_0007594', 'puparial adhesion', 46, 'lactating'), ('CHEBI_33290', 'food', 143, 'foods'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 227, 'β-carotene'), ('CHEBI_33290', 'food', 267, 'foods'), ('GO_0007631', 'feeding behavior', 334, 'intake'), ('CHEBI_33284', 'nutrient', 350, 'nutrient'), ('CHEBI_27300', 'vitamin D', 367, 'vitamin C')]
PMC3679329	6/2013	S79-PMC3679329	['a population based cohort study of Adults in the us DEMONSTRATED that supplement users, COMPARED TO non-users, GENERALLY had higher average Intakes of Foods which are IMPORTANT sources of Vitamin C and Carotenoids (i.e., fruits and certain vegetables) [12].']	[('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('PROBABLE_UNDERSTANDING', 111), ('IMPORTANT_CONSIDERATION', 167)]	4	[('UBERON_0007023', 'adult organism', 35, 'adults'), ('GO_0007631', 'feeding behavior', 140, 'intakes'), ('CHEBI_33290', 'food', 151, 'foods'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin C'), ('CHEBI_50815', 'norgestimate', 202, 'carotenoids')]
PMC3679329	6/2013	S81-PMC3679329	['also SHOWED that non-Pregnant, non-Lactating Adults who were regular users of any type of Supplement consumed more vegetables and fruits, especially those high in Vitamin C [20].']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('GO_0007565', 'female pregnancy', 21, 'pregnant'), ('GO_0007594', 'puparial adhesion', 35, 'lactating'), ('UBERON_0007023', 'adult organism', 45, 'adults'), ('CHEBI_16158', 'steroid sulfate', 90, 'supplement'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin C')]
PMC3685533	6/2013	S7-PMC3685533	['25Ohd values were higher in Cord Blood (p\u2009<\u20090.01) and neonatal Serum (p\u2009<\u20090.001) in subjects supplemented with Vitamin D. newborn fs SHOWED higher Vitamin D levels in Cord Blood when compared to lob and mbb (p\u2009<\u20090.01), and higher levels in neonatal Serum when compared to lob (p\u2009<\u20090.01).']	[('INCOMPLETE_EVIDENCE', 133)]	1	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 0, '25OHD'), ('UBERON_0002240', 'spinal cord', 28, 'cord'), ('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_28384', 'vitamin K', 111, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 167, 'cord'), ('UBERON_0000178', 'blood', 172, 'blood'), ('UBERON_0001977', 'blood serum', 249, 'serum')]
PMC3685533	6/2013	S10-PMC3685533	['conclusions\nthe PRESENT STUDY SHOWS a high prevalence of Vitamin D insufficiency and deficiency in newborns with significant differences observed to be DUE TO ethnicity, skin colour and maternal supplementation during the Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 152)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'pregnancy')]
PMC3685533	6/2013	S17-PMC3685533	['moreover, Vitamin D is a modulator of the Innate and Adaptive Immune System and prospective observational studies SUGGEST that Vitamin D supplements in infancy and early childhood MAY decrease the incidence of chronic diseases such as type 1 diabetes mellitus [1,2].']	[('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 180)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007631', 'feeding behavior', 42, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 53, 'adaptive immune system'), ('UBERON_0002405', 'immune system', 62, 'immune system'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC3685533	6/2013	S18-PMC3685533	['current data within the literature DEMONSTRATES a high prevalence of Vitamin D insufficiency not ONLY in Adult and in children, BUT ALSO in Pregnant women and in their neonates [3-5].']	[('INCOMPLETE_EVIDENCE', 35), ('ANOMALY_CURIOUS_FINDING', 97), ('ANOMALY_CURIOUS_FINDING', 128)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0007023', 'adult organism', 105, 'adult'), ('GO_0007565', 'female pregnancy', 140, 'pregnant')]
PMC3685533	6/2013	S22-PMC3685533	['in utero, the fetus is wholly dependent on the mother for Vitamin D. the 25Ohd crosses the Placenta into the Blood stream of the fetus with a half-Life of APPROXIMATELY 2 months [7].']	[('INCOMPLETE_EVIDENCE', 155)]	1	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 73, '25OHD'), ('UBERON_0001987', 'placenta', 91, 'placenta'), ('UBERON_0000178', 'blood', 109, 'blood'), ('UBERON_0000104', 'life cycle', 147, 'life')]
PMC3685533	6/2013	S26-PMC3685533	['population studies in europe HAVE SHOWN that immigrants from asia, the middle east or africa have a greater RISK of low Vitamin D levels [10-12].']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 108)]	2	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3685533	6/2013	S27-PMC3685533	['moreover, SOME STUDIES INDICATE that ethnic DIFFERENCES play a ROLE in the circulating levels of Serum Vitamin D [13-15].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('UBERON_0001977', 'blood serum', 97, 'serum'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC3685533	6/2013	S30-PMC3685533	['currently, the literature SHOWS that neonatal Vitamin D status at Birth is highly CORRELATED with maternal Vitamin storage.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007567', 'parturition', 66, 'birth'), ('CHEBI_33229', 'vitamin (role)', 107, 'vitamin')]
PMC3685533	6/2013	S31-PMC3685533	['data SUGGESTS that doses exceeding 1000 iu of Vitamin D per day are NECESSARY to achieve sufficienct 25Ohd concentrations in Pregnant women [18].']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 68)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 101, '25OHD'), ('GO_0007565', 'female pregnancy', 125, 'pregnant')]
PMC3685533	6/2013	S34-PMC3685533	['further, multivitamin use during Pregnancy HAS BEEN DEMONSTRATED to not be sufficient to correct pre-existing maternal Vitamin D deficiency [19-22].']	[('INCOMPLETE_EVIDENCE', 43)]	1	[('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3685533	6/2013	S78-PMC3685533	['when CONSIDERING the maternal multivitamin Intake during Pregnancy, all mothers supplemented with Vitamin D DEMONSTRATED higher 25Ohd values in both Cord Blood (24.5\u2009±\u200911.9 vs 17.2\u2009±\u20099.2 ng/ml; p\u2009<\u20090.01) and in neonatal Serum (17.7\u2009±\u20099.3 vs 11.1\u2009±\u20096 ng/ml; p\u2009<\u20090.001).']	[('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 108)]	2	[('GO_0007631', 'feeding behavior', 43, 'intake'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 128, '25OHD'), ('UBERON_0002240', 'spinal cord', 149, 'cord'), ('UBERON_0000178', 'blood', 154, 'blood'), ('UBERON_0001977', 'blood serum', 220, 'serum')]
PMC3685533	6/2013	S84-PMC3685533	['differences according to maternal supplementation, were shown ONLY in the mbb group (p\u2009<\u20090.01) with higher Vitamin D levels in Cord Blood and neonatal Serum with supplementation.']	[('INCOMPLETE_EVIDENCE', 62)]	1	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 127, 'cord'), ('UBERON_0000178', 'blood', 132, 'blood'), ('UBERON_0001977', 'blood serum', 151, 'serum')]
PMC3685533	6/2013	S87-PMC3685533	['neonates fs with no supplementation during Pregnancy, SHOWED Vitamin D levels higher than unsupplemented lob and mbb neonates (p\u2009<\u20090.05).']	[('INCOMPLETE_EVIDENCE', 54)]	1	[('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC3685533	6/2013	S98-PMC3685533	['multiple regression analysis REVEALED that Vitamin D levels in Cord Blood were PREDICTED (r2: 0.670; p\u2009<\u20090.0001) by neonatal Vitamin D values (standardized β: 0.818), when corrected for Vitamin D supplementation and Gestational age.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 79)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 63, 'cord'), ('UBERON_0000178', 'blood', 68, 'blood'), ('CHEBI_28384', 'vitamin K', 125, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'gestational')]
PMC3685533	6/2013	S100-PMC3685533	['discussion\nthe PRESENT STUDY DEMONSTRATES a high prevalence of Vitamin D deficiency and insufficiency both in Cord Blood and in neonatal Serum, with lower concentrations in infants Born from immigrant mothers.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 29)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0009472', 'axilla', 110, 'cord blood'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('GO_0007567', 'parturition', 181, 'born')]
PMC3685533	6/2013	S101-PMC3685533	['PREVIOUS STUDIES HAVE SHOWN a high prevalence of Vitamin D deficiency among neonates and their mothers, PARTICULARLY in united states, australia, south asia, the united kingdom, greece and in other european countries [24-29].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 104)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3685533	6/2013	S104-PMC3685533	['lob had lower Serum levels with respect to Mbb, SUGGESTING a particular ROLE for different skin colour in Metabolism and in Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('UBERON_0001977', 'blood serum', 14, 'serum'), ('PR_000010211', 'protein max', 43, 'MBB'), ('GO_0008152', 'metabolic process', 106, 'metabolism'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC3685533	6/2013	S106-PMC3685533	['the different skin colour INFLUENCES the Vitamin D levels with the CURRENTLY AVAILABLE DATA SUGGESTING that Plasma Vitamin D was lower in black neonates than white neonates [8-11].']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 92)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 108, 'plasma'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3685533	6/2013	S107-PMC3685533	['analyzing data by mothers according to their country of origin, 25Ohd Cord Blood levels were higher in neonates Born from italian mothers than from north african or african mothers, WHILE after Birth Vitamin D Serum levels were higher in italian newborns ONLY when compared with north african.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('ANOMALY_CURIOUS_FINDING', 255), ('INCOMPLETE_EVIDENCE', 255)]	3	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 64, '25OHD'), ('UBERON_0002240', 'spinal cord', 70, 'cord'), ('UBERON_0000178', 'blood', 75, 'blood'), ('GO_0007567', 'parturition', 112, 'born'), ('GO_0007567', 'parturition', 194, 'birth'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001977', 'blood serum', 210, 'serum')]
PMC3685533	6/2013	S112-PMC3685533	['[31], SHOWED mean Serum Vitamin D levels were significantly lower in african-american than in non –african american women and their infants.']	[('INCOMPLETE_EVIDENCE', 6)]	1	[('UBERON_0001977', 'blood serum', 18, 'serum'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC3685533	6/2013	S117-PMC3685533	['moreover, we OBSERVED higher Vitamin D levels in Cord Blood than in neonate Serum with a strong CORRELATION to each other.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 49, 'cord'), ('UBERON_0000178', 'blood', 54, 'blood'), ('UBERON_0001977', 'blood serum', 76, 'serum')]
PMC3685533	6/2013	S120-PMC3685533	['analyzing all subjects together, mothers supplemented with Vitamin D SHOWED 25Ohd values higher than mothers not supplemented both on Cord Blood and neonatal Serum.']	[('INCOMPLETE_EVIDENCE', 69)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 76, '25OHD'), ('UBERON_0009472', 'axilla', 134, 'cord blood'), ('UBERON_0001977', 'blood serum', 158, 'serum')]
PMC3685533	6/2013	S124-PMC3685533	['after Birth ONLY fs newborns unsupplemented SHOWED Vitamin D levels higher than lob and mbb; no differences were found in case of maternal supplementation in Pregnancy, MOST LIKELY DUE TO a specific ROLE of supplementation in neonates.']	[('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 169), ('PROBABLE_UNDERSTANDING', 181), ('PROBLEM_COMPLICATION', 181), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('GO_0007567', 'parturition', 6, 'birth'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy')]
PMC3685533	6/2013	S126-PMC3685533	['ALTHOUGH SEVERAL STUDIES are AVAILABLE on Vitamin D supplementation during Pregnancy, its APPROPRIATE dose is NOT CLEAR [19-21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 90), ('FULL_UNKNOWN', 110)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy')]
PMC3685533	6/2013	S128-PMC3685533	['a RECENT cochrane on Vitamin D supplementation during Pregnancy SHOWED that with supplementation, there is an increase Serum 25Ohd levels in neonates [22].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 64)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 125, '25OHD')]
PMC3685533	6/2013	S132-PMC3685533	['moreover, Vitamin D is INFLUENCED by seasonability and the study was conducted in a single season; HOWEVER, the data was collected in summer when better Vitamin D levels are DEMONSTRATED by literature [1].']	[('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('INCOMPLETE_EVIDENCE', 174)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3685533	6/2013	S136-PMC3685533	['conclusions\nthe PRESENT STUDY DEMONSTRATES a high prevalence of Vitamin D deficiency and insufficiency both in Cord Blood and in neonatal Serum with significant differences DUE TO ethnicity, skin colour and presence or absence of supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 173)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0009472', 'axilla', 111, 'cord blood'), ('UBERON_0001977', 'blood serum', 138, 'serum')]
PMC3691177	6/2013	S0-PMC3691177	['Prenatal Vitamin D supplementation and child Respiratory health: a randomised controlled trial\n\nabstract\n\nbackground\nOBSERVATIONAL studies SUGGEST high Prenatal Vitamin D intake MAY BE ASSOCIATED with reduced childhood wheezing.']	[('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0001004', 'respiratory system', 45, 'Respiratory'), ('GO_0007565', 'female pregnancy', 152, 'prenatal'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC3691177	6/2013	S13-PMC3691177	['trial registration\ncontrolled-trials.comisrctn68645785\n\nintroduction\nseveral observational studies have SUGGESTED a PROTECTIVE EFFECT of higher maternal Vitamin D intake during Pregnancy on RISK of wheezing[1]–[3], asthma and allergic rhinitis[4], and eczema[3]in offspring.']	[('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 127), ('IMPORTANT_CONSIDERATION', 190)]	4	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
PMC3691177	6/2013	S14-PMC3691177	['dietary intake of Vitamin D makes a relatively small CONTRIBUTION to overall Vitamin D status, and APPARENT EFFECTS of Vitamin D intake MAY BE CONFOUNDED by OTHER CORRELATED nutrients.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 136), ('DIFFICULT_TASK', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('SUPERFICIAL_RELATIONSHIP', 163)]	7	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3691177	6/2013	S15-PMC3691177	['THESE STUDIES DID NOT REPORT outcomes in RELATION to maternal Serum 25-Hydroxyvitamin D (25(Oh)D) concentration, which takes account of skin synthesis, our primary source of Vitamin D, and is the gold STANDARD measure of Vitamin D status[5],[6].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 201)]	4	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 68, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC3691177	6/2013	S19-PMC3691177	['the active Metabolite of Vitamin D, 1,25-Dihydroxyvitamin D, HAS BEEN SHOWN in Animal and in vitro MODELS to have potent Immune EFFECTS[12]and a ROLE in early Lung Development[13].']	[('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('CHEBI_39382', 'flufenoxuron', 11, 'metabolite'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 36, '1,25-dihydroxyvitamin D'), ('NCBITaxon_33208', 'Metazoa', 79, 'animal'), ('UBERON_0002405', 'immune system', 121, 'immune'), ('GO_0030324', 'lung development', 159, 'lung development'), ('UBERON_0002048', 'lung', 159, 'lung')]
PMC3691177	6/2013	S21-PMC3691177	['Vitamin D insufficiency is NEVERTHELESS very common during Pregnancy[15]–[17], and it HAS BEEN PROPOSED that Prenatal Vitamin D supplementation MAY PREVENT childhood wheezing and asthma[18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 95), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 148)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('GO_0007565', 'female pregnancy', 109, 'prenatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC3691177	6/2013	S74-PMC3691177	['as PREVIOUSLY reported[19], median Cord 25(Oh)D levels at Delivery were significantly higher in supplemented children COMPARED TO the control group [control 17 nmol/l (interquartile range (iqr) 14–22); daily dose 26 nmol/l (iqr 17–45); p<0.001; bolus dose 25 nmol/l (iqr 18–34); p<0.001)].10.1371/journal.pone.0066627.g001\n\ncaption (fig): figure 1\nrecruitment and follow up of study participants.10.1371/journal.pone.0066627.t001\n\ncaption (table-wrap): table 1\ncharacteristics of study participants followed up at age three years.controldaily Vitamin dbolus vitamin dcombined Vitamin D(n\u200a=\u200a50)(n\u200a=\u200a56)(n\u200a=\u200a52)(n\u200a=\u200a108)baseline maternal 25(Oh)D <25 nmol/l, n/n (%)24/50 (48)25/56 (45)22/52 (42)47/108 (44)male sex, n/n (%)27/50 (54)32/56 (57)26/52 (50)58/108 (55)Birth weight (g), mean (sd)3268 (585)3321 (525)3290 (467)3307 (497)ethnicity, n (%)asian12 (24)15 (27)13 (25)28 (26)middle eastern13 (26)14 (25)14 (26)28 (26)black12 (24)14 (25)13 (25)27 (25)white13 (26)13 (23)12 (24)25 (23)ga at Delivery (weeks), mean (sd)40 (1)39 (2)40 (1)39 (2)nulliparous mother, n/n (%)23/50 (46)20/56 (36)21/52 (40)41/108 (38)Vaginal Delivery, n/n (%)29/50 (58)35/56 (63)28/52 (54)63/108 (58)maternal smoking during Pregnancy, n/n (%)2/48 (4)3/55 (5)0/46 (0)3/101 (3)presence of household smokers, n/n (%)16/48 (33)15/55 (27)17/46 (37)32/101 (32)number of children in household, mean (sd)2 (1)2 (1)2 (1)2 (1)age mother left full time education, mean (sd)20 (3)20 (4)21 (4)21 (4)child in nursery, n/n (%)27/48 (56)36/55 (65)20/45 (44)57/101 (56)Cat or Dog in household, n/n (%)4/48 (8)5/54 (9)4/46 (9)9/100 (9)maternal fitzpatrick skin score grade 3–6, n/n (%)28/44 (64)33/49 (67)28/43 (65)61/92 (66)maternal regular vitamin intake at three years, n/n (%)9/46 (20)16/53 (30)16/45 (36)32/98 (33)at least one parent with allergic disease, n/n (%)23/45 (51)35/53 (66)21/45 (47)56/98 (57)exclusively Breast-Fed for 4 months, n/n (%)22/48 (46)20/54 (37)23/44 (52)43/98 (44)any child vitamin supplementation, n/n (%)30/48 (63)34/55 (62)30/46 (65)64/101 (63)completed immunizations to date, n/n (%)48/49 (98)54/55 (98)43/47 (91)97/102 (95)age at time of assessment (months), median (iqr)37.9 (36.9, 39.9)37.1 (36.5, 38.8)37.4 (36.5, 39.5)37.3 (36.5, 39.0)child fitzpatrick skin score grade 3–6, n (%)29/42 (69)34/48 (71)29/43 (67)63/91 (69)child bmi z score age 3, mean (sd)0.51 (1.48)0.35 (1.15)0.62 (1.15)0.47 (1.15)child outdoors >1 hour/day, n/n (%)32/48 (67)34/53 (64)33/45 (73)67/98 (68)child tv/computer >2 hours/day, n/n (%)24/48 (50)18/53 (34)17/45 (38)35/98 (36)child 25(Oh)D (nmol/l) age 3, median (iqr)42 (27, 68)35 (21, 66)42 (30, 93)41 (26, 72)\ndata shown are for all participants analysed.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	2	[('UBERON_0002240', 'spinal cord', 35, 'cord'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 40, '25(OH ... D'), ('GO_0007567', 'parturition', 58, 'delivery'), ('CHEBI_33229', 'vitamin (role)', 543, 'vitamin'), ('CHEBI_27300', 'vitamin D', 576, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 636, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 636, '25(OH ... D'), ('GO_0007567', 'parturition', 762, 'Birth'), ('GO_0007567', 'parturition', 992, 'delivery'), ('GO_0007567', 'parturition', 1111, 'Vaginal'), ('UBERON_0000970', 'eye', 1111, 'Vaginal'), ('GO_0007567', 'parturition', 1119, 'delivery'), ('GO_0007565', 'female pregnancy', 1201, 'pregnancy'), ('NCBITaxon_10088', 'Mus <genus>', 1529, 'Cat'), ('NCBITaxon_33208', 'Metazoa', 1536, 'dog'), ('GO_0007567', 'parturition', 1880, 'breast'), ('UBERON_0000310', 'breast', 1880, 'breast'), ('GO_0007631', 'feeding behavior', 1887, 'fed'), ('CHEBI_71657', 'versiconol acetate', 2555, '25(OH)D'), ('PR_000011614', 'opioid growth factor receptor', 2558, 'OH)D')]
PMC3691177	6/2013	S78-PMC3691177	['we FOUND significantly increased Bronchodilator use and higher prevalence of lrti’s in the offspring of the bolus group, but this did not remain significant after adjusting for multiple testing at a 20% threshold.file s1shows complete analyses of these outcomes for the offspring of mothers with Vitamin D deficiency at baseline (any Vitamin D vs. control, table s1 infile s1, daily vs. control, table s2 infile s1, bolus vs. control, table s3 infile s1).']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_60874', 'phenylacetylglycine(1-)', 33, 'bronchodilator'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D')]
PMC3691177	6/2013	S109-PMC3691177	['our results SUGGEST that the MOST LIKELY EXPLANATION for the FINDING of decreased wheezing risk in offspring of mothers with a higher Vitamin D intake during Pregnancy in observational studies[1]–[4], is CONFOUNDING by OTHER dietary or lifestyle factors ASSOCIATED with Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 29), ('PROBABLE_UNDERSTANDING', 34), ('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 61), ('PROBLEM_COMPLICATION', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 219), ('SUPERFICIAL_RELATIONSHIP', 254)]	8	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3691177	6/2013	S115-PMC3691177	['our power calculation was based on the study by camargo et al[2], which ESTIMATED a risk reduction for recurrent wheezing from 34% to 13% comparing mothers with the highest quartile of daily Vitamin D intake (median 724 iu) to those in the lowest quartile of intake (median 356 iu).']	[('INCOMPLETE_EVIDENCE', 72)]	1	[('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC3691177	6/2013	S117-PMC3691177	['the 95% confidence interval for our primary outcome measure was 0.49 to 1.50, so we are UNABLE TO confidently exclude EFFECTS of Prenatal vitamin D supplementation on RISK of wheezing, or on the development of atopy especially in mothers treated with daily Vitamin D. third, we DID NOT assess Vitamin D receptor polymorphisms or OTHER POTENTIALLY IMPORTANT genotypic variations.']	[('DIFFICULT_TASK', 88), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 278), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 347)]	7	[('GO_0007565', 'female pregnancy', 129, 'prenatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 146, 'D'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D')]
PMC3691177	6/2013	S118-PMC3691177	['IT IS POSSIBLE that Vitamin D supplementation is effective for preventing wheezing or atopy in the presence of specific maternal or infant genotypes, as SUGGESTED by others[27].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 153)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC3691177	6/2013	S121-PMC3691177	['ALTHOUGH randomisation in this trial was stratified by ethnicity, and we included baseline Vitamin D in our adjusted model, IT IS POSSIBLE that this source of heterogeneity could have masked positive findings.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 124)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC3691177	6/2013	S125-PMC3691177	['finally, we are also unable to exclude the POSSIBILITY that Vitamin D supplementation at a higher dose, MIGHT PROTECT against early childhood wheezing.']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 110)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3691177	6/2013	S126-PMC3691177	['ALTHOUGH the Vitamin D doses used in this trial were greater than the current RECOMMENDED intake for Pregnant women of 400 iu/day during Pregnancy in the united kingdom[14],[17], and 600 iu in the united states[25], ONLY a small percentage of offspring had Cord 25(Oh)D levels in the sufficient range (13% daily group, 3% bolus group).']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 78), ('INCOMPLETE_EVIDENCE', 216)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnant'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 257, 'cord'), ('CHEBI_71657', 'versiconol acetate', 262, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 262, '25(OH)D')]
PMC3691177	6/2013	S127-PMC3691177	['it HAS RECENTLY BEEN SHOWN that doses of 4000 iu of Vitamin D daily are SAFE and effective for short term treatment of Vitamin D deficiency during Pregnancy[30], ALTHOUGH the long term EFFECTS on child health have NOT BEEN STUDIED.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 72), ('ANOMALY_CURIOUS_FINDING', 162), ('SUPERFICIAL_RELATIONSHIP', 185), ('FULL_UNKNOWN', 214)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
PMC3691177	6/2013	S129-PMC3691177	['two RECENT OBSERVATIONAL STUDIES that DOCUMENTED Prenatal Vitamin D status by measuring Cord Blood 25(Oh)D concentration, FOUND RELATIONSHIPS with allergic sensitisation and/or wheezing in early childhood[8],[31].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 128)]	5	[('GO_0007565', 'female pregnancy', 49, 'prenatal'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 99, '25(OH ... D')]
PMC3691177	6/2013	S132-PMC3691177	['the results of our randomised controlled trial do not SUPPORT a strong causal RELATIONSHIP between low Prenatal Vitamin D status within the deficient/insufficient range and INCREASED RISK of Allergic sensitization or wheezing in early childhood.']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 173)]	3	[('GO_0007565', 'female pregnancy', 103, 'prenatal'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0040011', 'locomotion', 191, 'allergic')]
PMC3691177	6/2013	S134-PMC3691177	['the FINDINGS of OUR STUDY are specific to a population of Vitamin D deficient women (half had baseline 25(Oh)D levels below 25 nmol/l) and two specific forms of Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 103, '25(OH)D'), ('GO_0007565', 'female pregnancy', 161, 'prenatal'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC3691177	6/2013	S137-PMC3691177	['ALTHOUGH THESE FINDINGS cannot automatically be generalised to OTHER populations of Pregnant women, one MIGHT expect Prenatal Vitamin D supplementation to SHOW its clearest clinical EFFECTS in a deficient population such as this.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 182)]	7	[('GO_0007565', 'female pregnancy', 84, 'pregnant'), ('GO_0007565', 'female pregnancy', 117, 'prenatal'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC3691177	6/2013	S138-PMC3691177	['IN SUMMARY we FOUND NO EVIDENCE for a protective effect of Prenatal Vitamin D supplementation from 27 weeks Gestation on childhood wheezing, allergic disease, Lung function or markers of Airway inflammation in the first 3 years of Life.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 20)]	3	[('GO_0007565', 'female pregnancy', 59, 'prenatal'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'gestation'), ('UBERON_0002048', 'lung', 159, 'lung'), ('UBERON_0001005', 'respiratory airway', 187, 'airway'), ('UBERON_0000104', 'life cycle', 231, 'life')]
PMC3702245	6/2013	S0-PMC3702245	['Vitamin D nutrition in Pregnancy: current opinion\n\nabstract\nthere is INCREASING INTEREST in Vitamin D nutrition during Pregnancy because of widespread REPORTS of a high prevalence of low vitamin d status in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 151)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('GO_0007565', 'female pregnancy', 207, 'pregnant')]
PMC3702245	6/2013	S2-PMC3702245	['CONSISTENT with the expanded ROLE of Vitamin D, RECENT OBSERVATIONAL STUDIES have DEMONSTRATED that low Vitamin D status in Pregnancy is ASSOCIATED with multiple POTENTIAL adverse maternal, fetal, and infant outcomes and CONTRIBUTES to low Vitamin D status in infants at Birth.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 137), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 221)]	8	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0007567', 'parturition', 271, 'birth')]
PMC3702245	6/2013	S3-PMC3702245	['THEREFORE, an overview of the CURRENT understanding of Vitamin D nutrition in Pregnancy and a review of the results of studies to optimize Vitamin D status during Pregnancy and in the offspring is of PUBLIC HEALTH IMPORTANCE and timely.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 200), ('IMPORTANT_CONSIDERATION', 214)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'pregnancy')]
PMC3702245	6/2013	S4-PMC3702245	['introduction\nVitamin D deficiency in Pregnancy is widespread in many parts of the world,1and there is an ASSOCIATION between low Vitamin D status and multiple POTENTIAL adverse outcomes of Pregnancy.2–5therefore, Vitamin D nutrition in Pregnancy SHOULD BE of GLOBAL HEALTH INTEREST.']	[('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 159), ('FUTURE_WORK', 246), ('IMPORTANT_CONSIDERATION', 259)]	4	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 37, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]
PMC3702245	6/2013	S5-PMC3702245	['ALTHOUGH the Synthesis and Metabolism Of Vitamin D in the nonpregnant state is WELL KNOWN, its Metabolism during Pregnancy is LESS WELL UNDERSTOOD.3the classical action of vitamin d is to maintain Calcium Homeostasis and bone health.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 126)]	3	[('GO_0007416', 'synapse assembly', 13, 'synthesis ...'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 27, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0008152', 'metabolic process', 95, 'metabolism'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('GO_0055073', 'cadmium ion homeostasis', 197, 'calcium homeostasis')]
PMC3702245	6/2013	S6-PMC3702245	['in addition, it is now known to be INVOLVED in Immunomodulation, Cell Proliferation, and Cell Differentiation, and in other physiologic functions in diverse Tissues and Organs, including the Brain, Pancreas, and Heart.6despite the REPORTED high prevalence of Vitamin D deficiency and its POSSIBLE consequences, the criteria for defining an optimal level in the body, and HENCE the amount of Vitamin D intake REQUIRED to maintain adequate levels, is CONTROVERSIAL.3,7,8this overview addresses the CURRENT INFORMATION about Vitamin D function, the GLOBAL BURDEN and POTENTIAL consequences of low Vitamin D status in Pregnancy, and current STRATEGIES to optimize Vitamin D status in Pregnant mothers and their offspring.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 288), ('PROBABLE_UNDERSTANDING', 371), ('IMPORTANT_CONSIDERATION', 408), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 449), ('INCOMPLETE_EVIDENCE', 496), ('IMPORTANT_CONSIDERATION', 546), ('INCOMPLETE_EVIDENCE', 564), ('FUTURE_WORK', 637)]	10	[('GO_0050900', 'leukocyte migration', 47, 'immunomodulation'), ('GO_0008283', 'cell proliferation', 65, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 89, 'cell differentiation'), ('UBERON_0000479', 'tissue', 157, 'tissues'), ('UBERON_0000062', 'organ', 169, 'organs'), ('UBERON_0000955', 'brain', 191, 'brain'), ('UBERON_0001264', 'pancreas', 198, 'pancreas'), ('UBERON_0000948', 'heart', 212, 'heart'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 594, 'vitamin D'), ('GO_0007565', 'female pregnancy', 614, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('GO_0007565', 'female pregnancy', 680, 'pregnant')]
PMC3702245	6/2013	S7-PMC3702245	['Vitamin D sources and functions\nthe major source of Vitamin D is endogenous synthesis from Epidermal stores of 7-Dehy-Drocholesterol following exposure of the skin to Ultraviolet b radiation, resulting in formation of previtamin D3Which is subsequently converted to Vitamin D3(Cholecalciferol).9geographic location beyond latitude 35°, north or south, darker skin pigmentation due to Melanin, winter season, and lifestyle factors, including avoidance of sun exposure, clothing which covers most of the skin while outdoors, increased indoor activity, and the use of sunscreen, all reduce endogenous Synthesis Of Vitamin D.9,10endogenous synthesis accounts for ABOUT 90% of the body’s Vitamin D stores, while 10% is derived from dietary sources.']	[('INCOMPLETE_EVIDENCE', 659)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0007376', 'outer epithelium', 91, 'epidermal'), ('CHEBI_46852', 'N-(sulfoalkyl)piperazine', 111, '7-dehy'), ('CHEBI_16933', 'ergosterol', 118, 'drocholesterol'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 167, 'ultraviolet'), ('CHEBI_82466', 'Ethyl selenac', 229, 'D3which'), ('CHEBI_33279', 'vitamin D5', 266, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 266, 'vitamin D3'), ('CHEBI_52550', 'theopalauamide', 277, 'cholecalciferol'), ('CHEBI_25179', 'melanins', 384, 'melanin'), ('GO_0030474', 'spindle pole body duplication', 598, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 611, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 683, 'vitamin D')]
PMC3702245	6/2013	S9-PMC3702245	['SEVERAL REPORTS in the literature HAVE SHOWN that INADEQUATE or lack of sunlight exposure without appropriate corrective Vitamin D intake or supplements accounts FOR the high prevalence of Vitamin D deficiency in women.11–18\nafter synthesis in the skin, Vitamin D attaches to Vitamin D-binding protein and is transported to the Liver, where it undergoes a process of hydroxylation to form 25-Hydroxyvitamin D [25(Oh)D].9the Serum concentration of 25(Oh)D is the MOST reliable MARKER of Vitamin D nutritional status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 162), ('PROBABLE_UNDERSTANDING', 462), ('SUPERFICIAL_RELATIONSHIP', 476)]	7	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 284, 'D'), ('UBERON_0002107', 'liver', 328, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 389, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 410, '25(OH)D'), ('UBERON_0001977', 'blood serum', 424, 'serum'), ('CHEBI_71657', 'versiconol acetate', 447, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 486, 'vitamin D')]
PMC3702245	6/2013	S10-PMC3702245	['a second hydroxylation takes place in the Kidney, which converts 25(Oh)D to the most biologically active Metabolite, 1,25-Dihydroxyvitamin D, the major classical physiologic function of which is to increase calcium and Phosphorus absorption from the Gut in order to maintain Calcium Homeostasis and promote mineralization of Osteoid bone.9\nalthough the Renal 1-alpha hydroxylase (Cytochrome P450 [Cyp]27B1) enzyme is a MAJOR DETERMINANT of Synthesis of 1,25-Dihydroxyvitamin D, IT IS KNOWN that Cyp27B1 is Expressed in Nonrenal Tissues to produce 1,25 Dihydroxyvitamin D.6,19in addition, Vitamin D receptors are also Expressed in a variety of Organs, Tissues, and cells (seefigure 1).20the 1,25-Dihydroxyvitamin D locally produced in Extrarenal Tissues, such as immune cells, Pancreatic Beta Cells, the Intestine, Prostate, Breast, and other Organs, Controls multiple Vitamin D-responsive Genes, and THUS plays an important physiologic ROLE in Cardiovascular health,21,22the Adaptive and Innate Immune Responses,23,24insulin secretion,25,26regulation of Cell Proliferation, Differentiation, and Apoptosis, and inhibition of Angiogenesis.27\n\nVitamin D Homeostasis and functions during Pregnancy\nthe classical function of Vitamin D is to maintain calcium Homeostasis.']	[('IMPORTANT_CONSIDERATION', 419), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 478), ('PROBABLE_UNDERSTANDING', 900), ('SUPERFICIAL_RELATIONSHIP', 936)]	5	[('UBERON_0002113', 'kidney', 42, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 105, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 117, '1,25-dihydroxyvitamin D'), ('CHEBI_35885', 'secondary phosphine', 219, 'phosphorus'), ('UBERON_0001555', 'digestive tract', 250, 'gut'), ('GO_0055073', 'cadmium ion homeostasis', 275, 'calcium homeostasis'), ('UBERON_0008883', 'osteoid', 325, 'osteoid'), ('UBERON_0002113', 'kidney', 353, 'renal'), ('CHEBI_4056', 'cytochrome', 380, 'cytochrome'), ('PR_000006100', 'aromatase', 380, 'cytochrome P450'), ('PR_000006138', 'cytochrome P450 4F11', 397, 'CYP ... 27B1'), ('GO_0009057', 'macromolecule catabolic process', 440, 'synthesis'), ('CHEBI_67472', '15-epi-lupulin B', 453, '1,25-dihydroxyvitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 495, 'CYP27B1'), ('GO_0010467', 'gene expression', 506, 'expressed'), ('UBERON_0002481', 'bone tissue', 519, 'nonrenal tissues'), ('CHEBI_67469', '15-hydroxyajubractin C', 547, '1,25 dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 588, 'vitamin D'), ('GO_0010467', 'gene expression', 617, 'expressed'), ('UBERON_0000062', 'organ', 643, 'organs'), ('UBERON_0000479', 'tissue', 651, 'tissues'), ('CHEBI_67472', '15-epi-lupulin B', 690, '1,25-dihydroxyvitamin D'), ('UBERON_0005292', 'extraembryonic tissue', 734, 'extrarenal tissues'), ('CL_0000169', 'type B pancreatic cell', 776, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 776, 'pancreatic'), ('UBERON_0000160', 'intestine', 803, 'intestine'), ('UBERON_0002367', 'prostate gland', 814, 'prostate'), ('UBERON_0000310', 'breast', 824, 'breast'), ('UBERON_0000062', 'organ', 842, 'organs'), ('GO_0065007', 'biological regulation', 850, 'controls'), ('CHEBI_27300', 'vitamin D', 868, 'vitamin D'), ('SO_0000704', 'gene', 889, 'genes'), ('UBERON_0004535', 'cardiovascular system', 944, 'cardiovascular'), ('GO_0051886', 'negative regulation of timing of anagen', 975, 'adaptive ...'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 988, 'innate immune responses'), ('UBERON_0002405', 'immune system', 995, 'immune'), ('GO_0030154', 'cell differentiation', 1054, 'cell proliferation ... differentiation'), ('GO_0006915', 'apoptotic process', 1095, 'apoptosis'), ('GO_0001525', 'angiogenesis', 1124, 'angiogenesis'), ('CHEBI_28384', 'vitamin K', 1141, 'Vitamin D'), ('GO_0042592', 'homeostatic process', 1151, 'homeostasis'), ('GO_0007565', 'female pregnancy', 1184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1220, 'vitamin D'), ('GO_0042592', 'homeostatic process', 1253, 'homeostasis')]
PMC3702245	6/2013	S13-PMC3702245	['HOWEVER, sustained Vitamin D deficiency results in rickets in children and osteomalacia in Adults.28the COMMONLY evaluated BIOMARKERS of Vitamin D nutrition include Serum 25(Oh)D concentrations, the inverse RELATIONSHIP between 25(Oh)D and Parathyroid hormone, Intestinal calcium absorption, and assessment of Skeletal integrity.29WHILE there is an inverse RELATIONSHIP between Serum Parathyroid hormone and 25(Oh)D in nonpregnant states, this RELATIONSHIP HAS BEEN SHOWN in RECENT STUDIES to be weak during Pregnancy,6,18,30,31INDICATING that Serum Parathyroid hormone MAY BE a LESS RELIABLE BIOMARKER of maternal Vitamin D status during Pregnancy than Serum 25(Oh)d.32the maternal 25(Oh)D level does not vary significantly during Pregnancy unless there is a change in Vitamin D intake or Endogenous Synthesis.2,33,34HOWEVER, Serum 1,25(Oh)2D levels increase by 100%–200% starting in the first trimester in both the mother and the fetus.35–37the increase in maternal 1,25(Oh)2D, which originates mostly from the Kidneys, accounts for increased Intestinal calcium absorption during Pregnancy.38,39the increase in fetal 1,25(Oh)2D level SEEMS to BE RELATED to synthesis in Placental and Fetal Tissues.39,40\nan IMPORTANT aspect of Vitamin D nutrition in Pregnancy is that the Vitamin D status of the infant at Birth and in early infancy DEPENDS ON the vitamin d status of the mother during Pregnancy.41vitamin D stores in the infant start with transplacental Transfer of 25(Oh)D in early Pregnancy from mother to fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('SUPERFICIAL_RELATIONSHIP', 357), ('SUPERFICIAL_RELATIONSHIP', 444), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 526), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 579), ('IMPORTANT_CONSIDERATION', 584), ('SUPERFICIAL_RELATIONSHIP', 593), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 816), ('ANOMALY_CURIOUS_FINDING', 1136), ('ANOMALY_CURIOUS_FINDING', 1145), ('SUPERFICIAL_RELATIONSHIP', 1148), ('IMPORTANT_CONSIDERATION', 1209), ('SUPERFICIAL_RELATIONSHIP', 1335)]	20	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0007023', 'adult organism', 91, 'adults'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 177, 'D'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 240, 'parathyroid'), ('UBERON_0000160', 'intestine', 261, 'intestinal'), ('UBERON_0004288', 'skeleton', 310, 'skeletal'), ('UBERON_0001977', 'blood serum', 378, 'serum'), ('UBERON_0001132', 'parathyroid gland', 384, 'parathyroid'), ('CHEBI_71657', 'versiconol acetate', 408, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 411, 'OH ... D'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy'), ('UBERON_0001977', 'blood serum', 544, 'serum'), ('UBERON_0001132', 'parathyroid gland', 550, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('GO_0007565', 'female pregnancy', 639, 'pregnancy'), ('UBERON_0001977', 'blood serum', 654, 'serum'), ('CHEBI_30778', 'gallic acid', 660, '25(OH)'), ('CHEBI_71657', 'versiconol acetate', 683, '25(OH)D'), ('GO_0007565', 'female pregnancy', 732, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 770, 'vitamin D'), ('GO_0042400', 'ectoine catabolic process', 790, 'endogenous synthesis'), ('UBERON_0001977', 'blood serum', 827, 'serum'), ('CHEBI_37958', 'dye', 833, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 835, '25(OH)2D'), ('CHEBI_37958', 'dye', 968, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 970, '25(OH)2D'), ('UBERON_0002113', 'kidney', 1013, 'kidneys'), ('UBERON_0000160', 'intestine', 1045, 'intestinal'), ('GO_0007565', 'female pregnancy', 1082, 'pregnancy'), ('CHEBI_37958', 'dye', 1119, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 1121, '25(OH)2D'), ('UBERON_0001987', 'placenta', 1172, 'placental'), ('UBERON_0005291', 'embryonic tissue', 1186, 'fetal tissues'), ('CHEBI_27300', 'vitamin D', 1229, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1252, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1274, 'vitamin D'), ('GO_0007567', 'parturition', 1308, 'birth'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1408, 'D'), ('GO_0006412', 'translation', 1457, 'transfer'), ('CHEBI_71657', 'versiconol acetate', 1469, '25(OH)D'), ('GO_0007565', 'female pregnancy', 1486, 'pregnancy')]
PMC3702245	6/2013	S14-PMC3702245	['physiologically active 1,25(Oh)2D does not readily cross the Placenta.41MANY STUDIES HAVE SHOWN that the Vitamin D status of infants at Birth as measured by Cord Blood 25(Oh)D CORRELATES positively with maternal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('CHEBI_82784', 'PVP38-Ag NP', 23, '1,25(OH)2D'), ('UBERON_0001987', 'placenta', 61, 'placenta'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007567', 'parturition', 136, 'birth'), ('UBERON_0002240', 'spinal cord', 157, 'cord'), ('UBERON_0000178', 'blood', 162, 'blood'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 171, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC3702245	6/2013	S15-PMC3702245	['IN GENERAL, Cord Blood 25(Oh)D concentrations are APPROXIMATELY 60%–89% of the maternal value.11,17,35,41–47THEREFORE, maintaining optimum Vitamin D nutrition during Pregnancy is ESSENTIAL for PREVENTION of hypovitaminosis D in the fetus and Vitamin D deficiency at Birth and in early infancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 50), ('ANOMALY_CURIOUS_FINDING', 106), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0002240', 'spinal cord', 12, 'cord'), ('UBERON_0000178', 'blood', 17, 'blood'), ('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 23, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 223, 'D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('GO_0007567', 'parturition', 266, 'birth')]
PMC3702245	6/2013	S17-PMC3702245	['the institute of medicine in the us in its RECENT report RECOMMENDS that a Serum 25(Oh)D concentration of 50 nmol/l (20 ng/ml) is adequate for calcium absorption and bone health in Adults, including Pregnant women, in the us and canada.7HOWEVER, new clinical guidelines from the endocrine society RECOMMEND maintaining a Serum 25(Oh)D concentration >75 nmol/l (30 ng/ml) in order to maximize calcium absorption and bone health, and for POTENTIAL Extraskeletal benefits noted in observational studies.8many RECENT STUDIES13,15–17,48–57that evaluated Vitamin D nutrition during Pregnancy in different geographic locations REPORTED wide VARIATION in Vitamin D status depending on latitude, season, sunlight exposure behavior, and Vitamin D intake (table 1).']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('FUTURE_WORK', 297), ('INCOMPLETE_EVIDENCE', 436), ('INCOMPLETE_EVIDENCE', 506), ('INCOMPLETE_EVIDENCE', 620), ('DIFFICULT_TASK', 634)]	8	[('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 81, '25(OH)D'), ('UBERON_0007023', 'adult organism', 181, 'adults'), ('GO_0007565', 'female pregnancy', 199, 'pregnant'), ('UBERON_0001977', 'blood serum', 321, 'serum'), ('CHEBI_71657', 'versiconol acetate', 327, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 327, '25(OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 446, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 549, 'vitamin D'), ('GO_0007565', 'female pregnancy', 576, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 647, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin D')]
PMC3702245	6/2013	S19-PMC3702245	['there is a high prevalence of Vitamin D deficiency [Serum 25(Oh) D <50 nmol/l], and as shown intable 1, most women studied (>80%) have Serum 25(Oh)D concentrations <75 nmol/l, which are CONSIDERED “INSUFFICIENT”.8mean Serum 25(Oh)D concentrations are highest and the prevalence of Vitamin D deficiency is lowest in sun-enriched populations,51,57WHILE the lowest mean Serum 25(Oh)d and the highest prevalence of Vitamin D deficiency are REPORTED in sunshine-deprived populations.16,17,50,55,56the high prevalence of low Vitamin D ASSOCIATED with sunshine deprivation and INADEQUATE corrective Vitamin D intake SHOULD RAISE PUBLIC HEALTH CONCERN about the INCREASED RISK of adverse health EFFECTS of low Vitamin D status for the mother and fetus and poor Vitamin D nutrition in the infant at Birth.']	[('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 198), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('INCOMPLETE_EVIDENCE', 436), ('SUPERFICIAL_RELATIONSHIP', 529), ('IMPORTANT_CONSIDERATION', 570), ('FUTURE_WORK', 609), ('IMPORTANT_CONSIDERATION', 616), ('IMPORTANT_CONSIDERATION', 622), ('IMPORTANT_CONSIDERATION', 654), ('SUPERFICIAL_RELATIONSHIP', 687)]	11	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH) D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 141, '25(OH)D'), ('UBERON_0001977', 'blood serum', 218, 'serum'), ('CHEBI_30778', 'gallic acid', 224, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 230, 'D'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('UBERON_0001977', 'blood serum', 367, 'serum'), ('CHEBI_30778', 'gallic acid', 373, '25(OH)'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 592, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 702, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin D'), ('GO_0007567', 'parturition', 790, 'birth')]
PMC3702245	6/2013	S20-PMC3702245	['implications of low Vitamin D status during Pregnancy\n\nSkeletal and calcemic COMPLICATIONS\nit is GENERALLY ACCEPTED that maternal Vitamin D deficiency CAN result in osteomalacia.']	[('PROBLEM_COMPLICATION', 77), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 151)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('UBERON_0004288', 'skeleton', 55, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3702245	6/2013	S21-PMC3702245	['a Serum 25(Oh)D concentration <25 nmol/l (10 ng/ml), which is ASSOCIATED with INCREASED RISK of osteomalacia in Adults,7is common during Pregnancy, AS INDICATED by RECENT REPORTS from many parts of the world.1for example, Serum 25(Oh)D < 25 nmol/l during Pregnancy HAS BEEN REPORTED in 17%–18% of the caucasian population in the uk,48,4961% of a mixed population in new zealand,5432%–42% in the indian population,15,4559%–84% of a nonwestern population in the netherlands,1441% of the kuwaiti population,1680% of the iranian population,17and 75% of the arab population in the united arab emirates.1HOWEVER, there are LIMITED STUDIES on the ASSOCIATION between such low levels of Vitamin D status and Skeletal integrity in Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 78), ('PROBABLE_UNDERSTANDING', 148), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 265), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 597), ('INCOMPLETE_EVIDENCE', 617), ('SUPERFICIAL_RELATIONSHIP', 640)]	10	[('UBERON_0001977', 'blood serum', 2, 'serum'), ('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 8, '25(OH)D'), ('UBERON_0007023', 'adult organism', 112, 'adults'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 228, '25(OH)D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 679, 'vitamin D'), ('UBERON_0004288', 'skeleton', 700, 'skeletal'), ('GO_0007565', 'female pregnancy', 722, 'pregnant')]
PMC3702245	6/2013	S24-PMC3702245	['further, a RECENT STUDY of the RELATIONSHIP between Serum 25(Oh)D and bone turnover in Pregnant women in istanbul, turkey, FOUND a negative CORRELATION between the second and third trimester and Postpartum 25(Oh)D concentrations and Serum cross-linked c-terminal telopeptide of Type 1 Collagen, which is a MARKER of Bone Resorption.58THESE studies SEEM to INDICATE a LINK between very low Vitamin D status and subclinical osteomalacia in the mothers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 306), ('INCOMPLETE_EVIDENCE', 332), ('ANOMALY_CURIOUS_FINDING', 348), ('INCOMPLETE_EVIDENCE', 356), ('SUPERFICIAL_RELATIONSHIP', 367)]	9	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 58, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 87, 'pregnant'), ('GO_0007565', 'female pregnancy', 195, 'postpartum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('UBERON_0001977', 'blood serum', 233, 'serum'), ('PR_000002123', 'C-C motif chemokine 3', 278, 'type 1 collagen'), ('GO_0045453', 'bone resorption', 316, 'bone resorption'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D')]
PMC3702245	6/2013	S26-PMC3702245	['from Animal studies and SOME Human data, it is SUGGESTED that mineralization of the Fetal Skeleton is independent of Vitamin D and, THEREFORE, maternal Vitamin D deficiency has little EFFECT on fetal Skeletal Development.59IN CONTRAST, SOME recent OBSERVATIONAL STUDIES SUGGEST that Vitamin D nutrition during Pregnancy MAY AFFECT fetal Bone Development.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 47), ('PROBABLE_UNDERSTANDING', 132), ('SUPERFICIAL_RELATIONSHIP', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 248), ('INCOMPLETE_EVIDENCE', 270), ('INCOMPLETE_EVIDENCE', 320), ('SUPERFICIAL_RELATIONSHIP', 324)]	10	[('NCBITaxon_33208', 'Metazoa', 5, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 29, 'human'), ('UBERON_0000922', 'embryo', 84, 'fetal'), ('UBERON_0004288', 'skeleton', 90, 'skeleton'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('GO_0001501', 'skeletal system development', 200, 'skeletal development'), ('UBERON_0004288', 'skeleton', 200, 'skeletal'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy'), ('GO_0048539', 'bone marrow development', 337, 'bone development')]
PMC3702245	6/2013	S27-PMC3702245	['high resolution three-dimensional ultrasound assessment in a study from the uk FOUND greater splaying of the distal Femoral Metaphysis in the fetus when maternal Serum 25(Oh)D was <50 nmol/l,60AND the authors SUGGESTED that this FINDING is SIMILAR TO radiologic features in Vitamin D-deficient rickets.']	[('INCOMPLETE_EVIDENCE', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('INCOMPLETE_EVIDENCE', 209), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 240)]	5	[('UBERON_0013751', 'metaphysis of radius', 116, 'femoral metaphysis'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_63056', 'zinc cation', 168, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 174, 'D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC3702245	6/2013	S30-PMC3702245	['maternal 25(Oh)D concentrations during Pregnancy was SHOWN in ONE uk STUDY48TO AFFECT childhood bone mass at nine years of age, but this WAS NOT confirmed in a larger more RECENT STUDY from the uk.61in populations where Vitamin D deficiency is very SEVERE, maternal Vitamin D deficiency during Pregnancy HAS BEEN ASSOCIATED with neonatal craniotabes62and congenital rickets.63–65taken TOGETHER, the results from OBSERVATIONAL studies SUGGEST a POSSIBLE EFFECT of low maternal 25(Oh)D during Pregnancy on Fetal Bone Development, BUT the ASSOCIATION with lower childhood bone mass is UNPROVEN.']	[('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 137), ('INCOMPLETE_EVIDENCE', 172), ('IMPORTANT_CONSIDERATION', 249), ('INCOMPLETE_EVIDENCE', 304), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 385), ('INCOMPLETE_EVIDENCE', 412), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 444), ('SUPERFICIAL_RELATIONSHIP', 453), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 528), ('ANOMALY_CURIOUS_FINDING', 528), ('SUPERFICIAL_RELATIONSHIP', 536), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 582)]	19	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 9, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 476, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 479, 'OH ... D'), ('GO_0007565', 'female pregnancy', 491, 'pregnancy'), ('GO_0007631', 'feeding behavior', 504, 'fetal'), ('GO_0048539', 'bone marrow development', 510, 'bone development')]
PMC3702245	6/2013	S32-PMC3702245	['SEVERE hypocalcemia occasionally presenting as neonatal seizures is a known COMPLICATION of maternal Vitamin D deficiency during Pregnancy.66,67\n\nextraskeletal and noncalcemic COMPLICATIONS of Vitamin D deficiency during Pregnancy\nseveral Extraskeletal COMPLICATIONS of Vitamin D deficiency during Pregnancy HAVE BEEN REPORTED in the mother, fetus, and infant.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBLEM_COMPLICATION', 76), ('PROBLEM_COMPLICATION', 176), ('PROBLEM_COMPLICATION', 253), ('INCOMPLETE_EVIDENCE', 308)]	5	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy'), ('UBERON_0001431', 'distal carpal bone 2', 239, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007565', 'female pregnancy', 298, 'pregnancy')]
PMC3702245	6/2013	S34-PMC3702245	['Fetal growth\nthe ASSOCIATION between Birth weight and maternal Vitamin D status or intake REMAINS INCONCLUSIVE.5while SOME OBSERVATIONAL68–71and interventional53,72,73studies FOUND improvement in Birth weight with maternal Vitamin D supplementation or improved Vitamin D status, several other observational studies31,74–76and SOME interventional studies18,33,77,78showed no improvement with higher Vitamin D status or supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 326)]	7	[('GO_0008618', '7-methylguanosine metabolic process', 0, 'Fetal'), ('GO_0007567', 'parturition', 37, 'birth'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 196, 'birth'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 398, 'vitamin D')]
PMC3702245	6/2013	S35-PMC3702245	['a RECENT cochrane review79of five SMALL-sized intervention trials of Vitamin D supplementation CONCLUDED that mothers who were supplemented TENDED to have fewer babies weighing <2500 g (relative risk 0.48; 95% confidence interval [ci] 0.23–1.01).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3702245	6/2013	S36-PMC3702245	['intervention trials and observational studies have also FOUND an ASSOCIATION between risk of small-for-Gestational age infants and maternal Vitamin D nutrition during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('GO_0007565', 'female pregnancy', 103, 'gestational'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy')]
PMC3702245	6/2013	S38-PMC3702245	['the RELATIONSHIP between maternal Vitamin D status and small-for-Gestational age infants was found to be u-shaped in a study from pittsburgh in the us,81BUT this WAS NOT CONFIRMED in the above studies.68,80the REASONS for this DIFFERENCE are UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 162), ('PROBABLE_UNDERSTANDING', 210), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('FULL_UNKNOWN', 242)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational')]
PMC3702245	6/2013	S40-PMC3702245	['randomized controlled STUDIES including larger sample sizes and repeated Vitamin D measurements during Pregnancy WILL BE NEEDED to CONFIRM the RELATIONSHIP between Vitamin D supplementation and fetal growth.82\n\nmaternal COMPLICATIONS\nOBSERVATIONAL studies REPORTED an ASSOCIATION between maternal Vitamin D status during Pregnancy and development of pre-eclampsia, which has both a Genetic and an immunologic pathogenesis.']	[('FUTURE_WORK', 22), ('FUTURE_WORK', 113), ('INCOMPLETE_EVIDENCE', 131), ('SUPERFICIAL_RELATIONSHIP', 143), ('PROBLEM_COMPLICATION', 220), ('INCOMPLETE_EVIDENCE', 234), ('INCOMPLETE_EVIDENCE', 256), ('SUPERFICIAL_RELATIONSHIP', 268)]	8	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D'), ('GO_0007565', 'female pregnancy', 321, 'pregnancy'), ('SO_0000704', 'gene', 382, 'genetic')]
PMC3702245	6/2013	S41-PMC3702245	['a study from pittsburgh SHOWED an inverse RELATIONSHIP between Vitamin D status and the risk of pre-eclampsia.83the authors FOUND that the risk of pre-eclampsia was more than doubled (odds ratio 2.4; ci 1.1–5.4) for a 50 nmol/l decrease in maternal Serum 25(Oh)D concentration.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 124)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001977', 'blood serum', 249, 'serum'), ('CHEBI_71657', 'versiconol acetate', 255, '25(OH)D')]
PMC3702245	6/2013	S44-PMC3702245	['with INCREASING INTEREST in the ROLE of Vitamin D in Glucose Homeostasis, the ASSOCIATION between maternal Serum 25(Oh)D concentration in early Pregnancy and the risk of Gestational diabetes mellitus was investigated in a study from the national institutes of health, bethesda, md.85the authors FOUND that maternal Vitamin D deficiency [serum 25(Oh)D < 50 nmol/l] was ASSOCIATED with a higher risk of Gestational diabetes mellitus (adjusted odds ratio 2.66; ci 1.01–7.02).']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 295), ('SUPERFICIAL_RELATIONSHIP', 368)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_17234', 'glucose', 53, 'glucose'), ('GO_0042593', 'glucose homeostasis', 53, 'glucose homeostasis'), ('UBERON_0001977', 'blood serum', 107, 'serum'), ('CHEBI_71657', 'versiconol acetate', 113, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 113, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0007565', 'female pregnancy', 170, 'gestational'), ('CHEBI_27300', 'vitamin D', 315, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 343, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 343, '25(OH)D'), ('GO_0007565', 'female pregnancy', 401, 'gestational')]
PMC3702245	6/2013	S45-PMC3702245	['CONSISTENT with THIS report, a systematic review and meta-analysis of seven observational studies performed between 2008 and 2011 FOUND Serum 25(Oh)D < 50 nmol/l to be ASSOCIATED with Gestational diabetes BUT with an overall lower odds ratio of 1.61 (ci 1.19–2.17).86another meta-analysis of maternal Vitamin D status and Pregnancy outcomes,87which included 24 studies up to 2012, FOUND an overall INCREASED RISK of Preeclampsia (odds ratio 2.09; ci 1.50–2.90) and Gestational diabetes (odds ratio 1.38; ci 1.12–1.70).']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 205), ('INCOMPLETE_EVIDENCE', 381), ('IMPORTANT_CONSIDERATION', 398)]	7	[('UBERON_0001977', 'blood serum', 136, 'serum'), ('CHEBI_71657', 'versiconol acetate', 142, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 142, '25(OH)D'), ('GO_0007565', 'female pregnancy', 184, 'gestational'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('GO_0007565', 'female pregnancy', 322, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 416, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 465, 'gestational')]
PMC3702245	6/2013	S47-PMC3702245	['RECENT STUDIES have INDICATED a ROLE for Vitamin D in the Innate Immune Response.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0045087', 'innate immune response', 58, 'innate immune response'), ('UBERON_0002405', 'immune system', 65, 'immune')]
PMC3702245	6/2013	S48-PMC3702245	['Vitamin D HAS BEEN SHOWN to upregulate Endogenous Synthesis Of Cathelicidin, a potent Antimicrobial peptide, in response to Microbial Invasion, via activation of toll-like receptors on microphages and Monocytes.6,24given that Antimicrobial peptides provide rapid Defense against invading pathogens, it is PLAUSIBLE that Vitamin D plays a ROLE in host defense against infections in both mother and offspring.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 305), ('SUPERFICIAL_RELATIONSHIP', 338)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0009790', 'embryo development', 39, 'endogenous'), ('GO_0007608', 'sensory perception of smell', 50, 'synthesis of ...'), ('CHEBI_3364', 'Canthiumine', 63, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 63, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 86, 'antimicrobial'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'microbial'), ('GO_0007586', 'digestion', 134, 'invasion'), ('CL_0000576', 'monocyte', 201, 'monocytes'), ('CHEBI_65381', 'albizoside C', 226, 'antimicrobial'), ('GO_0006952', 'defense response', 263, 'defense'), ('CHEBI_27300', 'vitamin D', 320, 'vitamin D')]
PMC3702245	6/2013	S49-PMC3702245	['in SUPPORT of this premise is the FINDING that Vitamin D deficiency is an INDEPENDENT RISK FACTOR for bacterial vaginosis in Pregnant women.88a study from pittsburgh SHOWED an inverse dose-response RELATIONSHIP between Serum 25(Oh)D concentrations and the prevalence of bacterial vaginosis.88compared with a Serum concentration of 75 nmol/l, the prevalence of bacterial vaginosis increased 1.65-fold (ci 1.01–2.69) and 1.26-fold (ci 1.01–1.57) at Serum concentrations of 20 nmol/l and 50 nmol/l, respectively.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 166), ('SUPERFICIAL_RELATIONSHIP', 198)]	6	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant'), ('UBERON_0001977', 'blood serum', 219, 'serum'), ('CHEBI_71657', 'versiconol acetate', 225, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 225, '25(OH ... D'), ('UBERON_0001977', 'blood serum', 308, 'serum'), ('UBERON_0001977', 'blood serum', 447, 'serum')]
PMC3702245	6/2013	S50-PMC3702245	['in another large study from new york in the us,89bacterial vaginosis was ONLY ASSOCIATED with Vitamin D deficiency (Serum 25(Oh)D < 75 nmol/l) in Pregnant women (adjusted odds ratio 2.87; ci 1.13–7.28).']	[('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 78)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 122, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant')]
PMC3702245	6/2013	S51-PMC3702245	['further, there is a SUGGESTION of an ASSOCIATION between Vitamin D and Periodontal disease,90and maternal Serum 25(Oh)D < 75 nmol/l during Early Pregnancy HAS BEEN ASSOCIATED with a two-fold INCREASED risk of Periodontal disease.91in a RECENT randomized controlled TRIAL of Vitamin D supplementation from south carolina, Vitamin D supplementation of 4000 iu/day during Pregnancy was ASSOCIATED with a reduction in the risk of combined morbidities, such as Maternal infection, Preterm labor, and Preterm Birth.92\nIN VIEW of the POSSIBLE ASSOCIATION between maternal Vitamin D status and the pattern of fetal growth, pre-eclampsia, Gestational diabetes mellitus, and maternal infection, and the significant POTENTIAL for Perinatal morbidities ASSOCIATED with these conditions, evaluation of Vitamin D nutrition in early Pregnancy and the EFFECT of appropriate supplementation SEEMS WARRANTED.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 164), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 512), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 527), ('SUPERFICIAL_RELATIONSHIP', 536), ('INCOMPLETE_EVIDENCE', 705), ('SUPERFICIAL_RELATIONSHIP', 741), ('SUPERFICIAL_RELATIONSHIP', 836), ('ANOMALY_CURIOUS_FINDING', 874), ('FUTURE_WORK', 874)]	16	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001758', 'periodontium', 71, 'periodontal'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 112, '25(OH ... D'), ('GO_0051318', 'G1 phase', 139, 'early'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('UBERON_0001758', 'periodontium', 209, 'periodontal'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D'), ('GO_0007565', 'female pregnancy', 369, 'pregnancy'), ('GO_0007618', 'mating', 456, 'maternal'), ('GO_0007565', 'female pregnancy', 476, 'preterm'), ('GO_0007565', 'female pregnancy', 495, 'preterm'), ('GO_0007567', 'parturition', 503, 'birth'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D'), ('GO_0007565', 'female pregnancy', 630, 'gestational'), ('GO_0036268', 'swimming', 719, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 719, 'perinatal'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('GO_0007565', 'female pregnancy', 818, 'pregnancy')]
PMC3702245	6/2013	S52-PMC3702245	['IMPACT on neonate and infant\nboth in vitro and observational studies have DEMONSTRATED that Vitamin D status during Pregnancy IMPACTS the Immune Response of the offspring.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 126)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0006955', 'immune response', 138, 'immune response'), ('UBERON_0002405', 'immune system', 138, 'immune')]
PMC3702245	6/2013	S54-PMC3702245	['Monocytes cultured in Vitamin D-deficient Plasma (Serum 25(Oh)D < 30 nmol/l) SHOWED significantly decreased Tolllike Receptor-mediated Expression of Cathelicidin (p < 0.05) compared with those conditioned in Vitamin D-sufficient Plasma (Serum 25(Oh)D > 75 nmol/l).93CONSISTENT with these in vitro FINDINGS, OBSERVATIONAL clinical DATA FOUND an ASSOCIATION between Vitamin D status in Cord Blood and the RISK of Lower Respiratory Tract infection in the first year of Life.94the risk of Respiratory syncytial Virus bronchiolitis in the first year of Life is increased by six-fold (ci 1.6–24.9) in infants with Cord Blood 25(Oh)D < 50 nmol/l compared with infants with 25(Oh)D > 75 nmol/l.']	[('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('INCOMPLETE_EVIDENCE', 297), ('INCOMPLETE_EVIDENCE', 307), ('FUTURE_WORK', 330), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 344), ('IMPORTANT_CONSIDERATION', 403)]	9	[('CL_0000576', 'monocyte', 0, 'Monocytes'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000001660', 'prostaglandin F2-alpha receptor', 108, 'tolllike receptor'), ('GO_0010467', 'gene expression', 135, 'expression'), ('PR_000006009', 'alpha-catulin', 149, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 229, 'plasma'), ('UBERON_0001977', 'blood serum', 237, 'serum'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 384, 'cord'), ('UBERON_0000178', 'blood', 389, 'blood'), ('UBERON_0004905', 'articulation', 411, 'lower respiratory tract'), ('UBERON_0000104', 'life cycle', 466, 'life'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory'), ('NCBITaxon_1', 'root', 507, 'virus'), ('UBERON_0000104', 'life cycle', 548, 'life'), ('UBERON_0002240', 'spinal cord', 608, 'cord'), ('UBERON_0000178', 'blood', 613, 'blood'), ('CHEBI_71657', 'versiconol acetate', 619, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 619, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 666, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 666, '25(OH)D')]
PMC3702245	6/2013	S56-PMC3702245	['IN CONTRAST, an OBSERVATIONAL study REPORTED an increased RISK of infantile eczema and pneumonia in ASSOCIATION with maternal Serum 25(Oh)D > 75 nmol/l in the last trimester.76HOWEVER, another RECENT STUDY with a larger sample size from the same institution DID NOT FIND an ASSOCIATION between maternal 25(Oh)d > 75 nmol/l in late Pregnancy and eczema or asthma at 12 months and three and six years of age.97there was no report on the ASSOCIATION between maternal Vitamin D status and Respiratory infections in the latter study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 435)]	10	[('UBERON_0001977', 'blood serum', 126, 'serum'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 303, '25(OH)'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 303, '25(OH'), ('GO_0007565', 'female pregnancy', 331, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory')]
PMC3702245	6/2013	S57-PMC3702245	['regarding Neurocognitive Development, WHILE ONE STUDY FOUND no association between maternal Vitamin D status during Pregnancy and Neurocognitive function,76a RECENT larger-sized STUDY LINKED maternal Serum 25(Oh)D levels during Pregnancy with Language Development in the offspring.98the results of the above studies SUGGEST that childhood infections, atopy, and Neurocognitive development NEED TO BE included as outcomes of interest following Vitamin D supplementation in Pregnancy, and that clinical trials SHOULD include a RELEVANT group of subjects CONSIDERED to be replete for Vitamin D.\ntaken TOGETHER, the high prevalence of Vitamin D deficiency in Pregnancy and the POSSIBLE multiple POTENTIAL adverse EFFECTS on mother and offspring IDENTIFIED in SEVERAL epidemiologic STUDIES UNDERSCORE the URGENT NEED FOR large randomized controlled TRIALS to identify the amount of Vitamin D supplementation that optimizes Vitamin D status during Pregnancy, and to DETERMINE the EFFECT of supplementation on POTENTIAL adverse conditions ASSOCIATED with Vitamin D deficiency and any POSSIBLE Vitamin D excess.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 184), ('INCOMPLETE_EVIDENCE', 316), ('FUTURE_WORK', 389), ('FUTURE_WORK', 508), ('IMPORTANT_CONSIDERATION', 525), ('IMPORTANT_CONSIDERATION', 552), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 691), ('SUPERFICIAL_RELATIONSHIP', 709), ('INCOMPLETE_EVIDENCE', 741), ('INCOMPLETE_EVIDENCE', 755), ('IMPORTANT_CONSIDERATION', 785), ('IMPORTANT_CONSIDERATION', 800), ('FUTURE_WORK', 807), ('INCOMPLETE_EVIDENCE', 807), ('FUTURE_WORK', 844), ('QUESTION_ANSWERED_BY_THIS_WORK', 960), ('SUPERFICIAL_RELATIONSHIP', 974), ('INCOMPLETE_EVIDENCE', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1077)]	26	[('GO_0007399', 'nervous system development', 10, 'neurocognitive development'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0050905', 'neuromuscular process', 130, 'neurocognitive'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 206, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 243, 'language development'), ('GO_0050905', 'neuromuscular process', 362, 'neurocognitive'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D'), ('GO_0007565', 'female pregnancy', 472, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 581, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 631, 'vitamin D'), ('GO_0007565', 'female pregnancy', 655, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 877, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 918, 'vitamin D'), ('GO_0007565', 'female pregnancy', 942, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1048, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1086, 'vitamin D')]
PMC3702245	6/2013	S60-PMC3702245	['HOWEVER, a committee of Vitamin D EXPERTS99AND the Endocrine society8recommend a target Serum concentration >75 nmol/l BASED ON the AVAILABLE EVIDENCE in order to achieve optimal benefits for Skeletal health as well as POTENTIAL nonskeletal BENEFITS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 34), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 119), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 219), ('IMPORTANT_CONSIDERATION', 241)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 51, 'Endocrine'), ('UBERON_0001977', 'blood serum', 88, 'serum'), ('UBERON_0004288', 'skeleton', 192, 'skeletal')]
PMC3702245	6/2013	S61-PMC3702245	['a target concentration of 75 nmol/l is CONSISTENT with the Cord Blood 25(Oh)D level REPORTED in SOME STUDIES as being PROTECTIVE against lower respiratory infection, wheezing, and eczema in infants.94–96to achieve a target Serum concentration >75 nmol/l, the society RECOMMENDS a daily Vitamin D Intake of 1500–2000 iu.']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 118), ('FUTURE_WORK', 267)]	5	[('UBERON_0002240', 'spinal cord', 59, 'cord'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 70, '25(OH ... D'), ('UBERON_0001977', 'blood serum', 223, 'serum'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0007631', 'feeding behavior', 296, 'intake')]
PMC3702245	6/2013	S62-PMC3702245	['these RECOMMENDATIONS are based MOSTLY ON STUDIES from the us and MAY not be applicable worldwide DUE TO DIFFERENCES in baseline Vitamin D status,100particularly in populations where severe Vitamin D deficiency is PREVALENT.']	[('FUTURE_WORK', 6), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 32), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 66), ('PROBLEM_COMPLICATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('IMPORTANT_CONSIDERATION', 214)]	8	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC3702245	6/2013	S63-PMC3702245	['a review of the FEW previous randomized controlled TRIALS of Vitamin D supplementation during Pregnancy INDICATES that doses of 400–1600 iu/day were INSUFFICIENT in achieving a mean Serum 25(Oh)D concentration ≥50 nmol/l in most of the studies.41in a RECENT Vitamin D supplementation TRIAL from the uk, a multiethnic group of 180 Pregnant women were randomized at 27 weeks’ Gestation to receive a single Oral dose of 200,000 iu of Vitamin D, daily supplementation of 800 iu, or no treatment.33the median Serum 25(Oh)D concentration in the 800 iu/day group at study entry was 26 nmol/l (interquartile range 22–37), and the median 25(Oh)D concentration at delivery following supplementation was 42 nmol/l (interquartile range 31–76).']	[('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 51), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 149), ('PROBLEM_COMPLICATION', 149), ('INCOMPLETE_EVIDENCE', 251), ('INCOMPLETE_EVIDENCE', 284)]	7	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy'), ('UBERON_0001977', 'blood serum', 182, 'serum'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 188, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('GO_0007565', 'female pregnancy', 330, 'pregnant'), ('GO_0007565', 'female pregnancy', 374, 'gestation'), ('UBERON_0000165', 'mouth', 404, 'oral'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D'), ('UBERON_0001977', 'blood serum', 504, 'serum'), ('CHEBI_71657', 'versiconol acetate', 510, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 510, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 629, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 629, '25(OH)D')]
PMC3702245	6/2013	S64-PMC3702245	['ONLY 30% of the women treated with 800 iu/day of Vitamin D achieved a Serum 25(Oh)D concentration >50 nmol/l.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 76, '25(OH)D')]
PMC3702245	6/2013	S68-PMC3702245	['these two studies and older RESEARCH41INDICATE that, in populations with a high prevalence of SEVERE Vitamin D sufficiency, supplementation up to 1600 iu/day MAY BE inadequate to achieve the RECOMMENDED target Serum 25(Oh)D concentration of 50 nmol/l.7in two RECENT STUDIES from india, which used large single-dose supplementation of 120,000 iu at the fifth and seventh month of Gestation15Or at the second and third trimester,69only 25% and 62%, respectively, achieved a Serum 25(Oh)D concentration >50 nmol/l.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 94), ('INCOMPLETE_EVIDENCE', 158), ('FUTURE_WORK', 191), ('INCOMPLETE_EVIDENCE', 259)]	5	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0001977', 'blood serum', 210, 'serum'), ('CHEBI_71657', 'versiconol acetate', 216, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 216, '25(OH)D'), ('GO_0007565', 'female pregnancy', 379, 'gestation15or'), ('UBERON_0001977', 'blood serum', 472, 'serum'), ('CHEBI_71657', 'versiconol acetate', 478, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 478, '25(OH)D')]
PMC3702245	6/2013	S69-PMC3702245	['the RECENT cochrane review of Vitamin D supplementation alone during Pregnancy79Considered five trials that compared the EFFECTS of supplementation with placebo or no supplementation.33,73,77,78,102the review CONCLUDED that Vitamin D supplementation increases Serum 25(Oh)D concentrations during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 121), ('INCOMPLETE_EVIDENCE', 209)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0016441', 'posttranscriptional gene silencing', 69, 'pregnancy79considered'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('UBERON_0001977', 'blood serum', 260, 'serum'), ('CHEBI_71657', 'versiconol acetate', 266, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 266, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 296, 'pregnancy')]
PMC3702245	6/2013	S70-PMC3702245	['OF NOTE, in two of the five studies, the mean concentration of 25(Oh)D after supplementation was <50 nmol/l,33,78and Serum 25(Oh)D WAS NOT MEASURED in ONE STUDY.73all these STUDIES underscore the uncertainty about the amount of Vitamin D supplementation REQUIRED to optimize Vitamin D status in Pregnancy and which would be generalizable worldwide.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 131), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 173), ('IMPORTANT_CONSIDERATION', 254)]	5	[('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 123, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('GO_0007565', 'female pregnancy', 295, 'pregnancy')]
PMC3702245	6/2013	S72-PMC3702245	['the institute of MEDICINE7CONSIDERS a Serum 25(Oh)D concentration >50 nmol/l AS acceptable, WHILE the Endocrine society and Vitamin D EXPERTS RECOMMEND >75 nmol/l.8,99a RECENT STUDY among traditional populations in tanzania with type vi (dark) skin color living in a sun-abundant environment RECOMMENDED a mean Serum 25(Oh)D concentration of 115 nmol/l in nonpregnant Adults and 139 nmol/l in Pregnant women.57the question then is: WHAT Serum concentration of 25(Oh)D is “normal” in Adults, including during Pregnancy?']	[('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 134), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 169), ('FUTURE_WORK', 292), ('EXPLICIT_QUESTION', 432), ('EXPLICIT_QUESTION', 517)]	9	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 44, '25(OH)D'), ('UBERON_0005063', 'left ventricular compact myocardium', 102, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'serum'), ('CHEBI_71657', 'versiconol acetate', 317, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 317, '25(OH)D'), ('UBERON_0007023', 'adult organism', 368, 'adults'), ('GO_0007565', 'female pregnancy', 393, 'pregnant'), ('UBERON_0001977', 'blood serum', 437, 'serum'), ('CHEBI_71657', 'versiconol acetate', 460, '25(OH)D'), ('UBERON_0007023', 'adult organism', 483, 'adults'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy')]
PMC3702245	6/2013	S74-PMC3702245	['in studies of Adults and nonpregnant women, a Vitamin D intake of up to 10,000 iu/day is ASSOCIATED with achievement of a Serum 25(Oh)D concentration ≥80 nmol/l without Vitamin D toxicity.103,104from a review of PREVIOUS STUDIES, an additional daily intake of 100 iu of Vitamin D increases the Serum 25(Oh)D concentration by 1–2 nmol/l.7,105THEREFORE, knowing the population baseline Serum 25(Oh)D concentration, IT IS POSSIBLE to ESTIMATE the Vitamin D intake REQUIRED to replete body stores and achieve an expected target Serum 25(Oh)d concentration.']	[('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 212), ('PROBABLE_UNDERSTANDING', 338), ('INCOMPLETE_EVIDENCE', 413), ('INCOMPLETE_EVIDENCE', 431), ('IMPORTANT_CONSIDERATION', 461)]	6	[('UBERON_0007023', 'adult organism', 14, 'adults'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001977', 'blood serum', 122, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 131, 'OH)D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('UBERON_0001977', 'blood serum', 294, 'serum'), ('CHEBI_71657', 'versiconol acetate', 300, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 300, '25(OH)D'), ('UBERON_0001977', 'blood serum', 384, 'serum'), ('CHEBI_33010', 'chromide(1-)', 392, '(OH)D'), ('CHEBI_27300', 'vitamin D', 444, 'vitamin D'), ('UBERON_0001977', 'blood serum', 524, 'serum'), ('CHEBI_30778', 'gallic acid', 530, '25(OH)')]
PMC3702245	6/2013	S76-PMC3702245	['they HYPOTHESIZED that daily Vitamin D3Supplementation of 4000 iu/day would be more effective than 2000 iu and a standard dosing regimen of 400 iu in achieving a Serum 25(Oh)D concentration of >80 nmol/l without any safety ISSUES referable to Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 223), ('PROBLEM_COMPLICATION', 223)]	3	[('CHEBI_52915', 'phosphatediyl group', 29, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 29, 'vitamin D3supplementation'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 168, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC3702245	6/2013	S91-PMC3702245	['based on this protocol, the authors CONCLUDED that 4000 iu/day of Vitamin D3Supplementation is SAFE and MOST EFFECTIVE in achieving Vitamin D sufficiency in mothers and adequate Vitamin D status in their offspring, irrespective of ethnicity.']	[('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 95), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_52915', 'phosphatediyl group', 66, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 66, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC3702245	6/2013	S92-PMC3702245	['the authors also FOUND that maternal Vitamin D supplementation with 4000 iu/day decreased the risk of combined comorbidities, including infection, Preterm Birth, Gestational diabetes, and pre-eclampsia,82and SUGGESTED that ADDITIONAL STUDIES with adequate power for assessment of OTHER endpoints WERE NEEDED.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 208), ('FUTURE_WORK', 223), ('FUTURE_WORK', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 280), ('FUTURE_WORK', 296)]	6	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'preterm birth'), ('GO_0007565', 'female pregnancy', 162, 'gestational')]
PMC3702245	6/2013	S93-PMC3702245	['another RECENT STUDY from the united arab emirates among Pregnant arab women with a high prevalence of Vitamin D deficiency also CONFIRMED that 4000 iu/day of Vitamin D supplementation was SAFE and more EFFECTIVE than 2000 iu/day and 400 iu/day in optimizing Vitamin D status during Pregnancy and in achieving Vitamin D sufficiency at Birth in mothers and offspring.106in the united arab emirates study, the increment from baseline to Delivery was about four-fold higher than expected BASED ON previous pharmacokinetic STUDIES, POSSIBLY RELATED to low baseline Vitamin D status.100this INDICATES that baseline Vitamin D status SHOULD BE taken INTO CONSIDERATION when evaluating Vitamin D supplementation.100,107\nthe FINDINGS of these RECENT intervention STUDIES INDICATE an URGENT NEED for more randomized controlled trials in diverse geographic locations with large sample sizes to identify the Vitamin D intake REQUIRED to optimize Vitamin D status, and TO ASSESS the EFFECT on Pregnancy-related and infant-related COMPLICATIONS.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 189), ('SUPERFICIAL_RELATIONSHIP', 203), ('PROBABLE_UNDERSTANDING', 485), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 528), ('SUPERFICIAL_RELATIONSHIP', 537), ('INCOMPLETE_EVIDENCE', 586), ('FUTURE_WORK', 627), ('IMPORTANT_CONSIDERATION', 643), ('FUTURE_WORK', 648), ('INCOMPLETE_EVIDENCE', 716), ('INCOMPLETE_EVIDENCE', 734), ('INCOMPLETE_EVIDENCE', 762), ('IMPORTANT_CONSIDERATION', 774), ('FUTURE_WORK', 781), ('IMPORTANT_CONSIDERATION', 913), ('QUESTION_ANSWERED_BY_THIS_WORK', 956), ('SUPERFICIAL_RELATIONSHIP', 970), ('PROBLEM_COMPLICATION', 1017)]	21	[('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('GO_0007565', 'female pregnancy', 283, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('GO_0007567', 'parturition', 335, 'birth'), ('GO_0007567', 'parturition', 435, 'delivery'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 896, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 934, 'vitamin D'), ('GO_0007565', 'female pregnancy', 980, 'pregnancy')]
PMC3702245	6/2013	S94-PMC3702245	['BASED ON BIOMARKERS AFFECTED by Vitamin D status, and FINDINGS from observational studies and recent randomized trials, FUTURE STUDIES SHOULD include trial arms to achieve Serum 25(Oh)D concentrations that HAVE BEEN ASSOCIATED with POTENTIAL Extraskeletal benefits8,82,84,94–96of Vitamin D to understand BETTER both the benefits and risks of Vitamin D supplementation to mother and offspring.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 54), ('FUTURE_WORK', 120), ('FUTURE_WORK', 135), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 304)]	11	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001977', 'blood serum', 172, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 181, 'OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 242, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D')]
PMC3702245	6/2013	S95-PMC3702245	['conclusion\nthe criteria for defining optimal Vitamin D intake during Pregnancy REMAIN CONTROVERSIAL.']	[('INCOMPLETE_EVIDENCE', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy')]
PMC3702245	6/2013	S96-PMC3702245	['in VIEW of the high prevalence of low Vitamin D status in Pregnancy worldwide, INTERVENTION trials to identify optimal Vitamin D status and the REQUIRED SAFE Vitamin D intake COULD BE an IMPORTANT part of PUBLIC HEALTH STRATEGY to improve the health of mothers, and the short-term and long-term outcomes for their offspring.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 153), ('INCOMPLETE_EVIDENCE', 175), ('IMPORTANT_CONSIDERATION', 187), ('IMPORTANT_CONSIDERATION', 205), ('FUTURE_WORK', 219)]	8	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC3702339	6/2013	S128-PMC3702339	['ONLY 199 (28.4%) and 181 (25.6%) reported Consumption of provitamin a and preformed Vitamin A-rich Foods respectively.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0)]	2	[('GO_0007631', 'feeding behavior', 42, 'consumption'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A'), ('CHEBI_33290', 'food', 99, 'foods')]
PMC3702339	6/2013	S152-PMC3702339	['association between Vitamin A status and various POTENTIAL risk factors among Pregnant women in rural sidama, southern ethiopia, february 2011variableserum Retinol µmol/l (mean ±sd)vad+vad-crude or (95% ci)adjusted or (95% ci)**staple diet\xa0\xa0enset-based0.81±0.411802711.28 (0.93-1.77)-\xa0\xa0Cereal-based0.88±0.42851641r-dietary diversity in the previous day\xa0\xa0low (dds ≤3)0.75±0.411191242.55 (1.63-4.00)*1.94 (1.17-3.19)*\xa0\xa0optimal (dds of 4 or 5)0.87±0.411082101.37 (0.88-2.12)1.10 (0.70-1.72)\xa0\xa0high (dds ≥6)0.91±0.43381011r1rconsumed Foods from Animal source in the previous day\xa0\xa0no0.81±0.422163031.92 (1.33-2.78)*1.51 (1.04-2.13)*\xa0\xa0yes0.91±0.39491321r1rsevere acute malnutrition\xa0\xa0no (muac ≥220 mm)0.87±0.421783301r1r\xa0\xa0yes (muac <220 mm)0.75±0.39871051.54 (1.10-2.15)*1.26 (0.88-1.81)zinc deficiency status\xa0\xa0non-deficient0.92±0.41912381r1r\xa0\xa0deficient0.76±0.401741972.31 (1.68-3.17)*1.80 (1.28-2.53)*parity\xa0\xa000.89±0.4034821r1r\xa0\xa01-20.85±0.411021741.41 (0.86-2.26)1.14 (0.69-1.87)\xa0\xa03-40.84±0.42911401.57 (0.97-2.53)1.35 (0.81-2.26)\xa0\xa0≥50.72±0.4038392.35 (1.29-4.28)*1.92 (1.02-3.64)*walking distance from nearby Health facility\xa0\xa00-30 minutes0.83±0.412293691r-\xa0\xa0longer than 30 minutes0.89±0.4436660.88 (0.57-1.36)-number of anc follow-ups\xa0\xa000.87±0.411212431r1r\xa0\xa01-20.80±0.431341731.56 (1.14-2.13)*1.42 (0.97-2.02)\xa0\xa0≥30.86±0.4110191.06 (0.48-2.34)0.70 (0.30-1.64)received Nutrition education during Pregnancy\xa0\xa0yes0.80±0.41701051r-\xa0\xa0no0.85±0.421953300.89 (0.62-1.26)-\n*statistically significant association at 0.05 level of significance;\n**adjusted for all significant variables in the table plus Gestational age and crp level; ci=confidence interval; r=reference value; sd=standard deviation\n\nlinear regression modelling\nin the linear regression model, ABOUT 26.2% of the VARIABILITY in Serum Retinol level (μmol/l) was explained by 8 independent variables (table 2).']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 1742), ('DIFFICULT_TASK', 1761)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin A'), ('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_26536', 'retinoic acid', 156, 'retinol'), ('CHEBI_27989', 'cis-dodec-3-enoyl-CoA', 286, 'Cereal'), ('CHEBI_33290', 'food', 529, 'foods'), ('NCBITaxon_33208', 'Metazoa', 540, 'animal'), ('UBERON_0000025', 'tube', 1103, 'health'), ('CHEBI_35222', 'inhibitor', 1361, 'nutrition'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1585, 'gestational'), ('UBERON_0001977', 'blood serum', 1776, 'serum'), ('CHEBI_26536', 'retinoic acid', 1782, 'retinol')]
PMC3702339	6/2013	S197-PMC3702339	['the ASSOCIATION CAN be secondary to the INFLUENCE of zinc on the Metabolism Of Vitamin A (42).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 40)]	3	[('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 65, 'metabolism of vitamin A'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 87, 'A')]
PMC3702339	6/2013	S198-PMC3702339	['a study in Pregnant rhesus monkeys CONCLUDED that, in the zinc-deficient groups, zinc AFFECTS Vitamin A Metabolism by altering the formation or release of holo-Retinol-Binding Protein (43).']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('GO_0007565', 'female pregnancy', 11, 'pregnant'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 94, 'vitamin A metabolism'), ('CHEBI_26536', 'retinoic acid', 160, 'retinol'), ('PR_000013779', 'histone-binding protein RBBP7', 160, 'retinol-binding protein')]
PMC3702339	6/2013	S199-PMC3702339	['Zinc supplementation trial in Pregnant nepalese women also SUGGESTED that Zinc potentiates the EFFECT of Vitamin A in restoring night-Vision among night-blind Pregnant women with low initial Serum zinc concentrations (44).']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 95)]	2	[('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 0, 'Zinc'), ('GO_0007565', 'female pregnancy', 30, 'pregnant'), ('CHEBI_33340', 'zinc group element atom', 74, 'zinc'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('GO_0007601', 'visual perception', 134, 'vision'), ('GO_0007565', 'female pregnancy', 159, 'pregnant'), ('UBERON_0001977', 'blood serum', 191, 'serum')]
PMC3708703	6/2013	S243-PMC3708703	['in our trial we FOUND a high prevalence of Iodine (93%) and Vitamin D deficiency (18%) among women in late Pregnancy.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('CHEBI_24859', 'iodine atom', 43, 'iodine'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy')]
PMC3695234	7/2013	S0-PMC3695234	['CORRELATION between Serum Vitamin D level and the severity of atopic dermatitis ASSOCIATED with Food sensitization\n\nabstract\n\npurpose\na GROWING BODY of LITERATURE has LINKED Vitamin D deficiency with allergic diseases, particularly atopic dermatitis (ad).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 136), ('INCOMPLETE_EVIDENCE', 136), ('SUPERFICIAL_RELATIONSHIP', 167)]	5	[('UBERON_0001977', 'blood serum', 20, 'Serum'), ('CHEBI_28384', 'vitamin K', 26, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 26, 'Vitamin'), ('CHEBI_33290', 'food', 96, 'Food'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC3695234	7/2013	S11-PMC3695234	['conclusions\nthese results SUGGEST that Vitamin D deficiency is RELATED to the severity of ad ASSOCIATED with Food sensitization.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 93)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_33290', 'food', 109, 'food')]
PMC3695234	7/2013	S12-PMC3695234	['THUS, these data SUGGEST a ROLE for Vitamin D in a select group of ad patients.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 27)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3695234	7/2013	S17-PMC3695234	['ANOTHER STUDY REPORTED regional DIFFERENCES in the number of prescriptions of epipens within the united states; the highest rates were FOUND in new england, and the lowest in the southern states.2THESE results MAY provide IMPORTANT etiologic CLUES and INDICATE the POTENTIAL ROLE of Vitamin D in atopic disease susceptibility.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 135), ('PROBABLE_UNDERSTANDING', 195), ('PROBABLE_UNDERSTANDING', 195), ('INCOMPLETE_EVIDENCE', 210), ('IMPORTANT_CONSIDERATION', 222), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 252), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 275)]	12	[('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC3695234	7/2013	S19-PMC3695234	['there has also been increasing AWARENESS of the IMPORTANCE of one POTENTIAL FACTOR-Vitamin D-in the development and progress of atopic Diseases.']	[('IMPORTANT_CONSIDERATION', 31), ('IMPORTANT_CONSIDERATION', 48), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007586', 'digestion', 135, 'diseases')]
PMC3695234	7/2013	S20-PMC3695234	['a GROWING body of LITERATURE has LINKED decreased Serum Vitamin D levels with allergic diseases, PARTICULARLY ad.2-4HOWEVER, large-scale prospective and randomized studies are LACKING.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('FULL_UNKNOWN', 176)]	6	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC3695234	7/2013	S21-PMC3695234	['THUS, the available data highlights the NEED FOR FURTHER ANALYSIS of the ASSOCIATIONS between Vitamin D and atopic diseases in DIFFERENT populations.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 40), ('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3695234	7/2013	S49-PMC3695234	['discussion\nACCORDING TO the results of the 2005-2006 national Health and nutrition examinations survey (nhanes), Vitamin D deficiency is ASSOCIATED with higher levels of Ige sensitization in children and adolescents.6to ASSESS the RELATIONSHIP between Vitamin D levels and Respiratory outcomes, other analyses were performed on the same survey data.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 137), ('QUESTION_ANSWERED_BY_THIS_WORK', 220), ('SUPERFICIAL_RELATIONSHIP', 231)]	4	[('UBERON_0000925', 'endoderm', 62, 'Health'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 170, 'IgE'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 273, 'respiratory')]
PMC3695234	7/2013	S50-PMC3695234	['a PROTECTIVE EFFECT for Vitamin D against wheezing and asthma was found to be strongest for non-atopic and older subjects, SUGGESTING that Vitamin D modifies the risk of allergic and Respiratory disease through multiple mechanisms.7\nalthough Vitamin D deficiency is DEFINED AS a Serum level <20 ng/ml of 25(Oh)d3, there is also an increasing CONCERN about Vitamin D INSUFFICIENCY, which is characterized by levels of 25(Oh)D3Between 20 and 29 ng/ml.8in THIS STUDY, we FOUND that most participants with ad COULD BE categorized as having Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 266), ('PROBABLE_UNDERSTANDING', 274), ('IMPORTANT_CONSIDERATION', 342), ('IMPORTANT_CONSIDERATION', 366), ('QUESTION_ANSWERED_BY_THIS_WORK', 453), ('INCOMPLETE_EVIDENCE', 468), ('INCOMPLETE_EVIDENCE', 505)]	10	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 183, 'respiratory'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('UBERON_0001977', 'blood serum', 279, 'serum'), ('CHEBI_30778', 'gallic acid', 304, '25(OH)'), ('CHEBI_27300', 'vitamin D', 356, 'vitamin D'), ('CHEBI_52744', 'fort orange 600', 417, '25(OH)D3between 20'), ('CHEBI_27300', 'vitamin D', 536, 'vitamin D')]
PMC3695234	7/2013	S51-PMC3695234	['ALTHOUGH there was no healthy control group, OUR FINDINGS SHOWED lower normal levels of Serum Vitamin D (15.61±5.67 ng/ml) irrespective of ad severity, which SUGGESTS a CORRELATION between ad and the absorption and Metabolism Of Vitamin D.\nthis Metabolism begins with two processes: absorption into the skin as Vitamin D3And via the Gut as either Vitamin D2Or Vitamin D3.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 169)]	5	[('UBERON_0001977', 'blood serum', 88, 'serum'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 215, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('GO_0008152', 'metabolic process', 245, 'metabolism'), ('CHEBI_61991', 'maltotriose trisaccharide', 311, 'vitamin D3and'), ('PR_000027594', 'histone H3', 311, 'vitamin D3and'), ('UBERON_0001555', 'digestive tract', 333, 'gut'), ('CHEBI_27329', 'xanthosine phosphate', 347, 'vitamin D2or'), ('PR_000017209', 'utrophin', 347, 'vitamin D2or'), ('CHEBI_33279', 'vitamin D5', 360, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 360, 'vitamin D3')]
PMC3695234	7/2013	S52-PMC3695234	['these Molecules are then Metabolized in the Liver to 25(Oh) Vitamin D, the Vitamin D pro-hormone, which is USUALLY used to measure Vitamin d levels clinically.']	[('INCOMPLETE_EVIDENCE', 107)]	1	[('CHEBI_36357', 'polyatomic entity', 6, 'molecules'), ('GO_0008152', 'metabolic process', 25, 'metabolized'), ('UBERON_0002107', 'liver', 44, 'liver'), ('CHEBI_30778', 'gallic acid', 53, '25(OH)'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 131, 'vitamin')]
PMC3695234	7/2013	S54-PMC3695234	['THEREFORE, the RELATIONSHIP between Vitamin D and ad HAS been INVESTIGATED both HERE and in PREVIOUS STUDIES.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('IMPORTANT_CONSIDERATION', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('INCOMPLETE_EVIDENCE', 92)]	6	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3695234	7/2013	S55-PMC3695234	['there are several biologically PLAUSIBLE EXPLANATIONS for the inverse CORRELATION between Serum Vitamin D and the presence of ad.']	[('INCOMPLETE_EVIDENCE', 31), ('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('UBERON_0001977', 'blood serum', 90, 'serum'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC3695234	7/2013	S57-PMC3695234	['the 1,25(Oh)2D3Molecule induces Antimicrobial peptide Gene Expression in isolated Human Keratinocytes, Monocytes, Neutrophils, and Human cell lines.9tlr activation of Human Macrophages up-regulates the Expression of the Vitamin D receptor and Vitamin D-1-hydroxylase Genes, leading to the induction of the Cathelicidin.10these data SUGGEST a LINK between tlrs and Vitamin D-mediated Innate Immunity, INDICATING that a DIFFERENCE in the ability of Human populations to produce Vitamin D MAY contributes to susceptibility to Microbial infection.']	[('INCOMPLETE_EVIDENCE', 332), ('SUPERFICIAL_RELATIONSHIP', 342), ('INCOMPLETE_EVIDENCE', 400), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('INCOMPLETE_EVIDENCE', 486)]	5	[('CHEBI_84221', '1-ethyl-2-propylcyclohexane', 4, '1,25(OH)2D3molecule'), ('CHEBI_65381', 'albizoside C', 32, 'antimicrobial'), ('GO_0010467', 'gene expression', 54, 'gene expression'), ('SO_0000704', 'gene', 54, 'gene'), ('NCBITaxon_9606', 'Homo sapiens', 82, 'human'), ('CL_0000312', 'keratinocyte', 88, 'keratinocytes'), ('CL_0000576', 'monocyte', 103, 'monocytes'), ('CL_0000775', 'neutrophil', 114, 'neutrophils'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 167, 'human'), ('CL_0000235', 'macrophage', 173, 'macrophages'), ('GO_0010467', 'gene expression', 202, 'expression'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 228, 'D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('SO_0000704', 'gene', 267, 'genes'), ('PR_000006009', 'alpha-catulin', 306, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('GO_0045087', 'innate immune response', 383, 'innate immunity'), ('NCBITaxon_9606', 'Homo sapiens', 447, 'human'), ('CHEBI_27300', 'vitamin D', 476, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 523, 'microbial')]
PMC3695234	7/2013	S59-PMC3695234	['BASED ON the RELATIONSHIP between Vitamin D deficiency and ad, trials of Vitamin D supplementation in atopic populations or high-risk groups HAVE BEEN conducted.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 141)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC3695234	7/2013	S60-PMC3695234	['supplementation with oral Vitamin D in 14 atopic subjects with moderate-to-severe atopic dermatitis for 21 days resulted in a significant increase in Cathelicidin Expression in ad-lesional skin.11ANOTHER pilot STUDY of winter-time onset or exacerbation of ad also SHOWED a favorable IMPACT of Vitamin D supplementation.12HOWEVER, there are CONFLICTING data surrounding the EFFECT of Vitamin D on the development of allergic Skin disease.']	[('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 264), ('SUPERFICIAL_RELATIONSHIP', 283), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 319), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 340), ('SUPERFICIAL_RELATIONSHIP', 373)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 150, 'cathelicidin'), ('GO_0010467', 'gene expression', 163, 'expression'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('GO_0036331', 'avascular cornea development in camera-type eye', 424, 'skin')]
PMC3695234	7/2013	S61-PMC3695234	['camargo et al.13found no decreased risk of ad in the children of mothers with higher intakes of Vitamin D. a northern finland Birth cohort INDICATED the ASSOCIATION between Vitamin D supplementation in the first year of Life and an increased risk of atopy at age 31 years.14a FURTHER prospective study REPORTED that an increased concentration of 25(Oh)D3In maternal Serum predisposed infants to ad at 9 months of age.15these variable results MAY BE secondary to the differences in the absolute amount of Vitamin D exposure, the baseline Vitamin D status, and the timing of exposure.']	[('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 153), ('INCOMPLETE_EVIDENCE', 276), ('INCOMPLETE_EVIDENCE', 302), ('INCOMPLETE_EVIDENCE', 442)]	5	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('UBERON_0000104', 'life cycle', 220, 'life'), ('PR_000001883', 'lysosome-associated membrane protein', 346, '25(OH)D3in'), ('UBERON_0001977', 'blood serum', 366, 'serum'), ('CHEBI_27300', 'vitamin D', 504, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 537, 'vitamin D')]
PMC3695234	7/2013	S62-PMC3695234	['to DATE, most reports on this topic HAVE BEEN case-controlled or cross-sectional studies, and HAVE NOT ASCERTAINED any causal RELATIONSHIPS between Vitamin D deficiency and ad.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC3695234	7/2013	S64-PMC3695234	['chi et al.16ASSESSED the INFLUENCE of Prenatal Vitamin D status on Immune function at Birth.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 25)]	2	[('GO_0007565', 'female pregnancy', 38, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002405', 'immune system', 67, 'immune'), ('GO_0007567', 'parturition', 86, 'birth')]
PMC3695234	7/2013	S67-PMC3695234	['in that study, a significant INTERACTION between Il4 Gene polymorphism and Vitamin D deficiency was OBSERVED.17THESE data INDICATE that Vitamin D deficiency MAY increase the risk of Food sensitization in certain genotypes, PROVIDING EVIDENCE of Gene-Vitamin D INTERACTION in Food sensitization.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 100), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 122), ('INCOMPLETE_EVIDENCE', 157), ('PROBABLE_UNDERSTANDING', 223), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 260)]	8	[('PR_000008989', 'interleukin-1 family member 7', 49, 'IL4'), ('SO_0000704', 'gene', 53, 'gene'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_33290', 'food', 182, 'food'), ('SO_0000704', 'gene', 245, 'gene'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_33290', 'food', 275, 'food')]
PMC3695234	7/2013	S69-PMC3695234	['ACCORDING TO ANOTHER POINT OF VIEW, strict restriction of the offending Food Allergen provides an ALTERNATIVE EXPLANATION for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('PROBABLE_UNDERSTANDING', 110)]	5	[('CHEBI_33290', 'food', 72, 'food'), ('CHEBI_50904', 'allergen', 77, 'allergen'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC3695234	7/2013	S74-PMC3695234	['AS OUR STUDY is LIMITED by its retrospective cross-sectional design, we COULD NOT analyze the RELATIONSHIP between sun exposure and Vitamin D concentration.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 16), ('DIFFICULT_TASK', 72), ('ANOMALY_CURIOUS_FINDING', 78), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3695234	7/2013	S75-PMC3695234	['BASED ON the identification of Vitamin D receptors in RELEVANT Immune Cells, it HAS BEEN SUGGESTED that the Vitamin D pathway plays a ROLE in asthma and atopy.19,20using Single Nucleotide Polymorphism selection and genotyping, poon et al.20found six variants that are strongly ASSOCIATED with asthma and four with atopy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 54), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 134), ('SUPERFICIAL_RELATIONSHIP', 277)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CL_0000738', 'leukocyte', 63, 'immune cells'), ('UBERON_0002405', 'immune system', 63, 'immune'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('SO_0000694', 'SNP', 170, 'single nucleotide polymorphism')]
PMC3695234	7/2013	S76-PMC3695234	['these EFFORTS TO CLARIFY the RELATIONSHIP between Vitamin D and ad COULD lead to the IDENTIFICATION of POTENTIAL TARGETS for therapeutic intervention in ad.']	[('FUTURE_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 67), ('FUTURE_WORK', 85), ('INCOMPLETE_EVIDENCE', 103), ('FUTURE_WORK', 113)]	6	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3695234	7/2013	S77-PMC3695234	['in conclusion, the results of THIS STUDY SUGGEST that Vitamin D deficiency MIGHT be RELATED to the severity of ad that is ASSOCIATED with Food sensitization.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 84), ('SUPERFICIAL_RELATIONSHIP', 122)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_33290', 'food', 138, 'food')]
PMC3695234	7/2013	S78-PMC3695234	['THUS, these data INDICATE the POTENTIAL ROLE of Vitamin D in a select group of ad patients.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 40)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC3704911	7/2013	S24-PMC3704911	['additionally, Prenatal DEFICIENCIES in Vitamins D and E HAVE BEEN ASSOCIATED with increased incidences of Respiratory difficulties, including wheezing and asthma, in the offspring [7], and maternal Vitamin D deficiencies HAVE BEEN RELATED to observed hyper-Locomotion in the Adult Rat [8].']	[('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 221), ('SUPERFICIAL_RELATIONSHIP', 231)]	5	[('GO_0007565', 'female pregnancy', 14, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamins D'), ('PR_000006444', 'diacylglycerol kinase delta', 48, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 54, 'E'), ('UBERON_0001004', 'respiratory system', 106, 'respiratory'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0040011', 'locomotion', 257, 'locomotion'), ('UBERON_0007023', 'adult organism', 275, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 281, 'rat')]
PMC3704911	7/2013	S46-PMC3704911	['additionally, acculturation in hispanic populations HAS BEEN THOUGHT TO result in diets higher in fat and lower in fiber, with significantly lower intakes of protein, calcium, Vitamin A, Vitamin C, and Folic Acid [32].']	[('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 61)]	2	[('CHEBI_27300', 'vitamin D', 176, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin C'), ('CHEBI_30751', 'formic acid', 202, 'folic acid')]
PMC3710934	7/2013	S381-PMC3710934	['the authors SUGGEST that high dietary Heme Iron intake in combination with high intake of Vitamin C supplements MAY increase the risk of Lung cancer in Postmenopausal women.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 112)]	2	[('CHEBI_36084', 'dihydroxybenzoate', 38, 'heme iron'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin C'), ('UBERON_0002048', 'lung', 137, 'lung'), ('GO_0007595', 'lactation', 152, 'postmenopausal')]
PMC3713405	7/2013	S4-PMC3713405	['to address this we created an Animal MODEL of one such RISK FACTOR, developmental Vitamin D (Dvd) deficiency.']	[('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 55)]	2	[('NCBITaxon_33208', 'Metazoa', 30, 'animal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 93, 'DVD')]
PMC3713405	7/2013	S29-PMC3713405	['EVIDENCE CONTINUES to mount from both epidemiological and pre-clinical studies to INDICATE that developmental Vitamin D (Dvd) deficiency MAY BE also an IMPORTANT developmental RISK factor for schizophrenia.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 137), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 121, 'DVD')]
PMC3713405	7/2013	S34-PMC3713405	['we begin with a concise summary of the epidemiological CLUES that SUGGEST altered Prenatal/Perinatal Vitamin D levels increase the risk of developing schizophrenia.']	[('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 66)]	2	[('GO_0007565', 'female pregnancy', 82, 'prenatal'), ('GO_0036268', 'swimming', 91, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 91, 'perinatal'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC3713405	7/2013	S40-PMC3713405	['• schizophrenia\nNeurodevelopmental disorder ASSOCIATED with altered Dopamine function both prior to and during disease onset\n• developmental Vitamin D (Dvd) deficiency\nASSOCIATED with INCREASED susceptibility to schizophrenia\n• Dvd Rat MODEL\nDvd-deficiency in the Rat LEADS to a pattern of altered developmental and Adult Dopaminergic function\n• Vitamin D and Dopamine\nearly Vitamin D signaling is intrinsically LINKED with the developing Dopamine system\n• Animal MODELS of schizophrenia\nmultiple Animal MODELS of schizophrenia SHOW alterations in Dopamine Development prior to post-adolescent alterations in behavior\n• Dopamine and schizophrenia\nALTHOUGH FOCUS REMAINS TIED to Dopamine as a common endpoint in schizophrenia, understanding common Dopaminergic origins MAY BE\n\nthe epidemiology of vitamin d and schizophrenia\nnumerous pieces of epidemiological EVIDENCE IMPLICATE low levels of maternal Vitamin D AS a POTENTIAL risk factor for schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 184), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 268), ('SUPERFICIAL_RELATIONSHIP', 412), ('INCOMPLETE_EVIDENCE', 464), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 528), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 647), ('ANOMALY_CURIOUS_FINDING', 647), ('IMPORTANT_CONSIDERATION', 656), ('INCOMPLETE_EVIDENCE', 662), ('SUPERFICIAL_RELATIONSHIP', 670), ('INCOMPLETE_EVIDENCE', 768), ('INCOMPLETE_EVIDENCE', 859), ('SUPERFICIAL_RELATIONSHIP', 868), ('PROBABLE_UNDERSTANDING', 911), ('INCOMPLETE_EVIDENCE', 916)]	19	[('GO_0007285', 'primary spermatocyte growth', 16, 'Neurodevelopmental'), ('CHEBI_18243', 'dopamine', 68, 'dopamine'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 152, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 228, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 232, 'rat'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 242, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 264, 'rat'), ('UBERON_0007023', 'adult organism', 316, 'adult'), ('CHEBI_18243', 'dopamine', 322, 'dopaminergic'), ('CHEBI_28384', 'vitamin K', 346, 'Vitamin D'), ('CHEBI_18243', 'dopamine', 360, 'dopamine'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D'), ('CHEBI_18243', 'dopamine', 439, 'dopamine'), ('NCBITaxon_33208', 'Metazoa', 457, 'Animal'), ('NCBITaxon_33208', 'Metazoa', 497, 'animal'), ('CHEBI_18243', 'dopamine', 548, 'dopamine'), ('GO_0048597', 'post-embryonic camera-type eye morphogenesis', 548, 'dopamine development'), ('CHEBI_18243', 'dopamine', 620, 'Dopamine'), ('CHEBI_18243', 'dopamine', 678, 'dopamine'), ('CHEBI_18243', 'dopamine', 747, 'dopaminergic'), ('CHEBI_27300', 'vitamin D', 901, 'vitamin D')]
PMC3713405	7/2013	S46-PMC3713405	['GIVEN that Vitamin D deficiency is common (1) during winter and spring, (2) at high latitudes (holick et al., 1995), (3) in urban environments (mcgrath et al., 2001) and (4) in dark skinned Individuals (clemens et al., 1982;holick et al., 1995), these ecological data led TO the HYPOTHESIS that low maternal Vitamin D COULD BE a modified risk FACTOR for schizophrenia.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 272), ('INCOMPLETE_EVIDENCE', 279), ('INCOMPLETE_EVIDENCE', 318), ('SUPERFICIAL_RELATIONSHIP', 343)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 190, 'individuals'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D')]
PMC3713405	7/2013	S48-PMC3713405	['schizophrenia HAS BEEN SHOWN to be ameliorated by Vitamin D supplementation in the 1 year of Life (mcgrath et al., 2004).']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0000104', 'life cycle', 93, 'life')]
PMC3713405	7/2013	S49-PMC3713405	['most RECENTLY, and most IMPORTANTLY, a danish population-based case-control study (423 cases and 423 control) that directly assessed Vitamin D levels in Blood Spots from NEW born infants provided SOLID EVIDENCE SHOWING that low Prenatal Vitamin D levels are ASSOCIATED with an INCREASED RISK of schizophrenia (mcgrath et al., 2010).']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 24), ('FULL_UNKNOWN', 170), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 258), ('IMPORTANT_CONSIDERATION', 277)]	7	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 153, 'blood spots'), ('GO_0007565', 'female pregnancy', 228, 'prenatal'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC3713405	7/2013	S50-PMC3713405	['taken TOGETHER, these data SUPPORT the HYPOTHESIS that an absence of Vitamin D during development MAY lead to an INCREASED RISK of schizophrenia.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 98), ('IMPORTANT_CONSIDERATION', 113)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3713405	7/2013	S51-PMC3713405	['to establish the biological PLAUSIBILITY of WHETHER Dvd deficiency COULD BE RELATED to schizophrenia, our group ESTABLISHED a Dvd-deficient Rat MODEL which HAS SHOWN that low Prenatal Vitamin D adversely AFFECTS Brain Development and Adult behavior, ESPECIALLY da development and da-RELATED behaviors.']	[('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 204), ('IMPORTANT_CONSIDERATION', 250), ('SUPERFICIAL_RELATIONSHIP', 283)]	10	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 52, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 126, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 140, 'rat'), ('GO_0007565', 'female pregnancy', 175, 'prenatal'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007420', 'brain development', 212, 'brain development'), ('UBERON_0000955', 'brain', 212, 'brain'), ('UBERON_0007023', 'adult organism', 234, 'adult')]
PMC3713405	7/2013	S58-PMC3713405	['in this MODEL the exposure to Vitamin D3Depletion is only transient AS all dams are returned to a normal Vitamin D containing diet Ate Birth.']	[('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 68)]	2	[('CHEBI_61669', '2-methylbutanenitrile', 30, 'vitamin D3depletion'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 30, 'vitamin D3depletion'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0009636', 'response to toxic substance', 131, 'ate'), ('GO_0007567', 'parturition', 135, 'birth')]
PMC3713405	7/2013	S91-PMC3713405	['in the developing Brain, levels of Vitamin D Receptor (Vdr) Expression COINCIDE with increasing levels of Apoptosis and decreasing levels of mitosis (burket et al., 2003) SUGGESTING similar actions TO that SEEN in peripheral Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 171), ('QUESTION_ANSWERED_BY_THIS_WORK', 198), ('INCOMPLETE_EVIDENCE', 206)]	4	[('UBERON_0000955', 'brain', 18, 'brain'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 35, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 55, 'VDR'), ('GO_0010467', 'gene expression', 60, 'expression'), ('GO_0006915', 'apoptotic process', 106, 'apoptosis'), ('UBERON_0000479', 'tissue', 225, 'tissue')]
PMC3713405	7/2013	S133-PMC3713405	['the mechanism for HOW the developmental absence of Vitamin D MAY INFLUENCE Da Signaling in the Adult REMAINS UNKNOWN.']	[('EXPLICIT_QUESTION', 18), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 65), ('FULL_UNKNOWN', 101)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0038162', 'erythropoietin-mediated signaling pathway', 75, 'DA signaling'), ('UBERON_0007023', 'adult organism', 95, 'adult')]
PMC3713405	7/2013	S141-PMC3713405	['HOWEVER, it is the COINCIDENT Expression of the vdr within developing Da Neurons (cui et al., 2013) and Projections in the Brain that SUGGEST an important ROLE for Vitamin D in the developing da system.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 134), ('SUPERFICIAL_RELATIONSHIP', 155)]	4	[('GO_0010467', 'gene expression', 30, 'expression'), ('CL_0000589', 'cochlear inner hair cell', 70, 'DA neurons'), ('GO_0042995', 'cell projection', 104, 'projections'), ('UBERON_0000955', 'brain', 123, 'brain'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC3713405	7/2013	S144-PMC3713405	['dvd-deficient e12 Embryos show decreased Gene Expression of nurr1, P57Kip2 and th (cui et al., 2010) SUGGESTING altered Vitamin D Signaling AFFECTS early Monoamine Cell Development, PERHAPS EVEN prior to e12.']	[('INCOMPLETE_EVIDENCE', 101), ('SUPERFICIAL_RELATIONSHIP', 140), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 190)]	4	[('UBERON_0000922', 'embryo', 18, 'embryos'), ('GO_0010467', 'gene expression', 41, 'gene expression'), ('SO_0000704', 'gene', 41, 'gene'), ('PR_000004267', 'AT-rich interactive domain-containing protein 4A', 67, 'p57Kip2'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0043931', 'ossification involved in bone maturation', 120, 'vitamin D signaling'), ('CHEBI_17134', 'octopamine', 154, 'monoamine'), ('GO_0048468', 'cell development', 164, 'cell development')]
PMC3713405	7/2013	S150-PMC3713405	['CONSISTENT with the PREMISE that Vitamin D plays a ROLE in Dopaminergic Cell Development, Vdr Expression in the differentiating Field Of the Midbrain and Basal Ganglia can be observed by e15 (veenstra et al., 1998).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 51)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_18243', 'dopamine', 59, 'dopaminergic'), ('CL_0000700', 'dopaminergic neuron', 59, 'dopaminergic cell'), ('GO_0048569', 'post-embryonic animal organ development', 59, 'dopaminergic cell development'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 90, 'VDR'), ('GO_0010467', 'gene expression', 94, 'expression'), ('UBERON_0002615', 'ventral tegmental decussation', 128, 'field of ... midbrain'), ('UBERON_0002420', 'basal ganglion', 154, 'basal ganglia')]
PMC3713405	7/2013	S157-PMC3713405	['HOW the absence (or presence) of Vitamin D COULD alter nurr1 levels REMAINS UNKNOWN.']	[('EXPLICIT_QUESTION', 0), ('INCOMPLETE_EVIDENCE', 43), ('FULL_UNKNOWN', 68)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3713405	7/2013	S171-PMC3713405	['moreover, EVIDENCE continues to accumulate INDICATING Vitamin D positively Regulates Gdnf levels in the developing Mesencephalon (orme et al., 2013).']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 43)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0065007', 'biological regulation', 75, 'regulates'), ('PR_000007939', 'glial fibrillary acidic protein', 85, 'GDNF'), ('UBERON_0001891', 'midbrain', 115, 'mesencephalon')]
PMC3713405	7/2013	S189-PMC3713405	['both of these Vitamin D-induced alterations COULD POTENTIALLY lead to altered signaling in Da Neurons.']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 50)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CL_0000589', 'cochlear inner hair cell', 91, 'DA neurons')]
PMC3713405	7/2013	S210-PMC3713405	['the fact that the enlarged Lateral Ventricles in dvd-deficient Rats ONLY persist to Adulthood when the period of Vitamin D deficiency is extended to weaning (eyles et al., 2003;feron et al., 2005) SUPPORTS a titratable approach to Brain susceptibility.']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 197)]	2	[('UBERON_0002285', 'telencephalic ventricle', 27, 'lateral ventricles'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 63, 'rats'), ('UBERON_0000113', 'post-juvenile adult stage', 84, 'adulthood'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0000955', 'brain', 231, 'brain')]
PMC3713405	7/2013	S211-PMC3713405	['in addition, it also SUGGESTS that FURTHER STUDY on the temporal window of Vitamin D deficiency would be EXTREMELY INFORMATIVE.']	[('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 35), ('IMPORTANT_CONSIDERATION', 105), ('INCOMPLETE_EVIDENCE', 115)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC3728489	7/2013	S23-PMC3728489	['we will highlight examples of three Micronutrients—Folate, Iodine, and Vitamin D—and discuss their PROVEN and POTENTIAL preventive EFFECTS on Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 131)]	3	[('CHEBI_33839', 'macromolecule', 36, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 51, 'folate'), ('CHEBI_24859', 'iodine atom', 59, 'iodine'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007399', 'nervous system development', 142, 'neurodevelopmental')]
PMC3728489	7/2013	S169-PMC3728489	['it HAS also BEEN SUGGESTED that maternal Intake of Vitamin E and polyunsaturated Fatty Acids during Pregnancy MAY INFLUENCE Development Of the Immune System and be IMPLICATED in childhood asthma and allergy.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 164)]	5	[('GO_0007631', 'feeding behavior', 41, 'intake'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin E'), ('CHEBI_35366', 'fatty acid', 81, 'fatty acids'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('GO_0002020', 'protease binding', 124, 'development of ... immune system'), ('UBERON_0002405', 'immune system', 143, 'immune system')]
PMC3728489	7/2013	S282-PMC3728489	['for illustration, we have selected three Micronutrients—Folate, Iodine, and Vitamin D—and discuss their PROVEN and POTENTIAL PREVENTIVE EFFECTS on Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 125), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_33839', 'macromolecule', 41, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 56, 'folate'), ('CHEBI_24859', 'iodine atom', 64, 'iodine'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007399', 'nervous system development', 147, 'neurodevelopmental')]
PMC3728489	7/2013	S311-PMC3728489	['Vitamin D\nwe have DESCRIBED earlier HOW Vitamin D is PIVOTAL in early Immune Development and it is also known to be CRUCIAL for early Skeletal Development.']	[('INCOMPLETE_EVIDENCE', 18), ('EXPLICIT_QUESTION', 36), ('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 116)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0001822', 'kidney development', 70, 'immune development'), ('UBERON_0002405', 'immune system', 70, 'immune'), ('GO_0001501', 'skeletal system development', 134, 'skeletal development'), ('UBERON_0004288', 'skeleton', 134, 'skeletal')]
PMC3728489	7/2013	S312-PMC3728489	['it HAS BEEN PROPOSED, THOUGH NOT PROVEN, that low levels of Vitamin D during Pregnancy and infancy COULD increase the RISK of Neurodevelopmental disorders, and that supplementation COULD play a ROLE in prevention.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 118), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 194)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007399', 'nervous system development', 126, 'neurodevelopmental')]
PMC3728489	7/2013	S314-PMC3728489	['NOTABLY, in a RECENT population-based case control STUDY of 424 Individuals with schizophrenia and 424 matched controls, dried Blood spots taken at Birth were tested for Vitamin D levels (mcgrath et al.,2010).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 51)]	3	[('NCBITaxon_1', 'root', 64, 'individuals'), ('UBERON_0000178', 'blood', 127, 'blood'), ('GO_0007567', 'parturition', 148, 'birth'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC3728489	7/2013	S315-PMC3728489	['when Vitamin D levels were divided into quintiles, the investigators OBSERVED an increased risk of schizophrenia in Individuals with Vitamin D levels in the three lowest quintiles compared to the fourth quintile.']	[('INCOMPLETE_EVIDENCE', 69)]	1	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('NCBITaxon_1', 'root', 116, 'individuals'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC3728489	7/2013	S316-PMC3728489	['SURPRISINGLY, they also OBSERVED an increased risk for schizophrenia in Individuals with Vitamin D levels in the highest quintile.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24)]	2	[('NCBITaxon_1', 'root', 72, 'individuals'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3728489	7/2013	S319-PMC3728489	['fish oil (that commonly contains Vitamin D) and OTHER omega 3 Fatty Acid supplements taken in infancy HAVE BEEN ASSOCIATED with improved Cognitive development, THOUGH this evidence is also far from definitive (auestad et al.,2003; karr et al.,2011; meldrum et al.,2012; luchtman and song,2013).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 112), ('ANOMALY_CURIOUS_FINDING', 160)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_35366', 'fatty acid', 62, 'fatty acid'), ('GO_0050890', 'cognition', 137, 'cognitive')]
PMC3728489	7/2013	S339-PMC3728489	['in particular, maternal Micronutrient deficiencies in zinc, fat-soluble vitamins (e.g., Vitamins A, D, e) and nutritional factors RELATED to Single Carbon Metabolism (e.g., Choline, Vitamins B2, B6, B12 and Folate) HAVE BEEN SHOWN to play a ROLE in cell-mediated and Humoral Immune Responses.']	[('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 241)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 24, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 88, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 97, 'A'), ('PR_000006444', 'diacylglycerol kinase delta', 100, 'D'), ('GO_0046505', 'sulfolipid metabolic process', 141, 'single carbon metabolism'), ('CHEBI_15354', 'choline', 173, 'choline'), ('CHEBI_33277', 'gamma-tocotrienol', 182, 'vitamins'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 182, 'vitamins B2'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 195, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 199, 'B12'), ('CHEBI_30863', '5-azaorotic acid', 207, 'folate'), ('GO_0002544', 'chronic inflammatory response', 267, 'humoral immune responses'), ('UBERON_0002405', 'immune system', 275, 'immune')]
PMC3728489	7/2013	S340-PMC3728489	['they also HAVE BEEN ASSOCIATED with increased offspring risk for Respiratory infections (Vitamin D), Intestinal inflammation and diarrhea (Folate and Vitamin A), allergy and asthma (Vitamin E and Folate) and Neurodevelopmental disorders (Folate).']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('UBERON_0001004', 'respiratory system', 65, 'respiratory'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000160', 'intestine', 101, 'intestinal'), ('CHEBI_30863', '5-azaorotic acid', 139, 'folate'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 196, 'folate'), ('GO_0007399', 'nervous system development', 208, 'neurodevelopmental'), ('CHEBI_30863', '5-azaorotic acid', 238, 'folate')]
PMC3728489	7/2013	S348-PMC3728489	['we REPORTED three examples of Micronutrients—Folate, Iodine, and Vitamin D—and discussed their PROVEN and POTENTIAL preventive EFFECTS on Neurodevelopmental disorders.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 95), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('CHEBI_33839', 'macromolecule', 30, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 45, 'folate'), ('CHEBI_24859', 'iodine atom', 53, 'iodine'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007399', 'nervous system development', 138, 'neurodevelopmental')]
PMC3742894	7/2013	S27-PMC3742894	['to improve the nutritional status (the MAJOR cause of anemia in Pregnancy) of ethiopian women, there HAVE BEEN several interventions by the ministry of health through its essential nutrition action plan (ena), consisting of supplementation of three major Nutrients (Vitamin A, Iron, and Iodine) and other promotive activities to improve maternal and child nutrition (18).']	[('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 101)]	2	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('CHEBI_33284', 'nutrient', 255, 'nutrients'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin A'), ('CHEBI_24870', 'ion', 277, 'iron'), ('CHEBI_24859', 'iodine atom', 287, 'iodine')]
PMC3717763	8/2013	S18-PMC3717763	["in RECENT YEARS, there HAS BEEN particular CONCERN about Vitamin D levels among children in the uk, and the rise in Vitamin D deficiency disease, presenting as rickets, symptomatic hypocalcaemia and motor delay.5–12vitamin d is hard to source through diet alone; 90% comes from exposure to sunlight.13if the mother's Vitamin D status is low during Pregnancy, the infant will also have low levels.14estimates CONSISTENTLY SHOW that the MAJORITY of uk children aged between 1.5 and 3\u2005years do not get their daily reference Nutrient intake of Vitamin D.15–18one RECENT STUDY REPORTS that supplying hs Vitamins to all Pregnant women and young children resulted in a substantial reduction in symptomatic Vitamin D deficiency in children in one primary care trust (pct), where 75% of the population were from ethnic minority groups PARTICULARLY AT RISK of Vitamin D deficiency.19\nTHIS PAPER reports on research with parents and professionals with the AIM of understanding WHY the provision of free hs Vitamins has not resulted in higher levels of use among low income families in england."]	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 43), ('PROBABLE_UNDERSTANDING', 408), ('INCOMPLETE_EVIDENCE', 421), ('PROBABLE_UNDERSTANDING', 435), ('INCOMPLETE_EVIDENCE', 559), ('INCOMPLETE_EVIDENCE', 572), ('IMPORTANT_CONSIDERATION', 826), ('IMPORTANT_CONSIDERATION', 839), ('QUESTION_ANSWERED_BY_THIS_WORK', 874), ('QUESTION_ANSWERED_BY_THIS_WORK', 945), ('EXPLICIT_QUESTION', 966)]	13	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin D'), ('GO_0007565', 'female pregnancy', 348, 'pregnancy'), ('CHEBI_33284', 'nutrient', 521, 'nutrient'), ('CHEBI_27300', 'vitamin D', 540, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 598, 'vitamins'), ('GO_0007565', 'female pregnancy', 614, 'pregnant'), ('CHEBI_27300', 'vitamin D', 699, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 850, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 995, 'vitamins')]
PMC3717763	8/2013	S109-PMC3717763	['reports SUGGEST that less than half the midwives and health visitors are aware of the current uk Vitamin D GUIDELINES for ages under 5 years, and RECOMMEND supplementation to parents.29–31additionally, THIS STUDY INDICATES that workload pressures and infrequent contact with mothers CAN also discourage them from promoting hs Vitamins.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 107), ('FUTURE_WORK', 146), ('QUESTION_ANSWERED_BY_THIS_WORK', 202), ('INCOMPLETE_EVIDENCE', 213), ('INCOMPLETE_EVIDENCE', 283)]	6	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 105, 'D'), ('CHEBI_33277', 'gamma-tocotrienol', 326, 'vitamins')]
PMC3739737	8/2013	S14-PMC3739737	['introduction\nVitamin D deficiency is PREVALENT in the Adult population[1]and there is a GROWING body of EVIDENCE SHOWING that Vitamin D has an IMPACT on Brain function[2],[3].']	[('IMPORTANT_CONSIDERATION', 37), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 143)]	4	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adult'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('UBERON_0000955', 'brain', 153, 'brain')]
PMC3739737	8/2013	S15-PMC3739737	['several systematic reviews and meta-analyses HAVE BEEN undertaken, based on cross-sectional and prospective studies, that lend weight to hypotheses LINKING low Vitamin D with (a) adverse Cognitive outcomes and dementia[4],[5]and (b) depression[6].']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 148)]	2	[('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0050890', 'cognition', 187, 'cognitive')]
PMC3739737	8/2013	S17-PMC3739737	['the HYPOTHESIS that low Vitamin D levels AFFECT the developing Brain is SUPPORTED by data from Prenatal Vitamin D deficiency in rodents, in which the foetus develops in utero in a Vitamin D-deficient but normocalcaemic dam[7],[8].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 72)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0000955', 'brain', 63, 'brain'), ('GO_0007565', 'female pregnancy', 95, 'prenatal'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
PMC3739737	8/2013	S21-PMC3739737	['ONE STUDY based on male sprague-dawley Rats, exposed the Animals to a Vitamin D-deficient diet from weaning[17].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 39, 'rats'), ('NCBITaxon_33208', 'Metazoa', 57, 'animals'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC3739737	8/2013	S120-PMC3739737	['IN CONTRAST TO behavioural features IDENTIFIED in Rats exposed to developmental Vitamin D deficiency, avd deficiency was not associated with altered responses to Mk-801[13]or Amphetamine[14].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36)]	2	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 50, 'rats'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('PR_000000124', 'ribosomal protein S6 kinase beta-2', 162, 'MK-801'), ('CHEBI_2687', 'amsacrine', 175, 'amphetamine')]
PMC3739737	8/2013	S139-PMC3739737	['tenenhouse[22]assessed Neurotransmitter content in chronic Vitamin D-deficient Rats and FOUND increased Gaba in most regions investigated.']	[('INCOMPLETE_EVIDENCE', 88)]	1	[('CHEBI_25512', 'neurotransmitter', 23, 'neurotransmitter'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 79, 'rats'), ('CHEBI_16865', 'gamma-aminobutyric acid', 104, 'GABA')]
PMC3739737	8/2013	S145-PMC3739737	['FUTURE RESEARCH SHOULD investigate the POTENTIAL ROLE of Vitamin D-deficiency on Gaba, and POSSIBLE IMPLICATIONS on Cognition.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_16865', 'gamma-aminobutyric acid', 81, 'GABA'), ('GO_0050890', 'cognition', 116, 'cognition')]
PMC3739737	8/2013	S155-PMC3739737	['exploring a longer period of Vitamin D deficiency, or subsequent insults MAY have a greater IMPACT on Brain function and behaviour.']	[('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 92)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0000955', 'brain', 102, 'brain')]
PMC3739737	8/2013	S157-PMC3739737	['DESPITE rodents having a nocturnal lifestyle, shaved Rat skin is able to Synthesise Vitamin D after uvb exposure[32], and Hair-coated Animals, such as dairy Cows, Synthesise Vitamin D3[33], SUGGESTING that a full Coat Of Hair does not prevent cutaneous Vitamin D production.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 190)]	2	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 53, 'rat'), ('GO_0007601', 'visual perception', 73, 'synthesise'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0001037', 'strand of hair', 122, 'hair'), ('NCBITaxon_33208', 'Metazoa', 134, 'animals'), ('NCBITaxon_33208', 'Metazoa', 157, 'cows'), ('GO_0007601', 'visual perception', 163, 'synthesise'), ('CHEBI_33279', 'vitamin D5', 174, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 174, 'vitamin D3'), ('UBERON_0010166', 'coat of hair', 213, 'coat of hair'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC3739737	8/2013	S160-PMC3739737	['the lack of a marked behavioural phenotype in the avd MODEL in the male sprague-dawley Rat MAY have IMPORTANT IMPLICATIONS for FUTURE Animal models exploring the biological mechanisms that MAY underpin the epidemiological ASSOCIATIONS between low Vitamin D and adverse Brain outcomes.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 110), ('FUTURE_WORK', 127), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 222)]	7	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 87, 'rat'), ('NCBITaxon_33208', 'Metazoa', 134, 'animal'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('UBERON_0000955', 'brain', 269, 'brain')]
PMC3739737	8/2013	S163-PMC3739737	['RECENTLY, EVIDENCE has EMERGED from Animal MODELS to SUGGEST that Vitamin D insufficiency or deficiency MAY exacerbate the progression of an UNDERLYING Brain disorder.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 141)]	8	[('NCBITaxon_33208', 'Metazoa', 36, 'animal'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0000955', 'brain', 152, 'brain')]
PMC3739737	8/2013	S164-PMC3739737	['for example, in a study of ischemia it was REPORTED that Animals allocated to a Vitamin D deficient diet (prior to the stroke lesion) subsequently had significantly greater ischemic Brain damage and worse functional impairments, compared to rodents on a Vitamin D replete diet[35].']	[('INCOMPLETE_EVIDENCE', 43)]	1	[('NCBITaxon_33208', 'Metazoa', 57, 'animals'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0000955', 'brain', 182, 'brain'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC3739737	8/2013	S165-PMC3739737	['this FINDING is IN KEEPING WITH the WELL-KNOWN neuroprotective properties of Vitamin D[3].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 41)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC3739737	8/2013	S168-PMC3739737	['THUS, we SPECULATE that the epidemiological CLUES LINKING low Vitamin D and adverse Neurocognitive outcomes MAY BE MEDIATED by ‘two hits’ – in other words low vitamin d MAY exacerbate a separate Neurobiological stressor.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 169)]	7	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 84, 'neurocognitive'), ('UBERON_0002906', 'anterior occipital sulcus', 195, 'neurobiological')]
PMC3739737	8/2013	S169-PMC3739737	['evidence from a RECENTLY published randomized controlled trial of Vitamin D supplementation for the treatment of parkinson’s disease (pd) SUPPORT THIS HYPOTHESIS[40].']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 138), ('QUESTION_ANSWERED_BY_THIS_WORK', 146), ('INCOMPLETE_EVIDENCE', 151)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3739737	8/2013	S172-PMC3739737	['the results STRONGLY SUGGEST that low Vitamin D status exacerbates disease progression[41].']	[('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 21)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC3739737	8/2013	S176-PMC3739737	['FURTHER REFINEMENTS to the MODEL, such as combined with second hit exposures, MAY BE NECESSARY to MORE adequately MODEL the EFFECTS of Vitamin D deficiency in Human populations.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 85), ('ANOMALY_CURIOUS_FINDING', 98), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 124)]	8	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 159, 'human')]
PMC3798907	8/2013	S0-PMC3798907	['COMPLEX EFFECTS of Vitamin E and vitamin c supplementation on in vitro neonatal Mononuclear Cell responses to allergens\n\nabstract\nlow maternal dietary Vitamin E (but not Vitamin C) Intake during Pregnancy HAS BEEN ASSOCIATED with increased in vitro Cord Blood Mononuclear Cell (Cbmc) proliferative responses, childhood wheezing and asthma.']	[('DIFFICULT_TASK', 0), ('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 214)]	4	[('CHEBI_28384', 'vitamin K', 19, 'Vitamin E'), ('CL_0000842', 'mononuclear cell', 80, 'Mononuclear Cell'), ('GO_0030061', 'mitochondrial crista', 80, 'Mononuclear'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin C'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy'), ('CL_0002153', 'corneocyte', 249, 'cord'), ('UBERON_0002240', 'spinal cord', 249, 'cord'), ('CL_0000081', 'blood cell', 254, 'blood'), ('UBERON_0000178', 'blood', 254, 'blood'), ('CL_0000842', 'mononuclear cell', 260, 'mononuclear cell'), ('GO_0031097', 'medial cortex', 260, 'mononuclear'), ('CL_0002062', 'type I pneumocyte', 278, 'CBMC')]
PMC3798907	8/2013	S3-PMC3798907	['IN GENERAL, Vitamin E supplementation was ASSOCIATED with a TREND for reduced proliferative responses after stimulation with Antigens and house dust mite, and with increased Proliferation after stimulation with timothy grass allergen.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 60)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin E'), ('CHEBI_59132', 'antigen', 125, 'antigens'), ('GO_0008283', 'cell proliferation', 174, 'proliferation')]
PMC3798907	8/2013	S7-PMC3798907	['the OBSERVED ASSOCIATIONS between Vitamin E and childhood Respiratory disease are COMPLEX, and the nature and form of nutritional intervention NEED TO BE carefully CONSIDERED before inclusion in trials.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('DIFFICULT_TASK', 82), ('FUTURE_WORK', 143), ('FUTURE_WORK', 164)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin E'), ('UBERON_0001004', 'respiratory system', 58, 'respiratory')]
PMC3798907	8/2013	S14-PMC3798907	['three Birth cohort studies HAVE REPORTED reduced maternal dietary Vitamin E intake during Pregnancy to be ASSOCIATED with an increased LIKELIHOOD of childhood wheezing [9,10] and asthma [11].']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 106), ('PROBABLE_UNDERSTANDING', 135)]	3	[('GO_0007567', 'parturition', 6, 'birth'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin E'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy')]
PMC3798907	8/2013	S15-PMC3798907	['moreover, two of these cohorts have DEMONSTRATED that low maternal Vitamin E intake during Pregnancy is ASSOCIATED with increased in vitro proliferative responses by Cord Blood Mononuclear Cells (cbmc) and that this ASSOCIATION is independent of the POTENTIALLY CONFOUNDING EFFECTS of Birth order, sex, maternal atopy and maternal smoking [12,13].']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 216), ('INCOMPLETE_EVIDENCE', 250), ('PROBLEM_COMPLICATION', 262), ('SUPERFICIAL_RELATIONSHIP', 274)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin E'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CL_0000752', 'cone retinal bipolar cell', 166, 'cord blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 166, 'cord'), ('UBERON_0000178', 'blood', 171, 'blood'), ('GO_0031097', 'medial cortex', 177, 'mononuclear'), ('GO_0007567', 'parturition', 285, 'birth')]
PMC3798907	8/2013	S16-PMC3798907	['BASED ON these FINDINGS, there HAVE BEEN CALLS FOR trials of Vitamin E based intervention during Pregnancy [14].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 41)]	8	[('CHEBI_27300', 'vitamin D', 61, 'vitamin E'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy')]
PMC3798907	8/2013	S17-PMC3798907	['ALTHOUGH keen to conduct such an intervention trial we considered it IMPORTANT to conduct PRELIMINARY work to justify/REFUTE the use of Vitamin E supplements for several reasons.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	4	[('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]
PMC3798907	8/2013	S21-PMC3798907	['these considerations RAISE the POSSIBILITY that the OBSERVED epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses MAY NOT be a direct ASSOCIATION BUT MERELY a consequence of CONFOUNDING by other Nutrients ASSOCIATED with Vitamin E.\nTO INVESTIGATE these ISSUES further, and to inform any intervention trial, we CONDUCTED an ex vivo study to test WHETHER the OBSERVED epidemiological ASSOCIATION between reduced maternal Vitamin E intake during Pregnancy and increased cbmc responses COULD BE EXPLAINED by a direct causal EFFECT.']	[('EXPLICIT_QUESTION', 21), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 159), ('ANOMALY_CURIOUS_FINDING', 163), ('SUPERFICIAL_RELATIONSHIP', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('ANOMALY_CURIOUS_FINDING', 195), ('ANOMALY_CURIOUS_FINDING', 195), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 250), ('QUESTION_ANSWERED_BY_THIS_WORK', 277), ('PROBLEM_COMPLICATION', 298), ('QUESTION_ANSWERED_BY_THIS_WORK', 355), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 390), ('INCOMPLETE_EVIDENCE', 402), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 527), ('PROBABLE_UNDERSTANDING', 536), ('SUPERFICIAL_RELATIONSHIP', 565)]	21	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_33284', 'nutrient', 240, 'nutrients'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin E'), ('GO_0007565', 'female pregnancy', 488, 'pregnancy')]
PMC3798907	8/2013	S25-PMC3798907	['given the REPORTED age RELATED DIFFERENTIAL responsiveness of Vitamin E on Human Th-Cell Responses [4,8], a secondary AIM of the study was TO INVESTIGATE the in vitro EFFECTS of Vitamins E and C on Adult Peripheral Blood Mononuclear Cell (Pbmc) responses.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 118), ('QUESTION_ANSWERED_BY_THIS_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 167)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin E'), ('NCBITaxon_9606', 'Homo sapiens', 75, 'human'), ('CL_0000545', 'T-helper 1 cell', 81, 'Th-cell'), ('GO_0001783', 'B cell apoptotic process', 81, 'Th-cell responses'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 193, 'C'), ('PR_000004900', 'complement C3', 193, 'C'), ('UBERON_0007023', 'adult organism', 198, 'adult'), ('CL_0000111', 'peripheral neuron', 204, 'peripheral blood mononuclear cell'), ('UBERON_0012101', 'perinatal stage', 204, 'peripheral blood'), ('GO_0031097', 'medial cortex', 221, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 239, 'PBMC')]
PMC3798907	8/2013	S34-PMC3798907	['cell Cultures\nthe cell culture methodology was identical to that used in our PREVIOUS STUDY that DEMONSTRATED the ASSOCIATION between maternal Vitamin E intake and cbmc responses [12].']	[('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 114)]	3	[('CL_0000010', 'cultured cell', 5, 'Cultures'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin E')]
PMC3798907	8/2013	S38-PMC3798907	['antioxidant supplementation was at final concentrations of 6.5 μmol/l for Α-Tocopherol and 44.11 μmol/l for Ascorbic Acid, corresponding to the Cord Blood 95th centile concentrations measured in the original general population study that REPORTED an ASSOCIATION between maternal Vitamin E intake and cbmc responses [18].']	[('INCOMPLETE_EVIDENCE', 238), ('SUPERFICIAL_RELATIONSHIP', 250)]	2	[('CHEBI_27725', 'butin', 74, 'α-tocopherol'), ('CHEBI_22652', 'ascorbic acid', 108, 'ascorbic acid'), ('UBERON_0009472', 'axilla', 144, 'cord blood'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin E')]
PMC3798907	8/2013	S59-PMC3798907	['Vitamin E supplementation of cbmc\nthe addition of Vitamin E to 70 cbmc cultures REVEALED COMPLEX EFFECTS.']	[('INCOMPLETE_EVIDENCE', 80), ('DIFFICULT_TASK', 89), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin E')]
PMC3798907	8/2013	S65-PMC3798907	['significant p values for differences in responses between paired samples in cultures with or without Vitamin E supplementation are shown on the RELEVANT panels.nutrients-05-03337-t001_table 1\n\ncaption (table-wrap): table 1\n\nsummary table representing the mean responses of cbmc and Peripheral Blood Mononuclear Cell (Pbmc) samples to control stimuli and Allergens, after supplementation with Vitamin E or Vitamin C. the mean change in response is shown for 70 cbmc samples and 18 pbmc samples, after supplementation with Vitamin E, and for 51 cbmc and 18 pbmc samples, after supplementation with Vitamin C. significant p values for differences in responses between paired samples in cultures with or without Vitamin E/Vitamin C supplementation are shown on the RELEVANT panels.Vitamin eprolififn-γil-4il-10Tgf-βvitamin cprolififn-γil-4il-10tgf-β cordcord tg↑ p< 0.05↓ p< 0.05↓↓↑tg↑↑↑ p< 0.05↓↓hdm↓↓↓↓↑hdm↓↑↑↓ p< 0.05↓con a↓↑↓↓↑con a↓ p< 0.05↑↑↓↓ppd↓ p< 0.001↓↑↓↑ppd↓↑ p< 0.05↑ p< 0.05↓ p< 0.05↓klh↓ p< 0.001↓↓↓↑klh↓↑↑ p< 0.05↓↓ adultadult tg↓↑↑↑↑tg↑ p< 0.05↑↑↓↑hdm↓↑↑↑↑ p< 0.05hdm↓↑↑↓↑con a↓↓↑↓↑ p< 0.05con a↑↓ p< 0.05↑↓ p< 0.05↑ppd↑↓↑↓↑ppd↓↑↑↓↑klh↓↓↑↑↑klh↓↑↑ p< 0.05↓↑\noverall, there was a TREND for Antigen or allergen cbmc cultures supplemented with Vitamin E to exhibit decreased secretion of the cytokines Ifn-Γ, il-10 and Il-4 (figure 1andtable 1), ALTHOUGH Production Of Tgf-Β did NOT fit this pattern and was GENERALLY increased.']	[('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 1191), ('ANOMALY_CURIOUS_FINDING', 1355), ('ANOMALY_CURIOUS_FINDING', 1388), ('PROBABLE_UNDERSTANDING', 1417)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin E'), ('CL_0000111', 'peripheral neuron', 282, 'peripheral blood mononuclear cell'), ('UBERON_0012101', 'perinatal stage', 282, 'peripheral blood'), ('GO_0031097', 'medial cortex', 299, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 317, 'PBMC'), ('CHEBI_33663', 'cyclic hydrocarbon', 354, 'allergens'), ('CHEBI_27300', 'vitamin D', 392, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 405, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 521, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 596, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 708, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 718, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 777, 'Vitamin'), ('PR_000000037', 'BMP receptor type-2', 803, '-10TGF'), ('CHEBI_59132', 'antigen', 1201, 'antigen'), ('CHEBI_27300', 'vitamin D', 1253, 'vitamin E'), ('PR_000008920', 'interferon alpha-7', 1311, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 1328, 'IL-4'), ('GO_0036309', 'protein localization to M-band', 1364, 'production of TGF-β'), ('PR_000000046', 'TGF-beta', 1378, 'TGF-β')]
PMC3798907	8/2013	S70-PMC3798907	['HOWEVER, just as for cbmc, there was a TREND for GENERALLY enhanced secretion of the Regulatory cytokine Tgf-Β when pbmc were supplemented with Vitamin E, and these increases were significant in the cultures responding to con a (13 of 17 cultures exhibiting an increase) or hdm, (13 of 17 cultures exhibiting an increase) (figure 2andtable 1).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('PROBABLE_UNDERSTANDING', 49)]	3	[('GO_0065007', 'biological regulation', 85, 'regulatory'), ('PR_000000046', 'TGF-beta', 105, 'TGF-β'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin E')]
PMC3798907	8/2013	S73-PMC3798907	['UNLIKE Vitamin E supplementation, addition of Vitamin C was ASSOCIATED with a general TREND for increases in the Effector cytokines Ifn-Γ and Il-4, which was significant for both cytokines after ppd stimulation (Ifn-Γ: 26 of 43 cultures DEMONSTRATING an increase in Ifn-Γ, Il-4: 20 of 42 cultures), and for Il-4 in cultures responding to klh (21 of 41 cultures) or tg (20 of 46 cultures).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 237)]	4	[('CHEBI_27300', 'vitamin D', 7, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin C'), ('CHEBI_35224', 'effector', 113, 'effector'), ('PR_000008920', 'interferon alpha-7', 132, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 142, 'IL-4'), ('PR_000008920', 'interferon alpha-7', 212, 'IFN-γ'), ('PR_000008920', 'interferon alpha-7', 266, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 273, 'IL-4'), ('PR_000001470', 'interleukin-28B', 307, 'IL-4')]
PMC3798907	8/2013	S75-PMC3798907	['the TREND for enhanced Tgf-Β Responses after Vitamin E supplementation was NOT REPLICATED for Vitamin C, which GENERALLY reduced Production Of this Regulatory Cytokine, (figure 3andtable 1).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 111)]	3	[('GO_0033077', 'T cell differentiation in thymus', 23, 'TGF-β responses'), ('PR_000000046', 'TGF-beta', 23, 'TGF-β'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin C'), ('GO_0008283', 'cell proliferation', 129, 'production of ...'), ('GO_0043654', 'recognition of apoptotic cell', 148, 'regulatory cytokine')]
PMC3798907	8/2013	S85-PMC3798907	['HOWEVER, as was the case for cbmc, in general, Vitamin C supplementation was ASSOCIATED with a TREND for an increase in cytokines characteristic of Th Effector Cells; Ifn-Γ and Il-4, which was significant for the Il-4 response to klh, (10 of 16 cultures) ALTHOUGH this trend was not universal and there was decreased Ifn-Γ after stimulation with con a (figure 4andtable 1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 95), ('ANOMALY_CURIOUS_FINDING', 255)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin C'), ('CL_0000635', "Deiter's cell", 148, 'Th effector cells'), ('CHEBI_35224', 'effector', 151, 'effector'), ('PR_000008920', 'interferon alpha-7', 167, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 177, 'IL-4'), ('PR_000001470', 'interleukin-28B', 213, 'IL-4'), ('PR_000008920', 'interferon alpha-7', 317, 'IFN-γ')]
PMC3798907	8/2013	S86-PMC3798907	['Production Of the Regulatory Cytokine Il-10 TENDED to be lower after Vitamin C supplementation of pbmc, significantly so for con a, WHEREAS, UNLIKE cbmc, there was a TREND for Tgf-Β secretion to be increased.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 166)]	4	[('GO_0008283', 'cell proliferation', 0, 'Production of ...'), ('GO_0090106', 'pancreatic E cell fate commitment', 18, 'regulatory cytokine IL-'), ('PR_000001470', 'interleukin-28B', 38, 'IL-10'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin C'), ('PR_000000046', 'TGF-beta', 176, 'TGF-β')]
PMC3798907	8/2013	S102-PMC3798907	['before embarking on a Vitamin E intervention study during Pregnancy we wanted TO TEST WHETHER in vitro Vitamin E supplementation COULD Modulate Neonatal Immune Responses, REASONING that the demonstration of a direct EFFECT would justify Vitamin E supplementation, WHEREAS FAILURE to demonstrate a direct EFFECT would justify ALTERNATIVE dietary STRATEGIES to increase Vitamin E intake.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 129), ('PROBABLE_UNDERSTANDING', 171), ('PROBABLE_UNDERSTANDING', 171), ('SUPERFICIAL_RELATIONSHIP', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('PROBLEM_COMPLICATION', 272), ('SUPERFICIAL_RELATIONSHIP', 304), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 325), ('FUTURE_WORK', 345)]	11	[('CHEBI_27300', 'vitamin D', 22, 'vitamin E'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E'), ('GO_0065007', 'biological regulation', 135, 'modulate'), ('GO_0007567', 'parturition', 144, 'neonatal'), ('GO_0006955', 'immune response', 153, 'immune responses'), ('UBERON_0002405', 'immune system', 153, 'immune'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin E')]
PMC3798907	8/2013	S104-PMC3798907	['PREVIOUS work HAS REPORTED low maternal Vitamin E intake to be ASSOCIATED with increased Cbmc Proliferation to hdm and tg [13,16], encouraging the belief that the Nutrient has a direct EFFECT in Modulating neonatal T-Cell Responses.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin E'), ('CL_0002062', 'type I pneumocyte', 89, 'CBMC'), ('GO_0070343', 'white fat cell proliferation', 89, 'CBMC proliferation'), ('CHEBI_33284', 'nutrient', 163, 'nutrient'), ('GO_0065007', 'biological regulation', 195, 'modulating'), ('CL_0000084', 'T cell', 215, 'T-cell'), ('GO_0001914', 'regulation of T cell mediated cytotoxicity', 215, 'T-cell responses')]
PMC3798907	8/2013	S105-PMC3798907	['this EXPLANATION PREDICTS that that Vitamin E supplementation of cbmc cultures would reduce proliferative responses.']	[('PROBABLE_UNDERSTANDING', 5), ('INCOMPLETE_EVIDENCE', 17)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin E')]
PMC3798907	8/2013	S107-PMC3798907	['this is an IMPORTANT differential result because, together with the between-subject variation and the COMPLEX EFFECTS on Cytokine Production, it INDICATES that the observed in vivo epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses and childhood asthma/wheeze cannot be EXPLAINED by a direct and CONSISTENT EFFECT on overall th-cell responsiveness, as originally HYPOTHESISED [22].']	[('IMPORTANT_CONSIDERATION', 11), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 197), ('PROBABLE_UNDERSTANDING', 317), ('INCOMPLETE_EVIDENCE', 343), ('SUPERFICIAL_RELATIONSHIP', 354), ('INCOMPLETE_EVIDENCE', 410)]	9	[('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 121, 'cytokine production'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin E'), ('GO_0007565', 'female pregnancy', 250, 'pregnancy')]
PMC3798907	8/2013	S108-PMC3798907	['it is LIKELY that the OBSERVED in vivo epidemiological ASSOCIATIONS with Vitamin E intake REFLECT the EFFECTS of overall Nutrient/dietary patterns ASSOCIATED with higher Vitamin E intake.']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 90), ('SUPERFICIAL_RELATIONSHIP', 102), ('SUPERFICIAL_RELATIONSHIP', 147)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin E'), ('CHEBI_33284', 'nutrient', 121, 'nutrient'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin E')]
PMC3798907	8/2013	S109-PMC3798907	['a further POSSIBILITY raised by THE CURRENT STUDY is that isolated maternal Vitamin E supplementation during Pregnancy MAY have MIXED or EVEN adverse CONSEQUENCES for atopic sensitisation to different Allergens.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('ANOMALY_CURIOUS_FINDING', 137), ('PROBLEM_COMPLICATION', 150)]	6	[('CHEBI_27300', 'vitamin D', 76, 'vitamin E'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('CHEBI_33663', 'cyclic hydrocarbon', 201, 'allergens')]
PMC3798907	8/2013	S110-PMC3798907	['this CONCERN is SUPPORTED by the RECENT report that high-dose Antenatal Vitamin C and E supplementation is ASSOCIATED with increased infant healthcare utilisation and cost of care [23].']	[('IMPORTANT_CONSIDERATION', 5), ('PROBLEM_COMPLICATION', 5), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 107)]	5	[('GO_0007567', 'parturition', 62, 'antenatal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 86, 'E')]
PMC3798907	8/2013	S111-PMC3798907	['the DIFFERENTIAL EFFECTS of supplementation on hdm and tg responses EXCLUDES the POSSIBILITY that any suppressive EFFECTS of Vitamin E supplementation REPRESENT toxicity, which was also avoided by adding physiological concentrations representative of those measured in Cord Blood at Birth in the epidemiological study DEMONSTRATING an ASSOCIATION between Vitamin E and cbmc responses [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 68), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 151), ('INCOMPLETE_EVIDENCE', 318), ('SUPERFICIAL_RELATIONSHIP', 335)]	9	[('CHEBI_27300', 'vitamin D', 125, 'vitamin E'), ('UBERON_0002240', 'spinal cord', 269, 'cord'), ('UBERON_0000178', 'blood', 274, 'blood'), ('GO_0007567', 'parturition', 283, 'birth'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin E')]
PMC3798907	8/2013	S114-PMC3798907	['this SEEMS an UNLIKELY EXPLANATION for the DIFFERENTIAL EFFECTS of Vitamin E supplementation on tg and hdm responses SEEN in the current work because, as in our original observational study, cbmc samples were collected throughout the year [12].']	[('ANOMALY_CURIOUS_FINDING', 5), ('PROBABLE_UNDERSTANDING', 14), ('PROBABLE_UNDERSTANDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 117)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin E')]
PMC3798907	8/2013	S116-PMC3798907	['on the one hand, the POSSIBLE therapeutic use of Vitamin E to help produce a “balanced” Th-Cell profile in early Life is SUPPORTED by the FINDING that supplementation of cbmc with this Nutrient GENERALLY inhibited cytokines characteristic of Th Effector Responses, including both th1 (Ifn-Γ) and th2 (il-4) cytokines.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 138), ('PROBABLE_UNDERSTANDING', 194)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin E'), ('CL_0000545', 'T-helper 1 cell', 88, 'Th-cell'), ('UBERON_0000104', 'life cycle', 113, 'life'), ('CHEBI_33284', 'nutrient', 185, 'nutrient'), ('GO_0007596', 'blood coagulation', 242, 'Th ... responses'), ('CHEBI_35224', 'effector', 245, 'effector'), ('PR_000008920', 'interferon alpha-7', 285, 'IFN-γ')]
PMC3798907	8/2013	S122-PMC3798907	['ALTHOUGH the main FOCUS of our work was the supplementation of cbmc, we included a parallel study of Adult pbmc TO EXAMINE the EFFECT of the same in vitro Vitamin E supplementation on Adult Pbmc IN LIGHT OF the REPORTS of age RELATED differential responsiveness.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 127), ('PROBABLE_UNDERSTANDING', 195), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 226)]	7	[('UBERON_0007023', 'adult organism', 101, 'adult'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin E'), ('UBERON_0007023', 'adult organism', 184, 'adult'), ('UBERON_2005026', 'primary head sinus', 190, 'PBMC')]
PMC3798907	8/2013	S123-PMC3798907	['Vitamin E supplementation STUDIES in Colorectal cancer HAVE REPORTED a more pronounced stimulatory EFFECT by Vitamin E on naïve (Cd45Ra(+)) Th-Cells as compared with T Cells with a Memory/activated phenotype (Cd45Ro(+)) [4].']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('UBERON_0012652', 'colorectum', 37, 'colorectal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin E'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 129, 'CD45RA'), ('CL_0000545', 'T-helper 1 cell', 140, 'Th-cells'), ('CL_0000084', 'T cell', 166, 'T cells'), ('GO_0007613', 'memory', 181, 'memory'), ('PR_000005170', 'CD37 molecule', 209, 'CD45RO')]
PMC3798907	8/2013	S125-PMC3798907	['we FOUND NO CONVINCING evidence of differential responsiveness of cbmc and Adult Pbmc to Vitamin E supplementation; HOWEVER the dose of Vitamin E used in THE current study was CONSIDERABLY LESS than that REPORTED in PREVIOUS work [4].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('ANOMALY_CURIOUS_FINDING', 176), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 216)]	8	[('UBERON_0007023', 'adult organism', 75, 'adult'), ('UBERON_2005026', 'primary head sinus', 81, 'PBMC'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]
PMC3798907	8/2013	S132-PMC3798907	['ONLY single doses of Mitogen and Allergens were used to stimulate the cbmc; HOWEVER these were identical to those used to identify the original ASSOCIATION between maternal Vitamin E Intake and cbmc responses in a general population [12].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_52290', 'mitogen', 21, 'mitogen'), ('CHEBI_33663', 'cyclic hydrocarbon', 33, 'allergens'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin E'), ('GO_0007631', 'feeding behavior', 183, 'intake')]
PMC3798907	8/2013	S136-PMC3798907	['the original ASSOCIATION between maternal Vitamin E and cbmc responses was INDEPENDENT of many POTENTIALLY CONFOUNDING FACTORS (Birth order, maternal atopy, maternal smoking, sex [12], and maternal bmi [27], MAKING IT UNLIKELY that any EFFECT of in vitro Vitamin E supplementation was being negated by extraneous factors, moreover the EFFECT of supplementation was compared with an unsupplemented control for each subject.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 75), ('INCOMPLETE_EVIDENCE', 95), ('PROBLEM_COMPLICATION', 107), ('PROBABLE_UNDERSTANDING', 208), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 236), ('SUPERFICIAL_RELATIONSHIP', 335)]	8	[('CHEBI_27300', 'vitamin D', 42, 'vitamin E'), ('GO_0007567', 'parturition', 128, 'birth'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin E')]
PMC3798907	8/2013	S138-PMC3798907	['HOWEVER, our original OBSERVATION was between maternal Vitamin E intake and cbmc responses, we FOUND no associations between cbmc responses and maternal (and Cord) Blood Ascorbate Tocopherol at 10 weeks Gestation or at Delivery [12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin E'), ('UBERON_0002240', 'spinal cord', 158, 'cord'), ('UBERON_0000178', 'blood', 164, 'blood'), ('CHEBI_22651', 'ascorbate', 170, 'ascorbate'), ('CHEBI_27013', 'tocopherol', 180, 'tocopherol'), ('GO_0007565', 'female pregnancy', 203, 'gestation'), ('GO_0007567', 'parturition', 219, 'delivery')]
PMC3798907	8/2013	S139-PMC3798907	['a SMALL number ( n = 40) of Adult Pbmc samples were obtained to investigate a POSSIBLE age RELATED differential responsiveness to Vitamin E. consequently the concentrations of Ascorbate and Α-Tocopherol used to supplement these pbmc cultures, was the same as that used to supplement cbmc cultures, HOWEVER these levels are lower than those FOUND in the Plasma of healthy Adults, which COULD EXPLAIN the LACK OF EFFECTS SEEN in pbmc cultures.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('ANOMALY_CURIOUS_FINDING', 298), ('INCOMPLETE_EVIDENCE', 340), ('INCOMPLETE_EVIDENCE', 385), ('PROBABLE_UNDERSTANDING', 391), ('INCOMPLETE_EVIDENCE', 403), ('SUPERFICIAL_RELATIONSHIP', 411), ('INCOMPLETE_EVIDENCE', 419)]	11	[('UBERON_0007023', 'adult organism', 28, 'adult'), ('UBERON_2005026', 'primary head sinus', 34, 'PBMC'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin E'), ('CHEBI_22651', 'ascorbate', 176, 'ascorbate'), ('CHEBI_27725', 'butin', 190, 'α-tocopherol'), ('UBERON_0001969', 'blood plasma', 353, 'plasma'), ('UBERON_0007023', 'adult organism', 371, 'adults')]
PMC3798907	8/2013	S151-PMC3798907	['conclusions\noverall, THIS WORK DEMONSTRATES that in vitro supplementation of cbmc with Vitamins E or C CAN INFLUENCE their Immune function but NOT in the simple and consistent manner predicted by models arising from observational epidemiological studies.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 107), ('ANOMALY_CURIOUS_FINDING', 143)]	6	[('CHEBI_27300', 'vitamin D', 87, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 101, 'C'), ('UBERON_0002405', 'immune system', 123, 'immune')]
PMC3798907	8/2013	S153-PMC3798907	['this DISPARITY, in conjunction with RECENT Antenatal intervention DATA [21] EMPHASISES the COMPLEX nature of ASSOCIATIONS between Nutrients and disease and the NEED carefully to CONSIDER the nature of any Vitamin E based Antenatal intervention intended to reduce the LIKELIHOOD of childhood asthma.']	[('ANOMALY_CURIOUS_FINDING', 5), ('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 76), ('DIFFICULT_TASK', 91), ('SUPERFICIAL_RELATIONSHIP', 109), ('FUTURE_WORK', 160), ('FUTURE_WORK', 178), ('PROBABLE_UNDERSTANDING', 267)]	10	[('GO_0007567', 'parturition', 43, 'antenatal'), ('CHEBI_33284', 'nutrient', 130, 'nutrients'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin E'), ('GO_0007567', 'parturition', 221, 'antenatal')]
PMC3798907	8/2013	S154-PMC3798907	['the FINDINGS of THE CURRENT STUDY have changed the direction of our Vitamin E based intervention away from supplementation, towards dietary intervention, with Vitamin E in its natural Food based form [33].']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin E'), ('CHEBI_33290', 'food', 184, 'food')]
PMC3760821	9/2013	S1-PMC3760821	['the second AIM of the study was TO INVESTIGATE POTENTIAL INTERACTIONS between maternal body mass index (bmi) and foetal Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3760821	9/2013	S15-PMC3760821	['maternal Vitamin D levels EXHIBIT a significant negative RELATIONSHIP with hba1clevels, SUPPORTING a POTENTIAL ROLE for this Vitamin in maintaining Glycaemic Control.']	[('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 101), ('SUPERFICIAL_RELATIONSHIP', 111)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 125, 'vitamin'), ('GO_0051162', 'L-arabitol metabolic process', 148, 'glycaemic control')]
PMC3760821	9/2013	S16-PMC3760821	['introduction\nit is WELL ESTABLISHED that Vitamin D plays a primary ROLE in bone health, with SEVERE Vitamin D deficiency KNOWN to cause rickets in children and osteomalacia in Adults[1].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 93), ('INCOMPLETE_EVIDENCE', 121)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0007023', 'adult organism', 176, 'adults')]
PMC3760821	9/2013	S20-PMC3760821	['holick[4]SUGGESTS that for Extraskeletal health, sufficiency is achieved at Vitamin D levels >75 nmol/l.']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('UBERON_0001431', 'distal carpal bone 2', 27, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC3760821	9/2013	S21-PMC3760821	['hypovitaminosis D is commonly SEEN in both Pregnant and non-Pregnant women worldwide[5]; with many FACTORS IMPACTING on Vitamin D status, including; exposure to sunlight, skin colour, season, latitude and obesity, among others[6].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 16, 'D'), ('GO_0007565', 'female pregnancy', 43, 'pregnant'), ('GO_0007565', 'female pregnancy', 60, 'pregnant'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3760821	9/2013	S25-PMC3760821	['DESPITE the LACK OF change/decline in 25Ohd levels, levels of the biologically active Vitamin D Metabolite, 1,25 Dihydroxy Vitamin D [1,25(Oh)2D], are KNOWN to increase by 100% or more during Pregnancy[7],[10].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 151)]	3	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 38, '25OHD'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 96, 'metabolite'), ('CHEBI_50341', '1-hydroxyethyl group', 108, '1,25 dihydroxy'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_72698', '(2R)-trihomocitric acid', 138, '(OH)2D'), ('GO_0007565', 'female pregnancy', 192, 'pregnancy')]
PMC3760821	9/2013	S28-PMC3760821	['this APPARENT rise in 1,25(Oh)2D has LED TO the SUGGESTION that Pregnant women MAY REQUIRE higher cellular exposure to active Vitamin D during the second and third trimesters, and HAS BEEN interpreted by SOME as PROVIDING EVIDENCE for its POTENTIAL ROLE in obstetric well-Being[8].']	[('ANOMALY_CURIOUS_FINDING', 5), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 180), ('INCOMPLETE_EVIDENCE', 204), ('PROBABLE_UNDERSTANDING', 212), ('INCOMPLETE_EVIDENCE', 222), ('INCOMPLETE_EVIDENCE', 239), ('SUPERFICIAL_RELATIONSHIP', 249)]	11	[('CHEBI_17996', 'chloride', 23, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 24, '25(OH)2D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0016441', 'posttranscriptional gene silencing', 271, '-being')]
PMC3760821	9/2013	S30-PMC3760821	['it HAS BEEN SPECULATED that SOME adverse Perinatal outcomes MAY BE due to the immunomodulatory properties of Vitamin D, which MAY assist in the appropriate Immune response to the Placenta[7].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 126)]	5	[('GO_0036268', 'swimming', 41, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 41, 'perinatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0002405', 'immune system', 156, 'immune'), ('UBERON_0001987', 'placenta', 179, 'placenta')]
PMC3760821	9/2013	S33-PMC3760821	['there HAVE BEEN REPORTS of increased incidence of rickets cases in children Born to Vitamin D deficient mothers[13].']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16)]	2	[('GO_0007567', 'parturition', 76, 'born'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC3760821	9/2013	S34-PMC3760821	['the results of a large RECENTLY published prospective study has, HOWEVER, FOUND NO EVIDENCE of an association between the maternal Vitamin D status in Pregnancy and late childhood bone Mineral content (average age 10 yrs)[14].']	[('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 80)]	4	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('CHEBI_46662', 'mineral', 185, 'mineral')]
PMC3760821	9/2013	S35-PMC3760821	['IMPORTANTLY, this cohort was largely of white european origin and THEREFORE, less AT RISK of Vitamin D deficiency[15]; furthermore, the authors counselled that their FINDINGS SHOULD NOT BE taken to mean that individual 25Ohd concentrations are not an IMPORTANT DETERMINANT of bone health, and, moreover, that their study WAS NOT designed to examine non-bone health outcomes[14].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 166), ('FUTURE_WORK', 175), ('ANOMALY_CURIOUS_FINDING', 186), ('IMPORTANT_CONSIDERATION', 251), ('SUPERFICIAL_RELATIONSHIP', 261), ('INCOMPLETE_EVIDENCE', 321), ('ANOMALY_CURIOUS_FINDING', 325)]	10	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 219, '25OHD')]
PMC3760821	9/2013	S36-PMC3760821	['additionally, there is EMERGING EVIDENCE DEMONSTRATING an ASSOCIATION between foetal and early childhood Vitamin D deficiency and later Adult disease processes, such as multiple sclerosis, cardiovascular disease, schizophrenia, certain cancers and other Autoimmune diseases such as t1dm and lupus[16].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 136, 'adult'), ('UBERON_0001442', 'skeleton of manus', 254, 'autoimmune')]
PMC3760821	9/2013	S39-PMC3760821	['WHILE it HAS BEEN SPECULATED that Vitamin D deficiency MAY BE causal in the development of adiposity and, POTENTIALLY, its co-morbidities, a RECENT STUDY using Genetic Markers AS instrumental VARIABLES in bi-directional mendelian randomization analysis has PROVIDED EVIDENCE that a higher bmi leads to lower 25ohd and that the LIKELIHOOD of lower 25ohd increasing bmi is small[19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 141), ('PROBABLE_UNDERSTANDING', 176), ('SUPERFICIAL_RELATIONSHIP', 192), ('PROBABLE_UNDERSTANDING', 257), ('INCOMPLETE_EVIDENCE', 266), ('PROBABLE_UNDERSTANDING', 327)]	11	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0001645', 'genetic_marker', 160, 'genetic markers')]
PMC3760821	9/2013	S40-PMC3760821	['THESE FINDINGS led the study authors to CONCLUDE that population level INTERVENTIONS to reduce bmi would be expected to decrease the prevalence of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 71), ('SUPERFICIAL_RELATIONSHIP', 71)]	4	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC3760821	9/2013	S42-PMC3760821	['women with t1dm have an INCREASED RISK of Pregnancy complications including; Miscarriage, congenital malformations, macrosomia, still Birth, pre-term Birth and pre-eclampsia[22], SOME of which HAVE BEEN REPORTED to be ASSOCIATED with Vitamin D deficiency in Pregnancy.']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 218)]	4	[('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 77, 'miscarriage'), ('GO_0007567', 'parturition', 134, 'birth'), ('GO_0007567', 'parturition', 150, 'birth'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 258, 'pregnancy')]
PMC3760821	9/2013	S43-PMC3760821	['further, it HAS BEEN SUGGESTED that Vitamin D CAN alter Glucose and Insulin Metabolism, and, THEREFORE, IMPACT on energy available to the foetus[11].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 93), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_17234', 'glucose', 56, 'glucose'), ('GO_0007369', 'gastrulation', 56, 'glucose ...'), ('GO_1901142', 'insulin metabolic process', 68, 'insulin metabolism'), ('PR_000045358', 'insulin family protein', 68, 'insulin')]
PMC3760821	9/2013	S44-PMC3760821	['there are numerous REPORTS SUPPORTING a ROLE for Vitamin D in promoting Insulin sensitivity and maintaining Glycaemic Control in t2dm, WHILE the EVIDENCE for a similar ROLE in t1dm is more LIMITED.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 168), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('PR_000045358', 'insulin family protein', 72, 'insulin'), ('GO_0051162', 'L-arabitol metabolic process', 108, 'glycaemic control')]
PMC3760821	9/2013	S46-PMC3760821	['the second AIM of the study was TO INVESTIGATE POTENTIAL INTERACTIONS between maternal bmi and foetal Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC3760821	9/2013	S109-PMC3760821	['table 2 SHOWS that Vitamin D deficiency, defined as 25Ohd levels <25 nmol/l, was apparent in both the control and the t1dm groups across the entire Pregnancy.']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 52, '25OHD'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy')]
PMC3760821	9/2013	S112-PMC3760821	['SIMILAR TO maternal Vitamin D levels, the neonates had a high incidence of 25Ohd deficiency at Birth, with 28–32% exhibiting SEVERE deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 125)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 75, '25OHD'), ('GO_0007567', 'parturition', 95, 'birth')]
PMC3760821	9/2013	S113-PMC3760821	['all babies had Vitamin D levels <50 nmol/l, INDICATING complete lack of sufficiency within this population ( table 2 ).']	[('INCOMPLETE_EVIDENCE', 44)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC3760821	9/2013	S115-PMC3760821	['also, when compared within season, levels of Vitamin D were SIMILAR between the two groups, with a significant difference between the two groups ONLY apparent in autumn [control group vs. t1dm group (nmol/l±sd); 31.76±18.41 vs. 39.12±17.34, p \u200a=\u200a0.031].']	[('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 145)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3760821	9/2013	S134-PMC3760821	['a similar significant positive ASSOCIATION was SEEN between 25ohd at trimester 2 and trimester 3 in both groups.10.1371/journal.pone.0074068.t003\n\ncaption (table-wrap): table 3\nmaternal and Cord Vitamin D levels and their RELATIONSHIP with maternal and neonatal outcome variables.variablecontrol groupt1dm group rp value rp value maternal Vitamin D booking Vitamin D trimester 20.92<0.0010.46<0.001vitamin D trimester 30.76<0.0010.380.005hba1cbooking−0.160.49−0.380.004 maternal Vitamin D trimester 2 Vitamin D trimester 30.66<0.0010.64<0.001hba1cbooking−0.110.55−0.410.001hba1ctrimester 20.060.76−0.280.03birth weight (g)0.390.010.020.87neonatal bmi sds0.170.31−0.240.07birth height sds−0.060.730.230.08 maternal Vitamin D trimester 3 hba1cbooking−0.160.35−0.250.05hba1ctrimester 2−0.130.42−0.220.08neonatal bmi sds0.110.43−0.300.02birth height sds−0.0020.990.280.03 Cord Vitamin D neonatal measure\u2003neonatal bmi sds0.290.17−0.310.03\u2003Birth height sds−0.190.390.260.06maternal hba1c\u2003booking−0.140.57−0.440.001\u2003trimester 2−0.390.12−0.290.03\u2003trimester 3−0.230.29−0.220.12maternal Vitamin D\u2003booking0.390.260.330.02\u2003trimester 20.250.320.46<0.001\u2003trimester 30.73<0.0010.84<0.001\ncorrelations between continuous variables were assessed by pearson’s coefficients for correlations.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 222)]	3	[('UBERON_0002240', 'spinal cord', 190, 'cord'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 339, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 357, 'Vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 406, 'D'), ('CHEBI_28384', 'vitamin K', 479, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 501, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 714, 'Vitamin D'), ('UBERON_0000948', 'heart', 868, 'Cord'), ('CHEBI_28384', 'vitamin K', 873, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 873, 'Vitamin D'), ('GO_0007567', 'parturition', 934, 'Birth'), ('CHEBI_27300', 'vitamin D', 1077, 'vitamin D')]
PMC3760821	9/2013	S142-PMC3760821	['IMPACT of maternal bmi at booking on maternal and cord Vitamin D levels in women with t1dm\nin VIEW of the TREND towards a significant increase in bmi at booking in women with t1dm vs. controls ( table 1 ), the IMPACT of maternal bmi at booking (normal weight bmi <25 kg/m2vs.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 210)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3760821	9/2013	S146-PMC3760821	['multiple linear regression analysis INDICATED that maternal trimester 3 Vitamin D, (b\u200a=\u200a0.462; p<0.001) and obese bmi at booking (b\u200a=\u200a−5.132; p \u200a=\u200a0.013) significantly IMPACTED on Cord 25Ohd levels.']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 168)]	2	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 180, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 185, '25OHD')]
PMC3760821	9/2013	S150-PMC3760821	['multiple linear regression analysis INDICATED that maternal Vitamin D at booking (b\u200a=\u200a−0.015; p \u200a=\u200a0.011) and obese bmi at booking (b\u200a=\u200a0.566; p \u200a=\u200a0.045), both had a significant INDEPENDENT IMPACT on hba1cat booking.']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 191)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3760821	9/2013	S153-PMC3760821	['in addition, the study findings INDICATE that Cord Blood Vitamin D levels CORRELATE with those of the mother, and are significantly lower in obese women than in their normal weight counterparts.']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC3760821	9/2013	S154-PMC3760821	['maternal Vitamin D levels were also found to EXHIBIT a significant negative RELATIONSHIP with hba1clevels, SUPPORTING a ROLE for this Vitamin in maintaining Glycaemic Control.']	[('ANOMALY_CURIOUS_FINDING', 45), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 134, 'vitamin'), ('GO_0051162', 'L-arabitol metabolic process', 157, 'glycaemic control')]
PMC3760821	9/2013	S155-PMC3760821	['the FINDINGS of THE CURRENT STUDY that, in women with t1dm, low Vitamin D levels are EVIDENCED throughout Gestation are IN AGREEMENT with PREVIOUS GROUPS who HAVE reported compromised Vitamin D status in Pregnancy[5].']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 138), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'gestation'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy')]
PMC3760821	9/2013	S158-PMC3760821	['the present analysis FURTHER determined that, Cord Blood Vitamin D levels CORRELATED with those of the mother, and were, THUS, PREDOMINANTLY deficient/insufficient and, in women with t1dm, low Vitamin D levels PERSISTED post-Delivery.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 74), ('PROBABLE_UNDERSTANDING', 121), ('PROBABLE_UNDERSTANDING', 127), ('INCOMPLETE_EVIDENCE', 210)]	5	[('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007567', 'parturition', 225, 'delivery')]
PMC3760821	9/2013	S159-PMC3760821	['THESE FINDINGS SUPPORT the CONTENTION that measurement of Vitamin D levels prior to, and during Pregnancy, SHOULD BE RECOMMENDED, and that Vitamin D supplementation be initiated when deficiency is CONFIRMED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('FUTURE_WORK', 107), ('FUTURE_WORK', 117), ('INCOMPLETE_EVIDENCE', 197)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC3760821	9/2013	S160-PMC3760821	['EVEN given the LACK OF EVIDENCE SUPPORTING a causal LINK between low Vitamin D and a range of non-bone health outcomes, assessment and supplementation are ESSENTIAL with respect to the optimal bone health of both mother and off-spring.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 52), ('IMPORTANT_CONSIDERATION', 155)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3760821	9/2013	S163-PMC3760821	['department of health GUIDELINES in the uk CURRENTLY RECOMMEND Pregnant women to supplement with 10 µg/day to protect against Vitamin D deficiency[29], but this is DISPUTED by SOME[30].']	[('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 42), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('INCOMPLETE_EVIDENCE', 175)]	5	[('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3760821	9/2013	S164-PMC3760821	['hollis et al .,[30]ARGUE that supplementation of up to 100 µg/day is more effective at maintaining Vitamin D sufficiency throughout Pregnancy, when compared with 10 and 50 µg/day.']	[('INCOMPLETE_EVIDENCE', 19)]	1	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'pregnancy')]
PMC3760821	9/2013	S168-PMC3760821	['when the IMPACT of maternal bmi at booking on maternal and cord Vitamin D levels in t1dm women was examined, maternal levels of 25Ohd in women with t1dm classified as obese at booking displayed a TREND for being lower.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 196)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 128, '25OHD')]
PMC3760821	9/2013	S172-PMC3760821	['WHILE josefson et al ., REPORTED an IMPACT of maternal age and neonatal adiposity, directly measured by air displacement plethysmography, on Cord Vitamin D levels, in the CURRENT STUDY, ALTHOUGH neonatal bmi sds was significantly negatively CORRELATED with Cord 25Ohd in subjects with t1dm, regression analysis INDICATED that maternal age at Delivery and SURROGATE measures of neonatal adiposity (Subscapular Skinfold, Triceps Skinfold, and sds bmi) did not impact significantly on Cord Blood 25Ohd.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 171), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 186), ('SUPERFICIAL_RELATIONSHIP', 241), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 355)]	9	[('UBERON_0002240', 'spinal cord', 141, 'cord'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 257, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 262, '25OHD'), ('GO_0007567', 'parturition', 342, 'delivery'), ('UBERON_0007191', 'anterior paracentral gyrus', 397, 'subscapular skinfold'), ('UBERON_0005299', 'prepuce of clitoris', 419, 'triceps skinfold'), ('UBERON_0002240', 'spinal cord', 482, 'cord'), ('UBERON_0000178', 'blood', 487, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 493, '25OHD')]
PMC3760821	9/2013	S173-PMC3760821	['a KEY FINDING of THE CURRENT STUDY is that in t1dm Pregnancy, maternal Vitamin D levels EXHIBIT an INDEPENDENT inverse RELATIONSHIP with hba1clevels.']	[('IMPORTANT_CONSIDERATION', 2), ('INCOMPLETE_EVIDENCE', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ANOMALY_CURIOUS_FINDING', 88), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 119)]	6	[('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3760821	9/2013	S174-PMC3760821	['POTENTIAL mechanisms by which Vitamin D MIGHT INFLUENCE Glycaemic Control in t1dm include, the IMPACT of this Vitamin on Intracellular Calcium Regulation and, THUS, Glucose transport in target Tissues, INFLUENCES on Insulin receptor Expression and the EFFECT of Vitamin D on systemic inflammation ASSOCIATED with Insulin resistance[31],[32].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 95), ('PROBABLE_UNDERSTANDING', 159), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 252), ('SUPERFICIAL_RELATIONSHIP', 297)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0051162', 'L-arabitol metabolic process', 56, 'glycaemic control'), ('CHEBI_33229', 'vitamin (role)', 110, 'vitamin'), ('GO_0005622', 'intracellular anatomical structure', 121, 'intracellular'), ('GO_0006260', 'DNA replication', 121, 'intracellular'), ('GO_0051303', 'establishment of chromosome localization', 135, 'calcium regulation'), ('CHEBI_17234', 'glucose', 165, 'glucose'), ('UBERON_0000479', 'tissue', 193, 'tissues'), ('PR_000045358', 'insulin family protein', 216, 'insulin'), ('GO_0010467', 'gene expression', 233, 'expression'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('PR_000045358', 'insulin family protein', 313, 'insulin')]
PMC3760821	9/2013	S177-PMC3760821	['with respect to a causal LINK between Vitamin D repletion and improved Glucose Homeostasis, LIMITED STUDIES HAVE REPORTED substantial improvements in Glycaemic Control (hba1clevels) in t1dm patients who achieved higher circulating 25Ohd levels via supplementation[36],[37].']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 108)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_17234', 'glucose', 71, 'glucose'), ('GO_0042593', 'glucose homeostasis', 71, 'glucose homeostasis'), ('GO_0051162', 'L-arabitol metabolic process', 150, 'glycaemic control'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 231, '25OHD')]
PMC3760821	9/2013	S178-PMC3760821	['the results of a recent systematic review SUGGEST a weak EFFECT of Vitamin D supplementation in reducing fasting Glucose and improving Insulin resistance in patients with t2dm or impaired glucose tolerance[38].']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 57)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_17234', 'glucose', 113, 'glucose'), ('PR_000045358', 'insulin family protein', 135, 'insulin')]
PMC3760821	9/2013	S182-PMC3760821	['a further LIMITATION is that information is NOT AVAILABLE on dietary or supplemental Vitamin D intake, in these women.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 44)]	2	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3760821	9/2013	S183-PMC3760821	['HOWEVER, the low levels of Vitamin D FOUND in both the control and t1dm groups would APPEAR TO argue against the widespread use of augmented intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 85)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC3760821	9/2013	S184-PMC3760821	['in conclusion, the FINDING that Vitamin D DEPENDENT processes MAY BE negatively IMPACTED by maternal nutritional status and obesity in a t1dm cohort is a significant one and provides FURTHER EVIDENCE that population-based INTERVENTIONS aimed at reducing obesity and improving pre-Pregnancy and Gestational Vitamin D status ARE NEEDED.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 80), ('FUTURE_WORK', 183), ('INCOMPLETE_EVIDENCE', 183), ('FUTURE_WORK', 222), ('FUTURE_WORK', 323)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 280, 'pregnancy'), ('GO_0007565', 'female pregnancy', 294, 'gestational'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
PMC3760821	9/2013	S185-PMC3760821	['GIVEN the SAFETY of Vitamin D, the low cost of supplementation and its REQUIREMENT for OPTIMAL bone health (and POTENTIALLY other health outcomes) in both the mother and off-spring, the FINDINGS of THE CURRENT STUDY SUPPORT the case for determining Vitamin D status and, IF NECESSARY, administering Vitamin D in t1dm pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('IMPORTANT_CONSIDERATION', 71), ('IMPORTANT_CONSIDERATION', 87), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 198), ('INCOMPLETE_EVIDENCE', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 271), ('IMPORTANT_CONSIDERATION', 274)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC3814422	10/2013	S0-PMC3814422	['maternal 25-Hydroxyvitamin D and its ASSOCIATION with childhood atopic outcomes and Lung function\n\nabstract\n\nbackground\nit HAS BEEN SUGGESTED that maternal Vitamin D status in Pregnancy INFLUENCES the risk of asthma and atopy in the offspring.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 186)]	3	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 9, '25-hydroxyvitamin D'), ('UBERON_0002048', 'lung', 84, 'lung'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 176, 'pregnancy')]
PMC3814422	10/2013	S1-PMC3814422	['the epidemiological EVIDENCE TO SUPPORT these CLAIMS is CONFLICTING and MAY reflect chance FINDINGS and differences in HOW Vitamin D was assessed.']	[('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 91), ('EXPLICIT_QUESTION', 119)]	7	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC3814422	10/2013	S10-PMC3814422	['introduction\nVitamin D MAY play an IMPORTANT ROLE in normal fetal Lung and Immune System Development1And there is increasing SPECULATION that maternal Vitamin D status in Pregnancy MIGHT be causally LINKED to the development of asthma and atopy in the offspring.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0006266', 'DNA ligation', 66, 'lung ...'), ('UBERON_0002048', 'lung', 66, 'lung'), ('GO_0002415', 'immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor', 75, 'immune system development1and'), ('UBERON_0002405', 'immune system', 75, 'immune system'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
PMC3814422	10/2013	S11-PMC3814422	['it HAS BEEN ARGUED that maternal Vitamin D deficiency MIGHT, AT LEAST IN PART, EXPLAIN the rising PREVALENCE of asthma and allergic disease in SOME countries2.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 61), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 79), ('IMPORTANT_CONSIDERATION', 98), ('INCOMPLETE_EVIDENCE', 143)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3814422	10/2013	S12-PMC3814422	['HOWEVER, an OPPOSING argument holds that the increasing PREVALENCE of asthma and atopy MAY BE PARTLY a consequence of the fortification of childhood Foods with Vitamin D and HENCE high Vitamin D status in early childhood3–7.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('IMPORTANT_CONSIDERATION', 56), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 94), ('PROBABLE_UNDERSTANDING', 174)]	6	[('CHEBI_33290', 'food', 149, 'foods'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3814422	10/2013	S13-PMC3814422	['studies of maternal dietary Intake have MOSTLY REPORTED inverse RELATIONSHIPS between maternal Vitamin D intake in Pregnancy and early childhood wheeze, asthma, allergic rhinitis and eczema8–10.']	[('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 40), ('SUPERFICIAL_RELATIONSHIP', 64)]	3	[('GO_0007631', 'feeding behavior', 28, 'intake'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
PMC3814422	10/2013	S14-PMC3814422	['HOWEVER, a MAJOR LIMITATION of these studies is that diet makes a relatively minor CONTRIBUTION to total Vitamin D status, which is derived largely from Photosynthesis in the skin.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 153, 'photosynthesis')]
PMC3814422	10/2013	S15-PMC3814422	['HENCE, the value of analysing dietary Vitamin D intake alone AS a means of EFFECTIVELY establishing the INFLUENCE of Vitamin D on outcomes HAS BEEN QUESTIONED as it leads to considerable MISCLASSIFICATION of total exposure.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 61), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 139), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('PROBLEM_COMPLICATION', 187)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3814422	10/2013	S16-PMC3814422	['the gold STANDARD measure of Vitamin D status is the Blood concentration of 25-Hydroxyvitamin D (25(Oh)D)11.']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0000178', 'blood', 53, 'blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 76, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D')]
PMC3814422	10/2013	S20-PMC3814422	['factors such as residual CONFOUNDING, chance results attributable to SMALL sample sizes and differences in HOW Vitamin D exposure and childhood outcomes were measured (i.e.']	[('PROBLEM_COMPLICATION', 25), ('INCOMPLETE_EVIDENCE', 69), ('EXPLICIT_QUESTION', 107)]	3	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC3814422	10/2013	S47-PMC3814422	['potential confounders and mediators\nwe considered the following as POTENTIAL CONFOUNDERS BECAUSE of their KNOWN or POTENTIAL PLAUSIBLE ASSOCIATION with both maternal concentrations of Vitamin D and with childhood atopic and Lung function outcomes21,22: maternal FACTORS during Pregnancy [smoking, infections, anxiety score, Antibiotic use, Paracetamol use, body mass index (bmi) and Alcohol intake], OTHER maternal factors (educational level, housing tenure, financial difficulties, ethnicity, age, parity, history of asthma, eczema, rhinoconjunctivitis, migraine) and Postnatal FACTORS that MAY reflect a background socio-economic CONFOUNDING pathway originating prior to Birth (breastfeeding, day care, pets, exposure to damp/mould in home, environmental tobacco smoke exposure and number of younger siblings).']	[('INCOMPLETE_EVIDENCE', 67), ('PROBLEM_COMPLICATION', 77), ('PROBLEM_COMPLICATION', 89), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 135), ('SUPERFICIAL_RELATIONSHIP', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 400), ('SUPERFICIAL_RELATIONSHIP', 579), ('INCOMPLETE_EVIDENCE', 592), ('PROBLEM_COMPLICATION', 632)]	12	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0002048', 'lung', 224, 'lung'), ('GO_0007565', 'female pregnancy', 277, 'pregnancy'), ('CHEBI_33282', 'antibacterial agent', 324, 'antibiotic'), ('CHEBI_46195', 'paracetamol', 340, 'paracetamol'), ('CHEBI_30879', 'alcohol', 383, 'alcohol'), ('GO_0007567', 'parturition', 569, 'postnatal'), ('GO_0007567', 'parturition', 673, 'birth')]
PMC3814422	10/2013	S63-PMC3814422	['additional analyses\nTO TEST WHETHER ASSOCIATIONS were driven by a threshold effect of greater risk in those whose mothers had insufficient levels of Vitamin D, we EXAMINED ASSOCIATIONS of categories of 25(Oh)D levels (≥ 50 nmol/l; 27.5–49.99 nmol/l and < 27.5 nmol/l) with outcomes, we also repeated analyses using 75 nmol/l as a higher THRESHOLD for sufficiency as recommended in a more RECENT REVIEW23.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 163), ('SUPERFICIAL_RELATIONSHIP', 172), ('PROBABLE_UNDERSTANDING', 337), ('INCOMPLETE_EVIDENCE', 388)]	7	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 208, 'D')]
PMC3814422	10/2013	S118-PMC3814422	['HOWEVER, given the large sample size, and the range of Vitamin D values, we would have expected to see SOME EVIDENCE of qualitative TRENDS IF this were the case and none was present.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3814422	10/2013	S121-PMC3814422	['IT IS POSSIBLE that this is a POOR MARKER of Vitamin D levels over Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 30), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy')]
PMC3814422	10/2013	S123-PMC3814422	['Serum 25(Oh)D HAS BEEN CRITICIZED as a PROXY for Vitamin D ASSOCIATIONS.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 59)]	4	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3814422	10/2013	S124-PMC3814422	['for instance, it HAS BEEN SUGGESTED that there is a NEED to DISTINGUISH between Serum 25(Oh)D and EFFECTS of Vitamin D supplementation, the former being a prohormone representing a physiological state that is only relevant at extremely high or low levels, and the latter representing the non-physiological action of interest4.']	[('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 98)]	4	[('UBERON_0001977', 'blood serum', 80, 'serum'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 86, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC3814422	10/2013	S130-PMC3814422	['ALTHOUGH we COULD NOT directly investigate the ASSOCIATION of maternal 25(Oh)D with Early Life Respiratory infections, the LACK OF ASSOCIATION with transient early wheezing phenotype ARGUES AGAINST a PROTECTIVE EFFECT of Prenatal Vitamin D on Respiratory Viral infections in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 12), ('ANOMALY_CURIOUS_FINDING', 18), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 200), ('SUPERFICIAL_RELATIONSHIP', 211)]	9	[('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 71, '25(OH ... D'), ('UBERON_0001847', 'lobule of pinna', 84, 'early life'), ('UBERON_0001004', 'respiratory system', 95, 'respiratory'), ('GO_0007565', 'female pregnancy', 221, 'prenatal'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 243, 'respiratory'), ('NCBITaxon_1', 'root', 255, 'viral')]
PMC3814422	10/2013	S133-PMC3814422	['HOWEVER, given that Vitamin D intake is a POOR PROXY for total Vitamin D status11, APPARENT ASSOCIATIONS with dietary Vitamin D MAY HAVE BEEN CONFOUNDED by OTHER dietary or non-dietary factors which had not been controlled for in those Birth cohort studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 42), ('PROBLEM_COMPLICATION', 42), ('SUPERFICIAL_RELATIONSHIP', 47), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 132), ('DIFFICULT_TASK', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	11	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 236, 'birth')]
PMC3814422	10/2013	S134-PMC3814422	['by way of analogy, in a study of Vitamin D and Adult Lung function we FOUND that, WHILST there were APPARENT ASSOCIATIONS with dietary Vitamin D intake, there was NO EVIDENCE for an association with Blood 25(Oh)D concentrations29.']	[('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('ANOMALY_CURIOUS_FINDING', 82), ('ANOMALY_CURIOUS_FINDING', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 163)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0007023', 'adult organism', 47, 'adult'), ('UBERON_0002048', 'lung', 53, 'lung'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('UBERON_0000178', 'blood', 199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 205, '25(OH)D')]
PMC3814422	10/2013	S136-PMC3814422	["in SUPPORT of this, it is NOTABLE that analysis of the ASSOCIATION of maternal dietary Vitamin D with offspring asthma, wheeze and atopy in both the southampton women's survey13and alspac30failed to demonstrate an ASSOCIATION."]	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 214)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC3814422	10/2013	S137-PMC3814422	['ALTHOUGH Animal studies HAVE SHOWN that Vitamin D is INVOLVED in normal Fetal Lung Development31, OUR STUDY is IN GENERAL AGREEMENT with OTHER epidemiological STUDIES that have considered later offspring Lung function in the general population – two STUDIES HAVE REPORTED null ASSOCIATIONS of maternal 25(Oh)D13,32or dietary Vitamin D intake32with offspring Lung function.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 98), ('INCOMPLETE_EVIDENCE', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 277)]	11	[('NCBITaxon_33208', 'Metazoa', 9, 'animal'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007631', 'feeding behavior', 72, 'fetal'), ('GO_0030324', 'lung development', 78, 'lung development31'), ('UBERON_0002048', 'lung', 78, 'lung'), ('UBERON_0002048', 'lung', 204, 'lung'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 302, '25(OH)D13'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('UBERON_0002048', 'lung', 358, 'lung')]
PMC3814422	10/2013	S139-PMC3814422	['in particular, we have not FOUND EVIDENCE to SUGGEST that higher Prenatal Vitamin D status in Pregnancy PROTECTS against the development of early childhood wheezing or later asthma.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('GO_0007565', 'female pregnancy', 65, 'prenatal'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC3814422	10/2013	S140-PMC3814422	['WHILST definitive evidence will ONLY come from randomized trials of Vitamin D supplementation during Pregnancy, which are currently underway (e.g.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 32)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC3814422	10/2013	S142-PMC3814422	['reassuringly, our data also SUGGEST that higher maternal Vitamin D status in Pregnancy is UNLIKELY to increase the risk of atopy in the offspring.']	[('INCOMPLETE_EVIDENCE', 28), ('PROBABLE_UNDERSTANDING', 90)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy')]
PMC3827489	10/2013	S2-PMC3827489	['PREVIOUS STUDIES SUGGEST that sufficient Serum Vitamin D levels SHOULD BE maintained in order to enhance normal Calcification of the Growth Plate and bone mineralization.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 64)]	3	[('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0051301', 'cell division', 112, 'calcification'), ('UBERON_0002516', 'epiphyseal plate', 133, 'growth plate')]
PMC3827489	10/2013	S6-PMC3827489	['in conclusion, given the IMPORTANT ROLE of Vitamin D in childhood health, more time spent in outdoor activity (for sunlight exposure) and Vitamin D supplementation MAY be NECESSARY for optimal health in infants, children, and adolescents.']	[('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 171)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC3827489	10/2013	S19-PMC3827489	['the vdr HAS also BEEN FOUND in Hematolymphopoietic Cells, and Vitamin D HAS BEEN SHOWN to Regulate Cell Differentiation and the production of interleukins and cytokines1,2).']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 72)]	3	[('CL_0000988', 'hematopoietic cell', 31, 'hematolymphopoietic cells'), ('GO_0030097', 'hemopoiesis', 31, 'hematolymphopoietic'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0065007', 'biological regulation', 90, 'regulate'), ('GO_0030154', 'cell differentiation', 99, 'cell differentiation')]
PMC3827489	10/2013	S22-PMC3827489	['ALTHOUGH Vitamin D deficiency IS KNOWN to be prevalent in Adults, epidemiologic data on the prevalence of Vitamin D deficiency are LACKING in korean infants, children, and adolescents.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('FULL_UNKNOWN', 131)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 58, 'adults'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC3827489	10/2013	S23-PMC3827489	['RECENT STUDIES SUGGEST that Vitamin D insufficiency or deficiency MAY have a significant IMPACT on childhood health14,15).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC3827489	10/2013	S24-PMC3827489	['there are SEVERAL epidemiologic STUDIES SUGGESTING that Vitamin D plays an IMPORTANT ROLE in the prevention and management of various pediatric diseases.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 40), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 85)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC3827489	10/2013	S27-PMC3827489	['diagnostic criteria of Vitamin D insufficiency or deficiency\nNO CONSENSUS on the definition of Vitamin D deficiency exists; HOWEVER, most clinicians and researchers agree on the following stratifications BASED ON the Serum concentration of 25(Oh)D: deficiency, <50.0 nmol/l or <20.0 ng/ml; insufficiency, 50.0-74.9 nmol/l or 20.0-29.9 ng/ml; and sufficiency, ≥75.0 nmol/l or ≥30.0 ng/ml1,6,16,17).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 61), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 204), ('PROBABLE_UNDERSTANDING', 204)]	5	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0001977', 'blood serum', 217, 'serum'), ('CHEBI_71657', 'versiconol acetate', 240, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 240, '25(OH)D')]
PMC3827489	10/2013	S29-PMC3827489	['prevalence of Vitamin D insufficiency or deficiency\nepidemiologic data on the prevalence of Vitamin D insufficiency or deficiency in children are SPARSE or INCOMPLETE in most countries.']	[('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 156), ('PROBLEM_COMPLICATION', 156)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3827489	10/2013	S32-PMC3827489	['this INDICATED that Vitamin D insufficiency or deficiency was highly prevalent in koreans across all age groups23).']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC3827489	10/2013	S33-PMC3827489	['IN LINE WITH THESE data, a study FOCUSING on adolescents aged 12-13 years REPORTED that 98.9% of boys and 100% of girls showed Vitamin D insufficiency or deficiency; 5.3% had 25(Oh)D insufficiency (20.0-29.9 ng/ml), 94.2% had deficient concentrations (<20.0 ng/ml), and ONLY 1 boy (1.1%) had OPTIMAL concentrations of 25(Oh)d6).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('INCOMPLETE_EVIDENCE', 74), ('ANOMALY_CURIOUS_FINDING', 270), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 292)]	7	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 175, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 318, '25(OH')]
PMC3827489	10/2013	S34-PMC3827489	['a RECENT STUDY in hangzhou, china investigated the Vitamin D status of 6,008 chinese children aged 1 month to 16 years18).']	[('INCOMPLETE_EVIDENCE', 2)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3827489	10/2013	S36-PMC3827489	['they FOUND that in winter and spring, more than 50% of school age children and adolescents had a Vitamin D deficiency, and in winter, 100% of the adolescents and 93.7% of school age children had Vitamin D insufficiency18).']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC3827489	10/2013	S40-PMC3827489	['a RECENT STUDY based on the knhanes iv 2008-2009 examining a total of 1,510 healthy adolescents aged 12-18 years (806 male subjects and 704 female subjects; mean age, 14.7 years) ASSESSED that the prevalence of Vitamin D deficiency (25[Oh]D<20.0 ng/ml) was 89.1% in spring, 53.7% in summer, 63.9% in autumn, and 90.5% in winter, and that independent PREDICTORS for low Vitamin D status were season (winter), higher education level, and a lack of Vitamin D supplementation22).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 350)]	3	[('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 233, '25[OH]D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 446, 'vitamin D')]
PMC3827489	10/2013	S43-PMC3827489	['THEREFORE, they MAY not have enough exposure to sunlight for optimal cutaneous Production Of Vitamin D.\nA STUDY conducted in the united states SPECULATED that american adolescents tend to consume less dairy products27).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 143)]	4	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 79, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC3827489	10/2013	S44-PMC3827489	['girls are at particular RISK for low Vitamin D status, which HAS BEEN ASCRIBED to lifestyle factors such as frequent use of sunscreen or coverage of skin by clothing that COULD AFFECT cutaneous Synthesis Of Vitamin D6).']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 61), ('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0034205', 'amyloid-beta formation', 194, 'synthesis of ... D6'), ('CHEBI_33237', 'vitamin D4', 207, 'vitamin D6'), ('PR_000017299', 'VIP peptides', 207, 'vitamin D6')]
PMC3827489	10/2013	S45-PMC3827489	['MOUNTING EVIDENCE also SUGGESTS that there are ethnic DIFFERENCES in Vitamin D levels20,21).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3827489	10/2013	S47-PMC3827489	['low Vitamin D status in black Individuals MAY BE ATTRIBUTED MAINLY to decreased skin Synthesis Of Vitamin D due to greater skin pigmentation32)OR to the high prevalence of obesity in black populations25,33,34).']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 49), ('PROBABLE_UNDERSTANDING', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('NCBITaxon_1', 'root', 30, 'individuals'), ('GO_0030474', 'spindle pole body duplication', 85, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3827489	10/2013	S50-PMC3827489	['Vitamin D insufficiency/deficiency and childhood bone health\nthe CRITICAL ROLE of Vitamin D in Skeletal mineralization was the FIRST of its physiological functions to be IDENTIFIED.']	[('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 170)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0001501', 'skeletal system development', 95, 'skeletal'), ('UBERON_0004288', 'skeleton', 95, 'skeletal')]
PMC3827489	10/2013	S57-PMC3827489	['ONE STUDY REPORTED that IF the Vitamin D level was 30 ng/ml or less, there was a significant decrease in Intestinal calcium absorption36), which CORRELATED to increased circulating Parathyroid hormone (pth)37).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0000160', 'intestine', 105, 'intestinal'), ('UBERON_0001132', 'parathyroid gland', 181, 'parathyroid')]
PMC3827489	10/2013	S63-PMC3827489	['Vitamin D insufficiency/deficiency and Respiratory diseases\nemerging EVIDENCE SUGGESTS that Vitamin D plays an ESSENTIAL ROLE in the Modulation Of the Immune Responses.']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 111), ('SUPERFICIAL_RELATIONSHIP', 121)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001004', 'respiratory system', 39, 'respiratory'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0006880', 'intracellular sequestering of iron ion', 133, 'modulation of ... immune responses'), ('UBERON_0002405', 'immune system', 151, 'immune')]
PMC3827489	10/2013	S64-PMC3827489	['in addition, Vitamin D HAS BEEN recognized as an anti-infective agent due TO its EFFECTS on Innate and Adaptive Immune Responses.']	[('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007631', 'feeding behavior', 92, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 103, 'adaptive immune responses'), ('UBERON_0002405', 'immune system', 112, 'immune')]
PMC3827489	10/2013	S68-PMC3827489	['SEVERAL STUDIES conducted in DIFFERENT ethnic groups have FOUND a close ASSOCIATION between Vitamin D deficiency and an INCREASED RISK of tuberculosis43-45).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 120)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3827489	10/2013	S69-PMC3827489	['in addition, a RECENT meta-analysis FOUND that low Serum levels of Vitamin D were ASSOCIATED with a high RISK of active tuberculosis46).']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 82), ('IMPORTANT_CONSIDERATION', 105)]	4	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC3827489	10/2013	S70-PMC3827489	['IN CONTRAST, a cochrane review REPORTED that Vitamin D supplementation in patients diagnosed with tuberculosis did not alter the rates of Sputum smear Conversion in Adults or body weight in children47).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0007311', 'sputum', 138, 'sputum'), ('GO_0006936', 'muscle contraction', 151, 'conversion'), ('UBERON_0007023', 'adult organism', 165, 'adults')]
PMC3827489	10/2013	S73-PMC3827489	['another RECENT STUDY SHOWED that lower Vitamin D levels in 86 children with SEVERE, therapy-resistant asthma in the united kingdom were ASSOCIATED with worsened asthma Control and Lung function49).']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 76), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0065007', 'biological regulation', 168, 'control'), ('UBERON_0002048', 'lung', 180, 'lung')]
PMC3827489	10/2013	S74-PMC3827489	['a randomized placebo-controlled prospective study by majak et al.50)SHOWED that Vitamin D supplementation (500 iu of Cholecalciferol) daily for 6 months reduced the risk of bronchial asthma exacerbation triggered by acute Respiratory Tract infection.']	[('INCOMPLETE_EVIDENCE', 68)]	1	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 117, 'cholecalciferol'), ('UBERON_0000065', 'respiratory tract', 222, 'respiratory tract')]
PMC3827489	10/2013	S75-PMC3827489	['these observational and clinical studies INDICATE a beneficial EFFECT of Vitamin D supplementation in Vitamin D deficient children with asthma or acute or chronic Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 163, 'respiratory')]
PMC3827489	10/2013	S79-PMC3827489	['SOME obesity-related health consequences HAVE BEEN CORRELATED with Vitamin D deficiency or insufficiency5,52-54), and RECENT reports have SUGGESTED that Vitamin D supplementation MAY reduce these RISKS, ALTHOUGH the data are INCONSISTENT55,56).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 196), ('ANOMALY_CURIOUS_FINDING', 203), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225)]	9	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3827489	10/2013	S80-PMC3827489	['the inverse ASSOCIATION between higher body fat and low Vitamin D concentrations MAY BE ASCRIBED to Sequestration Of the fat-soluble Vitamin D within Adipose Tissues57).']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 81), ('PROBABLE_UNDERSTANDING', 88)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0051610', 'serotonin uptake', 100, 'sequestration of ... vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('UBERON_0007149', 'inferior thyroid artery', 150, 'adipose tissues57')]
PMC3827489	10/2013	S82-PMC3827489	['OTHER EVIDENCE SUGGESTS that low dietary Vitamin D and decreased sun exposure DUE to fewer outdoor activities are RISK FACTORS for the low Vitamin D levels OBSERVED in obese subjects4,20).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 78), ('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 156)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC3827489	10/2013	S83-PMC3827489	['studies have SUGGESTED that Vitamin D MAY directly Regulate Insulin secretion by binding to Pancreatic Β-Cell vdrs59), and MAY indirectly AFFECT Pancreatic Β-Cell function by Regulating Extracellular calcium concentrations59); these data SUGGEST that low Vitamin D levels MAY BE ASSOCIATED with Insulin resistance.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 138), ('INCOMPLETE_EVIDENCE', 238), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 279)]	7	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0065007', 'biological regulation', 51, 'regulate'), ('PR_000045358', 'insulin family protein', 60, 'insulin'), ('CL_0000173', 'pancreatic D cell', 92, 'pancreatic β-cell'), ('UBERON_0001069', 'head of pancreas', 92, 'pancreatic β-'), ('CL_0000173', 'pancreatic D cell', 145, 'pancreatic β-cell'), ('UBERON_0001069', 'head of pancreas', 145, 'pancreatic β-'), ('GO_0065007', 'biological regulation', 175, 'regulating'), ('GO_0005576', 'extracellular region', 186, 'extracellular'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('PR_000045358', 'insulin family protein', 295, 'insulin')]
PMC3827489	10/2013	S86-PMC3827489	['moreover, a randomized clinical trial determining the efficacy of Vitamin D supplementation in obese adolescents SHOWED that supplementation of 4,000 iu Vitamin D3/day for 6 months significantly improved Insulin sensitivity60).']	[('INCOMPLETE_EVIDENCE', 113)]	1	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 153, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 153, 'vitamin D3'), ('PR_000045358', 'insulin family protein', 204, 'insulin')]
PMC3827489	10/2013	S87-PMC3827489	['taken TOGETHER, THESE FINDINGS SUGGEST that PUBLIC HEALTH INTERVENTIONS such as outdoor activity and Vitamin D supplementation, which enhance Vitamin D status, MAY improve the health of adolescents with Metabolic PROBLEMS.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 44), ('FUTURE_WORK', 58), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 213)]	7	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0008152', 'metabolic process', 203, 'metabolic')]
PMC3827489	10/2013	S89-PMC3827489	['EFFECTS of maternal Vitamin D insufficiency/deficiency on infants and children\nstudies have SUGGESTED that Vitamin D concentrations in the fetus and newborn are highly DEPENDENT on and significantly RELATED to maternal Serum 25(Oh)D concentrations61-64).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0001977', 'blood serum', 219, 'serum'), ('CHEBI_71657', 'versiconol acetate', 225, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 225, '25(OH ... D')]
PMC3827489	10/2013	S92-PMC3827489	['this FINDING MAY BE EXPLAINED BY PREVIOUS STUDIES SUGGESTING that higher Vitamin D levels or appropriate Vitamin D intake in Pregnant women is ASSOCIATED with increased infant Birth weight66,67).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 17), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant'), ('GO_0007567', 'parturition', 176, 'birth')]
PMC3827489	10/2013	S93-PMC3827489	['IN CONTRAST, OTHER OBSERVATIONAL studies SHOWED no correlation between maternal Vitamin D status and infant Birth weight68,69).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 41)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'birth')]
PMC3827489	10/2013	S94-PMC3827489	['there are prospective studies SUGGESTING that higher maternal Vitamin D status during Pregnancy MAY lower the development of wheezing episodes in infancy70,71)or Lower Respiratory Tract infections72).']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 96)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('UBERON_0009567', 'nail of pedal digit', 162, 'lower'), ('UBERON_0000065', 'respiratory tract', 168, 'respiratory tract')]
PMC3827489	10/2013	S95-PMC3827489	['ONE STUDY FOUND that higher maternal Vitamin D status during Pregnancy increased the development of atopic dermatitis or asthma in the offspring69), and another FOUND no significant associations between maternal late-Pregnancy Vitamin D status and either asthma or wheezing at the age of 6 years73).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 161)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007565', 'female pregnancy', 217, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC3827489	10/2013	S96-PMC3827489	['IN GENERAL, the OBSERVATIONAL EVIDENCE LINKING low maternal Vitamin D status during Pregnancy to an increase in the risk of allergic diseases in the offspring SEEMS more convincing.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 159)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy')]
PMC3827489	10/2013	S97-PMC3827489	['RECOMMENDATION of Vitamin D supplementation for infants, children, and adolescents\nRECENTLY, the american academy of pediatrics (aap) RECOMMENDED that all infants (beginning soon after Birth), children, and adolescents have a minimum daily intake of 400 iu (10 µg) of Vitamin D74), which is two times the previous recommended dose of Vitamin D supplementation SUGGESTED in a 2003 clinical report from the aap.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 83), ('FUTURE_WORK', 134), ('INCOMPLETE_EVIDENCE', 360)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007567', 'parturition', 185, 'birth'), ('CHEBI_33279', 'vitamin D5', 268, 'vitamin D74'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D')]
PMC3827489	10/2013	S98-PMC3827489	['the daily Vitamin D RECOMMENDATION for women during Pregnancy and Lactation is 600 iu (15 µg) ACCORDING TO the u.s. Food and Drug administration.']	[('FUTURE_WORK', 20), ('INCOMPLETE_EVIDENCE', 94)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('GO_0007595', 'lactation', 66, 'lactation'), ('CHEBI_33290', 'food', 116, 'Food'), ('CHEBI_23888', 'drug', 125, 'Drug')]
PMC3827489	10/2013	S99-PMC3827489	['in 2011, the u.s. Endocrine task force on Vitamin D REPORTED that 600 iu/day MAY not be sufficient to correct Vitamin D deficiency in Pregnant and Lactating women, and THEREFORE SUGGESTED 1,500-2,000 iu/day for Pregnant and Lactating women with Vitamin D deficiency75).']	[('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 168), ('INCOMPLETE_EVIDENCE', 178)]	4	[('GO_0009790', 'embryo development', 18, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 42, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('GO_0007594', 'puparial adhesion', 147, 'lactating'), ('GO_0007565', 'female pregnancy', 211, 'pregnant'), ('GO_0007594', 'puparial adhesion', 224, 'lactating'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC3827489	10/2013	S100-PMC3827489	['it is NOT KNOWN, however, HOW much amount of Vitamin D supplementation is NEEDED for korean children and Pregnant women in order to maintain adequate concentrations of vitamin D. CONSIDERING the high prevalence of Vitamin D insufficiency or deficiency in koreans, ESPECIALLY children and adolscents6,22-24), this ISSUE NEEDS TO BE addressed URGENTLY by FUTURE STUDIES.']	[('FULL_UNKNOWN', 6), ('EXPLICIT_QUESTION', 26), ('IMPORTANT_CONSIDERATION', 74), ('INCOMPLETE_EVIDENCE', 179), ('IMPORTANT_CONSIDERATION', 264), ('PROBLEM_COMPLICATION', 313), ('IMPORTANT_CONSIDERATION', 319), ('IMPORTANT_CONSIDERATION', 341), ('FUTURE_WORK', 353)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 176, 'D'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3827489	10/2013	S103-PMC3827489	['from a perspective of integrative childhood care, it MAY BE advantageous to RECOMMEND more time spent in outdoor activity for sunlight exposure and increased Vitamin D supplementation to achieve OPTIMAL health in children and adolescents.']	[('INCOMPLETE_EVIDENCE', 53), ('FUTURE_WORK', 76), ('IMPORTANT_CONSIDERATION', 195)]	3	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC3855580	10/2013	S115-PMC3855580	['in the ONLY data from a randomised controlled trial, children of women in nepal who were supplemented with Vitamin A plus Folic Acid from early Gestation had less microalbuminuria and a lower prevalence of Metabolic syndrome at 6–8\xa0years than children of mothers supplemented with Vitamin A alone [29].']	[('INCOMPLETE_EVIDENCE', 7)]	1	[('CHEBI_27300', 'vitamin D', 107, 'vitamin A'), ('CHEBI_30751', 'formic acid', 122, 'folic acid'), ('GO_0007565', 'female pregnancy', 144, 'gestation'), ('GO_0008152', 'metabolic process', 206, 'metabolic'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin A')]
PMC3855580	10/2013	S153-PMC3855580	['we have PREVIOUSLY SHOWN that the ASSOCIATION between maternal Vitamin D deficiency [38] and Glucose intolerance [11,14] with offspring homa-ir was present at 9.5\xa0years of age, but NOT at 5\xa0years of age.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 34), ('ANOMALY_CURIOUS_FINDING', 181)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_17234', 'glucose', 93, 'glucose')]
PMC4231606	10/2013	S27-PMC4231606	['it is PLAUSIBLE that those with s-ecc are also DEFICIENT in IMPORTANT Vitamins and Nutrients, including Vitamin D [14].']	[('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 47), ('IMPORTANT_CONSIDERATION', 60)]	3	[('CHEBI_33277', 'gamma-tocotrienol', 70, 'vitamins'), ('CHEBI_33284', 'nutrient', 83, 'nutrients'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4231606	10/2013	S31-PMC4231606	['DEFICIENCY in Vitamin D during periods of Tooth Development MAY also result in developmental defects [17] including Enamel hypoplasia, a SIGNIFICANT RISK FACTOR for s-ecc.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 60), ('IMPORTANT_CONSIDERATION', 137), ('SUPERFICIAL_RELATIONSHIP', 149)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0048538', 'thymus development', 42, 'tooth development'), ('UBERON_0001091', 'calcareous tooth', 42, 'tooth'), ('UBERON_0001752', 'enamel', 116, 'enamel')]
PMC4231606	10/2013	S106-PMC4231606	['multiple regression for 25(Oh)D concentrations REVEALED that levels were significantly and INDEPENDENTLY ASSOCIATED with s-ecc, regular Milk Consumption, and season of assessment BUT NOT household income and or the use of Vitamin D drops (table\xa03).']	[('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 91), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 179)]	4	[('CHEBI_71657', 'versiconol acetate', 24, '25(OH)D'), ('UBERON_0001913', 'milk', 136, 'milk'), ('GO_0007631', 'feeding behavior', 141, 'consumption'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC4231606	10/2013	S108-PMC4231606	['logistic regression for caries status was also performed, REVEALING that lower household income, poorer ratings of children’s general health, and lower Vitamin D levels were significantly ASSOCIATED with s-ecc (table\xa04).']	[('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 188)]	2	[('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC4231606	10/2013	S113-PMC4231606	['WHILE HISTORICAL EVIDENCE SUGGESTS that Vitamin D supplementation CAN PREVENT caries onset and progression, much of this RESEARCH has been OVERLOOKED [18,29,30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	8	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4231606	10/2013	S116-PMC4231606	['much of the EARLY RESEARCH in this field was conducted by may mellanby, who IDENTIFIED an ASSOCIATION between Vitamin D supplementation and reduced caries-risk [18,31].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 90)]	3	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4231606	10/2013	S117-PMC4231606	['RECENTLY, a meta-analysis REPORTED that Vitamin D supplementation in childhood CAN help PREVENT caries [30], and it HAS also BEEN SUGGESTED that concentrations of 25(Oh)D between 75–100\xa0nmol/l MAY reduce the RISK for Caries [22].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 88), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 193), ('IMPORTANT_CONSIDERATION', 208)]	8	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 165, '(OH)D'), ('CHEBI_23042', 'carotene', 217, 'caries')]
PMC4231606	10/2013	S121-PMC4231606	['regular milk drinkers had BETTER Vitamin D concentrations, a FINDING SUPPORTED by A large-scale clinical STUDY OBSERVING an ASSOCIATION between frequent Milk Consumption and increased 25(Oh)D [33].']	[('IMPORTANT_CONSIDERATION', 26), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001913', 'milk', 153, 'milk'), ('GO_0007631', 'feeding behavior', 158, 'consumption'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 187, 'OH)D')]
PMC4231606	10/2013	S122-PMC4231606	['regression techniques were employed to determine WHETHER the ASSOCIATION between caries and Vitamin D status REMAINED after controlling for CONFOUNDERS.']	[('EXPLICIT_QUESTION', 49), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 140)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4231606	10/2013	S123-PMC4231606	['EVEN after controlling for seasonal INFLUENCE on Endogenous Synthesis, low household income, and infrequent Consumption of Vitamin D drops and milk, the significant ASSOCIATION REMAINED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 177)]	4	[('GO_0042400', 'ectoine catabolic process', 49, 'endogenous synthesis'), ('GO_0007631', 'feeding behavior', 108, 'consumption'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4231606	10/2013	S132-PMC4231606	['a DEFICIENCY in this protein IN CONJUNCTION WITH UNDESIRABLE Vitamin D, pth, and calcium levels MAY SUGGEST that children with s-ecc have nutritional DEFICIENCIES.']	[('IMPORTANT_CONSIDERATION', 2), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 150)]	6	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4231606	10/2013	S155-PMC4231606	['THIS STUDY SUGGESTS a CLEAR RELATIONSHIP between Vitamin D levels and the caries status of preschool children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 22), ('SUPERFICIAL_RELATIONSHIP', 28)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3829803	11/2013	S30-PMC3829803	['in the last 2 decades, MANY STUDIES have DOCUMENTED the beneficial EFFECTS of Vitamin A supplements on general mortality and/or morbidity in young children in a wide range of developing countries.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 67)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin A')]
PMC3829803	11/2013	S31-PMC3829803	['in 2000, a meta-analysis of eight studies DEMONSTRATED an overall 30% reduction in infant mortality attributable to Vitamin A supplements [13]–[15].']	[('INCOMPLETE_EVIDENCE', 42)]	1	[('CHEBI_27300', 'vitamin D', 116, 'vitamin A')]
PMC3829803	11/2013	S32-PMC3829803	['a SURPRISING spin-OFF from these Vitamin A supplementation STUDIES was the re-discovery that Vitamin A ‘treatment’ CAN significantly decrease the morbidity and mortality ASSOCIATED with acute Mev infection [16]–[19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('ANOMALY_CURIOUS_FINDING', 2), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 170)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 192, 'MeV')]
PMC3829803	11/2013	S168-PMC3829803	['Perinatal Vitamin A Supplements in hiv-positive women CAN improve the survival of the seronegative children but CAN increase Mother-To-Child Hiv Transmission [65], POSSIBLY through increased Viral loads in Breast Milk [66].']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 164)]	3	[('GO_0036268', 'swimming', 0, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 0, 'Perinatal'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin A'), ('CHEBI_33341', 'titanium atom', 20, 'supplements'), ('GO_0007063', 'regulation of sister chromatid cohesion', 125, 'mother-to-child HIV transmission'), ('NCBITaxon_1', 'root', 191, 'viral'), ('UBERON_0001348', 'brown adipose tissue', 206, 'breast milk')]
PMC3829803	11/2013	S173-PMC3829803	['studies with another paramyxovirus HAVE SHOWN that Vitamin A deficient Chickens suffer increased morbidity from newcastle disease virus (ndv) [75]–[77].']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 71, 'chickens')]
PMC3829803	11/2013	S174-PMC3829803	['using the paramyxovirus most closely RELATED to Measles, our group has DEMONSTRATED that canine distemper virus (cdv)-infected ferrets treated with Vitamin A develop less SEVERE disease [78].']	[('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 171)]	3	[('NCBITaxon_33208', 'Metazoa', 48, 'measles'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin A')]
PMC3829803	11/2013	S175-PMC3829803	['in aggregate, these OBSERVATIONS SUGGEST that Vitamin A and its derivatives MAY play an IMPORTANT ROLE in Antiviral Responses BUT demonstrate clearly that mechanistic studies are ESSENTIAL to fully UNDERSTAND and exploit this POTENTIAL.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 88), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('IMPORTANT_CONSIDERATION', 179), ('FUTURE_WORK', 198), ('INCOMPLETE_EVIDENCE', 226)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin A'), ('GO_0002901', 'mature B cell apoptotic process', 106, 'antiviral responses')]
PMC3829803	11/2013	S208-PMC3829803	['in this context, it is PLAUSIBLE that the modest reduction in the rate of Muv Replication that we OBSERVED with Retinoid ‘treatment’ in vitro COULD translate into clinical BENEFIT during natural disease, AS occurs with Vitamin A treatment in natural Mev infection.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 172), ('PROBABLE_UNDERSTANDING', 204)]	5	[('NCBITaxon_10088', 'Mus <genus>', 74, 'MuV'), ('PR_000010775', 'PWWP domain-containing DNA repair factor 3A', 74, 'MuV'), ('GO_0006260', 'DNA replication', 78, 'replication'), ('CHEBI_26537', 'retinoid', 112, 'retinoid'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 250, 'MeV')]
PMC3829803	11/2013	S249-PMC3829803	['HOWEVER, high doses of Vitamin A in children with Rsv infection have no benefit and MAY EVEN cause harm [74,88].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 84), ('ANOMALY_CURIOUS_FINDING', 88)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 50, 'RSV')]
PMC3829803	11/2013	S256-PMC3829803	['THIS is the FIRST work to DEMONSTRATE the antiviral EFFECT of Vitamin A on Muv and MAY CONTRIBUTE to better treatment OPTIONS for Muv.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 87), ('FUTURE_WORK', 118)]	8	[('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 75, 'MuV'), ('NCBITaxon_10088', 'Mus <genus>', 130, 'MuV')]
PMC3991049	11/2013	S2-PMC3991049	['the current GUIDELINES for Vitamin D intake during Pregnancy of 200–400 iu has LITTLE scientific SUPPORT and HAS BEEN RECENTLY CHALLENGED.']	[('IMPORTANT_CONSIDERATION', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy')]
PMC3991049	11/2013	S18-PMC3991049	['in RECENT YEARS there HAS BEEN an INCREASED UNDERSTANDING of the ROLE that Vitamin D plays in Regulation Of Cell Growth, immunity, and Cell Metabolism.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 65)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0051900', 'regulation of mitochondrial depolarization', 94, 'regulation of cell growth ...'), ('GO_0044237', 'cellular metabolic process', 135, 'cell metabolism')]
PMC3991049	11/2013	S20-PMC3991049	['BECAUSE 25-Hydroxyvitamin D crosses the Placenta,1and Fetal and Cord Blood levels of the new born Vitamin D status CORRELATE with the mother levels of Vitamin D,2,3a higher level of Vitamin D in the fetus MAY raise the concern of POSSIBLE POTENTIAL fetal harm.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 205), ('INCOMPLETE_EVIDENCE', 230), ('INCOMPLETE_EVIDENCE', 239)]	5	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 8, '25-hydroxyvitamin D'), ('UBERON_0001987', 'placenta', 40, 'placenta'), ('UBERON_0000922', 'embryo', 54, 'fetal'), ('UBERON_0002240', 'spinal cord', 64, 'cord'), ('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC3991049	11/2013	S21-PMC3991049	['a high prevalence of Vitamin D insufficiency was FOUND in Pregnant women in different studies with DIFFERENT ethnic and geographical backgrounds.4–8the average Prenatal Vitamins contain 400 iu of Vitamin D, which PARTIALLY EXPLAINS this high prevalence of Vitamin D insufficiency in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('INCOMPLETE_EVIDENCE', 213), ('PROBABLE_UNDERSTANDING', 223)]	4	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnant'), ('GO_0007565', 'female pregnancy', 160, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 169, 'vitamins'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('GO_0007565', 'female pregnancy', 283, 'pregnant')]
PMC3991049	11/2013	S22-PMC3991049	['Vitamin D supplementation during Pregnancy REMAINS CONTROVERSIAL and the current RECOMMENDED REQUIREMENT for Vitamin D during Pregnancy (200–400 iu/d) has LITTLE scientific SUPPORT.']	[('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('FUTURE_WORK', 81), ('IMPORTANT_CONSIDERATION', 93), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 173)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC3991049	11/2013	S24-PMC3991049	["a RECENT STUDY SHOWED that a daily supplement of 4000 iu of Vitamin D was REQUIRED to sustain normal Metabolism in Pregnancy and this dose was EFFECTIVE and SAFE.9\nin THIS STUDY we EVALUATED the prevalence of Vitamin D deficiency in Pregnant women and EVALUATED the EFFECT of weekly Oral 50,000 iu of Vitamin D on mothers' and newborn's level of Vitamin D.\n\nmethods\nTHIS is a prospective observational study conducted at a single center at hamad medical corporation in doha, qatar."]	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 143), ('IMPORTANT_CONSIDERATION', 157), ('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('QUESTION_ANSWERED_BY_THIS_WORK', 181), ('QUESTION_ANSWERED_BY_THIS_WORK', 252), ('SUPERFICIAL_RELATIONSHIP', 266), ('QUESTION_ANSWERED_BY_THIS_WORK', 366)]	10	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0008152', 'metabolic process', 101, 'metabolism'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('GO_0007565', 'female pregnancy', 233, 'pregnant'), ('UBERON_0000165', 'mouth', 283, 'oral'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]
PMC3991049	11/2013	S63-PMC3991049	["newborns' Vitamin D levels CORRELATED positively with maternal 25-Hydroxyvitamin D (p\xa0<\xa00.001).10in a study from china, jing wang et al., reported 57.1% of Pregnant women and 44.2% showed deficiency, and 97.4% of women and 96.1% of neonates SHOWED Vitamin D insufficiency.11\nbodnar et al.,12REPORTED the prevalence of Vitamin D deficiency and insufficiency in 200 caucasian and 200 african-american Pregnant women and in the Cord Blood samples of their neonates."]	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 241), ('INCOMPLETE_EVIDENCE', 289)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 63, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 156, 'pregnant'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0007565', 'female pregnancy', 399, 'pregnant'), ('UBERON_0002240', 'spinal cord', 425, 'cord'), ('UBERON_0000178', 'blood', 430, 'blood')]
PMC3991049	11/2013	S67-PMC3991049	['the IMPORTANCE of Vitamin D for fetal and infant Skeletal Development HAS LONG BEEN RECOGNIZED.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 74)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0001501', 'skeletal system development', 49, 'skeletal development'), ('UBERON_0004288', 'skeleton', 49, 'skeletal')]
PMC3991049	11/2013	S68-PMC3991049	['SEVERAL STUDIES have REPORTED ASSOCIATION between infant size and Vitamin D status.13,14reduced concentration of 25-Hydroxyvitamin D in mothers during late Pregnancy is ASSOCIATED with reduced Whole Body and Lumbar-Spine bone Mineral content in their children at the age of 9 years.15several studies HYPOTHESIZED that low Prenatal and Perinatal Vitamin D concentrations AFFECT the functional characteristics of various Tissues of the body, which leads to greater risk in later Life of multiple sclerosis, cancer, Insulin-dependent diabetes mellitus and schizophrenia.16,17\nthe current RECOMMENDED dose of Vitamin D during Pregnancy DIFFERS in DIFFERENT parts of the world.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 300), ('SUPERFICIAL_RELATIONSHIP', 370), ('FUTURE_WORK', 585), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 632), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643)]	9	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 113, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy'), ('UBERON_0000468', 'multicellular organism', 193, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 208, 'lumbar-spine'), ('CHEBI_46662', 'mineral', 226, 'mineral'), ('GO_0007565', 'female pregnancy', 322, 'prenatal'), ('GO_0036268', 'swimming', 335, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 335, 'perinatal'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0000479', 'tissue', 419, 'tissues'), ('UBERON_0000104', 'life cycle', 477, 'life'), ('PR_000045358', 'insulin family protein', 513, 'insulin'), ('CHEBI_27300', 'vitamin D', 605, 'vitamin D'), ('GO_0007565', 'female pregnancy', 622, 'pregnancy')]
PMC3991049	11/2013	S69-PMC3991049	['the RECOMMENDED daily intake of Vitamin D is 200 iu/day in the united states, australia, new zealand and canada.18–20in the uk, the daily recommended dose is 400 iu/day.21HISTORICALLY, Vitamin D supplementation during Pregnancy WAS THOUGHT TO be a risk factor for Supravalvular stenosis in infants, which was BASED ON a 1964 case report.22\nDIFFERENT STUDIES SUGGESTED that the daily use 1000 iu,23–272000 iu,284000 iu,29and 6400 iu30would HELP to eliminate Vitamin D insufficiency without apparent toxicity in Pregnant women and their infants.']	[('FUTURE_WORK', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 309), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 340), ('INCOMPLETE_EVIDENCE', 350), ('INCOMPLETE_EVIDENCE', 358), ('FUTURE_WORK', 439)]	9	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('GO_0007565', 'female pregnancy', 218, 'pregnancy'), ('UBERON_2000442', 'supraneural bone', 264, 'supravalvular'), ('CHEBI_27300', 'vitamin D', 457, 'vitamin D'), ('GO_0007565', 'female pregnancy', 510, 'pregnant')]
PMC3991049	11/2013	S70-PMC3991049	['all of this SUPPORTS that 400 iu of Vitamin D MAY BE INADEQUATE to raise the maternal Vitamin D level to optimum level PARTICULARLY for women living in northern latitude, women with darker skin or covered women, as well as for women who are not exposed to sunlight, not on dietary supplements or have absorption and metabolic PROBLEMS.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 53), ('PROBLEM_COMPLICATION', 53), ('ANOMALY_CURIOUS_FINDING', 119), ('PROBLEM_COMPLICATION', 326)]	6	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3991049	11/2013	S71-PMC3991049	['we used a 50,000 iu dose, AS per our PREVIOUS STUDIES, which DEMONSTRATED no toxicity when Vitamin D deficient rheumatology outpatient and health care professional were supplemented this dose.31–32\nthe CONCERN of using higher doses of Vitamin D MIGHT cause hypercalcemia, hypercalciuria, Renal calculi and soft Tissue and vascular calcification toxicity is LIKELY to worsen with Calcium supplementation.']	[('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 202), ('PROBLEM_COMPLICATION', 202), ('INCOMPLETE_EVIDENCE', 245), ('PROBABLE_UNDERSTANDING', 357)]	7	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('UBERON_0002113', 'kidney', 288, 'renal'), ('UBERON_0000479', 'tissue', 311, 'tissue'), ('CHEBI_22313', 'alkaline earth metal atom', 379, 'calcium')]
PMC3991049	11/2013	S74-PMC3991049	['no adverse effects were observed in these mothers or their infants.33\nOUR STUDY DEMONSTRATED that low Vitamin D level is common in Pregnant mothers in qatar.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('INCOMPLETE_EVIDENCE', 80), ('QUESTION_ANSWERED_BY_THIS_WORK', 80)]	3	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnant')]
PMC3991049	11/2013	S79-PMC3991049	['moreover, given that qatar is sunny all year, levels of Vitamin D were not correlated with the season; we knew that from our PREVIOUS STUDY that most of the population has low Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 125)]	1	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D')]
PMC3991049	11/2013	S81-PMC3991049	['studies are UNDERWAY in the us to establish Vitamin D REQUIREMENTS during Pregnancy (http://clinicaltrials.gov#r01hd043921).']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 54)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy')]
PMC3873449	12/2013	S0-PMC3873449	['the high prevalence of Vitamin D deficiency and its RELATED maternal FACTORS in Pregnant women in beijing\n\nabstract\nmaternal Vitamin D deficiency HAS BEEN SUGGESTED to INFLUENCE fetal and neonatal health.']	[('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 168)]	4	[('CHEBI_28384', 'vitamin K', 23, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3873449	12/2013	S13-PMC3873449	['HOWEVER, neither prolonging the time of sunlight exposure nor Multivitamin supplements CAN effectively prevent Pregnant women from Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 87)]	2	[('CHEBI_7025', 'mupirocin', 62, 'multivitamin'), ('GO_0007565', 'female pregnancy', 111, 'pregnant'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3873449	12/2013	S14-PMC3873449	['OTHER measures MIGHT have to be taken for Pregnant women to improve their Vitamin D status in winter.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15)]	2	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3873449	12/2013	S18-PMC3873449	['there is GROWING concern about the functional IMPACTS of maternal Vitamin D on their offspring.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3873449	12/2013	S22-PMC3873449	['a RECENT STUDY systematically reviews randomized controlled trials and observational studies of maternal Vitamin D status in Pregnancy on the Extraskeletal health of the offspring [7].']	[('INCOMPLETE_EVIDENCE', 2)]	1	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnancy'), ('UBERON_0001431', 'distal carpal bone 2', 142, 'extraskeletal')]
PMC3873449	12/2013	S23-PMC3873449	['it is SUGGESTED that Vitamin D is LIKELY to have an EFFECT on several offspring outcomes such as a race-DEPENDENT lowering of Birthweight, type i diabetes and early childhood infections.']	[('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 34), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007596', 'blood coagulation', 126, 'birthweight')]
PMC3873449	12/2013	S25-PMC3873449	['there is LITTLE EVIDENCE concerning the ROLE of maternal Vitamin D in Pregnancy in their child Autoimmune diseases.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 40)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 95, 'autoimmune')]
PMC3873449	12/2013	S27-PMC3873449	['during the past several decades, NUMEROUS STUDIES HAVE REPORTED a high prevalence of Vitamin D deficiency among Pregnant women in countries where women wear concealing clothing such as india [8], saudi arabia [9] and iran [10] and countries in northern latitudes such as the united kingdom [6] and norway [11].']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 50)]	2	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnant')]
PMC3873449	12/2013	S29-PMC3873449	['FEW STUDIES have examined Vitamin D status in chinese Pregnant women.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnant')]
PMC3873449	12/2013	S33-PMC3873449	['these FACTORS MAY LEAD TO an increase in the RISK of Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 18), ('IMPORTANT_CONSIDERATION', 45)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC3873449	12/2013	S34-PMC3873449	['indeed, in a RECENT small sample size STUDY[12], we FOUND an extremely high prevalence of Vitamin D deficiency (90%) in Pregnant women in beijing in spring.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 52)]	2	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 120, 'pregnant')]
PMC3873449	12/2013	S39-PMC3873449	['there is considerable INTEREST in FACTORS that MAY INFLUENCE Vitamin D status in chinese Pregnant women.']	[('ANOMALY_CURIOUS_FINDING', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 51)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant')]
PMC3873449	12/2013	S41-PMC3873449	['maternal pre-Pregnant weight and pre-Pregnant body mass index (bmi) are also included SINCE Adipose Tissue HAS BEEN SHOWN to Sequester Vitamin D [14].']	[('PROBABLE_UNDERSTANDING', 86), ('INCOMPLETE_EVIDENCE', 107)]	2	[('GO_0007565', 'female pregnancy', 13, 'pregnant'), ('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('UBERON_0001013', 'adipose tissue', 92, 'adipose tissue'), ('GO_0051235', 'maintenance of location', 125, 'sequester'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D')]
PMC3873449	12/2013	S44-PMC3873449	['the results SHOULD provide a BETTER UNDERSTANDING of the maternal FACTORS that INFLUENCE Vitamin D status during Pregnancy and help in raising AWARENESS as well as SUGGESTING STRATEGIES to prevent Vitamin D deficiency in china.']	[('FUTURE_WORK', 12), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 143), ('FUTURE_WORK', 164), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 175)]	8	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC3873449	12/2013	S62-PMC3873449	['ALTHOUGH there HAS BEEN DEBATE over WHICH level of Serum 25(Oh)D REFLECTS optimum Vitamin D status, it is GENERALLY ACCEPTED that Serum 25(Oh)d level of < 30ng/ml(75nmol/l) is the cut-off value for insufficiency [15-17], which is ASSOCIATED with maximal suppression of Parathyroid hormone [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('EXPLICIT_QUESTION', 36), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 230)]	9	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001977', 'blood serum', 130, 'serum'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('UBERON_0001132', 'parathyroid gland', 269, 'parathyroid')]
PMC3873449	12/2013	S115-PMC3873449	['discussion\nthe PRESENT STUDY SHOWED a high prevalence of Vitamin D deficiency among Pregnant women in the beijing urban area (39.9 °n), northern china in winter.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 29)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnant')]
PMC3873449	12/2013	S118-PMC3873449	['these STUDIES SUGGEST that Pregnant women in beijing are at very high RISK of Vitamin D deficiency in either winter or spring.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 70)]	3	[('GO_0007565', 'female pregnancy', 27, 'pregnant'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3873449	12/2013	S119-PMC3873449	['OTHER STUDIES have DEMONSTRATED that Vitamin D deficiency is common in Pregnant women in DIFFERENT countries, such as 31% in southern india [8], 19.5% in greece [20] and 5.7 % in iran [10].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'pregnant')]
PMC3873449	12/2013	S120-PMC3873449	['ONE STUDY OBSERVED the Vitamin D status in Pregnant women of several ethnic backgrounds who reside in the hague in the netherlands (52° n).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnant')]
PMC3873449	12/2013	S122-PMC3873449	['a study from chengdu urban area (30.7°n; southwest china) SHOWED that the prevalence of Vitamin D deficiency was 57.1% in Pregnant women in spring [22].']	[('INCOMPLETE_EVIDENCE', 58)]	1	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnant')]
PMC3873449	12/2013	S130-PMC3873449	['this SUGGESTS that sun exposure plays a ROLE in maintaining Vitamin D levels in chinese Pregnant women in winter.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 40)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 88, 'pregnant')]
PMC3873449	12/2013	S138-PMC3873449	['it HAS BEEN SUGGESTED that in sun-rich brisbane, australia, between 2 and 4 minutes sun exposure per day was needed during summer months, at noon, for a caucasian to produce enough Vitamin D[23].']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC3873449	12/2013	S140-PMC3873449	['PREVIOUS experiments SUGGEST that indians REQUIRE about three times the uv exposure as white caucasians to produce the same amount of Vitamin D [24].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 42)]	3	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC3873449	12/2013	S144-PMC3873449	['this MAY SUGGEST that the ROLE of sun exposure is LIMITED in elevating Vitamin D concentration in Pregnant women residing in beijing in winter.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 50)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnant')]
PMC3873449	12/2013	S147-PMC3873449	['it HAS BEEN REPORTED that minimal skin exposure of Arms and Face will only result in a nominal Production Of Vitamin D-3 [26].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12)]	2	[('UBERON_0001447', 'tarsal bone', 51, 'arms'), ('UBERON_0001456', 'face', 60, 'face'), ('GO_1902009', 'positive regulation of toxin transport', 95, 'production of vitamin D-'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 109, 'vitamin D-3')]
PMC3873449	12/2013	S156-PMC3873449	['DEMONSTRATED that a uv-b irradiation threshold of 18 mj/cm2was REQUIRED to induce Vitamin D-3 Production for healthy white subjects [30].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 63)]	2	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 82, 'vitamin D-3'), ('GO_0001555', 'oocyte growth', 94, '... production')]
PMC3873449	12/2013	S159-PMC3873449	['it HAS BEEN REPORTED that women in high latitudes have more Vitamin D insufficiency [31].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3873449	12/2013	S162-PMC3873449	['in addition, pollution MAY BE also a FACTOR that AFFECTS uv-b reaching the skin and reducing endogenous Vitamin D Production in the skin.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 104, 'vitamin D production')]
PMC3873449	12/2013	S165-PMC3873449	['ONE STUDY in india has FOUND that high atmospheric pollution decreases the percentage of uvb which reaches the earth surface and children in more polluted areas are at higher risk of Vitamin D deficiency [33].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 23)]	2	[('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC3873449	12/2013	S166-PMC3873449	['OTHER STUDIES have ALSO SHOWN that the air pollution has a significant INFLUENCE on Vitamin D status [34,35].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC3873449	12/2013	S168-PMC3873449	['THEREFORE OTHER EFFECTIVE measures MAY NEED to be taken to improve Vitamin D status in chinese Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 35), ('FUTURE_WORK', 39)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant')]
PMC3873449	12/2013	S169-PMC3873449	['it HAS BEEN REPORTED that Vitamin D supplementation CAN EFFECTIVELY improve Vitamin D status [36].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 56)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC3873449	12/2013	S170-PMC3873449	['a RECENT randomized clinical TRIAL in non-western immigrants in the netherlands (none asian) FOUND Vitamin D supplementation to be more EFFECTIVE than advised sunlight exposure for treating Vitamin D deficiency [37].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 136)]	3	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC3873449	12/2013	S171-PMC3873449	['in OUR STUDY nearly half of women did take multivitamins and these multivitamins did improve the Vitamin D level SOMEWHAT but DID NOT prevent Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 126)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC3873449	12/2013	S173-PMC3873449	['appropriate dose of Vitamin D supplementation for women MAY BE REQUIRED.']	[('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 63)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC3873449	12/2013	S177-PMC3873449	['higher amounts of Vitamin D MAY BE REQUIRED, THOUGH the precise dose REMAINS UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 35), ('ANOMALY_CURIOUS_FINDING', 45), ('FULL_UNKNOWN', 69)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC3873449	12/2013	S179-PMC3873449	['EITHER single (200,000 iu Vitamin D) OR daily (800 iu) dose of Vitamin D HAS BEEN effective at raising circulating 25(Oh)d concentrations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 73)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 115, '25(OH)')]
PMC3873449	12/2013	S180-PMC3873449	['HOWEVER, EVEN with supplementation, ONLY a SMALL percentage of women and babies were Vitamin D sufficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('ANOMALY_CURIOUS_FINDING', 36), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 43)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3873449	12/2013	S182-PMC3873449	['HOWEVER, in Pregnant women, a study evaluating Plasma Vitamin D status HAS SHOWN that Vitamin D supplementation of <2000 iu/day is not EFFECTIVE in achieving sufficiency [42].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 135)]	3	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('UBERON_0001969', 'blood plasma', 47, 'plasma'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC3873449	12/2013	S183-PMC3873449	['ANOTHER STUDY SHOWED that Vitamin D supplementation of 4000 iu/day for Pregnant women is MOST EFFECTIVE in achieving sufficiency in all women REGARDLESS OF race [43].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 142)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'pregnant')]
PMC3873449	12/2013	S187-PMC3873449	['ON THE BASIS of THESE FINDINGS, it SEEMS logical that Pregnant women SHOULD routinely be supplemented with Vitamin D in china.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('ANOMALY_CURIOUS_FINDING', 35), ('FUTURE_WORK', 69)]	4	[('GO_0007565', 'female pregnancy', 54, 'pregnant'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC3873449	12/2013	S188-PMC3873449	['HOWEVER, SINCE there is INSUFFICIENT DATA to evaluate the EFFECTIVENESS of Vitamin D supplementation during Pregnancy Vitamin D supplementation as routine Antenatal care is YET TO BE DETERMINED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 58), ('FULL_UNKNOWN', 173)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 155, 'antenatal')]
PMC3873449	12/2013	S191-PMC3873449	['a survey REVEALED CONSIDERABLE ignorance and confusion about the function of Vitamin D and sources of Vitamin D in chinese women [44].']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 18)]	2	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC3873449	12/2013	S197-PMC3873449	['this SUGGESTS that education levels are MOST LIKELY to INFLUENCE women’s health awareness RATHER than directly AFFECT Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('SUPERFICIAL_RELATIONSHIP', 111)]	6	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC3873449	12/2013	S199-PMC3873449	['it HAS BEEN REPORTED that pre-gravid obese women had significantly lower Serum 25(Oh)D concentrations and dose-DEPENDENT RELATIONS between pre-Pregnancy bmi and maternal Vitamin D status [48].']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 111), ('SUPERFICIAL_RELATIONSHIP', 121)]	3	[('UBERON_0001977', 'blood serum', 73, 'serum'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 79, '25(OH)D'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC3873449	12/2013	S210-PMC3873449	['TO OUR KNOWLEDGE, THIS STUDY is the FIRST to report the INFLUENCE of maternal FACTORS on Vitamin D status in chinese Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 78)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnant')]
PMC3873449	12/2013	S212-PMC3873449	['the EFFECT of prolonging the duration of sun exposure on maintaining appropriate Vitamin D levels is LIMITED in Pregnant women residing in beijing in winter.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 101)]	2	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnant')]
PMC3873449	12/2013	S213-PMC3873449	['IMPORTANTLY, we did have the INFORMATION on multivitamin supplement usage, which allowed us to SHOW that WHILE Pregnancy-specific multivitamin supplements improve the status in women at low risk of severe Vitamin D deficiency, it does not prevent women from Vitamin D deficiency in winter.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105)]	4	[('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC3873449	12/2013	S214-PMC3873449	['measures MAY HAVE TO BE taken to improve Vitamin D status in Pregnant women in china.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 13)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnant')]
PMC3882256	1/2014	S66-PMC3882256	['maternal Vitamin C intake (which we CONSIDERED a POTENTIAL effect modifier of maternal iron status on offspring outcomes) was calculated from the Food frequency questionnaire as described above for iron intake.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 49)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('PR_000004900', 'complement C3', 17, 'C'), ('CHEBI_33290', 'food', 146, 'food')]
PMC3882256	1/2014	S74-PMC3882256	['the POSSIBILITIES that offspring sex or maternal adequate intake of Vitamin C (≤ versus >50 mg/day) modified the ASSOCIATION of maternal exposures with offspring outcomes were assessed by examining stratified (by sex and maternal adequate Vitamin C intake) analyses and by including an interaction term in the confounder adjusted models.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 113)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin C'), ('PR_000004900', 'complement C3', 247, 'C')]
PMC3904479	1/2014	S32-PMC3904479	['this CONCEPT was FURTHER PROMOTED by DESCRIBING the RELATIONSHIP between maternal diet, Birth weight, and Vitamin D Receptor genotype alteration, all as a programmer of osteopenia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 25), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 52)]	5	[('GO_0007567', 'parturition', 88, 'birth'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 106, 'vitamin D receptor')]
PMC3926113	1/2014	S1-PMC3926113	['the Brain is one of the Organs containing the highest concentration of Vitamin C (Vitc) and Vitc deficiency during Foetal Development MAY place the Brain AT RISK of redox status imbalance.']	[('INCOMPLETE_EVIDENCE', 134), ('IMPORTANT_CONSIDERATION', 154)]	2	[('UBERON_0000955', 'brain', 4, 'brain'), ('UBERON_0000062', 'organ', 24, 'organs'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin C'), ('PR_000017299', 'VIP peptides', 82, 'VitC'), ('PR_000017299', 'VIP peptides', 92, 'VitC'), ('GO_0060324', 'face development', 115, 'foetal development'), ('UBERON_0000955', 'brain', 148, 'brain')]
PMC3926113	1/2014	S125-PMC3926113	['INTERACTION between Cytosolic Vitc and Membrane bound Vitamin E regenerates oxidized Vitamin E and results in an efficient antioxidant mechanism[9], which SUGGESTS that Vitc deficiency MAY alter Vitamin E levels HEREBY POSSIBLY disrupting Membrane integrity.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 212), ('INCOMPLETE_EVIDENCE', 219)]	5	[('GO_0005829', 'cytosol', 20, 'cytosolic'), ('PR_000017299', 'VIP peptides', 30, 'VitC'), ('GO_0016020', 'membrane', 39, 'membrane'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin E'), ('PR_000017299', 'VIP peptides', 169, 'VitC'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin E'), ('GO_0016020', 'membrane', 239, 'membrane')]
PMC3926113	1/2014	S126-PMC3926113	['SOME in-vivo STUDIES HAVE SHOWN that Intake of high vitc results in an increased Vitamin E in Tissues[5,17,18].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21)]	2	[('GO_0007631', 'feeding behavior', 37, 'intake'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin E'), ('UBERON_0000479', 'tissue', 94, 'tissues')]
PMC3930526	2/2014	S20-PMC3930526	['in belgian, it was REPORTED that 74.1% of Pregnant women were Vitamin D deficiency[3].']	[('INCOMPLETE_EVIDENCE', 19)]	1	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC3930526	2/2014	S27-PMC3930526	['it was REPORTED that children of mothers with higher levels of Vitamin C during Pregnancy MAY BE taller and heavier at the age of 6 and 12 months[10].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 90)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin C'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
PMC3930526	2/2014	S28-PMC3930526	['in another STUDY carried out in indonesia, Vitamin A supplementation among Pregnant women improves child growth at certain periods in the first two years compared with the combined supplementation of zinc and Vitamin A[11].']	[('INCOMPLETE_EVIDENCE', 11)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin A'), ('GO_0007565', 'female pregnancy', 75, 'pregnant'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin A')]
PMC3930526	2/2014	S150-PMC3930526	['Prenatal Selenium[62]and Vitamin A[63]COULD also play a ROLE in Postnatal growth.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27568', 'selenium atom', 9, 'selenium'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('GO_0007567', 'parturition', 64, 'postnatal')]
PMC4045304	2/2014	S1-PMC4045304	['though both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.']	[('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 174), ('SUPERFICIAL_RELATIONSHIP', 182), ('INCOMPLETE_EVIDENCE', 254)]	7	[('SO_0000704', 'gene', 12, 'genetic'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_30751', 'formic acid', 214, 'folic acid'), ('GO_0008152', 'metabolic process', 230, 'metabolic')]
PMC4045304	2/2014	S2-PMC4045304	['several RECENT STUDIES have PUT FORWARD HYPOTHESES to EXPLAIN the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 79)]	5	[('CHEBI_30751', 'formic acid', 104, 'folic acid'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4045304	2/2014	S4-PMC4045304	['there is also a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK for autism.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0000104', 'life cycle', 105, 'life')]
PMC4045304	2/2014	S5-PMC4045304	['in this communication, CONTROVERSIES regarding increase in ESTIMATE of prevalence, IMPLICATIONS of changes in definition, and POSSIBLE ASSOCIATION between SOME modifiable nutritional risk factors such as Folic Acid and Vitamin D and asd will be discussed.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 59), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 155)]	7	[('CHEBI_5054', 'Fibrin', 204, 'folic'), ('CHEBI_37527', 'acid', 210, 'acid'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC4045304	2/2014	S133-PMC4045304	['a GROWING body of LITERATURE SUGGESTS that certain modifiable RISK FACTORS such as maternal Metabolic syndrome and certain Vitamins such as Vitamin D and Folic Acid either in utero or early Life, MAY BE ASSOCIATED with increased risk of autism [43–45].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 203)]	5	[('GO_0008152', 'metabolic process', 92, 'metabolic'), ('CHEBI_33277', 'gamma-tocotrienol', 123, 'vitamins'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_30751', 'formic acid', 154, 'folic acid'), ('UBERON_0000104', 'life cycle', 190, 'life')]
PMC4045304	2/2014	S184-PMC4045304	['there is a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK of autism.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 105), ('IMPORTANT_CONSIDERATION', 114)]	6	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life')]
PMC4045304	2/2014	S190-PMC4045304	['Vitamin D and autism hypotheses\nseveral HYPOTHESES HAVE BEEN PROPOSED and tested to EXPLAIN the ASSOCIATION between Vitamin D status of mother and/or autistic child.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 61), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 96)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4045304	2/2014	S191-PMC4045304	['investigators have ADVANCED the HYPOTHESIS that ASSOCIATION between Vitamin D and autism COULD BE EXPLAINED by the RELATIONSHIP between seasonality and low maternal Serum 25-Hydroxyvitamin D concentration (a valid INDICATOR of Vitamin D status) [73].']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 214)]	7	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 171, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC4045304	2/2014	S192-PMC4045304	['BECAUSE activated Vitamin D (1, 25-Dihydroxy Vitamin D), a Secosteroid, upregulates the Dna Repair Gene, Vitamin deficiency during development MAY inhibit the Repair of de novo dna mutations in fetuses and infants and THUS CONTRIBUTE to risk of autism.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 143), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 223)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 29, '1, 25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_35785', 'sphingoid', 59, 'secosteroid'), ('GO_0006281', 'DNA repair', 88, 'DNA repair'), ('SO_0000704', 'gene', 99, 'gene'), ('CHEBI_33229', 'vitamin (role)', 105, 'vitamin'), ('GO_0006281', 'DNA repair', 159, 'repair')]
PMC4045304	2/2014	S193-PMC4045304	['OTHER mechanisms which MAY EXPLAIN the EFFECT of Vitamin D on autism symptoms are that Vitamin D MAY reduce the severity of autism through its anti-inflammatory actions, increasing T-Regulatory Cells, antiautoimmune effects, and upregulating Glutathione, a scavenger of oxidative byproducts [81–84].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 97)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CL_0000901', 'Tr1 cell', 181, 'T-regulatory cells'), ('GO_0065007', 'biological regulation', 183, 'regulatory'), ('CHEBI_16856', 'glutathione', 242, 'glutathione')]
PMC4045304	2/2014	S195-PMC4045304	['cannell PROPOSED a THEORY for the Genetic component of autism involving the Vitamin D system [84].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 19)]	2	[('SO_0000704', 'gene', 34, 'genetic'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4045304	2/2014	S196-PMC4045304	['CANNALL used one of the inherited components of the Vitamin D system and Vitamin D RELATED disease, atherosclerosis, as a MODEL to illustrate the mechanism of ASSOCIATION between autism and the Vitamin D system.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 159)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4045304	2/2014	S205-PMC4045304	['heritability of autism MAY BE EXPLAINED by quantitative Genetic variations in SOME facet of Vitamin D Metabolism, such as vdr or in the enzymes that activate Vitamin D [86].']	[('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 30), ('INCOMPLETE_EVIDENCE', 78)]	3	[('SO_0000704', 'gene', 56, 'genetic'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 92, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC4045304	2/2014	S206-PMC4045304	['lower levels of 25-Hydroxy Vitamin D HAVE BEEN REPORTED by SEVERAL investigators.']	[('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 59)]	2	[('CHEBI_43141', '3-hydroxypropoxy group', 16, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC4045304	2/2014	S207-PMC4045304	['a study conducted in saudi arabia FOUND that DESPITE the same amount of sun exposure, NOT ONLY was there much lower levels of 25-Hydroxy Vitamin D in autistic children as compared to controls (about half of those of controls), but also there was an extremely strong negative CORRELATION coefficient ( r = −0.84) between Vitamin D levels and autism severity on the autism severity scale [75].']	[('INCOMPLETE_EVIDENCE', 34), ('ANOMALY_CURIOUS_FINDING', 45), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 275)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 126, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 145, 'D'), ('CHEBI_27300', 'vitamin D', 320, 'vitamin D')]
PMC4045304	2/2014	S208-PMC4045304	['these OBSERVATIONS IMPLY that Vitamin D levels in autistic children are highly heritable [87].']	[('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 19)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC4045304	2/2014	S219-PMC4045304	["ANOTHER PROPOSED HYPOTHESIS for the ROLE of Vitamin D in development of autism HAS TO do with Vitamin D's function in the Dna Repair and maintenance [95]."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 79)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 94, 'Vitamin D'), ('GO_0006281', 'DNA repair', 122, 'DNA repair')]
PMC4045304	2/2014	S224-PMC4045304	['the EFFECT of a Genetically impaired Vitamin D system combined with INADEQUATE amounts of Vitamin D MAY BE ASSOCIATED with de novo mutations REPORTED in autism.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 68), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 141)]	5	[('SO_0000704', 'gene', 16, 'genetically'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4045304	2/2014	S226-PMC4045304	['the quantitative Genetic variation in various components of Vitamin D, as PROPOSED by cannall, MAY BE a piece of this puzzle.']	[('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 95)]	2	[('SO_0000704', 'gene', 17, 'genetic'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4045304	2/2014	S227-PMC4045304	['the ROLE or ROLES Vitamin D MAY play in development of asd MAY BE resolved by randomized clinical trials of Prenatal Vitamin D supplementation or Vitamin D supplementation of newborns or in early childhood.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 59)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'prenatal'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC4045304	2/2014	S243-PMC4045304	['these studies INDICATE that maternal mcs, particularly diabetes, MAY BE ASSOCIATED with Neurodevelopmental PROBLEMS in children and Vitamin D supplementation early in childhood SHOULD BE given further CONSIDERATION in treatment of asd [103–105].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 107), ('FUTURE_WORK', 177), ('FUTURE_WORK', 201)]	6	[('GO_0007399', 'nervous system development', 88, 'neurodevelopmental'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4045304	2/2014	S266-PMC4045304	['furthermore, OTHER modifiable, nutrition related RISK factors such as Folic Acid, Vitamin D, and maternal Metabolic syndrome MAY ACCOUNT FOR SOME proportion of increase in asd prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 125), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 141)]	5	[('CHEBI_30751', 'formic acid', 70, 'folic acid'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0008152', 'metabolic process', 106, 'metabolic')]
PMC4045304	2/2014	S272-PMC4045304	['POOR maternal Vitamin D status or early childhood Vitamin deficiency or low activity of various Vitamin D RELATED enzymes MAY result in deficient activity in the Vitamin D system crucial for Brain Development.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 122)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 50, 'vitamin'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007420', 'brain development', 191, 'brain development'), ('UBERON_0000955', 'brain', 191, 'brain')]
PMC4045304	2/2014	S274-PMC4045304	['PLAUSIBLE mechanisms HAVE BEEN put FORWARD to EXPLAIN the palliative ROLE of Vitamin D in children with autism via Dna Repair, anti-inflammatory actions, Autoimmune activities, and increase in Regulatory T Cells or stimulation antioxidant pathways.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 35), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0006281', 'DNA repair', 115, 'DNA repair'), ('UBERON_0001442', 'skeleton of manus', 154, 'autoimmune'), ('CL_0000815', 'regulatory T cell', 193, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 193, 'regulatory')]
PMC4045304	2/2014	S275-PMC4045304	['recruitment for an OPEN LABEL clinical trial TO EVALUATE large doses of Vitamin D in autistic children as a new treatment modality, with target 25-Hydroxyvitamin D3 levels of 80\u2009ng/ml is UNDERWAY [99].']	[('FULL_UNKNOWN', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 187)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_63991', '15-epi-lipoxin B4', 144, '25-hydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 162, 'D3')]
PMC3933171	3/2014	S12-PMC3933171	['introduction\nlow Vitamin D (vitd) status is a risk FACTOR for rickets and HAS BEEN ASSOCIATED with INCREASED prevalence of Respiratory infections and other adverse health outcomes in infants and children.12in response to the CONCERN about widespread childhood vitd deficiency, professional bodies have RECOMMENDED vitd intake of 400\u2005iu/ day for all infants.13the european society for paediatrics gastroenterology, hepatology and nutrition RECOMMENDS 800–1000\u2005iu/day for preterm infants.4based on BIOMARKERS of vitd status MOSTLY in adults, Serum 25-Hydroxyvitamin-D [25(Oh)D] concentration ≥50\u2005nmol/l was also RECOMMENDED.13HOWEVER, the functional benefit of this level is CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 225), ('FUTURE_WORK', 302), ('FUTURE_WORK', 439), ('SUPERFICIAL_RELATIONSHIP', 496), ('PROBABLE_UNDERSTANDING', 522), ('FUTURE_WORK', 610), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 622), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 673)]	12	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 123, 'respiratory'), ('UBERON_0001977', 'blood serum', 540, 'serum'), ('CHEBI_67320', 'majusculamide A', 546, '25-hydroxyvitamin-D'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D')]
PMC3953741	3/2014	S65-PMC3953741	['an experimental approach of conjugating the lipophilic Cation, Triphenylphosphonium, to an antioxidant such as Vitamin E or ubiquinone HAS BEEN SHOWN to permit the delivery of the antioxidant Moiety through the Mitochondrial Membrane.48,49WHEN this approach was DESCRIBED by murphy and smith in 2007,48it was their intention to employ the lipophilicity of Triphenylphosphonium to ensure diffusion of the antioxidant into the Mitochondria, where Ros neutralization is most useful in relegating oxidative stress.']	[('INCOMPLETE_EVIDENCE', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 237), ('INCOMPLETE_EVIDENCE', 262)]	3	[('CHEBI_36916', 'cation', 55, 'cation'), ('CHEBI_44880', 'tetraphenylphosphonium', 63, 'triphenylphosphonium'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin E'), ('CHEBI_29357', 'methanediyl', 192, 'moiety'), ('GO_0031966', 'mitochondrial membrane', 211, 'mitochondrial membrane'), ('CHEBI_44880', 'tetraphenylphosphonium', 356, 'triphenylphosphonium'), ('GO_0005739', 'mitochondrion', 425, 'mitochondria'), ('CHEBI_8756', 'RNA (poly(A))', 445, 'ROS')]
PMC4074693	3/2014	S81-PMC4074693	['[151620] the most commonly used was Vitamin C then followed by multivitamins, this is CONTRARY TO OTHER STUDIES where multivitamin was the most commonly used followed by Vitamin C and others.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 98)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin C')]
PMC3973641	4/2014	S35-PMC3973641	['DESPITE these STUDIES, LITTLE IS KNOWN about the EFFECTS of Vitamin B deficiency in fetuses and neonates on their Methionine-Homocysteine Metabolism programming and subsequent consequences to the Brain.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('FULL_UNKNOWN', 23), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin B'), ('GO_0006555', 'methionine metabolic process', 114, 'methionine- ... metabolism'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 125, 'homocysteine'), ('UBERON_0000955', 'brain', 196, 'brain')]
PMC3973641	4/2014	S180-PMC3973641	['the analysis on these time points allows us to infer the consequences of Vitamin B and Choline deficiency during Pregnancy and Pregnancy/Lactation in the short term (pnd 0, 5 and 28), and POSSIBLE changes that arise or remain even after the introduction of the standard diet (post-weaning) can be observed in the medium and long term, pnd 90 and 210, respectively.']	[('INCOMPLETE_EVIDENCE', 188)]	1	[('CHEBI_27300', 'vitamin D', 73, 'vitamin B'), ('CHEBI_15354', 'choline', 87, 'choline'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('GO_0007595', 'lactation', 137, 'lactation')]
PMC4018592	4/2014	S114-PMC4018592	['[43] in tanzania, when Micronutrient supplements providing amounts twice the RECOMMENDED dietary allowance (rda) for Vitamin E and 6-10 times for Vitamin C and several b Vitamins were administered, mean Birth weight increased by 67 g.[36] finally, the provision of multivitamin and multivitamin-Mineral supplements from two different Pharmaceutical companies MIGHT be INFLUENCED infants’ size.']	[('FUTURE_WORK', 77), ('INCOMPLETE_EVIDENCE', 359), ('SUPERFICIAL_RELATIONSHIP', 368)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 23, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin C'), ('CHEBI_33277', 'gamma-tocotrienol', 170, 'vitamins'), ('GO_0007567', 'parturition', 203, 'birth'), ('CHEBI_46662', 'mineral', 295, 'mineral'), ('CHEBI_52217', 'pharmaceutical', 334, 'pharmaceutical')]
PMC4034700	5/2014	S129-PMC4034700	['the ROLE of oxidative stress in mediating pe pathophysiology is SUPPORTED by REPORTS of significantly decreased levels of antioxidant Vitamins C, a, e, Β-Carotene, Glutathione levels, and iron-binding capacity in the maternal circulation of women with Preeclampsia.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 134, 'vitamins C'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 152, 'β-carotene'), ('CHEBI_16856', 'glutathione', 164, 'glutathione'), ('GO_0007128', 'meiotic prophase I', 252, 'preeclampsia')]
PMC4034700	5/2014	S134-PMC4034700	['we SHOWED that administration of Vitamins C and E can block hr-mediated Sflt-1 secretion, via inhibition of P38 and Nf-Κb Signaling Pathways (cindrova-davies et al., 2007;cindrova-davies, 2009).']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 48, 'E'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 72, 'sFlt-1'), ('GO_0007567', 'parturition', 108, 'p38 ...'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 108, 'p38'), ('GO_0038032', 'termination of G protein-coupled receptor signaling pathway', 116, 'NF-κB signaling pathways'), ('GO_0071159', 'NF-kappaB complex', 116, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 116, 'NF-κB')]
PMC4034700	5/2014	S137-PMC4034700	['HOWEVER, DESPITE encouraging in vitro DATA and cohort trials, clinical trials aimed to treat women AT RISK of Preeclampsia with Vitamins C and E (poston et al., 2006;rumbold et al., 2006) SHOWED no reduction in the incidence of the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('FUTURE_WORK', 38), ('IMPORTANT_CONSIDERATION', 99), ('INCOMPLETE_EVIDENCE', 188)]	5	[('GO_0007128', 'meiotic prophase I', 110, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 128, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'E')]
PMC4051754	6/2014	S244-PMC4051754	['parameters measured were: the indexes of Acute Phase Reaction, such as the positive Acute Phase protein haptoglobin and ceruloplasmin; the negative Acute Phase protein Albumin, paraoxonase and the other index RELATED to the negative Acute Phase Protein reaction such as Cholesterol, Β-Carotene, and Vitamin A; Bilirubin; the Liver enzymes aspartate aminotransferase (ast or got ) and γ- glutamyl transpeptidase ( ggt ); Minerals (Calcium, magnesium, zinc, and Phosphorous); creatinine; and Vitamin e. the concentration of total proteins was analyzed also previously[10]and the data were re-analyzed in the PRESENT STUDY in order to calculate accurately the concentration of globulins which are ESTIMATED by the difference between total proteins and albumin.']	[('SUPERFICIAL_RELATIONSHIP', 209), ('QUESTION_ANSWERED_BY_THIS_WORK', 606), ('INCOMPLETE_EVIDENCE', 694)]	3	[('GO_0007354', 'zygotic determination of anterior/posterior axis, embryo', 41, 'acute phase reaction'), ('GO_0006953', 'acute-phase response', 84, 'acute phase'), ('GO_0006953', 'acute-phase response', 148, 'acute phase'), ('PR_000005908', 'alpha-crystallin B chain', 168, 'albumin'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 233, 'acute phase protein'), ('CHEBI_16113', 'cholesterol', 270, 'cholesterol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 283, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin A'), ('CHEBI_16990', 'bilirubin IXalpha', 310, 'bilirubin'), ('UBERON_0002107', 'liver', 325, 'liver'), ('CHEBI_46751', 'quinolizidine', 420, 'minerals'), ('CHEBI_22313', 'alkaline earth metal atom', 430, 'calcium'), ('CHEBI_30207', 'phosphorus(.)', 460, 'phosphorous'), ('CHEBI_33229', 'vitamin (role)', 490, 'vitamin')]
PMC4071151	6/2014	S64-PMC4071151	['RISK factors MAY include preoperative malnutrition (e.g., Vitamin D, iron), decreased Food Intake (dumping syndrome, reduced hunger and increased satiety, Food intolerances), inadequate Nutrient supplementation (POOR compliance with multivitamin/multimineral regimen, insufficient amounts of Vitamins and/or Minerals in supplements) and/or nutritional support (lack of follow-up, INSUFFICIENT monitoring, DIFFICULTY in recognizing symptoms of deficiency), Nutrient malabsorption (reduced absorptive Gastro-Intestinal area) [18,19].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 212), ('PROBLEM_COMPLICATION', 380), ('DIFFICULT_TASK', 405)]	5	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 86, 'food'), ('GO_0007631', 'feeding behavior', 86, 'food intake'), ('CHEBI_33290', 'food', 155, 'food'), ('CHEBI_33284', 'nutrient', 186, 'nutrient'), ('CHEBI_33277', 'gamma-tocotrienol', 292, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 308, 'minerals'), ('CHEBI_33284', 'nutrient', 456, 'nutrient'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 499, 'gastro-intestinal')]
PMC4071151	6/2014	S69-PMC4071151	['Nutrients such as Vitamins A, b6, b12 and Folic Acid and zinc AFFECT Embryogenesis and a deficiency in any of these elements MAY BE RELATED to spontaneous abortion failure and to a spectrum of Neurodevelopmental disorders [16].']	[('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('CHEBI_33284', 'nutrient', 0, 'Nutrients'), ('CHEBI_27300', 'vitamin D', 18, 'vitamins A'), ('CHEBI_30751', 'formic acid', 42, 'folic acid'), ('GO_0009790', 'embryo development', 69, 'embryogenesis'), ('GO_0007399', 'nervous system development', 193, 'neurodevelopmental')]
PMC4071151	6/2014	S72-PMC4071151	['in particular, Folic Acid, Vitamin B12 and Vitamin A and its biologically active Metabolite Retinoic Acid are THOUGHT TO be INVOLVED in Neurulation and subsequent Neural Tube growth and patterning [20].']	[('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 124)]	2	[('CHEBI_30751', 'formic acid', 15, 'folic acid'), ('CHEBI_33279', 'vitamin D5', 27, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin A'), ('CHEBI_39382', 'flufenoxuron', 81, 'metabolite'), ('CHEBI_26536', 'retinoic acid', 92, 'retinoic acid'), ('GO_0000293', 'ferric-chelate reductase activity', 136, 'neurulation'), ('UBERON_0001049', 'neural tube', 163, 'neural tube')]
PMC4071151	6/2014	S80-PMC4071151	['signs of congenital Ocular abnormalities such as microphthalmia, characterized by abnormally small Eyes with or without structural abnormalities, MAY depend on Vitamin A deficiency leading to a disruption of Ocular Development [20,25].']	[('INCOMPLETE_EVIDENCE', 146)]	1	[('UBERON_0000970', 'eye', 20, 'ocular'), ('UBERON_0000970', 'eye', 99, 'eyes'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin A'), ('GO_0001654', 'eye development', 208, 'ocular development'), ('UBERON_0000970', 'eye', 208, 'ocular')]
PMC4071151	6/2014	S84-PMC4071151	['the precise pathogenesis of these conditions REMAINS UNKNOWN, BUT non-Genetic and non-infectious causes HAVE BEEN POSTULATED and include maternal Vitamin A deficiency [25].']	[('FULL_UNKNOWN', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 114)]	4	[('SO_0000704', 'gene', 70, 'genetic'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin A')]
PMC4072587	6/2014	S10-PMC4072587	['OUR FINDINGS STRENGTHEN the EVIDENCE for giving Vitamin D supplementation during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC4072587	6/2014	S12-PMC4072587	['IMPORTANT biological functions involving growth and developmental outcomes HAVE BEEN ATTRIBUTED to Vitamin D, and deficiency during Pregnancy MAY result in IMPORTANT health CONSEQUENCES for both mother and child[3],[4],[5].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 156), ('IMPORTANT_CONSIDERATION', 173)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'pregnancy')]
PMC4072587	6/2014	S15-PMC4072587	['dietary intake makes ONLY a small CONTRIBUTION to Vitamin D status[3],[7].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 34)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4072587	6/2014	S16-PMC4072587	['ALTHOUGH the current RECOMMENDED dietary intake of Vitamin D during Pregnancy ranges from 600 to 2000 international units (iu) per day[8], a standardised definition of Vitamin D deficiency during Pregnancy REMAINS CONTROVERSIAL[4],[9],[10],[11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy')]
PMC4072587	6/2014	S20-PMC4072587	['adverse maternal and neonatal outcomes HAVE previously BEEN DESCRIBED in ASSOCIATION with Antenatal Vitamin D deficiency, including INCREASED risk of pre-eclampsia, Gestational diabetes, caesarean section, as well as low Birth weight and small for Gestational age infants[15],[16],[17],[18],[19].']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 132)]	4	[('GO_0007567', 'parturition', 90, 'antenatal'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'gestational'), ('GO_0007567', 'parturition', 221, 'birth'), ('GO_0007565', 'female pregnancy', 248, 'gestational')]
PMC4072587	6/2014	S22-PMC4072587	['more RECENTLY, maternal Vitamin D deficiency HAS BEEN ASSOCIATED with impaired infant Language Development in school-aged children[24], and HAS BEEN SUGGESTED as a possible environmental risk FACTOR for autism spectrum disorder, HIGHLIGHTING the IMPORTANT ROLE of Vitamin D in Brain Development, Neuronal function and Gene Regulation[10],[25],[26].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 229), ('IMPORTANT_CONSIDERATION', 246), ('SUPERFICIAL_RELATIONSHIP', 256)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0060132', 'prolactin secreting cell development', 86, 'language development'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D'), ('GO_0007420', 'brain development', 277, 'brain development'), ('UBERON_0000955', 'brain', 277, 'brain'), ('CL_0000540', 'neuron', 296, 'neuronal'), ('SO_0000704', 'gene', 318, 'gene'), ('GO_0065007', 'biological regulation', 323, 'regulation')]
PMC4072587	6/2014	S23-PMC4072587	['Vitamin D insufficiency in vietnam HAS PREVIOUSLY been REPORTED to be as high as 46%[27],[28],[29], HOWEVER, there is LIMITED DATA on the BURDEN and CONSEQUENCES of Vitamin D deficiency during Pregnancy in this setting[17]and FEW STUDIES have followed Infants past the Neonatal Period.']	[('IMPORTANT_CONSIDERATION', 35), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 138), ('IMPORTANT_CONSIDERATION', 149), ('INCOMPLETE_EVIDENCE', 226)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy'), ('UBERON_0002397', 'maxilla', 252, 'infants'), ('UBERON_0007221', 'neonate stage', 269, 'neonatal period')]
PMC4072587	6/2014	S82-PMC4072587	['to further investigate the presence of a POTENTIAL threshold EFFECT of Vitamin D concentration on infant developmental outcomes[24], secondary statistical analyses were performed on maternal Vitamin D concentration categorized as deficient (<37.5 nmol/l), insufficient(≥37.5 nmol/l and <75 nmol/l) or replete (≥75 nmol/l).']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 61)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4072587	6/2014	S90-PMC4072587	['a TREND towards an ASSOCIATION with Preterm Delivery (odds ratio (or) 0.77 per 25 nmol/l increase in Vitamin D concentration, 95% ci 0.57 to 1.05) and small for Gestational age (odds ratio (or) 1.37 per 25 nmol/l increase in Vitamin D concentration, 95% ci 0.98 to 1.91) was observed.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 19)]	2	[('GO_0007565', 'female pregnancy', 36, 'preterm'), ('GO_0007567', 'parturition', 44, 'delivery'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'gestational'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC4072587	6/2014	S99-PMC4072587	['HOWEVER, lower language composite scores were SEEN in infants Born to women with Vitamin D deficiency (<37.5 nmol/l) compared to those Born to women who were Vitamin D replete (≥75 nmol/l) (md −3.48, 95% ci −5.52 to −1.44) (table 5).10.1371/journal.pone.0099005.t004\n\ncaption (table-wrap): table 4\ndevelopmental composite scores at 6 months of age ASSOCIATED with maternal Serum 25-Ohd concentration (nmol/l) at 32 weeks Gestation.unadjusted modeladjusted model 1adjusted model 2domainmean developmental composite score [sd]mean difference1,2(95% ci)p valuemean difference1,3(95% ci)p valuemean difference1,4(95% ci)p valuecognitive104.5 [10.1]−0.47 (−1.22 to 0.27)0.21−0.39 (−1.19 to 0.40)0.30−0.43 (−1.23 to 0.370.29language97.8 [7.6]−0.02 (−0.58 to 0.55)0.960.04 (−0.51 to 0.59)0.890.08 (−0.47 to 0.63)0.77motor110.9 [13.4]0.03 (−0.97 to 1.03)0.950.25 (−0.71 to 1.21)0.610.05 (−0.92 to 0.64)0.92socio-emotional79.6 [9.8]−0.12 (−0.85 to 0.61)0.75−0.06 (−0.81 to 0.70)0.88−0.14 (−0.92 to 0.64)0.71\nvalues are ESTIMATED mean difference for each outcome associated with a 25 nmol/l increase in Vitamin.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 348), ('INCOMPLETE_EVIDENCE', 1010)]	5	[('GO_0007567', 'parturition', 62, 'born'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 135, 'born'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001977', 'blood serum', 373, 'serum'), ('CHEBI_72765', 'verruculogen', 379, '25-OHD'), ('GO_0007565', 'female pregnancy', 421, 'gestation'), ('CHEBI_33229', 'vitamin (role)', 1093, 'vitamin')]
PMC4072587	6/2014	S108-PMC4072587	['maternal Vitamin D and anthropometric measurements at six months of age\nan inverse ASSOCIATION between maternal 25-Ohd and infant length-for-age z scores at 6 months of age was DEMONSTRATED (md −0.09 per 25 nmol/l increase in Vitamin D concentration, 95% ci −0.12 to −0.02) (table 6).10.1371/journal.pone.0099005.t006\n\ncaption (table-wrap): table 6\ninfant anthropometric outcomes at 6 months of age ASSOCIATED with maternal Serum 25-Ohd concentration (nmol/l) at 32 weeks Gestation.unadjusted modeladjusted modelinfant anthropometric outcomesmean [sd] ornumber(%)mean difference1,3or odds ratio2,3(95% ci)p valuemean difference1,4or odds ratio2,4(95% ci)p valuelength (cm)66.0 [2.28]−0.10 (−0.27 to 0.06)10.23−0.11 (−0.26 to 0.05)10.19weight (kg)7.71 [0.98]−0.02 (−0.09 to 0.05)10.61−0.03 (−0.10 to 0.04)10.45head circumference (cm)42.6 [1.43]0.003 (−0.10 to 0.11)10.95−0.01 (−0.10 to 0.11)10.95haz−0.57 [0.91]−0.09 (−0.15 to −0.02)1 0.02 −0.09 (−0.12 to −0.02)1 0.02 stunted55/891 (6.2)0.92 (0.68 to 1.26)20.620.89 (0.59 to 1.32)20.52\nvalues are estimated mean difference for each outcome associated with a 25 nmol/l increase in Vitamin D.\nconcentration (95% confidence interval).']	[('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 399)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 112, '25-OHD'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0001977', 'blood serum', 424, 'serum'), ('CHEBI_72765', 'verruculogen', 430, '25-OHD'), ('GO_0007565', 'female pregnancy', 472, 'gestation'), ('CHEBI_27300', 'vitamin D', 1130, 'vitamin D')]
PMC4072587	6/2014	S112-PMC4072587	['discussion\nthese results INDICATE that there is a high prevalence of Vitamin D insufficiency in Pregnant women residing in rural ha nam province, vietnam.']	[('INCOMPLETE_EVIDENCE', 25)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnant')]
PMC4072587	6/2014	S113-PMC4072587	['OUR FINDINGS SHOW that low Vitamin D levels in late Pregnancy (<37.5 nmol/l) are ASSOCIATED with reduced infant Language Development at six months of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 112, 'language development')]
PMC4072587	6/2014	S114-PMC4072587	['an ASSOCIATION between low maternal Vitamin D concentration and Language impairment has PREVIOUSLY been SUGGESTED by whitehouse et al.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 104)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0006266', 'DNA ligation', 64, 'language')]
PMC4072587	6/2014	S121-PMC4072587	['our finding of an ASSOCIATION between maternal Vitamin D and infant Language composite scores, that was ONLY observed when maternal Vitamin D levels fell below 37.5 nmol/l in late Pregnancy, RAISES the POSSIBILITY that there is a threshold EFFECT, and that Language impairment is a feature of more marked Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ANOMALY_CURIOUS_FINDING', 104), ('INCOMPLETE_EVIDENCE', 104), ('EXPLICIT_QUESTION', 191), ('INCOMPLETE_EVIDENCE', 202), ('SUPERFICIAL_RELATIONSHIP', 240)]	6	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0006266', 'DNA ligation', 68, 'language'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007565', 'female pregnancy', 180, 'pregnancy'), ('GO_0006266', 'DNA ligation', 257, 'language'), ('CHEBI_27300', 'vitamin D', 305, 'vitamin D')]
PMC4072587	6/2014	S122-PMC4072587	['the OBSERVED ASSOCIATION between Antenatal Vitamin D concentration and infant development is PLAUSIBLE AS Vitamin D has an IMPORTANT ROLE in Neurodevelopment through Cell Differentiation, cytokine Regulation, neurotransmitter synthesis and anti-oxidant activity, and it is HAS BEEN SUGGESTED that in utero exposure to Vitamin D deficiency during the second and third trimesters MAY AFFECT the development of the perisylvian structures, which are responsible for Language in children[24],[39].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 103), ('IMPORTANT_CONSIDERATION', 123), ('SUPERFICIAL_RELATIONSHIP', 133), ('INCOMPLETE_EVIDENCE', 273), ('INCOMPLETE_EVIDENCE', 378), ('SUPERFICIAL_RELATIONSHIP', 382)]	9	[('GO_0007567', 'parturition', 33, 'antenatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007399', 'nervous system development', 141, 'neurodevelopment'), ('GO_0030154', 'cell differentiation', 166, 'cell differentiation'), ('GO_0065007', 'biological regulation', 197, 'regulation'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0006266', 'DNA ligation', 462, 'language')]
PMC4072587	6/2014	S123-PMC4072587	['there HAS also BEEN interest in the LINK between autism and Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4072587	6/2014	S124-PMC4072587	['RECENT RESEARCH SUGGESTS that Vitamin D deficiency during Pregnancy or early childhood MAY BE an environmental TRIGGER for autism spectrum disorder in infants Genetically predisposed to autism, EITHER through its EFFECT on Neuronal function and Brain Development, or through Gene interaction and Regulation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('SUPERFICIAL_RELATIONSHIP', 213)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('SO_0000704', 'gene', 159, 'genetically'), ('CL_0000540', 'neuron', 223, 'neuronal'), ('GO_0007420', 'brain development', 245, 'brain development'), ('UBERON_0000955', 'brain', 245, 'brain'), ('SO_0000704', 'gene', 275, 'gene'), ('GO_0065007', 'biological regulation', 296, 'regulation')]
PMC4072587	6/2014	S126-PMC4072587	['we OBSERVED an inverse RELATIONSHIP between length-for-age z scores at 6 months of age and overall maternal Vitamin D concentration, ALTHOUGH the ESTIMATED magnitude of change ASSOCIATED with an increase in Vitamin D of 25 nmol/l was SMALL.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 23), ('ANOMALY_CURIOUS_FINDING', 133), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 234)]	6	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC4072587	6/2014	S127-PMC4072587	['SEVERAL STUDIES have FOUND an ASSOCIATION between maternal Vitamin D status and post-Natal growth, BUT results are INCONSISTENT and the majority are OBSERVATIONAL studies that HAVE been carried out in developed countries.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 149), ('IMPORTANT_CONSIDERATION', 176)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007567', 'parturition', 85, 'natal')]
PMC4072587	6/2014	S128-PMC4072587	['PREVIOUS authors have SUGGESTED that accelerated growth in length MAY occur during an infant’s first year of Life in infants Born to mothers with Vitamin D <30 nmol/l, as infant Vitamin D levels increase Postnatally, through post-Natal Vitamin D supplementation[5].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 66)]	3	[('UBERON_0000104', 'life cycle', 109, 'life'), ('GO_0007567', 'parturition', 125, 'born'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'postnatally'), ('GO_0007567', 'parturition', 230, 'natal'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
PMC4072587	6/2014	S129-PMC4072587	['OTHER STUDIES HAVE SHOWN no differences in weight or height across quartiles of Vitamin D status during infancy[40].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14)]	2	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4072587	6/2014	S130-PMC4072587	['we FOUND increasing maternal Vitamin D concentration SHOWED a TREND towards a reduced RISK of Preterm Delivery.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 86)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'preterm'), ('GO_0007567', 'parturition', 102, 'delivery')]
PMC4072587	6/2014	S131-PMC4072587	['a positive ASSOCIATION between maternal Vitamin D concentration and Gestational duration has PREVIOUSLY been DESCRIBED[41],[42], and morley et al.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 109)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'gestational')]
PMC4072587	6/2014	S133-PMC4072587	['a pooled analyses of two PREVIOUS STUDIES[17]SHOWED no significant link between Vitamin D supplementation and Preterm Delivery, however the two studies had SMALL sample sizes (350 and 180 participants)[4],[44], with relatively large loss to follow up (30%).']	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 156)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'preterm'), ('GO_0007567', 'parturition', 118, 'delivery')]
PMC4072587	6/2014	S135-PMC4072587	['the ASSOCIATION between Vitamin D concentration and Vaginal infection has PREVIOUSLY been DESCRIBED by several authors[45],[46],[47].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 90)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001987', 'placenta', 52, 'vaginal')]
PMC4072587	6/2014	S136-PMC4072587	['we FOUND no association between Vitamin D deficiency and infant Birth weight, low Birth weight and Birth length.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 64, 'birth'), ('GO_0007567', 'parturition', 82, 'birth'), ('GO_0007567', 'parturition', 99, 'birth')]
PMC4072587	6/2014	S137-PMC4072587	['this is IN KEEPING WITH a cochrane review of data from three trials SHOWING that Vitamin D supplementation during Pregnancy did not affect Birth weight or Birth length[13].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 68)]	2	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'pregnancy'), ('GO_0007567', 'parturition', 139, 'birth'), ('GO_0007567', 'parturition', 155, 'birth')]
PMC4072587	6/2014	S138-PMC4072587	['an inverse ASSOCIATION between Birth Head circumference and maternal Vitamin D was OBSERVED, HOWEVER this FINDING DID NOT persist at 6 months of age.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 83), ('ANOMALY_CURIOUS_FINDING', 93), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 114)]	5	[('GO_0007567', 'parturition', 31, 'birth'), ('UBERON_0000033', 'head', 37, 'head'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4072587	6/2014	S144-PMC4072587	['there are no standardised definitions for Vitamin D thresholds in Pregnancy (deficiency, insufficiency and sufficiency), HOWEVER a RECENT meta-analysis defined insufficiency for Pregnancy outcomes as less than 75 vnmol/l, and insufficiency for Birth variables as less than 37.5 nmol/l[12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('INCOMPLETE_EVIDENCE', 131)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('GO_0007567', 'parturition', 244, 'birth')]
PMC4072587	6/2014	S145-PMC4072587	['the REPORTED prevalence and definitions of Vitamin D insufficiency/deficiency in vietnamese women has VARIED in PREVIOUS STUDIES, ranging from 7% to 46%[27],[28],[29].']	[('INCOMPLETE_EVIDENCE', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 112)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4072587	6/2014	S146-PMC4072587	['in our trial, EVEN THOUGH the majority of women worked as farmers, we OBSERVED a very high prevalence (60%) of women with Vitamin D levels less than 75 nmol/l.']	[('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 70)]	3	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4072587	6/2014	S148-PMC4072587	['SOME authors have also SUGGESTED that the cut off for sufficient Vitamin D levels during Pregnancy SHOULD BE as high as 100–150 nmo/l[10],[11], and THEREFORE the PROBLEM of Vitamin D deficiency in vietnam and OTHER south east asian countries MAY BE EVEN more widespread than PREVIOUSLY THOUGHT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 99), ('PROBABLE_UNDERSTANDING', 148), ('IMPORTANT_CONSIDERATION', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 209), ('INCOMPLETE_EVIDENCE', 242), ('ANOMALY_CURIOUS_FINDING', 249), ('INCOMPLETE_EVIDENCE', 275), ('INCOMPLETE_EVIDENCE', 286)]	10	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC4072587	6/2014	S153-PMC4072587	['HOWEVER, SIMILAR FINDINGS in PREVIOUS STUDIES[24],[38],[41],[42],[43]and the INCREASING EVIDENCE for Vitamin D deficiency AS a POTENTIAL environmental risk FACTOR for autism[10],[25],[26]SUGGEST that these ASSOCIATIONS SHOULD NOT BE discounted.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 122), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 156), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 206), ('FUTURE_WORK', 219)]	10	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4072587	6/2014	S155-PMC4072587	['conclusions\nOUR STUDY INDICATES that low levels of Vitamin D during Pregnancy are of CONCERN in rural vietnam, and are ASSOCIATED with impaired Language Development at 6 months of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 22), ('PROBLEM_COMPLICATION', 85), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 144, 'language development')]
PMC4072587	6/2014	S156-PMC4072587	['our results STRENGTHEN the EVIDENCE for giving Vitamin D supplementation during Pregnancy and HIGHLIGHT the NEED FOR FURTHER RESEARCH to explore the IMPACT of supplementation on longer term child growth and developmental outcomes, PARTICULARLY with regard to language.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 108), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 149), ('IMPORTANT_CONSIDERATION', 231)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
PMC4106226	7/2014	S4-PMC4106226	['mechanistic studies SUGGESTED a ROLE for Vitamin D deficiency in asthma and type 1 diabetes and for reactivation of varicella-zoster virus in aseptic meningitis.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4106226	7/2014	S32-PMC4106226	['most People are AWARE from media REPORTS that Vitamin D deficiency CAN predispose to the occurrence of atopic diseases.']	[('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 67)]	3	[('NCBITaxon_10088', 'Mus <genus>', 5, 'people'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4106226	7/2014	S34-PMC4106226	['[4] REPORTED that asthmatic children had significant lower Vitamin D levels than healthy children in tekirdag, turkey.']	[('INCOMPLETE_EVIDENCE', 4)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4106226	7/2014	S36-PMC4106226	['OF INTEREST, asthmatic children had less exposure to sunlight and ate a diet less rich in Vitamin D. this MAY INDICATE that asthma Control MAY benefit from a healthier Life-style and a Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 139)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0065007', 'biological regulation', 131, 'control'), ('UBERON_0000104', 'life cycle', 168, 'life'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC4106226	7/2014	S39-PMC4106226	['RECENT STUDIES SUGGEST that Vitamin D deficiency MAY increase the RISK of developing Autoimmune diseases including type 1 diabetes (t1dm), by Modulating the Immune and inflammatory reactions.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 49), ('IMPORTANT_CONSIDERATION', 66)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 85, 'autoimmune'), ('GO_0065007', 'biological regulation', 142, 'modulating'), ('UBERON_0002405', 'immune system', 157, 'immune')]
PMC4106226	7/2014	S43-PMC4106226	['ALTHOUGH the SMALL SAMPLE size (80 t1dm cases aged 6 to 16\xa0years and 40 healthy children age and gender matched as control group), the authors FOUND that Serum Vitamin D levels were not significantly lower in diabetic subjects compared to the control group (24.7\u2009±\u20095.6 vs 26.5\u2009±\u20094.8\xa0ng/ml; p\u2009>\u20090.05).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 143)]	3	[('UBERON_0001977', 'blood serum', 154, 'serum'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4113768	7/2014	S2-PMC4113768	['this three-day meeting set out to achieve two main aims: to create a forum for researchers to meet and forge new collaborations, and to provide a STATE-of-the-art overview of the LATEST FINDINGS from clinical research in the field of Vitamin D. over 300 clinical researchers, students and commercial representatives attended.']	[('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 186)]	3	[('CHEBI_27300', 'vitamin D', 234, 'vitamin D')]
PMC4113768	7/2014	S4-PMC4113768	['commencing with a session of talks providing overviews of randomised trials of supplementation and global Vitamin D status, the meeting proceeded with a session on pre-Birth related Vitamin D RESEARCH—evolution, genetics & fertility—which led into several talks in the area of child health.']	[('INCOMPLETE_EVIDENCE', 192)]	1	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007567', 'parturition', 168, 'birth'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC4113768	7/2014	S9-PMC4113768	['mega-trials have the POTENTIAL to detect small effect sizes of Vitamin D supplementation on end-points such as incidence and mortality from Cardiovascular disease and cancer.']	[('INCOMPLETE_EVIDENCE', 21)]	1	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 140, 'cardiovascular')]
PMC4113768	7/2014	S12-PMC4113768	['a third EMERGING theme, also RELATING to Vitamin D dose–response RELATIONSHIPS, was the POTENTIAL DIFFERENTIAL EFFECT of daily vs. intermittent bolus dosing on biological outcomes.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('SUPERFICIAL_RELATIONSHIP', 111)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4113768	7/2014	S17-PMC4113768	['sex-specific ASSOCIATIONS between 25-Hydroxy Vitamin D3And Serum Lipids in elderly german subjects without intake of Lipid-modifying Drugs\n\njungert, a.; neuhäuser-berthold, m.\nbackground: ALTHOUGH EMERGING EVIDENCE INDICATES an ASSOCIATION between Vitamin D and Serum Lipids, the data are STILL INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188), ('ANOMALY_CURIOUS_FINDING', 188), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 289), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295)]	8	[('CHEBI_668', '1-Phenyl-5-heptene-1,3-diyne', 34, '25-Hydroxy Vitamin D3and'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 45, 'Vitamin D3and'), ('UBERON_0001977', 'blood serum', 59, 'Serum'), ('CHEBI_18059', 'lipid', 65, 'Lipids'), ('CHEBI_18059', 'lipid', 117, 'Lipid'), ('CHEBI_23888', 'drug', 133, 'Drugs'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('UBERON_0001977', 'blood serum', 262, 'serum'), ('CHEBI_18059', 'lipid', 268, 'lipids')]
PMC4113768	7/2014	S27-PMC4113768	['conclusions: sex-specific ASSOCIATIONS of 25(Oh)D3With Serum Lipids MAY exist in elderly subjects, and an adequate Vitamin D status MAY have a beneficial IMPACT on dyslipidaemia in elderly women.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 154)]	4	[('CHEBI_86970', 'N-[(15Z)-tetracosenoyl]-tetradecasphing-4-enine-1-phosphoethanolamine', 42, '25(OH)D3with'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 42, '25(OH'), ('PR_000006480', 'type I iodothyronine deiodinase', 48, 'D3with'), ('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_18059', 'lipid', 61, 'lipids'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4113768	7/2014	S29-PMC4113768	['ASSOCIATIONS between Vitamin D and biomarkers of Oxidative Stress in community-dwelling elderly subjects: a cross-sectional study\n\njungert, a.; neuhäuser-berthold, m.\nbackground: SOME STUDIES SUGGEST that Vitamin D MAY have anti-Oxidant and anti-inflammatory properties (asemi, z., et al.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 192), ('INCOMPLETE_EVIDENCE', 215)]	4	[('CHEBI_28384', 'vitamin K', 21, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 21, 'Vitamin D'), ('GO_0045733', 'acetate catabolic process', 49, 'Oxidative Stress'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_77969', 'food humectant', 229, 'oxidant')]
PMC4113768	7/2014	S55-PMC4113768	['conclusions: the PRESENT INVESTIGATION INDICATES that the Vitamin D status MAY function AS an INDEPENDENT positive PREDICTOR of sod, especially in non-obese, non-smoking elderly women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 115)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4113768	7/2014	S84-PMC4113768	['background: Serum 25-Hydroxy Vitamin D (25(Oh)D) is the ESTABLISHED BIOMARKER of Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 68)]	2	[('UBERON_0001977', 'blood serum', 12, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 18, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4113768	7/2014	S101-PMC4113768	['Cyp2R1 and Cyp24A1 are capable of the 25-hydroxylation and 24-Hydroxylation, respectively, of Vitamin D. IT IS REPORTED that different Single Nucleotide Polymorphisms of Cyp2R1 and Cyp24A1 are ASSOCIATED with the 25(Oh)D status (wang, t.j., et al.']	[('PROBABLE_UNDERSTANDING', 105), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 193)]	3	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 0, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 11, 'CYP24A1'), ('GO_0006298', 'mismatch repair', 59, '24-hydroxylation'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('SO_0000694', 'SNP', 135, 'single nucleotide polymorphisms'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 170, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 181, 'CYP24A1'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D')]
PMC4113768	7/2014	S118-PMC4113768	['background: PREVIOUS RESEARCH has FOUND an ASSOCIATION between Vitamin D status (25-Hydroxy Vitamin D, 25(Oh)D) and volumetric bone Mineral density (vbmd) in caucasians (pedone, c., et al.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 81, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('CHEBI_46662', 'mineral', 132, 'Mineral')]
PMC4113768	7/2014	S136-PMC4113768	['FURTHER ANALYSIS is underway to assess POSSIBLE EXPLANATIONS for these varying RELATIONSHIPS between Vitamin D status and bone geometry by ethnicity and bone site.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 39), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 79)]	4	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4113768	7/2014	S148-PMC4113768	['2012, 67 , 1139-1144), NO PUBLISHED research has specifically examined WHETHER there is a LINK between Vitamin D and Sleep.']	[('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('EXPLICIT_QUESTION', 71), ('SUPERFICIAL_RELATIONSHIP', 90)]	4	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0030431', 'sleep', 117, 'sleep')]
PMC4113768	7/2014	S161-PMC4113768	['conclusion: THIS research PROVIDES PRELIMINARY EVIDENCE that Vitamin D MIGHT be ASSOCIATED with Sleep quality.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 80)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0030431', 'sleep', 96, 'sleep')]
PMC4113768	7/2014	S162-PMC4113768	['ALTHOUGH there is SOME SUGGESTION that SELF-REPORTED sleep quality and sleep latency MIGHT be ASSOCIATED with Vitamin D status, results APPEAR TO vary by ethnicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 94), ('ANOMALY_CURIOUS_FINDING', 136)]	7	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4113768	7/2014	S168-PMC4113768	['background: RECENT experimental, ecological and epidemiological EVIDENCE LINKS Vitamin D with an anti-Carcinogenic EFFECT.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 115)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_76606', 'methyl carbamate', 102, 'carcinogenic')]
PMC4113768	7/2014	S176-PMC4113768	['high Vitamin D receptor Expression in tumour cells relative to normal cells was ASSOCIATED with improved disease-free survival in one prospective STUDY.']	[('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 146)]	2	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0010467', 'gene expression', 24, 'expression')]
PMC4113768	7/2014	S178-PMC4113768	['conclusions: epidemiological EVIDENCE SUPPORTS an ASSOCIATION between increased Vitamin D status and improved survival amongst Colorectal cancer patients.']	[('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 50)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0012652', 'colorectum', 127, 'colorectal')]
PMC4113768	7/2014	S213-PMC4113768	['Vitamin D HAS BEEN SHOWN to inhibit hiv-1 Replication in Macrophages, in vitro , while seasonal Vitamin D variation in europeans HAS BEEN ASSOCIATED with decreased Lymphocyte counts and enhanced pro-inflammatory responses in winter.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0006260', 'DNA replication', 42, 'replication'), ('CL_0000235', 'macrophage', 57, 'macrophages'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CL_0000542', 'lymphocyte', 164, 'lymphocyte')]
PMC4113768	7/2014	S228-PMC4113768	['current EVIDENCE SUGGESTS that immunomodulatory properties of Vitamin D MAY INFLUENCE lrti RISK.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 76), ('IMPORTANT_CONSIDERATION', 91)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4113768	7/2014	S244-PMC4113768	['conclusions: OUR FINDINGS SUGGEST that Vitamin D deficiency at Birth is ASSOCIATED with INCREASED RISK of lrti PARTICULARLY in infants Born to mothers without allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 88), ('ANOMALY_CURIOUS_FINDING', 111)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007567', 'parturition', 63, 'birth'), ('GO_0007567', 'parturition', 135, 'born')]
PMC4113768	7/2014	S246-PMC4113768	['strategies aimed at improving maternal Vitamin D status during Pregnancy, especially in the winter months, ARE NEEDED and MIGHT decrease the RISK of lrti in early childhood.']	[('FUTURE_WORK', 107), ('INCOMPLETE_EVIDENCE', 122), ('IMPORTANT_CONSIDERATION', 141)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy')]
PMC4113768	7/2014	S253-PMC4113768	['hiv progression, which is ASSOCIATED with excessive Immune Activation and impaired T-Cell Immunity, is also ASSOCIATED with low Serum Vitamin D level ALTHOUGH biological PLAUSIBILITY and causality have yet to be established.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('ANOMALY_CURIOUS_FINDING', 150), ('INCOMPLETE_EVIDENCE', 170)]	5	[('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 52, 'immune activation'), ('UBERON_0002405', 'immune system', 52, 'immune'), ('CL_0000084', 'T cell', 83, 'T-cell'), ('GO_0002456', 'T cell mediated immunity', 83, 'T-cell immunity'), ('GO_0005622', 'intracellular anatomical structure', 84, '-cell'), ('UBERON_0001977', 'blood serum', 128, 'serum'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4113768	7/2014	S273-PMC4113768	['the AIM was to find POSSIBLE clinical INDICATORS of Vitamin D deficiency in swedish and immigrant women at a primary Health care center in sweden.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0000025', 'tube', 117, 'health')]
PMC4113768	7/2014	S280-PMC4113768	['conclusion: pain in Muscles and Joints as well as balance problems MAY BE clinical INDICATORS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('UBERON_0005090', 'muscle structure', 20, 'muscles'), ('UBERON_0004905', 'articulation', 32, 'joints'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4113768	7/2014	S287-PMC4113768	['circulating vd is predominantly bound to Vitamin D Binding Protein (Vdbp) and Albumin (alb) and HENCE assessment of vd status during acute phase of critical illness MAY BE hazardous.']	[('PROBABLE_UNDERSTANDING', 96), ('INCOMPLETE_EVIDENCE', 165)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 68, 'VDBP'), ('PR_000005908', 'alpha-crystallin B chain', 78, 'albumin')]
PMC4113768	7/2014	S321-PMC4113768	['AT PRESENT, THERE ARE NO DATA about Vitamin D (vd) supplementation, osteopenia and bone Mineral density (bmd) in Adult burn patients.']	[('INCOMPLETE_EVIDENCE', 0), ('FULL_UNKNOWN', 12)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_46662', 'mineral', 88, 'mineral'), ('UBERON_0007023', 'adult organism', 113, 'adult')]
PMC4113768	7/2014	S356-PMC4113768	['DUE TO the unavailability of subsidized daily doses of Vitamin D and the unaffordability of Vitamin D testing in new zealand we have established a less than IDEAL process for treating and PREVENTING Vitamin D deficiency in our IDENTIFIED high risk women and children, using monthly doses of 50,000 iu Cal-D forte for women and Vitadol-c (multivitamin) for breast feeding babies.']	[('PROBLEM_COMPLICATION', 0), ('IMPORTANT_CONSIDERATION', 157), ('SUPERFICIAL_RELATIONSHIP', 188), ('INCOMPLETE_EVIDENCE', 227)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_17789', 'dihydrochelirubine', 301, 'Cal-D'), ('PR_000004968', 'calretinin', 301, 'Cal-D'), ('CHEBI_27355', 'xylulose phosphate', 327, 'vitadol')]
PMC4113768	7/2014	S377-PMC4113768	['background: INTERACTIONS between dietary Calcium and Vitamin D MAY have IMPLICATIONS for the Regulation of Serum 25-Hydroxy Vitamin D (25(Oh)D) and its Catabolism, and CONSEQUENTLY for the dietary REQUIREMENT for Vitamin D ((iom) institute of medicine.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 63), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 93), ('PROBABLE_UNDERSTANDING', 168), ('IMPORTANT_CONSIDERATION', 197)]	6	[('CHEBI_22313', 'alkaline earth metal atom', 41, 'calcium'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0065007', 'biological regulation', 93, 'regulation'), ('UBERON_0001977', 'blood serum', 107, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 113, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 135, '25(OH)D'), ('GO_0009056', 'catabolic process', 152, 'catabolism'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC4113768	7/2014	S381-PMC4113768	['results: repeated measures anova SHOWED that there was no significant ( p = 0.2) time × Vitamin D treatment × Calcium intake grouping interaction effect on mean Serum 25(Oh)D concentration over the 15-week intervention period.']	[('INCOMPLETE_EVIDENCE', 33)]	1	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 110, 'calcium'), ('UBERON_0001977', 'blood serum', 161, 'serum'), ('CHEBI_71657', 'versiconol acetate', 167, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 167, '25(OH)D')]
PMC4113768	7/2014	S385-PMC4113768	['conclusion: we DID NOT FIND EVIDENCE of a Vitamin D sparing EFFECT of high Calcium intake.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 75, 'calcium')]
PMC4113768	7/2014	S386-PMC4113768	['THUS, RECENT dietary Vitamin D REQUIREMENT ESTIMATES will cover the Vitamin D NEEDS of EVEN those in the population who do not have adequate Calcium intakes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 78), ('ANOMALY_CURIOUS_FINDING', 87)]	6	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 141, 'calcium')]
PMC4113768	7/2014	S389-PMC4113768	['background: RECENT STUDIES SUGGEST an ASSOCIATION between higher latitude, a PROXY of Vitamin D (vd) status, and allergic diseases.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 77)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4113768	7/2014	S407-PMC4113768	['jr.\nbackground: low Vitamin D (vd) status is common among patients with atopic dermatitis (ad) and SOME STUDIES SUGGEST an ASSOCIATION between vd deficiency and increased ad severity.']	[('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC4113768	7/2014	S427-PMC4113768	['of children older than 1 year of age, 16% did not eat fish (a POTENTIALLY good source of Vitamin D) and 40% ate Fish less than once per week.']	[('INCOMPLETE_EVIDENCE', 62)]	1	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 112, 'fish')]
PMC4113768	7/2014	S428-PMC4113768	['ONLY 8% of patients took multivitamin or Vitamin D supplements daily.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4113768	7/2014	S441-PMC4113768	['background: there is GROWING EVIDENCE from OBSERVATIONAL epidemiological and Animal studies that foetal Vitamin D deficiency MAY BE a risk factor for the development of neuropsychiatric disorders in adulthood, and that this MAY BE ASSOCIATED with increased Lateral Ventricle diameter (ventriculomegaly) in the foetal Brain.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 231)]	5	[('NCBITaxon_33208', 'Metazoa', 77, 'animal'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0002285', 'telencephalic ventricle', 257, 'lateral ventricle'), ('UBERON_0000955', 'brain', 317, 'brain')]
PMC4113768	7/2014	S443-PMC4113768	['IF Vitamin D status does indeed IMPACT on Neurodevelopment, seasonal variation in Lateral Ventricular diameter MIGHT be expected.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 111)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007399', 'nervous system development', 42, 'neurodevelopment'), ('UBERON_0004086', 'brain ventricle', 82, 'lateral ventricular')]
PMC4113768	7/2014	S456-PMC4113768	['THEREFORE, the larger mean foetal Lateral Ventricle size SEEN in october–december is LIKELY to RELATE to adverse exposure in june–september, when maternal Vitamin D status is highest.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 85), ('SUPERFICIAL_RELATIONSHIP', 95)]	4	[('UBERON_0002285', 'telencephalic ventricle', 34, 'lateral ventricle'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4113768	7/2014	S457-PMC4113768	['our data do not THEREFORE SUPPORT a ROLE for Vitamin D in protection against foetal Lateral Ventriculomegaly.']	[('PROBABLE_UNDERSTANDING', 16), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001359', 'cerebrospinal fluid', 84, 'lateral ventriculomegaly')]
PMC4113768	7/2014	S463-PMC4113768	['populations in developing countries are OFTEN deficient in Vitamin A. u or j shaped curves for benefits of increases in Vitamin D supplementation in are a GROWING CONCERN, as REPORTED in the western world.']	[('PROBABLE_UNDERSTANDING', 40), ('IMPORTANT_CONSIDERATION', 155), ('INCOMPLETE_EVIDENCE', 155), ('IMPORTANT_CONSIDERATION', 163), ('INCOMPLETE_EVIDENCE', 175)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S473-PMC4113768	['high intakes (above RECOMMENDED daily amounts) of Vitamin A HAVE BEEN REPORTED to counteract the EFFECTS of Vitamin D (including EFFECTS in rcts).']	[('FUTURE_WORK', 20), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 97), ('SUPERFICIAL_RELATIONSHIP', 129)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4113768	7/2014	S476-PMC4113768	['overall reductions in Lung cancer RISKS in never-smokers in the women’s health initiative (1771 cases in 128,779 women) were seen with vitamin D intakes >400 iu/day (or = 0.37, 95% ci: 0.18–0.77); HOWEVER, rct data for the 12% of women given Vitamin D supplements SHOWED lower Lung cancer risk ONLY in those with low intakes of Retinol (or = 0.69, 95% ci, 0.5–0.96).']	[('IMPORTANT_CONSIDERATION', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('ANOMALY_CURIOUS_FINDING', 197), ('INCOMPLETE_EVIDENCE', 264), ('ANOMALY_CURIOUS_FINDING', 294), ('INCOMPLETE_EVIDENCE', 294)]	6	[('UBERON_0002048', 'lung', 22, 'lung'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('UBERON_0002048', 'lung', 277, 'lung'), ('CHEBI_26536', 'retinoic acid', 328, 'retinol')]
PMC4113768	7/2014	S478-PMC4113768	['lower death rates from malignant melanoma are SEEN with higher Vitamin D intakes (or = 0.77, 95% ci, 0.64–0.93) BUT this benefit is smaller in those with high Retinol intakes (or = 0.99, 95% ci, 0.72–1.36).']	[('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_26536', 'retinoic acid', 159, 'retinol')]
PMC4113768	7/2014	S479-PMC4113768	['conclusions: (1) SINCE the use of supplements containing Vitamin A as well as Vitamin D is common, WHETHER in Cod Liver oil OR multi-vitamins, especially in developed countries, Vitamin A status is LIKELY to CONFOUND rcts of Vitamin D in westernized populations; (2) in particular, high Vitamin A Intakes COULD ACCOUNT for j or inverse u shaped curves for outcomes in rcts, AS COULD Gene polymorphisms increasing circulating Retinol/Retinoids; (3) CONVERSELY, poor Vitamin D status MAY BE expected to CONFOUND rcts of Vitamin A in developing countries; (4) as well as Vitamin A intakes, other lifestyle factors that are POTENTIAL CONFOUNDERS of the EFFECTS of Vitamin D SHOULD BE CONSIDERED in the PLANNING of FUTURE rcts of supplemental Vitamin D, including intakes of other Nutrients, tobacco usage, and also betel-chewing which MAY increase Catabolism Of Vitamin D and is a habit used by 10% of the world population.']	[('PROBABLE_UNDERSTANDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('PROBABLE_UNDERSTANDING', 198), ('PROBLEM_COMPLICATION', 208), ('INCOMPLETE_EVIDENCE', 305), ('IMPORTANT_CONSIDERATION', 311), ('PROBABLE_UNDERSTANDING', 374), ('INCOMPLETE_EVIDENCE', 377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 448), ('INCOMPLETE_EVIDENCE', 482), ('PROBLEM_COMPLICATION', 501), ('INCOMPLETE_EVIDENCE', 620), ('PROBLEM_COMPLICATION', 630), ('SUPERFICIAL_RELATIONSHIP', 649), ('FUTURE_WORK', 670), ('FUTURE_WORK', 680), ('FUTURE_WORK', 698), ('FUTURE_WORK', 710), ('INCOMPLETE_EVIDENCE', 831)]	19	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'cod'), ('UBERON_0002107', 'liver', 114, 'liver'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A'), ('GO_0007631', 'feeding behavior', 297, 'intakes'), ('SO_0000704', 'gene', 383, 'gene'), ('CHEBI_26536', 'retinoic acid', 425, 'retinol'), ('CHEBI_26537', 'retinoid', 433, 'retinoids'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 518, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 738, 'vitamin D'), ('CHEBI_33284', 'nutrient', 776, 'nutrients'), ('GO_0044851', 'hair cycle phase', 844, 'catabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 858, 'vitamin D')]
PMC4113768	7/2014	S484-PMC4113768	['background: Vitamin D MAY INFLUENCE Tissue Modelling and Repair in the Lungs throughout Life and THUS low levels of Vitamin D MAY have a negative IMPACT on Lung function.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 26), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 146)]	5	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('GO_0048771', 'tissue remodeling', 36, 'tissue modelling'), ('UBERON_0000479', 'tissue', 36, 'tissue'), ('GO_0006281', 'DNA repair', 57, 'repair'), ('UBERON_0002048', 'lung', 71, 'lungs'), ('UBERON_0000104', 'life cycle', 88, 'life'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0002048', 'lung', 156, 'lung')]
PMC4113768	7/2014	S485-PMC4113768	['in addition, an ASSOCIATION between INADEQUATE Vitamin D levels and impaired Lung function COULD BE EXPLAINED by an INCREASED RISK of Respiratory infections or a negative INFLUENCE on muscle function.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 36), ('INCOMPLETE_EVIDENCE', 91), ('PROBABLE_UNDERSTANDING', 100), ('IMPORTANT_CONSIDERATION', 116), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002048', 'lung', 77, 'lung'), ('UBERON_0001004', 'respiratory system', 134, 'respiratory')]
PMC4113768	7/2014	S502-PMC4113768	['RANDOMIZED controlled TRIALS ARE NEEDED to fully ELUCIDATE the POTENTIAL RELATIONS of Vitamin D with measures of Lung function.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('FUTURE_WORK', 49), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 73)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0002048', 'lung', 113, 'lung')]
PMC4113768	7/2014	S512-PMC4113768	['randomised controlled trials of Vitamin D supplementation in children with asthma for PREVENTION of exacerbation and uri HAVE REPORTED positive results; such trials have not previously been conducted in Adults.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 121)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0007023', 'adult organism', 203, 'adults')]
PMC4113768	7/2014	S579-PMC4113768	['background: SEVERAL STUDIES have investigated the ASSOCIATION between Vitamin D in Pregnancy and Birth weight, but the conclusion of the studies are NOT CLEAR.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 50), ('FULL_UNKNOWN', 149)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007567', 'parturition', 97, 'birth')]
PMC4113768	7/2014	S588-PMC4113768	['we SPECULATE that the EFFECT of Vitamin D exposure in Pregnancy is modified by the exposure prior to Conception.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 22)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('GO_0007620', 'copulation', 101, 'conception')]
PMC4113768	7/2014	S599-PMC4113768	['this NOVEL FINDING SUPPORTED an A priori HYPOTHESIS that low uvb exposure and low Vitamin D status have an etiologic ROLE in Food allergy.']	[('FULL_UNKNOWN', 5), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 32), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 117)]	6	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_33290', 'food', 125, 'food')]
PMC4113768	7/2014	S625-PMC4113768	['these prospective data SUPPORT the HYPOTHESIS that maternal Vitamin D status and child season of Birth CONTRIBUTE to RISK of childhood p/tn allergy.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 103), ('IMPORTANT_CONSIDERATION', 117)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007567', 'parturition', 97, 'birth')]
PMC4113768	7/2014	S631-PMC4113768	['; kiely, m.\nbackground: obesity is a RISK FACTOR for low circulating 25-Hydroxy Vitamin D (25(Oh)D), which is the BIOMARKER of Vitamin D status, and there are CONSISTENT negative ASSOCIATIONS between 25(Oh)D and measures of adiposity in Adults and children.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 179)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 69, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 206, 'D'), ('UBERON_0007023', 'adult organism', 237, 'adults')]
PMC4113768	7/2014	S668-PMC4113768	['; dyall, l.; kepa, m.\nbackground: POSSIBLE CONSEQUENCES of low Vitamin D status include osteoporosis, falls, Cardiovascular disease, cancer, and diabetes, all of which are LIKELY to be more SERIOUS for men and women of advanced age (>80 years) compared to younger Adults.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBLEM_COMPLICATION', 43), ('PROBABLE_UNDERSTANDING', 172), ('IMPORTANT_CONSIDERATION', 190)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 109, 'cardiovascular'), ('UBERON_0007023', 'adult organism', 264, 'adults')]
PMC4113768	7/2014	S682-PMC4113768	['conclusions: frequent use of high-dose oral Vitamin D APPEARS TO HAVE resulted in a high overall Vitamin D status in older new zealanders, which is in STARK CONTRAST TO the relatively low status REPORTED PREVIOUSLY.']	[('ANOMALY_CURIOUS_FINDING', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 195), ('INCOMPLETE_EVIDENCE', 204)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4113768	7/2014	S683-PMC4113768	['poorer Vitamin D status in māori MAY REFLECT darker skin tone or inequitable supply of oral Vitamin D. primary care practitioners SHOULD BE aware of the availability and common use of high-dose Vitamin D preparations, and SHOULD ask about over-the-counter Supplement use before prescribing Pharmaceutical Vitamin D in those of advanced aged.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 37), ('FUTURE_WORK', 130), ('FUTURE_WORK', 222)]	4	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 256, 'supplement'), ('CHEBI_52217', 'pharmaceutical', 290, 'pharmaceutical'), ('CHEBI_27300', 'vitamin D', 305, 'vitamin D')]
PMC4113768	7/2014	S747-PMC4113768	['25(Oh)D assay standardization is, THEREFORE, ESSENTIAL to the development of EVIDENCED-BASED clinical and PUBLIC HEALTH guidelines for Vitamin D.\nmethods: Vitamin D standardization program (vdsp) is an international program designed to promote the standardized laboratory measurement of 25(Oh)D. it was established in 2010 by the us nih office of dietary supplements in collaboration with us national institute of standards and technology (nist), cdc, and ghent university.']	[('PROBABLE_UNDERSTANDING', 34), ('IMPORTANT_CONSIDERATION', 45), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 106)]	4	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 6, 'D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 155, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 287, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 287, '25(OH)D')]
PMC4113768	7/2014	S782-PMC4113768	['RANDOMIZED controlled trials of Vitamin D supplementation MAY BE WARRANTED for infants with low 25(Oh)D during the initial months of Life, BUT careful selection of the regimen with close monitoring of safety for those who reach high 25(Oh)D levels will be NECESSARY.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 58), ('FUTURE_WORK', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('IMPORTANT_CONSIDERATION', 256)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 102, 'D'), ('UBERON_0000104', 'life cycle', 133, 'life'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 233, '25(OH ... D')]
PMC4113768	7/2014	S788-PMC4113768	['the Respiratory Epithelium is VITAL in the Defence Against such Infections, and THUS MAY BE an IMPORTANT FOCUS as to where Vitamin D has its immunomodulatory actions.']	[('IMPORTANT_CONSIDERATION', 30), ('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 95)]	4	[('UBERON_0004802', 'respiratory tract epithelium', 4, 'respiratory epithelium'), ('GO_0002235', 'detection of unfolded protein', 43, 'defence against'), ('GO_0007567', 'parturition', 64, 'infections'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4113768	7/2014	S807-PMC4113768	['these transporters contain putative Vitamin D receptor response elements within their Promoters, SUGGESTING that amino acid transporters MAY BE Modulated by maternal Vitamin D status, a measure previously shown to RELATE to adiposity and bone health of the offspring.']	[('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 214)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('SO_0000167', 'promoter', 86, 'promoters'), ('GO_0065007', 'biological regulation', 144, 'modulated'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC4113768	7/2014	S808-PMC4113768	['we THEREFORE AIMED TO ESTABLISH WHETHER maternal Vitamin D and Vitamin D-binding protein (dbp) levels MIGHT RELATE to the Expression of amino acid transporters in Human Placenta.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 108)]	6	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0010467', 'gene expression', 122, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 163, 'human'), ('UBERON_0001987', 'placenta', 169, 'placenta')]
PMC4113768	7/2014	S817-PMC4113768	['the CORRELATIONS between dbp levels and several amino acid transporters SUGGEST that Vitamin D Delivery MAY BE IMPORTANT for Placental function, but FURTHER WORK is now REQUIRED to establish WHETHER these ASSOCIATIONS are causal.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 111), ('FUTURE_WORK', 149), ('IMPORTANT_CONSIDERATION', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('SUPERFICIAL_RELATIONSHIP', 205)]	8	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007567', 'parturition', 95, 'delivery'), ('UBERON_0001987', 'placenta', 125, 'placental')]
PMC4113768	7/2014	S825-PMC4113768	['there is wide VARIATION in the content and availability of Vitamin D supplements, and DESPITE nice guidelines on Vitamin D supplementation implementation REMAINS UNCERTAIN.']	[('DIFFICULT_TASK', 14), ('ANOMALY_CURIOUS_FINDING', 86), ('INCOMPLETE_EVIDENCE', 154), ('FULL_UNKNOWN', 162)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC4113768	7/2014	S836-PMC4113768	['15% (3/20) women surveyed said they had RISK FACTORS for Vitamin D deficiency, BUT ONLY 2 were specifically asked about Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 83)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S841-PMC4113768	['ONLY one-third of staff IDENTIFIED (from options given) the correct dose of Vitamin D supplement for high-risk women.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4113768	7/2014	S843-PMC4113768	['knowledge levels APPEAR TO CORRELATE with use of Vitamin D supplementation, SUGGESTING that APPROPRIATE information provision is VITAL.']	[('ANOMALY_CURIOUS_FINDING', 17), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 92), ('IMPORTANT_CONSIDERATION', 129)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S850-PMC4113768	['background: the ROLE of Vitamin D in bone Metabolism is WELL KNOWN BUT its’ actions on muscle are INCOMPLETELY understood.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('INCOMPLETE_EVIDENCE', 98)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0008152', 'metabolic process', 42, 'metabolism')]
PMC4113768	7/2014	S851-PMC4113768	['clinical and laboratory evidence SUGGEST that muscle is a target Tissue for Vitamin D, with myopathy a RECOGNISED feature of d deficient Individuals and receptors present in Skeletal muscle.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 103)]	2	[('UBERON_0000479', 'tissue', 65, 'tissue'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('NCBITaxon_1', 'root', 137, 'individuals'), ('UBERON_0004288', 'skeleton', 174, 'skeletal')]
PMC4113768	7/2014	S852-PMC4113768	['most data regarding the EFFECTS of Vitamin D on non-Skeletal Tissues in young People HAS BEEN obtained from cross-sectional studies, with their ASSOCIATED LIMITATIONS.we have THEREFORE UNDERTAKEN a systematic review of randomised controlled trials (rcts) that has EXAMINED the IMPACT of Vitamin D on muscle strength and function in young People.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 144), ('INCOMPLETE_EVIDENCE', 155), ('PROBLEM_COMPLICATION', 155), ('PROBABLE_UNDERSTANDING', 175), ('QUESTION_ANSWERED_BY_THIS_WORK', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 264), ('SUPERFICIAL_RELATIONSHIP', 277)]	9	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0004288', 'skeleton', 52, 'skeletal'), ('UBERON_0000479', 'tissue', 61, 'tissues'), ('NCBITaxon_10088', 'Mus <genus>', 78, 'people'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 338, 'people')]
PMC4113768	7/2014	S870-PMC4113768	['IN CONTRAST TO observational studies that SHOW a beneficial EFFECT of Vitamin D on grip strength, there was no significant increase seen in grip strength in any of the included studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4113768	7/2014	S874-PMC4113768	['they ATTRIBUTED this improvement to an increase in both jumping velocity and height, SUGGESTING greater flexibility and muscular co-ordination after Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 85)]	2	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4113768	7/2014	S875-PMC4113768	['conclusions: this systematic REVIEW FOUND that correcting Vitamin D deficiency in young People did not result in improved muscle strength.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 36)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 88, 'people')]
PMC4113768	7/2014	S877-PMC4113768	['the results of this review are at ODDS with findings from SOME observational studies, which have SUGGESTED that Vitamin D status AFFECTS Hand-grip strength.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 129)]	4	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0002398', 'manus', 137, 'hand')]
PMC4113768	7/2014	S892-PMC4113768	['both SHOWED significant levels of intravascular haemolysis and Vitamin D levels of <10 nmol/l were DOCUMENTED.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 99)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC4113768	7/2014	S896-PMC4113768	['those patients REQUIRING frequent admissions for painful crises, together with Vitamin D deficiency, CAN develop vertebral changes.']	[('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 101)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC4113768	7/2014	S898-PMC4113768	['such OBSERVATIONS from a relatively small clinic SUGGEST Vitamin D deficiency ACTS as a comorbid FACTOR in leading to changes in the Vertebral Bodies.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 97)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0002347', 'thoracic vertebra', 133, 'vertebral bodies')]
PMC4113768	7/2014	S912-PMC4113768	['studies carried out in a number of types of Dogs by may mellanby SHOWED that Vitamin D deficiency damaged the Development Of Teeth at the same time as Bones and that this COULD BE reversed with a diet high in Vitamin D. she conducted a series of early randomized controlled trials in orphanages too that SHOWED lower rates of caries in children under 12 who were given diets higher in Vitamin D. RECENT RESEARCH in children with specific syndromes and in Gene knockout Mice have CONFIRMED a central ROLE for Vitamin D in Tooth mineralization with EFFECTS on Tooth structure, as described by may mellanby.']	[('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 304), ('INCOMPLETE_EVIDENCE', 396), ('INCOMPLETE_EVIDENCE', 479), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 547)]	7	[('NCBITaxon_33208', 'Metazoa', 44, 'dogs'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0042466', 'chemokinesis', 110, 'development of teeth'), ('UBERON_0001091', 'calcareous tooth', 125, 'teeth'), ('UBERON_0001474', 'bone element', 151, 'bones'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 385, 'vitamin D'), ('SO_0000704', 'gene', 455, 'gene'), ('NCBITaxon_10088', 'Mus <genus>', 469, 'mice'), ('CHEBI_27300', 'vitamin D', 508, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 521, 'tooth'), ('UBERON_0001091', 'calcareous tooth', 558, 'tooth')]
PMC4113768	7/2014	S914-PMC4113768	['conclusions: early work with dietary manipulations in a Dog MODEL together with trials in institutionalized children SUGGESTED that Vitamin D is an IMPORTANT PROTECTIVE factor against Dental decay.']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 148), ('SUPERFICIAL_RELATIONSHIP', 158)]	4	[('NCBITaxon_33208', 'Metazoa', 56, 'dog'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 184, 'dental')]
PMC4113768	7/2014	S917-PMC4113768	['what is LESS CLEAR is the RELEVANT SIGNIFICANCE of Vitamin D deficiency to Tooth Development, at a population level, in the uk at present.']	[('FULL_UNKNOWN', 8), ('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 35)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0048538', 'thymus development', 75, 'tooth development'), ('UBERON_0001091', 'calcareous tooth', 75, 'tooth')]
PMC4113768	7/2014	S920-PMC4113768	['; ayoub, d.\nbackground: RECENT reviews have SUGGESTED that Vitamin D deficiency rickets cannot begin to occur before Birth (kovacs, c.s.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 44)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007567', 'parturition', 117, 'birth')]
PMC4113768	7/2014	S926-PMC4113768	['methods: TO explore THIS issue we have reviewed clinical REPORTS of Vitamin D deficiency in neonates from 1930 onwards.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 57)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4113768	7/2014	S939-PMC4113768	['background: older authors from AT LEAST 1906 onwards were CLEAR that Vitamin D deficiency rickets COULD cause fractures.']	[('PROBABLE_UNDERSTANDING', 31), ('PROBABLE_UNDERSTANDING', 58), ('INCOMPLETE_EVIDENCE', 98)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4113768	7/2014	S941-PMC4113768	['radiology 2012, 262 , 234-241) the CONCLUSION was that fractures in early childhood were UNLIKELY to be caused by Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 89)]	2	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4113768	7/2014	S942-PMC4113768	['methods: to EXAMINE this VIEW reports of fractures at less than two years of age in rickets due to Vitamin D deficiency HAVE been reviewed.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 25), ('IMPORTANT_CONSIDERATION', 120)]	3	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4113768	7/2014	S965-PMC4113768	['the following demographic factors were FOUND to INDEPENDENTLY ASSOCIATE with increased risk of Vitamin D deficiency: bmi > 30 kg/m2(or 1.87, p = 0.04); Blood draw during winter and spring seasons (or 3.00, p< 0.01; or 2.50, p< 0.01, respectively).']	[('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0000178', 'blood', 152, 'blood')]
PMC4113768	7/2014	S966-PMC4113768	['the following lifestyle factors were FOUND to INDEPENDENTLY ASSOCIATE with reduced risk of Vitamin D deficiency: Consumption of a Vitamin D supplement, 100–400 iu/day (or 0.42, p< 0.01); a sunny holiday abroad defined as: a trip to any location within a latitude 51 degrees north or south of the equator, during the local sunny season, 2 months prior to Blood draw, for a duration of ≥1 week (or 0.27, p = 0.02).']	[('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007631', 'feeding behavior', 113, 'consumption'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('UBERON_0000178', 'blood', 354, 'blood')]
PMC4113768	7/2014	S971-PMC4113768	['Genetic variants in the Vitamin D pathway that HAVE PREVIOUSLY BEEN shown to ASSOCIATE with risk of Vitamin D deficiency in healthy Adult populations were not associated with deficiency in this patient group.']	[('IMPORTANT_CONSIDERATION', 47), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0007023', 'adult organism', 132, 'adult')]
PMC4113768	7/2014	S978-PMC4113768	['; kiely, m.\nbackground: persistence of the INFLUENCE of Vitamin D status at Birth into Infancy HAS RECENTLY BEEN SHOWN (við streym, s., et al .']	[('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 95)]	2	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007567', 'parturition', 76, 'birth'), ('UBERON_0000023', 'wing', 87, 'infancy')]
PMC4113768	7/2014	S983-PMC4113768	['apart from its well-DOCUMENTED ROLE in Bone mineralisation, Vitamin D is IMPLICATED in muscle strength and SEVERE Vitamin D deficiency CAN delay gross motor Development, such as walking in children (agarwal, a., et al .']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 107), ('INCOMPLETE_EVIDENCE', 135)]	5	[('GO_0007567', 'parturition', 39, 'bone'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0008289', 'lipid binding', 157, 'development')]
PMC4113768	7/2014	S1026-PMC4113768	['maternal Vitamin D supplementation reduces the risk of infection and pre-term Birth: a population study on 36,181 Pregnancies\n\nhyppönen, e.; cavadino, a.; williams, d.; czeizel, e.\nbackground: adequate Vitamin D nutrition HAS BEEN SUGGESTED to be ESSENTIAL for the successful maintenance of Pregnancy, with increasing interest on its EFFECTS on Placental function, infection risk and inflammatory responses.']	[('INCOMPLETE_EVIDENCE', 222), ('IMPORTANT_CONSIDERATION', 247), ('SUPERFICIAL_RELATIONSHIP', 334)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 9, 'Vitamin D'), ('GO_0007567', 'parturition', 78, 'Birth'), ('GO_0007565', 'female pregnancy', 114, 'Pregnancies'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('GO_0007565', 'female pregnancy', 291, 'pregnancy'), ('UBERON_0001987', 'placenta', 345, 'placental')]
PMC4113768	7/2014	S1027-PMC4113768	['THIS STUDY was done TO EVALUATE the ASSOCIATION between maternal Vitamin D supplementation during Pregnancy, the risk of bacterial and Viral infections, and their POSSIBLE CONTRIBUTION to the risk of pre-term Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 172)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('NCBITaxon_1', 'root', 135, 'viral'), ('GO_0007567', 'parturition', 209, 'birth')]
PMC4113768	7/2014	S1038-PMC4113768	['these data SUGGEST that the RELATED EFFECTS are strong and CONSISTENT across DIFFERENT types of infections, HIGHLIGHTING THE NEED to PREVENT Vitamin D deficiency in Pregnant mothers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('IMPORTANT_CONSIDERATION', 108), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 121), ('FUTURE_WORK', 125), ('SUPERFICIAL_RELATIONSHIP', 133)]	11	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnant')]
PMC4113768	7/2014	S1043-PMC4113768	['epidemiological studies in Adults SHOWED that bone Mineral density as well as bone turnover MARKERS are ASSOCIATED with Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 92), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('UBERON_0007023', 'adult organism', 27, 'adults'), ('CHEBI_46662', 'mineral', 51, 'mineral'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S1053-PMC4113768	['conclusions: THIS STUDY SHOWED ASSOCIATIONS between MARKERS of bone turnover and 25(Oh) Vitamin D which are DEPENDENT on Serum calcium level in school-aged children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 108)]	5	[('CHEBI_30778', 'gallic acid', 81, '25(OH)'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum')]
PMC4113768	7/2014	S1057-PMC4113768	['; van schoor, n.; de jongh, r.t.; visser, m.; lips, p.\nbackground: physical activity (pa) MAY have an IMPACT on Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 102)]	2	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4113768	7/2014	S1077-PMC4113768	['higher Serum 25(Oh) Vitamin D levels were CONSISTENTLY FOUND among subjects with no prevalent Cardiovascular risk factors ( p> 0.05) except for those subjects with serum crp level ≥3 mg/l, tc/Hdl-C ratio ≥5, and those with 4 or more Pregnancies.']	[('PROBABLE_UNDERSTANDING', 42), ('INCOMPLETE_EVIDENCE', 55)]	2	[('UBERON_0001977', 'blood serum', 7, 'serum'), ('CHEBI_30778', 'gallic acid', 13, '25(OH)'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 94, 'cardiovascular'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 192, 'HDL-C'), ('GO_0007565', 'female pregnancy', 233, 'pregnancies')]
PMC4113768	7/2014	S1084-PMC4113768	['background: reports SUGGEST that Vitamin D deficiency (vdd), and its clinical COMPLICATIONS, have increased in prevalence among children in the uk.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 78), ('PROBLEM_COMPLICATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4113768	7/2014	S1114-PMC4113768	['a minority of cases did not receive the RECOMMENDED type or dose of Vitamin D treatment, SUGGESTING a NEED to improve paediatricians’ knowledge regarding vdd management.']	[('FUTURE_WORK', 40), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 102)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4113768	7/2014	S1120-PMC4113768	['one hundred and fifty Individuals (65 men and 85 female) aged over 18 years with a body mass index between 18 and 30 kg/m2were selected because their Vitamin D concentrations were between 5 ng/ml and 20 ng/ml at inclusion, CONSISTENT with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 223)]	1	[('NCBITaxon_1', 'root', 22, 'individuals'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D')]
PMC4113768	7/2014	S1136-PMC4113768	['conclusion: THIS study DEMONSTRATED a dose-response between Vitamin D administration and Plasma levels after monthly administrations of 25,000, 50,000 or 100,000 iu of Vitamin D (d-cure®ampoule).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 23)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 89, 'plasma'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4113768	7/2014	S1152-PMC4113768	['it adds to SIMILAR FINDINGS from OTHER regions of the world, INDICATING Vitamin D deficiency in the population and especially in Individuals with asd.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 61)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_1', 'root', 129, 'individuals')]
PMC4113768	7/2014	S1158-PMC4113768	['THIS STUDY AIMED to develop a risk profile that CAN be used to easily identify older Individuals at high RISK for Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 105)]	4	[('NCBITaxon_1', 'root', 85, 'individuals'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4113768	7/2014	S1169-PMC4113768	['these risk scores MAY BE useful in clinical practice to identify Persons AT RISK for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 73)]	2	[('NCBITaxon_10088', 'Mus <genus>', 65, 'persons'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4113768	7/2014	S1172-PMC4113768	['studies FOUND INCONSISTENT results regarding the RELATIONSHIP of Vitamin D status and bone Mineral density (bmd) and quantitative ultrasound measurements (qus).']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_46662', 'mineral', 91, 'mineral')]
PMC4113768	7/2014	S1181-PMC4113768	['in lasa-ii no associations of Vitamin D status with bua were FOUND.']	[('INCOMPLETE_EVIDENCE', 61)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC4113768	7/2014	S1184-PMC4113768	['no significant associations of Vitamin D status and sos and bmd were FOUND.']	[('INCOMPLETE_EVIDENCE', 69)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC4113768	7/2014	S1189-PMC4113768	['; chaloner, c.\nbackground: the incidence of both symptomatic and asymptomatic Vitamin D deficiency is GROWING, especially among certain ethnic groups and those with particular dietary preferences.']	[('INCOMPLETE_EVIDENCE', 102)]	1	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4113768	7/2014	S1190-PMC4113768	['there are an increasing NUMBER OF disorders THOUGHT TO be LINKED to Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4113768	7/2014	S1191-PMC4113768	['several lifestyle factors, including shift work and mode of dress, HAVE BEEN IDENTIFIED as causes for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 77)]	2	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4113768	7/2014	S1193-PMC4113768	['THESE STUDIES have led to increased demand for measurement of Blood concentrations of 25-Hydroxy Vitamin D (25Ohd), but there are barriers to effective use of the Vitamin D service: (i) limited laboratory capacity; and (ii) inappropriate test requesting.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('UBERON_0000178', 'blood', 62, 'blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 86, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 105, 'D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 108, '25OHD'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4113768	7/2014	S1198-PMC4113768	['ONLY results available before subjects started Vitamin D replacement were included in the 2007 dataset but they were not excluded from the 2010 dataset.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4113768	7/2014	S1200-PMC4113768	['the percentage of patients with 25Ohd < 50 nmol/l fell (from 70% in 2007 to 58% in 2010), PERHAPS AS a result of including those who had started Vitamin D replacement.']	[('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 98)]	2	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 32, '25OHD'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC4113768	7/2014	S1203-PMC4113768	['conclusions: pth is the MOST LIKELY MARKER to be outside the reference range (raised) IF the patient is Vitamin D deficient BUT the literature SUGGESTS the RELATIONSHIP between 25Ohd and pth MAY BE COMPLICATED by Glomerular filtration rate.']	[('PROBABLE_UNDERSTANDING', 24), ('PROBABLE_UNDERSTANDING', 29), ('SUPERFICIAL_RELATIONSHIP', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 156), ('INCOMPLETE_EVIDENCE', 191), ('DIFFICULT_TASK', 198)]	9	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD'), ('UBERON_0000074', 'renal glomerulus', 213, 'glomerular')]
PMC4113768	7/2014	S1279-PMC4113768	['the study was LIMITED by the already sufficient Vitamin D levels at baseline.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC4113768	7/2014	S1283-PMC4113768	['; filteau, s.; trilok, kumar, g.\nbackground: Vitamin D status or parent-selected Vitamin D supplementation in infancy HAVE BEEN ASSOCIATED with better bone growth and mineralization in later childhood.']	[('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 128)]	2	[('CHEBI_28384', 'vitamin K', 45, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4113768	7/2014	S1285-PMC4113768	['a RECENT meta-analysis SHOWED INCONSISTENT EFFECTS of Vitamin D supplementation on bone Mineral density of healthy children.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_46662', 'mineral', 88, 'mineral')]
PMC4113768	7/2014	S1301-PMC4113768	['; wood, a.d.\nbackground: variation in Vitamin D binding protein (Vdbp) MAY EXPLAIN the INCONSISTENCIES between studies of Vitamin D; EITHER ( a ) through a mechanism by which the circulating half-life of 25-Hydroxy Vitamin D [25(Oh)D] MAY BE extended or ( b ) BECAUSE non-Vdbp bound or free Metabolites of Vitamin D MAY BETTER REFLECT biological activity.']	[('INCOMPLETE_EVIDENCE', 71), ('PROBABLE_UNDERSTANDING', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133), ('INCOMPLETE_EVIDENCE', 235), ('PROBABLE_UNDERSTANDING', 260), ('INCOMPLETE_EVIDENCE', 316), ('INCOMPLETE_EVIDENCE', 320), ('SUPERFICIAL_RELATIONSHIP', 327)]	9	[('CHEBI_28384', 'vitamin K', 38, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 38, 'Vitamin D'), ('PR_000017279', 'testis-specific basic protein Y 1', 65, 'VDBP'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 204, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 226, '25(OH)D'), ('PR_000017279', 'testis-specific basic protein Y 1', 272, 'VDBP'), ('CHEBI_25212', 'metabolite', 291, 'metabolites'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
PMC4113768	7/2014	S1321-PMC4113768	['IN CONTRAST, both Vitamin D doses caused a rapid increase in 25(Oh)D, reaching a plateau of 65[20] nmol/l for 400 iu, and 76[19] nmol/l for 1000 iu Vitamin D. we REPORTED that 1000 iu Vitamin D3But not 400 iu attenuated bone mineral density loss, WHEREAS the increase in 25(Oh)D for the 1000 iu dose was ONLY 25% above that for the 400 iu dose (2).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('ANOMALY_CURIOUS_FINDING', 247), ('ANOMALY_CURIOUS_FINDING', 304), ('INCOMPLETE_EVIDENCE', 304)]	6	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 61, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_82668', 'DH335(1+)', 184, 'vitamin D3but'), ('PR_000017209', 'utrophin', 184, 'vitamin D3but'), ('CHEBI_71657', 'versiconol acetate', 271, '25(OH)D')]
PMC4113768	7/2014	S1329-PMC4113768	['it is HYPOTHESISED that transient changes in Serum calcium MAY BE responsible for Remineralisation of marginally under-mineralised bone; and this MIGHT EXPLAIN WHY Vitamin D most benefits those who are AT RISK of deficiency.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 146), ('PROBABLE_UNDERSTANDING', 152), ('EXPLICIT_QUESTION', 160), ('IMPORTANT_CONSIDERATION', 202)]	6	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('GO_0031147', '1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one metabolic process', 82, 'remineralisation'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4113768	7/2014	S1331-PMC4113768	["Vitamin D supplementation in an edinburgh general practice population and ANECDOTAL evidence\n\nrhein, h.m.; johnson, g.\nbackground: after we became aware of the widespread Vitamin D deficiency in our scottish general practice population in edinburgh at a latitude of 56', our patients have received for the past few years the offer of prescriptions for Vitamin D supplements: 20,000 iu weekly for MOST Adults, 2000 iu daily for Pregnant women, 1000 iu daily for children aged 5–12, 400 iu daily for babies and children aged 0–5."]	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 396)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 352, 'vitamin D'), ('UBERON_0007023', 'adult organism', 401, 'adults'), ('GO_0007565', 'female pregnancy', 427, 'pregnant')]
PMC4113768	7/2014	S1348-PMC4113768	['in the absence of any known negative EFFECTS of Vitamin D supplementation and WHILE waiting for conclusive trials it COULD BE beneficial for many cancer patients to be tested and treated for Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('INCOMPLETE_EVIDENCE', 117)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4113768	7/2014	S1400-PMC4113768	['the EFFECTS on Cyp17A1 as well as Cyp19A1 SUGGEST that the levels of Estrogens MAY BE AFFECTED by Vitamin D.\nconclusions: the results INDICATE that Vitamin D has a suppressive EFFECT on some of the Genes for enzymes in the Brain Steroidogenesis implicating that the products of these enzymes MAY BE decreased.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 134), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 292)]	7	[('PR_000006101', 'cytochrome P450 1A1', 15, 'CYP17A1'), ('PR_000006101', 'cytochrome P450 1A1', 34, 'CYP19A1'), ('CHEBI_50114', 'estrogen', 69, 'estrogens'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('SO_0000704', 'gene', 198, 'genes'), ('UBERON_0000955', 'brain', 223, 'brain'), ('GO_0001501', 'skeletal system development', 229, 'steroidogenesis')]
PMC4113768	7/2014	S1401-PMC4113768	['these data CAN contribute to the understanding of Vitamin D: s complex function in the body and in the Brain.']	[('INCOMPLETE_EVIDENCE', 11)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0000955', 'brain', 103, 'brain')]
PMC4113768	7/2014	S1407-PMC4113768	['to COMPLICATE the picture, Genetic DIFFERENCES in the Vitamin D receptor (vdr) MAY also be of IMPORTANCE.']	[('DIFFICULT_TASK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 94)]	4	[('SO_0000704', 'gene', 27, 'genetic'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4113768	7/2014	S1415-PMC4113768	['conclusions: the vdr Snp rs7968585 PREDICTS the occurrence of t2dm, which MAY INDICATE a ROLE of Vitamin D in the pathogenesis of t2dm.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('SO_0000694', 'SNP', 21, 'SNP'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4113768	7/2014	S1439-PMC4113768	['this is of CONCERN SINCE it MAY REFLECT undiagnosed levels of Vitamin D deficiency/insufficiency in the wider population.']	[('PROBLEM_COMPLICATION', 11), ('PROBLEM_COMPLICATION', 19), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 32)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4113768	7/2014	S1444-PMC4113768	['background: epidemiological studies SUGGEST an ASSOCIATION between Vitamin D status and Cardiovascular disease (cvd) RISK.']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 117)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 88, 'cardiovascular')]
PMC4113768	7/2014	S1445-PMC4113768	['suboptimal Vitamin D status APPEARS TO increase an Individual’s RISK of developing cvd, ALTHOUGH the OPTIMAL level REQUIRED is UNCLEAR and the results of intervention studies REMAIN HETEROGENEOUS and INCONCLUSIVE.']	[('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 64), ('ANOMALY_CURIOUS_FINDING', 88), ('IMPORTANT_CONSIDERATION', 101), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 127), ('INCOMPLETE_EVIDENCE', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('DIFFICULT_TASK', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 51, 'individual')]
PMC4113768	7/2014	S1460-PMC4113768	['this study SUPPORTS a POTENTIAL ROLE for Vitamin D in cvd development, HOWEVER FURTHER RESEARCH IS REQUIRED to establish causality.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 99)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4113768	7/2014	S1466-PMC4113768	['; brenner, h.; schirmer, h.; jorde, r.; power, c.; llewellyn, d.; hyppönen, e.\nbackground: recent epidemiological and EXPERIMENTAL STUDIES have LINKED Vitamin D deficiency to a range of non-Skeletal conditions including reduced Cognitive function.']	[('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 144)]	2	[('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('UBERON_0004288', 'skeleton', 190, 'skeletal'), ('GO_0050890', 'cognition', 228, 'cognitive')]
PMC4113768	7/2014	S1519-PMC4113768	['THUS, Genetic FACTORS MAY help to identify who is MOST AT RISK of developing low Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 55)]	5	[('SO_0000704', 'gene', 6, 'genetic'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4113768	7/2014	S1522-PMC4113768	['the participants were genotyped for 25 Snps in the Vitamin D pathway and two common Single Nucleotide Polymorphisms (Snps) in the Cyp2R1 Gene (rs10741657 and rs10766197) and two common Snps in the gc Gene (rs4588 and rs842999) were FOUND to PREDICT baseline S-25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 232), ('SUPERFICIAL_RELATIONSHIP', 241)]	2	[('SO_0000694', 'SNP', 39, 'SNPs'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007601', 'visual perception', 51, 'vitamin D'), ('SO_0000694', 'SNP', 84, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 117, 'SNPs'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 130, 'CYP2R1'), ('SO_0000704', 'gene', 137, 'gene'), ('SO_0000694', 'SNP', 185, 'SNPs'), ('SO_0000704', 'gene', 200, 'gene'), ('PR_000015800', 'syntaxin-8', 258, 's-25(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 260, '25(OH)D')]
PMC4113768	7/2014	S1524-PMC4113768	['we ESTIMATED total Vitamin D intake as the sum of dietary Vitamin D, usage of multivitamin and Vitamin D supplementation and intake of Vitamin D3-fortified bread and Milk for the fortification group.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 135, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 135, 'vitamin D3'), ('UBERON_0001913', 'milk', 166, 'milk')]
PMC4113768	7/2014	S1529-PMC4113768	['we FOUND a significant positive linear RELATIONSHIP between carrying 0–2, 3, 4 or 5 risk Alleles, total Vitamin D intake and the increase in s-25(Oh)D concentrations ( p = 0.0012, 0.0001, 0.0118 and 0.0029), respectively.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('SO_0001023', 'allele', 89, 'alleles'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 143, '25(OH)D')]
PMC4113768	7/2014	S1534-PMC4113768	['carriers of a high grs MAY NEED a higher amount of Vitamin D supplementation to achieve adequate s-25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 27)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('PR_000000036', 'BMP receptor type-1B', 98, '-25'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 105, 'D')]
PMC4113768	7/2014	S1536-PMC4113768	['in the FUTURE, Genetic FACTORS MIGHT be taken into ACCOUNT when RECOMMENDING Vitamin D supplementation or Food fortification.']	[('FUTURE_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 51), ('FUTURE_WORK', 64)]	5	[('SO_0000704', 'gene', 15, 'genetic'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_33290', 'food', 106, 'food')]
PMC4113768	7/2014	S1540-PMC4113768	['background: Vitamin D IS KNOWN to AFFECT Immune function; HOWEVER it is UNCERTAIN IF Vitamin D CAN alter the Immune Response towards the persistent herpesviruses, Ebv and Cmv.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('FULL_UNKNOWN', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 95)]	6	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('UBERON_0002405', 'immune system', 41, 'immune'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0006955', 'immune response', 109, 'immune response'), ('UBERON_0002405', 'immune system', 109, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 163, 'EBV'), ('NCBITaxon_10088', 'Mus <genus>', 171, 'CMV')]
PMC4113768	7/2014	S1541-PMC4113768	['OBSERVATIONAL STUDIES SHOW that Vitamin D deficiency MAY increase the LIKELIHOOD of Ebv reactivation, and that there is a weak negative CORRELATION between Vitamin D and anti-Ebna1 titre.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 53), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 136)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 84, 'EBV'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('PR_000006877', 'Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial', 175, 'EBNA1')]
PMC4113768	7/2014	S1542-PMC4113768	['further, Vitamin D supplementation MAY specifically lower anti-Ebna-1 titres.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('PR_000006877', 'Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial', 63, 'EBNA-1')]
PMC4113768	7/2014	S1544-PMC4113768	['we INVESTIGATE for the FIRST TIME WHETHER Vitamin D levels MAY alter cmv serology in a cohort of non-white Adults resident in the uk.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 59)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 107, 'adults')]
PMC4113768	7/2014	S1560-PMC4113768	['conclusions: upon bivariate analysis, we OBSERVED a CORRELATION between Vitamin D and Cmv Antibody titre, SIMILAR in magnitude to a PREVIOUSLY PUBLISHED CORRELATION between Vitamin D and Ebna1 titres (salzer j, nystrom m, hallmans g, stenlund h, wadell g, sundstrom p. epstein-barr virus Antibodies and Vitamin D in prospective multiple sclerosis biobank samples.']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 153)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 86, 'CMV'), ('GO_0042571', 'immunoglobulin complex, circulating', 90, 'antibody'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('PR_000006877', 'Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial', 187, 'EBNA1'), ('GO_0042571', 'immunoglobulin complex, circulating', 288, 'antibodies'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
PMC4113768	7/2014	S1571-PMC4113768	['there is also EVIDENCE that Vitamin D plays an IMPORTANT ROLE in OTHER aspects of health, including infection and immunity.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4113768	7/2014	S1576-PMC4113768	['Vitamin D MAY aid in supporting the Innate and Adaptive Immune Responses, and henceforth Cd4 T-Cell preservation; STUDIES have FOUND that Vitamin D insufficiency was ASSOCIATED with cd4 changes after Antiretroviral Therapy (art) initiation (aziz, m., et al .']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 166)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 36, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 47, 'adaptive immune responses'), ('UBERON_0002405', 'immune system', 56, 'immune'), ('CL_0000810', 'CD4-positive, alpha-beta thymocyte', 89, 'CD4 T-cell'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_65417', '(+)-aplysinillin', 200, 'antiretroviral'), ('GO_0003064', 'regulation of heart rate by hormone', 200, 'antiretroviral therapy')]
PMC4113768	7/2014	S1578-PMC4113768	['AS MOST studies examining Vitamin D status and disease progression to date have included Individuals receiving art, the AIMS of THIS STUDY are TO EVALUATE the EFFECT of vitamin d status over time on immunological outcomes, such as cd4+ cell count and cd4+ percentage in hiv-infected Individuals with hiv viraemia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 120), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('QUESTION_ANSWERED_BY_THIS_WORK', 143), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('NCBITaxon_1', 'root', 283, 'individuals')]
PMC4113768	7/2014	S1597-PMC4113768	['SEVERAL STUDIES have FOUND an INTERACTION between Vitamin D status and Antiretroviral therapy on calcaemic outcomes such as 1,25(Oh)2D and pth levels.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_65417', '(+)-aplysinillin', 71, 'antiretroviral'), ('CHEBI_82784', 'PVP38-Ag NP', 124, '1,25(OH)2D')]
PMC4113768	7/2014	S1598-PMC4113768	['it is STILL UNCLEAR WHETHER the altered 25(Oh)D levels SEEN AFFECT the active Vitamin D Metabolite 1,25(Oh)2D and health outcomes (such as bone mineralization).']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 88, 'metabolite'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 101, '25(OH)2D')]
PMC4113768	7/2014	S1641-PMC4113768	['background: meta-analysis of clinical trials of Vitamin D supplementation for the PREVENTION of acute Respiratory infection (ari) SHOWS a PROTECTIVE EFFECT in the general population, BUT there is CONTROVERSY regarding the OPTIMAL dosing regimen.']	[('SUPERFICIAL_RELATIONSHIP', 82), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 222)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 102, 'respiratory')]
PMC4113768	7/2014	S1642-PMC4113768	['low-dose Vitamin D supplementation is already RECOMMENDED in older Adults for PREVENTION of fractures and falls, but clinical trials investigating WHETHER higher doses COULD provide additional protection against ari are LACKING.']	[('FUTURE_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 168), ('FULL_UNKNOWN', 220)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 67, 'adults')]
PMC4113768	7/2014	S1670-PMC4113768	['the difference in mean Serum 25(Oh)D concentration at follow-up vs. baseline REMAINED statistically significant after exclusion of 14 participants who were taking supplemental Vitamin D at follow-up and/or who had increased their sun exposure since time of diagnosis ( p = 0.005), and after exclusion of 17 participants whose baseline sample was taken from march to july inclusive ( p = 0.0003).']	[('INCOMPLETE_EVIDENCE', 77)]	1	[('UBERON_0001977', 'blood serum', 23, 'serum'), ('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 29, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D')]
PMC4113768	7/2014	S1674-PMC4113768	['OUR FINDINGS RAISE the POSSIBILITY that Vitamin D deficiency MAY BE a consequence, as well as a cause, of active tuberculosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('EXPLICIT_QUESTION', 13), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 61)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4113768	7/2014	S1678-PMC4113768	['it HAS BEEN PROVEN in MANY STUDIES that Vitamin D has a strong immunomodulator EFFECT and Vitamin D Receptor (Vdr) increases the Expression of certain anti-Mycobacterial Compound in Macrophages called cathecidilin.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 79)]	4	[('CHEBI_28384', 'vitamin K', 40, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 40, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 90, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 110, 'VDR'), ('GO_0010467', 'gene expression', 129, 'expression'), ('CHEBI_52217', 'pharmaceutical', 156, 'mycobacterial'), ('CHEBI_36357', 'polyatomic entity', 170, 'compound'), ('CL_0000235', 'macrophage', 182, 'macrophages')]
PMC4113768	7/2014	S1682-PMC4113768	['results: results INDICATE that most of the tb patients had Vitamin D deficiency i.e.']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4113768	7/2014	S1684-PMC4113768	['ONLY FEW patients (3.3%) had sufficient Vitamin D level.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4113768	7/2014	S1691-PMC4113768	['background: MANY epidemiological STUDIES in RECENT years SUGGEST that Vitamin D is ASSOCIATED with a high RISK of osteoporotic fractures, malignancy of Breast, Colon, Prostate and many Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0000310', 'breast', 152, 'breast'), ('UBERON_0001155', 'colon', 160, 'colon'), ('UBERON_0002367', 'prostate gland', 167, 'prostate'), ('GO_0045333', 'cellular respiration', 185, 'respiratory'), ('UBERON_0001004', 'respiratory system', 185, 'respiratory')]
PMC4113768	7/2014	S1692-PMC4113768	['AS sun is a rich source of Vitamin D so ONCE IT WAS THOUGHT that Vitamin D deficiency is RARE in asia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 40), ('ANOMALY_CURIOUS_FINDING', 45), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 89)]	5	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4113768	7/2014	S1693-PMC4113768	['BUT MANY STUDIES in india PROVED Vitamin D deficiency in healthy subjects.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 26), ('PROBABLE_UNDERSTANDING', 26)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4113768	7/2014	S1694-PMC4113768	['then later SOME researchers in pakistan also REPORTED Vitamin D deficiency in SOME regions of pakistan.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 78)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4113768	7/2014	S1700-PMC4113768	['results: it HAS BEEN OBSERVED that in Adult female of pakistan most of them have Vitamin D insufficiency and SOME of them were deficient while Serum calcium is not a significant BIOMARKER to check the level of Vitamin D. in obese female Vitamin D insufficiency is more than non obese.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('UBERON_0007023', 'adult organism', 38, 'adult'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0001977', 'blood serum', 143, 'serum'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC4113768	7/2014	S1702-PMC4113768	['conclusion: subjects that had Vitamin D deficiency not showed any significant clinical sign of any disease so this situation of Vitamin D deficiency COULD BE ignore at early stage that MAY lead to SOME drastic health EFFECTS in later stages that MAY BE OTHER then bone disorders.']	[('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 185), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 217), ('INCOMPLETE_EVIDENCE', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC4113768	7/2014	S1713-PMC4113768	['multivariate logistic regression was performed TO IDENTIFY POTENTIAL DETERMINANTS of Vitamin D status and of six clinical MARKERS of asthma Control (asthma Control test score, british Thoracic society treatment step, number of exacerbations in preceding 12 months, % predicted fev1, exhaled Nitric Oxide concentration and degree of reversibility of Airway obstruction following administration of inhaled Salbutamol).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0065007', 'biological regulation', 140, 'control'), ('GO_0065007', 'biological regulation', 156, 'Control'), ('UBERON_0000915', 'thoracic segment of trunk', 184, 'Thoracic'), ('CHEBI_16480', 'nitric oxide', 291, 'nitric oxide'), ('UBERON_0001005', 'respiratory airway', 349, 'airway'), ('CHEBI_66163', 'samaderine Y', 404, 'salbutamol')]
PMC4113768	7/2014	S1726-PMC4113768	['we INVESTIGATED the EFFECT of dbp genotype on estimates of f25ohd (gc-f25ohd), and on their RELATIONSHIP with 25ohd3t1/2, a measure of 25ohd tissue usage, in populations KNOWN to differ in dbp genotype and Vitamin D supply.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 170)]	4	[('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
PMC4113768	7/2014	S1743-PMC4113768	['in this study, f25ohd and gc-f25ohd, AS ESTIMATES of 25Ohd availability, DID NOT predict Vitamin D usage as assessed by 25ohd3half-life.']	[('PROBABLE_UNDERSTANDING', 37), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 73)]	3	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 53, '25OHD'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4113768	7/2014	S1748-PMC4113768	['MANY STUDIES HAVE SHOWN an inverse ASSOCIATION between 25Ohd levels and a wide range of disorders, THUS Vitamin D supplementation HAS BEEN promoted to support good health.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 99), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 55, '25OHD'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4113768	7/2014	S1783-PMC4113768	['the epidemiological data INDICATE that Vitamin D deficiency is relatively COMMON, AT LEAST in SOME parts of the united states and europe, and that INADEQUATE Serum levels of the Vitamin D are ASSOCIATED with an INCREASED RISK and POOR prognosis of several types of cancer.']	[('INCOMPLETE_EVIDENCE', 25), ('PROBABLE_UNDERSTANDING', 74), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 94), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 192), ('IMPORTANT_CONSIDERATION', 211), ('IMPORTANT_CONSIDERATION', 230)]	8	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0001977', 'blood serum', 158, 'serum'), ('CHEBI_28384', 'vitamin K', 178, 'Vitamin D')]
PMC4113768	7/2014	S1793-PMC4113768	['the AIM of the PRESENT STUDY was to follow up the study participants INVESTIGATING WHETHER the EFFECT of Vitamin D is restricted to the Prenatal period OR can also be SEEN in one or two year old infants INDEPENDENTLY from the maternal status during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 203)]	8	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'prenatal'), ('GO_0007565', 'female pregnancy', 249, 'pregnancy')]
PMC4113768	7/2014	S1801-PMC4113768	['HOWEVER, 25(Oh)D3Levels at year one SHOWED an INDEPENDENT TREND: due to the general rickets prophylaxis within the first year (87% of the children were supplemented with Vitamin D at least during the first 3 months), absolute 25(Oh)D3Was generally higher with almost no variations due to seasonal sunlight exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 58)]	5	[('CHEBI_51924', 'ethyl 2-cyanoacetoacetate', 9, '25(OH)D3levels'), ('PR_000006775', 'cytoplasmic dynein 2 heavy chain 1', 15, 'D3levels'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 226, '25(OH)D3was'), ('PR_000012979', 'DNA-directed DNA/RNA polymerase mu', 232, 'D3was')]
PMC4113768	7/2014	S1803-PMC4113768	['ACCORDING to ASSOCIATIONS with allergic outcomes we COULD SHOW comparable EFFECTS SEEN earlier within the lina cohort: there was NO EVIDENCE that Vitamin D has allergy-PROTECTIVE EFFECTS.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 179)]	9	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC4113768	7/2014	S1805-PMC4113768	['conclusions: OUR STUDY DEMONSTRATES that in east germany region (latitude: 51.3667) the Vitamin D status of one year old children is sufficient DUE to a general rickets prophylaxis, WHEREAS levels of two years old infants drop back to levels similar SEEN for Pregnant mothers.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('IMPORTANT_CONSIDERATION', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 250)]	6	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 259, 'pregnant')]
PMC4113768	7/2014	S1806-PMC4113768	['HOWEVER, according TO allergic outcomes our data RATHER POINT to a promoting THAN a protecting EFFECT of Vitamin D.\n\n2.82.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('INCOMPLETE_EVIDENCE', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('SUPERFICIAL_RELATIONSHIP', 95)]	6	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4113768	7/2014	S1827-PMC4113768	['conclusions: insufficient 25(Oh)D Plasma levels were common among elderly, more significantly among centenarians, which MAY SUGGEST Vitamin D deficiency with age, also among oldest old.']	[('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 124)]	2	[('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 26, '25 ... OH ... D'), ('UBERON_0001969', 'blood plasma', 34, 'plasma'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4113768	7/2014	S1828-PMC4113768	['in SOME of the elderly subjects lower Plasma 25(Oh)D levels coexisting with high alkaline phosphatase activity MAY INDICATE developing osteomalacia.taking INTO ACCOUNT lower Plasma 25(Oh)D, 1,25(Oh)D and calcium levels among the MAJORITY of centenarians, the sufficient Vitamin D and calcium supplementation SHOULD be systematically APPLIED also in the oldest old.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 155), ('PROBABLE_UNDERSTANDING', 229), ('FUTURE_WORK', 308), ('SUPERFICIAL_RELATIONSHIP', 333)]	7	[('UBERON_0001969', 'blood plasma', 38, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 45, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 174, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 181, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC4113768	7/2014	S1835-PMC4113768	['methods: IN ORDER TO ASSESS the POTENTIAL health EFFECTS of Consuming Vitamin D fortified Foods, we performed a registry based study, taking advantage of the extensive danish PUBLIC HEALTH registries.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 175)]	5	[('GO_0007631', 'feeding behavior', 60, 'consuming'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_33290', 'food', 90, 'foods')]
PMC4113768	7/2014	S1841-PMC4113768	['TO TEST the HYPOTHESIS of an ASSOCIATION between the Prenatal exposure to Vitamin D fortified Foods and the risk of the progeny developing schizophrenia later in Life, cox regression models were fit.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 29)]	3	[('GO_0007565', 'female pregnancy', 53, 'prenatal'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_33290', 'food', 94, 'foods'), ('UBERON_0000104', 'life cycle', 162, 'life')]
PMC4113768	7/2014	S1842-PMC4113768	['cox regression models were also used to test the HYPOTHESIS of INTERACTIONS between season of Birth and exposure to Vitamin D fortified Foods.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('GO_0007567', 'parturition', 94, 'birth'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_33290', 'food', 136, 'foods')]
PMC4113768	7/2014	S1843-PMC4113768	['results: the results of the cox regression analysis INDICATED that there was a significant INTERACTION between the season of Birth and exposure to Vitamin D fortified Margarine amongst children Born between 1983 and 1987.']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 91)]	2	[('GO_0007567', 'parturition', 125, 'birth'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_6784', 'mestranol', 167, 'margarine'), ('GO_0007567', 'parturition', 194, 'born')]
PMC4113768	7/2014	S1845-PMC4113768	['IN CONTRAST, there was NO EVIDENCE to SUGGEST a similar ASSOCIATION amongst the children Born while the Vitamin D fortification policy was in place.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 56)]	4	[('GO_0007567', 'parturition', 89, 'born'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4113768	7/2014	S1846-PMC4113768	['conclusion: the results of OUR STUDY SUGGEST that the Vitamin D fortification policy enacted in denmark until june 1st, 1985 had a PROTECTIVE EFFECT amongst children Born during the spring in regards to later development of schizophrenia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 142)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007567', 'parturition', 166, 'born')]
PMC4113768	7/2014	S1849-PMC4113768	['; parr, t.\nbackground: it is WELL KNOWN that Calcitriol, the active form of Vitamin D, is ESSENTIAL for Bone development and maintenance.']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 90)]	2	[('CHEBI_17823', 'calcitriol', 45, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007567', 'parturition', 104, 'bone')]
PMC4113768	7/2014	S1850-PMC4113768	['HOWEVER, in RECENT YEARS, it HAS BEEN SHOWN that the ROLE of Vitamin D goes beyond Calcium Homeostasis and Skeletal health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0050817', 'coagulation', 83, 'calcium'), ('GO_0042592', 'homeostatic process', 91, 'homeostasis'), ('UBERON_0004288', 'skeleton', 107, 'skeletal')]
PMC4113768	7/2014	S1851-PMC4113768	['NUMEROUS STUDIES have REPORTED that Vitamin D deficiency plays a significant ROLE in the Regulation Of Blood Pressure and Cardiovascular health.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0008217', 'regulation of blood pressure', 89, 'regulation of blood pressure'), ('UBERON_0000178', 'blood', 103, 'blood'), ('UBERON_0004535', 'cardiovascular system', 122, 'cardiovascular')]
PMC4113768	7/2014	S1852-PMC4113768	['moreover, it HAS BEEN RECOGNIZED that Vitamin D has a WIDE RANGE of biological functions, including Cell Differentiation, inhibition of cell growth and Regulation Of Gene Expression.']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0030154', 'cell differentiation', 100, 'cell differentiation'), ('GO_0010468', 'regulation of gene expression', 152, 'regulation of gene expression'), ('SO_0000704', 'gene', 166, 'gene')]
PMC4113768	7/2014	S1867-PMC4113768	['with the IMPLICATIONS of a low Vitamin D status KNOWN to include POOR bone and muscle function, establishing STRATEGIES to improve the availability of Vitamin D sources to the population is VITAL.']	[('IMPORTANT_CONSIDERATION', 9), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 65), ('FUTURE_WORK', 109), ('IMPORTANT_CONSIDERATION', 190)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
PMC4113768	7/2014	S1887-PMC4113768	['the uk national diet and nutrition survey (ndns) SHOWED that the average uk toddler is getting just 27% of their daily dietary intake of Vitamin D (bates, b., et al.']	[('INCOMPLETE_EVIDENCE', 49)]	1	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4113768	7/2014	S1890-PMC4113768	['a universal approach to Vitamin D supplementation HAS RECENTLY BEEN SUGGESTED by the chief medical officer (davies, d.c.']	[('INCOMPLETE_EVIDENCE', 50)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC4113768	7/2014	S1898-PMC4113768	['maguire and colleagues SHOWED that most canadian children could maintain their Vitamin D status by Consuming Vitamin D fortified milk (maguire, j.l., et al.']	[('INCOMPLETE_EVIDENCE', 23)]	1	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0007631', 'feeding behavior', 99, 'consuming'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC4113768	7/2014	S1899-PMC4113768	[', pediatrics 2013, 131 , 739-753), SUGGESTING this COULD BE a more EFFECTIVE way of increasing and maintaining children’s Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 67)]	3	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4113768	7/2014	S1909-PMC4113768	['conclusion: the ROLE of Vitamin D fortified Foods in the uk, especially in young children, COULD BE a useful mechanism for increasing the nutritional intake of this essential Nutrient.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 91)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_33290', 'food', 44, 'foods'), ('CHEBI_33284', 'nutrient', 175, 'nutrient')]
PMC4113768	7/2014	S1910-PMC4113768	['from this simulation we conclude that a daily Consumption of 300 ml fortified gum CAN HELP increase nutritional intakes of Vitamin D in young uk children.']	[('INCOMPLETE_EVIDENCE', 82), ('FUTURE_WORK', 86)]	2	[('GO_0007631', 'feeding behavior', 46, 'consumption'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4113768	7/2014	S1983-PMC4113768	['RECENT EVIDENCE SUGGESTS that Vitamin D MAY have a WIDE RANGE of PROTECTIVE EFFECT on Human health.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 76)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 86, 'human')]
PMC4113768	7/2014	S1994-PMC4113768	['THIS STUDY adds NEW EVIDENCE to the research body of Vitamin D deficiency in RELATION to INCREASED RISKS of clrd, cvd and all-cause mortality.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 77), ('IMPORTANT_CONSIDERATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4113768	7/2014	S1999-PMC4113768	['also, THERE IS EVIDENCE SUGGESTING that Vitamin D AFFECTS the Biosynthesis Of numerous Neurotransmitters and neurotrophic factors RELEVANT for mental health.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 130)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0001507', 'acetylcholine catabolic process in synaptic cleft', 62, 'biosynthesis of ... neurotransmitters'), ('CHEBI_25512', 'neurotransmitter', 87, 'neurotransmitters')]
PMC4113768	7/2014	S2000-PMC4113768	['this RAISES the HYPOTHESIS that low Vitamin D is RELATED to POOR mental health in the Adult general population.']	[('EXPLICIT_QUESTION', 5), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 60)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0007023', 'adult organism', 86, 'adult')]
PMC4113768	7/2014	S2019-PMC4113768	['conclusions: our results SUGGEST that low Serum 25(Oh) Vitamin D is not associated with symptoms of depression and anxiety in Adult danes from the general population.']	[('INCOMPLETE_EVIDENCE', 25)]	1	[('UBERON_0001977', 'blood serum', 42, 'serum'), ('CHEBI_30778', 'gallic acid', 48, '25(OH)'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0007023', 'adult organism', 126, 'adult')]
PMC4113768	7/2014	S2023-PMC4113768	['; lanham-new, s.; tripkovic, l.\nbackground: epidemiological research HAS SHOWN a close ASSOCIATION between Vitamin D deficiency (25Ohd < 25 nmol/l) and Cardiovascular mortality and morbidity.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 87)]	2	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 129, '25OHD'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular')]
PMC4113768	7/2014	S2039-PMC4113768	['; o’keane, m.; morrin, m.; molloy, e.; mccarthy, r.; onwuneme, c.; mcauliffe, f.; mcgowan, j.; toher, c.; murphy, n.; carroll, a.; flynn, m.\nbackground: we HAVE BEEN conducting clinical studies on Vitamin D status since the 1970s.']	[('INCOMPLETE_EVIDENCE', 156)]	1	[('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC4113768	7/2014	S2040-PMC4113768	['one of our early OBSERVATIONS was to note the primacy of Oral Intake over sunlight exposure in both the prevention and correction of hypovitaminosis d. we have DEMONSTRATED immense improvement in Vitamin D status since that time, DUE TO ready availability of low dose Vitamin D supplements and DUE TO the increasing fortification of foodstuffs with Vitamin D, starting with the fortification of milk in the mid-1980s.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 160), ('PROBABLE_UNDERSTANDING', 230), ('PROBABLE_UNDERSTANDING', 294)]	4	[('UBERON_0000165', 'mouth', 57, 'oral'), ('GO_0007631', 'feeding behavior', 62, 'intake'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 349, 'vitamin D')]
PMC4113768	7/2014	S2043-PMC4113768	['the RECENT iom 2011 report on dietary reference intakes for Calcium and Vitamin D for north america is apt for the irish population by providing the most COMPREHENSIVE EVIDENCE-BASED REPORT on Vitamin D.\nmethods: since 2007, we have conducted studies of Vitamin D status by measuring Serum 25-Hydroxy Vitamin D (25Ohd) in: preterm infants shortly after Birth ( n = 274) and after 15 weeks ( n = 148); paired term infants and mothers at Birth ( n = 39); children and adolescents from age 1 to 18 years ( n = 252); mothers during Pregnancy and infants at Birth divided according to winter Birth ( n = 30) and summer Birth ( n = 30); Pregnant mothers and ethnicity ( n = 116); patients attending an osteoporosis clinic ( n = 100); patients with cystic fibrosis ( n = 114); patients with multiple sclerosis ( n = 331) compared with healthy relatives ( n = 229) during winter months in 3 different regions in ireland; and patients with psoriasis undergoing phototherapy during the winter months ( n = 29) compared with controls ( n = 29).']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 154), ('INCOMPLETE_EVIDENCE', 168), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('INCOMPLETE_EVIDENCE', 183)]	6	[('CHEBI_31341', 'calcium dihydroxide', 60, 'Calcium'), ('CHEBI_28384', 'vitamin K', 72, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 201, 'D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('UBERON_0001977', 'blood serum', 284, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 290, '25-hydroxy vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 312, '25OHD'), ('GO_0007567', 'parturition', 353, 'birth'), ('GO_0007567', 'parturition', 436, 'birth'), ('GO_0007565', 'female pregnancy', 528, 'pregnancy'), ('GO_0007567', 'parturition', 553, 'birth'), ('GO_0007567', 'parturition', 587, 'birth'), ('GO_0007567', 'parturition', 614, 'birth'), ('GO_0007565', 'female pregnancy', 631, 'pregnant')]
PMC4113768	7/2014	S2051-PMC4113768	['evaluation of Vitamin D status in RELATION to Immune Response in children with Lower Respiratory Tract infections\n\ngori, m.; vierucci, f.; fanos, m.; del pistoia, m.; erba, p.; saggese, g.\nbackground: in addition to its KNOWN Skeletal EFFECTS, Vitamin D plays a ROLE in the Regulation of Immune Response.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 235), ('SUPERFICIAL_RELATIONSHIP', 262)]	4	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('GO_0006955', 'immune response', 46, 'Immune Response'), ('UBERON_0009567', 'nail of pedal digit', 79, 'Lower'), ('UBERON_0000061', 'anatomical structure', 85, 'Respiratory Tract'), ('UBERON_0004288', 'skeleton', 226, 'skeletal'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('GO_0065007', 'biological regulation', 274, 'regulation'), ('GO_0006955', 'immune response', 288, 'immune response'), ('UBERON_0002405', 'immune system', 288, 'immune')]
PMC4113768	7/2014	S2052-PMC4113768	['ONLY a LIMITED NUMBER OF studies EXAMINED the RELATIONSHIP between Vitamin D status and the prevalence and severity of Respiratory infections in children.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 119, 'respiratory')]
PMC4113768	7/2014	S2064-PMC4113768	['we OBSERVED a higher prevalence of dyspnea in children with pneumonia and Vitamin D deficiency COMPARED TO subjects with Vitamin D levels ≥20 ng/ml (85.6% vs. 14.3%, p = 0.01).']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4113768	7/2014	S2066-PMC4113768	['conclusions: the results of THIS STUDY SUGGEST an IMPORTANT ROLE for Vitamin D in the modulation of Immune response in children with Lower Respiratory Tract infections.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('UBERON_0004905', 'articulation', 133, 'lower respiratory tract')]
PMC4113768	7/2014	S2071-PMC4113768	['a WIDE RANGE of non-Skeletal conditions HAVE BEEN ASSOCIATED with Vitamin D deficiency, BUT EVIDENCE for a causal LINK is INCONCLUSIVE and INCONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	8	[('UBERON_0004288', 'skeleton', 20, 'skeletal'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4113768	7/2014	S2072-PMC4113768	['in VIEW of the concerns that unsubstantiated claims were being made concerning the levels of Vitamin D intake NEEDED for health, the governments of us and canada commissioned a report by the iom.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 110)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4113768	7/2014	S2073-PMC4113768	['the 2011 iom report CONCLUDED (i) that the ESTIMATED average Vitamin D REQUIREMENT from all dietary sources is 10 µg (400 iu) daily in those with minimal sunlight exposure, corresponding to a median Serum 25Ohd level of 40 nmol/l; (ii) that a 25Ohd level below 30 nmol/l indicated risk of deficiency; (iii) that a 25ohd level above 50 nmol/l INDICATED sufficiency in 97.5%; and (iv) that 25ohd levels in excess of 125 nmol/l COULD BE ASSOCIATED with harm.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 71), ('INCOMPLETE_EVIDENCE', 342), ('INCOMPLETE_EVIDENCE', 425), ('SUPERFICIAL_RELATIONSHIP', 434)]	6	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001977', 'blood serum', 199, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 205, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 243, '25OHD')]
PMC4113768	7/2014	S2086-PMC4113768	['conclusions: groups AT RISK of hypovitaminosis D NEED to consume Vitamin D-rich or fortified Foods and would BENEFIT from taking a daily low dose Vitamin D supplement of 5–10 µg (200–400 iu) IN KEEPING WITH the iom specifications for total daily Vitamin D intake.']	[('IMPORTANT_CONSIDERATION', 20), ('IMPORTANT_CONSIDERATION', 49), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 191)]	4	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 47, 'D'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_33290', 'food', 93, 'foods'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4113768	7/2014	S2088-PMC4113768	['the ESTIMATED average Vitamin D REQUIREMENT from all dietary sources is STRONGLY EVIDENCE-BASED and SHOULD represent the target total daily amount for everyone including Supplement users.']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 32), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 81), ('FUTURE_WORK', 100), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 170, 'supplement')]
PMC4113768	7/2014	S2097-PMC4113768	['background: ACCUMULATING EVIDENCE SUGGESTS that Vitamin D deficiency MAY BE a risk FACTOR for Cardiovascular disease BUT its ASSOCIATION with the risk of stroke is UNCERTAIN.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('SUPERFICIAL_RELATIONSHIP', 125), ('FULL_UNKNOWN', 164)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 94, 'cardiovascular')]
PMC4113768	7/2014	S2104-PMC4113768	['conclusions: low Vitamin D levels were ASSOCIATED with an INCREASED RISK of stroke in this prospective cohort study of older primary care patients.this ASSOCIATION was INDEPENDENT of several IMPORTANT CONFOUNDERS and ONLY PARTLY EXPLAINED by conventional risk factors and Cardiovascular disease AS POTENTIAL causal intermediates.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 191), ('PROBLEM_COMPLICATION', 201), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('PROBABLE_UNDERSTANDING', 295), ('INCOMPLETE_EVIDENCE', 298)]	11	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 272, 'cardiovascular')]
PMC4113768	7/2014	S2135-PMC4113768	['the IDENTIFIED DETERMINANTS of Serum 25(Oh)D MAY CONTRIBUTE to tailor EVIDENCE-BASED RECOMMENDATIONS for optimizing Vitamin D status to specific target groups.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 70), ('FUTURE_WORK', 85)]	6	[('UBERON_0001977', 'blood serum', 31, 'serum'), ('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 37, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4113768	7/2014	S2140-PMC4113768	['studies done in Animals and Humans HAVE REPORTED muscle atrophy/wasting in Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('NCBITaxon_33208', 'Metazoa', 16, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 28, 'humans'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC4113768	7/2014	S2145-PMC4113768	['methods: a Vitamin D deficient Rat MODEL was employed for the studies.Vitamin D deficient Rats were Fed a diet devoid of Vitamin D, while control Rats were given the same diet containing 1000 iu Vitamin D3/kg diet.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 31, 'rat'), ('CHEBI_28384', 'vitamin K', 70, 'Vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 90, 'rats'), ('GO_0007631', 'feeding behavior', 100, 'fed'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 146, 'rats'), ('CHEBI_33279', 'vitamin D5', 195, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 195, 'vitamin D3')]
PMC4113768	7/2014	S2146-PMC4113768	['Vitamin D deficiency was CONFIRMED by measuring the Serum Calcium and 25(Oh)D3, an indicator for Vitamin D status.vitamin D deficient Rats had undetectable Serum 25(Oh)D3And hypocalcaemia.']	[('INCOMPLETE_EVIDENCE', 25)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 58, 'calcium'), ('CHEBI_62946', 'ammonium sulfate', 70, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 70, '25(OH)D3'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 122, 'D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 134, 'rats'), ('UBERON_0001977', 'blood serum', 156, 'serum'), ('CHEBI_76945', 'manool', 162, '25(OH)D3and')]
PMC4113768	7/2014	S2147-PMC4113768	['Vitamin D deficient Rats were further subdivided into three groups: one group continued on deficient diet, second group was rescued with control diet to see for reversal of EFFECTS observed in d-deficiency, and the third group of Rats was supplemented with high calcium diet alone to delineate the ROLE of calcium per se on the muscle atrophy SEEN in Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 173), ('SUPERFICIAL_RELATIONSHIP', 298), ('INCOMPLETE_EVIDENCE', 343)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 20, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 230, 'rats'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin D')]
PMC4113768	7/2014	S2155-PMC4113768	['conclusions: IN SUMMARY, THIS STUDY DEMONSTRATES that during Vitamin D deficiency induced muscle wasting, the activity of the Ubiquitin Proteasome Pathway is elevated.']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 36)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0031371', 'ubiquitin conjugating enzyme complex', 126, 'ubiquitin proteasome'), ('GO_0036169', '3-methoxy-4-hydroxy-5-decaprenylbenzoic acid decarboxylase activity', 126, 'ubiquitin proteasome pathway')]
PMC4113768	7/2014	S2159-PMC4113768	['IN CONTRAST, a GROWING NUMBER OF SMALL randomised trials testing the EFFECT of Vitamin D supplementation on Blood pressure have REPORTED MIXED results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	7	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0000178', 'blood', 108, 'blood')]
PMC4113768	7/2014	S2172-PMC4113768	['conclusion: this meta-analysis SUGGESTS Vitamin D supplementation does not significantly reduce Blood pressure at the doses tested to date.']	[('INCOMPLETE_EVIDENCE', 31)]	1	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0000178', 'blood', 96, 'blood')]
PMC4113768	7/2014	S2182-PMC4113768	['we TESTED WHETHER high-dose intermittent oral Vitamin D therapy COULD reduce Blood pressure and Left Ventricular mass in patients with hypertension resistant to conventional treatment.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('INCOMPLETE_EVIDENCE', 64)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0000178', 'blood', 77, 'blood'), ('UBERON_0002084', 'heart left ventricle', 96, 'left ventricular')]
PMC4113768	7/2014	S2197-PMC4113768	['we TESTED WHETHER high-dose intermittent oral Vitamin D therapy COULD improve MARKERS of vascular health and fatigue in patients with chronic fatigue syndrome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4113768	7/2014	S2216-PMC4113768	['conclusions: these results SUGGEST that Vitamin D supplementation MAY not decrease the severity of infantile eczema at three months of age, but MAY RATHER increase the risk of later Food allergy up to two years of age.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_33290', 'food', 182, 'food')]
PMC4113768	7/2014	S2219-PMC4113768	['randomized, double-blind, placebo-controlled trial of Vitamin D supplement in parkinson’s disease\n\nurashima, m.; suzuki, m.; yoshioka, m.; hashimoto, m.; murakami, m.; noya, m.; takahashi, d.\nbackground: in our PREVIOUS STUDY, higher Serum 25-Hydroxy Vitamin D (25Ohd) levels and the Vitamin D receptor (vdr) fokicc genotype were ASSOCIATED with milder parkinson’s disease (pd).']	[('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 330)]	2	[('CHEBI_28384', 'vitamin K', 54, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 234, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 240, '25-hydroxy vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 259, 'D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 262, '25OHD'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC4113768	7/2014	S2244-PMC4113768	['background: DESPITE the identification of several Genetic polymorphisms in the Vitamin D Receptor Gene (Vdrg), the rs2228570 polymorphism, identified by the Fok1 restriction enzyme, APPEARS to be the ONLY one INFLUENCING the size of the Translated protein.']	[('ANOMALY_CURIOUS_FINDING', 12), ('ANOMALY_CURIOUS_FINDING', 182), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209)]	4	[('SO_0000704', 'gene', 50, 'genetic'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 79, 'vitamin D receptor'), ('SO_0000704', 'gene', 98, 'gene'), ('PR_000017279', 'testis-specific basic protein Y 1', 104, 'VDRG'), ('PR_000007593', 'glutamate carboxypeptidase 2', 157, 'Fok1'), ('GO_0006412', 'translation', 237, 'translated')]
PMC4113768	7/2014	S2252-PMC4113768	['a LACK OF association between the genotypes and 25-Hydroxy Vitamin D in patients SUGGESTS an absence of INFLUENCE of this polymorphism on circulating levels of Vitamin D.\n\n2.106.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('CHEBI_27844', "2',3'-cyclic AMP", 48, '25-Hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 67, 'D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 168, 'D')]
PMC4113768	7/2014	S2256-PMC4113768	['background: the latter part of the twentieth century has witnessed the identification of Nuclear Vitamin D receptors in almost every cell of the Human body, thereby EXPLAINING both Skeletal and PROPOSED Extra-Skeletal activities.']	[('PROBABLE_UNDERSTANDING', 165), ('INCOMPLETE_EVIDENCE', 194)]	2	[('GO_0005634', 'nucleus', 89, 'nuclear'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 105, 'D'), ('NCBITaxon_9606', 'Homo sapiens', 145, 'human'), ('UBERON_0004288', 'skeleton', 181, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 203, 'extra-skeletal')]
PMC4113768	7/2014	S2257-PMC4113768	['it is THUS CONCEIVABLE that polymorphisms in the Gene encoding this protein, the Vitamin D Receptor Gene (Vdr), MAY alter both its structure and functions and HENCE, MAY INFLUENCE one’s susceptibility to various debilitating diseases.']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 112), ('PROBABLE_UNDERSTANDING', 159), ('INCOMPLETE_EVIDENCE', 166), ('SUPERFICIAL_RELATIONSHIP', 170)]	7	[('SO_0000704', 'gene', 49, 'gene'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 81, 'vitamin D receptor'), ('SO_0000704', 'gene', 100, 'gene'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 106, 'VDR')]
PMC4113768	7/2014	S2272-PMC4113768	['background: ACCUMULATING EVIDENCE has stipulated a strong CORRELATION between Vitamin D (vitd) deficiency and Cardiovascular disease (cvd) HOWEVER a mechanistic LINK is missing.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('ANOMALY_CURIOUS_FINDING', 139), ('SUPERFICIAL_RELATIONSHIP', 161)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 110, 'cardiovascular')]
PMC4113768	7/2014	S2287-PMC4113768	['; mohammed, g.; alshahrani, f.\nbackground: there is LITTLE EVIDENCE published on prevalence of Vitamin D deficiency among saudi women, IN SPITE of the widespread Food fortification and the excellent opportunity of available sun light all over the year.']	[('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 135)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_33290', 'food', 162, 'food')]
PMC4113768	7/2014	S2303-PMC4113768	['in THIS cross-SECTIONAL case-CONTROL STUDY, we DESCRIBED the differences and ASSOCIATIONS in the Metabolic patterns of Adult saudis with and without hypothyroid dysfunction in RELATION to their Vitamin D status, pth, calcium and Lipid profile.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('GO_0008152', 'metabolic process', 97, 'metabolic'), ('UBERON_0007023', 'adult organism', 119, 'adult'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_18059', 'lipid', 229, 'lipid')]
PMC4113768	7/2014	S2311-PMC4113768	['the ASSOCIATION between pth and Cholesterol levels as well as the inverse ASSOCIATION between Vitamin D status and Ft3 NEEDS TO BE reassessed prospectively on a larger scale to confirm THESE FINDINGS.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 119), ('INCOMPLETE_EVIDENCE', 185)]	4	[('CHEBI_16113', 'cholesterol', 32, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 115, 'FT3')]
PMC4113768	7/2014	S2323-PMC4113768	['the Metformin group SHOWED the highest change in circulating Vitamin D levels both at 6 months (62.6%) and 12 months (50.6%) as COMPARED TO baseline ( p< 0.001).']	[('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128)]	2	[('CHEBI_6801', 'metformin', 4, 'metformin'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4113768	7/2014	S2351-PMC4113768	['conclusion: the results SUGGEST that a modest increase in Vitamin D levels among overweight and obese subjects through the promotion of lifestyle changes for one year have marginal EFFECTS in bone turnover markers as well as obesity itself.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 181)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4113768	7/2014	S2357-PMC4113768	['background: seasonal variations in circulating Vitamin D levels provide VITAL INFORMATION as to the most APPROPRIATE time to either start or increase Vitamin D supplementation in order to maintain OPTIMAL Vitamin D levels.']	[('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 105), ('IMPORTANT_CONSIDERATION', 197)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC4113768	7/2014	S2386-PMC4113768	['ANOTHER implication MIGHT BE that Serum 25-Ohd measurements during summertime SHOULD BE repeated during wintertime, OR that a higher threshold for Vitamin D deficiency ( i.e.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('FUTURE_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116)]	4	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_72765', 'verruculogen', 40, '25-OHD'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC4113768	7/2014	S2393-PMC4113768	['background: we performed a systematic review TO EXPLORE WHETHER (1) low maternal circulating 25(Oh)-Vitamin D (25(Oh)D) during Pregnancy is ASSOCIATED with impairment of offspring health; and (2) maternal supplementation with Vitamin D in Pregnancy MIGHT ameliorate these EFFECTS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('SUPERFICIAL_RELATIONSHIP', 140), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 272)]	5	[('CHEBI_63056', 'zinc cation', 93, '25(OH'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 111, '25(OH)D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy')]
PMC4113768	7/2014	S2402-PMC4113768	['indeed, no convincing evidence was FOUND for any association between maternal Vitamin D status and offspring asthma, atopy, type 1 diabetes or Blood pressure.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000178', 'blood', 143, 'blood')]
PMC4113768	7/2014	S2404-PMC4113768	['conclusions: there was MODEST EVIDENCE TO SUPPORT ASSOCIATIONS between maternal 25(oh)-Vitamin D status and offspring Serum Calcium concentrations, Birth weight and bone mass.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001977', 'blood serum', 118, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 124, 'calcium'), ('GO_0007567', 'parturition', 148, 'birth')]
PMC4113768	7/2014	S2414-PMC4113768	['we have PREVIOUSLY DEMONSTRATED that maternal lifestyle, body build, physical activity and Vitamin D status during Pregnancy are ASSOCIATED with offspring bone mass.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 129)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
PMC4113768	7/2014	S2421-PMC4113768	['conclusions: in addition to the mechanistic INSIGHTS afforded by ASSOCIATIONS between maternal free 25(oh)-Vitamin D index, rxra methylation in Umbilical Cord dna, and childhood bmc, such epigenetic marks in early Life MIGHT represent NOVEL BIOMARKERS for adverse bone outcomes in the offspring.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 219), ('FULL_UNKNOWN', 235), ('SUPERFICIAL_RELATIONSHIP', 241)]	5	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 144, 'umbilical cord'), ('UBERON_0000104', 'life cycle', 214, 'life')]
PMC4113768	7/2014	S2424-PMC4113768	['contemporary and historical EVIDENCE INDICATES the VALUE of Vitamin D in treating tb and Genetic variation in Vitamin D receptors HAS BEEN LINKED to ethnic variations in tb.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 139)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('SO_0000704', 'gene', 89, 'genetic'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4113768	7/2014	S2447-PMC4113768	['; macdonald, h.m.\nbackground: it HAS BEEN ASSUMED that most of the population in the uk obtain sufficient Vitamin D from casual exposure to summer sunlight.']	[('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('PROBABLE_UNDERSTANDING', 42)]	3	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4113768	7/2014	S2465-PMC4113768	['of the participants who did not take Supplements, none achieved the current uk RECOMMENDED dietary intake of 400 iu Vitamin D per day for those AT RISK of deficiency; and for the supplement users the RECOMMENDATION was ONLY achieved by one Person in spring and 2 People in summer and autumn.']	[('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 144), ('FUTURE_WORK', 200), ('INCOMPLETE_EVIDENCE', 219)]	4	[('CHEBI_33341', 'titanium atom', 37, 'supplements'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 240, 'person'), ('NCBITaxon_10088', 'Mus <genus>', 263, 'people')]
PMC4113768	7/2014	S2469-PMC4113768	['Vitamin D and tuberculosis in Adults in selected districts in the provinces baghlan, bamyan and badakhshan, afghanistan\n\nsarin, p.; manaseki-holland, s.; duffy, j.c.\nbackground: EVIDENCE for an ASSOCIATION between Vitamin D and tuberculosis (tb) is INCONSISTENT and NO previous STUDIES HAVE BEEN conducted in afghanistan.']	[('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('FULL_UNKNOWN', 266), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('UBERON_0007023', 'adult organism', 30, 'Adults'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4113768	7/2014	S2470-PMC4113768	['THIS STUDY AIMS to explore an ASSOCIATION between tb and Vitamin D levels in a rural afghan population and TO EXAMINE POSSIBLE factors RELATED to tb and Vitamin D levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 107), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 135)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4113768	7/2014	S2475-PMC4113768	['a questionnaire was administered to explore variables POTENTIALLY RELATED to tb and Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC4113768	7/2014	S2499-PMC4113768	['female ballet dancers and gymnasts are known to have POOR Vitamin D status POSSIBLY DUE TO heavy indoor training schedules limiting sun exposure, however it is LIKELY that their high levels of physical activity ameliorate the DETRIMENTAL EFFECTS of low Vitamin D and dietary Calcium.']	[('IMPORTANT_CONSIDERATION', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 160), ('IMPORTANT_CONSIDERATION', 226), ('SUPERFICIAL_RELATIONSHIP', 238)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 275, 'calcium')]
PMC4113768	7/2014	S2513-PMC4113768	['conclusions: contrary to PREVIOUS RESEARCH FINDINGS in ballet dancers and gymnasts, the participants in this study were Vitamin D replete.']	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 43)]	2	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S2517-PMC4113768	['THESE FINDINGS SUGGEST that; (1) there is no additional BENEFIT to calcium absorption or bone mineralisation from a Blood level for 25(Oh)D above ~75 nmol/l; (2)DESPITE adequate Vitamin D and regular physical activity lower dietary Calcium intake is STILL a PREDICTOR of lower total body bmd and bmc; and (3) in certain population groups with baseline 25(Oh)D > 75 nmol/l, Vitamin D supplementation of 50,000 iu/month does not significantly increase 25(Oh)D concentrations over a 12 month period, but POSSIBLY PREVENTS seasonal decline.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 56), ('ANOMALY_CURIOUS_FINDING', 161), ('IMPORTANT_CONSIDERATION', 250), ('SUPERFICIAL_RELATIONSHIP', 258), ('INCOMPLETE_EVIDENCE', 501), ('SUPERFICIAL_RELATIONSHIP', 510)]	8	[('UBERON_0000178', 'blood', 116, 'blood'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 232, 'calcium'), ('CHEBI_71657', 'versiconol acetate', 352, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 352, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 450, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 450, '25(OH)D')]
PMC4113768	7/2014	S2523-PMC4113768	['the dose response RELATIONSHIP between Vitamin D supplementation and Plasma 25(Oh)D levels IS THOUGHT TO be biphasic (exponential at low intakes and linear at high), HOWEVER this is NOT WELL DOCUMENTED for supplementation levels that exceed 2000 iu per day for large populations of healthy Individuals.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 182)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 69, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 76, '25(OH ... D'), ('NCBITaxon_1', 'root', 290, 'individuals')]
PMC4113768	7/2014	S2543-PMC4113768	['background: AS Vitamin D is ESSENTIAL to calcium Regulation, the concern HAS BEEN RAISED that high levels of Vitamin D MAY lead TO hypercalcemia (Plasma levels exceeding 2.6 mmol/l) that, in turn, MAY increase the RISK of adverse health events such as Cardiac arrest, Renal failure, and Hepatic injuries.']	[('PROBABLE_UNDERSTANDING', 12), ('IMPORTANT_CONSIDERATION', 28), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 73), ('EXPLICIT_QUESTION', 82), ('INCOMPLETE_EVIDENCE', 119), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('INCOMPLETE_EVIDENCE', 197), ('IMPORTANT_CONSIDERATION', 214)]	9	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0065007', 'biological regulation', 49, 'regulation'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 146, 'plasma'), ('UBERON_0000948', 'heart', 252, 'cardiac'), ('UBERON_0002113', 'kidney', 268, 'renal'), ('UBERON_0002107', 'liver', 287, 'hepatic')]
PMC4113768	7/2014	S2547-PMC4113768	['we applied gee regression methods to quantify the ASSOCIATIONS of Vitamin D supplementation and 25(Oh)D with Serum Calcium, while considering the CONFOUNDING POTENTIAL of age, gender, and body weight status.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('PROBLEM_COMPLICATION', 146), ('INCOMPLETE_EVIDENCE', 158)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 102, 'D'), ('UBERON_0001977', 'blood serum', 109, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 115, 'calcium')]
PMC4113768	7/2014	S2552-PMC4113768	['conclusion: these FINDING CONFIRM that healthy subjects supplementing with Vitamin D at modest levels are not at INCREASED RISK for hypercalcemia and SUGGEST that the same applies for supplementation levels as high as 20,000 iu per day.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 113), ('INCOMPLETE_EVIDENCE', 150)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC4113768	7/2014	S2560-PMC4113768	['background: SUBOPTIMAL Vitamin D status MAY BE ASSOCIATED with a variety of adverse health outcomes.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4113768	7/2014	S2561-PMC4113768	['it CAN be simply and effectively treated through Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S2574-PMC4113768	['conclusion: THIS work SHOWS that Genetic FACTORS are ASSOCIATED with change in 25(Oh)D after Vitamin D supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('SO_0000704', 'gene', 33, 'genetic'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4113768	7/2014	S2594-PMC4113768	['THIS sub-study TESTED the HYPOTHESIS that seasonality of month of Birth in t1d is more pronounced among Individuals who were not exposed to Vitamin D fortification during Gestation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 26)]	3	[('GO_0007567', 'parturition', 66, 'birth'), ('NCBITaxon_1', 'root', 104, 'individuals'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 171, 'gestation')]
PMC4113768	7/2014	S2603-PMC4113768	['we HYPOTHESIZED that Gestational exposure to milk fortified with Vitamin D would attenuate seasonality of month of Birth.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('GO_0007565', 'female pregnancy', 21, 'gestational'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007567', 'parturition', 115, 'birth')]
PMC4113768	7/2014	S2631-PMC4113768	['placebo is SUGGESTIVE of a beneficial EFFECT of Vitamin D supplementation on Arterial stiffness.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0001637', 'artery', 77, 'arterial')]
PMC4113768	7/2014	S2637-PMC4113768	['; inskip, h.m.; cooper, c.; harvey, n.c.\nbackground: maternal 25-Hydroxy-Vitamin D (25(Oh)d) status in Pregnancy HAS BEEN ASSOCIATED with offspring Bone Development and adiposity.']	[('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('CHEBI_70487', '(-)-sanguinolignan C', 62, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 84, '25(OH'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0048539', 'bone marrow development', 148, 'bone development')]
PMC4113768	7/2014	S2638-PMC4113768	['THERE IS EVIDENCE TO SUPPORT a ROLE for Vitamin D in muscle function, YET LITTLE IS KNOWN about the ROLE of Antenatal 25(Oh)D exposure in programming muscle development.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 70), ('FULL_UNKNOWN', 74), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'antenatal'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D')]
PMC4113768	7/2014	S2662-PMC4113768	['there is ACCUMULATING EVIDENCE from meta-analyses of cohort studies that Vitamin D deficiency, AS measured by low Serum levels of 25-Hydroxy Vitamin D (25(Oh)D), PREDICTS INCREASED RISK of all-cause mortality, Cardiovascular disease and hypertension.']	[('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 171)]	4	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001977', 'blood serum', 114, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 130, '25-hydroxy vitamin D'), ('CHEBI_33010', 'chromide(1-)', 154, '(OH)D'), ('UBERON_0004535', 'cardiovascular system', 210, 'cardiovascular')]
PMC4113768	7/2014	S2664-PMC4113768	['this uncertainty can ONLY be resolved by well-designed randomized controlled trials (rcts) to determine the EFFECT of Vitamin D supplementation on bp.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 108)]	2	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4113768	7/2014	S2665-PMC4113768	['PREVIOUS rcts MAINLY have given Vitamin D for short periods (<6 months) or at too low doses.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 14)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4113768	7/2014	S2673-PMC4113768	['the isolated decrease in systolic bp among the Vitamin D group at 5-months follow-up is MOST LIKELY a chance FINDING, SINCE this small difference was not observed at 18-months.']	[('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 109), ('PROBABLE_UNDERSTANDING', 118), ('PROBLEM_COMPLICATION', 118)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4113768	7/2014	S2722-PMC4113768	['conclusions: our results SHOW the WIDE RANGE of Vitamin D supplement regimes used by members of the public that have resulted in them having high to toxic levels of 25Ohd.']	[('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 165, '25OHD')]
PMC4113768	7/2014	S2725-PMC4113768	['OF CONCERN is that People taking 10,000 iu/day or less are SHOWING high to toxic levels of 25Ohd, ALTHOUGH we do NOT KNOW HOW many, if any, of these users are displaying signs of Vitamin D toxicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBLEM_COMPLICATION', 3), ('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 98), ('FULL_UNKNOWN', 113), ('EXPLICIT_QUESTION', 122)]	6	[('NCBITaxon_10088', 'Mus <genus>', 19, 'people'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 91, '25OHD'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4113768	7/2014	S2753-PMC4113768	['this MAY LINK in with the increased availability or awareness of Vitamin D supplementation through the healthy start scheme, launched in 2006, and other initiatives.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4113768	7/2014	S2772-PMC4113768	['these RELATIONS were almost exclusively SEEN in subjects not using Vitamin D and/or Calcium supplements.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 40)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 84, 'calcium')]
PMC4113768	7/2014	S2773-PMC4113768	['conclusions: the free and bio-available forms of 25(Oh)D MAY BE a more INFORMATIVE measure of Vitamin D status than total 25(Oh)d. adjustment for dbp phenotype MAY improve this FURTHER.']	[('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 160), ('FUTURE_WORK', 177), ('INCOMPLETE_EVIDENCE', 177)]	5	[('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 122, '25(OH')]
PMC4113768	7/2014	S2781-PMC4113768	['EVIDENCE from other Tissues INDICATES that local Synthesis Of active Vitamin D (1,25-Dihydroxy Vitamin D; 1,25(Oh)2D3) INFLUENCES Immune Responses and in particular Tlr Signalling.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 119)]	3	[('UBERON_0000479', 'tissue', 20, 'tissues'), ('GO_0051610', 'serotonin uptake', 49, 'synthesis of ... vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 80, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 107, ',25(OH)2D3'), ('GO_0006955', 'immune response', 130, 'immune responses'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('GO_0031929', 'TOR signaling', 165, 'TLR signalling')]
PMC4113768	7/2014	S2828-PMC4113768	['REPORTED Vitamin D intakes, HOWEVER, were SIMILAR between the sexes after adjusting for energy intake.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 42)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4113768	7/2014	S2831-PMC4113768	['cross-classification analysis REVEALED >90% of the group were classified in the same or adjacent tertiles for Vitamin D intakes when comparing results from the ffq and wfr.']	[('INCOMPLETE_EVIDENCE', 30)]	1	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4113768	7/2014	S2869-PMC4113768	['conclusion: our data REVEALED that Vitamin D Serum concentration in ssc are lowest in patients with advanced nvc pattern and severity of peripheral vascular disease using medsger’s severity scale.']	[('INCOMPLETE_EVIDENCE', 21)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0001977', 'blood serum', 45, 'serum')]
PMC4113768	7/2014	S2878-PMC4113768	['RECENTLY, Vitamin D status during icu admission HAS BEEN shown to be ASSOCIATED with the RISK of short-term (30-, 60-, and 90-day) and long-term (1-year) mortality in critically ill patients.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4113768	7/2014	S2918-PMC4113768	['epidemiologic studies INDICATE that there is an inverse RELATIONSHIP between Vitamin D and the RISK and prognosis of Lung cancer.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 95)]	3	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0002048', 'lung', 117, 'lung')]
PMC4113768	7/2014	S2930-PMC4113768	['conclusions: in CONCLUSION THIS STUDY INDICATES that Vitamin D deficiency promotes the development of dysplasia, increases Proliferation and inflammation, which is LIKELY promote the development of frank squamous Cell carcinoma, WHEREAS sufficiency retards this development.']	[('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('PROBABLE_UNDERSTANDING', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 229)]	5	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0008283', 'cell proliferation', 123, 'proliferation'), ('CL_0000573', 'retinal cone cell', 213, 'cell')]
PMC4113768	7/2014	S3066-PMC4113768	['RISK FACTORS for Cardiovascular disease HAVE also BEEN ASSOCIATED with low Serum (25(Oh)D. we AIMED TO INVESTIGATE WHETHER high-dose Vitamin D supplementation CAN improve Glucose Metabolism in a population with impaired fasting Glucose and/or impaired Glucose tolerance.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 55), ('QUESTION_ANSWERED_BY_THIS_WORK', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 159)]	7	[('UBERON_0004535', 'cardiovascular system', 17, 'cardiovascular'), ('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('CHEBI_17234', 'glucose', 171, 'glucose'), ('GO_0006006', 'glucose metabolic process', 171, 'glucose metabolism'), ('CHEBI_17234', 'glucose', 228, 'glucose'), ('CHEBI_17234', 'glucose', 252, 'glucose')]
PMC4113768	7/2014	S3079-PMC4113768	['; boyle, r.j.\nbackground: OBSERVATIONAL STUDIES SUGGEST high Prenatal Vitamin D intake MAY BE ASSOCIATED with reduced childhood wheezing.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 94)]	5	[('GO_0007565', 'female pregnancy', 61, 'prenatal'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4113768	7/2014	S3096-PMC4113768	['ALTHOUGH Vitamin D HAS BEEN ASSOCIATED with the development of tb in Adults, LITTLE RESEARCH has EXAMINED the IMPORTANCE of Vitamin D levels in children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('IMPORTANT_CONSIDERATION', 110)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 69, 'adults'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4113768	7/2014	S3120-PMC4113768	['background: RECENT STUDIES have SUGGESTED POSSIBLE LINKS between Vitamin D deficiency and type i hypersensitivity and atopic disease.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 51)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4113768	7/2014	S3122-PMC4113768	['the OBJECTIVE of THIS RETROSPECTIVE case-CONTROL STUDY was TO FURTHER INVESTIGATE the POSSIBLE LINK between type i hypersensitivity and Vitamin D status in an inner-city population KNOWN to have a high prevalence of Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 181)]	7	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC4113768	7/2014	S3130-PMC4113768	['conclusions: THESE FINDINGS CONTRAST WITH OTHER RECENT STUDIES which SHOWED clear ASSOCIATIONS between Ige levels and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 82)]	6	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 103, 'IgE'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4113768	7/2014	S3131-PMC4113768	['the very high prevalence of Vitamin D deficiency in this population and subsequent SMALL number of Vitamin D replete participants MAY have reduced the power of this study to detect a statistically significant ASSOCIATION between Vitamin D deficiency and hypersensitivity.']	[('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 209)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D')]
PMC4113768	7/2014	S3136-PMC4113768	['DEPENDING ON the cutoff chosen, dietary intakes of Vitamin D MAY OR MAY NOT provide sufficient IMPACT upon Vitamin D status, in improving levels of 25(Oh)d. purpose: we SOUGHT TO EXAMINE WHETHER a supplemental dose of 10 mcg (400 iu) as found in fortified foods OR as a supplement, has a measurable IMPACT on Vitamin D status, as defined by improving status from below to above 50 nmol/l, or from less than 30 nmol/l to above 30 nmol/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 169), ('QUESTION_ANSWERED_BY_THIS_WORK', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187), ('SUPERFICIAL_RELATIONSHIP', 299)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 148, '25(OH'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D')]
PMC4113768	7/2014	S3145-PMC4113768	['this SUGGESTS fortification with moderate amounts of Vitamin D MAY have positive EFFECTS on bone health of populations.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4113768	7/2014	S3147-PMC4113768	['Serum Vitamin D concentrations are ASSOCIATED with markers of Intestinal BUT NOT systemic inflammation in crohn’s disease in remission\n\nraftery, t.; smith, s.; o’morain, c.; mahmud, n.; healy, m.; cox, g.; mcnamara, d.; o’sullivan, m.\nbackground: there are ESTABLISHED ASSOCIATIONS between Vitamin D (vitd) status and crohn’s disease (cd).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 269)]	4	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_28384', 'vitamin K', 6, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 6, 'Vitamin D'), ('UBERON_0000160', 'intestine', 62, 'Intestinal'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
PMC4113768	7/2014	S3180-PMC4113768	['background: there are FEW STUDIES that look AT Vitamin D status in children living in sunny climates AS it is ASSUMED that they receive adequate Vitamin D from sun exposure.']	[('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 44), ('PROBABLE_UNDERSTANDING', 101), ('PROBABLE_UNDERSTANDING', 110)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC4113768	7/2014	S3189-PMC4113768	['knowing that modernization is bringing about a change in Vitamin D CAN inform policy-makers in ethiopia and other tropical countries about the need to implement PUBLIC HEALTH measures to prevent escalation of Vitamin D deficiency and its ASSOCIATED health outcomes.']	[('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 161), ('SUPERFICIAL_RELATIONSHIP', 238)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 65, 'D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC4113768	7/2014	S3194-PMC4113768	['; pearce, s.; rasvi, s.; jagger, c.\nbackground: DESPITE RECENT concerns about the high prevalence of low Vitamin D status in much of the british Adult and pediatric population, there is a dearth of data on Vitamin D status and its PREDICTORS in very old Adults, a sub-group of the population which is at INCREASED RISK of POOR Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('ANOMALY_CURIOUS_FINDING', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 304), ('IMPORTANT_CONSIDERATION', 322)]	6	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 145, 'adult'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0007023', 'adult organism', 254, 'adults'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D')]
PMC4113768	7/2014	S3209-PMC4113768	['25-Hydroxy Vitamin D3(25(Oh)D3) Modulates Innate Immunity and RECENT EVIDENCE HIGHLIGHTS ASSOCIATIONS between Vitamin D deficiency and several Respiratory illnesses.']	[('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 89)]	3	[('CHEBI_43141', '3-hydroxypropoxy group', 0, '25-hydroxy'), ('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('CHEBI_62946', 'ammonium sulfate', 22, '25(OH)D3'), ('GO_0065007', 'biological regulation', 32, 'modulates'), ('GO_0045087', 'innate immune response', 42, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 143, 'respiratory')]
PMC4113768	7/2014	S3241-PMC4113768	['these interim results SUGGEST an INDEPENDENT ROLE for Vitamin D in determining ari severity amongst nz children.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4113768	7/2014	S3248-PMC4113768	['Prenatal Vitamin D deficiency in a Rat pup MODEL HAS BEEN ASSOCIATED with Ventriculomegaly and Brain overgrowth and abnormal behaviour WHILE a FEW STUDIES have DEMONSTRATED an ASSOCIATION between Prenatal Vitamin D deficiency and lower Birthweight.']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 176)]	7	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 35, 'rat'), ('UBERON_0001137', 'dorsum', 74, 'ventriculomegaly'), ('UBERON_0000955', 'brain', 95, 'brain'), ('GO_0007565', 'female pregnancy', 196, 'prenatal'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0007596', 'blood coagulation', 236, 'birthweight')]
PMC4113768	7/2014	S3267-PMC4113768	['Vitamin D Metabolites SUPPORT anti-Viral activity in vitro , and a single-centre TRIAL in patients with predominantly SEVERE copd has REPORTED that Vitamin D supplementation reduced exacerbation RISK in patients with baseline Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 81), ('IMPORTANT_CONSIDERATION', 118), ('INCOMPLETE_EVIDENCE', 134), ('IMPORTANT_CONSIDERATION', 195)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_25212', 'metabolite', 10, 'metabolites'), ('NCBITaxon_1', 'root', 35, 'viral'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC4113768	7/2014	S3279-PMC4113768	['sub-group analysis REVEALED that Vitamin D supplementation was PROTECTIVE against moderate/severe exacerbation among the 148 participants who were Vitamin D deficient at baseline (ahr 0.57, 95% ci 0.35 to 0.92, p = 0.02), but not among the 92 participants with baseline Serum 25(Oh)D ≥ 50 nmol/l (ahr 1.45, 95% ci 0.81 to 2.62, p = 0.21; p for interaction = 0.02).']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0001977', 'blood serum', 270, 'serum'), ('CHEBI_33010', 'chromide(1-)', 278, '(OH)D')]
PMC4113768	7/2014	S3281-PMC4113768	['pre-specified sub-group analysis REVEALED a PROTECTIVE EFFECT of Vitamin D supplementation against moderate/severe exacerbations among participants who were Vitamin D deficient at baseline.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4113768	7/2014	S3300-PMC4113768	['there are many mechanisms whereby Vitamin D CAN reduce the RISK of cvd including reduced risk of diabetes mellitus and Metabolic syndrome, EFFECTS on Blood pressure, Cholesterol, cytokines, Endothelial disruption, Glucose Regulation, Insulin resistance, muscle strength, Respiratory infections, and vascular calcification.']	[('INCOMPLETE_EVIDENCE', 44), ('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0008152', 'metabolic process', 119, 'metabolic'), ('UBERON_0000178', 'blood', 150, 'blood'), ('CHEBI_16113', 'cholesterol', 166, 'cholesterol'), ('UBERON_0001986', 'endothelium', 190, 'endothelial'), ('CHEBI_17234', 'glucose', 214, 'glucose'), ('GO_0006094', 'gluconeogenesis', 214, 'glucose regulation'), ('PR_000045358', 'insulin family protein', 234, 'insulin'), ('UBERON_0001004', 'respiratory system', 271, 'respiratory')]
PMC4113768	7/2014	S3303-PMC4113768	['HOWEVER, rcts in iran, where the mean Serum 25(Oh)D levels TEND to be low, IN PART DUE TO sun avoidance during the hot summers, have FOUND beneficial EFFECTS of Vitamin D supplementation on cvd RISK FACTORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 75), ('PROBLEM_COMPLICATION', 83), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 150), ('SUPERFICIAL_RELATIONSHIP', 194)]	7	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 44, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC4113768	7/2014	S3316-PMC4113768	['background: since the publication of the ultraviolet b (uvb)-Vitamin D-cancer HYPOTHESIS BASED ON an ecological study of Colon cancer mortality rates with respect to annual solar radiation doses in the united states in 1980, the approach HAS BEEN extended to many types of cancer and various other health outcomes.']	[('INCOMPLETE_EVIDENCE', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 89), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 238)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001155', 'colon', 121, 'colon')]
PMC4113768	7/2014	S3318-PMC4113768	['however, SOME Vitamin D-sensitive diseases have seasonal variations with highest rates in winter or spring.']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
PMC4113768	7/2014	S3328-PMC4113768	['when ADDITIONAL EVIDENCE on EFFECTS RELATED to Vitamin D from OBSERVATIONAL studies with respect to Serum 25(Oh)D level or personal uvb irradiance, the ROLE of skin pigmentation, and laboratory studies of mechanisms, hill’s criteria for causality in a biological system (hill ab.']	[('FUTURE_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 152)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_71657', 'versiconol acetate', 106, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 106, '25(OH)D')]
PMC4113768	7/2014	S3331-PMC4113768	['1965; 58: 295–300) CAN be used to assess WHETHER Vitamin D is casually LINKED to reduced risk of the disease OR adverse health outcome.']	[('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4113768	7/2014	S3332-PMC4113768	['WHILE a FEW Vitamin D randomized controlled trials have SUPPORTED the ecological and observational STUDIES, MANY were NOT DESIGNED and/or conducted properly.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 118)]	6	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC4113768	7/2014	S3333-PMC4113768	['when they are, they, too, will add to the UNDERSTANDING of the ROLE of Vitamin D in reducing the RISK of many types of disease and adverse health outcomes.']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 63), ('IMPORTANT_CONSIDERATION', 97)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4113768	7/2014	S3336-PMC4113768	['; xiao, j.p.; zang, j.; fei, x.; zhu, y.; pei, j.j.\nbackground: thereare LITTLE DATA about the status of Vitamin D in Pregnant women and their newborns in china, and we EVALUATED the Vitamin D status in Pregnant women and their newborns all the year around in wuxi city (north latitude 32°), jiangsu province, china.']	[('FULL_UNKNOWN', 73), ('INCOMPLETE_EVIDENCE', 73), ('QUESTION_ANSWERED_BY_THIS_WORK', 169)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnant'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnant')]
PMC4113768	7/2014	S3345-PMC4113768	['(4) the Vitamin D status of Pregnant women SHOWED the same TREND as the air temperature fluctuations, BUT its phase lagged behind about two months, reaching its highest value in september.']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 102)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 28, 'pregnant')]
PMC4113768	7/2014	S3363-PMC4113768	['conclusion: the results SUGGESTED that quantitative ultrasound bmd COULD BE an INDICATOR for Vitamin D status in young children, and also provided FURTHER EVIDENCE to define Vitamin D deficiency for infants and children.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 147)]	4	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC4113768	7/2014	S3367-PMC4113768	['our OBJECTIVES are (1) to conduct unbiased Genome-wide methylation profiling of Vitamin D in Human Peripheral Leukocytes; (2) to comprehensively search differential functional Methylation Sites UNDERLYING Vitamin D deficiency; (3) TO TEST the HYPOTHESIS that Vitamin D supplementation increases global Dna Methylation level by performing a randomized clinical trial (rct) in overweight/obese african americans with Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 194), ('QUESTION_ANSWERED_BY_THIS_WORK', 231), ('INCOMPLETE_EVIDENCE', 243)]	4	[('SO_0001026', 'genome', 43, 'genome'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 93, 'human'), ('CL_0000118', 'basket cell', 99, 'peripheral leukocytes'), ('SO_0000134', 'genomically_imprinted', 176, 'methylation sites'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('GO_0006306', 'DNA methylation', 302, 'DNA methylation'), ('CHEBI_27300', 'vitamin D', 415, 'vitamin D')]
PMC4113768	7/2014	S3372-PMC4113768	['results: the Genome-wide methylation scan REVEALED that african americans with SEVERE Vitamin D deficiency had reduced levels of methylation compared with controls.']	[('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 79)]	2	[('SO_0001026', 'genome', 13, 'genome'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4113768	7/2014	S3379-PMC4113768	['conclusion: SEVERE Vitamin D deficiency is ASSOCIATED with methylation changes in Leukocyte dna in young african americans, which MAY BE INVOLVED in systemic inflammation.']	[('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CL_0000738', 'leukocyte', 82, 'leukocyte')]
PMC4113768	7/2014	S3382-PMC4113768	['increased Dna Methylation in peripheral Leukocytes MAY BE one UNDERLYING mechanism by which Vitamin D exerts its anti-inflammatory EFFECTS.']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 131)]	3	[('GO_0006306', 'DNA methylation', 10, 'DNA methylation'), ('CL_0000738', 'leukocyte', 40, 'leukocytes'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4142706	7/2014	S71-PMC4142706	['(2013b)SHOWED that Vitamin C caused dna breaks in Nucleoids (substrate) when trying to carry out the comet-based in vitro Repair assay to study the EFFECT of Vitamin C on Ber of caco-2 cells.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 148)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin C'), ('GO_0005730', 'nucleolus', 50, 'nucleoids'), ('GO_0006281', 'DNA repair', 122, 'repair'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin C'), ('UBERON_0000063', 'organ subunit', 171, 'BER')]
PMC4142706	7/2014	S72-PMC4142706	['this FINDING made it IMPOSSIBLE to carry out this test SINCE Vitamin C was present in cell extracts and masked the results (azqueta et al., 2009,2013b).']	[('INCOMPLETE_EVIDENCE', 5), ('DIFFICULT_TASK', 21), ('PROBLEM_COMPLICATION', 55)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin C')]
PMC4142706	7/2014	S138-PMC4142706	['an increase in ber was REPORTED with slow-release Vitamin C capsules in a 4-week placebo-controlled trial (guarnieri et al., 2008).']	[('INCOMPLETE_EVIDENCE', 23)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin C')]
PMC4129499	8/2014	S105-PMC4129499	['THESE FINDINGS encompass EITHER of two main disease-provoking mechanisms: a Cns disorder that is being detected peripherally [e.g., Serotonin and its Metabolites, Sulfate (54), low Platelet levels of Gamma-Aminobutyric Acid (Gaba) (55), low Oxytocin (which AFFECTS social affiliation) (56), and low Vitamin D levels (57,58)] or a systemic abnormality that has repercussions in the Brain (59).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 257)]	3	[('UBERON_0001017', 'central nervous system', 76, 'CNS'), ('CHEBI_28790', 'serotonin', 132, 'serotonin'), ('CHEBI_25212', 'metabolite', 150, 'metabolites'), ('CHEBI_16189', 'sulfate', 163, 'sulfate'), ('CL_0000233', 'platelet', 181, 'platelet'), ('CHEBI_16865', 'gamma-aminobutyric acid', 200, 'gamma-aminobutyric acid'), ('CHEBI_16865', 'gamma-aminobutyric acid', 225, 'GABA'), ('CHEBI_7872', 'oxytocin', 241, 'oxytocin'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('UBERON_0000955', 'brain', 381, 'brain')]
PMC4161853	8/2014	S216-PMC4161853	['it HAS BEEN SHOWN SOME decades ago that malnourished Vitamin A-deficient Rats exhibit impaired Migration Of recently Activated Mesenteric Lymphocytes, in addition to a marked decrease in the number of Iga-Antibody Secreting cells and Cd4+T Cells in the Ileum [117].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 18)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin A'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 73, 'rats'), ('GO_0002411', 'T cell tolerance induction to tumor cell', 95, 'migration of ... lymphocytes'), ('CL_0002627', 'mature astrocyte', 117, 'activated'), ('CL_0000134', 'mesenchymal stem cell', 127, 'mesenteric lymphocytes'), ('UBERON_0000080', 'mesonephros', 127, 'mesenteric'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 201, 'IgA'), ('GO_0042571', 'immunoglobulin complex, circulating', 205, 'antibody'), ('GO_0046903', 'secretion', 214, 'secreting'), ('CL_0000251', 'extramedullary cell', 234, 'CD4'), ('PR_000001204', 'C-C chemokine receptor type 8', 234, 'CD4'), ('CL_0000084', 'T cell', 238, 'T cells'), ('UBERON_0002116', 'ileum', 253, 'ileum')]
PMC4161853	8/2014	S217-PMC4161853	['moreover, Gestational Vitamin A deficiency in Animal models HAS BEEN SHOWN to reduce the Intestinal Immune Response by decreasing the number of Immune Cells in Rat offspring [119] and Controlling the size of Secondary Lymph Organ and the efficiency of Immune Responses in the Adult Mouse offspring [120].']	[('INCOMPLETE_EVIDENCE', 60)]	1	[('GO_0007565', 'female pregnancy', 10, 'gestational'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 46, 'animal'), ('UBERON_0000160', 'intestine', 89, 'intestinal'), ('GO_0006955', 'immune response', 100, 'immune response'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('CL_0000738', 'leukocyte', 144, 'immune cells'), ('UBERON_0002405', 'immune system', 144, 'immune'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 160, 'rat'), ('GO_0065007', 'biological regulation', 184, 'controlling'), ('UBERON_0005174', 'dorsal region element', 208, 'secondary lymph organ'), ('GO_0006955', 'immune response', 252, 'immune responses'), ('UBERON_0002405', 'immune system', 252, 'immune'), ('UBERON_0007023', 'adult organism', 276, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 282, 'mouse')]
PMC4161853	8/2014	S218-PMC4161853	['AS SEVERE malnutrition is one of the risk FACTORS to develop malaria-ibi co-infection, it is IMPORTANT TO evaluate the IMPACT of Vitamin A administration in the clinical management of children with malaria and ibi-co-infection in africa, EITHER as a therapeutic and/OR prophylactic measure, ESPECIALLY due to recent EVIDENCE of the positive IMPACT of Vitamin A and zinc supplementation on malaria morbidity in a study conducted in ghana [121,122].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 3), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('IMPORTANT_CONSIDERATION', 291), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 341)]	10	[('CHEBI_27300', 'vitamin D', 129, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin A')]
PMC4161853	8/2014	S219-PMC4161853	['HOWEVER, in Man, the ROLE of Vitamin A in malaria pathogenesis is multifaceted, and p. falciparum clearly BENEFITS from normal to high Vitamin A Hepatic stores, POSSIBLY depending on scavenged Vitamin A Metabolites to destabilize host Rbc Membranes facilitating invasion [123].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 106), ('INCOMPLETE_EVIDENCE', 161)]	4	[('NCBITaxon_40674', 'Mammalia', 12, 'man'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('UBERON_0002107', 'liver', 145, 'hepatic'), ('CHEBI_26871', 'terpene alkaloid', 193, 'vitamin A metabolites'), ('CL_0000232', 'erythrocyte', 235, 'RBC'), ('GO_0016020', 'membrane', 239, 'membranes')]
PMC4172095	8/2014	S134-PMC4172095	['nutritional guidelines for Pregnancy tend to HIGHLIGHT the IMPORTANCE of ensuring sufficient Intake of a range of Micronutrients, including Iron, Folic Acid, b vitamins, zinc, magnesium, Iodine, Vitamin A, and Calcium (kaiser et al., 2002).']	[('INCOMPLETE_EVIDENCE', 45), ('IMPORTANT_CONSIDERATION', 59)]	2	[('GO_0007565', 'female pregnancy', 27, 'pregnancy'), ('GO_0007631', 'feeding behavior', 93, 'intake'), ('CHEBI_33839', 'macromolecule', 114, 'micronutrients'), ('CHEBI_24870', 'ion', 140, 'iron'), ('CHEBI_30751', 'formic acid', 146, 'folic acid'), ('CHEBI_24859', 'iodine atom', 187, 'iodine'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin A'), ('CHEBI_22313', 'alkaline earth metal atom', 210, 'calcium')]
PMC4645901	8/2014	S9-PMC4645901	['the study FOUND 71% of babies to be Vitamin D deficient.']	[('INCOMPLETE_EVIDENCE', 10)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC4645901	8/2014	S32-PMC4645901	['WHILE Vitamin D CAN be found in some Foods, the only dietary source for babies is formula milk that has Vitamin D added.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_33290', 'food', 37, 'foods'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4645901	8/2014	S45-PMC4645901	['the results DEMONSTRATED an ALARMINGLY high proportion (71%) of babies with Vitamin D deficiency (table 1).']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 28)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4645901	8/2014	S73-PMC4645901	['this MAY BE due to the increased AWARENESS of Vitamin D deficiency by the general public, and THEREFORE an increased uptake of Vitamin supplements during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 33), ('PROBABLE_UNDERSTANDING', 94)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 127, 'vitamin'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy')]
PMC4645901	8/2014	S83-PMC4645901	['a relatively SMALL data set MEANT it was NOT POSSIBLE to draw convincing CONCLUSIONS between dose of vitamin supplementation during Pregnancy and Vitamin D levels in babies.']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 28), ('DIFFICULT_TASK', 41), ('PROBABLE_UNDERSTANDING', 73)]	4	[('GO_0007565', 'female pregnancy', 132, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC4161944	9/2014	S148-PMC4161944	['full reviews on Micronutrient malnutrition and immunity can be found elsewhere (114–116) and ONLY select Micronutrients (Selenium, zinc, and Vitamin A) known to Modulate Immunity are highlighted HERE.']	[('INCOMPLETE_EVIDENCE', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 195)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 16, 'micronutrient'), ('CHEBI_33839', 'macromolecule', 105, 'micronutrients'), ('CHEBI_27568', 'selenium atom', 121, 'selenium'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A'), ('GO_0065007', 'biological regulation', 161, 'modulate'), ('GO_0007566', 'embryo implantation', 170, 'immunity')]
PMC4161944	9/2014	S231-PMC4161944	['independent of nutrition or pathogen exposure, seasonality CAN also change diurnal exposure to sunlight and levels of circulating Vitamin D. in the united kingdom, Vitamin D status during Gestation and Birth month HAS BEEN ASSOCIATED with diseases with Immune involvement, including rheumatoid arthritis, irritable Bowel diseases, and multiple sclerosis (174).']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 223)]	3	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'gestation'), ('GO_0007567', 'parturition', 202, 'birth'), ('UBERON_0002405', 'immune system', 253, 'immune'), ('UBERON_0000160', 'intestine', 315, 'bowel')]
PMC4161944	9/2014	S232-PMC4161944	['assessment of seasonality, Vitamin D, and infectious disease HAS BEEN FURTHER explored with regards to tb in south africa, REVEALING a reciprocal seasonal variation in Serum 25(Oh)D concentration and tb notification (175).']	[('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 123)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0001977', 'blood serum', 168, 'serum'), ('CHEBI_33010', 'chromide(1-)', 176, '(OH)D')]
PMC4169453	9/2014	S11-PMC4169453	['conclusions\nVitamin D supplementation at a dose of 400 iu/d was not sufficient to maintain 25(Oh)D >20 ng/ml in nursing women, WHILE 1200 iu/d APPEARED more EFFECTIVE, but had no effect on Breastfed offspring Vitamin D status, or changes in the bone mass and the body composition OBSERVED in both during breastfeeding.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('ANOMALY_CURIOUS_FINDING', 143), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 280)]	5	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 91, '25(OH)D'), ('GO_0007567', 'parturition', 189, 'breastfed'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC4169453	9/2014	S12-PMC4169453	['trial registration\nclinicaltrials.govnct01506557\n\nintroduction\nGROWING EVIDENCE SUGGESTS that Vitamin D deficiency has a negative IMPACT on the Skeletal System and MAY BE a POTENTIAL RISK FACTOR for a wide range of diseases, including cancer, Cardiovascular disease, hypertension, diabetes, Autoimmune diseases, and allergies[1].']	[('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 183)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001434', 'skeletal system', 144, 'skeletal system'), ('UBERON_0004535', 'cardiovascular system', 243, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 291, 'autoimmune')]
PMC4169453	9/2014	S15-PMC4169453	['Postpartum deterioration of Vitamin D status MIGHT be EXPLAINED, AT LEAST IN PART, by less frequent multivitamin intake during Lactation compared to Pregnancy[5],[6]and decreasing multivitamin Intake in the course of Lactation[2].']	[('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 54), ('PROBABLE_UNDERSTANDING', 65), ('INCOMPLETE_EVIDENCE', 74)]	4	[('GO_0007567', 'parturition', 0, 'Postpartum'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007595', 'lactation', 127, 'lactation'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy'), ('GO_0007631', 'feeding behavior', 193, 'intake'), ('GO_0007595', 'lactation', 217, 'lactation')]
PMC4169453	9/2014	S16-PMC4169453	['Vitamin D supplementation in Lactating women MAY ensure APPROPRIATE maternal Vitamin D status in cases of low Vitamin D dietary consumption and restricted synthesis in the skin[7].']	[('INCOMPLETE_EVIDENCE', 45), ('IMPORTANT_CONSIDERATION', 56)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007594', 'puparial adhesion', 29, 'lactating'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4169453	9/2014	S17-PMC4169453	['most of the RECENTLY PUBLISHED rct in Lactating women HAVE BEEN focused on maternal supplementation as a method of achieving APPROPRIATE Vitamin D status in both, mothers and their Breastfed offspring[8]–[11].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 125)]	3	[('GO_0007594', 'puparial adhesion', 38, 'lactating'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007567', 'parturition', 181, 'breastfed')]
PMC4169453	9/2014	S19-PMC4169453	['HOWEVER, the OPTIMAL Vitamin D intake as well as OPTIMAL 25(Oh)D level for Lactating women (BASED ON ESTIMATED maternal NEEDS) STILL REMAINS NOT fully ESTABLISHED, or AT LEAST not accepted worldwide.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 127), ('FULL_UNKNOWN', 133), ('PROBABLE_UNDERSTANDING', 167)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('GO_0007594', 'puparial adhesion', 75, 'lactating')]
PMC4169453	9/2014	S20-PMC4169453	['the RECOMMENDED Vitamin D intake VARIES from 400 iu/d to 2000 iu/d[7],[12]–[16], BUT supplementation using less than 1000 iu/d MAY BE INADEQUATE for maintaining an “optimal” 25(Oh)D level[17].']	[('FUTURE_WORK', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 127), ('IMPORTANT_CONSIDERATION', 134), ('PROBLEM_COMPLICATION', 134)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 174, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 180, 'D')]
PMC4169453	9/2014	S26-PMC4169453	['a RECENTLY published rct of Vitamin D supplementation in breastfed infants SHOWED no effect of different oral dosages of Vitamin D (from 400 iu/d up to 1600 iu/d) on infants’ bone Mineral content[26].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 75)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_46662', 'mineral', 180, 'mineral')]
PMC4169453	9/2014	S28-PMC4169453	['we HYPOTHESIZED that maternal Vitamin D supplementation during Lactation at a dose of 1200 iu/d, BUT NOT 400 iu/d, is more beneficial for both breastfeeding mothers and Breastfed infants, when Vitamin D status, bone mass and body composition are controlled for.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007595', 'lactation', 63, 'lactation'), ('GO_0007567', 'parturition', 169, 'breastfed'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
PMC4169453	9/2014	S84-PMC4169453	['for statistical purposes, Vitamin D intake from Breast Milk was ESTIMATED to be 20 iu/d (500 ml of Breast Milk) at baseline and 40 iu/d (1000 ml of Breast Milk) at follow-up visits.']	[('INCOMPLETE_EVIDENCE', 64)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 48, 'breast milk'), ('UBERON_0001348', 'brown adipose tissue', 99, 'breast milk'), ('UBERON_0000310', 'breast', 148, 'breast'), ('UBERON_0001913', 'milk', 155, 'milk')]
PMC4169453	9/2014	S89-PMC4169453	['it was BASED ON an ASSUMPTION that each 400 iu/d of Vitamin D MAY increase 25(Ohd) level by 2.8–4.8 ng/ml (mean ∼4 ng/ml) and the standard deviation of 25(Oh)D measurements was 8[28],[29].']	[('PROBABLE_UNDERSTANDING', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 62)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_18009', 'NADP(+)', 75, '25(OHD'), ('CHEBI_71657', 'versiconol acetate', 152, '25(OH)D')]
PMC4169453	9/2014	S133-PMC4169453	['AS EXPECTED, a significant increase in 25(Oh)D occurred in breastfed infants supplemented with 400 iu/d of Vitamin D, and no differences were FOUND between the study groups (fig.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 142)]	2	[('CHEBI_71657', 'versiconol acetate', 39, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4169453	9/2014	S174-PMC4169453	['in OUR STUDY maternal median 25(Oh)D levels (∼15 ng/ml) at the baseline visit, INDICATING Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 79)]	2	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 29, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4169453	9/2014	S178-PMC4169453	['hollis and wagner[31]REPORTED a much larger decline (by ∼10 ng/ml) of maternal 25(Oh)D3 level during the first 3 months of Vitamin D supplementation at a dose of 400 iu/d.']	[('INCOMPLETE_EVIDENCE', 21)]	1	[('CHEBI_62946', 'ammonium sulfate', 79, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 79, '25(OH)D3'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4169453	9/2014	S183-PMC4169453	['in CONSEQUENCE, fundamental QUESTIONS of: a) HOW much Vitamin D is enough to reach and maintain OPTIMAL 25(Oh)D level, and b) what is the OPTIMAL range for 25(Oh)D levels, REMAIN an ISSUE of DEBATE[32],[33].']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 28), ('EXPLICIT_QUESTION', 45), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 138), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191)]	8	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 106, '(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D')]
PMC4169453	9/2014	S184-PMC4169453	['there is GROWING EVIDENCE SHOWING Serum 25(Oh)D levels higher than 30 ng/ml, or EVEN higher than 40 ng/ml as EFFECTIVE for expression of Extra-Skeletal EFFECTS RELATED to proper Vitamin D status[1],[34],[35].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 160)]	6	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 40, '25(OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 137, 'extra-skeletal'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC4169453	9/2014	S186-PMC4169453	['the studies performed in healthy Individuals INDICATE that Vitamin D supplementation at a dose of 3000–7000 iu/d MIGHT be NECESSARY to achieve a Serum 25(Oh)D level of at least 30 ng/ml in 97.5% of that population[17],[35]–[37].']	[('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 113), ('IMPORTANT_CONSIDERATION', 122)]	3	[('NCBITaxon_1', 'root', 33, 'individuals'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 154, 'OH)D')]
PMC4169453	9/2014	S188-PMC4169453	['KEEPING IN MIND RECENT LITERATURE, TO address the QUESTION of the lowest EFFECTIVE and SAFE Vitamin D dose NEEDED to observe health BENEFITS for both Lactating mother and Breastfed offspring, a higher Vitamin D doses would be chosen and evaluated in our rct (1500 iu/d vs. 2000 iu/d vs. 3000 iu/d).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('EXPLICIT_QUESTION', 50), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 87), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 132)]	8	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 150, 'lactating'), ('GO_0007567', 'parturition', 171, 'breastfed'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4169453	9/2014	S190-PMC4169453	['from a clinical POINT OF VIEW, the IMPACT of 1200 iu/d Vitamin D dose on the maternal 25(Oh)D concentration was very subtle.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D')]
PMC4169453	9/2014	S197-PMC4169453	['taking into account the maternal REQUIREMENT, 1200 iu/d of Vitamin D MAY PROTECT against Vitamin D deficiency, but SEEMS TOO low TO fully replenish Vitamin D insufficiency (20 ng/ml<25(Oh)D <30 ng/ml).']	[('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 73), ('ANOMALY_CURIOUS_FINDING', 115), ('DIFFICULT_TASK', 121)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 182, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 182, '25 ... OH ... D')]
PMC4169453	9/2014	S200-PMC4169453	['though supplementation at a dose of 2000 iu/d was PREVIOUSLY REPORTED to increase maternal 25(Oh)D to 30–39 ng/ml[35],[38],[39], it STILL MIGHT be insufficient for Vitamin D-deficient women[40],[41].']	[('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 132), ('INCOMPLETE_EVIDENCE', 138)]	4	[('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 91, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4169453	9/2014	S204-PMC4169453	['our results REVEALED that maternal Vitamin D supplementation at a dose up to 1200 iu/d had no influence on the breastfed offspring’s Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 12)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC4169453	9/2014	S206-PMC4169453	['NEVERTHELESS, we SHOULD KEEP IN MIND that each 400 iu/d of Vitamin D MAY increase Serum 25(Oh)D level by 2.8 ng/ml[17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 69)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 88, '25(OH)D')]
PMC4169453	9/2014	S210-PMC4169453	['INTERESTINGLY, the fish Intake was not associated with Serum 25(Oh)D level in that study, DESPITE fish being CONSIDERED a rich source of Vitamin D. ON THE OTHER HAND, a mean skin synthesis of Vitamin D was 200–650 iu/d at the summer peak, but it accounted for ONLY 10–25% of total basal Vitamin D input[37].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 90), ('INCOMPLETE_EVIDENCE', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('ANOMALY_CURIOUS_FINDING', 260)]	5	[('GO_0007631', 'feeding behavior', 24, 'intake'), ('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_74268', "N(1)-methylguanosine 5'-monophosphate", 61, '25(OH)d'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 61, '25(OH)d'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D')]
PMC4169453	9/2014	S217-PMC4169453	['ON THE OTHER HAND, stable and comparable pth concentrations were REPORTED by greer in infants supplemented with Vitamin D or receiving a placebo, DESPITE significantly lower 25(Oh)D levels in the placebo group[45].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 146)]	3	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 177, 'OH)D')]
PMC4169453	9/2014	S218-PMC4169453	['our results INDICATE that the pth concentration SHOULD NOT BE considered a reliable functional MARKER of Vitamin D status in newborn infants.']	[('INCOMPLETE_EVIDENCE', 12), ('FUTURE_WORK', 48), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4169453	9/2014	S223-PMC4169453	['the INFLUENCE of Vitamin D status and bone mass in nursing women MIGHT BE evaluated FURTHER BUT higher Vitamin D doses are NECESSARY.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 71), ('FUTURE_WORK', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('IMPORTANT_CONSIDERATION', 123)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4169453	9/2014	S230-PMC4169453	['IF the same mechanism exists in Humans, increasing the Vitamin D intake of Lactating women CAN be PRESUMED to have no beneficial effect on bone Mineral content and density.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 91), ('PROBABLE_UNDERSTANDING', 98)]	3	[('NCBITaxon_9606', 'Homo sapiens', 32, 'humans'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 75, 'lactating'), ('CHEBI_46662', 'mineral', 144, 'mineral')]
PMC4169453	9/2014	S233-PMC4169453	['gallo et al, also FOUND no differences in bmc between infants supplemented with diverse doses of Vitamin D (400–1600 iu/d)[26].']	[('INCOMPLETE_EVIDENCE', 18)]	1	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4169453	9/2014	S237-PMC4169453	['finally, dietary Vitamin D intake was based SOLELY on fish Consumption, not overall Food frequency.']	[('INCOMPLETE_EVIDENCE', 44)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007631', 'feeding behavior', 59, 'consumption'), ('CHEBI_33290', 'food', 84, 'food')]
PMC4169453	9/2014	S239-PMC4169453	['conclusions\nIN SUMMARY, OUR STUDY SHOWED a very high prevalence (∼65%) of Postpartum Vitamin D deficiency among caucasian mothers and their newborn offspring living at latitude 52°n.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 34)]	3	[('GO_0007565', 'female pregnancy', 74, 'postpartum'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4171568	9/2014	S72-PMC4171568	['high levels of Serum Mda and low Plasma Ascorbic Acid were FOUND in the sample as a whole BUT at follow-up normalisation of these MARKERS were observed ONLY in the group receiving Vitamin C as an adjunct to anti-psychotic treatment.']	[('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 90), ('SUPERFICIAL_RELATIONSHIP', 130), ('ANOMALY_CURIOUS_FINDING', 152)]	4	[('UBERON_0001977', 'blood serum', 15, 'serum'), ('CHEBI_34840', 'methyl methacrylate', 21, 'MDA'), ('UBERON_0001969', 'blood plasma', 33, 'plasma'), ('CHEBI_22652', 'ascorbic acid', 40, 'ascorbic acid'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin C')]
PMC4171568	9/2014	S135-PMC4171568	['Vitamin D as a risk factor for the development of schizophrenia\nit HAS BEEN HYPOTHESIZED that low Prenatal Vitamin D is a risk factor for the incidence of Adult-onset schizophrenia AS the lack of this fat-soluble Vitamin and Steroid Hormone MAY DETRIMENTALLY IMPACT on the developing foetal Brain [102].']	[('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 181), ('INCOMPLETE_EVIDENCE', 241), ('IMPORTANT_CONSIDERATION', 245), ('SUPERFICIAL_RELATIONSHIP', 259)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0007023', 'adult organism', 155, 'adult'), ('CHEBI_33229', 'vitamin (role)', 213, 'vitamin'), ('CHEBI_26764', 'steroid hormone', 225, 'steroid hormone'), ('UBERON_0000955', 'brain', 291, 'brain')]
PMC4171568	9/2014	S136-PMC4171568	['research using Animal MODELS HAS SHOWN that low Prenatal Vitamin D alters Brain Development [103].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29)]	2	[('NCBITaxon_33208', 'Metazoa', 15, 'animal'), ('GO_0007565', 'female pregnancy', 48, 'prenatal'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007420', 'brain development', 74, 'brain development'), ('UBERON_0000955', 'brain', 74, 'brain')]
PMC4171568	9/2014	S138-PMC4171568	['in a large-scale Birth cohort study of 9,114 people in finland, the use of Vitamin D supplements in the first year of Life was ASSOCIATED with a reduced risk of developing schizophrenia at 31\xa0years of age, with higher doses SEEN as more beneficial than lower amounts [110].']	[('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 224)]	2	[('GO_0007567', 'parturition', 17, 'birth'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
PMC4171568	9/2014	S141-PMC4171568	['HOWEVER, THERE IS EVIDENCE that high doses of Vitamin D are NOT NECESSARILY PROTECTIVE; in 424 matched pairs from a population-based cohort, a bi-modal RELATIONSHIP APPEARED in which the participants with the lowest and highest levels of Vitamin D had increased risk of schizophrenia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 152), ('ANOMALY_CURIOUS_FINDING', 165)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC4171568	9/2014	S142-PMC4171568	['THEREFORE, the RELATIONSHIP between Vitamin D and schizophrenia NEEDS FURTHER INVESTIGATION, EVEN THOUGH a RECENT review of the EVIDENCE CONCLUDED that adequate levels of Vitamin D are needed for normal Brain Development and function and furthermore that at-risk groups SHOULD BE offered supplementation [112].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('FUTURE_WORK', 64), ('FUTURE_WORK', 70), ('ANOMALY_CURIOUS_FINDING', 93), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 137), ('FUTURE_WORK', 270)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007420', 'brain development', 203, 'brain development'), ('UBERON_0000955', 'brain', 203, 'brain')]
PMC4192458	9/2014	S22-PMC4192458	['furthermore, Serum Nutrient levels (such as elevated polyunsaturated Fatty Acids, and decreased Vitamins C and E, zinc, and iron) HAVE BEEN ASSOCIATED with increased inflammation, oxidative stress, and dyslipidemia [9,10].']	[('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 140)]	2	[('UBERON_0001977', 'blood serum', 13, 'serum'), ('CHEBI_33284', 'nutrient', 19, 'nutrient'), ('CHEBI_35366', 'fatty acid', 69, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 96, 'vitamins C'), ('PR_000004900', 'complement C3', 105, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 111, 'E')]
PMC4192458	9/2014	S23-PMC4192458	['Nutrient status HAS also BEEN directly LINKED with increased risk of pre-eclampsia, including increased Serum Triglyceride and Fatty Acids, and reduced levels of Serum calcium, Vitamin D, magnesium, and zinc [9].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_33284', 'nutrient', 0, 'Nutrient'), ('UBERON_0001977', 'blood serum', 104, 'serum'), ('CHEBI_17855', 'triglyceride', 110, 'triglyceride'), ('CHEBI_35366', 'fatty acid', 127, 'fatty acids'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC4192458	9/2014	S182-PMC4192458	['four studies examining subtypes SUGGESTED a more pronounced risk for severe compared with mild pre-eclampsia for lower intake of Calcium [35], Vitamin C [26], and Probiotics [20], and higher Consumption of tea [36].']	[('INCOMPLETE_EVIDENCE', 32)]	1	[('CHEBI_22313', 'alkaline earth metal atom', 129, 'calcium'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin C'), ('CHEBI_26346', 'prostaglandins J', 163, 'probiotics'), ('GO_0007631', 'feeding behavior', 191, 'consumption')]
PMC4192458	9/2014	S217-PMC4192458	['CONSISTENT with results from randomized controlled trials on Nutrient supplementation, our results did not show associations between pre-eclampsia and reported intakes of Vitamin D, c, and e, and N-3 polyunsaturated Fatty Acids [11-13].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_33284', 'nutrient', 61, 'nutrient'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_30256', 'thiocarbonyl group', 196, 'n-3'), ('CHEBI_35366', 'fatty acid', 216, 'fatty acids')]
PMC4380518	9/2014	S6-PMC4380518	['conclusions\nongoing trials of Vitamin D supplementation during Pregnancy SHOULD CONSIDER POTENTIAL EFFECT MODIFICATION by race/ethnicity.']	[('FUTURE_WORK', 73), ('FUTURE_WORK', 80), ('INCOMPLETE_EVIDENCE', 89), ('PROBLEM_COMPLICATION', 99)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy')]
PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
PMC4380518	9/2014	S8-PMC4380518	['furthermore, WHILE multivitamin intake HAS BEEN SHOWN to VARY by race,19it REMAINS UNKNOWN WHETHER multivitamin intake improves Vitamin D status among the HIGHEST RISK groups (african americans and overweight/obese) during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 39), ('DIFFICULT_TASK', 57), ('FULL_UNKNOWN', 75), ('EXPLICIT_QUESTION', 91), ('IMPORTANT_CONSIDERATION', 155)]	6	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC4380518	9/2014	S10-PMC4380518	['our HYPOTHESIS was that lack of Prenatal vitamin (pnv) use WOULD BE ASSOCIATED with Vitamin D deficiency (DEFINED as <50 nmol/).']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_PREDICTION', 59), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 106)]	4	[('GO_0007565', 'female pregnancy', 32, 'prenatal'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC4380518	9/2014	S47-PMC4380518	['discussion\nour data SUGGEST that WHILE Prenatal pnv use is ASSOCIATED with lower odds of Vitamin D deficiency, the ASSOCIATION is NOT UNIFORM.']	[('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 115), ('DIFFICULT_TASK', 130)]	5	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4380518	9/2014	S51-PMC4380518	['in ANOTHER STUDY of massachusetts women, black women REPORTED taking periconceptional multivitamins half as often as white women.19additionally, our prevalence of Vitamin D deficiency is SIMILAR TO that REPORTED in nhanes24and in another boston cohort, project viva.13,25others have ANALYZED the ASSOCIATION between pnv use and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 187), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 283), ('SUPERFICIAL_RELATIONSHIP', 296)]	6	[('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 328, 'vitamin D')]
PMC4380518	9/2014	S52-PMC4380518	['shea et al studied 2500 elderly Adults and FOUND that lack of pnv use was ASSOCIATED with higher odds of Vitamin D insufficiency (<75 nmol/l) in both black (5.2 (95% ci: 3.5, 7.7)) and white participants (or 2.6, 95% ci: 2.0, 3.2), HOWEVER these subjects were much older and not Pregnant.26a SMALL turkish STUDY of 79 Pregnant women SHOWED significantly higher 25(Oh)D levels among women reporting pnv use in the third trimester,27BUT this study DID NOT include women of african descent and DID NOT have the power to address POTENTIAL INTERACTION by bmi.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 333), ('PROBLEM_COMPLICATION', 431), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 491), ('INCOMPLETE_EVIDENCE', 525), ('SUPERFICIAL_RELATIONSHIP', 535)]	10	[('UBERON_0007023', 'adult organism', 32, 'adults'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 279, 'pregnant'), ('GO_0007565', 'female pregnancy', 318, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 361, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 361, '25(OH)D')]
PMC4380518	9/2014	S62-PMC4380518	['we also LACKED DATA on Vitamin D binding protein which MAY DIFFER by race/ethnicity and COULD AFFECT the ASSOCIATION between pnv use and 25(Oh)D measured in the Plasma.']	[('FULL_UNKNOWN', 8), ('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 105)]	6	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 137, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 161, 'plasma')]
PMC4380518	9/2014	S63-PMC4380518	['the OPTIMAL method of Vitamin D measurement REMAINS CONTROVERSIAL, BUT our laboratory uses u.s. national institute of standards and technology level 1 and this method is COMMONLY used clinically and in the literature.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('PROBABLE_UNDERSTANDING', 170)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4380518	9/2014	S65-PMC4380518	['IN CONTRAST, our data SUPPORT INVESTIGATION into higher doses of Vitamin D in subgroups at high RISK IF BENEFITS are demonstrated by ONGOING TRIALS in Pregnancy of achieving higher 25(Oh)D levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 96), ('FUTURE_PREDICTION', 101), ('IMPORTANT_CONSIDERATION', 104), ('INCOMPLETE_EVIDENCE', 133)]	7	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 181, '25(OH)D')]
PMC4380518	9/2014	S67-PMC4380518	['in conclusion, we FOUND that lack of pnv use during Pregnancy was ASSOCIATED with Vitamin D deficiency early in Pregnancy, BUT NOT among black women.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 123)]	3	[('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC4380518	9/2014	S68-PMC4380518	['IN LIGHT OF two RECENT meta-analyses/systematic reviews CONCLUDING that low 25(Oh)D levels during Pregnancy are ASSOCIATED with SEVERAL morbidities in Pregnancy15,16, optimizing Vitamin D status during Pregnancy MAY BE IMPORTANT.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 219)]	7	[('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 76, '25 ... OH ... D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy15'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC4380518	9/2014	S69-PMC4380518	['ONGOING TRIALS of Vitamin D supplementation during Pregnancy SHOULD CONSIDER EFFECT MODIFICATION by race/ethnicity.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 61), ('FUTURE_WORK', 68), ('PROBLEM_COMPLICATION', 77)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy')]
PMC4193194	10/2014	S178-PMC4193194	['as with OTHER oxidative stress Metabolites, levels of antioxidant enzymes and Compounds, such as catalase, Superoxide dismutase (sod) and Vitamin E HAVE BEEN found to be variable in pe studies compared to normal Pregnancies (bilodeau,2014).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 148)]	2	[('CHEBI_25212', 'metabolite', 31, 'metabolites'), ('CHEBI_36357', 'polyatomic entity', 78, 'compounds'), ('CHEBI_18421', 'superoxide', 107, 'superoxide'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin E'), ('GO_0007565', 'female pregnancy', 212, 'pregnancies')]
PMC4193194	10/2014	S187-PMC4193194	['the study, called combined antioxidants and Preeclampsia prediction studies (capps), had the OBJECTIVE of determining WHETHER Vitamin C and E COULD reduce the frequency of Pregnancy related hypertension.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('INCOMPLETE_EVIDENCE', 142)]	3	[('GO_0007128', 'meiotic prophase I', 44, 'Preeclampsia'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 140, 'E'), ('GO_0007565', 'female pregnancy', 172, 'pregnancy')]
PMC4193194	10/2014	S188-PMC4193194	['results from this STUDY SHOWED that the supplementation with Vitamin C and E in a low-risk cohort of women DEMONSTRATED no significant differences in maternal or newborn complications RELATED to hypertension during Pregnancy (roberts et al.,2010; weissgerber et al.,2013).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 75, 'E'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy')]
PMC4193194	10/2014	S190-PMC4193194	['ALIGNED with this FINDINGS, the cochrane collaboration initiative have CONCLUDED on its latest review on Antioxidants for preventing pe that evidence from trials reviewed does NOT SUPPORT the use of Vitamin C and E during Pregnancy for the PREVENTION of Preeclampsia and other outcomes (rumbold et al.,2008; salles et al.,2012).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('SUPERFICIAL_RELATIONSHIP', 240)]	5	[('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 105, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 213, 'E'), ('GO_0007565', 'female pregnancy', 222, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 254, 'preeclampsia')]
PMC4193194	10/2014	S212-PMC4193194	['oral supplementation with Antioxidants like Vitamin C and E and EVEN N-Acetylcysteine HAVE BEEN PROVEN to be a failure on the prevention of the disease.']	[('ANOMALY_CURIOUS_FINDING', 64), ('INCOMPLETE_EVIDENCE', 86)]	2	[('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 26, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('CHEBI_44482', 'N-oxalylglycine', 69, 'n-acetylcysteine')]
PMC4194375	10/2014	S126-PMC4194375	['there was SOME EVIDENCE to SUGGEST that the EFFECT of the intervention on Iodine, Vitamin E and Folate intake was modified by maternal bmi category (interaction p \u2009<\u20090.05 in all cases), with overall Intake significantly increased in obese but not overweight women randomised to the lifestyle advice group (data not shown).']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 44)]	3	[('CHEBI_24859', 'iodine atom', 74, 'iodine'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 96, 'folate'), ('GO_0007631', 'feeding behavior', 199, 'intake')]
PMC4210909	10/2014	S91-PMC4210909	['iron status CAN also be AFFECTED by the intake of OTHER Nutrients that MAY inhibit (e.g., calcium, phytates) OR promote (e.g., Vitamin C) iron absorption [43].']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('INCOMPLETE_EVIDENCE', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109)]	5	[('CHEBI_33284', 'nutrient', 56, 'nutrients'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin C')]
PMC4210927	10/2014	S146-PMC4210927	['[65] FOUND that ONLY 36% of Lactating women meet energy, calcium and Vitamin D RECOMMENDATIONS.']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 16), ('FUTURE_WORK', 79)]	3	[('GO_0007594', 'puparial adhesion', 28, 'lactating'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4216020	10/2014	S72-PMC4216020	['a larger prospective study, HOWEVER, DID NOT demonstrate an ASSOCIATED RISK between maternal smoking and jia.92\nOTHER Perinatal exposures and Pregnancy-related FACTORS HAVE BEEN investigated.47,92an australian study that reviewed 262 cases and matched controls IDENTIFIED a TREND towards a PROTECTIVE EFFECT with Prenatal Nutritional Supplements.47the mothers of children that eventually developed jia were less LIKELY to receive supplementation with Prenatal multivitamins (24.9% versus 30.8%), Vitamin D (3.3% versus 7.8%), Fish Oil (2.9% versus 6.4%), Calcium (10.2% versus 14.9%), Iron (35.4% versus 40.3%), and Folate (61.4% versus 64.8%) while Pregnant compared to controls.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 168), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 290), ('SUPERFICIAL_RELATIONSHIP', 301), ('PROBABLE_UNDERSTANDING', 412)]	12	[('GO_0036268', 'swimming', 118, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 118, 'perinatal'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy'), ('GO_0007565', 'female pregnancy', 313, 'prenatal'), ('CHEBI_7495', 'nefazodone hydrochloride', 322, 'nutritional'), ('CHEBI_33341', 'titanium atom', 334, 'supplements'), ('GO_0007565', 'female pregnancy', 451, 'prenatal'), ('CHEBI_27300', 'vitamin D', 496, 'vitamin D'), ('CHEBI_34766', 'Furamizole', 526, 'fish oil'), ('CHEBI_22313', 'alkaline earth metal atom', 555, 'calcium'), ('CHEBI_24870', 'ion', 585, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 616, 'folate'), ('GO_0007565', 'female pregnancy', 650, 'pregnant')]
PMC4329404	10/2014	S0-PMC4329404	['Vitamin D deficiency induces th2 skewing and Eosinophilia in neonatal allergic Airways disease\n\nabstract\n\nbackground\nASSOCIATIONS between Vitamin D status and childhood asthma are increasingly REPORTED, but direct causation and mechanisms UNDERLYING an EFFECT remain UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 239), ('SUPERFICIAL_RELATIONSHIP', 253), ('FULL_UNKNOWN', 267)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CL_0000771', 'eosinophil', 45, 'eosinophilia'), ('UBERON_0001005', 'respiratory airway', 79, 'airways'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC4329404	10/2014	S14-PMC4329404	['an ASSOCIATION between Vitamin D Receptor (Vdr) Gene polymorphisms and asthma susceptibility is REPORTED (3,4); HOWEVER, the RELATIONSHIP between Serum Vitamin D levels and asthma REMAINS CONTROVERSIAL (5).']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 125), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188)]	6	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 23, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 43, 'VDR'), ('SO_0000704', 'gene', 48, 'gene'), ('UBERON_0001977', 'blood serum', 146, 'serum'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC4329404	10/2014	S15-PMC4329404	['an inverse ASSOCIATION between Serum Vitamin D and total Ige, Lung function and asthma exacerbations in physician diagnosed asthmatic children HAVE BEEN DESCRIBED (6–8).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 153)]	3	[('UBERON_0001977', 'blood serum', 31, 'serum'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 57, 'IgE'), ('UBERON_0002048', 'lung', 62, 'lung')]
PMC4329404	10/2014	S16-PMC4329404	['low Serum Vitamin D in childhood IS THOUGHT TO be PREDICTIVE of asthma in adolescent males (9).']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 50)]	3	[('UBERON_0001977', 'blood serum', 4, 'serum'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4329404	10/2014	S17-PMC4329404	['CONVERSELY, increased asthma was REPORTED in Adulthood after a period of Vitamin D supplementation during the first year of Life (10).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 33)]	2	[('UBERON_0000113', 'post-juvenile adult stage', 45, 'adulthood'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0000104', 'life cycle', 124, 'life')]
PMC4329404	10/2014	S18-PMC4329404	['a RECENT unselected cohort of over 2000 children OBSERVED no association between Serum Vitamin D and asthma or Lung function; HOWEVER, higher Serum Vitamin D was ASSOCIATED with a greater RISK of wheeze (11).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('ANOMALY_CURIOUS_FINDING', 126), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 188)]	6	[('UBERON_0001977', 'blood serum', 81, 'serum'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002048', 'lung', 111, 'lung'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4329404	10/2014	S19-PMC4329404	['Serum Vitamin D levels HAVE BEEN ASSOCIATED with disease severity in children and were reduced in severe compared to moderate asthmatics (12).']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC4329404	10/2014	S21-PMC4329404	["maternal Vitamin D status during Pregnancy MAY also determine risk of asthma Development RATHER than the child's own Vitamin D levels."]	[('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('GO_0008289', 'lipid binding', 77, 'development'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC4329404	10/2014	S22-PMC4329404	['reduced maternal Vitamin D during Pregnancy HAS BEEN ASSOCIATED with an increase in early wheeze, but this ASSOCIATION does not extend to asthma at school age (14–16).']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 34, 'pregnancy')]
PMC4329404	10/2014	S23-PMC4329404	['Cord Blood Vitamin D levels inversely CORRELATED with wheeze (17), WHILE a u-shaped RELATIONSHIP with total and Antigen-specific Ige HAS BEEN OBSERVED in a population of children in arizona (18).']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 133), ('INCOMPLETE_EVIDENCE', 142)]	5	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_59132', 'antigen', 112, 'antigen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 129, 'IgE')]
PMC4329404	10/2014	S24-PMC4329404	['CONVERSELY, maternal Vitamin D status HAS BEEN REPORTED to have no associations with asthma or wheeze (19,20).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 38)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC4329404	10/2014	S26-PMC4329404	['the ROLE of Vitamin D as an immunomodulator is BETTER DEFINED, with Vitamin D skewing the Immune System towards Regulation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 47)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002405', 'immune system', 90, 'immune system'), ('GO_0065007', 'biological regulation', 112, 'regulation')]
PMC4329404	10/2014	S28-PMC4329404	['MULTIPLE STUDIES HAVE REPORTED a positive CORRELATION between Serum Vitamin D and Foxp3+Regulatory T-Cell numbers in both the periphery and Airways of Adults (24) and children (25,26).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('PR_000017653', 'zinc finger protein ZFPM2', 82, 'FoxP3'), ('CL_0000815', 'regulatory T cell', 88, 'regulatory T-cell'), ('GO_0065007', 'biological regulation', 88, 'regulatory'), ('GO_0005854', 'nascent polypeptide-associated complex', 100, '-'), ('UBERON_0001005', 'respiratory airway', 140, 'airways'), ('UBERON_0007023', 'adult organism', 151, 'adults')]
PMC4329404	10/2014	S31-PMC4329404	['TO DETERMINE WHETHER Vitamin D deficiency exacerbates allergic Airways disease (aad), and the mechanisms underlying this, we used a neonatal MODEL of inhaled house dust Mite (hdm) exposure (28).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 141)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 63, 'airways'), ('CHEBI_46662', 'mineral', 169, 'mite'), ('NCBITaxon_10088', 'Mus <genus>', 169, 'mite')]
PMC4329404	10/2014	S32-PMC4329404	['we HYPOTHESIZED that pups experiencing in utero and early-Life Vitamin D deficiency would develop more SEVERE hdm-induced Airway hyper-responsiveness (ahr), Eosinophilic inflammation and remodelling due to a reduction in Regulatory T Cells in the Lung.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 103)]	2	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 122, 'airway'), ('CL_0000771', 'eosinophil', 157, 'eosinophilic'), ('CL_0000815', 'regulatory T cell', 221, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 221, 'regulatory'), ('UBERON_0002048', 'lung', 247, 'lung')]
PMC4329404	10/2014	S78-PMC4329404	['caption (fig): figure 2\n\nintroduction of dietary Vitamin D after in utero and early-Life insufficiency CAN reduce Eosinophilic Lung inflammation.']	[('INCOMPLETE_EVIDENCE', 103)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 84, 'life'), ('CL_0000771', 'eosinophil', 114, 'eosinophilic'), ('UBERON_0002048', 'lung', 127, 'lung')]
PMC4329404	10/2014	S105-PMC4329404	['caption (fig): figure 4\n\nintroduction of dietary Vitamin D after in utero and early-Life insufficiency CAN reduce Ige in pups at 6\xa0weeks of age.']	[('INCOMPLETE_EVIDENCE', 103)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 84, 'life'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 114, 'IgE')]
PMC4329404	10/2014	S122-PMC4329404	['the same reduction was still evident when Peri-Bronchiolar collagen was quantified (fig.5c,d), SUGGESTING Vitamin D supplementation MAY PROTECT from the development of Airway Remodelling.']	[('INCOMPLETE_EVIDENCE', 95), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 136)]	3	[('UBERON_0001789', 'outer nuclear layer of retina', 42, 'peri'), ('UBERON_0002186', 'bronchiole', 47, 'bronchiolar'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 168, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 168, 'airway')]
PMC4329404	10/2014	S133-PMC4329404	['discussion\nwe HAVE SHOWN that Adult female Mice given a Vitamin D-deficient diet for 4\xa0weeks (from day-16 Gestation until 3\xa0weeks Postpartum) developed a th2-skewed Pulmonary Immune phenotype, concomitant with reduced Cd4+Il-10+Regulatory Cells.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('UBERON_0007023', 'adult organism', 30, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 43, 'mice'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'gestation'), ('GO_0007565', 'female pregnancy', 130, 'postpartum'), ('UBERON_0002048', 'lung', 165, 'pulmonary'), ('UBERON_0002405', 'immune system', 175, 'immune'), ('PR_000001204', 'C-C chemokine receptor type 8', 218, 'CD4'), ('PR_000001470', 'interleukin-28B', 222, 'IL-10'), ('CL_0000232', 'erythrocyte', 228, 'regulatory cells'), ('GO_0065007', 'biological regulation', 228, 'regulatory')]
PMC4329404	10/2014	S137-PMC4329404	['dietary Vitamin D deficiency in an Adult MODEL of ovalbumin-induced aad DEMONSTRATED worse ahr, Eosinophilia and reduced Il-10 levels (31).']	[('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 72)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0007023', 'adult organism', 35, 'adult'), ('CL_0000771', 'eosinophil', 96, 'eosinophilia'), ('PR_000001470', 'interleukin-28B', 121, 'IL-10')]
PMC4329404	10/2014	S139-PMC4329404	['we HAVE SHOWN EFFECTS on Immune phenotype after ONLY 4\xa0weeks of a Vitamin D-deficient diet in females.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 48)]	3	[('UBERON_0002405', 'immune system', 25, 'immune'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4329404	10/2014	S140-PMC4329404	['ours is the FIRST STUDY TO INVESTIGATE the IMPACT of maternal Vitamin D status on early-Life allergic inflammation.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0000104', 'life cycle', 88, 'life')]
PMC4329404	10/2014	S141-PMC4329404	['a PREVIOUS STUDY has investigated the EFFECT of in utero and early-Life Vitamin D deficiency on aad, BUT Allergen challenge was commenced in Adult Mice, rather than during the Neonatal Period (32).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101)]	3	[('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_50904', 'allergen', 105, 'allergen'), ('UBERON_0007023', 'adult organism', 141, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mice'), ('UBERON_0007221', 'neonate stage', 176, 'neonatal period')]
PMC4329404	10/2014	S143-PMC4329404	['this CONCURRED with OUR FINDINGS SHOWING Allergen exposure in neonatal Mice with in utero and Postnatal Vitamin D deficiency did not affect Lung function.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 33)]	3	[('CHEBI_50904', 'allergen', 41, 'allergen'), ('NCBITaxon_10088', 'Mus <genus>', 71, 'mice'), ('GO_0007567', 'parturition', 94, 'postnatal'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0002048', 'lung', 140, 'lung')]
PMC4329404	10/2014	S145-PMC4329404	['isolated Vitamin D deficiency throughout Gestation HAS BEEN SHOWN to cause deficits in Lung function in 2-week-old Mouse offspring (27).']	[('INCOMPLETE_EVIDENCE', 51)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'gestation'), ('UBERON_0002048', 'lung', 87, 'lung'), ('NCBITaxon_10088', 'Mus <genus>', 115, 'mouse')]
PMC4329404	10/2014	S148-PMC4329404	['it is CONSISTENT with FINDINGS from epidemiological studies which have FAILED TO SHOW reliable EFFECTS of Vitamin D deficiency or insufficiency on Lung function in children with asthma (6–8,11) ALTHOUGH ASSOCIATIONS are REPORTED in Adults (33).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 22), ('DIFFICULT_TASK', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('ANOMALY_CURIOUS_FINDING', 194), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 220)]	10	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0002048', 'lung', 147, 'lung'), ('UBERON_0007023', 'adult organism', 232, 'adults')]
PMC4329404	10/2014	S149-PMC4329404	['overall, GIVEN OUR FINDINGS in a neonatal Mouse MODEL, and PREVIOUS REPORTS of Vitamin D deficiency in utero through Adulthood not resulting in significantly WORSE ahr, it SEEMS LIKELY that in the context of asthma in early Life, Vitamin D deficiency modifies Immunological Responses To Allergen by the induction of an exaggerated th2 skewed response and eosinophilia.']	[('INCOMPLETE_EVIDENCE', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 68), ('IMPORTANT_CONSIDERATION', 158), ('ANOMALY_CURIOUS_FINDING', 172), ('PROBABLE_UNDERSTANDING', 172), ('PROBABLE_UNDERSTANDING', 178)]	10	[('NCBITaxon_10088', 'Mus <genus>', 42, 'mouse'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 117, 'adulthood'), ('UBERON_0000104', 'life cycle', 224, 'life'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 260, 'immunological responses to allergen'), ('CHEBI_50904', 'allergen', 287, 'allergen')]
PMC4329404	10/2014	S150-PMC4329404	['studies in asthmatic children HAVE SHOWN ASSOCIATIONS between low Vitamin D status and increased use of inhaled Steroids (34), SUGGESTING the immunomodulatory EFFECTS of Vitamin D MAY impact on efficacy of Steroids.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 180)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_35341', 'steroid', 112, 'steroids'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_35341', 'steroid', 206, 'steroids')]
PMC4329404	10/2014	S151-PMC4329404	['data from Adult studies SHOW an ASSOCIATION between Vitamin D status and Steroid response (23).']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('UBERON_0007023', 'adult organism', 10, 'adult'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_35341', 'steroid', 73, 'steroid')]
PMC4329404	10/2014	S154-PMC4329404	['an IMPORTANT finding from our data is the partial PROTECTION from disease severity SEEN in pups that were Born to mothers on a Vitamin D-deficient diet, but were weaned onto a Vitamin D-replete diet.']	[('IMPORTANT_CONSIDERATION', 3), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 83)]	3	[('GO_0007567', 'parturition', 106, 'born'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D')]
PMC4329404	10/2014	S157-PMC4329404	['our data SUGGEST Vitamin D is playing a widespread ROLE in Immunomodulation, and further SUGGESTS that supplementation MAY BE beneficial and MAY reduce disease severity.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 141)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0050900', 'leukocyte migration', 59, 'immunomodulation')]
PMC4329404	10/2014	S158-PMC4329404	['an INTERESTING POINT to note is that after introduction of a Vitamin D-replete diet postweaning, Pulmonary Eosinophilic inflammation was EVEN lower than in Mice that were always Vitamin D sufficient (fig.2a).']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 15), ('ANOMALY_CURIOUS_FINDING', 137)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0002048', 'lung', 97, 'pulmonary'), ('CL_0000771', 'eosinophil', 107, 'eosinophilic'), ('NCBITaxon_10088', 'Mus <genus>', 156, 'mice'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC4329404	10/2014	S160-PMC4329404	['the same EFFECT was seen in a PREVIOUS STUDY that has investigated the EFFECTS of Vitamin D supplementation on allergic Airways disease in an ovalbumin MODEL using Adult Mice.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 152)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 120, 'airways'), ('UBERON_0007023', 'adult organism', 164, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 170, 'mice')]
PMC4329404	10/2014	S161-PMC4329404	['that study by agrawal and colleagues HAS SHOWN that the improvement in inflammation is significantly better in Mice that are supplemented with Vitamin D compared TO controls that were vitamin d sufficient (31).']	[('INCOMPLETE_EVIDENCE', 37), ('QUESTION_ANSWERED_BY_THIS_WORK', 162)]	2	[('NCBITaxon_10088', 'Mus <genus>', 111, 'mice'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC4329404	10/2014	S162-PMC4329404	['a mechanism for this FINDING was NOT REPORTED, but IN AGREEMENT with OUR FINDINGS, Vitamin D supplementation in that MODEL also ONLY SHOWED an improvement in allergic inflammation, BUT NOT a complete resolution down to levels in nonallergic Mice, and THUS, the authors conclude Vitamin D supplementation is LIKELY an IMPORTANT adjunct in the treatment of asthma, RATHER than a candidate that will achieve a cure.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('PROBABLE_UNDERSTANDING', 251), ('PROBABLE_UNDERSTANDING', 307), ('IMPORTANT_CONSIDERATION', 317), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 363)]	12	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 241, 'mice'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D')]
PMC4329404	10/2014	S163-PMC4329404	['SIMILAR FINDINGS HAVE not been REPORTED from trials of Vitamin D supplementation in Humans as they ONLY include patients that have deficient or insufficient levels prior to an intervention with Vitamin D or placebo.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 17), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 99)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 84, 'humans'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4329404	10/2014	S165-PMC4329404	['MODELS of Autoimmune disease have either supplemented Vitamin D-sufficient Animals and shown benefit or only compared responses in Vitamin D-deficient Animals, without a sufficient positive control group.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('UBERON_0001442', 'skeleton of manus', 10, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 75, 'animals'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 151, 'animals')]
PMC4329404	10/2014	S167-PMC4329404	['we HAVE SHOWN a reduction in both total Lung collagen and Peri-Bronchiolar collagen in Mice that were exposed to hdm and had Vitamin D supplementation after weaning.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('UBERON_0002048', 'lung', 40, 'lung'), ('UBERON_0001789', 'outer nuclear layer of retina', 58, 'peri'), ('UBERON_0002186', 'bronchiole', 63, 'bronchiolar'), ('NCBITaxon_10088', 'Mus <genus>', 87, 'mice'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4329404	10/2014	S168-PMC4329404	['a reduction in Airway Remodelling HAS BEEN SHOWN in Adult ovalbumin-induced aad with additional Vitamin D therapy (36).']	[('INCOMPLETE_EVIDENCE', 34)]	1	[('GO_0003313', 'heart rudiment development', 15, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 15, 'airway'), ('UBERON_0007023', 'adult organism', 52, 'adult'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4329404	10/2014	S173-PMC4329404	['a pilot STUDY of high-dose Vitamin D supplementation in Adults ( n \xa0=\xa04) HAS SHOWN an increase in circulating Il-10-producing Peripheral Blood Mononuclear Cells (Pbmcs) (37); HOWEVER, these were otherwise healthy subjects and only Circulating Cells were assessed.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0007023', 'adult organism', 56, 'adults'), ('PR_000001470', 'interleukin-28B', 110, 'IL-10'), ('UBERON_0012101', 'perinatal stage', 126, 'peripheral blood'), ('CL_0000226', 'single nucleate cell', 143, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 143, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 162, 'PBMCs'), ('CL_0000080', 'circulating cell', 231, 'circulating cells')]
PMC4329404	10/2014	S178-PMC4329404	['in addition, an Adult Murine MODEL of Vitamin D supplementation in ovalbumin-induced allergic Airways disease DEMONSTRATED an increase in Circulating T Regulatory Cells after Vitamin D supplementation, but levels of Pulmonary Tregs were NOT REPORTED (31).']	[('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 237)]	3	[('UBERON_0007023', 'adult organism', 16, 'adult'), ('NCBITaxon_39107', 'Murinae', 22, 'murine'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 94, 'airways'), ('CL_0000080', 'circulating cell', 138, 'circulating'), ('CL_0000902', 'induced T-regulatory cell', 150, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 152, 'regulatory'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0002048', 'lung', 216, 'pulmonary'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 226, 'Tregs')]
PMC4329404	10/2014	S180-PMC4329404	['it MAY BE that ONLY alterations in circulating T Regulatory Cells are apparent following supplementation with Vitamin D.\nwe have PREVIOUSLY SHOWN that transfer of T Regulatory Cells prevented Development Of Airway Remodelling in an Adult Mouse MODEL of aad (40).']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 244)]	5	[('CL_0000902', 'induced T-regulatory cell', 47, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 49, 'regulatory'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CL_0000902', 'induced T-regulatory cell', 163, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 165, 'regulatory'), ('GO_0032498', 'detection of muramyl dipeptide', 192, 'development of airway remodelling'), ('UBERON_0001005', 'respiratory airway', 207, 'airway'), ('UBERON_0007023', 'adult organism', 232, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 238, 'mouse')]
PMC4329404	10/2014	S181-PMC4329404	['a PROMISING ROLE of Vitamin D supplementation in children with asthma is the POTENTIAL of minimizing the development of a very early feature of Airway Remodelling, increased thickness of the reticular basement membrane (41,42), which would incorporate a NOVEL therapeutic target in asthma.']	[('PROBABLE_UNDERSTANDING', 2), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 77), ('FULL_UNKNOWN', 254)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 144, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 144, 'airway')]
PMC4329404	10/2014	S182-PMC4329404	['IN SUMMARY, we report for the FIRST TIME that in utero and Postnatal Vitamin D deficiency, with concomitant inhaled Allergen exposure in the Neonatal Period, results in increased Airway Eosinophilia and Th2 Cells and reduced Cd4+Il-10+T Regulatory Cells.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30)]	2	[('GO_0007567', 'parturition', 59, 'postnatal'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_50904', 'allergen', 116, 'allergen'), ('UBERON_0007221', 'neonate stage', 141, 'neonatal period'), ('UBERON_0001005', 'respiratory airway', 179, 'airway'), ('CL_0000771', 'eosinophil', 186, 'eosinophilia'), ('CL_0000546', 'T-helper 2 cell', 203, 'Th2 cells'), ('PR_000001204', 'C-C chemokine receptor type 8', 225, 'CD4'), ('PR_000001470', 'interleukin-28B', 229, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 235, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 237, 'regulatory')]
PMC4329404	10/2014	S184-PMC4329404	['our data SUGGEST Vitamin D deficiency in utero and early Life CONTRIBUTES to worse Eosinophilic inflammation and that Vitamin D supplementation after weaning reduces the development of both Pulmonary Eosinophilia and remodelling.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 62)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0000104', 'life cycle', 57, 'life'), ('CL_0000771', 'eosinophil', 83, 'eosinophilic'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0002048', 'lung', 190, 'pulmonary'), ('CL_0000771', 'eosinophil', 200, 'eosinophilia')]
PMC4329404	10/2014	S185-PMC4329404	['THEREFORE, ALTHOUGH it does not SEEM LIKELY that Vitamin D deficiency per se causes asthma in early Life, it is LIKELY that Vitamin D deficiency CONTRIBUTES to increased disease severity in children with asthma and that supplementation MAY reduce severity.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 11), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 112), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 236)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4329745	10/2014	S0-PMC4329745	['risk factors and prevalence of Vitamin D deficiency among iranian women attending two university hospitals\n\nabstract\n\nbackground:\nSEVERAL STUDIES INDICATED that there is a high prevalence of Vitamin D deficiency in middle east countries.']	[('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 146)]	2	[('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4329745	10/2014	S7-PMC4329745	['conclusions:\nTHIS study SHOWED a high prevalence of Vitamin D deficiency among iranian women especially in Reproductive ages.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 24)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0000003', 'reproduction', 107, 'reproductive')]
PMC4329745	10/2014	S9-PMC4329745	['background\nthere is INCREASING EVIDENCE for the CRUCIAL ROLE of Vitamin D in maintaining Human health (1).']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 89, 'human')]
PMC4329745	10/2014	S11-PMC4329745	['SEVERAL STUDIES HAVE SHOWN a high prevalence of Vitamin D deficiency in middle east countries (3); the figures for SUBOPTIMAL levels from several countries in this region were REPORTED between 20% and 80% (4).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 115), ('INCOMPLETE_EVIDENCE', 176)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC4329745	10/2014	S13-PMC4329745	['FEW STUDIES HAVE BEEN performed on Vitamin D status in this country, focused mainly on Pregnant or elderly women (5,6).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 87, 'pregnant')]
PMC4329745	10/2014	S29-PMC4329745	['CONSIDERING a Vitamin D deficiency prevalence of 75% ACCORDING TO PREVIOUS STUDIES and a power of 99%, the sample size was calculated as 517 participants\n\n3.1.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 66)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
PMC4329745	10/2014	S43-PMC4329745	['following the classification used in iranian studies as described in the method, the results would SHOW mild, moderate and severe Vitamin D deficiency in 10.4%, 38.3% and 20.3% (corresponding with 56,206 and 109 women in the three groups) respectively.']	[('INCOMPLETE_EVIDENCE', 99)]	1	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC4329745	10/2014	S66-PMC4329745	['insufficient Vitamin D MAY increase the RISK of Colon, Prostate, Breast and skin cancer as well as diabetes types i, multiple sclerosis and Arterial diseases.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 40)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0001155', 'colon', 48, 'colon'), ('UBERON_0002367', 'prostate gland', 55, 'prostate'), ('UBERON_0000310', 'breast', 65, 'breast'), ('UBERON_0001637', 'artery', 140, 'arterial')]
PMC4329745	10/2014	S69-PMC4329745	['DEMONSTRATED that low early-Pregnancy Vitamin D status was ASSOCIATED with more depressive symptoms in Pregnancy (11).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy')]
PMC4329745	10/2014	S70-PMC4329745	['as well, the RELATIONSHIP between schizophrenia in Adult men and Vitamin D supply during the first year of Life was SHOWN in a study conducted by mcgrath et al.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 116)]	2	[('UBERON_0007023', 'adult organism', 51, 'adult'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0000104', 'life cycle', 107, 'life')]
PMC4329745	10/2014	S74-PMC4329745	['OTHER STUDIES in iran also HAVE SHOWN Vitamin D deficiency in their study groups.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 27)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC4329745	10/2014	S80-PMC4329745	['in ANOTHER STUDY including Postmenopausal women in tehran, the median level of Serum Vitamin D was 54.4 nmol/l, 37% had levels between 25-50 nmol/l and 5% below 25 nmol/l (13).']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('GO_0007595', 'lactation', 27, 'postmenopausal'), ('UBERON_0001977', 'blood serum', 79, 'serum'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4329745	10/2014	S81-PMC4329745	['all these STUDIES SHOW low levels of Vitamin D in their participants, but the levels are SOMEWHAT higher than ours and severe cases are LESS FREQUENT.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 136)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4329745	10/2014	S84-PMC4329745	['the mean Vitamin D level among 321 Premenopausal saudi women was reduced at 27.5 nmol/l in ONE STUDY (14), WHILE a study in the lebanese population DEMONSTRATED that 60% of 465 women aged 20-59 years had Vitamin D levels below 25 nmol/l (15).']	[('INCOMPLETE_EVIDENCE', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('INCOMPLETE_EVIDENCE', 148)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0043277', 'apoptotic cell clearance', 35, 'premenopausal'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC4329745	10/2014	S86-PMC4329745	['(16), our results have DEMONSTRATED higher levels of Vitamin D among menopausal women.']	[('INCOMPLETE_EVIDENCE', 23)]	1	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4329745	10/2014	S87-PMC4329745	['OUR finding of higher Vitamin D levels in younger ages is IN CONTRAST WITH SOME EXISTING FACTS in the LITERATURE (17).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 80)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4329745	10/2014	S94-PMC4329745	['OTHER POSSIBLE causes of reduced Vitamin D Synthesis in the skin in our area COULD BE dark skin color, indoor lifestyle and air pollution (2); lack of dietary fortification with Vitamin D multivitamin supplements MIGHT as well AGGRAVATE the situation in iranian women (18).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 227)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 33, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC4329745	10/2014	S95-PMC4329745	['THIS STUDY was performed on Vitamin D status specially on women .we did have some LIMITATIONS in our work; detailed diet habits of the participants as well as rates of sun exposure were NOT CONSIDERED in the method BECAUSE of practical DIFFICULTIES.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 215), ('DIFFICULT_TASK', 236)]	5	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4329745	10/2014	S96-PMC4329745	['ON THE OTHER HAND, Blood samples were taken REGARDLESS OF season or weather conditions WHEREAS this COULD INFLUENCE the Serum Vitamin D levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0001977', 'blood serum', 120, 'serum'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC4329745	10/2014	S98-PMC4329745	['THIS STUDY SHOWS a very high prevalence of Vitamin D deficiency in a sample of iranian women, especially those in Reproductive ages.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0000003', 'reproduction', 114, 'reproductive')]
PMC5685050	10/2014	S0-PMC5685050	['vitamin D deficiency in thailand☆\nvitamin D deficiency has received INCREASED ATTENTION over the past several years since Vitamin D MAY play an IMPORTANT ROLE not ONLY in bone Metabolism but also in a variety of non-Skeletal diseases such as diabetes mellitus, Autoimmune diseases, infectious diseases, Cardiovascular diseases and cancer1,2,3.']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 132), ('IMPORTANT_CONSIDERATION', 144), ('SUPERFICIAL_RELATIONSHIP', 154), ('INCOMPLETE_EVIDENCE', 163)]	5	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 8, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 42, 'D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0008152', 'metabolic process', 176, 'metabolism'), ('UBERON_0004288', 'skeleton', 216, 'skeletal'), ('UBERON_0001442', 'skeleton of manus', 261, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 303, 'cardiovascular')]
PMC5685050	10/2014	S10-PMC5685050	['HOWEVER, according to the RECENT STUDIES, Vitamin D deficiency is also common in these countries10,11.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 26)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5685050	10/2014	S29-PMC5685050	['[18]showed in a RECENT STUDY in thai children that Vitamin D deficiency was also highly prevalent in school children aged 3–12.9 years.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5685050	10/2014	S49-PMC5685050	['the relatively high prevalence of Vitamin D insufficiency MAY have IMPORTANT health IMPLICATIONS for thai People as the science of Vitamin D continues to be UNRAVELED.']	[('INCOMPLETE_EVIDENCE', 58), ('IMPORTANT_CONSIDERATION', 67), ('IMPORTANT_CONSIDERATION', 84), ('INCOMPLETE_EVIDENCE', 157)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 106, 'people'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC4221707	11/2014	S11-PMC4221707	['AS they also had a low intake (below the nordic nutritional recommendations) of Folate, Vitamin D, and Iron from foods, some of these women and their unborn children are POSSIBLY AT RISK for adverse EFFECTS on the Pregnancy and Birth outcome.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 170), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('CHEBI_30863', '5-azaorotic acid', 80, 'folate'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_24870', 'ion', 103, 'iron'), ('GO_0007565', 'female pregnancy', 214, 'pregnancy'), ('GO_0007567', 'parturition', 228, 'birth')]
PMC4221707	11/2014	S20-PMC4221707	['SIMILAR STUDIES focusing on early Pregnant caucasian women in great britain HAVE SHOWN INADEQUATE intakes of Vitamin C, Folate, Calcium, and iron [8–10].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 76), ('PROBLEM_COMPLICATION', 87)]	3	[('GO_0007565', 'female pregnancy', 34, 'pregnant'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin C'), ('CHEBI_30863', '5-azaorotic acid', 120, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 128, 'calcium')]
PMC4221707	11/2014	S23-PMC4221707	['low Folate levels are also SUGGESTED to be ASSOCIATED with other Birth defects, such as cleft lip and palate, Heart defects, and autism [11,12], and low levels of Vitamin D are ASSOCIATED with various adverse Pregnancy and Birth outcomes [13,14].']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 177)]	3	[('CHEBI_30863', '5-azaorotic acid', 4, 'folate'), ('GO_0007567', 'parturition', 65, 'birth'), ('UBERON_0000948', 'heart', 110, 'heart'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('GO_0007565', 'female pregnancy', 209, 'pregnancy'), ('GO_0007567', 'parturition', 223, 'birth')]
PMC4221707	11/2014	S24-PMC4221707	['THUS, the low intake of Folate, Vitamin D, and iron FOUND in swedish women who are of Childbearing age is of SPECIAL CONCERN, as women do not SEEM to improve the quality of their overall diet during Pregnancy [7,15].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 109), ('PROBLEM_COMPLICATION', 117), ('ANOMALY_CURIOUS_FINDING', 142)]	5	[('CHEBI_30863', '5-azaorotic acid', 24, 'folate'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 86, 'childbearing'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC4221707	11/2014	S134-PMC4221707	['mean daily Intake (amounts/day) of whole grain, Sucrose, total fat, saturated fat, monounsaturated fat, polyunsaturated fat, Iodine, calcium, Vitamin D, Folate, and Vitamin B12 from Foods did not differ between the Pregnant and referent women REGARDLESS OF standardization by the residual method or not, WHEREAS iron Intake from Foods TENDED to be lower in the Pregnant women (table\xa02).']	[('INCOMPLETE_EVIDENCE', 243), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 304), ('SUPERFICIAL_RELATIONSHIP', 335)]	3	[('GO_0007631', 'feeding behavior', 11, 'intake'), ('CHEBI_17992', 'sucrose', 48, 'sucrose'), ('CHEBI_24859', 'iodine atom', 125, 'iodine'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 153, 'folate'), ('CHEBI_33279', 'vitamin D5', 165, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 165, 'vitamin B12'), ('CHEBI_33290', 'food', 182, 'foods'), ('GO_0007565', 'female pregnancy', 215, 'pregnant'), ('GO_0007631', 'feeding behavior', 317, 'intake'), ('CHEBI_33290', 'food', 329, 'foods'), ('GO_0007565', 'female pregnancy', 361, 'pregnant')]
PMC4221707	11/2014	S137-PMC4221707	['addition from Supplements LED TO significantly higher estimated intake of Vitamin D and Folate and borderline significantly higher intake of Calcium and Vitamin B12 in the Pregnant than referent women, WHEREAS ESTIMATED Intake of iron supplement EVENED out the difference in Intakes from Foods only (table\xa02).']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('INCOMPLETE_EVIDENCE', 210), ('ANOMALY_CURIOUS_FINDING', 246)]	4	[('CHEBI_33341', 'titanium atom', 14, 'supplements'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 88, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 141, 'calcium'), ('CHEBI_33279', 'vitamin D5', 153, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 153, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 172, 'pregnant'), ('GO_0007631', 'feeding behavior', 220, 'intake'), ('GO_0007631', 'feeding behavior', 275, 'intakes'), ('CHEBI_33290', 'food', 288, 'foods')]
PMC4221707	11/2014	S177-PMC4221707	['the european nutrition and health report 2009 [37] FOUND that Childbearing-aged women had a low intake of energy, fibre, and Micronutrients (e.g., Folate, iron, and Vitamin D) and a high intake of total and Saturated Fat.']	[('INCOMPLETE_EVIDENCE', 51)]	1	[('GO_0007129', 'homologous chromosome pairing at meiosis', 62, 'childbearing'), ('CHEBI_33839', 'macromolecule', 125, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 147, 'folate'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('CHEBI_26710', 'sodium chloride', 207, 'saturated fat')]
PMC4221707	11/2014	S178-PMC4221707	['IN GENERAL, this 2009 report FOUND that the intake of Folate and Vitamin D from foods was not sufficient to cover the nutritional demands during Pregnancy, and supplements were USUALLY REQUIRED before and during Pregnancy [37,38].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 177), ('IMPORTANT_CONSIDERATION', 185)]	4	[('CHEBI_30863', '5-azaorotic acid', 54, 'folate'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('GO_0007565', 'female pregnancy', 212, 'pregnancy')]
PMC4221707	11/2014	S183-PMC4221707	['AS IN PREVIOUS STUDIES from sweden in women in Childbearing age [7], THIS STUDY FOUND that early Pregnant women had a low intake of Vitamin D and Folate from Foods.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 80)]	4	[('GO_0007129', 'homologous chromosome pairing at meiosis', 47, 'childbearing'), ('GO_0007565', 'female pregnancy', 97, 'pregnant'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 146, 'folate'), ('CHEBI_33290', 'food', 158, 'foods')]
PMC4221707	11/2014	S192-PMC4221707	['inadequate Intake of either Calcium or Vitamin D CAN LEAD TO disturbances in mineralized Tissues of the foetus [13].']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('GO_0007631', 'feeding behavior', 11, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 28, 'calcium'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0000479', 'tissue', 89, 'tissues')]
PMC4258799	11/2014	S296-PMC4258799	['rcts and prospective studies CONCUR that oral supplementation of Vitamin E reduces Lipid Peroxidation damage [102,150], improves Sperm Motility [102,103] and function [101] as well as improve Fertilization [150] and Pregnancy rates [102,103].']	[('INCOMPLETE_EVIDENCE', 29)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin E'), ('CHEBI_18059', 'lipid', 83, 'lipid'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 89, 'peroxidation'), ('CL_0000019', 'sperm', 129, 'sperm'), ('GO_0065007', 'biological regulation', 135, 'motility'), ('GO_0009566', 'fertilization', 192, 'fertilization'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy')]
PMC4258799	11/2014	S297-PMC4258799	['in a SMALL prospective study (n\u2009=\u200915), geva’s group SHOWED that oral Vitamin E (200\xa0mg for 3\xa0months) increased Oocyte Fertilization rate per ivf cycle in fertile, normozoospermic men who initially had low Fertilization rates during a previous ivf attempt.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 52)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin E'), ('CL_0000023', 'oocyte', 111, 'oocyte'), ('GO_0009566', 'fertilization', 118, 'fertilization'), ('GO_0009566', 'fertilization', 205, 'fertilization')]
PMC4258799	11/2014	S299-PMC4258799	['in women with unexplained infertility, oral Vitamin E intake improved the Endometrial response, POSSIBLY DUE TO its antioxidant and anticoagulant EFFECTS as well as by Modulating the anti-Estrogenic EFFECT of Clomiphene Citrate.']	[('INCOMPLETE_EVIDENCE', 96), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin E'), ('UBERON_0001983', 'crypt of Lieberkuhn', 74, 'endometrial'), ('GO_0065007', 'biological regulation', 168, 'modulating'), ('CHEBI_59715', 'sodium squarate', 188, 'estrogenic'), ('CHEBI_3753', 'clomiphene citrate', 209, 'clomiphene citrate')]
PMC4258799	11/2014	S307-PMC4258799	['BASED ON their findings, it SEEMS that a combination of Vitamin E and Selenium had a more significant IMPACT on motility compared to morphology.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 102)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 70, 'selenium')]
PMC4258799	11/2014	S309-PMC4258799	['an initial rct REPORTED that Sperm parameters did not change after co-supplementation with Vitamins E and C [106].']	[('INCOMPLETE_EVIDENCE', 15)]	1	[('CL_0000019', 'sperm', 29, 'sperm'), ('CHEBI_27300', 'vitamin D', 91, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 106, 'C'), ('PR_000004900', 'complement C3', 106, 'C')]
PMC4258799	11/2014	S315-PMC4258799	['HOWEVER, smaller prospective studies SHOWED that oral Vitamin C supplementation in women, EITHER undergoing ivf-et treatment [123] or with Luteal phase defects [124], LEAD TO increased Pregnancy rates.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('SUPERFICIAL_RELATIONSHIP', 167)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin C'), ('GO_0007565', 'female pregnancy', 139, 'luteal'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy')]
PMC4251419	12/2014	S1-PMC4251419	['the active form of Vitamin D has an IMPORTANT ROLE in Calcium Metabolism and in bone mineralisation, BUT the EVIDENCE for OTHER health outcomes is MIXED, with the strongest EFFECTS SEEN in the weakest epidemiological study designs.']	[('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('SUPERFICIAL_RELATIONSHIP', 173), ('INCOMPLETE_EVIDENCE', 181)]	8	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0018884', 'carbazole metabolic process', 54, 'calcium metabolism')]
PMC4251419	12/2014	S2-PMC4251419	['there are PLAUSIBLE pathways whereby Vitamin D deficiency CAN impair Immune function, resulting in both overactivity and increased risk of Autoimmune disease, as well as Immune suppression with poorer resistance to infection.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 58)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0002405', 'immune system', 69, 'immune'), ('UBERON_0001442', 'skeleton of manus', 139, 'autoimmune'), ('UBERON_0002405', 'immune system', 170, 'immune')]
PMC4251419	12/2014	S4-PMC4251419	['exposure of the skin to ultraviolet radiation causes the production of a range of chemicals, including Vitamin D, and NEW RESEARCH is exploring POSSIBLE Vitamin D-independent Immunomodulatory pathways.']	[('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 144)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007566', 'embryo implantation', 175, 'immunomodulatory')]
PMC4251419	12/2014	S6-PMC4251419	['over the last 10-15 years, INCREASED RISK of a WIDE RANGE of health outcomes HAS BEEN LINKED to Vitamin D deficiency, ALTHOUGH in many cases the LINKS REMAIN rather weak.']	[('IMPORTANT_CONSIDERATION', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 86), ('ANOMALY_CURIOUS_FINDING', 118), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 151)]	7	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4251419	12/2014	S7-PMC4251419	['after the UNDISPUTED IMPORTANCE of Vitamin D for bone health, the STRONGEST EVIDENCE is PROBABLY for an increased RISK of Immune disorders in ASSOCIATION with Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 10), ('IMPORTANT_CONSIDERATION', 21), ('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 88), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4251419	12/2014	S9-PMC4251419	['clues from epidemiology\nindications that Vitamin D MAY BE ASSOCIATED with disorders of Human Immune function OFTEN originate from OBSERVATIONS of geographic VARIATION in disease occurrence.']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 109), ('INCOMPLETE_EVIDENCE', 130), ('DIFFICULT_TASK', 157)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 87, 'human'), ('UBERON_0002405', 'immune system', 93, 'immune')]
PMC4251419	12/2014	S15-PMC4251419	['both uvr and Vitamin D (in its active form 1,25(Oh)2D, seefigure 1) have immunomodulatory EFFECTS [8] that provide a PLAUSIBLE mechanism whereby higher levels COULD decrease the risk of Autoimmune diseases (see section on mechanisms, below) and, through the same pathways, COULD impair the Immune Response to vaccination or infection [9,10].']	[('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 273)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_17996', 'chloride', 44, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 45, '25(OH)2D'), ('UBERON_0001442', 'skeleton of manus', 186, 'autoimmune'), ('GO_0006955', 'immune response', 290, 'immune response'), ('UBERON_0002405', 'immune system', 290, 'immune')]
PMC4251419	12/2014	S26-PMC4251419	['lower Vitamin D status HAS BEEN LINKED to increased risk of multiple sclerosis (see case study [14]) and to type 1 diabetes [15], although not all studies SHOW a PROTECTIVE ASSOCIATION [16].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC4251419	12/2014	S27-PMC4251419	['DESPITE these relatively COHERENT FINDINGS from ecologic and OBSERVATIONAL studies, and PLAUSIBLE biological mechanisms, trials of Vitamin D supplementation for the PREVENTION of Immune-related diseases have LARGELY returned null results [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 208)]	8	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0002405', 'immune system', 179, 'immune')]
PMC4251419	12/2014	S30-PMC4251419	['NEVERTHELESS, there is not yet COMPELLING EVIDENCE from these studies that Vitamin D supplementation ameliorates any Immune-related disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0002405', 'immune system', 117, 'immune')]
PMC4251419	12/2014	S32-PMC4251419	['this BELIEF is DRIVEN BY recognition of cellular Expression of the Vitamin D receptor (vdr), the FINDING of multiple primary 1,25(Oh)2D target Genes in Immune Cells and the discovery that many Immune Cells (Macrophages, Dendritic Cells, T and B Lymphocytes) CAN convert 25(Oh)D to 1,25(Oh)2D through Cyp27B1 activity and therefore provide significant local levels of 1,25(Oh)2D for functional outcomes (for review [8,19]).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 258)]	4	[('GO_0010467', 'gene expression', 49, 'expression'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 125, '1,25(OH)2D'), ('SO_0000704', 'gene', 143, 'genes'), ('CL_0000738', 'leukocyte', 152, 'immune cells'), ('UBERON_0002405', 'immune system', 152, 'immune'), ('CL_0000738', 'leukocyte', 193, 'immune cells'), ('UBERON_0002405', 'immune system', 193, 'immune'), ('CL_0000235', 'macrophage', 207, 'macrophages'), ('CL_0000451', 'dendritic cell', 220, 'dendritic cells'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 237, 'T ...'), ('CL_0000236', 'B cell', 243, 'B lymphocytes'), ('CHEBI_71657', 'versiconol acetate', 270, '25(OH)D'), ('CHEBI_82784', 'PVP38-Ag NP', 281, '1,25(OH)2D'), ('PR_000006101', 'cytochrome P450 1A1', 300, 'CYP27B1'), ('CHEBI_82784', 'PVP38-Ag NP', 367, '1,25(OH)2D')]
PMC4251419	12/2014	S33-PMC4251419	['the amount of 1,25(Oh)2D produced MAY depend on the ability of Immune Cells to Express Cyp27B1 and OTHER enzymatic machinery of the Vitamin D pathway, including the Cyp24A1 deactivation enzyme.']	[('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99)]	2	[('CHEBI_37958', 'dye', 14, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 16, '25(OH)2D'), ('CL_0000738', 'leukocyte', 63, 'immune cells'), ('UBERON_0002405', 'immune system', 63, 'immune'), ('GO_0010467', 'gene expression', 79, 'express'), ('PR_000006101', 'cytochrome P450 1A1', 87, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 165, 'CYP24A1')]
PMC4251419	12/2014	S65-PMC4251419	['HOWEVER, the level of Vitamin D binding protein, and its affinity to 25(Oh)D, CAN also restrict the availability of 25(Oh)d to Dendritic Cells and POSSIBLY other cells [35].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 147)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 116, '25(OH)'), ('CL_0000451', 'dendritic cell', 127, 'dendritic cells')]
PMC4251419	12/2014	S68-PMC4251419	['multiple sclerosis: a case study\none of the earliest INDICATIONS of an ASSOCIATION between Vitamin D and disorders of Human Immune function was the geographical variation in prevalence of multiple sclerosis, as first described in 1922 [36].']	[('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 118, 'human'), ('UBERON_0002405', 'immune system', 124, 'immune')]
PMC4251419	12/2014	S71-PMC4251419	['YET, DESPITE PLAUSIBLE immunological pathways whereby Vitamin D (through stimulation of tregsand dampening of T Helper Type 1 over-reactivity) COULD diminish the risk of multiple sclerosis or disease activity, Vitamin D supplementation trials HAVE SHOWN immunological [42] and radiological [43], BUT NOT CLINICAL, benefit for People with multiple sclerosis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 243), ('FULL_UNKNOWN', 296), ('ANOMALY_CURIOUS_FINDING', 300)]	9	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CL_0002061', 'T-helper 9 cell', 110, 'T helper'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 110, 'T helper type 1'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 326, 'people')]
PMC4251419	12/2014	S73-PMC4251419	['LIMITED SUCCESS in Vitamin D supplementation trials SUGGESTS that Vitamin D-INDEPENDENT EFFECTS MAY CONTRIBUTE more strongly to disease RISK.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 88), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 136)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4251419	12/2014	S85-PMC4251419	['in the experimental Autoimmune encephalomyelitis Animal MODEL, Vitamin D supplementation in the Postnatal period delays the onset of the disease [52] but there is NO EVIDENCE that Antenatal Vitamin D supplementation has any EFFECT.']	[('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 224)]	3	[('UBERON_0001442', 'skeleton of manus', 20, 'autoimmune'), ('NCBITaxon_33208', 'Metazoa', 49, 'animal'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'postnatal'), ('GO_0007567', 'parturition', 180, 'antenatal'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC4251419	12/2014	S86-PMC4251419	['ALTHOUGH childhood Vitamin D levels and sun exposure APPEAR TO BE IMPORTANT DETERMINANTS of the risk of disease onset, higher 25(Oh)D levels early in the disease course MAY PREDICT the rate of disease progression in multiple sclerosis [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 53), ('IMPORTANT_CONSIDERATION', 66), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 173)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D')]
PMC4251419	12/2014	S87-PMC4251419	['an indirect pathway: Vitamin D, Immunity and the microbiome\nfollowing interactions with pathogens, Immune Cells like Monocytes can synthesise 1,25(Oh)2D, POSSIBLY through activation of specialised Immune receptors like the toll-like receptors [54], or following stimulation with other Immune-modulators like Tgfβ or interferon-γ [55].']	[('INCOMPLETE_EVIDENCE', 154)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007566', 'embryo implantation', 32, 'immunity'), ('CL_0000738', 'leukocyte', 99, 'immune cells'), ('UBERON_0002405', 'immune system', 99, 'immune'), ('CL_0000576', 'monocyte', 117, 'monocytes'), ('CHEBI_82784', 'PVP38-Ag NP', 142, '1,25(OH)2D'), ('UBERON_0002405', 'immune system', 197, 'immune'), ('UBERON_0002405', 'immune system', 285, 'immune'), ('PR_000000046', 'TGF-beta', 308, 'TGFβ')]
PMC4251419	12/2014	S96-PMC4251419	['in vitro bacterial targets of Vitamin D include m. tuberculosis, pseudomonas aeruginosa and other species [54], and there are REPORTED benefits of Vitamin D for the Control Of Viral or Fungal Infections, especially those of the Lower Respiratory Tract like influenza a [8].']	[('INCOMPLETE_EVIDENCE', 126)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0016049', 'cell growth', 165, 'control of ... fungal infections'), ('NCBITaxon_1', 'root', 176, 'viral'), ('NCBITaxon_10088', 'Mus <genus>', 185, 'fungal'), ('UBERON_0004905', 'articulation', 228, 'lower respiratory tract')]
PMC4251419	12/2014	S98-PMC4251419	['a PROPOSED network of INTERACTIONS between Vitamin D and the microbiome that MAY sway the Development Of Immune Tolerance or Tissue Inflammation\nActivation Of Immune Cells like Monocytes and Epithelial cells by bacterial-derived products (e.g.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0032253', 'dense core granule localization', 90, 'development of ... tolerance ... inflammation'), ('UBERON_0002405', 'immune system', 105, 'immune'), ('UBERON_0000479', 'tissue', 125, 'tissue'), ('GO_0006915', 'apoptotic process', 145, 'Activation of immune cells'), ('CL_0000738', 'leukocyte', 159, 'immune cells'), ('UBERON_0002405', 'immune system', 159, 'immune'), ('CL_0000576', 'monocyte', 177, 'monocytes'), ('CL_0000066', 'epithelial cell', 191, 'epithelial'), ('UBERON_0000483', 'epithelium', 191, 'epithelial')]
PMC4251419	12/2014	S101-PMC4251419	['ALTERNATIVELY, microbiome changes, like those induced following the use of Probiotics, MAY Regulate the responsiveness of Immune Cells to Vitamin D by enhancing the Expression of the Vitamin D receptor (vdr) THUS reducing Tissue inflammation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 87), ('PROBABLE_UNDERSTANDING', 208)]	3	[('CHEBI_26346', 'prostaglandins J', 75, 'probiotics'), ('GO_0065007', 'biological regulation', 91, 'regulate'), ('CL_0000738', 'leukocyte', 122, 'immune cells'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('GO_0007567', 'parturition', 129, 'cells'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0010467', 'gene expression', 165, 'expression'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('UBERON_0000479', 'tissue', 222, 'tissue')]
PMC4251419	12/2014	S105-PMC4251419	['OTHER STUDIES have LINKED Vitamin D with specific changes to the composition of the bacterial flora in the Gut microbiome.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 19)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 107, 'gut')]
PMC4251419	12/2014	S109-PMC4251419	['SIMILAR OBSERVATIONS HAVE BEEN made in Humans, whereby increased dietary Vitamin D changed the composition of Faecal microbiota [69].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21)]	2	[('NCBITaxon_9606', 'Homo sapiens', 39, 'humans'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001988', 'feces', 110, 'faecal')]
PMC4251419	12/2014	S110-PMC4251419	['collectively, these studies SUGGEST that Vitamin D is instrumental in Regulating the microbiome of the Lungs and Gut, and is ENTWINED with the maintenance of Immune tolerance.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 125)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0065007', 'biological regulation', 70, 'regulating'), ('UBERON_0002048', 'lung', 103, 'lungs'), ('UBERON_0001555', 'digestive tract', 113, 'gut'), ('UBERON_0002405', 'immune system', 158, 'immune')]
PMC4251419	12/2014	S111-PMC4251419	['as Murine STUDIES are STARTING TO illustrate in the Gut and Lungs, the interplay between Vitamin D, the microbiome and Immune tolerance MAY also curb skin inflammation.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 136)]	4	[('NCBITaxon_39107', 'Murinae', 3, 'murine'), ('UBERON_0001555', 'digestive tract', 52, 'gut'), ('UBERON_0002048', 'lung', 60, 'lungs'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0002405', 'immune system', 119, 'immune')]
PMC4251419	12/2014	S117-PMC4251419	['other studies SUGGEST that the microbiome MAY modify the capacity of Tissue Regulation by Vitamin D. in Rodent MODELS, Probiotics CAN upregulate Expression of the vdr in the Colon, reducing inflammation and delaying the transition to dysplasia and cancer [75].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 130)]	5	[('UBERON_0000479', 'tissue', 69, 'tissue'), ('GO_0065007', 'biological regulation', 76, 'regulation'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 104, 'rodent'), ('CHEBI_26346', 'prostaglandins J', 119, 'probiotics'), ('GO_0010467', 'gene expression', 145, 'expression'), ('UBERON_0001155', 'colon', 174, 'colon')]
PMC4251419	12/2014	S118-PMC4251419	['furthermore, Vitamin D supplementation MAY suppress the development of Intestinal Tumours in susceptible Mice [76].']	[('INCOMPLETE_EVIDENCE', 39)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0048262', 'determination of dorsal/ventral asymmetry', 71, 'intestinal tumours'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('NCBITaxon_10088', 'Mus <genus>', 105, 'mice')]
PMC4251419	12/2014	S120-PMC4251419	['these data SUGGEST that NOT ONLY can Vitamin D Modulate Tissue inflammation through modifications to the microbiome, BUT the reverse is also POSSIBLE—the microbiome and inflammation can change the responsiveness of Tissues to Vitamin D through Regulation of the vdr.']	[('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 24), ('INCOMPLETE_EVIDENCE', 141)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0065007', 'biological regulation', 47, 'modulate'), ('UBERON_0000479', 'tissue', 56, 'tissue'), ('UBERON_0000479', 'tissue', 215, 'tissues'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0065007', 'biological regulation', 244, 'regulation')]
PMC4251419	12/2014	S123-PMC4251419	["in the face of SUPPORTIVE OBSERVATIONAL and mechanistic EVIDENCE, WHY doesn't Vitamin D supplementation decrease disease RISKS?"]	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 56), ('EXPLICIT_QUESTION', 66), ('IMPORTANT_CONSIDERATION', 121), ('EXPLICIT_QUESTION', 126)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4251419	12/2014	S134-PMC4251419	['Vitamin D supplementation STUDIES take ACCOUNT ONLY of Vitamin D, without the POSSIBLY NECESSARY additional benefits of sun exposure.']	[('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 87)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4251419	12/2014	S137-PMC4251419	['HOWEVER, SEVERAL STUDIES SUGGEST that low Vitamin D status or low levels of ambient uvr during the in utero period [49], or during childhood [40], are ASSOCIATED with increased risk of Immune-related disorders.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002405', 'immune system', 185, 'immune')]
PMC4251419	12/2014	S138-PMC4251419	['the LACK OF any PROTECTIVE EFFECT of Vitamin D supplementation in Adulthood MAY BE BECAUSE the processes necessary for disease have already been put in place much earlier in life.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 83), ('PROBLEM_COMPLICATION', 83)]	6	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 66, 'adulthood')]
PMC4251419	12/2014	S139-PMC4251419	['Genetic variation in the physiological response to Vitamin D supplementation\na high degree of Individual VARIABILITY in the 25(Oh)D response to Vitamin D supplementation has been DESCRIBED that is the result of demographic, environmental and Genetic FACTORS [79].']	[('DIFFICULT_TASK', 105), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 250)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_1', 'root', 94, 'individual'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('SO_0000704', 'gene', 242, 'genetic')]
PMC4251419	12/2014	S141-PMC4251419	['corruption of the Vitamin D system by the disease\nmismanagement of the Vitamin D system MAY arise during SOME pathological processes.']	[('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 105)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4251419	12/2014	S142-PMC4251419	['for example, in leprosy, the mycobacterium leprae MAY hijack the use of cellular Micrornas to block Vitamin D-induced Antimicrobial Production [80].']	[('INCOMPLETE_EVIDENCE', 50)]	1	[('SO_0000276', 'miRNA', 81, 'microRNAs'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_65381', 'albizoside C', 118, 'antimicrobial'), ('GO_0002775', 'antimicrobial peptide production', 118, 'antimicrobial production')]
PMC4251419	12/2014	S145-PMC4251419	['TRADITIONALLY the level of total 25(Oh)D HAS BEEN CONSIDERED the best ESTIMATE of Vitamin D status, BUT RECENT STUDIES have SUGGESTED that the “bioavailable” (albumin-bound and free) 25(Oh)D concentration MAY BE more RELEVANT to health and disease [83].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 217)]	8	[('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 39, 'D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D')]
PMC4251419	12/2014	S149-PMC4251419	['most RECENT Vitamin D supplementation TRIALS use Vitamin D3, SUGGESTING that any DIFFERENCES between d2and d3do NOT ACCOUNT for the DIFFERENT findings from OBSERVATIONAL and Vitamin D supplementation trials.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('ANOMALY_CURIOUS_FINDING', 112), ('IMPORTANT_CONSIDERATION', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('INCOMPLETE_EVIDENCE', 156)]	8	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 49, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 49, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC4251419	12/2014	S155-PMC4251419	['SIMILARLY, in ONE rct of high-dose Vitamin D supplementation there was an INCREASED RISK of falls and fractures [93].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('IMPORTANT_CONSIDERATION', 74)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4251419	12/2014	S158-PMC4251419	['YET Vitamin D supplementation trials are GENERALLY relatively short-term, with supplementation for ONLY 1-2 years.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 99)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC4251419	12/2014	S159-PMC4251419	['this DISCREPANCY in timing MAY CONTRIBUTE to the failure of Vitamin D supplementation trials to decrease the RISK of disease onset.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4251419	12/2014	S161-PMC4251419	['EFFECTS MAY not be direct, but COULD work through alterations in the microbiome, OR be ONLY PARTLY Vitamin D-MEDIATED, with exposure to uvr itself also IMPORTANT.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 109), ('IMPORTANT_CONSIDERATION', 152)]	8	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4256222	12/2014	S0-PMC4256222	['maternal Vitamin D status and offspring bone fractures: prospective study over two decades in aarhus city, denmark\n\nabstract\n\nbackground\nstudies investigating the ASSOCIATION between maternal Vitamin D status and offspring bone mass measured by dual-energy x-ray absorptiometry (dxa) during childhood HAVE SHOWN CONFLICTING results.']	[('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 301), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 312)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC4256222	12/2014	S8-PMC4256222	['multivariable cox regression models using age as the underlying time scale INDICATED no overall association between maternal Vitamin D status and first time bone fractures.']	[('INCOMPLETE_EVIDENCE', 75)]	1	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4256222	12/2014	S10-PMC4256222	['adjustment for Vitamin D status strengthened this ASSOCIATION (1.82, 1.12–2.97), which INDICATED a POTENTIAL seasonal IMPACT on offspring fractures INDEPENDENT of maternal Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 118), ('SUPERFICIAL_RELATIONSHIP', 148)]	5	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC4256222	12/2014	S12-PMC4256222	['conclusion\noverall, our results DID NOT substantiate an association between maternal Vitamin D status and offspring bone fractures.']	[('INCOMPLETE_EVIDENCE', 32)]	1	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4256222	12/2014	S14-PMC4256222	['introduction\nAdult bone mass MAY BE INFLUENCED by FACTORS operating as early as in fetal Life[1], and there has in particular been interest on the ROLE of maternal Vitamin D status in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('UBERON_0007023', 'adult organism', 13, 'Adult'), ('UBERON_0000104', 'life cycle', 89, 'life'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
PMC4256222	12/2014	S16-PMC4256222	['CONSEQUENTLY, offspring of mothers with low status of Vitamin D MAY BE in a deficient state already from the first days of Life.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 64)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0000104', 'life cycle', 123, 'life')]
PMC4256222	12/2014	S17-PMC4256222	['Vitamin D plays a MAJOR ROLE in the REGULATION of calcium homeostasis[3],[4], and studies have FOUND that children Born to women with low Vitamin D status had lower Birth weight, Birth length, and lower bone Mineral content (bmc) at Birth[2].']	[('IMPORTANT_CONSIDERATION', 18), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 95)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007567', 'parturition', 115, 'born'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007567', 'parturition', 165, 'birth'), ('GO_0007567', 'parturition', 179, 'birth'), ('CHEBI_46662', 'mineral', 208, 'mineral'), ('GO_0007567', 'parturition', 233, 'birth')]
PMC4256222	12/2014	S18-PMC4256222	['DIFFERENT LINES of EVIDENCE also SUGGEST that maternal Vitamin D status MAY IMPACT offspring bone health in the short as well as the long term, BUT the studies have shown CONFLICTING results[5]–[9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171)]	8	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4256222	12/2014	S33-PMC4256222	['approximately 20 years later, the Serum samples were analyzed for concentrations of Vitamin D by the liquid chromatography coupled with a tandem mass spectrometric (lc-ms/ms) method (“ms/ms Vitamin D” kit from perkin elmer, waltham ma), which is CONSIDERED to be the most accurate measure of Vitamin D status[14].']	[('INCOMPLETE_EVIDENCE', 246)]	1	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 292, 'vitamin D')]
PMC4256222	12/2014	S34-PMC4256222	['the stability of Vitamin D is CONSIDERED to be relatively high and unaffected by time of storage[15],[16].']	[('INCOMPLETE_EVIDENCE', 30)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC4256222	12/2014	S73-PMC4256222	['no statistical differences in the characteristics were FOUND between women with available measured Vitamin D status and women without measured Vitamin D status, except for season at Blood draw (p\u200a=\u200a0.004).']	[('INCOMPLETE_EVIDENCE', 55)]	1	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000178', 'blood', 182, 'blood')]
PMC4256222	12/2014	S97-PMC4256222	['HOWEVER, in sensitivity analyses we FOUND a borderline significant inverse ASSOCIATION (p\u200a=\u200a0.054) between Vitamin D status in Pregnancy and offspring Forearm fractures.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('UBERON_0002386', 'forelimb zeugopod', 151, 'forearm')]
PMC4256222	12/2014	S102-PMC4256222	['in that study, the authors SUGGESTED their findings to be caused by seasonal variation in Vitamin D status during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 27)]	1	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'pregnancy')]
PMC4256222	12/2014	S103-PMC4256222	['HOWEVER, IF our results are reliable, there MIGHT be OTHER aspects UNDERLYING a seasonal variation during Pregnancy on bone fracture risk later in Life INDEPENDENTLY of Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 152)]	6	[('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4256222	12/2014	S106-PMC4256222	['the PRESENT STUDY is TO OUR KNOWLEDGE the FIRST to INVESTIGATE WHETHER maternal Vitamin D status PREDICTS offspring bone fractures.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('EXPLICIT_QUESTION', 63), ('SUPERFICIAL_RELATIONSHIP', 97)]	7	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4256222	12/2014	S108-PMC4256222	['[5]SHOWED a direct ASSOCIATION between maternal Vitamin D status during Pregnancy and bmc and bmd in 160 offspring at 9 years of age.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 19)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy')]
PMC4256222	12/2014	S113-PMC4256222	['[8]in the same cohort FOUND no RELEVANT association between maternal Vitamin D status in Pregnancy and bmc in 3960 offspring at 9–10 years of age.']	[('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 31)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy')]
PMC4256222	12/2014	S116-PMC4256222	['[9], in the australian raine study FOUND a lower peak bone mass in 341 offspring at 20 years of age, when the maternal Vitamin D status was below 50 nmol/l.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4256222	12/2014	S120-PMC4256222	['one POTENTIAL EXPLANATION for the null ASSOCIATION between maternal Vitamin D status and offspring bone fractures MAY BE the low prevalence of Vitamin D deficiency in our study population.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 14), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 114)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC4256222	12/2014	S121-PMC4256222	['IF a TRUE UNDERLYING beneficial EFFECT of maternal Vitamin D status on offspring bone health exists and is LIMITED to very low levels, we MAY not be able to detect such a RELATIONSHIP in our data, where ONLY 6.3% of the study population had a Vitamin D status below 25 nmol/l and 25.5% had a status below 50 nmol/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 5), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 203), ('INCOMPLETE_EVIDENCE', 203)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4256222	12/2014	S124-PMC4256222	['CONSISTENT with temporal TRENDS, there were also fewer Vitamin D deficient mothers in our study sample COMPARED TO two later danish studies, which measured Vitamin D in pregnant women[32]and in a general population sample[33]approximately 10 years later.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC4256222	12/2014	S126-PMC4256222	['we FOUND a borderline significant inverse ASSOCIATION between Vitamin D status in Pregnancy and offspring Forearm fractures.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('UBERON_0002386', 'forelimb zeugopod', 106, 'forearm')]
PMC4256222	12/2014	S133-PMC4256222	['until 1995, we ONLY have access to diagnoses recorded during hospitalization, which MAY EXPLAIN WHY maternal Vitamin D status in our data is unassociated with offspring bone fractures.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 84), ('PROBABLE_UNDERSTANDING', 88), ('EXPLICIT_QUESTION', 96)]	4	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC4256222	12/2014	S135-PMC4256222	['weight and height MAY BE RELATED both to maternal Vitamin D status and offspring bone mass, and our results MAY BE CONFOUNDED when those data are missing.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 108), ('DIFFICULT_TASK', 115)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4256222	12/2014	S137-PMC4256222	['furthermore, OBSERVATIONS HAVE SHOWN that infant Vitamin D deficiency CAN be eliminated as early as 9 months Postpartum, IF Vitamin D drops with 10 µg of Vitamin D per day are given as RECOMMENDED[34].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('FUTURE_WORK', 185)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'postpartum'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC4256222	12/2014	S140-PMC4256222	['in this context, a POTENTIAL negative IMPACT of maternal Vitamin D deficiency MAY have been BLURRED in our data, SINCE data are lacking on POTENTIALLY IMPORTANT CONFOUNDERS.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 113), ('PROBLEM_COMPLICATION', 113), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 151), ('PROBLEM_COMPLICATION', 161)]	9	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4256222	12/2014	S141-PMC4256222	['ON THE OTHER HAND, in the RECENT alspac STUDY[8]it WAS SHOWN that offspring level of physical activity and dietary Vitamin D intake were not associated with maternal Vitamin D status[10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 51)]	4	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC4256222	12/2014	S142-PMC4256222	['IF this also is the case in the dafo88 cohort, physical activity level and childhood Vitamin D intake COULD did NOT act as CONFOUNDERS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 102), ('ANOMALY_CURIOUS_FINDING', 112), ('PROBLEM_COMPLICATION', 123)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4256222	12/2014	S144-PMC4256222	['in conclusion, our data INDICATED no overall association between maternal Vitamin D status during Pregnancy and offspring bone fractures in a prospective cohort with 18 years of follow-up through high-quality registries.']	[('INCOMPLETE_EVIDENCE', 24)]	1	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy')]
PMC4263713	12/2014	S1-PMC4263713	['our PREVIOUS STUDY DEMONSTRATED that Gestational or early-Life Vitamin A deficiency decreases the number of Immune Cells in offspring.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 19)]	2	[('GO_0007565', 'female pregnancy', 37, 'gestational'), ('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin A'), ('CL_0000738', 'leukocyte', 108, 'immune cells'), ('UBERON_0002405', 'immune system', 108, 'immune')]
PMC4263713	12/2014	S2-PMC4263713	['the PRESENT STUDY AIMS TO TEST WHETHER Vitamin A supplementation CAN restore Lymphocyte pools in Vitamin A-deficient Rats and thereby improve the function of their Intestinal Mucosa; furthermore, the study AIMED TO IDENTIFY the BEST time frame for Vitamin A supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('INCOMPLETE_EVIDENCE', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 206), ('QUESTION_ANSWERED_BY_THIS_WORK', 212), ('IMPORTANT_CONSIDERATION', 228)]	8	[('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('CL_0000542', 'lymphocyte', 77, 'lymphocyte'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 117, 'rats'), ('UBERON_0001242', 'intestinal mucosa', 164, 'intestinal mucosa'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin A')]
PMC4263713	12/2014	S6-PMC4263713	["the Rats in this group had higher numbers of Cd8+Intestinal Intraepithelial Lymphocytes, Cd11C+Dendritic Cells in the Peyer'S Patches and Cd4+Cd25+T Cells in the Spleen compared with the Vitamin A-deficient Rats; flow cytometric analysis also DEMONSTRATED that Vitamin A supplementation decreased the number of B Cells in the Mesenteric Lymph Nodes."]	[('INCOMPLETE_EVIDENCE', 243)]	1	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 4, 'rats'), ('PR_000005170', 'CD37 molecule', 45, 'CD8'), ('CL_0002063', 'type II pneumocyte', 49, 'intestinal intraepithelial lymphocytes'), ('UBERON_0000160', 'intestine', 49, 'intestinal'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 60, 'intraepithelial'), ('PR_000001309', 'CD70 molecule', 89, 'CD11C'), ('CL_0000451', 'dendritic cell', 95, 'dendritic cells'), ('UBERON_0001330', 'pampiniform plexus', 118, "Peyer's patches"), ('PR_000001204', 'C-C chemokine receptor type 8', 138, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 142, 'CD25'), ('CL_0000084', 'T cell', 147, 'T cells'), ('UBERON_0002106', 'spleen', 162, 'spleen'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin A'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 207, 'rats'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin A'), ('CL_0000236', 'B cell', 311, 'B cells'), ('UBERON_0002509', 'mesenteric lymph node', 326, 'mesenteric lymph nodes')]
PMC4263713	12/2014	S10-PMC4263713	['introduction\nMANY STUDIES have REPORTED that Vitamin A (Va) acts as an anti-infection agent to reduce mortality[1]and morbidity in infants with diarrhea[2].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 31)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin A'), ('CHEBI_37958', 'dye', 56, 'VA')]
PMC4289552	12/2014	S141-PMC4289552	['Vitamin D is ESSENTIAL for calcium homeostatis and now recognized as an IMPORTANT Nutrient for bone health including modest SUPPORT for maternal Vitamin D status and increased offspring bone mass among [50].']	[('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 124)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_33284', 'nutrient', 82, 'nutrient'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC4514967	12/2014	S34-PMC4514967	['for example, subclinical Vitamin A deficiency is PREVALENT, AFFECTING an ESTIMATED one-third of children and 15% of Pregnant women,19and increases the risk of death from diarrhea (and measles).']	[('IMPORTANT_CONSIDERATION', 49), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 73)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('GO_0007565', 'female pregnancy', 116, 'pregnant')]
PMC4514967	12/2014	S68-PMC4514967	['the predominant EFFECTS of Vitamin A on the Immune System are THOUGHT TO be mediated by Retinoic Acid (ra).']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 62)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin A'), ('UBERON_0002405', 'immune system', 44, 'immune system'), ('CHEBI_26536', 'retinoic acid', 88, 'retinoic acid')]
PMC4514967	12/2014	S87-PMC4514967	['low Cord Blood Vitamin D levels are a PREDICTOR of subsequent infant Respiratory infections.70,71HOWEVER, data from clinical trials are too LIMITED to draw conclusions about the efficacy and SAFETY of Vitamin D supplementation in Pregnancy.72meta-analyses have HIGHLIGHTED THE NEED to extend endpoints in intervention trials of multiple Micronutrients in Pregnancy.30the timing of Nutrient interventions during Pregnancy or before Conception is an IMPORTANT clinical study parameter to CONSIDER in any meta-analysis designed to evaluate the EFFECTS of an intervention or interventions and the OBSERVED effect size.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 273), ('FUTURE_WORK', 277), ('IMPORTANT_CONSIDERATION', 448), ('FUTURE_WORK', 486), ('SUPERFICIAL_RELATIONSHIP', 541), ('INCOMPLETE_EVIDENCE', 593)]	11	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 69, 'respiratory'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0007565', 'female pregnancy', 230, 'pregnancy'), ('CHEBI_33839', 'macromolecule', 337, 'micronutrients'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('CHEBI_33284', 'nutrient', 381, 'nutrient'), ('GO_0007565', 'female pregnancy', 411, 'pregnancy'), ('GO_0007620', 'copulation', 431, 'conception')]
PMC4289064	1/2015	S26-PMC4289064	['we FOCUSED our analyses on children and women in developing countries, where high rates of malnutrition and limited access to Nutrient Supplements MAY make Individuals more susceptible to the EFFECTS of pollinator declines, and analyzed five of the most IMPORTANT Nutrients to global nutrition: Vitamin A, zinc, iron, Folate, and Calcium[14],[15](data on Iodine, another globally IMPORTANT Nutrient, were not available in the datasets we analyzed).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 192), ('IMPORTANT_CONSIDERATION', 254), ('IMPORTANT_CONSIDERATION', 380)]	5	[('CHEBI_33284', 'nutrient', 126, 'nutrient'), ('CHEBI_33341', 'titanium atom', 135, 'supplements'), ('NCBITaxon_1', 'root', 156, 'individuals'), ('CHEBI_33284', 'nutrient', 264, 'nutrients'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 318, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 330, 'calcium'), ('CHEBI_24859', 'iodine atom', 355, 'iodine'), ('CHEBI_33284', 'nutrient', 390, 'nutrient')]
PMC4289064	1/2015	S63-PMC4289064	['for Vitamin A, zinc, Folate, and Calcium, imapp uses the estimated average requirement (ear) (i.e., the daily intake of a specific Nutrient ESTIMATED to meet the needs of 50% of healthy People in a age- and gender-specific groups) cut-point method[27].']	[('INCOMPLETE_EVIDENCE', 140)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 21, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 33, 'calcium'), ('CHEBI_33284', 'nutrient', 131, 'nutrient'), ('NCBITaxon_10088', 'Mus <genus>', 186, 'people')]
PMC4289064	1/2015	S88-PMC4289064	['we also TESTED the INFLUENCE of uncertainty in the CONTRIBUTION of pollinators to crop yields on our results for Vitamin A Intake in children and FOUND that WHILE the specific values for the proportion of the population at risk of Nutrient deficiency changed slightly if we used the minimum, midpoint, or maximum percent yield due to pollinators of the categories defined by klein et al.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157)]	5	[('CHEBI_27300', 'vitamin D', 113, 'vitamin A'), ('GO_0007631', 'feeding behavior', 123, 'intake'), ('CHEBI_33284', 'nutrient', 231, 'nutrient')]
PMC4289064	1/2015	S103-PMC4289064	['for Vitamin A, Calcium, Folate, and zinc, imapp ESTIMATES the proportion of the population below the ear with standard error.']	[('INCOMPLETE_EVIDENCE', 48)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin A'), ('CHEBI_22313', 'alkaline earth metal atom', 15, 'calcium'), ('CHEBI_30863', '5-azaorotic acid', 24, 'folate')]
PMC4289064	1/2015	S133-PMC4289064	['“other” refers to oils, flavorings, drinks, candy, honey, and other items that do not fit into other Food groups.10.1371/journal.pone.0114805.t001\n\ncaption (table-wrap): table 1\naverage proportion of total Nutrient Intake by percent yield due to pollinators and country for children 1 to 3 years old.% yield due to pollinatorsenergyvitamin acalciumfolateironzinc bangladesh 00.740.380.550.480.620.6850.050.190.080.140.080.07250.080.100.130.170.110.10650.040.090.090.120.070.04950.080.250.160.100.120.12total1.001.001.001.001.001.00 mozambique 00.570.290.540.300.370.4950.140.130.190.290.200.16250.130.020.160.240.250.19650.140.270.080.150.120.13950.020.300.040.020.050.03total1.001.001.001.001.001.00 uganda 00.680.490.530.400.520.5550.140.090.140.300.130.16250.100.090.240.140.210.17650.040.020.010.080.020.05950.040.320.070.080.120.07total1.001.001.001.001.001.00 zambia 00.480.380.410.300.510.5150.170.110.170.350.210.24250.060.020.140.100.080.10650.120.210.130.180.070.03950.070.270.110.050.110.101000.090.000.040.020.030.02total1.001.001.001.001.001.00\nBASED ON these results, we HYPOTHESIZED that pollinators would be most IMPORTANT for nutritional health ASSOCIATED with Vitamin A, BUT less IMPORTANT for nutritional health ASSOCIATED with all other Nutrients.']	[('PROBABLE_UNDERSTANDING', 1058), ('INCOMPLETE_EVIDENCE', 1085), ('IMPORTANT_CONSIDERATION', 1129), ('SUPERFICIAL_RELATIONSHIP', 1162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1189), ('IMPORTANT_CONSIDERATION', 1198), ('SUPERFICIAL_RELATIONSHIP', 1231)]	7	[('CHEBI_33290', 'food', 101, 'food'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('GO_0007631', 'feeding behavior', 215, 'intake'), ('CHEBI_27300', 'vitamin D', 1178, 'vitamin A'), ('CHEBI_33284', 'nutrient', 1257, 'nutrients')]
PMC4289064	1/2015	S141-PMC4289064	['these results SUPPORTED our HYPOTHESIS that the risk of Vitamin A deficiency is more sensitive to pollinator removal than that of OTHER Nutrients.10.1371/journal.pone.0114805.g005\n\ncaption (fig): figure 5\ncumulative distributions of Vitamin A Intakes for the full Pollination scenario (blue) and Pollinator removal scenario (pink) for children 1 to 3 years old.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 130)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin A'), ('CHEBI_33284', 'nutrient', 136, 'nutrients'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin A'), ('GO_0007631', 'feeding behavior', 243, 'intakes'), ('GO_0009856', 'pollination', 264, 'pollination'), ('GO_0051008', 'Hsp27 protein binding', 296, 'pollinator')]
PMC4289064	1/2015	S143-PMC4289064	['vertical dotted lines indicate the ESTIMATED average requirement (ear) for Vitamin A intake in this age group (210 µg rae).']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 75, 'vitamin A')]
PMC4289064	1/2015	S154-PMC4289064	['WHILE the risk of Nutrient deficiency did not change substantially for most Nutrients when pollinators were removed, the increased risk we ESTIMATED for Vitamin A carries concerning PUBLIC HEALTH IMPLICATIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 196)]	5	[('CHEBI_33284', 'nutrient', 18, 'nutrient'), ('CHEBI_33284', 'nutrient', 76, 'nutrients'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin A')]
PMC4289064	1/2015	S155-PMC4289064	['each year, Vitamin A deficiency causes an ESTIMATED 800,000 deaths in women and children, including 20–24% of child mortality from measles, diarrhea and malaria and 20% of all-cause maternal mortality.']	[('INCOMPLETE_EVIDENCE', 42)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin A')]
PMC4289064	1/2015	S157-PMC4289064	['the pattern of results for Vitamin A also INDICATES that nutritional vulnerability to pollinator decline DEPENDS not ONLY on the specific sources of Nutrients in the diet and their pollinator DEPENDENCE, but also on the total amount of Nutrients being consumed.']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 117), ('SUPERFICIAL_RELATIONSHIP', 192)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin A'), ('CHEBI_33284', 'nutrient', 149, 'nutrients'), ('CHEBI_33284', 'nutrient', 236, 'nutrients')]
PMC4289064	1/2015	S165-PMC4289064	['the wide DIFFERENCES we find among populations for Vitamin A (table 2) SUGGEST that global data on crop and Nutrient Production (e.g.,[10]) are INSUFFICIENT for predicting the EFFECTS of pollinator declines on Human health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 71), ('PROBLEM_COMPLICATION', 144), ('SUPERFICIAL_RELATIONSHIP', 176)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('CHEBI_33284', 'nutrient', 108, 'nutrient'), ('GO_0007128', 'meiotic prophase I', 117, 'production'), ('NCBITaxon_9606', 'Homo sapiens', 210, 'human')]
PMC4289064	1/2015	S178-PMC4289064	['we tested the EFFECTS of this uncertainty[8]on a subset of our results for Vitamin A and FOUND no qualitative change in our results.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 89)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin A')]
PMC4302429	1/2015	S8-PMC4302429	['conclusion\nour OBSERVATIONS SUGGEST a DETRIMENTAL ROLE of Vitamin D deficiency in bacterial Central Nervous System infections.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 38), ('SUPERFICIAL_RELATIONSHIP', 50)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 92, 'central nervous system')]
PMC4302429	1/2015	S25-PMC4302429	['Vitamin D HAS long BEEN KNOWN to play a ROLE in building the Skeletal System and in Calcium Homeostasis; Vitamin D deficiency is KNOWN to be a cause of rickets and osteomalacia and aggravates osteoporosis [12].']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 129)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001434', 'skeletal system', 61, 'skeletal system'), ('GO_0055073', 'cadmium ion homeostasis', 84, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4302429	1/2015	S27-PMC4302429	['cells of the Immune System possess Vitamin D receptors and are capable of Metabolizing the active form of Vitamin D (1,25(Oh)2D3) [15], SUGGESTING Vitamin D as an IMPORTANT FACTOR in the Immune Response to Infection [16].']	[('INCOMPLETE_EVIDENCE', 136), ('IMPORTANT_CONSIDERATION', 163), ('SUPERFICIAL_RELATIONSHIP', 173)]	3	[('UBERON_0002405', 'immune system', 13, 'immune system'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0008152', 'metabolic process', 74, 'metabolizing'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 117, '1,25(OH)2D3'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0006955', 'immune response', 187, 'immune response'), ('UBERON_0002405', 'immune system', 187, 'immune'), ('GO_0007586', 'digestion', 206, 'infection')]
PMC4302429	1/2015	S28-PMC4302429	['studies of the Innate Immune Response to pathogens such as mycobacterium tuberculosis HAVE SHOWN that pathogen-recognition receptor (prr)-mediated activation of localized Vitamin D Metabolism and signaling is a key event ASSOCIATED with resistance to infection [17].']	[('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 221)]	2	[('GO_0045087', 'innate immune response', 15, 'innate immune response'), ('UBERON_0002405', 'immune system', 22, 'immune'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 171, 'vitamin D metabolism')]
PMC4302429	1/2015	S29-PMC4302429	['epidemiological studies have ESTABLISHED that Vitamin D deficiency plays an IMPORTANT ROLE in susceptibility to tuberculosis [18].']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 76), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4302429	1/2015	S85-PMC4302429	['results\n\nVitamin D3 Serum concentrations DEPENDED on dietary Vitamin D3 content\nthe analysis of the Vitamin D3 Metabolite 25-Oh-D3 in Serum samples obtained after six weeks of experimental diet REVEALED that the Vitamin D3 content in the diet determined the Vitamin D Serum concentrations of the Mice.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 194)]	2	[('CHEBI_33237', 'vitamin D4', 9, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 9, 'Vitamin D3'), ('UBERON_0001977', 'blood serum', 20, 'serum'), ('CHEBI_33279', 'vitamin D5', 61, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 61, 'vitamin D3'), ('CHEBI_33279', 'vitamin D5', 100, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 100, 'vitamin D3'), ('CHEBI_39382', 'flufenoxuron', 111, 'metabolite'), ('CHEBI_86945', 'syringaldehyde acetate', 122, '25-OH-D3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 122, '25-OH-D3'), ('UBERON_0001977', 'blood serum', 134, 'serum'), ('CHEBI_33279', 'vitamin D5', 212, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 212, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('UBERON_0001977', 'blood serum', 268, 'serum'), ('NCBITaxon_10088', 'Mus <genus>', 296, 'mice')]
PMC4302429	1/2015	S101-PMC4302429	['Vitamin D3 administration did not influence bacterial titers in Cns and Spleen at the end stage of the disease or 20\xa0hours after inoculation with E. Coli\nin 1986, rook and colleagues [17] FOUND in cultured Human Monocytes that active Vitamin D [1,25(Oh)2D3], CAN inhibit the growth of mycobacterium tuberculosis .']	[('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 259)]	2	[('CHEBI_33237', 'vitamin D4', 0, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3'), ('UBERON_0001017', 'central nervous system', 64, 'CNS'), ('UBERON_0002106', 'spleen', 72, 'spleen'), ('NCBITaxon_10088', 'Mus <genus>', 146, 'E. coli'), ('NCBITaxon_9606', 'Homo sapiens', 206, 'human'), ('CL_0000576', 'monocyte', 212, 'monocytes'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('CHEBI_17996', 'chloride', 246, ','), ('CHEBI_73394', 'Ala-Ser', 247, '25(OH)2D3')]
PMC4302429	1/2015	S125-PMC4302429	['high Vitamin D3 concentrations inhibited the Production of proinflammatory cytokine Il-6 and increased production of anti-inflammatory cytokine Il-10, WHILE Ifn-Γ production in the Cns stayed unaffected\nPREVIOUS investigations REVEALED that Vitamin D plays IMPORTANT ROLES in signaling in both the Adaptive and Innate Immune Response To Viral and bacterial Infection [16,25].']	[('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 227), ('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267)]	5	[('CHEBI_33279', 'vitamin D5', 5, 'vitamin D3'), ('GO_0007128', 'meiotic prophase I', 45, 'production'), ('PR_000001470', 'interleukin-28B', 84, 'IL-6'), ('PR_000001470', 'interleukin-28B', 144, 'IL-10'), ('PR_000008920', 'interferon alpha-7', 157, 'IFN-γ'), ('UBERON_0001017', 'central nervous system', 181, 'CNS'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0051886', 'negative regulation of timing of anagen', 298, 'adaptive ...'), ('GO_0045048', 'protein insertion into ER membrane', 311, 'innate immune response to ... infection'), ('UBERON_0002405', 'immune system', 318, 'immune'), ('NCBITaxon_1', 'root', 337, 'viral')]
PMC4302429	1/2015	S161-PMC4302429	['clinical and experimental observations SUPPORT the HYPOTHESIS that Vitamin D has an EFFECT on the Immune Response to infection and the ability to eliminate pathogens after entry Into the host.']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 84)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0006955', 'immune response', 98, 'immune response'), ('UBERON_0002405', 'immune system', 98, 'immune'), ('GO_0007631', 'feeding behavior', 178, 'into')]
PMC4302429	1/2015	S166-PMC4302429	['TO ASSESS the ROLE of Vitamin D in an in-vivo experimental MODEL of bacterial Cns infection, we analyzed the INFLUENCE of the infection on the survival and Immune Response of Mice Fed a diet containing different amounts of Vitamin D3 after injection of E. Coli directly into the right Frontal Lobe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 78, 'CNS'), ('GO_0006955', 'immune response', 156, 'immune response'), ('UBERON_0002405', 'immune system', 156, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 175, 'mice'), ('GO_0007631', 'feeding behavior', 180, 'fed'), ('CHEBI_33279', 'vitamin D5', 223, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 223, 'vitamin D3'), ('NCBITaxon_10088', 'Mus <genus>', 253, 'E. coli'), ('UBERON_0016525', 'frontal lobe', 285, 'frontal lobe')]
PMC4302429	1/2015	S168-PMC4302429	['the IMPORTANCE of Vitamin D for the resistance to infections HAS long BEEN appreciated but POORLY UNDERSTOOD.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 61), ('FULL_UNKNOWN', 91), ('PROBABLE_UNDERSTANDING', 98)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC4302429	1/2015	S172-PMC4302429	['a randomized double-blind intervention study SHOWED that supplementation with Vitamin D MAY reduce disease BURDEN in patients with frequent Respiratory Tract infections [33].']	[('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 88), ('IMPORTANT_CONSIDERATION', 107)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 140, 'respiratory tract')]
PMC4302429	1/2015	S173-PMC4302429	['in-vivo studies in Mice and Rats also SHOWED beneficial EFFECTS of Vitamin D in Lipopolysaccharide-induced sepsis [20,39], and antenatal Vitamin D therapy improved survival in newborn Rat pups and enhanced their Lung structure after exposure to endotoxin [40].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('NCBITaxon_10088', 'Mus <genus>', 19, 'mice'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 28, 'rats'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 80, 'lipopolysaccharide'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 184, 'rat'), ('UBERON_0002048', 'lung', 212, 'lung')]
PMC4302429	1/2015	S175-PMC4302429	['we THEREFORE ASKED WHETHER Vitamin D MIGHT Modulate the course of and survival from infection after bacterial meningoencephalitis and WHETHER Vitamin D COULD POTENTIALLY be used therapeutically to alleviate Cns pathology.']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('EXPLICIT_QUESTION', 134), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 158)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 43, 'modulate'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 207, 'CNS')]
PMC4302429	1/2015	S179-PMC4302429	['in an EARLY STUDY, rook and colleagues [17] DEMONSTRATED that active Vitamin D, (1,25(Oh)2D), CAN inhibit the growth of mycobacterium tuberculosis in vitro .']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 94)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_37958', 'dye', 81, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 83, '25(OH)2D')]
PMC4302429	1/2015	S185-PMC4302429	['one REASON for the mild Antimicrobial properties of Vitamin D3 in the present in-vivo MODEL MIGHT be that, UNLIKE the Human Cathelicidin Gene, the Mouse Gene does not contain a Vitamin D response element, and is not induced directly by 1,25(Oh)2D [16].']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107)]	4	[('CHEBI_65381', 'albizoside C', 24, 'antimicrobial'), ('CHEBI_33279', 'vitamin D5', 52, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 52, 'vitamin D3'), ('NCBITaxon_9606', 'Homo sapiens', 118, 'human'), ('PR_000006009', 'alpha-catulin', 124, 'cathelicidin'), ('SO_0000704', 'gene', 137, 'gene'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mouse'), ('SO_0000704', 'gene', 153, 'gene'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_37958', 'dye', 236, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 238, '25(OH)2D')]
PMC4302429	1/2015	S186-PMC4302429	['PRESUMABLY, in addition to Cathelicidin, OTHER Immune Mediators are INVOLVED in the Vitamin D-dependent Immune pathways.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('CHEBI_3364', 'Canthiumine', 27, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 27, 'cathelicidin'), ('UBERON_0002405', 'immune system', 47, 'immune'), ('CHEBI_35222', 'inhibitor', 54, 'mediators'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0002405', 'immune system', 104, 'immune')]
PMC4302429	1/2015	S190-PMC4302429	['a study on the Immune Response to an allergic stimulus in Mice in vivo SUGGESTED that Vitamin D supplementation (100\xa0ng 1,25(Oh)2D injection) given after the initial period of sensitization prevented high levels of Eosinophils ASSOCIATED with a reduced local inflammatory response in Bronchoalveolar Lavage Fluid and Lung Tissue.']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 227)]	2	[('GO_0006955', 'immune response', 15, 'immune response'), ('UBERON_0002405', 'immune system', 15, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 58, 'mice'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 120, '1,25(OH)2D'), ('CL_0000771', 'eosinophil', 215, 'eosinophils'), ('UBERON_0004212', 'glomerular capillary', 284, 'bronchoalveolar lavage fluid'), ('UBERON_0002048', 'lung', 317, 'lung tissue')]
PMC4302429	1/2015	S191-PMC4302429	['constant Vitamin D supplementation (100\xa0ng 1,25(Oh)2D injection every other day during the whole study period), HOWEVER, did not reduce the Entry Of Eosinophils Into the Respiratory Epithelia [45]; this is IN ACCORDANCE WITH our observation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 206)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 43, '1,25(OH)2D'), ('GO_0051639', 'actin filament network formation', 140, 'entry of eosinophils into ...'), ('CL_0000771', 'eosinophil', 149, 'eosinophils'), ('GO_0006314', 'intron homing', 170, 'respiratory epithelia'), ('UBERON_0004802', 'respiratory tract epithelium', 170, 'respiratory epithelia')]
PMC4302429	1/2015	S192-PMC4302429	['one mechanism of HOW Vitamin D3 MIGHT act beneficially in infections, COULD BE an increase in pathogen Phagocytosis with adequate levels of Vitamin D [21] and the ability of Calcitriol to maintain Antimicrobial peptide Gene Expression [13,14].']	[('EXPLICIT_QUESTION', 17), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 70)]	3	[('CHEBI_33279', 'vitamin D5', 21, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 21, 'vitamin D3'), ('GO_0006909', 'phagocytosis', 103, 'phagocytosis'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 174, 'calcitriol'), ('CHEBI_65381', 'albizoside C', 197, 'antimicrobial'), ('GO_0010467', 'gene expression', 219, 'gene expression'), ('SO_0000704', 'gene', 219, 'gene')]
PMC4302429	1/2015	S193-PMC4302429	['OTHER mechanisms COULD BE the Regulation of Anti- and proinflammatory Compounds by Vitamin D. for this PURPOSE, we INVESTIGATED the pattern of cytokine and Chemokine Production, a central feature in the development of Neuroinflammation, neurodegeneration, and demyelination in the Cns [46,47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 115)]	5	[('GO_0065007', 'biological regulation', 30, 'regulation'), ('CHEBI_67437', 'Euparin', 44, 'anti-'), ('CHEBI_36357', 'polyatomic entity', 70, 'compounds'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0032602', 'chemokine production', 156, 'chemokine production'), ('GO_0007009', 'plasma membrane organization', 218, 'neuroinflammation'), ('UBERON_0001017', 'central nervous system', 281, 'CNS')]
PMC4302429	1/2015	S200-PMC4302429	['this is IN ACCORDANCE with PREVIOUSLY published data that Vitamin D CAN increase Il-10 Production [16,53].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 68)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0032613', 'interleukin-10 production', 81, 'IL-10 production'), ('PR_000001470', 'interleukin-28B', 81, 'IL-10')]
PMC4302429	1/2015	S205-PMC4302429	['in early infection (20\xa0h), low, BUT approximately equal Ifn-Γ levels were measured, SUGGESTING that Ifn-Γ was not INVOLVED in the protective action of an adequate Vitamin D supply.']	[('ANOMALY_CURIOUS_FINDING', 32), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 114)]	3	[('PR_000008920', 'interferon alpha-7', 56, 'IFN-γ'), ('PR_000008920', 'interferon alpha-7', 100, 'IFN-γ'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4302429	1/2015	S206-PMC4302429	['conclusions\nour experiments IDENTIFIED for the FIRST TIME a DETRIMENTAL in-vivo EFFECT of Vitamin D deficiency on survival in experimental E. Coli meningoencephalitis.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 60), ('SUPERFICIAL_RELATIONSHIP', 80)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 139, 'E. coli')]
PMC4302429	1/2015	S210-PMC4302429	['high-dose Vitamin D MAY BE able to Modulate the inflammatory response to Cns infections.']	[('INCOMPLETE_EVIDENCE', 20)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0065007', 'biological regulation', 35, 'modulate'), ('UBERON_0001017', 'central nervous system', 73, 'CNS')]
PMC4303849	1/2015	S0-PMC4303849	['Regulation Of Calcitriol Biosynthesis and activity: focus on Gestational Vitamin D deficiency and adverse Pregnancy outcomes\n\nabstract\nVitamin D has garnered a great deal of ATTENTION in RECENT years DUE TO a GLOBAL prevalence of Vitamin D deficiency ASSOCIATED with an INCREASED RISK of a variety of Human diseases.']	[('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 187), ('PROBABLE_UNDERSTANDING', 200), ('IMPORTANT_CONSIDERATION', 209), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 270)]	6	[('GO_1900952', 'positive regulation of 18-methylnonadec-1-ene biosynthetic process', 0, 'Regulation of Calcitriol Biosynthesis'), ('CHEBI_17823', 'calcitriol', 14, 'Calcitriol'), ('PR_000004909', 'complement component C8 beta chain', 14, 'Calcitriol'), ('GO_0007565', 'female pregnancy', 61, 'Gestational'), ('CHEBI_28384', 'vitamin K', 73, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 73, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 135, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 135, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 301, 'human')]
PMC4303849	1/2015	S133-PMC4303849	['25Ohd values lesser than 50 nmol/l MAY sustain long-term adverse health consequences and are classified as “deficiency.” the 75 nmol/l cut-off is the point above which there is no upper stimulation of pth [102] and was thereafter designated as “sufficient.” HOWEVER, heaney POINTED out that 25Ohd concentrations < 80 nmol/l are ASSOCIATED with reduced calcium absorption and osteoporosis risk [103]; therefore, values lesser than 75 nmol/l are considered AS “insufficient.” the conversion factor between 25Ohd nmol/l and ng/ml is 2.5 (table 2).nutrients-07-00443-t001_table 1\n\ncaption (table-wrap): table 1\n\ntargets Modulated by Calcitriol in the Human Placenta (+ = stimulation; − = inhibition).targetbiological networkregulationbioeffectcell typereferenceplacental Lactogencell Life and death+growth controltrophoblast[97]Tnf-Αimmune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Il-6Immune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Csf2 (Colony Stimulating Factor 2)immune function−immunosupressiondecidual Cells[89]hctdimmune function+restraining infectiontrophoblast[90]Decidual Cells[89]Cyp24A1Bone and Mineral Metabolism+Calcitriol Catabolismtrophoblast[12]Decidual Cells[104]Cyp27B1Bone and Mineral Metabolism−Calcitriol synthesistrophoblast[12]Il-10 (Interleukin 10)immune function−reducing risk of infectiontrophoblast[105]Kcnh1 (potassium voltage-Gated channel)Cell Life and Death−unknowntrophoblast[106]Calbindin-D 28 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61,62]Calbindin-D 9 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61]hcg (Human Chorionic Gonadotrophin)Cell Life and Death+, −maintenance of Pregnancytrophoblast[96]3β-hsd (3Β-Hydroxysteroid dehydrogenase) *Cell Life and Death+Progesterone Synthesistrophoblast[95]Cyp19 (aromatase) *Cell Life and Death+Estradiol Synthesistrophoblast[95]Prolactincell Life and Death+Establishment Of Pregnancydecidual Cells[107]Vdrbone and Mineral Metabolism+allowing Calcitriol actionstrophoblast[62]Platelet-Activating factor acetylhydrolasecell life and Death−inactivation of Platelet-Activating factordecidual Macrophages[108]Hoxa10 (Homeobox A10)Cell Life and Death+Embryo Implantationdecidual cells[109]Osteopontinbone and Mineral Metabolism+Embryo Implantationdecidual Cells[104]Hbd2Immune function+restraining infectiontrophoblast[93]Hbd3Immune function+restraining infectiontrophoblast[93]\n* only observed at the enzyme activity level.nutrients-07-00443-t002_table 2\n\ncaption (table-wrap): table 2\n\ncut-offs in Vitamin D status according to the Endocrine society [110].Vitamin D status25ohd (nmol/l)25Ohd (ng/ml)severe deficiency<25<10deficiency<50<20insufficiency<75<30sufficiency75–11030–44toxicity>250>100\ntable 2shows the criteria for vd status as PROPOSED by the Endocrine society.']	[('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 258), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBABLE_UNDERSTANDING', 455), ('INCOMPLETE_EVIDENCE', 2831)]	6	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 0, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 291, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 504, '25OHD'), ('GO_0065007', 'biological regulation', 616, 'modulated'), ('CHEBI_17823', 'calcitriol', 629, 'calcitriol'), ('NCBITaxon_9606', 'Homo sapiens', 647, 'human'), ('UBERON_0001987', 'placenta', 653, 'placenta'), ('CHEBI_35417', 'alpha-amino-acid residue radical', 767, 'lactogenCell'), ('PR_000009797', 'LIM/homeobox protein Lhx9', 767, 'lactogenCell'), ('UBERON_0000104', 'life cycle', 780, 'life'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 824, 'TNF-αImmune'), ('PR_000008988', 'interleukin-1 family member 5', 922, 'IL-6Immune'), ('PR_000005890', 'crooked neck-like protein 1', 1019, 'CSF2'), ('PR_000005528', 'chloride channel protein, skeletal muscle', 1025, 'colony stimulating factor 2'), ('CL_0000573', 'retinal cone cell', 1094, 'cells'), ('CL_0000635', "Deiter's cell", 1159, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1177, 'CYP24A1Bone'), ('CHEBI_46662', 'mineral', 1193, 'mineral'), ('GO_0008152', 'metabolic process', 1201, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1212, 'Calcitriol'), ('GO_0019065', 'receptor-mediated endocytosis of virus by host cell', 1212, 'Calcitriol catabolismTrophoblast'), ('CL_0000635', "Deiter's cell", 1248, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1267, 'CYP27B1Bone'), ('CHEBI_46662', 'mineral', 1283, 'mineral'), ('GO_0008152', 'metabolic process', 1291, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1302, 'Calcitriol'), ('PR_000001470', 'interleukin-28B', 1337, 'IL-10'), ('PR_000001470', 'interleukin-28B', 1344, 'Interleukin 10'), ('PR_000000793', 'voltage-gated potassium channel KCNH4', 1417, 'KCNH1'), ('PR_000004587', 'beta-1,3-galactosyltransferase 6', 1441, '-gated'), ('GO_0008219', 'cell death', 1456, 'Cell life ... death'), ('PR_000004968', 'calretinin', 1499, 'Calbindin-D 28'), ('CHEBI_46662', 'mineral', 1526, 'mineral'), ('GO_0008152', 'metabolic process', 1534, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1545, 'Calcium'), ('PR_000004998', 'calmodulin-regulated spectrin-associated protein 1', 1579, 'Calbindin-D'), ('CHEBI_46662', 'mineral', 1605, 'mineral'), ('GO_0008152', 'metabolic process', 1613, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1624, 'Calcium'), ('NCBITaxon_9606', 'Homo sapiens', 1660, 'human'), ('PR_000005170', 'CD37 molecule', 1666, 'chorionic gonadotrophin'), ('UBERON_0003124', 'chorion', 1666, 'chorionic'), ('GO_0008219', 'cell death', 1690, 'Cell life ... death'), ('GO_0006412', 'translation', 1728, 'pregnancyTrophoblast'), ('CHEBI_36864', '25-hydroxy steroid', 1760, '3β-hydroxysteroid'), ('GO_0008219', 'cell death', 1794, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1799, 'life'), ('CHEBI_17026', 'progesterone', 1814, 'Progesterone'), ('GO_0072598', 'protein localization to chloroplast', 1814, 'Progesterone synthesisTrophoblast'), ('PR_000006100', 'aromatase', 1851, 'CYP19'), ('GO_0008219', 'cell death', 1870, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1875, 'life'), ('CHEBI_4856', 'esmolol', 1890, 'Estradiol'), ('GO_0072596', 'establishment of protein localization to chloroplast', 1890, 'Estradiol synthesisTrophoblast'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 1924, 'ProlactinCell'), ('GO_0006266', 'DNA ligation', 1938, 'life ... death'), ('GO_0006884', 'cell volume homeostasis', 1953, 'Establishment of pregnancyDecidual cells'), ('CL_0000573', 'retinal cone cell', 1988, 'cells'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1998, 'VDRBone'), ('CHEBI_46662', 'mineral', 2010, 'mineral'), ('GO_0008152', 'metabolic process', 2018, 'metabolism'), ('CHEBI_17823', 'calcitriol', 2038, 'calcitriol'), ('CL_0000233', 'platelet', 2071, 'Platelet'), ('GO_0030168', 'platelet activation', 2071, 'Platelet-activating'), ('GO_0007608', 'sensory perception of smell', 2127, '... death'), ('CL_0000233', 'platelet', 2149, 'platelet'), ('GO_0030168', 'platelet activation', 2149, 'platelet-activating'), ('CL_0000235', 'macrophage', 2184, 'macrophages'), ('PR_000008689', 'homeobox protein Hox-A13', 2200, 'HOXA10'), ('PR_000008469', 'holocytochrome c-type synthase', 2208, 'Homeobox A10'), ('GO_0008219', 'cell death', 2221, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 2226, 'life'), ('GO_0007601', 'visual perception', 2241, 'Embryo'), ('UBERON_0000922', 'embryo', 2241, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2248, 'implantationDecidual'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 2279, 'OsteopontinBone'), ('CHEBI_46662', 'mineral', 2299, 'mineral'), ('GO_0008152', 'metabolic process', 2307, 'metabolism'), ('UBERON_0000922', 'embryo', 2318, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2325, 'implantationDecidual'), ('CL_0000573', 'retinal cone cell', 2346, 'cells'), ('PR_000000035', 'BMP receptor type-1A', 2356, 'HBD2Immune'), ('PR_000000035', 'BMP receptor type-1A', 2412, 'HBD3Immune'), ('CHEBI_27300', 'vitamin D', 2590, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 2624, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 2648, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2648, 'Vitamin'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 2678, '25OHD'), ('UBERON_0005063', 'left ventricular compact myocardium', 2847, 'Endocrine')]
PMC4303849	1/2015	S246-PMC4303849	['in this regard, a study performed with Pregnant women in germany SHOWED that during the winter months, 98% of the maternal Blood samples and 94% of the Cord Blood samples had 25Ohd levels < 50 nmol/l, WHILE in the summer months, ONLY 49% of the women and 35% of the Cord Blood samples were Vitamin D deficient [220].']	[('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 201), ('ANOMALY_CURIOUS_FINDING', 229)]	3	[('GO_0007565', 'female pregnancy', 39, 'pregnant'), ('UBERON_0000178', 'blood', 123, 'blood'), ('UBERON_0002240', 'spinal cord', 152, 'cord'), ('UBERON_0000178', 'blood', 157, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 175, '25OHD'), ('UBERON_0002240', 'spinal cord', 266, 'cord'), ('UBERON_0000178', 'blood', 271, 'blood'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
PMC4383575	1/2015	S63-PMC4383575	['subgroups of Food items known to be sources of either higher levels of adduct-forming exposures (e.g., processed meat, meats, and leafy green vegetables), or higher levels of POTENTIAL PROTECTIVE components (e.g., fruits rich in Vitamin C, as well as their parent Food groups), were evaluated separately and as a dietary score.']	[('INCOMPLETE_EVIDENCE', 175), ('SUPERFICIAL_RELATIONSHIP', 185)]	2	[('CHEBI_33290', 'food', 13, 'food'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin C'), ('CHEBI_33290', 'food', 264, 'food')]
PMC4383575	1/2015	S147-PMC4383575	['several POTENTIAL modifiable FACTORS, such as higher maternal bmi, high dairy product intake, low Intake of healthy Food and fruits rich in Vitamin C, as well AS Delivery by cesarean section and country of Birth, were ASSOCIATED with higher adduct levels.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 29), ('PROBABLE_UNDERSTANDING', 159), ('SUPERFICIAL_RELATIONSHIP', 218)]	4	[('GO_0007631', 'feeding behavior', 98, 'intake'), ('CHEBI_33290', 'food', 116, 'food'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin C'), ('PR_000004900', 'complement C3', 148, 'C'), ('GO_0007567', 'parturition', 162, 'delivery'), ('GO_0007567', 'parturition', 206, 'birth')]
PMC4383575	1/2015	S187-PMC4383575	['maternal Intake of fruits rich in Vitamin C was ASSOCIATED with lower adduct levels in Cord Blood, which is IN LINE WITH PREVIOUS FINDINGS; inverse ASSOCIATIONS with vitamin c HAVE BEEN REPORTED in Adults (palli et al.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 176)]	5	[('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin C'), ('UBERON_0002240', 'spinal cord', 87, 'cord'), ('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0007023', 'adult organism', 198, 'adults')]
PMC4383575	1/2015	S195-PMC4383575	['2012b), and there were no associations OBSERVED between Placental dna adduct levels and Vitamins A or C or Β-Carotene in Plasma (daube et al.']	[('INCOMPLETE_EVIDENCE', 39)]	1	[('UBERON_0001987', 'placenta', 56, 'placental'), ('CHEBI_27300', 'vitamin D', 88, 'vitamins A'), ('CHEBI_18245', 'carboxylato group', 102, 'C'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 107, 'β-carotene'), ('UBERON_0001969', 'blood plasma', 121, 'plasma')]
PMC4383575	1/2015	S196-PMC4383575	['1997), BUT these two SMALL STUDIES DID NOT estimate fruits rich in Vitamin C. LIKEWISE, the inverse ASSOCIATION between dried fruits (rich in Flavonoids) and adduct levels COULD SUGGEST a POTENTIAL inhibition of adduct formation by these Nutrients.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 188)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin C'), ('CHEBI_72544', 'flavonoids', 142, 'flavonoids'), ('CHEBI_33284', 'nutrient', 238, 'nutrients')]
PMC4383575	1/2015	S238-PMC4383575	['OTHER POTENTIAL LIMITATIONS of OUR STUDY were the INABILITY to assess the intake of IMPORTANT dietary variables (i.e., Vitamins E, A, and C) (ragin et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 84)]	6	[('CHEBI_27300', 'vitamin D', 119, 'vitamins E'), ('PR_000024090', 'sensor protein TorS', 119, 'vitamins E'), ('PR_000004370', 'asialoglycoprotein receptor 2', 131, 'A'), ('PR_000004900', 'complement C3', 138, 'C')]
PMC4383575	1/2015	S254-PMC4383575	['several POTENTIAL modifiable FACTORS (e.g., higher maternal pre-Pregnancy bmi, low maternal Intake of healthy Foods, and low Intake of fruits rich in Vitamin C) were IDENTIFIED as POTENTIAL RISK FACTORS.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 180), ('SUPERFICIAL_RELATIONSHIP', 190)]	5	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007631', 'feeding behavior', 92, 'intake'), ('CHEBI_33290', 'food', 110, 'foods'), ('GO_0007631', 'feeding behavior', 125, 'intake'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin C')]
PMC4396835	1/2015	S0-PMC4396835	['autism spectrum disorder and low Vitamin D at Birth: a sibling control study\n\nabstract\n\nbackground\ninsufficient Vitamin D activity has attracted increasing INTEREST AS a POSSIBLE UNDERLYING RISK factor in disorders of the Central Nervous System, including autism.']	[('IMPORTANT_CONSIDERATION', 156), ('INCOMPLETE_EVIDENCE', 156), ('PROBABLE_UNDERSTANDING', 165), ('INCOMPLETE_EVIDENCE', 170), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 190)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 222, 'central nervous system')]
PMC4396835	1/2015	S7-PMC4396835	['conclusions\nthe FINDINGS SUGGEST that low Prenatal Vitamin D MAY act as a risk factor for asd, HOWEVER, there is a NEED FOR replication with larger samples.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('FUTURE_WORK', 115)]	5	[('GO_0007565', 'female pregnancy', 42, 'prenatal'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC4396835	1/2015	S8-PMC4396835	['FUTURE RESEARCH SHOULD study WHETHER OR NOT adequate supplementation of Vitamin D to Pregnant women MIGHT lower the RISK for asd in the offspring.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 116)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnant')]
PMC4396835	1/2015	S18-PMC4396835	['the INITIAL DISCOVERY that Rodent Brains contain Vitamin D receptors, targeted by Calcitriol, the hormonally active form of Vitamin D, was CRUCIAL for this research [14].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 139)]	3	[('NCBITaxon_33208', 'Metazoa', 27, 'rodent'), ('UBERON_0000955', 'brain', 34, 'brains'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 82, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4396835	1/2015	S20-PMC4396835	['stumpf and privette [16] first SUGGESTED that Vitamin D deficiency in Adults MIGHT CONTRIBUTE to the pathogenesis of certain psychiatric disorders, including depression.']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 83)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0007023', 'adult organism', 70, 'adults')]
PMC4396835	1/2015	S21-PMC4396835	['later, the negative IMPACT of Prenatal Vitamin D deficiency on Brain Development was POSTULATED by mcgrath [17], MAINLY BASED on epidemiological data.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 113), ('QUESTION_ANSWERED_BY_THIS_WORK', 120)]	4	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007420', 'brain development', 63, 'brain development'), ('UBERON_0000955', 'brain', 63, 'brain')]
PMC4396835	1/2015	S22-PMC4396835	['FURTHER research HAS SHOWN that Vitamin D has a ROLE in Brain Development and function, including Neuronal differentiation, Axonal connectivity, Dopamine ontogeny, immunological modulation and transcriptional Control over a large number of Genes [18–21].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007420', 'brain development', 56, 'brain development'), ('UBERON_0000955', 'brain', 56, 'brain'), ('CL_0000540', 'neuron', 98, 'neuronal'), ('GO_0030424', 'axon', 124, 'axonal'), ('CHEBI_18243', 'dopamine', 145, 'dopamine'), ('GO_0065007', 'biological regulation', 209, 'control'), ('SO_0000704', 'gene', 240, 'genes')]
PMC4396835	1/2015	S23-PMC4396835	['Prenatal Vitamin D deficiency HAS now been PROPOSED as a risk factor for Neurodevelopmental disorders such as schizophrenia [22] and autism [23–27].']	[('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 43)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007399', 'nervous system development', 73, 'neurodevelopmental')]
PMC4396835	1/2015	S24-PMC4396835	['several epidemiological FINDINGS indirectly SUPPORT a POSSIBLE ROLE for Prenatal Vitamin D deficiency in autism.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('GO_0007565', 'female pregnancy', 72, 'prenatal'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4396835	1/2015	S31-PMC4396835	['a NUMBER OF STUDIES in sweden, denmark, uk and north-east usa on season of Birth HAVE SHOWN that more children with asd are Born in winter and spring [42,43], with highest relative rates in march [44,45] SUGGESTING that lower Vitamin D status in the mother during Pregnancy may constitute a risk FACTOR [46].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 204), ('SUPERFICIAL_RELATIONSHIP', 296)]	4	[('GO_0007567', 'parturition', 75, 'birth'), ('GO_0007567', 'parturition', 124, 'born'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0007565', 'female pregnancy', 264, 'pregnancy')]
PMC4396835	1/2015	S35-PMC4396835	['HOWEVER, TO OUR KNOWLEDGE there HAS BEEN no study analysing Vitamin D levels in samples taken in the Neonatal Period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('INCOMPLETE_EVIDENCE', 32)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0007221', 'neonate stage', 101, 'neonatal period')]
PMC4396835	1/2015	S36-PMC4396835	['the AIM of the PRESENT STUDY was TO ADDRESS the EMERGING HYPOTHESIS that low levels of Vitamin D at Birth increase the RISK for asd.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007567', 'parturition', 100, 'birth')]
PMC4396835	1/2015	S89-PMC4396835	['GIVEN our main HYPOTHESIS of lower Vitamin D status in asd compared to controls, a case COULD BE made for one-tailed tests, HOWEVER, our results are conservatively reported as two-tailed with probabilities <0.05 accepted as significant.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4396835	1/2015	S121-PMC4396835	['the study - TO OUR KNOWLEDGE - is the FIRST in which Vitamin D levels in dried Blood Spots, from the Newborn Period, HAVE BEEN analysed in samples of children with asd and in their non-asd siblings, thereby controlling for shared environmental and Genetic causes for asd.']	[('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 117)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 79, 'blood spots'), ('UBERON_0007221', 'neonate stage', 101, 'newborn period'), ('SO_0000704', 'gene', 248, 'genetic')]
PMC4396835	1/2015	S126-PMC4396835	['this is IN LINE WITH OTHER scandinavian RESEARCH, SHOWING that somali born women have the lowest Vitamin D levels of all ethnic groups REPORTED in sweden [37], EVEN lower than in turkish and pakistani mothers living in norway [59].']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 135), ('ANOMALY_CURIOUS_FINDING', 160)]	6	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4396835	1/2015	S128-PMC4396835	['ACCORDINGLY, the swedish somali women and women from the middle east SEEM PARTICULARLY vulnerable to low Vitamin D levels, AFFECTING the Vitamin D status of the offspring, PRESUMABLY due to both dark skin [32] and covered clothing.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 69), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 123), ('PROBABLE_UNDERSTANDING', 172)]	5	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4396835	1/2015	S129-PMC4396835	['seasonal EFFECTS\nOUR FINDING that more children with asd of swedish or other non-african/non-middle east background were Born in the spring than during other seasons - COULD POSSIBLY implicate OTHER aetiological FACTORS THAN Vitamin D levels, such as, for instance, infections.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 168), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('SUPERFICIAL_RELATIONSHIP', 212), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 220)]	7	[('GO_0007567', 'parturition', 121, 'born'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC4396835	1/2015	S130-PMC4396835	['HOWEVER, the LACK OF effect of season of sampling (= season of Birth in OUR STUDY) on 25(Oh)D levels in our african/middle east group, all having low Vitamin D status throughout the year, HAS also BEEN REPORTED in women with african/middle east origin living in norway [59].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 72), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 202)]	5	[('GO_0007567', 'parturition', 63, 'birth'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC4396835	1/2015	S131-PMC4396835	['in conjunction with the elevated incidence of asd in these populations, this MAY SUPPORT a ROLE of Vitamin D deficiency - RATHER than OTHER seasonal factors - in the Development Of Autism.']	[('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134)]	5	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 166, 'development of autism')]
PMC4396835	1/2015	S134-PMC4396835	['OUR FINDINGS of lower Vitamin D levels in children with asd, COMPARED TO their siblings, also ACCORD WITH results from a population-based study from the faroe islands, in the north atlantic ocean, of Vitamin D levels in adolescents and young Adults with asd.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61), ('INCOMPLETE_EVIDENCE', 94)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0007023', 'adult organism', 242, 'adults')]
PMC4396835	1/2015	S136-PMC4396835	['PREVIOUS FINDINGS of low levels of Vitamin D COULD REFLECT the CONSEQUENCES of asd per se, that is, the IMPACT of a Person’s indoor lifestyle and circumscribed diet.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBLEM_COMPLICATION', 63), ('SUPERFICIAL_RELATIONSHIP', 104)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 116, 'person')]
PMC4396835	1/2015	S141-PMC4396835	['ON THE OTHER HAND, a LINK between Genomic actions of Vitamin D and serotonergic deviations in asd HAS BEEN PROPOSED by patrick and ames [63].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 107)]	4	[('SO_0001026', 'genome', 34, 'genomic'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4396835	1/2015	S142-PMC4396835	['ACCORDING TO these authors, low levels of Vitamin D MAY simultaneously cause hypo-activity of the central serotonergic system and hyperactivity of the peripheral, causing hyperserotoninemia, one of the most REPLICATED BIOMARKERS in asd research [64].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 207), ('SUPERFICIAL_RELATIONSHIP', 218)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4396835	1/2015	S153-PMC4396835	['HOWEVER, no difference in Vitamin D levels related to gender HAS BEEN FOUND in neonates [65].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 70)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC4396835	1/2015	S167-PMC4396835	['HOWEVER, as low Vitamin D is SUGGESTED to CONTRIBUTE to the pathogenesis of autoimmunity [69], OUR FINDINGS COULD BE relevant in this context as well.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 108)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC4396835	1/2015	S168-PMC4396835	['conclusion\nOUR FINDINGS of a low Vitamin D level in a group of newborn children, who later developed asd, provide SUPPORT for the HYPOTHESIS that developmental Vitamin D deficiency during late Pregnancy MAY carry an INCREASED risk of asd in the child, along with several other RISK FACTORS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 203), ('IMPORTANT_CONSIDERATION', 216), ('SUPERFICIAL_RELATIONSHIP', 277)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy')]
PMC4396835	1/2015	S169-PMC4396835	['three DIFFERENT independent findings POINT towards a ROLE for Vitamin D in the development of asd: (1) increased risk for asd in offspring of migrants, especially from countries with a dark-skinned population and from cultures where women use covered clothing; (2) low 25(Oh)D levels in groups of newborn children, who later have developed asd, and in groups of children and Adults with asd; and (3) an ASSOCIATION between season of Birth and asd, in OUR STUDY not extending to the high-risk groups of migrants, SUGGESTING that these groups are exposed to suboptimal Vitamin D levels the whole year.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 403), ('QUESTION_ANSWERED_BY_THIS_WORK', 451), ('INCOMPLETE_EVIDENCE', 512)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 269, '25(OH)D'), ('UBERON_0007023', 'adult organism', 375, 'adults'), ('GO_0007567', 'parturition', 433, 'birth'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC4396835	1/2015	S170-PMC4396835	['ALTHOUGH low levels of Vitamin D COULD have a Genetic origin and as SUCH be ASSOCIATED with asd, OUR STUDY is the FIRST TO RULE OUT asd-related lifestyle mechanisms AS EXPLANATION for low 25(Oh)D levels, SINCE the samples were taken in the Newborn Period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 68), ('SUPERFICIAL_RELATIONSHIP', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 165), ('PROBABLE_UNDERSTANDING', 168), ('PROBABLE_UNDERSTANDING', 204)]	10	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('SO_0000704', 'gene', 46, 'genetic'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 194, 'D'), ('UBERON_0007221', 'neonate stage', 240, 'newborn period')]
PMC4396835	1/2015	S171-PMC4396835	['FUTURE RESEARCH SHOULD include a larger cohort followed prospectively and also study WHETHER OR NOT adequate supplementation of Vitamin D to Pregnant women MIGHT lower the RISK for asd in the offspring.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 156), ('IMPORTANT_CONSIDERATION', 172)]	5	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnant')]
PMC4476607	1/2015	S147-PMC4476607	['ALTHOUGH antioxidant treatments in Animal MODELS are encouraging, researchers PREMATURELY terminated a clinical trial utilizing high doses of Vitamins C and E in women with Alcohol-exposed Pregnancies BECAUSE of SAFETY CONCERNS (goh et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 42), ('PROBLEM_COMPLICATION', 78), ('PROBLEM_COMPLICATION', 201), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 219), ('PROBLEM_COMPLICATION', 219)]	9	[('NCBITaxon_33208', 'Metazoa', 35, 'animal'), ('CHEBI_27300', 'vitamin D', 142, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 157, 'E'), ('CHEBI_30879', 'alcohol', 173, 'alcohol'), ('GO_0007565', 'female pregnancy', 189, 'pregnancies')]
PMC4383226	2/2015	S0-PMC4383226	['vitamin a Supplements, routine immunization, and the subsequent risk of plasmodium infection among children under 5 years in sub-saharan africa\n\nabstract\nRECENT STUDIES, PARTLY based on Murine MODELS, SUGGEST childhood immunization and Vitamin A Supplements MAY confer protection against malaria infection, ALTHOUGH STRONG EVIDENCE TO SUPPORT these THEORIES in Humans has so far BEEN LACKING.']	[('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 170), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 258), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 307), ('ANOMALY_CURIOUS_FINDING', 307), ('INCOMPLETE_EVIDENCE', 316), ('INCOMPLETE_EVIDENCE', 349), ('INCOMPLETE_EVIDENCE', 379)]	11	[('CHEBI_33341', 'titanium atom', 10, 'supplements'), ('NCBITaxon_39107', 'Murinae', 186, 'murine'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin A'), ('CHEBI_33341', 'titanium atom', 246, 'supplements'), ('NCBITaxon_9606', 'Homo sapiens', 361, 'humans')]
PMC4383226	2/2015	S11-PMC4383226	["many also receive Vitamin A supplements, which HAVE BEEN LINKED not ONLY to the protection of a child's Vision, but also to a lower RISK of death and an improved ability to Fight off infections."]	[('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57), ('ANOMALY_CURIOUS_FINDING', 68), ('IMPORTANT_CONSIDERATION', 132)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin A'), ('GO_0007601', 'visual perception', 104, 'vision'), ('GO_0007631', 'feeding behavior', 173, 'fight')]
PMC4383226	2/2015	S12-PMC4383226	['SOME researchers have SUGGESTED that Vitamin A supplements and routine childhood vaccinations for other diseases MAY also provide SOME protection against malaria.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 130)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A')]
PMC4383226	2/2015	S15-PMC4383226	['it is LESS CLEAR WHETHER vaccines OR Vitamin A have antimalarial EFFECTS in Humans.']	[('FULL_UNKNOWN', 6), ('INCOMPLETE_EVIDENCE', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 65)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('NCBITaxon_9606', 'Homo sapiens', 76, 'humans')]
PMC4383226	2/2015	S25-PMC4383226	['FOUND that children who received Vitamin A supplements were less LIKELY to become infected with malaria.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 65)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin A')]
PMC4383226	2/2015	S27-PMC4383226	['CLINICAL TRIALS ARE NOW NEEDED to CONFIRM these results and investigate HOW effectively Vitamin A prevents malaria.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 9), ('FUTURE_WORK', 34), ('INCOMPLETE_EVIDENCE', 34), ('EXPLICIT_QUESTION', 72)]	5	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A')]
PMC4383226	2/2015	S31-PMC4383226	['SEVERAL STUDIES have SUGGESTED that childhood immunization MAY confer non-specific health EFFECTS beyond targeted diseases, BUT the IMPACT of standard vaccination and Vitamin A supplementation on malaria Infection is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('SUPERFICIAL_RELATIONSHIP', 132), ('FULL_UNKNOWN', 217)]	7	[('CHEBI_27300', 'vitamin D', 167, 'vitamin A'), ('GO_0007586', 'digestion', 204, 'infection')]
PMC4383226	2/2015	S36-PMC4383226	['multiple clinical TRIALS in infants and young children have also IDENTIFIED PROTECTIVE EFFECTS from Vitamin A supplementation against illness (number and time to first clinical episode, risk of febrile illness, Spleen enlargement, and mean parasite density) (shankar et al., 1999;zeba et al., 2008) and death caused by malaria (fawzi et al., 1999;varandas et al., 2001;mwanga-amumpaire et al., 2012).']	[('FUTURE_WORK', 18), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 87)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin A'), ('UBERON_0002106', 'spleen', 211, 'spleen')]
PMC4383226	2/2015	S41-PMC4383226	['WHILE Vitamin A did not APPEAR to Modulate the risk of parasitemia in a clinical trial study of ghanaian children (binka et al., 1995) and tanzanian children previously hospitalized with pneumonia (villamor et al., 2003), a cluster randomized intervention trial for breastfeeding in uganda OBSERVED a sixfold decrease in the adjusted risk of malaria infection among children receiving Vitamin A (nankabirwa et al., 2011).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 24), ('INCOMPLETE_EVIDENCE', 290)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin A'), ('GO_0065007', 'biological regulation', 34, 'modulate'), ('CHEBI_27300', 'vitamin D', 385, 'vitamin A')]
PMC4383226	2/2015	S42-PMC4383226	['ON THE OTHER HAND, CONCERN HAS BEEN RAISED by an APPARENT increase in levels of parasitemia within Mouse MODELS, when combining Vitamin A supplements with dtp vaccination; an EFFECT THOUGHT TO be stronger among female Mice (jorgensen et al., 2011).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 19), ('INCOMPLETE_EVIDENCE', 27), ('EXPLICIT_QUESTION', 36), ('ANOMALY_CURIOUS_FINDING', 49), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 175), ('INCOMPLETE_EVIDENCE', 182)]	8	[('NCBITaxon_10088', 'Mus <genus>', 99, 'mouse'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 218, 'mice')]
PMC4383226	2/2015	S43-PMC4383226	['the underlying mechanisms of these EFFECTS are UNCLEAR, ALTHOUGH it HAS BEEN THEORIZED that Vitamin A MAY act as Adjuvant to dtp, which is POSTULATED to cause DETRIMENTAL EFFECTS (jorgensen et al., 2011).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('FULL_UNKNOWN', 47), ('ANOMALY_CURIOUS_FINDING', 56), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 77), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 171)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin A'), ('CHEBI_60809', 'adjuvant', 113, 'adjuvant')]
PMC4383226	2/2015	S79-PMC4383226	['these EFFECTS REMAINED after weighting.figure 2illustrates that the association between Vitamin A and plasmodium parasitemia was not impacted by season, age or time since supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 14)]	2	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A')]
PMC4383226	2/2015	S85-PMC4383226	['we had INSUFFICIENT data to identify cross-INTERACTIONS between vaccines and Vitamin A using an adjusted model, BUT in unadjusted models we found no significant interactions between vaccination and Vitamin A supplementation.10.7554/elife.03925.007\n\ncaption (table-wrap): table 3.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 112)]	3	[('CHEBI_27300', 'vitamin D', 77, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin A')]
PMC4383226	2/2015	S99-PMC4383226	['Vitamin A, dtp and gender\nOUR STUDY EXTENDS PREVIOUS randomized clinical TRIAL EVIDENCE from burkina faso (zeba et al., 2008), papua new guinea (shankar et al., 1999), tanzania (villamor et al., 2002), and uganda (nankabirwa et al., 2011) SHOWING consistent reductions in malaria-induced morbidity and Mortality from Vitamin A.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 239)]	6	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin A'), ('GO_0065007', 'biological regulation', 302, 'mortality'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 325, 'A')]
PMC4383226	2/2015	S100-PMC4383226	['STILL, it CONTRADICTS SUGGESTIONS that when combined with dtp (jorgensen et al., 2011), Vitamin A MAY increase the RISK of malaria infection.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 0), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 98), ('IMPORTANT_CONSIDERATION', 115)]	8	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A')]
PMC4383226	2/2015	S101-PMC4383226	["NOT ONLY did we identify a PROTECTIVE ASSOCIATION between Vitamin A and malaria in a study population with high immunization coverage for bcg, dtp, and poliomyelitis, we also FOUND in unadjusted MODELS that dtp did not modify Vitamin A's ASSOCIATION with malaria."]	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('SUPERFICIAL_RELATIONSHIP', 238)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A')]
PMC4383226	2/2015	S102-PMC4383226	['we FOUND no indication of an elevated gender EFFECT for either dtp or Vitamin A, ALTHOUGH the latter SEEMED TO BE more PROTECTIVE among children living in communities with higher Allele frequencies for x-linked g6pdd.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 81), ('ANOMALY_CURIOUS_FINDING', 101), ('SUPERFICIAL_RELATIONSHIP', 119)]	5	[('CHEBI_27300', 'vitamin D', 70, 'vitamin A'), ('SO_0001023', 'allele', 179, 'allele')]
PMC4383226	2/2015	S103-PMC4383226	['it is UNCLEAR HOW Vitamin A COULD INTERACT with G6Pd to INFLUENCE the risk of malaria infection; the ONLY literature discussion regarding Vitamin A and G6Pd is LIMITED to Animal FINDINGS on Adipose and Lipogenic activities (higueret et al., 1989;arana et al., 2008).']	[('FULL_UNKNOWN', 6), ('EXPLICIT_QUESTION', 14), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 178)]	8	[('CHEBI_27300', 'vitamin D', 18, 'vitamin A'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 48, 'G6PD'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 152, 'G6PD'), ('NCBITaxon_33208', 'Metazoa', 171, 'animal'), ('UBERON_2000251', 'adipose fin', 190, 'adipose'), ('GO_0008610', 'lipid biosynthetic process', 202, 'lipogenic')]
PMC4383226	2/2015	S106-PMC4383226	['all of the epidemiological EVIDENCE TO SUPPORT the DETRIMENTAL gender-BASED EFFECTS from Vitamin A and dtp on child mortality comes from guinea bissau (benn et al., 2009a,b2009b;fisker et al., 2013).']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('SUPERFICIAL_RELATIONSHIP', 76)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin A')]
PMC4383226	2/2015	S108-PMC4383226	["Placental malaria and Vitamin A\ndifferences in the IMPACT of Vitamin A on malaria infection by Birth weight, and having a mother who used Antimalarials during the child's Gestational period SUGGESTS exposure to Placental malaria MAY play a CRITICAL ROLE in Vitamin A's PROTECTIVE EFFECT mechanisms later on in childhood."]	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 229), ('IMPORTANT_CONSIDERATION', 240), ('SUPERFICIAL_RELATIONSHIP', 249), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 280)]	7	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('GO_0007567', 'parturition', 95, 'birth'), ('CHEBI_22580', 'anthraquinone', 138, 'antimalarials'), ('GO_0007565', 'female pregnancy', 171, 'gestational'), ('UBERON_0001987', 'placenta', 211, 'placental'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin A')]
PMC4383226	2/2015	S122-PMC4383226	['this analysis SHOWED that when mozambique data were EXCLUDED from Blood film analysis, the magnitude of PROTECTIVE Vitamin A EFFECTS in both Blood film and antigenemia MODELS were nearly identical.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 125), ('INCOMPLETE_EVIDENCE', 168)]	5	[('UBERON_0000178', 'blood', 66, 'blood'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin A'), ('UBERON_0000178', 'blood', 141, 'blood')]
PMC4383226	2/2015	S128-PMC4383226	['we have chosen to present data in this paper that includes mozambique because these results provide more conservative ESTIMATES of Vitamin A EFFECTS when using Blood films.']	[('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 141)]	2	[('CHEBI_27300', 'vitamin D', 131, 'vitamin A'), ('UBERON_0000178', 'blood', 160, 'blood')]
PMC4383226	2/2015	S132-PMC4383226	['this includes FURTHER CLARIFICATION regarding OPTIMAL dosages and the time sequence in which Vitamin A is administered in relation to other vaccines, as well as more accurate measures with regard to hbs and G6Pdd Allele frequency.']	[('FUTURE_WORK', 14), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 46)]	3	[('CHEBI_27300', 'vitamin D', 93, 'vitamin A'), ('PR_000007897', 'glutamate--cysteine ligase catalytic subunit', 207, 'G6PDd'), ('SO_0001023', 'allele', 213, 'allele')]
PMC4383226	2/2015	S133-PMC4383226	["in particular, our study ONLY CONSIDERED information regarding the last recorded dose of Vitamin A supplement RATHER than a child's history of supplementation."]	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin A')]
PMC4383226	2/2015	S134-PMC4383226	['given that Vitamin A is fat soluble and CAN be stored in the Liver for long periods of time (blomhoff, 1994;tanumihardjo, 2011), ADDITIONAL RESEARCH IS NEEDED to examine WHETHER regular supplementation has an IMPACT on increased protection.']	[('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 129), ('FUTURE_WORK', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 209)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin A'), ('UBERON_0002107', 'liver', 61, 'liver')]
PMC4383226	2/2015	S147-PMC4383226	['WHILE the PROTECTIVE ASSOCIATION between Vitamin A and malaria REMAINED, the low prevalence of maternal hiv in our study population (and HENCE LOW statistical power) makes it DIFFICULT to RULE OUT POTENTIAL Vitamin A–hiv INTERACTIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 63), ('PROBABLE_UNDERSTANDING', 137), ('PROBLEM_COMPLICATION', 143), ('DIFFICULT_TASK', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 221)]	11	[('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A')]
PMC4383226	2/2015	S148-PMC4383226	['FURTHER RESEARCH IS NEEDED to evaluate POTENTIAL INTERACTIONS between Vitamin A, hiv and malaria infection.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49)]	4	[('CHEBI_27300', 'vitamin D', 70, 'vitamin A')]
PMC4340999	3/2015	S13-PMC4340999	['low exposure to ultraviolet b radiation and subsequent reduced levels of Vitamin D during the late second and early third Trimesters MAY BE INVOLVED in these phenomena.']	[('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 140)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0002298', 'brainstem', 122, 'trimesters')]
PMC4340999	3/2015	S93-PMC4340999	['INCONSISTENT findings and MIXED explanations of underlying mechanism HAVE BEEN REPORTED, including SPECULATION that early temperature exposure is ASSOCIATED with physiological Regulation Of Birth Weight or that extremely low ambient temperature INFLUENCES the Conceived Embryo or the selection of the Sperm that fuses with the Ovum.19–21HOWEVER, the findings from the current study APPEARED to more strongly SUGGEST the POSSIBLE etiological ROLE of Prenatal maternal exposure to ultraviolet b radiation (uvb) and Vitamin D status in Adult chronic diseases.29–31\nsun exposure provides one of the MAJOR ways to meet Vitamin D REQUIREMENTS during Pregnancy, ESPECIALLY for those of older generations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 176), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 334), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 335), ('ANOMALY_CURIOUS_FINDING', 382), ('INCOMPLETE_EVIDENCE', 408), ('INCOMPLETE_EVIDENCE', 420), ('SUPERFICIAL_RELATIONSHIP', 441), ('IMPORTANT_CONSIDERATION', 595), ('IMPORTANT_CONSIDERATION', 624), ('IMPORTANT_CONSIDERATION', 655)]	16	[('GO_0009937', 'regulation of gibberellic acid mediated signaling pathway', 176, 'regulation of birth weight'), ('GO_0070268', 'cornification', 260, 'conceived'), ('UBERON_0000922', 'embryo', 270, 'embryo'), ('CL_0000019', 'sperm', 301, 'sperm'), ('UBERON_0000978', 'leg', 327, 'ovum'), ('GO_0007565', 'female pregnancy', 449, 'prenatal'), ('CHEBI_27300', 'vitamin D', 513, 'vitamin D'), ('UBERON_0007023', 'adult organism', 533, 'adult'), ('CHEBI_27300', 'vitamin D', 614, 'vitamin D'), ('GO_0007565', 'female pregnancy', 644, 'pregnancy')]
PMC4340999	3/2015	S94-PMC4340999	['for latitudes with distinct seasonal changes in availability of uvb, there is a WELL-DOCUMENTED seasonal cycle in Vitamin D status, with a maximum in late summer and a minimum in late winter.32low Vitamin D during Gestation MAY STRONGLY INFLUENCE susceptibility to obesity later in Life.33\nhowever, relatively LITTLE IS KNOWN about the critical period of fetal growth at which low Vitamin D is of particular IMPORTANCE.']	[('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 224), ('PROBABLE_UNDERSTANDING', 228), ('SUPERFICIAL_RELATIONSHIP', 237), ('FULL_UNKNOWN', 310), ('IMPORTANT_CONSIDERATION', 408)]	7	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestation'), ('UBERON_0000104', 'life cycle', 282, 'life'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D')]
PMC4340999	3/2015	S95-PMC4340999	['low Vitamin D during the second or third Trimester of Pregnancy HAS BEEN SUGGESTED to be ASSOCIATED with Adult obesity.31,33in THE CURRENT STUDY, spring and early summer peaks and winter troughs for bmi and wc were evident.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 127)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 41, 'trimester'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('UBERON_0007023', 'adult organism', 105, 'adult')]
PMC4340999	3/2015	S98-PMC4340999	['up to now, a FEW STUDIES have EXAMINED the ASSOCIATION between lower maternal Vitamin D levels in later Pregnancy and offspring adiposity at age 6 years34; at birth, age 9 months and age 9 years35; at ages 5 and 9.5 years36; and at age 35 years,37and shown INCONSISTENT results.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy')]
PMC4340999	3/2015	S102-PMC4340999	['ll in the PRESENT STUDY followed an opposite seasonal TREND to that of Adult adiposity measures, for which maternal uvb exposure (and HENCE Vitamin D status) is STILL a reasonable EXPLANATION.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 134), ('IMPORTANT_CONSIDERATION', 161), ('PROBABLE_UNDERSTANDING', 180)]	5	[('UBERON_0007023', 'adult organism', 71, 'adult'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4340999	3/2015	S106-PMC4340999	['lucas et al FOUND that seasonal variation in Vitamin D status in australian Adults (living in an area spanning 27°–43° south) had greater amplitude compared to australian Adults living in a different region, and Vitamin D deficiency increased with increasing latitude, REFLECTING stronger seasonal variation in ambient uvb and less skin exposure due to colder temperatures.38hunan, being another site presenting seasonal variation in ll, has lower latitude than seven other study sites but the greatest yearly sunshine variation of all the study sites (seeetable 1).']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 269)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0007023', 'adult organism', 76, 'adults'), ('UBERON_0007023', 'adult organism', 171, 'adults'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC4340999	3/2015	S109-PMC4340999	['results in the PRESENT STUDY IMPLY that Prenatal Vitamin D status MIGHT be a POTENTIAL pathway LINKING ll with Adult risks of obesity39,40and a range of chronic diseases.8–10HOWEVER, seasonal variation in ll DEPENDING ON region SUGGESTS that ll CAN ONLY be used as anthropometric BIOMARKER of Prenatal Vitamin D status in SOME geographic regions.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 29), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 245), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 280), ('INCOMPLETE_EVIDENCE', 322)]	12	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 293, 'prenatal'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC4340999	3/2015	S112-PMC4340999	['ALTHOUGH THE CURRENT STUDY is UNABLE TO precisely determine the REASON for mob variation in Adult measures of ll, general adiposity, and central adiposity, the study improves our current understanding of a POTENTIAL ASSOCIATION of Prenatal low exposure to Vitamin D during late second and early third trimesters with short ll and adiposity in later Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('DIFFICULT_TASK', 30), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('UBERON_0007023', 'adult organism', 92, 'adult'), ('GO_0007565', 'female pregnancy', 231, 'prenatal'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0000104', 'life cycle', 349, 'life')]
PMC4340999	3/2015	S113-PMC4340999	['Vitamin D insufficiency during Pregnancy is highly PREVALENT in a diverse range of populations living at various latitudes and in both developed and developing societies.29,33the adverse EFFECTS of Vitamin D insufficiency on offspring during development and later in Life HAVE also BEEN extended greatly.29–31from a PUBLIC HEALTH perspective, the POTENTIAL to PREVENT common chronic diseases via low-cost, simple, and SAFE Food fortification is an attractive option.33\nsome POTENTIAL limitations of this study WARRANT CONSIDERATION.']	[('IMPORTANT_CONSIDERATION', 51), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 272), ('IMPORTANT_CONSIDERATION', 316), ('INCOMPLETE_EVIDENCE', 347), ('SUPERFICIAL_RELATIONSHIP', 360), ('IMPORTANT_CONSIDERATION', 418), ('INCOMPLETE_EVIDENCE', 474), ('FUTURE_WORK', 510), ('FUTURE_WORK', 518)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 31, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0000104', 'life cycle', 267, 'life'), ('CHEBI_33290', 'food', 423, 'food')]
PMC4340999	3/2015	S125-PMC4340999	['this is also the FIRST-ever population-BASED EVIDENCE LINKING low Prenatal sun-RELATED uvb exposure (and lower Vitamin D by PROXY) to ll and the susceptibility to obesity later in Life and also SUGGESTING that late second and early third trimesters MIGHT be a CRITICAL period for the above-mentioned EFFECTS ALTHOUGH such EVIDENCE is non-specific, it WARRANTS FURTHER STUDIES in this AREA.']	[('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 79), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 249), ('IMPORTANT_CONSIDERATION', 260), ('SUPERFICIAL_RELATIONSHIP', 300), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('INCOMPLETE_EVIDENCE', 322), ('FUTURE_WORK', 351), ('FUTURE_WORK', 360), ('FUTURE_WORK', 384)]	15	[('GO_0007565', 'female pregnancy', 66, 'prenatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
PMC4368185	3/2015	S13-PMC4368185	['Folic Acid (Fa), a Water-soluble Vitamin B, is an ESSENTIAL Nutrient during Gestation for Dna Methylation, Synthesis and Repair, and it is well KNOWN to reduce the RISK of Neural Tube defect (ntd) in the new-born [1,2].']	[('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 144), ('IMPORTANT_CONSIDERATION', 164)]	3	[('CHEBI_30751', 'formic acid', 0, 'Folic acid'), ('CHEBI_30751', 'formic acid', 12, 'FA'), ('CHEBI_15377', 'water', 19, 'water'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin B'), ('CHEBI_33284', 'nutrient', 60, 'nutrient'), ('GO_0007565', 'female pregnancy', 76, 'gestation'), ('GO_0019277', 'UDP-N-acetylgalactosamine biosynthetic process', 90, 'DNA methylation ... synthesis'), ('GO_0006281', 'DNA repair', 121, 'repair'), ('UBERON_0001049', 'neural tube', 172, 'neural tube')]
PMC4377870	3/2015	S76-PMC4377870	['antioxidants including Lycopene APPEAR to have positive INFLUENCES in Respiratory conditions, further detail is provided below on EVIDENCE for Vitamin C, Vitamin E and Flavonoids and their ROLE in the maternal diet, diets of children and Adults with asthma and Adults with copd.']	[('ANOMALY_CURIOUS_FINDING', 32), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 189)]	4	[('CHEBI_15948', 'lycopene', 23, 'lycopene'), ('UBERON_0001004', 'respiratory system', 70, 'respiratory'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin E'), ('CHEBI_72544', 'flavonoids', 168, 'flavonoids'), ('UBERON_0007023', 'adult organism', 238, 'adults'), ('UBERON_0007023', 'adult organism', 261, 'adults')]
PMC4377870	3/2015	S79-PMC4377870	['in vitro data from Endothelial Cell lines SHOWED that Vitamin C could inhibit Nf-Κb Activation by Il-1, Tnf-Α and block production of il-8 via mechanisms not dependent on the antioxidant activity of Vitamin C [59].']	[('INCOMPLETE_EVIDENCE', 42)]	1	[('CL_0000115', 'endothelial cell', 19, 'endothelial cell'), ('UBERON_0001986', 'endothelium', 19, 'endothelial'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin C'), ('GO_0051092', 'positive regulation of NF-kappaB transcription factor activity', 78, 'NF-κB activation'), ('GO_0071159', 'NF-kappaB complex', 78, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 78, 'NF-κB'), ('PR_000001470', 'interleukin-28B', 98, 'IL-1'), ('PR_000000134', 'tumor necrosis factor alpha', 104, 'TNF-α'), ('PR_000000035', 'BMP receptor type-1A', 136, '-8'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin C'), ('PR_000004900', 'complement C3', 207, 'C')]
PMC4377870	3/2015	S80-PMC4377870	['anti-inflammatory and anti-asthmatic EFFECTS of Vitamin C supplementation in vivo , HAVE BEEN SHOWN through allergic Mouse MODELS of asthma.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 123)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin C'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'mouse')]
PMC4377870	3/2015	S85-PMC4377870	['OBSERVATIONAL studies in children SHOWED Consumption of fruit, a rich source of Vitamin C, was RELATED to reduced wheezing [62] and Vitamin C intake was negatively ASSOCIATED with wheezing [63], WHILE ANOTHER STUDY reported no relationship between Vitamin C intake and Lung function [64].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 95), ('SUPERFICIAL_RELATIONSHIP', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('INCOMPLETE_EVIDENCE', 201)]	6	[('GO_0007631', 'feeding behavior', 41, 'consumption'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin C'), ('UBERON_0002048', 'lung', 269, 'lung')]
PMC4377870	3/2015	S87-PMC4377870	['[22] also reported CONFLICTING EVIDENCE for EFFECTS of Vitamin C intake in Adults, with epidemiological STUDIES SHOWING a positive ASSOCIATION between Vitamin C intake and Lung function in SOME [65], but NOT ALL studies [23,66].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 189), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204)]	9	[('CHEBI_27300', 'vitamin D', 55, 'vitamin C'), ('UBERON_0007023', 'adult organism', 75, 'adults'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin C'), ('UBERON_0002048', 'lung', 172, 'lung')]
PMC4377870	3/2015	S88-PMC4377870	['DESPITE the OBSERVATIONAL data LINKING Vitamin C to Lung health, supplementation with Vitamin C has not been shown to reduce the RISK of asthma [66] which MAY be RELATED to the interdependence of Nutrients found in Foods, resulting in lack OF efficacy when supplementing with isolated Nutrients.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 162), ('ANOMALY_CURIOUS_FINDING', 240)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin C'), ('UBERON_0002048', 'lung', 52, 'lung'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin C'), ('CHEBI_33284', 'nutrient', 196, 'nutrients'), ('CHEBI_33290', 'food', 215, 'foods'), ('CHEBI_33284', 'nutrient', 285, 'nutrients')]
PMC4377870	3/2015	S92-PMC4377870	['a case control study in taiwan REPORTED that subjects with copd had lower dietary intake and lower Serum levels of Vitamin C than healthy controls [68].']	[('INCOMPLETE_EVIDENCE', 31)]	1	[('UBERON_0001977', 'blood serum', 99, 'serum'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin C')]
PMC4377870	3/2015	S93-PMC4377870	['indeed an epidemiological study in the united kingdom of over 7000 Adults aged 45–74 years FOUND that increased Plasma Vitamin C concentration was ASSOCIATED with a decreased risk of obstructive Airways disease, SUGGESTIVE of a PROTECTIVE EFFECT [69].']	[('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 212), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 239)]	5	[('UBERON_0007023', 'adult organism', 67, 'adults'), ('UBERON_0001969', 'blood plasma', 112, 'plasma'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin C'), ('UBERON_0001005', 'respiratory airway', 195, 'airways')]
PMC4377870	3/2015	S94-PMC4377870	['THUS, in SUMMARY, WHILE OBSERVATIONAL data has SUGGESTED that Vitamin C is IMPORTANT for Lung health, intervention trials SHOWING efficacy are lacking and it APPEARS that supplementation with Vitamin C-rich whole foods, such as fruit and vegetables MAY BE more EFFECTIVE.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 75), ('INCOMPLETE_EVIDENCE', 122), ('ANOMALY_CURIOUS_FINDING', 158), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 261)]	10	[('CHEBI_27300', 'vitamin D', 62, 'vitamin C'), ('UBERON_0002048', 'lung', 89, 'lung'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin C')]
PMC4377870	3/2015	S104-PMC4377870	['as a result, meta-analysis of Vitamin E EFFECTS on asthma outcomes is EQUIVOCAL; it is LIKELY that supplementation with physiological concentrations of Α-Tocopherol in the context of a background diet low in Γ-Tocopherol, MAY BE MOST beneficial in asthma and FURTHER RESEARCH testing this HYPOTHESIS IS REQUIRED.']	[('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('FUTURE_WORK', 259), ('INCOMPLETE_EVIDENCE', 289), ('FUTURE_WORK', 300), ('IMPORTANT_CONSIDERATION', 303)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamin E'), ('CHEBI_27725', 'butin', 152, 'α-tocopherol'), ('CHEBI_27725', 'butin', 208, 'γ-tocopherol')]
PMC4377870	3/2015	S105-PMC4377870	['in copd, Serum levels of Vitamin E HAVE BEEN SHOWN to be decreased during exacerbation, which SUGGESTS increased Intake MAY BE helpful to improve Vitamin E concentrations [84].']	[('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 120)]	3	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin E'), ('GO_0007631', 'feeding behavior', 113, 'intake'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin E')]
PMC4377870	3/2015	S108-PMC4377870	['dietary intake of Vitamin E lower than RECOMMENDED dietary intakes HAS BEEN REPORTED in Pregnant women with a family history of allergic disease [88] and RECENT work in Animal MODELS has HIGHLIGHTED Α-Tocopherol MAY BE IMPORTANT for allergic mothers in Pregnancy.']	[('FUTURE_WORK', 39), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 219)]	7	[('CHEBI_27300', 'vitamin D', 18, 'vitamin E'), ('GO_0007565', 'female pregnancy', 88, 'pregnant'), ('NCBITaxon_33208', 'Metazoa', 169, 'animal'), ('CHEBI_27725', 'butin', 199, 'α-tocopherol'), ('GO_0007565', 'female pregnancy', 253, 'pregnancy')]
PMC4377870	3/2015	S111-PMC4377870	['evidence from observational studies also SUGGESTS that reduced maternal dietary intake of Vitamin E is RELATED to an increased risk of childhood asthma and wheeze [90,91,92] and increased in vitro proliferative responses in Cord Blood Mononuclear Cells (Cbmc) [93].']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 103)]	2	[('CHEBI_27300', 'vitamin D', 90, 'vitamin E'), ('CL_0000752', 'cone retinal bipolar cell', 224, 'cord blood mononuclear cells'), ('UBERON_0002240', 'spinal cord', 224, 'cord'), ('UBERON_0000178', 'blood', 229, 'blood'), ('GO_0031097', 'medial cortex', 235, 'mononuclear'), ('CL_0002062', 'type I pneumocyte', 254, 'CBMC')]
PMC4377870	3/2015	S118-PMC4377870	['in asthma the experimental data for Vitamin E are COMPELLING, YET supplementation benefits are NOT WELL DESCRIBED.']	[('INCOMPLETE_EVIDENCE', 50), ('ANOMALY_CURIOUS_FINDING', 62), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin E')]
PMC4377870	3/2015	S119-PMC4377870	['in copd there is currently NOT ENOUGH EVIDENCE to make CONCLUSIONS about Vitamin E supplementation.']	[('INCOMPLETE_EVIDENCE', 27), ('PROBABLE_UNDERSTANDING', 55)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin E')]
PMC4377870	3/2015	S134-PMC4377870	['THOUGH like Vitamin C, it MAY BE DIFFICULT to disentangle the EFFECTS of Flavonoids from OTHER Nutrients in Flavonoid-rich foods.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('DIFFICULT_TASK', 33), ('SUPERFICIAL_RELATIONSHIP', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	5	[('CHEBI_27300', 'vitamin D', 12, 'vitamin C'), ('PR_000004900', 'complement C3', 20, 'C'), ('CHEBI_72544', 'flavonoids', 73, 'flavonoids'), ('CHEBI_33284', 'nutrient', 95, 'nutrients'), ('CHEBI_47916', 'flavonoid', 108, 'flavonoid')]
PMC4377870	3/2015	S137-PMC4377870	['Vitamin D\nepidemiological studies SHOW PROMISING ASSOCIATIONS between Vitamin D and Lung health; HOWEVER the mechanisms responsible for these EFFECTS are POORLY UNDERSTOOD.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('SUPERFICIAL_RELATIONSHIP', 142), ('FULL_UNKNOWN', 154)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0002048', 'lung', 84, 'lung')]
PMC4377870	3/2015	S138-PMC4377870	['Vitamin D CAN be obtained from dietary sources or supplementation; HOWEVER sun exposure is the main CONTRIBUTOR to Vitamin D levels [108].']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('SUPERFICIAL_RELATIONSHIP', 100)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4377870	3/2015	S139-PMC4377870	['WHILE Vitamin D has beneficial EFFECTS INDEPENDENT of uv exposure [109], it can be DIFFICULT to separate this POTENTIAL CONFOUNDER from direct EFFECTS of Vitamin D on Lung health [110].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 39), ('DIFFICULT_TASK', 83), ('INCOMPLETE_EVIDENCE', 110), ('PROBLEM_COMPLICATION', 120), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0002048', 'lung', 167, 'lung')]
PMC4377870	3/2015	S140-PMC4377870	['the review by foong and zosky [111] presents the CURRENT EVIDENCE for the ROLE of Vitamin D deficiency in disease onset, progression and exacerbation in Respiratory infections, asthma and copd.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 153, 'respiratory')]
PMC4377870	3/2015	S144-PMC4377870	['in vitro studies also SUPPORT the LINK between Vitamin D and Airway Remodelling AS active Vitamin D inhibits Airway Smooth Muscle (Asm) Cell Proliferation [114] and deficiency impairs normal Lung Development [115].']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('PROBABLE_UNDERSTANDING', 80)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 61, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 61, 'airway'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CL_0002633', 'respiratory basal cell', 109, 'airway smooth muscle ... cell'), ('UBERON_0001005', 'respiratory airway', 109, 'airway'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 116, 'smooth muscle'), ('UBERON_0001135', 'smooth muscle tissue', 116, 'smooth muscle'), ('UBERON_0001637', 'artery', 131, 'ASM'), ('GO_0008283', 'cell proliferation', 136, 'cell proliferation'), ('GO_0030324', 'lung development', 191, 'lung development'), ('UBERON_0002048', 'lung', 191, 'lung')]
PMC4377870	3/2015	S145-PMC4377870	['furthermore, Animal MODELS SUGGEST that Vitamin D CAN inhibit Th1 and Th2 Cell Cytokine Production [116].']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 50)]	3	[('NCBITaxon_33208', 'Metazoa', 13, 'animal'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CL_0000545', 'T-helper 1 cell', 62, 'Th1 ...'), ('GO_0042639', 'telogen', 62, 'Th1 ...'), ('CL_0000546', 'T-helper 2 cell', 70, 'Th2 cell'), ('GO_0035745', 'T-helper 2 cell cytokine production', 70, 'Th2 cell cytokine production')]
PMC4377870	3/2015	S146-PMC4377870	['epidemiological EVIDENCE LINKS low levels of Vitamin D with wheeze and Respiratory infections, THOUGH EVIDENCE for the LINK with asthma onset is weak and INCONSISTENT [111].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 71, 'respiratory')]
PMC4377870	3/2015	S149-PMC4377870	['other OBSERVATIONAL STUDIES report that in children, low levels of Vitamin D are ASSOCIATED with asthma exacerbation [118].']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 81)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4377870	3/2015	S150-PMC4377870	['several OBSERVATIONAL STUDIES SUPPORT the ROLE of Vitamin D for protection against Respiratory conditions in children.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 83, 'respiratory')]
PMC4377870	3/2015	S152-PMC4377870	['[119] FOUND that Vitamin D deficiency at 18 weeks Gestation was ASSOCIATED with lower Lung function and current wheeze in children 6 years of age and an increased risk of asthma in boys.']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'gestation'), ('UBERON_0002048', 'lung', 86, 'lung')]
PMC4377870	3/2015	S153-PMC4377870	['the ROLE for Vitamin D in enhancing Steroid responsiveness SUGGESTED by observational studies [120] is SUPPORTED by mechanistic studies [121], and in concert with the actions of Vitamin D in infection, MAY EXPLAIN the EFFECT of Vitamin D in reducing asthma exacerbations [111].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 206), ('SUPERFICIAL_RELATIONSHIP', 218)]	6	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_35341', 'steroid', 36, 'steroid'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC4377870	3/2015	S154-PMC4377870	['ONLY ONE intervention TRIAL HAS BEEN conducted using Vitamin D in Adults with asthma, which FOUND that rate of first exacerbation was reduced in subjects who demonstrated an increase in circulating Vitamin D3 following supplementation [122].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 92)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0007023', 'adult organism', 66, 'adults'), ('CHEBI_33279', 'vitamin D5', 198, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 198, 'vitamin D3')]
PMC4377870	3/2015	S155-PMC4377870	['data for the ROLE of Vitamin D in copd onset is LIMITED, THOUGH SEVERAL cross-sectional STUDIES HAVE REPORTED an ASSOCIATION between low Vitamin D levels, or deficiency, with copd incidence [123].']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 113)]	6	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4377870	3/2015	S156-PMC4377870	['Blood Vitamin D levels HAVE also BEEN CORRELATED with Lung function in copd patients [124,125].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0002048', 'lung', 54, 'lung')]
PMC4377870	3/2015	S157-PMC4377870	['experimental data SUGGEST that Vitamin D MAY BE IMPORTANT in copd for its EFFECT on normal Lung growth and Development, though Human data to support this is not available.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 41), ('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0030324', 'lung development', 91, 'lung ... development'), ('UBERON_0002048', 'lung', 91, 'lung'), ('NCBITaxon_9606', 'Homo sapiens', 127, 'human')]
PMC4377870	3/2015	S158-PMC4377870	['IT IS POSSIBLE that copd onset MAY also be IMPACTED by Cellular Responses to cigarette smoke exposure which inhibits the protective immunomodulatory EFFECTS of Vitamin D [126].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 149)]	4	[('GO_0006915', 'apoptotic process', 55, 'cellular responses'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4377870	3/2015	S159-PMC4377870	['there is research SUGGESTING a Genetic LINK between Vitamin D and copd pathogenesis.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('SO_0000704', 'gene', 31, 'genetic'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC4377870	3/2015	S160-PMC4377870	['in an OBSERVATIONAL study Single Nucleotide Polymorphisms in the Vitamin D Binding Protein (Vdbp) PREDICTED Vitamin D levels in copd patients and were FOUND TO BE a risk FACTOR for copd [123].']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 98), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 170)]	4	[('SO_0000694', 'SNP', 26, 'single nucleotide polymorphisms'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 65, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 92, 'VDBP'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4377870	3/2015	S162-PMC4377870	['copd progression MAY also be AFFECTED by Vitamin D status through absence of the Vitamin D receptor and Parenchyma degradation [128].']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 29)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000353', 'parenchyma', 104, 'parenchyma')]
PMC4377870	3/2015	S163-PMC4377870	['copd exacerbations are GENERALLY caused by Viral or bacterial Lung infections, and THOUGH Vitamin D has a positive ROLE in reducing infection, there is NO EVIDENCE to support that Vitamin D is ASSOCIATED with ameliorating exacerbations in copd patients [129].']	[('PROBABLE_UNDERSTANDING', 23), ('ANOMALY_CURIOUS_FINDING', 83), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('NCBITaxon_1', 'root', 43, 'viral'), ('UBERON_0002048', 'lung', 62, 'lung'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
PMC4377870	3/2015	S164-PMC4377870	['the extra-Skeletal EFFECTS of Vitamin D are WELL DOCUMENTED in both asthma and copd, and deficiency is ASSOCIATED with negative Respiratory and Immune outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('UBERON_0004288', 'skeleton', 10, 'skeletal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 128, 'respiratory'), ('UBERON_0002405', 'immune system', 144, 'immune')]
PMC4377870	3/2015	S178-PMC4377870	['a SMALL STUDY in sweden FOUND that in older subjects with SEVERE copd, Intakes of Folic Acid and Selenium were below recommended levels, and although intake of calcium was adequate, Serum calcium levels were low, LIKELY RELATED to their Vitamin D status AS Intake was lower than recommended [141].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 58), ('PROBABLE_UNDERSTANDING', 213), ('SUPERFICIAL_RELATIONSHIP', 220), ('PROBABLE_UNDERSTANDING', 254)]	6	[('GO_0007631', 'feeding behavior', 71, 'intakes'), ('CHEBI_30751', 'formic acid', 82, 'folic acid'), ('CHEBI_27568', 'selenium atom', 97, 'selenium'), ('UBERON_0001977', 'blood serum', 182, 'serum'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('GO_0007631', 'feeding behavior', 257, 'intake')]
PMC4377870	3/2015	S249-PMC4377870	['a whole Foods approach to Nutrient supplementation—for example, increasing intake of fruit and vegetables, has the benefit of increasing intake of multiple Nutrients, including vitamin C, Vitamin E, Carotenoids and Flavonoids and SHOWS more promise in Respiratory diseases in terms of reducing risk of copd [3] and incidence of asthma exacerbations [25].']	[('INCOMPLETE_EVIDENCE', 230)]	1	[('CHEBI_33290', 'food', 8, 'foods'), ('CHEBI_33284', 'nutrient', 26, 'nutrient'), ('CHEBI_33284', 'nutrient', 156, 'nutrients'), ('CHEBI_18245', 'carboxylato group', 185, 'C'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin E'), ('CHEBI_50815', 'norgestimate', 199, 'carotenoids'), ('CHEBI_72544', 'flavonoids', 215, 'flavonoids'), ('UBERON_0001004', 'respiratory system', 252, 'respiratory')]
PMC4377870	3/2015	S250-PMC4377870	['the EVIDENCE for mechanisms of Vitamin D in Lung Development and Immune function are yet to be fully established.']	[('INCOMPLETE_EVIDENCE', 4)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0030324', 'lung development', 44, 'lung development'), ('UBERON_0002048', 'lung', 44, 'lung'), ('GO_0007566', 'embryo implantation', 65, 'immune'), ('UBERON_0002405', 'immune system', 65, 'immune')]
PMC4377879	3/2015	S38-PMC4377879	['a systematic review identifying all studies that had been published between 1988 and 2008 reporting on Micronutrient intakes in women living in such environments, SHOWED that for women, the REPORTED mean/median intakes in over 50% of the studies were below the estimated average requirements (ear) for Micronutrient intakes, except for Vitamin a, Vitamin C, and niacin, where the reported intakes were around a third of the ear, 29%, 34% and 34% respectively [11].']	[('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 190)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 103, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 302, 'micronutrient'), ('CHEBI_33229', 'vitamin (role)', 336, 'vitamin'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin C')]
PMC4377879	3/2015	S89-PMC4377879	['a cochrane review FOUND a significant RELATIONSHIP between an increase in Serum Vitamin D concentrations at term and borderline reduction in low Birthweight [42] but there is yet NOT ENOUGH EVIDENCE for policy AS the NUMBER OF high-quality trials IS THOUGHT TO be currently too SMALL to draw conclusions on its usefulness and SAFETY [18].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 179), ('PROBABLE_UNDERSTANDING', 210), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 278), ('IMPORTANT_CONSIDERATION', 326)]	9	[('UBERON_0001977', 'blood serum', 74, 'serum'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007596', 'blood coagulation', 145, 'birthweight')]
PMC4377879	3/2015	S90-PMC4377879	['OTHER Vitamins : DEFICIENCIES of YET OTHER Vitamins such as Vitamin B12 and PERHAPS Vitamin A MAY BE IMPORTANT BUT EVIDENCE IS SPARSE OR CONFLICTING [22,43].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 17), ('ANOMALY_CURIOUS_FINDING', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 94), ('IMPORTANT_CONSIDERATION', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137)]	11	[('CHEBI_33277', 'gamma-tocotrienol', 6, 'vitamins'), ('CHEBI_33277', 'gamma-tocotrienol', 43, 'vitamins'), ('CHEBI_33279', 'vitamin D5', 60, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 60, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A')]
PMC4377879	3/2015	S95-PMC4377879	['POSSIBLE side-effects of overdosage of Vitamin E and Vitamin C in Pregnancy are discussed below (section 7.2).']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 39, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin C'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy')]
PMC4377879	3/2015	S128-PMC4377879	['christian and stewart [52] have SUGGESTED a conceptual FRAMEWORK for HOW Maternal diet and Micronutrient status MAY EFFECT the development of chronic disease; the MOST LIKELY, GIVEN PRESENT KNOWLEDGE, SEEM to be Vitamin A, Folate, iron and zinc and PERHAPS calcium and magnesium AS SHOWN in their conceptual framework (figure 1).']	[('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 55), ('EXPLICIT_QUESTION', 69), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 116), ('PROBABLE_UNDERSTANDING', 163), ('PROBABLE_UNDERSTANDING', 168), ('INCOMPLETE_EVIDENCE', 176), ('PROBABLE_UNDERSTANDING', 176), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 201), ('INCOMPLETE_EVIDENCE', 249), ('INCOMPLETE_EVIDENCE', 279)]	13	[('GO_0007618', 'mating', 73, 'maternal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 91, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 223, 'folate')]
PMC4377879	3/2015	S139-PMC4377879	['high-dose supplementation with Vitamin C and Vitamin E HAS BEEN FOUND to not prevent Preeclampsia but to increase the rate of babies Born with low birthweight [59].']	[('INCOMPLETE_EVIDENCE', 55)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin E'), ('GO_0007128', 'meiotic prophase I', 85, 'preeclampsia'), ('GO_0007567', 'parturition', 133, 'born')]
PMC4377879	3/2015	S141-PMC4377879	['there DOES NOT APPEAR TO BE EVIDENCE to RECOMMEND supplementation with Vitamins C and E.\n\n7.']	[('INCOMPLETE_EVIDENCE', 6), ('ANOMALY_CURIOUS_FINDING', 11), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 40)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamins C'), ('PR_000004900', 'complement C3', 80, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 86, 'E')]
PMC4377879	3/2015	S178-PMC4377879	['for example, Folate MAY mask symptoms of megaloblastic anemia, which COULD BE an INDICATOR of Vitamin B-12 deficiency [68].']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_30863', '5-azaorotic acid', 13, 'folate'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 94, 'vitamin B-12')]
PMC4377879	3/2015	S262-PMC4377879	['the provision of balanced energy protein supplementary Foods to underweight Pregnant women was also considered to have enough EVIDENCE of reduction in sga and stillbirths and improved Birthweights for widespread implementation, WHEREAS maternal Vitamin D and zinc supplementation, WHILE promising, were CONSIDERED to have INSUFFICIENT evidence [18].']	[('INCOMPLETE_EVIDENCE', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('ANOMALY_CURIOUS_FINDING', 281), ('INCOMPLETE_EVIDENCE', 303), ('INCOMPLETE_EVIDENCE', 322)]	6	[('CHEBI_33290', 'food', 55, 'foods'), ('GO_0007565', 'female pregnancy', 76, 'pregnant'), ('GO_0007596', 'blood coagulation', 184, 'birthweights'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC4377879	3/2015	S292-PMC4377879	['Micronutrients LIKELY to be IMPORTANT for maternal, infant and child outcomes include iron, Iodine, Folate, Vitamin B12, Vitamin D, Calcium, and Selenium, PROBABLY zinc and MAYBE others, along with appropriate dietary energy intakes.']	[('PROBABLE_UNDERSTANDING', 15), ('IMPORTANT_CONSIDERATION', 28), ('PROBABLE_UNDERSTANDING', 155), ('INCOMPLETE_EVIDENCE', 173)]	4	[('CHEBI_34850', 'milrinone lactate', 0, 'Micronutrients'), ('CHEBI_24859', 'iodine atom', 92, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 100, 'folate'), ('CHEBI_33279', 'vitamin D5', 108, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 132, 'calcium'), ('CHEBI_27568', 'selenium atom', 145, 'selenium')]
PMC4377888	3/2015	S25-PMC4377888	['for example, the EFFECTS of maternal dietary zinc, Vitamin A and protein restriction or maternal dietary fat excess all HAVE BEEN SHOWN to have a negative IMPACT on Kidney Development and later Renal disease in the offspring [16,17,18,19].']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 155)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0001822', 'kidney development', 165, 'kidney development'), ('UBERON_0002113', 'kidney', 165, 'kidney'), ('UBERON_0002113', 'kidney', 194, 'renal')]
PMC4377888	3/2015	S69-PMC4377888	['ALTHOUGH the ROLE of Vitamin A is well ESTABLISHED, OTHER maternal Micronutrient deficiencies are ASSOCIATED with abnormal Kidney structure or function in her offspring; BUT with LESS clear mechanisms lisle et al.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('INCOMPLETE_EVIDENCE', 179)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('UBERON_0002113', 'kidney', 123, 'kidney')]
PMC4377896	3/2015	S148-PMC4377896	['this MAY BE attributable to the synergistic EFFECTS of Food [34] and ASSOCIATED with fish being a source of OTHER Nutrients which are IMPORTANT for infant development such as Iodine and Vitamin D. presently, there HAVE BEEN NO randomised control TRIALS examining Neurocognitive outcomes ASSOCIATED with Prenatal multivitamin use and infant Neurodevelopment, and these are UNLIKELY to occur given ethical IMPLICATIONS of such [35].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('IMPORTANT_CONSIDERATION', 134), ('INCOMPLETE_EVIDENCE', 214), ('FULL_UNKNOWN', 224), ('SUPERFICIAL_RELATIONSHIP', 287), ('PROBABLE_UNDERSTANDING', 372), ('IMPORTANT_CONSIDERATION', 404)]	10	[('CHEBI_33290', 'food', 55, 'food'), ('CHEBI_33284', 'nutrient', 114, 'nutrients'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 263, 'neurocognitive'), ('GO_0007565', 'female pregnancy', 303, 'prenatal'), ('GO_0007399', 'nervous system development', 340, 'neurodevelopment')]
PMC4379001	3/2015	S18-PMC4379001	['waterland[8] et al SHOWED that dietary methyl supplementation with extra Folic Acid, Vitamin B (12), Choline, and betaine altered the phenotype of their offspring via increased Cpg Methylation.']	[('INCOMPLETE_EVIDENCE', 19)]	1	[('CHEBI_30751', 'formic acid', 73, 'folic acid'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin B'), ('CHEBI_15354', 'choline', 101, 'choline'), ('GO_0010424', 'DNA methylation on cytosine within a CG sequence', 177, 'CpG methylation')]
PMC4380381	3/2015	S91-PMC4380381	['a thorough review of the patient’s medications MAY reveal one of a NUMBER OF agents KNOWN to cause Intracranial hypertension including Vitamin A and Nitrofurantoin.35\nfirst-line therapy for iih in Pregnancy is diet and weight control.35second-line therapies include serial Lps and/or Acetazolamide (category c).']	[('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 84)]	3	[('UBERON_2000442', 'supraneural bone', 99, 'intracranial'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_85122', 'paraben', 149, 'nitrofurantoin'), ('GO_0007565', 'female pregnancy', 197, 'pregnancy'), ('CHEBI_16412', 'lipopolysaccharide', 273, 'LPs'), ('CHEBI_27690', 'acetazolamide', 284, 'acetazolamide')]
PMC4392531	3/2015	S72-PMC4392531	['they DEMONSTRATED that in those women who Consumed less than 10% of Foods containing Vitamin C and less than 21 mg per day of this Vitamin before Pregnancy, the risk of premature rupture Of the Fetal Membranes and Preterm Delivery were two times higher than in other women.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('GO_0007631', 'feeding behavior', 42, 'consumed'), ('CHEBI_33290', 'food', 68, 'foods'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 131, 'vitamin'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy'), ('GO_0007608', 'sensory perception of smell', 187, 'of ...'), ('UBERON_0000922', 'embryo', 194, 'fetal'), ('UBERON_0000922', 'embryo', 200, 'membranes'), ('GO_0007565', 'female pregnancy', 214, 'preterm'), ('GO_0007567', 'parturition', 222, 'delivery')]
PMC4392531	3/2015	S75-PMC4392531	['it is SUGGESTED that higher Consumption of fruits and vegetables containing Vitamin C and OTHER Antioxidants MAY reduce the incidence of pre-eclampsia.']	[('INCOMPLETE_EVIDENCE', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('INCOMPLETE_EVIDENCE', 109)]	3	[('GO_0007631', 'feeding behavior', 28, 'consumption'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin C'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 96, 'antioxidants')]
PMC4392531	3/2015	S77-PMC4392531	['[15] with reviewing a large NUMBER of controlled clinical trials, villar and colleagues CONCLUDED that lack of antioxidants including Vitamins A, e, and C in Pregnant women CAN increase the incidence of pre-eclampsia.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 173)]	3	[('CHEBI_27300', 'vitamin D', 134, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 143, 'A'), ('PR_000004900', 'complement C3', 153, 'C'), ('GO_0007565', 'female pregnancy', 158, 'pregnant')]
PMC4392531	3/2015	S89-PMC4392531	['HOWEVER, DUE TO the high amount of Vitamin A and e to protect Fatty Acids, the POSSIBILITY of hypervitaminosis SHOULD BE taken into account.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 79), ('FUTURE_WORK', 111)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin A'), ('CHEBI_35366', 'fatty acid', 62, 'fatty acids')]
PMC4392531	3/2015	S97-PMC4392531	["it is DOCUMENTED that limiting Milk Intake during Pregnancy COULD reduce the absorption of protein, calcium, and Vitamin D, which COULD THREATEN the infant's health through reducing the Birth weight."]	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 130), ('IMPORTANT_CONSIDERATION', 136)]	4	[('GO_0007614', 'short-term memory', 31, 'milk'), ('GO_0007631', 'feeding behavior', 36, 'intake'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007567', 'parturition', 186, 'birth')]
PMC4392553	3/2015	S389-PMC4392553	['[27] THUS, disruption of the shikimate pathway CONTRIBUTES to Vitamin K deficiency, which CAN lead to cholestasis.']	[('PROBABLE_UNDERSTANDING', 5), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 90)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin K')]
PMC4392553	3/2015	S425-PMC4392553	['[34] FOUND deficient levels of Vitamin D in 83% of black women and 92% of their newborns, as well as in 47% of white women and 66% of their newborns, DESPITE the fact that over 90% of the women were on Prenatal Vitamins.']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 150)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 202, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 211, 'vitamins')]
PMC4392553	3/2015	S431-PMC4392553	["[140]\nsamsel and seneff[248249] PROPOSED that the current Vitamin D deficiency EPIDEMIC is caused by Glyphosate, due TO Glyphosate's interference with cyp enzymes."]	[('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 117)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_17754', 'glycerol', 101, 'glyphosate'), ('CHEBI_17754', 'glycerol', 120, 'glyphosate')]
PMC4392553	3/2015	S432-PMC4392553	['the Metabolite that is USUALLY measured, 25-Hydroxy Vitamin D, is the product of activation in the Liver by a cyp enzyme that is also CRITICAL in Bile Acid Formation.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 134)]	2	[('CHEBI_39382', 'flufenoxuron', 4, 'metabolite'), ('CHEBI_43141', '3-hydroxypropoxy group', 41, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002107', 'liver', 99, 'liver'), ('CHEBI_3098', 'bile acid', 146, 'bile acid'), ('GO_0006699', 'bile acid biosynthetic process', 146, 'bile acid formation'), ('UBERON_0001970', 'bile', 146, 'bile')]
PMC4396888	3/2015	S10-PMC4396888	['nutrient intake SHOWED suboptimal Consumption Of Protein and Micronutrients like iron, Calcium, Vitamin A, Vitamin C, Thiamine, riboflavin niacin, zinc and Vitamin B12 by more than half of women.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('GO_0070278', 'extracellular matrix constituent secretion', 34, 'consumption of protein'), ('CHEBI_33839', 'macromolecule', 61, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 87, 'calcium'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin C'), ('CHEBI_26948', 'vitamin B1', 118, 'thiamine'), ('CHEBI_33279', 'vitamin D5', 156, 'vitamin B12')]
PMC4396888	3/2015	S28-PMC4396888	['studies HAVE SHOWN that Pregnant women in urban poor settlements in delhi had a poor dietary intake with majority of women Consuming less than 50% of recommended dietary allowances for protein, Iron and Vitamin A with their Intake not being significantly different from their non-Pregnant counterparts [15,16].']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('GO_0007565', 'female pregnancy', 24, 'pregnant'), ('GO_0007631', 'feeding behavior', 123, 'consuming'), ('CHEBI_24870', 'ion', 194, 'iron'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin A'), ('GO_0007631', 'feeding behavior', 224, 'intake'), ('GO_0007565', 'female pregnancy', 280, 'pregnant')]
PMC4404267	4/2015	S31-PMC4404267	['in addition, certain physiological conditions (Vitamin D depletion, hypokalaemia, Metabolic acidosis) and Pharmacological Drugs (Nsaids, Glucocorticoids) are KNOWN to down-regulate Slc13A1 mrna and protein Expression [27].']	[('INCOMPLETE_EVIDENCE', 158)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0008152', 'metabolic process', 82, 'metabolic'), ('CHEBI_33832', 'organic cyclic compound', 106, 'pharmacological drugs'), ('CHEBI_13389', 'NAD', 129, 'NSAIDS'), ('CHEBI_36597', 'phthalazine', 137, 'glucocorticoids'), ('PR_000014939', 'urea transporter 2', 181, 'SLC13A1'), ('GO_0010467', 'gene expression', 206, 'expression')]
PMC4405493	4/2015	S1-PMC4405493	['the EFFECT of Vitamin D deficiency in Pregnancy is UNKNOWN, but HAS BEEN ASSOCIATED with adverse Pregnancy outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('FULL_UNKNOWN', 51), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 73)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy')]
PMC4405493	4/2015	S13-PMC4405493	['HOWEVER, the high percentage of affected Individuals HIGHLIGHTS the prevalence of Vitamin D deficiency in young, Reproductive-aged women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 53)]	2	[('NCBITaxon_1', 'root', 41, 'individuals'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0000003', 'reproduction', 113, 'reproductive')]
PMC4405493	4/2015	S15-PMC4405493	['the etiology for this increase is LIKELY MULTIFACTORIAL, but due IN PART to low dietary intake of Vitamin D and limited exposure to sunlight.']	[('PROBABLE_UNDERSTANDING', 34), ('DIFFICULT_TASK', 41), ('INCOMPLETE_EVIDENCE', 65)]	3	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4405493	4/2015	S16-PMC4405493	['certain HIGH risk groups for Vitamin D deficiency in Pregnancy HAVE BEEN IDENTIFIED, including vegetarians, women with limited sun exposure (e.g., those who live in cold climates, northern latitudes, or wear sun and winter protective clothing), and ethnic minorities, especially those with darker skin [2].']	[('IMPORTANT_CONSIDERATION', 8), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 73)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 53, 'pregnancy')]
PMC4405493	4/2015	S18-PMC4405493	['during Pregnancy, severe maternal Vitamin D deficiency, AS defined as Serum 25-Hydroxyvitamin D (25-Oh Vitamin D) concentrations less than 5 ng/ml, HAS BEEN ASSOCIATED with disordered Skeletal Homeostasis, congenital rickets, and fractures of the newborn [4].']	[('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 157)]	3	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 76, '25-hydroxyvitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 97, '25-OH'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0043276', 'anoikis', 184, 'skeletal homeostasis'), ('UBERON_0004288', 'skeleton', 184, 'skeletal')]
PMC4405493	4/2015	S20-PMC4405493	['RECENT observational and randomized control trials have ATTEMPTED TO investigate THIS ISSUE, but there REMAINS LIMITED GUIDANCE on the management of Vitamin D deficiency during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('DIFFICULT_TASK', 56), ('INCOMPLETE_EVIDENCE', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 86), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 111), ('FUTURE_WORK', 119)]	9	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
PMC4405493	4/2015	S22-PMC4405493	['HOWEVER, OTHER STUDIES have DEMONSTRATED no association between Vitamin D status and adverse Pregnancy outcomes [11–12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy')]
PMC4405493	4/2015	S62-PMC4405493	['categorization of Vitamin D status\nRECENTLY published criteria from the institute of medicine were used to categorize Vitamin D status by Plasma 25-Oh Vitamin D concentrations: severe deficiency (<10 ng/ml [25nmol/l]); deficiency (< 20 ng/ml [50nmol/l]); insufficiency (21–29 ng/ml [51–74 nmol/l]); and sufficiency (≥ 30 ng/ml [75nmol/l] [18].']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 138, 'plasma'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 145, '25-OH'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
PMC4405493	4/2015	S63-PMC4405493	['statistics\nwe ESTIMATED the APPROXIMATE number of patients needed for adequate statistical power with an expected complication rate of 25% among all Vitamin D categories.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 28)]	2	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4405493	4/2015	S70-PMC4405493	['independent variables were Vitamin D category according to criteria RECENTLY published by the institute of medicine and Endocrine society (i.e., sufficient, >30 ng/ml; insufficient, 21–29 ng/ml; or deficient, <21 ng/ml) [18–19].']	[('INCOMPLETE_EVIDENCE', 68)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 120, 'Endocrine')]
PMC4405493	4/2015	S86-PMC4405493	['information on patient time in the area prior to Pregnancy, dietary intake of Vitamin D, and sun exposure was NOT AVAILABLE.']	[('INCOMPLETE_EVIDENCE', 110)]	1	[('GO_0007565', 'female pregnancy', 49, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4405493	4/2015	S114-PMC4405493	['ALTHOUGH we recruited ONLY young, nulliparous, previously healthy women, the majority of our patients were either Vitamin D deficient (10%, <20 ng/ml) or Vitamin D insufficient (60%, 20–29 ng/ml) according TO the criteria published by the institute for medicine.18of the 235 patients included in the study, 41 of them had a prior Pregnancy which had resulted in a spontaneous First Trimester Miscarriage or elective termination.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 206)]	3	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007565', 'female pregnancy', 330, 'pregnancy'), ('GO_0042733', 'embryonic digit morphogenesis', 376, 'first trimester'), ('GO_0046660', 'female sex differentiation', 392, 'miscarriage')]
PMC4405493	4/2015	S117-PMC4405493	['this study was NOT POWERED to detect ASSOCIATIONS between Vitamin D status and these individual Pregnancy complications.fig 1compares our study population with RECENTLY PUBLISHED cohort studies and randomized controlled trials (reviewed in christesen [2012] and wei [2013]) [13,39].10.1371/journal.pone.0123763.g001\n\ncaption (fig): fig 1\ncomparison of study parameters in recent Vitamin D OBSERVATIONAL and intervention studies.']	[('DIFFICULT_TASK', 15), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 389)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin D')]
PMC4405493	4/2015	S119-PMC4405493	['the PREVALENCE of Vitamin D deficiency in Reproductive aged women APPEARS TO BE increasing worldwide over the past two decades.1,3,13recent STUDIES INDICATE the prevalence of Vitamin D insufficiency and deficiency in nulliparous women, a result CORROBORATED by our study [40].']	[('IMPORTANT_CONSIDERATION', 4), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 245)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0000003', 'reproduction', 42, 'reproductive'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC4405493	4/2015	S120-PMC4405493	['the etiology of the decline of Vitamin D status in women is LIKELY MULTIFACTORIAL, but is due IN PART to increasing bmi and increased sun protection, coupled with decreased dietary intake of Vitamin D, such as milk and other dairy products.']	[('PROBABLE_UNDERSTANDING', 60), ('DIFFICULT_TASK', 67), ('INCOMPLETE_EVIDENCE', 94)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4405493	4/2015	S122-PMC4405493	['recent clinical GUIDELINES SUGGEST that doses of Vitamin D greater than 600 iu/day MAY BE needed to maintain adequate Plasma levels greater than 30 ng/ml (75 nmol/l), BUT the appropriate standard is still DEBATED [19,42–43].']	[('PROBABLE_UNDERSTANDING', 16), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 118, 'plasma')]
PMC4405493	4/2015	S123-PMC4405493	['in RECENT randomized controlled STUDIES, loading doses as high as 1000–4000 iu/day were needed before adequate Vitamin D Plasma concentrations were measured [18–19,44].']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 121, 'plasma')]
PMC4405493	4/2015	S133-PMC4405493	['these levels are CONSIDERED to be an accurate representation of the Vitamin D status of an Individual [1,45].']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('NCBITaxon_1', 'root', 91, 'individual')]
PMC4405493	4/2015	S138-PMC4405493	['as our study center is around 47 degrees latitude and 38% of our first Trimester Blood draws occurred in the winter, this CERTAINLY COULD CONTRIBUTE to the prevalence of Vitamin D deficiency in our population.']	[('ANOMALY_CURIOUS_FINDING', 122), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('GO_0009294', 'DNA mediated transformation', 71, 'trimester'), ('UBERON_0000178', 'blood', 81, 'blood'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC4405493	4/2015	S147-PMC4405493	['the ROLE Vitamin D plays in adverse clinical outcomes such as Preeclampsia, Gestational diabetes, Preterm Labor, growth restriction, and spontaneous Abortion is SPECULATIVE, but MAY INVOLVE Vitamin D’s Regulation Of Placental Trophoblast Invasion and Angiogenesis, in addition to its anti-inflammatory properties [5].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 182), ('SUPERFICIAL_RELATIONSHIP', 202)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 62, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 76, 'gestational'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 98, 'preterm labor'), ('GO_0007569', 'cell aging', 149, 'abortion'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('GO_1900101', 'regulation of endoplasmic reticulum unfolded protein response', 202, 'regulation of ... invasion ...'), ('UBERON_0001987', 'placenta', 216, 'placental'), ('UBERON_0000088', 'trophoblast', 226, 'trophoblast'), ('GO_0001525', 'angiogenesis', 251, 'angiogenesis')]
PMC4405493	4/2015	S148-PMC4405493	['for example, there is SOME EVIDENCE Vitamin D AFFECTS transcription and function of Genes responsible for Trophoblast invasion and Angiogenesis, two factors CRITICAL for Placenta Development.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 46), ('IMPORTANT_CONSIDERATION', 157)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('SO_0000704', 'gene', 84, 'genes'), ('UBERON_0000088', 'trophoblast', 106, 'trophoblast'), ('GO_0001525', 'angiogenesis', 131, 'angiogenesis'), ('GO_0001890', 'placenta development', 170, 'placenta development'), ('UBERON_0001987', 'placenta', 170, 'placenta')]
PMC4405493	4/2015	S150-PMC4405493	['maternal Vitamin D deficiency MAY also PREDISPOSE women to an increased inflammatory response that characterizes preeclampsia, ESPECIALLY SEVERE, early onset disease (reviewed in christesen [2012] and wei [2013]) [13,39].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 127), ('IMPORTANT_CONSIDERATION', 138)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4405493	4/2015	S155-PMC4405493	['THUS, in combination with its immunomodulatory and anti-inflammatory properties, Vitamin D MAY play a POTENTIAL ROLE in the PREVENTION of Preterm Birth and small-for-Gestational-age neonates.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 112), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'preterm birth'), ('GO_0007565', 'female pregnancy', 166, 'gestational')]
PMC4405493	4/2015	S157-PMC4405493	['HOWEVER, WHETHER Vitamin D deficiency is a RISK FACTOR for Gestational diabetes in itself OR IF Vitamin D supplementation CAN PREVENT gdm is YET UNKNOWN [72].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 126), ('FULL_UNKNOWN', 141)]	7	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'gestational'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4405493	4/2015	S158-PMC4405493	['although Vitamin D has a biologically POSSIBLE ROLE in all the aforementioned disorders, this WAS NOT DEMONSTRATED in our population AS Vitamin D deficiency did not increase the odds for adverse Pregnancy outcome in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 133), ('QUESTION_ANSWERED_BY_THIS_WORK', 216)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy')]
PMC4405493	4/2015	S162-PMC4405493	['obesity is also a KNOWN RISK FACTOR for Vitamin D deficiency[73].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 24)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4405493	4/2015	S176-PMC4405493	['HOWEVER, the high percentage of affected Individuals HIGHLIGHTS the prevalence of Vitamin D deficiency and insufficiency in young, healthy Reproductive-aged women in OUR STUDY population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 166)]	3	[('NCBITaxon_1', 'root', 41, 'individuals'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0000003', 'reproduction', 139, 'reproductive')]
PMC4405493	4/2015	S178-PMC4405493	['ALTHOUGH OUR STUDY DID NOT DEMONSTRATE an association of Vitamin D Plasma concentration with select clinical outcomes, the prevalence of sub-optimal Vitamin D concentrations in patient plasma EMPHASIZES THE NEED for CONTINUED RESEARCH on hypovitaminosis d in Pregnancy and Reproductive health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 192), ('INCOMPLETE_EVIDENCE', 203), ('FUTURE_WORK', 207), ('FUTURE_WORK', 216)]	10	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 67, 'plasma'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 259, 'pregnancy'), ('GO_0000003', 'reproduction', 273, 'reproductive')]
PMC4408096	4/2015	S14-PMC4408096	['WHILE iron deficiency IS CONSIDERED the LEADING cause of anemia, OTHER causes include deficiencies in Micronutrients such as Folate, Vitamin B12, and Vitamin A, infestations with parasites such as helminths or malaria, Genetically-inherited hemoglobinopathies, hiv/aids, and chronic inflammation [3,4].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65)]	4	[('CHEBI_33839', 'macromolecule', 102, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 125, 'folate'), ('CHEBI_33279', 'vitamin D5', 133, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin A'), ('SO_0000704', 'gene', 219, 'genetically')]
PMC4417995	4/2015	S1-PMC4417995	['a wealth of STUDIES describing a beneficial EFFECT of Vitamin D on atopic dermatitis (ad) prevalence and severity are KNOWN.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 118)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4417995	4/2015	S2-PMC4417995	['HOWEVER, OBSERVATIONS LINKING high Vitamin D levels to an INCREASED RISK of developing ad HAVE also BEEN published, EFFECTIVELY creating a CONTROVERSY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 58), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4417995	4/2015	S3-PMC4417995	['in THIS PAPER, we review the EXISTING LITERATURE on the ASSOCIATION between ad and Vitamin D levels, FOCUSING on childhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 101)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC4417995	4/2015	S4-PMC4417995	['as of today, the ROLE of Vitamin D in ad is FAR FROM CLEAR; ADDITIONAL STUDIES ARE PARTICULARLY NEEDED in order to confirm the PROMISING therapeutic ROLE of Vitamin D supplementation in childhood ad.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('FULL_UNKNOWN', 44), ('FUTURE_WORK', 60), ('FUTURE_WORK', 71), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 149)]	8	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4417995	4/2015	S12-PMC4417995	['the function of Vitamin D, traditionally ASSOCIATED with calcium and Phosphate Homeostasis, IS THOUGHT TO be highly COMPLEX, and its POTENTIAL ROLES in Cardiovascular, neoplastic, and Microbial infections and Autoimmune diseases HAVE BEEN investigated in RECENT STUDIES [5].']	[('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 92), ('DIFFICULT_TASK', 116), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 143), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 255)]	7	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0051320', 'S phase', 69, 'phosphate'), ('GO_0042592', 'homeostatic process', 79, 'homeostasis'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('NCBITaxon_10088', 'Mus <genus>', 184, 'microbial'), ('UBERON_0001442', 'skeleton of manus', 209, 'autoimmune')]
PMC4417995	4/2015	S24-PMC4417995	['data in Adults SUGGESTS that Vitamin D levels less than approximately 30\u2009ng/ml are ASSOCIATED with changes in Parathyroid hormone levels, as well as Intestinal calcium transport [13].']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('UBERON_0007023', 'adult organism', 8, 'adults'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 110, 'parathyroid'), ('UBERON_0000160', 'intestine', 149, 'intestinal')]
PMC4417995	4/2015	S37-PMC4417995	['[22] demonstrated that Vitamin D inhibits Ifn- Γ Production and promotes Il-4, Il-5, and Il-10 Production in a Mouse MODEL.']	[('INCOMPLETE_EVIDENCE', 117)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0072653', 'interferon-omega production', 42, 'IFN- γ production'), ('PR_000008920', 'interferon alpha-7', 42, 'IFN- γ'), ('PR_000001470', 'interleukin-28B', 73, 'IL-4'), ('PR_000001470', 'interleukin-28B', 79, 'IL-5'), ('PR_000001470', 'interleukin-28B', 89, 'IL-10'), ('GO_0001833', 'inner cell mass cell proliferation', 91, '-10 production'), ('NCBITaxon_10088', 'Mus <genus>', 111, 'mouse')]
PMC4417995	4/2015	S38-PMC4417995	['THESE STUDIES SUGGEST that deficiencies in Vitamin D levels and/or signaling would favor a PREDOMINANT th2 response and that the presence of Vitamin D, while suppressing th1 effects, also promotes th2 Responses.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 91)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0060033', 'anatomical structure regression', 201, 'responses')]
PMC4417995	4/2015	S39-PMC4417995	['HOWEVER LIMITED DATA showed Vitamin D MIGHT attenuate, RATHER than promote, Th2 responses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0006285', 'base-excision repair, AP site formation', 76, 'Th2')]
PMC4417995	4/2015	S45-PMC4417995	['GIVEN the above, Vitamin D deficiency MIGHT PREDISPOSE patients with ad to skin superinfection by staphylococcus aureus or its superantigens [24].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 44)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC4417995	4/2015	S47-PMC4417995	['Vitamin D levels and ad severity and prevalence\nFEW STUDIES have evaluated the prevalence and severity of ad in Vitamin D deficient children.']	[('INCOMPLETE_EVIDENCE', 48)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4417995	4/2015	S49-PMC4417995	['[25], in a case-control study of 290 obese patients, SHOWED that 5% of patients with Vitamin D deficiency had ad, compared with 1% of the Vitamin D-replete group.']	[('INCOMPLETE_EVIDENCE', 53)]	1	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC4417995	4/2015	S57-PMC4417995	['overall these data SEEM to INDICATE that Vitamin D deficiency is RELATED to the severity of ad.']	[('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4417995	4/2015	S61-PMC4417995	['[30] OBSERVED that higher intake of Vitamin D during the first year of Life was CORRELATED with increased risk of eczema at age six.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 71, 'life')]
PMC4417995	4/2015	S63-PMC4417995	['REGARDLESS OF family history of atopy, ad was more prevalent in those with the highest intake of Vitamin D.\nthrough a nationwide cross-sectional survey on 9838 german children and adolescents with eczema, heimbeck et al.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4417995	4/2015	S64-PMC4417995	['[31] FOUND a significantly reduced risk of eczema for the lowest Vitamin D Serum quartile COMPARED TO the reference quartile in a multivariate analysis.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001977', 'blood serum', 75, 'serum')]
PMC4417995	4/2015	S66-PMC4417995	['[32] evaluated 94 children of 1 to 16 years old living in urban milwaukee (usa), FINDING no statistically significant association between Vitamin D levels and ad severity.']	[('INCOMPLETE_EVIDENCE', 81)]	1	[('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC4417995	4/2015	S68-PMC4417995	['in CONCLUSION, ALTHOUGH there is a predominance of PAPERS POINTING TO Vitamin D as a PROTECTIVE FACTOR, VARIOUS STUDIES actually IDENTIFY it as a risk factor for ad.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 129)]	7	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4417995	4/2015	S70-PMC4417995	['[33], who PROPOSED a bimodal and/or gender specific RELATIONSHIP between Vitamin D and allergic skin diseases.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4417995	4/2015	S79-PMC4417995	['SINCE sun/uvb exposure increases Vitamin D Serum levels, SOME authors have logically HYPOTHESIZED that ad clinical improvement by sun/uvb MIGHT be MEDIATED at a molecular level by Vitamin D.\nthis is SUPPORTED by the observation that Vitamin D deficiency is ASSOCIATED with more SEVERE skin lesions localized on body sites that are not exposed to sun [37].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 257), ('IMPORTANT_CONSIDERATION', 278)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC4417995	4/2015	S80-PMC4417995	['this would be a CONSEQUENCE of Vitamin D decreased production in covered skin areas, THUS INDICATING a local PROTECTIVE EFFECT of Vitamin D against the development of ad lesions.']	[('PROBABLE_UNDERSTANDING', 16), ('PROBABLE_UNDERSTANDING', 85), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC4417995	4/2015	S82-PMC4417995	['[38] DEMONSTRATED that significantly higher concentrations of Serum Vitamin D were FOUND in carriers of Filaggrin mutations.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 83)]	2	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('PR_000007591', 'protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha', 104, 'filaggrin')]
PMC4417995	4/2015	S83-PMC4417995	['this indirectly CHALLENGES the HYPOTHESIS that the increased prevalence of atopic disease CAN be a CONSEQUENCE of Vitamin D insufficiency secondary to reduced solar/uvb exposure.']	[('DIFFICULT_TASK', 16), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 99)]	4	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4417995	4/2015	S86-PMC4417995	['[39], studying ad in 157 patients, 73.3% of which between the ages of 0–15, SHOWED that, in the 36 patients with diagnosed Food sensitization, mean Serum levels of Vitamin D were significantly higher in patients with mild ad (21.2 ± 5.18\u2009ng/ml) COMPARED TO those with moderate (17.9 ± 4.02\u2009ng/ml) or severe ad (13.3 ± 5.11\u2009ng/ml).']	[('INCOMPLETE_EVIDENCE', 76), ('ANOMALY_CURIOUS_FINDING', 245)]	2	[('CHEBI_33290', 'food', 123, 'food'), ('GO_0007631', 'feeding behavior', 123, 'food'), ('UBERON_0001977', 'blood serum', 148, 'serum'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4417995	4/2015	S90-PMC4417995	['[41] DEMONSTRATED a negative CORRELATION between the scorad [42] and Serum Vitamin D levels in allergic sensitized Individuals, WHEREAS no correlation was noted in the group without sensitization.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128)]	3	[('UBERON_0001977', 'blood serum', 69, 'serum'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('NCBITaxon_1', 'root', 115, 'individuals')]
PMC4417995	4/2015	S93-PMC4417995	['Pregnancy Vitamin D levels\nthe maternal Vitamin D profile during Pregnancy HAS also BEEN long DEBATED.']	[('INCOMPLETE_EVIDENCE', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94)]	2	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 10, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy')]
PMC4417995	4/2015	S96-PMC4417995	['[44] reported that high Vitamin D values during Pregnancy MIGHT also be harmful with respect to Allergic disease development: children whose mothers had a 25(Oh)D concentration during Pregnancy of greater than 30\u2009ng/ml had an increased risk of atopic eczema on examination at 9 months compared with children whose mothers had a concentration of less than 12\u2009ng/ml.']	[('INCOMPLETE_EVIDENCE', 58)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'pregnancy'), ('GO_0040011', 'locomotion', 96, 'allergic'), ('CHEBI_63056', 'zinc cation', 155, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 161, 'D'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
PMC4417995	4/2015	S97-PMC4417995	['CONVERSELY, OTHER STUDIES DEMONSTRATED that children Born from mothers with low Fish or Vitamin D intake during Pregnancy had an increased prevalence of ad [45,46].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 26)]	4	[('GO_0007567', 'parturition', 53, 'born'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 80, 'fish'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC4417995	4/2015	S102-PMC4417995	['[48], who DEMONSTRATED that, for each 4\u2009ng/ml increase in Cord Blood Vitamin D levels, the RISK of eczema diminished by 13.3%.']	[('INCOMPLETE_EVIDENCE', 10), ('IMPORTANT_CONSIDERATION', 91)]	2	[('UBERON_0002240', 'spinal cord', 58, 'cord'), ('UBERON_0000178', 'blood', 63, 'blood'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4417995	4/2015	S106-PMC4417995	['[50] DEMONSTRATED an inverse ASSOCIATION between Cord Plasma Vitamin D levels and T-Regulatory Cells number.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 29)]	2	[('UBERON_0002240', 'spinal cord', 49, 'cord'), ('UBERON_0001969', 'blood plasma', 54, 'plasma'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CL_0000901', 'Tr1 cell', 82, 'T-regulatory cells'), ('GO_0065007', 'biological regulation', 84, 'regulatory')]
PMC4417995	4/2015	S110-PMC4417995	['[30] also EVIDENCED that breastfeeding is GENERALLY ASSOCIATED with low Vitamin D intake, AS OPPOSED TO replacement formulas and dairy drinks fortified with Vitamin D, which provide a CONSIDERABLY higher Intake.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('ANOMALY_CURIOUS_FINDING', 184)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007631', 'feeding behavior', 204, 'intake')]
PMC4417995	4/2015	S111-PMC4417995	['TRYING to elucidate WHETHER maternal Vitamin D supplementation during Lactation improves infantile eczema and other subsequent allergic disorders, a randomized double-blind, placebo-controlled trial [52] was conducted on 164 breastfeeding mothers of infants with Facial eczema.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007595', 'lactation', 70, 'lactation'), ('UBERON_0001456', 'face', 263, 'facial')]
PMC4417995	4/2015	S112-PMC4417995	['the analysis SHOWED that Vitamin D supplementation MAY not decrease the severity of infantile eczema at 3 months of age but MAY RATHER increase the risk of later Food allergy up to 2 years of age.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_33290', 'food', 162, 'food')]
PMC4417995	4/2015	S118-PMC4417995	['THEREFORE, the increased prevalence of ad in children with a higher dietary intake of Vitamin D COULD result from such early alimentary exposure to this Antigen, RATHER than being a direct consequence of Vitamin D Serum levels.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_59132', 'antigen', 153, 'antigen'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('UBERON_0001977', 'blood serum', 214, 'serum')]
PMC4417995	4/2015	S134-PMC4417995	['Vitamin D supplementation\na nutritional survey [59] comparing ad patients ( n = 132) with healthy controls ( n = 132) DEMONSTRATED that patients with ad had a lower Vitamin D dietary intake than the control group.']	[('INCOMPLETE_EVIDENCE', 118)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
PMC4417995	4/2015	S135-PMC4417995	['HOWEVER, Serum Vitamin D levels were NOT MEASURED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37)]	2	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC4417995	4/2015	S145-PMC4417995	['a larger trial [62] also SHOWED a significant reduction in scorad after Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 25)]	1	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4417995	4/2015	S150-PMC4417995	['[63] tested a 3-week supplementation with 1000\u2009iu/day Vitamin D in 14 atopic subjects with moderate to severe ad, SHOWING a significant increase in Cathelicidins Expression in lesional skin.']	[('INCOMPLETE_EVIDENCE', 114)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('PR_000005190', 'cell division cycle protein 23', 148, 'cathelicidins'), ('GO_0010467', 'gene expression', 162, 'expression')]
PMC4417995	4/2015	S152-PMC4417995	['[64] CONFIRMED this by SHOWING that Vitamin D leads to cathelicidins production and activation in Keratinocytes.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 23)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CL_0000312', 'keratinocyte', 98, 'keratinocytes')]
PMC4417995	4/2015	S153-PMC4417995	['the above data MAY EXPLAIN WHY skin infections occur more frequently in winter, when Keratinocytes are less stimulated by Vitamin D to produce Antimicrobial peptides.']	[('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 19), ('EXPLICIT_QUESTION', 27)]	3	[('CL_0000312', 'keratinocyte', 85, 'keratinocytes'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_65381', 'albizoside C', 143, 'antimicrobial')]
PMC4417995	4/2015	S154-PMC4417995	['HOWEVER, DESPITE all of the above EVIDENCES, no significant difference in ad severity after Vitamin D supplementation compared with Placebo was FOUND in a 2012 systematic literature review [65].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 144)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 132, 'placebo')]
PMC4417995	4/2015	S167-PMC4417995	["'s [66] observation, SUGGESTS that improvement MAY BE more evident in case of SEVERE Vitamin D deficiency."]	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4417995	4/2015	S173-PMC4417995	['OF NOTE, a positive CORRELATION was EVIDENCED between the increase in Vitamin D levels and the decrease in the scorad index in march but not in january.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 36)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4417995	4/2015	S179-PMC4417995	['topical therapy\ncertain OBSERVATIONS FURTHER aimed at clarifying the ROLE of topical Vitamin D analogues.']	[('INCOMPLETE_EVIDENCE', 24), ('FUTURE_WORK', 37), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 69)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4417995	4/2015	S183-PMC4417995	['conclusions\nepidemiological and clinical EVIDENCES INDICATE a beneficial ROLE for Vitamin D in ad.']	[('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4417995	4/2015	S184-PMC4417995	['these OBSERVATIONS are SUPPORTED by basic research data SHOWING that Vitamin D acts on many different Immune Cell functions.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 56)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CL_0000738', 'leukocyte', 102, 'immune cell'), ('UBERON_0002405', 'immune system', 102, 'immune')]
PMC4417995	4/2015	S186-PMC4417995	['similarly, to devise a STRATEGY for using Vitamin D in the therapy of ad SEEMS at present to be NOT FEASIBLE for DIFFERENT reasons: many CONFOUNDING and unidentified VARIABLES appear in EXISTING STUDIES, and they are OFTEN LIMITED by SMALL numbers of participants, their short durations, and the use of a fixed dose without optimizing for adequate Serum levels.']	[('FUTURE_WORK', 23), ('ANOMALY_CURIOUS_FINDING', 73), ('DIFFICULT_TASK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('PROBLEM_COMPLICATION', 137), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 186), ('PROBABLE_UNDERSTANDING', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 234)]	10	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0001977', 'blood serum', 348, 'serum')]
PMC4417995	4/2015	S187-PMC4417995	['THEREFORE systematic supplementation of Vitamin D in childhood ad currently cannot be RECOMMENDED EXCEPT for UNCOMMON cases which MAY prove refractory to traditional therapeutic options.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4427001	4/2015	S19-PMC4427001	['besides that, GROWING EVIDENCE mounted that Vitamin D has a number of Extraskeletal functions.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 70, 'extraskeletal')]
PMC4427001	4/2015	S21-PMC4427001	['the COMPLEXITY of Vitamin D action is FURTHER increased by vdr Gene polymorphism.']	[('DIFFICULT_TASK', 4), ('INCOMPLETE_EVIDENCE', 38)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('SO_0000704', 'gene', 63, 'gene')]
PMC4427001	4/2015	S24-PMC4427001	['furthermore, Vitamin D has a strong immunomodulatory EFFECT; it inhibits Angiogenesis [8] and is also INVOLVED in the Regulation of Insulin secretion and POSSIBLY Insulin action [11,12].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 102), ('INCOMPLETE_EVIDENCE', 154)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0001525', 'angiogenesis', 73, 'angiogenesis'), ('GO_0065007', 'biological regulation', 118, 'regulation'), ('PR_000045358', 'insulin family protein', 132, 'insulin'), ('PR_000045358', 'insulin family protein', 163, 'insulin')]
PMC4427001	4/2015	S29-PMC4427001	["circulating Plasma concentration of 25(Oh)D IS CONSIDERED the MOST RELIABLE INDICATOR of Individual's Vitamin D status."]	[('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 62), ('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('UBERON_0001969', 'blood plasma', 12, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 36, '25(OH)D'), ('NCBITaxon_1', 'root', 89, 'individual'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4427001	4/2015	S33-PMC4427001	['a NUMBER OF STUDIES focused on PUTATIVE ROLE of Vitamin D deficiency in various Pregnancy pathologies including gdm [21–23].']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 31), ('SUPERFICIAL_RELATIONSHIP', 40)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
PMC4427001	4/2015	S34-PMC4427001	['OBSERVATIONAL studies REVEALED CORRELATION between low Vitamin D levels and preeclampsia or gdm [7].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 31)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4427001	4/2015	S38-PMC4427001	['currently, LITTLE IS KNOWN about Postpartum Vitamin D status in women with history of gdm and POSSIBLE RELATIONSHIP between 25(Oh)D Plasma levels measured at the time of gdm diagnosis and the degree of Glucose (in)tolerance Postpartum.']	[('FULL_UNKNOWN', 11), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0007565', 'female pregnancy', 33, 'postpartum'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 132, 'plasma'), ('CHEBI_17234', 'glucose', 202, 'glucose'), ('GO_0007565', 'female pregnancy', 224, 'postpartum')]
PMC4427001	4/2015	S40-PMC4427001	['THEREFORE, the AIMS of the PRESENT STUDY were (1) TO DETERMINE Midgestational and early Postpartum Vitamin D status by measuring 25(Oh)D Plasma levels in Pregnant women with and without gdm to CONFIRM the hypothetical deficiency in gdm in central european population and (2) to describe the RELATIONSHIP between Midgestational and Postpartum Vitamin D status and parallel changes of parameters characterising Glucose tolerance.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 291)]	6	[('GO_0007507', 'heart development', 63, 'midgestational'), ('GO_0007565', 'female pregnancy', 88, 'postpartum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 132, 'OH ... D'), ('UBERON_0001969', 'blood plasma', 137, 'plasma'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('GO_0007507', 'heart development', 312, 'midgestational'), ('GO_0007565', 'female pregnancy', 331, 'postpartum'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D'), ('CHEBI_17234', 'glucose', 409, 'glucose')]
PMC4427001	4/2015	S83-PMC4427001	["in OUR STUDY, we have FOUND that Midgestational Vitamin D deficiency (i.e., 25(Oh)D levels < 50\u2009nmol/l) was present in majority of the study sample, that is, 45 of 47 (95.7%) women with gdm and 27 of 29 (93.1%) healthy Pregnant women ( p = ns, fisher's exact test)."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 22)]	2	[('GO_0007507', 'heart development', 33, 'midgestational'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('GO_0007565', 'female pregnancy', 219, 'pregnant')]
PMC4427001	4/2015	S92-PMC4427001	['the EFFECT of Vitamin D on Regulation Of Pancreatic Β Cell Function and Insulin secretion COULD BE MEDIATED through Intracellular changes in calcium pool.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_1904353', 'regulation of telomere capping', 27, 'regulation of ... cell function'), ('CL_0005019', 'pancreatic epsilon cell', 41, 'pancreatic β cell'), ('UBERON_0001264', 'pancreas', 41, 'pancreatic'), ('PR_000045358', 'insulin family protein', 72, 'insulin'), ('GO_0005622', 'intracellular anatomical structure', 116, 'intracellular')]
PMC4427001	4/2015	S94-PMC4427001	['in addition, Vitamin D MAY also be NEEDED to ensure a normal rate of Calcium Flux Across Cell Membranes and maintenance of an adequate Cytosolic calcium pool, which is IMPORTANT for Insulin-mediated Intracellular Signalling in Insulin-responsive Tissues [35].']	[('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 35), ('IMPORTANT_CONSIDERATION', 168)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_1990171', 'SCF complex disassembly in response to cadmium stress', 69, 'calcium flux across cell membranes'), ('GO_0005886', 'plasma membrane', 89, 'cell membranes'), ('GO_0005829', 'cytosol', 135, 'cytosolic'), ('PR_000045358', 'insulin family protein', 182, 'insulin'), ('GO_0005622', 'intracellular anatomical structure', 199, 'intracellular'), ('GO_0035556', 'intracellular signal transduction', 199, 'intracellular signalling'), ('PR_000045358', 'insulin family protein', 227, 'insulin'), ('UBERON_0000479', 'tissue', 246, 'tissues')]
PMC4427001	4/2015	S95-PMC4427001	['finally, SEVERAL STUDIES SUGGEST that Vitamin D COULD play a ROLE in the pathogenesis of diabetes mellitus type 2 by AFFECTING Insulin sensitivity of Β Cell function [36,37].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 117)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('PR_000045358', 'insulin family protein', 127, 'insulin'), ('CL_0000570', 'parafollicular cell', 150, 'β cell')]
PMC4427001	4/2015	S97-PMC4427001	['ALTHOUGH there is NO GENERAL CONSENSUS on the criteria for Vitamin D deficiency in Pregnant women, in OUR STUDY we have FOUND high prevalence of deficiency (when using cut-off < 50\u2009nmol/l) in overall study sample: 95.7% of women with gdm and 93.1% of controls were Vitamin D deficient during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('INCOMPLETE_EVIDENCE', 120)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0007565', 'female pregnancy', 292, 'pregnancy')]
PMC4427001	4/2015	S105-PMC4427001	['[23] HAVE SHOWN that Vitamin D deficiency (≤50\u2009nmol/l) in caucasian population (irish women) CAN occur in 95% of Pregnant women in 12th week of Pregnancy, in 90% in 20th week, in 66% in 35th week, and in 15% 3 days Postpartum.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 93)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnant'), ('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0007565', 'female pregnancy', 215, 'postpartum')]
PMC4427001	4/2015	S109-PMC4427001	['CONTRADICTORY results COULD BE EXPLAINED by seasonal, geographical, or ethnic Vitamin D variation; the paper does NOT UNFORTUNATELY mention in WHAT season women were included in the study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 31), ('ANOMALY_CURIOUS_FINDING', 114), ('IMPORTANT_CONSIDERATION', 118), ('EXPLICIT_QUESTION', 143)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4427001	4/2015	S118-PMC4427001	['[26] FOUND an inverse ASSOCIATION between second trimester 25(Oh)D levels < 25\u2009nmol/l and 1\u2009hr after load Glucose (50\u2009g) levels; HOWEVER, ONLY 5% of studied women developed gdm and as mentioned above THRESHOLD for Vitamin D deficiency DIFFERED from our study.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('INCOMPLETE_EVIDENCE', 138), ('PROBABLE_UNDERSTANDING', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235)]	6	[('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 59, '25(OH ... D'), ('CHEBI_17234', 'glucose', 106, 'glucose'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4427001	4/2015	S120-PMC4427001	['[28] reported that prevalence of Vitamin D deficiency is higher among women with impaired Glucose tolerance or gdm in 204 iranian women but they DID NOT FIND CORRELATION with bmi or fpg.']	[('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 158)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_17234', 'glucose', 90, 'glucose')]
PMC4427001	4/2015	S123-PMC4427001	['our results are IN AGREEMENT with OTHER published STUDIES reporting LACK OF association between Vitamin D levels in Pregnancy and gdm.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 68)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy')]
PMC4427001	4/2015	S126-PMC4427001	['[43] DID NOT FIND association between maternal Vitamin D status in 559 nondiabetic Pregnant women from south india and the RISK of gdm.']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 123)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant')]
PMC4427001	4/2015	S137-PMC4427001	['SEVERAL STUDIES investigated Vitamin D supplementation in women with gdm [23,31].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC4427001	4/2015	S139-PMC4427001	['[31] studied WHETHER Vitamin D supplementation MAY improve Glycaemic Control in women with gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 47)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0051162', 'L-arabitol metabolic process', 59, 'glycaemic control')]
PMC4427001	4/2015	S142-PMC4427001	['[44] assessed the EFFECT of Calcium and Vitamin D cosupplementation on gdm in a randomised placebo-controlled study (56 iranian women with gdm) and they OBSERVED a significant reduction in fpg, serum Insulin levels, and homa-ir and increase in quicki compared with placebo, and also an increase in Glutathione and a reduction in Serum ldl-Cholesterol and total Cholesterol and a significant elevation in hdl-Cholesterol were common.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 153)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 28, 'calcium'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('PR_000045358', 'insulin family protein', 200, 'insulin'), ('CHEBI_16856', 'glutathione', 298, 'glutathione'), ('UBERON_0001977', 'blood serum', 329, 'serum'), ('CHEBI_16113', 'cholesterol', 339, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 361, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 408, 'cholesterol')]
PMC4427001	4/2015	S143-PMC4427001	['rudnicki and mølsted-pedersen [45] reported that supplementation with an active form of Vitamin D (1,25(Oh)2D) was ASSOCIATED with significant decrease of plasma Glucose level and POSSIBLE EFFECT on Insulin sensitivity.']	[('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 180), ('SUPERFICIAL_RELATIONSHIP', 189)]	3	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_37958', 'dye', 99, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 101, '25(OH)2D'), ('CHEBI_17234', 'glucose', 162, 'glucose'), ('PR_000045358', 'insulin family protein', 199, 'insulin')]
PMC4427001	4/2015	S150-PMC4427001	['conclusions\nour study in Pregnant women of central european population DID NOT REPLICATE sporadic PREVIOUS FINDINGS of significantly decreased levels of Vitamin D in Gdm Pregnancy; HOWEVER, results SEEM TO BE criteria-sensitive (who versus iadpsg) and the topic WARRANTS FURTHER STUDY.']	[('INCOMPLETE_EVIDENCE', 71), ('ANOMALY_CURIOUS_FINDING', 75), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ANOMALY_CURIOUS_FINDING', 198), ('FUTURE_WORK', 262), ('FUTURE_WORK', 271)]	9	[('GO_0007565', 'female pregnancy', 25, 'pregnant'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0070477', 'endospore core', 166, 'GDM'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC4427001	4/2015	S151-PMC4427001	['we CONFIRMED overall high prevalence of Vitamin D deficiency in Pregnant women IN SPITE of the gdm presence.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 79)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant')]
PMC4427001	4/2015	S153-PMC4427001	['POTENTIALLY beneficial EFFECT of Vitamin D supplementation and the PLAUSIBLE pathogenic ROLE of 25(Oh)D deficiency in the subsequent development of diabetes mellitus type 2 in women with gdm history HAS to be FURTHER explored considering the ROLE of Vitamin D in Modulating Insulin sensitivity and Glucose Metabolism.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 209), ('SUPERFICIAL_RELATIONSHIP', 242)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('GO_0065007', 'biological regulation', 263, 'modulating'), ('PR_000045358', 'insulin family protein', 274, 'insulin'), ('CHEBI_17234', 'glucose', 298, 'glucose'), ('GO_0006006', 'glucose metabolic process', 298, 'glucose metabolism')]
PMC4499266	4/2015	S43-PMC4499266	['the lack of Gestational Vitamin A HAS BEEN SUGGESTED to CONTRIBUTE to Hearing loss development in developing countries [7].']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('GO_0007565', 'female pregnancy', 12, 'gestational'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('GO_0007605', 'sensory perception of sound', 70, 'hearing')]
PMC4661586	4/2015	S43-PMC4661586	['Brain Development and Vitamin B HAVE also BEEN presented in the literature[19].']	[('INCOMPLETE_EVIDENCE', 32)]	1	[('GO_0060132', 'prolactin secreting cell development', 0, 'Brain development'), ('UBERON_0000955', 'brain', 0, 'Brain'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin B')]
PMC4661586	4/2015	S50-PMC4661586	['they FOUND out that women in the lowest tertile on the likert scale consumed significantly less fiber, Vitamin C, magnesium, potassium and fruit and vegetables than the upper tertiles[23].']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 103, 'vitamin C')]
PMC4438573	5/2015	S25-PMC4438573	['the ONLY STUDY to date that has assessed the EFFECTS of maternal Nutrient supplementation on malaria Antibody levels REPORTED that Vitamin A Prenatal supplements were ASSOCIATED with a reduction in Antibody responses to a Placental-binding isolate ej-24, but no significant changes in Antibody responses to non-Pregnancy related parasite Isolates were observed [22].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 117), ('SUPERFICIAL_RELATIONSHIP', 167)]	4	[('CHEBI_33284', 'nutrient', 65, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin A'), ('GO_0007565', 'female pregnancy', 141, 'prenatal'), ('GO_0042571', 'immunoglobulin complex, circulating', 198, 'antibody'), ('UBERON_0001987', 'placenta', 222, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 285, 'antibody'), ('GO_0007565', 'female pregnancy', 311, 'pregnancy'), ('SO_0001040', 'integrated_plasmid', 338, 'isolates')]
PMC4438628	5/2015	S151-PMC4438628	['WHETHER through changes in dietary patterns and/OR less time spent outdoors, the levels of Vitamin D MIGHT be lower [201-203].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 101)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4438628	5/2015	S184-PMC4438628	['Human and/or experimental research SHOWS that acute and cumulative psychological stress (and ASSOCIATED MARKERS of Allostatic load) [273-276], environmental Pollutants [277-282], crowding [283], acoustic stress [284], heat stress [285], westernized dietary patterns [286], high Fructose and Sodium [287], dietary Age and Food Additives via processed foods [288,289], lack of colorful dietary Phytochemicals [290,291], magnesium deficiency [292], inadequate omega-3 [293], Antibiotic administration [294], excess Alcohol consumption [295,296], the Oral periodontopathogen p. gingivalis (when Swallowed) [297], tobacco exposure [298,299], sedentary behavior [300], Circadian disruptions [301], Sleep problems with functional constipation [302], and low levels of Vitamin D [303,304] are each individually ASSOCIATED with marked shifts in the Intestinal microbiota.']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 803)]	4	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('GO_0007565', 'female pregnancy', 115, 'allostatic'), ('CHEBI_26199', 'polyprenol', 157, 'pollutants'), ('CHEBI_28757', 'fructose', 278, 'fructose'), ('CHEBI_52632', 'potassium-39 atom', 291, 'sodium'), ('CHEBI_80551', 'APC', 313, 'AGE'), ('CHEBI_77968', 'humectant', 321, 'food additives'), ('CHEBI_26254', 'prenylnaphthoquinone', 392, 'phytochemicals'), ('CHEBI_33282', 'antibacterial agent', 472, 'antibiotic'), ('CHEBI_30879', 'alcohol', 512, 'alcohol'), ('UBERON_0000165', 'mouth', 547, 'oral'), ('GO_0035196', 'production of miRNAs involved in gene silencing by miRNA', 591, 'swallowed'), ('GO_0051216', 'cartilage development', 663, 'circadian'), ('GO_0030431', 'sleep', 692, 'sleep'), ('CHEBI_27300', 'vitamin D', 761, 'vitamin D'), ('UBERON_0000160', 'intestine', 840, 'intestinal')]
PMC4448820	5/2015	S162-PMC4448820	['the case study Nutrients covered in this review are Vitamin A, iron, zinc, Vitamin D, Folic Acid, and Selenium and were chosen on the basis of their PUBLIC HEALTH IMPORTANCE and BECAUSE they provide the MOST RELEVANT EVIDENCE with regard to their KNOWN EFFECT on Immunity.']	[('IMPORTANT_CONSIDERATION', 149), ('IMPORTANT_CONSIDERATION', 163), ('PROBABLE_UNDERSTANDING', 178), ('PROBABLE_UNDERSTANDING', 203), ('IMPORTANT_CONSIDERATION', 208), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 247), ('SUPERFICIAL_RELATIONSHIP', 253)]	8	[('CHEBI_33284', 'nutrient', 15, 'nutrients'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_30751', 'formic acid', 86, 'folic acid'), ('CHEBI_27568', 'selenium atom', 102, 'selenium'), ('GO_0007566', 'embryo implantation', 263, 'immunity')]
PMC4448820	5/2015	S185-PMC4448820	['AS a result of increased INTEREST in the activities of Vitamin D beyond the traditional FOCUS on bone/calcium, an IMPORTANT NEW UNDERSTANDING of Vitamin D’s ROLE in Immune function has EMERGED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 88), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 185)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0002405', 'immune system', 165, 'immune')]
PMC4448820	5/2015	S187-PMC4448820	['(113) DESCRIBED a Vitamin D–dependent pathogen-sensing axis in Human Macrophages that HIGHLIGHTS the IMPORTANCE of Vitamin D in Innate Immunity.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 101)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 63, 'human'), ('CL_0000235', 'macrophage', 69, 'macrophages'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('GO_0045087', 'innate immune response', 128, 'innate immunity')]
PMC4448820	5/2015	S190-PMC4448820	['in this newly OBSERVED MODEL in Human Macrophages, Tlr Activation upregulates the Expression of the Vitamin D Receptor ( Vdr ) and the Vitamin D-1-hydroxylase Genes, leading to induction of the Antimicrobial peptide Cathelicidin and killing of Intracellular bacteria such as mycobacterium tuberculosis .']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23)]	2	[('NCBITaxon_9606', 'Homo sapiens', 32, 'human'), ('CL_0000235', 'macrophage', 38, 'macrophages'), ('GO_0034104', 'negative regulation of tissue remodeling', 51, 'TLR activation'), ('GO_0010467', 'gene expression', 82, 'expression'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 100, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 121, 'VDR'), ('CHEBI_28384', 'vitamin K', 135, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 135, 'Vitamin D'), ('SO_0000704', 'gene', 159, 'genes'), ('CHEBI_65381', 'albizoside C', 194, 'antimicrobial'), ('PR_000006009', 'alpha-catulin', 216, 'cathelicidin'), ('GO_0005622', 'intracellular anatomical structure', 244, 'intracellular')]
PMC4448820	5/2015	S192-PMC4448820	['INITIALLY, THESE OBSERVATIONS were RESTRICTED to Monocytes and Macrophages; HOWEVER, RECENT STUDIES SHOWED that cathelicidin Antimicrobial peptide (camp) is induced by Vitamin D in Keratinocytes and Respiratory and Bladder Epithelial Cells (113).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 100)]	7	[('CL_0000576', 'monocyte', 49, 'monocytes'), ('CL_0000235', 'macrophage', 63, 'macrophages'), ('CHEBI_65381', 'albizoside C', 125, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CL_0000312', 'keratinocyte', 181, 'keratinocytes'), ('CL_0000006', 'neuronal receptor cell', 199, 'respiratory ...'), ('GO_0045333', 'cellular respiration', 199, 'respiratory'), ('UBERON_0001004', 'respiratory system', 199, 'respiratory'), ('CL_1001428', 'bladder urothelial cell', 215, 'bladder epithelial cells'), ('UBERON_0001915', 'endothelium of capillary', 215, 'bladder epithelial')]
PMC4448820	5/2015	S194-PMC4448820	['in vivo data are EMERGING that SUPPORT Vitamin D–DEPENDENT induction of Cathelicidin in skin and peripheral Blood Monocytes by administration of large amounts of Vitamin D to Humans (115).']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 72, 'cathelicidin'), ('UBERON_0000178', 'blood', 108, 'blood'), ('CL_0000576', 'monocyte', 114, 'monocytes'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 175, 'humans')]
PMC4448820	5/2015	S205-PMC4448820	['mechanistic EVIDENCE for in vitro Vitamin A–inhibited basal and Lps, Tnf-Induced Nf-Κb Activation (119) includes\n○ Retinoic Acid Receptor (rar) α–mediated reduction in P65 protein (118) and\n○ Ligand-Dependent Cytoplasmic sequestration of P50/P65 by Retinoid x receptor (rxr) (120).']	[('INCOMPLETE_EVIDENCE', 12)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin A'), ('CHEBI_16412', 'lipopolysaccharide', 64, 'LPS'), ('GO_0036503', 'ERAD pathway', 69, 'TNF-induced'), ('GO_0051092', 'positive regulation of NF-kappaB transcription factor activity', 81, 'NF-κB activation'), ('GO_0071159', 'NF-kappaB complex', 81, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 81, 'NF-κB'), ('CHEBI_26536', 'retinoic acid', 115, 'retinoic acid'), ('PR_000001185', 'alpha-1D adrenergic receptor', 124, 'acid receptor'), ('PR_000001245', 'rhodopsin', 168, 'p65'), ('GO_0006266', 'DNA ligation', 192, 'ligand'), ('GO_0007567', 'parturition', 199, 'dependent'), ('GO_0005737', 'cytoplasm', 209, 'cytoplasmic'), ('PR_000003035', 'cellular tumor antigen p53', 238, 'p50'), ('PR_000001245', 'rhodopsin', 242, 'p65'), ('CHEBI_26537', 'retinoid', 249, 'retinoid')]
PMC4448820	5/2015	S212-PMC4448820	['INTERESTINGLY, this RELATION and its correction are PROPOSED as a POTENTIAL BIOMARKER for znd in a manner ANALOGOUS TO SOME of the classic enzyme stimulation assay for Vitamins (Vitamin B-6, Thiamin, and riboflavin).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 119)]	8	[('CHEBI_33277', 'gamma-tocotrienol', 168, 'vitamins'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin B'), ('CHEBI_26948', 'vitamin B1', 191, 'thiamin')]
PMC4448820	5/2015	S214-PMC4448820	['● Vitamin E: inhibition of Nf-Κb by such Antioxidants as Vitamin E HAS BEEN SHOWN to occur via multiple mechanisms (129).']	[('INCOMPLETE_EVIDENCE', 67)]	1	[('CHEBI_28384', 'vitamin K', 2, 'Vitamin E'), ('GO_0071159', 'NF-kappaB complex', 27, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 27, 'NF-κB'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 41, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin E')]
PMC4448820	5/2015	S239-PMC4448820	['in vivo data for Vitamin A– and Vitamin D–DEPENDENT induction of Tregs in Humans are EMERGING but are EXTREMELY DIFFICULT to establish methodologically BECAUSE of the LIKELY need to obtain biopsied materials (144–146).']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 102), ('DIFFICULT_TASK', 112), ('PROBLEM_COMPLICATION', 152), ('PROBABLE_UNDERSTANDING', 167)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 65, 'Tregs'), ('NCBITaxon_9606', 'Homo sapiens', 74, 'humans')]
PMC4448820	5/2015	S242-PMC4448820	['in addition to Vitamins A and D, OTHER Nutrients MAY AFFECT the induction of Tregs.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 53)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 30, 'D'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 77, 'Tregs')]
PMC4448820	5/2015	S249-PMC4448820	['● pem and deficiencies of Vitamin A, zinc, or iron have a ROBUST, ALBEIT variable EFFECT in reducing Antigen-Presenting Cell (Apc) function (150–160).']	[('INCOMPLETE_EVIDENCE', 58), ('ANOMALY_CURIOUS_FINDING', 66), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin A'), ('CHEBI_59132', 'antigen', 101, 'antigen'), ('CL_0000593', 'androgen secreting cell', 101, 'antigen ... presenting cell'), ('PR_000004122', 'adenomatous polyposis coli protein', 126, 'APC')]
PMC4448820	5/2015	S274-PMC4448820	['caption (boxed-text): text box 9\u2003\npotential pathways of intersection for Micronutrients\n\n● Myelomonocytic Cell Differentiation (Vitamins A and D)\n● Macrophage polarization (Vitamins a and d, zinc, Folic Acid)\n● B and T Cell Proliferation (zinc, Iron, Folic Acid, others)\n● T Cell Apoptosis (zinc, iron, Vitamin A, Vitamin E, others)\n● Regulation of Nf-Κb activity (Vitamins A, d, and e; zinc; iron; many others)\n● induction, and maintenance, of Treg Cells (Vitamins A and D, zinc, Folic Acid)\n● Regulation Of Gene Expression and/or activity of Protein Kinase C, cyclins, and cyclin-dependent kinases (e.g., as seen with iron): such defects in one or more of these factors MAY AFFECT or Modulate Lymphocyte Responses to stimuli\n\niv.']	[('INCOMPLETE_EVIDENCE', 672), ('SUPERFICIAL_RELATIONSHIP', 676)]	2	[('CHEBI_33839', 'macromolecule', 73, 'micronutrients'), ('CL_0000763', 'myeloid cell', 91, 'Myelomonocytic cell'), ('GO_0002270', 'plasmacytoid dendritic cell activation', 91, 'Myelomonocytic'), ('GO_0030154', 'cell differentiation', 106, 'cell differentiation'), ('CHEBI_27300', 'vitamin D', 128, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 137, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 143, 'D'), ('CL_0000235', 'macrophage', 148, 'Macrophage'), ('CHEBI_33277', 'gamma-tocotrienol', 173, 'vitamins'), ('CHEBI_30751', 'formic acid', 197, 'folic acid'), ('CL_0000969', 'regulatory B cell', 211, 'B ...'), ('CL_0000084', 'T cell', 217, 'T cell'), ('GO_0008283', 'cell proliferation', 219, 'cell proliferation'), ('CHEBI_24870', 'ion', 245, 'iron'), ('CHEBI_30751', 'formic acid', 251, 'folic acid'), ('CL_0000084', 'T cell', 273, 'T cell'), ('GO_0006915', 'apoptotic process', 275, 'cell apoptosis'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 314, 'vitamin E'), ('GO_0065007', 'biological regulation', 335, 'Regulation'), ('GO_0035773', 'insulin secretion involved in cellular response to glucose stimulus', 349, 'NF-κB'), ('GO_0071159', 'NF-kappaB complex', 349, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 349, 'NF-κB'), ('CHEBI_27300', 'vitamin D', 365, 'vitamins A'), ('CL_0000960', 'T3 B cell', 445, 'Treg cells'), ('CHEBI_27300', 'vitamin D', 457, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 472, 'D'), ('CHEBI_30751', 'formic acid', 481, 'folic acid'), ('GO_0010468', 'regulation of gene expression', 495, 'Regulation of gene expression'), ('SO_0000704', 'gene', 509, 'gene'), ('PR_000013390', '26S proteasome non-ATPase regulatory subunit 8', 544, 'protein kinase C'), ('GO_0065007', 'biological regulation', 686, 'modulate'), ('CL_0000542', 'lymphocyte', 695, 'lymphocyte'), ('GO_0060033', 'anatomical structure regression', 706, 'responses')]
PMC4448820	5/2015	S281-PMC4448820	['most of the EFFECTS of Vitamin A on Immune or inflammatory Responses CAN be EXPLAINED via binding of the Vitamin A Metabolite, Atra, to 1 of 3 zinc-finger proteins containing members of the Nuclear receptor superfamily, Rar-Α, Rar-Β, and Rar-Γ (185).']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 76)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('GO_0006955', 'immune response', 36, 'immune ... responses'), ('UBERON_0002405', 'immune system', 36, 'immune'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('CHEBI_39382', 'flufenoxuron', 115, 'metabolite'), ('CHEBI_17033', 'biliverdin', 127, 'ATRA'), ('GO_0005634', 'nucleus', 190, 'nuclear'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 220, 'RAR-α'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 227, 'RAR-β'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 238, 'RAR-γ')]
PMC4448820	5/2015	S291-PMC4448820	['ALTHOUGH SOME EFFECTS of Vitamin D are MEDIATED independently of vdr, the large MAJORITY of the activity of Vitamin D CAN be EXPLAINED via binding of the Vitamin D Metabolite [1,25(Oh)2D] to a single, zinc-finger containing, ligand-activated transcription factor, vdr.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 39), ('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 125)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 164, 'metabolite'), ('CHEBI_17996', 'chloride', 177, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 178, '25(OH)2D')]
PMC4448820	5/2015	S296-PMC4448820	['like Vitamin A, Vitamin D CAN AFFECT Immune function through this Genetic INTERACTION.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 5, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0002405', 'immune system', 37, 'immune'), ('SO_0000704', 'gene', 66, 'genetic')]
PMC4448820	5/2015	S347-PMC4448820	['cell culture MODELS and a very SMALL NUMBER OF Human clinical STUDIES INDICATE that nutritional factors including Vitamins A and D AFFECT numerous Genes INVOLVED in Chromatin Remodeling or processes that are INVOLVED in epigenetic Regulation.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 153), ('SUPERFICIAL_RELATIONSHIP', 208)]	7	[('NCBITaxon_9606', 'Homo sapiens', 47, 'human'), ('CHEBI_27300', 'vitamin D', 114, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 129, 'D'), ('SO_0000704', 'gene', 147, 'genes'), ('GO_0000785', 'chromatin', 165, 'chromatin'), ('GO_0006338', 'chromatin remodeling', 165, 'chromatin remodeling'), ('GO_0065007', 'biological regulation', 231, 'regulation')]
PMC4448820	5/2015	S351-PMC4448820	['because this mechanism has the POTENTIAL to alter the global abundance of Methyl Donors, and because Vitamin A has general actions on Cell Differentiation, it is UNKNOWN whether these EFFECTS are indirect OR WHETHER specific Genes are targeted for epigenetic Regulation by Vitamin A in vivo.']	[('INCOMPLETE_EVIDENCE', 31), ('FULL_UNKNOWN', 162), ('SUPERFICIAL_RELATIONSHIP', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208)]	5	[('CHEBI_6842', 'methoxychlor', 74, 'methyl donors'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('GO_0030154', 'cell differentiation', 134, 'cell differentiation'), ('SO_0000704', 'gene', 225, 'genes'), ('GO_0065007', 'biological regulation', 259, 'regulation'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin A')]
PMC4448820	5/2015	S354-PMC4448820	['EVIDENCE for EFFECTS of Vitamin A on epigenetic Regulation Of Immune Function is EMERGING.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 81)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('GO_0002019', 'regulation of renal output by angiotensin', 48, 'regulation of immune function'), ('UBERON_0002405', 'immune system', 62, 'immune')]
PMC4448820	5/2015	S373-PMC4448820	['EVIDENCE is EMERGING for Vitamin D in epigenetic Regulation Of Gene Expression.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0010468', 'regulation of gene expression', 49, 'regulation of gene expression'), ('SO_0000704', 'gene', 63, 'gene')]
PMC4448820	5/2015	S375-PMC4448820	['Kdm6B/Jmjd3 Histone demethylase is induced by Vitamin D, but NOT Atra, in Human Colon cancer cells (217) and HAS BEEN IMPLICATED in the Regulation of Cyclin-Dependent Kinase Inhibitor 1A ( Cdkn1A ) /P21Cip1 by 1,25(Oh)2D in normal Prostate cells (218).']	[('ANOMALY_CURIOUS_FINDING', 61), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 118)]	3	[('PR_000009209', 'juxtaposed with another zinc finger protein 1', 0, 'KDM6B'), ('PR_000009211', 'lysine-specific demethylase 3A', 6, 'JMJD3'), ('CHEBI_15358', 'histone', 12, 'histone'), ('PR_000043452', 'core histone', 12, 'histone'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17033', 'biliverdin', 65, 'ATRA'), ('NCBITaxon_9606', 'Homo sapiens', 74, 'human'), ('UBERON_0001155', 'colon', 80, 'colon'), ('GO_0065007', 'biological regulation', 136, 'regulation'), ('PR_000004910', 'complement component C8 gamma chain', 150, 'cyclin-dependent kinase inhibitor 1A'), ('CHEBI_35222', 'inhibitor', 174, 'inhibitor'), ('PR_000005259', 'cyclin-dependent kinase 5 activator 1', 189, 'CDKN1A'), ('PR_000014700', 'serpin B9', 199, 'p21CIP1'), ('CHEBI_37983', 'sulfur-35 atom', 210, '1'), ('CHEBI_17996', 'chloride', 211, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 212, '25(OH)2D'), ('CL_0002249', 'primitive cardiac myocyte', 231, 'prostate'), ('UBERON_0002367', 'prostate gland', 231, 'prostate')]
PMC4448820	5/2015	S378-PMC4448820	['Plasma Mirna profiles HAVE BEEN determined in subjects given high-dose Vitamin D, BUT the within-subject heterogeneity and SMALL number of subjects PRECLUDED any determination of definitive Vitamin D–Regulated Mirna (220).']	[('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 148)]	4	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('SO_0000276', 'miRNA', 7, 'miRNA'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('GO_0065007', 'biological regulation', 200, 'regulated'), ('SO_0000276', 'miRNA', 210, 'miRNA')]
PMC4448820	5/2015	S379-PMC4448820	['the ESSENTIALITY of Vitamin D in Regulating invariant invariant Nk T Cell Development in Mice IS THOUGHT TO be via epigenetic mechanisms (173).']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 97)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0065007', 'biological regulation', 33, 'regulating'), ('CL_0000213', 'lining cell', 64, 'NK T cell'), ('GO_0001822', 'kidney development', 64, 'NK T cell development'), ('GO_0005634', 'nucleus', 64, 'NK'), ('NCBITaxon_10088', 'Mus <genus>', 89, 'mice')]
PMC4448820	5/2015	S380-PMC4448820	['there is OTHER EVIDENCE for a transgenerational EFFECT of Vitamin D on immunity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4448820	5/2015	S388-PMC4448820	['these data SUGGEST that inflammation leads to decreased vdr activity and increased Vitamin D Catabolism.']	[('INCOMPLETE_EVIDENCE', 11)]	1	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0042188', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane catabolic process', 91, 'D catabolism')]
PMC4448820	5/2015	S405-PMC4448820	['v. Vitamin E.\npolymorphisms at cytokine Genes MAY determine the EFFECT of Vitamin E on Cytokine Production in the elderly (232).']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_28384', 'vitamin K', 3, 'Vitamin E'), ('PR_000017279', 'testis-specific basic protein Y 1', 3, 'Vitamin E'), ('SO_0000704', 'gene', 40, 'genes'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin E'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 87, 'cytokine production')]
PMC4448820	5/2015	S409-PMC4448820	['results SHOWED that participants with the a/a and a/g genotypes at Tnf 308g > a who were treated with Vitamin E had significantly lower tnf production (232).']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 67, 'TNF'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin E')]
PMC4448820	5/2015	S412-PMC4448820	['by using Pbmcs from healthy men who were treated with Lps, ANOTHER STUDY SHOWED that anti-inflammatory EFFECTS of Vitamin E supplementation (e.g., decreased Il-6 secretion) DEPENDS on having the gg genotype at position 313 of the Gstp1 Gene (236).']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('CL_0002246', 'peripheral blood stem cell', 9, 'PBMCs'), ('CHEBI_16412', 'lipopolysaccharide', 54, 'LPS'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin E'), ('PR_000001470', 'interleukin-28B', 157, 'IL-6'), ('PR_000008294', 'glutathione S-transferase A1', 230, 'GSTP1'), ('SO_0000704', 'gene', 236, 'gene')]
PMC4448820	5/2015	S460-PMC4448820	['○ during an apr, it circulates in the Plasma at molar concentrations 20-fold higher than the total amount of bound Vitamin D Metabolites (258), indicating that its immunologic role MAY dominate its transport function during the apr.']	[('INCOMPLETE_EVIDENCE', 181)]	1	[('UBERON_0001969', 'blood plasma', 38, 'plasma'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_25212', 'metabolite', 125, 'metabolites')]
PMC4448820	5/2015	S468-PMC4448820	['last, compartmentalization of Nutrients during inflammation MAY create a permissive environment for inflammation to occur via temporary removal of Nutrients (e.g., Vitamin A, zinc) that negatively regulate Nf-Κb activity (118,126).']	[('INCOMPLETE_EVIDENCE', 60)]	1	[('CHEBI_33284', 'nutrient', 30, 'nutrients'), ('CHEBI_33284', 'nutrient', 147, 'nutrients'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A'), ('GO_0005883', 'neurofilament', 206, 'NF-'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 206, 'NF-κB')]
PMC4448820	5/2015	S470-PMC4448820	['RATHER than a full discussion of each of the putative App mechanisms, a case study exploration of the various PROPOSED scenarios using Vitamin A as an example will be illuminating.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 110)]	2	[('PR_000004168', 'amyloid-beta precursor protein', 54, 'APP'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin A')]
PMC4448820	5/2015	S471-PMC4448820	['ALTHOUGH Vitamin A is absolutely REQUIRED for mounting an effective Immune Response, it is TEMPTING to SPECULATE that temporarily inhibiting Plasma Delivery Of Vitamin A to Tissues is beneficial to the host by creating a favorable environment for inflammation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 103)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0006955', 'immune response', 68, 'immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('GO_0070983', 'dendrite guidance', 148, 'delivery of vitamin A'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin A'), ('UBERON_0000479', 'tissue', 173, 'tissues')]
PMC4448820	5/2015	S473-PMC4448820	['caption (boxed-text): text box 17\u2003\nPOSSIBLE mechanisms to EXPLAIN Vitamin A’s ROLE in Immune Response\n\n● vitamin A, via conversion to atra, can inhibit Nf-Κb Activation (118).']	[('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin A'), ('GO_0006955', 'immune response', 86, 'immune response'), ('UBERON_0002405', 'immune system', 86, 'immune'), ('PR_000004370', 'asialoglycoprotein receptor 2', 113, 'A'), ('GO_0051092', 'positive regulation of NF-kappaB transcription factor activity', 152, 'NF-κB activation'), ('GO_0071159', 'NF-kappaB complex', 152, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 152, 'NF-κB')]
PMC4448820	5/2015	S476-PMC4448820	['confirmation of Vitamin A’s ROLE is provided by 4 types of observations:\n● elimination of infections SOMETIMES leads to a relatively rapid rebound in Plasma Retinol without nutritional intervention (23).']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 101)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin A'), ('UBERON_0001969', 'blood plasma', 150, 'plasma'), ('CHEBI_26536', 'retinoic acid', 157, 'retinol')]
PMC4448820	5/2015	S479-PMC4448820	['● Host-Pathogen competition for Vitamin A: examples include helminth parasites, such as ascaris and onchocerca , which Express a range of Retinol-binding proteins, Retinol dehydrogenases, and rars and MAY utilize Retinol/Retinoic Acid for growth and development (265–267).']	[('INCOMPLETE_EVIDENCE', 201)]	1	[('NCBITaxon_10088', 'Mus <genus>', 2, 'Host'), ('NCBITaxon_33208', 'Metazoa', 7, 'pathogen'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin A'), ('GO_0010467', 'gene expression', 119, 'express'), ('CHEBI_26536', 'retinoic acid', 138, 'retinol'), ('CHEBI_26536', 'retinoic acid', 164, 'retinol'), ('CHEBI_26536', 'retinoic acid', 213, 'retinol'), ('CHEBI_26536', 'retinoic acid', 221, 'retinoic acid')]
PMC4448820	5/2015	S521-PMC4448820	['a LIMITED NUMBER of other STUDIES also SUGGEST that Vitamin A (286), selenium (287), iron (288), and zinc deficiencies (289) MAY AFFECT the microbiome.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 129)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin A')]
PMC4448820	5/2015	S527-PMC4448820	['● supplementation CAN have BENEFITS (e.g., reducing mortality and some types of morbidity in the case of Vitamin A and zinc) but MAY also increase risk of adverse outcomes in selected populations as HAS BEEN seen for both Vitamin A and iron.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 27), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 199)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin A')]
PMC4448820	5/2015	S537-PMC4448820	['caption (table-wrap): table 6\n\neffects of Micronutrient supplementation on Immune function and vaccine responses (Human studies)1type of malnutrition and type of Immune functioneffects of supplementation on Immune System (reference)vitamin a\u2003Epithelial barrier function● high-dose vas above 6 mo of age decreases risk of death from infections such as measles and diarrheal diseases (290)● vas in the context of hiv infection or Lower Respiratory Tract infections HAS BEEN ASSOCIATED with adverse outcomes (105,263,290–292)● improved barrier function (105)● abnormal dual-Sugar (Lactulose, Mannitol) Intestinal permeability inversely CORRELATED with Serum Retinol (293) and PARTIALLY normalized by supplementation in va-deficient Individuals in SOME STUDIES (294) BUT NOT OTHERS (295,296)● increased symptomatology after high-dose vas during acute Lower Respiratory Tract infections REPORTED in SOME STUDIES (105) MAY INDICATE restored Mucus Production\u2003innate physiologic barriers● vas did not affect crp, saa, and/or agp concentrations among children with subclinical or clinical vad (297–299)● crp and agp did not change in men with low va stores given va (300)\u2003Macrophage function● increased Monocyte numbers (301)● decreased Tnf-Α concentrations in children (301) BUT the OPPOSITE in men (106)● decreased Ifn-Γ concentrations in children (302) but not in Pregnant women (303)● increased Il-10 concentrations in children (105,301) BUT no or an opposite effect in Adults (106,303,304)\u2003Neutrophil function● Neutrophil Phagocytosis of latex beads increased in va-deficient children given a single dose of Va (305)● Neutrophil Phagocytosis of E. Coli did not change in men with low Va stores given Va (300)\u2003Nk Cell function● an increase in Nk Cells in hiv-infected children supplemented with Va (105)● Nk Cell numbers did not change in men with low Va given supplemental Va; HOWEVER, there was a positive CORRELATION between Va stores and Peripheral Blood Nk Cells (300)\u2003T Cell function● increased Lymphocyte counts, particularly cd4 counts (105)● Cd4:Cd8 ratios were increased or unchanged by supplementation (306)● increase in Naive cd4 T Cells after supplementation; higher Memory Cd8, Cd45Ro (307)● higher Mitogen-induced Il-2, Il-4, and Tnf in response to supplementation (106)\u2003B Cell function● supplementation had no overall effect on Measles vaccine response (308) and a negative response in Individuals with baseline high titers (103)● no overall effect on oral polio vaccination● supplemented children increased Igg1 responses to dtp, minor igg3 response, no change in igg2 and igg4 (309)● no overall effect on bcg vaccine in Va-supplemented children, lower response in va-supplemented boys at 2 mo (310)● increased Antibody responses to some vaccines (Measles vaccine by 9 mo of age, oral polio vaccine, type 1, hepatitis b vaccine, rabies vaccine) (103)● short-term diminished cellular response to ppd in boys (103) and hospitalized children (105)Zinc\u2003Epithelial barrier function● zn supplementation in children LED TO an improvement in the lactulose:Mannitol Excretion ratio in SOME (311) BUT NOT OTHER (312,313) STUDIES; ratio MAY improve in infected children without zn deficiency given supplemental zn (314)\u2003innate physiologic barriers ● zn-supplemented children had higher Serum Complement C3 (315)\u2003Nk Cell function● children with diarrhea supplemented with zn supplementation do not exhibit an increase in Nk Cells (316)● increased Nk Cell activity in the elderly (317)\u2003T Cell function● increased cd4+ cell count in aids patients (318)● increased Thymocyte count in Thymus (319)● increased thymulin activity (320)● no CONSISTENT effect of zn supplementation on dth to tb Antigen [reviewed in (103)]\u2003B Cell function● no effect of zn supplementation of mothers on Bcg response in children (321)\nagp, α1-acid Glycoprotein; bcg, bacille calmette-guérin; cd, cluster of differentiation; Cd45Ro , Cluster Of Differentiation Antigen 45 Ro; Crp, c-reactive protein; dth, delayed-type hypersensitivity; dtp, diphtheria tetanus-pertussis; ppd, purified protein derivative; saa, Serum Amyloid a; tb, tuberculosis; va, Vitamin A; vad, Vitamin A deficiency; vas, Vitamin A supplementation.']	[('INCOMPLETE_EVIDENCE', 463), ('SUPERFICIAL_RELATIONSHIP', 472), ('SUPERFICIAL_RELATIONSHIP', 633), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 763), ('INCOMPLETE_EVIDENCE', 882), ('INCOMPLETE_EVIDENCE', 894), ('INCOMPLETE_EVIDENCE', 913), ('INCOMPLETE_EVIDENCE', 917), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1267), ('ANOMALY_CURIOUS_FINDING', 1267), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1433), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1873), ('SUPERFICIAL_RELATIONSHIP', 1903), ('SUPERFICIAL_RELATIONSHIP', 3021), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3088), ('INCOMPLETE_EVIDENCE', 3088), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3099), ('INCOMPLETE_EVIDENCE', 3123), ('INCOMPLETE_EVIDENCE', 3138), ('INCOMPLETE_EVIDENCE', 3633)]	23	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 42, 'micronutrient'), ('UBERON_0002405', 'immune system', 75, 'immune'), ('NCBITaxon_9606', 'Homo sapiens', 114, 'human'), ('UBERON_0002405', 'immune system', 162, 'immune'), ('UBERON_0002405', 'immune system', 207, 'immune system'), ('UBERON_0000483', 'epithelium', 242, 'Epithelial'), ('UBERON_0004905', 'articulation', 428, 'lower respiratory tract'), ('CHEBI_24870', 'ion', 571, 'sugar'), ('CHEBI_25098', 'lyxoside', 578, 'lactulose'), ('CHEBI_25169', 'mannoside', 589, 'mannitol'), ('UBERON_0000160', 'intestine', 599, 'intestinal'), ('UBERON_0001977', 'blood serum', 649, 'serum'), ('CHEBI_26536', 'retinoic acid', 655, 'retinol'), ('NCBITaxon_1', 'root', 729, 'individuals'), ('UBERON_0004905', 'articulation', 847, 'lower respiratory tract'), ('GO_0007498', 'mesoderm development', 935, 'mucus production'), ('UBERON_0000912', 'mucus', 935, 'mucus'), ('CL_0000235', 'macrophage', 1163, 'Macrophage'), ('CL_0000576', 'monocyte', 1194, 'monocyte'), ('PR_000000134', 'tumor necrosis factor alpha', 1228, 'TNF-α'), ('PR_000008920', 'interferon alpha-7', 1308, 'IFN-γ'), ('GO_0007565', 'female pregnancy', 1358, 'pregnant'), ('PR_000001470', 'interleukin-28B', 1390, 'IL-10'), ('UBERON_0007023', 'adult organism', 1465, 'adults'), ('CL_0000775', 'neutrophil', 1486, 'Neutrophil'), ('CL_0000775', 'neutrophil', 1507, 'Neutrophil'), ('GO_0007608', 'sensory perception of smell', 1507, 'Neutrophil'), ('GO_0006909', 'phagocytosis', 1518, 'phagocytosis'), ('CHEBI_37958', 'dye', 1604, 'VA'), ('CL_0000775', 'neutrophil', 1614, 'Neutrophil'), ('GO_0070231', 'T cell apoptotic process', 1614, 'Neutrophil phagocytosis'), ('NCBITaxon_10088', 'Mus <genus>', 1641, 'E. coli'), ('CHEBI_37958', 'dye', 1680, 'VA'), ('CHEBI_37958', 'dye', 1696, 'VA'), ('CL_0000623', 'natural killer cell', 1705, 'NK cell'), ('GO_0005634', 'nucleus', 1705, 'NK'), ('CL_0000623', 'natural killer cell', 1738, 'NK cells'), ('GO_0005634', 'nucleus', 1738, 'NK'), ('CHEBI_37958', 'dye', 1790, 'VA'), ('CL_0000623', 'natural killer cell', 1800, 'NK cell'), ('GO_0005634', 'nucleus', 1800, 'NK'), ('CHEBI_37958', 'dye', 1847, 'VA'), ('CHEBI_37958', 'dye', 1869, 'VA'), ('CHEBI_37958', 'dye', 1923, 'VA'), ('UBERON_0012101', 'perinatal stage', 1937, 'peripheral blood'), ('CL_0000623', 'natural killer cell', 1954, 'NK cells'), ('GO_0005634', 'nucleus', 1954, 'NK'), ('CL_0000084', 'T cell', 1969, 'T cell'), ('CL_0000542', 'lymphocyte', 1996, 'lymphocyte'), ('PR_000001204', 'C-C chemokine receptor type 8', 2046, 'CD4'), ('PR_000005170', 'CD37 molecule', 2050, 'CD8'), ('CL_0000898', 'naive T cell', 2127, 'naive ... T cells'), ('GO_0007613', 'memory', 2175, 'memory'), ('PR_000005170', 'CD37 molecule', 2182, 'CD8'), ('PR_000005170', 'CD37 molecule', 2187, 'CD45RO'), ('CHEBI_52290', 'mitogen', 2208, 'mitogen'), ('PR_000001470', 'interleukin-28B', 2224, 'IL-2'), ('PR_000001470', 'interleukin-28B', 2230, 'IL-4'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 2240, 'TNF'), ('CL_0000236', 'B cell', 2281, 'B cell'), ('NCBITaxon_33208', 'Metazoa', 2339, 'measles'), ('NCBITaxon_1', 'root', 2397, 'individuals'), ('GO_0071735', 'IgG immunoglobulin complex', 2519, 'IgG1'), ('CHEBI_37958', 'dye', 2633, 'VA'), ('GO_0042571', 'immunoglobulin complex, circulating', 2723, 'antibody'), ('NCBITaxon_33208', 'Metazoa', 2760, 'measles'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 2956, 'Zinc'), ('UBERON_0000483', 'epithelium', 2961, 'Epithelial'), ('CHEBI_25169', 'mannoside', 3060, 'mannitol'), ('GO_0007588', 'excretion', 3069, 'excretion'), ('UBERON_0001977', 'blood serum', 3287, 'serum'), ('PR_000004908', 'complement component C8 alpha chain', 3293, 'complement C3'), ('CL_0000623', 'natural killer cell', 3313, 'NK cell'), ('GO_0005634', 'nucleus', 3313, 'NK'), ('CL_0000623', 'natural killer cell', 3421, 'NK cells'), ('CL_0000623', 'natural killer cell', 3447, 'NK cell'), ('CL_0000084', 'T cell', 3485, 'T cell'), ('CL_0000893', 'thymocyte', 3562, 'thymocyte'), ('UBERON_0002370', 'thymus', 3581, 'thymus'), ('CHEBI_59132', 'antigen', 3686, 'antigen'), ('CL_0000236', 'B cell', 3714, 'B cell'), ('CHEBI_33250', 'atom', 3777, 'BCG'), ('CHEBI_17089', 'glycoprotein', 3821, 'glycoprotein'), ('PR_000005170', 'CD37 molecule', 3897, 'CD45RO'), ('PR_000011040', 'nuclear receptor coactivator 1', 3906, 'cluster of differentiation antigen 45 RO'), ('CHEBI_59132', 'antigen', 3933, 'antigen'), ('PR_000005890', 'crooked neck-like protein 1', 3948, 'CRP'), ('UBERON_0001977', 'blood serum', 4083, 'serum'), ('CHEBI_60425', 'amyloid fibril', 4089, 'amyloid'), ('CHEBI_27300', 'vitamin D', 4122, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4138, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4165, 'vitamin A')]
PMC4448820	5/2015	S546-PMC4448820	['the biology and biomarkers used for assessing Vitamin A were RECENTLY reviewed (324), and are discussed in more detail in wg 3.']	[('INCOMPLETE_EVIDENCE', 61)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin A')]
PMC4448820	5/2015	S549-PMC4448820	['● a high infectious disease burden CAN lead to decreased appetite, decreased absorption, Liver or Kidney disease, and other FACTORS AFFECTING loss of Retinol Binding Protein (rbp), and depletion of body stores through excessive Metabolism and increased Excretion Of Vitamin A (325).']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 124), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('UBERON_0002107', 'liver', 89, 'liver'), ('UBERON_0002113', 'kidney', 98, 'kidney'), ('CHEBI_26536', 'retinoic acid', 150, 'retinol'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 150, 'retinol binding protein'), ('GO_0008152', 'metabolic process', 228, 'metabolism'), ('GO_0006881', 'extracellular sequestering of iron ion', 253, 'excretion of vitamin A'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin A')]
PMC4448820	5/2015	S556-PMC4448820	['○ Conjunctival impression cytology HAS BEEN used as a marker for Vitamin A status but has not been widely adopted (324).']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('UBERON_0001811', 'conjunctiva', 2, 'Conjunctival'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin A')]
PMC4448820	5/2015	S571-PMC4448820	['SEVERAL Human STUDIES DOCUMENTED that vad is ASSOCIATED with increased Th1-Driven Delayed-type Hypersensitivity (dth) Responses and reduced th2-driven Antibody responses to vaccines; Vitamin A supplementation reverses these responses (104,105,326).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('GO_0044808', 'oncostatin M production', 71, 'Th1-driven'), ('GO_0001866', 'NK T cell proliferation', 82, 'delayed- ... hypersensitivity'), ('GO_0060033', 'anatomical structure regression', 118, 'responses'), ('GO_0042571', 'immunoglobulin complex, circulating', 151, 'antibody'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin A')]
PMC4448820	5/2015	S572-PMC4448820	['an Animal study INDICATED that a high Vitamin A intake MAY BE LINKED to asthma (164), an ASSOCIATION that REMAINS TO BE STUDIED in Humans.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 89), ('FULL_UNKNOWN', 106)]	5	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin A'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'humans')]
PMC4448820	5/2015	S574-PMC4448820	['the IMPORTANT EFFECTS of Vitamin A on Immune function are REFLECTED in the MANY community and clinical STUDIES that SHOWED that Vitamin A AFFECTS mortality and morbidity.']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 138)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('UBERON_0002405', 'immune system', 38, 'immune'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin A')]
PMC4448820	5/2015	S578-PMC4448820	['one POSSIBLE EXPLANATION for the APPARENT lack of benefit of Vitamin A supplementation below 6 mo of age is that infants in SUCH studies are PROTECTED from infection by maternally derived Immune factors (e.g., Serum Igg, factors in Breast Milk) to a greater degree than are older infants.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 13), ('ANOMALY_CURIOUS_FINDING', 33), ('PROBABLE_UNDERSTANDING', 124), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('UBERON_0002405', 'immune system', 188, 'immune'), ('UBERON_0001977', 'blood serum', 210, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 216, 'IgG'), ('UBERON_0001348', 'brown adipose tissue', 232, 'breast milk')]
PMC4448820	5/2015	S581-PMC4448820	['ALTHOUGH Vitamin A MAY have a preventive EFFECT on the incidence or severity of diarrhea and measles in community trials, it has had LITTLE or the OPPOSITE EFFECT on Respiratory infections (105).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('SUPERFICIAL_RELATIONSHIP', 156)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 166, 'respiratory')]
PMC4448820	5/2015	S582-PMC4448820	['the same is SEEN in studies of Vitamin A as a therapeutic agent (table 7).']	[('INCOMPLETE_EVIDENCE', 12)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin A')]
PMC4448820	5/2015	S586-PMC4448820	['also, ALTHOUGH it IS CLEAR that inflammation is ASSOCIATED with decreased Serum Retinol and rbp concentrations, the ROLE of Vitamin A supplementation on inflammation and its MARKERS is LESS CLEAR.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 174), ('FULL_UNKNOWN', 185), ('INCOMPLETE_EVIDENCE', 185)]	7	[('UBERON_0001977', 'blood serum', 74, 'serum'), ('CHEBI_26536', 'retinoic acid', 80, 'retinol'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin A')]
PMC4448820	5/2015	S593-PMC4448820	['HOWEVER, the EFFECTS of Vitamin A supplementation on the Immune System MAY lead TO variable clinical outcomes, DEPENDING ON the nature of the Immune Response NEEDED to combat the infecting pathogens.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('GO_0006955', 'immune response', 142, 'immune response'), ('UBERON_0002405', 'immune system', 142, 'immune')]
PMC4448820	5/2015	S594-PMC4448820	['FOR THIS REASON, Vitamin A supplementation MAY BE a double-edged sword.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 43)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin A')]
PMC4448820	5/2015	S595-PMC4448820	['for SOME—and on THE BASIS of the clinical trials, PRESUMABLY most—infectious diseases, Vitamin A supplementation MAY BE beneficial; in OTHER situations it MAY be harmful (369,370).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 50), ('INCOMPLETE_EVIDENCE', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 87, 'vitamin A')]
PMC4448820	5/2015	S596-PMC4448820	['important EFFECT modifiers MAY BE population Vitamin A status, age, sex, vaccination status, season, pathogen prevalence, disease type, and disease BURDEN.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 148)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin A')]
PMC4448820	5/2015	S774-PMC4448820	['as discussed above, adverse outcomes were SEEN during Vitamin A and Iron supplementation programs, and the mechanisms underlying these adverse EFFECTS MAY involve altered host resistance.']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 143), ('INCOMPLETE_EVIDENCE', 151)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('CHEBI_24870', 'ion', 68, 'iron')]
PMC4448820	5/2015	S782-PMC4448820	['caption (boxed-text): text box 27\u2003\nresearch priorities\n\n● accurate and stable biomarkers of vad\n● EFFECT of Vitamin A supplementation on inflammation and inflammatory markers\n● mechanisms behind the variable clinical outcomes SEEN as a result of the IMPACT of Vitamin A on the different Immune Responses\n● EFFECT of Vitamin A supplementation on neonates and infants <6 mo\n● INFLUENCE of zinc status on vaccine response\n● other CONFOUNDERS in the zinc–vaccine response ASSOCIATION (age, sex, degree of zinc deficiency, etc.)']	[('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 306), ('SUPERFICIAL_RELATIONSHIP', 374), ('PROBLEM_COMPLICATION', 427), ('SUPERFICIAL_RELATIONSHIP', 468)]	7	[('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin A'), ('GO_0006955', 'immune response', 287, 'immune responses'), ('UBERON_0002405', 'immune system', 287, 'immune'), ('CHEBI_27300', 'vitamin D', 316, 'vitamin A')]
PMC4448820	5/2015	S868-PMC4448820	['in infants of hiv-positive mothers, Postpartum maternal and neonatal Vitamin A supplementation MAY hasten progression to death in breastfed children who are pcr negative at 6 wk (291).']	[('INCOMPLETE_EVIDENCE', 95)]	1	[('GO_0007565', 'female pregnancy', 36, 'postpartum'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin A')]
PMC4448820	5/2015	S1001-PMC4448820	['a range of nutritional disturbances is CONSIDERED, including obesity, weight loss, muscle wasting, Adipose Tissue accumulation, and specifically, Micronutrients and Vitamins A and d (figure 1).']	[('INCOMPLETE_EVIDENCE', 39)]	1	[('UBERON_0001013', 'adipose tissue', 99, 'adipose tissue'), ('CHEBI_33839', 'macromolecule', 146, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 165, 'vitamins A')]
PMC4448820	5/2015	S1031-PMC4448820	['plausible mechanisms and EXTANT EVIDENCE for 2 Micronutrients, Vitamins A and D, are presented in text box 36 .']	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 32)]	2	[('CHEBI_33839', 'macromolecule', 47, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 63, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 72, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 78, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 78, 'D')]
PMC4448820	5/2015	S1037-PMC4448820	['● observational studies IDENTIFIED an inverse ASSOCIATION between asthma risk and Vitamin A status, which MAY BE EXPLAINED by reduction in Serum Retinol due to inflammation.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 106), ('PROBABLE_UNDERSTANDING', 113)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin A'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_26536', 'retinoic acid', 145, 'retinol')]
PMC4448820	5/2015	S1039-PMC4448820	['Vitamin D\n\n● POOR Prenatal Vitamin D status HAS BEEN IMPLICATED in increased asthma risk and severity in the offspring, ALTHOUGH EVIDENCE TO SUPPORT an IMPORTANT RELATION remains CONTROVERSIAL (577).']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 18, 'prenatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC4448820	5/2015	S1041-PMC4448820	['● low Vitamin D concentrations MAY increase risk of Allergic sensitization leading to abnormalities in the Allergic Immune Response (582).']	[('INCOMPLETE_EVIDENCE', 31)]	1	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0040011', 'locomotion', 52, 'allergic'), ('GO_0002250', 'adaptive immune response', 107, 'allergic immune response'), ('UBERON_0002405', 'immune system', 116, 'immune')]
PMC4448820	5/2015	S1043-PMC4448820	['● EVIDENCE exists for a LINK between lower maternal Vitamin D intake and higher RISK of wheezing, allergic rhinitis, and eczema in childhood (591–595).']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 24), ('IMPORTANT_CONSIDERATION', 80)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC4448820	5/2015	S1045-PMC4448820	['● no randomized trials HAVE BEEN published on the EFFECTS of Vitamin D supplementation to prevent asthma or to reduce morbidity.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4448820	5/2015	S1046-PMC4448820	['● five ONGOING clinical trials MAY provide FURTHER INSIGHTS into the ROLE of Vitamin D in the chronic inflammation RELATED to asthma (596).']	[('IMPORTANT_CONSIDERATION', 7), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 115)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4448820	5/2015	S1106-PMC4448820	['studies USUALLY DESCRIBE HOW infection and inflammation are ASSOCIATED with nutritional deficiencies [e.g., iron, Vitamin B-12, Folate, and Vitamin D for bacterial vaginosis (637–639) and anemia or obesity for stillbirths (640)].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 16), ('EXPLICIT_QUESTION', 25), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_27300', 'vitamin D', 114, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 114, 'vitamin B-12'), ('CHEBI_30863', '5-azaorotic acid', 128, 'folate'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4448820	5/2015	S1135-PMC4448820	['in SOME conditions, supplementation with Vitamins A, d, and e and copper and Selenium was PROTECTIVE against mastitis (652), BUT others REPORTED in hiv-infected women that antioxidant Micronutrient supplementation did not lower (660), and MIGHT EVEN increase the risk of scm (661).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 239), ('ANOMALY_CURIOUS_FINDING', 245)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamins A'), ('CHEBI_27568', 'selenium atom', 77, 'selenium'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 184, 'micronutrient')]
PMC4448820	5/2015	S1147-PMC4448820	['Animal experiments clearly SHOW that changes in maternal methyl-donor supply (Choline, methionine, Folate, and Vitamin B-12) CAN INFLUENCE the offspring phenotype (664).']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 129)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_15354', 'choline', 78, 'choline'), ('CHEBI_30863', '5-azaorotic acid', 99, 'folate'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 111, 'vitamin B-12')]
PMC4448820	5/2015	S1193-PMC4448820	['THIS STUDY, which was followed by numerous others, HIGHLIGHTS an IMPORTANT and underappreciated ROLE for Vitamin D in Drug Metabolism through the induction of Gene Expression of key Drug-Metabolizing enzymes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 51), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 96)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_23888', 'drug', 118, 'drug'), ('GO_0042737', 'drug catabolic process', 118, 'drug metabolism'), ('GO_0010467', 'gene expression', 159, 'gene expression'), ('SO_0000704', 'gene', 159, 'gene'), ('CHEBI_23888', 'drug', 182, 'drug'), ('GO_0016540', 'protein autoprocessing', 182, 'drug-metabolizing')]
PMC4448820	5/2015	S1194-PMC4448820	['this phenomenon SHOULD BE evaluated closely, particularly in light of the EXPANDING INTEREST in Vitamin D supplementation to boost Immune function and for use in numerous conditions including hiv and other infections.']	[('FUTURE_WORK', 16), ('INCOMPLETE_EVIDENCE', 74)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0002405', 'immune system', 131, 'immune')]
PMC4448820	5/2015	S1447-PMC4448820	['text box 47 provides a summary of currently available BIOMARKERS of Vitamin A.\n\ncaption (boxed-text): text box 47\u2003\nCURRENTLY available indicators of Vitamin A\n\n● night blindness: primary functional BIOMARKER\n● Serum Retinol:\n○ Retinol in Serum measured by hplc is the most widely used and ACCEPTED INDICATOR for Vitamin A status.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 198), ('INCOMPLETE_EVIDENCE', 289), ('SUPERFICIAL_RELATIONSHIP', 298)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin A'), ('UBERON_0001977', 'blood serum', 210, 'Serum'), ('CHEBI_26536', 'retinoic acid', 216, 'retinol'), ('CHEBI_27810', 'resorcinol', 227, 'Retinol'), ('UBERON_0001977', 'blood serum', 238, 'serum'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin A')]
PMC4448820	5/2015	S1453-PMC4448820	['○ BECAUSE it CORRELATES well with Retinol, rbp measurements CAN be used to ESTIMATE Vitamin A status.']	[('PROBABLE_UNDERSTANDING', 2), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 75)]	4	[('CHEBI_26536', 'retinoic acid', 34, 'retinol'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A')]
PMC4448820	5/2015	S1471-PMC4448820	['BECAUSE Human Milk HAS BEEN SUGGESTED as a POTENTIALLY useful BIOMARKER of Vitamin A status of women and, by extrapolation, of their children and POTENTIALLY OTHER groups within the population (324), it is useful to explore the POTENTIAL IMPACT of inflammation on the use of Breast-Milk Vitamin A concentrations and interpretation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 238)]	8	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('UBERON_0001913', 'milk', 14, 'milk'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin A'), ('UBERON_0000310', 'breast', 275, 'breast'), ('UBERON_0001913', 'milk', 282, 'milk'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A')]
PMC4448820	5/2015	S1472-PMC4448820	['to date, LIMITED EVIDENCE SUGGESTS that Human-milk Vitamin A is not susceptible to the INFLUENCE of inflammation (775).']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 87)]	3	[('NCBITaxon_9606', 'Homo sapiens', 40, 'human'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin A')]
PMC4448820	5/2015	S1473-PMC4448820	['HOWEVER, recent data from a subset of women recruited as part of a national survey in cameroon INDICATE that Human-milk Vitamin A concentrations (casual samples at ≥1 mo Postpartum) were ASSOCIATED with crp, and this ASSOCIATION SEEMED TO BE EXPLAINED by a decrease in Plasma rbp (776).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 187), ('SUPERFICIAL_RELATIONSHIP', 217), ('ANOMALY_CURIOUS_FINDING', 229), ('PROBABLE_UNDERSTANDING', 242)]	6	[('NCBITaxon_9606', 'Homo sapiens', 109, 'human'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('GO_0007565', 'female pregnancy', 170, 'postpartum'), ('UBERON_0001969', 'blood plasma', 269, 'plasma')]
PMC4448820	5/2015	S1474-PMC4448820	['the overall RELATION between inflammation, specific BIOMARKERS such as crp and Human-milk Vitamin A REMAINS UNRESOLVED.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108)]	4	[('NCBITaxon_9606', 'Homo sapiens', 79, 'human'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin A')]
PMC4448820	5/2015	S1500-PMC4448820	['Plasma total Homocysteine, which is elevated in deficiencies of Folate, Vitamin B-12, riboflavin, and Vitamin B-6, MAY also be elevated in chronic inflammation states (784).']	[('INCOMPLETE_EVIDENCE', 115)]	1	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 13, 'homocysteine'), ('CHEBI_30863', '5-azaorotic acid', 64, 'folate'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin B'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin B')]
PMC4448820	5/2015	S1503-PMC4448820	['the available BIOMARKERS of Vitamin B-12 were also RECENTLY reviewed (785) and are summarized in the text box 50 .']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 51)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 28, 'vitamin B-12')]
PMC4448820	5/2015	S1516-PMC4448820	['as outlined by wgs 1 and 2, an EXPANDING body of EVIDENCE ATTESTS to the IMPORTANCE of Vitamin D to Immune function and the inflammatory Response, with potential therapeutic applications for acute and chronic infectious and inflammatory diseases (790).']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 58), ('PROBABLE_UNDERSTANDING', 58), ('IMPORTANT_CONSIDERATION', 73)]	5	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('GO_0060033', 'anatomical structure regression', 137, 'response')]
PMC4448820	5/2015	S1518-PMC4448820	['caption (boxed-text): text box 52\u2003\nCURRENTLY available Vitamin D BIOMARKERS/indicators\n\n● 25(Oh)D:\n○ GENERALLY RECOGNIZED AS the best currently available biomarker\n○ reflects Intake\n○ functional relevance not clearly established\n● functional biomarkers:\n○ Parathyroid hormone\n○ calcium absorption\n○ Bone Resorption\n○ bone Mineral density\n\nINFLUENCE of inflammation on Vitamin D assessment.']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 101), ('INCOMPLETE_EVIDENCE', 111), ('PROBABLE_UNDERSTANDING', 111), ('PROBABLE_UNDERSTANDING', 122), ('SUPERFICIAL_RELATIONSHIP', 339)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 90, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 90, '25(OH ... D'), ('GO_0007631', 'feeding behavior', 175, 'intake'), ('GO_0007567', 'parturition', 182, '○'), ('UBERON_0001132', 'parathyroid gland', 256, 'parathyroid'), ('GO_0008218', 'bioluminescence', 299, 'bone resorption ○'), ('CHEBI_46662', 'mineral', 322, 'mineral'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin D')]
PMC4448820	5/2015	S1520-PMC4448820	['data on the INFLUENCE of inflammation on BIOMARKERS of Vitamin D status are LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 76)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4448820	5/2015	S1550-PMC4448820	['HOWEVER, it was POSSIBLE to interpret these Micronutrients IF the systemic inflammatory response was less severe: for zinc when crp is <20 mg/l, for Selenium and Vitamins A and D when crp is <10 mg/l, and for Vitamins B-6 and C when crp is <5 mg/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59)]	3	[('CHEBI_33839', 'macromolecule', 44, 'micronutrients'), ('CHEBI_27568', 'selenium atom', 149, 'selenium'), ('CHEBI_27300', 'vitamin D', 162, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 162, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 177, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 177, 'D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamins B'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 209, 'vitamins B-6'), ('PR_000004900', 'complement C3', 226, 'C')]
PMC4488777	5/2015	S1-PMC4488777	['abstract\nin the last decade, Vitamin D was in the SPOTLIGHT in MANY fields of research.']	[('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 63)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC4488777	5/2015	S9-PMC4488777	['high concentration of Vitamin D and its Metabolites in Decidua during the 1st trimester SUGGESTS its IMPORTANT ROLE in the Implantation process and a local immunological Embryo-protection.']	[('INCOMPLETE_EVIDENCE', 88), ('IMPORTANT_CONSIDERATION', 101), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 30, 'D'), ('CHEBI_25212', 'metabolite', 40, 'metabolites'), ('UBERON_0002450', 'decidua', 55, 'decidua'), ('GO_0007566', 'embryo implantation', 123, 'implantation'), ('UBERON_0000922', 'embryo', 170, 'embryo')]
PMC4488777	5/2015	S10-PMC4488777	['ON THE OTHER HAND, EVIDENCE-BASED research DID NOT prove a significant DIFFERENCE so far in Ovulation stimulation or Embryo Development depending on Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71)]	4	[('GO_0030728', 'ovulation', 92, 'ovulation'), ('GO_0009790', 'embryo development', 117, 'embryo development'), ('UBERON_0000922', 'embryo', 117, 'embryo'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4488777	5/2015	S11-PMC4488777	['in one of the publications, it was also FOUND that Vitamin D Binding Protein (Vdbp) has a molecular SIMILARITY to anti-Sperm Antibodies, and another one CONCLUDED that both low (<50 nmol/l) and high (>125 nmol/l) concentration of Vitamin D are ASSOCIATED with decreased number and quality of Spermatozoa in Semen.']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 244)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 51, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 78, 'VDBP'), ('CL_0000019', 'sperm', 119, 'sperm'), ('GO_0042571', 'immunoglobulin complex, circulating', 125, 'antibodies'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CL_0000019', 'sperm', 292, 'spermatozoa'), ('UBERON_0001968', 'semen', 307, 'semen')]
PMC4488777	5/2015	S12-PMC4488777	['Vitamin D is definitely not a trojan horse in Reproductive health, SINCE there were no adverse effects REPORTED for Vitamin D intake of up to 10,000 iu/day, BUT to PROCLAIM it the golden fleece, MORE EVIDENCE IS NEEDED.']	[('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 195)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0000003', 'reproduction', 46, 'reproductive'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4488777	5/2015	S14-PMC4488777	['introduction\nthe ROLE of Vitamin D in fertility treatment has been RECENTLY DESCRIBED in SOME COMPREHENSIVE REPORTS [1,2].']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 108)]	6	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC4488777	5/2015	S18-PMC4488777	['today we KNOW that, in a healthy woman, Vitamin D Serum concentration is higher than in patients suffering from polycystic Ovaries syndrome (pcos).']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('UBERON_0000992', 'ovary', 123, 'ovaries')]
PMC4488777	5/2015	S21-PMC4488777	['LIKEWISE, in patients with Vitamin D deficiency, a higher occurrence of Uterine myomas is OBSERVED—another established REASON for infertility.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 119)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0000995', 'uterus', 72, 'uterine')]
PMC4488777	5/2015	S29-PMC4488777	['lower Vitamin D levels HAVE BEEN FOUND in many Autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, type 1 diabetes mellitus, multiple sclerosis, Inflammatory Bowel diseases, Autoimmune Thyroid diseases [6,7].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 33)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 47, 'autoimmune'), ('UBERON_0001782', 'pigmented layer of retina', 194, 'inflammatory bowel'), ('UBERON_0001442', 'skeleton of manus', 223, 'autoimmune'), ('UBERON_0002046', 'thyroid gland', 234, 'thyroid')]
PMC4488777	5/2015	S32-PMC4488777	['for THE TIME BEING, we KNOW that Vitamin D exists in two forms: Vitamin D2(Ergocalciferol) and D3(Cholecalciferol).']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 23)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_28934', 'vitamin D2', 64, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 64, 'vitamin D2'), ('CHEBI_4910', 'etomidate', 75, 'ergocalciferol'), ('PR_000001177', 'D(2) dopamine receptor', 95, 'D3'), ('CHEBI_52550', 'theopalauamide', 98, 'cholecalciferol')]
PMC4488777	5/2015	S36-PMC4488777	['an OPTIMAL level of Vitamin D concentration in Blood Serum SHOULD range between 50 and 125 nmol/l [10], EVEN THOUGH SOME environmental STUDIES IMPLY that the target level SHOULD BE set much higher—up to 250, or even at 300 nmol/l [11,12].']	[('IMPORTANT_CONSIDERATION', 3), ('IMPORTANT_CONSIDERATION', 59), ('ANOMALY_CURIOUS_FINDING', 104), ('INCOMPLETE_EVIDENCE', 116), ('PROBABLE_UNDERSTANDING', 143), ('IMPORTANT_CONSIDERATION', 171)]	6	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0001977', 'blood serum', 53, 'serum')]
PMC4488777	5/2015	S39-PMC4488777	['the EFFECT of Vitamin D on Ovarian Granulosa Cells RESPONSIBLE for Steroidogenesis, as well as on Immune System Regulation, was ESTABLISHED after FINDING 1-α-hydroxylase and vdr receptors in Deciduae, Placentas, Ovaries, Endometriums and Pituitary Glands, and was CONFIRMED in vitro by DEMONSTRATING active Metabolites of Vitamin D such as 1,25[Oh]2D and 24,25[Oh]2D in mentioned Tissues [14,15,16,17,18].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CL_0000477', 'ovarian follicle cell', 27, 'ovarian granulosa cells'), ('UBERON_0000992', 'ovary', 27, 'ovarian'), ('GO_0001501', 'skeletal system development', 67, 'steroidogenesis'), ('UBERON_0002405', 'immune system', 98, 'immune system'), ('GO_0065007', 'biological regulation', 112, 'regulation'), ('UBERON_0002450', 'decidua', 191, 'deciduae'), ('UBERON_0001987', 'placenta', 201, 'placentas'), ('UBERON_0000992', 'ovary', 212, 'ovaries'), ('UBERON_0001852', 'endolymph', 221, 'endometriums'), ('UBERON_0000007', 'pituitary gland', 238, 'pituitary glands'), ('CHEBI_25212', 'metabolite', 307, 'metabolites'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 342, '25[OH]2D'), ('CHEBI_82784', 'PVP38-Ag NP', 358, '25[OH]2D'), ('UBERON_0000479', 'tissue', 380, 'tissues')]
PMC4488777	5/2015	S54-PMC4488777	['since our PREVIOUS REVIEW [2], two NEW ORIGINAL papers HAVE BEEN published, EXPLAINING the SIGNIFICANCE of Vitamin D in pcos pathogenesis.']	[('INCOMPLETE_EVIDENCE', 10), ('FULL_UNKNOWN', 35), ('FULL_UNKNOWN', 39), ('INCOMPLETE_EVIDENCE', 55), ('PROBABLE_UNDERSTANDING', 76), ('IMPORTANT_CONSIDERATION', 91)]	6	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4488777	5/2015	S102-PMC4488777	['the direct EFFECT of Vitamin D on Amh level and follicle development was also CONFIRMED in a RECENTLY published in vitro experiment [45].']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 93)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_16027', "adenosine 5'-monophosphate", 34, 'AMH')]
PMC4488777	5/2015	S104-PMC4488777	['the authors of the study SUGGEST a direct EFFECT of Vitamin D on Amh production, and THUS longer maintenance of Ovarian reserve in the patients with its higher concentration [46].']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 85)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_16027', "adenosine 5'-monophosphate", 65, 'AMH'), ('UBERON_0000992', 'ovary', 112, 'ovarian')]
PMC4488777	5/2015	S111-PMC4488777	['authors STATE that the Proliferation Of Spermatogenic Cells was decreased with calcium-dependent down REGULATION of Cyclin E and Cdk2, and up REGULATION of P53 and P21 Expression, which is not a direct EFFECT of active Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 102), ('SUPERFICIAL_RELATIONSHIP', 142), ('SUPERFICIAL_RELATIONSHIP', 202)]	4	[('GO_0043277', 'apoptotic cell clearance', 23, 'proliferation of spermatogenic cells'), ('PR_000005344', 'centrosomal protein of 170 kDa', 116, 'cyclin E'), ('PR_000005259', 'cyclin-dependent kinase 5 activator 1', 129, 'CDK2'), ('PR_000003035', 'cellular tumor antigen p53', 156, 'p53'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 164, 'p21'), ('GO_0010467', 'gene expression', 168, 'expression'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC4488777	5/2015	S115-PMC4488777	['earlier research SUGGESTED the adverse EFFECT of Vitamin D on fertility after a discovery of a molecular SIMILARITY of its transporting protein, the Vitamin D Binding Protein (Vdbp), to anti-Sperm Antibodies.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 105)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 149, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 176, 'VDBP'), ('CL_0000019', 'sperm', 191, 'sperm'), ('GO_0042571', 'immunoglobulin complex, circulating', 197, 'antibodies')]
PMC4488777	5/2015	S150-PMC4488777	['this very clever approach gave the authors of these, and of other SIMILAR STUDIES from both europe and the usa, REASONS to state that their data STRONGLY SUGGEST that the EFFECTS of Vitamin D MAY BE MEDIATED through the Endometrium, not the follicle or Oocyte [56,57].']	[('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 145), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 192), ('SUPERFICIAL_RELATIONSHIP', 199)]	7	[('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('UBERON_0001852', 'endolymph', 220, 'endometrium'), ('CL_0000023', 'oocyte', 253, 'oocyte')]
PMC4488777	5/2015	S159-PMC4488777	['the immunomodulating ROLE of Vitamin D was also CONFIRMED by Stimulation Of Nk Cells (natural killer Cd56+ve) isolated from the 1sttrimester Decidua.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 48)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0048870', 'cell motility', 61, 'stimulation of NK cells'), ('CL_0000623', 'natural killer cell', 76, 'NK cells'), ('GO_0005634', 'nucleus', 76, 'NK'), ('PR_000001309', 'CD70 molecule', 101, 'CD56'), ('UBERON_0002450', 'decidua', 141, 'decidua')]
PMC4488777	5/2015	S161-PMC4488777	['as STATED by the authors, the results of their study PROVE an increased Production Of active form Of Vitamin D in the first trimester Decidua, which Modulates reactions in a Paracrine manner between the mother’s and the Embryo’s Immune System during the Implantation.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 53)]	2	[('GO_0040007', 'growth', 72, 'production of ... of vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0002450', 'decidua', 134, 'decidua'), ('GO_0065007', 'biological regulation', 149, 'modulates'), ('GO_0038001', 'paracrine signaling', 174, 'paracrine'), ('UBERON_0000922', 'embryo', 220, 'embryo'), ('UBERON_0002405', 'immune system', 229, 'immune system'), ('GO_0007566', 'embryo implantation', 254, 'implantation')]
PMC4488777	5/2015	S187-PMC4488777	['conclusions\nCURRENT RESEARCH on the ROLE of Vitamin D in Fertility impairments, such as polycystic Ovary syndrome, Uterine fibroids, improper Semen parameters and in the case of in vitro treatments and Pregnancy failure, SUGGESTS it plays an IMPORTANT ROLE in Human Reproduction processes.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 242), ('SUPERFICIAL_RELATIONSHIP', 252)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0009566', 'fertilization', 57, 'fertility'), ('UBERON_0000992', 'ovary', 99, 'ovary'), ('UBERON_0000995', 'uterus', 115, 'uterine'), ('UBERON_0001968', 'semen', 142, 'semen'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 260, 'human'), ('GO_0000003', 'reproduction', 266, 'reproduction')]
PMC4488777	5/2015	S189-PMC4488777	['couples with Serum concentration exceeding 50 nmol/l have a higher CHANCE of Conception, but this DOES NOT REGARD all patients, where ESPECIALLY males SHOULD BE supplemented with Vitamin D from the beginning of the therapy.']	[('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 98), ('ANOMALY_CURIOUS_FINDING', 134), ('FUTURE_WORK', 151)]	4	[('UBERON_0001977', 'blood serum', 13, 'serum'), ('GO_0007620', 'copulation', 77, 'conception'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4488777	5/2015	S191-PMC4488777	['Vitamin D is definitely not a trojan horse in Reproductive health since there were no adverse EFFECTS REPORTED for Vitamin D intake of up to 10,000 iu/d [66], BUT to PROCLAIM it the golden fleece, MORE EVIDENCE IS still REQUIRED.']	[('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('INCOMPLETE_EVIDENCE', 166), ('FUTURE_WORK', 197)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0000003', 'reproduction', 46, 'reproductive'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4516109	5/2015	S20-PMC4516109	['clinical presentations include Abdominal pain, vomiting, lethargy, hallucinations, confusion, hypoglycemia, deafness, tinnitus, tachypnea, irritability, Metabolic acidosis, coma and death.15\nrisks of OTHER topical agents, such as Anthralin and Calcipotriol on Human studies are NOT KNOWN and THUS most authors CONTRAINDICATE these treatments.7,15calcipotriol is a by-product of Vitamin D3, OFTEN used in combination with topical Corticosteroids in order to increase their effectiveness and minimize irritation.12nevertheless, studies evidenced its systemic absorption in Humans after application on psoriasis plaques and the development of Vitamin D-induced toxicity after treatment with Calcipotriol TENDS to increase the risk of teratogenicity.12\nALTHOUGH the NUMBER OF cases is LIMITED, coal tar HAS BEEN ASSOCIATED with spontaneous Abortions and congenital disorders, and WAS CONSIDERED Teratogenic in Animal studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('FULL_UNKNOWN', 278), ('PROBABLE_UNDERSTANDING', 292), ('IMPORTANT_CONSIDERATION', 310), ('PROBABLE_UNDERSTANDING', 390), ('SUPERFICIAL_RELATIONSHIP', 701), ('ANOMALY_CURIOUS_FINDING', 749), ('INCOMPLETE_EVIDENCE', 762), ('INCOMPLETE_EVIDENCE', 781), ('INCOMPLETE_EVIDENCE', 799), ('SUPERFICIAL_RELATIONSHIP', 808), ('INCOMPLETE_EVIDENCE', 876)]	12	[('UBERON_0000916', 'abdomen', 31, 'abdominal'), ('GO_0008152', 'metabolic process', 153, 'metabolic'), ('CHEBI_37510', 'anthralin', 230, 'anthralin'), ('CHEBI_50749', 'calcipotriol', 244, 'calcipotriol'), ('NCBITaxon_9606', 'Homo sapiens', 260, 'human'), ('CHEBI_33279', 'vitamin D5', 378, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 378, 'vitamin D3'), ('CHEBI_50850', 'etabonate ester', 429, 'corticosteroids'), ('NCBITaxon_9606', 'Homo sapiens', 571, 'humans'), ('CHEBI_27300', 'vitamin D', 640, 'vitamin D'), ('CHEBI_50749', 'calcipotriol', 688, 'calcipotriol'), ('GO_0006915', 'apoptotic process', 836, 'abortions'), ('CHEBI_50905', 'teratogenic agent', 891, 'teratogenic'), ('NCBITaxon_33208', 'Metazoa', 906, 'animal')]
PMC4452099	6/2015	S3-PMC4452099	['we further MODELLED birth cohort EFFECTS in children developing t1d as a linear spline, and compared the slopes between the birth cohorts with various Prenatal and infancy exposures to Vitamin D fortification.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('GO_0007565', 'female pregnancy', 151, 'prenatal'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC4452099	6/2015	S7-PMC4452099	['in conclusion, we FOUND NO EVIDENCE TO SUPPORT that exposure to low dose Vitamin D from the danish mandatory Margarine fortification regimen during Gestational and first Postnatal year of Life changed the risk of developing t1d before the age of 15 years.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 24)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_6784', 'mestranol', 109, 'margarine'), ('GO_0007565', 'female pregnancy', 148, 'gestational'), ('GO_0007567', 'parturition', 170, 'postnatal'), ('UBERON_0000104', 'life cycle', 188, 'life')]
PMC4452099	6/2015	S13-PMC4452099	['a variety of environmental t1d risk and PROTECTIVE FACTORS, including Vitamin D supplementation during Gestation and in early infancy, HAVE BEEN investigated [5–9].']	[('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 135)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'gestation')]
PMC4452099	6/2015	S14-PMC4452099	['there are several REASONS to SUGGEST that Vitamin D supplementation early in Life MAY CONTRIBUTE to PREVENTING t1d.']	[('PROBABLE_UNDERSTANDING', 18), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0000104', 'life cycle', 77, 'life')]
PMC4452099	6/2015	S15-PMC4452099	['one HYPOTHESIS is that Vitamin D in Pregnant women is INVOLVED in the processes of Immunological Adaptation down-regulating the T Helper type 1 (th1) pro-inflammatory cytokine Responses, that POSSIBLY CONTRIBUTE to the Destruction Of Beta-Cells[10].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 192), ('SUPERFICIAL_RELATIONSHIP', 201)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 36, 'pregnant'), ('GO_0002455', 'humoral immune response mediated by circulating immunoglobulin', 83, 'immunological adaptation'), ('CL_0002061', 'T-helper 9 cell', 128, 'T helper'), ('GO_0060033', 'anatomical structure regression', 176, 'responses'), ('GO_0048468', 'cell development', 219, 'destruction of ... cells'), ('CL_0000349', 'extraembryonic cell', 234, 'beta-cells')]
PMC4452099	6/2015	S17-PMC4452099	['Animal studies DEMONSTRATED that in Mice, Prenatal Vitamin D supplementation PREVENTED the development of t1d [13,14].']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('NCBITaxon_10088', 'Mus <genus>', 36, 'mice'), ('GO_0007565', 'female pregnancy', 42, 'prenatal'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC4452099	6/2015	S18-PMC4452099	['SEVERAL epidemiological STUDIES also FOUND that the risk of t1d was decreased in Individuals supplemented with Vitamin D during Gestation or infancy, and that the PROTECTIVE EFFECT was directly DEPENDENT ON the supplementation dose: the larger the dose, the smaller t1d risk [15].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 163), ('SUPERFICIAL_RELATIONSHIP', 174), ('SUPERFICIAL_RELATIONSHIP', 194)]	6	[('NCBITaxon_1', 'root', 81, 'individuals'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0007565', 'female pregnancy', 128, 'gestation')]
PMC4452099	6/2015	S22-PMC4452099	['oral Intake MIGHT be further augmented by fortification and supplementation, which is especially IMPORTANT in order to maintain baseline Vitamin stores during winter in populations at northern latitudes, where the sun can initiate dermal Synthesis Of Vitamin D only from april to october [17,18].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 97)]	2	[('GO_0007631', 'feeding behavior', 5, 'intake'), ('CHEBI_33229', 'vitamin (role)', 137, 'vitamin'), ('GO_0030474', 'spindle pole body duplication', 238, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D')]
PMC4452099	6/2015	S23-PMC4452099	['a RECENT danish fortification trial has PROVED that the Intake of fortified Food PREVENTED Vitamin D deficiency during winter [19].']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 40), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('GO_0007631', 'feeding behavior', 56, 'intake'), ('CHEBI_33290', 'food', 76, 'food'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4452099	6/2015	S26-PMC4452099	['STILL, on average, 13% of all dietary Vitamin D among Adult danes was ESTIMATED to have come from the fortified Margarine [20].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 70)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adult'), ('CHEBI_6784', 'mestranol', 112, 'margarine')]
PMC4452099	6/2015	S27-PMC4452099	['the REPORTED REASON to initiate mandatory fortification was the need to substitute the lack of Vitamin D in Margarine COMPARED to butter, WHILE the decision to cancel mandatory margarine fortification was justified by the low Vitamin D doses added to the Margarine products—an ARGUMENT which, HOWEVER, DID NOT SEEM TO BE EVIDENCE-BASED.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 13), ('ANOMALY_CURIOUS_FINDING', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 277), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 293), ('INCOMPLETE_EVIDENCE', 302), ('ANOMALY_CURIOUS_FINDING', 310), ('INCOMPLETE_EVIDENCE', 315)]	9	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_6784', 'mestranol', 108, 'margarine'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('CHEBI_6784', 'mestranol', 255, 'margarine')]
PMC4452099	6/2015	S29-PMC4452099	['we HYPOTHESISED that t1d risk will be lower among Individuals Born in denmark during the period of obligatory Margarine fortification—and THEREFORE exposed to Vitamin D fortified Food during Gestation or Infancy—compared to Individuals Born in years when Margarine was not fortified—and CONSEQUENTLY unexposed to extra Vitamin D coming from fortified Margarine at any period of early Life.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 138), ('PROBABLE_UNDERSTANDING', 287)]	3	[('NCBITaxon_1', 'root', 50, 'individuals'), ('GO_0007567', 'parturition', 62, 'born'), ('CHEBI_6784', 'mestranol', 110, 'margarine'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_33290', 'food', 179, 'food'), ('GO_0007565', 'female pregnancy', 191, 'gestation'), ('UBERON_0000023', 'wing', 204, 'infancy'), ('NCBITaxon_1', 'root', 224, 'individuals'), ('GO_0007567', 'parturition', 236, 'born'), ('CHEBI_6784', 'mestranol', 255, 'margarine'), ('CHEBI_27300', 'vitamin D', 319, 'vitamin D'), ('CHEBI_6784', 'mestranol', 351, 'margarine'), ('UBERON_0000104', 'life cycle', 384, 'life')]
PMC4452099	6/2015	S30-PMC4452099	['materials and methods\n\nanalysis approach\ndue to the specifics of the data (please see below under “study population and data sources”) we analysed the exposed and unexposed to Vitamin D fortification Birth cohorts ONLY around the cancellation of Margarine fortification regimen.']	[('INCOMPLETE_EVIDENCE', 214)]	1	[('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('GO_0007567', 'parturition', 200, 'birth'), ('CHEBI_6784', 'mestranol', 246, 'margarine')]
PMC4452099	6/2015	S36-PMC4452099	['higher slope during the washout period, resulting in a jump of linear T1D increase in the non-exposure compared to the exposure period (fig 1b), and/or steeper slope in the non-exposure compared to exposure period (fig 1c) would INDICATE changes in t1d risk attributable to changes in Vitamin D fortification.']	[('INCOMPLETE_EVIDENCE', 229)]	1	[('PR_000016880', '5,6-dihydroxyindole-2-carboxylic acid oxidase', 70, 'T1D'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D')]
PMC4452099	6/2015	S77-PMC4452099	['when assessing the benefits of Food fortification, MOSTLY medium SCALE clinical TRIALS are conducted, SO FAR SHOWING that Vitamin D-fortified Foods improve Vitamin D status in Adults [22].']	[('INCOMPLETE_EVIDENCE', 51), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 109)]	4	[('CHEBI_33290', 'food', 31, 'food'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_33290', 'food', 142, 'foods'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('UBERON_0007023', 'adult organism', 176, 'adults')]
PMC4452099	6/2015	S79-PMC4452099	['additionally, in finland, where Vitamin D since february 2003 has been added to all liquid Milk products, Margarine and butter, before-after comparisons in various cohorts SHOWED that fortification has improved the Vitamin D status in both children and Adults [23,24].']	[('INCOMPLETE_EVIDENCE', 172)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001913', 'milk', 91, 'milk'), ('CHEBI_6784', 'mestranol', 106, 'margarine'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('UBERON_0007023', 'adult organism', 253, 'adults')]
PMC4452099	6/2015	S80-PMC4452099	['on the background of the great NEED of Vitamin D in finland due to its high latitude, this COULD have CONTRIBUTED to the recent levelling-off of the otherwise very high t1d incidence in 0–15 year old children [25].']	[('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 102)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4452099	6/2015	S83-PMC4452099	['this study CONFIRMED the linear increasing TREND in the incidence of childhood t1d in Individuals Born in denmark from 1983 to 1988, and we FOUND NO EVIDENCE to support that the Early Life exposure to small extra doses of Vitamin D from the danish mandatory Margarine fortification programme AFFECTED this TREND.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 292), ('INCOMPLETE_EVIDENCE', 306)]	6	[('NCBITaxon_1', 'root', 86, 'individuals'), ('GO_0007567', 'parturition', 98, 'born'), ('UBERON_0001847', 'lobule of pinna', 178, 'early life'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('CHEBI_6784', 'mestranol', 258, 'margarine')]
PMC4452099	6/2015	S84-PMC4452099	['one REASON for the absence of a detectable RELATIONSHIP between td risk and Early Life exposure to fortified Margarine COULD BE the actual dose of Vitamin D added to Margarine, and therefore the dose which Individuals were exposed to during Gestation and/or during the first year of Life.']	[('PROBABLE_UNDERSTANDING', 4), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 119)]	3	[('UBERON_0001847', 'lobule of pinna', 76, 'early life'), ('CHEBI_6784', 'mestranol', 109, 'margarine'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_6784', 'mestranol', 166, 'margarine'), ('NCBITaxon_1', 'root', 206, 'individuals'), ('GO_0007565', 'female pregnancy', 241, 'gestation'), ('UBERON_0000104', 'life cycle', 283, 'life')]
PMC4452099	6/2015	S86-PMC4452099	['ACCORDING TO results from PREVIOUS STUDIES, Pregnant danish women are getting APPROXIMATELY 3 μg of Vitamin D per day from the diet [26], which in turn SUGGESTS that the amount of Vitamin D coming from the fortified Margarine (i.e.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 152)]	4	[('GO_0007565', 'female pregnancy', 44, 'pregnant'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_6784', 'mestranol', 216, 'margarine')]
PMC4452099	6/2015	S88-PMC4452099	['this figure AGREES well with information from Food disappearance data SHOWING that danish citizens, during the period between 1983 and 1988, were buying on average 16,000–17,000 g Margarine per Person per year (equal to 44–46 g per Person per day), and thus taking on average 0.55–0.57 μg of Vitamin D per Person day from the fortified Margarine [27].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 70)]	2	[('CHEBI_33290', 'food', 46, 'food'), ('CHEBI_6784', 'mestranol', 180, 'margarine'), ('NCBITaxon_10088', 'Mus <genus>', 194, 'person'), ('NCBITaxon_10088', 'Mus <genus>', 232, 'person'), ('CHEBI_27300', 'vitamin D', 292, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 306, 'person'), ('CHEBI_6784', 'mestranol', 336, 'margarine')]
PMC4452099	6/2015	S92-PMC4452099	['AS the maternal Vitamin D fortification had EFFECT on babies´ Vitamin D levels via Breast feeding, Vitamin D intake during the first year of Life was LIKELY to HAVE BEEN lower than the maternal Intake.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('PROBABLE_UNDERSTANDING', 150), ('INCOMPLETE_EVIDENCE', 160)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0000310', 'breast', 83, 'breast'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0000104', 'life cycle', 141, 'life'), ('GO_0007631', 'feeding behavior', 194, 'intake')]
PMC4452099	6/2015	S93-PMC4452099	['additionally, SOME babies COULD have been getting small doses of Vitamin D via the complementary Feeding prepared using the fortified Margarine.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 26)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007631', 'feeding behavior', 97, 'feeding'), ('CHEBI_6784', 'mestranol', 134, 'margarine')]
PMC4452099	6/2015	S95-PMC4452099	['in comparison, in the PREVIOUSLY CONDUCTED finnish cohort STUDY, which SHOWED a decrease in t1d of around 20%, the Vitamin D supplementation doses given to infants were 50 μg per day [31].']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 71)]	3	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC4452099	6/2015	S96-PMC4452099	['ANOTHER POTENTIAL REASON WHY we DID NOT detect EFFECTS of early exposure to Vitamin D fortification on later t1d risk MAY BE RELATED to statistical power ISSUES [32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('EXPLICIT_QUESTION', 25), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 125), ('PROBLEM_COMPLICATION', 154)]	9	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4452099	6/2015	S100-PMC4452099	['all of these FACTORS, which in DIFFERENT ways MAY BE RELATED to either Vitamin D intake and/or t1d risk, can be ASSUMED to be balanced between the Individuals from the various exposure groups, and THEREFORE CONFOUNDING is not to be expected.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 197), ('PROBLEM_COMPLICATION', 207)]	7	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('NCBITaxon_1', 'root', 147, 'individuals')]
PMC4466139	6/2015	S15-PMC4466139	['moreover, in RECENT YEARS, Vitamin D deficiency HAS BEEN CONSIDERED AS a POSSIBLE cause of several diseases, including Microbial infections, Cardiovascular and allergic diseases, cancers, type 1 diabetes, multiple sclerosis and other Autoimmune diseases [1–10].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 73)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 119, 'microbial'), ('UBERON_0004535', 'cardiovascular system', 141, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 234, 'autoimmune')]
PMC4466139	6/2015	S16-PMC4466139	['Vitamin D levels during fetal Life and the Neonatal Period MAY play a ROLE in the development of these conditions through epigenetic changes [11], THEREFORE, Vitamin D status during Pregnancy and in the newborn COULD provide IMPORTANT information.']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 147), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 225)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 30, 'life'), ('UBERON_0007221', 'neonate stage', 43, 'neonatal period'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy')]
PMC4466139	6/2015	S82-PMC4466139	['s: subjects supplemented with Vitamin D; not s: subjects not supplemented with Vitamin D\nanalyzing epic italy semiquantitative questionnaires we FOUND an average daily Vitamin D intake of 136±68 ui (3.4 ± 1.7 μg) with a higher Intake in migrant mothers than italian (p = 0.0003) (table 3).']	[('INCOMPLETE_EVIDENCE', 145)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007631', 'feeding behavior', 227, 'intake')]
PMC4466139	6/2015	S83-PMC4466139	['a daily supplementation of 400 iu of Vitamin D LED TO 105 (37%) mothers (93 italian and 12 migrants) and 56 (20%) newborns (53 italian and 3 migrants) to have Blood 25Ohd values above the cut-off of sufficiency (fixed at 50 nmol/l) (table 5).10.1371/journal.pone.0129586.t005\n\ncaption (table-wrap): table 5\nnumber and percentage of subjects under Vitamin D supplementation (400 iu per day) SHOWING sufficient levels of Vitamin D (25Ohd≥50 nmol/l).subjectsall (283)italian (213)migrant (70)p value newborns 56 (20%)53 (24.9%)3 (4.3%)<0.001 mothers 105 (37%)93 (43.7%)12 (17.1%)<0.001\nno significant associations between maternal and neonatal 25Ohd levels and maternal weight gain in Pregnancy or Birth weight were FOUND.']	[('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 390), ('INCOMPLETE_EVIDENCE', 713)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0000178', 'blood', 159, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 165, '25OHD'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 430, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 641, '25OHD'), ('GO_0007565', 'female pregnancy', 682, 'pregnancy'), ('GO_0007567', 'parturition', 695, 'birth')]
PMC4466139	6/2015	S84-PMC4466139	['multivariate adjusted regression model analysis (r-square: 0.302), adjusted for maternal age and education SHOWED a LINK between maternal 25Ohd level and season (p<0.0001), country of origin (north africa, p<0.0001; africa, p = 0.0052; asia, p = 0.0003; south america, p = 0.0002) and Vitamin D supplementation in Pregnancy (p<0.0001), while Vitamin D Intake from diet was non-significant (p = 0.944).']	[('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 116)]	2	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 138, '25OHD'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D'), ('GO_0007565', 'female pregnancy', 314, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D'), ('GO_0007631', 'feeding behavior', 352, 'intake')]
PMC4466139	6/2015	S86-PMC4466139	['discussion\na high prevalence of Vitamin D deficiency HAS BEEN REPORTED among newborns and their mothers worldwide [23–27].']	[('INCOMPLETE_EVIDENCE', 53)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4466139	6/2015	S89-PMC4466139	['in OUR STUDY, north african mothers and newborns had the lowest 25Ohd values; this FINDING is IN LINE WITH PREVIOUS DATA SUGGESTING that ethnic origin is a risk FACTOR for Vitamin D deficiency [23–24].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 161)]	6	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 64, '25OHD'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC4466139	6/2015	S93-PMC4466139	['THESE STUDIES EVEN IF LIMITED to specific populations (caucasians [28], arab an asian [29], rural populations of south china [30]) SHOW a COMPLEX picture of Genetic FACTORS determining the level of 25Ohd and consequent risks of deficiency of Vitamin D. DESPITE this, the environmental COMPONENT is STILL preponderant ALTHOUGH LIMITED to 57–71% in determining the level of 25Ohd.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 131), ('DIFFICULT_TASK', 138), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253), ('ANOMALY_CURIOUS_FINDING', 253), ('SUPERFICIAL_RELATIONSHIP', 285), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 326)]	13	[('SO_0000704', 'gene', 157, 'genetic'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 198, '25OHD'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 372, '25OHD')]
PMC4466139	6/2015	S95-PMC4466139	['AS ALREADY KNOWN, Placental Transfer provides Vitamin D from mother to fetus, especially in the last trimester of Gestation [31] THUS neonatal and maternal 25Ohd levels are closely LINKED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 129), ('SUPERFICIAL_RELATIONSHIP', 181)]	4	[('UBERON_0001987', 'placenta', 18, 'placental'), ('GO_0006412', 'translation', 28, 'transfer'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'gestation'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 156, '25OHD')]
PMC4466139	6/2015	S97-PMC4466139	['moreover, in a PREVIOUS STUDY, we FOUND lower Vitamin D levels on Cord Blood than in maternal Serum [26].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 34)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 66, 'cord'), ('UBERON_0000178', 'blood', 71, 'blood'), ('UBERON_0001977', 'blood serum', 94, 'serum')]
PMC4466139	6/2015	S98-PMC4466139	['the mechanisms INVOLVED in this reduction of neonatal 25Ohd levels are NOT YET KNOWN; it MAY BE the result of DIFFERENT Vitamin D binding proteins concentrations OR a different 25Ohd half-life in the neonatal age [23,32].']	[('SUPERFICIAL_RELATIONSHIP', 15), ('FULL_UNKNOWN', 71), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162)]	5	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 54, '25OHD'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD')]
PMC4466139	6/2015	S102-PMC4466139	['our results SHOW that few migrant mothers are supplemented with Vitamin D during Pregnancy, especially in the last month, SUGGESTING that more extensive PREVENTION and education programs SHOULD be adopted.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 153), ('FUTURE_WORK', 187)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC4466139	6/2015	S106-PMC4466139	['these results SHOW a strong ROLE for supplementation in increasing 25Ohd levels and also that supplementation at 400 iu/die is INSUFFICIENT to provide an appropriate Vitamin D status in Pregnant women and their offsprings.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 28), ('PROBLEM_COMPLICATION', 127)]	3	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 67, '25OHD'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007565', 'female pregnancy', 186, 'pregnant')]
PMC4466139	6/2015	S108-PMC4466139	['Vitamin D deficiency in Pregnancy in spite of taking supplementation MAY BE AS a result of an INSUFFICIENT dose of Vitamin D contained in multivitamins in Prenatal supplements many of which contain only 400 iu or 500 iu, as PREVIOUSLY SHOWN in OTHER studies [33,34].']	[('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 76), ('IMPORTANT_CONSIDERATION', 94), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 244)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 24, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'prenatal')]
PMC4466139	6/2015	S111-PMC4466139	['PREVIOUS STUDIES HAVE SHOWN that Vitamin D supplementation of 600 ui/die leads to Vitamin D insufficiency in >50% of cases [33].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4466139	6/2015	S112-PMC4466139	['RECENTLY, an increasing NUMBER OF STUDIES HAVE SHOWN that higher doses of Vitamin D supplementation are SAFE and EFFECTIVE in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 104), ('SUPERFICIAL_RELATIONSHIP', 113)]	5	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnant')]
PMC4466139	6/2015	S115-PMC4466139	['moreover, SOME STUDIES HAVE SHOWN a large inter-Individual difference in response to treatment with identical doses of Vitamin D SUGGESTING that common Genetic variants IMPLICATED in Vitamin d Homeostasis MAY AFFECT the response to sun exposure or to Vitamin D supplementation [39].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 209)]	6	[('NCBITaxon_1', 'root', 48, 'individual'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('SO_0000704', 'gene', 152, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 183, 'vitamin'), ('GO_0042592', 'homeostatic process', 193, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D')]
PMC4466139	6/2015	S116-PMC4466139	['the RELATIONSHIP between 25Ohd levels, ethnicity and supplementation in Pregnancy SUGGESTS a ROLE for Genetic DETERMINANTS for Vitamin D status and STRESSES the IMPORTANCE of Vitamin D integration in preventative STRATEGIES.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 110), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 161), ('FUTURE_WORK', 213)]	7	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 25, '25OHD'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('SO_0000704', 'gene', 102, 'genetic'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC4466139	6/2015	S118-PMC4466139	['furthermore, AS maternal Vitamin D deficiency status AFFECTS the newborn, it MAY BE CONSIDERED as a risk FACTOR for other Vitamin D-related disorders in these newborns.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4466139	6/2015	S119-PMC4466139	['it is THEREFORE IMPORTANT to correct the deficiency in utero with higher doses in those AT RISK of SERIOUS deficiency and to closely follow these infants re the early detection of diseases RELATED to lack of Vitamin D.\nknowledge of a generalized Vitamin D deficiency and of RELATED RISK FACTORS MAY LEAD TO IMPROVING education and to more effective PUBLIC HEALTH initiatives.']	[('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 16), ('IMPORTANT_CONSIDERATION', 88), ('IMPORTANT_CONSIDERATION', 99), ('SUPERFICIAL_RELATIONSHIP', 189), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 295), ('PROBABLE_UNDERSTANDING', 299), ('FUTURE_WORK', 307), ('IMPORTANT_CONSIDERATION', 349)]	11	[('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4466139	6/2015	S120-PMC4466139	['we DID NOT investigate lifestyle variable such as clothing, outdoor sports activities and socio-economic status of the population and used two different assays re Vitamin D levels in newborns and mothers.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4490503	6/2015	S137-PMC4490503	['gdm develops when beta cell dysfunction coexists, and MAY BE characterised by further abnormalities in adipokine and cytokine profiles, increased Free Fatty Acids (ffa), Triglycerides (tg), low Vitamin D and Endothelial dysfunction.ijms-16-13442-t001_table 1\n\ncaption (table-wrap): table 1\n\nlongitudinal studies of inflammatory markers in prediction of gdm.inflammatory markerfirst author (year)study designgdm statusgdm diagnostic criteriagestational age at testing (weeks)EFFECT in gdmmatching or adjustment for confounderstnf-αkirwan (2002) [63]prospective5 gdm 10 ngt24–28 weeks carpenter and coustan criteria [64]pre-gravid 12–14 weeks 34–36 weekstnf-Α ↑ 34–36 weeks in gdm inversely CORRELATED with Insulin sensitivityfat massgao (2008) [65]nested case-control22 gdm 10 igt 20 ngtunknown12–20 weeks 24–32 weekstnf-Α ↑ in gdm positively CORRELATED with bmi 14–20 weeksn/ageorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmisaucedo (2011) [67]prospective60 gdm 60 ngt24–28 weeks ada criteria 2010 [68]30 weeks 6 weeks 6 months Postpartumtnf-Α ↑ in both groups at 6 weeks Tnf-Α ↑ 6months Postpartum in gdmage weightlopez-tinoco (2012) [69]case-control63 gdm 63 ngt24–28 weeks nddg criteria [70]mean ~29 weekstnf-Α ↑ in gdmbmiguillemette (2014) [71]prospective61 gdm 695 ngt24–28 weeks iadpsg criteria [44]5–16 weeks 24–28 weekstnf-Α ↑ in both groups and ASSOCIATED with Insulin resistanceage bmi tg adiponectin.il-6morrisett (2011) [72]case-control20 gdm 27 ngt26.1 ± 3.7 weeks cda criteria [73]26.1 ± 3.7 weeks 8 weeks post-partumil-6 ↑ in gdm and post-Partum, CORRELATED with Insulin sensitivity and bmibmihassiakos (2015) [74]case-control40 gdm 94 ngt24–28 weeks iadpsg criteria [44]11–14 weekil-6 ↑ in gdm and inversely RELATED to Birth weightmaternal weightleptinkirwan (2002) [63]prospective5 gdm 10 ngt24–28 weeks carpenter and coustan criteria [64]pre-gravid 12–14 weeks 34–36 weeksleptin ↑ across Pregnancy inverse CORRELATION with Insulin sensitivity, BUT non-significant when adjusted for fat massfat massgeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmiqiu (2004) [75]prospective47 gdm 776 ngt26–28 weeks carpenter and coustan criteria [64]13 weeks10-ng/ml ↑ in leptin ASSOCIATED with 20% ↑ gdmparity bmi family history of non-Insulin dependent diabetesadiponectingeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksage ethnicity gravidity parity bmimcmanus (2014) [76]case-control36 gdm 37 ngt24–28 weeks cda criteria [73]31 weekadiponectin ↓ gdm and offspringage maternal weightwilliams (2004) [77]nested case-control41 gdm 70 ngt26–28 weeks carpenter and coustan criteria [64]13 week4.6-fold ↑ risk of gdm if adiponectin < 6.4 mcg/ml, overweight women 11-fold ↑ risk of gdmbmilain (2008) [78]nested case-control30 gdm 29 ngt24–28 weeks carpenter and coustan criteria [64]9.3 ± 2.6 weeksadiponectin < 25th 11-fold ↑ risk gdmbmilowe (2010) [57]prospective1481 Pregnant women24–32 weeks 2 h 75 g ogtt unblinded if fpg > 5.8 mmol/l 2 h > 11.1 mmol/l or random Glucose ≥ 8.9 mmol/l24–32 weeks↓ adiponectin ASSOCIATED with ↑ Glucose and bmibmi c-peptide Gestation genderlacroix (2013) [79]prospective38 gdm 407 ngt24–28 weeks iadpsg criteria [44]6–13 week↓ adiponectin ASSOCIATED with ↑ risk gdm (or1.12 per 1 µg/ml ↓ of adiponectin) and ASSOCIATED with Insulin sensitivitybmi hba1cianniello (2013) [39]prospective16 gdm 32 ngt24–28 weeks carpenter and coustan criteria [64]all trimesters↓ adiponectin PREDICTIVE of gdm in overweight/obesen/aweerakiet (2006) [80]prospective60 gdm 299 ngt24–28 weeks carpenter and coustan criteria [64]21–27 weekadiponectin 10 µg/ml has sensitivity of 91% and specificity of 31% for gdmbmirbp-4krzyzanovska (2008) [81]nested case-control20 gdm 22 ngt24–28 weeks carpenter and coustan criteria [64]30 weekrbp-4 ↓ in gdmn/ananda (2013) [82]nested case-control60 gdm 240 ngt24–28 weeks who criteria 2006 [83]11–13 weeksno differencen/aabetew (2013) [84]nested case-control173 gdm 187 ngt24–28 weeks carpenter and coustan criteria [64]16 weeksrbp-4 ↑ in gdm BUT NOT significant after adjustmentmaternal age ethnicityresistinlain (2008) [78]nested case-control30 gdm 29 ngt24–28 weeks carpenter and coustan criteria [64]9.3 ± 2.6 weeksno differencebmigeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmilowe (2010) [57]prospective1481 Pregnant women24–32 weeks 2 h 75 g ogtt unblinded if fpg > 5.8 mmol/l 2 h > 11.1 mmol/l or Random Glucose ≥ 8.9 mmol/l24–32 weeksnot ASSOCIATED with Glucose or Birth weightbmi c-peptide Gestation gendernanda (2012) [85]nested case-control60 gdm 240 ngt24–28 weeks who criteria 2006 [83]11–13 weeksno differencen/amcmanus (2014) [76]case-control36 gdm 37 ngt24–28 weeks cda criteria [73]31 weeksresistin ↓ in gdm and offspringage maternal weightvisfatinkrzyzanovska (2006) [86]nested case-control64 gdm 30 ngt24–28 weeks carpenter and coustan criteria [64]28–30 weeks 38–40 weeks 2 weeks post-Partumvisfatin ↑ in gdmbmiferreira (2011) [87]case-control100 gdm 300 ngt24–28 weeks who criteria 2006 [83]11–13 weekvisfatin ↑ in gdmn/a\nngt = normal Glucose tolerance; igt = impaired Glucose tolerance; fpg = fasting plasma Glucose; homa-ir = homeostasis model assessment for Insulin resistance; matsuda index = measure of Insulin sensitivity; bmi = body mass index; tg = Triglycerides; n/a = not available; ↓ = decreased levels; ↑ = increased levels; adips = australasian diabetes in Pregnancy society; ada = american diabetes association; nddg = national diabetes data group; iadpsg = international association of diabetes and Pregnancy study group; cda = canadian diabetes association; who = world health organisation.']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 474), ('SUPERFICIAL_RELATIONSHIP', 689), ('SUPERFICIAL_RELATIONSHIP', 842), ('SUPERFICIAL_RELATIONSHIP', 1457), ('SUPERFICIAL_RELATIONSHIP', 1665), ('SUPERFICIAL_RELATIONSHIP', 1827), ('SUPERFICIAL_RELATIONSHIP', 2027), ('ANOMALY_CURIOUS_FINDING', 2065), ('SUPERFICIAL_RELATIONSHIP', 2387), ('SUPERFICIAL_RELATIONSHIP', 3275), ('SUPERFICIAL_RELATIONSHIP', 3437), ('SUPERFICIAL_RELATIONSHIP', 3506), ('SUPERFICIAL_RELATIONSHIP', 3670), ('ANOMALY_CURIOUS_FINDING', 4255), ('SUPERFICIAL_RELATIONSHIP', 4764)]	16	[('CHEBI_37958', 'dye', 146, 'free'), ('CHEBI_35366', 'fatty acid', 151, 'fatty acids'), ('CHEBI_17855', 'triglyceride', 170, 'triglycerides'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('UBERON_0001986', 'endothelium', 208, 'endothelial'), ('PR_000000034', 'BMP', 655, '-α'), ('PR_000045358', 'insulin family protein', 705, 'insulin'), ('PR_000000034', 'BMP', 819, '-α'), ('GO_0030254', 'protein secretion by the type III secretion system', 1131, 'postpartumTNF'), ('PR_000000034', 'BMP', 1144, '-α'), ('PR_000000134', 'tumor necrosis factor alpha', 1175, 'TNF-α'), ('GO_0007565', 'female pregnancy', 1191, 'postpartum'), ('PR_000000034', 'BMP', 1314, '-α'), ('PR_000000034', 'BMP', 1433, '-α'), ('PR_000045358', 'insulin family protein', 1473, 'insulin'), ('PR_000000035', 'BMP receptor type-1A', 1636, '-6'), ('GO_0007567', 'parturition', 1657, 'partum'), ('PR_000045358', 'insulin family protein', 1681, 'insulin'), ('PR_000000035', 'BMP receptor type-1A', 1801, '-6'), ('GO_0007567', 'parturition', 1838, 'birth'), ('GO_0007565', 'female pregnancy', 2009, 'pregnancy'), ('PR_000045358', 'insulin family protein', 2044, 'insulin'), ('PR_000045358', 'insulin family protein', 2445, 'insulin'), ('GO_0007565', 'female pregnancy', 3132, 'pregnant'), ('CHEBI_17234', 'glucose', 3230, 'glucose'), ('CHEBI_17234', 'glucose', 3293, 'glucose'), ('GO_0007565', 'female pregnancy', 3322, 'gestation'), ('PR_000045358', 'insulin family protein', 3522, 'insulin'), ('GO_0007565', 'female pregnancy', 4631, 'pregnant'), ('CHEBI_45267', 'praziquantel', 4722, 'random'), ('CHEBI_17234', 'glucose', 4729, 'glucose'), ('CHEBI_17234', 'glucose', 4780, 'glucose'), ('GO_0007567', 'parturition', 4791, 'birth'), ('GO_0007565', 'female pregnancy', 4817, 'gestation'), ('GO_0030164', 'protein denaturation', 5223, 'partumVisfatin'), ('CHEBI_17234', 'glucose', 5374, 'glucose'), ('CHEBI_17234', 'glucose', 5408, 'glucose'), ('CHEBI_17234', 'glucose', 5448, 'glucose'), ('PR_000045358', 'insulin family protein', 5500, 'insulin'), ('PR_000045358', 'insulin family protein', 5547, 'insulin'), ('CHEBI_17855', 'triglyceride', 5596, 'triglycerides'), ('GO_0007565', 'female pregnancy', 5709, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 5853, 'Pregnancy')]
PMC4490503	6/2015	S293-PMC4490503	['Vitamin D\nlow Vitamin D HAS BEEN IMPLICATED in the aetiology of obesity, Insulin resistance and t2dm [121].']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('PR_000045358', 'insulin family protein', 73, 'insulin')]
PMC4490503	6/2015	S296-PMC4490503	['early Pregnancy Vitamin D status HAS BEEN inversely ASSOCIATED with gdm risk [123].']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('GO_0007565', 'female pregnancy', 6, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC4490503	6/2015	S298-PMC4490503	['FOUND that increased Parathyroid hormone, RATHER than Vitamin D deficiency was INDEPENDENTLY ASSOCIATED with dysglycaemia in Pregnancy in 524 women when tested in conjunction with the ogtt [124].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('SUPERFICIAL_RELATIONSHIP', 79), ('SUPERFICIAL_RELATIONSHIP', 93)]	4	[('UBERON_0001132', 'parathyroid gland', 21, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnancy')]
PMC4490503	6/2015	S300-PMC4490503	['[122] FOUND lower first trimester 25-Hydroxyvitamin D (25-Ohd) levels were ASSOCIATED with higher risk of gdm after adjustment for Vitamin D confounders and gdm risk factors.']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 34, '25-hydroxyvitamin D'), ('CHEBI_72765', 'verruculogen', 55, '25-OHD'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC4516377	6/2015	S8-PMC4516377	['inverse RELATIONSHIP between Serum Vitamin D and measures of adiposity in children HAS BEEN OBSERVED and this ASSOCIATION was INFLUENCED by the sex of the patient and by the seasons of the year.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 110), ('SUPERFICIAL_RELATIONSHIP', 126)]	5	[('UBERON_0001977', 'blood serum', 29, 'serum'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4516377	6/2015	S9-PMC4516377	['conclusions:\nthe studies reviewed SHOWED an ASSOCIATION between Calcium and Vitamin D with childhood obesity.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 64, 'calcium'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
PMC4516377	6/2015	S37-PMC4516377	['CONSIDERING the studies that assessed the ASSOCIATION between Vitamin D and obesity in children, two were cross-sectional18,20and one longitudinal21(table 1).']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4516377	6/2015	S42-PMC4516377	['ANOTHER STUDY FOUND lower levels of Vitamin D in obese children when compared to normal weight ones.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC4516377	6/2015	S43-PMC4516377	['Serum levels of Vitamin D were significantly ASSOCIATED with higher bmi, waist circumference and Serum Triacylglycerols, as well as lower hdl levels.20the authors of this study used the same categorization of Vitamin D levels of the iom, BUT cited another reference.22finally, a longitudinal study in the brazilian amazon region, followed children from 2007 to 2012 with the OBJECTIVE of evaluating the EFFECT of the Fto Gene on bmi modifications during childhood, as well as verifying WHETHER the Vitamin D status COULD modify this EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('QUESTION_ANSWERED_BY_THIS_WORK', 375), ('SUPERFICIAL_RELATIONSHIP', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 486), ('INCOMPLETE_EVIDENCE', 515), ('SUPERFICIAL_RELATIONSHIP', 533)]	7	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001977', 'blood serum', 97, 'serum'), ('CHEBI_17075', '6-hydroxyhexano-6-lactone', 103, 'triacylglycerols'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 417, 'FTO'), ('SO_0000704', 'gene', 421, 'gene'), ('CHEBI_27300', 'vitamin D', 498, 'vitamin D')]
PMC4516377	6/2015	S44-PMC4516377	['with multiple regression models, the authors FOUND an EFFECT of the fto increasing bmi over the years and the Vitamin D deficiency (<75 nmol/l in 32% of the sample in 2007) exacerbating this EFFECT, i.e., further increasing bmi.21in all these studies on Vitamin D, the authors made adjustments for POTENTIAL confounders.']	[('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 191), ('INCOMPLETE_EVIDENCE', 298)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 262, 'D')]
PMC4516377	6/2015	S50-PMC4516377	['these mechanisms are not yet FULLY ELUCIDATED; HOWEVER, SOME STUDIES have provided a FEW PLAUSIBLE explanations.24,25one EXPLANATION is that low Calcium intake increases serum Calcitriol levels, which can stimulate the flow of calcium from Adipocytes by Vitamin D Membrane receptors, identified as ASSOCIATED with rapid Membrane response to Steroids.']	[('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 121), ('SUPERFICIAL_RELATIONSHIP', 298)]	7	[('CHEBI_22313', 'alkaline earth metal atom', 145, 'calcium'), ('CHEBI_17823', 'calcitriol', 176, 'calcitriol'), ('CL_0000136', 'fat cell', 240, 'adipocytes'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0016020', 'membrane', 264, 'membrane'), ('GO_0016020', 'membrane', 320, 'membrane'), ('CHEBI_35341', 'steroid', 341, 'steroids')]
PMC4516377	6/2015	S65-PMC4516377	['THUS, the active transport becomes the main mechanism of calcium absorption when its Ingestion is low.34\nit can be OBSERVED that many of the mechanisms that explain adiposity and its ASSOCIATION with the assessed Micronutrients DEMONSTRATE the close ASSOCIATION between Calcium and the Vitamin D present in the Metabolic events of Adipogenesis, and the fact that the presence or absence of one of them CAN bring damage not only to bone, but health as a whole.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 183), ('QUESTION_ANSWERED_BY_THIS_WORK', 228), ('SUPERFICIAL_RELATIONSHIP', 250), ('INCOMPLETE_EVIDENCE', 402)]	6	[('GO_0007631', 'feeding behavior', 85, 'ingestion'), ('CHEBI_33839', 'macromolecule', 213, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 270, 'calcium'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0008152', 'metabolic process', 311, 'metabolic'), ('GO_0060612', 'adipose tissue development', 331, 'adipogenesis')]
PMC4516377	6/2015	S66-PMC4516377	['the mechanisms INVOLVED in the ASSOCIATION between obesity and Serum levels of Vitamin D have not been described specifically for children.figure 3shows the POSSIBLE mechanisms INVOLVED in the ASSOCIATION between Vitamin D and obesity.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 157), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC4516377	6/2015	S70-PMC4516377	['it is NOTEWORTHY that ALTHOUGH 25 (Oh) D3 (Calcidiol) is not the most active Metabolite, is the most COMMONLY ASSESSED, AS Plasma levels of active Vitamin D, 1,25 Dihydroxyvitamin D (1,25 (Oh) 2D3), are regularly maintained at normal concentrations; furthermore, Plasma levels of 25 (Oh) D3 are APPROXIMATELY 100 times higher than those of 1,25 (Oh) 2D3 and the half-life of 1,25 (Oh) 2D3 is APPROXIMATELY six hours, whereas that of 25 (Oh) D3 is two to three weeks.11\nwhen comparing Serum levels of Vitamin D in the children assessed in the study carried out by lourenço21in brazil with a study carried out in the usa,35higher levels were observed in brazil.']	[('ANOMALY_CURIOUS_FINDING', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 110), ('PROBABLE_UNDERSTANDING', 120), ('INCOMPLETE_EVIDENCE', 295), ('INCOMPLETE_EVIDENCE', 392)]	8	[('CHEBI_62946', 'ammonium sulfate', 31, '25 (OH) D3'), ('CHEBI_17933', 'calcidiol', 43, 'calcidiol'), ('CHEBI_39382', 'flufenoxuron', 77, 'metabolite'), ('UBERON_0001969', 'blood plasma', 123, 'plasma'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_67469', '15-hydroxyajubractin C', 158, '1,25 dihydroxyvitamin D'), ('CHEBI_72779', '11-trans-LTE4', 183, '1,25 (OH) 2D3'), ('UBERON_0001969', 'blood plasma', 263, 'plasma'), ('CHEBI_62946', 'ammonium sulfate', 280, '25 (OH) D3'), ('CHEBI_73394', 'Ala-Ser', 342, '25 (OH) 2D3'), ('CHEBI_34898', 'OM-174', 381, 'OH) 2D3'), ('CHEBI_62946', 'ammonium sulfate', 433, '25 (OH) D3'), ('UBERON_0001977', 'blood serum', 484, 'serum'), ('CHEBI_27300', 'vitamin D', 500, 'vitamin D')]
PMC4516377	6/2015	S72-PMC4516377	['webb, kline & holick36have already EXPLAINED this phenomenon, SHOWING that latitude and seasons AFFECT the quality and quantity of solar radiation that reach earth, especially uvb spectrum, drastically INFLUENCING the cutaneous Synthesis Of Vitamin D. it is also BELIEVED that Vitamin D deficiency MAY BE RELATED to lack of sun exposure in obese Individuals, as they become more sedentary and remain more sheltered from the sun.']	[('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 35), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 298), ('SUPERFICIAL_RELATIONSHIP', 305)]	8	[('GO_0030474', 'spindle pole body duplication', 228, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('NCBITaxon_1', 'root', 346, 'individuals')]
PMC4516377	6/2015	S73-PMC4516377	['as these FACTORS are INTERCONNECTED with worsening in the obesity context, the cause-and-effect ASSOCIATION between the two pathologies is NOT yet CLEAR.37\nlee et al.18EMPHASIZED that DIFFERENCES in Serum levels of Vitamin D in RELATION to gender CAN be EXPLAINED by the fact that girls reported having a healthier diet for all questions asked.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 96), ('FULL_UNKNOWN', 139), ('INCOMPLETE_EVIDENCE', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 228), ('INCOMPLETE_EVIDENCE', 247), ('PROBABLE_UNDERSTANDING', 254)]	9	[('UBERON_0001977', 'blood serum', 199, 'serum'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
PMC4516377	6/2015	S74-PMC4516377	['ON THE OTHER HAND, this gender DIFFERENCE was NOT FOUND in ANOTHER study.20\nthe mechanism by which Vitamin D INFLUENCES adiposity is not COMPLETELY understood, but there are LINES OF RESEARCH that try to explain this phenomenon.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('ANOMALY_CURIOUS_FINDING', 46), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 109), ('PROBABLE_UNDERSTANDING', 137), ('INCOMPLETE_EVIDENCE', 174)]	9	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4516377	6/2015	S76-PMC4516377	['that reduces its bioavailability and triggers the Hypothalamus to generate a cascade of reactions that leads to increased feelings of hunger and decreased energy expenditure, to compensate for the lack of the vitamin.37among these reactions is the increase in Parathyroid hormone (pth) levels, which promotes Lipogenesis38,39and CAN Modulate Adipogenesis by suppressing the Vitamin D receptor, which inhibits Compounds INVOLVED in Adipocyte differentiation and maturation.39,40in general, it can be OBSERVED that the increase in Bf can aggravate Vitamin D deficiency which, in turn, can further increase the accumulation of fat, creating a cycle (fig.']	[('INCOMPLETE_EVIDENCE', 329), ('SUPERFICIAL_RELATIONSHIP', 419), ('INCOMPLETE_EVIDENCE', 499)]	3	[('UBERON_0001898', 'hypothalamus', 50, 'hypothalamus'), ('UBERON_0001132', 'parathyroid gland', 260, 'parathyroid'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 309, 'lipogenesis38'), ('GO_0065007', 'biological regulation', 333, 'modulate'), ('GO_0060612', 'adipose tissue development', 342, 'adipogenesis'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_36357', 'polyatomic entity', 409, 'compounds'), ('CL_0000136', 'fat cell', 431, 'adipocyte'), ('UBERON_0002061', 'truncus arteriosus', 529, 'BF'), ('CHEBI_27300', 'vitamin D', 546, 'vitamin D')]
PMC4516377	6/2015	S79-PMC4516377	['SOME STUDIES17,18,20that evaluated the ASSOCIATION of Calcium and Vitamin D with obesity SHOWED a cross-sectional design and it is IMPORTANT to CONSIDER the existence of SOME LIMITATIONS, especially REVERSE causality, AS the exposure and outcome are collected simultaneously.30moreover, it is IMPORTANT to TAKE INTO account that one of the STUDIES14DID not make adjustments for CONFOUNDING FACTORS in the statistical analyses, in addition to the SMALL sample size used by others,13,14which CAN lead to erroneous conclusions.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 131), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 175), ('PROBLEM_COMPLICATION', 199), ('PROBABLE_UNDERSTANDING', 218), ('IMPORTANT_CONSIDERATION', 293), ('IMPORTANT_CONSIDERATION', 306), ('INCOMPLETE_EVIDENCE', 340), ('PROBLEM_COMPLICATION', 378), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 490)]	15	[('CHEBI_22313', 'alkaline earth metal atom', 54, 'calcium'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4516377	6/2015	S84-PMC4516377	['regarding Vitamin D, STUDIES are RECENT and promising.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 33)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4516377	6/2015	S85-PMC4516377	['all SHOW an inverse ASSOCIATION between serum Vitamin D and obesity or measures of adiposity in children, with this ASSOCIATION being INFLUENCED by the seasons of the year and gender.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 20), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 134)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4877864	6/2015	S75-PMC4877864	['low intake of Vitamin D and Calcium were OBSERVED in participated autistic children COMPARED to rdas for their ages and more obvious in older age group (6-9 years) [17].']	[('INCOMPLETE_EVIDENCE', 41), ('ANOMALY_CURIOUS_FINDING', 84)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_31341', 'calcium dihydroxide', 28, 'Calcium')]
PMC4877864	6/2015	S83-PMC4877864	['furthermore, SEVERE Gestational Vitamin D deficiency in Rats produces pups with increased Brain size and enlarged Ventricles [23], Anatomical abnormalities SIMILAR TO those FOUND in autism [24].']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 173)]	3	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 56, 'rats'), ('UBERON_0000955', 'brain', 90, 'brain'), ('UBERON_0002082', 'cardiac ventricle', 114, 'ventricles'), ('UBERON_0001062', 'anatomical entity', 131, 'anatomical')]
PMC4877864	6/2015	S84-PMC4877864	['maintaining Vitamin D sufficiency in utero and during early Life, to satisfy the Vitamin D receptor transcriptional activity in the Brain, MAY BE IMPORTANT for Brain Development as well as for maintenance of mental function later in Life [25].']	[('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 146)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0000104', 'life cycle', 60, 'life'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000955', 'brain', 132, 'brain'), ('GO_0007420', 'brain development', 160, 'brain development'), ('UBERON_0000955', 'brain', 160, 'brain'), ('UBERON_0000104', 'life cycle', 233, 'life')]
PMC4877864	6/2015	S87-PMC4877864	['WHILE, the results of THIS STUDY SHOWED that Vitamin C and Folate contents were ranged between borderline and inadequate Intake in both groups (group 1 and group 2) COMPARED TO their rdas (p<0.005), HOWEVER Vitamin A was ON THE OTHER HAND adequate.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('INCOMPLETE_EVIDENCE', 33), ('ANOMALY_CURIOUS_FINDING', 165), ('QUESTION_ANSWERED_BY_THIS_WORK', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 199), ('ANOMALY_CURIOUS_FINDING', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	8	[('CHEBI_27300', 'vitamin D', 45, 'vitamin C'), ('CHEBI_30863', '5-azaorotic acid', 59, 'folate'), ('GO_0007631', 'feeding behavior', 121, 'intake'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A')]
PMC4877864	6/2015	S89-PMC4877864	['inadequate intake of Folic Acid and Vitamin C HAS also BEEN REPORTED among autistic children in china [27].']	[('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 60)]	2	[('CHEBI_30751', 'formic acid', 21, 'folic acid'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin C')]
PMC4877864	6/2015	S90-PMC4877864	['on the positive side, Nutrients Intake SHOWED an increase in Vitamin B6Intake while Vitamin E remained adequate this is IN AGREEMENT with xia et al.']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 120)]	2	[('CHEBI_33284', 'nutrient', 22, 'nutrients'), ('GO_0007631', 'feeding behavior', 32, 'intake'), ('CHEBI_83610', 'valifenalate', 61, 'vitamin B6intake'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin E')]
PMC4877864	6/2015	S97-PMC4877864	['OTHER STUDIES HAVE REPORTED similar improvements in autistic children supplemented with Vitamin B6, Folate, and Vitamin C [30].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14)]	2	[('CHEBI_33237', 'vitamin D4', 88, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 100, 'folate'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin C')]
PMC4910734	6/2015	S86-PMC4910734	['HOWEVER, SOME reports INDICATE that the same children do not have night blindness,53and SOME reports SUGGEST that asd symptoms are reduced by Retinol treatment.54the lack of night blindness in asd cases of Vitamin A deficiencies SUGGESTS that Retinal is present, but conversion to Retinoic Acid is blocked.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 229)]	7	[('CHEBI_26536', 'retinoic acid', 142, 'retinol'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin A'), ('UBERON_0000966', 'retina', 243, 'retinal'), ('CHEBI_26536', 'retinoic acid', 281, 'retinoic acid')]
PMC4910734	6/2015	S133-PMC4910734	['autistic children are NOTORIOUS picky eaters, leading to SOME DOCUMENTED DEFICIENCIES in individual case STUDIES, such as Vitamin A deficiencies.53nutritional status based on dietary record keeping, not surprisingly, gives CONFLICTING results,118in PART BECAUSE autistic children OFTEN SUFFER from Gastrointestinal mal-absorption PROBLEMS77OR BECAUSE Genetic factors MAY play a ROLE in nutritional deficiency.']	[('IMPORTANT_CONSIDERATION', 22), ('IMPORTANT_CONSIDERATION', 22), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 73), ('INCOMPLETE_EVIDENCE', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 223), ('SUPERFICIAL_RELATIONSHIP', 249), ('PROBABLE_UNDERSTANDING', 254), ('PROBABLE_UNDERSTANDING', 280), ('IMPORTANT_CONSIDERATION', 286), ('IMPORTANT_CONSIDERATION', 330), ('PROBABLE_UNDERSTANDING', 343), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 378)]	15	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 298, 'gastrointestinal'), ('SO_0000704', 'gene', 351, 'genetic')]
PMC4910734	6/2015	S135-PMC4910734	['MANY of the Micronutrients STUDIES HAVE BEEN BASED ON Plasma and Urinary clinical results, which SUGGEST the elevation of Lipid Peroxide-generated Aldehydes (Hne, mda)84–86as well as deficiencies in antioxidants, such as Vitamin E, Sulfur-containing Compounds, such as cysteine, methionine, and Gsh,119carnitine,120biotin,121and ( n -3) pufas.122given the depressed levels of Sulfur-containing Compounds in asd Individuals, it is NOT SURPRISING that these children are more sensitive than neurotypicals to the exposure of mercury and other heavy metals.78the antioxidant supplements, which SHOW symptom improvements include, but are not limited to Ubiquinol,123nac,124carnosine, and Vitamin C.125other Micronutrients, including b1,126B6-Mg2+,127Folate, Vitamin E, Retinol, and Zn2+, HAVE BEEN selected for a variety of reasons RELATING to the INVOLVEMENT in abnormal Metabolic pathways IMPLICATED in asd,1even THOUGH the clinical assays do not always show a deficiency in asd Individuals compared to neurotypical controls.119with all of the single Micronutrient STUDIES, there are CONFLICTING results regarding efficacy.119there are a FEW STUDIES, which utilize broad-spectrum Micronutrient supplementation and report improvements in clinical BIOMARKERS and/or various autism-rating scales.76,121,128the broad-spectrum Micronutrient STUDIES are very PROMISING BECAUSE all DEMONSTRATE a significant CORRELATION between nutritional deficiencies and severity of autistic symptoms.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 430), ('ANOMALY_CURIOUS_FINDING', 434), ('INCOMPLETE_EVIDENCE', 590), ('INCOMPLETE_EVIDENCE', 783), ('SUPERFICIAL_RELATIONSHIP', 827), ('SUPERFICIAL_RELATIONSHIP', 843), ('SUPERFICIAL_RELATIONSHIP', 886), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 910), ('ANOMALY_CURIOUS_FINDING', 910), ('INCOMPLETE_EVIDENCE', 1062), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('INCOMPLETE_EVIDENCE', 1135), ('SUPERFICIAL_RELATIONSHIP', 1243), ('INCOMPLETE_EVIDENCE', 1333), ('PROBABLE_UNDERSTANDING', 1350), ('PROBABLE_UNDERSTANDING', 1360), ('INCOMPLETE_EVIDENCE', 1372), ('SUPERFICIAL_RELATIONSHIP', 1398)]	23	[('CHEBI_33839', 'macromolecule', 12, 'micronutrients'), ('UBERON_0001969', 'blood plasma', 54, 'plasma'), ('UBERON_0001088', 'urine', 65, 'urinary'), ('CHEBI_48107', 'nitric acid', 122, 'lipid peroxide'), ('CHEBI_17478', 'aldehyde', 147, 'aldehydes'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 158, 'HNE'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin E'), ('CHEBI_36933', 'oxygen-19 atom', 232, 'sulfur'), ('CHEBI_36357', 'polyatomic entity', 250, 'compounds'), ('CHEBI_16856', 'glutathione', 295, 'GSH'), ('CHEBI_36933', 'oxygen-19 atom', 376, 'sulfur'), ('CHEBI_36357', 'polyatomic entity', 394, 'compounds'), ('NCBITaxon_1', 'root', 411, 'individuals'), ('CHEBI_17976', 'ubiquinol', 648, 'ubiquinol'), ('CHEBI_27300', 'vitamin D', 683, 'vitamin C'), ('CHEBI_33839', 'macromolecule', 702, 'micronutrients'), ('CHEBI_73173', '2,4-DB', 731, '126B6'), ('CHEBI_6636', 'magnesium dichloride', 737, 'Mg2+,'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 742, '127folate'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin E'), ('CHEBI_26536', 'retinoic acid', 764, 'retinol'), ('CHEBI_29105', 'zinc(2+)', 777, 'Zn2+,'), ('GO_0008152', 'metabolic process', 867, 'metabolic'), ('NCBITaxon_1', 'root', 976, 'individuals'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1048, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1177, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1319, 'micronutrient')]
PMC4910734	6/2015	S189-PMC4910734	['HOWEVER, SOME reports INDICATE that the same children do not have night blindness53and SOME SUGGEST that asd symptoms are reduced by Retinol treatment.54the lack of night blindness in asd cases of Vitamin A deficiencies SUGGESTS that Retinal is present, but conversion to Retinoic Acid is blocked.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 220)]	7	[('CHEBI_26536', 'retinoic acid', 133, 'retinol'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin A'), ('UBERON_0000966', 'retina', 234, 'retinal'), ('CHEBI_26536', 'retinoic acid', 272, 'retinoic acid')]
PMC4918713	6/2015	S55-PMC4918713	['Animal STUDIES HAVE SHOWN that neonatal copper deficiency is ASSOCIATED with developmental abnormalities and altered Thyroid and Immune function.38\na similar DIFFERENTIAL EFFECT between mother and fetus is also SEEN in Vitamin A Metabolism.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 211)]	6	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('UBERON_0002046', 'thyroid gland', 117, 'thyroid'), ('UBERON_0002405', 'immune system', 129, 'immune'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 219, 'vitamin A metabolism'), ('PR_000004370', 'asialoglycoprotein receptor 2', 227, 'A')]
PMC4499946	7/2015	S1-PMC4499946	['SOME observational STUDIES have SUGGESTED that Prenatal Vitamin D deficiency increases the RISK of adverse Pregnancy and/or Birth outcomes; HOWEVER, there is SCANT EVIDENCE from controlled trials, leading the world health organization to advise against routine Vitamin D supplementation in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140), ('INCOMPLETE_EVIDENCE', 158)]	5	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 107, 'pregnancy ...'), ('GO_0007567', 'parturition', 124, 'birth'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('GO_0007565', 'female pregnancy', 290, 'pregnancy')]
PMC4499946	7/2015	S10-PMC4499946	['THIS TRIAL is expected to contribute unique INSIGHTS into the EFFECTS of improving maternal-infant Vitamin D status in a low-income setting where stunting and adverse Perinatal outcomes represent SIGNIFICANT PUBLIC HEALTH BURDENS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 196), ('IMPORTANT_CONSIDERATION', 208)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0036268', 'swimming', 167, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 167, 'perinatal')]
PMC4499946	7/2015	S22-PMC4499946	['EFFECTS of improvements in Vitamin D status on linear growth in infants and children without rickets have not been widely studied; HOWEVER, in one TRIAL in india, weekly Vitamin D supplementation of low Birth weight infants reduced the risk of stunting in adjusted analyses [14].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 147)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0007567', 'parturition', 203, 'birth')]
PMC4499946	7/2015	S23-PMC4499946	['Vitamin D status is THEREFORE a logical CANDIDATE AS a modifiable nutritional DETERMINANT of linear growth in communities where stunting is prevalent and Vitamin D status is commonly SUBOPTIMAL.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 183)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC4499946	7/2015	S24-PMC4499946	['in south asia, there is a high prevalence of biochemical Vitamin D deficiency among women and young infants [15]; in dhaka, we FOUND that 34 % of Pregnant women at 26–29 weeks Gestation ( n = 160) had Serum 25-Hydroxyvitamin D (25(Oh)D) concentrations less than 30 nmol/l, and that 64 % had 25(Oh)D levels less than 50 nmol/l [16], a threshold for sufficiency adopted by the institute of medicine (iom) [17].']	[('INCOMPLETE_EVIDENCE', 127)]	1	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant'), ('GO_0007565', 'female pregnancy', 176, 'gestation'), ('UBERON_0001977', 'blood serum', 201, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 207, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 291, '25(OH)D')]
PMC4499946	7/2015	S26-PMC4499946	['THEREFORE, in bangladesh, we have OBSERVED that the period of greatest vulnerability with respect to Perinatal Vitamin D deficiency OVERLAPS with a critical period of fetal and early infant growth.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('GO_0036268', 'swimming', 101, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 101, 'perinatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC4499946	7/2015	S28-PMC4499946	['OBSERVATIONAL studies of the ASSOCIATION between maternal Prenatal Vitamin D status and infant anthropometry have yielded CONFLICTING findings [19–23].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	3	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4499946	7/2015	S34-PMC4499946	['analyses of the EFFECT of Prenatal Vitamin D supplementation on infant length among 134 infants followed up to 1 year of age REVEALED that infants Born to women in the Vitamin D group had mean length for age z-scores (lazs) at 1 year that were significantly greater than infants in the placebo group (mean = 0.44 z-score units higher; 95% confidence interval [ci], 0.06–0.82) [26].']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 125)]	2	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007567', 'parturition', 147, 'born'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4499946	7/2015	S37-PMC4499946	['HOWEVER, SOME Animal [27] and observational [21,28] studies have SUGGESTED an EFFECT of maternal Prenatal Vitamin D status on growth of the fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('NCBITaxon_33208', 'Metazoa', 14, 'animal'), ('GO_0007565', 'female pregnancy', 97, 'prenatal'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4499946	7/2015	S38-PMC4499946	['there has BEEN considerable RECENT INTEREST in the ROLE of Vitamin D in maternal and infant health outcomes in low-income settings [29].']	[('ANOMALY_CURIOUS_FINDING', 10), ('INCOMPLETE_EVIDENCE', 28), ('ANOMALY_CURIOUS_FINDING', 35), ('SUPERFICIAL_RELATIONSHIP', 51)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4499946	7/2015	S39-PMC4499946	['some observational studies have SUGGESTED that Antenatal Vitamin D deficiency increases the RISK of adverse Pregnancy and Birth outcomes, including sga [30,31].']	[('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 92)]	2	[('GO_0007567', 'parturition', 47, 'antenatal'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('GO_0007567', 'parturition', 122, 'birth')]
PMC4499946	7/2015	S40-PMC4499946	['HOWEVER, there is SCANT EVIDENCE from controlled clinical trials [31,32], and the world health organization (who) RECENTLY advised against routine Vitamin D supplementation in Pregnancy until further data become available [33].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 114)]	3	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007565', 'female pregnancy', 176, 'pregnancy')]
PMC4499946	7/2015	S41-PMC4499946	['BUILDING ON our EARLIER FINDINGS of a beneficial EFFECT of Prenatal Vitamin D supplementation on infant length in a PRELIMINARY TRIAL [26], we are conducting a larger dose-ranging trial of maternal Vitamin D3Supplementation in dhaka, bangladesh.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 116)]	5	[('GO_0007565', 'female pregnancy', 59, 'prenatal'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_52915', 'phosphatediyl group', 198, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 198, 'vitamin D3supplementation')]
PMC4499946	7/2015	S42-PMC4499946	['the primary AIM is TO INVESTIGATE the EFFECT of maternal Vitamin D supplementation on infant length at 1 year of age, but the trial also provides an OPPORTUNITY to study a range of OTHER POTENTIAL Vitamin D–responsive outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('SUPERFICIAL_RELATIONSHIP', 38), ('FUTURE_WORK', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('INCOMPLETE_EVIDENCE', 187)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC4499946	7/2015	S65-PMC4499946	['Pregnant women are not enrolled if any of the following exclusion criteria apply: self-reported history of any medical condition or Medications that MAY predispose to Vitamin D sensitivity, altered Vitamin D Metabolism, and/or hypercalcemia (e.g., active tuberculosis or current therapy for tuberculosis, sarcoidosis, history of Renal and/or Ureteral stones, Parathyroid disease, Renal or Liver failure, or current use of antiseizure Medications); high-risk Pregnancy based on point-of-care (poc) testing (hemoglobin [hb]<70 g/l; proteinuria, defined as ≥300 mg/dl based on Urine dipstick; hypertension, defined as systolic Blood pressure ≥140 mmhg and/or diastolic Blood pressure ≥90 mmhg); high-risk Pregnancy based on maternal report and/or past ultrasound findings (multiple Gestation, major congenital anomaly, severe oligohydramnios); unwillingness to stop taking non-study Vitamin D or Calcium supplements or a multivitamins containing Calcium and/or Vitamin D; currently prescribed Vitamin D supplements as part of a physician’s treatment plan for Vitamin D deficiency; and/or previous enrollment in the mdig trial during a prior Pregnancy.']	[('INCOMPLETE_EVIDENCE', 149)]	1	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('CHEBI_25441', 'mycothiols', 132, 'medications'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 198, 'vitamin D metabolism'), ('UBERON_0002113', 'kidney', 329, 'renal'), ('UBERON_0000056', 'ureter', 342, 'ureteral'), ('UBERON_0001132', 'parathyroid gland', 359, 'parathyroid'), ('UBERON_0002113', 'kidney', 380, 'renal'), ('UBERON_0002107', 'liver', 389, 'liver'), ('CHEBI_25441', 'mycothiols', 434, 'medications'), ('GO_0007565', 'female pregnancy', 458, 'pregnancy'), ('UBERON_0001088', 'urine', 574, 'urine'), ('UBERON_0000178', 'blood', 624, 'blood'), ('UBERON_0000178', 'blood', 666, 'blood'), ('GO_0007565', 'female pregnancy', 702, 'pregnancy'), ('GO_0007565', 'female pregnancy', 779, 'gestation'), ('CHEBI_27300', 'vitamin D', 880, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 893, 'calcium'), ('CHEBI_22313', 'alkaline earth metal atom', 943, 'calcium'), ('CHEBI_27300', 'vitamin D', 958, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 990, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1056, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1138, 'pregnancy')]
PMC4499946	7/2015	S80-PMC4499946	['in our PRELIMINARY trial, we OBSERVED an increase in Laz of 0.44 at 1 year attributable to Prenatal Vitamin D supplementation, which CORRESPONDED to an increase of 1.1 cm (95 % ci, 0.06–2.0), adjusted for sex [26].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 133)]	3	[('PR_000009655', 'laminin subunit beta-2', 53, 'LAZ'), ('GO_0007565', 'female pregnancy', 91, 'prenatal'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC4499946	7/2015	S93-PMC4499946	['the allocation scheme will be made available to the data and safety monitoring board (dsmb) in cases in which individual participants need to be unmasked because of suspected Supplement-related adverse events (i.e., hypercalcemia or clinical features SUGGESTIVE of Vitamin D toxicity).']	[('INCOMPLETE_EVIDENCE', 251)]	1	[('CHEBI_16158', 'steroid sulfate', 175, 'supplement'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC4499946	7/2015	S97-PMC4499946	['Pharmacological principles and EMPIRICAL data INDICATE that weekly doses of Vitamin D achieve 25(Oh)D levels SIMILAR TO equivalent daily doses [39]; THUS, the equivalent daily doses in increasing order are 600 iu/day, 2400 iu/day, and 4000 iu/day.']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 109), ('PROBABLE_UNDERSTANDING', 149)]	4	[('CHEBI_52217', 'pharmaceutical', 0, 'Pharmacological'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 94, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 100, 'D')]
PMC4499946	7/2015	S98-PMC4499946	['our PREVIOUS pharmacokinetic FINDINGS among Pregnant women in dhaka [16,40] HAVE GENERALLY BEEN CONSISTENT with published ESTIMATES of the Vitamin D-to-25(Oh)D dose–response RELATIONSHIP in non-Pregnant Adults (i.e., an APPROXIMATELY 0.7 nmol/l increase in 25(Oh)D at steady state for each 1 μg/day of Vitamin D3[41,42]).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 81), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 220)]	8	[('GO_0007565', 'female pregnancy', 44, 'pregnant'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 155, 'OH)D'), ('GO_0007565', 'female pregnancy', 194, 'pregnant'), ('UBERON_0007023', 'adult organism', 203, 'adults'), ('CHEBI_63056', 'zinc cation', 257, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 263, 'D'), ('CHEBI_33279', 'vitamin D5', 302, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 302, 'vitamin D3')]
PMC4499946	7/2015	S205-PMC4499946	['Genomic dna will be subjected to Bisulfite modification, and amplified Pcr Products will be analyzed by quantitative pyrosequencing to assess Dna Methylation at several consecutive Cpg Sites within an APPROXIMATELY 150-Bp region at the Promoters of two Genes INVOLVED in Vitamin D Metabolism ( Cyp27B1 and Cyp24A1 ).']	[('INCOMPLETE_EVIDENCE', 201), ('SUPERFICIAL_RELATIONSHIP', 259)]	2	[('SO_0001026', 'genome', 0, 'Genomic'), ('CHEBI_29874', 'bromine dioxide', 33, 'bisulfite'), ('SO_0000006', 'PCR_product', 71, 'PCR products'), ('GO_0006306', 'DNA methylation', 142, 'DNA methylation'), ('SO_0000036', 'matrix_attachment_site', 181, 'CpG sites'), ('SO_0000028', 'base_pair', 219, 'bp'), ('SO_0000167', 'promoter', 236, 'promoters'), ('SO_0000704', 'gene', 253, 'genes'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 271, 'vitamin D metabolism'), ('PR_000006101', 'cytochrome P450 1A1', 294, 'CYP27B1'), ('PR_000006101', 'cytochrome P450 1A1', 306, 'CYP24A1')]
PMC4499946	7/2015	S218-PMC4499946	['our PRELIMINARY trial data REVEALED a discernible EFFECT of Prenatal Vitamin D supplementation on infant Laz at 1 year [26].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 50)]	3	[('GO_0007565', 'female pregnancy', 60, 'prenatal'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('PR_000009655', 'laminin subunit beta-2', 105, 'LAZ')]
PMC4499946	7/2015	S255-PMC4499946	['participant safety monitoring\nparticipant safety during the intervention phase is monitored by study personnel based on (1) a checklist of maternal symptoms that MAY INDICATE Vitamin D toxicity or other medical concerns during weekly follow-up visits, (2) passive and active monitoring for maternal and infant clinical events, and (3) maternal Serum calcium measurement at scheduled intervals during the intervention phase (baseline, 30 weeks of Gestation, Delivery, 3 months Postpartum, and 6 months Postpartum).']	[('INCOMPLETE_EVIDENCE', 162), ('INCOMPLETE_EVIDENCE', 166)]	2	[('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0001977', 'blood serum', 344, 'serum'), ('GO_0007565', 'female pregnancy', 446, 'gestation'), ('GO_0007567', 'parturition', 457, 'delivery'), ('GO_0007565', 'female pregnancy', 476, 'postpartum'), ('GO_0007565', 'female pregnancy', 501, 'postpartum')]
PMC4499946	7/2015	S284-PMC4499946	['the only clinical events that will routinely lead to discontinuation of study supplementation are those adverse events that are ascertained to be Supplement-related or the diagnosis of a medical condition that POTENTIALLY or THEORETICALLY increases sensitivity to Vitamin D supplementation following clinical review by the trial steering committee (tsc): confirmed hypercalcemia (see definition above), symptomatic Vitamin D deficiency diagnosed by a study physician or consultant physician (e.g., osteomalacia), fetal or infant death, or onset of a medical condition or initiation of a Medication following enrollment that MAY REASONABLY predispose to Vitamin D sensitivity, altered Vitamin D Metabolism, and/or hypercalcemia (e.g., tuberculosis or therapy for tuberculosis, sarcoidosis, Renal and/or Ureteral stones, Parathyroid disease, Renal or Liver failure, or use of Anticonvulsants).']	[('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 225), ('INCOMPLETE_EVIDENCE', 624), ('PROBABLE_UNDERSTANDING', 628)]	4	[('CHEBI_16158', 'steroid sulfate', 146, 'supplement'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 415, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 423, 'D'), ('CHEBI_60211', 'compound Z', 587, 'medication'), ('CHEBI_27300', 'vitamin D', 653, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 684, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 684, 'vitamin D metabolism'), ('UBERON_0002113', 'kidney', 789, 'renal'), ('UBERON_0000056', 'ureter', 802, 'ureteral'), ('UBERON_0001132', 'parathyroid gland', 819, 'parathyroid'), ('UBERON_0002113', 'kidney', 840, 'renal'), ('UBERON_0002107', 'liver', 849, 'liver'), ('CHEBI_37540', 'arabinarate(2-)', 874, 'anticonvulsants')]
PMC4499946	7/2015	S290-PMC4499946	['discussion\nsince the publication of the 2010 iom report on Vitamin D and the design of the mdig trial and dosing regimens in 2012, there have been several new REPORTS of biochemical and clinical findings of Prenatal Vitamin D supplementation trials conducted in iran [67–69], the united arab emirates [70], pakistan [71], new zealand [72], and australia [73].']	[('INCOMPLETE_EVIDENCE', 159)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 207, 'prenatal'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC4499946	7/2015	S295-PMC4499946	['the mdig trial will THEREFORE offer unique INSIGHTS into the EFFECT of improving maternal-infant Vitamin D status in a low-income setting where Vitamin D insufficiency is common and there is a high prevalence of infant linear growth faltering.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC4499946	7/2015	S296-PMC4499946	['the trial is primarily DESIGNED and powered TO EVALUATE the dose–response EFFECTS of Vitamin D on infant length, an outcome that is directly ALIGNED with the classical ROLE of Vitamin D in Mineral Metabolism and bone health BUT MAY also be interpreted as a SURROGATE marker for Organ (including Brain) Growth and Development.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 257)]	8	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('CHEBI_46662', 'mineral', 189, 'mineral'), ('GO_0008152', 'metabolic process', 197, 'metabolism'), ('UBERON_0000062', 'organ', 278, 'organ'), ('GO_0007420', 'brain development', 295, 'brain ... growth ... development'), ('UBERON_0000955', 'brain', 295, 'brain')]
PMC4499946	7/2015	S298-PMC4499946	['longer-term surveillance of the infant cohort will IDEALLY enable the assessment of OTHER IMPORTANT clinical outcomes (e.g., asthma, Neurodevelopment) that MAY be INFLUENCED by the NON-CLASSICAL ROLE of Vitamin D in immunoregulation and Extraskeletal Cellular Proliferation and Differentiation.']	[('IMPORTANT_CONSIDERATION', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 163), ('PROBLEM_COMPLICATION', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('GO_0007399', 'nervous system development', 133, 'neurodevelopment'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 237, 'extraskeletal'), ('GO_0030154', 'cell differentiation', 251, 'cellular proliferation ... differentiation')]
PMC4555116	7/2015	S25-PMC4555116	['ONE STUDY FOUND that after adjusting for energy intake, low maternal dietary intake of vegetable protein, fibre, Beta-Carotene, Vitamin C, Vitamin D, iron and magnesium were LINKED to an increased risk of orofacial clefts in newborns [13].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 174)]	3	[('CHEBI_17579', 'beta-carotene', 113, 'beta-carotene'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC4555116	7/2015	S124-PMC4555116	['women in the present study were OBSERVED to have lower energy intake [20,26], lower fat intake [13], higher Vitamin D and lower Vitamin B12[26].']	[('INCOMPLETE_EVIDENCE', 32)]	1	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 128, 'vitamin B12')]
PMC4581239	8/2015	S56-PMC4581239	['in a longitudinal cohort study researchers FOUND a dose-response RELATIONSHIP between Micronutrient nutrition deficiency (specifically deficiencies in zinc, iron, and Vitamin B) at 3 years of age, and Externalizing behavior PROBLEMS across childhood and into Adolescence [8].']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 224)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 86, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin B'), ('GO_0007530', 'sex determination', 201, 'externalizing'), ('GO_0048848', 'neurohypophysis morphogenesis', 259, 'adolescence')]
PMC4613350	9/2015	S85-PMC4613350	['matched for body mass index (bmi);6exclusion: Vitamin C and/or Vitamin E supplements, history of major medical complications, major fetal defects, repeated spontaneous abortion, use of an Illicit Drug or Warfarin treatment during the current Pregnancy;7inclusion: nulliparous women with singleton Pregnancies without major fetal chromosomal or structural anomaly;8exclusion: women who had a previous fetus with a chromosomal abnormality and women with Insulin-dependent diabetes mellitus;9exclusion: aids or hepatitis, cases of major fetal anomaly, fetal death and women with Placenta previa, Placenta accrete, or Placental abruption;10general population, singleton Pregnancies;11a priori high risk Pregnancies;12general population;13inclusion: singleton Pregnancy, exclusion: diabetes and chromosomal abnormalities;14exclusion: chronic Hepatic or Renal diseases, Pregnancies with major fetal abnormalities and those ending in termination, Miscarriage or fetal death <24 weeks;15exclusion : known aneuploidy and major congenital malformations;16exclusion: Miscarriages;17exclusion: congenital abnormalities or Medication use;18randomly selected controls;19exclusion: multifetal Gestation, diabetes, chromosomal or structural abnormalities;20exclusion: increased risk factors of pe, sga or ptb, known major fetal anomaly or abnormal karyotype, intervention that MAY modify Pregnancy outcome such as treatment with Aspirin or Progesterone;21inclusion: history of pe in a previous Pregnancy, chronic hypertension, chronic Renal disease, Antiphospholipid syndrome, systemic lupus erythematosus, Pregestational diabetes mellitus, obesity (bmi ≥ 30 kg/m2).']	[('INCOMPLETE_EVIDENCE', 1361)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin E'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 188, 'illicit drug'), ('CHEBI_10033', 'warfarin', 204, 'warfarin'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 297, 'pregnancies'), ('PR_000045358', 'insulin family protein', 452, 'insulin'), ('UBERON_0001987', 'placenta', 576, 'placenta'), ('UBERON_0001987', 'placenta', 593, 'placenta'), ('UBERON_0001987', 'placenta', 614, 'placental'), ('GO_0007565', 'female pregnancy', 666, 'pregnancies'), ('GO_0007565', 'female pregnancy', 699, 'pregnancies'), ('GO_0007565', 'female pregnancy', 755, 'pregnancy'), ('UBERON_0002107', 'liver', 837, 'hepatic'), ('UBERON_0002113', 'kidney', 848, 'renal'), ('GO_0007565', 'female pregnancy', 864, 'pregnancies'), ('GO_0046660', 'female sex differentiation', 940, 'miscarriage'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 1056, 'miscarriages'), ('CHEBI_60211', 'compound Z', 1110, 'medication'), ('GO_0007565', 'female pregnancy', 1178, 'gestation'), ('GO_0007565', 'female pregnancy', 1372, 'pregnancy'), ('CHEBI_2904', 'atenolol', 1413, 'aspirin'), ('CHEBI_17026', 'progesterone', 1424, 'progesterone'), ('GO_0007565', 'female pregnancy', 1478, 'pregnancy'), ('UBERON_0002113', 'kidney', 1519, 'renal'), ('CHEBI_16240', 'hydrogen peroxide', 1534, 'antiphospholipid'), ('GO_0007565', 'female pregnancy', 1591, 'pregestational')]
PMC4586450	10/2015	S222-PMC4586450	['the amount of free Sugars consumed at all ages was much higher (table 4) than the maximum 10% of energy recommended.93fiber (nonstarch Polysaccharide) Intakes were approximately 75% of the recommended adequate intake at each age throughout childhood (table 4); e.g., an adequate intake for children aged 3 years is APPROXIMATELY 10.8 g nonstarch Polysaccharide/day, but the mean Intake in these children at age 3.5 years was 8.2 g/day.16,99\nmost Micronutrient intakes were adequate at all ages when compared with the recommendations,93the exceptions being low intakes of Vitamin D and iron.']	[('INCOMPLETE_EVIDENCE', 315)]	1	[('CHEBI_26822', 'sulfide', 19, 'sugars'), ('CHEBI_18154', 'polysaccharide', 135, 'polysaccharide'), ('GO_0007631', 'feeding behavior', 151, 'intakes'), ('CHEBI_18154', 'polysaccharide', 346, 'polysaccharide'), ('GO_0007631', 'feeding behavior', 379, 'intake'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 446, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 571, 'vitamin D')]
PMC4586450	10/2015	S233-PMC4586450	['the DIFFERENCES in SOME Micronutrients were substantial, e.g., Vitamin C was 23% lower, Carotene was 15% lower, Retinol was 12% lower, and Sodium was 3% higher in the low compared with the high Maternal education groups.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 19)]	2	[('CHEBI_33839', 'macromolecule', 24, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin C'), ('CHEBI_23042', 'carotene', 88, 'carotene'), ('CHEBI_26536', 'retinoic acid', 112, 'retinol'), ('CHEBI_52632', 'potassium-39 atom', 139, 'sodium'), ('GO_0007618', 'mating', 194, 'maternal')]
PMC4586450	10/2015	S245-PMC4586450	['these results SUGGEST that within the range of fat intakes normally consumed by united kingdom preschool children, there is no EVIDENCE of an EFFECT on growth or obesity development of increasing the proportion of ei coming from fat in the diet.vitamin a\nthe sources of Vitamin A (Retinol equivalents) in the diet and changes in Intake between age 1.5 years and age 3.5 years were examined longitudinally (n = 755 with Food records at both ages).23the diet was categorized by core and noncore Foods, and THERE was EVIDENCE that the quality of the diet deteriorated with age.23between age 1.5 years and age 3.5 years, the dietary Intake of Vitamin A decreased by 56 µg/day (95% ci, −17 to −95 µg/d; p = 0.005) MAINLY due to decreased Intake of whole milk (390 g/d at age 1.5 y; 261 g/d at age 3.5 y) and increased Intake of energy-dense, Nutrient-poor Foods such as puddings, cakes, biscuits, confectionery, and crisps.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 514), ('PROBABLE_UNDERSTANDING', 709)]	6	[('CHEBI_27300', 'vitamin D', 270, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 281, 'retinol'), ('GO_0007631', 'feeding behavior', 329, 'intake'), ('CHEBI_33290', 'food', 419, 'food'), ('CHEBI_33290', 'food', 493, 'foods'), ('GO_0007631', 'feeding behavior', 629, 'intake'), ('CHEBI_27300', 'vitamin D', 639, 'vitamin A'), ('GO_0007631', 'feeding behavior', 733, 'intake'), ('GO_0007631', 'feeding behavior', 813, 'intake'), ('CHEBI_33284', 'nutrient', 837, 'nutrient'), ('CHEBI_33290', 'food', 851, 'foods')]
PMC4586450	10/2015	S247-PMC4586450	['these analyses HIGHLIGHT the IMPORTANCE of Feeding young children Foods that are rich in Nutrients in place of energy-dense, Nutrient-poor Foods.Vitamin D\na parallel analysis investigated Vitamin D and Calcium intakes and changes with age between 1.5 and 3.5 years.24overall, Vitamin D intakes were low; all children had intakes below the uk dietary recommendations at both ages.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 29)]	2	[('GO_0007631', 'feeding behavior', 43, 'feeding'), ('CHEBI_33290', 'food', 66, 'foods'), ('CHEBI_33284', 'nutrient', 89, 'nutrients'), ('CHEBI_33284', 'nutrient', 125, 'nutrient'), ('CHEBI_33290', 'food', 139, 'foods'), ('CHEBI_28384', 'vitamin K', 145, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 145, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 202, 'calcium'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D')]
PMC4586450	10/2015	S252-PMC4586450	['WHETHER fortification of Foods COULD BE the answer to THIS problem was EXAMINED; the THEORETICAL intakes from DIFFERENT fortification regimens tested SUGGESTED that milk fortified at 2 µg vitamin d/100 g would provide MOST preschool children with adequate but not excessive intakes.24later work in the alspac looking at Plasma concentrations in mid-childhood of Vitamin D (25-Hydroxyvitamin-D2And 25-Hydroxyvitamin-D3) in RELATION to Cortical bone measures FOUND positive ASSOCIATIONS with D3Only, SUGGESTING that in supplementation OR fortification, d3should be used in PREFERENCE to d2.25these 2 PAPERS give valuable INSIGHTS into HOW the lack of Vitamin D in the diets of the majority of uk residents COULD BE TACKLED.iron\niron is a Nutrient that is ESSENTIAL to a child’s growth and development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 71), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('INCOMPLETE_EVIDENCE', 150), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 422), ('INCOMPLETE_EVIDENCE', 457), ('SUPERFICIAL_RELATIONSHIP', 472), ('INCOMPLETE_EVIDENCE', 498), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 533), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 571), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 619), ('EXPLICIT_QUESTION', 633), ('INCOMPLETE_EVIDENCE', 704), ('FUTURE_WORK', 713), ('IMPORTANT_CONSIDERATION', 753)]	20	[('CHEBI_33290', 'food', 25, 'foods'), ('UBERON_0001969', 'blood plasma', 320, 'plasma'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin D'), ('CHEBI_66469', 'senegin III', 373, '25-hydroxyvitamin-D2and'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 373, '25'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 390, '-D2and'), ('CHEBI_65129', '2-hydroxy-AMP', 397, '25-hydroxyvitamin-D3'), ('PR_000000037', 'BMP receptor type-2', 414, '-D3'), ('UBERON_0001851', 'cortex', 434, 'cortical'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 490, 'D3only'), ('CHEBI_27300', 'vitamin D', 649, 'vitamin D'), ('CHEBI_33284', 'nutrient', 736, 'nutrient')]
PMC4586450	10/2015	S443-PMC4586450	['the ONLY ROBUST RELATIONSHIP of Nutrients with hemoglobin was positive with Vitamin C intake ( r = 0.13; p = 0.001).']	[('ANOMALY_CURIOUS_FINDING', 4), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 16)]	4	[('CHEBI_33284', 'nutrient', 32, 'nutrients'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin C')]
PMC4586450	10/2015	S445-PMC4586450	['both Iron and Vitamin C intakes were lower and calcium intakes higher in the highest compared with the lowest fat intake quartiles ( p< 0.001), and these DIFFERENCES MAY ACCOUNT FOR the lower ferritin concentration FOUND.60because the strongest ASSOCIATION between Nutrient intake and ferritin at age 1.5 years was a negative one with Calcium Intake ( p< 0.001), IT IS POSSIBLE that this is due to the presence of Calcium in the Gut adversely AFFECTING the absorption of iron from the diet.114cows’ Milk is the main source of calcium in the diet at this age (61% of calcium), and the amount of Cows’ Milk consumed was negatively ASSOCIATED with ferritin ( p< 0.001).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 154), ('INCOMPLETE_EVIDENCE', 166), ('PROBABLE_UNDERSTANDING', 170), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 245), ('INCOMPLETE_EVIDENCE', 363), ('SUPERFICIAL_RELATIONSHIP', 443), ('SUPERFICIAL_RELATIONSHIP', 629)]	8	[('CHEBI_24870', 'ion', 5, 'iron'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin C'), ('CHEBI_33284', 'nutrient', 265, 'nutrient'), ('CHEBI_22313', 'alkaline earth metal atom', 335, 'calcium'), ('GO_0007631', 'feeding behavior', 343, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 414, 'calcium'), ('UBERON_0001555', 'digestive tract', 429, 'gut'), ('UBERON_0001913', 'milk', 499, 'milk'), ('NCBITaxon_33208', 'Metazoa', 594, 'cows'), ('UBERON_0001913', 'milk', 600, 'milk')]
PMC4586450	10/2015	S517-PMC4586450	['Nutrient intakes ESTIMATED from the ffq at age 3 years did not differ between children with asds and control subjects, EXCEPT those with asds had slightly lower intakes of Vitamin C and Ate less variety of Foods, particularly Consuming fruit and vegetables less often.']	[('INCOMPLETE_EVIDENCE', 17), ('ANOMALY_CURIOUS_FINDING', 119)]	2	[('CHEBI_33284', 'nutrient', 0, 'Nutrient'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin C'), ('GO_0009636', 'response to toxic substance', 186, 'ate'), ('CHEBI_33290', 'food', 206, 'foods'), ('GO_0007631', 'feeding behavior', 226, 'consuming')]
PMC4586450	10/2015	S528-PMC4586450	['uptake of Vitamin D supplements was low, IN LINE WITH national surveys and DESPITE RECOMMENDATIONS that all children aged 1–5 years SHOULD receive them.']	[('INCOMPLETE_EVIDENCE', 41), ('ANOMALY_CURIOUS_FINDING', 75), ('FUTURE_WORK', 83), ('FUTURE_WORK', 132)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC4586450	10/2015	S544-PMC4586450	['overall, the diets of children in the alspac were adequate for most Nutrients, with the NOTABLE EXCEPTION of Vitamin D. at age 1.5 years and age 3.5 years, all of the alspac children were found to be below the united kingdom dietary recommendations for Vitamin D intake, and children who had low intakes at age 1.5 years were twice as LIKELY to have low intakes at age 3.5 years.24ALTHOUGH it HAS BEEN RECOMMENDED for 25 years or more that children aged <5 years SHOULD BE given Vitamin D supplements,93only a minority in either the alspac24or the national surveys actually were supplemented.101it IS POSSIBLE that a fortification program COULD be a good option to improve this situation.']	[('ANOMALY_CURIOUS_FINDING', 88), ('ANOMALY_CURIOUS_FINDING', 96), ('PROBABLE_UNDERSTANDING', 335), ('ANOMALY_CURIOUS_FINDING', 379), ('INCOMPLETE_EVIDENCE', 393), ('FUTURE_WORK', 402), ('FUTURE_WORK', 463), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 639)]	9	[('CHEBI_33284', 'nutrient', 68, 'nutrients'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 479, 'vitamin D')]
PMC4586451	10/2015	S17-PMC4586451	['for example, it HAS BEEN FOUND that excessive intakes of Vitamin A or low intakes of Folate CAN be Teratogenic at this critical period during the early weeks of Pregnancy when the first Embryonic Processes occur, resulting in an assortment of Birth defects.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 92)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 85, 'folate'), ('CHEBI_50905', 'teratogenic agent', 99, 'teratogenic'), ('GO_0007565', 'female pregnancy', 161, 'pregnancy'), ('UBERON_0004023', 'ganglionic eminence', 186, 'embryonic processes'), ('GO_0007567', 'parturition', 243, 'birth')]
PMC4586451	10/2015	S18-PMC4586451	['this has LED to dietary RECOMMENDATIONS for Pregnancy that limit concentrated sources of Vitamin A and stress the IMPORTANCE of periconceptional Folic Acid supplementation, which HAS BEEN SHOWN to be PROTECTIVE against Neural Tube defects.4\nTHERE IS EVIDENCE that optimal fetal Neurodevelopment is DEPENDENT on specific Nutrients supplied by the mother mainly from dietary sources; these MAY include Long-Chain polyunsaturated Fatty Acids (lc-pufas) such as Docosahexaenoic Acid (Dha), an N-3 Fatty Acid, and arachidonic acid, an N-6 Fatty Acid.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('FUTURE_WORK', 24), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 200), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 298), ('INCOMPLETE_EVIDENCE', 388)]	8	[('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_30751', 'formic acid', 145, 'folic acid'), ('UBERON_0001049', 'neural tube', 219, 'neural tube'), ('GO_0007399', 'nervous system development', 278, 'neurodevelopment'), ('CHEBI_33284', 'nutrient', 320, 'nutrients'), ('CHEBI_28911', 'cob(III)alamin', 400, 'long-chain'), ('CHEBI_35366', 'fatty acid', 427, 'fatty acids'), ('CHEBI_36003', 'decenoic acid', 458, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 480, 'DHA'), ('CHEBI_35245', 'GDP-galactose', 489, 'n-3 fatty acid'), ('CHEBI_18320', '1,4-dithiothreitol', 530, 'n-6'), ('CHEBI_35366', 'fatty acid', 534, 'fatty acid')]
PMC4586451	10/2015	S21-PMC4586451	['it is also POSSIBLE that fish Intake during Pregnancy INFLUENCES Neurodevelopment via a mechanism not related to its Fatty Acid content; OTHER active substances include its Vitamin D and Iodine content or its POSSIBLE contamination with mercury.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 209)]	4	[('GO_0007631', 'feeding behavior', 30, 'intake'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('GO_0007399', 'nervous system development', 65, 'neurodevelopment'), ('CHEBI_35366', 'fatty acid', 117, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 187, 'iodine')]
PMC4586451	10/2015	S190-PMC4586451	['a weak ASSOCIATION was FOUND between maternal dietary iron and magnesium Intake and height, particularly sitting height; it was greatly attenuated on full adjustment.19\n\ncaption (table-wrap): table 3\n\nassociations of maternal dietary intakes, iron supplement use, anemia, and Vitamin D status during Pregnancy with measures of offspring growth, Blood pressure, and Bone developmentmeasure in childdietary factoradjustments appliedminimally adjusted resultsfully adjusted resultscommentsheight at 7.5 y, n = 6663 singletons19\niron\nmagnesium\nvitamin c\nminimal: child sex, age at measurement, Pregnancy energy Intake\nfull: plus maternal age, bmi, height, smoking, seb, parity, breastfeeding\nβ = 0.08 (95% ci, 0.05–0.12), p< 0.001\nβ = 0.10 (95% ci, 0.07–0.14), p< 0.001\nβ = 0.05 (95% ci, 0.03–0.08), p< 0.001\nβ = 0.04 (95% ci, 0.01–0.08), p = 0.02\nβ = 0.05 (95% ci, 0.01–0.08), p = 0.04\nβ = 0.02 (95% ci, −0.01 to 0.04), p = 0.2\nregression analysis using standard deviation scores.']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 23)]	2	[('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('GO_0007565', 'female pregnancy', 300, 'pregnancy'), ('UBERON_0000178', 'blood', 345, 'blood'), ('GO_0007567', 'parturition', 365, 'bone'), ('GO_0007565', 'female pregnancy', 590, 'pregnancy'), ('GO_0007631', 'feeding behavior', 607, 'intake')]
PMC4586451	10/2015	S212-PMC4586451	['there was also no evidence of an association between maternal Vitamin D status during Pregnancy and offspring bone Mineral content (table 3).24the SUGGESTION that maternal body fat stores are IMPORTANT for fetal bone Mineral deposition was investigated in a further study.25there was NO evidence of an independent association between maternal Prepregnancy bmi and offspring bone mass at age 9 years once adjustments were made for Birth weight and the current height and weight of the child.25\nthese data SUGGEST it is UNLIKELY that Pregnancy diet has an IMPORTANT EFFECT on any of the outcomes investigated in this section, ALTHOUGH the ASSOCIATIONS that were FOUND were with Nutrients that are most LIKELY to be inadequate in the diet of this population.8\n\nNeurocognitive and behavioral development Of the offspring\nBrain Cell Membranes have a high content of n-3 lc-pufas, and the predominant sources of these Nutrients in the diets of uk residents are fish and seafood.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 284), ('INCOMPLETE_EVIDENCE', 504), ('PROBABLE_UNDERSTANDING', 518), ('IMPORTANT_CONSIDERATION', 554), ('SUPERFICIAL_RELATIONSHIP', 564), ('ANOMALY_CURIOUS_FINDING', 624), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 660), ('PROBABLE_UNDERSTANDING', 700)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('CHEBI_46662', 'mineral', 115, 'mineral'), ('CHEBI_46662', 'mineral', 217, 'mineral'), ('GO_0007565', 'female pregnancy', 343, 'prepregnancy'), ('GO_0007567', 'parturition', 430, 'birth'), ('GO_0007565', 'female pregnancy', 532, 'pregnancy'), ('CHEBI_33284', 'nutrient', 676, 'nutrients'), ('GO_0043102', 'amino acid salvage', 758, 'Neurocognitive ... of ...'), ('UBERON_0000955', 'brain', 817, 'Brain'), ('GO_0005886', 'plasma membrane', 823, 'cell membranes'), ('CHEBI_33284', 'nutrient', 912, 'nutrients')]
PMC4592566	10/2015	S330-PMC4592566	['the researchers FOUND that most women’s diets exceeded the upper limit for saturated fat intake and the majority of women’s diets were sub-optimal in RELATION to copper, iron, selenium, and ABOUT half were deficient in vitamin a, with smaller proportions deficient in various b Vitamins, Vitamin C and vitamin e [45].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 150), ('INCOMPLETE_EVIDENCE', 190)]	3	[('CHEBI_33277', 'gamma-tocotrienol', 278, 'vitamins'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin C')]
PMC4595656	10/2015	S0-PMC4595656	['Vitamin D and Hippocampal Development-the story so far\n\nabstract\nepidemiological studies SUGGEST that Vitamin D insufficiency MAY BE PREVALENT in young as well as older populations.']	[('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 126), ('IMPORTANT_CONSIDERATION', 133)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('GO_0003163', 'sinoatrial node development', 14, 'hippocampal development'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4595656	10/2015	S1-PMC4595656	['the pleiotropic EFFECTS of Vitamin D are now BEYOND DISPUTE and a GROWING NUMBER OF STUDIES provide ACCUMULATING EVIDENCE of a ROLE for Vitamin D in Brain Development and function.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 127)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0007420', 'brain development', 149, 'brain development'), ('UBERON_0000955', 'brain', 149, 'brain')]
PMC4595656	10/2015	S2-PMC4595656	['a NUMBER OF STUDIES to date have investigated the EFFECTS of early-Life Vitamin D deprivation on Adult hippocampus in Animals and Humans, and there is a growing BODY OF EVIDENCE to SUGGEST a ROLE for this hormone in the development of selected hippocampal functions such as latent inhibition and hole board Habituation in Rats.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 191)]	5	[('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0007023', 'adult organism', 97, 'adult'), ('NCBITaxon_33208', 'Metazoa', 118, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 130, 'humans'), ('GO_0046959', 'habituation', 307, 'habituation'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 322, 'rats')]
PMC4595656	10/2015	S3-PMC4595656	['there are FEW STUDIES to date of Vitamin D deprivation or supplementation on early hippocampal development in vivo .']	[('INCOMPLETE_EVIDENCE', 10)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4595656	10/2015	S4-PMC4595656	['HOWEVER, a SMALL NUMBER OF STUDIES, MOSTLY in vitro , POINT to a ROLE for Vitamin D in Differentiation and Development Of Hippocampal Neurons.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 65)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0030254', 'protein secretion by the type III secretion system', 87, 'differentiation ...'), ('GO_0048513', 'animal organ development', 107, 'development of ... neurons'), ('CL_0002608', 'hippocampal neuron', 122, 'hippocampal neurons')]
PMC4595656	10/2015	S5-PMC4595656	['there is also LIMITED EVIDENCE that supplementation with Vitamin D following a period of deprivation is capable of restoring cellular activity and later function.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4595656	10/2015	S9-PMC4595656	['introduction\nuntil a little over 30 years ago, the ROLE of hormonal Vitamin D was classically ASSOCIATED with Calcium Homeostasis, bone formation and maintenance, its up-Regulation by Parathyroid hormone being KNOWN for MANY YEARS.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 220)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 110, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 170, 'regulation'), ('UBERON_0001132', 'parathyroid gland', 184, 'parathyroid')]
PMC4595656	10/2015	S10-PMC4595656	['HOWEVER in RECENT YEARS, myriad OTHER functions and ROLES for Vitamin D HAVE BEEN gradually POSTULATED and VERIFIED, and its pleiotropic EFFECTS are now BEYOND DISPUTE (kalueff and tuohimaa,2007; mccann and ames,2008; lai and fang,2013; schlogl and holick,2014).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 137), ('IMPORTANT_CONSIDERATION', 153), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4595656	10/2015	S15-PMC4595656	['the increased demands of the developing fetus combined with a POSSIBLE decrease in environmental exposure to sunlight, MAY result in diminished circulating Vitamin D (hillman and haddad,1976; markestad et al.,1983).']	[('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 119)]	2	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC4595656	10/2015	S24-PMC4595656	['ON THE BASIS OF the extensive presence of Vitamin D within the Brain, they PROPOSED that Calcitriol be renamed solitriol, the sunlight activated Steroid hormone, to reflect its wider physiological remit.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 75)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0000955', 'brain', 63, 'brain'), ('CHEBI_17823', 'calcitriol', 89, 'calcitriol'), ('CHEBI_35341', 'steroid', 145, 'steroid')]
PMC4595656	10/2015	S25-PMC4595656	['since then the investigation of a neural ROLE for Vitamin D has gained SIGNIFICANT traction and a PLETHORA OF Animal STUDIES have SHED LIGHT both on its presence and its biological activity within the Cns independent of Transport via the Blood-Brain Barrier.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 71), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 110, 'animal'), ('UBERON_0001017', 'central nervous system', 201, 'CNS'), ('GO_0006809', 'nitric oxide biosynthetic process', 220, 'transport'), ('UBERON_0000178', 'blood', 238, 'blood'), ('UBERON_0000052', 'fornix of brain', 244, 'brain barrier')]
PMC4595656	10/2015	S29-PMC4595656	['this was followed by SEVERAL functional STUDIES on physiological and cellular EFFECTS of Vitamin D on various aspects of Brain cellular function (for examples see ko et al.,2004; lin et al.,2005; taniura et al.,2006).']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000955', 'brain', 121, 'brain')]
PMC4595656	10/2015	S30-PMC4595656	['a GROWING BODY of EVIDENCE also POINTS to a ROLE for Vitamin D in the Development Of the Cns.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0030324', 'lung development', 70, 'development of ... CNS'), ('UBERON_0001017', 'central nervous system', 89, 'CNS')]
PMC4595656	10/2015	S32-PMC4595656	['in addition, transient deprivation of Vitamin D early in Life leads to changes in the new-born Rat Brain which MAY persist into Adulthood.']	[('INCOMPLETE_EVIDENCE', 111)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000104', 'life cycle', 57, 'life'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 95, 'rat'), ('UBERON_0000955', 'brain', 99, 'brain'), ('UBERON_0000113', 'post-juvenile adult stage', 128, 'adulthood')]
PMC4595656	10/2015	S36-PMC4595656	['targeted Gene arrays specific for Apoptosis and Cell Cycle Genes CONFIRM a pattern of transcription Deregulation in the deplete group CONSISTENT with the KNOWN properties of Vitamin D (ko et al.,2004).']	[('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 134), ('INCOMPLETE_EVIDENCE', 154)]	3	[('SO_0000704', 'gene', 9, 'gene'), ('GO_0006915', 'apoptotic process', 34, 'apoptosis'), ('GO_0007049', 'cell cycle', 48, 'cell cycle'), ('SO_0000704', 'gene', 59, 'genes'), ('GO_0050893', 'sensory processing', 100, 'deregulation'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC4595656	10/2015	S38-PMC4595656	['in addition, Vitamin D HAS BEEN DEMONSTRATED to increase levels of Ngf and Neurotrophins Nt-3 and Nt-4 in Cultured Glial Cells, Astrocytes and Oligodendrocytes (neveu et al.,1994a,b; baas et al.,2000).']	[('INCOMPLETE_EVIDENCE', 23)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('PR_000011159', 'nexilin', 67, 'NGF'), ('PR_000021998', 'neurotrophin', 75, 'neurotrophins'), ('PR_000011459', 'neurotrophin-3', 89, 'NT-3'), ('PR_000011459', 'neurotrophin-3', 98, 'NT-4'), ('CL_0000010', 'cultured cell', 106, 'cultured'), ('CL_0000125', 'glial cell', 115, 'glial cells'), ('CL_0000127', 'astrocyte', 128, 'astrocytes'), ('CL_0000128', 'oligodendrocyte', 143, 'oligodendrocytes')]
PMC4595656	10/2015	S56-PMC4595656	['the authors CONCLUDED that exposure to low Prenatal Vitamin D has a selective IMPACT on certain aspects of Memory ONLY, with disruption of latent inhibition, but no effect on Memory acquisition and Memory Retrieval.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 114)]	3	[('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007613', 'memory', 107, 'memory'), ('GO_0007613', 'memory', 175, 'memory'), ('GO_0030317', 'flagellated sperm motility', 198, 'memory retrieval')]
PMC4595656	10/2015	S68-PMC4595656	['it MUST BE BORNE IN MIND also, that Rats in the cited studies received SOME Vitamin D from their mothers from the time of Birth until weaning, and IT IS POSSIBLE that this COULD have resulted in a partial restoration of hippocampal structure and function.']	[('IMPORTANT_CONSIDERATION', 3), ('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 147), ('INCOMPLETE_EVIDENCE', 172)]	5	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 36, 'rats'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007567', 'parturition', 122, 'birth')]
PMC4595656	10/2015	S70-PMC4595656	['one STUDY to date has investigated the EFFECTS of Vitamin D deprivation over time on this reflex in Rats (burne et al.,2004).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 100, 'rats')]
PMC4595656	10/2015	S71-PMC4595656	['several groups of Rats were treated and compared e.g., no depletion, replete at Birth, replete at weaning, depleted until 10 weeks of age, or depleted between 5 and 10 weeks of age, and they FOUND that ONLY the combined Prenatal and chronic Postnatal Vitamin D deprivation, BUT NOT early Life hypovitaminosis on its own, resulted in an impaired response.']	[('INCOMPLETE_EVIDENCE', 191), ('ANOMALY_CURIOUS_FINDING', 202), ('ANOMALY_CURIOUS_FINDING', 274)]	3	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 18, 'rats'), ('GO_0007567', 'parturition', 80, 'birth'), ('GO_0007565', 'female pregnancy', 220, 'prenatal'), ('GO_0007567', 'parturition', 241, 'postnatal'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D'), ('UBERON_0000104', 'life cycle', 288, 'life')]
PMC4595656	10/2015	S74-PMC4595656	['HOWEVER the phenotype did not extend into Adulthood, SUGGESTING that EITHER normal Postnatal development OR the reintroduction of Vitamin D at Birth MAY have corrected the deficit (harms et al.,2012).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('INCOMPLETE_EVIDENCE', 149)]	5	[('UBERON_0000113', 'post-juvenile adult stage', 42, 'adulthood'), ('GO_0007567', 'parturition', 83, 'postnatal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007567', 'parturition', 143, 'birth')]
PMC4595656	10/2015	S80-PMC4595656	['the FIRST STUDY, utilising a 1-α hydroxylase knock-out Mouse MODEL investigated the hippocampus of 8 week old Mice Born of Vitamin D-depleted dams following injection with labeled Bromodeoxyuridine (bdu; zhu et al.,2012).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 61)]	2	[('NCBITaxon_10088', 'Mus <genus>', 55, 'mouse'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'mice'), ('GO_0007567', 'parturition', 115, 'born'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_472552', "5-bromo-2'-deoxyuridine", 180, 'bromodeoxyuridine')]
PMC4595656	10/2015	S85-PMC4595656	['HOWEVER the FINDING of increased numbers of Apoptotic Cells in the hippocampus is IN CONTRAST TO the FINDINGS of decreased numbers of Apoptotic Cells at Birth in the developing Cortex (ko et al.,2004) and with the KNOWN overall EFFECTS of Vitamin D on Apoptosis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 228)]	6	[('CL_0000445', 'apoptosis fated cell', 44, 'apoptotic cells'), ('CL_0000445', 'apoptosis fated cell', 134, 'apoptotic cells'), ('GO_0007567', 'parturition', 153, 'birth'), ('UBERON_0001851', 'cortex', 177, 'cortex'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('GO_0006915', 'apoptotic process', 252, 'apoptosis')]
PMC4595656	10/2015	S91-PMC4595656	['two STUDIES have investigated the EFFECT of a single treatment of 50 μg of Vitamin D on Neurotransmitter concentrations in offspring of Rats, and FOUND that within the hippocampus, levels of Serotonin and 5h1aa, BUT NOT Dopamine or hva, were negatively AFFECTED by the single treatment, which the authors referred to as Hormonal Imprinting (tekes et al.,2009a,b).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 146), ('ANOMALY_CURIOUS_FINDING', 212), ('SUPERFICIAL_RELATIONSHIP', 253)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_25512', 'neurotransmitter', 88, 'neurotransmitter'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 136, 'rats'), ('CHEBI_28790', 'serotonin', 191, 'serotonin'), ('CHEBI_18243', 'dopamine', 220, 'dopamine'), ('GO_0007601', 'visual perception', 320, 'hormonal'), ('GO_0071514', 'genetic imprinting', 329, 'imprinting')]
PMC4595656	10/2015	S93-PMC4595656	['apart from ELUCIDATING valuable data on the direct EFFECT of Vitamin D on Neurotransmitter levels within the hippocampus, such studies carried out on young Animals COULD also shed valuable light on Hippocampal Development when combined with behavioral testing.']	[('FUTURE_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 164)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_25512', 'neurotransmitter', 74, 'neurotransmitter'), ('NCBITaxon_33208', 'Metazoa', 156, 'animals'), ('GO_0003163', 'sinoatrial node development', 198, 'hippocampal development')]
PMC4595656	10/2015	S95-PMC4595656	['in vitro studies\nSEVERAL groups have investigated Vitamin D supplementation of up to 100 nm on developing cultured Hippocampal Neurons (brann et al.,1999; brown et al.,2003; marini et al.,2010).']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CL_0002608', 'hippocampal neuron', 115, 'hippocampal neurons')]
PMC4595656	10/2015	S98-PMC4595656	['marini’s group REPORTED translocation of Vitamin D from the Cytoplasm to the Nucleus and back to the Cytoplasm, which caused a delay in Cell Proliferation and induction of Cell Differentiation (marini et al.,2010).']	[('INCOMPLETE_EVIDENCE', 15)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0005737', 'cytoplasm', 60, 'cytoplasm'), ('GO_0005634', 'nucleus', 77, 'nucleus'), ('GO_0006260', 'DNA replication', 77, 'nucleus'), ('GO_0005737', 'cytoplasm', 101, 'cytoplasm'), ('GO_0008283', 'cell proliferation', 136, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 172, 'cell differentiation')]
PMC4595656	10/2015	S104-PMC4595656	['in a later STUDY, the same group FOUND that when Serum is withdrawn from Cultured Hippocampal Cells, treatment with 100 nm Vitamin D fails to trigger differentiation.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 33)]	2	[('UBERON_0001977', 'blood serum', 49, 'serum'), ('CL_0000010', 'cultured cell', 73, 'cultured'), ('CL_0002608', 'hippocampal neuron', 82, 'hippocampal cells'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4595656	10/2015	S106-PMC4595656	['this FINDING POINTS to DIFFERENTIAL EFFECTS of varying concentrations of Vitamin D on Cellular Hippocampal Development and WARRANT FURTHER EXPLORATION.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 36), ('FUTURE_WORK', 123)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0045168', 'cell-cell signaling involved in cell fate commitment', 86, 'cellular hippocampal development')]
PMC4595656	10/2015	S107-PMC4595656	['ALTHOUGH the concentration of hormone used to supplement in vitro is higher than that DETECTED in standard Rat Chow, Vitamin D levels in Humans HAVE BEEN FOUND in more than ONE STUDY to be elevated in Pregnancy (seki et al.,1991; ardawi et al.,1997).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 86), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 173)]	5	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 107, 'rat'), ('CHEBI_33290', 'food', 111, 'chow'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 137, 'humans'), ('GO_0007565', 'female pregnancy', 201, 'pregnancy')]
PMC4595656	10/2015	S110-PMC4595656	['they FOUND an increase in the number of Neurospheres formed in culture from the Subventricular Zone (Svz), which was unaffected by subsequent supplementation with Vitamin D. the authors CONCLUDED that Vitamin D CAN Regulate Cellular Proliferation in the developing Brain.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 186), ('INCOMPLETE_EVIDENCE', 211)]	3	[('CL_0000855', 'sensory hair cell', 40, 'neurospheres'), ('UBERON_0004922', 'postnatal subventricular zone', 80, 'subventricular zone'), ('UBERON_0004922', 'postnatal subventricular zone', 101, 'SVZ'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0065007', 'biological regulation', 215, 'regulate'), ('GO_0008283', 'cell proliferation', 224, 'cellular proliferation'), ('UBERON_0000955', 'brain', 265, 'brain')]
PMC4595656	10/2015	S112-PMC4595656	['this CONTRASTS with the restoration of normal development following Vitamin D repletion in whole Animals (féron et al.,2005), and highlights the POTENTIAL DISPARITY between in vitro and in vivo FINDINGS.']	[('ANOMALY_CURIOUS_FINDING', 5), ('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('INCOMPLETE_EVIDENCE', 194)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 97, 'animals')]
PMC4595656	10/2015	S118-PMC4595656	['the antagonistic EFFECTS of Vitamin D on Glucocoticoid action was POSTULATED to have POTENTIAL significance in treatment of Cognitive impairments and major depression, both of which are accompanied by high amounts of circulating Corticosteroids (holsboer,2000).']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 85)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_24261', 'glucocorticoid', 41, 'glucocoticoid'), ('GO_0050890', 'cognition', 124, 'cognitive'), ('CHEBI_50850', 'etabonate ester', 229, 'corticosteroids')]
PMC4595656	10/2015	S119-PMC4595656	['FUTURE DIRECTIONS and conclusions\nin LIGHT of the ACCUMULATING Animal and in vitro EVIDENCE to DATE, it is LIKELY that Vitamin D plays a ROLE in hippocampal development in vivo .']	[('FUTURE_WORK', 0), ('PROBABLE_UNDERSTANDING', 37), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 107), ('SUPERFICIAL_RELATIONSHIP', 137)]	7	[('NCBITaxon_33208', 'Metazoa', 63, 'animal'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4595656	10/2015	S124-PMC4595656	['IT IS POSSIBLE that there are temporal variations in the EFFECTS of Vitamin D such that particular time points along the spectrum of hippocampal Development are more sensitive to its absence or its supply, than are others.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 57)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0008289', 'lipid binding', 145, 'development')]
PMC4595656	10/2015	S130-PMC4595656	['low Prenatal Vitamin D HAS BEEN POSTULATED AS an epigenetic risk factor for same (mcgrath,1999), and transient vd IS CONSIDERED a developmental MODEL in schizophrenia research.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 43), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 144)]	5	[('GO_0007565', 'female pregnancy', 4, 'prenatal'), ('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC4595656	10/2015	S141-PMC4595656	['this would shed the MOST valuable light POSSIBLE on the ROLE of Vitamin D in early Hippocampal Development.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0003163', 'sinoatrial node development', 83, 'hippocampal development')]
PMC4598849	10/2015	S6-PMC4598849	['THIS STUDY PROVIDES the FIRST epidemiological EVIDENCE that there was an inverted u shaped RELATIONSHIP between neonatal Vitamin D status and fetal growth, and the risk of sga reduced at moderate concentration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4598849	10/2015	S11-PMC4598849	['the LINK between maternal Vitamin D status and fetal growth, AS measured most frequently by infant Birth weight and small for Gestational age (sga), HAS BEEN explored by a NUMBER OF observational STUDIES9101112131415AND randomized supplementation trials1617181920worldwide with MIXED results.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 61), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 196), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 278)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 99, 'birth'), ('GO_0007565', 'female pregnancy', 126, 'gestational')]
PMC4598849	10/2015	S13-PMC4598849	['EVIDENCES from SOME STUDIES SUPPORT the HYPOTHESIS that lower Vitamin D status causes adverse fetal growth in a linear way, more SEVERE deficiency would be expected to have a stronger EFFECT than less severe deficiency or sufficiency91012131416.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40), ('IMPORTANT_CONSIDERATION', 129), ('SUPERFICIAL_RELATIONSHIP', 184)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4598849	10/2015	S15-PMC4598849	['the CONFLICTING findings MAY BE DUE TO VARIATIONS of study designs including the Gestational weeks of Vitamin D testing, the cut-point of Vitamin D, ethnicity of the study population, Genetic variation and outcome variables.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 25), ('PROBLEM_COMPLICATION', 32), ('DIFFICULT_TASK', 39)]	4	[('GO_0007565', 'female pregnancy', 81, 'gestational'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('SO_0000704', 'gene', 184, 'genetic')]
PMC4598849	10/2015	S48-PMC4598849	['compared with north american and european countries (the mean 25(Oh)D levels of Pregnant women in us and uk is APPROXIMATELY 50\u2009nmol/l), asian countries MAYBE have more Pregnant women with Vitamin D deficiency1326272829.']	[('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 153)]	2	[('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 62, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 80, 'pregnant'), ('GO_0007565', 'female pregnancy', 169, 'pregnant'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
PMC4598849	10/2015	S51-PMC4598849	['currently, there is LIMITED INFORMATION on the ASSOCIATION between fetal Vitamin D status and fetal growth.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4598849	10/2015	S54-PMC4598849	['another case-control study SUGGESTED that infants Born before 32 wks’ Gestation had an increased RISK of Vitamin D deficiency compared with mature infant, HOWEVER, there was no statistically significant difference in mean Cord Blood 25(Oh)D levels between sga and non-sga infants29.']	[('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('ANOMALY_CURIOUS_FINDING', 155)]	4	[('GO_0007567', 'parturition', 50, 'born'), ('GO_0007565', 'female pregnancy', 70, 'gestation'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 222, 'cord'), ('UBERON_0000178', 'blood', 227, 'blood'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 233, '25(OH ... D')]
PMC4598849	10/2015	S55-PMC4598849	['PREVIOUS STUDIES have several LIMITATIONS including SMALL sample sizes, INCONSISTENT definitions for fetal Vitamin D status, FEW adjustment for confounders and ONLY linear models performed.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4598849	10/2015	S56-PMC4598849	['in THIS STUDY with a large sample, adjustment for more confounders and using non-linear models, we FOUND that there was an inverted u-shaped RELATIONSHIP between Cord Blood 25(Oh)D and Birth weight, SUGGESTING that the newborn with low or high levels of fetal Vitamin D are both in INCREASED risk of growth restriction and higher levels of fetal Vitamin D HAVE not been shown to confer greater BENEFITS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 141), ('INCOMPLETE_EVIDENCE', 199), ('IMPORTANT_CONSIDERATION', 282), ('IMPORTANT_CONSIDERATION', 356), ('IMPORTANT_CONSIDERATION', 394)]	7	[('UBERON_0002240', 'spinal cord', 162, 'cord'), ('UBERON_0000178', 'blood', 167, 'blood'), ('CHEBI_71657', 'versiconol acetate', 173, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 173, '25(OH)D'), ('GO_0007567', 'parturition', 185, 'birth'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]
PMC4598849	10/2015	S59-PMC4598849	['the FINDING that Vitamin D levels in the upper range increased the health RISK in THIS STUDY was CONSISTENT with PREVIOUS STUDIES examining the risk of fetal growth restriction11, Allergic Response3031, lower-extremity function32, frailty status33, as well as Cardiovascular disease3435.']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 74), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0019267', 'asparagine biosynthetic process from cysteine', 180, 'allergic response3031'), ('UBERON_0004535', 'cardiovascular system', 260, 'cardiovascular')]
PMC4598849	10/2015	S60-PMC4598849	['ALTHOUGH the neonatal 25(Oh)D levels at Birth cannot fully represent the Vitamin D status during CRITICAL times of Gestation DUE TO a half-life of several weeks of 25(Oh)D34, IT was quite POSSIBLE that the neonates with lower or higher Cord Blood 25(Oh)D levels MAY also have lower or higher average levels of 25(Oh)D during the whole Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 97), ('PROBLEM_COMPLICATION', 125), ('ANOMALY_CURIOUS_FINDING', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_71657', 'versiconol acetate', 22, '25(OH)D'), ('GO_0007567', 'parturition', 40, 'birth'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestation'), ('CHEBI_79189', 'D-ribofuranose-2,5-bisphosphate', 164, '25(OH)D34'), ('PR_000001177', 'D(2) dopamine receptor', 170, 'D34'), ('UBERON_0002240', 'spinal cord', 236, 'cord'), ('UBERON_0000178', 'blood', 241, 'blood'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 253, 'D'), ('CHEBI_71657', 'versiconol acetate', 310, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 316, 'D'), ('GO_0007565', 'female pregnancy', 335, 'pregnancy')]
PMC4598849	10/2015	S61-PMC4598849	['THEREFORE, the inverted u shaped RELATIONSHIP in THIS STUDY MAYBE SUGGESTED that Gestational Vitamin D MAY have dual biological EFFECTS on the fetal growth.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 128)]	7	[('GO_0007565', 'female pregnancy', 81, 'gestational'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4598849	10/2015	S72-PMC4598849	['first, we ONLY measured 25(Oh)D concentrations, which is one member of the Vitamin D family.']	[('INCOMPLETE_EVIDENCE', 10)]	1	[('CHEBI_71657', 'versiconol acetate', 24, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC4598849	10/2015	S73-PMC4598849	['at Birth, there are POTENTIAL changes to levels of Vitamin D binding protein, 1,25(Oh)2D, the Cyp27 enzyme and Expression of Vitamin D receptors40, which MAY INFLUENCE the ASSOCIATION between 25(Oh)D and fetal growth41.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 158), ('SUPERFICIAL_RELATIONSHIP', 172)]	4	[('GO_0007567', 'parturition', 3, 'birth'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 80, '25(OH)2D'), ('PR_000006100', 'aromatase', 94, 'CYP27'), ('GO_0010467', 'gene expression', 111, 'expression'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 133, 'D'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH)D')]
PMC4598849	10/2015	S79-PMC4598849	['in CONCLUSION, THIS STUDY PROVIDES the FIRST epidemiological EVIDENCE that there was an inverted u shaped RELATIONSHIP between neonatal Vitamin D status and fetal growth.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 106)]	6	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4598849	10/2015	S80-PMC4598849	['the FINDINGS SUGGESTED that Vitamin D supplements during Pregnancy SHOULD BE ENCOURAGED, BUT with CAUTION.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 13), ('FUTURE_WORK', 67), ('FUTURE_WORK', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy')]
PMC4600246	10/2015	S0-PMC4600246	['the health benefits of Vitamin K\n\nabstract\nvitamin K has IMPORTANT functions within the body, SOME of which are STILL being DISCOVERED.']	[('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 94), ('IMPORTANT_CONSIDERATION', 112), ('INCOMPLETE_EVIDENCE', 124)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin K'), ('CHEBI_52071', 'dextran', 51, 'K')]
PMC4600246	10/2015	S1-PMC4600246	['RESEARCH HAS SHOWN that Vitamin K is an Anticalcification, anticancer, bone-forming and Insulin-sensitising Molecule.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 9)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin K'), ('GO_0009948', 'anterior/posterior axis specification', 40, 'anticalcification'), ('PR_000045358', 'insulin family protein', 88, 'insulin'), ('CHEBI_36357', 'polyatomic entity', 108, 'molecule')]
PMC4600246	10/2015	S2-PMC4600246	['RECENT DATA INDICATE that subclinical Vitamin K deficiency is not uncommon.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin K')]
PMC4600246	10/2015	S3-PMC4600246	['additionally, Vitamin K antagonists such as warfarin MAY cause DETRIMENTAL side EFFECTS, which MAY PARTLY be blunted through Vitamin K supplementation.']	[('INCOMPLETE_EVIDENCE', 53), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 95)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin K')]
PMC4600246	10/2015	S4-PMC4600246	['introduction\nVitamin K is a fat-soluble Vitamin, IMPORTANT for the function of numerous proteins within the body, such as the Coagulation factors (ii, vii, Ix, x and protein c and protein s), Osteocalcin (a bone-Forming Protein) and Matrix-Gla Protein (Mgp) (an anticalcification protein), to name a few.1–3vitamin K exists naturally as Vitamin K1(Phylloquinone) and Vitamin K2(Menaquinone, mk-4 through mk-10).2–5vitamin K1Is mainly found in green leafy vegetables as well as olive oil and soyabean oil, whereas Vitamin K2(Menaquinone) is found in small amounts in Chicken, butter, Egg Yolks, cheese and fermented soyabeans (BETTER KNOWN as natto).26–9\nVitamin K1And Vitamin K2Are REQUIRED for the γ-glutamyl carboxylation of all Vitamin K-dependent proteins.2DESPITE the fact that Mammalian bacterial Intestinal flora are able to produce Vitamin K2, the amount produced IS THOUGHT TO be negligible.2the adequate intake (ai) for Vitamin K HAS BEEN PROPOSED to be 90\u2005µg/day for women and 120\u2005µg/day for men.210HOWEVER, it HAS BEEN SPECULATED that the ai for Vitamin K (90–120\u2005µg/day) is not sufficient to induce complete carboxylation of all Vitamin K-dependent proteins.21112\n\nvitamin K deficiency\nthe measurement and treatment of Vitamin K deficiency based on Blood tests is not perfect.']	[('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 626), ('IMPORTANT_CONSIDERATION', 682), ('ANOMALY_CURIOUS_FINDING', 760), ('INCOMPLETE_EVIDENCE', 872), ('INCOMPLETE_EVIDENCE', 875), ('INCOMPLETE_EVIDENCE', 940), ('INCOMPLETE_EVIDENCE', 949), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1007), ('INCOMPLETE_EVIDENCE', 1022), ('INCOMPLETE_EVIDENCE', 1031)]	11	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 40, 'vitamin'), ('GO_0050817', 'coagulation', 126, 'coagulation'), ('PR_000008875', 'islet amyloid polypeptide', 156, 'IX'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 192, 'osteocalcin'), ('PR_000004759', 'Bloom syndrome protein', 211, '-forming protein'), ('GO_0031012', 'extracellular matrix', 233, 'matrix'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 233, 'matrix-Gla protein'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 253, 'MGP'), ('CHEBI_52071', 'dextran', 315, 'K'), ('CHEBI_33229', 'vitamin (role)', 337, 'vitamin'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 337, 'vitamin K1'), ('CHEBI_26124', 'phytosteroid', 348, 'phylloquinone'), ('CHEBI_28934', 'vitamin D2', 367, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 367, 'vitamin K2'), ('CHEBI_18154', 'polysaccharide', 378, 'menaquinone'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 422, 'K1is'), ('CHEBI_28934', 'vitamin D2', 513, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 513, 'vitamin K2'), ('CHEBI_18154', 'polysaccharide', 524, 'menaquinone'), ('NCBITaxon_33208', 'Metazoa', 566, 'chicken'), ('UBERON_0005079', 'eggshell', 583, 'egg yolks'), ('CHEBI_33229', 'vitamin (role)', 654, 'Vitamin'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 654, 'Vitamin K1and'), ('PR_000017209', 'utrophin', 668, 'vitamin K2are'), ('CHEBI_27300', 'vitamin D', 731, 'vitamin K'), ('NCBITaxon_40674', 'Mammalia', 783, 'mammalian'), ('UBERON_0000160', 'intestine', 803, 'intestinal'), ('CHEBI_28934', 'vitamin D2', 840, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 840, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 930, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 1058, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 1142, 'vitamin K'), ('CHEBI_52071', 'dextran', 1186, 'K'), ('CHEBI_27300', 'vitamin D', 1232, 'vitamin K'), ('UBERON_0000178', 'blood', 1262, 'blood')]
PMC4600246	10/2015	S5-PMC4600246	['Plasma Phylloquinone concentrations fluctuate BASED on recent dietary intakes.213DESPITE the fact that a high percentage of undercarboxylated osteocalcin INDICATES poor Vitamin K status, this value can also vary based on recent Vitamin K intake and supplementation214and MAY not INDICATE chronic Vitamin K status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 271), ('INCOMPLETE_EVIDENCE', 279)]	5	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_26124', 'phytosteroid', 7, 'phylloquinone'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin K')]
PMC4600246	10/2015	S6-PMC4600246	['moreover, a normal carboxylated mgp protein in the Serum MAY NOT NECESSARILY INDICATE a normal Vitamin K status, AS carboxylated mgp in the Serum COULD BE normal, BUT suboptimal in the Arteries (where Vitamin K2Is needed to prevent vascular calcification.)']	[('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 113), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163)]	6	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin K'), ('UBERON_0001977', 'blood serum', 140, 'serum'), ('UBERON_0001637', 'artery', 185, 'arteries'), ('CHEBI_35684', 'antiplatyhelmintic drug', 201, 'vitamin K2is')]
PMC4600246	10/2015	S9-PMC4600246	['HOWEVER, the RECENTLY updated usa preventive services task force (uspstf) has RECENTLY STATED that there is INSUFFICIENT EVIDENCE that Calcium and Vitamin D PREVENT a fracture in Premenopausal women or in men who have not experienced a fracture and now RECOMMENDS against daily supplementation with 400\u2005iu or less of Vitamin D3 and 1000\u2005mg or less of calcium for the primary prevention of fractures in non-institutionalised Postmenopausal women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 157), ('FUTURE_WORK', 253)]	7	[('CHEBI_22313', 'alkaline earth metal atom', 135, 'calcium'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0043277', 'apoptotic cell clearance', 179, 'premenopausal'), ('CHEBI_33279', 'vitamin D5', 317, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 317, 'vitamin D3'), ('GO_0007595', 'lactation', 424, 'postmenopausal')]
PMC4600246	10/2015	S10-PMC4600246	['THUS, UNLESS you are an institutionalised Postmenopausal woman or you have already experienced a fracture, the uspstf does not RECOMMEND Calcium and Vitamin D for preventing a first-time fracture, AS there is a LACK OF EVIDENCE.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('FUTURE_WORK', 127), ('PROBABLE_UNDERSTANDING', 197), ('INCOMPLETE_EVIDENCE', 211)]	5	[('GO_0007595', 'lactation', 42, 'postmenopausal'), ('CHEBI_22313', 'alkaline earth metal atom', 137, 'calcium'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4600246	10/2015	S12-PMC4600246	['a broad amount of DATA SEEMS to INDICATE substantial POTENTIAL for supplementary Vitamin K. HOWEVER, currently FEW GUIDELINES RECOMMEND Vitamin K therapy for PREVENTION or treatment of osteoporosis.']	[('FUTURE_WORK', 18), ('ANOMALY_CURIOUS_FINDING', 23), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 111), ('PROBABLE_UNDERSTANDING', 115), ('FUTURE_WORK', 126), ('SUPERFICIAL_RELATIONSHIP', 158)]	9	[('CHEBI_27300', 'vitamin D', 81, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin K')]
PMC4600246	10/2015	S14-PMC4600246	['the benefit of Vitamin K on bone IS THOUGHT TO be UNRELATED to increasing bmd BUT RATHER increasing bone strength.19a RECENT meta-analysis HAS SHOWN that vitamin K2(45\u2005mg/day) significantly reduces Hip (77% reduction), vertebral (60% reduction) and all non-vertebral fractures (81% reduction).20whether the results of vitamin K2At a dose of 45\u2005mg CAN be translated to over the counter doses of Vitamin K1(such as 1–5\u2005mg) is STILL a matter of DEBATE, BUT Vitamin K1On its own HAS already BEEN SHOWN to reduce fractures and cancer in a clinical TRIAL, ALTHOUGH more DATA ARE NEEDED TO CONFIRM these benefits.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 347), ('IMPORTANT_CONSIDERATION', 424), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 442), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 450), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 543), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 550), ('FUTURE_WORK', 564), ('INCOMPLETE_EVIDENCE', 583)]	16	[('CHEBI_27300', 'vitamin D', 15, 'vitamin K'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 162, 'K2'), ('UBERON_0001464', 'hip', 198, 'hip'), ('CHEBI_34810', 'Lactitol dihydrate', 326, 'K2at'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 326, 'K2at'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 394, 'vitamin K1'), ('CHEBI_33227', '(E)-cinnamyl alcohol', 454, 'vitamin K1on'), ('PR_000009495', 'keratin, type II cytoskeletal 8', 462, 'K1on')]
PMC4600246	10/2015	S15-PMC4600246	['Vitamin K and vascular calcifications\nCoronary Artery calcium (cac) HAS BEEN SHOWN to have increasing prevalence as Kidney function declines.3indeed, cac prevalence HAS BEEN reported in 13% of ‘healthy’ patients without Renal disease,2140% of patients with chronic Kidney disease patients not on dialysis,2157% of patients starting dialysis22and 83% of patients on long-term dialysis.23diets lacking Vitamin K can PRECIPITATE the development of Vitamin K deficiency in as little as 7\u2005days.24additionally, subclinical Vitamin K deficiency is not UNCOMMON, especially in patients receiving warfarin.25cross-sectional and cohort data HAVE SHOWN a lower risk of Coronary Heart disease (chd), chd mortality, all-cause mortality and SEVERE Aortic calcifications with higher Vitamin K2(Menaquinone) intake526(box 1).']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 165), ('SUPERFICIAL_RELATIONSHIP', 414), ('INCOMPLETE_EVIDENCE', 545), ('INCOMPLETE_EVIDENCE', 631), ('IMPORTANT_CONSIDERATION', 727)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('UBERON_0001621', 'coronary artery', 38, 'Coronary artery'), ('UBERON_0002113', 'kidney', 116, 'kidney'), ('UBERON_0002113', 'kidney', 220, 'renal'), ('UBERON_0002113', 'kidney', 265, 'kidney'), ('CHEBI_27300', 'vitamin D', 400, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 517, 'vitamin K'), ('UBERON_0004151', 'cardiac chamber', 658, 'coronary heart'), ('UBERON_0000947', 'aorta', 734, 'aortic'), ('CHEBI_28934', 'vitamin D2', 768, 'vitamin K2'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 776, 'K2'), ('CHEBI_18154', 'polysaccharide', 779, 'menaquinone')]
PMC4600246	10/2015	S16-PMC4600246	['this was NOT SHOWN with vitamin k1intake (Phylloquinone, the major dietary source of Vitamin K.2627thus, dietary vitamin k1intake, without Vitamin K2, MAY not be sufficient to suppress Arterial calcifications and/or reduce RISK for subsequent Cardiovascular events and death.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 151), ('IMPORTANT_CONSIDERATION', 223)]	3	[('CHEBI_26124', 'phytosteroid', 42, 'phylloquinone'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin K'), ('CHEBI_28934', 'vitamin D2', 139, 'vitamin K2'), ('UBERON_0001637', 'artery', 185, 'arterial'), ('UBERON_0004535', 'cardiovascular system', 243, 'cardiovascular')]
PMC4600246	10/2015	S17-PMC4600246	['the Menaquinone form of Vitamin K (ie, Vitamin K2) HAS BEEN PRESUMED to be more effective than Vitamin K1At preventing and reversing Arterial calcifications.']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 60)]	3	[('CHEBI_18154', 'polysaccharide', 4, 'menaquinone'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin K'), ('CHEBI_28934', 'vitamin D2', 39, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 39, 'vitamin K2'), ('CHEBI_83630', 'essential oil', 95, 'vitamin K1at'), ('PR_000009486', 'keratin, type II cytoskeletal 71', 103, 'K1at'), ('UBERON_0001637', 'artery', 133, 'arterial')]
PMC4600246	10/2015	S18-PMC4600246	['it HAS BEEN PROPOSED that a substantial amount of APPARENTLY healthy patients are subclinically Vitamin K deficient BASED ON undercarboxylated Osteocalcin and Mgp,25presumably increasing the risk of vascular calcifications, cancer and osteoporosis.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 50), ('PROBABLE_UNDERSTANDING', 116)]	4	[('CHEBI_27300', 'vitamin D', 96, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 143, 'osteocalcin'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 159, 'MGP')]
PMC4600246	10/2015	S19-PMC4600246	['caption (boxed-text): box 1\nthe health benefits of Vitamin K (box 1)\nbone health\nMAY help to prevent fractures due to osteopenia and osteoporosis18–20\ntrial evidence\nVitamin K1(5\u2005mg daily) given to 440 Postmenopausal women with osteopenia for 2\u2005years in a randomised, placebo-controlled, double-blind trial caused a greater than 50% reduction in clinical fractures (9 vs 20, p=0.04) versus Placebo.']	[('INCOMPLETE_EVIDENCE', 81)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin K'), ('CHEBI_28384', 'vitamin K', 166, 'Vitamin K1'), ('PR_000017269', 'ventral anterior homeobox 2', 166, 'Vitamin K1'), ('GO_0007595', 'lactation', 202, 'postmenopausal'), ('CHEBI_26130', 'biological pigment', 390, 'placebo')]
PMC4600246	10/2015	S23-PMC4600246	['this WAS NOT FOUND with Vitamin D alone.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC4600246	10/2015	S24-PMC4600246	['Coronary Heart disease (chd)\nMAY reduce the RISK of chd, chd mortality and all-cause mortality52676\nInsulin sensitivity\nMAY help improve Insulin sensitivity40\nwarfarin international normalised ratio (inr)\nMAY help to stabilise inr in patients on warfarin41\nlow Vitamin K status (indicated by undercarboxylated mgp) is ASSOCIATED with increased vascular calcifications, and these levels CAN be improved by effective Vitamin K supplementation28–32it was long BELIEVED that Vitamin K was ONLY INVOLVED in forming Coagulation factors (ie, maintaining Haemostasis).']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 44), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 318), ('INCOMPLETE_EVIDENCE', 386), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 485), ('SUPERFICIAL_RELATIONSHIP', 490)]	9	[('UBERON_0002949', 'tectospinal tract', 0, 'Coronary heart'), ('PR_000045358', 'insulin family protein', 100, 'Insulin'), ('PR_000045358', 'insulin family protein', 137, 'insulin'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 415, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin K'), ('GO_0050817', 'coagulation', 510, 'coagulation'), ('GO_0007599', 'hemostasis', 547, 'haemostasis')]
PMC4600246	10/2015	S27-PMC4600246	['low levels of Vitamin K impair activation of Osteocalcin and decrease the activity of Osteoblasts (cells IMPORTANT for building bone).3334thus, Vitamin K is VITAL to the functionality of proteins such as Osteocalcin (IMPORTANT for building bone), (mgp, the most potent Arterial Calcification Inhibitor known) and the growth-arrest sequence-6 protein (Gas6, INVOLVED in Cell Growth Regulation35\nVitamin K HAS BEEN SHOWN to significantly delay the development of cac in a 3-year, double-blind, randomised controlled trial of 452 patients (229 patients on Vitamin K1And 223 patients in the control group).36all patients were assigned to a multivitamin (containing 1.6\u2005mg Thiamine, 1.8\u2005mg riboflavin, 2.1\u2005mg Vitamin B-6, 3\u2005µg Vitamin B12, 75\u2005mg Vitamin C, 12\u2005mg Vitamin E, 6\u2005mg Pantothenic Acid, 20\u2005mg niacin, 160\u2005µg Folate and 30\u2005µg of Biotin) as well as calcium (600\u2005mg Calcium Carbonate) and Vitamin D (Cholecalciferol 400\u2005iu).']	[('IMPORTANT_CONSIDERATION', 105), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 217), ('SUPERFICIAL_RELATIONSHIP', 357), ('INCOMPLETE_EVIDENCE', 404)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 45, 'osteocalcin'), ('CL_0000062', 'osteoblast', 86, 'osteoblasts'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 204, 'osteocalcin'), ('UBERON_0001637', 'artery', 269, 'arterial'), ('GO_0051301', 'cell division', 278, 'calcification'), ('CHEBI_35222', 'inhibitor', 292, 'inhibitor'), ('PR_000008000', 'gap junction beta-4 protein', 351, 'Gas6'), ('GO_0071475', 'cellular hyperosmotic salinity response', 369, 'cell growth regulation35'), ('CHEBI_28384', 'vitamin K', 394, 'Vitamin K'), ('CHEBI_10124', 'zolmitriptan', 553, 'vitamin K1and'), ('PR_000017209', 'utrophin', 553, 'vitamin K1and'), ('CHEBI_26948', 'vitamin B1', 668, 'thiamine'), ('CHEBI_27300', 'vitamin D', 704, 'vitamin B'), ('CHEBI_33279', 'vitamin D5', 722, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 741, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 758, 'vitamin E'), ('CHEBI_7916', 'pantothenic acid', 774, 'pantothenic acid'), ('CHEBI_30863', '5-azaorotic acid', 813, 'folate'), ('CHEBI_15956', 'biotin', 833, 'biotin'), ('CHEBI_3311', 'calcium carbonate', 868, 'calcium carbonate'), ('CHEBI_27300', 'vitamin D', 891, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 902, 'cholecalciferol')]
PMC4600246	10/2015	S31-PMC4600246	['DESPITE the fact that Serum mgp increased in the vitamin k1group, WHEREAS mgp was decreased in the control group (treatment effect: p<0.03 in itt and secondary analyses), neither baseline nor change in mgp predicted the change in cac, SUGGESTING that the benefit of Vitamin K on cac progression is not related to increases in Serum mgp.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 235)]	4	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin K'), ('UBERON_0001977', 'blood serum', 326, 'serum')]
PMC4600246	10/2015	S35-PMC4600246	["THUS, the EFFECT of Vitamin K on cac MIGHT be independent of changes in Serum cytokine levels (BUT NOT NECESSARILY RULING out Vitamin K's benefit on the blunting of the EFFECTS of these cytokines)."]	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('SUPERFICIAL_RELATIONSHIP', 169)]	7	[('CHEBI_27300', 'vitamin D', 20, 'vitamin K'), ('UBERON_0001977', 'blood serum', 72, 'serum'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin K')]
PMC4600246	10/2015	S37-PMC4600246	['Vitamin K administration HAS BEEN SHOWN to significantly delay the progression of cac and, in addition, it HAS also BEEN shown to significantly delay the deterioration of Arterial elasticity.37in another 3-year, double-blind, placebo-controlled trial, Vitamin D and Vitamin K were INVESTIGATED.']	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 107), ('QUESTION_ANSWERED_BY_THIS_WORK', 281)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('UBERON_0001637', 'artery', 171, 'arterial'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin K')]
PMC4600246	10/2015	S41-PMC4600246	['IN SUMMARY, Vitamin K1Along with Vitamin D has beneficial EFFECTS on Arterial elasticity.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_33229', 'vitamin (role)', 12, 'vitamin'), ('PR_000009209', 'juxtaposed with another zinc finger protein 1', 20, 'K1along'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001637', 'artery', 69, 'arterial')]
PMC4600246	10/2015	S42-PMC4600246	['Vitamin K and warfarin\nsince warfarin directly leads to the inhibition of Vitamin K, it would be PRESUMED that there COULD BE increased Arterial calcifications in patients given warfarin.']	[('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 117)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin K'), ('UBERON_0001637', 'artery', 136, 'arterial')]
PMC4600246	10/2015	S44-PMC4600246	['furthermore, most Individuals taking warfarin are counselled to avoid Vitamin K-containing foods, such as green leafy vegetables, which MAY lead to an EVEN further increase in cac.36vitamin k deficiency CAN be exacerbated further when Warfarin is initiated.38the negative IMPACT that warfarin CAN have on the body HAS LONG BEEN RECOGNISED.39\nwarfarin HAS BEEN SHOWN to cause SEVERE Arterial calcifications in the Aorta and the Carotid Arteries of Rats.']	[('INCOMPLETE_EVIDENCE', 136), ('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 272), ('INCOMPLETE_EVIDENCE', 293), ('INCOMPLETE_EVIDENCE', 314), ('PROBABLE_UNDERSTANDING', 318), ('PROBABLE_UNDERSTANDING', 328), ('INCOMPLETE_EVIDENCE', 351), ('IMPORTANT_CONSIDERATION', 375)]	10	[('NCBITaxon_1', 'root', 18, 'individuals'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin K'), ('CHEBI_10033', 'warfarin', 235, 'warfarin'), ('UBERON_0001637', 'artery', 382, 'arterial'), ('UBERON_0000947', 'aorta', 413, 'aorta'), ('UBERON_0005396', 'carotid artery segment', 427, 'carotid arteries'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 447, 'rats')]
PMC4600246	10/2015	S46-PMC4600246	['moreover, high-dose Vitamin K1Or Vitamin K2Restored Arterial distensibility back to that SEEN in control Rats.38thus, Animal data INDICATE that Vitamin K (k1or k2) MAY BE able to reverse Arterial calcifications and at the same time improve Arterial compliance.']	[('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 164)]	3	[('CHEBI_31633', 'formoterol fumarate', 20, 'vitamin K1or'), ('CHEBI_51197', 'calixaromatic', 33, 'vitamin K2restored'), ('UBERON_0001637', 'artery', 52, 'arterial'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 105, 'rats'), ('NCBITaxon_33208', 'Metazoa', 118, 'animal'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin K'), ('UBERON_0001637', 'artery', 187, 'arterial'), ('UBERON_0001637', 'artery', 240, 'arterial')]
PMC4600246	10/2015	S50-PMC4600246	['it HAS BEEN PRESUMED that Prenatal Vitamin K deficiency induced by warfarin MAY BE the UNDERLYING cause of these calcifications.4344indeed, SEVERAL STUDIES INDICATE a CONNECTION between warfarin and Arterial calcifications.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 167)]	8	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin K'), ('UBERON_0001637', 'artery', 199, 'arterial')]
PMC4600246	10/2015	S65-PMC4600246	['this HAS BEEN SHOWN in one retrospective and two prospective studies.41\n\nVitamin K and Insulin sensitivity\nin a 3-year randomised, double-blind, controlled trial of 355 patients, Vitamin K significantly improved Insulin sensitivity in men with diabetes.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_28384', 'vitamin K', 73, 'Vitamin K'), ('PR_000045358', 'insulin family protein', 87, 'insulin'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin K'), ('PR_000045358', 'insulin family protein', 212, 'insulin')]
PMC4600246	10/2015	S68-PMC4600246	['IN SUMMARY, Vitamin K MAY improve Insulin sensitivity in men with diabetes.40\n\nVitamin K and cancer\nVitamin K2Has BEEN SHOWN to inhibit the growth of Human cancer cell lines, including Hepatoma lines, as well as to treat myelodysplastic syndrome.50–53two trials SEEM to INDICATE that Vitamin K245\u2005mg/day reduces the Development Of Hepatocellular Carcinoma (Hcc) in patients with Liver cirrhosis and that Vitamin K2Significantly reduces the recurrence of hcc in patients following the curative treatment of hcc with an ASSOCIATED reduction in all-cause mortality in these patients.54–61the POSSIBLE reduction in mortality with Vitamin K2May be EXPLAINED by multiple mechanisms.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 262), ('INCOMPLETE_EVIDENCE', 270), ('SUPERFICIAL_RELATIONSHIP', 518), ('INCOMPLETE_EVIDENCE', 589), ('PROBABLE_UNDERSTANDING', 643)]	8	[('CHEBI_27300', 'vitamin D', 12, 'vitamin K'), ('PR_000045358', 'insulin family protein', 34, 'insulin'), ('CHEBI_28384', 'vitamin K', 79, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 100, 'Vitamin'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 108, 'K2has'), ('NCBITaxon_9606', 'Homo sapiens', 150, 'human'), ('UBERON_0004705', 'fenestra', 185, 'hepatoma'), ('CHEBI_86324', 'quinolone antibiotic', 284, 'vitamin K245'), ('GO_0002234', 'detection of endoplasmic reticulum overloading', 316, 'development of hepatocellular carcinoma'), ('UBERON_0012474', 'hepatic cecum', 331, 'hepatocellular'), ('GO_0000724', 'double-strand break repair via homologous recombination', 357, 'HCC'), ('UBERON_0002107', 'liver', 379, 'liver'), ('CHEBI_64387', 'thiosultap(1-)', 404, 'vitamin K2significantly'), ('CHEBI_27325', 'xanthophyll', 626, 'vitamin K2may'), ('PR_000017209', 'utrophin', 626, 'vitamin K2may')]
PMC4600246	10/2015	S74-PMC4600246	['combining Vitamin K2With an Ace Inhibitor (Perindopril) HAS SHOWN synergistic EFFECTS on hcc recurrence and survival, and THUS this combination SHOULD also BE FURTHER explored.60moreover, ADDITIONAL STUDIES SHOULD BE explored combining Vitamin K2With Acyclic Retinoids, AS this combination HAS also SHOWN positive results on Human Hcc cell lines.69the health benefits of Vitamin K have been summarised inbox 1.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 78), ('PROBABLE_UNDERSTANDING', 122), ('FUTURE_WORK', 144), ('ANOMALY_CURIOUS_FINDING', 156), ('FUTURE_WORK', 159), ('FUTURE_WORK', 188), ('FUTURE_WORK', 207), ('PROBABLE_UNDERSTANDING', 270), ('INCOMPLETE_EVIDENCE', 290)]	10	[('CHEBI_77570', 'tropisetron hydrochloride', 10, 'vitamin K2with'), ('CHEBI_78720', 'tetramethylrhodamine ethyl ester perchlorate', 28, 'ACE inhibitor'), ('CHEBI_8024', 'perindopril', 43, 'perindopril'), ('CHEBI_77570', 'tropisetron hydrochloride', 236, 'vitamin K2with'), ('CHEBI_33333', 'alkylidene group', 251, 'acyclic retinoids'), ('NCBITaxon_9606', 'Homo sapiens', 325, 'human'), ('CL_0000745', 'retina horizontal cell', 331, 'HCC'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin K')]
PMC4600246	10/2015	S75-PMC4600246	['Vitamin K and haemodialysis\npilkey et al 70DEMONSTRATED that 29% of patients with haemodialysis have coexisting subclinical Vitamin K deficiency.']	[('INCOMPLETE_EVIDENCE', 41)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin K'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin K')]
PMC4600246	10/2015	S76-PMC4600246	['later, cranenburg et al ,71while evaluating Vitamin K status and Intake in such patients, REPORTED subnormal levels in 45% of study participants.']	[('INCOMPLETE_EVIDENCE', 90)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin K'), ('GO_0007631', 'feeding behavior', 65, 'intake')]
PMC4600246	10/2015	S77-PMC4600246	['finally, in the RECENT vitamin k italian (viki) dialysis STUDY, 23.5% of patients were FOUND to be Vitamin K deficient, and this deficiency was FOUND TO BE the strongest PREDICTOR of vertebral fractures (or: 2.94; 95% ci 1.38 to 6.26).72other data HAVE SHOWN that vitamin K2May improve Bone Remodelling in patients with haemodialysis with low Serum Parathyroid hormone levels.73supplementing with at LEAST 200\u2005µg Menaquinone-7 (a form of Vitamin K2) daily MAY help to achieve near maximal protection from vascular calcification, osteoporosis and cancer (measured by maximal gamma carboxylation of Vitamin K dependent proteins).35\n\nconclusion\nVitamin K has a plethora of POTENTIAL IMPLICATIONS, including prevention and treatment of Arterial calcifications, Coronary Heart disease and cancer, improvements in bone strength and reduced risks of fractures as well as improvements in Insulin sensitivity.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 144), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 248), ('PROBABLE_UNDERSTANDING', 400), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 670), ('IMPORTANT_CONSIDERATION', 680)]	10	[('CHEBI_27300', 'vitamin D', 99, 'vitamin K'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 272, 'K2may'), ('GO_0046849', 'bone remodeling', 286, 'bone remodelling'), ('UBERON_0001977', 'blood serum', 343, 'serum'), ('UBERON_0001132', 'parathyroid gland', 349, 'parathyroid'), ('CHEBI_18154', 'polysaccharide', 413, 'menaquinone'), ('CHEBI_28934', 'vitamin D2', 438, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 438, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 597, 'vitamin K'), ('CHEBI_28384', 'vitamin K', 642, 'Vitamin K'), ('UBERON_0001637', 'artery', 732, 'arterial'), ('UBERON_0004151', 'cardiac chamber', 757, 'coronary heart'), ('PR_000045358', 'insulin family protein', 880, 'insulin')]
PMC4600246	10/2015	S78-PMC4600246	['additionally, Vitamin K MAY EVEN play a VITAL ROLE in the stabilisation of inr control for patients on warfarin.']	[('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 40), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K')]
PMC4600246	10/2015	S79-PMC4600246	['on THE BASIS of PREVIOUSLY PRESENTED data, Warfarin MAY increase Arterial calcifications and osteoporosis through the inhibition of Vitamin K. LARGER TRIALS SHOULD BE performed to FURTHER ELUCIDATE the negative long-term health CONSEQUENCES of warfarin and IF these CAN PERHAPS be PREVENTED through the institution of supplemental Vitamin K.\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 52), ('FUTURE_WORK', 143), ('FUTURE_WORK', 157), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 188), ('PROBLEM_COMPLICATION', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257), ('INCOMPLETE_EVIDENCE', 266), ('INCOMPLETE_EVIDENCE', 270), ('SUPERFICIAL_RELATIONSHIP', 281)]	12	[('CHEBI_10033', 'warfarin', 43, 'warfarin'), ('UBERON_0001637', 'artery', 65, 'arterial'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin K')]
PMC4624803	10/2015	S3-PMC4624803	['results\nno differences in Cord Blood Vitamin D concentration were FOUND between children with attention deficit/hyperactivity disorder (median 13.0 ng/ml) and controls (median 13.5 ng/ml) (p = 0.43).']	[('INCOMPLETE_EVIDENCE', 66)]	1	[('UBERON_0002240', 'spinal cord', 26, 'cord'), ('UBERON_0000178', 'blood', 31, 'blood'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4624803	10/2015	S4-PMC4624803	['in a logistic regression analysis, attention deficit/hyperactivity disorder SHOWED a significant ASSOCIATION with maternal age (odds ratio: 0.96, 95% confidence interval: 0.92–0.99) but not with Vitamin D levels (odds ratio: 0.99, 95% confidence interval: 0.97–1.02).']	[('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 97)]	2	[('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC4624803	10/2015	S5-PMC4624803	['conclusion\nwe FOUND no difference in Intrauterine Vitamin D levels between children later developing attention deficit/hyperactivity disorder and matched control children.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('UBERON_0022293', 'reproductive gland secretion', 37, 'intrauterine'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4624803	10/2015	S9-PMC4624803	['several HYPOTHESES concerning the IMPORTANCE of Vitamin D for Brain Development, ESPECIALLY Prenatally and during the early Neonatal Period, HAVE BEEN formulated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('IMPORTANT_CONSIDERATION', 34), ('IMPORTANT_CONSIDERATION', 81), ('INCOMPLETE_EVIDENCE', 141)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007420', 'brain development', 62, 'brain development'), ('UBERON_0000955', 'brain', 62, 'brain'), ('GO_0019230', 'proprioception', 92, 'prenatally'), ('UBERON_0007221', 'neonate stage', 124, 'neonatal period')]
PMC4624803	10/2015	S11-PMC4624803	['it HAS BEEN PROPOSED that Vitamin D deficiency COULD BE a risk FACTOR for developing attention deficit/hyperactivity disorder (adhd) [5,6].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC4624803	10/2015	S13-PMC4624803	['results from two RECENT STUDIES on the ASSOCIATION between Vitamin D status and adhd diagnosis SHOWED an ASSOCIATION between low levels of D vitamin and an adhd diagnosis [5,6].']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 105)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 139, 'D')]
PMC4624803	10/2015	S18-PMC4624803	['the levels of Vitamin D at Birth SHOULD BE a good ESTIMATE of the child’s Vitamin D levels, AT LEAST in the later part of the Gestation.']	[('FUTURE_WORK', 33), ('INCOMPLETE_EVIDENCE', 50), ('PROBABLE_UNDERSTANDING', 92)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007567', 'parturition', 27, 'birth'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestation')]
PMC4624803	10/2015	S19-PMC4624803	['AIM\nthe AIM of the STUDY was TO TEST the HYPOTHESIS that low levels of Vitamin D in the child during Pregnancy are a risk FACTOR for adhd in the offspring.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 122)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC4624803	10/2015	S54-PMC4624803	['the kruskal-wallis/wilcoxon test was used to compare Vitamin D levels stratified for POSSIBLE confounders.']	[('INCOMPLETE_EVIDENCE', 85)]	1	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4624803	10/2015	S56-PMC4624803	['a POSSIBLE linear relationship between Vitamin D levels and the risk of adhd was INVESTIGATED using logistic regression analysis.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 81)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4624803	10/2015	S58-PMC4624803	['a spline analysis was performed which did not detect any POSSIBLE threshold for the Vitamin D–adhd analyses.']	[('INCOMPLETE_EVIDENCE', 57)]	1	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC4624803	10/2015	S59-PMC4624803	['the 10thand 25thpercentiles of Vitamin D levels among controls were arbitrarily chosen to define POSSIBLE thresholds.']	[('INCOMPLETE_EVIDENCE', 97)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC4624803	10/2015	S61-PMC4624803	['the POSSIBLE ASSOCIATIONS between Vitamin D levels below the thresholds and adhd were tested using conditional logistic regression.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC4624803	10/2015	S70-PMC4624803	['a logistic regression analysis REVEALED no linear association between Vitamin D levels and adhd.']	[('INCOMPLETE_EVIDENCE', 31)]	1	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4624803	10/2015	S78-PMC4624803	['maternal age (or: 0.95; 95% ci: 0.91–0.99) and season of Birth july to september (or: 2.30; 95% ci: 1.27–4.16) SHOWED a significant ASSOCIATION with adhd (or: 0.96; 95% ci: 0.92–0.99), but not smoking (or: 1.17; 95% ci: 0.89–1.53), season of Birth january to march (or: 1.45; 95% ci: 0.79–2.65) or Vitamin D levels (or: 0.98; 95% ci: 0.95–1.01).10.1371/journal.pone.0140164.g001\n\ncaption (fig): fig 1\nVitamin D concentrations in Individuals with adhd and controls.']	[('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 132)]	2	[('GO_0007567', 'parturition', 57, 'birth'), ('GO_0007567', 'parturition', 242, 'birth'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 401, 'Vitamin D'), ('NCBITaxon_1', 'root', 429, 'individuals')]
PMC4624803	10/2015	S85-PMC4624803	['adjustment was made for the covariates age of mother, smoking of mother, season of Birth january to march and season of Birth july to september.all childrenchildren with mothers Born in swedenestimate95% confidence limitsp-valueestimate95% confidence limitsp-valuemodel 1-0.77-2.32, 0.770.32-1.11-2.76, 0.530.18model 2-0.77-2.25, 0.700.30-1.08-2.77, 0.620.21model 3-1.00-2.40, 0.390.16-1.00-2.47, 0.460.18model 4-0.99-2.34, 0.360.15-1.11-2.66, 0.440.16\n\ndiscussion\nOUR STUDY FAILS to SUPPORT the HYPOTHESIS that low levels of Vitamin D during Pregnancy are a risk FACTOR for adhd in the offspring.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 465), ('PROBLEM_COMPLICATION', 475), ('INCOMPLETE_EVIDENCE', 484), ('INCOMPLETE_EVIDENCE', 496), ('SUPERFICIAL_RELATIONSHIP', 564)]	5	[('GO_0007567', 'parturition', 83, 'birth'), ('GO_0007567', 'parturition', 120, 'birth'), ('GO_0007567', 'parturition', 178, 'born'), ('CHEBI_27300', 'vitamin D', 526, 'vitamin D'), ('GO_0007565', 'female pregnancy', 543, 'pregnancy')]
PMC4624803	10/2015	S90-PMC4624803	['that study also SHOWED that children with adhd had lower levels of Vitamin D in Serum [6].']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0001977', 'blood serum', 80, 'serum')]
PMC4624803	10/2015	S92-PMC4624803	['[16] who, in a large english study, FOUND no association between low levels of Vitamin D and behavioural PROBLEMS, including inattention and hyperactivity.']	[('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 105)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC4624803	10/2015	S94-PMC4624803	['[17] reviewed the Animal research literature and CONCLUDED that there are INDICATIONS of behavioural EFFECTS of Vitamin D inadequacy, BUT that the EVIDENCE is WEAK.']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('INCOMPLETE_EVIDENCE', 147), ('INCOMPLETE_EVIDENCE', 159)]	6	[('NCBITaxon_33208', 'Metazoa', 18, 'animal'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4624803	10/2015	S95-PMC4624803	['Human studies have INDICATED that Vitamin D deficiency is ASSOCIATED with an INCREASED RISK of developing many diseases and disorders, like parkinson’s disease, epilepsy, depression, multiple sclerosis, schizophrenia, autism, and Autoimmune diseases like rheumatoid arthritis and type i diabetes mellitus [18–20].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 58), ('IMPORTANT_CONSIDERATION', 77)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 230, 'autoimmune')]
PMC4624803	10/2015	S96-PMC4624803	['from a THEORETICAL POINT OF VIEW, in foetal Life and during early childhood, the immature Brain SHOULD BE more vulnerable to environmental INFLUENCES like Vitamin D deficiency [3,4].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 139)]	4	[('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0000955', 'brain', 90, 'brain'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4624803	10/2015	S99-PMC4624803	['[11] SHOWED that the mother’s Vitamin D status during Pregnancy had no association with behavioural problems in the offspring, including symptoms of adhd, several years later.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy')]
PMC4624803	10/2015	S103-PMC4624803	['THIS MEANS THAT our study, like the studies by strøm et al., gale et al., and whitehouse et al [10–12] BUT UNLIKE the RECENTLY published studies in quatar and turkey [5,6], has a prospective design where Vitamin D levels are measured at a time before the child receives a diagnosis.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('INCOMPLETE_EVIDENCE', 118)]	4	[('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC4624803	10/2015	S107-PMC4624803	['such lifestyle FACTORS COULD lead to lower levels of Vitamin D.\n\nlimitations\nTHIS is a medium- sized STUDY and a WEAK ASSOCIATION with the risk of developing adhd with Vitamin D deficiency COULD NOT BE EXCLUDED.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4624803	10/2015	S111-PMC4624803	['this MAY NOT reflect Vitamin D levels over time.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC4624803	10/2015	S115-PMC4624803	['conclusion\nwe FOUND NO SUPPORT for the HYPOTHESIS that low levels of Vitamin D during Pregnancy are a risk factor for adhd in the offspring.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('INCOMPLETE_EVIDENCE', 39)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy')]
PMC4624803	10/2015	S116-PMC4624803	['AS a CONSEQUENCE of the LIMITED statistical power, we cannot exclude that the MAY BE a small to medium sized ASSOCIATION between Vitamin D levels at Birth and a later diagnosis of adhd.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 5), ('PROBLEM_COMPLICATION', 5), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 109)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007567', 'parturition', 149, 'birth')]
PMC4627942	10/2015	S61-PMC4627942	['a study in west kiang hdss, gambia, SHOWED that nutritional rickets, a disease caused largely by Vitamin D deficiency, the EFFECTS of which CAN include Cardiac failure and hypoglycaemic seizures, was more PREVALENT in infants whose mothers had poor Vitamin D status during Pregnancy (21).']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 123), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 205)]	4	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('UBERON_0000948', 'heart', 152, 'cardiac'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
PMC4627942	10/2015	S93-PMC4627942	['(31) FOUND that providing Pregnant women who are hiv-positive with Vitamin A supplementation MAY improve the Gut function of their hiv-infected infants.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 93)]	2	[('GO_0007565', 'female pregnancy', 26, 'pregnant'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin A'), ('UBERON_0001555', 'digestive tract', 109, 'gut')]
PMC4627942	10/2015	S94-PMC4627942	['they also FOUND that Vitamin A supplementation for hiv-infected infants MAY decrease Gastrointestinal morbidity.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 72)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 85, 'gastrointestinal')]
PMC4627942	10/2015	S103-PMC4627942	['caption (table-wrap): table 2\n\nbiological causes of malnutrition: findings from indepth studieshdss siteyearauthorsmain findingsagincourt hdss, south africa2011kimani-murage et al.children infected with hiv had significantly worse nutritional outcomes than their uninfected peers.west kiang hdss, gambia2008nwenekahiv-positive children had significantly worse scores in terms of weight-for-age, height-for-age, and bmi than hiv-negative children.africa centre, south africa2007papathakis et al.breastfeeding mothers in south africa who were hiv-positive had poorer protein and Micronutrient status than hiv-negative women.africa centre, south africa2001filteau et al.providing Pregnant women who are hiv-positive with Vitamin A supplementation MAY improve Gut function of their hiv-infected infants.']	[('INCOMPLETE_EVIDENCE', 744)]	1	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 577, 'micronutrient'), ('GO_0007565', 'female pregnancy', 677, 'pregnant'), ('CHEBI_27300', 'vitamin D', 718, 'vitamin A'), ('UBERON_0001555', 'digestive tract', 756, 'gut')]
PMC4627942	10/2015	S179-PMC4627942	["studies by the bandim hdss in guinea-bissau of malnutrition campaigns during that country's 1998 civil war FOUND that Vitamin A supplementation for children (64) and a supplementary Feeding programme for children (65) helped to reduce mortality during the conflict."]	[('INCOMPLETE_EVIDENCE', 107)]	1	[('CHEBI_27300', 'vitamin D', 118, 'vitamin A'), ('GO_0007631', 'feeding behavior', 182, 'feeding')]
PMC4627942	10/2015	S180-PMC4627942	['compared with the 3-year period before the war, the authors REPORTED that children offered Vitamin A at home during the war had a 12% reduction in mortality, WHEREAS the overall IMPACT of the war was an 89% increase in mortality.']	[('INCOMPLETE_EVIDENCE', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 178)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin A')]
PMC4627942	10/2015	S184-PMC4627942	['the effectiveness of Vitamin A supplementation HAS also BEEN QUESTIONED.']	[('INCOMPLETE_EVIDENCE', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A')]
PMC4627942	10/2015	S185-PMC4627942	['ALTHOUGH it APPEARED TO BE beneficial in the above-mentioned trial in guinea-bissau, researchers at kintampo hdss in ghana FOUND no positive effect of Vitamin A supplements in combination with vaccines during the first few months of Life (68).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 123)]	3	[('CHEBI_27300', 'vitamin D', 151, 'vitamin A'), ('UBERON_0000104', 'life cycle', 233, 'life')]
PMC4632418	10/2015	S3-PMC4632418	['the meta-analysis of 20 studies including 9209 participants SHOWED that women with Vitamin D deficiency experienced a significantly INCREASED RISK for developing gdm (odds ratio (or) = 1.53; 95% confidence intervals (ci), 1.33, 1.75) with a little heterogeneity ( i2= 16.20%, p = 0.252).']	[('INCOMPLETE_EVIDENCE', 60), ('IMPORTANT_CONSIDERATION', 132)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC4632418	10/2015	S7-PMC4632418	['IN SUMMARY, the EVIDENCE from this meta-analysis INDICATES a CONSISTENT ASSOCIATION between Vitamin D deficiency and an INCREASED RISK of gdm.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 120)]	6	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4632418	10/2015	S15-PMC4632418	['the NON-CLASSICAL functions of Vitamin D are GAINING ATTENTION for its closer ASSOCIATIONS between Vitamin D deficiency and t2dm, Heart disease, Autoimmune diseases and certain types of cancers [4,5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0000948', 'heart', 130, 'heart'), ('UBERON_0001442', 'skeleton of manus', 145, 'autoimmune')]
PMC4632418	10/2015	S18-PMC4632418	['IN ACCORDANCE WITH these definitions, EVEN middle-age Adults are at equally high RISK with elder and children for Vitamin D deficiency and insufficiency worldwide [6].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 38), ('IMPORTANT_CONSIDERATION', 81)]	3	[('UBERON_0007023', 'adult organism', 54, 'adults'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4632418	10/2015	S20-PMC4632418	['it HAS BEEN REPORTED that 40%–100% of Vitamin D deficiency during Pregnancy are FOUND in sweden, oman, uk, usa, australia, pakista, urban india, japan and china [7,8,9,10,11].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 80)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy')]
PMC4632418	10/2015	S21-PMC4632418	['the scientific EVIDENCE LINKING Vitamin D deficiency with diabetes is GROWING large, but data investigating the RELATIONSHIP between Vitamin D levels and gdm are INCONSISTENT.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC4632418	10/2015	S24-PMC4632418	['CONTRADICTORILY, SOME STUDIES SUGGESTED that no significant differences in Vitamin D status were FOUND between women with gdm and normal Glucose tolerance [15,16].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 97)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_17234', 'glucose', 137, 'glucose')]
PMC4632418	10/2015	S74-PMC4632418	['main analysis\namong the 20 studies, ONLY six SHOWED a significant ASSOCIATION between Vitamin D deficiency (25(Oh)D levels below 50 nmol/l) and risk of gdm.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 108, '25(OH)D')]
PMC4632418	10/2015	S75-PMC4632418	['HOWEVER, this meta-analysis SHOWED that women with Vitamin D deficiency COMPARED TO the control group experienced a significantly INCREASED RISK for developing gdm (or = 1.53; 95% ci, 1.33, 1.75) on a fixed-effects model (figure 2).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('IMPORTANT_CONSIDERATION', 130)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC4632418	10/2015	S78-PMC4632418	['these results INDICATED that Vitamin D deficiency significantly increase the risk of gdm, and the higher degree of deficiency SHOWED higher TREND of gdm risk RELEVANCE.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 158)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC4632418	10/2015	S84-PMC4632418	['this result SHOWED Serum 25(Oh)D level was significant lower in participants with gdm than the control and also DEMONSTRATED that Vitamin D deficiency is significantly ASSOCIATED with an INCREASED RISK of gmd.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 187)]	4	[('UBERON_0001977', 'blood serum', 19, 'serum'), ('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC4632418	10/2015	S88-PMC4632418	['exclusion of two studies [15,36] in which Pregnant women were Vitamin D sufficient (with 25(Oh)D level greater than 75 nmol/l) yielded SIMILAR results (wmd = −5.04; 95% ci, −6.43 to −3.64), and LITTLE evidence of heterogeneity was OBSERVED among the remaining studies ( i2= 37.50%, p = 0.077).']	[('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 231)]	3	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D')]
PMC4632418	10/2015	S96-PMC4632418	['discussion\nthere HAS BEEN a rapidly GROWING INTEREST in the ASSOCIATION between Vitamin D and risk of Gestational diabetes mellitus.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'gestational')]
PMC4632418	10/2015	S98-PMC4632418	['SIMILARLY, our meta-analysis of 20 independent observational studies provided STRONG EVIDENCE that Vitamin D deficiency was ASSOCIATED with an INCREASED RISK of Gestational diabetes.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 78), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 124), ('IMPORTANT_CONSIDERATION', 143)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'gestational')]
PMC4632418	10/2015	S105-PMC4632418	['our sensitivity analyses SUGGESTED two studies [15,36] conducted in women with Vitamin D sufficiency PROBABLY CONTRIBUTED to the HETEROGENEITY.']	[('INCOMPLETE_EVIDENCE', 25), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 110), ('DIFFICULT_TASK', 129)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC4632418	10/2015	S107-PMC4632418	['for ONE STUDY, the majority of study participants were reported Consuming Prenatal multivitamins or taking Nutritional supplements, as well as living in a geographical location which MAY AFFECT the Vitamin D status [15].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 187)]	3	[('GO_0007631', 'feeding behavior', 64, 'consuming'), ('GO_0007565', 'female pregnancy', 74, 'prenatal'), ('CHEBI_7495', 'nefazodone hydrochloride', 107, 'nutritional'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC4632418	10/2015	S109-PMC4632418	['UNDOUBTEDLY, the 25(Oh)D level in two studies was high, WHEREAS the prevalence of Vitamin D deficiency was low.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56)]	3	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4632418	10/2015	S111-PMC4632418	['OUR FINDINGS for increased risk of Gestational diabetes with Vitamin D deficiency are biologically PLAUSIBLE.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 99)]	2	[('GO_0007565', 'female pregnancy', 35, 'gestational'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4632418	10/2015	S119-PMC4632418	['besides, EARLIER STUDIES have IDENTIFIED a NUMBER OF FACTORS that INFLUENCE Serum levels of 25(Oh)D, including obesity, fat malabsorption syndrome which is UNABLE TO absorb the fat-soluble Vitamin D, medications enhancing the Catabolism of 25(Oh)D and 1,25(Oh)2D3, and so on [5].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 66), ('DIFFICULT_TASK', 156)]	6	[('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0009056', 'catabolic process', 226, 'catabolism'), ('CHEBI_71657', 'versiconol acetate', 240, '25(OH)D'), ('CHEBI_73394', 'Ala-Ser', 254, '25(OH)2D3')]
PMC4632418	10/2015	S125-PMC4632418	['INTERESTINGLY, we just FOUND that two researches [23,34] of Pregnant women with Vitamin D sufficiency are nested case-control and case-control studies, respectively, which tests the HYPOTHESIS mentioned above BETTER.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 182), ('INCOMPLETE_EVIDENCE', 209)]	4	[('GO_0007565', 'female pregnancy', 60, 'pregnant'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4632418	10/2015	S126-PMC4632418	['thirdly, there is one more POINT that the OBSERVED ASSOCIATIONS between maternal Vitamin D status and the risk of adverse Pregnancy outcomes COULD BE AFFECTED by CONFOUNDING FACTORS, such as bmi and skin tone.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 150), ('PROBLEM_COMPLICATION', 162)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC4632418	10/2015	S129-PMC4632418	['HOWEVER, the ASSOCIATION between Vitamin D deficiency and gdm STILL REMAINS (or = 1.67; 95% ci, 1.31, 2.13; i2= 25.6%, p = 0.251) EVEN after adjusting for maternal age, bmi and ethnicity (supplementary figure s4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('ANOMALY_CURIOUS_FINDING', 62), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 68), ('ANOMALY_CURIOUS_FINDING', 130)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4632418	10/2015	S132-PMC4632418	['conclusions\nin CONCLUSION, the EVIDENCE from THIS ARTICLE INDICATES a CONSISTENT ASSOCIATION between Vitamin D deficiency and an INCREASED RISK of Gestational diabetes mellitus.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 129)]	7	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'gestational')]
PMC4632418	10/2015	S135-PMC4632418	['UNTIL then, screening women who are AT RISK of Vitamin D deficiency and supplementation with Vitamin D COULD BE CONSIDERED.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 103), ('INCOMPLETE_EVIDENCE', 103), ('FUTURE_WORK', 112)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4632423	10/2015	S72-PMC4632423	['analysis of Serum levels of Micronutrients in the random subset of 25 very severely obese compared with 25 lean women CONFIRMED the significantly lower circulating levels of iron, vitamin b12, Folate, Vitamin A, copper, zinc and selenium with TRENDS for lower Vitamin E/Cholesterol and 25(Oh)D in very severely obese in early Pregnancy (table 3).']	[('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 243), ('SUPERFICIAL_RELATIONSHIP', 243)]	3	[('UBERON_0001977', 'blood serum', 12, 'serum'), ('CHEBI_33839', 'macromolecule', 28, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 193, 'folate'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin A'), ('CHEBI_28384', 'vitamin K', 260, 'Vitamin E'), ('CHEBI_16113', 'cholesterol', 270, 'cholesterol'), ('CHEBI_71657', 'versiconol acetate', 286, '25(OH)D'), ('GO_0007565', 'female pregnancy', 326, 'pregnancy')]
PMC4632423	10/2015	S100-PMC4632423	['both Folate and Vitamin D deficiencies HAVE BEEN ASSOCIATED with INCREASED RISKS of pre-eclampsia, Preterm Delivery, low Birth weight and fetal growth restriction [26,27].']	[('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 65)]	3	[('CHEBI_30863', '5-azaorotic acid', 5, 'folate'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 99, 'preterm'), ('GO_0007567', 'parturition', 107, 'delivery'), ('GO_0007567', 'parturition', 121, 'birth')]
PMC4632423	10/2015	S107-PMC4632423	['likewise concentrations of Anti-Oxidant Micronutrient Vitamins A, E and Selenium are often lower in smokers [30], PERHAPS BECAUSE of increased utilisation, and more of the obese women in our study were current smokers.']	[('INCOMPLETE_EVIDENCE', 114), ('PROBABLE_UNDERSTANDING', 122)]	2	[('CHEBI_74351', 'aclacinomycin T', 27, 'anti-oxidant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 40, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 54, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 63, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 66, 'E'), ('CHEBI_27568', 'selenium atom', 72, 'selenium')]
PMC4825101	10/2015	S106-PMC4825101	['Vitamins A and c, zinc and protein-energy status) have SO FAR NOT yielded positive findings.']	[('INCOMPLETE_EVIDENCE', 55)]	1	[('CHEBI_27300', 'vitamin D', 0, 'vitamins A')]
PMC4832516	10/2015	S0-PMC4832516	['season of Birth is ASSOCIATED with Birth weight, Pubertal timing, Adult body size and educational attainment: a uk biobank study\n\nabstract\nseason of Birth, a marker of in utero Vitamin D exposure, HAS BEEN ASSOCIATED with a WIDE RANGE of health outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224)]	4	[('GO_0007567', 'parturition', 10, 'birth'), ('GO_0007567', 'parturition', 35, 'birth'), ('GO_0007567', 'parturition', 49, 'pubertal'), ('UBERON_0007023', 'adult organism', 66, 'adult'), ('GO_0007567', 'parturition', 149, 'birth'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC4832516	10/2015	S10-PMC4832516	['WHILST OTHER mechanisms MAY contribute to these ASSOCIATIONS, these FINDINGS are CONSISTENT with a POSSIBLE ROLE of in utero Vitamin D exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 108)]	8	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4832516	10/2015	S19-PMC4832516	['marked seasonal changes HAVE BEEN REPORTED in maternal circulating 25-Hydroxyvitamin D levels (25(Oh)D)[11], which reflect sunshine exposure and directly INFLUENCE fetal Vitamin D exposure.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 154)]	2	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 67, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 95, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC4832516	10/2015	S22-PMC4832516	['Age At Menarche is a well-recalled measure of Pubertal timing in girls and HAS BEEN LINKED to Vitamin D status in prospective[13]and Genetic[14]studies.']	[('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('GO_0007568', 'aging', 0, 'Age at'), ('GO_0042696', 'menarche', 7, 'menarche'), ('GO_0007567', 'parturition', 46, 'pubertal'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('SO_0000704', 'gene', 133, 'genetic')]
PMC4832516	10/2015	S101-PMC4832516	['EXTENSIVE EVIDENCE from randomised controlled trials[20]SUPPORT maternal 25(Oh) Vitamin D as the causal mechanism.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 56)]	2	[('CHEBI_30778', 'gallic acid', 73, '25(OH)'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4832516	10/2015	S109-PMC4832516	['furthermore, recent Genetic studies have INDICATED POTENTIAL aetiological ROLES for the Vitamin D receptor (vdr) and RELATED Nuclear hormone receptors in Pubertal timing[14].']	[('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0005634', 'nucleus', 125, 'nuclear'), ('GO_0007567', 'parturition', 154, 'pubertal')]
PMC4832516	10/2015	S132-PMC4832516	['LIMITATIONS of the study include no direct measurement of maternal/fetal Vitamin D status to fully establish a causal mechanism.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4832516	10/2015	S139-PMC4832516	['WHILE the ASSOCIATIONS between season of Birth, or ESTIMATED Antenatal sunshine exposure, with Birth weight are CONSISTENT with experimental EFFECTS of in utero Vitamin D exposure on fetal growth, differing patterns of seasonality and INDEPENDENT ASSOCIATIONS SUGGEST that OTHER mechanisms MAY LINK season of Birth to Adult height and also puberty timing in women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 235), ('SUPERFICIAL_RELATIONSHIP', 247), ('INCOMPLETE_EVIDENCE', 260), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 273), ('INCOMPLETE_EVIDENCE', 290), ('SUPERFICIAL_RELATIONSHIP', 294)]	12	[('GO_0007567', 'parturition', 41, 'birth'), ('GO_0007567', 'parturition', 61, 'antenatal'), ('GO_0007567', 'parturition', 95, 'birth'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007567', 'parturition', 309, 'birth'), ('UBERON_0007023', 'adult organism', 318, 'adult')]
PMC4605923	11/2015	S2-PMC4605923	['Food intake is a WELL-known environmental FACTOR that INFLUENCES Allergy Development and three specific Nutrients-Vitamin D, Omega 3 polyunsaturated Fatty Acids and Folate-have RECENTLY attracted ATTENTION.1\nthe methyl donor Folate is a WELL-KNOWN Nutrient supplement given during early Pregnancy to prevent neutral Tube defects in the developing fetus.']	[('PROBABLE_UNDERSTANDING', 17), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 177), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 237)]	6	[('CHEBI_33290', 'food', 0, 'Food'), ('GO_0060021', 'roof of mouth development', 65, 'allergy development'), ('CHEBI_33284', 'nutrient', 104, 'nutrients'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_82673', "2-amino-6,7-dimethyl-4-oxo-8-(1'-D-ribityl)-4,8-dihydropteridine", 125, 'omega 3'), ('CHEBI_35366', 'fatty acid', 149, 'fatty acids'), ('CHEBI_30863', '5-azaorotic acid', 165, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 225, 'folate'), ('CHEBI_33284', 'nutrient', 248, 'nutrient'), ('GO_0007565', 'female pregnancy', 287, 'pregnancy'), ('UBERON_0000025', 'tube', 316, 'tube')]
PMC4663595	11/2015	S175-PMC4663595	['our group also REPORTED that Dha supplementation with 400 mg/day during Pregnancy induced Dna Methylation changes in inflammatory Genes and Line-1 , especially in infants born to mothers who smoked during Pregnancy [99].nutrients-07-05467-t002_table 2\n\ncaption (table-wrap): table 2\n\nintervention studies for maternal nutritional status and epigenetic profile in offspring.Nutrientsmechanismoutcomesamplemethodref.Folate and Multivitamins(1)Dna Methylation↓ methylation of Igf2 2r in girls, ↓ methylation of Gtl2-2 in boyscord Blood27K illumina[93]folatedna methylation↓ methylation of Line1 Cord Bloodpyrosequencing[94]Dna Methylation↑ methylation of Igf2 dmrcord Bloodepi-typer[95]Dna Methylation↓ methylation of h19 dmr (4 cpgs)Cord Bloodpyrosequencing[96]Dna Methylation↓ methylation of peg3 and Line1 ; ↑ methylation of Igf2 Cord Bloodpyrosequencing[97]cholinedna methylationhistone modification↑ methylation of crh , Nr3C1 in Placenta; ↓ methylation of crh , Nr3C1 in Cord Blood Leukocyte; ↑ H3K9Me2Placenta, Cord Bloodlc-ms/ms[98]Dhadna Methylation↑ Line1 methylation ↑ Infγ/Il13 methylation ratiocord Bloodpyrosequencing[99]\n(1)Zinc and Vitamins A, b, c and d; Peg3, Paternally-Expressed Gene 3; Crh, Corticotropin-Releasing Hormone; Nr3C1, Nuclear receptor subfamily 3, Group C, Member 1.']	[('INCOMPLETE_EVIDENCE', 15)]	1	[('CHEBI_17874', 'dihydrozeatin', 29, 'DHA'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0006306', 'DNA methylation', 90, 'DNA methylation'), ('SO_0000704', 'gene', 130, 'genes'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 140, 'LINE-1'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy'), ('CHEBI_8329', 'Pomiferin', 373, 'NutrientsMechanismOutcomeSampleMethodRef'), ('CHEBI_81245', 'Vulpecholate', 414, 'Folate'), ('CHEBI_7036', 'Musennin', 425, 'Multivitamins'), ('GO_0006323', 'DNA packaging', 441, 'DNA methylation↓'), ('PR_000008989', 'interleukin-1 family member 7', 473, 'IGF2'), ('PR_000008305', 'glutathione S-transferase theta-1', 508, 'GTL2'), ('UBERON_0001977', 'blood serum', 527, 'blood27k'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 586, 'LINE1'), ('UBERON_0000948', 'heart', 592, 'Cord'), ('UBERON_0011919', 'yolk sac blood island', 597, 'bloodPyrosequencing'), ('GO_0006306', 'DNA methylation', 620, 'DNA methylation'), ('PR_000008989', 'interleukin-1 family member 7', 652, 'IGF2'), ('UBERON_0001970', 'bile', 665, 'bloodEpi'), ('GO_0006323', 'DNA packaging', 683, 'DNA methylation↓'), ('UBERON_0000948', 'heart', 731, 'Cord'), ('UBERON_0011919', 'yolk sac blood island', 736, 'bloodPyrosequencing'), ('GO_0006323', 'DNA packaging', 759, 'DNA methylation↓'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 800, 'LINE1'), ('PR_000008989', 'interleukin-1 family member 7', 825, 'IGF2'), ('UBERON_0000948', 'heart', 830, 'Cord'), ('UBERON_0011919', 'yolk sac blood island', 835, 'bloodPyrosequencing'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 923, 'NR3C1'), ('UBERON_0001987', 'placenta', 932, 'placenta'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 965, 'NR3C1'), ('CL_0000107', 'autonomic neuron', 974, 'cord blood'), ('UBERON_0002240', 'spinal cord', 974, 'cord'), ('UBERON_0000178', 'blood', 979, 'blood'), ('CL_0000738', 'leukocyte', 985, 'leukocyte'), ('SO_0001736', 'H3K9_methylation_site', 998, 'H3K9me2Placenta'), ('UBERON_0002240', 'spinal cord', 1015, 'cord'), ('UBERON_0000178', 'blood', 1020, 'bloodLC'), ('GO_0010424', 'DNA methylation on cytosine within a CG sequence', 1037, 'DHADNA methylation'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 1057, 'LINE1'), ('PR_000009020', "Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase", 1077, 'INFγ'), ('PR_000001470', 'interleukin-28B', 1082, 'IL13'), ('UBERON_0011919', 'yolk sac blood island', 1109, 'bloodPyrosequencing'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 1136, 'Zinc'), ('CHEBI_27300', 'vitamin D', 1145, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 1154, 'A'), ('PR_000012529', 'PDZK1-interacting protein 1', 1169, 'PEG3'), ('PR_000012270', 'pappalysin-1', 1175, 'paternally-expressed gene 3'), ('GO_0010467', 'gene expression', 1186, 'expressed'), ('SO_0000704', 'gene', 1196, 'gene'), ('PR_000005864', 'protein CREG2', 1204, 'CRH'), ('CHEBI_3918', 'crocetin', 1209, 'corticotropin'), ('PR_000005968', 'cystatin-M', 1209, 'corticotropin-releasing hormone'), ('CHEBI_33280', 'molecular messenger', 1233, 'hormone'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 1242, 'NR3C1'), ('GO_0005634', 'nucleus', 1249, 'nuclear'), ('PR_000008294', 'glutathione S-transferase A1', 1279, 'group C, member 1')]
PMC4673623	11/2015	S8-PMC4673623	['elevations in circulating maternal Folate were evident in the hf-hed group INDICATING impaired Folate Metabolism (methyl-trap) AS a CONSEQUENCE of maternal Vitamin B-12 depletion.']	[('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 127), ('PROBABLE_UNDERSTANDING', 132)]	3	[('CHEBI_30863', '5-azaorotic acid', 35, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 95, 'folate'), ('GO_0046655', 'folic acid metabolic process', 95, 'folate metabolism'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin B')]
PMC4673623	11/2015	S113-PMC4673623	['a POSSIBLE EXPLANATION for the rise in Folate is impaired Vitamin B-12 dependent methionine synthase activity, with subsequent cellular accumulation of 5-Methyl-Thf (i.e., Metabolic trapping of Folate; methyl trap) (caudill et\xa0al.2012).']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 11)]	2	[('CHEBI_30863', '5-azaorotic acid', 39, 'folate'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 58, 'vitamin B-12'), ('CHEBI_44700', 'L-ornithyl group', 152, '5-methyl'), ('CHEBI_17038', 'fecosterol', 161, 'THF'), ('GO_0008152', 'metabolic process', 172, 'metabolic'), ('CHEBI_30863', '5-azaorotic acid', 194, 'folate')]
PMC4673623	11/2015	S116-PMC4673623	['the Vitamin B-12 deficiency that led to the Metabolic trapping of Folate in the hf-hed group MAY BE RELATED to the caloric/Lipid load (mccurdy2009) and increased use of Vitamin B-12 as a lipotrope.']	[('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 100)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 4, 'vitamin B-12'), ('GO_0008152', 'metabolic process', 44, 'metabolic'), ('CHEBI_30863', '5-azaorotic acid', 66, 'folate'), ('CHEBI_18059', 'lipid', 123, 'lipid'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 169, 'vitamin B-12')]
PMC4673623	11/2015	S118-PMC4673623	['IN CONTRAST, ALTHOUGH absolute Vitamin B-12 Intake MAY HAVE been slightly lower among the hf-hed (vs. control) group, this modestly lower Intake would not be expected to cause the functional B-12 deficiency OBSERVED in the hf-hed moms.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 51), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 207)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 31, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 44, 'intake'), ('GO_0007631', 'feeding behavior', 138, 'intake'), ('PR_000004770', 'Polycomb complex protein BMI-1', 191, 'B-12')]
PMC4673623	11/2015	S131-PMC4673623	['Vitamin B-12 supplementation) MAY BE WARRANTED.']	[('FUTURE_WORK', 30), ('INCOMPLETE_EVIDENCE', 30)]	2	[('CHEBI_27300', 'vitamin D', 0, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 0, 'vitamin B-12')]
PMC4934634	11/2015	S1-PMC4934634	['RECENT RESEARCH has SUGGESTED that Vitamin D MAY exert a broad RANGE of ROLES throughout the Human Life Cycle starting from Reproduction to Adult chronic disease risk.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('SUPERFICIAL_RELATIONSHIP', 72)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 93, 'human'), ('UBERON_0000104', 'life cycle', 99, 'life cycle'), ('GO_0007049', 'cell cycle', 104, 'cycle'), ('GO_0000003', 'reproduction', 124, 'reproduction'), ('UBERON_0007023', 'adult organism', 140, 'adult')]
PMC4934634	11/2015	S4-PMC4934634	['Vitamin D is found naturally in only a few foods THUS supplementation CAN provide an accessible and effective way to raise Vitamin D status when dietary intakes and sunlight exposure are low.']	[('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 70)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4934634	11/2015	S8-PMC4934634	['introduction\nWHILE the beneficial EFFECTS of Vitamin D supplementation with respect to reducing the RISK of rickets HAS BEEN recognized for close to 100 years, there is increasing concern that rickets in young children is reemerging in numerous countries [1,2].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 34), ('IMPORTANT_CONSIDERATION', 100), ('INCOMPLETE_EVIDENCE', 116)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC4934634	11/2015	S10-PMC4934634	['over the past two decades, it HAS BEEN WELL ACCEPTED that Vitamin D is a pro-hormone, and suboptimal Vitamin D status HAS been increasingly LINKED to a broad range of diseases including, cancer, diabetes, Cardiovascular disease, and Autoimmune disorders.']	[('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 39), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 140)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 205, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 233, 'autoimmune')]
PMC4934634	11/2015	S12-PMC4934634	['currently, it is RECOGNIZED that Vitamin D deficiency CAN be demonstrated in numerous ethnic populations and locations around the world.']	[('PROBABLE_UNDERSTANDING', 17), ('INCOMPLETE_EVIDENCE', 54)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4934634	11/2015	S13-PMC4934634	['HOWEVER, the prevalence of Vitamin D deficiency is a subject of intense DEBATE, IN PART DUE TO DIFFERENCES of opinion regarding WHAT actually constitutes a “deficiency”.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 80), ('PROBLEM_COMPLICATION', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('EXPLICIT_QUESTION', 128)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC4934634	11/2015	S19-PMC4934634	['rickets will not be discussed in this review (readers are referred to a review on this topic by elder and bishop, 2014 [5]) as this paper is FOCUSED on RECENT LITERATURE regarding the IMPORTANCE of maternal Vitamin D status on Pregnancy and infant outcomes, with an EMPHASIS on supplementation trials.healthcare-03-01097-t001_table 1\n\ncaption (table-wrap): table 1\n\ndesignation of Vitamin D status based on circulating Vitamin D levels by the u.s. institute of medicine (iom) and the Endocrine society.Vitamin D statusiomendocrine societydeficiency<12 ng/ml (30 nmol/l)<20 ng/ml (50 nmol/l)insufficiency12–20 ng/ml (30–50 nmol/l)21–29 ng/ml (52.5–72.5 nmol/l)sufficiency>20 ng/ml (50 nmol/l)>30 ng/ml (75 nmol/l)toxicity>50 ng/ml (125 nmol/l)>150 ng/ml (375 nmol/l)\n\n2.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 141), ('INCOMPLETE_EVIDENCE', 152), ('IMPORTANT_CONSIDERATION', 184), ('IMPORTANT_CONSIDERATION', 266)]	4	[('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('GO_0007565', 'female pregnancy', 227, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 484, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 502, 'Vitamin D')]
PMC4934634	11/2015	S20-PMC4934634	['factors INFLUENCING Vitamin D status\nnumerous and diverse lifestyle choices, and environmental and Genetic FACTORS CAN alter Vitamin D status [6];figure 1.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 115)]	3	[('CHEBI_28384', 'vitamin K', 20, 'Vitamin D'), ('SO_0000704', 'gene', 99, 'genetic'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4934634	11/2015	S23-PMC4934634	['differences in the degree of skin Melanin CAN modify uvb-induced Production Of Vitamin D by over 90%, putting dark skinned Individuals at higher risk for a deficiency.']	[('INCOMPLETE_EVIDENCE', 42)]	1	[('CHEBI_25179', 'melanins', 34, 'melanin'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 65, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('NCBITaxon_1', 'root', 123, 'individuals')]
PMC4934634	11/2015	S24-PMC4934634	['increased time spent indoors, dermatologist RECOMMENDATIONS of daily sunscreen application, geographical location (northern latitude) and seasonal changes (winter) CAN reduce exposure to uvb radiation and subsequently lower Vitamin D Synthesis leading to lower Vitamin D levels [6].']	[('FUTURE_WORK', 44), ('INCOMPLETE_EVIDENCE', 164)]	2	[('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 224, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D')]
PMC4934634	11/2015	S28-PMC4934634	['Genetic variations in Cyp2R1 and Vitamin D binding protein CAN reduce the subsequent increases of Serum Vitamin D after uvb exposure and Consumption of Vitamin D fortified foods, respectively, SUGGESTING genetics play a ROLE in determining Vitamin D status [7].']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 220)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 22, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007631', 'feeding behavior', 137, 'consumption'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC4934634	11/2015	S30-PMC4934634	['GIVEN the above it HAS BEEN ARGUED that obese Individuals are a population that is at an INCREASED RISK for Vitamin D deficiency [3,8].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 89)]	4	[('NCBITaxon_1', 'root', 46, 'individuals'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4934634	11/2015	S31-PMC4934634	['CONSISTENT with this, it HAS BEEN REPORTED that obese Pregnant women have lower Vitamin D levels THAN non-obese women, EVEN when they have higher Vitamin D Intakes during the first trimester [9].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('ANOMALY_CURIOUS_FINDING', 119)]	5	[('GO_0007565', 'female pregnancy', 54, 'pregnant'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0007631', 'feeding behavior', 156, 'intakes')]
PMC4934634	11/2015	S32-PMC4934634	['BASED ON lower circulating 25(Oh)D concentrations at a given Vitamin D supplement level in obese and overweight subjects compared to normal weight subjects, ekwaru and coworkers RECENTLY RECOMMENDED that “Vitamin D supplementation be 2–3 times higher for obese subjects and 1.5 times higher for overweight subjects relative to normal weight subjects” [10].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 178), ('FUTURE_WORK', 187)]	3	[('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 27, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC4934634	11/2015	S39-PMC4934634	['today, Vitamin D IS THOUGHT TO have multiple functions beyond its ROLE(s) in bone health [13].']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D')]
PMC4934634	11/2015	S40-PMC4934634	['ILLUSTRATIVE of this, Vitamin D Nuclear receptors (vdr) HAVE BEEN IDENTIFIED in numerous Tissues including Organs INVOLVED in Reproduction and infant growth such as the Ovary, Testis, Placenta and Mammary Gland [14,15].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 114)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0005634', 'nucleus', 32, 'nuclear'), ('UBERON_0000479', 'tissue', 89, 'tissues'), ('UBERON_0000062', 'organ', 107, 'organs'), ('GO_0000003', 'reproduction', 126, 'reproduction'), ('UBERON_0000992', 'ovary', 169, 'ovary'), ('UBERON_0000473', 'testis', 176, 'testis'), ('UBERON_0001987', 'placenta', 184, 'placenta'), ('UBERON_0001911', 'mammary gland', 197, 'mammary gland')]
PMC4934634	11/2015	S50-PMC4934634	['convincing data from Animal MODELS SHOW that Vitamin D deficiency or altered function CAN result in reduced liter size or loss of overall fertility in CONJUNCTION with an increase in maternal and offspring mortality [16,17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('NCBITaxon_33208', 'Metazoa', 21, 'animal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC4934634	11/2015	S51-PMC4934634	['the reductions in fertility CAN be restored by Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 28)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4934634	11/2015	S53-PMC4934634	['vdr and enzymes NECESSARY for Vitamin D Metabolism HAVE BEEN FOUND in male Testis, mature Spermatozoa, and the Ejaculatory Tract SUGGESTING an IMPORTANT ROLE of this Vitamin in Male Fertility [19].']	[('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 143), ('SUPERFICIAL_RELATIONSHIP', 153)]	5	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 30, 'vitamin D metabolism'), ('UBERON_0000473', 'testis', 75, 'testis'), ('CL_0000019', 'sperm', 90, 'spermatozoa'), ('UBERON_0002649', 'dorsolateral fasciculus of medulla', 111, 'ejaculatory tract'), ('CHEBI_33229', 'vitamin (role)', 166, 'vitamin'), ('GO_0007141', 'male meiosis I', 177, 'male fertility')]
PMC4934634	11/2015	S55-PMC4934634	['ONLY 40% of the females inseminated by Vitamin D deficient Rats had normal sized litters compared to 76% from Vitamin D-replete males IN PART due to increased Pregnancy complications.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 134)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 59, 'rats'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy')]
PMC4934634	11/2015	S57-PMC4934634	['supplementation with Estrogen was able to prevent the histological changes to vdr-null male Testis and normalize follicular stimulating hormone (fsh), and Luteinizing hormone (lh) levels, INDICATING Vitamin D MIGHT have a contributing ROLE in Spermatogenesis and Male Fertility.']	[('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 209), ('SUPERFICIAL_RELATIONSHIP', 235)]	3	[('CHEBI_50114', 'estrogen', 21, 'estrogen'), ('UBERON_0000473', 'testis', 92, 'testis'), ('GO_0001905', 'activation of membrane attack complex', 155, 'luteinizing'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0007283', 'spermatogenesis', 243, 'spermatogenesis'), ('GO_0007141', 'male meiosis I', 263, 'male fertility')]
PMC4934634	11/2015	S58-PMC4934634	['IN AGREEMENT, epidemiological studies HAVE SHOWN that men with deficient Vitamin D levels (using either the iom cut-off of <25 nmol/l [22] or the endocrine society cut-off of <50 nmol/l [23]) have reduced Sperm Motility, progressive motility, and number of mature Spermatozoa.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 38)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CL_0000019', 'sperm', 205, 'sperm'), ('GO_0065007', 'biological regulation', 211, 'motility'), ('CL_0000019', 'sperm', 264, 'spermatozoa')]
PMC4934634	11/2015	S62-PMC4934634	[', restored fertility and litter size by Feeding a high calcium diet to female Vdr null Mice SUGGESTING a PLAUSIBLE ROLE of Vitamin D in Calcium Homeostasis RATHER than a direct EFFECT on vdr [17].']	[('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('GO_0007631', 'feeding behavior', 40, 'feeding'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 78, 'VDR'), ('NCBITaxon_10088', 'Mus <genus>', 87, 'mice'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 136, 'calcium'), ('GO_0055073', 'cadmium ion homeostasis', 136, 'calcium homeostasis')]
PMC4934634	11/2015	S66-PMC4934634	[', REPORTED that 47.4% of women with recurrent Pregnancy losses (rpl), defined as three or more consecutive spontaneous Abortions before 20 weeks Gestation, had low Serum 25(Oh)D levels e.g., below 30 ng/ml, the Endocrine society cut-off for Vitamin D sufficiency status (table 1) [25].']	[('INCOMPLETE_EVIDENCE', 2)]	1	[('GO_0007565', 'female pregnancy', 46, 'pregnancy'), ('GO_0006915', 'apoptotic process', 119, 'abortions'), ('GO_0007565', 'female pregnancy', 145, 'gestation'), ('UBERON_0001977', 'blood serum', 164, 'serum'), ('CHEBI_71657', 'versiconol acetate', 170, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 170, '25(OH ... D'), ('UBERON_0005063', 'left ventricular compact myocardium', 211, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D')]
PMC4934634	11/2015	S70-PMC4934634	[', REPORTED that danish women (odense child cohort) with 25(Oh)D levels < 50 nmol/l (iom cut-off for Vitamin D sufficiency and endocrine society cut-off for deficiency,table 1) had a greater than 2-fold increased adjusted hazards ratio for First-Trimester Miscarriage [27].']	[('INCOMPLETE_EVIDENCE', 2)]	1	[('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 56, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007631', 'feeding behavior', 239, 'first'), ('GO_0009294', 'DNA mediated transformation', 245, 'trimester'), ('GO_0046660', 'female sex differentiation', 255, 'miscarriage')]
PMC4934634	11/2015	S72-PMC4934634	[', DETECTED no difference in Pre-Pregnancy Vitamin D status among healthy danish women who were able to Conceive COMPARED TO those who could not Conceive in a ~6 month time period [28].']	[('INCOMPLETE_EVIDENCE', 2), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112)]	2	[('GO_0007568', 'aging', 28, 'pre'), ('GO_0007565', 'female pregnancy', 32, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007631', 'feeding behavior', 103, 'conceive'), ('GO_0007631', 'feeding behavior', 144, 'conceive')]
PMC4934634	11/2015	S75-PMC4934634	['MANY observational STUDIES have LINKED higher maternal Vitamin D status to an increase in rates of both clinical Pregnancy (sonographic presence of a heartbeat following ivf) and live Birth [29,30,31].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('GO_0007567', 'parturition', 184, 'birth')]
PMC4934634	11/2015	S79-PMC4934634	['this INDICATES Vitamin D CAN have a positive IMPACT on the Endometrium and subsequent Embryo Implantation, an IDEA SUPPORTED BY Animal MODELS [32].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 135)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001852', 'endolymph', 59, 'endometrium'), ('GO_0007601', 'visual perception', 86, 'embryo'), ('UBERON_0000922', 'embryo', 86, 'embryo'), ('GO_0007566', 'embryo implantation', 93, 'implantation'), ('NCBITaxon_33208', 'Metazoa', 128, 'animal')]
PMC4934634	11/2015	S80-PMC4934634	['the positive RELATIONSHIP between maternal Vitamin D status and post-Ivf Pregnancy in non-hispanic white, BUT NOT in asian women, SUGGESTS that genetics play a ROLE in the RELATIONSHIP between Vitamin D and fertility.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ANOMALY_CURIOUS_FINDING', 106), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 160), ('SUPERFICIAL_RELATIONSHIP', 172)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0002006', 'vasoconstriction by vasopressin involved in systemic arterial blood pressure control', 69, 'IVF'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
PMC4934634	11/2015	S81-PMC4934634	['this FINDING COULD IMPACT doctor’s RECOMMENDATION of what are CONSIDERED OPTIMAL Vitamin D levels when women of different ethnic groups undergo ivf.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 19), ('FUTURE_WORK', 35), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 73)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4934634	11/2015	S82-PMC4934634	['a supplementation trial involving 128 Vitamin D insufficient (<30 ng/ml, as classified by the authors) iranian women six to eight weeks prior to undergoing freeze-thaw Embryo transfer FOUND no differences in Pregnancy rates between women receiving 50,000 iu Vitamin D/week compared to women receiving Placebo [33].']	[('INCOMPLETE_EVIDENCE', 184)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000922', 'embryo', 168, 'embryo'), ('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 301, 'placebo')]
PMC4934634	11/2015	S85-PMC4934634	['ADDITIONAL clinical TRIALS in ethnically diverse populations with differing baseline Vitamin D levels ARE NEEDED to BETTER DELINEATE the EFFECT of Vitamin D status on Assisted Reproductive technology outcomes.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 102), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 167, 'assisted reproductive')]
PMC4934634	11/2015	S89-PMC4934634	['ALTHOUGH the amount of Vitamin D provided through the Supplement is lower than the current rdas set by EITHER the iom or Endocrine society, this study SHOULD provide new INSIGHTS into HOW Periconceptional dietary interventions CAN IMPACT Female and Male Fertility, a RESEARCH area that is presently LACKING.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('FUTURE_WORK', 151), ('INCOMPLETE_EVIDENCE', 170), ('EXPLICIT_QUESTION', 184), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 231), ('INCOMPLETE_EVIDENCE', 267), ('INCOMPLETE_EVIDENCE', 299)]	9	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 54, 'supplement'), ('UBERON_0005063', 'left ventricular compact myocardium', 121, 'Endocrine'), ('GO_0007565', 'female pregnancy', 188, 'periconceptional'), ('GO_0007601', 'visual perception', 238, 'female ...'), ('GO_0007141', 'male meiosis I', 249, 'male fertility')]
PMC4934634	11/2015	S91-PMC4934634	['Pregnancy\nthe 2004–2008 national health and nutrition examination survey (nhanes) data SHOWS that the cumulative frequency of Vitamin D deficiency during Pregnancy in all races is 29% according to endocrine society criteria (< 20 ng/ml).']	[('INCOMPLETE_EVIDENCE', 87)]	1	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy')]
PMC4934634	11/2015	S93-PMC4934634	['evaluation of nhanes data from 2001 to 2006 using iom GUIDELINES REPORTS that 7% of Pregnant women are Vitamin D deficient (< 12 ng/ml) and 21% are Vitamin D insufficient (12–20 ng/ml) [35].']	[('PROBABLE_UNDERSTANDING', 54), ('INCOMPLETE_EVIDENCE', 65)]	2	[('GO_0007565', 'female pregnancy', 84, 'pregnant'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4934634	11/2015	S94-PMC4934634	['these data FURTHER ILLUSTRATE HOW DIFFERENT cut-offs used by the iom vs. endocrine society for defining Vitamin D status (table 1) INFLUENCES the reporting of Vitamin D deficiency PREVALENCE in the population.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('EXPLICIT_QUESTION', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 131), ('IMPORTANT_CONSIDERATION', 180)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4934634	11/2015	S97-PMC4934634	['IN CONTRAST TO iom RECOMMENDATIONS, the endocrine society RECOMMENDS a Vitamin D intake of AT LEAST 600 iu/day, BUT states that 1500–2000 iu/day MAY BE needed for Pregnant or Lactating females to maintain a 25(Oh)D level ≥ 30 ng/ml.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 19), ('FUTURE_WORK', 58), ('PROBABLE_UNDERSTANDING', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 145)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'pregnant'), ('GO_0007594', 'puparial adhesion', 175, 'lactating'), ('CHEBI_71657', 'versiconol acetate', 207, '25(OH)D')]
PMC4934634	11/2015	S109-PMC4934634	['Gestational diabetes\nthe IMPACT of Vitamin D on vascular health and Glucose Control CAN LIKEWISE TRANSLATE to adverse EFFECTS of Vitamin D deficiency on Pregnancy outcomes including an INCREASED risk for Gestational diabetes and Preeclampsia.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 97), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 185)]	6	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_28384', 'vitamin K', 35, 'Vitamin D'), ('CHEBI_17234', 'glucose', 68, 'glucose'), ('GO_0046323', 'glucose import', 68, 'glucose control'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'gestational'), ('GO_0007128', 'meiotic prophase I', 229, 'preeclampsia')]
PMC4934634	11/2015	S110-PMC4934634	['low Vitamin D HAS BEEN ASSOCIATED with Insulin resistance.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 23)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('PR_000045358', 'insulin family protein', 39, 'insulin')]
PMC4934634	11/2015	S111-PMC4934634	['the THEORY that Vitamin D supplementation CAN help normalize Blood Glucose levels and reduce the incidence of Gestational diabetes is an active AREA of research.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 42), ('FUTURE_WORK', 144)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_17234', 'glucose', 67, 'glucose'), ('GO_0007565', 'female pregnancy', 110, 'gestational')]
PMC4934634	11/2015	S123-PMC4934634	['with regard to Pregnancy outcome, there were no cases of polyhydramnios (the accumulation of excess Amniotic Fluid) in the Vitamin D group compared to 17.4% in the placebo group, and a marked reduction of hyperbilirubinemia in infants from the Vitamin D supplemented group (27.3%) COMPARED TO the placebo group (60.9%) was REPORTED ( p = 0.02) [47].']	[('ANOMALY_CURIOUS_FINDING', 281), ('INCOMPLETE_EVIDENCE', 323)]	2	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('UBERON_0000173', 'amniotic fluid', 100, 'amniotic fluid'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D')]
PMC4934634	11/2015	S124-PMC4934634	['these data SUGGEST a positive EFFECT of Vitamin D supplementation on Pregnancy outcomes in women with Gestational diabetes.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0007565', 'female pregnancy', 102, 'gestational')]
PMC4934634	11/2015	S129-PMC4934634	['IN AGREEMENT WITH ANOTHER STUDY by the same group [45], Vitamin D plus calcium supplementation improved fasting Plasma Glucose, serum Insulin, homa-ir, hdl, and ldl in women with Gestational diabetes compared TO placebo.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 209)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 112, 'plasma'), ('CHEBI_17234', 'glucose', 119, 'glucose'), ('PR_000045358', 'insulin family protein', 134, 'insulin'), ('GO_0007565', 'female pregnancy', 179, 'gestational')]
PMC4934634	11/2015	S131-PMC4934634	['GIVEN the heightened response with co-supplementation, it SUGGESTS that the EFFECTS of Vitamin D on Gestational diabetes MIGHT be enhanced with the use of Calcium.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 121)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_22313', 'alkaline earth metal atom', 155, 'calcium')]
PMC4934634	11/2015	S136-PMC4934634	['Serum Calcium was SIMILAR among the groups further SUGGESTING no adverse side effects with the Vitamin D dosages tested.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 51)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_22313', 'alkaline earth metal atom', 6, 'calcium'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC4934634	11/2015	S142-PMC4934634	['it SHOULD BE NOTED that OTHER STUDIES have FAILED TO CONFIRM OBSERVATIONS that lower 25(Oh)D status is ASSOCIATED with the occurrence of Preeclampsia, and it is STILL UNCLEAR WHETHER suboptimal Vitamin D status is a cause, OR an EFFECT, of preeclampsia [55,56].']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('ANOMALY_CURIOUS_FINDING', 43), ('DIFFICULT_TASK', 43), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 103), ('FULL_UNKNOWN', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('SUPERFICIAL_RELATIONSHIP', 229)]	14	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 137, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4934634	11/2015	S143-PMC4934634	['anti-inflammatory and Immune modulating properties of Vitamin D are POSTULATED to CONTRIBUTE to the protective mechanism against Preeclampsia.']	[('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('UBERON_0002405', 'immune system', 22, 'immune'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 129, 'preeclampsia')]
PMC4934634	11/2015	S149-PMC4934634	['TO INVESTIGATE the EFFECT of Vitamin D supplementation on Blood pressure and Circulating T Cells, the Rats induced by reduced Uterine perfusion pressure (rupp), a MODEL of preeclampsia, were administered Vitamin D2Or Vitamin D3On Gestation days 14–18 [57].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 163)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CL_0000080', 'circulating cell', 77, 'circulating'), ('CL_0000084', 'T cell', 89, 'T cells'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 102, 'rats'), ('UBERON_0000995', 'uterus', 126, 'uterine'), ('CHEBI_27329', 'xanthosine phosphate', 204, 'vitamin D2or'), ('PR_000017209', 'utrophin', 204, 'vitamin D2or'), ('CHEBI_63460', 'parkeol', 217, 'vitamin D3on'), ('PR_000017209', 'utrophin', 217, 'vitamin D3on'), ('GO_0007565', 'female pregnancy', 230, 'gestation')]
PMC4934634	11/2015	S156-PMC4934634	['the authors CONCLUDED that these LINKS are ONLY SUGGESTIVE since there was no difference in Pregnancy complication risk among the Vitamin D intervention groups.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 48)]	4	[('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC4934634	11/2015	S160-PMC4934634	['combining the main comorbidities, for every 10 ng/ml increase in 25(Oh)D at Delivery, the odds ratio was reduced to 0.84 ( p = 0.006) INDICATING fewer adverse Pregnancy outcomes as maternal Vitamin D levels increased.']	[('INCOMPLETE_EVIDENCE', 134)]	1	[('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 65, '25(OH)D'), ('GO_0007567', 'parturition', 76, 'delivery'), ('GO_0007565', 'female pregnancy', 159, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC4934634	11/2015	S164-PMC4934634	['THUS, it is NOT SURPRISING that this study FOUND no effect of the Vitamin D supplementation on incidences of Preterm Birth, Preeclampsia, or small for Gestation age SINCE 23% of participants had persistent Serum 25(Oh)D below 10 ng/ml which IS CONSIDERED Vitamin D deficiency status by both the iom and endocrine society (table 1).']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 43), ('PROBABLE_UNDERSTANDING', 165), ('INCOMPLETE_EVIDENCE', 241)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'preterm birth'), ('GO_0007128', 'meiotic prophase I', 124, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 151, 'gestation'), ('UBERON_0001977', 'blood serum', 206, 'serum'), ('CHEBI_71657', 'versiconol acetate', 212, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 212, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
PMC4934634	11/2015	S176-PMC4934634	['it HAS BEEN PROPOSED that Vitamin D-induced epigenetic changes during development are INVOLVED in susceptibility to multiple morbidities ranging from allergies to cancer later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0000104', 'life cycle', 179, 'life')]
PMC4934634	11/2015	S177-PMC4934634	['THUS it COULD BE ARGUED that adequate Maternal-fetal transfer of Vitamin D in utero and early Infancy is IMPORTANT for Life-long optimal health.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 105)]	4	[('GO_0007618', 'mating', 38, 'maternal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0000023', 'wing', 94, 'infancy'), ('UBERON_0000104', 'life cycle', 119, 'life')]
PMC4934634	11/2015	S184-PMC4934634	['using dietary Intake data ALONE CAN be PROBLEMATIC SINCE uvb-induced skin Formation of Vitamin D CAN significantly alter Serum 25(Oh)D, THUS, dietary Intakes MIGHT not be a reliable INDICATOR of overall Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 32), ('PROBLEM_COMPLICATION', 39), ('PROBABLE_UNDERSTANDING', 51), ('PROBLEM_COMPLICATION', 51), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 182)]	9	[('GO_0007631', 'feeding behavior', 14, 'intake'), ('GO_0009057', 'macromolecule catabolic process', 74, 'formation'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('GO_0007631', 'feeding behavior', 150, 'intakes'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4934634	11/2015	S203-PMC4934634	['in an on-GOING TRIAL (Vitamin D antenatal asthma reduction trial, vdaart) the INFLUENCE of Vitamin D supplementation beginning in the second Trimester on different infant allergic disease risk at three years of age is being explored [76].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 78)]	2	[('CHEBI_28384', 'vitamin K', 22, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 141, 'trimester')]
PMC4934634	11/2015	S209-PMC4934634	[', REPORTED that supplementing both mother/infant pairs with Vitamin D from the third trimester to 6 months Postnatal reduced the amount of primary care visits for acute respiratory infection [77].']	[('INCOMPLETE_EVIDENCE', 2)]	1	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007567', 'parturition', 107, 'postnatal')]
PMC4934634	11/2015	S212-PMC4934634	['SINCE THE study LOOKED AT the number of visits RATHER than confirmed diagnosis of infection, THIS STUDY SUGGESTS infant Vitamin D supplementation in addition to Prenatal supplementation MIGHT be BENEFICIAL in reducing health care visits for acute Respiratory infections.']	[('PROBLEM_COMPLICATION', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 186), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'prenatal'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory')]
PMC4934634	11/2015	S213-PMC4934634	['the data concerning Vitamin D treatment on the clinical severity of atopic dermatitis has BEEN more CONSISTENT.']	[('ANOMALY_CURIOUS_FINDING', 90), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC4934634	11/2015	S225-PMC4934634	['risk of toxicity\nthe causes of Vitamin D intoxication from high dietary intakes CAN result from errors in fortification dosages, manufacturing mistakes of over-the-counter supplements, or misunderstanding doctor recommendations.']	[('INCOMPLETE_EVIDENCE', 80)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC4934634	11/2015	S226-PMC4934634	['the long half-life and Storage Of 25(Oh)D in fat MAY pose PROBLEMS with regard to Vitamin D toxicity.']	[('INCOMPLETE_EVIDENCE', 49), ('PROBLEM_COMPLICATION', 58)]	2	[('GO_1990170', 'stress response to cadmium ion', 23, 'storage of 25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 34, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4934634	11/2015	S234-PMC4934634	['STILL, SOME professionals fear that with the increase in supplementation rates, there COULD BE a rise in Vitamin D toxicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 86)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4934634	11/2015	S237-PMC4934634	['as mentioned earlier, genetics CAN play a ROLE in determining an Individual’s Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('NCBITaxon_1', 'root', 65, 'individual'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4934634	11/2015	S239-PMC4934634	['loss of function of 24-hydroxlase (Cyp24A1), the enzyme responsible for the breakdown of 1,25(Oh)2D and 25(Oh)D, CAN increase the risk of Vitamin D toxicity due to a reduced ability to inactivate these Vitamin D Compounds in the body [86].']	[('INCOMPLETE_EVIDENCE', 113)]	1	[('PR_000006101', 'cytochrome P450 1A1', 35, 'CYP24A1'), ('CHEBI_82784', 'PVP38-Ag NP', 89, '1,25(OH)2D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_36357', 'polyatomic entity', 212, 'compounds')]
PMC4934634	11/2015	S241-PMC4934634	['POTENTIAL consequences of excess Vitamin D intakes: maternal and infant\nduring Pregnancy, the current RECOMMENDED dietary intake of Vitamin D and upper limit ranges from 200 to 2000 iu/day and 3200 to 10,000 iu/day, respectively (table 2).']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 102)]	2	[('CHEBI_28384', 'vitamin K', 33, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4934634	11/2015	S253-PMC4934634	['also, studies powered TO DETERMINE the EFFECT of separate ethnic groups’ varying baseline Vitamin D levels on 25(Oh)D levels after different Vitamin D supplementation doses will provide more concrete INFORMATION for individualized RECOMMENDATIONS during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 200), ('FUTURE_WORK', 231)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 112, '(OH)D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy')]
PMC4934634	11/2015	S261-PMC4934634	['ALTHOUGH both single and daily doses of Vitamin D3Seem to be SAFE, CAUTION SHOULD BE CONSIDERED when supplementing at these high doses in Pregnant women, PARTICULARLY if baseline Vitamin D status is sufficient.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 61), ('FUTURE_WORK', 67), ('INCOMPLETE_EVIDENCE', 67), ('FUTURE_WORK', 75), ('FUTURE_WORK', 85), ('ANOMALY_CURIOUS_FINDING', 154), ('IMPORTANT_CONSIDERATION', 154)]	8	[('CHEBI_64387', 'thiosultap(1-)', 40, 'vitamin D3seem'), ('GO_0007565', 'female pregnancy', 138, 'pregnant'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4934634	11/2015	S265-PMC4934634	['it is not COMPLETELY known HOW large, acute increases in circulating 25(Oh)D levels immediately following supplementation CAN AFFECT a fetus/infant, who are VULNERABLE to Vitamin D toxicity at this time in development.']	[('PROBABLE_UNDERSTANDING', 10), ('EXPLICIT_QUESTION', 27), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 126), ('IMPORTANT_CONSIDERATION', 157)]	5	[('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 69, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC4934634	11/2015	S266-PMC4934634	['as PREVIOUSLY mentioned, short-term studies GENERALLY AGREE with its SAFETY BUT long-term STUDIES ARE NEEDED to address the QUESTION of WHETHER large bolus Vitamin D supplementation during Pregnancy is ASSOCIATED with any adverse health outcomes in the offspring later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 44), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('FUTURE_WORK', 90), ('EXPLICIT_QUESTION', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('EXPLICIT_QUESTION', 136), ('SUPERFICIAL_RELATIONSHIP', 202)]	10	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('UBERON_0000104', 'life cycle', 272, 'life')]
PMC4934634	11/2015	S276-PMC4934634	['higher Vitamin D supplement arms were able to sustain higher infant Vitamin D Serum levels at 12 months when compared to 400 iu/day, which AGREES WITH a study by grant et al.']	[('INCOMPLETE_EVIDENCE', 139)]	1	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0001977', 'blood serum', 78, 'serum')]
PMC4934634	11/2015	S279-PMC4934634	['ALTHOUGH numerous cases of newborn Vitamin D toxicity HAVE BEEN REPORTED over the past 80 years, toxicity is RARE when compared to the number of newborns receiving Vitamin D supplementation [95,96,97,98].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 109)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4934634	11/2015	S280-PMC4934634	['a RECENT case report on an exclusively Breastfed four-month old infant receiving over the counter liquid Vitamin D supplementation SHOWED 25(Oh)D levels of 294 ng/ml, severe hypercalcemia, hypercalciuria, and nephrocalcinosis [95].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 131)]	2	[('GO_0007567', 'parturition', 39, 'breastfed'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 138, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 144, 'D')]
PMC4934634	11/2015	S288-PMC4934634	['also, loss of function mutations in 24-hydroylase was found to be a risk factor for idiopathic infantile hypercalcemia making those infants more susceptible to Vitamin D toxicity EVEN at lower Vitamin D supplementation doses [86], THUS genetics CAN play a ROLE in both Vitamin D deficiency and toxicity.']	[('ANOMALY_CURIOUS_FINDING', 179), ('PROBABLE_UNDERSTANDING', 231), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 256)]	4	[('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4934634	11/2015	S292-PMC4934634	['MANY countries currently mandate the fortification of certain Foods with Vitamin D, e.g., 100 iu/cup milk in the united states, 30–45 iu/ 100 ml Milk in canada, and edible oil spreads (Margarine) in australia, HOWEVER, a large proportion of dietary intakes are STILL below RECOMMENDED levels [100,101].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 210), ('IMPORTANT_CONSIDERATION', 261), ('FUTURE_WORK', 273)]	4	[('CHEBI_33290', 'food', 62, 'foods'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001913', 'milk', 145, 'milk'), ('CHEBI_6784', 'mestranol', 185, 'margarine')]
PMC4934634	11/2015	S294-PMC4934634	['a RECENT report by the 2015 dietary guidelines advisory committee NOTED that EVEN with careful Food choices and following RECOMMENDED amounts from each Food group in the (current) usda Food patterns, the rda for Vitamin D cannot be met [103].']	[('INCOMPLETE_EVIDENCE', 2), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 66), ('ANOMALY_CURIOUS_FINDING', 77), ('FUTURE_WORK', 122)]	5	[('CHEBI_33290', 'food', 95, 'food'), ('CHEBI_33290', 'food', 152, 'food'), ('CHEBI_33290', 'food', 185, 'food'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC4934634	11/2015	S295-PMC4934634	['their conclusion: “through the use of a diet rich in seafood and fortified foods, ear, BUT NOT rda, levels of Vitamin D CAN be achieved.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('INCOMPLETE_EVIDENCE', 120)]	2	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4934634	11/2015	S297-PMC4934634	['UNLIKE Folic Acid fortification of grain products, Vitamin D fortification has primarily focused on dairy products, POTENTIALLY missing certain populations DUE TO cultural practices or perceived or actual Lactose intolerance.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 116), ('PROBLEM_COMPLICATION', 156)]	3	[('CHEBI_30751', 'formic acid', 7, 'folic acid'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_17716', 'lactose', 205, 'lactose')]
PMC4934634	11/2015	S300-PMC4934634	['Hens Fed diets high in Vitamin D CAN increase the amount of Vitamin D3In the Yolks from 50 iu to over 2000 iu per Egg without causing harm to the hen or Egg quality [105].']	[('INCOMPLETE_EVIDENCE', 33)]	1	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Hens'), ('GO_0007631', 'feeding behavior', 5, 'fed'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 60, 'vitamin D3in'), ('PR_000017209', 'utrophin', 60, 'vitamin D3in'), ('UBERON_0001040', 'yolk sac', 77, 'yolks'), ('CL_0000025', 'egg cell', 114, 'egg'), ('CL_0000025', 'egg cell', 153, 'egg')]
PMC4934634	11/2015	S303-PMC4934634	['Vitamin D supplementation/fortification HAS also BEEN met with OPPOSITION [107] DUE TO CONCERNS that Vitamin D is a hormone and SHOULD BE treated as such including addressing efficacy, dose and side effects.']	[('INCOMPLETE_EVIDENCE', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('PROBLEM_COMPLICATION', 80), ('PROBLEM_COMPLICATION', 87), ('FUTURE_WORK', 128)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4934634	11/2015	S305-PMC4934634	['OTHER CONCERNS are the INSUFFICIENT EVIDENCE to determine the EFFECTS of Vitamin D supplementation/fortification on bone health and fracture incidence and that fda RECOMMENDATIONS to include Vitamin D on Food labels MAY ENCOURAGE fortification of Vitamin D in products that would not otherwise necessarily be RECOMMENDED, and lastly, that there is SOME EVIDENCE for POSSIBLE adverse consequences to Vitamin D fortification [107].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 6), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 62), ('FUTURE_WORK', 164), ('INCOMPLETE_EVIDENCE', 216), ('FUTURE_WORK', 220), ('FUTURE_WORK', 309), ('INCOMPLETE_EVIDENCE', 348), ('INCOMPLETE_EVIDENCE', 366)]	10	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33290', 'food', 204, 'food'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D')]
PMC4277121	12/2015	S185-PMC4277121	['antioxidants\noxidative stress and Mitochondrial dysfunction are both CONSIDERED hallmarks of ds Tissues and CONTRIBUTORS to Neurological phenotypes across the ds Lifespan.1,91cortical Neurons derived from ds fetal Brains show elevated levels of Reactive Oxygen Species, and survival is enhanced by treatment with Antioxidants.92several Hsa21 Genes, among them Sod1 , Bach1 , ets2 , and S100B , are KNOWN to CONTRIBUTE to the Regulation of oxidative stress when Overexpressed.9CONSISTENT with these OBSERVATIONS, it was SHOWN that levels of oxidative stress are elevated in the Brains of Adult ts65dn, and when male ts65dn Mice were Fed a diet high in Vitamin E (0.4 g per kg) from the age of 4 months to ~8 months and 10 months, the levels of oxidative stress were decreased.93performance in the Wram was improved at 8 months, and at 10 months; loss of the Trka receptor in the Bfcn had been PREVENTED.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 398), ('SUPERFICIAL_RELATIONSHIP', 407), ('SUPERFICIAL_RELATIONSHIP', 425), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 519), ('SUPERFICIAL_RELATIONSHIP', 892)]	11	[('GO_0005739', 'mitochondrion', 34, 'mitochondrial'), ('UBERON_0000479', 'tissue', 96, 'tissues'), ('UBERON_0001016', 'nervous system', 124, 'neurological'), ('UBERON_0000104', 'life cycle', 162, 'lifespan'), ('CL_0000540', 'neuron', 184, 'neurons'), ('UBERON_0000955', 'brain', 214, 'brains'), ('CHEBI_26523', 'reactive oxygen species', 245, 'reactive oxygen species'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 313, 'antioxidants'), ('PR_000008820', 'heat shock protein beta-8', 336, 'Hsa21'), ('SO_0000704', 'gene', 342, 'genes'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 360, 'SOD1'), ('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 367, 'BACH1'), ('PR_000014404', 'protein S100-A11', 386, 'S100B'), ('GO_0065007', 'biological regulation', 425, 'regulation'), ('GO_0003054', 'circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus', 461, 'overexpressed'), ('UBERON_0000955', 'brain', 577, 'brains'), ('UBERON_0007023', 'adult organism', 587, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 622, 'mice'), ('GO_0007631', 'feeding behavior', 632, 'fed'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin E'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 796, 'WRAM'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 857, 'TRKA'), ('UBERON_0001943', 'midbrain tegmentum', 878, 'BFCN')]
PMC4277121	12/2015	S231-PMC4277121	['among the Drugs showing only partial rescue in specific l/m tasks, Minocycline, Memantine, and Vitamin E were tested in the Wram, while Melatonin, Nap + sal, and peptide 6 ONLY PARTIALLY rescued acquisition in the mwm.']	[('ANOMALY_CURIOUS_FINDING', 172), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 177)]	3	[('CHEBI_23888', 'drug', 10, 'drugs'), ('CHEBI_50694', 'minocycline', 67, 'minocycline'), ('CHEBI_64312', 'memantine', 80, 'memantine'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin E'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 124, 'WRAM'), ('CHEBI_25179', 'melanins', 136, 'melatonin'), ('CHEBI_13389', 'NAD', 147, 'NAP')]
PMC4670104	12/2015	S19-PMC4670104	['also, apps are OFTEN RECOMMENDED for use in population studies as correction factors for assessing status with respect to Micronutrients, whose indicator concentrations MAY decrease (e.g., Serum Retinol for Vitamin A) or rise (e.g, Serum ferritin for iron) with inflammation [13–15].']	[('PROBABLE_UNDERSTANDING', 15), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 169)]	3	[('CHEBI_33839', 'macromolecule', 122, 'micronutrients'), ('UBERON_0001977', 'blood serum', 189, 'serum'), ('CHEBI_26536', 'retinoic acid', 195, 'retinol'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A'), ('UBERON_0001977', 'blood serum', 232, 'serum')]
PMC4670104	12/2015	S145-PMC4670104	['about half of the proteins negatively CORRELATED with agp (i.e., that decline in relative abundance with inflammation) are also CONSIDERED Hepatic proteins released into the Bloodstream, but more INVOLVED in Transport and Metabolism Of Nutrients and Small Molecules (e.g., Rbp4 and ttr for Vitamin A; Apolipoproteins A1/A2/h/m for Lipid or Cholesterol Transport and Metabolism; and ahsg for Calcium And Phosphate Metabolism), sex Hormone and growth factor binding (e.g., Shbg and Igfals) or serine endopeptidase or proteinase inhibition in Regulating Blood Coagulation and complement cascades, among other ROLES.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 196), ('SUPERFICIAL_RELATIONSHIP', 606)]	4	[('UBERON_0002107', 'liver', 139, 'hepatic'), ('UBERON_0001969', 'blood plasma', 174, 'bloodstream'), ('GO_0009294', 'DNA mediated transformation', 208, 'transport ...'), ('GO_0019503', 'stachydrine biosynthetic process', 222, 'metabolism of nutrients'), ('CHEBI_33284', 'nutrient', 236, 'nutrients'), ('GO_0044403', 'biological process involved in symbiotic interaction', 250, 'small molecules'), ('CHEBI_36357', 'polyatomic entity', 256, 'molecules'), ('PR_000013819', 'retinol-binding protein 2', 273, 'RBP4'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin A'), ('CHEBI_39015', 'apolipoprotein', 301, 'apolipoproteins'), ('PR_000004140', 'apolipoprotein A-I', 301, 'apolipoproteins A1'), ('PR_000004105', 'AP-3 complex subunit beta-2', 320, 'A2'), ('CHEBI_18059', 'lipid', 331, 'lipid'), ('GO_0006266', 'DNA ligation', 331, 'lipid ...'), ('CHEBI_16113', 'cholesterol', 340, 'cholesterol'), ('GO_0030204', 'chondroitin sulfate metabolic process', 340, 'cholesterol transport ... metabolism'), ('CHEBI_77635', 'calcium phosphate', 391, 'calcium and phosphate'), ('GO_0019752', 'carboxylic acid metabolic process', 391, 'calcium ... metabolism'), ('CHEBI_33280', 'molecular messenger', 430, 'hormone'), ('PR_000014843', 'protein shisa-3', 471, 'SHBG'), ('PR_000008940', 'intraflagellar transport protein 88', 480, 'IGFALS'), ('GO_0065007', 'biological regulation', 540, 'regulating'), ('GO_0007596', 'blood coagulation', 551, 'blood coagulation'), ('UBERON_0000178', 'blood', 551, 'blood')]
PMC4670104	12/2015	S177-PMC4670104	['Rbp4, ttr, Ahsg, and Apoa1/2 are WELL-KNOWN negative Acute Phase proteins [10] that are CONSISTENT with KNOWN redistributions of Vitamin A, Calcium, Phosphate and Lipids during inflammation [57–60].']	[('PROBABLE_UNDERSTANDING', 33), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 104)]	3	[('PR_000013819', 'retinol-binding protein 2', 0, 'RBP4'), ('PR_000003880', 'GTP:AMP phosphotransferase, mitochondrial', 11, 'AHSG'), ('PR_000004100', 'AP-2 complex subunit alpha-2', 21, 'APOA1'), ('GO_0006953', 'acute-phase response', 53, 'acute phase'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin A'), ('CHEBI_22313', 'alkaline earth metal atom', 140, 'calcium'), ('CHEBI_18367', 'phosphate(3-)', 149, 'phosphate'), ('CHEBI_18059', 'lipid', 163, 'lipids')]
PMC4676908	12/2015	S111-PMC4676908	['the content of each anc visit is also IMPORTANT, AS SOME anc INTERVENTIONS MAY not be beneficial, such as high does concomitant supplementation with Vitamin C and Vitamin e to PREVENT pre-eclampsia in high-risk women (poston2006).']	[('IMPORTANT_CONSIDERATION', 38), ('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 149, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin')]
PMC4684854	12/2015	S2-PMC4684854	['THIS PAPER provides a brief review of POTENTIAL health outcomes RECENTLY LINKED to Gestational Vitamin D deficiency, including Preterm Birth, cesarean Delivery, and Gestational diabetes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 73)]	4	[('GO_0007565', 'female pregnancy', 83, 'gestational'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'preterm birth'), ('GO_0007567', 'parturition', 151, 'delivery'), ('GO_0007565', 'female pregnancy', 165, 'gestational')]
PMC4684854	12/2015	S3-PMC4684854	['ALTHOUGH immediate costs for obstetric COMPLICATIONS RELATED to Gestational Vitamin D insufficiency MAY BE modest, the short- and long-term costs for pediatric healthcare resulting from such Gestational COMPLICATIONS MAY BE enormous and present an enduring BURDEN on Healthcare systems.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBLEM_COMPLICATION', 39), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 203), ('INCOMPLETE_EVIDENCE', 217), ('IMPORTANT_CONSIDERATION', 257)]	7	[('GO_0007565', 'female pregnancy', 64, 'gestational'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'gestational'), ('UBERON_0004151', 'cardiac chamber', 267, 'healthcare')]
PMC4684854	12/2015	S4-PMC4684854	['with INCREASING EVIDENCE POINTING TO fetal origins of SOME later Life disease, securing Vitamin D sufficiency in Pregnancy APPEARS TO BE a simple, SAFE, and cost-EFFECTIVE measure that CAN be incorporated into routine Preconception and Prenatal Care in the offices of primary care clinicians.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 54), ('ANOMALY_CURIOUS_FINDING', 123), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 162), ('INCOMPLETE_EVIDENCE', 185)]	7	[('UBERON_0000104', 'life cycle', 65, 'life'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('GO_0007565', 'female pregnancy', 218, 'preconception'), ('GO_0008283', 'cell proliferation', 236, 'prenatal care')]
PMC4684854	12/2015	S38-PMC4684854	['with the EMERGING EVIDENCE that Vitamin D acts epigenetically in the Regulation of over 2700 different Genes [36], there HAS BEEN much RECENT RESEARCH exploring the widespread prevalence of Vitamin D deficiency through the continuum of Life, including the Gestational and Neonatal Period.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 135)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 69, 'regulation'), ('SO_0000704', 'gene', 103, 'genes'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0000104', 'life cycle', 236, 'life'), ('GO_0007565', 'female pregnancy', 256, 'gestational'), ('UBERON_0007221', 'neonate stage', 272, 'neonatal period')]
PMC4684854	12/2015	S39-PMC4684854	['THIS PAPER is DESIGNED to review the literature FINDINGS about the enduring IMPACT of Gestational Vitamin D sufficiency on Maternal and pediatric health and Well-Being.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('GO_0007565', 'female pregnancy', 86, 'gestational'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007618', 'mating', 123, 'maternal'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 157, 'well-being')]
PMC4684854	12/2015	S43-PMC4684854	['a primary OBSERVATION, HOWEVER, was that LIMITED scientific LITERATURE is available on the issue of Gestational Vitamin D insufficiency as it RELATES to long-term health outcomes.']	[('ANOMALY_CURIOUS_FINDING', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 142)]	4	[('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4684854	12/2015	S54-PMC4684854	['these iom RECOMMENDATIONS for REQUIRED Vitamin D intake HAVE BEEN put into SERIOUS question [42], HOWEVER, AS a significant statistical ERROR HAS BEEN identified in the way their recommendations were arrived AT [43].']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('PROBABLE_UNDERSTANDING', 107), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 208)]	9	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4684854	12/2015	S55-PMC4684854	['ACCORDINGLY, exploration of consensus FINDINGS on the clinical BENEFITS of Vitamin D supplementation is in order in all medical disciplines including Reproductive healthcare.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 63)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0000003', 'reproduction', 150, 'reproductive')]
PMC4684854	12/2015	S57-PMC4684854	['LIMITATIONS of Vitamin D research as RELATED to Gestational outcomes\nALTHOUGH maternal-fetal outcomes in the presence of adequate Gestational Vitamin D are GENERALLY favorable as REPORTED in the medical literature, SOME reports HAVE BEEN INCONSISTENT and CAST DOUBT on the LINK between Gestational Vitamin D sufficiency and health.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ANOMALY_CURIOUS_FINDING', 69), ('PROBABLE_UNDERSTANDING', 156), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 215), ('INCOMPLETE_EVIDENCE', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260), ('INCOMPLETE_EVIDENCE', 260), ('SUPERFICIAL_RELATIONSHIP', 273)]	13	[('CHEBI_28384', 'vitamin K', 15, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'Gestational'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 286, 'gestational'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D')]
PMC4684854	12/2015	S58-PMC4684854	['specifically, supplementation of Vitamin D in Pregnancy in SOME studies APPEARS TO SUGGEST marked BENEFIT WHILE research in OTHER publications does NOT APPEAR TO confer significant improvement in maternal-fetal outcomes [44].']	[('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 72), ('INCOMPLETE_EVIDENCE', 83), ('IMPORTANT_CONSIDERATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('ANOMALY_CURIOUS_FINDING', 148), ('ANOMALY_CURIOUS_FINDING', 152)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy')]
PMC4684854	12/2015	S60-PMC4684854	['FOUND that Gestational Vitamin D supplementation was ASSOCIATED with increased Birth weight and Birth length BUT, UNLIKE SOME OTHER RESEARCH, was not associated with other beneficial maternal and neonatal outcomes such as reductions in preeclampsia, Gestational diabetes, small for Gestational age infants, Preterm Birth, or rates of cesarean Delivery [44].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('ANOMALY_CURIOUS_FINDING', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126)]	7	[('GO_0007565', 'female pregnancy', 11, 'gestational'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007567', 'parturition', 79, 'birth'), ('GO_0007567', 'parturition', 96, 'birth'), ('GO_0007565', 'female pregnancy', 250, 'gestational'), ('GO_0007565', 'female pregnancy', 282, 'gestational'), ('GO_0007565', 'female pregnancy', 307, 'preterm birth'), ('GO_0007567', 'parturition', 343, 'delivery')]
PMC4684854	12/2015	S61-PMC4684854	['the APPARENT DISPARITY between findings in VARIOUS STUDIES has caused SOME to reflexively CONCLUDE that Vitamin D status in Pregnancy is IRRELEVANT to maternal-fetal outcomes.']	[('ANOMALY_CURIOUS_FINDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('ANOMALY_CURIOUS_FINDING', 13), ('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 90), ('IMPORTANT_CONSIDERATION', 137)]	8	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy')]
PMC4684854	12/2015	S62-PMC4684854	['studies on Reproductive outcomes RELATED to Vitamin D supplementation, HOWEVER, are inherently PLAGUED by a NUMBER OF common CONFOUNDERS which CLOUD the picture.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 125), ('INCOMPLETE_EVIDENCE', 143)]	6	[('GO_0000003', 'reproduction', 11, 'reproductive'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4684854	12/2015	S64-PMC4684854	['many FACTORS MAY AFFECT the resultant status of Vitamin D in the body (AS reflected by measurement of 25(Oh)D levels) after Ingested supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 71)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 108, 'D'), ('GO_0007631', 'feeding behavior', 124, 'ingested')]
PMC4684854	12/2015	S66-PMC4684854	['many of the RECENT publications CHALLENGING the efficacy of Gestational Vitamin D sufficiency HAVE BEEN meta-analyses which ATTEMPT to synthesize diverse data from numerous observational and supplementation studies which do NOT NECESSARILY incorporate individual differences in these central DETERMINANTS.']	[('INCOMPLETE_EVIDENCE', 12), ('DIFFICULT_TASK', 32), ('INCOMPLETE_EVIDENCE', 94), ('DIFFICULT_TASK', 124), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 292)]	6	[('GO_0007565', 'female pregnancy', 60, 'gestational'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4684854	12/2015	S67-PMC4684854	['specific CONCERNS about several Vitamin D meta-analyses CAN account for the varying outcomes REPORTED from this type of research.']	[('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 93)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4684854	12/2015	S70-PMC4684854	['(ii) commencement of supplementation at differing times during the Gestation MAY miss CRITICAL periods when Vitamin D MAY play a PIVOTAL ROLE.']	[('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 86), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 129), ('SUPERFICIAL_RELATIONSHIP', 137)]	5	[('GO_0007565', 'female pregnancy', 67, 'gestation'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4684854	12/2015	S77-PMC4684854	['early in Pregnancy, for example, an increased risk of First Trimester Miscarriage HAS BEEN LINKED to INADEQUATE maternal Vitamin D levels [49].']	[('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 91), ('IMPORTANT_CONSIDERATION', 101)]	3	[('GO_0007565', 'female pregnancy', 9, 'pregnancy'), ('GO_0042733', 'embryonic digit morphogenesis', 54, 'first trimester'), ('GO_0046660', 'female sex differentiation', 70, 'miscarriage'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4684854	12/2015	S79-PMC4684854	['this research FOUND that lower Vitamin D levels were ASSOCIATED with Immune Dysregulation in a NUMBER OF ways, including differences in indices involving Natural Killer Cells, various cytokines, and certain Regulatory proteins, when compared to those with sufficient Vitamin D levels [50].']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0001774', 'microglial cell activation', 69, 'immune dysregulation'), ('UBERON_0002405', 'immune system', 69, 'immune'), ('CL_0000623', 'natural killer cell', 154, 'natural killer cells'), ('GO_0065007', 'biological regulation', 207, 'regulatory'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]
PMC4684854	12/2015	S80-PMC4684854	['the authors of this study also NOTED that women with lower Vitamin D levels had higher degrees of various Autoantibodies including Antiphospholipid Antibody [50], a clinical state that HAS BEEN ASSOCIATED with fetal death, recurrent early Miscarriage, Preeclampsia, and Placental insufficiency [51].']	[('ANOMALY_CURIOUS_FINDING', 31), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 194)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0044308', 'axonal spine', 106, 'autoantibodies'), ('CHEBI_16240', 'hydrogen peroxide', 131, 'antiphospholipid'), ('GO_0042571', 'immunoglobulin complex, circulating', 148, 'antibody'), ('GO_0046660', 'female sex differentiation', 239, 'miscarriage'), ('GO_0007128', 'meiotic prophase I', 252, 'preeclampsia'), ('UBERON_0001987', 'placenta', 270, 'placental')]
PMC4684854	12/2015	S81-PMC4684854	['a NUMBER OF papers have CONFIRMED an INCREASED RISK of developing Gestational diabetes in those with INADEQUATE Vitamin D levels [52,53].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 37), ('IMPORTANT_CONSIDERATION', 101)]	4	[('GO_0007565', 'female pregnancy', 66, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4684854	12/2015	S85-PMC4684854	['NUMEROUS STUDIES have also CORRELATED low levels of Vitamin D with the development of Preeclampsia [52,53,55,56], PERHAPS through Immune mechanisms involving Antiphospholipid Antibody [51], and/or inflammatory mechanisms involving cytokines [56].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 114)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 86, 'preeclampsia'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('CHEBI_16240', 'hydrogen peroxide', 158, 'antiphospholipid'), ('GO_0042571', 'immunoglobulin complex, circulating', 175, 'antibody')]
PMC4684854	12/2015	S87-PMC4684854	['escalating EVIDENCE in the literature CONFIRMS a PROTECTIVE ASSOCIATION between maternal Vitamin D sufficiency and the incidence of Preterm Birth [58–60].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'preterm birth')]
PMC4684854	12/2015	S90-PMC4684854	['ANOTHER STUDY FOUND that infants Born before 32 weeks of Gestation were 2.4 times more LIKELY to have Vitamin D levels below 50\u2009nmol/l when compared with those Born after 32 weeks of Gestation [61].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 87)]	3	[('GO_0007567', 'parturition', 33, 'born'), ('GO_0007565', 'female pregnancy', 57, 'gestation'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007567', 'parturition', 160, 'born'), ('GO_0007565', 'female pregnancy', 183, 'gestation')]
PMC4684854	12/2015	S93-PMC4684854	['as well as individual studies, systematic reviews exploring ASSOCIATION between Vitamin D sufficiency and health outcomes HAVE also BEEN illuminating.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 122)]	2	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4684854	12/2015	S94-PMC4684854	['a systematic review and meta-analysis of 24 studies SUGGESTED that low maternal Vitamin D levels in Pregnancy MAY BE ASSOCIATED with an INCREASED RISK of small for Gestational age infants, as well as being LINKED to preeclampsia, Gestational diabetes, and Preterm Birth [66].']	[('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 117), ('IMPORTANT_CONSIDERATION', 136), ('SUPERFICIAL_RELATIONSHIP', 206)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('GO_0007565', 'female pregnancy', 164, 'gestational'), ('GO_0007565', 'female pregnancy', 230, 'gestational'), ('GO_0007565', 'female pregnancy', 256, 'preterm birth')]
PMC4684854	12/2015	S98-PMC4684854	['in ONE STUDY, women with Vitamin D levels below 37.5\u2009nmol/l were almost four times as LIKELY to REQUIRE a primary Cesarean Delivery as women with higher levels [67].']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 86), ('IMPORTANT_CONSIDERATION', 96)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0044808', 'oncostatin M production', 114, 'cesarean'), ('GO_0007567', 'parturition', 123, 'delivery')]
PMC4684854	12/2015	S103-PMC4684854	['there is escalating EVIDENCE in general that low Vitamin D levels are CORRELATED with higher RISK for a variety of mental health PROBLEMS including depressive illness [70], as Vitamin D IS KNOWN to play an IMPORTANT ROLE in activating Genes that release Neurotransmitters such as Dopamine and Serotonin [70,71].']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 70), ('IMPORTANT_CONSIDERATION', 93), ('IMPORTANT_CONSIDERATION', 129), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('SO_0000704', 'gene', 235, 'genes'), ('CHEBI_25512', 'neurotransmitter', 254, 'neurotransmitters'), ('CHEBI_18243', 'dopamine', 280, 'dopamine'), ('CHEBI_28790', 'serotonin', 293, 'serotonin')]
PMC4684854	12/2015	S108-PMC4684854	['for example, PRELIMINARY EVIDENCE SUGGESTS that insufficient levels of Prenatal Vitamin D MAY BE a factor in the development of autism [74] and lower Respiratory infections [75].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 90)]	3	[('GO_0007565', 'female pregnancy', 71, 'prenatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 150, 'respiratory')]
PMC4684854	12/2015	S109-PMC4684854	['a spanish study to this end FOUND that mothers who had Gestational Vitamin D levels above 75\u2009nmol/l had offspring with a one-third lower rate of acute Respiratory Tract infections during the first year of Life [76].']	[('INCOMPLETE_EVIDENCE', 28)]	1	[('GO_0007565', 'female pregnancy', 55, 'gestational'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 151, 'respiratory tract'), ('UBERON_0000104', 'life cycle', 205, 'life')]
PMC4684854	12/2015	S110-PMC4684854	['a RECENT body of work has begun TO SUGGEST that lower Gestational Vitamin D levels MAY also be ASSOCIATED with higher rates of pediatric atopic disease [77], food sensitivities [78], atopic dermatitis [79], eczema [80], asthma [81], impaired Lung function [82], allergic disease [83], and other conditions frequently characterized by a hypersensitive Immune state.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 95)]	5	[('GO_0007565', 'female pregnancy', 54, 'gestational'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0002048', 'lung', 242, 'lung'), ('UBERON_0002405', 'immune system', 351, 'immune')]
PMC4684854	12/2015	S111-PMC4684854	['it APPEARS that fetal Vitamin D levels MAY play a modulating ROLE in Immune functions INVOLVED in atopic disorders.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 86)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 69, 'immune')]
PMC4684854	12/2015	S112-PMC4684854	['AS hypersensitivity outcomes MAY also be seen in those children Born to mothers contaminated with assorted Xenobiotics in Pregnancy [84–89], HOWEVER, it is NOT KNOWN WHETHER the Immune Dysregulation and hypersensitivity MAY BE the consequence of a primary Gestational insufficiency of Vitamin D, OR WHETHER various chemical Toxicants MIGHT play a ROLE by impairing Vitamin D Uptake, Renal synthesis, and assimilation [25,90] WHILE at the same time inducing Immune compromise and hypersensitivity through OTHER mechanisms [91].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('FULL_UNKNOWN', 156), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 220), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 296), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 299), ('INCOMPLETE_EVIDENCE', 334), ('SUPERFICIAL_RELATIONSHIP', 347), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 425), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504)]	12	[('GO_0007567', 'parturition', 64, 'born'), ('CHEBI_35703', 'xenobiotic', 107, 'xenobiotics'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('GO_0001774', 'microglial cell activation', 178, 'immune dysregulation'), ('UBERON_0002405', 'immune system', 178, 'immune'), ('GO_0007565', 'female pregnancy', 256, 'gestational'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 324, 'toxicants'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('GO_0071939', 'vitamin A import', 365, 'vitamin D uptake'), ('UBERON_0002113', 'kidney', 383, 'renal'), ('UBERON_0002405', 'immune system', 457, 'immune')]
PMC4684854	12/2015	S115-PMC4684854	['furthermore, an INTERESTING cohort study CORRELATING maternal Vitamin D deficiency at 18 weeks of Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20 years [93].']	[('ANOMALY_CURIOUS_FINDING', 16), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 187)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('GO_0007565', 'female pregnancy', 150, 'gestational'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0030324', 'lung development', 212, 'lung development'), ('UBERON_0002048', 'lung', 212, 'lung'), ('GO_0050905', 'neuromuscular process', 254, 'neurocognitive'), ('GO_0051318', 'G1 phase', 311, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 331, 'adolescence')]
PMC4684854	12/2015	S116-PMC4684854	['the authors STATE that “Vitamin D MAY have an IMPORTANT, multifaceted ROLE in the Development Of fetal Lungs, Brain, and Bone” [93].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 46), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 82, 'development of ... lungs ... brain'), ('UBERON_0002048', 'lung', 103, 'lungs'), ('UBERON_0000955', 'brain', 110, 'brain'), ('GO_0007567', 'parturition', 121, 'bone')]
PMC4684854	12/2015	S117-PMC4684854	['finally, Gestational Vitamin D levels MAY IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the development of Adult onset multiple sclerosis [94].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 62), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151)]	7	[('GO_0007565', 'female pregnancy', 9, 'gestational'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0007023', 'adult organism', 49, 'adult'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('UBERON_0007023', 'adult organism', 178, 'adult')]
PMC4684854	12/2015	S119-PMC4684854	['economic burden of Gestational Vitamin D deficiency\nthe economic IMPACT of Vitamin D deficiency as it RELATES to maternal-fetal health is DIFFICULT to objectively quantify AS INSUFFICIENT evidence has ACCUMULATED THUS FAR on the totality of short- and long-term sequelae of Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 102), ('DIFFICULT_TASK', 138), ('PROBABLE_UNDERSTANDING', 172), ('INCOMPLETE_EVIDENCE', 175), ('PROBLEM_COMPLICATION', 175), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 213)]	8	[('GO_0007565', 'female pregnancy', 19, 'Gestational'), ('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC4684854	12/2015	S127-PMC4684854	['with regard to economic challenges ASSOCIATED with Vitamin D insufficiency, SUFFICE it to say that there are CONSIDERABLE costs POTENTIALLY ASSOCIATED with Gestational Vitamin D insufficiency [99] as well as corresponding BENEFITS and cost savings resulting from inexpensive supplementation with this ESSENTIAL Nutrient [99].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('IMPORTANT_CONSIDERATION', 76), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 140), ('IMPORTANT_CONSIDERATION', 222), ('IMPORTANT_CONSIDERATION', 301)]	7	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 156, 'gestational'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_33284', 'nutrient', 311, 'nutrient')]
PMC4684854	12/2015	S132-PMC4684854	['it is APPARENT that training is REQUIRED to establish clinical competency in (i) understanding of the ROLE of various Nutrients in Human health, (ii) HOW TO ASSESS nutritional biochemistry in patients, and (iii) and HOW to intervene to secure Nutrient sufficiency for Individuals and population groups\nwith the MOUNTING EVIDENCE of several health sequelae ASSOCIATED with Gestational Vitamin D deficiency, the VALUE of Preconception education and care by health providers and PUBLIC HEALTH bodies to secure Vitamin D sufficiency throughout Gestation is EVIDENT.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 102), ('EXPLICIT_QUESTION', 150), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('EXPLICIT_QUESTION', 216), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 356), ('IMPORTANT_CONSIDERATION', 410), ('IMPORTANT_CONSIDERATION', 476), ('PROBABLE_UNDERSTANDING', 553)]	12	[('CHEBI_33284', 'nutrient', 118, 'nutrients'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('CHEBI_33284', 'nutrient', 243, 'nutrient'), ('NCBITaxon_1', 'root', 268, 'individuals'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('GO_0007565', 'female pregnancy', 419, 'preconception'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('GO_0007565', 'female pregnancy', 540, 'gestation')]
PMC4684854	12/2015	S133-PMC4684854	['as Pregnant women [105], particularly those with dark skin [106], are at CONSIDERABLE RISK for experiencing Vitamin D insufficiency [39], it is IMPORTANT to have a HIGH INDEX OF SUSPICION and to EFFECTIVELY preclude, assess for, and manage Vitamin D inadequacy, as would be done with OTHER biochemical irregularities.']	[('IMPORTANT_CONSIDERATION', 73), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 195), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 284)]	5	[('GO_0007565', 'female pregnancy', 3, 'pregnant'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC4684854	12/2015	S136-PMC4684854	['one researcher has SUGGESTED that the dietary REQUIREMENT during Pregnancy and Lactation MAY actually be as high as 6000\u2009iu/day [108], BUT most researchers have concluded, with OUR CURRENT KNOWLEDGE, that a supplemental Vitamin D intake of 4000\u2009iu/day is OPTIMAL [30].']	[('INCOMPLETE_EVIDENCE', 19), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('INCOMPLETE_EVIDENCE', 181), ('FUTURE_WORK', 189), ('IMPORTANT_CONSIDERATION', 255)]	8	[('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('GO_0007595', 'lactation', 79, 'lactation'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC4684854	12/2015	S137-PMC4684854	["as discussed, individual Vitamin D indices CAN be INFLUENCED by various DETERMINANTS DESPITE specific levels of supplementation; it is THUS the author's RECOMMENDATION that a personalized medical approach be taken via individual screening for 25(Oh)D as a routine part of Preconception and Prenatal care."]	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 85), ('PROBABLE_UNDERSTANDING', 135), ('FUTURE_WORK', 153)]	6	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('GO_0007565', 'female pregnancy', 272, 'preconception'), ('GO_0007565', 'female pregnancy', 290, 'prenatal')]
PMC4684854	12/2015	S138-PMC4684854	['with EVIDENCE that a major proportion of the Adult population [38], particularly in northern climates [39], is POTENTIALLY deficient in Vitamin D, it APPEARS that, at minimum, one out of every few expectant mothers will have INADEQUATE levels of this ESSENTIAL Nutrient.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 111), ('ANOMALY_CURIOUS_FINDING', 150), ('IMPORTANT_CONSIDERATION', 225), ('IMPORTANT_CONSIDERATION', 251)]	5	[('UBERON_0007023', 'adult organism', 45, 'adult'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_33284', 'nutrient', 261, 'nutrient')]
PMC4684854	12/2015	S140-PMC4684854	['the ONGOING personal health BURDEN ASSOCIATED with Gestational Vitamin D insufficiency throughout many parts of the world has the POTENTIAL to be ameliorated CONSIDERABLY by straightforward educational and healthcare measures in the Preconception and Prenatal period to secure Vitamin D sufficiency throughout Pregnancy.']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 28), ('PROBLEM_COMPLICATION', 28), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 130), ('ANOMALY_CURIOUS_FINDING', 158)]	6	[('GO_0007565', 'female pregnancy', 51, 'gestational'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 233, 'preconception'), ('GO_0007565', 'female pregnancy', 251, 'prenatal'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy')]
PMC4684854	12/2015	S141-PMC4684854	['it is time for maternity health providers to be apprised of the POTENTIAL for improved and enduring health and well-Being ASSOCIATED with inexpensive measures to secure Vitamin D nutritional adequacy during Gestation, the most vulnerable time in the Life Cycle of the developing child.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('GO_0016441', 'posttranscriptional gene silencing', 115, '-being'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007565', 'female pregnancy', 207, 'gestation'), ('UBERON_0000104', 'life cycle', 250, 'life cycle')]
PMC4689556	12/2015	S13-PMC4689556	['conclusions\nwe FOUND NO EVIDENCE that Prenatal Vitamin D supplementation from 27 weeks Gestation to Delivery, at doses which FAILED to completely correct maternal Vitamin D deficiency, INFLUENCE overall healthcare utilisation in children in the first 3 years.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 21), ('DIFFICULT_TASK', 125), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('GO_0007565', 'female pregnancy', 38, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 87, 'gestation'), ('GO_0007567', 'parturition', 100, 'delivery'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4689556	12/2015	S15-PMC4689556	['there is MIXED OBSERVATIONAL evidence with regards to the EFFECT of pre-Natal 25(Oh) Vitamin D status on child health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('GO_0007567', 'parturition', 72, 'natal'), ('CHEBI_30778', 'gallic acid', 78, '25(OH)'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4689556	12/2015	S16-PMC4689556	['SEVERAL STUDIES have LINKED low Vitamin D status to a number of resource intensive childhood health PROBLEMS including allergy and infection [2–7], in addition to the WELL-ESTABLISHED EFFECTS on bone Metabolism.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 100), ('PROBABLE_UNDERSTANDING', 167), ('SUPERFICIAL_RELATIONSHIP', 184)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0008152', 'metabolic process', 200, 'metabolism')]
PMC4689556	12/2015	S20-PMC4689556	['thus FAR there HAS BEEN a LACK OF randomised controlled trial evidence to definitively confirm OR REFUTE the RELATIONSHIP between Prenatal Vitamin D and childhood health outcomes FOUND in OBSERVATIONAL studies.']	[('ANOMALY_CURIOUS_FINDING', 5), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 188)]	8	[('GO_0007565', 'female pregnancy', 130, 'prenatal'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC4689556	12/2015	S26-PMC4689556	['we HYPOTHESIZED that Prenatal Vitamin D supplementation during Pregnancy would reduce a child’s healthcare utilisation during the first three years of Life through improved health status, by using the e-hr to quantify our outcome total healthcare utilisation.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('GO_0007565', 'female pregnancy', 21, 'prenatal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('UBERON_0000104', 'life cycle', 151, 'life')]
PMC4689556	12/2015	S129-PMC4689556	['there was WEAK EVIDENCE that offspring of mothers who received bolus Vitamin D were more LIKELY to have been prescribed a wheezing medication (p = 0.05), and that offspring of mothers who received daily Vitamin D were more LIKELY to have been prescribed an eczema medication (p = 0.04) (table 8).']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 89), ('PROBABLE_UNDERSTANDING', 223)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4689556	12/2015	S132-PMC4689556	['there were INSUFFICIENT data to analyse bolus and daily Vitamin D groups separately for this outcome.10.1371/journal.pone.0145303.t008\n\ncaption (table-wrap): table 8\nany prescription for wheezing or eczema.']	[('INCOMPLETE_EVIDENCE', 11)]	1	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4689556	12/2015	S137-PMC4689556	['to further investigate the WEAK EVIDENCE for a LINK between Cord Blood 25(Oh) Vitamin D concentration and eczema cost (table 9), we analysed WHETHER there was a RELATIONSHIP between Cord 25(Oh) Vitamin D level and prescription of a medicated cream (aor 2.52, p = 0.10, 95% ci 0.85–7.47) and WHETHER cord 25(Oh) Vitamin D was ASSOCIATED with the number of eczema Medications prescribed (r = 0.07, p = 0.91, 95% ci -0.72–7.80).']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 291), ('SUPERFICIAL_RELATIONSHIP', 325)]	6	[('UBERON_0002240', 'spinal cord', 60, 'cord'), ('UBERON_0000178', 'blood', 65, 'blood'), ('CHEBI_30778', 'gallic acid', 71, '25(OH)'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 182, 'cord'), ('CHEBI_30778', 'gallic acid', 187, '25(OH)'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 304, '25(OH)'), ('CHEBI_27300', 'vitamin D', 311, 'vitamin D'), ('CHEBI_25441', 'mycothiols', 362, 'medications')]
PMC4689556	12/2015	S141-PMC4689556	['discussion\nwe EVALUATED WHETHER two specific dosing regimens of Prenatal Vitamin D supplementation COULD reduce health care utilisation in the first three years of Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 99)]	3	[('GO_0007565', 'female pregnancy', 64, 'prenatal'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0000104', 'life cycle', 164, 'life')]
PMC4689556	12/2015	S142-PMC4689556	['we FOUND NO CONSISTENT evidence for a treatment effect on overall or disease-specific unscheduled healthcare utilisation in the first three years, ALTHOUGH it should be NOTED that neither of the intervention regimens resulted in adequate Vitamin D levels in mothers or Cord Blood, JUDGED by current international Vitamin D RECOMMENDATIONS [36,37].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ANOMALY_CURIOUS_FINDING', 147), ('ANOMALY_CURIOUS_FINDING', 169), ('PROBABLE_UNDERSTANDING', 281), ('FUTURE_WORK', 323)]	7	[('CHEBI_27300', 'vitamin D', 238, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 269, 'cord'), ('UBERON_0000178', 'blood', 274, 'blood'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D')]
PMC4689556	12/2015	S143-PMC4689556	['we FOUND NO EVIDENCE that Prenatal Vitamin D status is RELATED to healthcare utilisation, HOWEVER one MIGHT argue that the very SMALL number of subjects with adequate Vitamin D status LIMITED the power of this analysis.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 184)]	7	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC4689556	12/2015	S144-PMC4689556	['these data CONTRAST WITH RECENT FINDINGS that higher dose Vitamin D during Pregnancy and infancy CAN reduce Upper Respiratory Tract infections in infancy [38].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 97)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('UBERON_0001557', 'upper respiratory tract', 108, 'upper respiratory tract')]
PMC4689556	12/2015	S145-PMC4689556	['our NEW FINDINGS SUGGEST that Prenatal maternal Vitamin D levels MAY BE less IMPORTANT than Postnatal infant Vitamin D levels for determining infant health outcomes, AT LEAST within the insufficient/deficient range.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 65), ('IMPORTANT_CONSIDERATION', 77), ('PROBABLE_UNDERSTANDING', 166)]	5	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007567', 'parturition', 92, 'postnatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC4689556	12/2015	S149-PMC4689556	['[39]\nstudies in OTHER populations, USUALLY with higher Prenatal Vitamin D status THAN ours, have FOUND an inverse RELATIONSHIP between Cord Blood 25(Oh) Vitamin D level and child health outcomes [4].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('GO_0007565', 'female pregnancy', 55, 'prenatal'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 135, 'cord'), ('UBERON_0000178', 'blood', 140, 'blood'), ('CHEBI_30778', 'gallic acid', 146, '25(OH)'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4689556	12/2015	S151-PMC4689556	['the FINDINGS from our trial, the FIRST Prenatal Vitamin D intervention trial to report child health outcomes, SUGGEST that either the dosing regimen used in this study was INADEQUATE, OR that the RELATIONSHIP between Cord Blood 25(Oh) Vitamin D and child health SEEN in OBSERVATIONAL studies MAY BE RELATED to hidden CONFOUNDERS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 172), ('PROBLEM_COMPLICATION', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 196), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 270), ('INCOMPLETE_EVIDENCE', 292), ('SUPERFICIAL_RELATIONSHIP', 299), ('PROBLEM_COMPLICATION', 317)]	12	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0009472', 'axilla', 217, 'cord blood'), ('CHEBI_30778', 'gallic acid', 228, '25(OH)'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D')]
PMC4689556	12/2015	S165-PMC4689556	['), there REMAINS an IMPORTANT QUESTION WHETHER Prenatal Vitamin D supplementation at doses which reliably achieve sufficiency in the target population, CAN improve healthcare outcomes for young children.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 20), ('EXPLICIT_QUESTION', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 39), ('EXPLICIT_QUESTION', 39), ('INCOMPLETE_EVIDENCE', 152)]	6	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4689556	12/2015	S166-PMC4689556	['the RELATIONSHIP between Prenatal Vitamin D status and child health outcomes MAY not be linear.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 77)]	2	[('GO_0007565', 'female pregnancy', 25, 'prenatal'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC4689556	12/2015	S167-PMC4689556	['given that SOME observational studies SUGGEST adverse child Respiratory health outcomes are ASSOCIATED with very high maternal Vitamin D level during Pregnancy, empiric data ARE NEEDED before high dose Prenatal Vitamin D supplementation CAN be routinely RECOMMENDED [44].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 92), ('FUTURE_WORK', 174), ('INCOMPLETE_EVIDENCE', 237), ('FUTURE_WORK', 254)]	6	[('UBERON_0001004', 'respiratory system', 60, 'respiratory'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0007565', 'female pregnancy', 202, 'prenatal'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC4689556	12/2015	S171-PMC4689556	['a further LIMITATION of the study is its SMALL size and wide confidence intervals, SO that a small EFFECT of Prenatal Vitamin D on child healthcare utilization in the first 3 years CANNOT BE confidently EXCLUDED.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 83), ('SUPERFICIAL_RELATIONSHIP', 99), ('DIFFICULT_TASK', 181), ('INCOMPLETE_EVIDENCE', 203)]	6	[('GO_0007565', 'female pregnancy', 109, 'prenatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4689556	12/2015	S173-PMC4689556	['overall the data SUGGEST that a clinically meaningful RELATIONSHIP between this regime of Vitamin D supplementation in Pregnancy in a deficient population, or these levels of Vitamin D in Cord-Blood or at three years of age, and healthcare utilization is UNLIKELY.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 54), ('PROBABLE_UNDERSTANDING', 255)]	3	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 188, 'cord'), ('UBERON_0000178', 'blood', 193, 'blood')]
PMC4689556	12/2015	S180-PMC4689556	['HOWEVER, multivariate analysis of our data SHOWED that ALTHOUGH maternal ethnicity CORRELATED with 25(Oh) Vitamin D level there was no relationship between maternal ethnicity and our measures of healthcare utilization in this trial.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 55), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_30778', 'gallic acid', 99, '25(OH)'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4689556	12/2015	S181-PMC4689556	['in conclusion we have FOUND NO EVIDENCE that supplementation of a Vitamin D deficient, urban mixed race population with either a single Oral bolus dose of 200,000 iu Cholecalciferol at 27 weeks or 800 iu Ergocalciferol daily from 27 weeks until Delivery had any EFFECT on child healthcare utilization in the first 3 years of Life.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 262)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0000165', 'mouth', 136, 'oral'), ('CHEBI_52550', 'theopalauamide', 166, 'cholecalciferol'), ('CHEBI_4910', 'etomidate', 204, 'ergocalciferol'), ('GO_0007567', 'parturition', 245, 'delivery'), ('UBERON_0000104', 'life cycle', 325, 'life')]
PMC4689556	12/2015	S182-PMC4689556	['moreover we FOUND NO EVIDENCE of a relationship between Cord Blood 25(Oh) Vitamin D level and healthcare utilization in this population.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 18)]	2	[('UBERON_0009472', 'axilla', 56, 'cord blood'), ('CHEBI_30778', 'gallic acid', 67, '25(OH)'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC4689556	12/2015	S183-PMC4689556	['ALTHOUGH our confidence in the findings is LIMITED by the SMALL SAMPLE size, these data SUGGEST that IF Prenatal Vitamin D is used to promote improved child health outcome, then a Postnatal component to treatment, and/or or higher doses MAY BE NEEDED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 101), ('INCOMPLETE_EVIDENCE', 237), ('FUTURE_WORK', 244)]	7	[('GO_0007565', 'female pregnancy', 104, 'prenatal'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007567', 'parturition', 180, 'postnatal')]
PMC4689556	12/2015	S184-PMC4689556	['a RECENT systematic REVIEW of Prenatal Vitamin D supplementation FOUND HETEROGENEOUS study designs and INCONSISTENT findings [52].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	5	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4689556	12/2015	S185-PMC4689556	['outcomes of a subsequent intervention trial SUGGEST that higher dose Vitamin D, and POSSIBLY combined mother/infant supplementation MAY BE NEEDED for positive health EFFECTS on the child [38].']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 132), ('FUTURE_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 166)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4690051	12/2015	S0-PMC4690051	['Gestational vitamin 25(oh)d status as a risk factor for Receptive Language Development: a 24-month, longitudinal, observational study\n\nabstract\nemerging data suggest that Vitamin D status during childhood and Adolescence CAN AFFECT Neurocognitive Development.']	[('INCOMPLETE_EVIDENCE', 221), ('SUPERFICIAL_RELATIONSHIP', 225)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('GO_0000003', 'reproduction', 56, 'Receptive'), ('GO_0008584', 'male gonad development', 66, 'Language Development'), ('UBERON_0003215', 'alveolus', 66, 'Language'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 209, 'adolescence'), ('GO_0007399', 'nervous system development', 232, 'neurocognitive development')]
PMC4690051	12/2015	S12-PMC4690051	['WHILE THRESHOLDS for Vitamin D sufficiency HAVE BEEN DEBATED RECENTLY [10,11], low circulating levels of 25(Oh)D HAVE BEEN ASSOCIATED with increased mortality in black and white older adults dwelling in north america [12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 123)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 105, '25(OH)D')]
PMC4690051	12/2015	S18-PMC4690051	['this transport mechanism, along with OTHER Renal and Skeletal adaptations by aa [21,22,23], MAY buffer the developing Brain from ambient Vitamin D insufficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 92)]	2	[('UBERON_0002113', 'kidney', 43, 'renal'), ('UBERON_0004288', 'skeleton', 53, 'skeletal'), ('UBERON_0000955', 'brain', 118, 'brain'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4690051	12/2015	S76-PMC4690051	['using stepwise selection (0.20 for entry, 0.05 to stay) to remove the insignificant variables, we retained 25(Oh)D status in the model while assessing the following POSSIBLE CONFOUNDERS: race (aa or ea), maternal iq, use of tobacco products or Alcohol during Pregnancy, maternal dietary Intake of Vitamin D, age, pre-Pregnancy bmi, total number of completed Pregnancies, Gestational hypertension or Gestational diabetes, insurance status, level of maternal education, marital status, child’s age at cv2, and Gestational age at Birth.']	[('INCOMPLETE_EVIDENCE', 165), ('PROBLEM_COMPLICATION', 174)]	2	[('CHEBI_71657', 'versiconol acetate', 107, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 107, '25(OH)D'), ('CHEBI_30879', 'alcohol', 244, 'alcohol'), ('GO_0007565', 'female pregnancy', 259, 'pregnancy'), ('GO_0007631', 'feeding behavior', 287, 'intake'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D'), ('GO_0007565', 'female pregnancy', 317, 'pregnancy'), ('GO_0007565', 'female pregnancy', 358, 'pregnancies'), ('GO_0007565', 'female pregnancy', 371, 'gestational'), ('GO_0007565', 'female pregnancy', 399, 'gestational'), ('GO_0007565', 'female pregnancy', 508, 'gestational'), ('GO_0007567', 'parturition', 527, 'birth')]
PMC4690051	12/2015	S114-PMC4690051	['Animal studies provide biological PLAUSIBILITY for the HYPOTHESIS that in utero Vitamin D exposure AFFECTS Human Brain Development [39,40].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 107, 'human'), ('GO_0007420', 'brain development', 113, 'brain development'), ('UBERON_0000955', 'brain', 113, 'brain')]
PMC4690051	12/2015	S116-PMC4690051	['the presence of 1α-hydroxylase activity within numerous Brain Regions SUGGESTS that Brain Tissue can locally produce Metabolically active Vitamin D, further IMPLICATING a ROLE for Vitamin D in Brain Development.']	[('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 157), ('SUPERFICIAL_RELATIONSHIP', 171)]	3	[('UBERON_0002616', 'regional part of brain', 56, 'brain regions'), ('UBERON_0000955', 'brain', 84, 'brain'), ('UBERON_0000479', 'tissue', 90, 'tissue'), ('GO_0008152', 'metabolic process', 117, 'metabolically'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0007420', 'brain development', 193, 'brain development'), ('UBERON_0000955', 'brain', 193, 'brain')]
PMC4690051	12/2015	S117-PMC4690051	['Murine dams maintained on Vitamin D deficient diets before and during Pregnancy display alterations in Murine Brain morphology that COULD CONTRIBUTE to deficits in Memory, Learning, and attention processing [39].']	[('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 138)]	2	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Murine'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('NCBITaxon_39107', 'Murinae', 103, 'murine'), ('UBERON_0000955', 'brain', 110, 'brain'), ('GO_0007613', 'memory', 164, 'memory'), ('GO_0007612', 'learning', 172, 'learning')]
PMC4690051	12/2015	S135-PMC4690051	['Animal data SUGGEST the Genetic Expression of Fox2 , a regulator of Speech and Language, was lower in those on the Vitamin D deficiency diet at 14.5 days BUT Expression was higher at 17.5 days, compared to those on a Vitamin D sufficient diet [39].']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 154)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('SO_0000704', 'gene', 24, 'genetic'), ('GO_0010467', 'gene expression', 32, 'expression'), ('PR_000017653', 'zinc finger protein ZFPM2', 46, 'Fox2'), ('GO_0008380', 'RNA splicing', 68, 'speech'), ('GO_0006266', 'DNA ligation', 79, 'language'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('GO_0010467', 'gene expression', 158, 'expression'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC4690051	12/2015	S136-PMC4690051	['THESE FINDINGS SUGGEST that SOME compensatory mechanisms MAY exist to minimize EFFECTS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 79)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4690051	12/2015	S167-PMC4690051	['we RECENTLY REPORTED [57] that Dna Methylation is jointly Modulated by ancestry and Gestational Vitamin D levels, observations which SUPPORT multidimensional FACTORS.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 158)]	4	[('GO_0006306', 'DNA methylation', 31, 'DNA methylation'), ('GO_0065007', 'biological regulation', 58, 'modulated'), ('GO_0007565', 'female pregnancy', 84, 'gestational'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC4690051	12/2015	S171-PMC4690051	['the design also COULD NOT control for POTENTIAL CONFOUNDING by differences in sunscreen use, sun exposure (e.g., air pollution or outdoor lifestyles), culture, skin cover by clothing, or post-Natal Vitamin D intake via diet.']	[('DIFFICULT_TASK', 16), ('INCOMPLETE_EVIDENCE', 38), ('PROBLEM_COMPLICATION', 48)]	3	[('GO_0007567', 'parturition', 192, 'natal'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC4691762	12/2015	S0-PMC4691762	['vitality trial: protocol for a randomised controlled trial to establish the ROLE of Postnatal Vitamin D supplementation in infant Immune health\n\nabstract\n\nintroduction\nPostnatal Vitamin D supplementation MAY be ASSOCIATED with a reduction in Ige-mediated Food allergy, Lower Respiratory Tract infections and improved bone health.']	[('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 204), ('SUPERFICIAL_RELATIONSHIP', 211)]	3	[('GO_0007567', 'parturition', 84, 'postnatal'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('GO_0007567', 'parturition', 168, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007630', 'jump response', 242, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 242, 'IgE'), ('CHEBI_33290', 'food', 255, 'food'), ('GO_0007631', 'feeding behavior', 255, 'food'), ('UBERON_0004905', 'articulation', 269, 'lower respiratory tract')]
PMC4691762	12/2015	S13-PMC4691762	['LARGE SCALE trials of Postnatal Vitamin D for any disease outcome are LACKING.']	[('INCOMPLETE_EVIDENCE', 0), ('FULL_UNKNOWN', 70)]	2	[('GO_0007567', 'parturition', 22, 'postnatal'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4691762	12/2015	S15-PMC4691762	['introduction\nVitamin D is LIKELY to play a ROLE in early infant Immune health, with EMERGING EVIDENCE that early Life Vitamin D deficiency increases the risk of developing childhood diseases such as Food allergy1lower Respiratory infections (lris)2and eczema.3a marked shift to Vitamin D deficiency in early Life in modern populations MAY BE an underlying driver of the REPORTED rise in allergic diseases including Food allergy and eczema.']	[('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 370)]	5	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0002405', 'immune system', 64, 'immune'), ('UBERON_0000104', 'life cycle', 113, 'life'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 199, 'food'), ('UBERON_0001004', 'respiratory system', 218, 'respiratory'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D'), ('UBERON_0000104', 'life cycle', 308, 'life'), ('CHEBI_33290', 'food', 415, 'food')]
PMC4691762	12/2015	S17-PMC4691762	['RECENT EVIDENCE SUGGESTS that low Vitamin D at Birth or during Infancy is ASSOCIATED with an increased RISK of Food allergy6and eczema.7in addition Food allergy and eczema prevalence is higher the further from the equator a Person resides, LENDING SUPPORT to the HYPOTHESES that low Vitamin D (through low ultraviolet (uv) exposure) MAY play a ROLE in aberrant Immune Development in early Life and increase the risk of developing Food allergy and eczema.3food allergy is one of the earliest manifestations of the Immune deviation,8but also STRONGLY COASSOCIATES with eczema in infancy and asthma later in Life.9\nVitamin D supplementation in the first year of Life has also BEEN ASSOCIATED with a reduced risk of lris10and reduced recovery time in infants with acute bronchiolitis.11since early Life wheezy lris are also strongly ASSOCIATED with longer term respiratory outcomes including asthma12understanding the ROLE of Vitamin D in the RISK of early Life Respiratory diseases is also IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 263), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 333), ('SUPERFICIAL_RELATIONSHIP', 344), ('PROBABLE_UNDERSTANDING', 540), ('SUPERFICIAL_RELATIONSHIP', 549), ('ANOMALY_CURIOUS_FINDING', 673), ('SUPERFICIAL_RELATIONSHIP', 678), ('SUPERFICIAL_RELATIONSHIP', 829), ('SUPERFICIAL_RELATIONSHIP', 914), ('IMPORTANT_CONSIDERATION', 939), ('IMPORTANT_CONSIDERATION', 987)]	18	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007567', 'parturition', 47, 'birth'), ('GO_0007631', 'feeding behavior', 63, 'infancy'), ('CHEBI_33290', 'food', 111, 'food'), ('CHEBI_33290', 'food', 148, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'person'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0001822', 'kidney development', 361, 'immune development'), ('UBERON_0002405', 'immune system', 361, 'immune'), ('UBERON_0000104', 'life cycle', 389, 'life'), ('CHEBI_33290', 'food', 430, 'food'), ('UBERON_0002405', 'immune system', 513, 'immune'), ('UBERON_0000104', 'life cycle', 605, 'life'), ('CHEBI_28384', 'vitamin K', 612, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 659, 'life'), ('UBERON_0000104', 'life cycle', 794, 'life'), ('CHEBI_27300', 'vitamin D', 922, 'vitamin D'), ('UBERON_0000104', 'life cycle', 953, 'life'), ('UBERON_0001004', 'respiratory system', 958, 'respiratory')]
PMC4691762	12/2015	S25-PMC4691762	['the study is restricted to Breast Fed infants because formula Feeding from Birth can be equivalent to Vitamin D supplementation as formula contains APPROXIMATELY 400\u2005iu of Vitamin D/l.']	[('INCOMPLETE_EVIDENCE', 148)]	1	[('GO_0007567', 'parturition', 27, 'breast'), ('GO_0007631', 'feeding behavior', 34, 'fed'), ('GO_0007631', 'feeding behavior', 62, 'feeding'), ('GO_0007567', 'parturition', 75, 'birth'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC4691762	12/2015	S70-PMC4691762	['parent questionnaire (3 monthly) : to capture dietary Vitamin D intake and environmental uv radiation (uvr) exposure, we will ask questions about maternal Vitamin D supplements, infant diet, maternal and infant sun exposure and sun Protective behaviours as in our PREVIOUS work,15for example, number of hours spent in the sun per day, during summer or winter, weekends and holidays, will be collected for mother and child.']	[('INCOMPLETE_EVIDENCE', 264)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0019230', 'proprioception', 232, 'protective')]
PMC4691762	12/2015	S79-PMC4691762	['it will MODEL the POTENTIAL cost-effectiveness of routine infant Vitamin D supplementation compared to no supplementation, ASSUMING australia-wide implementation.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 73, 'D')]
PMC4691762	12/2015	S105-PMC4691762	['we will monitor the CURRENT literature including changes in australian guidelines for infant Vitamin D dosing and send a quarterly report to the dsmc who will make decisions regarding any requirements for trial discontinuation.']	[('INCOMPLETE_EVIDENCE', 20)]	1	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4691762	12/2015	S106-PMC4691762	['we will not be monitoring Serum 25(Oh)D for safety reasons nor considering the association between 25(Oh)D and outcome frequency given that 400\u2005Iu HAS BEEN SHOWN to be SAFE in term babies,1926preterm infants27and is the current RECOMMENDED dose in the usa, canada, the uk and europe.18\n\ndiscussion\nthe results of the vitality trial will determine WHETHER Vitamin D supplementation has a ROLE in optimising infant Immune health in the first year of Life, reducing the risk of allergic disease and Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 168), ('FUTURE_WORK', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('SUPERFICIAL_RELATIONSHIP', 387)]	5	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 32, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 99, '25(OH)D'), ('CHEBI_17883', 'hydrogen chloride', 144, 'IU'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin D'), ('UBERON_0002405', 'immune system', 413, 'immune'), ('UBERON_0000104', 'life cycle', 448, 'life'), ('UBERON_0001004', 'respiratory system', 496, 'respiratory')]
PMC4691762	12/2015	S107-PMC4691762	['furthermore FINDINGS will provide EVIDENCE to inform GUIDELINES for Vitamin D supplementation of infants.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 53)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4691762	12/2015	S108-PMC4691762	['this will be the FIRST population-based trial of Postnatal infant Vitamin D supplementation sufficiently powered to address the IMPACT on any disease outcome including allergic disease, lris and bone health.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 128)]	2	[('GO_0007567', 'parturition', 49, 'postnatal'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4691762	12/2015	S113-PMC4691762	['restricting the trial to infants with Vitamin D deficiency would REQUIRE a smaller trial, HOWEVER it would be UNETHICAL to randomise these infants to placebo thereby not treating with Vitamin D. the use of Vitamin D supplements in the placebo group is ANOTHER POTENTIAL ISSUE HOWEVER we are collecting sufficient data regarding Feeding practices, Supplement use and sun exposure to account for this.']	[('FUTURE_WORK', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('DIFFICULT_TASK', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('INCOMPLETE_EVIDENCE', 260), ('PROBLEM_COMPLICATION', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 276)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007631', 'feeding behavior', 328, 'feeding'), ('CHEBI_16158', 'steroid sulfate', 347, 'supplement')]
PMC4691762	12/2015	S114-PMC4691762	['there are several PLAUSIBLE biological mechanisms for the ROLE of Vitamin D in early infant, Immune health.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0002405', 'immune system', 93, 'immune')]
PMC4691762	12/2015	S118-PMC4691762	['it acts by inducing Antimicrobial peptides in Epithelial Cells, Neutrophils and Macrophages28And increases transcription of the innate Immune protein (hcap-18) which is capable of killing a wide variety of Viral and bacterial pathogens.29THESE FINDINGS are SUPPORTED by the observation that Vitamin D receptor polymorphisms (which decrease the bioavailability of Vitamin D to the cell) are ASSOCIATED with more SEVERE bronchiolitis30and that defective Control Of Vitamin D receptor-Mediated Cell Signalling PREDISPOSES to SEVERE Respiratory syncytial Virus bronchiolitis.31\n\nconclusions\ninternational enthusiasm for supplemental Vitamin D has OUTPACED AVAILABLE EVIDENCE on its EFFECTIVENESS32AND in fact ARGUMENT for routine supplementation is in equipoise.']	[('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 411), ('SUPERFICIAL_RELATIONSHIP', 507), ('IMPORTANT_CONSIDERATION', 522), ('ANOMALY_CURIOUS_FINDING', 643), ('ANOMALY_CURIOUS_FINDING', 643), ('INCOMPLETE_EVIDENCE', 652), ('SUPERFICIAL_RELATIONSHIP', 678), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 705)]	11	[('CHEBI_65381', 'albizoside C', 20, 'antimicrobial'), ('CL_0000066', 'epithelial cell', 46, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 46, 'epithelial'), ('CL_0000775', 'neutrophil', 64, 'neutrophils'), ('CL_0000091', 'Kupffer cell', 80, 'macrophages28and'), ('UBERON_0002405', 'immune system', 135, 'immune'), ('NCBITaxon_1', 'root', 206, 'viral'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('GO_0060070', 'canonical Wnt signaling pathway', 452, 'control of ... -mediated cell signalling'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 529, 'respiratory'), ('NCBITaxon_1', 'root', 551, 'virus'), ('CHEBI_27300', 'vitamin D', 629, 'vitamin D')]
PMC4691762	12/2015	S119-PMC4691762	['if FOUND to be both efficacious and cost-effective, Vitamin D infant supplementation would provide a readily available, low harm INTERVENTION that would optimise infant Immune health in the first year of Life and significantly reduce the population BURDEN of allergic disease.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 129), ('IMPORTANT_CONSIDERATION', 249)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002405', 'immune system', 169, 'immune'), ('UBERON_0000104', 'life cycle', 204, 'life')]
PMC4691762	12/2015	S120-PMC4691762	['the vitality trial will also enable a FUTURE evaluation of WHETHER Postnatal Vitamin D supplementation is ASSOCIATED with IMPROVED bone health in later childhood—the historical basis of widespread Postnatal Vitamin D supplementation, which REMAINS essentially UNTESTED.']	[('FUTURE_WORK', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 106), ('IMPORTANT_CONSIDERATION', 122), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 260)]	6	[('GO_0007567', 'parturition', 67, 'postnatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'postnatal'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC4765528	12/2015	S117-PMC4765528	['one of the MODELS that HAS BEEN POSTULATED is the ROLE of maternal Vitamin D status and Postnatal calcium transfer.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 50)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 88, 'postnatal')]
PMC4765528	12/2015	S118-PMC4765528	['early work on methylation and Vitamin D Receptors and Placental calcium transporters SUGGESTS that epigenetic Regulation MIGHT explain HOW maternal Vitamin D levels AFFECT bone mineralization in the neonate [51].']	[('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 121), ('EXPLICIT_QUESTION', 135), ('SUPERFICIAL_RELATIONSHIP', 165)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 30, 'vitamin D receptors'), ('UBERON_0001987', 'placenta', 54, 'placental'), ('GO_0065007', 'biological regulation', 110, 'regulation'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4765528	12/2015	S123-PMC4765528	['studies using the alspac cohort SHOW that Bone Development of the child is clearly RELATED to the in utero environment, BUT that SOME of the ASSOCIATIONS CAN be explained IN PART by the shared ASSOCIATIONS with bone and body size, ALTHOUGH maternal Vitamin D status exerts persisting EFFECTS on bone mass development [19].']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 141), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 193), ('ANOMALY_CURIOUS_FINDING', 231), ('SUPERFICIAL_RELATIONSHIP', 284)]	10	[('GO_0048539', 'bone marrow development', 42, 'bone development'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC4765528	12/2015	S124-PMC4765528	['FINDINGS from the southampton women’ survey also CORROBORATE the ROLE of low maternal Vitamin D levels on offspring bone mass and SUGGESTS that the mechanism is RELATED to Umbilical Venous calcium concentrations [56,58].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 161)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0007118', 'umbilicus', 172, 'umbilical'), ('UBERON_0001638', 'vein', 182, 'venous')]
PMC4765528	12/2015	S125-PMC4765528	['further work from that group also SUGGESTS that maternal Vitamin D stores CAN INFLUENCE Fetal Femoral Development at as early as 19 weeks Gestation [59].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007631', 'feeding behavior', 88, 'fetal'), ('GO_0009556', 'microsporogenesis', 94, 'femoral development'), ('UBERON_0000981', 'femur', 94, 'femoral'), ('GO_0007565', 'female pregnancy', 138, 'gestation')]
PMC4996336	12/2015	S18-PMC4996336	['two of THESE STUDIES INVOLVED Calcium supplementation,16,17one INVOLVED supplementation with Calcium plus Vitamin D,18two INVOLVED supplementation with zinc,19,20and one included four intervention arms in females of Childbearing age (i.e.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_22313', 'alkaline earth metal atom', 30, 'calcium'), ('CHEBI_22313', 'alkaline earth metal atom', 93, 'calcium'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 216, 'childbearing')]
PMC4714725	1/2016	S96-PMC4714725	['ab, a Micronutrients and Herbal supplements\nthere is NO CLEAR EVIDENCE that dietary supplementation with Vitamins, Minerals, herbs, or spices CAN improve diabetes, and there MAY BE safety CONCERNS regarding the long-term use of antioxidant supplements such as Vitamins E and C and Carotene.c Alcohol\nadults with diabetes who drink alcohol SHOULD do so in moderation (no more than one drink per day for Adult women and no more than two drinks per day for Adult men).c\nAlcohol Consumption MAY place People with diabetes at INCREASED risk for delayed hypoglycemia, ESPECIALLY IF taking Insulin or Insulin secretagogues.']	[('FULL_UNKNOWN', 53), ('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 174), ('PROBLEM_COMPLICATION', 188), ('FUTURE_WORK', 339), ('INCOMPLETE_EVIDENCE', 487), ('IMPORTANT_CONSIDERATION', 521), ('ANOMALY_CURIOUS_FINDING', 562), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 573)]	10	[('CHEBI_34850', 'milrinone lactate', 6, 'Micronutrients'), ('NCBITaxon_7955', 'Danio rerio', 25, 'herbal'), ('CHEBI_33277', 'gamma-tocotrienol', 105, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 115, 'minerals'), ('CHEBI_27300', 'vitamin D', 260, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 275, 'C'), ('PR_000004900', 'complement C3', 275, 'C'), ('CHEBI_23042', 'carotene', 281, 'carotene'), ('CHEBI_30879', 'alcohol', 292, 'Alcohol'), ('UBERON_0007023', 'adult organism', 402, 'adult'), ('UBERON_0007023', 'adult organism', 454, 'adult'), ('CHEBI_30879', 'alcohol', 467, 'Alcohol'), ('GO_0007631', 'feeding behavior', 475, 'consumption'), ('NCBITaxon_10088', 'Mus <genus>', 497, 'people'), ('PR_000045358', 'insulin family protein', 583, 'insulin'), ('PR_000045358', 'insulin family protein', 594, 'insulin')]
PMC4714725	1/2016	S282-PMC4714725	['management of ckd in diabetesgfr (ml/min/1.73 m2)recommended managementall patientsyearly measurement of creatinine, uacr, potassium45–60referral to a nephrologist IF POSSIBILITY for nondiabetic Kidney disease exists (duration of type 1 diabetes <10 years, persistent albuminuria, abnormal findings on Renal ultrasound, resistant hypertension, rapid fall in egfr, or active Urinary sediment on Urine microscopic examination)consider THE NEED for dose adjustment of Medicationsmonitor egfr every 6 monthsmonitor electrolytes, bicarbonate, hemoglobin, calcium, Phosphorus, and Parathyroid hormone at least yearlyassure Vitamin D sufficiencyconsider bone density testingreferral for dietary counseling30–44monitor egfr every 3 monthsmonitor electrolytes, bicarbonate, calcium, phosphorus, Parathyroid hormone, hemoglobin, albumin, and weight every 3–6 monthsconsider the need for dose adjustment of Medications<30referral to a nephrologist\n\ndiabetic retinopathy\n\nrecommendations\n\noptimize Glycemic Control to reduce the RISK or slow the progression of diabetic retinopathy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 164), ('INCOMPLETE_EVIDENCE', 167), ('INCOMPLETE_EVIDENCE', 433), ('IMPORTANT_CONSIDERATION', 1017)]	4	[('UBERON_0002113', 'kidney', 195, 'kidney'), ('UBERON_0002113', 'kidney', 302, 'renal'), ('UBERON_0001088', 'urine', 374, 'urinary'), ('UBERON_0001088', 'urine', 394, 'urine'), ('CHEBI_25354', 'mineralocorticoid', 465, 'medicationsMonitor'), ('CHEBI_35885', 'secondary phosphine', 559, 'phosphorus'), ('UBERON_0001132', 'parathyroid gland', 575, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 617, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 786, 'parathyroid'), ('CHEBI_25441', 'mycothiols', 896, 'medications'), ('GO_0006094', 'gluconeogenesis', 986, 'glycemic control')]
PMC4719746	1/2016	S13-PMC4719746	['in europe, Vitamin D deficiency is REPORTED to be PREVALENT among Pregnant ethnic minority women in the netherlands [2] and uk [3], but is also OBSERVED in the majority population [3–5].']	[('INCOMPLETE_EVIDENCE', 35), ('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 144)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnant')]
PMC4719746	1/2016	S14-PMC4719746	['LITTLE IS KNOWN about the prevalence of Vitamin D deficiency among asian and african Pregnant women living in northern europe, although a FEW SMALL STUDIES from sweden [6,7] and norway [8] report a high prevalence of Vitamin D deficiency among somali and pakistani women.']	[('FULL_UNKNOWN', 0), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 142)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnant'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC4719746	1/2016	S15-PMC4719746	['there are FEW population-based STUDIES exploring Vitamin D deficiency in Pregnancy in today’s multiethnic europe, and LITTLE IS KNOWN about the IMPACT of socioeconomic status or the EFFECT of Vitamin D supplements [9,10].']	[('INCOMPLETE_EVIDENCE', 10), ('FULL_UNKNOWN', 118), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 182)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC4719746	1/2016	S18-PMC4719746	['HOWEVER, the current state of evidence SUGGESTS unclear benefits of routine Vitamin D supplementation for most maternal or child health outcomes [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 39)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4719746	1/2016	S20-PMC4719746	['DESPITE the CONTROVERSIES RELATED to adverse outcomes, and LACK OF EVIDENCE of clear benefits of routine supplementation, most western countries RECOMMEND Vitamin D supplementation during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 59), ('FUTURE_WORK', 145)]	5	[('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnancy')]
PMC4719746	1/2016	S38-PMC4719746	['in THIS PAPER, Vitamin D deficiency was DEFINED AS 25(Oh) D <50\xa0nmol/l, and severe Vitamin D deficiency was DEFINED as 25(Oh) D <25\xa0nmol/l, IN ACCORDANCE WITH RELEVANT LITERATURE [20].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 48), ('PROBABLE_UNDERSTANDING', 108), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 159), ('INCOMPLETE_EVIDENCE', 168)]	7	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH) D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 121, '(OH) D')]
PMC4719746	1/2016	S50-PMC4719746	['the RECOMMENDATION of Vitamin D supplementation\npre-planned, and ACCORDING TO the protocol, women with 25(Oh)D less than the laboratory’s lower reference range (<37\xa0nmol/l) at Gestational week 15 were provided with written information describing their 25(Oh)D D concentration, and they were RECOMMENDED to consult their general practitioner (gp) for treatment.']	[('FUTURE_WORK', 4), ('INCOMPLETE_EVIDENCE', 65), ('FUTURE_WORK', 291)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('GO_0007565', 'female pregnancy', 176, 'gestational'), ('CHEBI_29156', 'Gly-tRNA(Gly)', 252, '25(OH)D D'), ('PR_000007367', 'fibrosin-1-like protein', 252, '25(OH)D D')]
PMC4719746	1/2016	S54-PMC4719746	['we have NO INFORMATION on the exact dose of Vitamin D supplements taken if SELF-REPORTED intake was >10\xa0μg/day.']	[('FULL_UNKNOWN', 8), ('INCOMPLETE_EVIDENCE', 75)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4719746	1/2016	S63-PMC4719746	['explanatory linear regression models were performed TO ASSESS the relationship between ethnicity and the concentration of 25(Oh)D, both at inclusion and in Gestational week 28, accounting for the following POTENTIAL CONFOUNDING FACTORS: Gestational week, age, parity, season, education, Vitamin D supplements and pre-Pregnancy bmi.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('INCOMPLETE_EVIDENCE', 206), ('PROBLEM_COMPLICATION', 216)]	3	[('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 128, 'D'), ('GO_0007565', 'female pregnancy', 156, 'gestational'), ('GO_0007565', 'female pregnancy', 237, 'gestational'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('GO_0007565', 'female pregnancy', 317, 'pregnancy')]
PMC4719746	1/2016	S87-PMC4719746	['crude mean (sd) Vitamin D [25(Oh)D in nmol/l] levels according to POTENTIAL explanatory factorsat inclusionat Gestational week 28 n \u2009=\u2009748 n \u2009=\u2009748mean(sd)mean(sd)overall mean 25(Oh)d50(27)59(29)age at inclusion\u2009\u2009\u2009≤30\xa0years47(25)55(27)\u2009\u2009\u2009>30\xa0years54(28)62(30)parity (para 0 ref)53(26)61(29)\u2009\u2009\u2009para 152(28)59(27)\u2009\u2009\u2009para ≥242(25)52(30)western europe (ref)69(24)72(28)\u2009\u2009\u2009south asia32(19)46(23)\u2009\u2009\u2009middle east34(20)51(29)\u2009\u2009\u2009sub-saharan africa38(18)45(25)\u2009\u2009\u2009east asia51(17)53(19)\u2009\u2009\u2009other56(21)63(26)season of Blood sample\u2009\u2009\u2009summer56(29)60(29)\u2009\u2009\u2009winter46(24)57(27)education level (>12\xa0years ref)60(27)67(27)\u2009\u2009\u200910-12 years46(25)56(29)\u2009\u2009\u2009<10\xa0years37(20)44(23)Vitamin D supplements\u2009\u2009\u2009≥10\xa0μga57(26)61(28)\u2009\u2009\u2009no or <10\xa0μg42(26)53(29)pre-Pregnancy bmi; kg/m2(normal weight (<25) ref)51(27)59(29)\u2009\u2009\u2009overweight (≥25/<30)51(27)61(31)\u2009\u2009\u2009obesity (≥30)48(24)54(24)\naintake of ≥10\xa0μg Vitamin D daily past two weeks\n\ncaption (fig): fig.']	[('INCOMPLETE_EVIDENCE', 66)]	1	[('CHEBI_28384', 'vitamin K', 16, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 16, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 27, '25 ... OH ... D'), ('GO_0007565', 'female pregnancy', 110, 'gestational'), ('CHEBI_30778', 'gallic acid', 176, '25(OH)'), ('UBERON_0000178', 'blood', 503, 'blood'), ('CHEBI_28384', 'vitamin K', 650, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 724, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 863, 'vitamin D')]
PMC4719746	1/2016	S104-PMC4719746	['ONLY 37\xa0% of these women reported an intake of ≥10\xa0μg/day of Vitamin D supplements, BUT at Gestational week 28, this proportion had increased to 73\xa0% ( p \u2009<\u20090.01).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 84)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'gestational')]
PMC4719746	1/2016	S118-PMC4719746	['women with <37\xa0nmol/l at baseline were RECOMMENDED 20\xa0μg or 30\xa0μg Vitamin D daily\n\ndiscussion\n\nmain findings\nin THIS cohort study we FOUND a high prevalence of Vitamin D deficiency (<50\xa0nmol/l) in early Pregnancy among women from south asia, middle east and sub-saharan africa, and severe deficiency (<25\xa0nmol/l) was prevalent among women from these regions.']	[('FUTURE_WORK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('INCOMPLETE_EVIDENCE', 133)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC4719746	1/2016	S131-PMC4719746	['INTERPRETATION\nOUR FINDINGS are IN LINE WITH others CONFIRMING widespread Vitamin D deficiency during Pregnancy among ethnic minorities [2,3,11,23,24], although SOME STUDIES from northern europe have FOUND a comparatively higher prevalence and more SEVERE deficiency THAN observed in OUR STUDY [6,25].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 52), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 200), ('IMPORTANT_CONSIDERATION', 249), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 267), ('QUESTION_ANSWERED_BY_THIS_WORK', 284)]	9	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy')]
PMC4719746	1/2016	S132-PMC4719746	['RECENT STUDIES from the same part of oslo MAY have increased AWARENESS of Vitamin D deficiency among health personnel [26–28], which MAY have CONTRIBUTED to the SOMEWHAT lower prevalence of Vitamin D deficiency in ethnic minorities in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 61), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 161), ('QUESTION_ANSWERED_BY_THIS_WORK', 235)]	7	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC4719746	1/2016	S133-PMC4719746	['HOWEVER, direct comparison of 25(Oh)D values between studies are hampered by DIFFERENT methodologies such as INCONSISTENT definitions of Vitamin D deficiency, laboratory measurements and degree of adjustment for POSSIBLE CONFOUNDERS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('INCOMPLETE_EVIDENCE', 212), ('PROBLEM_COMPLICATION', 221)]	5	[('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4719746	1/2016	S134-PMC4719746	['most studies that we IDENTIFIED were cross-sectional, and FEW adjusted for Intake of Vitamin D supplements, education, parity and seasonal variance [5,29].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 58)]	2	[('GO_0007631', 'feeding behavior', 75, 'intake'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4719746	1/2016	S139-PMC4719746	['our data also INDICATED that low SELF-REPORTED Intake of Vitamin D supplements was an INDEPENDENT RISK FACTOR for Vitamin D deficiency, also FOUND in an irish study [3].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 141)]	5	[('GO_0007631', 'feeding behavior', 47, 'intake'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4719746	1/2016	S147-PMC4719746	['SEVERAL STUDIES among Pregnant women have SHOWED a marked increase in 25(Oh)D with daily supplements of Vitamin D [11,24,43,44].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 42)]	2	[('GO_0007565', 'female pregnancy', 22, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4719746	1/2016	S149-PMC4719746	['HOWEVER, SOME EVIDENCE SUGGESTS Vitamin D binding protein MAY increase and the free fraction of 25(Oh)D MAY decrease [46,47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 104)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D')]
PMC4719746	1/2016	S150-PMC4719746	['in women who were RECOMMENDED daily Vitamin D supplements of 20\xa0μg or 30\xa0μg due to low values in early Pregnancy, we OBSERVED an increase in self-reported use of supplements at the follow-up visit.']	[('FUTURE_WORK', 18), ('INCOMPLETE_EVIDENCE', 117)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy')]
PMC4719746	1/2016	S152-PMC4719746	['the SMALL increase of 25(Oh)D OBSERVED among women with a slight deficiency at baseline who did not receive the recommendation, MAY BE RELATED to usual practices in norway of routinely RECOMMENDING a daily intake of 10\xa0μg Vitamin D as part of Antenatal Care [21].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 135), ('FUTURE_WORK', 185)]	5	[('CHEBI_71657', 'versiconol acetate', 22, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 22, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 243, 'antenatal care')]
PMC4719746	1/2016	S154-PMC4719746	['compared with no change or a small increase in 25(Oh)D concentrations in women with adequate levels or mild Vitamin D deficiency, this DIFFERENTIAL change may INDICATE a beneficial EFFECT of the RECOMMENDATIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 181), ('FUTURE_WORK', 195)]	4	[('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 53, 'D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4719746	1/2016	S155-PMC4719746	['HOWEVER, it SHOULD BE NOTED that severe Vitamin D deficiency was STILL FOUND in 15-20\xa0% of the high risk groups.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 12), ('ANOMALY_CURIOUS_FINDING', 22), ('IMPORTANT_CONSIDERATION', 65), ('INCOMPLETE_EVIDENCE', 71)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4719746	1/2016	S158-PMC4719746	['conclusion\nwe FOUND that Vitamin D deficiency was PREVALENT among south asian, middle eastern and african women in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 50)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 121, 'pregnancy')]
PMC4728620	1/2016	S137-PMC4728620	['furthermore, a trial that provided a teaspoonful of cod Liver oil (free of Vitamin A and D) from 9 to 12 month of age FOUND an increase in voluntary attention in a free play test after the intervention, ESPECIALLY in boys, compared with un-supplemented children [73].']	[('INCOMPLETE_EVIDENCE', 118), ('ANOMALY_CURIOUS_FINDING', 203)]	2	[('UBERON_0002107', 'liver', 56, 'liver'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 83, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 89, 'D')]
PMC4729160	1/2016	S22-PMC4729160	['the MAJORITY of studies focus on vad of Pregnant women, it FOUND Vitamin A deficiency was strongly ASSOCIATED with Pregnancy and Birth outcomes.']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('GO_0007565', 'female pregnancy', 40, 'pregnant'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin A'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('GO_0007567', 'parturition', 129, 'birth')]
PMC4729160	1/2016	S23-PMC4729160	['they FOUND Antenatal Vitamin A supplementation decreased anemia [4,5], Preterm Delivery [5,6], Intrauterine growth retardation [6], low Birth weight [4], deformity [7], preeclampsia/eclampsia [8,9], poor infant growth [4], neonatal and infant mortality [4,10], and maternal mortality [10,11].']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('GO_0007567', 'parturition', 11, 'antenatal'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('GO_0007565', 'female pregnancy', 71, 'preterm'), ('GO_0007567', 'parturition', 79, 'delivery'), ('UBERON_0022293', 'reproductive gland secretion', 95, 'intrauterine'), ('GO_0007567', 'parturition', 136, 'birth')]
PMC4729160	1/2016	S25-PMC4729160	['a PREVIOUS STUDY [12] which BASED ON SMALL sample size FOUND that chinese Pregnant women’s Vitamin A concentration was 1.13\u2009±\u20090.37\xa0μmol/l, and 24 of 143 Pregnant women (16.80\xa0%) was Vitamin A deficiency, while another 52 Pregnant women (36.4\xa0%) was marginal Vitamin A deficiency.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 55)]	4	[('GO_0007565', 'female pregnancy', 74, 'pregnant'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin A'), ('GO_0007565', 'female pregnancy', 153, 'pregnant'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin A'), ('GO_0007565', 'female pregnancy', 221, 'pregnant'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin A')]
PMC4729160	1/2016	S87-PMC4729160	['62(0.24–1.62)–\u2003general rural areas72840.94(0.42–2.13)–\u2003poor rural areas332383.48(1.72–7.03)a4.73(2.67–8.41)acollege or university\u2003no527802.03(1.07–3.85)a3.17 (1.51–6.67)a\u2003yes1236511income\u2003\u2009<\u200910,000141854.60(1.30–16.24)a4.91 (1.31–18.46)a\u200310,000–20,000223174.21(1.24–14.26)a4.33 (1.18–15.90)a\u200320,000–30,000254613.29(0.98–11.03)a3.64 (1.01–13.16)a\u2003\u2009>\u2009=30,000318211drinking\u2003yes201184.00(2.26–6.94)a3.10 (1.65–5.81)a\u2003no44102711smoking\u2003non-smoker without passive smoking2452911\u2003non-smoker with passive smoking315941.15(0.67–1.99)–\u2003smokers9229.02(3.75–21.67)a5.68 (2.23–14.49)agestational age\u2003first trimester1046111\u2003second trimester182743.03(1.38–6.66)a2.40(1.05–5.46)a\u2003third trimester364104.05(1.98–8.26)a2.82(1.34–5.93)a\nastatistically significant at 0.05 level of significance\n\ndiscussion\nOUR STUDY FIRST REPORTED about the Vitamin A nutritional status in a large group of chinese Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 786), ('INCOMPLETE_EVIDENCE', 796), ('INCOMPLETE_EVIDENCE', 802)]	3	[('CHEBI_27300', 'vitamin D', 821, 'vitamin A'), ('GO_0007565', 'female pregnancy', 878, 'pregnant')]
PMC4729160	1/2016	S100-PMC4729160	['the PRESENT STUDY SHOWED that Retinol concentrations of anemia and Pregnant women with Vitamin A supplements were higher than no anemia and Pregnant women without Vitamin A supplements.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 18)]	2	[('CHEBI_26536', 'retinoic acid', 30, 'retinol'), ('GO_0007565', 'female pregnancy', 67, 'pregnant'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin A'), ('GO_0007565', 'female pregnancy', 140, 'pregnant'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin A')]
PMC4729160	1/2016	S108-PMC4729160	['this MAY REFLECT a TRUE reduction in Vitamin A stores with increasing Gestation, as PROPOSED by a large trial of weekly Vitamin A supplementation in bangladesh [24].']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 19), ('INCOMPLETE_EVIDENCE', 84)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('GO_0007565', 'female pregnancy', 70, 'gestation'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A')]
PMC4729160	1/2016	S117-PMC4729160	['the REASON MAYBE that population was easily to access to Foods rich in preformed Vitamin A.']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 11)]	2	[('CHEBI_33290', 'food', 57, 'foods'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 89, 'A')]
PMC4729160	1/2016	S127-PMC4729160	['it is also LACK OF assessment of the participants’ physical behavior condition which INFLUENCES Vitamin A status of chinese Pregnant women.']	[('FULL_UNKNOWN', 11), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('GO_0007565', 'female pregnancy', 124, 'pregnant')]
PMC4729160	1/2016	S129-PMC4729160	['conclusions\nIN SUMMARY, THE CURRENT STUDY REPORTED the prevalence of Vitamin A among chinese Pregnant women and the prevalence of vad was 5.3\xa0%, which was a MILD PUBLIC-HEALTH ISSUE in china.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 162), ('IMPORTANT_CONSIDERATION', 176)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A'), ('GO_0007565', 'female pregnancy', 93, 'pregnant')]
PMC4764019	1/2016	S7-PMC4764019	['the barker HYPOTHESIS HAS BEEN ELABORATED and evaluated in several reviews,2–4BUT TO THE BEST OF MY KNOWLEDGE, there HAS BEEN NO ATTEMPT to evaluate the HYPOTHESIS specifically for Vitamin D. THUS, what i PROPOSE TO explore in THIS very brief REVIEW is the EVIDENCE RELATING UNRECOGNIZED, Perinatal Vitamin D inadequacy to increased risk of certain chronic diseases later in Life, that is, to ascertain WHETHER any such EFFECTS MIGHT be an instance of the “barker HYPOTHESIS.”\ni deliberately avoid use of labels such as “deficient” or “insufficient” in characterizing Vitamin D status, AS these terms are OFTEN LINKED to specific values for serum 25-Hydroxyvitamin D [25(Oh)D], about which there is considerable CONTROVERSY.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 153), ('PROBABLE_UNDERSTANDING', 192), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 243), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 266), ('INCOMPLETE_EVIDENCE', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('SUPERFICIAL_RELATIONSHIP', 420), ('INCOMPLETE_EVIDENCE', 428), ('INCOMPLETE_EVIDENCE', 464), ('PROBABLE_UNDERSTANDING', 586), ('PROBABLE_UNDERSTANDING', 605), ('SUPERFICIAL_RELATIONSHIP', 611), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 712)]	25	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('GO_0036268', 'swimming', 289, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 289, 'perinatal'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('UBERON_0000104', 'life cycle', 375, 'life'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 647, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 668, '25(OH)D')]
PMC4764019	1/2016	S8-PMC4764019	['INSTEAD, i use terms such as “low” or “inadequate,” referencing in each such use prevailing values for Vitamin D status or input relative to values FOUND in those Individuals who do not manifest the disorders concerned.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 148)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('NCBITaxon_1', 'root', 163, 'individuals')]
PMC4764019	1/2016	S17-PMC4764019	['autoimmune disorders\ntwo SERIOUS Autoimmune diseases HAVE BEEN LINKED to low Vitamin D status in early Life, type 1 diabetes mellitus (dm1) and multiple sclerosis (ms).']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0001442', 'skeleton of manus', 33, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0000104', 'life cycle', 103, 'life')]
PMC4764019	1/2016	S18-PMC4764019	['the eurodiab STUDY5SHOWED that 7 european centers that practiced regular Vitamin D supplementation during infancy had a 33% lower incidence of juvenile diabetes prior to age 15 years than centers that DID NOT ENCOURAGE regular supplementation.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 201), ('FUTURE_WORK', 209)]	3	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4764019	1/2016	S36-PMC4764019	['pregnancy complications\none of the most STRIKING and SURPRISING findings to emerge from the finnish Birth cohort study DESCRIBED PREVIOUSLY was the fact that 20+ years after their infancy exposure to Vitamin D, women in the cohort who, as Adults, became Pregnant exhibited an APPROXIMATE 50% reduction in risk of Preeclampsia in their own first Pregnancies,8once again, relative to women who had not received the then RECOMMENDED 2000 iu/d of Vitamin D in infancy.']	[('ANOMALY_CURIOUS_FINDING', 40), ('ANOMALY_CURIOUS_FINDING', 53), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 276), ('FUTURE_WORK', 418)]	6	[('GO_0007567', 'parturition', 100, 'birth'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0007023', 'adult organism', 239, 'adults'), ('GO_0007565', 'female pregnancy', 254, 'pregnant'), ('GO_0007128', 'meiotic prophase I', 313, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 345, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D')]
PMC4764019	1/2016	S39-PMC4764019	['the OBSERVED ASSOCIATION is so strong that mcgrath et al ESTIMATED that 50% of the BURDEN of schizophrenia in the entire country of denmark COULD PERHAPS be ATTRIBUTED to PROBLEMS produced by low Perinatal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 157), ('IMPORTANT_CONSIDERATION', 171)]	8	[('GO_0036268', 'swimming', 196, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 196, 'perinatal'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
PMC4764019	1/2016	S40-PMC4764019	['WHILE this ASSOCIATION MIGHT initially SEEM far-fetched, it is IMPORTANT TO NOTE that the great famine in china in 1958 to 1961 was ASSOCIATED with a subsequent rise in the incidence of schizophrenia in famine victims.2measured Vitamin D status values in these Individuals are NOT AVAILABLE, but it HAS long BEEN KNOWN that rickets was endemic in china and certainly was so at the time of the famine.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 132), ('INCOMPLETE_EVIDENCE', 277), ('INCOMPLETE_EVIDENCE', 299)]	8	[('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('NCBITaxon_1', 'root', 261, 'individuals')]
PMC4764019	1/2016	S42-PMC4764019	['mcgrath et al also POINT out that Rats reared on Vitamin D–deficient diets produce pups that have morphologically abnormal Brain structures.9–11schizophrenia is USUALLY considered more a functional disorder with morphological alterations THAN a primarily morphologic one, and the Rat data INDICATE that Vitamin D is ESSENTIAL for normal Brain Development and HENCE plausibly for normal Brain function.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('INCOMPLETE_EVIDENCE', 289), ('IMPORTANT_CONSIDERATION', 316), ('PROBABLE_UNDERSTANDING', 359)]	6	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 34, 'rats'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000955', 'brain', 123, 'brain'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 280, 'rat'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('GO_0007420', 'brain development', 337, 'brain development'), ('UBERON_0000955', 'brain', 337, 'brain'), ('UBERON_0000955', 'brain', 386, 'brain')]
PMC4764019	1/2016	S45-PMC4764019	['BECAUSE OTHER FACTORS, such as socioeconomic status and ethnic background, COULD EXPLAIN both the low Vitamin D status and the poor performance in school in this group of children, this ASSOCIATION CANNOT BE CONSIDERED causal.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 186), ('INCOMPLETE_EVIDENCE', 198)]	7	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4764019	1/2016	S51-PMC4764019	['CAN it be that Vitamin D inadequacy CONTRIBUTES to the disease BURDEN of so many otherwise UNRELATED disorders?']	[('EXPLICIT_QUESTION', 0), ('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 91), ('EXPLICIT_QUESTION', 110)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC4764019	1/2016	S53-PMC4764019	['well over 1000 Human Genes (and PERHAPS as many as 3000) have Vitamin D response elements.']	[('INCOMPLETE_EVIDENCE', 32)]	1	[('NCBITaxon_9606', 'Homo sapiens', 15, 'human'), ('SO_0000704', 'gene', 21, 'genes'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4764019	1/2016	S59-PMC4764019	['in the final analysis, the underlying HYPOTHESIS is not that Vitamin D supplementation will reduce the disease BURDEN of dm1, preeclampsia, ms, schizophrenia, or the OTHER disorders listed, RATHER, the RELEVANT HYPOTHESIS is, INSTEAD, that it is precisely Vitamin D inadequacy that increases or aggravates the disease BURDEN of these varied outcomes.']	[('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('IMPORTANT_CONSIDERATION', 202), ('INCOMPLETE_EVIDENCE', 211), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226), ('IMPORTANT_CONSIDERATION', 318)]	8	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC4764019	1/2016	S67-PMC4764019	['ARE there RECOGNIZED mechanisms whereby Vitamin D status MAY INFLUENCE late-Life outcomes?']	[('EXPLICIT_QUESTION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('EXPLICIT_QUESTION', 89)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0000104', 'life cycle', 76, 'life')]
PMC4764019	1/2016	S71-PMC4764019	['the enzymes responsible for doing this are themselves encoded in the Genome,14and AT LEAST SOME have Vitamin D response elements of their own.']	[('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 91)]	2	[('SO_0001026', 'genome', 69, 'genome'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4764019	1/2016	S72-PMC4764019	['THAT MEANS that Vitamin D status CAN INFLUENCE not so much the content of our Genetic heritage as WHEN and to WHAT extent it gets Expressed.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 37), ('EXPLICIT_QUESTION', 98), ('EXPLICIT_QUESTION', 110)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('SO_0000704', 'gene', 78, 'genetic'), ('GO_0010467', 'gene expression', 130, 'expressed')]
PMC4764019	1/2016	S76-PMC4764019	['HENCE, the barker HYPOTHESIS, OR something closely approximating it, is very LIKELY to be operative in the functioning of the Vitamin D economy during Human development.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 77)]	4	[('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 151, 'human')]
PMC4764019	1/2016	S82-PMC4764019	['in closing, it would SEEM IMPORTANT TO EMPHASIZE that the LIKELY Vitamin D status values (and the corresponding daily intakes) ASSOCIATED with protection from the delayed outcomes DISCUSSED HERE are entirely physiological, not Pharmacological (ie, in the range of 40–60 ng/ml).']	[('ANOMALY_CURIOUS_FINDING', 21), ('IMPORTANT_CONSIDERATION', 26), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 190)]	6	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 227, 'pharmacological')]
PMC4764019	1/2016	S83-PMC4764019	['african nationals living under ancestral conditions exhibit Vitamin D status values in the middle of this range (ie, approximately 46 ng/ml).16\nin conclusion, WHILE one cannot say that the barker HYPOTHESIS HAS BEEN definitively ESTABLISHED for each of the delayed Vitamin D inadequacy outcomes DESCRIBED HERE, it would SEEM that the PRUDENT course, both for oneself as an Individual and for one’s patients and clients, is to assume the applicability of the HYPOTHESIS and, accordingly, to ensure a Vitamin D status approximating that of ancestral Humans.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 295), ('QUESTION_ANSWERED_BY_THIS_WORK', 305), ('ANOMALY_CURIOUS_FINDING', 320), ('FUTURE_WORK', 334), ('INCOMPLETE_EVIDENCE', 458)]	9	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('NCBITaxon_1', 'root', 373, 'individual'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 548, 'humans')]
PMC4770602	1/2016	S9-PMC4770602	['conclusion:\nIN SUMMARY, our results DEMONSTRATED that Vitamin D supplementation during the third Trimester of Pregnancy; DESPITE the non-significant ASSOCIATION between Vitamin D supplementation and preeclampsia, reduce the risk of preeclampsia.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 36), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 149)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 97, 'trimester'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4770602	1/2016	S14-PMC4770602	['[123] data from SOME STUDIES SUPPORTS ASSOCIATIONS of Vitamin D deficiency and Preterm Birth, decreased Birth weight, and hypertensive disease in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'preterm'), ('GO_0007567', 'parturition', 87, 'birth'), ('GO_0007567', 'parturition', 104, 'birth'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy')]
PMC4770602	1/2016	S15-PMC4770602	['[45678] another data SUGGESTING an ASSOCIATION between Vitamin D deficiency and preeclampsia is now developing.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4770602	1/2016	S16-PMC4770602	['[5] and an ASSOCIATION between low maternal Vitamin D and early-onset, SEVERE Preeclampsia is RECENTLY REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('IMPORTANT_CONSIDERATION', 71), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 103)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 78, 'preeclampsia')]
PMC4770602	1/2016	S17-PMC4770602	['[9] WHEREAS, an INCREASED RISK for preeclampsia is REPORTED in an investigation when Serum Vitamin D levels decreased around 20 ng/ml after adjusting for CONFOUNDERS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 51), ('PROBLEM_COMPLICATION', 154)]	4	[('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4770602	1/2016	S18-PMC4770602	['[5] another data SUGGESTED with ONLY a 10ng/ml increase in maternal Vitamin D a POSSIBLE reduction of the RISK of Preeclampsia.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 80), ('IMPORTANT_CONSIDERATION', 106)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 114, 'preeclampsia')]
PMC4770602	1/2016	S19-PMC4770602	['[9] also, ASSOCIATION between Vitamin D deficiency and preeclampsia is REPORTED in a population based study on 23,423 women, which authors FOUND that a 27 percent reduction in the risk for Preeclampsia was ASSOCIATED with Vitamin D intake of 15-20 micrograms per day relative to less than 5 micrograms per day.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 206)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 189, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC4770602	1/2016	S21-PMC4770602	['[5] deficiency of Vitamin D is diagnosed at level of <32 ng/ml and using the secriteria,[10] Vitamin D deficiency is very common in Pregnancy with up to 50% of Individuals,[111213] THOUGH, DEPENDING ON the country of residence and local clothing customs, a prevalence ranges from 18-84% is REPORTED by PREVIOUS STUDIES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ANOMALY_CURIOUS_FINDING', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 189), ('INCOMPLETE_EVIDENCE', 290), ('INCOMPLETE_EVIDENCE', 302)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('GO_0007565', 'female pregnancy', 132, 'pregnancy'), ('NCBITaxon_1', 'root', 160, 'individuals')]
PMC4770602	1/2016	S23-PMC4770602	['[518]\nbased ON the ROLE of maternal Vitamin D deficiency, AS a POTENTIAL in DEPENDENT RISK FACTOR for Preeclampsia, Vitamin D supplementation in early Pregnancy REMAINS a POSSIBLE intervention and POSSIBLE improved Pregnancy outcomes through PREVENTION or delay of Preeclampsia.']	[('ANOMALY_CURIOUS_FINDING', 12), ('ANOMALY_CURIOUS_FINDING', 12), ('SUPERFICIAL_RELATIONSHIP', 19), ('PROBABLE_UNDERSTANDING', 58), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 242)]	11	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 102, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 265, 'preeclampsia')]
PMC4770602	1/2016	S25-PMC4770602	['and FURTHER prospective longitudinal STUDIES or randomized controlled trials to assess the POTENTIAL EFFECT of Vitamin D supplementation on adverse Pregnancy outcomes are SUGGESTED.']	[('FUTURE_WORK', 4), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 101), ('INCOMPLETE_EVIDENCE', 171)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy')]
PMC4770602	1/2016	S46-PMC4770602	['infant Birth weight in case group who received Vitamin D supplementation was higher than control group, result of independent sample t-test SHOWS that this difference in the mean of infant Birth weight between groups was statistically significant.']	[('INCOMPLETE_EVIDENCE', 140)]	1	[('GO_0007567', 'parturition', 7, 'birth'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007567', 'parturition', 189, 'birth')]
PMC4770602	1/2016	S58-PMC4770602	['cases included 68 pregnant women who received supplementation contain Vitamin D (600 iu/d) and control group included 70 pregnant women who received supplementation without Vitamin D. differences between both groups were not statistically significant ( p -value = 0.84)\n\ndiscussion\nEVIDENCE TO EVALUATE the effectiveness of Vitamin D in Pregnancy is no enough and much of what we KNOW comes from observational RATHER than experimental design, THEREFORE, AT PRESENT Vitamin D supplementation is NOT routinely offered to all pregnant women.']	[('INCOMPLETE_EVIDENCE', 282), ('QUESTION_ANSWERED_BY_THIS_WORK', 291), ('INCOMPLETE_EVIDENCE', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 410), ('PROBABLE_UNDERSTANDING', 443), ('INCOMPLETE_EVIDENCE', 454), ('ANOMALY_CURIOUS_FINDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 324, 'vitamin D'), ('GO_0007565', 'female pregnancy', 337, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D')]
PMC4770602	1/2016	S60-PMC4770602	['our results SHOWED that the frequency of Preeclampsia in case group, who received Vitamin D supplementation, was lower than control group but this difference between case and control groups was not statistically significant.']	[('INCOMPLETE_EVIDENCE', 12)]	1	[('GO_0007128', 'meiotic prophase I', 41, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4770602	1/2016	S63-PMC4770602	['Preeclampsia is one of the LEADING CAUSES of Maternal and Perinatal Morbidity and mortality which, Vitamin D HAS BEEN HYPOTHESIZED to INFLUENCE Preeclampsia RISK.']	[('IMPORTANT_CONSIDERATION', 27), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 157)]	5	[('GO_0007128', 'meiotic prophase I', 0, 'Preeclampsia'), ('GO_0007618', 'mating', 45, 'maternal ...'), ('GO_0019230', 'proprioception', 58, 'perinatal morbidity'), ('UBERON_0012101', 'perinatal stage', 58, 'perinatal'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 144, 'preeclampsia')]
PMC4770602	1/2016	S64-PMC4770602	['[3] in the norwegian mother and child cohort study, the ASSOCIATION between Intake of Vitamin D during Pregnancy and the risk of Preeclampsia in 23,423 Nulliparous Pregnant women was ESTIMATED and authors OBSERVED 27% reduction in risk of Preeclampsia after Vitamin D supplementation in these women.']	[('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 205)]	3	[('GO_0007631', 'feeding behavior', 76, 'intake'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 129, 'preeclampsia'), ('GO_0046662', 'regulation of oviposition', 152, 'nulliparous'), ('GO_0007565', 'female pregnancy', 164, 'pregnant'), ('GO_0007128', 'meiotic prophase I', 239, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC4770602	1/2016	S65-PMC4770602	["[8] investigators in ANOTHER cohort STUDY REPORTED that the risk of Preeclampsia in the female offspring's first Pregnancy reduced after regular supplementation with Vitamin D in the first year of Life."]	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 42)]	2	[('GO_0007128', 'meiotic prophase I', 68, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('UBERON_0000104', 'life cycle', 197, 'life')]
PMC4770602	1/2016	S66-PMC4770602	['[20] also, ROLE of Vitamin D in the PREVENTION of Preeclampsia is SUPPORTED by two clinical TRIALS, HOWEVER, in one of these STUDIES as an uncontrolled trial, supplementation with a multivitamin/Mineral supplement and halibut Liver oil provided at 20 week Gestation reduced the odds of Preeclampsia.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 66), ('FUTURE_WORK', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 125)]	6	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 50, 'preeclampsia'), ('CHEBI_46662', 'mineral', 195, 'mineral'), ('UBERON_0002107', 'liver', 226, 'liver'), ('GO_0007565', 'female pregnancy', 256, 'gestation'), ('GO_0007128', 'meiotic prophase I', 286, 'preeclampsia')]
PMC4770602	1/2016	S67-PMC4770602	['[21] in other study,400 women at 20-24 week Gestation randomized to Vitamin D and Calcium supplements or no treatment, results of this study SHOWS that in the treated group reduction occurred in the incidence of Preeclampsia compared with the untreated group THOUGH this was not statistically significant.']	[('INCOMPLETE_EVIDENCE', 141), ('ANOMALY_CURIOUS_FINDING', 259)]	2	[('GO_0007565', 'female pregnancy', 44, 'gestation'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 82, 'calcium'), ('GO_0007128', 'meiotic prophase I', 212, 'preeclampsia')]
PMC4770602	1/2016	S69-PMC4770602	['indirectly, during the Gestation Vitamin D consumption MAY AFFECT infant Birth weight.']	[('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('GO_0007565', 'female pregnancy', 23, 'gestation'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007567', 'parturition', 73, 'birth')]
PMC4770602	1/2016	S71-PMC4770602	['this result is in SIMILAR with OTHER FINDINGS which REPORTED that Intake of milk, and THEREFORE Vitamin D and Calcium, during Pregnancy is ASSOCIATED with increased infant birth weight.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 86), ('SUPERFICIAL_RELATIONSHIP', 139)]	5	[('GO_0007631', 'feeding behavior', 66, 'intake'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 110, 'calcium'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC4770602	1/2016	S72-PMC4770602	['authors in THIS STUDY SHOWED that the Birth weights of infants Born to women with low milk consumption, observed AS those least LIKELY to consume a daily Vitamin D Intake of 200 iu, was lower compared with those Born to women who did not limit their Consumption of milk.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 113), ('PROBABLE_UNDERSTANDING', 128)]	4	[('GO_0007567', 'parturition', 38, 'birth'), ('GO_0007567', 'parturition', 63, 'born'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007631', 'feeding behavior', 164, 'intake'), ('GO_0007567', 'parturition', 212, 'born'), ('GO_0007631', 'feeding behavior', 250, 'consumption')]
PMC4770602	1/2016	S73-PMC4770602	['[24] in ANOTHER STUDY asian woman with Vitamin D-deficient received 1,000 iu/day of Vitamin D during the third Trimester and result shows a lower proportion of neonates with low Birthweight COMPARED TO the placebo group.']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 111, 'trimester'), ('GO_0007596', 'blood coagulation', 178, 'birthweight')]
PMC4770602	1/2016	S74-PMC4770602	['[25] also, marya et al ., REPORTED the highest Birth weight of infants in mothers who received 600,000 iu of Vitamin D during the seventh and eighth months, of Pregnancy.']	[('INCOMPLETE_EVIDENCE', 26)]	1	[('GO_0007567', 'parturition', 47, 'birth'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy')]
PMC4770602	1/2016	S75-PMC4770602	['[22] IN CONTRAST WITH our results OTHER study SHOWED that low Birth weight is NOTED in infants of mothers supplemented with Vitamin D.\nwe THINKS that some POSSIBLE LIMITATIONS of the present study that SHOULD BE addressed and noted in FUTURE STUDIES are included; unmeasured sun exposure, maternal baseline 25-Oh-D and Preconception, physical activity, local area and early Pregnancy dietary Intake to HELP realize the EFFECT of these FACTORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 46), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 202), ('FUTURE_WORK', 235), ('FUTURE_WORK', 402), ('SUPERFICIAL_RELATIONSHIP', 419), ('SUPERFICIAL_RELATIONSHIP', 435)]	12	[('GO_0007567', 'parturition', 62, 'birth'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 307, '25-OH-D'), ('PR_000000164', 'BMP2', 309, '-OH'), ('PR_000006444', 'diacylglycerol kinase delta', 313, 'D'), ('GO_0007565', 'female pregnancy', 319, 'preconception'), ('GO_0007565', 'female pregnancy', 374, 'pregnancy'), ('GO_0007631', 'feeding behavior', 392, 'intake')]
PMC4770602	1/2016	S76-PMC4770602	['level of calcium in studied women was an IMPORTANT unmeasured covariate in OUR STUDY, WHEREAS, low calcium intake MAY BE ASSOCIATED with Vitamin D deficiency and MAY be a RISK FACTOR for Preeclampsia.']	[('IMPORTANT_CONSIDERATION', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 121), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 171)]	7	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 187, 'preeclampsia')]
PMC4770602	1/2016	S77-PMC4770602	['THEREFORE, Calcium intake MAY CONFOUND an ASSOCIATION between maternal Vitamin D deficiency and preeclampsia RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('PROBLEM_COMPLICATION', 30), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 109)]	5	[('CHEBI_22313', 'alkaline earth metal atom', 11, 'calcium'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4770602	1/2016	S78-PMC4770602	['THEREFORE, ADDITIONAL well-designed, prospective, randomized TRIALS of supplementation with good sample size that control for dietary exposure will BE NECESSARY to determine a POTENTIAL ROLE for Vitamin D in the PREVENTION of Preeclampsia.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 11), ('FUTURE_WORK', 148), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 186), ('SUPERFICIAL_RELATIONSHIP', 212)]	6	[('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 226, 'preeclampsia')]
PMC4770602	1/2016	S79-PMC4770602	['in CONCLUSION, results of the PRESENT STUDY DEMONSTRATED that Vitamin D supplementation during the third Trimester of Pregnancy; reduce the RISK of Preeclampsia HOWEVER, this was not statistically significant.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 44), ('IMPORTANT_CONSIDERATION', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 161)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 105, 'trimester'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 148, 'preeclampsia')]
PMC4864049	1/2016	S348-PMC4864049	['the number of asd diagnoses in regions with low sun exposure in the usa is increased and HAS also BEEN LINKED to Vitamin D insufficiency\xa0[159].']	[('INCOMPLETE_EVIDENCE', 89), ('SUPERFICIAL_RELATIONSHIP', 103)]	2	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC4864049	1/2016	S349-PMC4864049	['RECENT STUDIES SHOW that Vitamin D activates the Expression of Tryptophan hydroxylase, the enzyme ASSOCIATED with Serotonin Synthesis\xa0[159].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 98)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0010467', 'gene expression', 49, 'expression'), ('PR_000001447', 'cadherin-1', 63, 'tryptophan'), ('CHEBI_28790', 'serotonin', 114, 'serotonin'), ('GO_0042427', 'serotonin biosynthetic process', 114, 'serotonin synthesis')]
PMC4864049	1/2016	S350-PMC4864049	['this is PARTICULARLY INTERESTING because it LINKS FINDINGS SHOWING decreased levels of Serotonin in asd patients\xa0[160] and reduced levels of Vitamin D. HOWEVER, a previous study FOUND LITTLE EVIDENCE that maternal Gestational Vitamin D levels are RELATED to the asd phenotype among offspring\xa0[161].']	[('ANOMALY_CURIOUS_FINDING', 8), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 184), ('SUPERFICIAL_RELATIONSHIP', 247)]	10	[('CHEBI_28790', 'serotonin', 87, 'serotonin'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestational'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC4864049	1/2016	S351-PMC4864049	['in addition, WHILE THERE IS EVIDENCE that Vitamin D MAY increase Dna Demethylation of selected Gene Promoters, the mechanisms behind this EFFECT are NOT CLEAR\xa0[162].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 138), ('FULL_UNKNOWN', 149)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0006306', 'DNA methylation', 65, 'DNA demethylation'), ('SO_0000704', 'gene', 95, 'gene'), ('SO_0000167', 'promoter', 100, 'promoters')]
PMC4864049	1/2016	S352-PMC4864049	['there is STRONGER EVIDENCE that Vitamin D acts to Modulate Chromatin Access through interactions with Histone acetyltransferases\xa0[162].']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 50, 'modulate'), ('GO_0000785', 'chromatin', 59, 'chromatin'), ('GO_0007623', 'circadian rhythm', 59, 'chromatin access'), ('CHEBI_15358', 'histone', 102, 'histone'), ('PR_000043452', 'core histone', 102, 'histone')]
PMC4864049	1/2016	S353-PMC4864049	['moreover, aside from activating Vitamin D responsive Genes through a coactivator mediated pathway, the means by which Vitamin D facilitates changes in Chromatin Relaxation are ONLY beginning to be understood.']	[('INCOMPLETE_EVIDENCE', 176)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('SO_0000704', 'gene', 53, 'genes'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0000785', 'chromatin', 151, 'chromatin'), ('GO_0032809', 'neuronal cell body membrane', 161, 'relaxation')]
PMC5115165	1/2016	S14-PMC5115165	['introduction\npotatoes are the third most commonly Consumed Food crop in the world, after rice and wheat.1in the united states, about 35% of women of Reproductive Age (that is, aged 19-50) Consume potatoes daily, accounting FOR 8% of daily total energy intake.2the health EFFECTS of potatoes are INCONCLUSIVE,13and there HAVE BEEN longstanding DEBATES on the appropriate placement of potatoes in dietary guidance.456nonetheless, the dietary guidelines for americans continue to include potatoes in the vegetable Food group and encourage Consumption.7THOUGH potatoes are rich in Vitamin C, Potassium, dietary fiber, and some Phytochemicals,6unlike other vegetables they CAN have DETRIMENTAL EFFECTS on Glucose Metabolism because they contain large amounts of rapidly absorbable Starch.3indeed, SEVERAL epidemiologic STUDIES have LINKED higher potato Consumption to increased concentrations of fasting Plasma Glucose,8insulin resistance,8and an increased risk of type 2 diabetes mellitus.910\nGestational diabetes mellitus (gdm) is a common COMPLICATION of Pregnancy characterized by Glucose intolerance with onset or first recognition during Pregnancy.11gdm is not only ASSOCIATED with adverse Perinatal outcomes,12it is also RELATED to increased long term Cardiometabolic risk in both mothers and their offspring.1113it is THEREFORE CRUCIAL to identify modifiable RISK FACTORS that COULD CONTRIBUTE to the PREVENTION of gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 223), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 320), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('ANOMALY_CURIOUS_FINDING', 548), ('INCOMPLETE_EVIDENCE', 668), ('IMPORTANT_CONSIDERATION', 677), ('SUPERFICIAL_RELATIONSHIP', 689), ('INCOMPLETE_EVIDENCE', 792), ('SUPERFICIAL_RELATIONSHIP', 827), ('PROBLEM_COMPLICATION', 1037), ('SUPERFICIAL_RELATIONSHIP', 1167), ('SUPERFICIAL_RELATIONSHIP', 1223), ('PROBABLE_UNDERSTANDING', 1321), ('IMPORTANT_CONSIDERATION', 1331), ('SUPERFICIAL_RELATIONSHIP', 1362), ('INCOMPLETE_EVIDENCE', 1380), ('SUPERFICIAL_RELATIONSHIP', 1386), ('SUPERFICIAL_RELATIONSHIP', 1404)]	20	[('GO_0007631', 'feeding behavior', 50, 'consumed'), ('CHEBI_33290', 'food', 59, 'food'), ('GO_0000003', 'reproduction', 149, 'reproductive age'), ('GO_0007631', 'feeding behavior', 188, 'consume'), ('CHEBI_33290', 'food', 511, 'food'), ('GO_0007631', 'feeding behavior', 536, 'consumption'), ('CHEBI_27300', 'vitamin D', 577, 'vitamin C'), ('CHEBI_22314', 'alkali metal atom', 588, 'potassium'), ('CHEBI_26254', 'prenylnaphthoquinone', 623, 'phytochemicals'), ('CHEBI_17234', 'glucose', 700, 'glucose'), ('GO_0006006', 'glucose metabolic process', 700, 'glucose metabolism'), ('CHEBI_28017', 'starch', 776, 'starch'), ('GO_0007631', 'feeding behavior', 848, 'consumption'), ('UBERON_0001969', 'blood plasma', 899, 'plasma'), ('CHEBI_17234', 'glucose', 906, 'glucose'), ('GO_0007565', 'female pregnancy', 989, 'Gestational'), ('GO_0007565', 'female pregnancy', 1053, 'pregnancy'), ('CHEBI_17234', 'glucose', 1080, 'glucose'), ('GO_0007565', 'female pregnancy', 1139, 'pregnancy'), ('GO_0036268', 'swimming', 1191, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1191, 'perinatal'), ('GO_0007599', 'hemostasis', 1254, 'cardiometabolic')]
PMC4778858	3/2016	S19-PMC4778858	['for example, it HAS BEEN SHOWN that children Born to Vitamin D deficient mothers have increased adiposity [10] and higher risk of Food allergy [11] in childhood.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('GO_0007567', 'parturition', 45, 'born'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_33290', 'food', 130, 'food')]
PMC4778858	3/2016	S22-PMC4778858	['frank maternal Vitamin D deficiency, using levels ranging from less than 12–15.5 ng/ml, HAS BEEN ASSOCIATED with low Birth weight [13], increased rates of small for Gestational age Births [13,14], and gdm [15].']	[('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 97)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007567', 'parturition', 117, 'birth'), ('GO_0007565', 'female pregnancy', 165, 'gestational'), ('GO_0007567', 'parturition', 181, 'births')]
PMC4778858	3/2016	S23-PMC4778858	['HOWEVER, PREVIOUS STUDIES on Birth weight outcomes and RISK of gdm among Vitamin D deficient mothers DID NOT adequately address rates of maternal obesity, used an inaccurate vitamin d assay, or studied neonates of varying Gestational ages, thus CONFOUNDING interpretation of results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 101), ('PROBLEM_COMPLICATION', 245)]	5	[('GO_0007567', 'parturition', 29, 'birth'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'gestational')]
PMC4778858	3/2016	S100-PMC4778858	['HOWEVER, CAUTION for too much Vitamin D supplementation SHOULD BE raised AS ONE STUDY DETERMINED higher concentrations of neonatal 25-Ohd are POSSIBLY ASSOCIATED with an elevated risk of becoming overweight in Adult Life [26].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 56), ('PROBABLE_UNDERSTANDING', 73), ('INCOMPLETE_EVIDENCE', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 131, '25-OHD'), ('UBERON_0000113', 'post-juvenile adult stage', 210, 'adult life')]
PMC4778858	3/2016	S101-PMC4778858	['the results of THIS STUDY INDICATE that mothers with higher bmi are AT RISK for lower Vitamin D levels, and CONSEQUENTLY, lower Vitamin D levels in their neonates.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 108)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC4778858	3/2016	S102-PMC4778858	['as addressed PREVIOUSLY by our group [12] and others [27], obese women MAY REQUIRE larger amounts of Vitamin D supplementation compared to normal weight women to provide their neonates with sufficient levels of Vitamin D. YET the definition of neonatal Vitamin D sufficiency has NOT BEEN DETERMINED.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 222), ('ANOMALY_CURIOUS_FINDING', 222), ('FULL_UNKNOWN', 279)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC4778858	3/2016	S104-PMC4778858	['a FEW STUDIES have DOCUMENTED adverse health outcomes in children Born to mothers with Vitamin D deficiency such as increased adiposity [10], less muscle mass [28], reduced bone Mineral density [29] and increased risk of Food allergy [11].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 19)]	2	[('GO_0007567', 'parturition', 66, 'born'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_46662', 'mineral', 178, 'mineral'), ('CHEBI_33290', 'food', 221, 'food')]
PMC4778858	3/2016	S108-PMC4778858	['these results are IN CONTRAST TO OTHER reports SUGGESTING that Vitamin D levels INFLUENCE the RISK of gdm [15,32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 94)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC4778858	3/2016	S110-PMC4778858	['mcleod and colleagues [33], who also conducted an ancillary study on Hapo participants, FOUND a WEAK, YET significant ASSOCIATION between 25-Ohd and fasting glucose in an australian Vitamin D replete population.']	[('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 96), ('ANOMALY_CURIOUS_FINDING', 102), ('SUPERFICIAL_RELATIONSHIP', 118)]	4	[('CHEBI_17883', 'hydrogen chloride', 69, 'HAPO'), ('CHEBI_72765', 'verruculogen', 138, '25-OHD'), ('PR_000012086', 'homeobox protein OTX2', 141, 'OHD'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC4778858	3/2016	S124-PMC4778858	['a MAJOR strength of THIS PLANNED STUDY was its design to reduce POTENTIAL CONFOUNDERS of ASSOCIATIONS between maternal and Cord Blood Vitamin D levels and maternal bmi.']	[('IMPORTANT_CONSIDERATION', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 64), ('PROBLEM_COMPLICATION', 74), ('SUPERFICIAL_RELATIONSHIP', 89)]	6	[('UBERON_0002240', 'spinal cord', 123, 'cord'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4778858	3/2016	S129-PMC4778858	['the results are NOT NECESSARILY applicable to the general population AS ONLY white women were studied, and it is WELL ESTABLISHED that Vitamin D levels are lower among People with darker skin Complexions [36,37].']	[('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 69), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 113), ('PROBABLE_UNDERSTANDING', 113)]	5	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 168, 'people'), ('GO_0042600', 'egg chorion', 192, 'complexions')]
PMC4778858	3/2016	S130-PMC4778858	['information on Prenatal Vitamin use or additional Vitamin D supplementation within this cohort WAS NOT COLLECTED.']	[('INCOMPLETE_EVIDENCE', 95), ('INCOMPLETE_EVIDENCE', 99)]	2	[('GO_0007565', 'female pregnancy', 15, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 24, 'vitamin'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4784858	3/2016	S61-PMC4784858	['in this STUDY, the updated pandiet score for the french sample was composed of 27 probabilities of adequacy (protein, total Carbohydrate, dietary fibre, total fat, la, ala, dha, epa+Dha, Vitamin A, Thiamin, riboflavin, Niacin, Pantothenic Acid, Vitamin B6, Folate, Vitamin B12, Vitamin C, Vitamin D, Vitamin E, calcium, Iodine, iron, magnesium, Phosphorus, Potassium, Selenium and zinc) in the as and of seven probabilities of adequacy (protein, total Carbohydrate, Free Sugars, total fat, Saturated Fatty Acids, Cholesterol and Sodium) plus 14 POTENTIAL penalties (Retinol, niacin, Vitamin B6, Folate, Vitamin C, Vitamin D, Vitamin E, Calcium, Iodine, iron, magnesium, Phosphorus, Selenium and zinc) in the ms.\ndietary reference values used to calculate the pandiet for the french sample were those emitted by the french agency for Food, environmental and occupational health (anses), (s1 table) [25,26], except for iron for which the probability of adequacy was determined using values published by the institute of medicine [27,28].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 545)]	2	[('CHEBI_16730', 'chloramphenicol 3-acetate', 124, 'carbohydrate'), ('CHEBI_17874', 'dihydrozeatin', 182, 'DHA'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin A'), ('CHEBI_26948', 'vitamin B1', 198, 'thiamin'), ('CHEBI_7542', 'neurotensin', 219, 'niacin'), ('CHEBI_7916', 'pantothenic acid', 227, 'pantothenic acid'), ('CHEBI_33237', 'vitamin D4', 245, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 257, 'folate'), ('CHEBI_33279', 'vitamin D5', 265, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin E'), ('CHEBI_24859', 'iodine atom', 320, 'iodine'), ('CHEBI_35885', 'secondary phosphine', 345, 'phosphorus'), ('CHEBI_22314', 'alkali metal atom', 357, 'potassium'), ('CHEBI_27568', 'selenium atom', 368, 'selenium'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 452, 'carbohydrate'), ('CHEBI_37958', 'dye', 466, 'free'), ('CHEBI_26822', 'sulfide', 471, 'sugars'), ('CHEBI_26604', 'santonin', 490, 'saturated fatty acids'), ('CHEBI_16113', 'cholesterol', 513, 'cholesterol'), ('CHEBI_52632', 'potassium-39 atom', 529, 'sodium'), ('CHEBI_26536', 'retinoic acid', 566, 'retinol'), ('CHEBI_33237', 'vitamin D4', 583, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 595, 'folate'), ('CHEBI_27300', 'vitamin D', 603, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 614, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 625, 'vitamin E'), ('CHEBI_22313', 'alkaline earth metal atom', 636, 'calcium'), ('CHEBI_24859', 'iodine atom', 645, 'iodine'), ('CHEBI_35885', 'secondary phosphine', 670, 'phosphorus'), ('CHEBI_27568', 'selenium atom', 682, 'selenium'), ('CHEBI_33290', 'food', 833, 'Food')]
PMC4784858	3/2016	S67-PMC4784858	['in THIS STUDY, the updated pandiet score for the us population was composed of 25 probabilities of adequacy in the as (protein, total Carbohydrate, total fat, la, ala, dha, epa+dha, dietary fibre, Vitamin A, Thiamin, riboflavin, niacin, Vitamin B6, Folate, Vitamin B12, Vitamin C, Vitamin D and Vitamin E, calcium, iron, magnesium, Phosphorus, Potassium, Selenium and zinc) and five probabilities of adequacy (total Carbohydrate, total fat, saturated Fatty Acids, Cholesterol and Sodium) plus 12 POTENTIAL penalties (Retinol, niacin, Vitamin B6, Folate, Vitamin C, Vitamin D and Vitamin E, calcium, iron, Phosphorus, Selenium and zinc) in the ms.\ndietary reference intakes used to calculate the pandiet for the us population were those given by the institute of medicine (s2 table) [27,28], except for Dha and Epa+Dha.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 496)]	2	[('CHEBI_16730', 'chloramphenicol 3-acetate', 134, 'carbohydrate'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin A'), ('CHEBI_26948', 'vitamin B1', 208, 'thiamin'), ('CHEBI_33237', 'vitamin D4', 237, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 249, 'folate'), ('CHEBI_33279', 'vitamin D5', 257, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin E'), ('CHEBI_35885', 'secondary phosphine', 332, 'phosphorus'), ('CHEBI_22314', 'alkali metal atom', 344, 'potassium'), ('CHEBI_27568', 'selenium atom', 355, 'selenium'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 416, 'carbohydrate'), ('CHEBI_35366', 'fatty acid', 451, 'fatty acids'), ('CHEBI_16113', 'cholesterol', 464, 'cholesterol'), ('CHEBI_52632', 'potassium-39 atom', 480, 'sodium'), ('CHEBI_26536', 'retinoic acid', 517, 'retinol'), ('CHEBI_33237', 'vitamin D4', 534, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 546, 'folate'), ('CHEBI_27300', 'vitamin D', 554, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 579, 'vitamin E'), ('CHEBI_35885', 'secondary phosphine', 605, 'phosphorus'), ('CHEBI_27568', 'selenium atom', 617, 'selenium'), ('CHEBI_17874', 'dihydrozeatin', 802, 'DHA'), ('CHEBI_34733', 'EPN', 810, 'EPA'), ('CHEBI_17874', 'dihydrozeatin', 814, 'DHA')]
PMC4784858	3/2016	S166-PMC4784858	['HOWEVER, the risk of Neural Tube defects HAS also BEEN ASSOCIATED with a diet quality scoring that takes into account more Nutrients in addition to Folate (Calcium, iron, Vitamin B6 and Vitamin A, and percentage of calories from fat and from sweets) [43].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('UBERON_0001049', 'neural tube', 21, 'neural tube'), ('CHEBI_33284', 'nutrient', 123, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 148, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 156, 'calcium'), ('CHEBI_33237', 'vitamin D4', 171, 'vitamin B6'), ('PR_000017255', 'Vang-like protein 1', 171, 'vitamin B6'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin A')]
PMC4785305	3/2016	S3-PMC4785305	['our HYPOTHESIS is that in middle eastern Pregnant women, a Vitamin D dose of 3000\u2005iu/day is REQUIRED to reach a DESIRABLE maternal 25-Hydroxyvitamin D [25(Oh)D] level, and to positively IMPACT infant bone Mineral content (bmc).']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 92), ('IMPORTANT_CONSIDERATION', 112), ('SUPERFICIAL_RELATIONSHIP', 186)]	4	[('GO_0007565', 'female pregnancy', 41, 'pregnant'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 131, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 152, '25(OH)D'), ('CHEBI_46662', 'mineral', 205, 'mineral')]
PMC4785305	3/2016	S16-PMC4785305	['caption (boxed-text)\nstrengths and limitations of this study\n\nTHIS is the FIRST randomised controlled trial (rct) in the middle east directly addressing the applicability of the institute of medicine RECOMMENDATIONS in this specific population, and assessing the EFFECT of Vitamin D supplementation on neonatal bone Mineral content.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('INCOMPLETE_EVIDENCE', 74), ('FUTURE_WORK', 200), ('SUPERFICIAL_RELATIONSHIP', 263)]	4	[('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_46662', 'mineral', 316, 'mineral')]
PMC4785305	3/2016	S19-PMC4785305	['the findings of this trial will help guide the public health policymaker regarding Vitamin D supplementation in Pregnant women and will allow a step forward in EVIDENCE-BASED RECOMMENDATIONS SPECIFIC to the middle east.']	[('INCOMPLETE_EVIDENCE', 160), ('FUTURE_WORK', 175), ('FUTURE_WORK', 191)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnant')]
PMC4785305	3/2016	S23-PMC4785305	['maternal Vitamin D status during Pregnancy\nvitamin D deficiency during Pregnancy is PREVALENT worldwide, ESPECIALLY in developing countries.8in a systematic review of 18 studies conducted in western countries during the first Trimester, white caucasian Pregnant women were found to have a mean 25(Oh)D level between 29 and 73\u2005nmol/l.9mean 25(Oh)D levels were lower in non-caucasian Pregnant women, ranging between 15.2 and 43\u2005nmol/l.9in addition to ethnicity, higher latitude was a significant predisposing FACTOR for hypovitaminosis d.9similarly, in non-western countries, more than half of the Pregnant women who were beyond their first trimester had 25(Oh)D levels below 75\u2005nmol/l; these include countries such as india,10kuwait,11pakistan12and turkey.13even lower levels (<25\u2005nmol/l) HAVE BEEN REPORTED at Delivery in saudi arabia, iran and the united arab emirates.14furthermore, immigrant women were at PARTICULAR RISK.1516an OBSERVATIONAL study from the netherlands SHOWED significantly lower 25(Oh)D levels during the first Trimester in immigrant Pregnant women (turkish, moroccan and others), compared to western participants.17\n\nASSOCIATION between maternal Vitamin D status and maternal adverse outcomes\nVitamin D insufficiency during Pregnancy is ASSOCIATED with adverse maternal outcomes such as increased risk of Gestational diabetes mellitus (gdm), preeclampsia, caesarean-section Delivery and bacterial vaginosis.18in a recent meta-analysis of observational studies, the risk of gdm was FOUND TO BE increased by 40–84% in Pregnant women with low 25(Oh)D levels, defined as <50\u2005nmol/l or <75\u2005nmol/l, DEPENDING ON the studies.19–21while Preeclampsia risk was significantly increased in Vitamin D insufficient women,22c-section rates were INCONSISTENTLY AFFECTED by Vitamin D status.23HOWEVER, THESE FINDINGS REMAIN LIMITED by the inherent BIASES of OBSERVATIONAL studies, INCONSISTENT adjustment for CONFOUNDERS, in addition to the wide HETEROGENEITY in Vitamin D assays and Vitamin D cut-offs definition.']	[('IMPORTANT_CONSIDERATION', 84), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 507), ('INCOMPLETE_EVIDENCE', 788), ('IMPORTANT_CONSIDERATION', 909), ('INCOMPLETE_EVIDENCE', 932), ('INCOMPLETE_EVIDENCE', 973), ('SUPERFICIAL_RELATIONSHIP', 1139), ('SUPERFICIAL_RELATIONSHIP', 1259), ('ANOMALY_CURIOUS_FINDING', 1503), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1752), ('SUPERFICIAL_RELATIONSHIP', 1767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1796), ('INCOMPLETE_EVIDENCE', 1807), ('INCOMPLETE_EVIDENCE', 1822), ('INCOMPLETE_EVIDENCE', 1829), ('PROBLEM_COMPLICATION', 1853), ('INCOMPLETE_EVIDENCE', 1863), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1886), ('PROBLEM_COMPLICATION', 1914), ('DIFFICULT_TASK', 1951)]	22	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 51, 'D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 226, 'trimester'), ('GO_0007565', 'female pregnancy', 253, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 294, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 294, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 345, 'D'), ('GO_0007565', 'female pregnancy', 382, 'pregnant'), ('GO_0007565', 'female pregnancy', 596, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 653, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 653, '25(OH)D'), ('GO_0007567', 'parturition', 810, 'delivery'), ('CHEBI_71657', 'versiconol acetate', 1000, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1000, '25(OH)D'), ('GO_0009294', 'DNA mediated transformation', 1032, 'trimester'), ('GO_0007565', 'female pregnancy', 1055, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1168, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 1215, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1246, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1327, 'gestational'), ('GO_0007567', 'parturition', 1396, 'delivery'), ('GO_0007565', 'female pregnancy', 1538, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 1562, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 1651, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 1700, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1779, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1968, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1989, 'vitamin D')]
PMC4785305	3/2016	S24-PMC4785305	["ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women's survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\n\nVitamin d replacement guidelines during Pregnancy\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially."]	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]
PMC4785305	3/2016	S25-PMC4785305	['the 2010 institute of medicine (iom) report on dietary reference intakes for Calcium and Vitamin D RECOMMENDED 600\u2005iu to Pregnant women as the recommended daily allowance (rda), the rda being the dose that is projected to allow at least 97.5% of the Pregnant women population to reach the DESIRABLE target 25(Oh)D level ≥50\u2005nmol/l.29this RECOMMENDATION was BASED ON OBSERVATIONAL studies, NONE of which were conducted in the middle east.29CONVERSELY, the Endocrine society 2011 GUIDELINES RECOMMENDED that 1500–2000\u2005iu daily of Vitamin D is NEEDED to reach a target 25(Oh)D level ≥75\u2005nmol/l (a RECOMMENDATION that was graded as weak with moderate quality of evidence).30the american college of obstetricians and gynecologists (acog) does not RECOMMEND screening for Vitamin D level in Pregnancy, and abides by the iom RECOMMENDATIONS.31moreover, the who 2012 guidelines on Vitamin D replacement during Pregnancy DID NOT RECOMMEND vitamin D supplementation as part of Prenatal care.32this was based ON a meta-analysis of Vitamin D trials during Pregnancy, which IDENTIFIED a LIMITED NUMBER of high-quality studies DEMONSTRATING a beneficial EFFECT of supplementation on maternal and neonatal outcomes, and CONCLUDED that FURTHER randomised controlled trials (rcts) ARE NEEDED.33in the uk, HOWEVER, Pregnant women are CONSIDERED AT RISK of Vitamin D deficiency, and supplementation with 400\u2005iu daily is REQUIRED.34\nit is NOT CLEAR WHETHER any of the above RECOMMENDED doses are applicable to non-western populations, with lower baseline Vitamin D levels, such as in lebanon and other middle eastern countries.']	[('FUTURE_WORK', 99), ('IMPORTANT_CONSIDERATION', 289), ('FUTURE_WORK', 338), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 366), ('INCOMPLETE_EVIDENCE', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 437), ('PROBABLE_UNDERSTANDING', 478), ('FUTURE_WORK', 489), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 541), ('FUTURE_WORK', 594), ('FUTURE_WORK', 742), ('FUTURE_WORK', 818), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 920), ('ANOMALY_CURIOUS_FINDING', 998), ('ANOMALY_CURIOUS_FINDING', 998), ('INCOMPLETE_EVIDENCE', 1061), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1113), ('SUPERFICIAL_RELATIONSHIP', 1140), ('INCOMPLETE_EVIDENCE', 1205), ('FUTURE_WORK', 1220), ('FUTURE_WORK', 1264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1288), ('IMPORTANT_CONSIDERATION', 1316), ('INCOMPLETE_EVIDENCE', 1316), ('IMPORTANT_CONSIDERATION', 1327), ('IMPORTANT_CONSIDERATION', 1401), ('FULL_UNKNOWN', 1419), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1429), ('FUTURE_WORK', 1454)]	33	[('CHEBI_31341', 'calcium dihydroxide', 77, 'Calcium'), ('CHEBI_28384', 'vitamin K', 89, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 89, 'Vitamin'), ('GO_0007565', 'female pregnancy', 121, 'pregnant'), ('GO_0007565', 'female pregnancy', 250, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 309, 'OH)D'), ('PR_000013502', 'parvalbumin alpha', 311, ')D'), ('UBERON_0005063', 'left ventricular compact myocardium', 455, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 566, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 566, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 766, 'vitamin D'), ('GO_0007565', 'female pregnancy', 785, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('GO_0007565', 'female pregnancy', 902, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 938, 'D'), ('GO_0007565', 'female pregnancy', 967, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1020, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1044, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1297, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1338, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1535, 'vitamin D')]
PMC4785305	3/2016	S26-PMC4785305	['indeed, the who Pregnancy guidelines clearly STATED that “Vitamin D supplementation will PROBABLY have the most BENEFIT in populations of poor countries, those with darker skin colour and in populations with a high prevalence of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 89), ('IMPORTANT_CONSIDERATION', 112)]	3	[('GO_0007565', 'female pregnancy', 16, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 58, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D')]
PMC4785305	3/2016	S28-PMC4785305	['rcts of Vitamin D supplementation during Pregnancy\ntwo landmark rcts HAVE BEEN conducted in the usa35and the uk.36hollis et al 35SHOWED that in Pregnant women in the usa, with a baseline 25(Oh)D level around 60\u2005nmol/l, a Vitamin dose of 4000\u2005iu daily allowed 82% of participants to reach a 25(Oh)D level of 80\u2005nmol/l, WHILE ONLY 70% and 50% reached this TARGET in the intermediate (2000\u2005iu daily) and low (400\u2005iu daily) doses, respectively.']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 127), ('ANOMALY_CURIOUS_FINDING', 318), ('ANOMALY_CURIOUS_FINDING', 324), ('FUTURE_WORK', 354)]	5	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('GO_0007565', 'female pregnancy', 144, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 187, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 187, '25(OH)D'), ('CHEBI_33229', 'vitamin (role)', 221, 'vitamin'), ('CHEBI_71657', 'versiconol acetate', 290, '25(OH)D')]
PMC4785305	3/2016	S29-PMC4785305	['cooper et al 36SHOWED that Vitamin D supplementation of 1000\u2005iu daily, COMPARED TO placebo, in Pregnant women in the uk allowed a significant increase in bone Mineral content (bmc) of neonates, HOWEVER, ONLY when they were Born in winter.']	[('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 71), ('ANOMALY_CURIOUS_FINDING', 194), ('ANOMALY_CURIOUS_FINDING', 203)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('CHEBI_46662', 'mineral', 159, 'Mineral'), ('GO_0007567', 'parturition', 223, 'born')]
PMC4785305	3/2016	S30-PMC4785305	['ONE STUDY from india, comparing non-intervention to Vitamin D supplementation groups, with the dose being DEPENDENT on 25(Oh)D levels at 20\u2005weeks Gestation, SHOWED that Vitamin D supplementation resulted in a significant difference in the achieved 25(Oh)D level at Delivery (43.1 (81.3) nmol/l in the former group versus 56.8 (47.5) nmol/l in the latter group).37hollis et al 36and sablok et al 37SHOWED that Vitamin D supplementation decreased the RISK of Preterm labour, Gestational diabetes and hypertensive complications (all combined).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 157), ('INCOMPLETE_EVIDENCE', 395), ('IMPORTANT_CONSIDERATION', 449)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 125, 'D'), ('GO_0007565', 'female pregnancy', 146, 'gestation'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 248, '25(OH)D'), ('GO_0007567', 'parturition', 265, 'delivery'), ('CHEBI_27300', 'vitamin D', 409, 'vitamin D'), ('GO_0007565', 'female pregnancy', 457, 'preterm'), ('GO_0007565', 'female pregnancy', 473, 'gestational')]
PMC4785305	3/2016	S31-PMC4785305	['in the middle east and north africa region, there are FEW RECENT rcts that attempted to determine the OPTIMAL regimen of Vitamin D replacement in healthy Pregnant women.38–41WITH the exception of soheilykhah et al 40who ASSESSED the EFFECT of Vitamin D supplementation on Insulin resistance, the primary outcomes in THESE studies were MOSTLY maternal and neonatal 25(Oh)D levels (seeonline supplementary appendix1).']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 58), ('IMPORTANT_CONSIDERATION', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 233), ('INCOMPLETE_EVIDENCE', 316), ('PROBABLE_UNDERSTANDING', 335)]	8	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('PR_000045358', 'insulin family protein', 272, 'insulin'), ('CHEBI_71657', 'versiconol acetate', 364, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 364, '25 ... OH ... D')]
PMC4785305	3/2016	S34-PMC4785305	['ONLY two of the ONGOING trials are being conducted in the middle east, one in iran and one in israel, start supplementation in the third Trimester and use Vitamin D doses of 7000\u2005iu and 2000\u2005iu daily, respectively.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 16)]	2	[('GO_0009294', 'DNA mediated transformation', 137, 'trimester'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4785305	3/2016	S39-PMC4785305	['hypothesis\nthe study HYPOTHESIS is that a high dose of Vitamin D, equivalent to 3000\u2005iu/day, is NEEDED to optimise maternal Vitamin D level and neonatal Musculoskeletal parameters, compared to a low dose of 600\u2005iu/day.']	[('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 96)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 153, 'musculoskeletal')]
PMC4785305	3/2016	S120-PMC4785305	['CONSIDERING that each 100\u2005iu Vitamin D supplementation increases the level by 1.7\u2005nmol/l,49the EXPECTED levels reached in the low-dose and high-dose arms would be 67\u2005nmol/l and 106\u2005nmol/l, respectively.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 95)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC4785305	3/2016	S125-PMC4785305	['this meta-analysis SHOWED that, in Pregnant women from the mena region, a Vitamin D dose of 800–2000\u2005iu daily results in an increase in the 25(Oh)D level by 2.5\u2005nmol/l, and a high dose of >2000\u2005iu daily results in an increase in the 25(Oh)D level by 1.67\u2005nmol/l.']	[('INCOMPLETE_EVIDENCE', 19)]	1	[('GO_0007565', 'female pregnancy', 35, 'pregnant'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 140, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 146, 'D'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D')]
PMC4785305	3/2016	S130-PMC4785305	['they SHOWED a significant difference of 6\u2005g (sd 10\u2005g) in neonatal mean bmc in the Vitamin D supplemented group, compared to placebo, in the winter season.36for a 90% power and a type i error of 2.5%, considering an sd of bmc of 10\u2005g, to detect a 6\u2005g difference in bmc between high-dose and low-dose groups, 69 participants per arm are needed.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4785305	3/2016	S157-PMC4785305	['it is NOTEWORTHY that high doses of Vitamin D (up to 4000\u2005iu daily) HAVE BEEN used in PREVIOUS TRIALS conducted during Pregnancy with no reported adverse events (seeonline supplementary appendix1).']	[('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 86)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy')]
PMC4785305	3/2016	S168-PMC4785305	['furthermore, GIVEN the LACK OF EVIDENCE-BASED guidelines that define the OPTIMAL rda for Vitamin D supplementation during Pregnancy in our population, and the LIMITED NUMBER of randomised clinical trials completed so far in our region, this trial will fill an IMPORTANT KNOWLEDGE GAP.']	[('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 73), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 260), ('FULL_UNKNOWN', 270)]	6	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC4785305	3/2016	S172-PMC4785305	['the findings of this trial will help guide the public health policymaker regarding Vitamin D supplementation in Pregnant women and will allow a step forward in EVIDENCE-BASED RECOMMENDATIONS SPECIFIC to the middle east.']	[('INCOMPLETE_EVIDENCE', 160), ('FUTURE_WORK', 175), ('FUTURE_WORK', 191)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnant')]
PMC4785305	3/2016	S174-PMC4785305	['FINDINGS from our trial, and SIMILAR TO results derived from Nutrient rcts, are PRONE to the CONFOUNDING effect of several FACTORS.52indeed, the baseline 25(Oh)D level, the dietary Intake of Vitamin D and OTHER Nutrients, such as Calcium and proteins, sun exposure and others, REMAIN IMPORTANT PREDICTORS AFFECTING the response to Vitamin D supplementation, but are very DIFFICULT to quantify accurately.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 80), ('PROBLEM_COMPLICATION', 93), ('SUPERFICIAL_RELATIONSHIP', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('INCOMPLETE_EVIDENCE', 277), ('IMPORTANT_CONSIDERATION', 284), ('SUPERFICIAL_RELATIONSHIP', 294), ('SUPERFICIAL_RELATIONSHIP', 305), ('DIFFICULT_TASK', 371)]	11	[('CHEBI_33284', 'nutrient', 61, 'nutrient'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 157, 'OH)D'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33284', 'nutrient', 211, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 230, 'calcium'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D')]
PMC4811107	3/2016	S12-PMC4811107	['the BEST EVIDENCE for the ROLE of Vitamin D in health is RELATED to its IMPORTANCE to bone health [1,2].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 72)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC4811107	3/2016	S18-PMC4811107	['PREVIOUS RESEARCH has DEMONSTRATED that the Vitamin D levels of women and their neonates are highly RELATED [7–11].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 100)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4811107	3/2016	S20-PMC4811107	['these analyses COULD identify Pregnant women who NEED a Prenatal Vitamin D intervention tailored to them BASED ON the various characteristics, as well as identifying children who MAY have a lower level of 25(Oh)D at Birth and MAY BE prioritized for Vitamin D screening.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 49), ('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 226)]	5	[('GO_0007565', 'female pregnancy', 30, 'pregnant'), ('GO_0007565', 'female pregnancy', 56, 'prenatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('GO_0007567', 'parturition', 216, 'birth'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC4811107	3/2016	S94-PMC4811107	['REPORTED that neonatal Vitamin D had a positive CORRELATION with maternal Vitamin D levels ( r = 0.69, p< 0.001) in those mothers with normal Vitamin D levels BUT NOT in those with hypovitaminosis ( n = 123 maternal-child pairs) [29].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 48), ('ANOMALY_CURIOUS_FINDING', 159), ('ANOMALY_CURIOUS_FINDING', 163)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC4811107	3/2016	S109-PMC4811107	["NOT ONLY do these studies INDICATE that use of the Prenatal level of 25(Oh)D to represent the child's early Life Vitamin D level is not specific, but also the data SUGGEST that a maternal THRESHOLD exists below which the mother LIMITS her CONTRIBUTION of 25(Oh)D to the fetus."]	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 164), ('PROBABLE_UNDERSTANDING', 188), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 239)]	6	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 75, 'D'), ('UBERON_0000104', 'life cycle', 108, 'life'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 255, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 257, '(OH)D')]
PMC4811107	3/2016	S111-PMC4811107	['furthermore, children who are black and not firstborn and those Born to women with very low 25(Oh)D MAY identify a PRIORITY group for Vitamin D deficiency screening.']	[('INCOMPLETE_EVIDENCE', 100), ('IMPORTANT_CONSIDERATION', 115)]	2	[('GO_0007567', 'parturition', 64, 'born'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4811107	3/2016	S116-PMC4811107	['children who are not firstborn, those who are black, and those Born to women with very low 25(Oh)D MAY identify a PRIORITY group for Vitamin D deficiency screening.']	[('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 114)]	2	[('GO_0007567', 'parturition', 63, 'born'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 91, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC4811441	3/2016	S2-PMC4811441	['the pathophysiology of the Development Of Hypertension In Pregnancy is UNKNOWN, but studies SUGGEST an ASSOCIATION with Vitamin D status, measured as 25-Hydroxyvitamin D (25(Oh)D).']	[('FULL_UNKNOWN', 71), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0002234', 'detection of endoplasmic reticulum overloading', 27, 'development of hypertension in'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 150, '25-hydroxyvitamin D'), ('CHEBI_33010', 'chromide(1-)', 173, '(OH)D')]
PMC4811441	3/2016	S12-PMC4811441	['in conclusion, an increase in 25(Oh)D concentration during Pregnancy of at LEAST 30 nmol/l, REGARDLESS OF Vitamin D status in t1, was ASSOCIATED with a lower odds ratio for Preeclampsia.']	[('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 173, 'preeclampsia')]
PMC4811441	3/2016	S28-PMC4811441	['SO FAR, controlled intervention trials sufficiently powered for pe are lacking [9], but one SMALL STUDY conducted REPORTS no effects of Vitamin D supplementation on pe [10].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 114)]	3	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4811441	3/2016	S29-PMC4811441	['poorer Vitamin D status (measured as 25-Hydroxyvitamin D (25(Oh)D) during Pregnancy HAS BEEN ASSOCIATED with INCREASED RISKS of pe and Gestational hypertension in SOME [11,12] BUT NOT ALL observational studies [13,14].']	[('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 93), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('ANOMALY_CURIOUS_FINDING', 180)]	6	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 37, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 135, 'gestational')]
PMC4811441	3/2016	S31-PMC4811441	['case-control STUDIES OFTEN have INSUFFICIENT or no matching, GENERATING CONCERNS about CONFOUNDING AS VARIATIONS in Vitamin D status ASSOCIATED with season, skin pigmentation and lifestyle factors are known [15].']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 21), ('PROBLEM_COMPLICATION', 32), ('PROBABLE_UNDERSTANDING', 61), ('PROBLEM_COMPLICATION', 72), ('PROBLEM_COMPLICATION', 87), ('PROBABLE_UNDERSTANDING', 99), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 133)]	9	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4811441	3/2016	S34-PMC4811441	['this LIMITS the evaluation of the POTENTIAL ROLE of Vitamin D status during early Pregnancy in the development and progression Of Pe.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 44)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0001554', 'luteolysis', 127, 'of PE')]
PMC4811441	3/2016	S136-PMC4811441	['also, an increase in 25(Oh)D ≥30 nmol/l was not associated with Pregnancy-induced hypertension.10.1371/journal.pone.0152198.t004\n\ncaption (table-wrap): table 4\nbivariable and multivariable logistic regression analysis of the DETERMINANTS of Pregnancy-induced hypertension.bivariablemultivariableabor95% cipbor95% ciplowerupperlowerupper25(Oh)D t10.0081.0081.0011.0140.0240.0021.0020.9931.0100.709obesity t10.3661.4430.8972.3210.131-0.1690.8440.4641.5380.844nulliparity0.3611.4351.0391.9830.0290.2051.2280.8541.7650.269excessive gwg0.4731.6041.1462.2460.0060.3631.4380.9952.0780.054preexisting medical condition t10.6321.8810.8764.0400.1050.0891.0930.4542.6290.842assisted reproduction0.1821.2000.7881.8280.3950.0841.0880.6561.8030.745tobacco use t1-0.6330.5310.2161.3080.169-0.4470.6400.2621.5630.327height0.0541.0551.0291.083<0.0010.0351.0351.0051.0660.021age ≥40 years t1-0.1410.8680.3732.0240.744-0.1920.8250.3122.1840.699dbp t10.0871.0911.0691.114<0.0010.0881.0921.0671.117<0.001\n25(Oh)d = 25-Hydroxyvitamin D, t1 = first trimester, gwg = Gestational weight gain, dbp = diastolic Blood pressure,\ndichotomous: age ≥40 years, obesity, nulliparity, excessive gwg, preexisting medical condition and assisted reproduction\na.adjusted for multifetal Pregnancy, baseline employment status, Gestational age at t1, month of Conception and northern european country of Birth\n\ndiscussion\nthese results are the primary outcome of the gravid study–TO OUR KNOWLEDGE the FIRST STUDY reporting on the RELATIONSHIP between longitudinal Vitamin D status and its RELATION to pe and Gestational bp trajectory.']	[('SUPERFICIAL_RELATIONSHIP', 225), ('PROBABLE_UNDERSTANDING', 1438), ('INCOMPLETE_EVIDENCE', 1459), ('SUPERFICIAL_RELATIONSHIP', 1488), ('SUPERFICIAL_RELATIONSHIP', 1547)]	5	[('CHEBI_71657', 'versiconol acetate', 21, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 21, '25(OH)D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007565', 'female pregnancy', 241, 'pregnancy'), ('CHEBI_33010', 'chromide(1-)', 338, '(OH)D'), ('CHEBI_63056', 'zinc cation', 984, '25(OH'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 994, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 1043, 'gestational'), ('UBERON_0000178', 'blood', 1084, 'blood'), ('GO_0007565', 'female pregnancy', 1247, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1286, 'gestational'), ('GO_0007620', 'copulation', 1318, 'conception'), ('GO_0007567', 'parturition', 1362, 'birth'), ('CHEBI_27300', 'vitamin D', 1522, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1566, 'gestational')]
PMC4811441	3/2016	S137-PMC4811441	['our results SUGGEST that an increase of AT LEAST 30 nmol/l in 25(Oh)D concentration during Pregnancy is RELATED to lower odds of pe, REGARDLESS OF Vitamin D status in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 40), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 133)]	4	[('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
PMC4811441	3/2016	S141-PMC4811441	['THEREFORE, IT IS POSSIBLE that Vitamin D status in early Pregnancy MIGHT not play a MAJOR ROLE in Placental Development, but that an increment during Gestation MAY prevent the Development Of Pe.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('GO_0001890', 'placenta development', 98, 'placental development'), ('UBERON_0001987', 'placenta', 98, 'placental'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('GO_0042494', 'detection of bacterial lipoprotein', 176, 'development of PE')]
PMC4811441	3/2016	S149-PMC4811441	['we FOUND a positive ASSOCIATION between Vitamin D status and bp trajectory, BUT non-significant for dbp after adjustment for baseline bp.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 76)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4811441	3/2016	S169-PMC4811441	['our results SHOW that an increment in 25(Oh)D concentration during Pregnancy is ASSOCIATED with lower odds of pe, REGARDLESS OF early Pregnancy Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 114)]	3	[('CHEBI_71657', 'versiconol acetate', 38, '25(OH)D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC4811441	3/2016	S171-PMC4811441	['in conclusion, an increase in 25(Oh)D concentration during Pregnancy of at LEAST 30 nmol/l, REGARDLESS OF Vitamin D status at t1, was ASSOCIATED with a lower odds ratio for pe.']	[('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC5487839	3/2016	S131-PMC5487839	['an increased risk of malformations events has NOT been OBSERVED in Humans (LIMITED DATA) [360]cvitamin dthe ROLE for Vitamin D supplementation in Pregnancy is CONTROVERSIAL, BUT there is NO EVIDENCE of a reduction in adverse Pregnancy outcomes (e.g., Preeclampsia, Stillbirth, neonatal death) [361] or improvement in bone Mineral content in children in studies in which supplementation was given INDEPENDENTLY from Blood levels [362].']	[('FULL_UNKNOWN', 46), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 396)]	7	[('NCBITaxon_9606', 'Homo sapiens', 67, 'humans'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy'), ('GO_0007565', 'female pregnancy', 225, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 251, 'preeclampsia'), ('GO_0001966', 'thigmotaxis', 265, 'stillbirth'), ('CHEBI_46662', 'mineral', 322, 'mineral'), ('UBERON_0000178', 'blood', 415, 'blood')]
PMC5487839	3/2016	S201-PMC5487839	['the data obtained in a relatively SMALL group of patients are IN LINE WITH REPORTS on the advantages of vegetal proteins in reducing Kidney disease progression in non-Pregnant Humans, with a systematic review on vegan-vegetarian diets in Pregnancy, and with the position of the american dietary association, provided that b12, iron and Vitamin D are Controlled and supplied upon NEED [170–178].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 379)]	4	[('UBERON_0002113', 'kidney', 133, 'kidney'), ('GO_0007565', 'female pregnancy', 167, 'pregnant'), ('NCBITaxon_9606', 'Homo sapiens', 176, 'humans'), ('GO_0007565', 'female pregnancy', 238, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D'), ('GO_0065007', 'biological regulation', 350, 'controlled')]
PMC4843009	4/2016	S4-PMC4843009	['to THIS END kl/kl -Mice and wild-type Mice were treated with Nh4Cl and either control diet or Vitamin D deficient diet (lvd).']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('NCBITaxon_10088', 'Mus <genus>', 19, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 38, 'mice'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 61, 'NH4Cl'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC4843009	4/2016	S24-PMC4843009	['in Animals, Vitamin D deficiency HAS BEEN SHOWN to decrease explorative behavior and enhance anxiety, aberrant grooming, submissive social behavior, social neglect and maternal cannibalism333435.']	[('INCOMPLETE_EVIDENCE', 33)]	1	[('NCBITaxon_33208', 'Metazoa', 3, 'animals'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC4843009	4/2016	S26-PMC4843009	['deletion of the Vitamin D Receptor (vdr) HAS SIMILARLY BEEN SHOWN to AFFECT Murine behavior34373839404142.']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 69)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 16, 'vitamin D receptor'), ('NCBITaxon_39107', 'Murinae', 76, 'murine')]
PMC4843009	4/2016	S38-PMC4843009	['thus, kl/kl Mice and wild-type Mice were treated with Nh4Cl (280\u2009mm in drinking Water) and with either control diet or Vitamin D deficient diet, which HAS PREVIOUSLY BEEN shown to normalize Plasma 1,25(Oh)2D3Levels in kl/kl Mice55.']	[('IMPORTANT_CONSIDERATION', 151), ('INCOMPLETE_EVIDENCE', 155)]	2	[('NCBITaxon_10088', 'Mus <genus>', 12, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 31, 'mice'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 54, 'NH4Cl'), ('CHEBI_15377', 'water', 80, 'water'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 190, 'plasma'), ('CHEBI_17996', 'chloride', 198, ','), ('CHEBI_51467', 'PicoGreen', 199, '25(OH)2D3levels'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'mice55')]
PMC4843009	4/2016	S50-PMC4843009	['HOWEVER, Vitamin D deficient diet decreased the values of all three parameters in Plasma of kl/kl Mice to values SIMILAR as those in wild-type Mice.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 113)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 82, 'plasma'), ('NCBITaxon_10088', 'Mus <genus>', 98, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 143, 'mice')]
PMC4843009	4/2016	S114-PMC4843009	['the difference is abrogated by Vitamin D deficient diet, INDICATING that the excessive 1,25(oh)2d3formation in kl/kl Mice ACCOUNTED for the observed differences between Nh4Cl treated kl/kl Mice and wild-type Mice.']	[('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 122)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'mice'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 169, 'NH4Cl'), ('NCBITaxon_10088', 'Mus <genus>', 189, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 208, 'mice')]
PMC4843009	4/2016	S120-PMC4843009	['the present OBSERVATIONS underscore the powerful direct or indirect INFLUENCE of 1,25(Oh)2D3On the Brain, which PRESUMABLY accounts FOR the various Cerebral EFFECTS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 112), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('CHEBI_37958', 'dye', 81, '1,'), ('CHEBI_35448', '1,2-phenylene group', 83, '25(OH)2D3on'), ('UBERON_0000955', 'brain', 99, 'brain'), ('UBERON_0001893', 'telencephalon', 148, 'cerebral'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4843009	4/2016	S122-PMC4843009	['CONVERSELY, Vitamin D supplementation HAS BEEN REPORTED to counteract depressive symptoms515253.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 47)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
PMC4846845	4/2016	S156-PMC4846845	['a RECENT meta-analysis did NOT see a positive change in ptb, lbw, pre-eclampsia, and Gestational diabetes rates with Vitamin D supplementation, THOUGH they did CONCLUDE that Vitamin D has “PLAUSIBLE EFFECTS” on many Perinatal outcomes [119].']	[('INCOMPLETE_EVIDENCE', 2), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 144), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('GO_0007565', 'female pregnancy', 85, 'gestational'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0036268', 'swimming', 216, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 216, 'perinatal')]
PMC4846845	4/2016	S168-PMC4846845	['the EFFECTS of maternal Vitamin D levels MAY INFLUENCE Perinatal and long-term outcomes through immune, antibacterial, and anti-inflammatory responses [99,129].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0036268', 'swimming', 55, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 55, 'perinatal')]
PMC4846845	4/2016	S169-PMC4846845	['a RECENT STUDY has FOUND ASSOCIATIONS between Vitamin D levels in maternal and Cord Blood and Immune Cell type proportions, as well as Placental Expression of Immune System related Genes [130].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 79, 'cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CL_0000738', 'leukocyte', 94, 'immune cell'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('UBERON_0001987', 'placenta', 135, 'placental'), ('GO_0010467', 'gene expression', 145, 'expression'), ('UBERON_0002405', 'immune system', 159, 'immune system'), ('SO_0000704', 'gene', 181, 'genes')]
PMC4846845	4/2016	S173-PMC4846845	['ACCUMULATING DATA SUPPORT that Vitamin D deficiency plays a ROLE in DISPARITIES in Reproductive health outcomes [132,134].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 68)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0000003', 'reproduction', 83, 'reproductive')]
PMC4846845	4/2016	S174-PMC4846845	['a RECENT STUDY REPORTED that methylation of a subset of Cpg Sites identified through a network analysis is AFFECTED by both ancestry and maternal Vitamin D concentrations, SUGGESTING that both of these factors MAY IMPACT the methylome of the neonate [135].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 210), ('SUPERFICIAL_RELATIONSHIP', 214)]	6	[('SO_0000036', 'matrix_attachment_site', 56, 'CpG sites'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC4848664	4/2016	S15-PMC4848664	['the institute of medicine (iom) conducted a comprehensive review of Folic Acid SAFETY and CONCLUDED that progression of neuropathy among Vitamin B-12-deficient Individuals receiving Folic Acid doses ≥5000 µg/day was a POTENTIAL adverse EFFECT of Folic Acid.']	[('IMPORTANT_CONSIDERATION', 79), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 218), ('SUPERFICIAL_RELATIONSHIP', 236)]	4	[('CHEBI_30751', 'formic acid', 68, 'folic acid'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 137, 'vitamin B-12'), ('NCBITaxon_1', 'root', 160, 'individuals'), ('CHEBI_30751', 'formic acid', 182, 'folic acid'), ('CHEBI_30751', 'formic acid', 246, 'folic acid')]
PMC4848664	4/2016	S131-PMC4848664	['development of the Folic Acid ul was BASED ON EVIDENCE of masking of Vitamin B-12 deficiency anemia, and THUS, CONCERNS about the Folic Acid ul are ONLY applicable to those with a Vitamin B-12 deficiency and not to the general population.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 105), ('PROBLEM_COMPLICATION', 111), ('INCOMPLETE_EVIDENCE', 148)]	7	[('CHEBI_30751', 'formic acid', 19, 'folic acid'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 69, 'vitamin B-12'), ('CHEBI_30751', 'formic acid', 130, 'folic acid'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 180, 'vitamin B-12')]
PMC4848664	4/2016	S132-PMC4848664	['the Folic Acid ul MAY BE MISINTERPRETED as an “upper limit”, but SHOULD ONLY BE CONSIDERED a tolerable upper intake level for Individuals with a Vitamin B-12 deficiency.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 25), ('FUTURE_WORK', 65), ('INCOMPLETE_EVIDENCE', 72), ('ANOMALY_CURIOUS_FINDING', 77), ('INCOMPLETE_EVIDENCE', 80)]	9	[('CHEBI_30751', 'formic acid', 4, 'folic acid'), ('NCBITaxon_1', 'root', 126, 'individuals'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin B')]
PMC4896250	4/2016	S2791-PMC4896250	['the GROWING DATA SUGGESTS that Vitamin D deficiency plays an IMPORTANT ROLE in the development of childhood asthma.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 61), ('SUPERFICIAL_RELATIONSHIP', 71)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC4896250	4/2016	S3003-PMC4896250	['a209 regional differences of Vitamin D and Food-induced anaphylaxis in korea\n\nsi-heon kim1, gil-soon choi2, su-chin kim1, ji hye kim1, ga young ban1, yoo seob shin1, hae-sim park1, young min ye1\n\n1ajou university school of medicine south korea;2kosin university gospel hospital\n\ncorrespondence: si-heon kim – ajou university school of medicine, south korea\nbackground: it HAS BEEN SUGGESTED that Vitamin D deficiency has an INFLUENCE on increase in the prevalence of allergic disease.']	[('INCOMPLETE_EVIDENCE', 372), ('SUPERFICIAL_RELATIONSHIP', 424)]	2	[('CHEBI_28384', 'vitamin K', 29, 'Vitamin D'), ('CHEBI_33290', 'food', 43, 'Food'), ('CHEBI_27300', 'vitamin D', 396, 'vitamin D')]
PMC4896250	4/2016	S3016-PMC4896250	['conclusions: overall, higher fia incidence and lower Vitamin D levels were FOUND in relatively higher latitude region compared with lower region.']	[('INCOMPLETE_EVIDENCE', 75)]	1	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4896250	4/2016	S3695-PMC4896250	['a259 ASSOCIATION of vdr and Cyp2R1 polymorphisms with persistent allergic rhinitis in a han chinese population\n\nhui-qin tian, lei cheng, xin-yuan chen\n\nthe first affiliated hospital of nanjing medical university, china\n\ncorrespondence: hui-qin tian – the first affiliated hospital of nanjing medical university china\na) background: as recent STUDIES have DESCRIBED an ASSOCIATION between Vitamin D and allergic rhinitis, we HYPOTHESIZED that Genes encoding components of the Vitamin D pathway MAY BE CANDIDATE Genes for susceptibility to allergic rhinitis.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 342), ('INCOMPLETE_EVIDENCE', 355), ('SUPERFICIAL_RELATIONSHIP', 368), ('INCOMPLETE_EVIDENCE', 424), ('INCOMPLETE_EVIDENCE', 493), ('INCOMPLETE_EVIDENCE', 500)]	7	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 28, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 388, 'vitamin D'), ('SO_0000704', 'gene', 442, 'genes'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin D'), ('GO_0007601', 'visual perception', 475, 'vitamin D'), ('SO_0000704', 'gene', 510, 'genes')]
PMC4896250	4/2016	S4148-PMC4896250	['a294 low Vitamin D levels are RELATED to high house dust mite sensitization in patients with severe atopic dermatitis\n\nyong hyun jang\n\nkyungpook national university school of medicine, south korea\nbackground: the RELATIONSHIP between atopic dermatitis (ad) and low Vitamin D levels HAS BEEN studied.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 213), ('INCOMPLETE_EVIDENCE', 282)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC4896250	4/2016	S4149-PMC4896250	['emerging EVIDENCE has IMPLICATED Vitamin D as a CRITICAL REGULATOR of Immunity, playing a ROLE in both the innate and cell-Mediated Immune Systems.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 90)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007566', 'embryo implantation', 70, 'immunity'), ('GO_0007127', 'meiosis I', 123, 'mediated immune'), ('UBERON_0002405', 'immune system', 132, 'immune systems')]
PMC4896250	4/2016	S4157-PMC4896250	['in addition, a significant negative CORRELATION was FOUND between Vitamin D levels and hdm sensitization in the severe ad group.']	[('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 52)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4896250	4/2016	S4159-PMC4896250	['conclusions: our results DEMONSTRATE that low Vitamin D levels MAY LINK to high hdm sensitization in patients with the SEVERE ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 119)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4896250	4/2016	S4160-PMC4896250	['FURTHER ELUCIDATION of the ROLE of Vitamin D in hdm sensitization MAY hold PROFOUND IMPLICATIONS for the prevention and treatment of ad.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 66), ('IMPORTANT_CONSIDERATION', 75), ('IMPORTANT_CONSIDERATION', 84)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4896250	4/2016	S4484-PMC4896250	['RECENTLY, epidemiologic studies HAVE SHOWN that the lack of Vitamin D levels MAY BE ASSOCIATED with high asthma prevalence.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 84)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4896250	4/2016	S4490-PMC4896250	['also, we FOUND that when Serum Vitamin D level is 1 ng/ml decreases, the prevalence of asthma increase to 0.788-fold (or, 0.788; 95% ci, 0.707-0.879; p<0.001).']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('UBERON_0001977', 'blood serum', 25, 'serum'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC4896250	4/2016	S4492-PMC4896250	['conclusion: these results SUGGEST that Serum Vitamin D levels were ASSOCIATED with pediatric asthma in korea.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('UBERON_0001977', 'blood serum', 39, 'serum'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC4896250	4/2016	S6120-PMC4896250	['SOME STUDIES had SUGGESTED a RELATIONSHIP between Vitamin D status and allergic rhinitis, and others DID NOT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 101)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4896250	4/2016	S6132-PMC4896250	['SINCE THESE studies were very HETEROGENEOUS and the retrospective or the observational cohort studies, large randomized controlled TRIALS ARE NEEDED to determine WHETHER Vitamin D supplementation MAY BE beneficial in the PREVENTION of ar.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 6), ('DIFFICULT_TASK', 30), ('FUTURE_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 221)]	7	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC4896250	4/2016	S6528-PMC4896250	['we SOUGHT TO DETERMINE WHETHER the immunomodulatory properties of Vitamin D MIGHT have beneficial EFFECTS on crs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4896250	4/2016	S6538-PMC4896250	['conclusions: these results SUGGEST that Vitamin D MIGHT Modulate mediators INVOLVED in Immune Responses in crs.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0065007', 'biological regulation', 56, 'modulate'), ('GO_0006955', 'immune response', 87, 'immune responses'), ('UBERON_0002405', 'immune system', 87, 'immune')]
PMC4896250	4/2016	S7522-PMC4896250	['a531 the ASSOCIATION between Serum Vitamin D levels and allergic diseases in elementary schoolchildren\n\nhea-kyoung yang1, ji young lee1, minji kim1, kangmo ahn2, jihyun kim1, young-min kim1, hye-young kim3, yong mean park4, woo kyung kim5, so-yeon lee6\n\n1samsung medical center, south korea;2samsung;3medical research institute of pusan national university hospital;4konkuk university school of medicine;5seoul paik hospital/inje university college of medicine;6department of pediatrics, hallym sacred Heart hospital, hallym university college of medicine\n\ncorrespondence: hea-kyoung yang – samsung medical center, south korea\npurpose: there are CONTROVERSIES about the RELATIONSHIP between Vitamin D and allergic diseases, ALTHOUGH there HAS BEEN GROWING INTEREST in Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 646), ('SUPERFICIAL_RELATIONSHIP', 670), ('ANOMALY_CURIOUS_FINDING', 724), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 748)]	6	[('UBERON_0001977', 'blood serum', 29, 'Serum'), ('CHEBI_28384', 'vitamin K', 35, 'Vitamin D'), ('UBERON_0000948', 'heart', 502, 'Heart'), ('CHEBI_27300', 'vitamin D', 691, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 768, 'vitamin D')]
PMC4896250	4/2016	S7535-PMC4896250	['conclusion: a high prevalence of Vitamin D deficiency and insufficiency was FOUND in korean elementary schoolchildren, but Vitamin D level was not associated with the recent symptoms of Allergic diseases.']	[('INCOMPLETE_EVIDENCE', 76)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0040011', 'locomotion', 186, 'allergic')]
PMC4896250	4/2016	S8291-PMC4896250	['in RECENT YEARS, SEVERAL STUDIES HAVE REPORTED an ASSOCIATION between Vitamin D levels, atopy, asthma and Respiratory Tract infections.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 50)]	4	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 106, 'respiratory tract')]
PMC4896250	4/2016	S8292-PMC4896250	['objective\nwe AIMED TO INVESTIGATE WHETHER Vitamin D insufficiency in asthmatic Adults ASSOCIATES with atopy, poor asthma Control, and more frequent Respiratory Tract infections, and WHETHER these patients CAN BENEFIT from Vitamin D supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 209)]	7	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('GO_0065007', 'biological regulation', 121, 'control'), ('UBERON_0000065', 'respiratory tract', 148, 'respiratory tract'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC4896250	4/2016	S8303-PMC4896250	['conclusions\nwe FOUND that Vitamin D insufficiency in patients with asthma CORRELATES with allergic sensitization.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC4896250	4/2016	S9073-PMC4896250	['from this data, the amount of various Nutrients COULD BE ESTIMATED, including fibers, Sugar, tryptophan, Beta-Carotene, calcium, niacin, Folate, Thiamin, Carbohydrates, riboflavin, Vitamin A (Retinol), Vitamin B6, Vitamin B12, Vitamin C, Vitamin D, and Cholesterol.']	[('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 57)]	2	[('CHEBI_33284', 'nutrient', 38, 'nutrients'), ('CHEBI_24870', 'ion', 86, 'sugar'), ('CHEBI_17579', 'beta-carotene', 105, 'beta-carotene'), ('CHEBI_30863', '5-azaorotic acid', 137, 'folate'), ('CHEBI_26948', 'vitamin B1', 145, 'thiamin'), ('CHEBI_16646', 'carbohydrate', 154, 'carbohydrates'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 192, 'retinol'), ('CHEBI_33237', 'vitamin D4', 202, 'vitamin B6'), ('CHEBI_33279', 'vitamin D5', 214, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D'), ('CHEBI_16113', 'cholesterol', 253, 'cholesterol')]
PMC4896250	4/2016	S9520-PMC4896250	['Epidermal barrier injury and Dysregulatory of Immune System COULD BE induced by Vitamin D. the AIM of STUDY was TO REVEAL RELATION in between of Serum level of 25-hydroxyvitamin d with atopic dermatitis occurrence and severity in children.']	[('INCOMPLETE_EVIDENCE', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 122)]	6	[('UBERON_0007376', 'outer epithelium', 0, 'Epidermal'), ('GO_0007631', 'feeding behavior', 29, 'dysregulatory'), ('UBERON_0002405', 'immune system', 46, 'immune system'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 53, 'system'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum')]
PMC4998950	4/2016	S0-PMC4998950	['maternal Vitamin D deficiency and the risk of autism spectrum disorders: population-based study\n\nabstract\n\nbackground\nmaternal Vitamin D deficiency MAY increase risk of autism spectrum disorder (asd), BUT DIRECT EVIDENCE IS LACKING.']	[('INCOMPLETE_EVIDENCE', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201), ('INCOMPLETE_EVIDENCE', 205), ('FULL_UNKNOWN', 224)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4998950	4/2016	S5-PMC4998950	['conclusions\nif REFLECTING ASSOCIATIONS for Prenatal hypovitaminosis, THESE FINDINGS IMPLY Gestational Vitamin D substitution AS a means of asd PREVENTION.']	[('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 84), ('PROBABLE_UNDERSTANDING', 125), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('GO_0007565', 'female pregnancy', 90, 'gestational'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]
PMC4998950	4/2016	S13-PMC4998950	['method\nwe conducted a cohort study using the syc, comprising all swedish-born Individuals aged 4–17 years who were resident for at least 4 years in stockholm county between 2001 and 2011 and had complete covariate data ( n =509 639).7prospectively recorded data on probands and their relatives were retrieved from registers as PREVIOUSLY described.7\nwe identified cases from several national and regional registers, using a validated approach covering all known pathways of asd diagnosis and care in stockholm county.7the national patient register contains the dates and discharge diagnoses of all in-patient (since 1973) and specialist out-patient care (since 2001) in sweden.7using this source, we defined exposure as a lifetime-recorded diagnosis of unspecified Vitamin D deficiency (icd-10 e55.9 or icd-9 268.9), corresponding to a Serum 25-Hydroxyvitamin D level of less than 25 nmol/l (with clinical manifestations such as osteomalacia, muscle aches and weakness), in the biological mother.']	[('INCOMPLETE_EVIDENCE', 327)]	1	[('NCBITaxon_1', 'root', 78, 'individuals'), ('CHEBI_27300', 'vitamin D', 765, 'vitamin D'), ('UBERON_0001977', 'blood serum', 836, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 842, '25-hydroxyvitamin D')]
PMC4998950	4/2016	S14-PMC4998950	['we considered other parental characteristics described below (also seetable 1) as POTENTIAL CONFOUNDERS or mediators BASED ON their ASSOCIATIONS with asd and Vitamin D deficiency.5,8,9\n\ncaption (table-wrap): table 1\nstudy population characteristics in relation to lifetime maternal history of diagnosed Vitamin D deficiencymaternal history of Vitamin D deficiencycharacteristicnoyes p allindividuals, n (%)509 092 (99.9)547 (0.1)509 639 (100.0)cases of asd with intellectual disability, n (%)2463 (0.5)13 (2.4)<0.00012476 (0.5)cases of asd without intellectual disability, n (%)7396 (1.4)10 (1.8)0.467406 (1.4)male (%)51.352.60.5151.3maternal age, years: mean29.928.5<0.000129.9paternal age, years: mean32.834.0<0.000132.8maternal country of Birth (%)\u2003sweden76.319.2<0.000176.2\u2003europe8.34.60.0028.3\u2003outside europe12.838.9<0.000112.9\u2003sub-saharan africa2.637.3<0.00012.6lowest quintile of disposable family income (%)14.835.6<0.000114.8elementary maternal education (%)15.643.1<0.000115.6elementary paternal education (%)16.832.7<0.000116.8born small for Gestational age (%)2.53.70.092.5premature Birth (<37 weeks, %)5.96.20.075.9maternal history of neuropsychiatric disorder (%)a2.49.3<0.00012.4paternal history of neuropsychiatric disorder (%)a2.02.00.982.0maternal history of affective disorder (%)b15.436.8<0.000115.4paternal history of affective disorder (%)b8.110.80.028.1maternal history of epilepsy (%)1.01.50.251.0paternal history of epilepsy (%)1.00.70.521.0\nparental histories of neuropsychiatric disorder include any in-patient or secondary care out-patient record of diagnosed non-affective psychosis, bipolar disorder, attention-deficit hyperactivity disorder, asd, or intellectual disability.']	[('INCOMPLETE_EVIDENCE', 82), ('PROBLEM_COMPLICATION', 92), ('PROBABLE_UNDERSTANDING', 117), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 132)]	5	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 343, 'vitamin D'), ('GO_0007567', 'parturition', 742, 'birth'), ('GO_0007565', 'female pregnancy', 1053, 'gestational'), ('GO_0007567', 'parturition', 1095, 'birth')]
PMC4998950	4/2016	S26-PMC4998950	['lifetime maternal Vitamin D deficiency was RARE ACCORDING TO secondary care diagnoses and recorded in ONLY 547 Individuals (0.1%).']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 48), ('ANOMALY_CURIOUS_FINDING', 102), ('INCOMPLETE_EVIDENCE', 102)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('NCBITaxon_1', 'root', 111, 'individuals')]
PMC4998950	4/2016	S28-PMC4998950	['diagnosed lifetime maternal Vitamin D deficiency was ASSOCIATED with risk of asd and, in particular, of asd with intellectual disability ( p for homogeneity 0.17) (table 2), ALTHOUGH there was SOME attenuation upon adjustment for parental characteristics.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 174), ('INCOMPLETE_EVIDENCE', 193)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4998950	4/2016	S33-PMC4998950	['discussion\nTHIS STUDY is, TO OUR KNOWLEDGE, the FIRST population-based study to ESTIMATE the RELATIONSHIP between maternal Vitamin D deficiency and the RISK of asd in a child.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 93), ('IMPORTANT_CONSIDERATION', 152)]	6	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4998950	4/2016	S37-PMC4998950	['second, maternal Vitamin D status was IDENTIFIED from secondary care records, and THEREFORE under-ascertained and PERHAPS DIFFERENTIALLY so with regard to asd RISK FACTORS.']	[('INCOMPLETE_EVIDENCE', 38), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 159)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC4998950	4/2016	S42-PMC4998950	['HOWEVER, given that Vitamin D deficiency among Pregnant women in sweden is detected ONLY when outright screened for,12many cases of deficiency are LIKELY to manifest well before any official diagnosis is recorded.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 84), ('PROBABLE_UNDERSTANDING', 147)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnant')]
PMC4998950	4/2016	S43-PMC4998950	['our finding of a stronger ASSOCIATION between maternal hypovitaminosis d and asd with intellectual disability than without intellectual disability is IN LINE WITH migrant STUDIES, DEMONSTRATING that offspring risk of severe forms of asd – BUT NOT asperger’s syndrome or asd without intellectual disability – is increased in migrant populations where Vitamin D deficiency is highly prevalent.3–6,8there is also MOUNTING EVIDENCE that environmental FACTORS are more RELEVANT (THAN Genetic factors) for the development of lower-functioning asd.2we, as well as others,6FURTHER OBSERVED heterogeneity in the ASSOCIATIONS between Vitamin D deficiency and asd between children with and without maternal migrant history.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 150), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239), ('ANOMALY_CURIOUS_FINDING', 239), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 447), ('IMPORTANT_CONSIDERATION', 464), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 474), ('INCOMPLETE_EVIDENCE', 564), ('INCOMPLETE_EVIDENCE', 573), ('SUPERFICIAL_RELATIONSHIP', 603)]	13	[('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('SO_0000704', 'gene', 479, 'genetic'), ('CHEBI_27300', 'vitamin D', 624, 'vitamin D')]
PMC4998950	4/2016	S44-PMC4998950	['this DISCREPANCY MIGHT be DUE TO a limited range of exposure in children of immigrant mothers, AS the majority of children and Pregnant mothers with migrant background have neonatal/Gestational Vitamin D deficiency, ACCORDING TO RECENT swedish REPORTS.6,11\ncausality cannot be inferred from our study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 17), ('PROBLEM_COMPLICATION', 26), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 244)]	7	[('GO_0007565', 'female pregnancy', 127, 'pregnant'), ('GO_0007565', 'female pregnancy', 182, 'gestational'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4998950	4/2016	S45-PMC4998950	['there are, HOWEVER, biological UNDERPINNINGS of a TRUE ASSOCIATION AS experimental studies INDICATE CRITICAL ROLES of Vitamin D in the Development and functioning Of the Brain.4\nIN SUMMARY, our results SUPPORT, BUT DO NOT PROVE, the HYPOTHESIS that maternal Vitamin D status is IMPLICATED in the aetiology of asd with comorbid intellectual disability.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 55), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('FULL_UNKNOWN', 215), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 278)]	14	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 135, 'development ... of ... brain'), ('UBERON_0000955', 'brain', 170, 'brain'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC5035678	4/2016	S1-PMC5035678	['objectives\nwe report the FIRST STUDY of the IMPACT of Prenatal Vitamin D supplementation on Postpartum dysglycemia in gdm patients in a randomized clinical trial.']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('GO_0007565', 'female pregnancy', 54, 'prenatal'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 92, 'postpartum')]
PMC5035678	4/2016	S9-PMC5035678	['conclusions\nALTHOUGH the high Vitamin D supplementation dose in the PRESENT STUDY (compared to the 400 iu/day dose USUALLY recommended for Pregnancy) SAFELY increases the Serum 25Ohd, in gdm cases, the higher dose does not affect the plasma Glucose level or Insulin resistance at short term follow-up after Delivery.']	[('ANOMALY_CURIOUS_FINDING', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('INCOMPLETE_EVIDENCE', 115), ('IMPORTANT_CONSIDERATION', 150)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'pregnancy'), ('UBERON_0001977', 'blood serum', 171, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD'), ('CHEBI_17234', 'glucose', 241, 'glucose'), ('PR_000045358', 'insulin family protein', 258, 'insulin'), ('GO_0007567', 'parturition', 307, 'delivery')]
PMC5035678	4/2016	S19-PMC5035678	['an inverse RELATIONSHIP between serum Vitamin D levels and Glucose Metabolism in women with gdm HAS BEEN REPORTED in several observational studies (8-11).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 96)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_17234', 'glucose', 59, 'glucose'), ('GO_0006006', 'glucose metabolic process', 59, 'glucose metabolism')]
PMC5035678	4/2016	S23-PMC5035678	['a RECENT STUDY SHOWED that post-Parturition Vitamin D supplementation MAY PREVENT the progression of Insulin resistance in patients with a recent history of gdm (16).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('GO_0019230', 'proprioception', 32, 'parturition'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('PR_000045358', 'insulin family protein', 101, 'insulin')]
PMC5035678	4/2016	S53-PMC5035678	['after taking 400,000 iu Vitamin D3, a random Urinary Calcium/creatinine (ca/cr) test was performed as a safety measure against Vitamin D toxicity, which is the FIRST SIGN of hypervitaminosis d (25Ohd > 100 ng/ml) (19).']	[('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 166)]	2	[('CHEBI_33279', 'vitamin D5', 24, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 24, 'vitamin D3'), ('UBERON_0001088', 'urine', 45, 'urinary'), ('CHEBI_31341', 'calcium dihydroxide', 53, 'Calcium'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 194, '25OHD')]
PMC5035678	4/2016	S109-PMC5035678	['discussion\nTO OUR KNOWLEDGE, THIS is the FIRST STUDY TO EVALUATE the EFFECTS of Vitamin D supplementation during Pregnancy on Glucose Metabolism shortly after Delivery.']	[('PROBABLE_UNDERSTANDING', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 69)]	6	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('CHEBI_17234', 'glucose', 126, 'glucose'), ('GO_0006006', 'glucose metabolic process', 126, 'glucose metabolism'), ('GO_0007567', 'parturition', 159, 'delivery')]
PMC5035678	4/2016	S110-PMC5035678	['OUR STUDY DEMONSTRATES that high dose Vitamin D supplementation during Pregnancy in women with gdm and impairment of 25Ohd concentration has no effect on post-Partum Plasma Glucose and Insulin resistance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 117, '25OHD'), ('GO_0007567', 'parturition', 159, 'partum'), ('UBERON_0001969', 'blood plasma', 166, 'plasma'), ('CHEBI_17234', 'glucose', 173, 'glucose'), ('PR_000045358', 'insulin family protein', 185, 'insulin')]
PMC5035678	4/2016	S112-PMC5035678	['fifty eight percent of group c remained Vitamin D deficient, which INDICATES that the usual multivitamin that is prescribed for a majority of Pregnant women (containing 400 iu Vitamin D3) is not adequate to correct hypovitaminosis D. THEREFORE, Pregnant women NEED a higher dose of Vitamin D than that typically consumed.']	[('INCOMPLETE_EVIDENCE', 67), ('PROBABLE_UNDERSTANDING', 234), ('IMPORTANT_CONSIDERATION', 260)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 142, 'pregnant'), ('CHEBI_33279', 'vitamin D5', 176, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 176, 'vitamin D3'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 231, 'D'), ('GO_0007565', 'female pregnancy', 245, 'pregnant'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC5035678	4/2016	S113-PMC5035678	['several observational STUDIES INDICATE that Serum 25Ohd has an inverse RELATIONSHIP with Insulin resistance and incidence of gdm (22,23), and that Vitamin D deficiency is ASSOCIATED with type 2 diabetes (24).']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 171)]	4	[('UBERON_0001977', 'blood serum', 44, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 50, '25OHD'), ('PR_000045358', 'insulin family protein', 89, 'insulin'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC5035678	4/2016	S114-PMC5035678	['in addition, Animal studies have DEMONSTRATED that Vitamin D deficiency causes Insulin secretion defects (25).']	[('INCOMPLETE_EVIDENCE', 33)]	1	[('NCBITaxon_33208', 'Metazoa', 13, 'animal'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('PR_000045358', 'insulin family protein', 79, 'insulin')]
PMC5035678	4/2016	S115-PMC5035678	['HOWEVER, there is SCARCE INFORMATION about the EFFECT of Vitamin D supplementation on Glucose Metabolism, especially during Pregnancy and after Delivery.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_17234', 'glucose', 86, 'glucose'), ('GO_0006006', 'glucose metabolic process', 86, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('GO_0007567', 'parturition', 144, 'delivery')]
PMC5035678	4/2016	S117-PMC5035678	['(26) REVEALED a positive EFFECT of co-supplementation with Vitamin D and Calcium on Insulin resistance during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 25)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 73, 'calcium'), ('PR_000045358', 'insulin family protein', 84, 'insulin'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy')]
PMC5035678	4/2016	S128-PMC5035678	['(28) FOUND that 1000 mg elemental Calcium plus 400 iu Vitamin D daily, in middle age and elderly women for a median of 7 years, did not reduce the incidence of diabetes and Insulin resistance.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_22313', 'alkaline earth metal atom', 34, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('PR_000045358', 'insulin family protein', 173, 'insulin')]
PMC5035678	4/2016	S132-PMC5035678	['they FOUND that high dose supplementation for a mean of 14 weeks during Pregnancy was not beneficial to the patients’ plasma Glucose level or Insulin resistance during Pregnancy, BUT that their babies BENEFITTED from the supplementation with decreased neonatal hypovitaminosis D. the authors CONCLUDED that the commencement of Vitamin D supplementation MAY HAVE been too late to cause any observable EFFECTS on Β-Cell function, and they SUGGESTED that earlier supplementation, EVEN before Pregnancy, MIGHT be EFFECTIVE.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('IMPORTANT_CONSIDERATION', 201), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 353), ('IMPORTANT_CONSIDERATION', 357), ('SUPERFICIAL_RELATIONSHIP', 400), ('INCOMPLETE_EVIDENCE', 437), ('ANOMALY_CURIOUS_FINDING', 477), ('INCOMPLETE_EVIDENCE', 500), ('SUPERFICIAL_RELATIONSHIP', 509)]	11	[('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('CHEBI_17234', 'glucose', 125, 'glucose'), ('PR_000045358', 'insulin family protein', 142, 'insulin'), ('GO_0007565', 'female pregnancy', 168, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 277, 'D'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D'), ('CL_0000623', 'natural killer cell', 411, 'β-cell'), ('GO_0007565', 'female pregnancy', 489, 'pregnancy')]
PMC5035678	4/2016	S134-PMC5035678	['this negative result was LIKELY caused by inadequate doses of Vitamin D3, time limitations, or the LACK OF a causal RELATION between Vitamin D and type 2 diabetes.']	[('PROBABLE_UNDERSTANDING', 25), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('CHEBI_33279', 'vitamin D5', 62, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 62, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC5035678	4/2016	S135-PMC5035678	['as mentioned by yap, this result MAY INDICATE that it is actually dysglycemia that leads to defects in Liver Hydroxylation of Vitamin D.\nVitamin D supplementation has diverse EFFECTS on the non-Pregnant population.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 175)]	3	[('UBERON_0002107', 'liver', 103, 'liver'), ('GO_0044444', 'cytoplasmic part', 109, 'hydroxylation'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 137, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 194, 'pregnant')]
PMC5035678	4/2016	S137-PMC5035678	['(30) REPORTED that daily 4,000 iu Vitamin D3 supplementation for 6 months (720,000 iu total) significantly decreased Insulin resistance in south asian women with Vitamin D deficiency and Insulin resistance.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_33279', 'vitamin D5', 34, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 34, 'vitamin D3'), ('PR_000045358', 'insulin family protein', 117, 'insulin'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('PR_000045358', 'insulin family protein', 187, 'insulin')]
PMC5035678	4/2016	S143-PMC5035678	['in ANOTHER STUDY of the non-Pregnant population, and CONSISTENT with our results, davidson and colleagues FOUND that a mean supplement dose of 88,865 iu Vitamin D per week, in 56 subjects with hypovitaminosis D and pre-diabetes, had no effect on Insulin resistance and plasma Glucose levels at 3, 6, 9, and 12 months after intervention, compared to 53 subjects in a placebo group (31).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 106)]	3	[('GO_0007565', 'female pregnancy', 28, 'pregnant'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 209, 'D'), ('PR_000045358', 'insulin family protein', 246, 'insulin'), ('CHEBI_17234', 'glucose', 276, 'glucose')]
PMC5035678	4/2016	S147-PMC5035678	['as PREVIOUSLY discussed, a LIMITED NUMBER OF STUDIES have evaluated the EFFECT of Vitamin D on Glucose Metabolism and Insulin resistance, especially during and after Pregnancy.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 72)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_17234', 'glucose', 95, 'glucose'), ('GO_0006006', 'glucose metabolic process', 95, 'glucose metabolism'), ('PR_000045358', 'insulin family protein', 118, 'insulin'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy')]
PMC5035678	4/2016	S148-PMC5035678	['CONSISTENT with our results, THESE STUDIES have FOUND that Vitamin D is ineffective or has UNCERTAIN EFFECTS.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 48), ('FULL_UNKNOWN', 91), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC5035678	4/2016	S150-PMC5035678	['the study was DESIGNED to detect any EFFECTS of Vitamin D on Insulin resistance by allowing for adequate time between the start of supplementation and the measurement of outcomes, and with the FEWEST number of patients lost to follow up.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 193)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('PR_000045358', 'insulin family protein', 61, 'insulin')]
PMC5035678	4/2016	S157-PMC5035678	['we DID NOT adjust the supplementation dose of Vitamin D3 based on the patient’s weight in order to provide an appropriate volume of distribution of Vitamin D in every patient, and the results would have been more reliable by calculating the proper dose for each Individual.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_33279', 'vitamin D5', 46, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 46, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('NCBITaxon_1', 'root', 262, 'individual')]
PMC5035678	4/2016	S158-PMC5035678	['regarding the predicted prevalence of 35%, the DETECTED incidence of dysglycemia (31%) MIGHT have led to an UNDERESTIMATION of the IMPACT of Vitamin D in our study.']	[('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 87), ('PROBLEM_COMPLICATION', 108), ('SUPERFICIAL_RELATIONSHIP', 131)]	4	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5035678	4/2016	S160-PMC5035678	['IN SPITE of these LIMITATIONS, THIS is currently the ONLY study in the literature that evaluates the INFLUENCE of Vitamin D supplementation during Pregnancy on Postpartum dysglycemia.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy'), ('GO_0007565', 'female pregnancy', 160, 'postpartum')]
PMC4800340	5/2016	S13-PMC4800340	["we FOCUS on selective common Food Allergens (Peanuts and Tree nuts, Cow's Milk, and egg) and Nutrients (Vitamin D and n-3 Fatty Acids) that HAVE BEEN RATHER widely studied."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150)]	3	[('CHEBI_33290', 'food', 29, 'food'), ('CHEBI_33663', 'cyclic hydrocarbon', 34, 'allergens'), ('NCBITaxon_10088', 'Mus <genus>', 45, 'peanuts'), ('NCBITaxon_1', 'root', 57, 'tree'), ('NCBITaxon_33208', 'Metazoa', 68, 'cow'), ('UBERON_0001913', 'milk', 74, 'milk'), ('CHEBI_33284', 'nutrient', 93, 'nutrients'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_35366', 'fatty acid', 122, 'fatty acids')]
PMC4800340	5/2016	S23-PMC4800340	['Vitamin D\nthe POSSIBLE ROLE of Vitamin D in Food allergy HAS BEEN HYPOTHESIZED BECAUSE several observational studies REPORTED varying Food allergy incidence ASSOCIATED with geographic or seasonal variation (sun exposure).']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 79), ('INCOMPLETE_EVIDENCE', 117), ('SUPERFICIAL_RELATIONSHIP', 157)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_33290', 'food', 44, 'food'), ('CHEBI_33290', 'food', 134, 'food')]
PMC4800340	5/2016	S25-PMC4800340	["THIS STUDY SUGGESTS that low sunlight and PRESUMABLY suboptimal Vitamin D status at Birth is ASSOCIATED with Food Allergy Development in childhood.30a large scale population-based study in australia SHOWED that infants with low Serum 25-Hydroxyvitamin (Oh) D3Levels (≤50 nmol/l) had almost 12 times and 4 times higher risk of developing Peanut and egg allergies, respectively, in the first year of Life THAN infants with adequate Serum Vitamin D level.31HOWEVER, ANOTHER STUDY conducted in germany DEMONSTRATED that 25(Oh)D3Concentration in Pregnant women's Serum and in Cord Blood were positively ASSOCIATED with increased risk of Food Allergy Development among children in the first 2 years.32a RECENT randomized double-blind controlled TRIAL SHOWED that maternal Vitamin D3Supplementation for 6 weeks during Lactation increased the risk of Food allergy diagnosis by 3.42 times [95% confidence interval (ci)=1.02–11.77] among children of supplementation group compared to control group by 2 years of age.33due to lack OF robustly designed studies, a causal ASSOCIATION between Vitamin D status during Prenatal and Neonatal Period and Food allergy Development In Children remains INCONCLUSIVE."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 452), ('INCOMPLETE_EVIDENCE', 463), ('INCOMPLETE_EVIDENCE', 498), ('SUPERFICIAL_RELATIONSHIP', 598), ('INCOMPLETE_EVIDENCE', 697), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 745), ('ANOMALY_CURIOUS_FINDING', 1020), ('SUPERFICIAL_RELATIONSHIP', 1059), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1181)]	16	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007567', 'parturition', 84, 'birth'), ('CHEBI_33290', 'food', 109, 'food'), ('GO_0048467', 'gynoecium development', 109, 'food allergy development'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('CHEBI_60346', 'alpha-Kdo-(2->8)-alpha-Kdo-OAll', 234, '25-hydroxyvitamin (OH) D3levels'), ('NCBITaxon_10088', 'Mus <genus>', 337, 'peanut'), ('UBERON_0000104', 'life cycle', 398, 'life'), ('UBERON_0001977', 'blood serum', 430, 'serum'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 516, '25(OH)D3concentration'), ('GO_0007565', 'female pregnancy', 541, 'pregnant'), ('UBERON_0001977', 'blood serum', 558, 'serum'), ('UBERON_0009472', 'axilla', 571, 'cord blood'), ('CHEBI_33290', 'food', 632, 'food'), ('GO_0048467', 'gynoecium development', 632, 'food allergy development'), ('CHEBI_52915', 'phosphatediyl group', 766, 'vitamin D3supplementation'), ('GO_0007595', 'lactation', 811, 'lactation'), ('CHEBI_33290', 'food', 843, 'food'), ('CHEBI_27300', 'vitamin D', 1079, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1103, 'prenatal'), ('UBERON_0007221', 'neonate stage', 1116, 'neonatal period'), ('CHEBI_33290', 'food', 1136, 'food'), ('GO_0030163', 'protein catabolic process', 1149, 'development in children')]
PMC4800340	5/2016	S40-PMC4800340	['in the boston Birth cohort study, Cord Blood Vitamin D deficiency [25(Oh)D concentration <11 ng/ml] was not FOUND TO be ASSOCIATED with Food sensitization to eight common Food Allergen in children.67HOWEVER, when individual Genetic variant of 4 CANDIDATE Genes INVOLVED in Ige synthesis and Vitamin D Metabolism were jointly considered, there is a statistically strong Gene-Vitamin D INTERACTION (pinteraction=9×10-6) on Food sensitization.']	[('ANOMALY_CURIOUS_FINDING', 108), ('SUPERFICIAL_RELATIONSHIP', 120), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 384)]	6	[('GO_0007567', 'parturition', 14, 'birth'), ('UBERON_0002240', 'spinal cord', 34, 'cord'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 67, '25(OH)D'), ('CHEBI_33290', 'food', 136, 'food'), ('CHEBI_33290', 'food', 171, 'food'), ('CHEBI_50904', 'allergen', 176, 'allergen'), ('SO_0000704', 'gene', 224, 'genetic'), ('SO_0000704', 'gene', 255, 'genes'), ('GO_0007630', 'jump response', 273, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 273, 'IgE'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 299, 'D metabolism'), ('SO_0000704', 'gene', 369, 'gene'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33290', 'food', 421, 'food')]
PMC4800340	5/2016	S51-PMC4800340	['the results of these studies SUGGEST that differential Dna Methylation in the regions of Genes RELATED to T-Cell Differentiation and balance between th1 and th2 during the critical Period Of early Life MAY BE POTENTIAL mechanisms of allergic disease development.73\n\nepigenetic Regulation by Nutrients\nALTHOUGH POSSIBLE ROLES of Prenatal Folate, N-3 Pufa, and Vitamin D in Immune programming HAVE BEEN SUGGESTED,3474only a LIMITED NUMBER OF STUDIES examined epigenetic Regulation by these Nutrients as a POTENTIAL biological pathway of allergic diseases.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('ANOMALY_CURIOUS_FINDING', 301), ('INCOMPLETE_EVIDENCE', 310), ('SUPERFICIAL_RELATIONSHIP', 319), ('INCOMPLETE_EVIDENCE', 391), ('INCOMPLETE_EVIDENCE', 401), ('INCOMPLETE_EVIDENCE', 422), ('INCOMPLETE_EVIDENCE', 503)]	12	[('GO_0006306', 'DNA methylation', 55, 'DNA methylation'), ('SO_0000704', 'gene', 89, 'genes'), ('CL_0000084', 'T cell', 106, 'T-cell'), ('GO_0030217', 'T cell differentiation', 106, 'T-cell differentiation'), ('UBERON_0008266', 'periodontal ligament', 181, 'period of ... life'), ('GO_0065007', 'biological regulation', 277, 'regulation'), ('CHEBI_33284', 'nutrient', 291, 'nutrients'), ('GO_0007565', 'female pregnancy', 328, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 337, 'folate'), ('CHEBI_80445', '9,10-EOT', 345, 'n-3 PUFA'), ('CHEBI_27300', 'vitamin D', 359, 'vitamin D'), ('GO_0007566', 'embryo implantation', 372, 'immune'), ('UBERON_0002405', 'immune system', 372, 'immune'), ('GO_0065007', 'biological regulation', 468, 'regulation'), ('CHEBI_33284', 'nutrient', 488, 'nutrients')]
PMC4800340	5/2016	S56-PMC4800340	['THIS STUDY SHOWED that Prenatal Vitamin D-mediated epigenetic Regulation in Tslp increased the RISK of wheezing in children.77more Human STUDIES ARE NEEDED to substantiate the ROLE of epigenetic Regulation by Nutrients in the growing epidemic of Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 137), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('GO_0007565', 'female pregnancy', 23, 'prenatal'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'regulation'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 76, 'TSLP'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('GO_0065007', 'biological regulation', 195, 'regulation'), ('CHEBI_33284', 'nutrient', 209, 'nutrients'), ('CHEBI_33290', 'food', 246, 'food')]
PMC4829940	5/2016	S8-PMC4829940	['in this large Genome wide assessment of the POTENTIAL INFLUENCE of maternal Vitamin D status on Dna Methylation, we DID NOT FIND any convincing ASSOCIATIONS in 1416 newborns.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 144)]	4	[('SO_0001026', 'genome', 14, 'genome'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0006306', 'DNA methylation', 96, 'DNA methylation')]
PMC4829940	5/2016	S14-PMC4829940	['low 25(Oh)D levels HAVE BEEN ASSOCIATED with a range of adverse conditions, from Pregnancy outcomes to childhood illnesses and chronic disease including osteoporosis, cancer and Cardiovascular disease in Adulthood[3], ALTHOUGH randomized controlled trials of Vitamin D supplements do NOT SUPPORT causality for Extra-Skeletal outcomes[4],[5].']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 29), ('ANOMALY_CURIOUS_FINDING', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 284)]	4	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 4, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('UBERON_0004535', 'cardiovascular system', 178, 'cardiovascular'), ('UBERON_0000113', 'post-juvenile adult stage', 204, 'adulthood'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 310, 'extra-skeletal')]
PMC4829940	5/2016	S19-PMC4829940	['ALTHOUGH a NUMBER OF STUDIES have REPORTED inverse ASSOCIATIONS between maternal Vitamin D status and Postnatal health outcomes, systematic reviews SHOW that there is STILL substantial heterogeneity between studies in terms of methodology and results, and FEW or NO randomized TRIALS HAVE BEEN performed[6],[8],[10],[11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 148), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 256), ('FULL_UNKNOWN', 263), ('INCOMPLETE_EVIDENCE', 284)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'postnatal')]
PMC4829940	5/2016	S20-PMC4829940	['ALTHOUGH two RECENT randomized controlled trials observed SUGGESTIVE reductions in the incidence of asthma and recurrent wheezing following Vitamin D supplementation during Pregnancy[12],[13], the primary endpoints were not statistically significant.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 58)]	4	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
PMC4829940	5/2016	S24-PMC4829940	['the activated Vitamin D receptor has a large number of POTENTIAL target Genes, identified both experimentally using in vitro MODELS and in silico by identification of Vitamin D responsive elements[15].']	[('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 125)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('SO_0000704', 'gene', 72, 'genes'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 175, 'D')]
PMC4829940	5/2016	S26-PMC4829940	['a FEW smaller STUDIES have investigated Dna Methylation at SOME CANDIDATE loci in RELATION to Vitamin D[16].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 82)]	4	[('GO_0006306', 'DNA methylation', 40, 'DNA methylation'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC4829940	5/2016	S27-PMC4829940	['one RECENT STUDY examined the ASSOCIATION between Vitamin D deficiency and Genome wide Dna Methylation in african children[17].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('SO_0001026', 'genome', 75, 'genome'), ('GO_0006306', 'DNA methylation', 87, 'DNA methylation')]
PMC4829940	5/2016	S28-PMC4829940	['another STUDY explored epigenetic Regulation of Vitamin D converting enzymes[18], WHILE a third FOUND a RELATIONSHIP between methylation of the Genes Cyp24R1 and Cyp27A1 and variations in circulating 25(Oh)D levels[19].']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('GO_0065007', 'biological regulation', 34, 'regulation'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('SO_0000704', 'gene', 144, 'genes'), ('PR_000006101', 'cytochrome P450 1A1', 150, 'CYP24R1'), ('PR_000006101', 'cytochrome P450 1A1', 162, 'CYP27A1'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 200, '25(OH ... D')]
PMC4829940	5/2016	S115-PMC4829940	['DESPITE the EXISTING HYPOTHESIS that maternal Vitamin D status MAY INFLUENCE offspring health[41], we FOUND NO EVIDENCE for any Dna Methylation based EFFECT in Cord Blood, EITHER Genome-wide or in four candidate Genes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	10	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0006306', 'DNA methylation', 128, 'DNA methylation'), ('UBERON_0002240', 'spinal cord', 160, 'cord'), ('UBERON_0000178', 'blood', 165, 'blood'), ('SO_0001026', 'genome', 179, 'genome'), ('SO_0000704', 'gene', 212, 'genes')]
PMC4829940	5/2016	S118-PMC4829940	['epigenetic EFFECTS of maternal Vitamin D levels on offspring methylomes can NEVERTHELESS not be excluded; the cpg’s in the neighborhood of the CANDIDATE Genes, as mapped by the illumina humanmethylation450 beadchip, MAY not be the same as the ones REPORTED from OTHER studies.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 262), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('SO_0000704', 'gene', 153, 'genes')]
PMC4829940	5/2016	S127-PMC4829940	['HOWEVER, a FEW other STUDIES have explored RELATIONSHIPS between Vitamin D supplementation or circulating 25(Oh)D and methylation at a few Cpg Sites in two to four candidate Genes in Adults[18],[46], and one Genome-wide Dna Methylation study explored ASSOCIATION with Vitamin D deficiency in african children[17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 251)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 106, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 106, '25(OH)D'), ('SO_0000036', 'matrix_attachment_site', 139, 'CpG sites'), ('SO_0000704', 'gene', 174, 'genes'), ('UBERON_0007023', 'adult organism', 183, 'adults'), ('SO_0001026', 'genome', 208, 'genome'), ('GO_0006306', 'DNA methylation', 220, 'DNA methylation'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin D')]
PMC4829940	5/2016	S128-PMC4829940	['given that Vitamin D status fluctuates throughout Pregnancy, IT IS POSSIBLE that the fetus is more sensitive to Vitamin D levels at certain Gestational periods[6].']	[('INCOMPLETE_EVIDENCE', 61)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'gestational')]
PMC4859539	5/2016	S10-PMC4859539	['the LACK OF association between Vitamin D status and Cathelicidin in THIS STUDY MAY BE DUE TO the NARROW RANGE in OBSERVED 25(Oh)D values and WARRANTS ADDITIONAL STUDIES for further observation.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 80), ('PROBLEM_COMPLICATION', 87), ('PROBLEM_COMPLICATION', 98), ('INCOMPLETE_EVIDENCE', 114), ('FUTURE_WORK', 142), ('FUTURE_WORK', 151)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 53, 'cathelicidin'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D')]
PMC4859539	5/2016	S13-PMC4859539	['PREVIOUS STUDIES have focused on Cathelicidin and Vitamin D concentrations in patient populations affected by various illnesses or diseases [6], such as tuberculosis [7], pneumonia [8], sepsis [9], hiv [10–12], and end-stage Renal disease hemodialysis [13], as well as healthy Adult populations [14–19].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('PR_000006009', 'alpha-catulin', 33, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0002113', 'kidney', 225, 'renal'), ('UBERON_0007023', 'adult organism', 277, 'adult')]
PMC4859539	5/2016	S14-PMC4859539	['additionally, WHILE ONE STUDY examined the levels of maternal and neonatal Vitamin D and Cathelicidin concentrations in healthy children at Delivery, there is a LACK OF research TO DETERMINE CORRELATIONS between Vitamin D status and cathelicidin among healthy children over time [20], as well as WHICH FACTORS such as age of the child, gender, and body composition MAY INDEPENDENTLY IMPACT Cathelicidin concentrations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 161), ('QUESTION_ANSWERED_BY_THIS_WORK', 178), ('SUPERFICIAL_RELATIONSHIP', 191), ('EXPLICIT_QUESTION', 296), ('SUPERFICIAL_RELATIONSHIP', 302), ('INCOMPLETE_EVIDENCE', 365), ('SUPERFICIAL_RELATIONSHIP', 369), ('SUPERFICIAL_RELATIONSHIP', 383)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 89, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 89, 'cathelicidin'), ('GO_0007567', 'parturition', 140, 'delivery'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 390, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 390, 'cathelicidin')]
PMC4859539	5/2016	S97-PMC4859539	["in MODELS 1 and 4, there was also a TREND NOTED with the child’s percent fat being positively ASSOCIATED with Cathelicidin (beta = 0.028, p = 0.052 and beta = 0.025, p = 0.087).10.1371/journal.pone.0152711.t003\n\ncaption (table-wrap): table 3\nmultivariable linear regression models assessing factors associated with natural logarithm for Cathelicidin.model 1 \xa0\xa0independent variablesbetase1p valuerace/ethnicity\xa0\xa0black-0.0390.230.864white---------hispanic-0.1490.2000.459genderfemale---------male0.3180.16 0.047 age0.1450.065 0.028 percent fat0.0280.0140.052child's current 25(Oh)D-0.0050.010.598 model 2 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicityblack0.0350.210.868white---------hispanic-0.1490.210.470genderfemale---------male0.2750.170.104age0.2120.07 0.004 percent fat0.0250.020.087child's 25(Oh)D at Birth-0.0030.010.748 model 3 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0410.180.821white---------hispanic-0.1220.160.458genderfemale---------male0.0910.140.507age0.1550.07 0.023 percent fat0.0120.010.359maternal 25(Oh)D throughout Pregnancy<-0.000100.999 model 4 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0460.1990.816white---------hispanic-0.0800.1850.669genderfemale---------male0.3180.158 0.047 age0.1510.064 0.021 percent fat0.0260.010.069maternal 25(Oh)D 1-month before Delivery0.0030.010.606\n1se represents standard error\n\ndiscussion\nin THIS STUDY of healthy children whose mothers had participated in a Vitamin D supplementation trial during Pregnancy, DESPITE DIFFERENCES in both maternal and childhood Vitamin D status, there were no significant differences in Cathelicidin concentration between the three racial/ethnic groups studied."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 36), ('ANOMALY_CURIOUS_FINDING', 42), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 1391), ('ANOMALY_CURIOUS_FINDING', 1508), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1516)]	7	[('CHEBI_3364', 'Canthiumine', 110, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 110, 'cathelicidin'), ('CHEBI_3461', 'Casuarictin', 337, 'Cathelicidin'), ('CHEBI_71657', 'versiconol acetate', 572, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 572, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 801, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 807, 'D'), ('GO_0007567', 'parturition', 812, 'birth'), ('CHEBI_71657', 'versiconol acetate', 1042, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1048, 'D'), ('GO_0007565', 'female pregnancy', 1061, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 1300, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1300, '25(OH)D'), ('GO_0007567', 'parturition', 1323, 'delivery0'), ('CHEBI_27300', 'vitamin D', 1458, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1497, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1559, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 1618, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 1618, 'cathelicidin')]
PMC4859539	5/2016	S99-PMC4859539	['REGARDLESS OF Vitamin D status, there was no statistically significant difference in Cathelicidin concentrations between subjects, CONSISTENT with the FINDINGS of other RECENT STUDIES [6,7,12,14,17,20].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 131), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 169)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 85, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 85, 'cathelicidin')]
PMC4859539	5/2016	S102-PMC4859539	['DIFFERENCES in age, health and initial Vitamin D status between cohorts, as well as study design, MAY EXPLAIN the CONFLICTING data.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 98), ('PROBABLE_UNDERSTANDING', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4859539	5/2016	S104-PMC4859539	['additionally, the LACK OF CORRELATION MAY SUGGEST that circulating Cathelicidin concentration is NOT REFLECTIVE of WHAT is happening at the cellular level, and in this regard, cathelicidin mrna Expression by Immune Cells or target Tissue MAY BE a BETTER indicator of Vitamin D’s long-term EFFECT on the Cathelicidin system.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 42), ('FULL_UNKNOWN', 97), ('EXPLICIT_QUESTION', 115), ('INCOMPLETE_EVIDENCE', 238), ('FUTURE_PREDICTION', 247), ('SUPERFICIAL_RELATIONSHIP', 289)]	9	[('CHEBI_3364', 'Canthiumine', 67, 'cathelicidin'), ('GO_0010467', 'gene expression', 194, 'expression'), ('CL_0000738', 'leukocyte', 208, 'immune cells'), ('UBERON_0002405', 'immune system', 208, 'immune'), ('UBERON_0000479', 'tissue', 231, 'tissue'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 303, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 303, 'cathelicidin')]
PMC4859539	5/2016	S105-PMC4859539	['Adipose Tissue is also BELIEVED to be ASSOCIATED with Vitamin D [26–29].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4859539	5/2016	S124-PMC4859539	['lastly, total circulating Cathelicidin was measured RATHER than cell-specific mrna Expression of Cathelicidin or 1,25(Oh)2D3Concentration [17], which MAY BE more closely LINKED with Vitamin D status during Fetal and childhood Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('PR_000006009', 'alpha-catulin', 26, 'cathelicidin'), ('GO_0010467', 'gene expression', 83, 'expression'), ('PR_000006009', 'alpha-catulin', 97, 'cathelicidin'), ('CHEBI_52815', 'cresyl violet', 113, '1,25(OH)2D3concentration'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0030540', 'female genitalia development', 206, 'fetal ... development')]
PMC4861121	5/2016	S74-PMC4861121	['micronutrient analysis REVEALED that, regarding SOME of the KEY Nutrients NECESSARY for a healthy Pregnancy, only 26% of women reached Folate recommendations, 0.9% reached Vitamin D recommendations, 36% met calcium recommendations and 17.6% met iron recommendations, from Food.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 60), ('IMPORTANT_CONSIDERATION', 74)]	4	[('CHEBI_33284', 'nutrient', 64, 'nutrients'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('CHEBI_30863', '5-azaorotic acid', 135, 'folate'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_33290', 'food', 272, 'food')]
PMC4874157	5/2016	S115-PMC4874157	['several other STUDIES SUGGEST that, WHENEVER POSSIBLE, Interferon Β treatment SHOULD BE discontinued prior to Conception.21–28HOWEVER, SIMILAR women in OTHER STUDIES continued to receive treatment modalities throughout Pregnancy.1015–19\ninitially, Vitamin D was given as a supplement to address the paucity women MAY SUFFER from during Pregnancy,29and to attend to the Vitamin D deficiency in the general lebanese population.30more RECENT STUDIES have also SHOWN that maintaining adequate levels of Vitamin D during Pregnancy MIGHT have a PROTECTIVE EFFECT and lower the risk of developing Postpartum relapses.31\npsychological support was CRUCIAL in maintaining the mental well-Being of the mother.32some women exhibited signs of anxiety and depression.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('INCOMPLETE_EVIDENCE', 45), ('FUTURE_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 313), ('IMPORTANT_CONSIDERATION', 317), ('INCOMPLETE_EVIDENCE', 432), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 539), ('SUPERFICIAL_RELATIONSHIP', 550), ('IMPORTANT_CONSIDERATION', 639)]	16	[('CHEBI_76163', 'isoxicam', 55, 'interferon β'), ('PR_000008918', 'interferon alpha-5', 55, 'interferon β'), ('GO_0007620', 'copulation', 110, 'conception'), ('GO_0007565', 'female pregnancy', 219, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 336, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('GO_0007565', 'female pregnancy', 516, 'pregnancy'), ('GO_0007565', 'female pregnancy', 590, 'postpartum'), ('GO_0016441', 'posttranscriptional gene silencing', 677, '-being')]
PMC4889866	5/2016	S0-PMC4889866	['maternal Vitamin D level is ASSOCIATED with Viral toll-like receptor triggered Il-10 response but not the risk of infectious diseases in infancy\n\nabstract\nreports on the EFFECT of Prenatal Vitamin D status on fetal Immune Development and infectious diseases in childhood are LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 275)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'Viral'), ('PR_000001470', 'interleukin-28B', 79, 'IL-10'), ('GO_0007565', 'female pregnancy', 180, 'prenatal'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0001822', 'kidney development', 215, 'immune development'), ('UBERON_0002405', 'immune system', 215, 'immune')]
PMC4889866	5/2016	S9-PMC4889866	['in CONCLUSION, OUR STUDY HAD SHOWN that maternal Vitamin D, BUT NOT cord Vitamin D level, was ASSOCIATED with Viral tlr-triggered Il-10 response.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 94)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('NCBITaxon_1', 'root', 110, 'viral'), ('PR_000001470', 'interleukin-28B', 130, 'IL-10')]
PMC4889866	5/2016	S12-PMC4889866	['in vitro studies have DEMONSTRATED Vitamin D to CORRELATE with alterations of several cytokines such as Il-4, Il-5, Il-6, Il-10, Il-13, and Interferon Γ [1–3].']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 104, 'IL-4'), ('PR_000001470', 'interleukin-28B', 110, 'IL-5'), ('PR_000001470', 'interleukin-28B', 116, 'IL-6'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 122, 'IL'), ('PR_000001470', 'interleukin-28B', 129, 'IL-13'), ('PR_000008918', 'interferon alpha-5', 140, 'interferon γ')]
PMC4889866	5/2016	S13-PMC4889866	['HENCE, AS a potent Immune modulator, Vitamin D WAS shown to be ASSOCIATED with childhood asthma and allergic diseases [4–6].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 7), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('UBERON_0002405', 'immune system', 19, 'immune'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4889866	5/2016	S14-PMC4889866	['in addition to allergic diseases, Vitamin D also partakes a POTENTIAL ROLE in Airway inflammation, THUS, STRONGLY LINKED with acute infectious illness such as upper or lower Respiratory Tract infections, sepsis, and hospitalization [7–10].']	[('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 99), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 78, 'airway'), ('UBERON_0000065', 'respiratory tract', 174, 'respiratory tract')]
PMC4889866	5/2016	S16-PMC4889866	['STUDIES HAVE SHOWN Vitamin D to downregulate tlr Expression in order to dampen Immune Cytokine response in multiple basic science MODELS [11–13].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 130)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0010467', 'gene expression', 49, 'expression'), ('GO_0002225', 'positive regulation of antimicrobial peptide production', 79, 'immune cytokine'), ('UBERON_0002405', 'immune system', 79, 'immune')]
PMC4889866	5/2016	S17-PMC4889866	['IN CONTRAST, SOME reports HAVE SHOWN treatment with Vitamin D to result in increased Tlr Activation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 26)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0034104', 'negative regulation of tissue remodeling', 85, 'TLR activation')]
PMC4889866	5/2016	S19-PMC4889866	['THUS, DESPITE a WIDE VARIETY of studies that acknowledged the immunomodulatory ROLE of Vitamin D, the results HAVE BEEN CONFLICTING.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ANOMALY_CURIOUS_FINDING', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	7	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC4889866	5/2016	S20-PMC4889866	['furthermore, VERY FEW STUDIES address the IMPACT of Prenatal Vitamin D status on tlr-RELATED Innate Immune Response in neonatal infants.']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 85)]	4	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0045087', 'innate immune response', 93, 'innate immune response'), ('UBERON_0002405', 'immune system', 100, 'immune')]
PMC4889866	5/2016	S73-PMC4889866	['an EVEN higher percentage of Vitamin D deficiency was FOUND in the neonatal Cord Blood, with 279 (75.8%) having levels less than 20\u2009ng/ml, and 55 (15%) between 20 and 30\u2009ng/ml.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 54)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 76, 'cord'), ('UBERON_0000178', 'blood', 81, 'blood')]
PMC4889866	5/2016	S81-PMC4889866	['PRELIMINARY analysis was also performed on maternal innate Immune function; the result SHOWED no correlation between maternal Vitamin D status and cytokine response to tlr ligands in maternal Mononuclear cells (supplement 1) (see supplementary material available online athttp://dx.doi.org/10.1155/2016/8175898).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 87)]	2	[('UBERON_0002405', 'immune system', 59, 'immune'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CL_0000100', 'motor neuron', 192, 'mononuclear'), ('GO_0031097', 'medial cortex', 192, 'mononuclear')]
PMC4889866	5/2016	S85-PMC4889866	['the results, summarized intable 3, SHOWED no significant association between maternal Vitamin D status and the incidence of infection during the first year of Life.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000104', 'life cycle', 159, 'life')]
PMC4889866	5/2016	S88-PMC4889866	['discussion\nthe result from OUR STUDY SHOWED that maternal, BUT NOT Cord Blood Vitamin D level, was ASSOCIATED with Tlr-3 and Tlr7-8 triggered il-10 response.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 99)]	4	[('UBERON_0002240', 'spinal cord', 67, 'cord'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('PR_000001959', 'tumor necrosis factor receptor superfamily member 1B', 115, 'TLR-3'), ('PR_000001155', 'Toll-like receptor 4', 125, 'TLR7')]
PMC4889866	5/2016	S89-PMC4889866	['TO OUR KNOWLEDGE, THIS is the FIRST cohort STUDY TO simultaneously ASSESS the EFFECT of both maternal and Cord Blood Vitamin D status on tlr-RELATED immune response and various infectious diseases during Infancy.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 67), ('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 141)]	8	[('UBERON_0002240', 'spinal cord', 106, 'cord'), ('UBERON_0000178', 'blood', 111, 'blood'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007631', 'feeding behavior', 204, 'infancy')]
PMC4889866	5/2016	S90-PMC4889866	['DESPITE extensive investigations on Vitamin D, its ROLE in Neonatal Immune Development and health outcome REMAINS INCONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007567', 'parturition', 59, 'neonatal'), ('GO_0001822', 'kidney development', 68, 'immune development'), ('UBERON_0002405', 'immune system', 68, 'immune')]
PMC4889866	5/2016	S91-PMC4889866	['the REASONS for various CONFLICTING results MIGHT be DUE TO DIFFERENCES in the study designs, age of the study population, definition of clinical outcomes, and also DISPARITIES in the assessment of Vitamin D concentration (use of maternal Blood or Cord Blood).']	[('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 44), ('PROBLEM_COMPLICATION', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('IMPORTANT_CONSIDERATION', 165)]	7	[('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0000178', 'blood', 239, 'blood'), ('UBERON_0002240', 'spinal cord', 248, 'cord'), ('UBERON_0000178', 'blood', 253, 'blood')]
PMC4889866	5/2016	S92-PMC4889866	['our result SUGGESTED that the latter MIGHT be an IMPORTANT ISSUE to CONSIDER, BECAUSE DESPITE a strong CORRELATION between maternal and Cord Vitamin D level, OUR study had OBSERVED a distinction between maternal and cord Vitamin D status in their ASSOCIATION with tlr-triggered cytokine response.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 49), ('PROBLEM_COMPLICATION', 59), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 68), ('PROBLEM_COMPLICATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 247)]	13	[('UBERON_0002240', 'spinal cord', 136, 'cord'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC4889866	5/2016	S93-PMC4889866	['THUS, when addressing the IMPACT of Prenatal Vitamin D status on various outcomes, it MIGHT be IMPORTANT to CONSIDER that Vitamin D levels in the Pregnant mothers and Cord Blood MIGHT not always correspond uniformly.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 108), ('IMPORTANT_CONSIDERATION', 108), ('INCOMPLETE_EVIDENCE', 178)]	7	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant'), ('UBERON_0002240', 'spinal cord', 167, 'cord'), ('UBERON_0000178', 'blood', 172, 'blood')]
PMC4889866	5/2016	S94-PMC4889866	['similar OBSERVATIONS were noted in FEW other STUDIES that concurrently assessed maternal and Cord Vitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 35)]	2	[('UBERON_0002240', 'spinal cord', 93, 'cord'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4889866	5/2016	S96-PMC4889866	["ANOTHER RECENT publication had DEMONSTRATED that ALTHOUGH low levels of Vitamin D in the Cord Blood were ASSOCIATED with higher Airway resistance in childhood, maternal Vitamin D level was not related to the children's Airway resistance [20]."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 49), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 89, 'cord'), ('UBERON_0000178', 'blood', 94, 'blood'), ('UBERON_0001005', 'respiratory airway', 128, 'airway'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 219, 'airway')]
PMC4889866	5/2016	S97-PMC4889866	['the RELATIONSHIP between Vitamin D and Il-10 HAS BEEN established CONSIDERABLY.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 45), ('ANOMALY_CURIOUS_FINDING', 66)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 39, 'IL-10')]
PMC4889866	5/2016	S98-PMC4889866	['our result had OBSERVED a negative CORRELATION between maternal Vitamin D concentration and tlr-induced Il-10 response.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 104, 'IL-10')]
PMC4889866	5/2016	S100-PMC4889866	['had OBSERVED lower Cord Blood Il-10 level in Vitamin D deficient or insufficient subjects.']	[('INCOMPLETE_EVIDENCE', 4)]	1	[('UBERON_0009472', 'axilla', 19, 'cord blood'), ('PR_000001470', 'interleukin-28B', 30, 'IL-10'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC4889866	5/2016	S101-PMC4889866	['in vitro studies HAVE also SHOWN direct Vitamin D supplementation in culture Human cells to upregulate Il-10 secretion [3,21–24].']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 77, 'human'), ('PR_000001470', 'interleukin-28B', 103, 'IL-10')]
PMC4889866	5/2016	S102-PMC4889866	['the DIFFERENCE between OUR FINDINGS and those of published reports MIGHT BE EXPLAINED by distinctive study design, AS ours assessed cytokine response to tlr ligands under different Vitamin D concentrations, and not cytokine response to direct Vitamin D stimulation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('INCOMPLETE_EVIDENCE', 67), ('ANOMALY_CURIOUS_FINDING', 73), ('PROBABLE_UNDERSTANDING', 76), ('PROBABLE_UNDERSTANDING', 115)]	6	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4889866	5/2016	S103-PMC4889866	['BECAUSE direct Vitamin D supplementation DEEMED to increase Il-10 Production, our result SUGGESTED a reduced Il-10 response to Tlr Stimulation with higher Vitamin D concentration.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 89)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0032613', 'interleukin-10 production', 60, 'IL-10 production'), ('PR_000001470', 'interleukin-28B', 60, 'IL-10'), ('PR_000001470', 'interleukin-28B', 109, 'IL-10'), ('GO_0031295', 'T cell costimulation', 127, 'TLR stimulation'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4889866	5/2016	S105-PMC4889866	['AS a potent Anti-inflammatory Immune Modulator, STUDIES HAVE SHOWN Vitamin D to downregulate tlr Expression in Monocytes resulting in reduced downstream Cytokine Production [11,13].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 56)]	3	[('CHEBI_67437', 'Euparin', 12, 'anti-'), ('UBERON_0002405', 'immune system', 30, 'immune'), ('CHEBI_33220', '3-monobromobisphenol A', 37, 'modulator'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0010467', 'gene expression', 97, 'expression'), ('CL_0000576', 'monocyte', 111, 'monocytes'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 153, 'cytokine production')]
PMC4889866	5/2016	S106-PMC4889866	['THUS, we SPECULATED that, with increasing Vitamin D level, the ability of tlr to trigger Il-10 Production is diminished when compared to lower concentration, THUS displaying a negative CORRELATION between Vitamin D level and Cytokine Response to Tlr Stimulation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 158), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0032613', 'interleukin-10 production', 89, 'IL-10 production'), ('PR_000001470', 'interleukin-28B', 89, 'IL-10'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0008036', 'diuretic hormone receptor activity', 225, 'cytokine response'), ('GO_0031295', 'T cell costimulation', 246, 'TLR stimulation')]
PMC4889866	5/2016	S107-PMC4889866	['in addition, studies have DEMONSTRATED higher Vitamin D levels at Birth to be ASSOCIATED with lower number of T Regulatory (Treg) Cells in the Cord Blood [2,16].']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 78)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007567', 'parturition', 66, 'birth'), ('CL_0000902', 'induced T-regulatory cell', 110, 'T regulatory ...'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 110, 'T regulatory'), ('CL_0000960', 'T3 B cell', 124, 'Treg ... cells'), ('UBERON_0002240', 'spinal cord', 143, 'cord'), ('UBERON_0000178', 'blood', 148, 'blood')]
PMC4889866	5/2016	S108-PMC4889866	['SINCE one POTENTIAL source of Il-10 is Treg, it was SPECULATED that higher Vitamin D level would be ASSOCIATED with less Treg Cells to respond to tlr stimulation, THUS resulting in lower Il-10 response as SEEN in OUR STUDY.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 100), ('PROBABLE_UNDERSTANDING', 163), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213)]	7	[('PR_000001470', 'interleukin-28B', 30, 'IL-10'), ('CL_0000901', 'Tr1 cell', 39, 'Treg'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CL_0000960', 'T3 B cell', 121, 'Treg cells'), ('PR_000001470', 'interleukin-28B', 187, 'IL-10')]
PMC4889866	5/2016	S112-PMC4889866	['our OBSERVATIONS are AT ODDS with SEVERAL STUDIES that SHOWED lower Vitamin D status to be ASSOCIATED with increased incidence or severity of infection during early childhood.']	[('INCOMPLETE_EVIDENCE', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4889866	5/2016	S113-PMC4889866	['HOWEVER, most studies that SHOWED PROTECTIVE EFFECT of Vitamin D against Respiratory diseases were of interventional studies that used supplementary Vitamin D and DID NOT measure Serum Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 163)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 73, 'respiratory'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('UBERON_0001977', 'blood serum', 179, 'serum'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC4889866	5/2016	S115-PMC4889866	['DEMONSTRATED an ASSOCIATION between low Cord Blood Vitamin D level and increased Respiratory syncytial Virus infections in infancy, HOWEVER, UNLIKE our participants, around 50% of their neonates were Vitamin D sufficient [27–29].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ANOMALY_CURIOUS_FINDING', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141)]	5	[('UBERON_0002240', 'spinal cord', 40, 'cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 81, 'respiratory'), ('NCBITaxon_1', 'root', 103, 'virus'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC4889866	5/2016	S116-PMC4889866	['SINCE the MAJORITY of our participants were Vitamin D deficient, IT IS POSSIBLE that higher Serum levels MIGHT be REQUIRED to reach optimal PROTECTIVE EFFECT to result in significant clinical DIFFERENCES.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 105), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0001977', 'blood serum', 92, 'serum')]
PMC4889866	5/2016	S117-PMC4889866	['NONETHELESS, in SUPPORT of our results, SEVERAL STUDIES also FAILED to show a difference in Serum Vitamin D level between children with and without Respiratory infections [30–32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61)]	4	[('UBERON_0001977', 'blood serum', 92, 'serum'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 148, 'respiratory')]
PMC4889866	5/2016	S118-PMC4889866	['these INCONSISTENT OBSERVATIONS POINT to the COMPLICATED ROLE of Vitamin D in the Immune modulation and disease process.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 32), ('DIFFICULT_TASK', 45), ('SUPERFICIAL_RELATIONSHIP', 57)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0002405', 'immune system', 82, 'immune')]
PMC4889866	5/2016	S121-PMC4889866	['first, the predominantly low Serum level of 25(Oh)D in THIS STUDY has LIMITED our ability TO DETERMINE WHETHER there is an ASSOCIATION between higher concentration of Vitamin D and infection.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 70), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('SUPERFICIAL_RELATIONSHIP', 123)]	5	[('UBERON_0001977', 'blood serum', 29, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC4889866	5/2016	S122-PMC4889866	['it has also LIMITED the applicability of our result in representing the general population, ALTHOUGH INADEQUATE Vitamin D concentration SEEMS PARTICULARLY common among Pregnant woman [3,19].']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 92), ('IMPORTANT_CONSIDERATION', 101), ('ANOMALY_CURIOUS_FINDING', 136), ('ANOMALY_CURIOUS_FINDING', 142)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnant')]
PMC4889866	5/2016	S127-PMC4889866	['finally, ALTHOUGH PRESENT STUDY had OBSERVED an ASSOCIATION between Prenatal Vitamin D status and Viral tlrs-triggered response (Tlr3 and Tlr7/8, both of which recognize Viral rna), the EFFECT of Vitamin D on cpg Double Stranded dna motif (Tlr9) of the Viral Genome also DEMANDS FURTHER EXPLORATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 186), ('IMPORTANT_CONSIDERATION', 271), ('FUTURE_WORK', 279)]	7	[('GO_0007565', 'female pregnancy', 68, 'prenatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('NCBITaxon_1', 'root', 98, 'viral'), ('PR_000001155', 'Toll-like receptor 4', 129, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 138, 'TLR7'), ('NCBITaxon_1', 'root', 170, 'viral'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('SO_0000985', 'double', 213, 'double stranded'), ('PR_000001155', 'Toll-like receptor 4', 240, 'TLR9'), ('NCBITaxon_1', 'root', 253, 'viral'), ('SO_0001026', 'genome', 259, 'genome')]
PMC4889866	5/2016	S129-PMC4889866	['the result SHOWED no correlation between maternal Vitamin D status and neonatal Tlr9 triggered cytokine response (supplement 2), THOUGH such conclusion NEEDED to be INTERPRETED with CAUTION for the null CORRELATION MIGHT be DUE TO LACK OF POWER OWING TO SMALL number of test samples.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ANOMALY_CURIOUS_FINDING', 129), ('FUTURE_WORK', 152), ('FULL_UNKNOWN', 165), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 215), ('PROBLEM_COMPLICATION', 224), ('INCOMPLETE_EVIDENCE', 231), ('PROBLEM_COMPLICATION', 231), ('PROBLEM_COMPLICATION', 245), ('INCOMPLETE_EVIDENCE', 254)]	13	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 80, 'TLR9')]
PMC4889866	5/2016	S130-PMC4889866	['in CONCLUSION, OUR STUDY HAD SHOWN that maternal Vitamin D level, BUT NOT cord Vitamin D, was ASSOCIATED with Tlr3 and Tlr7-8 triggered il-10 response.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('SUPERFICIAL_RELATIONSHIP', 94)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 110, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 119, 'TLR7')]
PMC4889866	5/2016	S131-PMC4889866	['THIS STUDY EMPHASIZED that EVEN THOUGH Cord Vitamin D level was STRONGLY CORRELATED with maternal Vitamin D status, the extent of IMPACT on fetal Immune Cytokine Response MIGHT be distinctive.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 11), ('IMPORTANT_CONSIDERATION', 11), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 64), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 171)]	9	[('UBERON_0002240', 'spinal cord', 39, 'cord'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0002250', 'adaptive immune response', 146, 'immune cytokine response'), ('UBERON_0002405', 'immune system', 146, 'immune')]
PMC4889866	5/2016	S132-PMC4889866	['ALTHOUGH OUR study DID NOT SHOW maternal Vitamin D concentration to have a significant IMPACT on the magnitude or functional capacity of the young infant to defend against infection, we BELIEVE OUR STUDY MAY contribute to a BETTER understanding of the EFFECT of Prenatal Vitamin D status on neonatal Innate Immunity and infectious disease during early Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 252)]	9	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 262, 'prenatal'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0045087', 'innate immune response', 300, 'innate immunity'), ('UBERON_0000104', 'life cycle', 352, 'life')]
PMC4889866	5/2016	S136-PMC4889866	['PRELIMINARY result SHOWED no correlation between maternal Vitamin D status and cytokine response to tlr ligands in maternal Mononuclear Cells.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CL_0000226', 'single nucleate cell', 124, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 124, 'mononuclear')]
PMC4889866	5/2016	S140-PMC4889866	['PRELIMINARY result SHOWED no correlation between cord Vitamin D status and neonatal Tlr9-triggered cytokine response.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 84, 'TLR9')]
PMC4897157	5/2016	S13-PMC4897157	['among such FACTORS, there is GROWING RECOGNITION of the INFLUENCE of sunlight exposure and Vitamin D. since its immunomodulatory EFFECT was FIRST CONFIRMED, Vitamin D has emerged as a variable of interest in the pathogenesis of Allergic diseases; accordingly, there is also interest in sunlight exposure because of its ASSOCIATION with the generation of vitamin D. SEVERAL STUDIES HAVE SHOWN that Vitamin D has an EFFECT on the pathogenesis of allergic diseases56).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 319), ('INCOMPLETE_EVIDENCE', 365), ('INCOMPLETE_EVIDENCE', 381), ('SUPERFICIAL_RELATIONSHIP', 414)]	11	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0040011', 'locomotion', 228, 'allergic'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 362, 'D'), ('CHEBI_27300', 'vitamin D', 397, 'vitamin D')]
PMC4897157	5/2016	S15-PMC4897157	['RECENT report REPORTED that fa was MORE COMMON in children Born in boston, during the autumn and winter seasons, SUGGESTING that seasonal fluctuations in sunlight, and perhaps also Vitamin D levels, MAY BE INVOLVED in the pathogenesis of fa7).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 35), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 206)]	6	[('GO_0007567', 'parturition', 59, 'born'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4897157	5/2016	S16-PMC4897157	['RECENT REPORTS HAVE SHOWN that Vitamin D deficiency is very common in korea9), particularly in young Adults10).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 15)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0007023', 'adult organism', 101, 'adults10')]
PMC4897157	5/2016	S17-PMC4897157	['the increased prevalence of Vitamin D deficiency MAY in turn be ASSOCIATED with the increased prevalence of allergic diseases in korea.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4897157	5/2016	S19-PMC4897157	['THEREFORE, it MAY BE HYPOTHESIZED that the level of sun exposure determines the level of Vitamin D in the Human body.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 21)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 106, 'human')]
PMC4897157	5/2016	S87-PMC4897157	['discussion\nwe HYPOTHESIZED that there MAY BE an ASSOCIATION between the Perinatal Vitamin D status and the development of Allergic Diseases.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('GO_0036268', 'swimming', 72, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 72, 'perinatal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0000381', 'regulation of alternative mRNA splicing, via spliceosome', 122, 'allergic diseases')]
PMC4897157	5/2016	S92-PMC4897157	['ALTHOUGH results are EQUIVOCAL, a CONSIDERABLE body of EVIDENCE SUGGESTS that Vitamin D has an IMPORTANT IMPACT on the progression of allergic diseases11).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4897157	5/2016	S93-PMC4897157	['following CONFIRMATION of the Immunomodulatory EFFECTS of Vitamin D and formulation of the HYPOTHESIS that Vitamin D MAY BE ASSOCIATED with allergic disease prevalence, numerous studies pertaining to the RELATIONSHIP between Vitamin D and allergic diseases HAVE BEEN conducted.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 117), ('SUPERFICIAL_RELATIONSHIP', 124), ('SUPERFICIAL_RELATIONSHIP', 204), ('INCOMPLETE_EVIDENCE', 257)]	7	[('GO_0007566', 'embryo implantation', 30, 'immunomodulatory'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC4897157	5/2016	S97-PMC4897157	['insufficient Vitamin D HAS BEEN REPORTED in 47.3% of males and 64.5% of females: the prevalence rate of Vitamin D deficits is highest in those aged 20 to 29 years (65.0% of males and 79.9% of females)10).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4897157	5/2016	S106-PMC4897157	['ALTHOUGH the UNDERLYING mechanism REMAINS TO BE CLEARLY ESTABLISHED, seasonal differences in Ultraviolet B exposure, and PERHAPS also Vitamin D levels, MAY BE INVOLVED in the development of allergic diseases718).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 34), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_72754', 'bisphenol AF', 93, 'ultraviolet B'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4897157	5/2016	S112-PMC4897157	['in ANOTHER STUDY, autumn Birth was ASSOCIATED with an increased risk of fa; this risk was greatest among those most LIKELY to experience seasonal variations in Vitamin D during infancy (caucasians) and in those at risk of skin barrier dysfunction (i.e., subjects with a history of eczema)18).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 116)]	3	[('GO_0007567', 'parturition', 25, 'birth'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4897157	5/2016	S117-PMC4897157	['in a Birth cohort study cord Blood 25(Oh)-Vitamin D deficiency was ASSOCIATED with INCREASED RISK of recurrent troublesome Lung symptoms till age 7 years, BUT SHOWED no association with Respiratory infection, asthma, or rhinitis21).']	[('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 83), ('ANOMALY_CURIOUS_FINDING', 155), ('INCOMPLETE_EVIDENCE', 159)]	4	[('GO_0007567', 'parturition', 5, 'birth'), ('UBERON_0000178', 'blood', 29, 'blood'), ('CHEBI_63056', 'zinc cation', 35, '25(OH'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002048', 'lung', 123, 'lung'), ('UBERON_0001004', 'respiratory system', 186, 'respiratory')]
PMC4897157	5/2016	S123-PMC4897157	['THEREFORE, we SUGGEST that sun exposure and Vitamin D status during infancy MAY have an IMPACT on the LIKELIHOOD of developing allergic diseases.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 88), ('PROBABLE_UNDERSTANDING', 102)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4897157	5/2016	S126-PMC4897157	['BECAUSE SEVERAL STUDIES SHOWED that winter Birth COULD BE a risk factor for fa718), and Vitamin D IS CONSIDERED AS the factor that MEDIATES the ASSOCIATION between Birth season and allergic diseases, we expected that insufficient sun exposure during infancy would exert a same INFLUENCE on the presence of Fa.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 98), ('PROBABLE_UNDERSTANDING', 112), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 277)]	9	[('GO_0007567', 'parturition', 43, 'birth'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007567', 'parturition', 164, 'birth'), ('CHEBI_30751', 'formic acid', 306, 'FA')]
PMC4897157	5/2016	S128-PMC4897157	['NUMEROUS STUDIES HAVE SHOWN that Vitamin D deficiency is ASSOCIATED with an increased incidence of allergic diseases2324).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4897157	5/2016	S135-PMC4897157	['HOWEVER, OTHER reports SUGGEST that the recent Vitamin D status is ASSOCIATED with Allergen sensitization32526).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 67)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_50904', 'allergen', 83, 'allergen')]
PMC4897157	5/2016	S136-PMC4897157	['in ONE STUDY, Vitamin D deficiency in children and adolescents was reportedly ASSOCIATED with an increased prevalence of Allergen sensitization24).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 78)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_50904', 'allergen', 121, 'allergen')]
PMC4897157	5/2016	S149-PMC4897157	['finally, there is a LACK OF research on the EFFECT FACTOR for amount of sun exposure and Vitamin D status such as clothes and Vitamin D supplements.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 51)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC4897157	5/2016	S153-PMC4897157	['to CONFIRM the EFFECT of sun exposure during infancy on the development of Allergic Diseases, FURTHER prospective INVESTIGATIONS that measure Serum Vitamin D levels ARE REQUIRED.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('FUTURE_WORK', 94), ('FUTURE_WORK', 165), ('IMPORTANT_CONSIDERATION', 169)]	5	[('GO_0000381', 'regulation of alternative mRNA splicing, via spliceosome', 75, 'allergic diseases'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4903143	5/2016	S88-PMC4903143	['Pregnant women screened in ONE STUDY in western canada, for example, DEMONSTRATED that the majority of women in one city had clearly INADEQUATE Vitamin D levels [75].']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 69), ('IMPORTANT_CONSIDERATION', 133)]	3	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC4903143	5/2016	S92-PMC4903143	['THE literature has discussed that Vitamin D insufficiency MAY BE ASSOCIATED with first Trimester Pregnancy loss [85,86], Gestational diabetes [103,104], Preeclampsia [89,105], Preterm Birth [92,93], higher rates of primary and emergency caesarean Delivery [94,106], small for Gestational age infants [95], and maternal Postpartum depression [96].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 87, 'trimester'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('GO_0007565', 'female pregnancy', 121, 'gestational'), ('GO_0007128', 'meiotic prophase I', 153, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 176, 'preterm birth'), ('GO_0007567', 'parturition', 247, 'delivery'), ('GO_0007565', 'female pregnancy', 276, 'gestational'), ('GO_0007565', 'female pregnancy', 319, 'postpartum')]
PMC4903143	5/2016	S97-PMC4903143	["an INTERESTING cohort study CORRELATING maternal Vitamin D deficiency at 18 weeks' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency is ASSOCIATED with impaired Lung development in 6-year-old offspring, Neurocognitive difficulties at age 10, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20 years [34]."]	[('ANOMALY_CURIOUS_FINDING', 3), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 171)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007565', 'female pregnancy', 135, 'gestational'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0002048', 'lung', 196, 'lung'), ('GO_0050905', 'neuromuscular process', 238, 'neurocognitive'), ('GO_0051318', 'G1 phase', 295, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 315, 'adolescence')]
PMC4903143	5/2016	S98-PMC4903143	['in addition, Gestational Vitamin D levels MAY EVEN IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the Development Of Adult-onset multiple Sclerosis [33].']	[('INCOMPLETE_EVIDENCE', 42), ('ANOMALY_CURIOUS_FINDING', 46), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('SUPERFICIAL_RELATIONSHIP', 160)]	8	[('GO_0007565', 'female pregnancy', 13, 'gestational'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0007023', 'adult organism', 58, 'adult'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 128, 'pregnancy'), ('GO_0048513', 'animal organ development', 172, 'development of ... sclerosis'), ('UBERON_0007023', 'adult organism', 187, 'adult')]
PMC4903143	5/2016	S99-PMC4903143	['with ABUNDANT EVIDENCE of myriad health sequelae ASSOCIATED with Gestational Vitamin D deficiency, there is POTENTIAL for CONSIDERABLE amelioration of maternal and fetal health outcomes by educational and healthcare measures in the Preconception and Prenatal period to secure Vitamin D sufficiency throughout Gestation [76].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 122)]	4	[('GO_0007565', 'female pregnancy', 65, 'gestational'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 232, 'preconception'), ('GO_0007565', 'female pregnancy', 250, 'prenatal'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('GO_0007565', 'female pregnancy', 309, 'gestation')]
PMC4903143	5/2016	S157-PMC4903143	['AS operative Delivery via caesarean Section MAY result in deficiency or disruption of a healthy biome, steps to diminish the need for operative Delivery by addressing POTENTIALLY modifiable DETERMINANTS such as elevated bmi [159] and Vitamin D deficiency [94] in Pregnancy MAY BE in order.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 190), ('INCOMPLETE_EVIDENCE', 273)]	5	[('GO_0007567', 'parturition', 13, 'delivery'), ('GO_0007601', 'visual perception', 36, 'section'), ('GO_0007567', 'parturition', 144, 'delivery'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 263, 'pregnancy')]
PMC4923982	5/2016	S64-PMC4923982	['we also ASSESSED the POSSIBILITY that bmi (<25 = referent vs. ≥25), smoking (never = referent vs. ever), dietary Vitamin C intake (below median = referent vs. median or above) and dietary Calcium Intake (below median = referent vs. median or above) MAY have synergistic or antagonistic EFFECTS on the ASSOCIATION between dietary iron intake and gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 286), ('SUPERFICIAL_RELATIONSHIP', 301)]	5	[('CHEBI_27300', 'vitamin D', 113, 'vitamin C'), ('CHEBI_22313', 'alkaline earth metal atom', 188, 'calcium'), ('GO_0007631', 'feeding behavior', 196, 'intake')]
PMC4923982	5/2016	S114-PMC4923982	['IN LIGHT OF this PROPOSED oxidative pathway, we EXAMINED the POSSIBILITY that the antioxidant Vitamin C modified the ASSOCIATION between iron and gdm, but we FOUND that dietary Intake of Vitamin C above the median had no measurable effect on gdm.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 158)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin C'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin C')]
PMC5084734	5/2016	S28-PMC5084734	['gaps in Nutrient intake at this age are GENERALLY greatest for iron and zinc (vitta & dewey2013), BUT OTHER Nutrients MAY BE PROBLEMATIC (such as calcium, Vitamin A and certain b Vitamins) DEPENDING ON the types of foods consumed (dewey2013).']	[('PROBABLE_UNDERSTANDING', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 118), ('PROBLEM_COMPLICATION', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 189)]	6	[('CHEBI_33284', 'nutrient', 8, 'nutrient'), ('CHEBI_33284', 'nutrient', 108, 'nutrients'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin A'), ('CHEBI_33277', 'gamma-tocotrienol', 179, 'vitamins'), ('PR_000027594', 'histone H3', 179, 'vitamins')]
PMC4908484	6/2016	S0-PMC4908484	['protective EFFECTS of 1 Α ,25‐Dihydroxyvitamin D3 on Cultured Neural Cells exposed to catalytic iron\n\nabstractabstract\nRECENT STUDIES have POSTULATED a ROLE for Vitamin D and its receptor on Cerebral function, and anti‐inflammatory, immunomodulatory and Neuroprotective EFFECTS HAVE BEEN DESCRIBED; Vitamin D can inhibit proinflammatory cytokines and Nitric Oxide synthesis during various neurodegenerative insults, and MAY BE CONSIDERED as a POTENTIAL Drug for the treatment of these disorders.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 270), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 288), ('INCOMPLETE_EVIDENCE', 420), ('FUTURE_WORK', 427), ('INCOMPLETE_EVIDENCE', 443)]	10	[('CHEBI_37983', 'sulfur-35 atom', 22, '1'), ('CHEBI_63991', '15-epi-lipoxin B4', 24, 'α ,25‐Dihydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 47, 'D3'), ('CL_0000010', 'cultured cell', 53, 'cultured'), ('CL_0002319', 'neural cell', 62, 'neural cells'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('UBERON_0001893', 'telencephalon', 191, 'cerebral'), ('GO_0019234', 'sensory perception of fast pain', 254, 'neuroprotective'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('CHEBI_16480', 'nitric oxide', 351, 'nitric oxide'), ('GO_0000740', 'nuclear membrane fusion', 351, 'nitric oxide'), ('CHEBI_23888', 'drug', 453, 'drug')]
PMC4908484	6/2016	S6-PMC4908484	['RECENTLY, a NUMBER OF Extraskeletal actions of Vitamin D HAVE BEEN REPORTED, including EFFECTS on Nitric Oxide Production, antioxidant activity, and Endothelial Proliferation and Migration (molinari et\xa0al.2011; uberti et\xa0al.2014; pittarella et\xa0al.2015).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 87)]	4	[('UBERON_0001431', 'distal carpal bone 2', 22, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_16480', 'nitric oxide', 98, 'nitric oxide'), ('GO_0070706', 'RNA nucleotide deletion', 98, 'nitric oxide production'), ('GO_0001714', 'endodermal cell fate specification', 149, 'endothelial proliferation ... migration'), ('UBERON_0001986', 'endothelium', 149, 'endothelial')]
PMC4908484	6/2016	S8-PMC4908484	['ALTHOUGH in Human, most of the Vitamin D that ends up in the Blood is produced in the Kidneys, Vitamin D MAY BE synthesized in OTHER Tissues such as Endothelium, Placenta, Prostate, skin, Colon, Breast, and the Central Nervous System (Cns).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	3	[('NCBITaxon_9606', 'Homo sapiens', 12, 'human'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0000178', 'blood', 61, 'blood'), ('UBERON_0002113', 'kidney', 86, 'kidneys'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0000479', 'tissue', 133, 'tissues'), ('UBERON_0001986', 'endothelium', 149, 'endothelium'), ('UBERON_0001987', 'placenta', 162, 'placenta'), ('UBERON_0002367', 'prostate gland', 172, 'prostate'), ('UBERON_0001155', 'colon', 188, 'colon'), ('UBERON_0000310', 'breast', 195, 'breast'), ('UBERON_0001017', 'central nervous system', 211, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 235, 'CNS')]
PMC4908484	6/2016	S10-PMC4908484	['as regards the Cns, several RECENT STUDIES have POSTULATED anti‐inflammatory, immunomodulatory, and neuroprotective ROLES for Vitamin D (garcion et\xa0al.2002).']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('UBERON_0001017', 'central nervous system', 15, 'CNS'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC4908484	6/2016	S11-PMC4908484	['both 1alpha‐hydroxylase and Vdr are widely Expressed in Neurons and Glial Cells, SUGGESTING that Vitamin D MAY have autocrine and Paracrine actions in the Brain (prüfer et\xa0al.1999; eyles et\xa0al.2005).']	[('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 107)]	2	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 28, 'VDR'), ('GO_0010467', 'gene expression', 43, 'expressed'), ('CL_0000540', 'neuron', 56, 'neurons'), ('CL_0000125', 'glial cell', 68, 'glial cells'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0038001', 'paracrine signaling', 130, 'paracrine'), ('UBERON_0000955', 'brain', 155, 'brain')]
PMC4908484	6/2016	S13-PMC4908484	['MOUNTING EVIDENCE INDICATES that Vitamin D and its receptor have EFFECTS that include neuroprotection and Immunomodulation (aloia et\xa0al.2010).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0050900', 'leukocyte migration', 106, 'immunomodulation')]
PMC4908484	6/2016	S19-PMC4908484	['it HAS BEEN HYPOTHESIZED that Vitamin D exerts these EFFECTS by Modulation of Neuronal Ca2+Homeostasis, in particular through downregulation of l‐type voltage‐sensitive ca2+channels in Hippocampal Neurons against excitotoxic insults (tetich et\xa0al.2005), ACCOMPANIED by an increase in vdr density.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 254)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0065007', 'biological regulation', 64, 'modulation'), ('CL_0000540', 'neuron', 78, 'neuronal'), ('CHEBI_29108', 'calcium(2+)', 87, 'Ca2+'), ('GO_0007608', 'sensory perception of smell', 90, '... +'), ('GO_0042592', 'homeostatic process', 91, 'homeostasis'), ('CHEBI_29238', 'tritium atom', 172, '+'), ('CL_0002608', 'hippocampal neuron', 185, 'hippocampal neurons')]
PMC4908484	6/2016	S22-PMC4908484	["early Vitamin D deficiency MAY BE a RISK FACTOR for a number of disorders including schizophrenia, autism (thompson et\xa0al.1998; pilz et\xa0al.2011; chowdhury et\xa0al.2012), multiple sclerosis, parkinson's disease, and stroke (sun et\xa0al.2012)."]	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 36)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC4908484	6/2016	S35-PMC4908484	['RECENTLY, a RELATIONSHIP between iron and Vitamin D HAS BEEN OBSERVED, especially in the context of iron deficiency and anemia (lee et\xa0al.2009).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 61)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4908484	6/2016	S36-PMC4908484	['moreover, a neuroprotective EFFECT of Vitamin D against iron‐induced oxidative injury in locus coeruleus of Rat HAS BEEN REPORTED (chen et\xa0al.2003).']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 121)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 108, 'rat')]
PMC4908484	6/2016	S168-PMC4908484	['(2003) FIRST SUGGESTED a POSSIBLE use of Vitamin D supplementation, after reporting that systemic administration of Vitamin D attenuates iron‐induced oxidative injuries in the Rat locus coeruleus.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 25)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 176, 'rat')]
PMC4908484	6/2016	S169-PMC4908484	['THUS, THERE IS EVIDENCE that the neuroprotective action of Vitamin D involves Neuronal calcium Regulation, Antioxidative pathway, Immunomodulation, and Detoxification.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CL_0000540', 'neuron', 78, 'neuronal'), ('GO_0065007', 'biological regulation', 95, 'regulation'), ('GO_0019286', 'glycine betaine biosynthetic process from glycine', 107, 'antioxidative'), ('GO_0050900', 'leukocyte migration', 130, 'immunomodulation'), ('GO_0098754', 'detoxification', 152, 'detoxification')]
PMC4908484	6/2016	S176-PMC4908484	['the results SUPPORT the POTENTIAL use of Vitamin D supplementation as a therapeutic STRATEGY in neurodegeneration disorders.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 24), ('FUTURE_WORK', 84)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4910255	6/2016	S102-PMC4910255	['in SOME cases, a comparison group of iron 60\xa0mg and Folic Acid 400\xa0μg WAS NOT AVAILABLE: nepal sarlahi included additional Vitamin A [34], mexico DID not include Folic Acid [25], indonesia used 30\xa0mg iron [29], and bangladesh jivita used 27\xa0mg iron and 600\xa0μg Folate [26].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 74), ('ANOMALY_CURIOUS_FINDING', 146)]	4	[('CHEBI_30751', 'formic acid', 52, 'folic acid'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin A'), ('CHEBI_30751', 'formic acid', 162, 'folic acid'), ('CHEBI_30863', '5-azaorotic acid', 260, 'folate')]
PMC4910255	6/2016	S272-PMC4910255	['other outcomes\ncomparison of follow-ups did NOT confirm the impression of transiently lower systolic Blood pressure at 2.5\xa0years in the nepal janakpur trial, or of improved Lung function in children SEEN in a similar trial of Vitamin A supplementation from nepal sarlahi [66].']	[('ANOMALY_CURIOUS_FINDING', 44), ('INCOMPLETE_EVIDENCE', 199)]	2	[('UBERON_0000178', 'blood', 101, 'blood'), ('UBERON_0002048', 'lung', 173, 'lung'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A')]
PMC4910255	6/2016	S283-PMC4910255	['the mechanisms of action are LIKELY to be MULTIFACTORIAL and follow-up REPORTS SUGGEST OTHER mechanisms such as the EFFECT of Vitamin A on Regulation of fetal Lung growth, branching and alveolarisation [67,68].']	[('PROBABLE_UNDERSTANDING', 29), ('DIFFICULT_TASK', 42), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('SUPERFICIAL_RELATIONSHIP', 116)]	6	[('CHEBI_27300', 'vitamin D', 126, 'vitamin A'), ('GO_0065007', 'biological regulation', 139, 'regulation'), ('UBERON_0002048', 'lung', 159, 'lung')]
PMC4924183	6/2016	S42-PMC4924183	['grieger and clifton, provide updated EVIDENCE from epidemiological and rcts on the IMPACT of dietary and supplemental intakes of Omega-3 Long-Chain polyunsaturated Fatty Acids, zinc, Folate, iron, Calcium, and Vitamin D, as well as dietary patterns, on infant Birth weight [16].']	[('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_76261', '1-nitropropane', 129, 'omega-3 long-chain'), ('CHEBI_35366', 'fatty acid', 164, 'fatty acids'), ('CHEBI_30863', '5-azaorotic acid', 183, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 197, 'calcium'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007567', 'parturition', 260, 'birth')]
PMC4930210	7/2016	S8-PMC4930210	['conclusions\nwe DEMONSTRATED the current rda (600 iu/ day) MAY not be adequate to achieve Vitamin D status >75 nmol/l in SOME Pregnant women who are residing in higher latitudes (calgary, 51°n) in alberta, canada and the current Vitamin D RECOMMENDATIONS for canadian Pregnant women NEED TO be re-evaluated.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 120), ('FUTURE_WORK', 238), ('IMPORTANT_CONSIDERATION', 282)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('GO_0007565', 'female pregnancy', 267, 'pregnant')]
PMC4930210	7/2016	S9-PMC4930210	['introduction\nVitamin D plays an IMPORTANT ROLE in promoting healthy Pregnancy and Fetal Development, and POOR Vitamin D status HAS BEEN ASSOCIATED with adverse maternal and infant health [1].']	[('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 105), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 136)]	5	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007608', 'sensory perception of smell', 68, 'pregnancy ...'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 82, 'fetal development'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4930210	7/2016	S10-PMC4930210	['there is also EVIDENCE that Pregnancy RISKS MAY BE mitigated by Vitamin D supplementation, ALTHOUGH the optimal daily dose is NOT CLEAR [2].']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 38), ('INCOMPLETE_EVIDENCE', 44), ('ANOMALY_CURIOUS_FINDING', 91), ('FULL_UNKNOWN', 126)]	5	[('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4930210	7/2016	S13-PMC4930210	['CURRENTLY, there is a LACK OF CONSENSUS on WHAT constitutes Vitamin D sufficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 22), ('EXPLICIT_QUESTION', 43)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4930210	7/2016	S19-PMC4930210	['a combined analysis of two randomized clinical trials of 494 Pregnant women taking 400, 2000, and 4000 iu/day Vitamin D during Pregnancy SHOWED that Vitamin D supplementation of 4000 iu/day was more EFFECTIVE in achieving Serum concentrations ≥ 80 nmol/l than 400 and 2000 iu/day in all women and their neonates REGARDLESS OF race, SUGGESTING that the current dietary RECOMMENDATION in the absence of supplementation in Pregnancy MAY not be OPTIMAL [9].']	[('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 199), ('INCOMPLETE_EVIDENCE', 312), ('INCOMPLETE_EVIDENCE', 332), ('FUTURE_WORK', 368), ('INCOMPLETE_EVIDENCE', 430), ('IMPORTANT_CONSIDERATION', 441)]	7	[('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('GO_0007565', 'female pregnancy', 420, 'pregnancy')]
PMC4930210	7/2016	S20-PMC4930210	['HOWEVER, THESE STUDIES used sub-optimal quantification methods (radio-immunoassays) and DID NOT CONSIDER the POTENTIAL CONTRIBUTION of dietary Vitamin D to total intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 119)]	5	[('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC4930210	7/2016	S21-PMC4930210	['a RECENT systematic REVIEW of Vitamin D supplementation in Pregnancy CONCLUDED that EVIDENCE is currently INSUFFICIENT TO SUPPORT DEFINITE clinical RECOMMENDATIONS regarding Vitamin D supplementation in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 106), ('PROBLEM_COMPLICATION', 106), ('PROBABLE_UNDERSTANDING', 130), ('FUTURE_WORK', 148)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC4930210	7/2016	S22-PMC4930210	['THIS REVIEW HIGHLIGHTED the extremely HETEROGENEOUS evidence in regards to definition of Serum Vitamin D concentration THRESHOLD and the LACK OF high-quality interventional studies [10].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('DIFFICULT_TASK', 38), ('PROBABLE_UNDERSTANDING', 119), ('INCOMPLETE_EVIDENCE', 137), ('ANOMALY_CURIOUS_FINDING', 142)]	6	[('UBERON_0001977', 'blood serum', 89, 'serum'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC4930210	7/2016	S26-PMC4930210	['we RECENTLY SHOWED that not separating out Plasma 3-epi-25-hydroxycholecalciferol (3-Epi-25(Oh)D3) from Vitamin D status calculation UNDERESTIMATES the classification of Pregnant women and their newborns at risk for Vitamin D insufficiency (>75 nmol/l) [13].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('PROBLEM_COMPLICATION', 133)]	3	[('UBERON_0001969', 'blood plasma', 43, 'plasma'), ('CHEBI_76629', '2-lysophosphatidic acid', 83, '3-epi-25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 95, 'D3'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'pregnant'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC4930210	7/2016	S27-PMC4930210	['ALTHOUGH the literature regarding Vitamin D in Pregnancy is growing rapidly, several gaps in our knowledge REMAIN, including the prevalence of Vitamin D deficiency/ insufficiency during Pregnancy and the intake of Vitamin D during Pregnancy NEEDED to ensure optimal status.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 107), ('FUTURE_WORK', 241)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D'), ('GO_0007565', 'female pregnancy', 231, 'pregnancy')]
PMC4930210	7/2016	S39-PMC4930210	['the ESTIMATED dietary Intake of Vitamin D from the 24-hour Recall WAS NOT SPECIFICALLY VALIDATED against another dietary Intake tool.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 70)]	3	[('GO_0007631', 'feeding behavior', 22, 'intake'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0060033', 'anatomical structure regression', 59, 'recall'), ('GO_0007631', 'feeding behavior', 121, 'intake')]
PMC4930210	7/2016	S40-PMC4930210	['HOWEVER, Intake from Food and beverages ONLY accounted for 39% of total Vitamin D intake and the major source (39%) was from milk, which was consumed on a regular basis by participants during the second Trimester of Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 40), ('INCOMPLETE_EVIDENCE', 40)]	3	[('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_33290', 'food', 21, 'food'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 203, 'trimester'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy')]
PMC4930210	7/2016	S68-PMC4930210	['Plasma concentrations of 25(Oh)D at <25 nmol/l [3,4], <50 nmol/l [3,4], and <75 nmol/l [5,6] were used to REFLECT several laboratory definitions of Vitamin D status CURRENTLY used.']	[('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 165)]	2	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 31, 'D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4930210	7/2016	S83-PMC4930210	['we measured Vitamin D Metabolites with lc-ms/ms and SHOWED that, except for 25(Oh)D2, there were no significant differences between the two trimesters for any other Metabolite (table 2).10.1371/journal.pone.0157262.t001\n\ncaption (table-wrap): table 1\ncharacteristics of participants in a longitudinal cohort of Pregnant women in alberta, canada.characteristics of participantsoverall (n = 537)age, y31 ± 4 (n = 537)Gestational agea19.6 ± 3.4 (n = 502) race, % (n = 513)black1caucasian87others12 family annual incomeb, % (n = 537)< $70,00019≥ $70,00081 type of education, % (n = 514)< high school2high school8trade school20undergraduate47postgraduate23 prior Births ≥37 weeks Gestation, % (n = 537)058132283140.4 season of sampling, % (n = 546)springc33summerd25falle14winterf28bmig26 ± 5 (n = 537)\naat time of Blood sample.']	[('INCOMPLETE_EVIDENCE', 52)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_25212', 'metabolite', 22, 'metabolites'), ('CHEBI_77765', '2,4,6-trihydroxybenzophenone(1-)', 76, '25(OH)D2'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 76, '25(OH)D2'), ('CHEBI_39382', 'flufenoxuron', 165, 'metabolite'), ('GO_0007565', 'female pregnancy', 311, 'Pregnant'), ('GO_0007565', 'female pregnancy', 415, 'Gestational'), ('GO_0007567', 'parturition', 658, 'births'), ('GO_0007565', 'female pregnancy', 675, 'gestation'), ('UBERON_0000178', 'blood', 810, 'blood')]
PMC4930210	7/2016	S86-PMC4930210	['REPORTED dietary Vitamin D intake (diet and supplements) .table 3shows the reported intake from diet and supplements for all the trimesters of Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy')]
PMC4930210	7/2016	S89-PMC4930210	['a repeated measures anova SHOWED no significant difference in log transformed mean reported Vitamin D intake from diet (24-hour Recall) (p = 0.13) between time-points.']	[('INCOMPLETE_EVIDENCE', 26)]	1	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0060033', 'anatomical structure regression', 128, 'recall')]
PMC4930210	7/2016	S106-PMC4930210	['three-epi-25(Oh)D3Comprised 5.0% of total 25(Oh)D. when 3-epi-25(oh)D3Was EXCLUDED from the Vitamin D estimations, 19% of women were considered to have levels <75 nmol/l; HOWEVER, with 3-Epi-25(Oh)D3Included, the percentage of women with Vitamin D concentration of <75 nmol/l decreased to 12%.']	[('INCOMPLETE_EVIDENCE', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171)]	2	[('CHEBI_37194', 'nonaplumbide(4-)', 10, '25(OH)D3comprised'), ('CHEBI_71657', 'versiconol acetate', 42, '25(OH)D'), ('PR_000012979', 'DNA-directed DNA/RNA polymerase mu', 68, 'D3was'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_62409', 'trans,trans-deca-2,4-dienoyl-CoA', 185, '3-epi'), ('CHEBI_75897', 'iron(2+) sulfides', 191, '25(OH)D3included'), ('PR_000027695', 'nuclear receptor coactivator 3 isoform 1 phosphorylated 3', 191, '25(OH)D3included'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC4930210	7/2016	S126-PMC4930210	['discussion\nTO OUR KNOWLEDGE, THIS is the largest STUDY TO date to SHOW 44% of Pregnant women with a higher socioeconomic status reported Vitamin D intake (diet and supplements) not meeting the dietary reference intakes (dri) recomendations.']	[('PROBABLE_UNDERSTANDING', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 66)]	5	[('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4930210	7/2016	S127-PMC4930210	['using lc-ms/ms, we separated epimer from estimation of Vitamin D status and were able to ACCURATELY ESTIMATE the prevalence of Vitamin D insufficiency in our Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnant')]
PMC4930210	7/2016	S128-PMC4930210	['we also FOUND that 20% of Pregnant women had Vitamin D concentraion <75 nmol/l, DESPITE more than half of these women reporting taking more than 600 iu/day of Vitamin D (the current rda) BASED ON their REPORTED intake from diet and supplements.']	[('INCOMPLETE_EVIDENCE', 8), ('ANOMALY_CURIOUS_FINDING', 80), ('INCOMPLETE_EVIDENCE', 187), ('INCOMPLETE_EVIDENCE', 202)]	4	[('GO_0007565', 'female pregnancy', 26, 'pregnant'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4930210	7/2016	S129-PMC4930210	['in northern countries such as canada, the latitude of the country further reduces the POTENTIAL CONTRIBUTION of dermal synthesis to the maintenance of appropriate Vitamin D concentrations, placing women at greater RISK for Vitamin D deficiency/ insufficiency [21,22].']	[('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 96), ('IMPORTANT_CONSIDERATION', 214)]	3	[('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D')]
PMC4930210	7/2016	S132-PMC4930210	['canadian community nutrition intakes data for non-Pregnant women of Child-Bearing age (19–50 years) REPORTED that 90% of canadian women are not Consuming the current RECOMMENDATIONS for Vitamin D through their diet [25].']	[('INCOMPLETE_EVIDENCE', 100), ('FUTURE_WORK', 166)]	2	[('GO_0007565', 'female pregnancy', 50, 'pregnant'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 68, 'child-bearing'), ('GO_0007631', 'feeding behavior', 144, 'consuming'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC4930210	7/2016	S133-PMC4930210	['in THE CURRENT STUDY, we SHOWED that Pregnant women are taking small amounts of Vitamin D from Food and beverages in their diet (<200 iu/day), and they are relying on supplemental sources of Vitamin D to meet the current dris.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 25)]	2	[('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_33290', 'food', 95, 'food'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4930210	7/2016	S134-PMC4930210	['we SHOWED Consuming lower doses of Vitamin D (< than the current dri) is ASSOCIATED with a higher rate of Vitamin D insufficiency (>75nmol/l).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('GO_0007631', 'feeding behavior', 10, 'consuming'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4930210	7/2016	S135-PMC4930210	['OUR FINDINGS are SUPPORTIVE of a GROWING body of LITERATURE SUGGESTING that the RECOMMENDED dose of Vitamin D during Pregnancy is INADEQUATE in preventing Vitamin D deficiency/insufficiency [26].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 60), ('FUTURE_WORK', 80), ('IMPORTANT_CONSIDERATION', 130), ('PROBLEM_COMPLICATION', 130)]	8	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4930210	7/2016	S136-PMC4930210	['a RECENT STUDY of maternal Vitamin D status at third Trimester of Pregnancy and Postpartum periods of 467 Pregnant women in toronto SHOWED persistent Vitamin D deficiency/ insufficiency in two-thirds of participants DESPITE taking 400 iu/day of Vitamin D through their Prenatal Vitamin D [27].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 132), ('ANOMALY_CURIOUS_FINDING', 216)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 53, 'trimester'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007565', 'female pregnancy', 80, 'postpartum'), ('GO_0007565', 'female pregnancy', 106, 'pregnant'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('GO_0007565', 'female pregnancy', 269, 'prenatal'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D')]
PMC4930210	7/2016	S137-PMC4930210	['another RECENT american longitudinal STUDY of 193 Pregnant women from mid-Pregnancy to Birth SHOWED Consuming a Prenatal Vitamin D supplement (334 iu/day) did not PREVENT precipitous drops in maternal Plasma 25(Oh)D concentration [28].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 163)]	4	[('GO_0007565', 'female pregnancy', 50, 'pregnant'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007567', 'parturition', 87, 'birth'), ('GO_0007631', 'feeding behavior', 100, 'consuming'), ('GO_0007565', 'female pregnancy', 112, 'prenatal'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 201, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 208, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 208, '25(OH)D')]
PMC4930210	7/2016	S138-PMC4930210	['IN FACT, randomized clinical trials of 2000 and 4000 iu/day Vitamin D during Pregnancy HAVE SHOWN that Vitamin D supplementation of 4000 iu/day was more EFFECTIVE in achieving Serum concentrations ≥80 nmol/l of Vitamin D [9].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 153)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0001977', 'blood serum', 176, 'serum'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC4930210	7/2016	S139-PMC4930210	['one STRENGTH of THE CURRENT STUDY is its use of a quantification method capable of ACCURATELY measuring 25(Oh)D (separating epimer) and adding the potential CONTRIBUTION of dietary Vitamin D to the total intake ESTIMATE.']	[('IMPORTANT_CONSIDERATION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 211)]	5	[('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4930210	7/2016	S140-PMC4930210	['in addition, we DEMONSTRATED the presence of 3-Epi-25(Oh)D3In all our Pregnant women’s Plasma samples across Pregnancy (second trimester), and that including this epimer in the measurement of Vitamin D status significantly INFLUENCED the classification of prevalence of Vitamin D sufficiency in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 223)]	2	[('CHEBI_15616', '(3S,5S)-3,5-diaminohexanoic acid', 45, '3-epi-25(OH)D3in'), ('PR_000011622', 'S-acyl fatty acid synthase thioesterase, medium chain', 54, 'OH ... D3in'), ('GO_0007565', 'female pregnancy', 70, 'pregnant'), ('UBERON_0001969', 'blood plasma', 87, 'plasma'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007565', 'female pregnancy', 295, 'pregnancy')]
PMC4930210	7/2016	S141-PMC4930210	['this FINDING is CONSISTENT with our PREVIOUS STUDY SHOWING epimer CAN alter Vitamin D status estimation of Pregnant women at the time of Delivery and in their Cord Blood [13].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 66)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'pregnant'), ('GO_0007567', 'parturition', 137, 'delivery'), ('UBERON_0002240', 'spinal cord', 159, 'cord'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC4930210	7/2016	S142-PMC4930210	['ALTHOUGH PREVIOUS STUDIES HAVE SHOWN FACTORS like age, season, and Vitamin D supplementation AFFECT 3-Epi-25(Oh)D3[29,30], in OUR STUDY the ONLY FACTOR positively CORRELATED with level of the 3-Epi-25(Oh)D3Was Vitamin D intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('ANOMALY_CURIOUS_FINDING', 140), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 145), ('SUPERFICIAL_RELATIONSHIP', 163)]	10	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_76629', '2-lysophosphatidic acid', 100, '3-epi-25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 112, 'D3'), ('CHEBI_73839', 'D-Leu-D-Leu', 192, '3-epi-25(OH)D3was'), ('PR_000012979', 'DNA-directed DNA/RNA polymerase mu', 204, 'D3was'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC4930210	7/2016	S143-PMC4930210	['the fact that season significantly AFFECTED 25(Oh)D concentration BUT NOT 3-epi-25(oh)d3suggests that Vitamin D supplements COULD BE a source for 3-Epi-25(Oh)D3As SHOWN in a PREVIOUS STUDY [30].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 174)]	5	[('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 50, 'D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_63219', "alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer", 146, '3-epi-25(OH)D3as'), ('PR_000006270', 'triokinase/FMN cyclase', 158, 'D3as')]
PMC4930210	7/2016	S144-PMC4930210	['ALTHOUGH the physiological ROLE of the c3-epimerization pathway has NOT YET BEEN ELUCIDATED, there are INDICATIONS that it has SOME anti-proliferative activity and differentiation activity ONLY at levels of APPROXIMATELY 10%-30%, respectively, COMPARED TO non-epimeric Vitamin D Metabolites [11,12].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('FULL_UNKNOWN', 68), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 127), ('ANOMALY_CURIOUS_FINDING', 189), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 207), ('ANOMALY_CURIOUS_FINDING', 244)]	9	[('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('CHEBI_25212', 'metabolite', 279, 'metabolites')]
PMC4930210	7/2016	S147-PMC4930210	['THESE FINDINGS EMPHASIZE THE NEED for FURTHER identification of the functional ROLE and clinical SIGNIFICANCE of 3-Epi-25(Oh)D3In the assessment of Vitamin D status in Pregnant women, given the fact that the cut-off for Vitamin D sufficiency in Pregnancy is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 29), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 97), ('FULL_UNKNOWN', 258)]	8	[('CHEBI_15616', '(3S,5S)-3,5-diaminohexanoic acid', 113, '3-epi-25(OH)D3in'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 125, 'D3in'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnant'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
PMC4930210	7/2016	S154-PMC4930210	['the lower rate of Vitamin D insufficiency in OUR STUDY COULD BE RELATED to the cohort characteristics involving very educated, high socio-economic status Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 64)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant')]
PMC4930210	7/2016	S155-PMC4930210	['still, we FOUND a wide distribution of Vitamin D intake and status, which allowed us to study the ASSOCIATION between maternal reported Vitamin D intake and maternal Vitamin d concentrations.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 98)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 166, 'vitamin')]
PMC4930210	7/2016	S157-PMC4930210	['HOWEVER, given that Vitamin D from Foods in canada makes such a small overall CONTRIBUTION to Vitamin D dietary Intake (table 3), the accuracy of the 24-hour recalls is LESS CRITICAL in estimating women’s total Vitamin D intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 169), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_33290', 'food', 35, 'foods'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007631', 'feeding behavior', 112, 'intake'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC4930210	7/2016	S160-PMC4930210	['STUDIES [34,35] HAVE SHOWN that ultraviolet radiation (uvr)-derived Vitamin D is an IMPORTANT FACTOR in 25(Oh)D3Concentration.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 94)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 104, '25(OH)D3concentration'), ('PR_000006744', 'dual specificity protein phosphatase 18', 110, 'D3concentration')]
PMC4930210	7/2016	S164-PMC4930210	['THUS, it APPEARS that ALTHOUGH winter uvr exposure MAY BE insufficient, VARIATIONS in summer sun exposure will alter fall 25(Oh)D concentration and THUS indirectly INFLUENCE winter Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 51), ('DIFFICULT_TASK', 72), ('PROBABLE_UNDERSTANDING', 148), ('SUPERFICIAL_RELATIONSHIP', 164)]	7	[('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 122, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4930210	7/2016	S165-PMC4930210	['ANOTHER RECENT canadian STUDY [35] SHOWED summer sun exposure was a PREDICTOR of 25(Oh)D3Concentration BUT fall sun exposure was NOT, which MAY BE RELATED to lower Vitamin D-weighted climatological uv in toronto during the fall.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ANOMALY_CURIOUS_FINDING', 129), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 147)]	9	[('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 81, '25(OH)D3concentration'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 81, '25('), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 86, ')D3concentration'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4930210	7/2016	S168-PMC4930210	['WHILE the current canadian cancer society RECOMMENDATIONS [38] are to avoid sun exposure or failing that, use of sunscreen at all times when out in the sun, our participants undoubtedly were getting sunlight exposure AS SEEN by a seasonal variation in 25(Oh)D.\nin CONCLUSION, we FOUND a 20% rate of Vitamin D insufficiency (<75 nmol/l) in a large, well-nourished cohort of Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 42), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 220), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 279)]	6	[('CHEBI_71657', 'versiconol acetate', 252, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 252, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('GO_0007565', 'female pregnancy', 373, 'pregnant')]
PMC4930210	7/2016	S170-PMC4930210	['this FINDING EXTENDS the literature SUGGESTING that 600 iu/day MAY not be enough to achieve Vitamin D status >75 nmol/l in Pregnant women residing in higher latitudes with limited sun exposure.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 63)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnant')]
PMC4930210	7/2016	S172-PMC4930210	['THESE FINDINGS, together with EXISTING DATA, HIGHLIGHT THE NEED for re-evaluation of our current Vitamin D RECOMMENDATIONS for Pregnant women residing in countries with higher latitude.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 55), ('FUTURE_WORK', 59), ('FUTURE_WORK', 107)]	6	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnant')]
PMC4933715	7/2016	S70-PMC4933715	['Human studies with antioxidants like melatonin (karaaslan and suzen,2015; kwon et al.,2015) and omega 3 fatty acid, Vitamin C, Vitamin E, and n acetyl cysteine HAVE BEEN tried in single cases.']	[('INCOMPLETE_EVIDENCE', 160)]	1	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin E')]
PMC4933715	7/2016	S598-PMC4933715	['(4) ALTHOUGH SOMETIMES SUGGESTED, there SEEMS to be sufficient EVIDENCE that there is no association with asd for many Maternal infections in Pregnancy (i.e., herpes viruses, epstein barr virus, varicella—Zoster Virus, Parvovirus), smoking, exposure to heavy metals or Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('ANOMALY_CURIOUS_FINDING', 4), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 40), ('INCOMPLETE_EVIDENCE', 63)]	6	[('GO_0007618', 'mating', 119, 'maternal'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy'), ('NCBITaxon_10088', 'Mus <genus>', 205, 'zoster virus'), ('NCBITaxon_10088', 'Mus <genus>', 219, 'parvovirus'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4944244	7/2016	S10-PMC4944244	['FURTHER STUDIES NEED TO BE conducted among health care workers to determine their level of knowledge RELATED to Vitamin D, AS they are front liner in detecting the hypovitaminosis d.\n\nbackground\nmalaysia is rich with sunshine, a MAJOR source of Vitamin D. HOWEVER, a study by moy [1] among a cohort of malays SHOWED that 67.9\xa0% had insufficient Vitamin D especially in women, with Serum mean concentration of 25(Oh)D of 36.2\u2009±\u200913.4\xa0nmol/l in women and 56.2\u2009±\u200918.9\xa0nmol/l in men.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 101), ('PROBABLE_UNDERSTANDING', 123), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 309)]	7	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0001977', 'blood serum', 381, 'serum'), ('CHEBI_71657', 'versiconol acetate', 409, '25(OH)D')]
PMC4944244	7/2016	S14-PMC4944244	['[3] among primary school children in malaysia had SHOWN lack of Vitamin D with 70.4\xa0% having Serum 25 (Oh) D <50\xa0nmol/l.']	[('INCOMPLETE_EVIDENCE', 50)]	1	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0001977', 'blood serum', 93, 'serum'), ('CHEBI_71657', 'versiconol acetate', 99, '25 (OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 99, '25 (OH) D')]
PMC4944244	7/2016	S15-PMC4944244	['lack of Vitamin D MAY have an adverse health EFFECTS including death, cancer, Cardiovascular disease, impaired Immune function and Glucose Metabolism [4].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 78, 'cardiovascular'), ('UBERON_0002405', 'immune system', 111, 'immune'), ('CHEBI_17234', 'glucose', 131, 'glucose'), ('GO_0006006', 'glucose metabolic process', 131, 'glucose metabolism')]
PMC4944244	7/2016	S18-PMC4944244	['[10] reported that Vitamin D status among Pregnant and non-Pregnant women (Reproductive age) living in vietnam SHOWED that the mean Serum 25(Oh)d differed between those living in urban and rural areas (78\xa0nmol/l versus 85\xa0nmol/l) with p \u2009=\u20090.02.']	[('INCOMPLETE_EVIDENCE', 111)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('GO_0000003', 'reproduction', 75, 'reproductive'), ('UBERON_0001977', 'blood serum', 132, 'serum'), ('CHEBI_37972', 'phosphorus-32 atom', 138, '25'), ('CHEBI_17792', 'organohalogen compound', 141, 'OH')]
PMC4944244	7/2016	S21-PMC4944244	['[12] REVEALED that ethnic minorities (asian) SHOULD BE RECOMMENDED for biochemical screening in early Pregnancy, followed by supplement if low levels of Vitamin D was FOUND.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 45), ('FUTURE_WORK', 55), ('INCOMPLETE_EVIDENCE', 167)]	4	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4944244	7/2016	S26-PMC4944244	['moreover, Foods containing Vitamin D is LIMITED.']	[('INCOMPLETE_EVIDENCE', 40)]	1	[('CHEBI_33290', 'food', 10, 'foods'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC4944244	7/2016	S27-PMC4944244	['healthcare workers USUALLY ENCOURAGE Pregnant women to increase calcium intake BUT they are LESS AWARE that without sufficient Vitamin D, calcium intake will not have much EFFECT ESPECIALLY during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 97), ('SUPERFICIAL_RELATIONSHIP', 172), ('ANOMALY_CURIOUS_FINDING', 179)]	8	[('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'pregnancy')]
PMC4944244	7/2016	S40-PMC4944244	['these criteria were EXCLUDED AS it would INFLUENCE the Vitamin D level.']	[('INCOMPLETE_EVIDENCE', 20), ('PROBABLE_UNDERSTANDING', 29), ('SUPERFICIAL_RELATIONSHIP', 41)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4944244	7/2016	S74-PMC4944244	['ONLY five respondents (1.3\xa0%) had enough Vitamin D (Serum\u2009≥\u200975\xa0nmol/l) (table\xa02).']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0001977', 'blood serum', 52, 'serum')]
PMC4944244	7/2016	S91-PMC4944244	['hypovitaminosis D is expected to be high AS PREVIOUS STUDIES RELATED to Vitamin D conducted in malaysia among children and malay women were also high.']	[('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 16, 'D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4944244	7/2016	S96-PMC4944244	['the Serum Vitamin D level was low PROBABLY BECAUSE our respondents were first Trimester Pregnant women who MAY have morning sickness and limited outdoor physical activity.']	[('PROBABLE_UNDERSTANDING', 34), ('PROBABLE_UNDERSTANDING', 43), ('INCOMPLETE_EVIDENCE', 107)]	3	[('UBERON_0001977', 'blood serum', 4, 'serum'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 78, 'trimester'), ('GO_0007565', 'female pregnancy', 88, 'pregnant')]
PMC4944244	7/2016	S100-PMC4944244	['this is IN LINE WITH OUR STUDY, where the PREVALENCE of hypovitaminosis D (25 (Oh) D Serum <50\xa0nmol/l) in the first trimester was high (90.4\xa0%) and only 11.1\xa0% took supplements containing Vitamin D. moreover, most of them had just started the Supplements and the results MAY not have AFFECTED their Vitamin D status yet.']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('IMPORTANT_CONSIDERATION', 42), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 284)]	5	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 72, 'D'), ('CHEBI_71657', 'versiconol acetate', 75, '25 (OH) D'), ('PR_000003010', 'moesin isoform 1', 78, '(OH ... D'), ('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 243, 'supplements'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC4944244	7/2016	S104-PMC4944244	['in comparison, our results SHOWED a much lower prevalence of Vitamin D deficiency with 43.9\xa0% having Serum 25(Oh)D <25\xa0nmol/l (table\xa02).']	[('INCOMPLETE_EVIDENCE', 27)]	1	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001977', 'blood serum', 101, 'serum'), ('CHEBI_71657', 'versiconol acetate', 107, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 107, '25(OH)D')]
PMC4944244	7/2016	S121-PMC4944244	['[22] SUGGESTED that Vitamin D deficiency is common among Pregnant women in thailand, especially in the first trimester [16].']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnant')]
PMC4944244	7/2016	S122-PMC4944244	['their study was SIMILAR TO ours, where intake of Vitamin D supplement or Prenatal Vitamins containing Vitamin D in the first trimester was not associated with adequate Serum 25(Oh)D level.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 82, 'vitamins'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001977', 'blood serum', 168, 'serum'), ('CHEBI_33010', 'chromide(1-)', 176, '(OH)D')]
PMC4944244	7/2016	S123-PMC4944244	['this was DUE TO ONLY 11.1\xa0% respondents took Vitamin D supplements or Antenatal Vitamin supplements containing Vitamin D in the first Trimester.']	[('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 16)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007567', 'parturition', 70, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 80, 'vitamin'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 134, 'trimester')]
PMC4944244	7/2016	S131-PMC4944244	['in order to standardize the level of Vitamin D, cut off point for Serum 25(Oh) D of <50\xa0nmol/l was used for comparison between VARIOUS STUDIES.']	[('INCOMPLETE_EVIDENCE', 127)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 72, '25(OH) D')]
PMC4944244	7/2016	S171-PMC4944244	['HOWEVER, this ASSUMPTION would not be EFFECTIVE for countries with less exposure to the sun, where low education was ASSOCIATED with lower Serum 25(Oh)D, PERHAPS AS a result of less dietary intake of Vitamin D and less opportunity for sunbathing leisure and vacation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 154), ('PROBABLE_UNDERSTANDING', 162)]	6	[('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_71657', 'versiconol acetate', 145, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 145, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC4944244	7/2016	S173-PMC4944244	['[10] CLAIMED that work status (farmer versus non farmer) have significant IMPACT on Vitamin D levels, where farmers had higher levels of Serum 25(Oh)D COMPARED TO non-farmers.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 146, 'OH)D')]
PMC4944244	7/2016	S177-PMC4944244	['most of the studies CLAIMED that there was no association between household income per month and Vitamin D status [34].']	[('INCOMPLETE_EVIDENCE', 20)]	1	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4944244	7/2016	S184-PMC4944244	['[22] also CLAIMED that there was no significant relationship between pre-Pregnancy bmi parity or gravidity with insufficient Vitamin D level in any trimester.']	[('INCOMPLETE_EVIDENCE', 10)]	1	[('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4944244	7/2016	S192-PMC4944244	['this MAY BE due to a decreased ratio of body surface area to bulk with increased body weight and deposition of nutritional elements such as Vitamin D in body fat.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4944244	7/2016	S200-PMC4944244	['[36] claimed that increased skin pigmentation CAN reduce the transmission of ultraviolet rays to synthesize Vitamin D3 and this LEADS TO a high risk of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 128)]	2	[('CHEBI_33279', 'vitamin D5', 108, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 108, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC4944244	7/2016	S203-PMC4944244	['OUR STUDY SHOWED SIMILAR results where fair skin such as chinese had a higher level of Serum 25(Oh) D. initially, by using simple logistic regression analysis, the skin color type, Melanin index measurement and sun protection score SHOWED CORRELATION with Vitamin D status ( p \u2009<\u20090.05).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 232), ('SUPERFICIAL_RELATIONSHIP', 239)]	5	[('UBERON_0001977', 'blood serum', 87, 'serum'), ('CHEBI_71657', 'versiconol acetate', 93, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 93, '25(OH) D'), ('CHEBI_25179', 'melanins', 181, 'melanin'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC4944244	7/2016	S212-PMC4944244	['certain Dress code and sun block had limited the ability of the skin to synthesize Vitamin D.\nVitamin D Intake from Food is one of the MODIFIABLE FACTORS that CAN reduce the RISK of hypovitaminosis d. a total of 55.1\xa0% of respondents have met the malaysian recommended Nutrient intakes (rni) for Vitamin D in Pregnant women which REQUIRE Intake of 5\xa0μg (200\xa0iu) per day [38,39] (table\xa01).']	[('IMPORTANT_CONSIDERATION', 135), ('SUPERFICIAL_RELATIONSHIP', 146), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 174), ('IMPORTANT_CONSIDERATION', 330)]	5	[('UBERON_0001348', 'brown adipose tissue', 8, 'dress'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('CHEBI_28384', 'vitamin K', 94, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 104, 'intake'), ('CHEBI_33290', 'food', 116, 'food'), ('CHEBI_33284', 'nutrient', 269, 'Nutrient'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D'), ('GO_0007565', 'female pregnancy', 309, 'pregnant'), ('GO_0007631', 'feeding behavior', 338, 'intake')]
PMC4944244	7/2016	S217-PMC4944244	['[22] also CLAIMED that there was a significant difference in Serum 25(Oh)D between Pregnant women who took 400\xa0iu or more Vitamin D as Supplements during the Antenatal period and Pregnant women who took\u2009<\u2009400\xa0iu/day or none (or 0.19; 95\xa0% ci: 0.06 to 0.56, p <0.01).']	[('INCOMPLETE_EVIDENCE', 10)]	1	[('UBERON_0001977', 'blood serum', 61, 'serum'), ('CHEBI_71657', 'versiconol acetate', 67, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 67, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 135, 'supplements'), ('GO_0007567', 'parturition', 158, 'antenatal'), ('UBERON_0001760', 'frontal sinus', 158, 'antenatal'), ('GO_0007565', 'female pregnancy', 179, 'pregnant')]
PMC4944244	7/2016	S226-PMC4944244	['health care workers SHOULD also know the functions and the sources of Vitamin D, so that ADVICE COULD BE given to patients especially those with Lactose intolerance or low Milk Consumption during Pregnancy.']	[('FUTURE_WORK', 20), ('FUTURE_WORK', 89), ('INCOMPLETE_EVIDENCE', 96)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 78, 'D'), ('CHEBI_17716', 'lactose', 145, 'lactose'), ('GO_0001774', 'microglial cell activation', 172, 'milk consumption'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy')]
PMC4944244	7/2016	S229-PMC4944244	['dietary Intake of Food containing Vitamin D was found to reduce hypovitaminosis D. nutrition education NEEDS TO BE EMPHASIZED among Pregnant women, ESPECIALLY those of malay and indian ethnicity, who Consume little or no milk, and those who work at desk jobs as INDICATED by high education levels.']	[('FUTURE_WORK', 103), ('IMPORTANT_CONSIDERATION', 109), ('IMPORTANT_CONSIDERATION', 148), ('INCOMPLETE_EVIDENCE', 262)]	4	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_33290', 'food', 18, 'food'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 80, 'D'), ('GO_0007565', 'female pregnancy', 132, 'pregnant'), ('GO_0007631', 'feeding behavior', 200, 'consume')]
PMC4949006	7/2016	S11-PMC4949006	['Folic Acid, Iodine, and Calcium in all Pregnant women and Vitamin C in smokers are the ONLY Supplements SO FAR SHOWN to be of value for routine use.']	[('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 111)]	3	[('CHEBI_30751', 'formic acid', 0, 'Folic acid'), ('CHEBI_24859', 'iodine atom', 12, 'iodine'), ('CHEBI_22313', 'alkaline earth metal atom', 24, 'calcium'), ('GO_0007565', 'female pregnancy', 39, 'pregnant'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin C'), ('CHEBI_33341', 'titanium atom', 92, 'supplements')]
PMC4949006	7/2016	S136-PMC4949006	['Vitamin B6Supplementation HAS BEEN shown in 3 SMALL STUDIES to give a modest gain in Birth weight.99Vitamin C supplementation has not been shown to be of value in improving Pregnancy outcomes,99but HAS SHOWN value for PREVENTION of wheezing and asthma in the children of smokers.100\n\nVitamin E\nONE STUDY CORRELATED risk of wheeze inversely to the level of Vitamin E as well as a linear RELATIONSHIP between the level and the forced Expiratory volume at 1 minute.101NO OTHER STUDIES APPEAR to support OR REFUTE this.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 294), ('SUPERFICIAL_RELATIONSHIP', 304), ('SUPERFICIAL_RELATIONSHIP', 386), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 462), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 468), ('ANOMALY_CURIOUS_FINDING', 482), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 503)]	13	[('CHEBI_10122', 'Zizyphine F', 0, 'Vitamin B6supplementation'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin B6supplementation'), ('GO_0007567', 'parturition', 85, 'birth'), ('CHEBI_65430', 'ardisiphenol A', 98, '99Vitamin C'), ('PR_000004900', 'complement C3', 108, 'C'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 284, 'Vitamin E'), ('CHEBI_27300', 'vitamin D', 356, 'vitamin E'), ('GO_0010467', 'gene expression', 432, 'expiratory')]
PMC4949006	7/2016	S142-PMC4949006	['american college of obstetricians and gynecologists103suggests that CURRENT EVIDENCE DOES NOT SUPPORT routine screening of all Pregnant women for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 85)]	2	[('GO_0007565', 'female pregnancy', 127, 'pregnant'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC4949006	7/2016	S145-PMC4949006	['HOWEVER, when Vitamin D deficiency is identified during Pregnancy, supplementation with up to 1000 to 2000 iu/d is CONSIDERED SAFE by MOST EXPERTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 115), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 134), ('PROBABLE_UNDERSTANDING', 139)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnancy')]
PMC4949006	7/2016	S147-PMC4949006	['it HAS BEEN IDENTIFIED as a Nutrient of PUBLIC HEALTH CONCERN by the us department of health and Human services.104\nNUMEROUS STUDIES HAVE SHOWN a prevalence of vitamin d levels of less than 50 nmol/l in 30% to 96% of Pregnant women, increasing with latitude and with nonwhite race.105–111a study done using archived samples of Cord Blood in denmark SHOWED an increased risk of developing schizophrenia with either elevated or low levels of Vitamin D. it was HYPOTHESIZED that IF all the infants COULD have been Born with normal levels there would have been a reduction of 43% in the incidence of schizophrenia among the Adults.112there is also an ASSOCIATION of Vitamin D deficiency and Insulin resistance,113which was reversed with a single injection of the vitamin114(not approved in the united states).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 133), ('INCOMPLETE_EVIDENCE', 349), ('INCOMPLETE_EVIDENCE', 458), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 476), ('INCOMPLETE_EVIDENCE', 495), ('SUPERFICIAL_RELATIONSHIP', 647)]	10	[('CHEBI_33284', 'nutrient', 28, 'nutrient'), ('NCBITaxon_10088', 'Mus <genus>', 97, 'Human'), ('GO_0007565', 'female pregnancy', 217, 'pregnant'), ('UBERON_0002240', 'spinal cord', 327, 'cord'), ('UBERON_0000178', 'blood', 332, 'blood'), ('CHEBI_28384', 'vitamin K', 440, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 440, 'Vitamin D'), ('GO_0007567', 'parturition', 511, 'born'), ('UBERON_0007023', 'adult organism', 620, 'adults'), ('CHEBI_27300', 'vitamin D', 662, 'vitamin D'), ('PR_000045358', 'insulin family protein', 687, 'insulin')]
PMC4949006	7/2016	S148-PMC4949006	['SOME STUDIES REPORT higher long-bone density in fetuses of women with adequate amounts of Vitamin D,115,116but the numbers are SMALL.117the general RECOMMENDATION is 1000 to 2000 mg/d of supplementation, BUT there are no AGREED-UPON levels for sufficiency or insufficiency in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 204), ('INCOMPLETE_EVIDENCE', 221)]	6	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 276, 'pregnancy')]
PMC4949006	7/2016	S149-PMC4949006	['THERE ARE NO STUDIES clearly SHOWING DIFFERENCES in maternal outcomes or fetal survival, Birth weight, or Gestational length relative to Vitamin D,118but studies on bone health (and Lung function and asthma at age 6 years119) SUPPORT a level of AT LEAST 50 nmol/l, which implies a need for some supplementation for all Pregnant women.120–123\n\nCalcium\nwomen lose 3% to 5% of their bone mass while Lactating but rapidly regain it within 6 months after weaning.']	[('FULL_UNKNOWN', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 226), ('PROBABLE_UNDERSTANDING', 245)]	6	[('GO_0007567', 'parturition', 89, 'birth'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0002048', 'lung', 182, 'lung'), ('GO_0007565', 'female pregnancy', 319, 'pregnant'), ('CHEBI_31341', 'calcium dihydroxide', 343, 'Calcium'), ('GO_0007594', 'puparial adhesion', 396, 'lactating')]
PMC4949006	7/2016	S195-PMC4949006	['there is NO GOOD current EVIDENCE to SHOW value in supplementation for iron and vitamins A, B6, B12, A, e, or D at this time, ALTHOUGH there are many SUGGESTIVE STUDIES for Vitamin D. all Pregnant women SHOULD BE ENCOURAGED to eat a balanced diet rich in fresh or frozen fruits and vegetables, high-quality Carbohydrates including whole grains, and with a good mix of proteins from beans, lean meats, fish, and seafood.']	[('FULL_UNKNOWN', 9), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 126), ('INCOMPLETE_EVIDENCE', 150), ('FUTURE_WORK', 203), ('FUTURE_WORK', 213)]	7	[('PR_000004370', 'asialoglycoprotein receptor 2', 89, 'A'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 92, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 96, 'B12'), ('PR_000004370', 'asialoglycoprotein receptor 2', 101, 'A'), ('PR_000006444', 'diacylglycerol kinase delta', 110, 'D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnant'), ('CHEBI_16646', 'carbohydrate', 307, 'carbohydrates')]
PMC4976416	7/2016	S3-PMC4976416	['experimental studies SUGGEST that Vitamin E has antitumorigenic and photoprotective properties.']	[('INCOMPLETE_EVIDENCE', 21)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin E')]
PMC4976416	7/2016	S4-PMC4976416	['there is a PAUCITY of controlled clinical studies providing a rationale for well-defined dosages and clinical indications of Vitamin E usage in dermatological practice.']	[('INCOMPLETE_EVIDENCE', 11)]	1	[('CHEBI_27300', 'vitamin D', 125, 'vitamin E')]
PMC4976416	7/2016	S15-PMC4976416	['the stability of topical Vitamin E MAY BE increased by the use of Vitamin E conjugates, which are Esters of Tocopherol, resistant to oxidation but can still penetrate Skin Layers.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin E'), ('CHEBI_35701', 'ester', 98, 'esters'), ('CHEBI_27013', 'tocopherol', 108, 'tocopherol'), ('UBERON_0002097', 'skin of body', 167, 'skin layers')]
PMC4976416	7/2016	S16-PMC4976416	['[8]\nALTHOUGH many cosmeceuticals contain Vitamins C and e, VERY FEW are actually EFFECTIVE in topical application because the stability is COMPROMISED as soon as the product is opened and exposed to air and light.']	[('ANOMALY_CURIOUS_FINDING', 4), ('IMPORTANT_CONSIDERATION', 59), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 139)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamins C')]
PMC4976416	7/2016	S23-PMC4976416	['[16]\nheadache is a RECOGNIZED EFFECT of methemoglobinemia, and reduction of previously elevated methemoglobin concentration is PRESUMABLY the mechanism by which Vitamin E improves this symptom, AS improved methemoglobin concentration SEEMS to be the most CONSISTENT laboratory parameter in studies of Vitamin E for protection against dapsone side effects.']	[('PROBABLE_UNDERSTANDING', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 127), ('PROBABLE_UNDERSTANDING', 194), ('ANOMALY_CURIOUS_FINDING', 234), ('INCOMPLETE_EVIDENCE', 255)]	6	[('CHEBI_27300', 'vitamin D', 161, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin E')]
PMC4976416	7/2016	S29-PMC4976416	['they FOUND an improvement and near remission of atopic dermatitis and a 62% decrease in Serum Ige levels in the Vitamin E-treated group.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('UBERON_0001977', 'blood serum', 88, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 94, 'IgE'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin E')]
PMC4976416	7/2016	S31-PMC4976416	['[19] the CORRELATION between Vitamin E intake, Ige levels, and the clinical manifestations of atopy INDICATE that Vitamin E COULD BE a therapeutic tool for atopic dermatitis.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 100), ('INCOMPLETE_EVIDENCE', 124)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin E'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 47, 'IgE'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin E')]
PMC4976416	7/2016	S32-PMC4976416	['hailey–hailey disease\nin 1975, ayres and mihan REPORTED Control of the condition of three patients with hailey–hailey disease by oral administration of Vitamin E in the form of D-Α-Tocopheryl Acetate in doses of 800–1200 iu/l.']	[('INCOMPLETE_EVIDENCE', 47)]	1	[('GO_0065007', 'biological regulation', 56, 'control'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin E'), ('CHEBI_16237', '4-chlorophenylacetate', 177, 'd-α-tocopheryl acetate')]
PMC4976416	7/2016	S34-PMC4976416	['[21]\n\nEpidermolysis Bullosa\nseveral case reports SUGGEST efficacy of Vitamin E (300–600 iu/day) for the management of Epidermolysis Bullosa.']	[('INCOMPLETE_EVIDENCE', 49)]	1	[('UBERON_0007010', 'cleaving embryo', 6, 'Epidermolysis'), ('UBERON_0001970', 'bile', 20, 'bullosa'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin E'), ('UBERON_0007771', 'epidermis gland', 118, 'epidermolysis bullosa')]
PMC4976416	7/2016	S42-PMC4976416	['[27] multiple Human studies HAVE SHOWN no effects of Vitamin E on the prevention or Development Of Skin Cancers.']	[('INCOMPLETE_EVIDENCE', 28)]	1	[('NCBITaxon_9606', 'Homo sapiens', 14, 'human'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin E'), ('GO_0042461', 'photoreceptor cell development', 84, 'development of skin cancers')]
PMC4976416	7/2016	S44-PMC4976416	['[30] the antioxidant supplementation through Vitamins E and C and the Mineral zinc HAS BEEN seen to APPARENTLY enhance the antioxidant protection against oxidative stress and allow less time for wound Healing.']	[('INCOMPLETE_EVIDENCE', 83), ('ANOMALY_CURIOUS_FINDING', 100)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamins E'), ('PR_000004900', 'complement C3', 60, 'C'), ('CHEBI_46662', 'mineral', 70, 'mineral'), ('GO_0007605', 'sensory perception of sound', 201, 'healing')]
PMC4976416	7/2016	S59-PMC4976416	['HOWEVER, studies have DEMONSTRATED that Vitamin E does not significantly ameliorate Retinoid side effects when combined with isotretinoin in the treatment of acne.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin E'), ('CHEBI_26537', 'retinoid', 84, 'retinoid')]
PMC4976416	7/2016	S61-PMC4976416	['[42] antioxidants such as Vitamin E MIGHT, THEREFORE, be beneficial.']	[('INCOMPLETE_EVIDENCE', 36), ('PROBABLE_UNDERSTANDING', 43)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin E')]
PMC4976416	7/2016	S64-PMC4976416	["[43]\nvarious components of scleroderma, including morphea, calcinosis cutis, and raynaud's phenomenon respond to Vitamin E.[44] the dose of Vitamin e in THESE reports ranged from 200 to 1200 iu per day."]	[('INCOMPLETE_EVIDENCE', 153)]	1	[('CHEBI_27300', 'vitamin D', 113, 'vitamin E'), ('CHEBI_33229', 'vitamin (role)', 140, 'vitamin')]
PMC4976416	7/2016	S68-PMC4976416	['[45]\n\ndermatological indications for which there are ANECDOTAL reports of beneficial EFFECTS of Vitamin E\nchronic cutaneous lupus erythematosus[46]\nkeratosis follicularis[47]\npostherpetic neuralgia[48]\npseudoxanthoma elasticum[49]\nporphyria cutanea tarda.']	[('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 85)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin E')]
PMC4976416	7/2016	S69-PMC4976416	['[50]\n\nrecommended dose of Vitamin E\nin case of Vitamin E, the RECOMMENDED intake (6–10 mg of Α-Tocopherol or the equivalent) is BASED SOLELY ON an ESTIMATE of how much Tocopherol the average Person Consumes.']	[('FUTURE_WORK', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('INCOMPLETE_EVIDENCE', 134), ('INCOMPLETE_EVIDENCE', 147)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin E'), ('CHEBI_27725', 'butin', 93, 'α-tocopherol'), ('CHEBI_27013', 'tocopherol', 168, 'tocopherol'), ('NCBITaxon_10088', 'Mus <genus>', 191, 'person'), ('GO_0007631', 'feeding behavior', 198, 'consumes')]
PMC4976416	7/2016	S70-PMC4976416	['[51] in a healthy Adult who had been on a normal diet it would take an ESTIMATED 4 years to fully deplete body stores of Vitamin E.[52]\n\ntopical vitamin E in dermatology\ntopical Vitamin E has emerged as a popular treatment for a number of skin disorders OWING TO its antioxidant properties.']	[('INCOMPLETE_EVIDENCE', 71), ('PROBABLE_UNDERSTANDING', 254)]	2	[('UBERON_0007023', 'adult organism', 18, 'adult'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin E'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 153, 'E'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin E')]
PMC4976416	7/2016	S73-PMC4976416	['HOWEVER, studies looking AT the efficacy of Vitamin E in the treatment of burns and scars HAVE BEEN DISAPPOINTING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 90), ('ANOMALY_CURIOUS_FINDING', 100)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin E')]
PMC4976416	7/2016	S74-PMC4976416	['[5455]\ntopical Vitamin E HAS also BEEN FOUND to be effective in Granuloma annulare.']	[('INCOMPLETE_EVIDENCE', 25), ('ANOMALY_CURIOUS_FINDING', 39)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin E'), ('CL_0000592', 'large luteal cell', 64, 'granuloma')]
PMC4976416	7/2016	S76-PMC4976416	['[57] topical application of the gel containing 2% phytonadione, 0.1% Retinol, 0.1% Vitamin C, and 0.1% Vitamin E HAS BEEN SEEN to be fairly or moderately effective in reducing dark under-Eye circles, especially in cases of Hemostasis.']	[('INCOMPLETE_EVIDENCE', 113)]	1	[('CHEBI_26536', 'retinoic acid', 69, 'retinol'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E'), ('UBERON_0000970', 'eye', 187, 'eye'), ('GO_0007599', 'hemostasis', 223, 'hemostasis')]
PMC4976416	7/2016	S77-PMC4976416	['[58]\n\nvitamin e intake during pregnancy and childhood\nVitamin E supplements in Pregnancy USUALLY contain only small doses of Vitamin E, ALTHOUGH adverse EFFECTS have not been OBSERVED EVEN at higher doses.']	[('INCOMPLETE_EVIDENCE', 89), ('ANOMALY_CURIOUS_FINDING', 136), ('SUPERFICIAL_RELATIONSHIP', 153), ('INCOMPLETE_EVIDENCE', 175), ('ANOMALY_CURIOUS_FINDING', 184)]	5	[('CHEBI_28384', 'vitamin K', 54, 'Vitamin E'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin E')]
PMC4976416	7/2016	S83-PMC4976416	['[60]\ntopical application of Vitamin E CAN RARELY cause contact dermatitis,[61] erythema multiforme,[62] and xanthomatous reaction.']	[('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 42)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin E')]
PMC4976416	7/2016	S85-PMC4976416	['conclusion\nDESPITE development of new Formulations for use in cosmetics and skin care products, there is a LACK OF controlled clinical trials providing a rationale for well-defined dosages and clinical indications for oral and topical Vitamin E. after so MANY YEARS of RESEARCH on Vitamin E, it is STILL UNCLEAR as to WHETHER millions of dollars worth of Vitamin E products paid for by patients and consumers have been of any benefit.']	[('ANOMALY_CURIOUS_FINDING', 11), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 269), ('FULL_UNKNOWN', 298), ('IMPORTANT_CONSIDERATION', 298), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 318)]	7	[('CHEBI_38864', 'propetamphos', 38, 'formulations'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin E')]
PMC5264377	7/2016	S18-PMC5264377	['the ROLE of Vitamin D in fertility and Ovarian function is STILL LARGELY UNEXPLORED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 59), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 73)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('UBERON_0000992', 'ovary', 39, 'ovarian')]
PMC5264377	7/2016	S20-PMC5264377	['there is a direct ASSOCIATION between Vitamin D levels and Fertilization rates in DIFFERENT Animal MODELS (panda et al ., 2001;luk et al ., 2012).']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 99)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0009566', 'fertilization', 59, 'fertilization'), ('NCBITaxon_33208', 'Metazoa', 92, 'animal')]
PMC5264377	7/2016	S36-PMC5264377	['EVEN THOUGH tian FOUND a positive ASSOCIATION between maternal Vitamin D levels and infant weight at Birth, Vitamin D supplementation for Pregnant women with low Serum levels of 25(Oh)D3 failed to improve Birth weight outcomes.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 34)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 101, 'birth'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'pregnant'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_32029', 'potassium acetate', 180, '(OH)D3'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 183, ')D3'), ('GO_0007567', 'parturition', 205, 'birth')]
PMC5264377	7/2016	S100-PMC5264377	['ANOTHER PLAUSIBLE EXPLANATION is the molecular abduction of Vitamin D by Adipose Tissue discussed above.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 73, 'adipose tissue')]
PMC5264377	7/2016	S106-PMC5264377	['both groups had equal distributions of causes of infertility, SUGGESTING the absence of an association with the Metabolism Of Vitamin D.\nto sum up with, women with deficient levels of 25(Oh)D3 measured in single follicles were significantly heavier REGARDLESS OF their infertility statuses.']	[('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 249)]	2	[('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 112, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_62946', 'ammonium sulfate', 184, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 184, '25(OH)D3')]
PMC4969253	8/2016	S2-PMC4969253	['disruption in ra signaling or Vitamin A deficiency (vad) HAS BEEN LINKED to aberrant Development Of the Lung including alterations in the Airway Smooth Muscle (sm) differentiation, development, and function.']	[('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin A'), ('GO_0008053', 'mitochondrial fusion', 85, 'development of ... lung'), ('UBERON_0002048', 'lung', 104, 'lung'), ('UBERON_0001005', 'respiratory airway', 138, 'airway'), ('UBERON_0001135', 'smooth muscle tissue', 145, 'smooth muscle')]
PMC4969253	8/2016	S4-PMC4969253	['introduction: Retinoic Acid, a CRUCIAL signal for Formation Of the Embryonic Lung\nCLASSIC STUDIES in multiple species, including Hamsters, Rats, and Mice, HAVE SHOWN major pleiotropic EFFECTS of maternal dietary Vitamin A deprivation in Embryonic Development.']	[('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_26536', 'retinoic acid', 14, 'retinoic acid'), ('GO_0001703', 'gastrulation with mouth forming first', 50, 'formation of ... lung'), ('UBERON_0000922', 'embryo', 67, 'embryonic'), ('UBERON_0002048', 'lung', 77, 'lung'), ('NCBITaxon_33208', 'Metazoa', 129, 'hamsters'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 139, 'rats'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'mice'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('GO_0009790', 'embryo development', 237, 'embryonic development'), ('UBERON_0000922', 'embryo', 237, 'embryonic')]
PMC4969253	8/2016	S6-PMC4969253	['the developing Lung is PARTICULARLY sensitive to changes in the levels of ra; Vitamin A deficiency IS KNOWN to result in Lung hypoplasia and, when most severe, Lung Agenesis, the inability to form primordial Lung Buds [1].']	[('ANOMALY_CURIOUS_FINDING', 23), ('INCOMPLETE_EVIDENCE', 99)]	2	[('UBERON_0002048', 'lung', 15, 'lung'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin A'), ('UBERON_0002048', 'lung', 121, 'lung'), ('GO_0060425', 'lung morphogenesis', 160, 'lung agenesis'), ('UBERON_0002048', 'lung', 160, 'lung'), ('UBERON_0000118', 'lung bud', 208, 'lung buds')]
PMC4969253	8/2016	S11-PMC4969253	['disruption of Aldh1A2 , in Mouse mutants, reproduces the Lung agenesis phenotype REPORTED in the SEVERE Vitamin A deficiency MODELS.']	[('INCOMPLETE_EVIDENCE', 81), ('IMPORTANT_CONSIDERATION', 97), ('INCOMPLETE_EVIDENCE', 125)]	3	[('PR_000003920', 'retinal dehydrogenase 1', 14, 'Aldh1a2'), ('NCBITaxon_10088', 'Mus <genus>', 27, 'mouse'), ('UBERON_0002048', 'lung', 57, 'lung'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin A')]
PMC4969253	8/2016	S24-PMC4969253	['this mechanism LIKELY represents the molecular basis of the Lung agenesis classically DESCRIBED in the MODELS of Vitamin A deficiency.']	[('PROBABLE_UNDERSTANDING', 15), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 103)]	3	[('UBERON_0002048', 'lung', 60, 'lung'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin A')]
PMC4969253	8/2016	S41-PMC4969253	['CONFIRMATION of this Ra-Sm Regulation in vivo was provided by EVIDENCE that restricting maternal Vitamin A dietary intake during initiation of Airway Development resulted in aberrant overly differentiated and ectopic distribution of sm in these Airways.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 62)]	3	[('PR_000013779', 'histone-binding protein RBBP7', 21, 'RA-SM'), ('GO_0065007', 'biological regulation', 27, 'regulation'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0035904', 'aorta development', 143, 'airway development'), ('UBERON_0001005', 'respiratory airway', 143, 'airway'), ('UBERON_0001005', 'respiratory airway', 245, 'airways')]
PMC4969253	8/2016	S43-PMC4969253	['the decreasing ra reporter signals in proximal Airways where sm is already formed and the aberrant sm phenotype of Vitamin A-ra deficiency STRONGLY SUGGEST that endogenous ra represses Sm differentiation.']	[('PROBABLE_UNDERSTANDING', 139), ('INCOMPLETE_EVIDENCE', 148)]	2	[('UBERON_0001005', 'respiratory airway', 47, 'airways'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin A'), ('PR_000000035', 'BMP receptor type-1A', 185, 'SM')]
PMC4969253	8/2016	S48-PMC4969253	['vitamin a-ra and Postnatal Airway disease\na NUMBER OF epidemiological STUDIES in children and Adult subjects have LINKED Vitamin A status with chronic Airway diseases.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 114)]	2	[('GO_0007567', 'parturition', 17, 'postnatal'), ('UBERON_0001005', 'respiratory airway', 27, 'airway'), ('UBERON_0007023', 'adult organism', 94, 'adult'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin A'), ('UBERON_0001005', 'respiratory airway', 151, 'airway')]
PMC4969253	8/2016	S49-PMC4969253	['there HAVE BEEN multiple STUDIES LINKING low Serum Vitamin A levels to prevalence and severity of asthma.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin A')]
PMC4969253	8/2016	S50-PMC4969253	['in populations in which Vitamin A deficiency is prevalent, studies HAVE SHOWN that children with asthma have lower Vitamin A levels than those who do not have asthma [16].']	[('INCOMPLETE_EVIDENCE', 67)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin A')]
PMC4969253	8/2016	S53-PMC4969253	['INTERESTINGLY, a study in a well-nourished population of japanese children SHOWED mean Serum Vitamin A concentration significantly lower in those asthmatic than in non-asthmatic control subjects [18].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 75)]	2	[('UBERON_0001977', 'blood serum', 87, 'serum'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin A')]
PMC4969253	8/2016	S54-PMC4969253	['decreased fev1 HAS BEEN REPORTED in both children and adolescents with Vitamin A deficiency [19].']	[('INCOMPLETE_EVIDENCE', 15)]	1	[('CHEBI_27300', 'vitamin D', 71, 'vitamin A')]
PMC4969253	8/2016	S59-PMC4969253	['premature infants were shown to have lower concentrations of Plasma Vitamin A, raising the POSSIBILITY that Vitamin A deficiency in preterm infants MAY CONTRIBUTE to INCREASED RISK of developing chronic Lung disease.']	[('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 152), ('IMPORTANT_CONSIDERATION', 166)]	4	[('UBERON_0001969', 'blood plasma', 61, 'plasma'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('UBERON_0002048', 'lung', 203, 'lung')]
PMC4969253	8/2016	S60-PMC4969253	['a series of nine trials have BEEN RECENTLY reviewed to determine the IMPACT of Vitamin A supplementation in PREVENTING mortality and short- and long-term morbidities in very low Birth weight infants [21].']	[('ANOMALY_CURIOUS_FINDING', 29), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 108)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('GO_0007567', 'parturition', 178, 'birth')]
PMC4969253	8/2016	S61-PMC4969253	['a meta-analysis of these data [21] SHOWED that at 36\xa0weeks of age, there was a significant reduction in oxygen use in the preterm infants treated with Vitamin A supplementation COMPARED TO the control (placebo) group, ALTHOUGH ONLY a TREND towards reduction of death or chronic Lung disease was observed.']	[('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 177), ('ANOMALY_CURIOUS_FINDING', 218), ('ANOMALY_CURIOUS_FINDING', 227), ('INCOMPLETE_EVIDENCE', 234)]	5	[('CHEBI_27300', 'vitamin D', 151, 'vitamin A'), ('UBERON_0002048', 'lung', 278, 'lung')]
PMC4969253	8/2016	S62-PMC4969253	['at 1\xa0month of age, ONLY one of the nine trials SHOWED a significant reduction of death or chronic Lung disease in the infants of the Vitamin A group.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 47)]	2	[('UBERON_0002048', 'lung', 98, 'lung'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A')]
PMC4969253	8/2016	S63-PMC4969253	['the MAJORITY of these STUDIES used an intramuscular regimen of a “standard” dose vs a higher dose of Vitamin A.']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 22)]	2	[('CHEBI_27300', 'vitamin D', 101, 'vitamin A')]
PMC4969253	8/2016	S65-PMC4969253	['no adverse effects due to Vitamin A supplementation were REPORTED in these trials [21].']	[('INCOMPLETE_EVIDENCE', 57)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin A')]
PMC4969253	8/2016	S74-PMC4969253	['the IDEA that changes in Vitamin A-ra status during fetal Life CAN alter structural and mechanical properties of the Lung in Adult Life HAS BEEN SUGGESTED in few studies.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 145)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 33, 'A'), ('UBERON_0000104', 'life cycle', 58, 'life'), ('UBERON_0002048', 'lung', 117, 'lung'), ('UBERON_0000113', 'post-juvenile adult stage', 125, 'adult life')]
PMC4969253	8/2016	S78-PMC4969253	['a study in a population with chronic Vitamin A deficiency SHOWED that maternal Vitamin A deficiency has a negative IMPACT in Postnatal Lung function of the offspring with reduced fev1, fvc in childhood.']	[('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 115)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('GO_0007567', 'parturition', 125, 'postnatal'), ('UBERON_0002048', 'lung', 135, 'lung')]
PMC4969253	8/2016	S79-PMC4969253	['these EFFECTS CAN be PREVENTED or alleviated by proper Vitamin A supplementation during Gestation [25].']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin A'), ('GO_0007565', 'female pregnancy', 88, 'gestation')]
PMC4969253	8/2016	S80-PMC4969253	['the IMPACT of Prenatal disruption of ra signaling in Adult Airway structure and function HAS BEEN WELL DEMONSTRATED using a MODEL of Vitamin A deficiency in Mice [14].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 98), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 124)]	5	[('GO_0007565', 'female pregnancy', 14, 'prenatal'), ('UBERON_0007023', 'adult organism', 53, 'adult'), ('UBERON_0001005', 'respiratory airway', 59, 'airway'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 157, 'mice')]
PMC4969253	8/2016	S84-PMC4969253	['these OBSERVATIONS STRONGLY SUPPORT the IDEA that Prenatal Vitamin A deficiency predisposes to Airway hyperreactivity.']	[('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 19), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40)]	4	[('GO_0007565', 'female pregnancy', 50, 'prenatal'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin A'), ('UBERON_0001005', 'respiratory airway', 95, 'airway')]
PMC4969253	8/2016	S86-PMC4969253	['conclusions\noverall, the OBSERVATIONS HERE underscore the IMPORTANCE of dietary Vitamin A/Retinoids, a SIGNIFICANT challenge in developing countries.']	[('INCOMPLETE_EVIDENCE', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('IMPORTANT_CONSIDERATION', 58), ('IMPORTANT_CONSIDERATION', 103)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CHEBI_26537', 'retinoid', 90, 'retinoids')]
PMC4969253	8/2016	S90-PMC4969253	['circulating levels of Vitamin A (Retinol), Retinyl Esters, or ra do NOT NECESSARILY REFLECT the Retinoid status of target cells, SINCE activation of ra signaling depends on a COMPLEX interplay of the components of this pathway, including the presence of ra-synthesizing enzymes, ra receptors (rar, rxr), co-activators/co-repressors, and ra-Metabolizing enzymes.']	[('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 84), ('PROBABLE_UNDERSTANDING', 129), ('PROBLEM_COMPLICATION', 129), ('DIFFICULT_TASK', 175)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 33, 'retinol'), ('CHEBI_26523', 'reactive oxygen species', 43, 'retinyl esters'), ('CHEBI_26537', 'retinoid', 96, 'retinoid'), ('GO_0008152', 'metabolic process', 340, 'metabolizing')]
PMC4971719	8/2016	S9-PMC4971719	['results\nwe FOUND that Vitamin D levels at 12–20 weeks were inversely ASSOCIATED with bdi scores both at 12—20 and at 34–36 weeks’ Gestation ( p \u2009<\u20090.05, both).']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'gestation')]
PMC4971719	8/2016	S13-PMC4971719	['FUTURE INVESTIGATIONS SHOULD study WHETHER Vitamin D supplementation in early Pregnancy MAY PREVENT Perinatal depressive symptoms.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0036268', 'swimming', 100, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 100, 'perinatal')]
PMC4971719	8/2016	S19-PMC4971719	['for instance, a systematic review and meta-analysis of observational studies involving 31,424 non-Pregnant Adults FOUND low Vitamin D levels to be significantly ASSOCIATED with clinical diagnoses of depression [13].']	[('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 161)]	2	[('GO_0007565', 'female pregnancy', 98, 'pregnant'), ('UBERON_0007023', 'adult organism', 107, 'adults'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4971719	8/2016	S22-PMC4971719	['one HYPOTHESIZED physiologic mechanism through which Vitamin D MAY act to AFFECT depressive symptoms has emerged with the understanding that Vitamin D acts as a neuroactive hormone, in addition to its ROLE as a fat-soluble Vitamin [15].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 201)]	4	[('CHEBI_28384', 'vitamin K', 53, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 223, 'vitamin')]
PMC4971719	8/2016	S24-PMC4971719	['DEMONSTRATED that Vitamin D receptors are broadly distributed throughout the Human Brain [16] and Animal studies have FOUND that Vitamin D deficiency or dietary manipulation/addition of Vitamin D alters Neurotransmitters that are KNOWN to be INVOLVED in depressive symptoms and depression [17–20].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 230), ('SUPERFICIAL_RELATIONSHIP', 242)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 77, 'human'), ('UBERON_0000955', 'brain', 83, 'brain'), ('NCBITaxon_33208', 'Metazoa', 98, 'animal'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_25512', 'neurotransmitter', 203, 'neurotransmitters')]
PMC4971719	8/2016	S28-PMC4971719	['in a follow-up study of a subset of this cohort, the authors also DEMONSTRATED an ASSOCIATION of low early Pregnancy Vitamin D levels with Postpartum depressive symptoms [23].']	[('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('GO_0007565', 'female pregnancy', 107, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'postpartum')]
PMC4971719	8/2016	S30-PMC4971719	['FOUND an ASSOCIATION between low early Pregnancy Vitamin D levels and depressive symptoms measured at 16\xa0weeks Gestation [24].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 111, 'gestation')]
PMC4971719	8/2016	S31-PMC4971719	['the more RECENT huang et al., STUDY EXAMINED the ASSOCIATION 25 Oh Vitamin D levels measured at 15\xa0weeks Gestation with depression and anxiety symptoms measured at that same time point [25].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_63058', '(2R,3S)-EHNA', 61, '25 OH'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'gestation')]
PMC4971719	8/2016	S32-PMC4971719	['SEVERAL STUDIES have evaluated the ASSOCIATION of Vitamin D levels with Postpartum symptoms of depression.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'postpartum')]
PMC4971719	8/2016	S33-PMC4971719	['robinson, et al., in an unselected australian cohort of caucasian women, FOUND Vitamin D levels at 18\xa0weeks’ Gestation to be ASSOCIATED with Postnatal depressive symptoms measured at 3\xa0days Postpartum [26].']	[('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 125)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'gestation'), ('GO_0007567', 'parturition', 141, 'postnatal'), ('GO_0007565', 'female pregnancy', 190, 'postpartum')]
PMC4971719	8/2016	S34-PMC4971719	['similarly, gur, et al., FOUND a significant ASSOCIATED between mid-Pregnancy Vitamin D levels and depression and depression screen scores measured longitudinally in the Postpartum period among healthy women who were not considered AT RISK for depression [27].']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 44), ('IMPORTANT_CONSIDERATION', 231)]	3	[('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 169, 'postpartum')]
PMC4971719	8/2016	S36-PMC4971719	['FOUND an ASSOCIATION between Vitamin D levels <32\xa0ng/ml measured monthly for 7\xa0months Postpartum and depression symptom scores at these same time points [28].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'postpartum')]
PMC4971719	8/2016	S37-PMC4971719	['BY CONTRAST, the RECENT nielsen case-control danish national Birth cohort FOUND that high levels of Vitamin D in mid Pregnancy were ASSOCIATED with antidepressant use in the Postpartum Period, an UNEXPECTED FINDING [29].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 132), ('ANOMALY_CURIOUS_FINDING', 196), ('INCOMPLETE_EVIDENCE', 207)]	6	[('GO_0007567', 'parturition', 61, 'Birth'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('GO_0007565', 'female pregnancy', 174, 'postpartum'), ('UBERON_2001055', 'pronephric duct opening', 185, 'period')]
PMC4971719	8/2016	S39-PMC4971719	['this study DIFFERS from PREVIOUSLY-reported investigations in that our subjects were selected BASED ON predisposition to depression and both 25 [Oh] Vitamin D and depression scores were measured at several time points.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('CHEBI_74958', 'N-isovaleryl-L-homoserine lactone', 141, '25 [OH]'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4971719	8/2016	S41-PMC4971719	['we HYPOTHESIZED that lower Vitamin D levels during Pregnancy would be ASSOCIATED with higher depression symptom scores during Pregnancy and at 6–8 weeks Postpartum.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('GO_0007565', 'female pregnancy', 153, 'postpartum')]
PMC4971719	8/2016	S93-PMC4971719	['NO threshold has been ESTABLISHED for prevention of other diseases HYPOTHESIZED to be RELATED to Vitamin D status [43,45–47].']	[('FULL_UNKNOWN', 0), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4971719	8/2016	S94-PMC4971719	['OF NOTE, the endocrine society has SUGGESTED a Vitamin D target for Pregnant women of ≥30\xa0ng/ml [43].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 35)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnant')]
PMC4971719	8/2016	S95-PMC4971719	['we used stepwise linear regression analyses to better define the RELATIONSHIP between “low Vitamin D” and bdi score while adjusting for POTENTIALLY CONFOUNDING EFFECTS.']	[('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 136), ('PROBLEM_COMPLICATION', 148), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4971719	8/2016	S128-PMC4971719	['using analysis of covariance (ancova), and adjusting for season, (winter/non-winter), we FOUND that Vitamin D at 12–20 weeks was a significant PREDICTOR of the Bdi score at 12–20 ( p \u2009<\u20090.05) weeks and at 34–36 weeks Gestation ( p \u2009<\u20090.05).']	[('INCOMPLETE_EVIDENCE', 89), ('SUPERFICIAL_RELATIONSHIP', 143)]	2	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('PR_000004717', "transcription factor TFIIIB component B''", 160, 'BDI'), ('GO_0007565', 'female pregnancy', 217, 'gestation')]
PMC4971719	8/2016	S129-PMC4971719	['for every one unit increase in Vitamin D in early Pregnancy there was an APPROXIMATE 0.14 unit decrease in the bdi score at visit 1 (95\xa0% confidence interval −0.26, −0.017) and visit 3 (−0.27, −0.011).']	[('INCOMPLETE_EVIDENCE', 73)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy')]
PMC4971719	8/2016	S133-PMC4971719	['there was a non-significant TREND towards ASSOCIATION of the most recent Vitamin D level with the bdi score ( p \u2009=\u20090.07).']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC4971719	8/2016	S137-PMC4971719	['BECAUSE our study participants were drawn from a parent study looking at Omega-3 Fatty Acids (Dha and Epa) and their RELATIONSHIP to depression, and to adjust for other POTENTIAL CONFOUNDERS, we CONDUCTED a stepwise linear regression to BETTER UNDERSTAND the ASSOCIATION of Vitamin D with the bdi score.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 169), ('PROBLEM_COMPLICATION', 179), ('QUESTION_ANSWERED_BY_THIS_WORK', 195), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 259)]	7	[('CHEBI_75862', 'alpha-D-rhamnofuranose', 73, 'omega-3 fatty acids'), ('CHEBI_17874', 'dihydrozeatin', 94, 'DHA'), ('CHEBI_34733', 'EPN', 102, 'EPA'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC4971719	8/2016	S138-PMC4971719	['in this adjusted model, “low Vitamin D”, at visit 1 (again, as a categorical variable) was ASSOCIATED with the bdi at 34–36 weeks’ Gestation ( p \u2009=\u20090.01), WHILE there was a TREND toward ASSOCIATION of low Dha ( p \u2009=\u20090.06) and low epa ( p \u2009=\u20090.09) with higher Bdi scores at that time point as well (r2for the model\u2009=\u20090.12).']	[('SUPERFICIAL_RELATIONSHIP', 91), ('ANOMALY_CURIOUS_FINDING', 155), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 186)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'gestation'), ('CHEBI_17874', 'dihydrozeatin', 205, 'DHA'), ('PR_000004717', "transcription factor TFIIIB component B''", 259, 'BDI')]
PMC4971719	8/2016	S142-PMC4971719	['we FOUND that 12\xa0% of the variance in the bdi score at 34–36 weeks was PREDICTED by low Vitamin D levels, low epa, and low Dha at 12–20 weeks.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_17874', 'dihydrozeatin', 123, 'DHA')]
PMC4971719	8/2016	S145-PMC4971719	['discussion\n\nmain findings\nTHIS STUDY presents EVIDENCE that low Vitamin D levels in early Pregnancy (12–20 weeks) are significantly ASSOCIATED with higher depression symptom scores at in early and late Pregnancy in a group of women AT RISK for depression.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 132), ('IMPORTANT_CONSIDERATION', 232)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC4971719	8/2016	S146-PMC4971719	['CONVERSELY, we FOUND that ALTHOUGH there was a TREND toward an ASSOCIATION of most recent Vitamin D levels with the bdi score in later Pregnancy and Postpartum, this trend was not significant and largely disappeared after adjustment for the baseline Bdi score.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy'), ('GO_0007565', 'female pregnancy', 149, 'postpartum'), ('PR_000004717', "transcription factor TFIIIB component B''", 250, 'BDI')]
PMC4971719	8/2016	S152-PMC4971719	['the LACK OF association OBSERVED between Vitamin D level in early or late Pregnancy and the 6–8 week Postpartum bdi score MAY BE EXPLAINED by the COMPLEXITY of the pathogenesis of Postpartum depression symptoms, OR it MAY represent a TRUE negative FINDING.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 122), ('ANOMALY_CURIOUS_FINDING', 126), ('PROBABLE_UNDERSTANDING', 129), ('DIFFICULT_TASK', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 212), ('INCOMPLETE_EVIDENCE', 218), ('PROBABLE_UNDERSTANDING', 234), ('INCOMPLETE_EVIDENCE', 248)]	10	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 101, 'postpartum'), ('GO_0007565', 'female pregnancy', 180, 'postpartum')]
PMC4971719	8/2016	S160-PMC4971719	['an additional LIMITATION of OUR STUDY was that we were unable to explore the POTENTIALLY modulatory EFFECTS of inflammatory cytokines on the RELATIONSHIP between Vitamin D and depressive symptoms [23].']	[('INCOMPLETE_EVIDENCE', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 100), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC4971719	8/2016	S161-PMC4971719	['OUR STUDY FOUND an ASSOCIATION between low Vitamin D levels in early Pregnancy and depressive symptoms during Pregnancy BUT NOT Postpartum.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('GO_0007565', 'female pregnancy', 128, 'postpartum')]
PMC4971719	8/2016	S162-PMC4971719	['in the PUBLISHED LITERATURE, both low and high Vitamin D levels HAVE BEEN ASSOCIATED with Perinatal depression, a FINDING that others HAVE HYPOTHESIZED MAY BE due to a 24-hydroxylase-based degradation mechanism responding to abnormally high concentrations of Vitamin D [29].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 134), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 152)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0036268', 'swimming', 90, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 90, 'perinatal'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC4971719	8/2016	S164-PMC4971719	['our regression model SUGGESTED that 12\xa0% of the variance in bdi score at 34–36 weeks was PREDICTED by a combination of low Vitamin D, low epa and low Dha levels in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_17874', 'dihydrozeatin', 150, 'DHA'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC4971719	8/2016	S167-PMC4971719	['IF randomized studies SHOW a benefit for Vitamin D for PREVENTION or treatment of Perinatal depression, supplementation MAY benefit maternal fetal and neonatal health [49,50].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 120)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0036268', 'swimming', 82, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 82, 'perinatal')]
PMC4971719	8/2016	S168-PMC4971719	['conclusions\nOUR FINDINGS SUGGEST that lower Vitamin D levels in early Pregnancy are ASSOCIATED with depressive symptoms in early and late Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 84)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy')]
PMC4971719	8/2016	S169-PMC4971719	['this ASSOCIATION MAY BE ATTRIBUTED to a true EFFECT of nutritional deficiency OR ALTERNATELY MIGHT be RELATED to DIFFERENCES in Vitamin D Metabolism between women who are predisposed to depression and those who are not.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113)]	9	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 128, 'vitamin D metabolism')]
PMC4971719	8/2016	S171-PMC4971719	['such FUTURE RESEARCH SHOULD also explore any POTENTIAL INTERACTION between inflammatory cytokines and Vitamin D on depression symptoms.']	[('FUTURE_WORK', 5), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 55)]	4	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4973215	8/2016	S7-PMC4973215	['conclusion:\nidentification of RISK FACTORS (black race, medicaid status, obesity and lack of Prenatal Vitamin use) CAN LEAD TO OPPORTUNITIES for targeted Prenatal Vitamin supplementation to reduce the risk of neonatal Vitamin D deficiency and sga status.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('FUTURE_WORK', 127)]	4	[('GO_0007565', 'female pregnancy', 93, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 102, 'vitamin'), ('GO_0007565', 'female pregnancy', 154, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC4973215	8/2016	S10-PMC4973215	['THUS, levels of neonates at Birth depend entirely on that of the mother and, ACCORDINGLY, SEVERAL STUDIES have CONSISTENTLY CORRELATED Cord Blood 25(Oh)D levels to those of their mothers.1,2,3,4,5,6in addition, maternal Vitamin D deficiency HAS BEEN LINKED to decreased fetal growth and Birth size in OBSERVATIONAL studies.7,8,9\nmaternal Vitamin D deficiency is PREVALENT, the extent of which CAN be INFLUENCED by many variables including skin pigmentation, sun exposure, season, age, Vitamin supplementation and obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 111), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 250), ('INCOMPLETE_EVIDENCE', 301), ('IMPORTANT_CONSIDERATION', 362), ('INCOMPLETE_EVIDENCE', 393), ('SUPERFICIAL_RELATIONSHIP', 400)]	11	[('GO_0007567', 'parturition', 28, 'birth'), ('UBERON_0002240', 'spinal cord', 135, 'cord'), ('UBERON_0000178', 'blood', 140, 'blood'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007567', 'parturition', 287, 'birth'), ('CHEBI_27300', 'vitamin D', 338, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 485, 'vitamin')]
PMC4973215	8/2016	S11-PMC4973215	['several large OBSERVATIONAL studies and meta-analyses have DESCRIBED the ASSOCIATION of maternal Vitamin D deficiency with Pregnancy COMPLICATIONS such as pre-eclampsia, Gestational diabetes and premature Birth.10,11,12,13racial DISPARITIES in maternal and neonatal Vitamin D deficiency HAVE BEEN DESCRIBED.1,14,15vitamin D deficiency is MORE COMMON and more SEVERE in black mothers.10,15,16,17,18,19racial DISPARITIES are also SEEN with Pregnancy COMPLICATIONS such as Preterm birth, pre-eclampsia and Gestational diabetes, as well as adverse neonatal outcomes including low Birth weight and small-for-Gestational-age (sga) status.15,17,20,21HOWEVER, the MAJORITY of studies EXAMINED maternal Vitamin D levels during the first and second Trimesters of Pregnancy7,8,22,23and CORRELATED these levels to neonatal outcomes.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBLEM_COMPLICATION', 133), ('IMPORTANT_CONSIDERATION', 229), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('PROBABLE_UNDERSTANDING', 338), ('IMPORTANT_CONSIDERATION', 359), ('IMPORTANT_CONSIDERATION', 407), ('INCOMPLETE_EVIDENCE', 428), ('PROBLEM_COMPLICATION', 448), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('PROBABLE_UNDERSTANDING', 656), ('INCOMPLETE_EVIDENCE', 676), ('SUPERFICIAL_RELATIONSHIP', 775)]	16	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy'), ('GO_0007565', 'female pregnancy', 170, 'gestational'), ('GO_0007567', 'parturition', 205, 'birth'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 322, 'D'), ('GO_0007565', 'female pregnancy', 438, 'pregnancy'), ('GO_0007565', 'female pregnancy', 470, 'preterm'), ('GO_0007565', 'female pregnancy', 503, 'gestational'), ('GO_0007567', 'parturition', 576, 'birth'), ('GO_0007565', 'female pregnancy', 603, 'gestational'), ('CHEBI_27300', 'vitamin D', 694, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 739, 'trimesters'), ('GO_0007565', 'female pregnancy', 753, 'pregnancy7')]
PMC4973215	8/2016	S12-PMC4973215	['far FEWER STUDIES have EXAMINED the RELATIONSHIP between Cord Blood Vitamin D levels, which MAY more ACCURATELY REFLECT fetal levels of Vitamin D, and neonatal outcomes.14,24GIVEN the racial DISPARITIES SEEN in both Vitamin D deficiency and Perinatal outcomes, Vitamin D HAS BEEN PROPOSED as part of the EXPLANATION for this DISPARITY, PARTICULARLY with regard to fetal growth and sga.8\nINCREASED AWARENESS of the GROWING PREVALENCE of maternal Vitamin D deficiency has LED TO an URGENT NEED for CONSIDERATION of supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 92), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 112), ('PROBABLE_UNDERSTANDING', 174), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 271), ('INCOMPLETE_EVIDENCE', 280), ('PROBABLE_UNDERSTANDING', 304), ('IMPORTANT_CONSIDERATION', 325), ('IMPORTANT_CONSIDERATION', 336), ('IMPORTANT_CONSIDERATION', 387), ('INCOMPLETE_EVIDENCE', 414), ('IMPORTANT_CONSIDERATION', 422), ('SUPERFICIAL_RELATIONSHIP', 470), ('IMPORTANT_CONSIDERATION', 480), ('FUTURE_WORK', 487), ('FUTURE_WORK', 496)]	21	[('UBERON_0002240', 'spinal cord', 57, 'cord'), ('UBERON_0000178', 'blood', 62, 'blood'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0036268', 'swimming', 241, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 241, 'perinatal'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0007565', 'female pregnancy', 536, 'pregnancy')]
PMC4973215	8/2016	S13-PMC4973215	['ALTHOUGH studies HAVE SHOWN that supplementation increases maternal and Cord Blood Vitamin D levels, changes in clinical outcomes HAVE NOT yet BEEN WELL PROVEN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 130)]	3	[('UBERON_0002240', 'spinal cord', 72, 'cord'), ('UBERON_0000178', 'blood', 77, 'blood'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC4973215	8/2016	S14-PMC4973215	['THUS, sufficient EVIDENCE is LACKING at this time to RECOMMEND routine Vitamin D supplementation during Pregnancy.12HOWEVER, identification of specific RISK FACTORS for Vitamin D deficiency and the additive EFFECTS of these RISK FACTORS MAY LEAD TO OPPORTUNITIES for targeted supplementation with improved outcomes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 207), ('SUPERFICIAL_RELATIONSHIP', 224), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 241), ('FUTURE_WORK', 249)]	10	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4973215	8/2016	S17-PMC4973215	['our GOAL was TO IDENTIFY specific high-risk subsets of Pregnant women who MAY BENEFIT from Vitamin D supplementation IN ORDER TO mitigate adverse Perinatal outcomes such as sga.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 74), ('IMPORTANT_CONSIDERATION', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 117)]	5	[('GO_0007565', 'female pregnancy', 55, 'pregnant'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0036268', 'swimming', 146, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 146, 'perinatal')]
PMC4973215	8/2016	S29-PMC4973215	['to explore RELATIONSHIPS between race, Vitamin D levels and sga, we first EVALUATED race as a PREDICTOR of Vitamin D levels (sufficient or deficient) in cord Blood and ASSESSED for POTENTIAL CONFOUNDERS: medicaid status, bmi at Delivery, hypertension, maternal age and Prenatal Vitamin use.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 168), ('INCOMPLETE_EVIDENCE', 181), ('PROBLEM_COMPLICATION', 191)]	6	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0000178', 'blood', 158, 'blood'), ('GO_0007567', 'parturition', 228, 'delivery'), ('GO_0007565', 'female pregnancy', 269, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 278, 'vitamin')]
PMC4973215	8/2016	S30-PMC4973215	['these results informed the next stage of analyses that examined race and Vitamin D levels with the outcome of sga by assessing POTENTIAL CONFOUNDERS: race, smoking, pre-eclampsia, maternal age, medicaid status and bmi at Delivery.']	[('INCOMPLETE_EVIDENCE', 127), ('PROBLEM_COMPLICATION', 137)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007567', 'parturition', 221, 'delivery')]
PMC4973215	8/2016	S38-PMC4973215	['differences in the distributions of Cord Blood 25(Oh)D concentrations by race were evident (figure 1), with a higher proportion of Vitamin D-deficient samples FOUND in the black population.']	[('INCOMPLETE_EVIDENCE', 159)]	1	[('UBERON_0009472', 'axilla', 36, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 47, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC4973215	8/2016	S45-PMC4973215	['SIMILARLY, infants on medicaid, a MARKER of socioeconomic status, had higher odds of Vitamin D deficiency (odds ratio (or) 2.3, 95% ci: 1.4, 3.8), WHEREAS Prenatal Vitamin use SHOWED a PROTECTIVE EFFECT (or 0.24, 95% ci: 0.09, 0.62).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 185), ('SUPERFICIAL_RELATIONSHIP', 196)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 164, 'vitamin')]
PMC4973215	8/2016	S61-PMC4973215	['discussion\nin OUR STUDY population, we FOUND that compared with white infants, black infants had significantly lower Cord Blood Vitamin D levels and a greater proportion of vitamin d deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 39)]	2	[('UBERON_0009472', 'axilla', 117, 'cord blood'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC4973215	8/2016	S62-PMC4973215	['ALTHOUGH the prevalence of Vitamin D deficiency in black mothers and neonates is WELL KNOWN, DEBATE exists as to the RELATIONSHIP between race, Vitamin D deficiency and sga.12,14,15,17,18we EXAMINED this RELATIONSHIP in conjunction with additional maternal characteristics in order TO IDENTIFY groups of Pregnant women who could BENEFIT MOST from Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 190), ('SUPERFICIAL_RELATIONSHIP', 204), ('QUESTION_ANSWERED_BY_THIS_WORK', 282), ('IMPORTANT_CONSIDERATION', 329), ('PROBABLE_UNDERSTANDING', 337)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 304, 'pregnant'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D')]
PMC4973215	8/2016	S63-PMC4973215	['we FOUND that black race was ASSOCIATED with a significantly greater incidence of sga, and that black race and Vitamin D deficiency TOGETHER were ASSOCIATED with EVEN greater odds of sga.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 146), ('ANOMALY_CURIOUS_FINDING', 162)]	5	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC4973215	8/2016	S66-PMC4973215	['ONLY a SMALL proportion of white infants were sga, and this MAY have LIMITED our ability to detect significant ASSOCIATIONS between Vitamin D and sga among white infants.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 111)]	5	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4973215	8/2016	S67-PMC4973215	['Vitamin D MAY AFFECT fetal growth through its EFFECT on Calcium Metabolism, bone growth and Placental Development.32ALTHOUGH INITIAL STUDIES SHOWED CONFLICTING results, more RECENT STUDIES SUGGEST that Vitamin D deficiency MAY adversely AFFECT growth and LEAD TO low Birth weight or sga infants.7,9,11,12,18,22,23,33BECAUSE of a KNOWN RELATIONSHIP between race and Vitamin D status, ATTENTION then turned to investigation of the RELATIONSHIP between race, Vitamin D deficiency and sga.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 223), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 255), ('PROBABLE_UNDERSTANDING', 316), ('INCOMPLETE_EVIDENCE', 329), ('SUPERFICIAL_RELATIONSHIP', 335), ('IMPORTANT_CONSIDERATION', 383), ('SUPERFICIAL_RELATIONSHIP', 429)]	17	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 56, 'calcium metabolism'), ('GO_0001890', 'placenta development', 92, 'placental development'), ('UBERON_0001987', 'placenta', 92, 'placental'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('GO_0007567', 'parturition', 267, 'birth'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 456, 'vitamin D')]
PMC4973215	8/2016	S70-PMC4973215	["for white mothers, measurement of maternal Serum 25(Oh)D at <22 weeks' Gestation SHOWED a u-shaped RELATIONSHIP between Vitamin D status and risk of sga, where the highest risk for sga was SEEN with both low and high Vitamin D levels."]	[('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 99), ('INCOMPLETE_EVIDENCE', 189)]	3	[('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 49, '25(OH)D'), ('GO_0007565', 'female pregnancy', 71, 'gestation'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC4973215	8/2016	S72-PMC4973215	['in a larger study, burris et al.14EXAMINED the RELATIONSHIP between second-Trimester Serum 25(Oh)D levels and sga in blacks and whites and FOUND a higher risk of sga in both Vitamin D-deficient black and white infants.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 139)]	3	[('GO_0009294', 'DNA mediated transformation', 75, 'trimester'), ('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 91, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC4973215	8/2016	S73-PMC4973215	['gernand et al.22also EXAMINED second-Trimester Vitamin D levels and risk of sga in a population AT RISK of pre-eclampsia.']	[('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 96)]	2	[('GO_0009294', 'DNA mediated transformation', 37, 'trimester'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4973215	8/2016	S74-PMC4973215	['they FOUND that Vitamin D status was ASSOCIATED with risk of sga in white and nonobese women, BUT that there was no association between Vitamin D and sga in black or obese mothers.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4973215	8/2016	S75-PMC4973215	['IN CONTRAST TO the above-mentioned studies, our results SHOW that the combination of black race and Vitamin D deficiency was ASSOCIATED with increased odds of sga, BUT this RELATIONSHIP was not preserved for white infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 125), ('ANOMALY_CURIOUS_FINDING', 164), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC4973215	8/2016	S78-PMC4973215	['furthermore, this study was CONDUCTED in hamilton county, ohio, an area with worse Perinatal outcomes THAN national averages, including higher infant mortality, Preterm Birth and low Birth weight rates, as well as CONSIDERABLE racial DISPARITIES in infant mortality and Perinatal outcomes.34all of Cord Blood samples were collected over one winter season, THUS negating seasonal variations in Vitamin D levels that MAY have been SEEN in OTHER STUDIES.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('IMPORTANT_CONSIDERATION', 214), ('IMPORTANT_CONSIDERATION', 234), ('PROBABLE_UNDERSTANDING', 356), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 429), ('INCOMPLETE_EVIDENCE', 437)]	8	[('GO_0036268', 'swimming', 83, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 83, 'perinatal'), ('GO_0007565', 'female pregnancy', 161, 'preterm birth'), ('GO_0007567', 'parturition', 183, 'birth'), ('GO_0036268', 'swimming', 270, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 270, 'perinatal'), ('UBERON_0002240', 'spinal cord', 298, 'cord'), ('UBERON_0000178', 'blood', 303, 'blood'), ('CHEBI_27300', 'vitamin D', 393, 'vitamin D')]
PMC4973215	8/2016	S79-PMC4973215	['finally, we ANALYZED Cord Blood Vitamin D levels at the time of Delivery, RATHER THAN maternal Serum Vitamin D levels during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81)]	3	[('UBERON_0002240', 'spinal cord', 21, 'cord'), ('UBERON_0000178', 'blood', 26, 'blood'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 64, 'delivery'), ('UBERON_0001977', 'blood serum', 95, 'serum'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnancy')]
PMC4973215	8/2016	S80-PMC4973215	['ALTHOUGH Cord Blood 25(Oh)D levels do CORRELATE to maternal levels, FACTORS that AFFECT fetal growth MAY not be uniform throughout Pregnancy and this DIFFERENCE in timing COULD AFFECT study FINDINGS.1,3,4,5,6in addition, maternal characteristics such as obesity or pre-eclampsia COULD also AFFECT results that MAY NOT HAVE BEEN SEEN IF Vitamin D samples were obtained during early Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 81), ('INCOMPLETE_EVIDENCE', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 177), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 279), ('SUPERFICIAL_RELATIONSHIP', 290), ('INCOMPLETE_EVIDENCE', 310), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 318), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 333)]	15	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('UBERON_0000178', 'blood', 14, 'blood'), ('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 22, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D'), ('GO_0007565', 'female pregnancy', 381, 'pregnancy')]
PMC4973215	8/2016	S81-PMC4973215	['concurrently, we also EXAMINED maternal variables KNOWN to POTENTIALLY AFFECT Vitamin D levels and sga in an effort to BETTER UNDERSTAND the ROLE of these RISK FACTORS in vitamin d levels and risk of sga.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 155)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4973215	8/2016	S83-PMC4973215	['obesity is WELL KNOWN to be a RISK FACTOR for Vitamin D deficiency BECAUSE of a Sequestering Of Vitamin D in Adipose Tissue.35maternal obesity during Pregnancy HAS also BEEN ASSOCIATED with lower Vitamin D levels in neonates at Delivery.24,36,37,38our data are CONSISTENT and illustrate the inverse RELATIONSHIP between maternal bmi at Delivery and Vitamin D status after adjusting for confounding variables.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 299)]	7	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0051208', 'sequestering of calcium ion', 80, 'sequestering of vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 109, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('GO_0007567', 'parturition', 228, 'delivery'), ('GO_0007567', 'parturition', 336, 'delivery'), ('CHEBI_27300', 'vitamin D', 349, 'vitamin D')]
PMC4973215	8/2016	S84-PMC4973215	['the increased odds of Vitamin D deficiency in neonates relative to maternal bmi level were SEEN in both blacks and whites in our study population and SUPPORTS SIMILAR FINDINGS SEEN in a study done by bodnar et al.38ALTHOUGH Prenatal Vitamin use was not significantly different between blacks and whites in our study, Prenatal Vitamin use was significant among those with and without Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 150), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 176), ('ANOMALY_CURIOUS_FINDING', 215)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 224, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 233, 'vitamin'), ('GO_0007565', 'female pregnancy', 317, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 326, 'vitamin'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D')]
PMC4973215	8/2016	S85-PMC4973215	['furthermore, the PROTECTIVE EFFECT against Vitamin D deficiency was SEEN in both blacks and whites in our study, IN CONTRAST TO a RECENTLY PUBLISHED STUDY by burris et al.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4973215	8/2016	S86-PMC4973215	[',39who FOUND that lack of Prenatal vitamin use was ASSOCIATED with Vitamin D deficiency in white BUT NOT black women.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97)]	3	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4973215	8/2016	S87-PMC4973215	['IMPORTANTLY, OUR STUDY ILLUSTRATES the ADDITIVE EFFECT of maternal RISK FACTORS and their PREDICTIVE probabilities for Vitamin D deficiency and sga.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 90)]	7	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4973215	8/2016	S92-PMC4973215	['this corresponds to the WELL-KNOWN ASSOCIATION that women with higher bmi TEND to Deliver infants with higher Birth weights.40,41,42\nfurthermore, identification and recognition of women and infants at high risk of Vitamin D deficiency and sga CAN LEAD TO OPPORTUNITIES for risk modification and reduction in adverse outcomes.']	[('PROBABLE_UNDERSTANDING', 24), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 243), ('PROBABLE_UNDERSTANDING', 247), ('FUTURE_WORK', 255)]	6	[('GO_0007567', 'parturition', 82, 'deliver'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4973215	8/2016	S94-PMC4973215	['Vitamin D supplementation during Pregnancy HAS BEEN SHOWN to positively AFFECT Cord Blood Vitamin D levels at Birth.43,44studies of Vitamin D supplementation during Pregnancy THUS FAR HAVE SHOWN CONFLICTING results with respect to Birth weight and reduction of sga.43,45,46,47,48adequately powered and randomized controlled trials of vitamin d supplementation during Pregnancy ARE NEEDED TO ASSESS the IMPACT of supplementation on sga as well as the APPROPRIATE dose and timing of supplementation.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 195), ('FUTURE_WORK', 377), ('FUTURE_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 402), ('IMPORTANT_CONSIDERATION', 450)]	9	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 79, 'cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy'), ('GO_0007567', 'parturition', 231, 'birth'), ('GO_0007565', 'female pregnancy', 367, 'pregnancy')]
PMC4973215	8/2016	S96-PMC4973215	['if Vitamin D supplementation does not occur during Pregnancy, it MAY BE IMPERATIVE to identify and offer additional supplementation beyond the routinely recommended 400\u2009iu per day for all infants.28\nthere were several LIMITATIONS to our study.']	[('FUTURE_WORK', 65), ('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 218)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy')]
PMC4973215	8/2016	S97-PMC4973215	['first, we DID NOT have information regarding exact amounts of dietary maternal Vitamin D intake and sun exposure that MAY AFFECT maternal and Cord Blood Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 122)]	3	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 142, 'cord'), ('UBERON_0000178', 'blood', 147, 'blood'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4973215	8/2016	S104-PMC4973215	['we IDENTIFIED additive and modifiable maternal RISK FACTORS that WOULD BENEFIT MOST from risk reduction and targeted Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_PREDICTION', 65), ('IMPORTANT_CONSIDERATION', 71), ('PROBABLE_UNDERSTANDING', 79)]	5	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC4973215	8/2016	S105-PMC4973215	['a GREATER UNDERSTANDING of the variables that INFLUENCE Vitamin D status during Pregnancy CAN have an immense PUBLIC HEALTH IMPACT in the reduction of adverse Perinatal outcomes such as sga.']	[('IMPORTANT_CONSIDERATION', 2), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 110), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0036268', 'swimming', 159, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 159, 'perinatal')]
PMC4975901	8/2016	S14-PMC4975901	['ACCORDING TO the centers for disease control and prevention (cdc), APPROXIMATELY 34\xa0% of women aged 20–39 used a dietary supplement containing Folic Acid and 30\xa0% reported using supplemental Vitamin D in 2003–2006 [2].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 67)]	2	[('CHEBI_30751', 'formic acid', 143, 'folic acid'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4979151	8/2016	S10-PMC4979151	['introduction\nthe IMPORTANCE of adequate Vitamin D status during Pregnancy HAS BEEN SUGGESTED by OBSERVATIONAL studies DEMONSTRATING ASSOCIATIONS between low 25(Oh)D3And adverse Birth outcomes, childhood infections, and atopy [1,2].']	[('IMPORTANT_CONSIDERATION', 17), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 132)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('CHEBI_76945', 'manool', 157, '25(OH)D3and'), ('PR_000036846', 'class II olfactory receptor', 157, '25(OH)D3and'), ('GO_0007567', 'parturition', 177, 'birth')]
PMC4979151	8/2016	S12-PMC4979151	['IN CONTRAST, no association [6,7] or negative EFFECTS of high Vitamin D intake in Pregnancy on the RISK of eczema, asthma and wheezing in the offspring HAVE also BEEN SHOWN [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 46), ('IMPORTANT_CONSIDERATION', 99), ('INCOMPLETE_EVIDENCE', 152)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy')]
PMC4979151	8/2016	S13-PMC4979151	['there is NO CONSENSUS on the cutoff value for Vitamin D deficiency and the optimum dosage for supplementation during Pregnancy REMAINS CONTROVERSIAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy')]
PMC4979151	8/2016	S15-PMC4979151	['maternal Vitamin D status during Pregnancy MAY AFFECT the fetal Immune System and CONTRIBUTE to the risk of development of Immune-mediated diseases and infection in the offspring.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 47), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0002405', 'immune system', 64, 'immune system'), ('UBERON_0002405', 'immune system', 123, 'immune')]
PMC4979151	8/2016	S17-PMC4979151	['VARIOUS in vitro STUDIES of the EFFECTS of Vitamin D on the T-Cell phenotype HAVE SHOWN that active Vitamin D3(1,25(Oh)2D3) suppresses Production Of Th1 Cytokines and Il-17 [12,13] and promotes Th2 Responses [14,15] and T Regulatory Cells (Treg) to maintain a balance and prevent exacerbated Immune Responses [16,17].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CL_0000084', 'T cell', 60, 'T-cell'), ('CHEBI_33279', 'vitamin D5', 100, 'vitamin D3'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 112, ',25(OH)2D3'), ('GO_0006915', 'apoptotic process', 135, 'production of Th1 cytokines'), ('PR_000001470', 'interleukin-28B', 167, 'IL-17'), ('GO_0007596', 'blood coagulation', 194, 'Th2 responses'), ('CL_0000902', 'induced T-regulatory cell', 220, 'T regulatory cells'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 220, 'T regulatory'), ('CL_0000901', 'Tr1 cell', 240, 'Treg'), ('GO_0006955', 'immune response', 292, 'immune responses'), ('UBERON_0002405', 'immune system', 292, 'immune')]
PMC4979151	8/2016	S114-PMC4979151	['discussion\nwe PREVIOUSLY SHOWED that supplementation with vitd3during the 3rd trimester of Pregnancy improved maternal and Cord Blood Vitamin D status [18] and reduction of antibacterial peptide ll-37 in Monocytes [20].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 25)]	2	[('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 123, 'cord'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CL_0000576', 'monocyte', 204, 'monocytes')]
PMC4979151	8/2016	S117-PMC4979151	['there is a SCARCITY of in vivo data in Humans during Pregnancy SHOWING EFFECTS of Vitamin D supplementation on neonatal Immune function.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('NCBITaxon_9606', 'Homo sapiens', 39, 'humans'), ('GO_0007565', 'female pregnancy', 53, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0002405', 'immune system', 120, 'immune')]
PMC4979151	8/2016	S125-PMC4979151	['increased frequency of B Cells and Antibody Production HAS BEEN REPORTED in Vitamin D deficient women and their neonates (Cord Blood) compared to the Vitamin D sufficient group [16].']	[('INCOMPLETE_EVIDENCE', 55)]	1	[('CL_0000236', 'B cell', 23, 'B cells'), ('GO_0001781', 'neutrophil apoptotic process', 23, 'B cells'), ('GO_0002376', 'immune system process', 35, 'antibody production'), ('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibody'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 122, 'cord'), ('UBERON_0000178', 'blood', 127, 'blood'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC4979151	8/2016	S132-PMC4979151	['klug-micu et al SHOWED that two parallel T-Cell-mediated mechanisms, Ifn-Γ released by T Cells and induction of Cd40L on T Cells, trigger Antimicrobial Responses against Intracellular pathogens through a common Vitamin D-dependent Antimicrobial pathway [29].']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('CL_0000084', 'T cell', 41, 'T-cell'), ('PR_000008920', 'interferon alpha-7', 69, 'IFN-γ'), ('CL_0000084', 'T cell', 87, 'T cells'), ('PR_000001309', 'CD70 molecule', 112, 'CD40L'), ('CL_0000084', 'T cell', 121, 'T cells'), ('CHEBI_65381', 'albizoside C', 138, 'antimicrobial'), ('GO_0051607', 'defense response to virus', 138, 'antimicrobial responses'), ('GO_0005622', 'intracellular anatomical structure', 170, 'intracellular'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_65381', 'albizoside C', 231, 'antimicrobial'), ('GO_0007602', 'phototransduction', 231, 'antimicrobial')]
PMC4979151	8/2016	S146-PMC4979151	['down-regulation of Genes in the Tcr Complex, T Cell co-stimulatory Molecules and Major Histocompatibility Complexes (T Cell Adaptive Immunity) in the vitd group SUGGESTS suppression of T Cell Signaling Pathway by Vitamin D. induction of Cd2, Cd40Lg and Il-12Rb2 Expression that are IMPORTANT in T and Nk Cell function and inflammatory responses, and down-regulation of receptors for these ligands SUGGEST balanced responses to in vivo vitd3supplementation that would be expected to mitigate MAJOR downstream effects.']	[('DIFFICULT_TASK', 36), ('INCOMPLETE_EVIDENCE', 161), ('IMPORTANT_CONSIDERATION', 282), ('INCOMPLETE_EVIDENCE', 397), ('IMPORTANT_CONSIDERATION', 491)]	5	[('SO_0000704', 'gene', 19, 'genes'), ('GO_0042101', 'T cell receptor complex', 32, 'TCR complex'), ('CL_0000084', 'T cell', 45, 'T cell'), ('CHEBI_36357', 'polyatomic entity', 67, 'molecules'), ('GO_0042611', 'MHC protein complex', 81, 'major histocompatibility complexes'), ('CL_0000084', 'T cell', 117, 'T cell'), ('GO_0002456', 'T cell mediated immunity', 117, 'T cell adaptive immunity'), ('CL_0000084', 'T cell', 185, 'T cell'), ('GO_0002770', 'T cell inhibitory signaling pathway', 185, 'T cell signaling pathway'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('PR_000001204', 'C-C chemokine receptor type 8', 237, 'CD2'), ('PR_000001309', 'CD70 molecule', 242, 'CD40LG'), ('PR_000008990', 'interleukin-1 family member 9', 253, 'IL-12RB2'), ('GO_0010467', 'gene expression', 262, 'expression'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 295, 'T ...'), ('CL_0000623', 'natural killer cell', 301, 'NK cell'), ('GO_0005634', 'nucleus', 301, 'NK')]
PMC4979151	8/2016	S155-PMC4979151	['stimulation of cbmc with B Cell stimulant or tlr ligands such as Lps MIGHT have yielded a more COMPREHENSIVE picture of Vitamin D RELATED cytokine functions.']	[('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 130)]	3	[('CL_0000236', 'B cell', 25, 'B cell'), ('CHEBI_16412', 'lipopolysaccharide', 65, 'LPS'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4979151	8/2016	S160-PMC4979151	['it HAS BEEN REPORTED that the anti-inflammatory benefits of Vitamin D and optimal Immune function was SEEN in Individuals with 25(Oh)D3As high as 100\xa0nmol/l [30,45].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 102)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002405', 'immune system', 82, 'immune'), ('NCBITaxon_1', 'root', 110, 'individuals'), ('CHEBI_73376', 'Ala-Met-Ser-Arg', 127, '25(OH)D3as'), ('PR_000036866', 'neurexin-3-beta', 127, '25(OH)D3as')]
PMC4982007	8/2016	S14-PMC4982007	['among three studies of maternal Vitamin D status, two SHOWED lower Cognitive function in children of deficient mothers.']	[('INCOMPLETE_EVIDENCE', 54)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0050890', 'cognition', 67, 'cognitive')]
PMC4982007	8/2016	S126-PMC4982007	['of the three studies, one FOUND a two-fold increase in Language impairment in children of mothers with Vitamin D deficiency (<46\xa0nmol/l) compared to children of mothers with Vitamin D >70\xa0nmol/l [21].']	[('INCOMPLETE_EVIDENCE', 26)]	1	[('GO_0006266', 'DNA ligation', 55, 'language'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC4982007	8/2016	S127-PMC4982007	['ANOTHER STUDY FOUND higher Mental and Psychomotor Development scores (2-3 score points (0.1-0.2 sd)) in children of mothers with normal Vitamin D status (>75\xa0nmol/l) compared to those with deficiency (<50\xa0nmol/l) [22].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14)]	2	[('GO_0007613', 'memory', 27, 'mental ...'), ('GO_0030324', 'lung development', 38, 'psychomotor development'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4982007	8/2016	S128-PMC4982007	['it also FOUND a positive ASSOCIATION between maternal Vitamin D concentrations and offspring Mental and Psychomotor Development scores (0.8-0.9 score points (~0.06 sd) per 25\xa0nmol/l increase).']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 25)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007613', 'memory', 93, 'mental ...'), ('GO_0030324', 'lung development', 104, 'psychomotor development')]
PMC4982007	8/2016	S228-PMC4982007	['two out of three studies of maternal Vitamin D status SHOWED lower Cognitive function in children of deficient mothers.']	[('INCOMPLETE_EVIDENCE', 54)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0050890', 'cognition', 67, 'cognitive')]
PMC4982007	8/2016	S269-PMC4982007	['maternal Vitamin D\ntwo of the three AVAILABLE STUDIES, all from developed populations, SHOWED an ASSOCIATION of higher maternal Vitamin D concentrations with better Cognitive function in the children [21,22].']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0050890', 'cognition', 165, 'cognitive')]
PMC4982007	8/2016	S273-PMC4982007	['HOWEVER, the percentage with Language impairment was double in children of Vitamin D deficient mothers COMPARED TO normal mothers in ONE STUDY [21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 133)]	4	[('GO_0006266', 'DNA ligation', 29, 'language'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC4982007	8/2016	S275-PMC4982007	['THESE FINDINGS are CONSISTENT with Animal studies which have DEMONSTRATED poor Learning and Memory, and alterations in attention, in response to Vitamin D deficiency before Conception and/or during Gestation [57,58].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 61)]	3	[('NCBITaxon_33208', 'Metazoa', 35, 'animal'), ('GO_0007612', 'learning', 79, 'learning'), ('GO_0007613', 'memory', 92, 'memory'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0007620', 'copulation', 173, 'conception'), ('GO_0007565', 'female pregnancy', 198, 'gestation')]
PMC4982007	8/2016	S278-PMC4982007	['another LIMITATION was that maternal Vitamin D status was available ONLY during the second trimester; SINCE Vitamin D IS KNOWN to fluctuate with sunlight exposure, the timing of deficiency MAY BE CRUCIAL in determining Cognitive function.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 68), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 189), ('IMPORTANT_CONSIDERATION', 196)]	6	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0050890', 'cognition', 219, 'cognitive')]
PMC4982007	8/2016	S280-PMC4982007	['THUS, based ON a LIMITED NUMBER OF observational studies evidence LINKING maternal Vitamin D deficiency with reduced offspring Cognitive function is NOT CONCLUSIVE.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0050890', 'cognition', 127, 'cognitive')]
PMC4982007	8/2016	S359-PMC4982007	['we FOUND SOME EVIDENCE LINKING maternal obesity and low Micronutrient status, in particular, that of Vitamin D, Folate and B12 during Pregnancy with poorer offspring Cognitive function, SUGGESTING that maternal nutrition is IMPORTANT for optimal offspring Neurodevelopment and Long-Term Cognition.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 224)]	5	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 56, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 112, 'folate'), ('CHEBI_27778', 'abequose', 123, 'B12'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('GO_0050890', 'cognition', 166, 'cognitive'), ('GO_0007399', 'nervous system development', 256, 'neurodevelopment'), ('GO_0007040', 'lysosome organization', 277, 'long-term cognition')]
PMC4988030	8/2016	S142-PMC4988030	['LIKEWISE, clinically meaningful increases in percentages of pat participants meeting recommendations for Cholesterol and Vitamin C intakes between gm 4 and gm 8 were OBSERVED (65 to 84\xa0% and 86 to 97\xa0%, respectively).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 166)]	2	[('CHEBI_16113', 'cholesterol', 105, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin C')]
PMC4988030	8/2016	S164-PMC4988030	['the three point increase in total hei-2010 score and improvements in Saturated fat, Cholesterol and Vitamin C intake in the pat arm SUGGESTS that simple nutrition messaging, when presented in the context of a more GLOBAL maternal and child health curriculum, MAY promote positive maternal dietary behaviors in the Gestational period.']	[('INCOMPLETE_EVIDENCE', 132), ('IMPORTANT_CONSIDERATION', 214), ('INCOMPLETE_EVIDENCE', 259)]	3	[('CHEBI_51247', 'texas red', 69, 'saturated'), ('CHEBI_16113', 'cholesterol', 84, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin C'), ('GO_0007565', 'female pregnancy', 314, 'gestational')]
PMC4989298	8/2016	S237-PMC4989298	['NUMEROUS STUDIES have also evaluated the Intake of Vitamins (vit a, e, c) and Minerals (Mg, zn, Ca, p) [please NOTE that except for this chapter the data on Vitamin D is treated in a special section], BUT these often include methodological ERRORS, starting with the DIFFICULTY of FINDING a correct quantification of dietary Intakes of various Foods.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201), ('PROBLEM_COMPLICATION', 240), ('DIFFICULT_TASK', 266), ('INCOMPLETE_EVIDENCE', 280)]	6	[('GO_0007631', 'feeding behavior', 41, 'intake'), ('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 78, 'minerals'), ('CHEBI_34829', 'Medrysone', 88, 'Mg'), ('CHEBI_32588', 'potassium chloride', 96, 'Ca'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007631', 'feeding behavior', 324, 'intakes'), ('CHEBI_33290', 'food', 343, 'foods')]
PMC4989298	8/2016	S334-PMC4989298	['Vitamin D\nthe PURPOSE of THIS document is to CONSIDER the administration of Vitamin D for the primary prevention of allergies on the basis of the AVAILABLE SCIENTIFIC EVIDENCE.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('FUTURE_WORK', 45), ('INCOMPLETE_EVIDENCE', 146)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4989298	8/2016	S337-PMC4989298	['in RECENT YEARS a POSSIBLE ROLE in PREVENTION HAS BEEN ATTRIBUTED to Vitamin D. indeed, OBSERVATIONAL and cohort studies have DOCUMENTED the existence of a CORRELATION between vitamin d intake (from dietary sources or supplementation) in Pregnant women and children and the risk of wheezing, asthma or Food allergy later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 156)]	9	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 238, 'pregnant'), ('CHEBI_33290', 'food', 302, 'food'), ('UBERON_0000104', 'life cycle', 324, 'life')]
PMC4989298	8/2016	S345-PMC4989298	['HOWEVER, SEVERAL STUDIES report SUBOPTIMAL Vitamin D status in large parts of the population of children and Adults.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 32)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0007023', 'adult organism', 109, 'adults')]
PMC4989298	8/2016	S346-PMC4989298	['in italy, RECENT STUDIES have DOCUMENTED Vitamin D levels below 20\xa0ng/ml in 32\xa0% of children of normal weight and in 44\xa0% of obese children [119].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 30)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC4989298	8/2016	S347-PMC4989298	['low levels of Vitamin D HAVE BEEN DETECTED in up to 40\xa0% of adolescents in one study population [120].']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 34)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
PMC4989298	8/2016	S349-PMC4989298	['HISTORICALLY, Vitamin D HAS BEEN ASSOCIATED with Musculoskeletal diseases such as rachitism, osteoporosis, fractures and muscle weakness.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 49, 'musculoskeletal')]
PMC4989298	8/2016	S351-PMC4989298	['the results of this meta-analysis SUPPORTS a CORRELATION between low Vitamin D status and diseases such as hypertension, rachitism in children, vaginosis in Pregnancy, the level of activity of rheumatoid arthritis, Colorectal cancer and falls in the elderly.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnancy'), ('UBERON_0012652', 'colorectum', 215, 'colorectal')]
PMC4989298	8/2016	S359-PMC4989298	['IS the administration of Vitamin D in doses compliant with RECOMMENDED intakes SUGGESTED for the first year of Life RECOMMENDED for the prevention of allergic disease?']	[('EXPLICIT_QUESTION', 0), ('FUTURE_WORK', 59), ('INCOMPLETE_EVIDENCE', 79), ('FUTURE_WORK', 116), ('EXPLICIT_QUESTION', 166)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 111, 'life')]
PMC4989298	8/2016	S361-PMC4989298	['evaluated 10 OBSERVATIONAL studies (including 7 neonatal cohorts) on the maternal action of Vitamin D in the diet or Serum levels and asthma [122].']	[('INCOMPLETE_EVIDENCE', 13)]	1	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('UBERON_0001977', 'blood serum', 117, 'serum')]
PMC4989298	8/2016	S365-PMC4989298	['one SHOWED no correlation and the other 5 FOUND an inverse RELATIONSHIP between Vitamin D intake (through diet or supplementation) or Vitamin D levels in Umbilical Cord blood and the incidence of asthma or wheezing at 1–3 or 5\xa0years of age.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 154, 'umbilical cord')]
PMC4989298	8/2016	S368-PMC4989298	['in 2013, a randomised, controlled study by goldring and co-workers studied 113 children receiving Prenatal supplementation of Vitamin D. no effect on atopy, risk of atopic dermatitis, Pulmonary function and exhaled Nitric Oxide was FOUND [125].']	[('INCOMPLETE_EVIDENCE', 232)]	1	[('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('UBERON_0002048', 'lung', 184, 'pulmonary'), ('CHEBI_16480', 'nitric oxide', 215, 'nitric oxide')]
PMC4989298	8/2016	S370-PMC4989298	['published an exhaustive review CONCLUDING that there were NO conclusive DATA identifying a POSSIBLE dose of Vitamin D resulting in PREVENTION of Food allergy [126].']	[('INCOMPLETE_EVIDENCE', 31), ('PROBABLE_UNDERSTANDING', 31), ('FULL_UNKNOWN', 58), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_33290', 'food', 145, 'food')]
PMC4989298	8/2016	S371-PMC4989298	['in particular, in addition to studies SHOWING an inverse RELATIONSHIP between Vitamin D and atopic dermatitis, STUDIES report that high Vitamin D levels in Umbilical Cord Blood determines a higher risk of Allergic Sensitisation and Food allergy [127,128].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 111)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 156, 'umbilical cord'), ('UBERON_0000178', 'blood', 171, 'blood'), ('GO_0046631', 'alpha-beta T cell activation', 205, 'allergic sensitisation'), ('CHEBI_33290', 'food', 232, 'food')]
PMC4989298	8/2016	S373-PMC4989298	['the results REMAIN CONTROVERSIAL EVEN when CORRELATIONS between Vitamin D levels in maternal and Umbilical Cord Blood and allergic disease risk are measured directly.']	[('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('ANOMALY_CURIOUS_FINDING', 33), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 97, 'umbilical cord'), ('UBERON_0000178', 'blood', 112, 'blood')]
PMC4989298	8/2016	S375-PMC4989298	['conclusions\nALTHOUGH the AVAILABLE literature data SUGGEST the existence of a RELATIONSHIP between latitude and its consequent degree of ultraviolet radiation exposure, Vitamin D levels and the prevalence and severity of allergic diseases, the data of OBSERVATIONAL studies are encouraging, BUT CONTROVERSIAL and the ONLY available rct FAILS to SHOW an EFFECT on allergic disease prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 252), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 291), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 317), ('PROBLEM_COMPLICATION', 336), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 353)]	12	[('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4989298	8/2016	S376-PMC4989298	['the use of Vitamin D supplementation for the primary PREVENTION of allergic diseases REMAINS an attractive TOPIC of study, BUT CURRENT KNOWLEDGE and AVAILABLE EVIDENCE does not warrant its RECOMMENDATION [129].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 149), ('FUTURE_WORK', 189)]	7	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC4989298	8/2016	S379-PMC4989298	['on BASIS of the AVAILABLE EVIDENCE, the use of Vitamin D supplementation is not RECOMMENDED for the primary prevention of allergic disease.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 80)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4990268	8/2016	S39-PMC4990268	['the interventions considered by this review are outlined intable 1(numbered to correspond to the sections of the paper where they are addressed).10.1371/journal.pone.0160562.t001\n\ncaption (table-wrap): table 1\ninterventions addressed in THIS review.Nutritioninfectionobstetrical and other• immediate & exclusive breastfeeding• deworming• advance distribution of Misoprostol for use immediately after Childbirth for preventing post-Partum hemorrhage• antenatal Iron supplementation & anemia screening & treatment• intermittent presumptive treatment of malaria & use of Insecticide-treated nets• pre-eclampsia screening & treatment• multi-Micronutrient supplementation• Tetanus Toxoid• clean Delivery practices• Calcium supplementation• advance distribution of Chlorhexidine for application to the Umbilical Cord Stump• thermal care• antenatal Vitamin A supplementation• syphilis screening & treatment• Birth preparedness & complication readiness• advance distribution of Vitamin A for administration to the newborn• hiv screening/ pmtct• tobacco, alcohol use• Iodized Salt use• Family Planning• balanced protein-energy supplementation\n\neffects modified by context\nfor each of these INTERVENTIONS, the review addresses: 1) EVIDENCE on EFFECTS with regard to mortality and other IMPORTANT endpoints and 2) variation in expected EFFECTS by context.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 237), ('SUPERFICIAL_RELATIONSHIP', 1181), ('INCOMPLETE_EVIDENCE', 1221), ('SUPERFICIAL_RELATIONSHIP', 1233), ('IMPORTANT_CONSIDERATION', 1276), ('SUPERFICIAL_RELATIONSHIP', 1325)]	6	[('GO_0012501', 'programmed cell death', 249, 'NutritionInfectionObstetrical'), ('CHEBI_63610', 'misoprostol', 362, 'misoprostol'), ('GO_0007623', 'circadian rhythm', 400, 'childbirth'), ('GO_0007567', 'parturition', 431, 'partum'), ('UBERON_0001013', 'adipose tissue', 431, 'partum'), ('CHEBI_24870', 'ion', 460, 'iron'), ('CHEBI_24852', 'insecticide', 568, 'insecticide'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 637, 'micronutrient'), ('CHEBI_32848', 'serine residue', 668, 'Tetanus'), ('CHEBI_29238', 'tritium atom', 676, 'toxoid'), ('GO_0007567', 'parturition', 690, 'delivery'), ('CHEBI_31341', 'calcium dihydroxide', 710, 'Calcium'), ('CHEBI_3647', 'chlorpromazine', 759, 'chlorhexidine'), ('UBERON_0010270', 'filum terminale externum', 796, 'umbilical cord stump'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 850, 'A'), ('GO_0007567', 'parturition', 901, 'Birth'), ('CHEBI_27300', 'vitamin D', 970, 'vitamin A'), ('CHEBI_31721', 'Irsogladine maleate', 1059, 'Iodized salt'), ('GO_0006437', 'tyrosyl-tRNA aminoacylation', 1077, 'Family Planning')]
PMC4990268	8/2016	S224-PMC4990268	['multi-Micronutrient supplementation\nvarious Micronutrients HAVE BEEN investigated for their ROLE in Pregnancy outcomes (Iron, Folic Acid, Calcium, magnesium, zinc, Vitamin A/ B-Carotene, Vitamin D3, Iodine, Omega-3 Fatty Acids, and others).']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 92)]	2	[('CHEBI_6956', 'Mitragynine', 6, 'Micronutrient'), ('CHEBI_33839', 'macromolecule', 44, 'micronutrients'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('CHEBI_24870', 'ion', 120, 'iron'), ('CHEBI_30751', 'formic acid', 126, 'folic acid'), ('CHEBI_22313', 'alkaline earth metal atom', 138, 'calcium'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A'), ('CHEBI_27793', 'beta-carotene 5,6-epoxide', 175, 'B-carotene'), ('CHEBI_33279', 'vitamin D5', 187, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 187, 'vitamin D3'), ('CHEBI_24859', 'iodine atom', 199, 'iodine'), ('CHEBI_79370', 'ibho#10', 207, 'omega-3'), ('CHEBI_35366', 'fatty acid', 215, 'fatty acids')]
PMC4990268	8/2016	S292-PMC4990268	['antenatal vitamin a\nclose to 20 million Pregnant women annually are ESTIMATED to be Vitamin A deficient (vad) to some degree, most in south and southeast asia[101].']	[('INCOMPLETE_EVIDENCE', 68)]	1	[('GO_0007565', 'female pregnancy', 40, 'pregnant'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A')]
PMC4990268	8/2016	S293-PMC4990268	['YET the Ocular manifestations of Vitamin A deficiency during Pregnancy are RARE except for night blindness which typically occurs late in Pregnancy and is indicative of depleted Liver reserves.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 75)]	2	[('UBERON_0000970', 'eye', 8, 'ocular'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy'), ('UBERON_0002107', 'liver', 178, 'liver')]
PMC4990268	8/2016	S294-PMC4990268	['Pregnant women who are Vitamin A deficient and their infants CAN suffer SIGNIFICANT adverse consequences AS a result of this deficiency.']	[('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 72), ('PROBABLE_UNDERSTANDING', 105)]	3	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin A')]
PMC4990268	8/2016	S297-PMC4990268	['IN FACT, the CURRENT EVIDENCE provides SOME SUPPORT for this RELATED to Vitamin A supplementation during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 61)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('GO_0007565', 'female pregnancy', 105, 'pregnancy')]
PMC4990268	8/2016	S299-PMC4990268	['that said, there is also EVIDENCE that Vitamin A deficiency INTERFERES with proper fetal development[103].']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin A')]
PMC4990268	8/2016	S314-PMC4990268	['IN SUMMARY, there is CONFLICTING EVIDENCE for benefit of Vitamin A or Β-Carotene supplementation on maternal mortality.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 33)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 70, 'β-carotene')]
PMC4990268	8/2016	S315-PMC4990268	['meta-analyses do not SUPPORT this intervention as a Maternal survival strategy[101,108] HOWEVER the most RECENT such analysis NOTED significant heterogeneity in trial outcomes (i2 = 52%, p = 0.04) MOST LIKELY due TO VARIATIONS in underlying population levels of Vitamin A deficiency between studies[101].']	[('INCOMPLETE_EVIDENCE', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('INCOMPLETE_EVIDENCE', 105), ('ANOMALY_CURIOUS_FINDING', 126), ('PROBABLE_UNDERSTANDING', 197), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('DIFFICULT_TASK', 216)]	7	[('GO_0007618', 'mating', 52, 'maternal'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin A')]
PMC4990268	8/2016	S317-PMC4990268	['there was NO EVIDENCE that Antenatal Vitamin A supplementation reduced infant mortality, Stillbirth, Preterm Birth or increased Birthweight[19,101,107–110].']	[('INCOMPLETE_EVIDENCE', 10)]	1	[('GO_0007567', 'parturition', 27, 'antenatal'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('GO_0001966', 'thigmotaxis', 89, 'stillbirth'), ('GO_0007565', 'female pregnancy', 101, 'preterm birth'), ('GO_0007596', 'blood coagulation', 128, 'birthweight')]
PMC4990268	8/2016	S318-PMC4990268	['in ONE TRIAL from indonesia, there was a small increase in Birth length among newborns whose mothers received Antenatal Vitamin A versus placebo or combined Vitamin A plus zinc, but the difference was SMALL (0.5 cm) and there was no difference in Birthweight[110].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 201)]	2	[('GO_0007567', 'parturition', 59, 'birth'), ('GO_0007567', 'parturition', 110, 'antenatal'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin A'), ('GO_0007596', 'blood coagulation', 247, 'birthweight')]
PMC4990268	8/2016	S319-PMC4990268	['overall, there is NO CONSISTENT EVIDENCE that Antenatal Vitamin A supplementation improves growth of infants through the first year of Life[101].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 21)]	2	[('GO_0007567', 'parturition', 46, 'antenatal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin A'), ('UBERON_0000104', 'life cycle', 135, 'life')]
PMC4990268	8/2016	S323-PMC4990268	['night blindness in Pregnancy: a stratified analysis of the nepal trial SHOWED significantly higher infant mortality for children Born to women who were night blind during Pregnancy and that Antenatal Vitamin A supplementation attenuated this risk[111].']	[('INCOMPLETE_EVIDENCE', 71)]	1	[('GO_0007565', 'female pregnancy', 19, 'Pregnancy'), ('GO_0007567', 'parturition', 129, 'born'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy'), ('GO_0007567', 'parturition', 190, 'antenatal'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin A')]
PMC4990268	8/2016	S325-PMC4990268	['these results SUPPORTS the current RECOMMENDATION of treating Pregnant women with Vitamin A who present with night blindness.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 35)]	2	[('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin A')]
PMC4990268	8/2016	S326-PMC4990268	['maternal hiv infection: there is NO CONSISTENT EVIDENCE that Antenatal Vitamin A supplementation reduces RISK of Mother-To-child-Transmission Of Hiv (mtct) BUT there is significant heterogeneity in trial results [101].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	4	[('GO_0007567', 'parturition', 61, 'antenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin A'), ('GO_0007533', 'mating type switching', 113, 'mother-to ... transmission of HIV')]
PMC4990268	8/2016	S336-PMC4990268	['MULTIPLE STUDIES have DEMONSTRATED that Vitamin A supplementation among children 6 months to 5 years of age in populations with endemic Vitamin A deficiency CAN reduce mortality[116].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 157)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin A')]
PMC4990268	8/2016	S338-PMC4990268	['SUPPORTING this VIEW, there was NO EVIDENCE of benefit of Vitamin A supplementation on mortality among children under 6 months[117] until humphrey et al.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin A')]
PMC4990268	8/2016	S343-PMC4990268	['evidence: the studies identified for this review FOUND VARYING results of Vitamin A supplementation on infant mortality.']	[('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin A')]
PMC4990268	8/2016	S354-PMC4990268	['among hiv positive women in zimbabwe, there was NO EVIDENCE for IMPACT of Vitamin A supplementation for mothers and/or their newborns on mortality[127].']	[('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin A')]
PMC4990268	8/2016	S355-PMC4990268	['a trial in guinea-bissau SHOWED that Vitamin A supplementation (25,000 iu at Birth) was not significantly associated with mortality (rr = 1.08, 95% ci: 0.79–1.47)[122].']	[('INCOMPLETE_EVIDENCE', 25)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('GO_0007567', 'parturition', 77, 'birth')]
PMC4990268	8/2016	S359-PMC4990268	['WHILE those results are not yet published, they SHOW a DIFFERENCE between the results of trials conducted in settings with significant maternal Vitamin A deficiency (indonesia, south india, bangladesh, and north india) and those in settings with little to no maternal Vitamin A deficiency (zimbabwe, guinea-bissau, ghana, and tanzania).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55)]	3	[('CHEBI_27300', 'vitamin D', 144, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin A')]
PMC4990268	8/2016	S361-PMC4990268	['conclusion: pooling results across all rcts SHOWS no benefit from newborn Vitamin A supplementation on early infant mortality.']	[('INCOMPLETE_EVIDENCE', 44)]	1	[('CHEBI_27300', 'vitamin D', 74, 'vitamin A')]
PMC4990268	8/2016	S1116-PMC4990268	['intable 6below, we have offered very brief comments on such implementation CONSIDERATIONS.10.1371/journal.pone.0160562.t006\n\ncaption (table-wrap): table 6\n“best buy” ratings for interventions reviewed.interventionpopulation impactease of Deliverycommentsbreastfeeding—early initiation ✓ ☺large magnitude EFFECT on newborn mortalityiron/ anemia ✓✓✓ ☺LIKELY a significant mortality EFFECT, BUT EVIDENCE is WEAK; clear benefit however for iugr multi-Micronutrient supplementation✓ ☺ ALTHOUGH iugr is reduced , in many low income settings there MAY BE no net benefit; under SOME conditions there MAY BE net harm Calcium ✓✓✓😐 large magnitude EFFECTS but significant logistical barriers at currently recommended dose antenatal Vitamin A ☺ no effects on our outcomes of interest Postnatal Vitamin A ✓ ☺EVIDENCE for IMPACT on early infant deaths in Vitamin-A deficient populationsiodine ✓ ☺major benefit in ↓’d burden of Cognitive disabilitybalanced protein-energy supplementation ✓✓✓😐 significant benefits, but cost & logistical challenges limit scalability deworming ☺ no effects on our outcomes of interest iptp/itns ✓✓✓✓ ☺large magnitude EFFECTS in malarious areastetanus Toxoid ✓ ☺in most settings, coverage is now relatively high; this NEEDS to be sustainedchlorhexidine advance distribution ✓ ☺large magnitude EFFECT on newborn mortality in high nmr populationssyphilis screening & treatment ✓✓✓ ☺relatively inexpensive and straightforward diagnostics and treatmentpmtct ✓😐 high population effective coverage REQUIRES robust services and systemsmisoprostol advance distribution ✓ ☺to ensure SAFETY, Delivery strategy NEEDS to reliably ensure counseling on correct timing of use (i.e.']	[('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 349), ('SUPERFICIAL_RELATIONSHIP', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('INCOMPLETE_EVIDENCE', 392), ('INCOMPLETE_EVIDENCE', 404), ('ANOMALY_CURIOUS_FINDING', 480), ('INCOMPLETE_EVIDENCE', 541), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 592), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 795), ('SUPERFICIAL_RELATIONSHIP', 808), ('SUPERFICIAL_RELATIONSHIP', 1134), ('FUTURE_WORK', 1234), ('SUPERFICIAL_RELATIONSHIP', 1309), ('IMPORTANT_CONSIDERATION', 1508), ('IMPORTANT_CONSIDERATION', 1590), ('FUTURE_WORK', 1616), ('IMPORTANT_CONSIDERATION', 1616)]	21	[('GO_0031078', 'histone deacetylase activity (H3-K14 specific)', 238, 'DeliveryCommentsBreastfeeding'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 447, 'micronutrient'), ('CHEBI_31341', 'calcium dihydroxide', 608, 'Calcium'), ('CHEBI_77082', 'O-adipoylcarnitine(1-)', 616, '✓✓✓😐'), ('CHEBI_33233', 'fundamental particle', 721, 'vitamin A ☺'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 721, 'vitamin A ☺'), ('GO_0007567', 'parturition', 772, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 782, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 841, 'vitamin'), ('PR_000027594', 'histone H3', 841, 'vitamin-A'), ('GO_0050890', 'cognition', 913, 'cognitive'), ('CHEBI_29238', 'tritium atom', 1168, 'toxoid'), ('GO_0007567', 'parturition', 1598, 'delivery')]
PMC4990268	8/2016	S1153-PMC4990268	['DEPENDING ON the setting, this COULD BE supplemented by clinical preventive interventions that CAN be put into operation at the time of home Births, NOTABLY the use of Misoprostol for prevention of pph, application of Chlorhexidine to the Umbilical Cord Stump and newborn Vitamin A supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 95), ('IMPORTANT_CONSIDERATION', 149)]	4	[('GO_0007567', 'parturition', 141, 'births'), ('CHEBI_63610', 'misoprostol', 168, 'misoprostol'), ('CHEBI_3647', 'chlorpromazine', 218, 'chlorhexidine'), ('UBERON_0010270', 'filum terminale externum', 239, 'umbilical cord stump'), ('CHEBI_27300', 'vitamin D', 272, 'vitamin A')]
PMC4990268	8/2016	S1184-PMC4990268	['BUT current RECOMMENDED dose imposes IMPORTANT logistical DIFFICULTIES.antenatal vitamin aroutine supplementation not indicated BUT in Vitamin A deficient populations screening for night blindness and treating such cases with Vitamin A CAN be RECOMMENDED.Postnatal vitamin abenefit expected in Vitamin A deficient populations (e.g.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 12), ('IMPORTANT_CONSIDERATION', 37), ('DIFFICULT_TASK', 58), ('PROBLEM_COMPLICATION', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 236), ('FUTURE_WORK', 243)]	8	[('CHEBI_27300', 'vitamin D', 135, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A'), ('GO_0007567', 'parturition', 255, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 294, 'vitamin A')]
PMC4990280	8/2016	S150-PMC4990280	['the mm supplement of unicef/who/unu contained IMPORTANT antioxidants such as Vitamin E, Vitamin C and Selenium which are KNOWN to reduce inflammatory responses.']	[('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 121)]	2	[('CHEBI_27300', 'vitamin D', 77, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin C'), ('CHEBI_27568', 'selenium atom', 102, 'selenium')]
PMC4990280	8/2016	S154-PMC4990280	['a study in nepal DEMONSTRATED that maternal Vitamin A supplementation enhanced natural Antibody concentrations in children at preadolescent age (9 to 13 years); the authors POSTULATED that pre-Natal supplementation lead TO a higher reservoir and sustained natural immunity in these children [37].']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 173), ('QUESTION_ANSWERED_BY_THIS_WORK', 220)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('GO_0042571', 'immunoglobulin complex, circulating', 87, 'antibody'), ('GO_0007567', 'parturition', 193, 'natal')]
PMC4990280	8/2016	S159-PMC4990280	['the positive ASSOCIATION between hb and Plasma concentration of ferritin, B12, hepcidin and Vitamin A MAINLY in fe60f group INDICATED a beneficial IMPACT of the higher dose of Antenatal iron on hb concentration in 9 years old children.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('UBERON_0001969', 'blood plasma', 40, 'plasma'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 74, 'B12'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin A'), ('GO_0007567', 'parturition', 176, 'antenatal')]
PMC4992225	8/2016	S1-PMC4992225	['researchers have studied the RELATIONSHIP between low Serum Vitamin D concentration and Perinatal depression, ALTHOUGH NO clinical trial HAS BEEN CONDUCTED on Vitamin D’s EFFECTS on depression RELATED to Childbirth.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('ANOMALY_CURIOUS_FINDING', 110), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 171), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0036268', 'swimming', 88, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 88, 'perinatal'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 204, 'childbirth')]
PMC4992225	8/2016	S38-PMC4992225	['SEVERAL STUDIES have REVEALED that Vitamin D supplementation can raise Vitamin D reserves gradually, according to baseline concentration of Vitamin D, dose and duration of Consumption [16–18].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007631', 'feeding behavior', 172, 'consumption')]
PMC4992225	8/2016	S39-PMC4992225	['IN ACCORDANCE to a GUIDELINE by holick et al., 6–8 weeks Consumption of a high dose Vitamin D supplement are ESSENTIAL to obtain an adequate Blood reserves of Vitamin D [19].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 19), ('IMPORTANT_CONSIDERATION', 109)]	3	[('GO_0007631', 'feeding behavior', 57, 'consumption'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0000178', 'blood', 141, 'blood'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4992225	8/2016	S45-PMC4992225	['in a study by mozaffari- khosravi et al., high doses of Vitamin D HAVE BEEN effective in men and women who were depressed [30].']	[('INCOMPLETE_EVIDENCE', 66)]	1	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4992225	8/2016	S47-PMC4992225	['SUGGESTED that more accurate clinical trials are REQUIRED to reach a CONCLUSION about the effectiveness of Vitamin D on depression [31].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 69)]	3	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4992225	8/2016	S48-PMC4992225	['CONSIDERING the POSSIBLE CONNECTION between low Serum Vitamin D and depression, researchers studied the RELATIONSHIP between low Vitamin D and Perinatal depression.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0036268', 'swimming', 143, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 143, 'perinatal')]
PMC4992225	8/2016	S63-PMC4992225	['ACCORDING TO OUR KNOWLEDGE, THERE WAS NO clinical trial that has evaluated the effectiveness of Vitamin D on Perinatal depression.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 10), ('FULL_UNKNOWN', 28)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0036268', 'swimming', 109, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 109, 'perinatal')]
PMC4992225	8/2016	S87-PMC4992225	['ACCORDING TO the institute of medicine (iom), we CONSIDERED Vitamin D deficiency AS a Serum 25-Hydroxyvitamin D of less than 20\xa0ng/ml.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 81)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 92, '25-hydroxyvitamin D')]
PMC4992225	8/2016	S88-PMC4992225	['we also CONSIDERED Vitamin D INSUFFICIENCY AS a Serum 25-Hydroxyvitamin D of 21–29\xa0ng/ml, and the participants who had Serum 25-Hydroxyvitamin d of\u2009≥\u200930\xa0ng/ml AS sufficient [19,46].']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 29), ('PROBABLE_UNDERSTANDING', 43), ('PROBABLE_UNDERSTANDING', 159)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 54, '25-hydroxyvitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 125, '25-hydroxyvitamin')]
PMC4992225	8/2016	S164-PMC4992225	['results SHOWED that in the Vitamin D group the number of participants with depression scores of <9 were more than the control group at 38–40 weeks of Gestation also, at 4 and 8 weeks after Birth (table\xa03).']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('GO_0007567', 'parturition', 189, 'birth')]
PMC4992225	8/2016	S170-PMC4992225	['2\n\nwithin groups comparison related to depression scores: the results SHOWED, between the two groups, the difference regards to over-time reduction of depression scores was significant ( p \u2009<\u20090.001)\nthe Vitamin D group also had gone through changes with regards to their depression scores ( p \u2009<\u20090.001) (fig.']	[('INCOMPLETE_EVIDENCE', 70)]	1	[('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4992225	8/2016	S175-PMC4992225	['the results SHOWED that in both subgroups, the Vitamin D group had statistically significant higher 25-Hydroxyvitamin D concentrations at Childbirth and lower depression score at 4 and 8 weeks Postpartum than the control group (table\xa04).']	[('INCOMPLETE_EVIDENCE', 12)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 100, '25-hydroxyvitamin D'), ('GO_0007623', 'circadian rhythm', 138, 'childbirth'), ('GO_0007565', 'female pregnancy', 193, 'postpartum')]
PMC4992225	8/2016	S180-PMC4992225	['ACCORDING TO OUR KNOWLEDGE, this study was the FIRST trial held on Vitamin D and Perinatal depression.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 47)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0036268', 'swimming', 81, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 81, 'perinatal')]
PMC4992225	8/2016	S186-PMC4992225	['the high prevalence of Vitamin D deficiency in iran was SHOWED in numerous studies.']	[('INCOMPLETE_EVIDENCE', 56)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC4992225	8/2016	S188-PMC4992225	['saki et al., SHOWED high prevalence of Vitamin D deficiency in southern iranian children, more than 80\xa0% were deficient [53].']	[('INCOMPLETE_EVIDENCE', 13)]	1	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4992225	8/2016	S190-PMC4992225	['FOUND Vitamin D deficiency in 52.9\xa0% of women aged 20–74 years in shiraz, iran [54].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC4992225	8/2016	S196-PMC4992225	['IN CONTRAST, in the PREVIOUS STUDIES 2000\xa0iu Vitamin D supplementation was more sufficient to increase Serum 25-Hydroxyvitamin D concentrations up to the adequate amount (≥32\xa0ng/ml) [18,57,58].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001977', 'blood serum', 103, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 109, '25-hydroxyvitamin D')]
PMC4992225	8/2016	S238-PMC4992225	['PREVIOUS clinical TRIALS, in which Vitamin D supplementations were consumed during Pregnancy [18,58], HAVE NOT EVALUATED the Antenatal and Postnatal depression disorders.']	[('INCOMPLETE_EVIDENCE', 0), ('FULL_UNKNOWN', 102), ('FULL_UNKNOWN', 107)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007567', 'parturition', 125, 'antenatal'), ('GO_0007567', 'parturition', 139, 'postnatal')]
PMC4992225	8/2016	S241-PMC4992225	['SOME clinical trials in non-Pregnant People SHOWED that Vitamin D was EFFECTIVE in decreasing depression level.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('GO_0007565', 'female pregnancy', 28, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 37, 'people'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4992225	8/2016	S245-PMC4992225	['IN CONTRAST, in ANOTHER STUDY 40,000\xa0iu Vitamin D per week was used for 6\xa0months, BUT Vitamin D was not EFFECTIVE in decreasing depression level compared to the control group [68].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4992225	8/2016	S247-PMC4992225	['FOUND that 5000\xa0iu Vitamin D per day for 6\xa0weeks had no effect on men and women’s Cognitive and emotional function [69].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0050890', 'cognition', 82, 'cognitive')]
PMC4992225	8/2016	S253-PMC4992225	['an increase in Vitamin D CAN cause Parathyroid hormones to decrease.']	[('INCOMPLETE_EVIDENCE', 25)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 35, 'parathyroid')]
PMC4992225	8/2016	S260-PMC4992225	['it is also POSSIBLE that AS a result of vascular changes in Pregnancy the maternal Cerebral environment is more vulnerable to inflammation PERHAPS, EXPLAINING IN PART the LINK between Vitamin D and depression in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 25), ('INCOMPLETE_EVIDENCE', 139), ('PROBABLE_UNDERSTANDING', 148), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('UBERON_0001893', 'telencephalon', 83, 'cerebral'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 212, 'pregnancy')]
PMC4992225	8/2016	S261-PMC4992225	['IN LIGHT OF the inflammatory nature of depression and the strong ROLE of Vitamin D AS an anti-inflammatory and immunomodulator, inflammation MAY MEDIATE the RELATIONSHIP between vitamin d deficiency and depression during Pregnancy [73,74].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 83), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 145), ('SUPERFICIAL_RELATIONSHIP', 157)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy')]
PMC4992225	8/2016	S263-PMC4992225	['it was INTERESTING TO INVESTIGATE TREND of Vitamin D EFFECTIVENESS in the two primiparous and multiparous subgroups.']	[('ANOMALY_CURIOUS_FINDING', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4992225	8/2016	S274-PMC4992225	['meaning that over time, depression scores decreased much more in the Vitamin D group in comparison to control group and this SHOWS the POSSIBLE EFFECTS of the Vitamin D3Supplementation.']	[('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_52915', 'phosphatediyl group', 159, 'vitamin D3supplementation')]
PMC4992225	8/2016	S281-PMC4992225	['also, SINCE more than 95\xa0% of the mothers had lower than 30\xa0ng/ml Serum 25-Hydroxyvitamin D concentration, it is NOT CLEAR IF the same results WOULD BE OBSERVED in mothers with higher levels of 25-Hydroxyvitamin D. THEREFORE, we SUGGEST FURTHER clinical TRIALS, using 2000\xa0iu Vitamin D on a larger population, mothers with high levels of depression, and high Serum 25-Hydroxyvitamin D concentrations.']	[('PROBLEM_COMPLICATION', 6), ('FULL_UNKNOWN', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('FUTURE_PREDICTION', 143), ('INCOMPLETE_EVIDENCE', 152), ('PROBABLE_UNDERSTANDING', 215), ('INCOMPLETE_EVIDENCE', 229), ('FUTURE_WORK', 237)]	8	[('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 72, '25-hydroxyvitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 194, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('UBERON_0001977', 'blood serum', 359, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 365, '25-hydroxyvitamin D')]
PMC4993554	8/2016	S118-PMC4993554	['less than one-third of the women (30%) correctly identified all the three Nutrients (Vitamin A, Vitamin D, and Vitamin B6) as micro-Nutrients that MAY pose a risk when taken during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 147)]	1	[('CHEBI_33284', 'nutrient', 74, 'nutrients'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 111, 'vitamin B6'), ('PR_000017255', 'Vang-like protein 1', 111, 'vitamin B6'), ('CHEBI_33284', 'nutrient', 132, 'nutrients'), ('GO_0007565', 'female pregnancy', 181, 'pregnancy')]
PMC4993554	8/2016	S175-PMC4993554	['although Liver is a rich source of key Nutrients such as Iron and Folate, avoiding it in Pregnancy is RECOMMENDED as it contains a high level of Vitamin A and the upper safer limit is UNCERTAIN.52a high dose of Vitamin A in Pregnancy poses a SERIOUS risk of Birth defects.53ALTHOUGH our study DID NOT provide information on HOW this low awareness of Vitamin A-rich source Food COULD AFFECT Pregnant women’s Food choices, written comments (open text sections of the survey) in the PRESENT STUDY INDICATED that SOME women MAY BE INFLUENCED by some of nonevidence-based information.']	[('FUTURE_WORK', 102), ('FULL_UNKNOWN', 184), ('IMPORTANT_CONSIDERATION', 242), ('ANOMALY_CURIOUS_FINDING', 272), ('INCOMPLETE_EVIDENCE', 293), ('EXPLICIT_QUESTION', 324), ('INCOMPLETE_EVIDENCE', 377), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 480), ('INCOMPLETE_EVIDENCE', 494), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 520), ('SUPERFICIAL_RELATIONSHIP', 527)]	13	[('UBERON_0002107', 'liver', 9, 'liver'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CHEBI_24870', 'ion', 57, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 66, 'folate'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin A'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007567', 'parturition', 258, 'birth'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin A'), ('CHEBI_33290', 'food', 372, 'food'), ('GO_0007565', 'female pregnancy', 390, 'pregnant'), ('CHEBI_33290', 'food', 407, 'food')]
PMC4997421	8/2016	S14-PMC4997421	['maternal Vitamin A deficiency increases the RISK of COMPLICATIONS during Pregnancy and in the Postpartum Period and HAS BEEN positively ASSOCIATED with Preterm Delivery [3], maternal infections, night blindness, anemia [4], and Birth defects [5].']	[('IMPORTANT_CONSIDERATION', 44), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('GO_0007565', 'female pregnancy', 94, 'postpartum'), ('UBERON_2001055', 'pronephric duct opening', 105, 'period'), ('GO_0007565', 'female pregnancy', 152, 'preterm'), ('GO_0007567', 'parturition', 160, 'delivery'), ('GO_0007567', 'parturition', 228, 'birth')]
PMC4997421	8/2016	S18-PMC4997421	['the united states has BEEN assumed to be free of Vitamin A deficiency BASED ON a high gross domestic product [12] and Vitamin A status has ONLY rarely BEEN investigated in the us population, especially in women of Childbearing age.']	[('ANOMALY_CURIOUS_FINDING', 22), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 139), ('ANOMALY_CURIOUS_FINDING', 151)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 214, 'childbearing')]
PMC4997421	8/2016	S20-PMC4997421	['signs of Vitamin A deficiency MAY not be observed in the mother, but the rapidly developing fetus is more vulnerable to these EFFECTS [13].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 126)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A')]
PMC4997421	8/2016	S39-PMC4997421	['Carotenes and beta-crytoxanthin have pre-Vitamin A activity, and lutein + zeaxanthin and Lycopene HAVE BEEN SHOWN in the literature to POTENTIALLY be important to the developing fetus [18,19].']	[('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 135)]	2	[('CHEBI_23042', 'carotene', 0, 'Carotenes'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_15948', 'lycopene', 89, 'lycopene')]
PMC4997421	8/2016	S90-PMC4997421	['OUR STUDY SHOWS that lower poverty status and race increase the risk of suboptimal Vitamin A stores in women of Childbearing age in the united states.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 112, 'childbearing')]
PMC4997421	8/2016	S93-PMC4997421	['FOUND a significantly increased RISK of spontaneous Preterm Delivery, maternal anemia, and Pregnancy-induced hypertension when Retinol levels were below 0.70 µmol/l, and BASED ON those functional EFFECTS RECOMMEND a level of 0.70 µmol/l to define Vitamin A deficiency in Pregnancy [3].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 170), ('QUESTION_ANSWERED_BY_THIS_WORK', 170), ('SUPERFICIAL_RELATIONSHIP', 196), ('FUTURE_WORK', 204)]	6	[('GO_0007565', 'female pregnancy', 52, 'preterm'), ('GO_0007567', 'parturition', 60, 'delivery'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CHEBI_26536', 'retinoic acid', 127, 'retinol'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin A'), ('GO_0007565', 'female pregnancy', 271, 'pregnancy')]
PMC4997421	8/2016	S94-PMC4997421	['measurements of Vitamin A concentrations in Breast Milk, maternal Serum Vitamin A concentration, and maternal dietary intake SUGGEST that a maternal concentration of ≥1.05 µmol/l is NECESSARY in order to maintain a sufficient Vitamin A content in Breast Milk [26].']	[('INCOMPLETE_EVIDENCE', 125), ('IMPORTANT_CONSIDERATION', 182)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin A'), ('UBERON_0001348', 'brown adipose tissue', 44, 'breast milk'), ('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 80, 'A'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin A'), ('UBERON_0000310', 'breast', 247, 'breast'), ('UBERON_0001913', 'milk', 254, 'milk')]
PMC4997421	8/2016	S99-PMC4997421	['our analysis used the most recent nhanes cycles containing Serum Retinol information, and OUR FINDINGS also SUPPORT an overall low prevalence of Vitamin A deficiency and insufficiency during this time period.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('INCOMPLETE_EVIDENCE', 108)]	2	[('UBERON_0001977', 'blood serum', 59, 'serum'), ('CHEBI_26536', 'retinoic acid', 65, 'retinol'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A')]
PMC4997421	8/2016	S100-PMC4997421	['our results also SUPPORT the FINDING that there is not an even distribution of Vitamin A status across ethnic, racial, and socioeconomic strata.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 29)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin A')]
PMC4997421	8/2016	S108-PMC4997421	['RECENT STUDIES have raised concerns regarding Nutrient intake in the united states, ESPECIALLY with regard to Vitamin A and Vitamin A precursors from fruits and vegetables.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 84)]	2	[('CHEBI_33284', 'nutrient', 46, 'nutrient'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin A')]
PMC4997421	8/2016	S109-PMC4997421	['data from 2003 to 2008 nhanes cycles DEMONSTRATE that women of Childbearing age in the united states are not meeting Nutrient guidelines for Vitamin A intake, with distinct differences present between ethnic groups and socioeconomic strata [20,31,32].']	[('INCOMPLETE_EVIDENCE', 37)]	1	[('GO_0007129', 'homologous chromosome pairing at meiosis', 63, 'childbearing'), ('CHEBI_33284', 'nutrient', 117, 'nutrient'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A')]
PMC4997421	8/2016	S135-PMC4997421	['Serum Retinol levels are also under tight Homeostatic Control and MAY not be reliable indicators of the Vitamin A status of an Individual [44].']	[('INCOMPLETE_EVIDENCE', 66)]	1	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_26536', 'retinoic acid', 6, 'retinol'), ('GO_0042592', 'homeostatic process', 42, 'homeostatic'), ('GO_0065007', 'biological regulation', 54, 'control'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin A'), ('NCBITaxon_1', 'root', 127, 'individual')]
PMC4997421	8/2016	S136-PMC4997421	['our use of the who Retinol classifications, HOWEVER, does provide us with INFORMATION about the Vitamin A status of this IMPORTANT population [44], women of Childbearing age.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('INCOMPLETE_EVIDENCE', 74), ('IMPORTANT_CONSIDERATION', 121)]	3	[('CHEBI_26536', 'retinoic acid', 19, 'retinol'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 157, 'childbearing')]
PMC4997421	8/2016	S138-PMC4997421	['conclusions\nour results DEMONSTRATE IT IS POSSIBLE that Vitamin A deficiency is a PUBLIC HEALTH CONCERN in nutritionally disadvantaged populations of industrialized societies.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 82)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin A')]
PMC4997567	8/2016	S60-PMC4997567	['the laboratory biochemical profile SHOWED that 213 Rachitic Genu varus cases (85.2%) had Serum calcium less than 9 mg/dl; 188 cases (75.2%) had Serum Phosphorus less than 3 mg/dl; 205 cases (82%) had Serum alkaline phosphatase level more than 25k.u; and 163 cases (65.2%) had Serum active Vitamin D 1,25(Oh)2D less than 15 ng/dl.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('UBERON_0001762', 'turbinate bone', 51, 'rachitic genu'), ('UBERON_0001977', 'blood serum', 89, 'serum'), ('UBERON_0001977', 'blood serum', 144, 'serum'), ('CHEBI_35885', 'secondary phosphine', 150, 'phosphorus'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('UBERON_0001977', 'blood serum', 276, 'serum'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 297, 'D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 301, '25(OH)2D'), ('PR_000005450', 'chromatin accessibility complex protein 1', 307, '2D')]
PMC4997567	8/2016	S82-PMC4997567	['(2008) [14], and bakeit and megeid (2012) [13] who REPORTED deficient maternal geastational supplementation of Calcium and Vitamin D as a cause of infantile Vitamin D deficiency rickets.']	[('INCOMPLETE_EVIDENCE', 51)]	1	[('CHEBI_22313', 'alkaline earth metal atom', 111, 'calcium'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4997567	8/2016	S88-PMC4997567	['(2008) [17] who REVEALED that most of the rachitic children were Breast-Fed; the incidence of Vitamin D deficiency rickets is expected with icreasing rate of breast feeding.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('GO_0007567', 'parturition', 65, 'breast'), ('GO_0007631', 'feeding behavior', 72, 'fed'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC4997567	8/2016	S91-PMC4997567	['(2008) [19], and bakeit and megeid (2012) [13], who REVEALED that most of the rickets children were Breast-Fed which may LEAD TO decreased Vitamin D 25-Hydroxy Vitamin D(25-Ohd) intake from OTHER sources and thereby causing rickets.']	[('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 121), ('SUPERFICIAL_RELATIONSHIP', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190)]	4	[('GO_0007567', 'parturition', 100, 'breast'), ('UBERON_0000310', 'breast', 100, 'breast'), ('GO_0007631', 'feeding behavior', 107, 'fed'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_43141', '3-hydroxypropoxy group', 149, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 170, '25-OHD')]
PMC4997567	8/2016	S93-PMC4997567	['(1992) [20] who OBSERVED that the Breast- Fed infant with insufficiency Intake of Vitamin D supplement are susceptible to nutritional rickets.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('UBERON_0000310', 'breast', 34, 'breast'), ('GO_0007631', 'feeding behavior', 42, 'fed'), ('GO_0007631', 'feeding behavior', 72, 'intake'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC5000726	8/2016	S232-PMC5000726	['low maternal Calcium and Vitamin D intake during late Pregnancy HAS BEEN ASSOCIATED with reduced bone Mineral content.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 13, 'calcium'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('CHEBI_46662', 'mineral', 102, 'mineral')]
PMC5014971	8/2016	S4-PMC5014971	['a majority INDICATED that Vitamin D insufficiency was a PROBLEM in their patient population (68.4%) and that most of their Pregnant patients would BENEFIT from vitamin D supplementation (66.3%).']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 56), ('PROBLEM_COMPLICATION', 56), ('IMPORTANT_CONSIDERATION', 147)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnant'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 168, 'D')]
PMC5014971	8/2016	S6-PMC5014971	['ONLY one in four (25.8%) routinely screen their Pregnant patients for Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('GO_0007565', 'female pregnancy', 48, 'pregnant'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5014971	8/2016	S10-PMC5014971	['introduction\nit is ONLY relatively recently in Human history that Vitamin D became a REQUIRED Nutrient.']	[('INCOMPLETE_EVIDENCE', 19), ('IMPORTANT_CONSIDERATION', 85)]	2	[('NCBITaxon_9606', 'Homo sapiens', 47, 'human'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_33284', 'nutrient', 94, 'nutrient')]
PMC5014971	8/2016	S19-PMC5014971	['as many as 30% of Pregnant women in the us MAY have INADEQUATE Vitamin D status [12].']	[('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 52)]	2	[('GO_0007565', 'female pregnancy', 18, 'pregnant'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5014971	8/2016	S20-PMC5014971	['in SOME populations, especially during the winter months in higher latitudes, the proportion of Pregnant women with INADEQUATE Vitamin D status MAY exceed 50% [13], DEPENDING ON whose definition of INADEQUATE is used.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 116), ('INCOMPLETE_EVIDENCE', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('PROBLEM_COMPLICATION', 198)]	5	[('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC5014971	8/2016	S21-PMC5014971	['there is SOME uncertainty over the extent of the us population that has INADEQUATE Vitamin D status DUE TO DISAGREEMENTS between experts as to WHAT constitutes INADEQUATE status.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 72), ('PROBLEM_COMPLICATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('EXPLICIT_QUESTION', 143), ('IMPORTANT_CONSIDERATION', 160)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5014971	8/2016	S24-PMC5014971	['other researchers have QUESTIONED this FINDING, citing both a CONCERN that circulating levels of 25-Oh-D at 20\u2009ng/ml have not been shown to be sufficient for bone health for all populations and that OTHER nonskeletal functions of Vitamin D POTENTIALLY IMPORTANT for health, which the iom report DISCOUNTS BASED ON INADEQUATE evidence, MAY yet be shown to be IMPORTANT and REQUIRE higher circulating levels of 25-Oh-D [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 199), ('INCOMPLETE_EVIDENCE', 240), ('IMPORTANT_CONSIDERATION', 252), ('INCOMPLETE_EVIDENCE', 295), ('PROBABLE_UNDERSTANDING', 305), ('ANOMALY_CURIOUS_FINDING', 311), ('IMPORTANT_CONSIDERATION', 314), ('PROBLEM_COMPLICATION', 314), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 358), ('IMPORTANT_CONSIDERATION', 372)]	15	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 97, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 409, '25-OH-D')]
PMC5014971	8/2016	S26-PMC5014971	['the two groups also RECOMMEND DIFFERENT levels of Vitamin D supplementation, IN LARGE PART DUE TO the DIFFERENT stable levels of circulating 25-Oh-D they are attempting to obtain.']	[('FUTURE_WORK', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 141, '25-OH-D')]
PMC5014971	8/2016	S29-PMC5014971	['OBSERVATIONAL studies have CONSISTENTLY FOUND an ASSOCIATION with low maternal Vitamin D status and INCREASED risk of neonatal infectious disease and later inflammatory and atopic disease in offspring [21].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 27), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 100)]	5	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5014971	8/2016	S30-PMC5014971	['in vitro studies HAVE SHOWN that 1,25-Dihydroxyvitamin D downregulates Gene Expression of inflammatory markers and Contractile associated proteins in Human Myometrial Cells [23,24], providing a biologically PLAUSIBLE mechanism for Vitamin D action in reducing inflammatory and contractile responses due to infection.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 207)]	2	[('CHEBI_67472', '15-epi-lupulin B', 33, '1,25-dihydroxyvitamin D'), ('GO_0010467', 'gene expression', 71, 'gene expression'), ('SO_0000704', 'gene', 71, 'gene'), ('GO_0006936', 'muscle contraction', 115, 'contractile'), ('NCBITaxon_9606', 'Homo sapiens', 150, 'human'), ('CL_0002366', 'myometrial cell', 156, 'myometrial cells'), ('UBERON_0001697', 'orbit of skull', 156, 'myometrial'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
PMC5014971	8/2016	S33-PMC5014971	['Vitamin D supplementation during Pregnancy is GENERALLY CONSIDERED SAFE, THOUGH rigorous studies on high doses of Vitamin D supplementation are LACKING [25].']	[('PROBABLE_UNDERSTANDING', 46), ('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 67), ('ANOMALY_CURIOUS_FINDING', 73), ('INCOMPLETE_EVIDENCE', 144)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5014971	8/2016	S34-PMC5014971	['results from a RECENT STUDY INDICATE that Vitamin D supplementation during Pregnancy with up to 4,000\u2009iu/day is SAFE and EFFECTIVE [26].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 112), ('SUPERFICIAL_RELATIONSHIP', 121)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy')]
PMC5014971	8/2016	S69-PMC5014971	['respondents were CONCERNED about Vitamin D deficiency and osteoporosis (91.1%) and bone fractures (88.1%), but less CONCERNED about other POSSIBLE sequelae of Vitamin D deficiency such as a weakened Immune System (32.7%), Colon cancer (27.7%), Cardiovascular disease (23.8%), impaired glucose Metabolism (22.8%), vulnerability to preeclampsia (22.8%), increased risk of small-for-Gestational-age infant (21.8%), vulnerability to Preterm Labor (19.8%), Breast cancer (14.9%), hypertension (12.9%), and infertility (10.9%).']	[('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 116), ('INCOMPLETE_EVIDENCE', 138)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('UBERON_0002405', 'immune system', 199, 'immune system'), ('UBERON_0001155', 'colon', 222, 'colon'), ('UBERON_0004535', 'cardiovascular system', 244, 'cardiovascular'), ('GO_0008152', 'metabolic process', 293, 'metabolism'), ('GO_0007565', 'female pregnancy', 380, 'gestational'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 429, 'preterm labor'), ('UBERON_0000310', 'breast', 452, 'breast')]
PMC5014971	8/2016	S94-PMC5014971	['discussion\nthe results of THIS STUDY SUGGEST that practicing obstetrician-gynecologists GENERALLY are SOMEWHAT CONCERNED about the Vitamin D status of their Pregnant patients and consider Vitamin D supplementation during Pregnancy to be SAFE.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 102), ('IMPORTANT_CONSIDERATION', 111), ('IMPORTANT_CONSIDERATION', 237)]	6	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnant'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy')]
PMC5014971	8/2016	S98-PMC5014971	['there was a LACK OF CONSENSUS regarding the APPROPRIATE level of Vitamin D supplementation during Pregnancy and the value of circulating 25-Hydroxyvitamin D, below which there is CONCERN regarding Vitamin D insufficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 44), ('IMPORTANT_CONSIDERATION', 179), ('PROBLEM_COMPLICATION', 179)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 137, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC5014971	8/2016	S102-PMC5014971	['in SUPPORT of the endocrine society RECOMMENDATIONS, SOME researchers POINT to the LIKELY higher circulating levels of 25-Oh-D in our ancestors that relied PRIMARILY on Photosynthetic Production Of Vitamin D, arguing that our Vitamin D Metabolism is adapted to high endogenous production [17,18].']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 36), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 83), ('PROBABLE_UNDERSTANDING', 156)]	6	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 119, '25-OH-D'), ('GO_0010264', 'myo-inositol hexakisphosphate biosynthetic process', 169, 'photosynthetic'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 184, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0007601', 'visual perception', 226, 'vitamin D'), ('GO_0008152', 'metabolic process', 236, 'metabolism')]
PMC5014971	8/2016	S105-PMC5014971	['there is also a direct ASSOCIATION between circulating 25-Oh-D and 1,25-Oh2-D, which is not the case outside of Pregnancy, SUGGESTING both higher substrate (25-Oh-D) turnover and a greater EFFECT of 25-Oh-D levels on Vitamin D actions on physiology and Metabolism [2].']	[('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 189)]	3	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 55, '25-OH-D'), ('CHEBI_78731', '9(R)-HPETE', 69, '25-OH2-D'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 157, '25-OH-D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 199, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0008152', 'metabolic process', 253, 'metabolism')]
PMC5014971	8/2016	S108-PMC5014971	['EVEN researchers SKEPTICAL of the causality of Vitamin D EFFECTS on Pregnancy outcomes POINT to a knowledge deficit that NEEDS ADDRESSING, ESPECIALLY in areas such as maternal and neonatal infections (e.g., [21]).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 87), ('FUTURE_WORK', 121), ('IMPORTANT_CONSIDERATION', 121), ('FUTURE_WORK', 127), ('IMPORTANT_CONSIDERATION', 139)]	8	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC5014971	8/2016	S110-PMC5014971	['on a CAUTIONARY NOTE, the EVIDENCE for positive BENEFITS of circulating levels of 25-Oh-D and Vitamin D supplementation above those from iom can hardly be called definitive.']	[('IMPORTANT_CONSIDERATION', 5), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 48)]	4	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 82, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5014971	8/2016	S111-PMC5014971	['a RECENT STUDY on a mother-offspring cohort in singapore FOUND NO EVIDENCE for an effect of Vitamin D status on Birth outcome, THOUGH the authors CAUTION that the population had a low prevalence of Vitamin D deficiency/insufficiency and THUS they MAY NOT HAVE BEEN able to detect small EFFECTS [29].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('INCOMPLETE_EVIDENCE', 146), ('PROBABLE_UNDERSTANDING', 237), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 286)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007567', 'parturition', 112, 'birth'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC5014971	8/2016	S123-PMC5014971	['the majority of respondents would consider screening for specific patient conditions (e.g., Gastric bypass surgery); a lesser proportion would consider screening BECAUSE of obesity or for african american women DESPITE both of these patient characteristics being KNOWN RISK FACTORS for INADEQUATE Vitamin D status.']	[('PROBLEM_COMPLICATION', 162), ('ANOMALY_CURIOUS_FINDING', 211), ('INCOMPLETE_EVIDENCE', 263), ('SUPERFICIAL_RELATIONSHIP', 269), ('IMPORTANT_CONSIDERATION', 286)]	5	[('UBERON_0001844', 'cochlea', 92, 'gastric'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
PMC5017622	9/2016	S25-PMC5017622	['women of Reproductive age, ESPECIALLY Pregnant women, in low and middle income countries are AT RISK of several Micronutrient deficiencies, such as Iron, Folic Acid, Iodine, zinc, Vitamins A and d, riboflavin, b6 and b12, which COULD adversely AFFECT the mother and Pregnancy outcome [13,14,15].']	[('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 93), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 244)]	4	[('GO_0000003', 'reproduction', 9, 'reproductive'), ('GO_0007565', 'female pregnancy', 38, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 112, 'micronutrient'), ('CHEBI_24870', 'ion', 148, 'iron'), ('CHEBI_30751', 'formic acid', 154, 'folic acid'), ('CHEBI_24859', 'iodine atom', 166, 'iodine'), ('CHEBI_27300', 'vitamin D', 180, 'vitamins A'), ('GO_0007565', 'female pregnancy', 266, 'pregnancy')]
PMC5024431	9/2016	S105-PMC5024431	['Eating Out less/Eat at home morei want to only dine out for 1 meal a weekeat more at home\u2003evening/night time Eating (e.g., healthier and/or restricting)no Eating after 8:00pmlimit snacks at night\u2003follow\xa0canada’s Food guidefollow canada’s Food guide\u2003follow \ufeffvegetarian/vegan dietseat mostly vegan\u2003follow\xa0fad diets (not gluten free)more alkaline and less Acidic Foods\u2003gluten free (includes wheat free)follow celiac diet\u2003follow\xa0other plans (includes fodmap guidelines, Heart healthy, diabetes, optifast®, weight watchers®, dash, dietitian meal plans, weight lifting, Pregnancy diet, unspecified diet plans)following the dietitian’s plan, eat only my shakes this week, follow diet, follow diabetes diet\u2003glycemic indexkeep a low glycemic index diet\u2003clean Eating (includes unprocessed, whole, fresh, raw, natural foods)Eating cleaner, eat as much raw as possible, to eat fresh Food\u2003supplementstake 600-800 iu Vitamin D daily\u2003planning and preparing Food†cook dinner from scratch a minimum of 3 times per week, plan 4–5 smaller meals per daybetter Planning and Preparing Of Food, plan healthy meals, plan meals\u2003goals describing when Food is Eaten or not Eaten/Eating patternseat breakfast, Lunch, dinner & snack every day, not to eat in between mealseat more regularly, try not to snack so much throughout the day\u2003breakfasteating healthy breakfastincorporate cereal or smoothies more often for breakfast\u2003psychological aspects of Eatingdon’t binge, drink Water or 0 cal drink when hungry, stop emotional eatingto Control Food Intake, respect Food AS a means of nutrition and to satisfy hunger\u2003general Eating improvementseat healthy meals and snacks, eat the RECOMMENDED dv of Minerals and Vitamins, eat a variety of foodseat healthy, eat a balanced diet, eat right to avoid ibs symptoms\noverall, there were n\u2009= \u20091,986, n\u2009= \u2009614, n\u2009= \u2009233, and n\u2009= \u20091,134 daily, weekly, monthly, and one-time write your own goal statements, respectively (excluding irrelevant to health/Nonsense goals); these goals were RARELY tracked.']	[('PROBABLE_UNDERSTANDING', 1538), ('FUTURE_WORK', 1649), ('INCOMPLETE_EVIDENCE', 1993)]	3	[('GO_0006897', 'endocytosis', 0, 'Eating out'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 16, 'Eat'), ('GO_0051318', 'G1 phase', 109, 'eating'), ('GO_0051318', 'G1 phase', 155, 'eating'), ('CHEBI_33290', 'food', 212, 'Food'), ('CHEBI_33290', 'food', 238, 'food'), ('CHEBI_37527', 'acid', 353, 'acidic'), ('CHEBI_33290', 'food', 360, 'foods'), ('UBERON_0000948', 'heart', 466, 'heart'), ('GO_0007565', 'female pregnancy', 564, 'pregnancy'), ('GO_0051318', 'G1 phase', 750, 'eating'), ('GO_0007568', 'aging', 813, 'Eating'), ('CHEBI_33290', 'food', 871, 'food'), ('CHEBI_27300', 'vitamin D', 903, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 911, 'D'), ('CHEBI_33290', 'food', 942, 'food'), ('GO_0006260', 'DNA replication', 1040, 'planning'), ('GO_0007565', 'female pregnancy', 1053, 'preparing of food'), ('CHEBI_33290', 'food', 1066, 'food'), ('CHEBI_33290', 'food', 1125, 'food'), ('GO_0036268', 'swimming', 1133, 'eaten'), ('GO_0036268', 'swimming', 1146, 'eaten'), ('GO_0051318', 'G1 phase', 1152, 'eating'), ('UBERON_0010164', 'collection of hairs', 1182, 'Lunch'), ('GO_0050957', 'equilibrioception', 1421, 'eatingDon'), ('CHEBI_15377', 'water', 1446, 'water'), ('GO_0065007', 'biological regulation', 1504, 'control'), ('CHEBI_33290', 'food', 1512, 'food'), ('GO_0007631', 'feeding behavior', 1512, 'food intake'), ('CHEBI_33290', 'food', 1533, 'food'), ('GO_0051318', 'G1 phase', 1592, 'eating'), ('CHEBI_46751', 'quinolizidine', 1667, 'minerals'), ('CHEBI_33277', 'gamma-tocotrienol', 1680, 'vitamins'), ('GO_0001967', 'suckling behavior', 1959, 'nonsense')]
PMC5024513	9/2016	S36-PMC5024513	['HOWEVER the author CONCLUDED that there was SOME consensus in the AVAILABLE LITERATURE that Pregnant adolescents had intakes of energy, iron, Folate, Calcium, Vitamin E and magnesium which were below the dietary RECOMMENDED intakes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 66), ('FUTURE_WORK', 212)]	5	[('GO_0007565', 'female pregnancy', 92, 'pregnant'), ('CHEBI_30863', '5-azaorotic acid', 142, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 150, 'calcium'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin E')]
PMC5024513	9/2016	S71-PMC5024513	['caption (table-wrap): table 2\n\ncharacteristics of included studiesstudy informationparticipantssupplementsmeasurementqualitystudycountrystudy designstudy groupsnumberageinclusion criteriaexclusion criteriasupplement type and dosenumber with available dataestimated compliance: n (%)data collection method (s)time period(s)quality ratingbaker et.al (2009) [23]ukcross-sectional studyna50014–18singleton Pregnancy, age 14–18, Gestational age\u2009<\u2009=20\xa0weeksinability to provide informed consent, preeclampsia, Clotting disorders, hiv/aids, haemoglobinopathies, diabetes, Renal disease, hypertension, multiple Gestations, history of 3=\u2009>\u2009previous Miscarriagespreconception folic acid49834 (6.9)24\xa0h recall (multiple)third Trimester+Folic Acid in early pregnancy498220 (44.2)Iron in early pregnancy49839 (7.8)multivitamins in early pregnancy49819 (3.8)Folic Acid only in 3rd trimester2905 (1.7)Iron and Folic Acid in 3rd trimester29013 (4.5)Iron only in 3rd trimester29042 (14.5)multivitamins in 3rd trimester2907 (2.4)castillo-duran et.al (2001) [43]chilerctzinc supplemented24916.4 (mean)beginning Prenatal visits before 20\xa0weeks Gestation, aged <19 at estimated due dateadolescents whose background included chronic diseases, Drug abuse, mental retardation, illiteracy or Pregnancy due to incest or rape20\xa0mg Zinc Sulphate dailyintervention group - 249at least 50\xa0% compliance24\xa0h Recall (multiple)second and third Trimester+placebo25840\xa0mg Iron Sulphateall participants - 507chan et.al (2006) [24]usarctcontrol group, 2 intervention groups excluded from review*2315–17enrolled before 20\xa0weeks Gestationhypertension, diabetes, Renal or Liver disease, alcohol or tobacco use, using medicines effecting Ca Metabolismno additional supplements reportedfood diary (weighing not mentioned)second and third Trimester−/+chang et.al (2003) [37]usaretrospective chart reviewna91812–17self-reported racial group as african-american; singleton Pregnancybirth results not AVAILABLE DUE TO abortion, Miscarriage or transfer of care90\xa0mg Carbonyl Iron daily plus additional up to 120\xa0mg for those classified as anaemic918not reportednot reportedsecond and third Trimester+dawson et.al (2000) [35]usarctone-a-day without iron2016–20aged 16–20, less than 16\xa0weeks Gestation, no Iron supplementation for previous 30\xa0dayshypertension; diabetes; other medical problems; haemoglobin <11\xa0g/dl; haematocrit <30\xa0%vitamin a 5000\xa0iu, Vitamin D 400\xa0iu, Vitamin E 10\xa0mg, Vitamin C 60\xa0mg, Folic Acid 0.4\xa0mg, Thiamine 1.5\xa0mg, riboflavin 1.7\xa0mg, niacin 20\xa0mg, Pyridoxine 2\xa0mg, Vitamin B- 6\xa0mg, Pantothenic Acid 10\xa0mg20not reportedvenous Blood samplesecond and third Trimester and Delivery−/+one-a-day with iron2018\xa0mg iron, vitamin a 5000\xa0iu, Vitamin D 400\xa0iu, Vitamin E 10\xa0mg, Vitamin C 60\xa0mg, Folic Acid 0.4\xa0mg, Thiamine 1.5\xa0mg, riboflavin 1.7\xa0mg, Niacin 20\xa0mg, Pyridoxine 2\xa0mg, Vitamin B- 6\xa0mg, pantothenic Acid 10\xa0mg20derbyshire (2009) [39]ukcross-sectional studyna2015–19attending Antenatal classes or community clinicsincomplete diarynone reportedfood diary unweighedthird Trimester+gadowsky et.al (1995) [42]canadacross-sectional studyna5814–19not reportednot reportedfolic Acid mean 479\xa0μg/day5882\xa0%Venous Blood samplethird trimester+Elemental Iron mean 31.5\xa0mg/daycyanocobalamin (B12) mean 2.24\xa0μg/dgiddens et.al (2000) [27]usarct (subset from a larger study)na5913–18singleton Pregnancies, between 13 and 19\xa0weeks Gestationnot REPORTEDREPORTED that any contribution from Supplements was not included in analysisfood diary weighedmean over Pregnancy−/+ginde et.al (2010) [32]usasecondary analysis of cross sectional surveyna8413–19not reportednot reportedsome participants taking Vitamin D Supplementsnot reportednot reportedvenous Blood samplemean over Pregnancy+gutierrez et.al (1999) [28]usacross-sectional studyna4613–18self-identified ethnicity as mexican american, primigravida, 13–18 years of agehistory of Miscarriage or health problems, involved in competitive athletic performances or heavy exercise, planned to move away during study periodnone reported24\xa0h recall (single)second and third Trimester+iannotti et.al (2005) [36]usacross-sectional studyna8013–18self-reported racial group as african-american; singleton Pregnancynot reportednone reported10\xa0ml Venous Blood samplesecond and third trimesters+job et.al (1995) [41]australiacross-sectional studyna3513–19not reportednot reportednone REPORTED24\xa0h recallmean over Pregnancy+lee et.al (2013) [25]usacross-sectional studyna15613–18age 18 or under, carrying a single fetus, 12–30 weeks Gestation at recruitmentnot REPORTEDREPORTED that any CONTRIBUTION from Supplements was not included in analysis24\xa0h recall (multiple)<23\xa0weeks Gestation, 23–30 weeks Gestation and mean over Pregnancy+mcguire et.al.']	[('INCOMPLETE_EVIDENCE', 1954), ('PROBLEM_COMPLICATION', 1964), ('INCOMPLETE_EVIDENCE', 3401), ('INCOMPLETE_EVIDENCE', 4377), ('INCOMPLETE_EVIDENCE', 4553), ('SUPERFICIAL_RELATIONSHIP', 4579)]	6	[('GO_0007565', 'female pregnancy', 402, 'pregnancy'), ('GO_0007565', 'female pregnancy', 424, 'gestational'), ('GO_0050817', 'coagulation', 504, 'clotting'), ('UBERON_0002113', 'kidney', 565, 'renal'), ('GO_0007565', 'female pregnancy', 603, 'gestations'), ('GO_0050788', 'sequestering of mercury', 640, 'miscarriagesPreconception'), ('GO_0009294', 'DNA mediated transformation', 715, 'trimester'), ('CHEBI_30751', 'formic acid', 725, 'Folic acid'), ('CHEBI_24870', 'ion', 767, 'Iron'), ('CHEBI_30751', 'formic acid', 844, 'Folic acid'), ('CHEBI_24870', 'ion', 886, 'Iron'), ('CHEBI_30751', 'formic acid', 895, 'folic acid'), ('CHEBI_24870', 'ion', 933, 'Iron'), ('GO_0007565', 'female pregnancy', 1092, 'prenatal'), ('GO_0007565', 'female pregnancy', 1124, 'gestation'), ('CHEBI_23888', 'drug', 1221, 'drug'), ('GO_0007565', 'female pregnancy', 1267, 'pregnancy'), ('CHEBI_10127', 'zonisamide', 1304, 'Zinc sulphate'), ('GO_0060033', 'anatomical structure regression', 1376, 'recall'), ('GO_0009294', 'DNA mediated transformation', 1410, 'trimester'), ('CHEBI_83530', 'atenolol-desisopropyl', 1436, 'iron sulphateAll'), ('GO_0051866', 'general adaptation syndrome', 1589, 'gestationHypertension'), ('UBERON_0002113', 'kidney', 1622, 'renal'), ('UBERON_0002107', 'liver', 1631, 'liver'), ('CHEBI_32588', 'potassium chloride', 1696, 'Ca'), ('GO_0008152', 'metabolic process', 1699, 'metabolismNo'), ('GO_0009294', 'DNA mediated transformation', 1795, 'trimester'), ('GO_0007605', 'sensory perception of sound', 1927, 'pregnancyBirth'), ('GO_0046660', 'female sex differentiation', 1981, 'miscarriage'), ('CHEBI_30255', 'sulfidocarbonate(.1-)', 2018, 'carbonyl iron'), ('GO_0009294', 'DNA mediated transformation', 2142, 'trimester'), ('GO_0007565', 'female pregnancy', 2242, 'gestation'), ('CHEBI_24870', 'ion', 2256, 'iron'), ('CHEBI_27300', 'vitamin D', 2403, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2421, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 2438, 'vitamin C'), ('CHEBI_30751', 'formic acid', 2455, 'folic acid'), ('CHEBI_26948', 'vitamin B1', 2474, 'thiamine'), ('CHEBI_16410', 'pyridoxamine', 2524, 'pyridoxine'), ('CHEBI_27300', 'vitamin D', 2541, 'vitamin B'), ('CHEBI_7916', 'pantothenic acid', 2558, 'pantothenic acid'), ('UBERON_0000178', 'blood', 2601, 'blood'), ('GO_0009294', 'DNA mediated transformation', 2630, 'trimester'), ('GO_0007567', 'parturition', 2644, 'delivery'), ('CHEBI_27300', 'vitamin D', 2707, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2725, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 2742, 'vitamin C'), ('CHEBI_30751', 'formic acid', 2759, 'folic acid'), ('CHEBI_26948', 'vitamin B1', 2778, 'thiamine'), ('CHEBI_7542', 'neurotensin', 2814, 'niacin'), ('CHEBI_16410', 'pyridoxamine', 2828, 'pyridoxine'), ('CHEBI_27300', 'vitamin D', 2845, 'vitamin B'), ('CHEBI_37527', 'acid', 2874, 'acid'), ('GO_0007567', 'parturition', 2950, 'antenatal'), ('GO_0009294', 'DNA mediated transformation', 3043, 'trimester'), ('CHEBI_37527', 'acid', 3145, 'Acid'), ('UBERON_0001638', 'vein', 3171, 'Venous'), ('UBERON_0000178', 'blood', 3178, 'blood'), ('CHEBI_4779', 'emedastine', 3206, 'Elemental'), ('CHEBI_24870', 'ion', 3216, 'Iron'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 3253, 'B12'), ('GO_0007565', 'female pregnancy', 3351, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3388, 'gestationNot'), ('CHEBI_33341', 'titanium atom', 3445, 'supplements'), ('GO_0007565', 'female pregnancy', 3513, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 3653, 'vitamin D'), ('CHEBI_46978', 'thiazinemonocarboxylic acid', 3663, 'supplementsNot'), ('UBERON_0000178', 'blood', 3705, 'blood'), ('GO_0007565', 'female pregnancy', 3727, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3887, 'miscarriage'), ('GO_0009294', 'DNA mediated transformation', 4074, 'trimester'), ('GO_0006915', 'apoptotic process', 4201, 'pregnancyNot'), ('UBERON_0001638', 'vein', 4241, 'Venous'), ('UBERON_0000178', 'blood', 4248, 'blood'), ('GO_0007565', 'female pregnancy', 4406, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4525, 'gestation'), ('CHEBI_33341', 'titanium atom', 4597, 'supplements'), ('GO_0007565', 'female pregnancy', 4669, 'gestation'), ('GO_0007565', 'female pregnancy', 4692, 'gestation'), ('GO_0007565', 'female pregnancy', 4716, 'pregnancy')]
PMC5024513	9/2016	S104-PMC5024513	['caption (table-wrap): table 5\n\nintake of Micronutrients in individual studies compared to uk and us dietary reference values - mineralscomparison to uk dietary reference valuecomparison to us dietary reference valuenutrientstudysecond trimesterthird trimestermean over Pregnancysecond trimesterthird trimestermean over Pregnancy n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence intervalcalcium mg/dayabaker (2009)290↔840800, 880290↓840800, 880chan (2006)23↔835711, 95923↔862714, 101023↓835711, 95924↓862714, 1010derbyshire (2009)20↑1007867, 114720↓1007867, 1147giddens (2000)59↑989904, 107459↓989904, 1074gutierrez (1999)46↑15611334, 178946↑16551424, 188646↑15611334, 178946↑16551424, 1886job (1995)70↔923756, 109070↓923756, 1090lee (2013)133↑916838, 995156↑886824, 948133↓916838, 995156↓886824, 948pobocik (2003)434↓743689, 797434↓743689, 797phosphorous mg/daybchan (2006)23↑934811, 105723↑961812, 111023↓934811, 105724↓961812, 1110giddens (2000)59↑13401248, 143259↔13401248, 1432lee (2013)133↑12641182, 1347156↑11961131, 1261133↔12641182, 1347156↔11961131, 1261pobocik (2003)434↑13381279, 1397434↑13381279, 1397iron mg/daycbaker (2009)290↑1715, 19290↓1715, 19castillo-duran (2001) a249↑15.515, 16249↑16.816, 17249↓15.515, 16249↓16.816, 17castillo-duran (2001) b258↑16.616, 17258↑16.816, 17258↓16.616, 17258↓16.816, 17chan (2006)23↑2218, 2623↑2520, 3023↓2218, 2623↔2520, 30derbyshire (2009)20↓12.611, 1420↔12.611, 14giddens (2000)59↔1615, 1759↓1615, 17gutierrez (1999)46↑17.715, 2046↑22.717, 2846↓17.715, 2046↔22.717, 28job (1995)70↓11.210, 1270↓11.210, 12lee (2013)133↑18.817, 20156↑18.617, 20133↓18.817, 20156↓18.617, 20pobocik (2003)434↑2019, 21434↓2019, 21magnesium mg/daydbaker (2009)290↓236227, 245↓236227, 245chan (2006)23↓263230, 29623↓264231, 297↓263230, 296↓264231, 297derbyshire (2009)20↓244218, 270↓244218, 270giddens (2000)59↓252234, 270↓252234, 270lee (2013)133↓237222, 253156↓231218, 244↓237222, 253↓231218, 244pobocik (2003)434↓270258, 282↓270258, 282potassium mg/dayechan (2006)23↓28022512, 309223↓29542635, 327323↓28022512, 309223↓29542635, 3273derbyshire (2009)20↓29482659, 323720↓29482659, 3237zinc mg/dayfbaker (2009)290↑8.17.8, 8.4290↓8.17.8, 8.4castillo-duran (2001) a249↑7.47.1, 7.7249↑7.77.4, 8249↓7.47.1, 7.7249↓7.77.4, 8castillo-duran (2001) b258↑7.47.1, 7.7258↑7.47.2, 7.6258↓7.47.1, 7.7258↓7.47.2, 7.6chan (2006)23↑1611.9, 20.123↑1813.5, 22.523↔1611.9, 20.123↑1813.5, 22.5derbyshire (2009)20↑8.17.4, 8.9207.4, 8.9giddens (2000)59↑11.610.5, 12.759↑11.610.5, 12.7gutierrez (1999)46↑14.512.6, 16.446↑15.313.4, 17.246↑14.512.6, 16.446↑15.313.4, 17.2job (1995)70↑9.58.5, 10.570↑9.58.5, 10.5lee (2013)133↑12.8156↑12.611.4, 13.8133↑12.8156↑12.611.4, 13.8pobocik (2003)434↑1312.2, 13.8434↑1312.2, 13.8sodium mg/daygchan (2006)23↑33162809, 382323↑33232812, 3834↑33162809, 3823↑33232812, 3834derbyshire (2009)20↑30892722, 3456↑30892722, 3456copper μg/dayhgiddens (2000)59↑12001098, 130259↑12001098, 1302lee (2013)133↑11001015, 1185156↑10851021, 1151133↑11001015, 1185156↑10851021, 1151selenium μg/dayigiddens (2000)59↑116109, 12359↑116109, 123\nacomparison to uk Rni 800\xa0mg/day and us rda 1300\xa0mg/day,bcomparison to uk Rni 625\xa0mg/day and us rda 1250\xa0mg/day,ccomparison to uk rni 14.8\xa0mg/day and us rda 27\xa0mg/day,dcomparison to uk rni 300\xa0mg/day and us rda 400\xa0mg/day,ecomparison to uk rni 3500\xa0mg/day and us rda 4700\xa0mg/day,fcomparison to uk rni 7\xa0mg/day and us rda 12\xa0mg/day,gcomparison to uk Rni 1500\xa0mg/day and us rda 1600\xa0mg/day,hcomparison to uk Rni 1000\xa0μg/day and us Rda 1000\xa0μg/day,icomparison to uk rni 60\xa0μg/day and us rda 60\xa0μg/day, ↑ study mean higher than reference value ( p \u2009<\u20090.05), ↔ study mean not different to reference value ( p \u2009<\u20090.05), ↓ study mean lower than reference value ( p \u2009<\u20090.05)\n\ncaption (table-wrap): table 6\n\nintake of Micronutrients in individual studies compared to uk and us dietary reference values - Vitaminscomparison to uk dietary reference valuecomparison to us dietary reference valuenutrientstudysecond trimesterthird trimestermean over Pregnancysecond trimesterthird trimestermean over Pregnancy n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence intervalvitamin d μg/dayabaker (2009)290↓2.12, 2.3290↓2.12, 2.3chan (2006)23↓2.81.9, 3.723↓3.12.2, 423↓2.81.9, 3.723↓3.12.2, 4derbyshire (2009)20↓2.01.5, 2.620↓2.01.5, 2.6giddens (2000)59↓6.45.7, 7.159↓6.45.7, 7.1lee (2013)133↓5.44.7, 6.1156↓5.14.6, 5.6133↓5.44.7, 6.1156↓5.14.6, 5.6vitamin ebbaker (2009)290↓8.98.3, 9.5derbyshire (2009)20↓7.76.5, 8.9gutierrez (1999)46↓10.710.746↓11.28.2, 14.1lee (2013)133↓6.96.2, 7.6156↓6.96.4, 7.4pobocik (2003)434↓87.2, 8.8vitamin ccbaker (2009)290↑160146, 174290↑160146, 174derbyshire (2009)20↑138111, 16520↑138111, 165giddens (2000)59↑128112, 14459↑128112, 144gutierrez (1999)46↑252208, 29646↑231190, 27146↑252208, 29646↑231190, 271job (1995)70↑13592, 17870↑13592, 178lee (2013)133↑9781, 113156↑10694, 118133↑9781, 113156↑10694, 118pobocik (2003)434↑167150, 184434↑167150, 184folatedbaker (2009)290↔285269, 301290↓285269, 301derbyshire (2009)20↓227205, 24920↓227205, 249giddens (2000)59↔312277, 34759↓312277, 347gutierrez (1999)46↑447355, 54046↑393340, 44546↓447355, 54046↓393340, 445lee (2013)133↑829723, 935156↑849645, 1053133↑829723, 935156↑849645, 1053pobocik (2003)434↔292269, 315434↓292269, 315riboflavinechan (2006)23↑2.31.8, 2.823↑2.42, 2.823↑2.31.8, 2.823↑2.42, 2.8giddens (2000)59↑2.359↑2.32.1, 2.5lee (2013)133↑2.52.3, 2.7156↑2.4133↑2.52.3, 2.7156↑2.42.2, 2.6pobocik (2003)434↑2.1434↑2.12, 2.2b12fbaker (2009)290↑5.34.7, 5.9290↑5.34.7, 5.9chan (2006)23↑53.8, 6.223↑5.23.7, 6.723↑53.8, 6.223↑5.23.7, 6.7giddens (2000)59↑5.34.6, 659↑5.34.6, 6lee (2013)133↑5.65, 6.2156↑5.55, 6133↑5.65, 6.2156↑5.55, 6pobocik (2003)434↑5.54.8, 6.2434↑5.54.8, 6.2thiamingbaker (2009)290↑1.61.5, 1.7290↑1.61.5, 1.7giddens (2000)59↑2.11.9, 2.359↑2.11.9, 2.3lee (2013)133↑2.11.9, 2.3156↑2.11.9, 2.3133↑2.11.9, 2.3156↑2.11.9, 2.3pobocik (2003)4342.42.3, 2.54342.42.3, 2.5niacinhbaker (2009)290↑3332, 35290↑3432, 35giddens (2000)59↑2422, 2659↑2422, 26lee (2013)133↑2826, 30156↑2624, 27133↑2826, 30156↑2624, 27pobocik (2003)434↑3029, 31434↑3029, 31b6ibaker (2009)290↑2.32.1, 2.4290↑2.32.1, 2.4giddens (2000)59↑1.91.7, 2.159↑1.91.7, 2.1lee (2013)133↑2.22, 2.4156↑2.11.9, 2.3133↑2.22, 2.4156↑2.11.9, 2.3pobocik (2003)434↑21.9, 2.1434↑21.9, 2.1vitamin ajbaker (2009)290↑759651, 867290↑759651, 867derbyshire (2009)20↑555439, 67120↓555439, 671giddens (2000)↑10559↑1053907, 1199↑105359↑1053907, 1199gutierrez (1999)46↑24921466, 351846↑1971432, 252346↑24921466, 351846↑19781432, 2523job (1995)70↑973802, 114470↑973802, 1144lee (2013)133↑698614, 783156↑666615, 717133↑698614, 783156↓666615, 717pobocik (2003)434↑109944, 1242434↑1093944, 1242vitamin kklee (2013)133↔7057, 83156↔7059, 81\nacomparison to uk Rni 10\xa0μg/day and us rda 15\xa0μg/day,bcomparison to us rda 15\xa0mg/day,ccomparison to uk Rni 40\xa0mg/day and us rda 80\xa0mg/day,dcomparison to uk rni 200\xa0μg/day and us rda 600\xa0μg/day,ecomparison to uk rni 1.1\xa0mg/day and us rda 1.4\xa0mg/day,fcomparison to uk rni 1.5\xa0μg/day and us rda 2.6\xa0μg/day,gcomparison to uk rni 0.8\xa0mg/day and us rda 1.4\xa0mg/day,hcomparison to uk rni 14\xa0mg/day and us rda 18\xa0mg/day,icomparison to uk rni 1.2\xa0mg/day and us rda 1.9\xa0mg/day,jcomparison to uk rni 600\xa0μg/day and us rda 750\xa0μg/day,kcomparison to us ai 75\xa0μg/day, ↑ study mean higher than reference value ( p \u2009<\u20090.05), ↔ study mean not different to reference value ( p \u2009<\u20090.05), ↓ study mean lower than reference value ( p \u2009<\u20090.05)\nthe individual study results SHOW that the MAJORITY of reported Nutrient Intakes were significantly below both the uk rni and us rda for Vitamin D, potassium and magnesium and below the us rda for Calcium, Vitamin E, Folate, Phosphorous and iron.']	[('INCOMPLETE_EVIDENCE', 7670), ('PROBABLE_UNDERSTANDING', 7684)]	2	[('CHEBI_33839', 'macromolecule', 41, 'micronutrients'), ('GO_0007605', 'sensory perception of sound', 269, 'pregnancySecond'), ('GO_0007565', 'female pregnancy', 319, 'pregnancy'), ('CHEBI_52240', 'p-quaterphenyl', 3186, 'RNI'), ('CHEBI_52240', 'p-quaterphenyl', 3242, 'RNI'), ('CHEBI_52240', 'p-quaterphenyl', 3517, 'RNI'), ('CHEBI_52240', 'p-quaterphenyl', 3574, 'RNI'), ('CHEBI_34944', 'RU 5135', 3597, 'RDA'), ('CHEBI_33839', 'macromolecule', 3877, 'micronutrients'), ('CHEBI_60409', 'Ins-1-P-Cer(d18:0/2-OH-26:0)', 3963, 'vitaminsComparison'), ('GO_0007605', 'sensory perception of sound', 4105, 'pregnancySecond'), ('GO_0007565', 'female pregnancy', 4155, 'pregnancy'), ('CHEBI_52240', 'p-quaterphenyl', 6938, 'RNI'), ('CHEBI_52240', 'p-quaterphenyl', 7023, 'RNI'), ('CHEBI_33284', 'nutrient', 7705, 'nutrient'), ('GO_0007631', 'feeding behavior', 7714, 'intakes'), ('CHEBI_27300', 'vitamin D', 7778, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 7838, 'calcium'), ('CHEBI_27300', 'vitamin D', 7847, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 7858, 'folate'), ('CHEBI_30207', 'phosphorus(.)', 7866, 'phosphorous')]
PMC5024513	9/2016	S106-PMC5024513	['results of the pooled analyses HOWEVER SHOWED that ONLY intake of Vitamin D remained significantly below both the uk rni and us rda, and intakes of potassium below the us rda.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('ANOMALY_CURIOUS_FINDING', 31), ('INCOMPLETE_EVIDENCE', 39), ('ANOMALY_CURIOUS_FINDING', 51)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5024513	9/2016	S107-PMC5024513	['sub-group analysis SHOWED that Micronutrient intake was lower in uk based studies than those based in the usa for all Micronutrients with the EXCEPTION of Vitamin C, HOWEVER Vitamin D was the ONLY Micronutrient where the percentage of the Drv in uk based studies was below the uk rni (21.4\xa0%, ci 0–63.5\xa0%) and us rda (14.3\xa0%, ci 0–42.3\xa0%).']	[('INCOMPLETE_EVIDENCE', 19), ('ANOMALY_CURIOUS_FINDING', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 192)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 31, 'micronutrient'), ('CHEBI_33839', 'macromolecule', 118, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 197, 'micronutrient'), ('UBERON_0004004', 'cerebellum lobule', 239, 'DRV')]
PMC5024513	9/2016	S112-PMC5024513	['2\n\npooled weighted mean Micronutrient intake compared to uk and us dietary reference values\nmicronutrient analysis by stage of Pregnancy SHOWED that intake of Vitamin D in the second (28\xa0% of the uk rni, ci 26–30\xa0%) and third (31.2\xa0% of the uk rni, ci 0–47\xa0%) trimesters was below recommendations; this was not the case for measures reported as a mean over Pregnancy (54\xa0% of the uk rni, ci 0–114.3\xa0%).']	[('INCOMPLETE_EVIDENCE', 137)]	1	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 24, 'micronutrient'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('GO_0007565', 'female pregnancy', 357, 'pregnancy')]
PMC5024513	9/2016	S127-PMC5024513	['the summary results SHOW that there MAY BE areas of CONCERN in adolescent’s nutritional intake during Pregnancy, PARTICULARLY COMPARED to us RECOMMENDATIONS, with regard to calcium, Vitamin D, Vitamin E, Folate, potassium and magnesium.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 36), ('PROBLEM_COMPLICATION', 52), ('IMPORTANT_CONSIDERATION', 113), ('ANOMALY_CURIOUS_FINDING', 126), ('FUTURE_WORK', 141)]	6	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 204, 'folate')]
PMC5024513	9/2016	S129-PMC5024513	['in terms of comparison with dietary reference values, combined analysis of the individual study means SHOWED very few statistically significant results, with the EXCEPTION of Vitamin D. one POSSIBLE EXPLANATION for this is that there was a high level of variance between participants in the majority of studies resulting in very wide confidence intervals.']	[('INCOMPLETE_EVIDENCE', 102), ('ANOMALY_CURIOUS_FINDING', 162), ('INCOMPLETE_EVIDENCE', 190), ('PROBABLE_UNDERSTANDING', 199)]	4	[('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC5024513	9/2016	S157-PMC5024513	['it was NOT POSSIBLE to conduct analysis of Vitamin D status by ethnicity or exposure to sunlight, however, which are FACTORS KNOWN to have a significant IMPACT on Vitamin D status [51–53].']	[('DIFFICULT_TASK', 7), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 153)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC5024513	9/2016	S168-PMC5024513	['a systematic review of Micronutrient intakes in Pregnancy FOUND that intakes of Folate, Vitamin D and Iron were sub-optimal [63].']	[('INCOMPLETE_EVIDENCE', 58)]	1	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 23, 'micronutrient'), ('GO_0007565', 'female pregnancy', 48, 'pregnancy'), ('CHEBI_30863', '5-azaorotic acid', 80, 'folate'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_24870', 'ion', 102, 'iron')]
PMC5024513	9/2016	S189-PMC5024513	['the prevalence of Vitamin D deficiency in MANY of THESE STUDIES was also higher than SUGGESTED by the analysis of study means.']	[('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 85)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC5030591	9/2016	S80-PMC5030591	["caption (table-wrap): table 4\n\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient's clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient's Hips."]	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]
PMC5045149	9/2016	S143-PMC5045149	['it is PRUDENT at this time to CONSIDER diverse combinations of Nutrients from a variety of natural Food sources, although SOME specific Nutrients, such as Omega-3 Fatty Acids or Vitamin C, as treatment modalities [45,46].']	[('FUTURE_WORK', 6), ('IMPORTANT_CONSIDERATION', 6), ('FUTURE_WORK', 30), ('INCOMPLETE_EVIDENCE', 122)]	4	[('CHEBI_33284', 'nutrient', 63, 'nutrients'), ('CHEBI_33290', 'food', 99, 'food'), ('CHEBI_33284', 'nutrient', 136, 'nutrients'), ('CHEBI_30823', 'oleate', 155, 'omega'), ('CHEBI_35366', 'fatty acid', 163, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin C')]
PMC5051327	9/2016	S2-PMC5051327	['in THIS PILOT STUDY, we HYPOTHESISED that low maternal Vitamin D levels are over-represented in Pregnancies with fetal distress/Birth asphyxia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 24)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancies'), ('GO_0007567', 'parturition', 128, 'birth')]
PMC5051327	9/2016	S10-PMC5051327	['conclusions\nlow Vitamin D levels in early Pregnancy MAY BE ASSOCIATED with emergency caesarean section DUE TO suspected fetal distress and Birth asphyxia.']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 59), ('PROBLEM_COMPLICATION', 103)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0007567', 'parturition', 139, 'birth')]
PMC5051327	9/2016	S11-PMC5051327	['IF OUR FINDINGS are SUPPORTED by FURTHER STUDIES, PREFERABLY on SEVERE Birth asphyxia, Vitamin D supplementation/sun exposure in Pregnancy MAY lower the risk of subsequent Birth asphyxia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 20), ('FUTURE_WORK', 33), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 64), ('INCOMPLETE_EVIDENCE', 139)]	7	[('GO_0007567', 'parturition', 71, 'birth'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007567', 'parturition', 172, 'birth')]
PMC5051327	9/2016	S12-PMC5051327	['caption (boxed-text)\nstrengths and limitations of THIS STUDY\nTHIS is the FIRST STUDY to SHOW that women who underwent an emergency caesarean section due to suspected fetal distress had lower Vitamin D levels in early Pregnancy as compared to those in a control group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('INCOMPLETE_EVIDENCE', 73), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('INCOMPLETE_EVIDENCE', 88)]	5	[('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0007565', 'female pregnancy', 217, 'pregnancy')]
PMC5051327	9/2016	S15-PMC5051327	['ONLY one Blood sample drawn from each mother gives us a snapshot of the Vitamin D status in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy')]
PMC5051327	9/2016	S17-PMC5051327	['introduction\nVitamin D is NECESSARY for optimal Skeletal function and deficiency is RELATED to rachitis.1\nit is, HOWEVER, IMPORTANT for bone Metabolism, as well as for optimal function of Striated and Smooth Muscle strength including Heart Muscle, and is RELATED to Postnatal muscle strength.2vitamin D supplementation has a positive IMPACT on muscle strength on Individuals with Vitamin D deficiency.134THE institute of medicine (iom), usa RECOMMENDS daily nutritional intake of Vitamin D of 600\u2005u, BUT OTHERS RECOMMEND higher doses.56a RECENT swedish STUDY SHOWED that the mean nutritional intake of Vitamin D was <200\u2005u/day.7ALTHOUGH Vitamin D is found in low amounts in the diet, mainly in oily fish and egg, the primary source of Vitamin D for Humans is skin conversion to Vitamin D from solar ultraviolet radiation.1pregnant women residing at high latitudes are AT RISK of Vitamin D deficiency BECAUSE of low solar intensity, especially during the winter months.18vitamin D deficiency is common in the nordic countries, ESPECIALLY among those not exposing themselves to the sun.8since fetal Vitamin D levels are directly RELATED to that of their mothers there is also a high LIKELIHOOD of fetal Vitamin D deficiency in our population.9\nBirth asphyxia is ASSOCIATED with Cardiovascular dysfunction, including low Ventricular output, lower left Ventricular Ejection fraction and increased troponin levels.1011congestive Heart failure MAY occur in severe cases of asphyxia.12intrauterine fetal distress is RELATED to an increase in Blood pressure, redistribution and a change in fetal Heart rate pattern.']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('IMPORTANT_CONSIDERATION', 122), ('SUPERFICIAL_RELATIONSHIP', 255), ('SUPERFICIAL_RELATIONSHIP', 334), ('INCOMPLETE_EVIDENCE', 401), ('FUTURE_WORK', 441), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504), ('FUTURE_WORK', 511), ('INCOMPLETE_EVIDENCE', 538), ('INCOMPLETE_EVIDENCE', 559), ('ANOMALY_CURIOUS_FINDING', 627), ('IMPORTANT_CONSIDERATION', 868), ('PROBABLE_UNDERSTANDING', 900), ('ANOMALY_CURIOUS_FINDING', 1026), ('SUPERFICIAL_RELATIONSHIP', 1127), ('PROBABLE_UNDERSTANDING', 1181), ('SUPERFICIAL_RELATIONSHIP', 1260), ('INCOMPLETE_EVIDENCE', 1438), ('SUPERFICIAL_RELATIONSHIP', 1509)]	22	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0004288', 'skeleton', 48, 'skeletal'), ('GO_0008152', 'metabolic process', 141, 'metabolism'), ('UBERON_0002435', 'striatum', 188, 'striated'), ('UBERON_0001135', 'smooth muscle tissue', 201, 'smooth muscle'), ('UBERON_0001133', 'cardiac muscle tissue', 234, 'heart muscle'), ('GO_0007567', 'parturition', 266, 'postnatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 301, 'D'), ('NCBITaxon_1', 'root', 363, 'individuals'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 480, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 637, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 735, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'humans'), ('CHEBI_27300', 'vitamin D', 778, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 879, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 978, 'D'), ('CHEBI_27300', 'vitamin D', 1097, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1201, 'vitamin D'), ('GO_0007567', 'parturition', 1242, 'Birth'), ('UBERON_0004535', 'cardiovascular system', 1276, 'cardiovascular'), ('UBERON_0002082', 'cardiac ventricle', 1318, 'ventricular'), ('UBERON_0002082', 'cardiac ventricle', 1349, 'ventricular'), ('UBERON_0000970', 'eye', 1361, 'ejection'), ('UBERON_0000948', 'heart', 1424, 'heart'), ('UBERON_0000178', 'blood', 1535, 'blood'), ('UBERON_0000948', 'heart', 1588, 'heart')]
PMC5051327	9/2016	S18-PMC5051327	['THEREFORE, cardiotocography (ctg) is the main instrument of fetal Surveillance.13it is PLAUSIBLE that Vitamin D deficiency COULD make the fetal Heart more vulnerable to fetal distress/Birth asphyxia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 123)]	3	[('GO_0065007', 'biological regulation', 66, 'surveillance'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0000948', 'heart', 144, 'heart'), ('GO_0007567', 'parturition', 184, 'birth')]
PMC5051327	9/2016	S19-PMC5051327	['SEVERAL STUDIES HAVE REPORTED increased frequency of emergency caesarean Delivery in RELATION to low Vitamin D,1415but NO PREVIOUS STUDY HAS BEEN particularly designed to study the RELATION between low Vitamin D levels, measured as 25-Hydroxy\xa0(Oh) Vitamin D, in early Pregnancy and the RISK for fetal distress/Birth asphyxia.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 85), ('FULL_UNKNOWN', 119), ('INCOMPLETE_EVIDENCE', 131), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 181), ('IMPORTANT_CONSIDERATION', 286)]	8	[('GO_0007567', 'parturition', 73, 'delivery'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_29991', 'L-aspartate(1-)', 232, '25-hydroxy (OH)'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 268, 'pregnancy'), ('GO_0007567', 'parturition', 310, 'birth')]
PMC5051327	9/2016	S37-PMC5051327	['the mean 25-Oh Vitamin D level was expected to be 50±27.5\u2005nmol/l, BASED ON a scandinavian study.8\n\nresults\nthe background characteristics were not different between cases and controls other than an expected increased PROBABILITY of being Nulliparous and having a Preterm Delivery among women undergoing caesarean Delivery due to suspected fetal distress (table 1).']	[('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 217)]	2	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 9, '25-OH'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0046662', 'regulation of oviposition', 238, 'nulliparous'), ('GO_0007565', 'female pregnancy', 263, 'preterm'), ('GO_0007567', 'parturition', 271, 'delivery'), ('GO_0007567', 'parturition', 313, 'delivery')]
PMC5051327	9/2016	S52-PMC5051327	['discussion\nTHIS PILOT STUDY is the FIRST to SHOW that women who underwent emergency caesarean section due to suspected fetal asphyxia had lower Vitamin D levels in early Pregnancy as COMPARED TO a control group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183)]	5	[('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC5051327	9/2016	S54-PMC5051327	['IN FACT, the ONLY study PREVIOUSLY addressing THIS topic was performed in southern china, where Vitamin D deficiency is relatively UNCOMMON and no RELATION to Birth asphyxia was FOUND.19two randomised controlled studies of Antenatal Vitamin D supplementation REPORTED lower apgar score at 1 and 5\u2005min, respectively.2021in addition, in the latter study REPORTED, 13% of Vitamin D deficient newborn had apgar score at 5\u2005min <7, as compared TO 1.1% among those who were sufficient.21our observational study design disables us from investigating a causal RELATION between Vitamin D levels and fetal distress/Birth asphyxia.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('INCOMPLETE_EVIDENCE', 131), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 259), ('INCOMPLETE_EVIDENCE', 352), ('QUESTION_ANSWERED_BY_THIS_WORK', 438), ('SUPERFICIAL_RELATIONSHIP', 551)]	11	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007567', 'parturition', 159, 'birth'), ('GO_0007567', 'parturition', 223, 'antenatal'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('GO_0007567', 'parturition', 604, 'birth')]
PMC5051327	9/2016	S55-PMC5051327	['beside the two STUDIES SHOWING increased caesarean Delivery rate with low Vitamin D levels,1415a large STUDY with Blood drawn in early Pregnancy SHOWED no difference between caesarean and Vaginal Delivery depending on Vitamin D levels after adjustments.22HOWEVER, in the subgroup of women with caesarean Delivery due to fetal distress (n=46), the median 25-Oh Vitamin D level was 32.9\u2005nmol/l, as compared to 46.6\u2005nmol/l among the control group (n=796).']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253)]	5	[('GO_0007567', 'parturition', 51, 'delivery'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('UBERON_0000178', 'blood', 114, 'blood'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy'), ('GO_0007601', 'visual perception', 188, 'vaginal'), ('UBERON_0001987', 'placenta', 188, 'vaginal'), ('GO_0007567', 'parturition', 196, 'delivery'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D'), ('GO_0007567', 'parturition', 304, 'delivery'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 354, '25-OH'), ('CHEBI_27300', 'vitamin D', 360, 'vitamin D')]
PMC5051327	9/2016	S56-PMC5051327	['Vitamin D deficiency was ASSOCIATED with a significantly shorter Gestational age at Delivery, which is IN LINE WITH OTHER DATA.23furthermore, there SEEMS TO be an inverse RELATION between low active Vitamin D (1,25-Dihydroxy Vitamin D) and meconium-stained Amniotic Fluid, a sign of fetal distress, in Pregnancies complicated by Intrahepatic cholestasis.24\nthe FINDINGS that more than two-third of mothers were Vitamin D deficient during winter/spring season and one-third at summer are CONSISTENT with PREVIOUS reports.2526in THIS STUDY, we used the LIMITS of 25-Oh Vitamin D SUGGESTED by the iom,17BUT the discussion of WHAT levels SHOULD BE CONSIDERED deficient is ONGOING.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 361), ('INCOMPLETE_EVIDENCE', 487), ('INCOMPLETE_EVIDENCE', 503), ('QUESTION_ANSWERED_BY_THIS_WORK', 527), ('INCOMPLETE_EVIDENCE', 551), ('INCOMPLETE_EVIDENCE', 577), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 598), ('EXPLICIT_QUESTION', 622), ('FUTURE_WORK', 634), ('FUTURE_WORK', 644), ('IMPORTANT_CONSIDERATION', 668)]	16	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational'), ('GO_0007567', 'parturition', 84, 'delivery'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 210, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000173', 'amniotic fluid', 257, 'amniotic fluid'), ('GO_0007565', 'female pregnancy', 302, 'pregnancies'), ('UBERON_0001226', 'major calyx', 329, 'intrahepatic'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 561, '25-OH'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC5051327	9/2016	S58-PMC5051327	['Animal studies SHOW that the addition of active Vitamin D to Vitamin D deficient chick Heart Cells showed an increased Ca2+influx.']	[('INCOMPLETE_EVIDENCE', 15)]	1	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CL_0002494', 'cardiocyte', 87, 'heart cells'), ('UBERON_0000948', 'heart', 87, 'heart'), ('CHEBI_29108', 'calcium(2+)', 119, 'Ca2+')]
PMC5051327	9/2016	S60-PMC5051327	['both Oestrogenic Compounds and Parathyroid Hormone upregulate 1,25-Dihydroxy Vitamin D in Vascular Smooth Muscle Cells.33thus, there are several Vitamin D-RELATED mechanisms that COULD AFFECT the strained fetal Heart during the CRITICAL time of Birth.']	[('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 185), ('IMPORTANT_CONSIDERATION', 228)]	4	[('CHEBI_33838', 'nucleoside', 5, 'oestrogenic compounds'), ('GO_0001896', 'autolysis', 5, 'oestrogenic'), ('UBERON_0001132', 'parathyroid gland', 31, 'parathyroid'), ('CHEBI_33280', 'molecular messenger', 43, 'hormone'), ('CHEBI_50341', '1-hydroxyethyl group', 62, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CL_0000359', 'vascular associated smooth muscle cell', 90, 'vascular smooth muscle cells'), ('UBERON_0004237', 'blood vessel smooth muscle', 90, 'vascular smooth muscle'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0000948', 'heart', 211, 'heart'), ('GO_0007567', 'parturition', 245, 'birth')]
PMC5051327	9/2016	S61-PMC5051327	['these mechanisms are POSSIBLE EXPLANATIONS of our finding that the rate of Birth asphyxia was more than doubled in women with Vitamin D deficiency compared to non-deficient women.']	[('INCOMPLETE_EVIDENCE', 21), ('PROBABLE_UNDERSTANDING', 30)]	2	[('GO_0007567', 'parturition', 75, 'birth'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC5051327	9/2016	S66-PMC5051327	['antoniucci et al 34HAVE SHOWN that thawing and refreezing of samples up to four times do not affect the Vitamin D analysis.']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC5051327	9/2016	S68-PMC5051327	['in the logistic regression analysis of Vitamin D levels in women who underwent caesarean section due to suspected fetal distress/Birth asphyxia, we DID NOT adjust for maternal bmi SINCE it SEEMS to be INVOLVED in a causal pathway.35HOWEVER, SIMILAR results were FOUND in stratified analysis of lean women (≤25 in bmi).']	[('INCOMPLETE_EVIDENCE', 148), ('PROBABLE_UNDERSTANDING', 180), ('ANOMALY_CURIOUS_FINDING', 189), ('SUPERFICIAL_RELATIONSHIP', 201), ('ANOMALY_CURIOUS_FINDING', 230), ('INCOMPLETE_EVIDENCE', 241), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007567', 'parturition', 129, 'birth')]
PMC5051327	9/2016	S70-PMC5051327	['SINCE PRIOR STUDIES had REPORTED on INCREASED RISK of emergency caesarean Delivery in RELATION to low Vitamin D, we used caesarean Delivery DUE TO suspected fetal distress AS a main outcome and Birth asphyxia as a secondary outcome.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 86), ('PROBLEM_COMPLICATION', 140), ('PROBABLE_UNDERSTANDING', 172)]	7	[('GO_0007567', 'parturition', 74, 'delivery'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007567', 'parturition', 131, 'delivery'), ('GO_0007567', 'parturition', 194, 'birth')]
PMC5051327	9/2016	S72-PMC5051327	['the fact that there was ONLY one Blood sample drawn from each mother just gives us a snapshot of the Vitamin D status in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 24)]	1	[('UBERON_0000178', 'blood', 33, 'blood'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy')]
PMC5051327	9/2016	S73-PMC5051327	['we DID NOT obtain Vitamin D data in late Pregnancy in these women.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy')]
PMC5051327	9/2016	S77-PMC5051327	['further, Vitamin D non-deficient women MAY have a healthier lifestyle for which we COULD NOT control.']	[('INCOMPLETE_EVIDENCE', 39), ('DIFFICULT_TASK', 83)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC5051327	9/2016	S80-PMC5051327	['we SPECULATE that our finding of shorter maternal height among Vitamin D deficient women MIGHT be DUE TO an increased prevalence of Vitamin D deficiency during childhood and Adolescence.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 98)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 174, 'adolescence')]
PMC5051327	9/2016	S81-PMC5051327	['low Vitamin D levels during the longitudinal growth period MIGHT have resulted in that these Individuals did not reach their full growth potential.']	[('INCOMPLETE_EVIDENCE', 59)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('NCBITaxon_1', 'root', 93, 'individuals')]
PMC5051327	9/2016	S82-PMC5051327	['we FOUND that women Delivered by emergency caesarean section due to suspected fetal distress had lower Vitamin D levels in early Pregnancy and Birth asphyxia was MORE COMMON in Vitamin D deficient women as compared to non-deficient women.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 162)]	2	[('GO_0007567', 'parturition', 20, 'delivered'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007567', 'parturition', 143, 'birth'), ('CHEBI_33229', 'vitamin (role)', 177, 'vitamin'), ('PR_000006444', 'diacylglycerol kinase delta', 185, 'D')]
PMC5051327	9/2016	S83-PMC5051327	['IF OTHER groups REPRODUCE our FINDINGS and a causal RELATIONSHIP CAN be established, we MIGHT be in a position to lower the risk of fetal distress/Birth asphyxia with Vitamin D supplementation/sun exposure in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 88)]	7	[('GO_0007567', 'parturition', 147, 'birth'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0007565', 'female pregnancy', 209, 'pregnancy')]
PMC5054480	9/2016	S79-PMC5054480	['other causes are SIMILAR TO those encountered in the nonpregnant population, namely hyperthyroidism, Vitamin A or D toxicity, familial hypocalciuric hypercalcemia, acute or chronic Renal failure, granulomatous diseases, Milk–alkali syndrome, and malignancy.']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 114, 'D'), ('UBERON_0002113', 'kidney', 181, 'renal'), ('UBERON_0001913', 'milk', 220, 'milk')]
PMC5085625	9/2016	S24-PMC5085625	['DEFICIENCY of Vitamin D is commonly diagnosed among Pregnant women worldwide, and WAS SHOWN to be ASSOCIATED with an INCREASED RISK of Pregnancy-related complications [1].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 98), ('IMPORTANT_CONSIDERATION', 117)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy')]
PMC5085625	9/2016	S38-PMC5085625	['ALTHOUGH the biological ROLE of Vitamin D HAS BEEN studied extensively, the consequences of its deficiency for maternal, fetal and neonatal health are STILL UNCLEAR [4,22,24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 42), ('FULL_UNKNOWN', 151)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5085625	9/2016	S62-PMC5085625	['DESPITE widespread deficiency of Vitamin D among Pregnant women worldwide, its ROLE in Pregnancy has LARGELY BEEN IGNORED [25,26,27].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 114)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'pregnant'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy')]
PMC5085625	9/2016	S64-PMC5085625	['one POTENTIAL EXPLANATION for such a high prevalence of Vitamin D insufficiency/deficiency among Pregnant polish women is a relatively low number of sunny days in our country.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 14)]	2	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 97, 'pregnant')]
PMC5085625	9/2016	S67-PMC5085625	['OUR FINDINGS are CONSISTENT with the results of ANOTHER STUDY conducted in a central european population, which also DOCUMENTED a high prevalence of Vitamin D deficiency [23].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 117)]	4	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC5085625	9/2016	S71-PMC5085625	['[13] who DEMONSTRATED that Vitamin D status CORRELATES significantly with Blood pressure during the first trimester and Gestational systolic Blood pressure trajectory, BUT NOT with the prevalence of gh.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 44), ('ANOMALY_CURIOUS_FINDING', 168)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0000178', 'blood', 74, 'blood'), ('GO_0007565', 'female pregnancy', 120, 'gestational'), ('UBERON_0000178', 'blood', 141, 'blood')]
PMC5085625	9/2016	S72-PMC5085625	['the RELATIONSHIP between Vitamin D status and gh HAS also BEEN a subject of OTHER STUDIES.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 76)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC5085625	9/2016	S74-PMC5085625	['ANALYZED ASSOCIATIONS between Vitamin D status, Blood pressure at the onset of Pregnancy and occurrence of a mid-Pregnancy decrease in the latter parameters.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000178', 'blood', 48, 'blood'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
PMC5085625	9/2016	S75-PMC5085625	['moreover, the authors searched for a POTENTIAL mechanism EXPLAINING the ASSOCIATION between Vitamin D status and Pregnancy-related hypertensive disorders.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 57), ('SUPERFICIAL_RELATIONSHIP', 72)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
PMC5085625	9/2016	S76-PMC5085625	['SIMILAR TO OUR STUDY, they FOUND no association between Vitamin D status, prevalence of gh, Blood pressure at early Gestation and mid-Pregnancy decrease in this parameter [30].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 27)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0000178', 'blood', 92, 'blood'), ('GO_0007565', 'female pregnancy', 116, 'gestation'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy')]
PMC5085625	9/2016	S82-PMC5085625	['in our opinion, SOME DISCREPANCIES between the results of PREVIOUS STUDIES MAY result from LACK OF adjustment for Vitamin D supplementation and season of the Blood sampling.']	[('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 75), ('PROBLEM_COMPLICATION', 91)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('UBERON_0000178', 'blood', 158, 'blood')]
PMC5085625	9/2016	S84-PMC5085625	['HENCE, we POSTULATE to conduct a well-designed randomized study TO ASSESS the ROLE of Vitamin D in the etiopathogenesis of gh.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 64), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5085625	9/2016	S90-PMC5085625	['ACCORDING to barebring et al., AT LEAST a 30 nmol/l increase in Serum 25(Oh)D concentration is ASSOCIATED with lower odds of pe, REGARDLESS OF Vitamin D status in early Pregnancy [13].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('PROBABLE_UNDERSTANDING', 31), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 129)]	4	[('UBERON_0001977', 'blood serum', 64, 'serum'), ('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 70, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy')]
PMC5085625	9/2016	S99-PMC5085625	['preeclampsia in patients with Vitamin D insufficiency MAY BE LINKED to a low concentration of the Vascular Endothelial Growth Factor (Vegf) and high levels of inflammatory cytokines; expressions of these FACTORS are under a strong INFLUENCE of Vitamin D [35,36,37,38].']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 204), ('SUPERFICIAL_RELATIONSHIP', 231)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 98, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 107, 'endothelial'), ('PR_000017279', 'testis-specific basic protein Y 1', 134, 'VEGF'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D')]
PMC5085625	9/2016	S100-PMC5085625	['both a RECENT meta-analysis and several OBSERVATIONAL studies SHOWED a significant ASSOCIATION between Vitamin D deficiency and INCREASED RISK for Preeclampsia [39,40,41].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 128)]	5	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 147, 'preeclampsia')]
PMC5085625	9/2016	S105-PMC5085625	['SOME EVIDENCE SUGGESTS that Preeclampsia MAY BE ASSOCIATED with a decrease in Placental and fetal concentrations of Vitamin D, and Placental dysfunction plays an IMPORTANT ROLE in the pathogenesis of pe [44].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 162), ('SUPERFICIAL_RELATIONSHIP', 172)]	6	[('GO_0007128', 'meiotic prophase I', 28, 'preeclampsia'), ('UBERON_0001987', 'placenta', 78, 'placental'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0001987', 'placenta', 131, 'placental')]
PMC5085625	9/2016	S109-PMC5085625	['ALTHOUGH preeclampsia HAS BEEN LINKED to maternal Vitamin D insufficiency/deficiency, STILL LITTLE IS KNOWN on POTENTIAL differences in Placental Metabolism Of this Vitamin in uncomplicated and preeclamptic Pregnancies [32].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 86), ('IMPORTANT_CONSIDERATION', 86), ('FULL_UNKNOWN', 92), ('INCOMPLETE_EVIDENCE', 111)]	7	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'placental'), ('UBERON_0001987', 'placenta', 136, 'placental'), ('GO_0006583', 'melanin biosynthetic process from tyrosine', 146, 'metabolism of ... vitamin'), ('CHEBI_33229', 'vitamin (role)', 165, 'vitamin'), ('GO_0007565', 'female pregnancy', 207, 'pregnancies')]
PMC5085625	9/2016	S110-PMC5085625	['owing the POTENTIAL CONTRIBUTION of an altered Vitamin D Metabolism to diabetes mellitus, we compared Serum concentrations of 25(Oh)D in patients with type 1 and 2 gdm (gdm g1 and gdm g2) and healthy controls.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 47, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 102, 'serum'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D')]
PMC5085625	9/2016	S119-PMC5085625	['DID NOT observe significant differences in Vitamin D levels among Pregnant women and healthy controls; NEVERTHELESS, the prevalence of a Vitamin D deficiency in both groups was quite high [23].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnant'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC5085625	9/2016	S120-PMC5085625	['HOWEVER, PUBLISHED EVIDENCE regarding the RELATIONSHIP between Vitamin D level and occurrence of gdm is INCONCLUSIVE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5085625	9/2016	S121-PMC5085625	['furthermore, a direct LINK between Glucose Metabolism and Vitamin D pathways HAS BEEN identified.']	[('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 77)]	2	[('CHEBI_17234', 'glucose', 35, 'glucose'), ('GO_0006006', 'glucose metabolic process', 35, 'glucose metabolism'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5085625	9/2016	S124-PMC5085625	['DEMONSTRATED that deficiency of Vitamin D MAY PREDISPOSE to gdm.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5085625	9/2016	S169-PMC5085625	['conclusions\nin CONCLUSION, both the results of PREVIOUS STUDIES and OUR FINDINGS PRESENTED HERE, documenting the LINK between Maternal deficiency of Vitamin D and the INCREASED RISK of Preeclampsia, POINT TO the IMPORTANT ROLE of an appropriate level and adequate Metabolism Of this Vitamin in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 91), ('SUPERFICIAL_RELATIONSHIP', 113), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 199), ('IMPORTANT_CONSIDERATION', 212), ('SUPERFICIAL_RELATIONSHIP', 222)]	10	[('GO_0007618', 'mating', 126, 'maternal'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 185, 'preeclampsia'), ('GO_0006583', 'melanin biosynthetic process from tyrosine', 264, 'metabolism of ... vitamin'), ('CHEBI_33229', 'vitamin (role)', 283, 'vitamin'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy')]
PMC5085625	9/2016	S174-PMC5085625	['AVAILABLE EVIDENCE is STILL INSUFFICIENT to CONFIRM a causative LINK between Vitamin D and Pregnancy disorders IN LINE WITH hill’s criteria.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 22), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 64), ('INCOMPLETE_EVIDENCE', 111)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy')]
PMC5028238	10/2016	S4-PMC5028238	['we DESCRIBE the functional environment around Dhcr7, including Pharmacological Dhcr7 Inhibitors and Cholesterol and Vitamin D synthesis.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('PR_000006474', 'ATP-dependent RNA helicase A', 46, 'DHCR7'), ('CHEBI_52217', 'pharmaceutical', 63, 'pharmacological'), ('PR_000006474', 'ATP-dependent RNA helicase A', 79, 'DHCR7'), ('CHEBI_35222', 'inhibitor', 85, 'inhibitors'), ('CHEBI_16113', 'cholesterol', 100, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5028238	10/2016	S78-PMC5028238	['pathway LINKS Dhcr7, Vitamin D Synthesis and Cholesterol Synthesis\n\nevolutionary advantage for Dhcr7 mutations\nheterozygote advantage among carriers HAS BEEN PROPOSED PREVIOUSLY17BASED on the RELATIONSHIP between Dhcr7 and Vitamin d. heterozygote carriers have lower amounts of functional dhcr7 resulting from their carrier state.8this would lower the amount of available 7-Dehydrocholesterol that is converted to Cholesterol.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 192)]	5	[('PR_000006474', 'ATP-dependent RNA helicase A', 14, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 21, 'vitamin D synthesis'), ('CHEBI_16113', 'cholesterol', 45, 'cholesterol'), ('GO_0006695', 'cholesterol biosynthetic process', 45, 'cholesterol synthesis'), ('PR_000006474', 'ATP-dependent RNA helicase A', 95, 'DHCR7'), ('PR_000006474', 'ATP-dependent RNA helicase A', 213, 'DHCR7'), ('CHEBI_33229', 'vitamin (role)', 223, 'vitamin'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 372, '7-dehydrocholesterol'), ('CHEBI_16113', 'cholesterol', 414, 'cholesterol')]
PMC5028238	10/2016	S80-PMC5028238	['this would PROTECT Individuals from developing rickets (a Vitamin D deficiency condition that results in bone softening and malformations) and osteomalacia (an Adult form of rickets).17\ncertain Dhcr7 variants were found to be evolutionarily favored in northern climates, including europe and asia28suggesting a selective pressure and a PLAUSIBLE heterozygote advantage for those variants.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 336)]	2	[('NCBITaxon_1', 'root', 19, 'individuals'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0007023', 'adult organism', 160, 'adult'), ('PR_000006474', 'ATP-dependent RNA helicase A', 194, 'DHCR7')]
PMC5028238	10/2016	S81-PMC5028238	['researchers FOUND certain Dhcr7 variants were ASSOCIATED with lower Vitamin D levels in the general population45and among Individuals with polycystic Ovary syndrome.46this FURTHER LINKS Vitamin D levels with Dhcr7 variants.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 180), ('SUPERFICIAL_RELATIONSHIP', 180)]	5	[('PR_000006474', 'ATP-dependent RNA helicase A', 26, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('NCBITaxon_1', 'root', 122, 'individuals'), ('UBERON_0000992', 'ovary', 150, 'ovary'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('PR_000006474', 'ATP-dependent RNA helicase A', 208, 'DHCR7')]
PMC5028238	10/2016	S85-PMC5028238	['this HAS BEEN used TO EXPLAIN WHY northern populations have a higher prevalence of slos.11\ncarriers also are HYPOTHESIZED to have a Reproductive advantage because of the reduced fetal death due to Rachitic Cephalopelvic disproportion.11,35this is again RELATED to increased Vitamin D Production causing improved bone formation.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('PROBABLE_UNDERSTANDING', 22), ('EXPLICIT_QUESTION', 30), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 253)]	6	[('GO_0000003', 'reproduction', 132, 'reproductive'), ('UBERON_0001286', "Bowman's space", 197, 'rachitic cephalopelvic'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 284, 'production')]
PMC5028238	10/2016	S86-PMC5028238	['improved hip formation IS THOUGHT TO enable females to produce more offspring and thereby provide another carrier advantage.11,35in addition, Vitamin D HAS BEEN SHOWN to increase chances of Pregnancy for infertile women receiving in Vitro Fertilization.48vitamin d has many pleiotropic ROLES in Reproductive outcomes and CAN AFFECT both male and female Fertility.49THEREFORE, there COULD BE MULTIPLE mechanisms that COULD EXPLAIN WHY evolution favors Vitamin D Production in northern climates through mutations in Dhcr7 (and other Genes).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 321), ('SUPERFICIAL_RELATIONSHIP', 325), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 363), ('INCOMPLETE_EVIDENCE', 382), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 391), ('INCOMPLETE_EVIDENCE', 416), ('PROBABLE_UNDERSTANDING', 422), ('EXPLICIT_QUESTION', 430)]	12	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0007601', 'visual perception', 233, 'vitro'), ('GO_0009566', 'fertilization', 239, 'fertilization'), ('GO_0000003', 'reproduction', 295, 'reproductive'), ('GO_0009566', 'fertilization', 353, 'fertility'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 451, 'vitamin D production'), ('PR_000006474', 'ATP-dependent RNA helicase A', 514, 'DHCR7'), ('SO_0000704', 'gene', 531, 'genes')]
PMC5028238	10/2016	S89-PMC5028238	["the conversion Of 7-Dehydrocholesterol to Vitamin D occurs in the skin upon exposure to ultraviolet b light (290–320\u2009nm).50under normal sunlight conditions, ONLY around 15% of available 7-Dehydrocholesterol will be converted to Vitamin D, WHEREAS excess 7-Dehydrocholesterol in the skin will be converted to inert compounds for degradation.51,52dhcr7 is the sole enzyme used to convert 7-Dehydrocholesterol to Cholesterol.53a shortage of Dhcr7 would decrease the body's ability to convert 7-Dehydrocholesterol into Cholesterol thereby causing a build-up of 7-Dehydrocholesterol, which COULD BE converted into Vitamin D in the skin."]	[('ANOMALY_CURIOUS_FINDING', 157), ('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239), ('INCOMPLETE_EVIDENCE', 585)]	4	[('GO_0007608', 'sensory perception of smell', 15, 'of ...'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 18, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 186, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 236, 'D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 254, '7-dehydrocholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 386, '7-dehydrocholesterol'), ('CHEBI_16113', 'cholesterol', 410, 'cholesterol'), ('PR_000006474', 'ATP-dependent RNA helicase A', 438, 'DHCR7'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 489, '7-dehydrocholesterol'), ('CHEBI_16113', 'cholesterol', 515, 'cholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 557, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 609, 'vitamin D')]
PMC5028238	10/2016	S93-PMC5028238	['however, Vitamin D levels in slos patients are REPORTED to be low.55this COULD BE DUE TO many lifestyle factors that occur when a patient is SERIOUSLY ill with slos.']	[('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 73), ('PROBABLE_UNDERSTANDING', 82), ('PROBLEM_COMPLICATION', 82), ('IMPORTANT_CONSIDERATION', 141)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC5028238	10/2016	S94-PMC5028238	['one POSSIBLE biological EXPLANATION that fits with the literature-derived mechanism (figure 3) is that slos patients spent less time outdoors thereby reducing their Ultraviolet b exposure (another CRITICAL REQUIREMENT for Vitamin D Synthesis).55\n\nGenetic understanding of slos-inducing Dhcr7 mutations: IMPLICATIONS for FUTURE WORK\n\nchanging our understanding of slos genetics using large-scale Genomics studies\nusing exac,24we were able to compare the frequencies of Dhcr7 slos-inducing mutations in the slos population (extracted from the literature) and the assumed-healthy exac population.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 24), ('IMPORTANT_CONSIDERATION', 197), ('IMPORTANT_CONSIDERATION', 206), ('IMPORTANT_CONSIDERATION', 303), ('FUTURE_WORK', 320)]	6	[('CHEBI_75275', 'tetradecyl sulfonic acid', 165, 'ultraviolet'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('GO_0031151', 'histone methyltransferase activity (H3-K79 specific)', 230, 'D synthesis'), ('SO_0000704', 'gene', 247, 'Genetic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 286, 'DHCR7'), ('SO_0001026', 'genome', 395, 'genomics'), ('PR_000006474', 'ATP-dependent RNA helicase A', 468, 'DHCR7')]
PMC5028238	10/2016	S146-PMC5028238	["SEVERAL clinical trials were performed in the 1970s for Nafoxidine.69,70,71,72the major reaction to the Drug consisted of dermatitis (55% of patients) exacerbated by sunlight.72this INDICATES that the Drug EFFECTED patients' dermal response to sunlight exposure (which COULD BE RELATED to its inhibition of Dhcr7 and Dysregulation of Vitamin D Synthesis pathways)."]	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 206), ('INCOMPLETE_EVIDENCE', 269), ('SUPERFICIAL_RELATIONSHIP', 278)]	5	[('CHEBI_7447', 'nafcillin', 56, 'nafoxidine'), ('CHEBI_23888', 'drug', 104, 'drug'), ('CHEBI_23888', 'drug', 201, 'drug'), ('PR_000006474', 'ATP-dependent RNA helicase A', 307, 'DHCR7'), ('GO_0060233', 'oenocyte delamination', 317, 'dysregulation'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 334, 'vitamin D synthesis')]
PMC5028238	10/2016	S201-PMC5028238	["COMMENT on Vitamin D3's in-direct inhibition of Dhcr7\nOF NOTE, Vitamin D (Cholecalciferol) decreases the Dhcr7 activity through an indirect mechanism.54there HAS BEEN SOME SPECULATION on the POSSIBILITY of Teratogenic AFFECTS resulting from high doses of Vitamin D when taken as a Prenatal supplement.89HOWEVER, a RECENT REVIEW of Vitamin D supplementation among Pregnant women FOUND that Vitamin D supplementation MAY reduce the RISK of pre-eclampsia, low Birth weight, Preterm Birth90,91and adverse Kidney outcomes in offspring.92BECAUSE the mechanism of Vitamin D3's inhibition of Dhcr7 is indirect (UNLIKE our studied Pharmacological Dhcr7 Inhibitors) it is LIKELY to be MEDIATED through a COMPLEX pathway with many INTERACTING feedback loops."]	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 54), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 167), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 191), ('SUPERFICIAL_RELATIONSHIP', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 378), ('INCOMPLETE_EVIDENCE', 415), ('IMPORTANT_CONSIDERATION', 430), ('PROBABLE_UNDERSTANDING', 530), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 603), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 675), ('DIFFICULT_TASK', 694), ('SUPERFICIAL_RELATIONSHIP', 720)]	18	[('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 48, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 74, 'cholecalciferol'), ('PR_000006474', 'ATP-dependent RNA helicase A', 105, 'DHCR7'), ('CHEBI_50905', 'teratogenic agent', 206, 'teratogenic'), ('GO_0031649', 'heat generation', 206, 'teratogenic'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('GO_0007565', 'female pregnancy', 281, 'prenatal'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D'), ('GO_0007565', 'female pregnancy', 363, 'pregnant'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('GO_0007567', 'parturition', 457, 'birth'), ('GO_0007565', 'female pregnancy', 471, 'preterm'), ('GO_0042633', 'hair cycle', 479, 'birth90'), ('UBERON_0002113', 'kidney', 501, 'kidney'), ('CHEBI_33279', 'vitamin D5', 557, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 557, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 584, 'DHCR7'), ('CHEBI_52217', 'pharmaceutical', 622, 'pharmacological'), ('PR_000006474', 'ATP-dependent RNA helicase A', 638, 'DHCR7'), ('CHEBI_35222', 'inhibitor', 644, 'inhibitors')]
PMC5028238	10/2016	S202-PMC5028238	['studies involving moderate Prenatal Vitamin D supplementation HAVE REPORTED no adverse EFFECTS.89THEREFORE, we would not expect Vitamin D to result in slos-RELATED Teratogenic EFFECTS, ALTHOUGH ADDITIONAL STUDIES would BE NEEDED to ascertain the EFFECTS of large doses of Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 87), ('PROBABLE_UNDERSTANDING', 95), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 156), ('SUPERFICIAL_RELATIONSHIP', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('FUTURE_WORK', 194), ('FUTURE_WORK', 205), ('FUTURE_WORK', 219), ('SUPERFICIAL_RELATIONSHIP', 246)]	11	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_50905', 'teratogenic agent', 164, 'teratogenic'), ('GO_0007565', 'female pregnancy', 272, 'prenatal'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D')]
PMC5039809	10/2016	S0-PMC5039809	['maternal Serum Retinol and Β-Carotene concentrations and neonatal bone mineralization: results from the southampton women’s survey cohort\n\nabstract\nbackground: studies in older Adults and Animals have SUGGESTED CONTRASTING RELATIONS between bone health and DIFFERENT Vitamin A Compounds.']	[('INCOMPLETE_EVIDENCE', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('SUPERFICIAL_RELATIONSHIP', 223), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257)]	4	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_26536', 'retinoic acid', 15, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 27, 'β-carotene'), ('UBERON_0007023', 'adult organism', 177, 'adults'), ('NCBITaxon_33208', 'Metazoa', 188, 'animals'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin A'), ('CHEBI_36357', 'polyatomic entity', 277, 'compounds')]
PMC5039809	10/2016	S17-PMC5039809	['THERE IS EVIDENCE in Adults that Vitamin A intake is ASSOCIATED with measures of bone health, BUT NOTABLY, the DIFFERENT forms of dietary Vitamin A HAVE BEEN demonstrated to have OPPOSING ASSOCIATIONS with fracture risk (6).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 94), ('ANOMALY_CURIOUS_FINDING', 98), ('IMPORTANT_CONSIDERATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 148), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 188)]	9	[('UBERON_0007023', 'adult organism', 21, 'adults'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin A')]
PMC5039809	10/2016	S21-PMC5039809	['FEW STUDIES to OUR KNOWLEDGE have RELATED maternal Vitamin A nutrition during Pregnancy to Offspring Bone Development.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 34)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0007608', 'sensory perception of smell', 91, 'offspring'), ('GO_0048539', 'bone marrow development', 101, 'bone development')]
PMC5039809	10/2016	S104-PMC5039809	['adjusting for Vitamin D status made little difference; the pattern of ASSOCIATIONS OBSERVED between Serum Retinol and Β-Carotene concentrations and neonatal bone indexes REMAINED the same (data not shown).']	[('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 170)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_26536', 'retinoic acid', 106, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 118, 'β-carotene')]
PMC5039809	10/2016	S109-PMC5039809	['PREVIOUS intervention STUDIES have NOT CONSISTENTLY DEMONSTRATED that Prenatal Vitamin A supplementation CAN increase Birth size.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 105)]	4	[('GO_0007565', 'female pregnancy', 70, 'prenatal'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('GO_0007567', 'parturition', 118, 'birth')]
PMC5039809	10/2016	S110-PMC5039809	['HOWEVER, these STUDIES have TYPICALLY been performed in developing countries with a high prevalence of Vitamin A deficiency, and MANY have used an interventional product containing both Retinol and Β-Carotene (17).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 129)]	4	[('CHEBI_27300', 'vitamin D', 103, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 186, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 198, 'β-carotene')]
PMC5039809	10/2016	S112-PMC5039809	['there are FEW STUDIES to OUR KNOWLEDGE that have RELATED maternal Vitamin A status to offspring Bone Development.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin A'), ('GO_0048539', 'bone marrow development', 96, 'bone development')]
PMC5039809	10/2016	S115-PMC5039809	['the RELATIONS between Vitamin A nutrition, assessed by an ffq or Serum measurements, and fracture risk or bmd in Adults are INCONSISTENT (18), BUT in a RECENT meta-analysis wu et al.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 152)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('UBERON_0001977', 'blood serum', 65, 'serum'), ('UBERON_0007023', 'adult organism', 113, 'adults')]
PMC5039809	10/2016	S118-PMC5039809	['Animal studies HAVE SHOWN that both high and low intakes of Vitamin A CAN be DETRIMENTAL to the bone.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 70), ('IMPORTANT_CONSIDERATION', 77)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A')]
PMC5045784	10/2016	S13-PMC5045784	['introduction\nbronchopulmonary dysplasia (bpd) is the MOST PREVALENT long-term morbidity among surviving EXTREMELY preterm infants and has a MULTIFACTORIAL etiology.1bpd is ASSOCIATED with later risk of reactive Airways disease, such as asthma,2post neonatal mortality and adverse Neurodevelopmental outcomes.1bpd AFFECTS ~20% of preterm infants, and up to 60% of extremely preterm infants who are Born before 26 completed weeks of Gestation.2an ESTIMATED 10\u2009000 to 15\u2009000 infants are affected in the united states each year and this has substantial medical and socioeconomic IMPLICATIONS.2,3\nACCUMULATING epidemiologic EVIDENCE SUGGESTS that Vitamin D deficiency or insufficiency is ASSOCIATED with Respiratory disease in children.']	[('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 104), ('DIFFICULT_TASK', 140), ('SUPERFICIAL_RELATIONSHIP', 172), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 445), ('IMPORTANT_CONSIDERATION', 575), ('INCOMPLETE_EVIDENCE', 592), ('INCOMPLETE_EVIDENCE', 628), ('SUPERFICIAL_RELATIONSHIP', 683)]	10	[('UBERON_0001005', 'respiratory airway', 211, 'airways'), ('GO_0007399', 'nervous system development', 280, 'neurodevelopmental'), ('GO_0007567', 'parturition', 397, 'born'), ('GO_0007565', 'female pregnancy', 431, 'gestation'), ('CHEBI_27300', 'vitamin D', 642, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 699, 'respiratory')]
PMC5045784	10/2016	S14-PMC5045784	['camargo et al.4DEMONSTRATED that lower maternal Intake of Vitamin D during Pregnancy is ASSOCIATED with recurrent wheezing and asthma in their offspring during early childhood.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 88)]	2	[('GO_0007631', 'feeding behavior', 48, 'intake'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy')]
PMC5045784	10/2016	S17-PMC5045784	['in addition, Animal studies SUPPORT the HYPOTHESIS that Vitamin D status MIGHT AFFECT the RISK of bpd GIVEN that both Vitamin D and the Vitamin D receptor (vdr) have IMPORTANT ROLES in Perinatal Lung Development.7,8thus, we SPECULATED that Vitamin D deficiency MIGHT predispose to and/or have a ROLE in the pathogenesis of bpd.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 102), ('IMPORTANT_CONSIDERATION', 166), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 295)]	11	[('NCBITaxon_33208', 'Metazoa', 13, 'animal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0036268', 'swimming', 185, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 185, 'perinatal'), ('GO_0030324', 'lung development', 195, 'lung development'), ('UBERON_0002048', 'lung', 195, 'lung'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC5045784	10/2016	S58-PMC5045784	["our study is IN AGREEMENT with a study by onwuneme et al.16in which, in a cohort of 94 preterm infants (<32 weeks' Gestation), there was no association with bpd or other morbidities of Prematurity although the authors FOUND an ASSOCIATION between Vitamin D status and acute Respiratory morbidity (AS defined by differences in duration of positive pressure ventilation and highest oxygen concentration required in the delivery room and the odds of requiring assisted ventilation)."]	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 218), ('SUPERFICIAL_RELATIONSHIP', 227), ('PROBABLE_UNDERSTANDING', 297)]	4	[('GO_0007565', 'female pregnancy', 115, 'gestation'), ('GO_0007565', 'female pregnancy', 185, 'prematurity'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 274, 'respiratory')]
PMC5045784	10/2016	S59-PMC5045784	['SIMILARLY, a RECENT interventional TRIAL of three dosing regimens for Vitamin D supplementation in extremely preterm infants FOUND no association between Vitamin D status and Respiratory outcomes.17\nthe IMPORTANCE of Vitamin D status in pediatric Respiratory health is SUPPORTED by large epidemiologic studies of term infants SHOWING an ASSOCIATION between suboptimal Vitamin D status and wheezing.4,18in addition, Animal studies demonstrate an IMPORTANT biologic ROLE for Vitamin D in Lung Development and Maturation, including Differentiation Of Type Ii Pneumocytes, Surfactant Phospholipid synthesis and secretion,19as well as an immunomodulatory ROLE in Epithelial Cells, Neutrophils and Macrophages.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 125), ('IMPORTANT_CONSIDERATION', 203), ('INCOMPLETE_EVIDENCE', 269), ('INCOMPLETE_EVIDENCE', 326), ('SUPERFICIAL_RELATIONSHIP', 337), ('IMPORTANT_CONSIDERATION', 445), ('SUPERFICIAL_RELATIONSHIP', 464), ('SUPERFICIAL_RELATIONSHIP', 650)]	10	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 175, 'respiratory'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 415, 'animal'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D'), ('GO_0035180', 'larval wandering behavior', 486, 'lung development ... maturation'), ('UBERON_0002048', 'lung', 486, 'lung'), ('GO_0007620', 'copulation', 529, 'differentiation of ...'), ('CL_0002063', 'type II pneumocyte', 548, 'type II pneumocytes'), ('CHEBI_53015', 'N(6)-carboxymethyl-L-lysine residue', 569, 'surfactant phospholipid'), ('CL_0000066', 'epithelial cell', 658, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 658, 'epithelial'), ('CL_0000775', 'neutrophil', 676, 'neutrophils'), ('CL_0000235', 'macrophage', 692, 'macrophages')]
PMC5045784	10/2016	S60-PMC5045784	['finally, interventional Animal and Human studies provide STRONG EVIDENCE for a beneficial ROLE of Vitamin D supplementation in Pulmonary outcomes.7,20\nthe ROLE of Vitamin D status in the development of bpd REMAINS incompletely understood.']	[('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 57), ('SUPERFICIAL_RELATIONSHIP', 90), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 206)]	5	[('NCBITaxon_33208', 'Metazoa', 24, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 35, 'human'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0002048', 'lung', 127, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC5045784	10/2016	S61-PMC5045784	['mandel et al.7REPORTED a PROTECTIVE ROLE for Vitamin D in a Rodent MODEL of neonatal Lung injury induced by in utero exposure to endotoxin.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 67)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 60, 'rodent'), ('UBERON_0002048', 'lung', 85, 'lung')]
PMC5045784	10/2016	S62-PMC5045784	['backstrom et al.21CONDUCTED a randomized trial of 39 preterm infants (<33 weeks) to 200 vs 960\u2009iu of Vitamin D per day for 3 months and OBSERVED, as a secondary outcome, a reduced need for assisted ventilation in the high-dose group.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 136)]	2	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC5045784	10/2016	S66-PMC5045784	['given that Vitamin D has IMPORTANT ROLES in early Lung Development and Innate Immunity, the LACK OF ASSOCIATION between Vitamin D status and development of bpd SUPPORTS the multifactorial etiology of and POSSIBLE Genetic predisposition to bpd.']	[('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 204)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0030324', 'lung development', 50, 'lung development'), ('UBERON_0002048', 'lung', 50, 'lung'), ('GO_0045087', 'innate immune response', 71, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('SO_0000704', 'gene', 213, 'genetic')]
PMC5045784	10/2016	S67-PMC5045784	['the ASSOCIATION between low Vitamin D levels and Respiratory morbidity as SEEN in older children and Adults MAY BE DUE TO DIFFERENT pathology than that SEEN in bpd, which is characterized by Alveolar simplification and impaired septation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('INCOMPLETE_EVIDENCE', 152)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 49, 'respiratory'), ('UBERON_0007023', 'adult organism', 101, 'adults'), ('UBERON_0003215', 'alveolus', 191, 'alveolar')]
PMC5045784	10/2016	S69-PMC5045784	['a variety of host FACTORS MAY confer altered susceptibility to bpd in preterm infants and SOME of these MAY BE Genetic and RELATED to Vitamin D bioavailability that is not REFLECTED in 25(Oh)D levels.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 172)]	7	[('SO_0000704', 'gene', 111, 'genetic'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 185, '25(OH)D')]
PMC5045784	10/2016	S70-PMC5045784	['for example, common Vitamin D-related polymorphisms, in Vitamin D-binding protein or vdr LIKELY alter the bioavailable levels of 25(Oh)D.24A STUDY by koroglu et al.25EXAMINED the ROLE of the vdr variant Fok 1 in bpd risk among 109 preterm neonates but DID NOT FIND a significant change in the odds ratio.']	[('PROBABLE_UNDERSTANDING', 89), ('INCOMPLETE_EVIDENCE', 137), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 252)]	5	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 129, '25(OH ... D'), ('PR_000007593', 'glutamate carboxypeptidase 2', 203, 'Fok 1')]
PMC5045784	10/2016	S71-PMC5045784	['in addition, large-SCALE Human studies MAY yield altered risk for bpd in ASSOCIATION with Vitamin D-Binding Protein and Vdr polymorphisms.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('NCBITaxon_9606', 'Homo sapiens', 25, 'human'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 90, 'vitamin D-binding protein'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 120, 'VDR')]
PMC5045784	10/2016	S74-PMC5045784	['fetal and newborn concentrations of 25(Oh)D DEPEND ON and CORRELATE with maternal Serum levels AS the fetus has no endogenous production of 25(Oh)d and DEPENDS on transplacental transfer.28THIS occurs MAINLY in the third trimester and THEREFORE, as we and others PREVIOUSLY REPORTED, preterm infants are at INCREASED RISK of Vitamin D deficiency.10,29our PRIOR STUDY DEMONSTRATED that Birth before 32 completed weeks of Gestation is an INDEPENDENT RISK FACTOR for low 25(Oh)d levels at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 152), ('PROBABLE_UNDERSTANDING', 187), ('PROBABLE_UNDERSTANDING', 201), ('PROBABLE_UNDERSTANDING', 235), ('INCOMPLETE_EVIDENCE', 263), ('IMPORTANT_CONSIDERATION', 307), ('INCOMPLETE_EVIDENCE', 355), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 436), ('SUPERFICIAL_RELATIONSHIP', 448)]	13	[('CHEBI_71657', 'versiconol acetate', 36, '25(OH)D'), ('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_63056', 'zinc cation', 140, '25(OH'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('GO_0007567', 'parturition', 385, 'birth'), ('GO_0007565', 'female pregnancy', 420, 'gestation'), ('CHEBI_30778', 'gallic acid', 468, '25(OH)'), ('GO_0007567', 'parturition', 486, 'birth')]
PMC5045784	10/2016	S77-PMC5045784	[', wagner et al.30,31and others have DEMONSTRATED that Vitamin D status at Birth is modifiable through maternal supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 36)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007567', 'parturition', 74, 'birth'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy')]
PMC5045784	10/2016	S78-PMC5045784	['two RECENTLY published large intervention trials of additional Vitamin D supplementation during Pregnancy in the united states32and europe33showed TRENDS but no significant decreases in the incidence of childhood wheezing and asthma in the first 3 years of Life among the offspring.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 147)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('UBERON_0000104', 'life cycle', 257, 'life')]
PMC5045784	10/2016	S79-PMC5045784	['HOWEVER, these studies DID NOT address the ROLE of Vitamin D status in bpd, wheezing and asthma among preterm infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5045784	10/2016	S85-PMC5045784	['the adequacy of current Postnatal nutritional supplementation of Vitamin D HAS RECENTLY BEEN assessed in Preterm infants in the united states and in europe.']	[('INCOMPLETE_EVIDENCE', 75)]	1	[('GO_0007567', 'parturition', 24, 'postnatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'preterm')]
PMC5045784	10/2016	S86-PMC5045784	['mccarthy et al.29REPORTED that in a cohort of 274 preterm infants (<32 weeks) in ireland, levels of 25(Oh)D REMAINED under 20\u2009ng\u2009ml−1in 78% of subjects DESPITE 18 days on average of enteral Feeding and Vitamin D supplementation.29a RECENT intervention TRIAL by fort et al.17DEMONSTRATED that biochemical Vitamin D deficiency among EXTREMELY preterm infants CAN be reduced by additional supplementation with 200 units of Vitamin D daily, and PREVENTED by additional supplementation with 800 units of Vitamin D daily17and these two regimens were FOUND TO BE SAFE.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 108), ('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 232), ('PROBABLE_UNDERSTANDING', 272), ('PROBABLE_UNDERSTANDING', 272), ('IMPORTANT_CONSIDERATION', 331), ('INCOMPLETE_EVIDENCE', 357), ('SUPERFICIAL_RELATIONSHIP', 441), ('ANOMALY_CURIOUS_FINDING', 544), ('IMPORTANT_CONSIDERATION', 556)]	11	[('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 106, 'D'), ('GO_0007631', 'feeding behavior', 190, 'feeding'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 420, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D')]
PMC5045784	10/2016	S87-PMC5045784	['there are several LIMITATIONS in OUR STUDY, including its SMALL sample size, risk of selection bias and lack of data on Prenatal Vitamin D supplementation and maternal 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('INCOMPLETE_EVIDENCE', 58)]	3	[('GO_0007565', 'female pregnancy', 120, 'prenatal'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 170, '(OH)D')]
PMC5045784	10/2016	S91-PMC5045784	['in CONCLUSION, we FOUND that low 25(Oh)D levels (<30\u2009ng\u2009ml−1) are frequent and MODIFIABLE among preterm infants at Birth, HOWEVER, in our study samples we did not detect any association between Vitamin D status and Pulmonary or other morbidities of prematurity.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	4	[('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 39, 'D'), ('GO_0007567', 'parturition', 115, 'birth'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('UBERON_0002048', 'lung', 215, 'pulmonary')]
PMC5045784	10/2016	S92-PMC5045784	["the CURRENT PRACTICE of TARGETING nutritional Intake of 400\u2009iu per day Vitamin D is sufficient to achieve Serum 25(Oh)D levels >30\u2009ng\u2009ml−1at 36 weeks' corrected age."]	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_WORK', 24)]	2	[('GO_0007631', 'feeding behavior', 46, 'intake'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 112, '25(OH)D')]
PMC5045784	10/2016	S93-PMC5045784	['given the LIMITATIONS of a MODEST sample size of our study, we PROPOSE that our data combined with others for a meta-analysis MAY BE WARRANTED before CONSIDERATION of interventional trials of Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 126), ('FUTURE_WORK', 133), ('FUTURE_WORK', 150)]	6	[('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC5062906	10/2016	S0-PMC5062906	['maternal Vitamin D depletion alters Dna Methylation at Imprinted loci in multiple generations\n\nabstract\n\nbackground\nenvironmental perturbation of epigenetic mechanisms is LINKED to a GROWING NUMBER OF diseases.']	[('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 191)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0006306', 'DNA methylation', 36, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 55, 'imprinted')]
PMC5062906	10/2016	S13-PMC5062906	['conclusions\nTHESE FINDINGS DEMONSTRATE that maternal Vitamin D status plays a ROLE in determining Dna Methylation state in the germline and Soma.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0006306', 'DNA methylation', 98, 'DNA methylation'), ('GO_0044297', 'cell body', 140, 'soma')]
PMC5062906	10/2016	S14-PMC5062906	['detection of methylation changes in the unexposed second-generation DEMONSTRATES that maternal Vitamin D depletion CAN have long-term EFFECTS on the epigenome of subsequent generations.']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5062906	10/2016	S15-PMC5062906	['differences in Vitamin D-dependent epigenetic state between cell types and generations INDICATE perturbation of the epigenetic landscape RATHER than a targeted, locus-specific EFFECT.']	[('INCOMPLETE_EVIDENCE', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC5062906	10/2016	S33-PMC5062906	['APPROXIMATELY 32\xa0% of americans are AT RISK for Vitamin D inadequacy, having less than 25\xa0ng/ml Serum 25-Hydroxyvitamin D [15].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 36)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0001977', 'blood serum', 96, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 102, '25-hydroxyvitamin D')]
PMC5062906	10/2016	S39-PMC5062906	['HOWEVER, RECENT FINDINGS implicate Vitamin D in Regulating Histone Modifications [16,17] and Dna Methylation [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0065007', 'biological regulation', 48, 'regulating'), ('CHEBI_15358', 'histone', 59, 'histone'), ('GO_0016570', 'histone modification', 59, 'histone modifications'), ('PR_000043452', 'core histone', 59, 'histone'), ('GO_0006306', 'DNA methylation', 93, 'DNA methylation')]
PMC5062906	10/2016	S47-PMC5062906	['THESE FINDINGS IMPLICATE a ROLE for Vitamin D in determining epigenetic state and HIGHLIGHT the NEED FOR FURTHER STUDY to determine the mechanism and POTENTIAL LINKS to health and disease.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 82), ('FUTURE_WORK', 96), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 160)]	8	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC5062906	10/2016	S48-PMC5062906	['to address the ROLE of maternal Vitamin D in determining offspring epigenetic state, we used a Mouse MODEL to characterize WHETHER depletion of maternal Vitamin D during Gestation and Lactation AFFECTS epigenetic and developmental outcomes of progeny.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('SUPERFICIAL_RELATIONSHIP', 194)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 95, 'mouse'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'gestation'), ('GO_0007595', 'lactation', 184, 'lactation')]
PMC5062906	10/2016	S64-PMC5062906	['we FOUND that depletion of maternal Vitamin D results in perturbation of Dna Methylation state at icrs in Somatic Cells and to a lesser degree in Germ Cells in two generations of offspring.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0006306', 'DNA methylation', 73, 'DNA methylation'), ('CL_0002371', 'somatic cell', 106, 'somatic cells'), ('CL_0000586', 'germ cell', 146, 'germ cells')]
PMC5062906	10/2016	S68-PMC5062906	['the INFLUENCE of grandmaternal Vitamin D status on phenotypic and epigenetic outcomes DEMONSTRATES inheritance of perturbed epigenetic landscapes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 86)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5062906	10/2016	S78-PMC5062906	['1c) DEMONSTRATING a Genetic INFLUENCE on response to dietary Vitamin D depletion.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5062906	10/2016	S219-PMC5062906	['TO DETERMINE WHETHER the Vitamin D-dependent epigenetic perturbation REPORTED HERE results in transcriptional perturbation, we measured relative levels of igf2 , H19 , snrpn , and Grb10 in g2neonatal Liver.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 69), ('QUESTION_ANSWERED_BY_THIS_WORK', 78)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 162, 'H19'), ('PR_000008210', 'glutathione peroxidase 1', 180, 'Grb10'), ('UBERON_0002107', 'liver', 200, 'liver')]
PMC5062906	10/2016	S232-PMC5062906	['ONE LIKELY EXPLANATION for the sporadic methylation changes OBSERVED in response to Vitamin D depletion is perturbation of global epigenetic Programming AS an indirect EFFECT of Dysregulation of master epigenetic REGULATORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 4), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 153), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 213)]	7	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'programming'), ('GO_0060233', 'oenocyte delamination', 178, 'dysregulation')]
PMC5062906	10/2016	S242-PMC5062906	['we also FIND that parent and grandparent of origin plays in an IMPORTANT ROLE in the direction and extent of Vitamin D-DEPENDENT developmental and epigenetic EFFECTS in the offspring.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 158)]	5	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC5062906	10/2016	S250-PMC5062906	['ALTHOUGH Vitamin D deficiency HAS BEEN LINKED to adverse Pregnancy/Birth outcomes [14,46–52], there is currently NO STANDARD practice of screening women for Vitamin D deficiency during Pregnancy nor are there standard RECOMMENDATIONS beyond Prenatal Vitamins for supplementation during this CRITICAL time [53,54].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 113), ('FUTURE_WORK', 218), ('IMPORTANT_CONSIDERATION', 291)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 57, 'pregnancy ...'), ('GO_0007567', 'parturition', 67, 'birth'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy'), ('GO_0007565', 'female pregnancy', 241, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 250, 'vitamins')]
PMC5062906	10/2016	S251-PMC5062906	['our data HIGHLIGHT two mechanisms that CONTRIBUTE to interindividual DIFFERENCES in response to Vitamin D deficiency: the Genetic INFLUENCE on maternal Plasma depletion of 25(Oh)D and the INFLUENCE of parent and grandparent of origin in the extent of Vitamin D-DEPENDENT developmental and epigenetic outcomes.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('SUPERFICIAL_RELATIONSHIP', 130), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 261)]	6	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('SO_0000704', 'gene', 122, 'genetic'), ('UBERON_0001969', 'blood plasma', 152, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 172, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D')]
PMC5062906	10/2016	S254-PMC5062906	['this is MOST LIKELY the result of Genetic DIFFERENCES in Vitamin D Metabolism and STUDIES are ONGOING to identify and characterize the loci responsible.']	[('PROBABLE_UNDERSTANDING', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 82), ('IMPORTANT_CONSIDERATION', 94)]	4	[('SO_0000704', 'gene', 34, 'genetic'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 57, 'vitamin D metabolism')]
PMC5062906	10/2016	S256-PMC5062906	['Genetic INFLUENCES on adiposity MAY also indirectly explain DIFFERENCES in Vitamin D depletion SINCE adiposity HAS BEEN LINKED to Vitamin D levels [55].']	[('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 120)]	6	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5062906	10/2016	S264-PMC5062906	['THEREFORE, the Vitamin D-dependent parent of origin EFFECTS REPORTED HERE MAY BE INFLUENCED by EITHER epigenetic mechanisms OR Genetic DIFFERENCES in cis or trans .']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135)]	8	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic')]
PMC5062906	10/2016	S268-PMC5062906	['HOWEVER, we CANNOT COMPLETELY RULE OUT the POSSIBILITY that cis -acting Allelic DIFFERENCES in g1and g2animals somehow INFLUENCES the Vitamin D-DEPENDENT parent of origin epigenetic EFFECTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 182)]	7	[('SO_0001023', 'allele', 72, 'allelic'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5062906	10/2016	S269-PMC5062906	['the grandmaternal dietary INFLUENCE on g2phenotype and epigenetic outcome we report HERE DEMONSTRATES inheritance of Vitamin D-induced epigenetic perturbation.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 84), ('INCOMPLETE_EVIDENCE', 89)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5062906	10/2016	S283-PMC5062906	['these observations SUGGEST that Vitamin D-induced changes in methylation are MOST LIKELY the result of sporadic epimutations due TO global dysregulation of epigenetic maintenance and that disruption of epigenetic Regulatory mechanisms is MOST LIKELY the causal FACTOR.']	[('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 77), ('PROBABLE_UNDERSTANDING', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 129), ('PROBABLE_UNDERSTANDING', 238), ('PROBABLE_UNDERSTANDING', 243), ('SUPERFICIAL_RELATIONSHIP', 261)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 213, 'regulatory')]
PMC5062906	10/2016	S292-PMC5062906	['percent variation explained by each component is listed in parentheses on each axis\nin SUPPORT of our hypotheses that maternal Vitamin D deficiency leads to global dysregulation of epigenetic maintenance via disruption of epigenetic Regulatory factors, we find that dnmt3b Transcript levels are upregulated in cross 1 neonatal Liver from lvd group compared to con.']	[('INCOMPLETE_EVIDENCE', 87)]	1	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0065007', 'biological regulation', 233, 'regulatory'), ('SO_0000673', 'transcript', 273, 'transcript'), ('UBERON_0002107', 'liver', 327, 'liver')]
PMC5062906	10/2016	S296-PMC5062906	['our data SUGGESTS that Vitamin D-dependent dysregulation of epigenetic mechanisms is spatially and temporally Regulated.']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0065007', 'biological regulation', 110, 'regulated')]
PMC5062906	10/2016	S305-PMC5062906	['7b) INDICATING that epigenetic changes in the Soma resulting from direct exposure to Vitamin D deficiency in utero are DIFFERENT than those resulting from indirect exposure in the next Generation (G2).']	[('INCOMPLETE_EVIDENCE', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119)]	2	[('GO_0044297', 'cell body', 46, 'soma'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007281', 'germ cell development', 185, 'generation ... G2 ...')]
PMC5062906	10/2016	S313-PMC5062906	['STUDIES are ONGOING to characterize Genome-wide epigenetic EFFECTS of maternal Vitamin D depletion including the IMPACT of Genetic differences in determining epigenetic and phenotypic outcomes.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('SO_0001026', 'genome', 36, 'genome'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('SO_0000704', 'gene', 123, 'genetic')]
PMC5064894	10/2016	S9-PMC5064894	['we HYPOTHESIZE that among infants 0–6 months of age, the incidence of microbiologically-confirmed viral ari will be significantly lower in infants whose mothers received high-dose Prenatal/Postpartum Vitamin D supplements versus placebo.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('GO_0007565', 'female pregnancy', 180, 'prenatal'), ('GO_0007565', 'female pregnancy', 189, 'postpartum'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC5064894	10/2016	S11-PMC5064894	['discussion\nIF SHOWN to reduce the RISK of viral ari in infancy, integration of maternal Prenatal/Postpartum Vitamin D supplementation into Antenatal Care programs in south asia may be a FEASIBLE primary preventive STRATEGY to reduce THE BURDEN of ari-ASSOCIATED morbidity and mortality in young infants.']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 34), ('PROBABLE_UNDERSTANDING', 186), ('FUTURE_WORK', 214), ('IMPORTANT_CONSIDERATION', 233), ('SUPERFICIAL_RELATIONSHIP', 251)]	6	[('GO_0007565', 'female pregnancy', 88, 'prenatal'), ('GO_0007565', 'female pregnancy', 97, 'postpartum'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 139, 'antenatal care')]
PMC5064894	10/2016	S19-PMC5064894	['it HAS BEEN POSTULATED that lower Vitamin D levels MAY explain the seasonal variation in influenza and studies HAVE SHOWN that children with rickets are at INCREASED RISK of lower Respiratory Tract disease or pneumonia [2–4].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 111), ('IMPORTANT_CONSIDERATION', 156)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 180, 'respiratory tract')]
PMC5064894	10/2016	S20-PMC5064894	['higher rates of invasive pneumococcal disease HAVE BEEN ASSOCIATED with decreased ultraviolet light exposure through the POSTULATED mechanism of lower Vitamin D levels [5].']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 121)]	3	[('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
PMC5064894	10/2016	S21-PMC5064894	['Vitamin D HAS BEEN SHOWN to Modulate the Innate Immune Response in Lung Epithelial Cells [6,7], and Antimicrobial peptides induced by Vitamin D MAY have antiviral EFFECTS BASED on observed activity against Herpes Simplex Virus-1 (Hsv-1) [8], adenovirus [9], human immunodeficiency virus (hiv) [10] and vaccinia [11].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 163), ('QUESTION_ANSWERED_BY_THIS_WORK', 171)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0065007', 'biological regulation', 28, 'modulate'), ('GO_0045087', 'innate immune response', 41, 'innate immune response'), ('UBERON_0002405', 'immune system', 48, 'immune'), ('CL_0000082', 'epithelial cell of lung', 67, 'lung epithelial cells'), ('UBERON_0000115', 'lung epithelium', 67, 'lung epithelial'), ('CHEBI_65381', 'albizoside C', 100, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000008476', 'orexin', 206, 'herpes simplex virus'), ('NCBITaxon_10088', 'Mus <genus>', 230, 'HSV'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 230, 'HSV-1')]
PMC5064894	10/2016	S28-PMC5064894	['DESPITE these SUGGESTIVE results from observational studies, there HAVE BEEN FEW prospective randomized controlled trials examining the IMPACT of Vitamin D supplementation on RISK of ari in children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 175)]	7	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC5064894	10/2016	S32-PMC5064894	['the FIRST randomized trial of Prenatal Vitamin D supplementation on childhood wheeze was RECENTLY published [25].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 89)]	2	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC5064894	10/2016	S35-PMC5064894	['HOWEVER, the researchers identified multiple LIMITATIONS in their study including lack OF blinding of participants and subjective outcomes, SMALL sample size and LIMITED statistical power, and dosages of Vitamin D that lead to ONLY 13\xa0% of the daily group and 3\xa0% of the bolus group having Cord Serum 25 (Oh) D levels considered to be in a sufficient range.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 45), ('ANOMALY_CURIOUS_FINDING', 87), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 162), ('ANOMALY_CURIOUS_FINDING', 227)]	6	[('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 290, 'cord'), ('UBERON_0001977', 'blood serum', 295, 'serum'), ('CHEBI_71657', 'versiconol acetate', 301, '25 (OH) D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 305, 'OH ... D')]
PMC5064894	10/2016	S37-PMC5064894	['first, THERE HAVE BEEN NO STUDIES examining the EFFECT of Prenatal Vitamin D supplementation on a primary outcome of laboratory-confirmed Viral Respiratory infections in the first 6\xa0months of Life, a high-risk period for both Vitamin D deficiency and Respiratory Tract infections.']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('NCBITaxon_1', 'root', 138, 'viral'), ('UBERON_0001004', 'respiratory system', 144, 'respiratory'), ('UBERON_0000104', 'life cycle', 192, 'life'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 251, 'respiratory tract')]
PMC5064894	10/2016	S39-PMC5064894	['third, THERE HAVE BEEN NO STUDIES assessing the ASSOCIATION between Vitamin D supplementation and quantitative Nasal carriage of streptococcus pneumoniae (pneumococcus), the most IMPORTANT cause of bacterial lrti in young children worldwide.']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 179)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000004', 'nose', 111, 'nasal')]
PMC5064894	10/2016	S43-PMC5064894	['we HYPOTHESIZE that among infants 0–6 months, the incidence of microbiologically confirmed ari will be significantly lower in infants of mothers who received a relatively high dose of Vitamin D (28,000\xa0iu/week) during Pregnancy plus continued Postpartum supplementation (to 6\xa0months Postpartum) compared to mothers who received placebo throughout the Prenatal and Postpartum periods.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 218, 'pregnancy'), ('GO_0007565', 'female pregnancy', 243, 'postpartum'), ('GO_0007565', 'female pregnancy', 283, 'postpartum'), ('GO_0007565', 'female pregnancy', 351, 'prenatal'), ('GO_0007565', 'female pregnancy', 364, 'postpartum')]
PMC5064894	10/2016	S44-PMC5064894	['if a significantly decreased incidence of microbiologically confirmed ari is FOUND, we will further assess for EFFECT of lower doses of Prenatal maternal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 111)]	2	[('GO_0007565', 'female pregnancy', 136, 'prenatal'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5064894	10/2016	S163-PMC5064894	['THIS will TEST the core mechanistic HYPOTHESIS that IMPROVEMENTS in Vitamin D status via maternal Vitamin D supplementation reduce the RISK of ari among infants in dhaka.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 52), ('IMPORTANT_CONSIDERATION', 135)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC5064894	10/2016	S168-PMC5064894	['we thus maintain 80\xa0% power to address the QUESTION of WHETHER maternal Vitamin D supplementation CAN reduce the rate of microbiologically-confirmed acute Respiratory infections, while simultaneously being able to address WHETHER lower doses are also EFFECTIVE, and TO INVESTIGATE WHETHER a dose–response RELATIONSHIP exists, thereby SUPPORTING the biological PLAUSIBILITY and robustness of inferences.']	[('EXPLICIT_QUESTION', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55), ('EXPLICIT_QUESTION', 55), ('INCOMPLETE_EVIDENCE', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 222), ('SUPERFICIAL_RELATIONSHIP', 251), ('QUESTION_ANSWERED_BY_THIS_WORK', 266), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('SUPERFICIAL_RELATIONSHIP', 305), ('INCOMPLETE_EVIDENCE', 334), ('INCOMPLETE_EVIDENCE', 360)]	11	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]
PMC5064894	10/2016	S171-PMC5064894	['in secondary analyses, we will consider aggregation of multiple Vitamin D arms (e.g., group d and e), which will have the benefit of increasing the sample size; HOWEVER, for the a priori primary outcome analysis, we have decided to retain the separation of the groups (according to the design of the mdig trial) to LIMIT the POSSIBILITY of increasing a type ii ERROR IF a TRUE effect of the longer duration or higher-dose intervention were diluted by the lack OF effect of the other group(s).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 161), ('INCOMPLETE_EVIDENCE', 315), ('INCOMPLETE_EVIDENCE', 325), ('PROBLEM_COMPLICATION', 361), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('PROBABLE_UNDERSTANDING', 372), ('ANOMALY_CURIOUS_FINDING', 460)]	7	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5064894	10/2016	S193-PMC5064894	['discussion\nthe mdari study in dhaka, bangladesh leverages the infrastructure of a large randomized placebo controlled, dose-ranging trial of maternal Vitamin D supplementation during Pregnancy and Lactation in bangladesh TO TEST the HYPOTHESIS that maternal Vitamin D supplementation CAN decrease infant Respiratory infections during the HIGH RISK first 6\xa0months of infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 221), ('INCOMPLETE_EVIDENCE', 233), ('INCOMPLETE_EVIDENCE', 284), ('IMPORTANT_CONSIDERATION', 338)]	4	[('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'pregnancy'), ('GO_0007595', 'lactation', 197, 'lactation'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 304, 'respiratory')]
PMC5064894	10/2016	S194-PMC5064894	['IF SHOWN to reduce the RISK of ari in infancy, integration of maternal Prenatal/Postpartum Vitamin D supplementation into Antenatal Care programs in south asia MAY BE a FEASIBLE primary preventive STRATEGY to reduce THE BURDEN of ari-associated morbidity and mortality in young infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 160), ('PROBABLE_UNDERSTANDING', 169), ('FUTURE_WORK', 197), ('IMPORTANT_CONSIDERATION', 216)]	7	[('GO_0007565', 'female pregnancy', 71, 'prenatal'), ('GO_0007565', 'female pregnancy', 80, 'postpartum'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 122, 'antenatal care')]
PMC5084016	10/2016	S93-PMC5084016	['Calcium metabolism also REQUIRES Vitamin D, the lack of which CAN also be due to calcium deficiency: in both cases, the result is a reduced mineralization of the bone matrix.']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 62)]	2	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5084016	10/2016	S117-PMC5084016	['the circulating levels of Vitamin D are ONLY PARTLY AFFECTED by the dietary intakes.']	[('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 52)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC5084016	10/2016	S118-PMC5084016	['IN FACT, ONLY the FIRST of the two Hydroxylation processes occurring in Vitamin D Metabolism (e.g., that responsible for the production of 25-Hydroxy-Vitamin D) is Modulated by the dietary contribution to SOME extent (the increase of circulating levels is not proportional to the amount Ingested).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 205)]	4	[('GO_0044444', 'cytoplasmic part', 35, 'hydroxylation'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 72, 'vitamin D metabolism'), ('CHEBI_43141', '3-hydroxypropoxy group', 139, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('GO_0065007', 'biological regulation', 164, 'modulated'), ('GO_0007631', 'feeding behavior', 287, 'ingested')]
PMC5084016	10/2016	S121-PMC5084016	['with Aging, the Synthesis Of Vitamin D in the Epidermis Layer becomes less efficient; also, diseases ASSOCIATED with Intestinal malabsorption, such as celiac disease, crohn’s disease, cystic fibrosis, ulcerative colitis, Liver and Kidney disorders and SOME Pharmacological treatments, MAY CONTRIBUTE to the development of Vitamin D deficiency [57].']	[('SUPERFICIAL_RELATIONSHIP', 101), ('INCOMPLETE_EVIDENCE', 252), ('INCOMPLETE_EVIDENCE', 285), ('SUPERFICIAL_RELATIONSHIP', 289)]	4	[('GO_0007568', 'aging', 5, 'aging'), ('GO_0030474', 'spindle pole body duplication', 16, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0002027', 'stratum corneum of epidermis', 46, 'epidermis layer'), ('UBERON_0000160', 'intestine', 117, 'intestinal'), ('UBERON_0002107', 'liver', 221, 'liver'), ('UBERON_0002113', 'kidney', 231, 'kidney'), ('CHEBI_52217', 'pharmaceutical', 257, 'pharmacological'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D')]
PMC5084016	10/2016	S132-PMC5084016	['DESPITE the LACK OF CONSENSUS on adequate intakes among DIFFERENT countries (table 3), supplementation with Vitamin D is RECOMMENDED for all Pregnant women at a dose of 600 iu/day (15 µg/day) [57].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('FUTURE_WORK', 121)]	6	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'pregnant')]
PMC5084016	10/2016	S136-PMC5084016	['moreover, the habitual dietary Intake of Vitamin D MAY BE limited in specific conditions of higher REQUIREMENTS and in areas and/or countries with little availability of food sources [62].']	[('INCOMPLETE_EVIDENCE', 51), ('IMPORTANT_CONSIDERATION', 99)]	2	[('GO_0007631', 'feeding behavior', 31, 'intake'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5084016	10/2016	S170-PMC5084016	['a systematic review of the literature HIGHLIGHTED an INCREASED RISK of iron and Vitamin B 12 deficiency and low Birth weight in ASSOCIATION with vegetarian or strictly vegan diets, DESPITE the absence of adverse EFFECTS for the fetus [79].']	[('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 53), ('SUPERFICIAL_RELATIONSHIP', 128), ('ANOMALY_CURIOUS_FINDING', 181), ('SUPERFICIAL_RELATIONSHIP', 212)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin B'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 80, 'vitamin B 12'), ('GO_0007567', 'parturition', 112, 'birth')]
PMC5084016	10/2016	S185-PMC5084016	['in cases of post-surgery Conception, specific nutritional deficiencies CAN AFFECT Visual Acuity (Vitamin A) and the Development Of the Nervous System (Vitamin B12) and Neural Tube (folates) [87,88].']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('GO_0007620', 'copulation', 25, 'conception'), ('GO_0019042', 'viral latency', 82, 'visual acuity'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0035882', 'defecation rhythm', 116, 'development of ... nervous system'), ('UBERON_0001016', 'nervous system', 135, 'nervous system'), ('CHEBI_33279', 'vitamin D5', 151, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 151, 'vitamin B12'), ('UBERON_0001049', 'neural tube', 168, 'neural tube')]
PMC5084028	10/2016	S151-PMC5084028	['this is because Nutrients CAN INTERACT with each other in both a positive (e.g., Vitamin A and zinc [127]) and negative manner (e.g., calcium or iron and zinc [128,129]).']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_33284', 'nutrient', 16, 'nutrients'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin A')]
PMC5084041	10/2016	S0-PMC5084041	['Vitamin D status during Pregnancy in a multi-ethnic population-representative swedish cohort\n\nabstract\nthere is currently LITTLE INFORMATION on changes in Vitamin D status during Pregnancy and its PREDICTORS.']	[('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 197)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 24, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 179, 'pregnancy')]
PMC5084041	10/2016	S10-PMC5084041	['the DETERMINANTS of season-corrected change in 25(Oh)D were origin, sun-Seeking behaviour, clothing style, dietary Vitamin D intake, Vitamin D supplementation and recent travel <35° n. in CONCLUSION, season-corrected 25(Oh)D concentration increased during Pregnancy and DEPENDED PARTLY on lifestyle FACTORS.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 188), ('SUPERFICIAL_RELATIONSHIP', 270), ('INCOMPLETE_EVIDENCE', 279), ('SUPERFICIAL_RELATIONSHIP', 299)]	5	[('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 53, 'D'), ('GO_0007601', 'visual perception', 72, 'seeking'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 133, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 141, 'D'), ('CHEBI_71657', 'versiconol acetate', 217, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 217, '25(OH)D'), ('GO_0007565', 'female pregnancy', 256, 'pregnancy')]
PMC5084041	10/2016	S12-PMC5084041	['among them, the DETERMINANTS of both Vitamin D deficiency and change in season-corrected Vitamin D status were fewer, INDICATING a smaller EFFECT of sun exposure.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5084041	10/2016	S14-PMC5084041	['introduction\nduring the past decade, Vitamin D has received INCREASING ATTENTION and has been ASSOCIATED with health BENEFITS in addition to its RECOGNIZED EFFECTS on bone health.']	[('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 94), ('IMPORTANT_CONSIDERATION', 117), ('PROBABLE_UNDERSTANDING', 145), ('SUPERFICIAL_RELATIONSHIP', 156)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5084041	10/2016	S18-PMC5084041	['POOR maternal Vitamin D status HAS also BEEN ASSOCIATED with Pregnancy COMPLICATIONS such as Preeclampsia [3], premature Birth [4] and infants Born small for Gestational age [5].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('PROBLEM_COMPLICATION', 71)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 93, 'preeclampsia'), ('GO_0007567', 'parturition', 121, 'birth'), ('GO_0007567', 'parturition', 143, 'born'), ('GO_0007565', 'female pregnancy', 158, 'gestational')]
PMC5084041	10/2016	S22-PMC5084041	['SINCE data on Gestational Vitamin D status in populations living at latitudes without seasonality in cutaneous Vitamin D Synthesis are SCARCE, a season-corrected analysis is a way of investigating changes in 25(Oh)D during Pregnancy per se.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 135)]	2	[('GO_0007565', 'female pregnancy', 14, 'gestational'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 111, 'vitamin D synthesis'), ('CHEBI_71657', 'versiconol acetate', 208, '25(OH)D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC5084041	10/2016	S23-PMC5084041	['such analyses of 25(Oh)D concentrations during Pregnancy SHOW that Vitamin D status between early and late Pregnancy tracks moderately and that change DEPENDS ON supplement use, Gestational weight gain and physical activity [12].']	[('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 151)]	2	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH)D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy'), ('GO_0007565', 'female pregnancy', 178, 'gestational')]
PMC5084041	10/2016	S26-PMC5084041	['data from other studies SHOW that immigrant women in sweden are at higher RISK of Vitamin D deficiency than women of swedish origin [14,15].']	[('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 74)]	2	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC5084041	10/2016	S31-PMC5084041	['population-representative data on Vitamin D status during Pregnancy IS NEEDED to evaluate the POTENTIAL NEED for new PUBLIC-HEALTH policies and to provide reliable data on potential RISK groups for Vitamin D deficiency.']	[('FUTURE_WORK', 68), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 104), ('IMPORTANT_CONSIDERATION', 117), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 182)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC5084041	10/2016	S32-PMC5084041	['FEW STUDIES have investigated Vitamin D status longitudinally in a large cohort of Pregnant women, and knowledge of change in Vitamin D status during Pregnancy and its DETERMINANTS are LACKING.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 168), ('FULL_UNKNOWN', 185)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy')]
PMC5084041	10/2016	S69-PMC5084041	['variables included in multivariate analyses were selected on the basis of biological PLAUSIBILITY; the POTENTIAL DETERMINANTS of Vitamin D deficiency at t1 were season, Clothing style, recent travel to <35° n, sun-seeking behaviour, Vitamin D supplement use (including multivitamin supplements containing Vitamin D), Vitamin D intake (from oily fish and Milk), origin, bmi at t1, tobacco use at t1 and age.']	[('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_2002051', 'scale circulus', 169, 'clothing'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 305, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin D'), ('UBERON_0001913', 'milk', 354, 'milk')]
PMC5084041	10/2016	S106-PMC5084041	['a season-corrected analysis of change in 25(Oh)D SHOWED that the DETERMINANTS of change in 25(Oh)D during Pregnancy were origin, sun-Seeking behaviour, clothing style, dietary Vitamin D intake at t3, Vitamin D supplementation at t3 and having travelled to <35° n in the past six months (adjusted r2= 0.186) (table 3).']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('CHEBI_71657', 'versiconol acetate', 41, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 47, 'D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('GO_0007601', 'visual perception', 133, 'seeking'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC5084041	10/2016	S110-PMC5084041	['discussion\noverall, OUR FINDINGS SHOW that the prevalence of Vitamin D deficiency is low among Pregnant women in sweden.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 33)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant')]
PMC5084041	10/2016	S113-PMC5084041	['OUR FINDINGS SHOW that the prevalence of Vitamin D deficiency is 10% overall and 2% among women Born in north europe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'born')]
PMC5084041	10/2016	S116-PMC5084041	['RISK FACTORS for Vitamin D deficiency (25(Oh)D <30 nmol/l) in early Pregnancy were IN LINE WITH PREVIOUS FINDINGS [13,17,27].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 96)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 39, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 39, '25'), ('PR_000006444', 'diacylglycerol kinase delta', 45, 'D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC5084041	10/2016	S118-PMC5084041	['FEW STUDIES have PREVIOUSLY investigated changes in Vitamin D status during Pregnancy and results were CONFLICTING.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC5084041	10/2016	S123-PMC5084041	['this MAY PARTLY be EXPLAINED by less Vitamin D supplement use in late Pregnancy than in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 19)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC5084041	10/2016	S124-PMC5084041	['in OUR STUDY, the proportion of women using Vitamin D supplements was SIMILAR at t1 and t3, but IT IS POSSIBLE that supplement use CONTRIBUTED to the increase in 25(Oh)D if supplementation was initiated shortly before t1.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 131)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D')]
PMC5084041	10/2016	S136-PMC5084041	['we FOUND that DETERMINANTS of change in season-corrected Vitamin D status were RELATED to sun exposure (sun-Seeking behaviour, clothing style, and travel <35° n), Vitamin D intake (dietary and supplementary) and origin.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 79)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007568', 'aging', 107, '-seeking'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC5084041	10/2016	S138-PMC5084041	['moon et al SHOWED that Vitamin D supplementation is RELATED to changes in 25(Oh)D between the first and the third trimester, which SUPPORTS OUR FINDINGS [12].']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 140)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 74, '25(OH)D')]
PMC5084041	10/2016	S141-PMC5084041	['we FOUND that the ONLY DETERMINANT of change in the subgroup Born in africa and asia was Vitamin D supplement use.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 18), ('SUPERFICIAL_RELATIONSHIP', 23)]	3	[('GO_0007567', 'parturition', 61, 'born'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5084041	10/2016	S143-PMC5084041	['a LIMITATION of THIS STUDY is that sampling was overrepresented during autumn and spring, when Vitamin D status is highest and lowest, respectively.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5084041	10/2016	S145-PMC5084041	['HOWEVER, this was, IN PART, overcome by the season-correction of change in Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 19)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5084041	10/2016	S156-PMC5084041	['among women Born in africa and asia, the DETERMINANTS of both Vitamin D deficiency and change in season-corrected Vitamin D status were fewer, INDICATING a smaller EFFECT of sun exposure.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 164)]	3	[('GO_0007567', 'parturition', 12, 'born'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5084041	10/2016	S157-PMC5084041	['these results SUGGEST that TARGETED PUBLIC HEALTH INTERVENTION to treat and prevent Vitamin D deficiency in these RISK groups IS WARRANTED.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 27), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 114), ('FUTURE_WORK', 126)]	6	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC5100620	10/2016	S154-PMC5100620	['no such effects on Lipids were FOUND in the nepal trial that included multiple Micronutrient supplements and allocated Vitamin A only as control.19\n\nGlucose Metabolism\nchildren of mothers receiving mms had significantly lower fasting Glucose levels as compared with those allocated to the standard fe60f.']	[('INCOMPLETE_EVIDENCE', 31)]	1	[('CHEBI_18059', 'lipid', 19, 'lipids'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 79, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin A'), ('CHEBI_17234', 'glucose', 149, 'Glucose'), ('GO_0006006', 'glucose metabolic process', 149, 'Glucose metabolism'), ('CHEBI_17234', 'glucose', 234, 'glucose')]
PMC5129897	10/2016	S0-PMC5129897	['estimated economic BENEFIT of increasing 25-Hydroxyvitamin D concentrations of canadians to or above 100\xa0nmol/l\n\nabstractabstract\nMOUNTING EVIDENCE from observational and clinical TRIALS INDICATES that optimal Vitamin D reduces the RISK of many diseases.']	[('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 130), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 232)]	5	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 41, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC5129897	10/2016	S4-PMC5129897	['we used 25(Oh)D concentration–health outcome RELATIONS for Breast cancer and Cardiovascular disease and results of clinical trials with Vitamin D for Respiratory infections and Musculoskeletal disorders to ESTIMATE the reductions in disease BURDEN for increased 25(Oh)D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 206), ('IMPORTANT_CONSIDERATION', 241)]	3	[('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 14, 'D'), ('UBERON_0000310', 'breast', 59, 'breast'), ('UBERON_0004535', 'cardiovascular system', 77, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 150, 'respiratory'), ('UBERON_0002204', 'musculoskeletal system', 177, 'musculoskeletal'), ('CHEBI_71657', 'versiconol acetate', 262, '25(OH)D')]
PMC5129897	10/2016	S6-PMC5129897	['HOWEVER, the EFFECTS on disease incidence, economic BURDEN, and mortality rate would be phased in gradually over several years PRIMARILY because once a chronic disease is established, Vitamin D AFFECTS its progression ONLY modestly.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 52), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 194), ('ANOMALY_CURIOUS_FINDING', 218), ('INCOMPLETE_EVIDENCE', 218)]	7	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5129897	10/2016	S8-PMC5129897	['introduction\nduring the past 15\xa0years, CONSIDERABLE INTEREST in the health BENEFITS of Vitamin D has emerged BECAUSE People with higher ultraviolet-b (uvb) exposure and/or 25-Hydroxyvitamin D [25(Oh)D] concentrations have lower RISK of many diseases and conditions.1our analysis is LIMITED to the diseases with the greatest economic EFFECT and the STRONGEST evidence of PROTECTIVE ROLES of Vitamin D—namely, cancer, Cardiovascular disease (cvd), dementia, diabetes mellitus (dm), falls and fractures, multiple sclerosis (ms), and Respiratory Tract infections.']	[('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 75), ('PROBABLE_UNDERSTANDING', 109), ('IMPORTANT_CONSIDERATION', 228), ('INCOMPLETE_EVIDENCE', 282), ('SUPERFICIAL_RELATIONSHIP', 333), ('INCOMPLETE_EVIDENCE', 348), ('SUPERFICIAL_RELATIONSHIP', 370), ('SUPERFICIAL_RELATIONSHIP', 381)]	11	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'people'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 172, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 390, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 416, 'cardiovascular'), ('UBERON_0000065', 'respiratory tract', 530, 'respiratory tract')]
PMC5129897	10/2016	S9-PMC5129897	['table\xa01outlines information SUPPORTING the ROLE of Vitamin D in reducing RISK of those diseases.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 43), ('IMPORTANT_CONSIDERATION', 73)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5129897	10/2016	S12-PMC5129897	['the clinical trials listed FURTHER SUPPORT the ROLE of Vitamin D for SOME diseases.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 69)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5129897	10/2016	S14-PMC5129897	['FEW well-designed clinical TRIALS SHOW beneficial EFFECTS of Vitamin D MAINLY BECAUSE many such trials were BASED ON GUIDELINES for Pharmaceutical Drugs.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 50), ('PROBABLE_UNDERSTANDING', 71), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 108), ('ANOMALY_CURIOUS_FINDING', 114), ('ANOMALY_CURIOUS_FINDING', 114), ('PROBABLE_UNDERSTANDING', 117)]	9	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 132, 'pharmaceutical drugs')]
PMC5129897	10/2016	S16-PMC5129897	['NEITHER ASSUMPTION holds for Vitamin D. robert heaney OUTLINED the GUIDELINES for Nutrient studies including Vitamin D. the most RELEVANT features are that one SHOULD start with an understanding of the 25(Oh)D concentration–health outcome RELATION, 25(Oh)D concentrations SHOULD BE measured in prospective participants, ONLY those with low concentrations SHOULD BE enrolled, sufficient Vitamin D SHOULD BE given to raise 25(Oh)D concentrations to where a significant beneficial EFFECT is expected, and achieved 25(Oh)D concentrations SHOULD BE measured.2until those steps are followed routinely, FEW Vitamin D clinical TRIALS will report beneficial EFFECTS.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 67), ('PROBABLE_UNDERSTANDING', 67), ('IMPORTANT_CONSIDERATION', 129), ('FUTURE_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 239), ('FUTURE_WORK', 272), ('INCOMPLETE_EVIDENCE', 320), ('FUTURE_WORK', 355), ('FUTURE_WORK', 396), ('SUPERFICIAL_RELATIONSHIP', 478), ('FUTURE_WORK', 534), ('INCOMPLETE_EVIDENCE', 596), ('FUTURE_WORK', 619), ('SUPERFICIAL_RELATIONSHIP', 649)]	17	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_33284', 'nutrient', 82, 'nutrient'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 249, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 386, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 421, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 427, 'D'), ('CHEBI_71657', 'versiconol acetate', 511, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 517, 'D'), ('CHEBI_27300', 'vitamin D', 600, 'vitamin D')]
PMC5129897	10/2016	S17-PMC5129897	['a review of clinical trials of Vitamin D with respect to biomarkers of inflammation SHOWS WHY following those guidelines is IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 84), ('EXPLICIT_QUESTION', 90), ('IMPORTANT_CONSIDERATION', 124)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5129897	10/2016	S20-PMC5129897	['the criteria most RELEVANT for Vitamin D are strength of ASSOCIATION, CONSISTENT findings in DIFFERENT populations, temporality, biological gradient, plausibility (e.g., mechanisms), coherence with known facts, and experiments (e.g., clinical trials).5not all criteria NEED be satisfied, BUT the more that are, the stronger the case.']	[('IMPORTANT_CONSIDERATION', 18), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('IMPORTANT_CONSIDERATION', 269), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 288)]	6	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5129897	10/2016	S21-PMC5129897	["hill's criteria HAVE BEEN used to evaluate the beneficial EFFECTS of Vitamin D for cancer,6,7cvd,8and ms.9\n\ncaption (table-Wrap): table 1."]	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('PR_000017453', 'protein Wnt-9b', 123, 'WRAP')]
PMC5129897	10/2016	S22-PMC5129897	['diseases included in THIS STUDY along with a brief overview of the mechanisms of Vitamin D for each disease and a listing of a few observational studies and clinical trials in support.diseasemechanismsobservational studiesclinical trialscancereffects on cells, Angiogenesis, and metastasis10breast and Colorectal cancer incidence11; survival12breast and all-cancer incidence13cvdeffects on Serum Cholesterol levels, Arterial stiffness, Insulin resistance, hyperglycemia, and increased incident Metabolic syndrome are POTENTIALLY PLAUSIBLE mediators8refs.14,15effect on cvd risk factors16dementiaregulation of Calcium Homeostasis, clearance of Amyloid-Β peptide, antioxidant and anti-inflammatory EFFECTS, and POSSIBLE protection against the neurodegenerative mechanisms ASSOCIATED with ad17incidence18\xa0dmimproves Insulin sensitivity and secretion, mainly via its anti-inflammatory properties19incidence20; meta-analysis21\xa0falls and fracturesreduces bone mass loss by reducing inflammation22; maintains cognition23; helps maintain muscle mass24ref.25ref.26mseffects on Regulatory T and B Cells27Ref.28\xa0respiratory infectionsinduction of Cathelicidin and defensins29; strengthens Adaptive and innate Immune System30Pneumonia31Influenza32,33; ari34\nad, alzheimer disease; ari, acute Respiratory Tract infection; cvd, Cardiovascular disease; dm, diabetes mellitus; ms, multiple sclerosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 517), ('INCOMPLETE_EVIDENCE', 529), ('SUPERFICIAL_RELATIONSHIP', 696), ('INCOMPLETE_EVIDENCE', 709), ('SUPERFICIAL_RELATIONSHIP', 770)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0001525', 'angiogenesis', 261, 'angiogenesis'), ('UBERON_0012652', 'colorectum', 302, 'colorectal'), ('UBERON_0001977', 'blood serum', 390, 'serum'), ('CHEBI_16113', 'cholesterol', 396, 'cholesterol'), ('UBERON_0001637', 'artery', 416, 'arterial'), ('PR_000045358', 'insulin family protein', 436, 'insulin'), ('GO_0008152', 'metabolic process', 494, 'metabolic'), ('GO_0055073', 'cadmium ion homeostasis', 609, 'calcium homeostasis'), ('PR_000004519', 'autism susceptibility gene 2 protein', 643, 'amyloid-β'), ('PR_000045358', 'insulin family protein', 813, 'insulin'), ('CL_0000815', 'regulatory T cell', 1068, 'regulatory T ...'), ('GO_0065007', 'biological regulation', 1068, 'regulatory'), ('CL_0000960', 'T3 B cell', 1085, 'B cells27Ref'), ('PR_000006009', 'alpha-catulin', 1136, 'cathelicidin'), ('GO_0051886', 'negative regulation of timing of anagen', 1178, 'adaptive ...'), ('UBERON_0003822', 'forelimb stylopod', 1198, 'immune system30Pneumonia31Influenza32'), ('UBERON_0000065', 'respiratory tract', 1280, 'respiratory tract'), ('UBERON_0004535', 'cardiovascular system', 1314, 'cardiovascular')]
PMC5129897	10/2016	S23-PMC5129897	['the PURPOSE of THIS NEW STUDY is to revisit Vitamin D concentrations of canadians and to ESTIMATE the economic BENEFIT of increasing 25(Oh)D concentrations, with the knowledge that overall 25(Oh)D concentrations have gone down since our PREVIOUS STUDY.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('FULL_UNKNOWN', 20), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 111), ('INCOMPLETE_EVIDENCE', 237)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 139, 'D'), ('CHEBI_71657', 'versiconol acetate', 189, '25(OH)D')]
PMC5129897	10/2016	S24-PMC5129897	['the EVIDENCE for the ROLE of Vitamin D for diseases considered in 2010 has increased.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 21)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5129897	10/2016	S27-PMC5129897	['materials and methods\npublications on the RELATIONS between 25(Oh)D concentrations and health outcomes were obtained LARGELY by searchingpubmed.govandscholar.google.comfor terms such as Vitamin D, 25-Hydroxyvitamin D, meta-analysis, Back and Spine disorders, cancer, Cardiovascular disease, Immune System, osteoporosis, Respiratory infection, economic BURDEN, canada, cost, season, mortality, incidence , and risk .']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 352)]	3	[('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 60, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 197, '25-hydroxyvitamin D'), ('UBERON_0001137', 'dorsum', 233, 'back'), ('UBERON_0001013', 'adipose tissue', 242, 'spine'), ('UBERON_0004535', 'cardiovascular system', 267, 'cardiovascular'), ('UBERON_0002405', 'immune system', 291, 'immune system'), ('UBERON_0001004', 'respiratory system', 320, 'respiratory')]
PMC5129897	10/2016	S70-PMC5129897	['a meta-analysis of Lung cancer incidence versus 25(Oh)D concentration at the time of enrollment FOUND that relative risk decreased from 1.0 at 20\xa0nmol/l to 0.86 at 40\xa0nmol/l and 0.84 at 50\xa0nmol/l, after which the 95% confidence intervals became very large.47most of the 13 studies were prospective studies with long follow-up times, and ONE STUDY involved smokers who had taken large doses of Vitamin A, which MAY have AFFECTED cancer risk since it competes with Vitamin D.50thus, doubling the calculated change in relative risk to 0.72 at 40\xa0nmol/l and 0.68 at 50\xa0nmol/l and higher SEEMS REASONABLE.']	[('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 337), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 419), ('ANOMALY_CURIOUS_FINDING', 583), ('PROBABLE_UNDERSTANDING', 583), ('PROBABLE_UNDERSTANDING', 589)]	7	[('UBERON_0002048', 'lung', 19, 'lung'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 48, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 54, 'D'), ('CHEBI_27300', 'vitamin D', 393, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D')]
PMC5129897	10/2016	S74-PMC5129897	["based on data from the us for 2004–2013, using the national cancer institute's surveillance, epidemiology, and end results (seer) program, cancer incidence rates for those aged 20–49\xa0y is 2% of that for those aged >50\xa0y.53\n\nrespiratory infections\ninfluenza and pneumonia accounted for 5,694 deaths of canadians in 2012.54the total economic impact for Respiratory infections was $5.4\xa0billion in 2008.55the ESTIMATED economic BURDEN in 2016 is$5.4\xa0billion\u2009×\u2009(1.033)2\u2009×\u2009(0.994)6\u2009×\u2009(36.3\xa0million/33.3\xa0million)\xa0=\xa0$6.1\xa0billion\nclinical trials SUPPORT the ROLE of Vitamin D in reducing RISK of influenza."]	[('INCOMPLETE_EVIDENCE', 405), ('IMPORTANT_CONSIDERATION', 424), ('INCOMPLETE_EVIDENCE', 537), ('SUPERFICIAL_RELATIONSHIP', 549), ('IMPORTANT_CONSIDERATION', 579)]	5	[('UBERON_0001004', 'respiratory system', 351, 'respiratory'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D')]
PMC5129897	10/2016	S78-PMC5129897	['a clinical trial involving 8- to 12-year-old schoolchildren in japan receiving 1200 iu/d of Vitamin D3Found a significant reduction in incidence of type a influenza for those who had not been taking Vitamin D supplements (relative risk = 0.36 [95% ci, 0.17–0.79]).33a study in mongolia involving children near 10\xa0y of age with a baseline 25(Oh)D concentration of 18\xa0nmol/l (95% ci, 13–25\xa0nmol/l) FOUND that giving them a loading dose of Vitamin D3Followed by 300 iu/d of Vitamin D, which raised the 25(Oh)D concentration to 47\xa0nmol/l (95% ci, 39–57\xa0nmol/l), resulted in a 3-month adjusted relative risk of acute Respiratory Tract infections (aris) of 0.50 (95% ci, 0.28–0.88).34that study SHOWS that People with low 25(Oh)D concentrations have significant reductions in aris with modest increases in 25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 396), ('INCOMPLETE_EVIDENCE', 689)]	2	[('CHEBI_59712', 'squarate', 92, 'vitamin D3found'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 92, 'vitamin D3found'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 338, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 338, '25(OH)D'), ('CHEBI_83261', 'pyribencarb', 437, 'vitamin D3followed'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 499, '25(OH)D'), ('UBERON_0000065', 'respiratory tract', 612, 'respiratory tract'), ('NCBITaxon_10088', 'Mus <genus>', 700, 'people'), ('CHEBI_71657', 'versiconol acetate', 716, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 800, '25(OH)D')]
PMC5129897	10/2016	S82-PMC5129897	['a comparison during september–october FOUND a relative risk of clinical Upper Respiratory Tract infection of 0.79 (95% ci, 0.61–1.03; p = 0.09) for 258 students taking 10,000 iu/wk of Vitamin D3, compared with 234 students taking a placebo.58ALTHOUGH that study DID NOT measure 25(Oh)D concentrations, it INDICATES that young canadians taking the equivalent of 1400 iu/d of Vitamin D had a marginally nonsignificantly reduced risk of Upper Respiratory Tract infections.']	[('INCOMPLETE_EVIDENCE', 38), ('ANOMALY_CURIOUS_FINDING', 240), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 305)]	4	[('UBERON_0001557', 'upper respiratory tract', 72, 'upper respiratory tract'), ('CHEBI_33279', 'vitamin D5', 184, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 184, 'vitamin D3'), ('CHEBI_71657', 'versiconol acetate', 278, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 284, 'D'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('UBERON_0001557', 'upper respiratory tract', 434, 'upper respiratory tract')]
PMC5129897	10/2016	S86-PMC5129897	['OBSERVATIONAL STUDIES offer GOOD EVIDENCE that Vitamin D AFFECTS RISK of dm.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 28), ('PROBABLE_UNDERSTANDING', 28), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 65)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5129897	10/2016	S93-PMC5129897	['a RECENT PAPER by EXPERTS in ms ESTIMATED that Vitamin D supplementation COULD PREVENT 40% of ms cases.63using that value, the total economic BURDEN of ms in canada could eventually be reduced by $1.5\xa0billion.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 18), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 142)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5129897	10/2016	S99-PMC5129897	['Vitamin D supplementation CAN improve osteoporosis and reduce fractures.26the classical ROLE of Vitamin D is to help with calcium absorption and Metabolism, leading to strong Bones.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 88)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0008152', 'metabolic process', 145, 'metabolism'), ('UBERON_0001474', 'bone element', 175, 'bones')]
PMC5129897	10/2016	S102-PMC5129897	['other health outcomes\nVARIOUS STUDIES have REPORTED beneficial EFFECTS from Vitamin D for several other health outcomes.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5129897	10/2016	S105-PMC5129897	['Dental services cost about $12.6\xa0billion per year in canada.70for children aged 3–14\xa0years, SEVERAL Vitamin D supplementation trials were conducted in the united states and great britain between 1928 and 1942.71for an average supplementation of ABOUT 600 iu/d, the rate of Dental caries decreased by half (relative risk = 0.51[95% ci, 0.40–0.65]).']	[('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 245)]	2	[('UBERON_0001091', 'calcareous tooth', 0, 'Dental'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0001091', 'calcareous tooth', 273, 'dental')]
PMC5129897	10/2016	S107-PMC5129897	['Tooth loss was reduced by 40% in the elderly over a 2-year period with Vitamin D and Calcium supplementation.73\nMOUNTING EVIDENCE INDICATES that Vitamin D reduces risk of major depression disorder (mdd) as well as treats it.']	[('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 130)]	2	[('UBERON_0001091', 'calcareous tooth', 0, 'Tooth'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 85, 'calcium'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5129897	10/2016	S112-PMC5129897	['a prospective study in korea FOUND that incidence of depressive symptoms was increased for those Individuals with 25(Oh)D concentrations <50\xa0nmol/l compared with those with >50\xa0nmol/l if they had Serum Total Cholesterol levels of < 240\xa0mg/dl (odds ratio [or] = 1.60 [95% ci, 1.23–2.08]) but NOT for those with Serum Total Cholesterol >240\xa0ng/dl (or = 0.97 [95% ci, 0.52–1.81]) after adjustment for confounding variables.75a study in italy conducted a clinical trial with Vitamin D for outpatients of mean age 74 ± 6\xa0years with mdd being treated with antidepressant therapy.76at the start of the 4-week trial, mean hamilton depression rating scale scores were 21.1 for the treated cases and 21.5 for the comparison subjects.']	[('INCOMPLETE_EVIDENCE', 29), ('ANOMALY_CURIOUS_FINDING', 291)]	2	[('NCBITaxon_1', 'root', 97, 'individuals'), ('CHEBI_71657', 'versiconol acetate', 114, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 114, '25(OH)D'), ('UBERON_0001977', 'blood serum', 196, 'serum'), ('CHEBI_15891', 'taurine', 202, 'total'), ('CHEBI_16113', 'cholesterol', 208, 'cholesterol'), ('UBERON_0001977', 'blood serum', 310, 'serum'), ('CHEBI_66254', 'topopyrone C', 316, 'total cholesterol'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D')]
PMC5129897	10/2016	S117-PMC5129897	["the annual economic BURDEN of crohn's disease in canada is $1.7\xa0billion, WHEREAS that of ulcerative colitis is $1.2\xa0billion.78several papers HAVE REPORTED inverse CORRELATIONS between Vitamin D status and incidence, prevalence, and/or severity of Inflammatory Bowel disease.79,80\nEVIDENCE is mounting that higher 25(Oh)D concentrations are ASSOCIATED with BETTER Pregnancy and Birth outcomes."]	[('IMPORTANT_CONSIDERATION', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 280), ('SUPERFICIAL_RELATIONSHIP', 340), ('IMPORTANT_CONSIDERATION', 356)]	7	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0001782', 'pigmented layer of retina', 247, 'inflammatory bowel'), ('CHEBI_71657', 'versiconol acetate', 313, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 319, 'D'), ('GO_0007565', 'female pregnancy', 363, 'pregnancy'), ('GO_0007567', 'parturition', 377, 'birth')]
PMC5129897	10/2016	S118-PMC5129897	["“the CURRENTLY AVAILABLE results INDICATE that Vitamin D supplementation during Pregnancy reduces the RISK of Preterm Birth, low Birth weight, Dental caries of infancy, and neonatal infectious diseases such as Respiratory infections and sepsis.”81furthermore, with UNFOLDING RESEARCH into fetal origins of pediatric and Adult disease, EVIDENCE increasingly INDICATES that Gestational Vitamin D indices MAY determine health in later Life.82for example, an INTERESTING cohort study CORRELATING maternal Vitamin D levels at 18\xa0weeks' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with a higher risk of impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10\xa0years, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20\xa0y.83\na RECENT STUDY CONCLUDED that Vitamin D is reduces exacerbations of asthma.84\n\nall-cause mortality rate\ngarland and colleagues85presented a meta-analysis of 32 prospective observational studies that investigated all-cause mortality rate with respect to 25(Oh)D concentration at time of enrollment."]	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 102), ('INCOMPLETE_EVIDENCE', 265), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 402), ('ANOMALY_CURIOUS_FINDING', 455), ('SUPERFICIAL_RELATIONSHIP', 480), ('INCOMPLETE_EVIDENCE', 572), ('SUPERFICIAL_RELATIONSHIP', 620), ('INCOMPLETE_EVIDENCE', 838), ('INCOMPLETE_EVIDENCE', 851)]	13	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'preterm'), ('GO_0007567', 'parturition', 118, 'birth'), ('GO_0007567', 'parturition', 129, 'birth'), ('UBERON_0001091', 'calcareous tooth', 143, 'dental'), ('UBERON_0001004', 'respiratory system', 210, 'respiratory'), ('UBERON_0007023', 'adult organism', 320, 'adult'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('UBERON_0000104', 'life cycle', 432, 'life'), ('CHEBI_27300', 'vitamin D', 501, 'vitamin D'), ('GO_0007565', 'female pregnancy', 531, 'pregnancy'), ('GO_0007565', 'female pregnancy', 583, 'gestational'), ('CHEBI_27300', 'vitamin D', 595, 'vitamin D'), ('GO_0030324', 'lung development', 662, 'lung development'), ('UBERON_0002048', 'lung', 662, 'lung'), ('GO_0050905', 'neuromuscular process', 704, 'neurocognitive'), ('GO_0051318', 'G1 phase', 767, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 787, 'adolescence'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1089, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1089, '25(OH ... D')]
PMC5129897	10/2016	S134-PMC5129897	['the total economic BURDEN of the Vitamin D–sensitive diseases CONSIDERED HERE is ESTIMATED at $79.1\xa0billion in 2016 (table\xa08).']	[('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 73), ('INCOMPLETE_EVIDENCE', 81)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5129897	10/2016	S146-PMC5129897	['cost ESTIMATES for Vitamin D–sensitive outcomes; within direct costs including morbidity and mortality and time lost from work.outcometotal direct costs ($m)total indirect costs ($m)total reportedyeartotal econ ($b) 2016**referencecancer\xa0\xa0650020107.3ref.44cvd\xa0\xa020,900200824.6ref.40dementia\xa0\xa016,200201616.2ref.66dm12,0003,00015,000201515.7ref.59ms\xa0\xa0377020093.7ref.62osteoporosis\xa0\xa0390020105.0ref.68respiratory infections25932818541120086.1ref.55total\xa0\xa0\xa0\xa078.6\xa0\n*, adjusted for inflation.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC5129897	10/2016	S151-PMC5129897	['as with all ESTIMATES, these have uncertainties, including the 25(Oh)D concentration–health outcome RELATIONS used; the ESTIMATES of economic BURDENS; whether reducing risk of specific diseases would translate into the same fraction of economic BURDEN; the extent to which changing risk-modifying risk factors such as smoking, alcohol Consumption, diet, and obesity modify the relative reduction due to higher 25(Oh)D concentration; and that the analysis omitted several Vitamin D–sensitive diseases and conditions BECAUSE of LIMITED UNDERSTANDING of the EFFECTS.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 120), ('IMPORTANT_CONSIDERATION', 142), ('IMPORTANT_CONSIDERATION', 245), ('PROBLEM_COMPLICATION', 515), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 555)]	8	[('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 63, '25(OH)D'), ('GO_0007631', 'feeding behavior', 335, 'consumption'), ('CHEBI_71657', 'versiconol acetate', 410, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin D')]
PMC5129897	10/2016	S158-PMC5129897	['the ESTIMATES intable\xa09SHOW a POTENTIAL large BENEFIT of improving Vitamin D status in terms of reduction in economic BURDEN ($12.5billion) and premature deaths (23,000/yr) ON THE BASIS OF the types of disease for which EVIDENCE IS STRONG that higher 25(Oh)D concentrations have beneficial EFFECTS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 118), ('INCOMPLETE_EVIDENCE', 173), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 290)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 251, '25(OH)D')]
PMC5129897	10/2016	S159-PMC5129897	['the uncertainty in the numbers is ABOUT 50% AS a result of omitting other diseases with LESS EVIDENCE FOR Vitamin D EFFECTS as well as the POSSIBILITY that the ESTIMATES are too high.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 44), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC5129897	10/2016	S161-PMC5129897	['those ESTIMATES are SIMILAR TO those in the PREVIOUS PAPER on THIS topic, which ESTIMATED that if the 25(Oh)D concentration of all canadians were raised from a mean value of 67\xa0nmol/l to 105\xa0nmol/l, the death rate could fall by 37,000 (22,300–52,300 deaths), REPRESENTING 16.1% (9.7%–22.7%) of annual deaths, and the economic BURDEN could fall by 6.9% (3.8%–10.0%), or $14.4\xa0billion ($8.0\xa0billion–$20.1\xa0billion).89that paper CONSIDERED HOW Vitamin D AFFECTS cancer, cvd, dm, falls and fractures, Heart disease, influenza and pneumonia, ms, and septicemia as well as Pregnancy and Birth outcomes.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('INCOMPLETE_EVIDENCE', 80), ('PROBABLE_UNDERSTANDING', 259), ('IMPORTANT_CONSIDERATION', 326), ('INCOMPLETE_EVIDENCE', 425), ('EXPLICIT_QUESTION', 436), ('SUPERFICIAL_RELATIONSHIP', 450)]	11	[('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 440, 'vitamin D'), ('UBERON_0000948', 'heart', 496, 'heart'), ('GO_0007565', 'female pregnancy', 566, 'pregnancy'), ('GO_0007567', 'parturition', 580, 'birth')]
PMC5129897	10/2016	S168-PMC5129897	['for some intermediate situations, such as cancer, survival rates are better with higher 25(Oh)D concentrations.12,93thus, EVEN IF all canadians achieved concentrations of > 100\xa0nmol/l immediately, the beneficial EFFECTS would accrue slowly, PERHAPS over 10–20\xa0y because for many health outcomes, the beneficial EFFECTS of Vitamin D are much stronger for PREVENTION than for treatment.']	[('ANOMALY_CURIOUS_FINDING', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('SUPERFICIAL_RELATIONSHIP', 212), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 311), ('SUPERFICIAL_RELATIONSHIP', 354)]	6	[('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 94, 'D'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D')]
PMC5129897	10/2016	S176-PMC5129897	['the results of observational studies are GENERALLY not well-SUPPORTED by clinical trials of Vitamin D supplementation.94the primary REASON for that lack OF support SEEMS TO be that the trials were NOT WELL DESIGNED, being based LARGELY on the guidelines for Pharmaceutical Drugs RATHER than for Nutrients.2another WORRISOME POINT is that clinical trials have BEEN much more successful when baseline 25(Oh)D concentrations were low.']	[('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 132), ('ANOMALY_CURIOUS_FINDING', 153), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 279), ('IMPORTANT_CONSIDERATION', 314), ('IMPORTANT_CONSIDERATION', 324), ('ANOMALY_CURIOUS_FINDING', 359)]	11	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 258, 'pharmaceutical'), ('CHEBI_23888', 'drug', 273, 'drugs'), ('CHEBI_33284', 'nutrient', 295, 'nutrients'), ('CHEBI_71657', 'versiconol acetate', 399, '25(OH)D')]
PMC5129897	10/2016	S177-PMC5129897	['for example, 50% of the clinical trials with baseline 25(Oh)D concentration <50\xa0nmol/l FOUND beneficial EFFECTS of Vitamin D on BIOMARKERS of inflammation, WHEREAS ONLY 26% of those with higher baseline 25(Oh)D concentrations did.3the DIFFERENT results with respect to baseline 25(Oh)D concentration MAY BE DUE TO the LIMITED accuracy of clinical trials but COULD also be DUE TO CONSIDERABLY less BENEFIT for those with 25(Oh)D concentrations above 50\xa0nmol/l.']	[('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156), ('ANOMALY_CURIOUS_FINDING', 156), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('INCOMPLETE_EVIDENCE', 300), ('PROBLEM_COMPLICATION', 307), ('INCOMPLETE_EVIDENCE', 318), ('INCOMPLETE_EVIDENCE', 358), ('PROBLEM_COMPLICATION', 372), ('ANOMALY_CURIOUS_FINDING', 379), ('IMPORTANT_CONSIDERATION', 397)]	15	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 203, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 203, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 278, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 284, 'D'), ('CHEBI_71657', 'versiconol acetate', 420, '25(OH)D')]
PMC5129897	10/2016	S178-PMC5129897	['ANOTHER LIMITATION of clinical trials is that they are of short duration—GENERALLY a few months to a few years—YET chronic diseases MAY develop slowly over decades, and the half-life of Vitamin D is about 3\xa0weeks, requiring several months of supplementation to show benefit.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 73), ('ANOMALY_CURIOUS_FINDING', 111), ('INCOMPLETE_EVIDENCE', 132)]	5	[('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC5129897	10/2016	S180-PMC5129897	['BUT SOME STUDIES FOUND that Vitamin D AFFECTS mortality rates more than incidence rates.94our ESTIMATES also do NOT take into account prevalence rates for the various diseases.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 94), ('ANOMALY_CURIOUS_FINDING', 112)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5129897	10/2016	S187-PMC5129897	['the institute FOUND no EVIDENCE of adverse health EFFECTS for the general population for intakes as high as 10,000 iu/d.96given the latitudes of canada, sun exposure is a good source of Vitamin D primarily in the summer and then best near solar noon.97\nmore than12 million canadians do not meet the minimum Vitamin D GUIDELINES of 50\xa0nmol/l put forth by health canada.98sun exposure HAS BEEN RECOGNIZED AS a KEY FACTOR INFLUENCING Vitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 317), ('PROBABLE_UNDERSTANDING', 317), ('INCOMPLETE_EVIDENCE', 383), ('PROBABLE_UNDERSTANDING', 392), ('PROBABLE_UNDERSTANDING', 403), ('IMPORTANT_CONSIDERATION', 408), ('SUPERFICIAL_RELATIONSHIP', 412), ('SUPERFICIAL_RELATIONSHIP', 419)]	11	[('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 307, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D')]
PMC5129897	10/2016	S188-PMC5129897	['according to a consensus Vitamin D position statement published by 7 joint health organizations in the uk, enjoying the sun safely, while taking care not to burn, CAN HELP to provide the benefits of Vitamin D without unduly raising the risk of skin cancer.99HOWEVER, sun exposure in the uk as well as in canada is a RECOMMENDATION for ONLY 5–7\xa0months of the year(except for People traveling to sun destinations during winter months).']	[('INCOMPLETE_EVIDENCE', 163), ('FUTURE_WORK', 167), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('FUTURE_WORK', 316), ('INCOMPLETE_EVIDENCE', 335)]	5	[('CHEBI_28384', 'vitamin K', 25, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 25, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 374, 'people')]
PMC5129897	10/2016	S189-PMC5129897	['artificial sources of uvb COULD substitute when appropriate solar uvb doses are not available.100\nuv exposure confers health BENEFITS beyond Vitamin D production.']	[('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 125)]	2	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5129897	10/2016	S190-PMC5129897	['one is reduction in Blood pressure through liberating Nitric Oxide from subcutaneous Nitrogen stores.101another is that uv MAY Modulate the Immune Response to psoriasis, asthma, ms, and infection through mechanisms independent of Vitamin D.102uvb exposure APPARENTLY reduces the risk of ms through both Vitamin D–DEPENDENT and –INDEPENDENT mechanisms.103\nthe CONCERNS regarding RISK of skin cancer and melanoma are OFTEN overstated in comparison with the benefits of non burning, moderate uv exposure.']	[('INCOMPLETE_EVIDENCE', 123), ('ANOMALY_CURIOUS_FINDING', 256), ('SUPERFICIAL_RELATIONSHIP', 313), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBLEM_COMPLICATION', 359), ('IMPORTANT_CONSIDERATION', 378), ('PROBABLE_UNDERSTANDING', 415)]	7	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_16480', 'nitric oxide', 54, 'nitric oxide'), ('CHEBI_33300', 'pnictogen', 85, 'nitrogen'), ('GO_0065007', 'biological regulation', 127, 'modulate'), ('GO_0006955', 'immune response', 140, 'immune response'), ('UBERON_0002405', 'immune system', 140, 'immune'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
PMC5133057	10/2016	S0-PMC5133057	['Serum Retinol levels in Pregnant adolescents and their RELATIONSHIP with habitual Food intake, infection and obstetric, nutritional and socioeconomic variables\n\nabstract\nglobally, Vitamin A deficiency (vad) AFFECTS ABOUT 19.1 million Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 207), ('INCOMPLETE_EVIDENCE', 215)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27810', 'resorcinol', 6, 'Retinol'), ('GO_0007565', 'female pregnancy', 24, 'Pregnant'), ('CHEBI_33290', 'food', 82, 'Food'), ('GO_0007601', 'visual perception', 82, 'Food'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin A'), ('GO_0007565', 'female pregnancy', 234, 'pregnant')]
PMC5133057	10/2016	S17-PMC5133057	['its occurrence is classically ASSOCIATED with low Intake of Vitamin A from Food sources [5,12], BUT it MAY also be ASSOCIATED with OTHER FACTORS such as socioeconomic status, and inadequate sanitation and the presence of infection [13,14,15].']	[('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('GO_0007631', 'feeding behavior', 50, 'intake'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('CHEBI_33290', 'food', 75, 'food')]
PMC5133057	10/2016	S18-PMC5133057	['in brazil, vad HAS BEEN DOCUMENTED in the northeast and in SOME parts of the southeast [16]; HOWEVER, there are STILL ONLY a FEW STUDIES that evaluate the Consumption of Vitamin A by Pregnant women [17], and there are EVEN FEWER STUDIES investigating the occurrence of vad among Pregnant teenagers.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('IMPORTANT_CONSIDERATION', 112), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 125), ('ANOMALY_CURIOUS_FINDING', 218), ('INCOMPLETE_EVIDENCE', 223)]	9	[('GO_0007631', 'feeding behavior', 155, 'consumption'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin A'), ('GO_0007565', 'female pregnancy', 183, 'pregnant'), ('GO_0007565', 'female pregnancy', 279, 'pregnant')]
PMC5133057	10/2016	S74-PMC5133057	['analyzing to Food Intake, significant difference is ONLY observed between the average Intake of Vitamin A and iron; for Vitamin A, there is a higher average consumption in relation to the recommended value for the group and for iron, the average Consumption is lower than that recommended (table 2).']	[('INCOMPLETE_EVIDENCE', 52)]	1	[('CHEBI_33290', 'food', 13, 'food'), ('GO_0007631', 'feeding behavior', 13, 'food intake'), ('GO_0007631', 'feeding behavior', 86, 'intake'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('GO_0007631', 'feeding behavior', 246, 'consumption')]
PMC5133057	10/2016	S116-PMC5133057	['[42], where the authors assessed the nutritional status of 75 Pregnant adolescents in venezuela, using the same cutoff points as in OUR STUDY and FOUND low weight in 34.6% of the sample, which also presented insufficient Intake of energy, protein, zinc, Calcium, and Vitamin A.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('INCOMPLETE_EVIDENCE', 146)]	2	[('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('GO_0007631', 'feeding behavior', 221, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 254, 'calcium'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin A')]
PMC5133057	10/2016	S119-PMC5133057	['the results SHOWED a significant linear CORRELATION between Maternal Intake of Vitamin A obtained by 24hr and Serum Retinol.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 40)]	2	[('GO_0007618', 'mating', 60, 'maternal'), ('GO_0007631', 'feeding behavior', 69, 'intake'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('UBERON_0001977', 'blood serum', 110, 'serum'), ('CHEBI_26536', 'retinoic acid', 116, 'retinol')]
PMC5133057	10/2016	S128-PMC5133057	['moreover, considering the high prevalence of vad OBSERVED in THIS STUDY, as well as its IMPACT on the Pregnancy process, there is a NEED FOR regular assessment of the nutritional status of Prenatal Vitamin A in teens in order to achieve early diagnosis and proper management of this nutritional deficiency.']	[('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('SUPERFICIAL_RELATIONSHIP', 88), ('FUTURE_WORK', 132)]	4	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 189, 'prenatal'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin A')]
PMC5090877	11/2016	S76-PMC5090877	['ASSESSED the adequacy of nutrient Intake including proteins, energy, calcium, iron, Folate, and Vitamin C and IDENTIFIED the factors ASSOCIATED with nutrient intake in kenya [44].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 133)]	3	[('GO_0007631', 'feeding behavior', 34, 'intake'), ('CHEBI_30863', '5-azaorotic acid', 84, 'folate'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin C')]
PMC5095257	11/2016	S9-PMC5095257	['exposure to seasonal Viral infections in the Perinatal Period, coupled with Vitamin D deficiency, COULD lead to dysregulation of innate immunity AFFECTING the risk of developing aad.']	[('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 145)]	2	[('NCBITaxon_1', 'root', 21, 'viral'), ('GO_0036268', 'swimming', 45, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 45, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5095257	11/2016	S80-PMC5095257	['one of the POSTULATED mechanisms EXPLAINING a month-of-Birth EFFECT in Autoimmune disease is the ROLE that Vitamin D deficiency MIGHT play in the pathophysiology of such diseases (31).']	[('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 33), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 97), ('INCOMPLETE_EVIDENCE', 128)]	5	[('GO_0007567', 'parturition', 55, 'birth'), ('UBERON_0001442', 'skeleton of manus', 71, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC5095257	11/2016	S82-PMC5095257	['this HYPOTHESIS is PARTICULARLY PLAUSIBLE in the case of aad because of the KNOWN ASSOCIATION of the disease with polymorphisms in both the Vitamin D Receptor ( Vdr ) Gene and the Cyp27B1 Gene encoding 1-α-hydroxylase converting 25-Hydroxyvitamin D into its active form 1,25-Dihydroxyvitamin D (8,27,33).']	[('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 140, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 161, 'VDR'), ('SO_0000704', 'gene', 167, 'gene'), ('PR_000006101', 'cytochrome P450 1A1', 180, 'CYP27B1'), ('SO_0000704', 'gene', 188, 'gene'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 229, '25-hydroxyvitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 270, '1,25-dihydroxyvitamin D')]
PMC5095257	11/2016	S83-PMC5095257	['TO EXPLORE the POSSIBLE EFFECT of uvb radiation exposure, which IS KNOWN to INFLUENCE Vitamin D status, on the seasonality pattern OBSERVED in aad, we compared monthly ors (supplemental figure 1) dividing the cohort into 2 groups according to geographical latitude.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 131)]	6	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5095257	11/2016	S86-PMC5095257	['verifying Vitamin D deficiency and aad risk by ascertaining 25 (Oh)D status in infancy, HOWEVER, will be difficult given the RARITY of the condition and the fact that diagnosis is USUALLY made in Individuals in their third to fifth decade.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('DIFFICULT_TASK', 125), ('INCOMPLETE_EVIDENCE', 180)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 60, '25 (OH)D'), ('NCBITaxon_1', 'root', 196, 'individuals')]
PMC5095257	11/2016	S97-PMC5095257	['exposure to seasonal Viral infections in the Perinatal Period coupled with Vitamin D deficiency leading to dysregulation of innate immunity COULD BE the POTENTIAL initial triggers for the eventual development of aad, ALTHOUGH this REQUIRES FURTHER EXPLORATION.']	[('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 153), ('ANOMALY_CURIOUS_FINDING', 217), ('IMPORTANT_CONSIDERATION', 231), ('FUTURE_WORK', 240)]	5	[('NCBITaxon_1', 'root', 21, 'viral'), ('GO_0036268', 'swimming', 45, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 45, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5387760	11/2016	S188-PMC5387760	['the advantage of Ca Intake to the Human body also DEPENDS ON OPTIMAL levels of Vitamin D. OUR STUDY’s ability TO DETERMINE multiple INTERACTION EFFECTS among different Micronutrients and Vitamins in RELATION to Birth outcomes and early child survival was LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 61), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('QUESTION_ANSWERED_BY_THIS_WORK', 110), ('SUPERFICIAL_RELATIONSHIP', 132), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 199), ('INCOMPLETE_EVIDENCE', 255)]	8	[('CHEBI_32588', 'potassium chloride', 17, 'Ca'), ('GO_0007631', 'feeding behavior', 20, 'intake'), ('NCBITaxon_9606', 'Homo sapiens', 34, 'human'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_33839', 'macromolecule', 168, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 187, 'vitamins'), ('GO_0007567', 'parturition', 211, 'birth')]
PMC5118763	12/2016	S22-PMC5118763	['ALTHOUGH PREVIOUS reports from this trial SHOWED a high prevalence of anemia, zinc, and Vitamin B-12 deficiencies in early Pregnancy among the women in the trial (14), there was no differential effect of using the mmn regimen on women’s hemoglobin concentration compared with standard Iron–Folic Acid supplementation regimens (11).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 42)]	4	[('CHEBI_27300', 'vitamin D', 88, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 88, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy'), ('CHEBI_24870', 'ion', 285, 'iron'), ('CHEBI_30751', 'formic acid', 290, 'folic acid')]
PMC5118763	12/2016	S107-PMC5118763	['this was CONFIRMED by regression analyses when evaluating dose-response over the full range of capsule Intake because there were no linear associations between the number of Capsules taken and Plasma concentration of Vitamin B-12 for any of the Micronutrient supplementation types (results not shown).']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('GO_0007631', 'feeding behavior', 103, 'intake'), ('CHEBI_23042', 'carotene', 174, 'capsules'), ('UBERON_0001969', 'blood plasma', 193, 'plasma'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 217, 'vitamin B-12'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 245, 'micronutrient')]
PMC5118763	12/2016	S151-PMC5118763	['discussion\nin THIS STUDY, women who were assigned to the mmn regimen had higher concentrations of Plasma Vitamin B-12 at week 30 of Pregnancy, but no other differences between Food and Micronutrient regimens were OBSERVED.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 213)]	2	[('UBERON_0001969', 'blood plasma', 98, 'plasma'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 105, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 132, 'pregnancy'), ('CHEBI_33290', 'food', 176, 'food'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 185, 'micronutrient')]
PMC5118763	12/2016	S158-PMC5118763	['HOWEVER, there was no dose-response relation between the number of mmn capsules taken and Plasma Vitamin B-12 that COULD EXPLAIN the higher Plasma concentrations of Vitamin B-12 at week 30 in the mmn group.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 121)]	4	[('UBERON_0001969', 'blood plasma', 90, 'plasma'), ('CHEBI_85855', 'diacylglycerol 46:7', 97, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 97, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 140, 'plasma'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 165, 'vitamin B-12')]
PMC5118763	12/2016	S160-PMC5118763	['a positive EFFECT of mmn supplementation on maternal Plasma Vitamin B-12 HAS also BEEN observed among Pregnant women in nepal (17).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 73)]	2	[('UBERON_0001969', 'blood plasma', 53, 'plasma'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 60, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 102, 'pregnant')]
PMC5118763	12/2016	S162-PMC5118763	['hemodilution and Placental Transport Of Vitamin B-12 To the Fetus (18) MAY BE POSSIBLE EXPLANATIONS for the OBSERVED decrease in Plasma concentrations of Vitamin B-12.']	[('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 78), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 108)]	4	[('GO_0007565', 'female pregnancy', 17, 'placental'), ('UBERON_0001987', 'placenta', 17, 'placental'), ('GO_0042790', 'nucleolar large rRNA transcription by RNA polymerase I', 27, 'transport of vitamin B-12 to'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 40, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 60, 'fetus'), ('UBERON_0001969', 'blood plasma', 129, 'plasma'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin B')]
PMC5118763	12/2016	S170-PMC5118763	['there is SOME EVIDENCE that high maternal Folate status in combination with low Vitamin B-12 status MAY increase the risk of obesity and Insulin resistance in the offspring (21).']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_30863', '5-azaorotic acid', 42, 'folate'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 80, 'vitamin B-12'), ('PR_000045358', 'insulin family protein', 137, 'insulin')]
PMC5118763	12/2016	S171-PMC5118763	['APPROXIMATELY 35% of women in our study had Vitamin B-12 deficiency in combination with normal Plasma Folate at week 14 (14), which increased to 64% at week 30.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 44, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 95, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 102, 'folate')]
PMC5118763	12/2016	S184-PMC5118763	['the presence of OTHER Micronutrients in Mmns such as Vitamins C and a, which CAN improve the absorption of iron (26), MAY EXPLAIN this equivalence DESPITE the lower content of iron in the Mmn.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 122), ('ANOMALY_CURIOUS_FINDING', 147)]	5	[('CHEBI_33839', 'macromolecule', 22, 'micronutrients'), ('UBERON_0002544', 'digit', 40, 'MMNs'), ('CHEBI_27300', 'vitamin D', 53, 'vitamins C'), ('PR_000004900', 'complement C3', 62, 'C'), ('UBERON_0003109', 'parapophysis', 188, 'MMN')]
PMC5137891	12/2016	S138-PMC5137891	['other key FACTORS that MAY CONTRIBUTE to anemia include: OTHER Nutrient deficiencies (Folate, Vitamin B12, and Vitamin A), Genetic traits (including Sickle-Cell anemia and thalassaemia), malaria, schistosomiasis, hookworm and Trichuris infection, and hiv and some non-communicable diseases [1].']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57)]	4	[('CHEBI_33284', 'nutrient', 63, 'nutrient'), ('CHEBI_30863', '5-azaorotic acid', 86, 'folate'), ('CHEBI_33279', 'vitamin D5', 94, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 102, 'B12'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin A'), ('SO_0000704', 'gene', 123, 'genetic'), ('CL_0000429', 'imaginal disc cell', 149, 'sickle-cell'), ('NCBITaxon_10088', 'Mus <genus>', 226, 'trichuris')]
PMC5137891	12/2016	S140-PMC5137891	['many women were not meeting the ESTIMATED average REQUIREMENT for key Micronutrients (percent below ESTIMATED average requirement- ear: 25% for iron, 16% for zinc, 54% for Folate, 64% for Vitamin B12 and 27% for Vitamin A) [43].']	[('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 100)]	3	[('CHEBI_33839', 'macromolecule', 70, 'micronutrients'), ('CHEBI_30863', '5-azaorotic acid', 172, 'folate'), ('CHEBI_33279', 'vitamin D5', 188, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A')]
PMC5137891	12/2016	S144-PMC5137891	['HOWEVER, SIMILAR TO the low levels of iron deficiency in our population ONLY 4% of women were Vitamin A deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ANOMALY_CURIOUS_FINDING', 72), ('INCOMPLETE_EVIDENCE', 72)]	5	[('CHEBI_27300', 'vitamin D', 94, 'vitamin A')]
PMC5146866	12/2016	S0-PMC5146866	['prevalence and RISK factors for Vitamin D insufficiency and deficiency at Birth and ASSOCIATED outcome\n\nabstract\n\nbackground\noccurrence and consequence of Cord Blood (Cb) Vitamin D insufficiency/deficiency has not BEEN ADEQUATELY explored DESPITE rising CONCERN regarding THIS topic in pediatrics.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 214), ('ANOMALY_CURIOUS_FINDING', 239), ('PROBLEM_COMPLICATION', 254), ('QUESTION_ANSWERED_BY_THIS_WORK', 272)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 74, 'birth'), ('UBERON_0002240', 'spinal cord', 155, 'cord'), ('UBERON_0000178', 'blood', 160, 'blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 167, 'CB'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC5146866	12/2016	S16-PMC5146866	['SEVERAL STUDIES were designed TO IDENTIFY the rates of Vitamin D insufficiency in cb of infants Born to different maternal populations.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 30)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'born')]
PMC5146866	12/2016	S19-PMC5146866	['[14] REPORTED cb Vitamin D deficiency (<15\xa0ng/ml) and insufficiency (15–32\xa0ng/ml) in 45.6 and 46.8% of african american infants, and 9.7 and 56.4% of white neonates from the northern united states.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC5146866	12/2016	S21-PMC5146866	['a population-based study from australia REPORTED Vitamin D levels of\u2009≤\u200910\xa0ng/ml (≤25\xa0nmol/l) in 11% of the Cord Blood samples [16].']	[('INCOMPLETE_EVIDENCE', 40)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 107, 'cord'), ('UBERON_0000178', 'blood', 112, 'blood')]
PMC5146866	12/2016	S22-PMC5146866	['cb samples from multiethnic infants living in the tropical region SHOWED deficient Vitamin D levels (<20\xa0ng/ml) in 28% and insufficient levels (20–30\xa0ng/ml) in 50% of the cases [17].']	[('INCOMPLETE_EVIDENCE', 66)]	1	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5146866	12/2016	S23-PMC5146866	['DIFFERENCES in the classification [8–10] used to assess the infants’ Vitamin D status and strong DEPENDENCE of their Vitamin D pool on maternal Vitamin D levels [18] MAY BE RESPONSIBLE for the wide VARIABILITY in the REPORTED rates of Vitamin D deficiency/insufficiency in infants at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 97), ('INCOMPLETE_EVIDENCE', 166), ('PROBABLE_UNDERSTANDING', 173), ('DIFFICULT_TASK', 198), ('INCOMPLETE_EVIDENCE', 217)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007567', 'parturition', 284, 'birth')]
PMC5146866	12/2016	S26-PMC5146866	['TO THE BEST OF OUR KNOWLEDGE, OUR STUDY is the FIRST that in addition to identifying the rate, also ESTIMATES the risk of Vitamin D deficiency/insufficiency in the cb and ASSOCIATED outcome in a diverse population of infants.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 171)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC5146866	12/2016	S60-PMC5146866	['in addition, we IDENTIFIED significant variability in the infant’s Vitamin D level at Birth due to maternal race/ethnicity (fig.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 86, 'birth')]
PMC5146866	12/2016	S67-PMC5146866	['inclusion of maternal race/ethnicity (white vs. non-white), age, and gravidity in the multiple regression models REVEALED INDEPENDENT ASSOCIATION of Vitamin D deficiency and insufficiency in the infant’s cb with non-white maternal race/ethnicity, younger age, and increased number of Pregnancies (table\xa01).']	[('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 284, 'pregnancies')]
PMC5146866	12/2016	S69-PMC5146866	['risk for detection of Vitamin D insufficiency in cb of infants Born to black or hispanic mothers was COMPARABLE to those in white neonates BUT higher in babies Born to asian mothers.']	[('INCOMPLETE_EVIDENCE', 101), ('ANOMALY_CURIOUS_FINDING', 139)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007567', 'parturition', 63, 'born'), ('GO_0007567', 'parturition', 160, 'born')]
PMC5146866	12/2016	S70-PMC5146866	['a comparable magnitude of the INDEPENDENT EFFECT of maternal age and gravidity on Vitamin D status was IDENTIFIED in each race/ethnicity model (data not presented).']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 103)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC5146866	12/2016	S78-PMC5146866	['caption (table-wrap): table 3\n\ncharacteristics of neonates during Birth hospitalization with respect to their cb Vitamin D statusparametricvitamin D satus p valuedeficiency n \u2009=\u200995insufficiency n \u2009=\u200979sufficiency n \u2009=\u200991gestational age (weeks)38.8(38.6–39.1)39.2(38.9–39.5)38.9(38.7–39.3)0.65birth weight (g)3301(3215–3387)3433(3322–3544)3306(3305–3406)0.35birth length (cm)48.8(48.1–49.6)49.5(49.0–50.0)48.3(47.2–49.5)0.53apgar 1\xa0min <72.1%(0.6–7.0)2.6%(0.7–8.9)6.5%(2.4–12.2)0.21nicu admission6.3%(0.87–11.7)5.1%(0–10.6)8.9%(2.4–15.3)0.62hypoglycemia (%)01.3%(0–4.4)1.1%(0–3.6)0.56neonatal jaundice (%)21.1%(12.6–29.6)13.9%(5.3–22.5)13.9%(6.4–21.4)0.27phototherapy (%)5.3%(0.3–10.3)1.3%(0–4.4)1.1%(0–3.6)0.13\ndata presented as mean or proportion (%) with 95% confidence intervals of mean or %\n\ndiscussion\nwe FOUND that up to 45% infants are AT RISK for deficient and 35% for INSUFFICIENT levels of Vitamin D. the APPROXIMATED probability of an infant being Born with a sufficient Vitamin D level as defined by the aap for children [8] is less than 40%.']	[('INCOMPLETE_EVIDENCE', 810), ('IMPORTANT_CONSIDERATION', 843), ('IMPORTANT_CONSIDERATION', 877), ('INCOMPLETE_EVIDENCE', 915)]	4	[('GO_0007567', 'parturition', 66, 'birth'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 147, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 147, 'D'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin D'), ('GO_0007567', 'parturition', 959, 'born'), ('CHEBI_27300', 'vitamin D', 982, 'vitamin D')]
PMC5146866	12/2016	S79-PMC5146866	['IMPORTANTLY, the upper limit of Vitamin D that is defined as sufficient [8] COULD BE SUBOPTIMAL BECAUSE Vitamin D levels of <30\xa0ng/ml have been ASSOCIATED with increased secretion of intact Parathyroid hormone and reduced Intestinal calcium absorption in healthy Adults [22,23].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 85), ('PROBABLE_UNDERSTANDING', 96), ('SUPERFICIAL_RELATIONSHIP', 144)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 190, 'parathyroid'), ('UBERON_0000160', 'intestine', 222, 'intestinal'), ('UBERON_0007023', 'adult organism', 263, 'adults')]
PMC5146866	12/2016	S80-PMC5146866	['WHILE a Vitamin D level of 20\xa0ng/ml IS CONSIDERED sufficient, maintenance of 30\xa0ng/ml is RECOMMENDED for better health in children and Adults [24] DESPITE the LACK OF CLEAR EVIDENCE of an OPTIMAL concentration of Vitamin D for bone and general health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 89), ('ANOMALY_CURIOUS_FINDING', 147), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0007023', 'adult organism', 135, 'adults'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC5146866	12/2016	S82-PMC5146866	['OUR FINDINGS confirmed PREVIOUS reports SHOWING an INCREASED RISK for Vitamin D deficiency in infants Born to mothers of non-white race/ethnicity [11,14,15,28].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 40), ('IMPORTANT_CONSIDERATION', 51)]	4	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'born')]
PMC5146866	12/2016	S85-PMC5146866	['moreover, the internal VALIDITY of the EXISTING STUDIES is a subject for discussion because the INDEPENDENT EFFECT of maternal race/ethnicity on the Vitamin D status was not controlled for and other maternal FACTORS MAY also have an ASSOCIATION with the development of Vitamin D deficiency/insufficiency in infants at Birth.']	[('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 208), ('INCOMPLETE_EVIDENCE', 216), ('SUPERFICIAL_RELATIONSHIP', 233)]	7	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('GO_0007567', 'parturition', 318, 'birth')]
PMC5146866	12/2016	S86-PMC5146866	['we FOUND that INDEPENDENTLY from the race/ethnicity, younger maternal age and increased number of Pregnancies were ASSOCIATED with Vitamin D deficiency and insufficiency in cb of the studied infants.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 115)]	3	[('GO_0007565', 'female pregnancy', 98, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5146866	12/2016	S89-PMC5146866	['european data SHOWED both, decreased risk and no effect of parity on Vitamin D insufficiency/deficiency in mothers during Pregnancy [29,30].']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC5146866	12/2016	S90-PMC5146866	['unadjusted analysis of the association between clinical data and Vitamin D levels in the cb that was conducted on 241 mother-infant pairs (72.6% black and 81.3% multiparous) REVEALED lower Vitamin D levels in the Cord Blood of nulliparous women [31].']	[('INCOMPLETE_EVIDENCE', 174)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 213, 'cord'), ('UBERON_0000178', 'blood', 218, 'blood')]
PMC5146866	12/2016	S91-PMC5146866	['COMPARABLE to PREVIOUS reports we FOUND no difference between the cb Vitamin D status and maternal multivitamin supplementation [30,32].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 34)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5146866	12/2016	S94-PMC5146866	['[14], we DID NOT find an association between the cb Vitamin D level and season of Birth.']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007567', 'parturition', 82, 'birth')]
PMC5146866	12/2016	S96-PMC5146866	['HOWEVER, there was a TENDENCY for a higher use of phototherapy in infants Born with Vitamin D deficiency as compared to those with Vitamin D sufficiency (5.3 vs. 1.1%, one-sided p \u2009=\u20090.053).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('GO_0007567', 'parturition', 74, 'born'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5146866	12/2016	S101-PMC5146866	['maternal data that MAY CORRELATE with neonatal Vitamin D levels at Birth, including the pre-Pregnancy weight [35], skin color [13], and sun exposure during Pregnancy [36] were NOT COLLECTED.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 176)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007567', 'parturition', 67, 'birth'), ('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy')]
PMC5146866	12/2016	S102-PMC5146866	['HOWEVER, it is UNLIKELY that these limitations will AFFECT the OBSERVED rate of Vitamin D deficiency and insufficiency SEEN at Birth in the studied infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 119)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007567', 'parturition', 127, 'birth')]
PMC5146866	12/2016	S104-PMC5146866	['moreover, a review of the literature REVEALED that data obtained from questionnaires regarding the assessment of sunlight exposure do NOT precisely estimate Vitamin D status [37].']	[('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 134)]	2	[('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC5146866	12/2016	S105-PMC5146866	['we would like to highlight the strengths of the PRESENT report that include: (i) prospective observation of a sufficient number and diverse population of mother-infant pairs, (ii) use of 95% confidence intervals to present the POTENTIAL variability in prevalence of Vitamin D deficiency/ insufficiency in cb, (iii) use of regression models for identifying maternal FACTORS that increase the risk for Vitamin D deficiency/insufficiency in infant at Birth, and (iv) reporting clinical characteristics of the neonates in ASSOCIATION with their Vitamin D status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 365), ('SUPERFICIAL_RELATIONSHIP', 518)]	4	[('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 400, 'vitamin D'), ('GO_0007567', 'parturition', 448, 'birth'), ('CHEBI_27300', 'vitamin D', 541, 'vitamin D'), ('GO_0007567', 'parturition', 561, 'birth')]
PMC5146866	12/2016	S107-PMC5146866	['our data SHOULD ENCOURAGE pediatricians to supplement infants with Vitamin D ESPECIALLY CONSIDERING the REPORTED POOR COMPLIANCE with the aap’s RECOMMENDATIONS by both, pediatricians and parents [38].']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 16), ('IMPORTANT_CONSIDERATION', 77), ('IMPORTANT_CONSIDERATION', 88), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 113), ('PROBLEM_COMPLICATION', 113), ('PROBLEM_COMPLICATION', 118), ('FUTURE_WORK', 144)]	10	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5146866	12/2016	S108-PMC5146866	['moreover, DUE TO the high LIKELIHOOD of Vitamin D insufficiency/deficiency at Birth, FURTHER STUDIES MAY be REQUIRED to determine the ROLE of implementing Vitamin D supplementation with respect to the cb Vitamin D status.']	[('PROBLEM_COMPLICATION', 10), ('PROBABLE_UNDERSTANDING', 26), ('FUTURE_WORK', 85), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 108), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 78, 'birth'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC5155676	12/2016	S0-PMC5155676	['DETERMINANTS of the maternal 25-Hydroxyvitamin D response to Vitamin D supplementation during Pregnancy\n\nabstract\n\ncontext:\ncurrent approaches to Antenatal Vitamin D supplementation do NOT ACCOUNT for interindividual differences in 25-Hydroxyvitamin D (25(Oh)D) response.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 185)]	2	[('CHEBI_27844', "2',3'-cyclic AMP", 29, '25-Hydroxyvitamin D'), ('CHEBI_28384', 'vitamin K', 61, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 61, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'Pregnancy'), ('GO_0007567', 'parturition', 146, 'antenatal'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 232, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 253, '25(OH)D')]
PMC5155676	12/2016	S14-PMC5155676	['maternal Vitamin D INSUFFICIENCY during Pregnancy is common (1,2), and THERE IS EVIDENCE that this MIGHT have DETRIMENTAL EFFECTS on maternal health, Fetal Development (3,4) and the long-term Skeletal health of children (1,3).']	[('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 110), ('SUPERFICIAL_RELATIONSHIP', 122)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 150, 'fetal development'), ('UBERON_0004288', 'skeleton', 192, 'skeletal')]
PMC5155676	12/2016	S15-PMC5155676	['SEVERE maternal Vitamin D deficiency during Pregnancy CAN result in symptomatic hypocalcaemia in the neonate (3).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 54)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy')]
PMC5155676	12/2016	S17-PMC5155676	['NONETHELESS, the institute of medicine (iom) has SUGGESTED that risk of Vitamin D insufficiency, DEFINED as a 25(Oh)D less than 50 nmol/l, SHOULD BE avoided during Pregnancy (5), and this is SUPPORTED by the RECENT global consensus on the prevention of rickets (6).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 97), ('FUTURE_WORK', 139), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 208)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('GO_0007565', 'female pregnancy', 164, 'pregnancy')]
PMC5155676	12/2016	S18-PMC5155676	['indeed MANY national GUIDELINES RECOMMEND universal Antenatal Vitamin D supplementation to prevent Vitamin D INSUFFICIENCY (7–9).']	[('INCOMPLETE_EVIDENCE', 7), ('PROBABLE_UNDERSTANDING', 21), ('FUTURE_WORK', 32), ('IMPORTANT_CONSIDERATION', 109)]	4	[('GO_0007567', 'parturition', 52, 'antenatal'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC5155676	12/2016	S19-PMC5155676	['RISK FACTORS for Vitamin D insufficiency are WELL DESCRIBED, and include ethnicity, extensive skin covering and liberal use of sun protection, overweight/obesity, low dietary Vitamin D intake, and smoking (1,10,11), in addition to the seasonal variation that is OBSERVED at temperate latitudes (11,12).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 262)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC5155676	12/2016	S20-PMC5155676	['ALTHOUGH Vitamin D supplementation CAN improve maternal 25(Oh)D status (10), LITTLE IS KNOWN about HOW maternal characteristics MIGHT INFLUENCE the 25(Oh)d achieved after supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 35), ('FULL_UNKNOWN', 77), ('EXPLICIT_QUESTION', 99), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 148, '25(OH)')]
PMC5155676	12/2016	S22-PMC5155676	['during Pregnancy, maternal hemodilution is ACCOMPANIED by a number OF physiological changes to both Vitamin D Metabolism (15) and maternal body composition (16); such adaptations MIGHT lead to DIFFERENCES in the DETERMINANTS of response to Vitamin D supplementation between Pregnant and nonpregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 67), ('INCOMPLETE_EVIDENCE', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('SUPERFICIAL_RELATIONSHIP', 212)]	5	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007601', 'visual perception', 100, 'vitamin D'), ('GO_0008152', 'metabolic process', 110, 'metabolism'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0007565', 'female pregnancy', 274, 'pregnant')]
PMC5155676	12/2016	S23-PMC5155676	['clinically, understanding HOW Individuals respond COULD LEAD to individualized Antenatal counseling regarding Vitamin D supplementation to ensure Vitamin D repletion is achieved without increasing the RISK of Vitamin D toxicity.']	[('EXPLICIT_QUESTION', 26), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 201)]	4	[('NCBITaxon_1', 'root', 30, 'individuals'), ('GO_0007567', 'parturition', 79, 'antenatal'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC5155676	12/2016	S72-PMC5155676	['no participant reported symptoms SUGGESTIVE of Vitamin D toxicity.']	[('INCOMPLETE_EVIDENCE', 33)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5155676	12/2016	S95-PMC5155676	['the maternal characteristics ASSOCIATED with 25(Oh)D at 34 weeks of Gestation and achieving Vitamin D replete status were SIMILAR TO those observed in the whole cohort.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 122)]	2	[('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 51, 'D'), ('GO_0007565', 'female pregnancy', 68, 'gestation'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC5155676	12/2016	S97-PMC5155676	['this dose achieved Vitamin D repletion in over 80% of women, without leading to 25(Oh)D levels POTENTIALLY ASSOCIATED with Vitamin D toxicity (at least within the included baseline of 25–100 nmol/l 25(Oh)D).']	[('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 107)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 198, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 198, '25(OH ... D')]
PMC5155676	12/2016	S99-PMC5155676	['THUS, those women who are AT RISK of Vitamin D insufficiency in early Pregnancy, gain greater weight, and Deliver in winter MIGHT NEED supplementation with a higher dose of Cholecalciferol to achieve SIMILAR 25(Oh)D concentrations.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 26), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 130), ('SUPERFICIAL_RELATIONSHIP', 200)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007567', 'parturition', 106, 'deliver'), ('CHEBI_52550', 'theopalauamide', 173, 'cholecalciferol'), ('CHEBI_71657', 'versiconol acetate', 208, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 214, 'D')]
PMC5155676	12/2016	S103-PMC5155676	['it is WELL RECOGNIZED that Individuals who are overweight or obese are at higher RISK of Vitamin D insufficiency, and this is SIMILARLY OBSERVED in Pregnancy (2,22).']	[('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 11), ('IMPORTANT_CONSIDERATION', 81), ('SUPERFICIAL_RELATIONSHIP', 126), ('INCOMPLETE_EVIDENCE', 136)]	5	[('NCBITaxon_1', 'root', 27, 'individuals'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy')]
PMC5155676	12/2016	S105-PMC5155676	['metaanalysis of Vitamin D supplementation STUDIES has SUGGESTED that over 50% of the variance in 25(Oh)D increment in response to supplementation is explained by body weight (13).']	[('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 54)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 103, 'D')]
PMC5155676	12/2016	S108-PMC5155676	['weight gain in Pregnancy REPRESENTS NOT ONLY increased fat mass BUT ALSO Feto-Placental Tissues and hemodilution (16); our data, THEREFORE, SUGGEST that overall volume of dilution, and not just adiposity, MAY BE IMPORTANT for response to Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('ANOMALY_CURIOUS_FINDING', 36), ('ANOMALY_CURIOUS_FINDING', 64), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 212)]	7	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('UBERON_0000981', 'femur', 73, 'feto'), ('UBERON_0002483', 'trabecular bone tissue', 78, 'placental tissues'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5155676	12/2016	S112-PMC5155676	['HOWEVER, it is NOTABLE that there were marked DIFFERENCES in baseline 25(Oh)D concentrations between these investigations, and we OBSERVED that initial 25(Oh)D status was positively ASSOCIATED with both the LIKELIHOOD of achieving Vitamin D replete status and absolute 25(Oh)D status at 34 weeks of Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 182), ('PROBABLE_UNDERSTANDING', 207)]	7	[('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 76, 'D'), ('CHEBI_63056', 'zinc cation', 152, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('GO_0007565', 'female pregnancy', 299, 'gestation')]
PMC5155676	12/2016	S113-PMC5155676	['IMPORTANTLY, the difference between the 25(Oh)D achieved at 34 weeks of Gestation in women randomized to Placebo compared with Cholecalciferol decreased with increasing baseline 25(Oh)D. this is CONSISTENT with PREVIOUS STUDIES in Adults, which HAVE SHOWN that the incremental response to Vitamin D supplementation is higher in Vitamin D insufficient than replete subjects (13,14) and that the increase in 25(Oh)D relative to supplementation dose is negatively ASSOCIATED with dose of vitamin D supplement (26).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 195), ('INCOMPLETE_EVIDENCE', 211), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 461)]	5	[('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('GO_0007565', 'female pregnancy', 72, 'gestation'), ('CHEBI_26130', 'biological pigment', 105, 'placebo'), ('CHEBI_52550', 'theopalauamide', 127, 'cholecalciferol'), ('CHEBI_33010', 'chromide(1-)', 180, '(OH)D'), ('UBERON_0007023', 'adult organism', 231, 'adults'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 328, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 412, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 493, 'D')]
PMC5155676	12/2016	S115-PMC5155676	['this mechanism MIGHT be IMPORTANT in preventing hypervitaminosis D. HOWEVER, studies comparing the effectiveness of DIFFERING doses of Vitamin D in Pregnancy HAVE SHOWN that 4000 iu/d CAN achieve a higher 25(Oh)D than 400 iu/d (10,28), BUT WHETHER these higher doses are of clinical benefit is YET to be DEMONSTRATED (4,29) and at the general population level, lower doses would be compatible with keeping 25(Oh)D below a concentration which MIGHT be concerning.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('ANOMALY_CURIOUS_FINDING', 294), ('INCOMPLETE_EVIDENCE', 304), ('INCOMPLETE_EVIDENCE', 442)]	11	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 65, 'D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 205, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 211, 'D'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 412, 'D')]
PMC5155676	12/2016	S118-PMC5155676	['hollis et al SIMILARLY FOUND that EVEN with 4000 iu/d Vitamin D during Pregnancy, african-american women had lower 25(Oh)D in late Pregnancy than caucasian or hispanic women (10).']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 34)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 115, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 121, 'D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy')]
PMC5155676	12/2016	S123-PMC5155676	['data from healthy and hospitalized Adults have SIMILARLY SHOWN that older Individuals achieve a higher 25(Oh)D after Vitamin D supplementation (13,32).']	[('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('UBERON_0007023', 'adult organism', 35, 'adults'), ('NCBITaxon_1', 'root', 74, 'individuals'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('PR_000010220', 'mannose-binding protein C', 105, '('), ('PR_000006444', 'diacylglycerol kinase delta', 109, 'D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5155676	12/2016	S124-PMC5155676	['AS such, young Pregnant women MIGHT PARTICULARLY REQUIRE ADVICE on the need for, and compliance with, Vitamin D supplementation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('ANOMALY_CURIOUS_FINDING', 36), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 49), ('IMPORTANT_CONSIDERATION', 49), ('FUTURE_WORK', 57)]	7	[('GO_0007565', 'female pregnancy', 15, 'pregnant'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5155676	12/2016	S125-PMC5155676	['ALTHOUGH OUR FINDINGS are NOVEL, and MAY enable the development of individualized ADVICE for Antenatal Vitamin D supplementation, there are a NUMBER OF LIMITATIONS which SHOULD BE CONSIDERED in the INTERPRETATION of this study.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FULL_UNKNOWN', 26), ('INCOMPLETE_EVIDENCE', 37), ('FUTURE_WORK', 82), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 152), ('PROBLEM_COMPLICATION', 152), ('FUTURE_WORK', 170), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 198)]	11	[('GO_0007567', 'parturition', 93, 'antenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC5155676	12/2016	S131-PMC5155676	['thirdly, we DID NOT examine Genetic determinants of the response to Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 12)]	1	[('SO_0000704', 'gene', 28, 'genetic'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5155676	12/2016	S132-PMC5155676	['it HAS BEEN demonstrated PREVIOUSLY that the incremental rise in 25(Oh)D after supplementation DIFFERS by Single Nucleotide Polymorphisms in Vitamin D Binding Protein (33,34) and 25-hydroxylase Genes (33).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	3	[('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 65, '25(OH ... D'), ('SO_0000694', 'SNP', 106, 'single nucleotide polymorphisms'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 141, 'vitamin D binding protein'), ('SO_0000704', 'gene', 194, 'genes')]
PMC5155676	12/2016	S133-PMC5155676	['ALTHOUGH this Genetic information CAN enable a more COMPREHENSIVE understanding of the biochemical response to Vitamin D supplementation, the current inability to undertake genotyping on a widespread population basis means this additional information WOULD NOT ALLOW for alterations to current clinical PRACTICE regarding Vitamin D supplementation in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 52), ('DIFFICULT_TASK', 251), ('INCOMPLETE_EVIDENCE', 303)]	6	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('GO_0007565', 'female pregnancy', 351, 'pregnancy')]
PMC5155676	12/2016	S136-PMC5155676	['FUTURE STUDIES SHOULD AIM to determine appropriate doses to enable consistent repletion of 25(Oh)D during Pregnancy, and OUR FINDINGS SUPPORT the NOTION that clinical approaches to Vitamin D repletion MAY BE informed by individual characteristics.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 121), ('INCOMPLETE_EVIDENCE', 134), ('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 201)]	6	[('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 93, '(OH ... D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC5155676	12/2016	S137-PMC5155676	['AS SUCH, personalized Vitamin D supplementation ADVICE MIGHT become part of future Antenatal care.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 48), ('INCOMPLETE_EVIDENCE', 55)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007567', 'parturition', 83, 'antenatal')]
PMC5167470	12/2016	S41-PMC5167470	['this was followed by Vitamin 25-Oh-D3 deficiency in 40.5% of patients, B12 deficiency in 22.6%, Vitamin A in 7.7%, Calcium in 6.6%, Vitamin E in 6% and Folic Acid in 5.4%.5in another RECENT prospective STUDY that followed 49 women who got Pregnant after bs, progressively decreasing levels of Vitamins A, D, b12, and iron were OBSERVED over the course of Pregnancy, DESPITE correct compliance with oral supplements, before and during Gestation.']	[('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 327), ('ANOMALY_CURIOUS_FINDING', 366)]	3	[('CHEBI_85670', 'N-oleoyl-sn-glycero-3-phosphoethanolamine', 21, 'vitamin 25-OH-D3'), ('CHEBI_27778', 'abequose', 71, 'B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 71, 'B12'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('CHEBI_22313', 'alkaline earth metal atom', 115, 'calcium'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin E'), ('CHEBI_30751', 'formic acid', 152, 'folic acid'), ('GO_0007565', 'female pregnancy', 239, 'pregnant'), ('CHEBI_27300', 'vitamin D', 293, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 302, 'A'), ('PR_000006444', 'diacylglycerol kinase delta', 305, 'D'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('GO_0007565', 'female pregnancy', 434, 'gestation')]
PMC5167470	12/2016	S43-PMC5167470	['in this regard, there HAVE BEEN REPORTS of Kidney abnormalities in the offspring of women who took between 40,000 and 50,000 u/d of Vitamin A during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 32)]	2	[('UBERON_0002113', 'kidney', 43, 'kidney'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 140, 'A'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy')]
PMC5167470	12/2016	S44-PMC5167470	['HOWEVER, daily ingestion of multivitamin tablets that include around 6,000–8,000 u/d of Vitamin A do not SEEM to increase the rate of malformations RELATED to Isotretinoine (13-Cis Retinoic) exposure, and this result is from SEVERAL long-term case-control STUDIES.25,26for Vitamin D, exposure to high doses increased the rate of fetal Cardiac malformations, especially Aortic stenosis, which HAS BEEN ASSOCIATED with an intake of 4,000 iu/d.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 225), ('INCOMPLETE_EVIDENCE', 256), ('INCOMPLETE_EVIDENCE', 392), ('SUPERFICIAL_RELATIONSHIP', 401)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin A'), ('CHEBI_31719', 'ipriflavone', 159, 'isotretinoine'), ('CHEBI_33804', 'gluconates', 174, '13-cis'), ('CHEBI_26537', 'retinoid', 181, 'retinoic'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('UBERON_0000948', 'heart', 335, 'cardiac'), ('UBERON_0000947', 'aorta', 369, 'aortic')]
PMC5167470	12/2016	S100-PMC5167470	['in this regard, the most FREQUENTLY DESCRIBED maternal Micronutrient deficiency is that of Folic Acid, which entails a high risk of fetal Neural Tube defects.68moreover, there HAVE BEEN case reports of maternal and fetal hypercoagulability due to Vitamin K deficiency following bpd, Ophthalmic and Renal malformations due to SEVERE maternal and fetal Vitamin a deficiency, and megaloblastic anemia due to Vitamin B12 deficiency.69–71\n\nconclusion\nPregnancy after bs is SAFE, both for the mother and for the fetus.']	[('ANOMALY_CURIOUS_FINDING', 25), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 176), ('IMPORTANT_CONSIDERATION', 325), ('IMPORTANT_CONSIDERATION', 468)]	5	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 55, 'micronutrient'), ('CHEBI_30751', 'formic acid', 91, 'folic acid'), ('UBERON_0001049', 'neural tube', 138, 'neural tube'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin K'), ('UBERON_0000970', 'eye', 283, 'ophthalmic'), ('UBERON_0002113', 'kidney', 298, 'renal'), ('CHEBI_33229', 'vitamin (role)', 351, 'vitamin'), ('CHEBI_33279', 'vitamin D5', 405, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 405, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 446, 'Pregnancy')]
PMC5187820	12/2016	S100-PMC5187820	['a NUMBER OF Animal STUDIES have INDICATED that Pravastatin, aminoguanidine, Pioglitazone, Probucol, farnesoid x Receptor Agonists, Vitamin E, melatonin, Resveratrol, n -Acetylcysteine, and aliskiren can increase the activity and/or Expression of ddah, and thereby reduce adma levels [9,30,47,63].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 32)]	3	[('NCBITaxon_33208', 'Metazoa', 12, 'animal'), ('CHEBI_63618', 'pravastatin', 47, 'pravastatin'), ('CHEBI_8228', 'pioglitazone', 76, 'pioglitazone'), ('CHEBI_8427', 'probucol', 90, 'probucol'), ('CHEBI_26543', 'rhamnogalacturonan', 112, 'receptor agonists'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin E'), ('CHEBI_27881', 'resveratrol', 153, 'resveratrol'), ('CHEBI_22198', 'acetylcysteine', 169, 'acetylcysteine'), ('GO_0010467', 'gene expression', 232, 'expression')]
PMC5223368	12/2016	S135-PMC5223368	['Pregnancy health is STRONGLY ASSOCIATED with Serum 25-Hydroxy Vitamin D [26], and the ROLE of Vitamin D in bone mineralization is WELL KNOWN [26,27].']	[('PROBABLE_UNDERSTANDING', 20), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 130)]	4	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 51, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5223368	12/2016	S136-PMC5223368	['a study in london REPORTED that maternal Vitamin D insufficiency at Pregnancy as early as 19\xa0weeks CAN INFLUENCE Fetal Femoral Development, and SUGGESTED that maternal Vitamin D should be improved in early Pregnancy [14].']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 103), ('INCOMPLETE_EVIDENCE', 144)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007631', 'feeding behavior', 113, 'fetal'), ('GO_0009556', 'microsporogenesis', 119, 'femoral development'), ('UBERON_0000981', 'femur', 119, 'femoral'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007565', 'female pregnancy', 206, 'pregnancy')]
PMC5223368	12/2016	S139-PMC5223368	['an australian study DEMONSTRATED that infants whose mother was Vitamin D deficient (<28\xa0nmol/l) at the third trimester had shorter Knee-Heel length [29].']	[('INCOMPLETE_EVIDENCE', 20)]	1	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001465', 'knee', 131, 'knee'), ('UBERON_0015875', 'heel', 136, 'heel')]
PMC5223368	12/2016	S144-PMC5223368	['THEREFORE, the positive ASSOCIATION between high temperature at the third Trimester and increased Birth length in THIS STUDY MIGHT be PARTLY EXPLAINED by Vitamin D status of mothers [31].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 114), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 134), ('PROBABLE_UNDERSTANDING', 141)]	6	[('GO_0009294', 'DNA mediated transformation', 74, 'trimester'), ('GO_0007567', 'parturition', 98, 'birth'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5223368	12/2016	S185-PMC5223368	['one of the LIMITATIONS of THIS STUDY was that FACTORS which COULD AFFECT Birth size such as maternal dietary information and maternal Vitamin D status during Pregnancy were NOT available.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 173)]	6	[('GO_0007567', 'parturition', 73, 'birth'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy')]
PMC5295046	12/2016	S97-PMC5295046	['first, we FURTHER adjusted our lme models for maternal smoking, alcohol Intake, physical activities, and Plasma Vitamin D and Folate concentrations.']	[('INCOMPLETE_EVIDENCE', 10)]	1	[('GO_0007631', 'feeding behavior', 72, 'intake'), ('UBERON_0001969', 'blood plasma', 105, 'plasma'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 126, 'folate')]
PMC5240436	1/2017	S114-PMC5240436	['a PREVIOUS STUDY that provided combined Vitamin A and zinc supplementation to children in ghana LED TO a reduction in the RISK of clinical malaria episodes [46] possibly DUE TO the synergistic EFFECTS of Vitamin A and zinc on Immune function [47].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 96), ('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 170), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A'), ('UBERON_0002405', 'immune system', 226, 'immune')]
PMC5240436	1/2017	S115-PMC5240436	['CONTRARY to our expectation BASED ON these PREVIOUS STUDIES, sq-Lns and mmn which contained both Vitamin A and zinc were not associated with a lower risk of p. falciparum parasitaemia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 43)]	4	[('UBERON_0000029', 'lymph node', 64, 'LNS'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A')]
PMC5240436	1/2017	S116-PMC5240436	['the LACK OF treatment response DESPITE the provision of adequate doses of Vitamin A and zinc in mmn and sq-lns and reasonable adherence to supplementation [24] COULD HAVE been due to dietary factors inhibiting zinc absorption [48] or haemodilution in the latter half of Pregnancy lowering levels of Retinol binding protein resulting in functional Vitamin A deficiency [49].']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 31), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 166)]	4	[('CHEBI_27300', 'vitamin D', 74, 'vitamin A'), ('GO_0007565', 'female pregnancy', 270, 'pregnancy'), ('CHEBI_26536', 'retinoic acid', 299, 'retinol'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin A')]
PMC5240436	1/2017	S120-PMC5240436	['FURTHER clinical TRIALS supplementing single Nutrients (efas, Vitamin A or zinc) MAY BE CRUCIAL in isolating the IMPACT of each Nutrient on maternal infections.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 81), ('IMPORTANT_CONSIDERATION', 88), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('CHEBI_33284', 'nutrient', 45, 'nutrients'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('CHEBI_33284', 'nutrient', 128, 'nutrient')]
PMC5241768	1/2017	S324-PMC5241768	['management of ckd in diabetesegfr (ml/min/1.73 m2)recommended managementall patients• yearly measurement of uacr, serum creatinine, and potassium45–60• refer to a nephrologist IF POSSIBILITY for nondiabetic Kidney disease exists (duration of type 1 diabetes <10 years, persistent albuminuria, abnormal findings on Renal ultrasound, resistant hypertension, rapid fall in egfr, or active Urinary sediment on Urine microscopic examination)• consider the need for dose adjustment of Medications• monitor egfr every 6 months• monitor electrolytes, bicarbonate, hemoglobin, calcium, Phosphorus, and Parathyroid hormone at least yearly• assure Vitamin D sufficiency• vaccinate against hepatitis b Virus• consider bone density testing• refer for dietary counseling30–44• monitor egfr every 3 months• monitor electrolytes, bicarbonate, calcium, phosphorus, Parathyroid hormone, hemoglobin, albumin, and weight every 3–6 months• consider THE NEED for dose adjustment of Medications<30• refer to a nephrologist\n\ndiabetic retinopathy\nrecommendations\noptimize Glycemic Control to reduce the RISK or slow the progression of diabetic retinopathy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 928), ('IMPORTANT_CONSIDERATION', 1078)]	4	[('UBERON_0002113', 'kidney', 207, 'kidney'), ('UBERON_0002113', 'kidney', 314, 'renal'), ('UBERON_0001088', 'urine', 386, 'urinary'), ('UBERON_0001088', 'urine', 406, 'urine'), ('CHEBI_25441', 'mycothiols', 479, 'medications'), ('CHEBI_35885', 'secondary phosphine', 577, 'phosphorus'), ('UBERON_0001132', 'parathyroid gland', 593, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 637, 'vitamin D'), ('NCBITaxon_1', 'root', 690, 'virus'), ('UBERON_0001132', 'parathyroid gland', 848, 'parathyroid'), ('CHEBI_25441', 'mycothiols', 960, 'medications'), ('GO_0006094', 'gluconeogenesis', 1047, 'glycemic control')]
PMC5310660	1/2017	S38-PMC5310660	['several seasonal factors acting during Pregnancy and the Perinatal Period HAVE BEEN PROPOSED to EXPLAIN these data, including infections, dietary factors (e.g., low intake of antioxidants in winter), and Vitamin D deficiency through lack of sun exposure during Pregnancy.[8].']	[('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 84), ('PROBABLE_UNDERSTANDING', 96)]	3	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('GO_0036268', 'swimming', 57, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 57, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'pregnancy')]
PMC5310660	1/2017	S43-PMC5310660	['during Pregnancy, when a higher amount of Vitamin D is REQUIRED, many Pregnant women CAN develop a Vitamin D deficiency.']	[('IMPORTANT_CONSIDERATION', 55), ('INCOMPLETE_EVIDENCE', 85)]	2	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnant'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC5310660	1/2017	S44-PMC5310660	['in ireland, a higher prevalence of Vitamin D deficiency (25(Oh)D <27.5 nmol/l) was OBSERVED in Pregnant than in nonpregnant women, both in spring (44% vs. 18%) and in winter (35% vs 29%) [15].']	[('INCOMPLETE_EVIDENCE', 83)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant')]
PMC5310660	1/2017	S45-PMC5310660	['newborns CAN have lower Vitamin D levels than their mothers.']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5310660	1/2017	S46-PMC5310660	['in the usa, in winter and spring, a Vitamin D deficiency (25(Oh)D <37 nmol/l) was FOUND in 5% of new mothers and in 9.7% of their newborns [16].']	[('INCOMPLETE_EVIDENCE', 82)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D')]
PMC5310660	1/2017	S47-PMC5310660	['in italy, low Vitamin D levels (25(Oh)D<25 nmol/l) were FOUND in 18% of new mothers and in 38% of their newborns [17].']	[('INCOMPLETE_EVIDENCE', 56)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D')]
PMC5310660	1/2017	S48-PMC5310660	['Gestational Vitamin D concentration IS CONSIDERED IMPORTANT for the Development Of the Immune System.']	[('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 50)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0002020', 'protease binding', 68, 'development of ... immune system'), ('UBERON_0002405', 'immune system', 87, 'immune system')]
PMC5310660	1/2017	S50-PMC5310660	['Genes ASSOCIATED with many Autoimmune diseases are enriched for Vitamin D receptor-Binding Sites [19-21], SUGGESTING that the combined EFFECT of Vitamin D deficiency, Genetic variation, and exposure to other environmental agents MAY concur in the pathogenesis.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 229)]	4	[('SO_0000704', 'gene', 0, 'Genes'), ('UBERON_0001442', 'skeleton of manus', 27, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('SO_0000409', 'binding_site', 83, 'binding sites'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('SO_0000704', 'gene', 167, 'genetic')]
PMC5310660	1/2017	S52-PMC5310660	['in Animal models, Gestational Vitamin D deficiency AFFECTS Brain Development [23], and the myelination process [24], and it COULD have an EFFECT on Retinal Cells.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('GO_0007565', 'female pregnancy', 18, 'gestational'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007420', 'brain development', 59, 'brain development'), ('UBERON_0000955', 'brain', 59, 'brain'), ('CL_0009004', 'retinal cell', 148, 'retinal cells'), ('UBERON_0000966', 'retina', 148, 'retinal')]
PMC5310660	1/2017	S53-PMC5310660	['Vitamin D is INVOLVED in the pathogenesis of neovascular amd, and a significant CORRELATION HAS BEEN FOUND between reduced Plasma Vitamin D level and the prevalence of amd [25-28].']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 101)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 123, 'plasma'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5318550	2/2017	S19-PMC5318550	['HOWEVER, an integral test of these POSSIBLE explanations for the RISK of POOR Neurodevelopmental outcomes is LACKING and newer HYPOTHESES, such as variation in Vitamin D levels, HAVE NOT BEEN INVESTIGATED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 35), ('IMPORTANT_CONSIDERATION', 65), ('IMPORTANT_CONSIDERATION', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('FULL_UNKNOWN', 109), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 178), ('IMPORTANT_CONSIDERATION', 178)]	10	[('GO_0007399', 'nervous system development', 78, 'neurodevelopmental'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC5318550	2/2017	S21-PMC5318550	['the MAJORITY of studies focused on maternal influenza as the primary cause for a higher prevalence of schizophrenia ASSOCIATED with certain Birth months.3poor Prenatal nutrition HAS BEEN PROPOSED to be RELATED to the Birth seasonality of Individuals who develop schizophrenia.4\nadverse Birth outcomes are RISK FACTORS for impaired Cognitive Development.56PREVIOUS STUDIES have repeatedly described RELATIONSHIPS between season of Birth and Birth weight, and duration of Gestation.7\nRECENTLY, a strong INTEREST in the EFFECTS of Vitamin D on development of the Brain emerged.']	[('PROBABLE_UNDERSTANDING', 4), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 305), ('INCOMPLETE_EVIDENCE', 353), ('SUPERFICIAL_RELATIONSHIP', 398), ('INCOMPLETE_EVIDENCE', 482), ('INCOMPLETE_EVIDENCE', 501), ('SUPERFICIAL_RELATIONSHIP', 517)]	11	[('GO_0007567', 'parturition', 140, 'birth'), ('GO_0007565', 'female pregnancy', 159, 'prenatal'), ('GO_0007567', 'parturition', 217, 'birth'), ('NCBITaxon_1', 'root', 238, 'individuals'), ('GO_0007567', 'parturition', 286, 'birth'), ('GO_0050787', 'detoxification of mercury ion', 331, 'cognitive development'), ('GO_0007567', 'parturition', 430, 'birth'), ('GO_0007567', 'parturition', 440, 'birth'), ('GO_0007565', 'female pregnancy', 470, 'gestation'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('UBERON_0000955', 'brain', 560, 'brain')]
PMC5318550	2/2017	S22-PMC5318550	['owing to its RELATIONSHIP with the duration of the photoperiod, low Vitamin D levels are put forward AS a POTENTIAL mechanism between season of Birth and Neurological outcomes.8\nanother CANDIDATE mechanism for the seasonal PATTERNS in intellectual ability are the educational policies regarding school entry.9age at school entrance and the relative age compared with peers are considered to AFFECT the youngest in class.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBABLE_UNDERSTANDING', 101), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 186), ('SUPERFICIAL_RELATIONSHIP', 223), ('SUPERFICIAL_RELATIONSHIP', 391)]	6	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007567', 'parturition', 144, 'birth'), ('UBERON_0001016', 'nervous system', 154, 'neurological')]
PMC5318550	2/2017	S28-PMC5318550	['next, we determined in additional models WHETHER this ASSOCIATION COULD BE explained by specific variables—thereby testing DIFFERENT HYPOTHESES; (2) sociodemographic factors and maternal iq; (3) child Birth weight and Gestational duration; (4) Pregnancy Vitamin D plasma status; (5) maternal nutritional intake; (6) maternal exposure to fever during Pregnancy; and (7) child age relative to peers at school.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133)]	5	[('GO_0007567', 'parturition', 201, 'birth'), ('GO_0007565', 'female pregnancy', 218, 'gestational'), ('GO_0007565', 'female pregnancy', 244, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0007565', 'female pregnancy', 350, 'pregnancy')]
PMC5318550	2/2017	S67-PMC5318550	['portion sizes were estimated using household measures and photographs.21to calculate average daily nutritional values, the dutch Food composition table 2006 was used.22\non the basis of their seasonal variations in PREVIOUS literature, we selected fat, Carbohydrate, Vitamin C, b, Sodium, Potassium, calcium, Phosphorus and zinc intakes and adjusted for energy intake.23\nFolate concentrations were analysed in edta Plasma samples, drawn in early Pregnancy (median 13.1\u2005weeks of Gestation; 90% range 10.5–16.9\u2005weeks).']	[('INCOMPLETE_EVIDENCE', 214)]	1	[('CHEBI_33290', 'food', 129, 'food'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 252, 'carbohydrate'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin C'), ('CHEBI_52632', 'potassium-39 atom', 280, 'sodium'), ('CHEBI_22314', 'alkali metal atom', 288, 'potassium'), ('CHEBI_35885', 'secondary phosphine', 308, 'phosphorus'), ('CHEBI_81245', 'Vulpecholate', 370, 'Folate'), ('UBERON_0001969', 'blood plasma', 414, 'plasma'), ('GO_0007565', 'female pregnancy', 445, 'pregnancy'), ('GO_0007565', 'female pregnancy', 477, 'gestation')]
PMC5318550	2/2017	S106-PMC5318550	['Maternal Plasma and Cord Blood Vitamin D Plasma levels explained 124.8% of the variance in this basic model not adjusted for POTENTIAL confounders (r2change 0.050, p<0.001).']	[('INCOMPLETE_EVIDENCE', 125)]	1	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001969', 'blood plasma', 9, 'plasma'), ('UBERON_0002240', 'spinal cord', 20, 'cord'), ('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 41, 'plasma')]
PMC5318550	2/2017	S136-PMC5318550	['nutrition is regarded as an UNLIKELY driver of seasonal Birth outcomes in developed countries, where Food supply fluctuates little over the year.27likewise, maternal and Cord blood Vitamin D concentrations had ONLY a very modest improvement of the MODEL.']	[('PROBABLE_UNDERSTANDING', 28), ('ANOMALY_CURIOUS_FINDING', 210), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 248)]	4	[('GO_0007567', 'parturition', 56, 'birth'), ('CHEBI_33290', 'food', 101, 'food'), ('UBERON_0002240', 'spinal cord', 170, 'cord'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC5322422	2/2017	S4-PMC5322422	['further questioning REVEALED the patient had not received prophylactic Vitamin K at Birth.']	[('INCOMPLETE_EVIDENCE', 20)]	1	[('CHEBI_27300', 'vitamin D', 71, 'vitamin K'), ('GO_0007567', 'parturition', 84, 'birth')]
PMC5322422	2/2017	S51-PMC5322422	['IN LIGHT OF these pathologic findings as well as the medical history and clinical response to Vitamin K and ffp, the final diagnosis for this patient was Thymic hemorrhage secondary to Vitamin K deficiency, with POSSIBLE component of Thymic hyperplasia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 212)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin K'), ('UBERON_0002370', 'thymus', 154, 'thymic'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin K'), ('UBERON_0002370', 'thymus', 234, 'thymic')]
PMC5322422	2/2017	S55-PMC5322422	['first, Placental Transfer of Vitamin K is LIMITED with extremely low Cord concentrations (<0.05\u2009 μ g/l) compared to Adult levels [1].']	[('INCOMPLETE_EVIDENCE', 42)]	1	[('UBERON_0001987', 'placenta', 7, 'placental'), ('GO_0006412', 'translation', 17, 'transfer'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin K'), ('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0007023', 'adult organism', 116, 'adult')]
PMC5322422	2/2017	S60-PMC5322422	['early vkdb occurs in the first 24 hours of Life BUT typically ONLY is SEEN in infants whose mothers take Medications that interfere with Vitamin K Metabolism (e.g., Anticoagulants, Anticonvulsants, or Antituberculosis Drugs).']	[('ANOMALY_CURIOUS_FINDING', 48), ('ANOMALY_CURIOUS_FINDING', 62), ('INCOMPLETE_EVIDENCE', 70)]	3	[('UBERON_0000104', 'life cycle', 43, 'life'), ('CHEBI_25441', 'mycothiols', 105, 'medications'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin K'), ('GO_0006565', 'L-serine catabolic process', 145, 'K metabolism'), ('CHEBI_33282', 'antibacterial agent', 165, 'anticoagulants'), ('CHEBI_37540', 'arabinarate(2-)', 181, 'anticonvulsants'), ('CHEBI_48617', '5-(hydroxymethyl)piperidine-2,3,4-triol', 201, 'antituberculosis'), ('CHEBI_23888', 'drug', 218, 'drugs')]
PMC5322422	2/2017	S64-PMC5322422	["to prevent all forms of vkdb, administration of intramuscular Vitamin K at Birth HAS BEEN a standard practice in the united states since 1961 when the american academy of pediatrics' RECOMMENDED the injection for all newborns [5]."]	[('INCOMPLETE_EVIDENCE', 81), ('FUTURE_WORK', 183)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin K'), ('GO_0007567', 'parturition', 75, 'birth')]
PMC5322422	2/2017	S67-PMC5322422	['HOWEVER, authors SPECULATE these ESTIMATES are lower than the actual figures because the number of exclusively Breastfed infants who do not receive intramuscular Vitamin K are UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 33), ('FULL_UNKNOWN', 176)]	4	[('GO_0007567', 'parturition', 111, 'breastfed'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin K')]
PMC5325195	2/2017	S93-PMC5325195	['cbhvs also actively promoted facility-based delivery.10.1371/journal.pone.0170739.t001\n\ncaption (table-wrap): table 1\ncbhv messages to Pregnant women transmitted through pictorial counselling cards.1 importance of Antenatal clinic attendance for Pregnant women 2 importance of screening tests, including hiv in Pregnancy 3 importance of intermittent preventive therapy for malaria in Pregnancy using Sulphadoxine-Pyrimethamine tablets 4 importance of skilled attendance in Labor and Postpartum care 5 importance of an Insecticide-treated net and HOW to use it at home 6 types of Food, importance of an adequate and balanced diet in Pregnancy, and Vitamin A supplementation for children 7 the IMPORTANCE of iron and Folic Acid during Pregnancy 8 importance of using Misoprostol tablets after Delivery Of the Baby and HOW to use it 9 the IMPORTANCE of Chlorhexidine gel for Cord care and HOW to apply it on the Cord; avoiding use of POTENTIALLY harmful substances to the Cord 10 the care for low Birth weight babies with kangaroo care 11 HOW to prepare the Oral rehydration Solution (ors) for diarrheal diseases in children under 5 years, and the IMPORTANCE of ors.']	[('EXPLICIT_QUESTION', 546), ('IMPORTANT_CONSIDERATION', 692), ('EXPLICIT_QUESTION', 816), ('IMPORTANT_CONSIDERATION', 836), ('EXPLICIT_QUESTION', 886), ('INCOMPLETE_EVIDENCE', 931), ('EXPLICIT_QUESTION', 1036), ('IMPORTANT_CONSIDERATION', 1145)]	8	[('GO_0007565', 'female pregnancy', 135, 'pregnant'), ('GO_0007567', 'parturition', 214, 'antenatal'), ('GO_0007565', 'female pregnancy', 246, 'pregnant'), ('GO_0007565', 'female pregnancy', 311, 'pregnancy'), ('GO_0007565', 'female pregnancy', 384, 'pregnancy'), ('CHEBI_9329', 'sulfadoxine', 400, 'Sulphadoxine'), ('CHEBI_16610', 'spermidine', 413, 'pyrimethamine'), ('GO_0007612', 'learning', 473, 'labor'), ('GO_0007565', 'female pregnancy', 483, 'postpartum'), ('CHEBI_24852', 'insecticide', 518, 'insecticide'), ('CHEBI_33290', 'food', 579, 'food'), ('GO_0007565', 'female pregnancy', 632, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 647, 'vitamin A'), ('CHEBI_30751', 'formic acid', 715, 'folic acid'), ('GO_0007565', 'female pregnancy', 733, 'pregnancy'), ('CHEBI_63610', 'misoprostol', 765, 'misoprostol'), ('GO_0046697', 'decidualization', 791, 'delivery of ... baby'), ('CHEBI_3647', 'chlorpromazine', 850, 'chlorhexidine'), ('UBERON_0002240', 'spinal cord', 872, 'cord'), ('UBERON_0002240', 'spinal cord', 909, 'cord'), ('UBERON_0002240', 'spinal cord', 969, 'cord'), ('GO_0007567', 'parturition', 994, 'birth'), ('UBERON_0000978', 'leg', 1055, 'Oral'), ('CHEBI_75958', 'solution', 1072, 'Solution')]
PMC5332602	3/2017	S44-PMC5332602	['additionally, Serum Vitamin A, Vitamin E, and Selenium levels were significantly increased at the end of the experiment in protein-deficient groups but not in protein-sufficient groups, SUGGESTIVE of a positive “30-day response” (as seen in Vitamin A-deficient children [17]) to supplementation of these Micronutrients in the diet.']	[('INCOMPLETE_EVIDENCE', 186)]	1	[('UBERON_0001977', 'blood serum', 14, 'serum'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 46, 'selenium'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin A'), ('CHEBI_33839', 'macromolecule', 304, 'micronutrients')]
PMC5332602	3/2017	S180-PMC5332602	['in addition to decreased Serum protein, Albumin, and Glucose levels, we observed that protein malnutrition AFFECTED the Homeostatic Control of Selenium and Vitamins A and e, CONSISTENT with SIMILAR observations on secondary Micronutrient deficiencies ASSOCIATED with childhood malnourishment (1).']	[('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 190), ('SUPERFICIAL_RELATIONSHIP', 251)]	4	[('UBERON_0001977', 'blood serum', 25, 'serum'), ('PR_000005908', 'alpha-crystallin B chain', 40, 'albumin'), ('CHEBI_17234', 'glucose', 53, 'glucose'), ('GO_0042592', 'homeostatic process', 120, 'homeostatic'), ('GO_0065007', 'biological regulation', 132, 'control'), ('CHEBI_27568', 'selenium atom', 143, 'selenium'), ('GO_0007601', 'visual perception', 143, 'selenium'), ('CHEBI_27300', 'vitamin D', 156, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 156, 'vitamins A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 224, 'micronutrient')]
PMC5332602	3/2017	S181-PMC5332602	['THUS, UNLIKE in our MODEL of Prenatal Vitamin A deficiency (single-Micronutrient deficiency) (31), protein deficiency AFFECTED the levels or Homeostatic Control of multiple Macro- and Micronutrients, limiting the ability of neonatal Pigs to adapt/maintain Homeostasis through compensatory mechanisms.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 118)]	4	[('GO_0007565', 'female pregnancy', 29, 'prenatal'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('GO_0042592', 'homeostatic process', 141, 'homeostatic'), ('GO_0065007', 'biological regulation', 153, 'control'), ('CHEBI_34830', 'mefenacet', 173, 'macro'), ('CHEBI_33839', 'macromolecule', 184, 'micronutrients'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'pigs'), ('GO_0042592', 'homeostatic process', 256, 'homeostasis')]
PMC5332602	3/2017	S182-PMC5332602	['this is IN AGREEMENT with the uniform suppression of the various innate Immune parameters evaluated in THIS STUDY and ASSOCIATED with protein deficiency versus concurrent up- or downregulation of those in Vitamin A-deficient Pigs (31).']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('SUPERFICIAL_RELATIONSHIP', 118)]	3	[('UBERON_0002405', 'immune system', 72, 'immune'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 225, 'pigs')]
PMC5340372	3/2017	S10-PMC5340372	['conclusion\nalthough a high CORRELATION was FOUND between maternal and Cord Vitamin D levels, the EFFECT on Respiratory outcome was DIFFERENT.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131)]	4	[('UBERON_0002240', 'spinal cord', 70, 'cord'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory')]
PMC5340372	3/2017	S15-PMC5340372	['REPORTED an inverse CORRELATION between Prenatal Vitamin D intake and recurrent wheezing of offspring [5].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC5340372	3/2017	S19-PMC5340372	['have RECENTLY SHOWN that infants with low Cord Serum Vitamin D levels have a higher RISK of childhood wheezing [7,11].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 84)]	3	[('UBERON_0002240', 'spinal cord', 42, 'cord'), ('UBERON_0001977', 'blood serum', 47, 'serum'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC5340372	3/2017	S93-PMC5340372	['ALTHOUGH a circulating level of 25(Oh)D less than 20 ng/ml is DEFINED AS Vitamin D deficiency [27,28], the mean levels MAY VARY among DIFFERENT populations [29].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 62), ('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 119), ('DIFFICULT_TASK', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134)]	6	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 38, 'D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5340372	3/2017	S99-PMC5340372	['Animal STUDIES have FOUND that Vitamin D deficiency CAN cause deficits in Lung function, which CAN be EXPLAINED by a change in Lung Development [32].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 102)]	5	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0002048', 'lung', 74, 'lung'), ('GO_0030324', 'lung development', 127, 'lung development'), ('UBERON_0002048', 'lung', 127, 'lung')]
PMC5340372	3/2017	S102-PMC5340372	['also no association was also FOUND between a children’s Vitamin D levels and their Lung function at 6–7 years of age in the koala Birth cohort study [34].']	[('INCOMPLETE_EVIDENCE', 29)]	1	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0002048', 'lung', 83, 'lung'), ('GO_0007567', 'parturition', 130, 'birth')]
PMC5340372	3/2017	S103-PMC5340372	['HOWEVER, in CONTRARY to these REPORTS, a survey in canadian children SHOWED that both low and high Vitamin D levels were RELATED to INCREASED RISK of wheeze and reduced performance of Lung function [35].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 121), ('IMPORTANT_CONSIDERATION', 132)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0002048', 'lung', 184, 'lung')]
PMC5340372	3/2017	S117-PMC5340372	['in THIS STUDY, infants with low 25(Oh)D had higher rrs BUT SIMILAR vmaxfrc, which IMPLIES that low Perinatal Vitamin D levels MIGHT be ASSOCIATED with a higher resistance of the Extrathoracic Airway.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ANOMALY_CURIOUS_FINDING', 55), ('SUPERFICIAL_RELATIONSHIP', 59), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135)]	6	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('GO_0036268', 'swimming', 99, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 99, 'perinatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0001601', 'extra-ocular muscle', 178, 'extrathoracic airway')]
PMC5340372	3/2017	S123-PMC5340372	['RECENT STUDIES HAVE SHOWN that Vitamin D CAN directly stimulate several Immune Cells and CAN promote the Production Of Antimicrobial Peptides [45–47].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 89)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CL_0000738', 'leukocyte', 72, 'immune cells'), ('UBERON_0002405', 'immune system', 72, 'immune'), ('GO_0008283', 'cell proliferation', 105, 'production of ... peptides'), ('CHEBI_65381', 'albizoside C', 119, 'antimicrobial')]
PMC5340372	3/2017	S126-PMC5340372	['in a randomized control TRIAL, a Vitamin D supplement CAN EVEN decrease the RISK of seasonal flu in children [50].']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 54), ('ANOMALY_CURIOUS_FINDING', 58), ('IMPORTANT_CONSIDERATION', 76)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5340372	3/2017	S136-PMC5340372	['second, our PREVIOUS report CONCLUDED that relatively low Vitamin D levels were COMMON in the patch population sample of children and young Adults with an inverse CORRELATION between 25(Oh)D level and age being SHOWN HERE [51].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 28), ('PROBABLE_UNDERSTANDING', 80), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 211), ('QUESTION_ANSWERED_BY_THIS_WORK', 217)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0007023', 'adult organism', 140, 'adults'), ('CHEBI_33010', 'chromide(1-)', 185, '(OH)D')]
PMC5340372	3/2017	S143-PMC5340372	['last, the sample size was rather SMALL, and the Vitamin D levels of the participants were GENERALLY SUBOPTIMAL in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 90), ('IMPORTANT_CONSIDERATION', 100), ('QUESTION_ANSWERED_BY_THIS_WORK', 114)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5340372	3/2017	S144-PMC5340372	['ALTHOUGH poor Lung function performance and an INCREASED RISK of Respiratory Tract infection were RELATED to relatively low cord Serum Vitamin D levels, FURTHER extrapolating the EFFECTS of Vitamin d on the Respiratory function of the general infant population MIGHT STILL BE DIFFICULT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 153), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 261), ('FUTURE_WORK', 267), ('DIFFICULT_TASK', 276)]	8	[('UBERON_0002048', 'lung', 14, 'lung'), ('UBERON_0000065', 'respiratory tract', 65, 'respiratory tract'), ('UBERON_0001977', 'blood serum', 129, 'serum'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 190, 'vitamin'), ('UBERON_0001004', 'respiratory system', 207, 'respiratory')]
PMC5340372	3/2017	S148-PMC5340372	['we BELIEVE that THIS STUDY PROVIDES a CLEARER UNDERSTANDING of the EFFECT of Perinatal Vitamin D levels on Respiratory function and Respiratory outcome in infancy.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('PROBABLE_UNDERSTANDING', 27), ('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 67)]	5	[('GO_0036268', 'swimming', 77, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 77, 'perinatal'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory'), ('UBERON_0001004', 'respiratory system', 132, 'respiratory')]
PMC5351212	3/2017	S4-PMC5351212	['in addition, given the KNOWN immunomodulatory and neuroprotective EFFECTS of Vitamin D, we also INVESTIGATED WHETHER the co-administration of Vitamin D COULD block mia-induced asd-related behaviors.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('INCOMPLETE_EVIDENCE', 152)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5351212	3/2017	S9-PMC5351212	['HOWEVER, Prenatal administration of Vitamin D had no effect on pro-inflammatory cytokine levels in dams or in fetal Brains SUGGESTING the anti-inflammatory actions of Vitamin d are not the CRITICAL mechanism for its preventive actions in this asd Animal MODEL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 123), ('IMPORTANT_CONSIDERATION', 189), ('INCOMPLETE_EVIDENCE', 254)]	5	[('GO_0007565', 'female pregnancy', 9, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000955', 'brain', 116, 'brains'), ('CHEBI_33229', 'vitamin (role)', 167, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 247, 'animal')]
PMC5351212	3/2017	S10-PMC5351212	['conclusions\nthis work RAISES the POSSIBILITY that early dietary supplementation with Vitamin D MAY open NEW AVENUES for a successful attenuation or EVEN PREVENTION of Neurodevelopmental disorders following maternal inflammation during Pregnancy.']	[('EXPLICIT_QUESTION', 22), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 95), ('FULL_UNKNOWN', 104), ('FUTURE_WORK', 108), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 153)]	7	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007399', 'nervous system development', 167, 'neurodevelopmental'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy')]
PMC5351212	3/2017	S26-PMC5351212	['besides its ROLE in schizophrenia etiology, there is a GROWING body of EVIDENCE LINKING Vitamin D deficiency with autism [23].']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 80)]	3	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5351212	3/2017	S27-PMC5351212	['Birth cohort studies have provided EVIDENCE that maternal Vitamin D deficiency is ASSOCIATED with a range of later autism-related outcomes including impaired Language Development [24] and Cognitive Development in offspring [25].']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('GO_0007567', 'parturition', 0, 'Birth'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0060132', 'prolactin secreting cell development', 158, 'language development'), ('GO_0050787', 'detoxification of mercury ion', 188, 'cognitive development')]
PMC5351212	3/2017	S28-PMC5351212	['most RECENTLY, we HAVE SHOWN that low levels of Vitamin D at Birth are ASSOCIATED with increased incidence of autism in children [26].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007567', 'parturition', 61, 'birth')]
PMC5351212	3/2017	S34-PMC5351212	['developmental Vitamin D deficiency HAS further BEEN shown to induce persistent alterations in Immune function, by increasing central Immune Organ size and inducing a pro-inflammatory Lymphocyte phenotype [32].']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('UBERON_0000945', 'stomach', 133, 'immune organ'), ('CL_0000542', 'lymphocyte', 183, 'lymphocyte')]
PMC5351212	3/2017	S35-PMC5351212	['THEREFORE, inflammatory factors produced early in Brain Development EITHER directly, by inducing mia, OR indirectly, by the maternal absence of a potent anti-inflammatory factor such as Vitamin D MAY, REPRESENT a CONVERGENT pathway towards developmental Brain abnormalities and psychiatric conditions later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 201), ('SUPERFICIAL_RELATIONSHIP', 213)]	5	[('GO_0007420', 'brain development', 50, 'brain development'), ('UBERON_0000955', 'brain', 50, 'brain'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('UBERON_0000955', 'brain', 254, 'brain'), ('UBERON_0000104', 'life cycle', 310, 'life')]
PMC5351212	3/2017	S36-PMC5351212	['INITIAL EVIDENCE for this HYPOTHESIS stems from PREVIOUS OBSERVATIONS SHOWING Prenatal poly(I:c)-induced mia, and developmental Vitamin D deficiency in rodents produce an overlapping spectrum of long-term behavioral abnormalities and early molecular changes in the fetal Brains [33–37].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 70)]	5	[('GO_0007565', 'female pregnancy', 78, 'prenatal'), ('CHEBI_16382', 'iodide', 92, 'I:'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('UBERON_0000955', 'brain', 271, 'brains')]
PMC5351212	3/2017	S39-PMC5351212	['(b) GIVEN the anti-inflammatory properties of Vitamin D, the PRESENT STUDY was DESIGNED TO INVESTIGATE WHETHER use of Calcitriol, [1α, 25-Dihydroxy Vitamin D3 (1,25Ohd)], the hormonally active form of Vitamin D, COULD prevent Poly(I:C)-induced behavioral dysfunctions RELEVANT TO asd, including deficits in Social Interaction, stereotyped behavior, innate anxiety, and Emotional Learning.']	[('PROBABLE_UNDERSTANDING', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 212), ('SUPERFICIAL_RELATIONSHIP', 268)]	7	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 118, 'calcitriol'), ('CHEBI_43176', 'hydroxy group', 138, 'dihydroxy'), ('CHEBI_33279', 'vitamin D5', 148, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 148, 'vitamin D3'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 162, '25OHD'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('CHEBI_77358', 'CDP-dipalmitoyl-sn-glycerol', 226, 'poly(I:C'), ('GO_0019417', 'sulfur oxidation', 307, 'social interaction'), ('GO_0050959', 'echolocation', 369, 'emotional learning')]
PMC5351212	3/2017	S192-PMC5351212	['4a), SUGGESTING that Vitamin D blocked the EFFECTS of mia on Emotional Learning.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 43)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0050959', 'echolocation', 61, 'emotional learning')]
PMC5351212	3/2017	S197-PMC5351212	['this mia-induced reduction in fear acquisition was not evident when vitdwas co-administered SUGGESTING that Vitamin D blocked the EFFECTS of Mia on Emotional Learning.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 130)]	2	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_34840', 'methyl methacrylate', 141, 'MIA'), ('GO_0050959', 'echolocation', 148, 'emotional learning')]
PMC5351212	3/2017	S262-PMC5351212	['HOWEVER, the fact that mia with poly(I:c) has induced abnormalities in Social Interaction and Cognition at a more translationally RELEVANT age, i.e., juveniles, together with the presence of behavioral abnormalities not normally associated with schizophrenia such as altered digging behavior SUGGEST to us that this Animal MODEL MAY have greater relevance to asd\n\nvitddoes not alter maternal or fetal inflammatory Cytokine Production\nin VIEW OF the KNOWN immunomodulatory EFFECTS of Vitamin D, an obvious neuroprotective mechanism explored HERE was the POSSIBILITY that vitdameliorates the inflammatory response induced by Poly(I:c).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 323), ('INCOMPLETE_EVIDENCE', 329), ('INCOMPLETE_EVIDENCE', 437), ('INCOMPLETE_EVIDENCE', 449), ('SUPERFICIAL_RELATIONSHIP', 472), ('QUESTION_ANSWERED_BY_THIS_WORK', 540), ('INCOMPLETE_EVIDENCE', 553)]	10	[('CHEBI_51686', 'haematoxylin', 37, 'I'), ('GO_0019417', 'sulfur oxidation', 71, 'social interaction'), ('GO_0050890', 'cognition', 94, 'cognition'), ('NCBITaxon_33208', 'Metazoa', 316, 'animal'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 414, 'cytokine production'), ('CHEBI_27300', 'vitamin D', 483, 'vitamin D'), ('CHEBI_37311', 'einsteinium molecular entity', 623, 'poly'), ('CHEBI_51686', 'haematoxylin', 628, 'I')]
PMC5351212	3/2017	S273-PMC5351212	['Inflammatory Agents upregulate both the vitdreceptor and the Cyp271B which is the primary enzyme responsible for the Production Of the active Vitamin D Hormone via a Tlr2/4 mechanism, INDICATING the close reciprocal feedback between vitdand these receptors [60,61].']	[('INCOMPLETE_EVIDENCE', 184)]	1	[('CHEBI_35701', 'ester', 0, 'Inflammatory agents'), ('PR_000006100', 'aromatase', 61, 'CYP271b'), ('GO_0008036', 'diuretic hormone receptor activity', 117, 'production of ... D hormone'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 166, 'TLR2')]
PMC5351212	3/2017	S304-PMC5351212	['finally, GIVEN that mia and maternal Vitamin D deficiency are both risk-modifying factors for autism and GIVEN that the distinct OVERLAP in behavioral phenotypes produced in the Animal MODELS of these environmental RISK FACTORS, we ADDRESSED the issue of WHETHER mia induces Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 215), ('QUESTION_ANSWERED_BY_THIS_WORK', 232), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 178, 'animal'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC5351212	3/2017	S305-PMC5351212	['OBVIOUSLY, IF this were the case then the corrective actions of the active Vitamin D hormone MAY SIMPLY be treating an mia-induced Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 97)]	4	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5351212	3/2017	S306-PMC5351212	['HOWEVER, our results clearly SHOW no effect of Poly(I:C) on both major Circulatory measures of Vitamin D, RULING OUT this POSSIBILITY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('INCOMPLETE_EVIDENCE', 122)]	6	[('CHEBI_77358', 'CDP-dipalmitoyl-sn-glycerol', 47, 'poly(I:C'), ('UBERON_0001009', 'circulatory system', 71, 'circulatory'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5359891	3/2017	S7-PMC5359891	['the additional Micronutrients seek to address DEFICIENCIES of SOME b-group Vitamins and Vitamin D that are both common during Pregnancy and that HAVE BEEN ASSOCIATED with maternal dysglycaemia, epigenetic changes and greater offspring adiposity.']	[('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 155)]	4	[('CHEBI_33839', 'macromolecule', 15, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 75, 'vitamins'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC5359891	3/2017	S42-PMC5359891	['meta-analysis of observational studies STRONGLY POINTS to a ROLE for maternal Vitamin D deficiency in gdm [37], and additional Vitamin D in Pregnant women with gdm HAS BEEN SHOWN to have beneficial EFFECTS on glycaemia and total and low-density lipoprotein Cholesterol (ldl)-Cholesterol concentrations [38].']	[('PROBABLE_UNDERSTANDING', 39), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 198)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'pregnant'), ('CHEBI_16113', 'cholesterol', 257, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 275, 'cholesterol')]
PMC5359891	3/2017	S53-PMC5359891	['taken TOGETHER, there is strong SUPPORT for NEW intervention studies commencing before Pregnancy to provide myo-inositol and Probiotics, and to improve maternal Vitamin B6, Vitamin B12, Vitamin D and zinc status, AIMED at optimising maternal glycaemia and Glucose supply to the Feto-Placental Unit to promote healthy offspring growth and body composition.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 44), ('QUESTION_ANSWERED_BY_THIS_WORK', 213)]	4	[('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_26346', 'prostaglandins J', 125, 'probiotics'), ('CHEBI_33237', 'vitamin D4', 161, 'vitamin B6'), ('CHEBI_33229', 'vitamin (role)', 173, 'vitamin'), ('CHEBI_27778', 'abequose', 181, 'B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 181, 'B12'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_17234', 'glucose', 256, 'glucose'), ('UBERON_0000981', 'femur', 278, 'feto'), ('UBERON_0013765', 'digestive system element', 283, 'placental unit')]
PMC5359891	3/2017	S92-PMC5359891	['the intervention\nthe nutritional intervention Preconception and during Pregnancy to maintain healthy Glucose Metabolism and offspring health (nipper) intervention comprises: (1) a Micronutrient-enriched nutritional drink containing myo-inositol, Vitamin D, riboflavin, Vitamin B6, Vitamin B12And zinc together with standard Folic Acid, Iodine, calcium, β-Carotene and iron; the quantities PROPOSED are either standard amounts (Myo-Inositol [54]), enhanced amounts that are available in over-the-counter products (Vitamins b6, b12, riboflavin), RECOMMENDED daily allowance amounts in uk for Pregnant women (Vitamin D, zinc, Folic Acid, Iodine) or minimal amounts for Micronutrients LINKED with POTENTIAL DETRIMENTAL EFFECTS at higher doses (Iron, Β-Carotene, Calcium) and (2) Probiotics (containing lactobacillus rhamnosus ncc 4007 (cgmcc 1.3724) also known as lpr and bifidobacterium animalis Sp.']	[('INCOMPLETE_EVIDENCE', 389), ('FUTURE_WORK', 544), ('SUPERFICIAL_RELATIONSHIP', 681), ('INCOMPLETE_EVIDENCE', 693), ('IMPORTANT_CONSIDERATION', 703), ('SUPERFICIAL_RELATIONSHIP', 715)]	6	[('GO_0007565', 'female pregnancy', 46, 'Preconception'), ('GO_0007565', 'female pregnancy', 71, 'Pregnancy'), ('CHEBI_17234', 'glucose', 101, 'Glucose'), ('GO_0006006', 'glucose metabolic process', 101, 'Glucose Metabolism'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 180, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 269, 'vitamin B6'), ('CHEBI_10124', 'zolmitriptan', 281, 'vitamin B12and'), ('CHEBI_30751', 'formic acid', 324, 'folic acid'), ('CHEBI_24859', 'iodine atom', 336, 'iodine'), ('CHEBI_23042', 'carotene', 355, 'carotene'), ('CHEBI_25435', 'mutagen', 427, 'myo-inositol'), ('CHEBI_33277', 'gamma-tocotrienol', 513, 'vitamins'), ('GO_0007565', 'female pregnancy', 590, 'pregnant'), ('CHEBI_27300', 'vitamin D', 606, 'vitamin D'), ('CHEBI_30751', 'formic acid', 623, 'folic acid'), ('CHEBI_24859', 'iodine atom', 635, 'iodine'), ('CHEBI_33839', 'macromolecule', 666, 'micronutrients'), ('CHEBI_24870', 'ion', 740, 'iron'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 746, 'β-carotene'), ('CHEBI_22313', 'alkaline earth metal atom', 758, 'calcium'), ('CHEBI_26346', 'prostaglandins J', 775, 'probiotics'), ('NCBITaxon_10088', 'Mus <genus>', 893, 'sp')]
PMC5359891	3/2017	S108-PMC5359891	['omission from control group SUPPORTED by usual clinical practiceβ-Carotene720\xa0μg (15% of Vitamin A REQUIREMENTS, as Retinol equivalents)required in Pregnancy in some jurisdictionsfolic acid400\xa0μgstandard Preconception RECOMMENDATIONIRON12\xa0mgiron is routinely prescribed and taken before/during Pregnancy, THOUGH WITHOUT CONVINCING EVIDENCE of benefit; low dose included to lessen LIKELIHOOD of additionally receiving a high-dose iron product, which HAS BEEN LINKED with Glucose Metabolism in Pregnancycalcium150\xa0mga low dose of Calcium is commonly taken before/during Pregnancy; provision of this will lessen the LIKELIHOOD of additional products being takeniodine150\xa0μgstandard preconception recommendationprobiotictaking a combination of two Probiotics HAS BEEN LINKED with maintenance of healthy Glucose Metabolism in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 99), ('FUTURE_WORK', 218), ('ANOMALY_CURIOUS_FINDING', 305), ('INCOMPLETE_EVIDENCE', 312), ('PROBABLE_UNDERSTANDING', 380), ('INCOMPLETE_EVIDENCE', 449), ('SUPERFICIAL_RELATIONSHIP', 458), ('PROBABLE_UNDERSTANDING', 613), ('INCOMPLETE_EVIDENCE', 755), ('SUPERFICIAL_RELATIONSHIP', 764)]	11	[('CHEBI_85000', '1-octadecenoyl-2-icosatetraenoyl-sn-glycero-3-phosphoethanolamine', 65, '-carotene720'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 116, 'retinol'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'preconception'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_17234', 'glucose', 470, 'glucose'), ('GO_0006006', 'glucose metabolic process', 470, 'glucose metabolism'), ('GO_0051561', 'positive regulation of mitochondrial calcium ion concentration', 492, 'pregnancyCalcium150'), ('CHEBI_22313', 'alkaline earth metal atom', 528, 'calcium'), ('GO_0007565', 'female pregnancy', 568, 'pregnancy'), ('CHEBI_26346', 'prostaglandins J', 744, 'probiotics'), ('CHEBI_17234', 'glucose', 799, 'glucose'), ('GO_0006006', 'glucose metabolic process', 799, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 821, 'pregnancy')]
PMC5359891	3/2017	S110-PMC5359891	['lactis ncc 2818 (cncm i-3446) also known as bl818control groupfolic Acid400\xa0μgstandard Preconception recommendationiron12\xa0mgiron is routinely prescribed and taken before/during Pregnancy, though WITHOUT CONVINCING EVIDENCE of benefit; low dose included to lessen LIKELIHOOD of additionally receiving a high-dose Iron product, which HAS BEEN LINKED with Glucose Metabolism in Pregnancycalcium150\xa0mga low dose of Calcium is commonly taken before/during Pregnancy; provision of this will lessen the LIKELIHOOD of additional products being takeniodine150\xa0μgstandard Preconception recommendationhttp://www.cdc.gov/Preconception/documents/clinical-content_womensnutritionfactsheet3.pdfβ-Carotene720\xa0μg (15% of Vitamin A REQUIREMENTS, as Retinol equivalents)required in Pregnancy in some jurisdictions\n\noutcome measurements\nthe primary analysis will adjust for site, ethnicity and Preconception glycaemia to account for POTENTIAL imbalance between treatment arms amongst Pregnancies which reach 28\xa0weeks’ Gestation, examining for differences in means between the control and intervention groups for the primary endpoint, specifically the fasting and/or 60-min and/or 2-h Glucose concentrations following a 75-g ogtt at 28\xa0weeks’ Gestation.']	[('INCOMPLETE_EVIDENCE', 195), ('PROBABLE_UNDERSTANDING', 263), ('INCOMPLETE_EVIDENCE', 332), ('SUPERFICIAL_RELATIONSHIP', 341), ('PROBABLE_UNDERSTANDING', 496), ('IMPORTANT_CONSIDERATION', 714), ('INCOMPLETE_EVIDENCE', 913)]	7	[('CHEBI_82451', "3,3'-Dimethoxybenzidine-4,4'-diisocyanate", 68, 'acid400'), ('GO_0007565', 'female pregnancy', 87, 'preconception'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('CHEBI_24870', 'ion', 312, 'iron'), ('CHEBI_17234', 'glucose', 353, 'glucose'), ('GO_0006006', 'glucose metabolic process', 353, 'glucose metabolism'), ('GO_0051561', 'positive regulation of mitochondrial calcium ion concentration', 375, 'pregnancyCalcium150'), ('CHEBI_22313', 'alkaline earth metal atom', 411, 'calcium'), ('GO_0007565', 'female pregnancy', 451, 'pregnancy'), ('GO_0007565', 'female pregnancy', 562, 'preconception'), ('GO_0007565', 'female pregnancy', 609, 'preconception'), ('CHEBI_52743', 'bromine-79 atom', 681, 'carotene720'), ('CHEBI_27300', 'vitamin D', 704, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 731, 'retinol'), ('GO_0007565', 'female pregnancy', 763, 'pregnancy'), ('GO_0007565', 'female pregnancy', 874, 'preconception'), ('GO_0007565', 'female pregnancy', 964, 'pregnancies'), ('GO_0007565', 'female pregnancy', 998, 'gestation'), ('CHEBI_17234', 'glucose', 1164, 'glucose'), ('GO_0007565', 'female pregnancy', 1222, 'gestation')]
PMC5359891	3/2017	S112-PMC5359891	['secondary maternal outcomes of the initial phase of the nipper study are:\nmaintenance of a healthy Pregnancy, including normal duration of Gestation (at least 37\xa0weeks’ Gestation), absence of gdm (defined using the international association of the diabetes and Pregnancy study groups criteria: Glucose cut-off values of ≥5.1\xa0mmol/l for fasting Plasma Glucose, and/or ≥10.0\xa0mmol/l for 1-h and/or ≥8.5\xa0mmol/l for 2-h post load), change in fasting Glucose and ogtt Glucose area under the curve from Preconception baseline to 28\xa0weeks’ Gestation, maternal wellbeing/mood, absence of excessive nausea and vomiting, adequate Pregnancy weight gain (institute of medicine criteria) and Vaginal Delivery rates\nreduction in maternal Micronutrient insufficiency, specifically less riboflavin, Vitamin B6, Vitamin B12, zinc and Vitamin D insufficiency, before and during Pregnancy\nalteration in Gut microbiota CONSISTENT with enhanced wellbeing\nalteration in maternal metabolomic and epigenetic biomarkers CONSISTENT with improved maternal and/or offspring wellbeing\nenhancement of Breast Milk Micronutrient content, altered Immunological factors, epigenetic and metabolomic profiles (subsample) and maintenance of healthy Lactogenesis\nsecondary offspring outcomes of the initial phase of the nipper study are:\nneonatal adiposity measured by pea pod\nBirthweight 2500–4000\xa0g, size for Gestational age at Birth and customised birthweight centile\nreduced adiposity gain during Infancy, analysed taking account of infant Feeding\nreduction in Cord Blood c-peptide as a marker of overall glycaemia during Gestation\npromotion of offspring wellbeing and healthy Cardiometabolic RISK FACTORS, including Visceral adiposity and markers of Insulin resistance, during infancy\nalteration in offspring metabolomic and epigenetic biomarkers in Perinatal samples, CONSISTENT with improved infant Metabolic and allergic Wellbeing\nalteration in Gut microbiota to a microbiota ASSOCIATED with infant Metabolic and allergic Wellbeing\n\ndata and biosample collection\nstudy data will be collected by trained research staff using an access-controlled, web-based database (medscinet, stockholm) managed with support from the data management staff of the mrc Lifecourse epidemiology unit and the singapore institute for clinical sciences.']	[('INCOMPLETE_EVIDENCE', 898), ('INCOMPLETE_EVIDENCE', 994), ('SUPERFICIAL_RELATIONSHIP', 1658), ('INCOMPLETE_EVIDENCE', 1835), ('SUPERFICIAL_RELATIONSHIP', 1945)]	5	[('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('GO_0007565', 'female pregnancy', 139, 'gestation'), ('GO_0007565', 'female pregnancy', 169, 'gestation'), ('GO_0007565', 'female pregnancy', 261, 'Pregnancy'), ('CHEBI_17234', 'glucose', 294, 'glucose'), ('UBERON_0001969', 'blood plasma', 344, 'plasma'), ('CHEBI_17234', 'glucose', 351, 'glucose'), ('CHEBI_17234', 'glucose', 445, 'glucose'), ('CHEBI_17234', 'glucose', 462, 'glucose'), ('GO_0007565', 'female pregnancy', 496, 'preconception'), ('GO_0007565', 'female pregnancy', 532, 'gestation'), ('GO_0007565', 'female pregnancy', 619, 'pregnancy'), ('UBERON_0001987', 'placenta', 678, 'vaginal'), ('GO_0007567', 'parturition', 686, 'delivery'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 723, 'micronutrient'), ('CHEBI_33237', 'vitamin D4', 782, 'vitamin B6'), ('CHEBI_33279', 'vitamin D5', 794, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 816, 'vitamin D'), ('GO_0007565', 'female pregnancy', 859, 'pregnancy'), ('UBERON_0001555', 'digestive tract', 883, 'gut'), ('UBERON_0001348', 'brown adipose tissue', 1070, 'breast milk'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1082, 'micronutrient'), ('UBERON_0003222', 'flexor digitorum superficialis', 1113, 'immunological'), ('GO_0001554', 'luteolysis', 1211, 'lactogenesis'), ('GO_0007608', 'sensory perception of smell', 1338, 'Birthweight'), ('GO_0007565', 'female pregnancy', 1372, 'gestational'), ('GO_0007567', 'parturition', 1391, 'birth'), ('UBERON_0000023', 'wing', 1462, 'infancy'), ('GO_0007631', 'feeding behavior', 1505, 'feeding'), ('UBERON_0002240', 'spinal cord', 1526, 'cord'), ('UBERON_0000178', 'blood', 1531, 'blood'), ('GO_0007565', 'female pregnancy', 1587, 'gestation'), ('GO_0007599', 'hemostasis', 1642, 'cardiometabolic'), ('UBERON_0002075', 'viscus', 1682, 'visceral'), ('PR_000045358', 'insulin family protein', 1716, 'insulin'), ('GO_0036268', 'swimming', 1816, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1816, 'perinatal'), ('GO_0051238', 'sequestering of metal ion', 1867, 'metabolic ... wellbeing'), ('UBERON_0001555', 'digestive tract', 1914, 'gut'), ('GO_0051238', 'sequestering of metal ion', 1968, 'metabolic ... wellbeing'), ('UBERON_0001281', 'hepatic sinusoid', 2220, 'Lifecourse')]
PMC5371920	3/2017	S121-PMC5371920	['for the correction of Micronutrient deficiencies, such as Vitamin D deficiency during Pregnancy, traditional randomized controlled trials provide ROBUST, well-controlled FRAMEWORKS for THEORETICAL and pragmatic evaluation of the candidate policy.']	[('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 185)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 22, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy')]
PMC5371920	3/2017	S126-PMC5371920	['the RECENT uk-based TRIAL of Vitamin D supplementation—maternal Vitamin D osteoporosis study (mavidos), tested the HYPOTHESIS that maternal Antenatal Vitamin D supplementation LEADS to increased offspring bone Mineral content.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 176)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 64, 'Vitamin D'), ('GO_0007567', 'parturition', 140, 'antenatal'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_46662', 'mineral', 210, 'mineral')]
PMC5371920	3/2017	S135-PMC5371920	['IN CONTRAST, 25(Oh)D concentrations in mothers allocated to Vitamin D supplementation rose REGARDLESS OF season of Delivery.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 91)]	2	[('CHEBI_71657', 'versiconol acetate', 13, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 19, 'D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007567', 'parturition', 115, 'delivery')]
PMC5371920	3/2017	S137-PMC5371920	['Vitamin D supplementation APPEARED SAFE; THESE FINDINGS SUPPORT current RECOMMENDATIONS in uk and elsewhere, and MAY SUGGEST the basis for more stratified approaches to Vitamin D supplementation in Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 26), ('IMPORTANT_CONSIDERATION', 35), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 56), ('FUTURE_WORK', 72), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 117)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy')]
PMC5372327	3/2017	S0-PMC5372327	['towards EVIDENCE-BASED Vitamin D supplementation in infants: Vitamin D intervention in infants (vidi) — study design and methods of a randomised controlled double-blinded intervention study\n\nabstract\n\nbackground\nVitamin D is IMPORTANT for bone mass accrual during growth.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 225)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 212, 'Vitamin D')]
PMC5372327	3/2017	S2-PMC5372327	['MANY countries apply Vitamin D supplementation STRATEGIES in infants, but the guidelines are NOT BASED ON scientific EVIDENCE and AIM at PREVENTION of rickets.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 47), ('INCOMPLETE_EVIDENCE', 93), ('FUTURE_WORK', 130), ('SUPERFICIAL_RELATIONSHIP', 137)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5372327	3/2017	S3-PMC5372327	['it REMAINS UNCLEAR WHETHER the RECOMMENDED doses are sufficient for the wide array of OTHER EFFECTS of Vitamin D. the vidi trial performed in finland is the FIRST large randomised controlled study for evaluation of the EFFECTS of different Vitamin D supplemental doses in infancy on:\nbone strength\ninfections and immunity\nallergy, atopy and asthma\nCognitive development\nGenetic Regulation Of Mineral Homeostasis\n\nmethods/design\nvidi, a randomised controlled double-blinded single-centre intervention study is conducted in infants from the age of 2\xa0weeks to 24\xa0months.']	[('FULL_UNKNOWN', 3), ('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('FUTURE_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 157), ('SUPERFICIAL_RELATIONSHIP', 219)]	8	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0050890', 'cognition', 348, 'cognitive'), ('SO_0000704', 'gene', 370, 'genetic'), ('GO_1900046', 'regulation of hemostasis', 378, 'regulation of ... homeostasis'), ('CHEBI_46662', 'mineral', 392, 'mineral')]
PMC5372327	3/2017	S7-PMC5372327	['the results enable institution of EVIDENCE-BASED guidelines for Vitamin D supplementation in infancy.']	[('INCOMPLETE_EVIDENCE', 34)]	1	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5372327	3/2017	S13-PMC5372327	['based ON the number of cell types Expressing Vitamin D receptors (vdr), 38 POTENTIAL target Tissues HAVE BEEN recognised [3].']	[('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 100)]	3	[('GO_0010467', 'gene expression', 34, 'expressing'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0000479', 'tissue', 92, 'tissues')]
PMC5372327	3/2017	S16-PMC5372327	['IN FACT, Vitamin D HAS BEEN ESTIMATED to directly and indirectly Regulate the Expression of 2–3% of the Human Genome [4].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0065007', 'biological regulation', 65, 'regulate'), ('GO_0010467', 'gene expression', 78, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 104, 'human'), ('SO_0001026', 'genome', 110, 'genome')]
PMC5372327	3/2017	S24-PMC5372327	['in addition, we have PREVIOUSLY SHOWN that more than 70% of 195 apparently healthy school children in helsinki, finland, were Vitamin D deficient (<50\xa0nmol/l) during the school year [9,10].']	[('INCOMPLETE_EVIDENCE', 21)]	1	[('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC5372327	3/2017	S29-PMC5372327	['HOWEVER, data on the RELATIONSHIP between Vitamin D and bmd in children are SOMEWHAT CONTRADICTORY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5372327	3/2017	S31-PMC5372327	['in infants, severe Vitamin D deficiency (<25\xa0nmol/l) ASSOCIATES with poor linear growth and delayed motor development POSSIBLY due to muscle weakness [16,17].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 118)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC5372327	3/2017	S45-PMC5372327	['identification, treatment, and PREVENTION of Vitamin D deficiency in early childhood MAY THEREFORE have widespread health EFFECTS throughout childhood.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5372327	3/2017	S47-PMC5372327	['BASED ON epidemiological studies, low maternal Intake of Vitamin D at Pregnancy and low Cord Blood 25-Ohd concentration HAVE BEEN ASSOCIATED with a higher risk for asthma, allergic rhinitis and atopic eczema in the offspring, as assessed at 5\xa0years of age [35–38].']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 130)]	4	[('GO_0007631', 'feeding behavior', 47, 'intake'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CHEBI_72765', 'verruculogen', 99, '25-OHD')]
PMC5372327	3/2017	S48-PMC5372327	['HOWEVER, findings have NOT been CONSISTENT [39] and RECENT STUDIES on Prenatal Vitamin D supplementation have not demonstrated an EFFECT on wheezing at 3\xa0years of age [40,41].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 130)]	5	[('GO_0007565', 'female pregnancy', 70, 'prenatal'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5372327	3/2017	S52-PMC5372327	['Vitamin D trials are RARE and they have not been able to SUPPORT beneficial EFFECTS of Vitamin D supplementation on Cognitive functions among Adults [47,48].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0050890', 'cognition', 116, 'cognitive'), ('UBERON_0007023', 'adult organism', 142, 'adults')]
PMC5372327	3/2017	S53-PMC5372327	['LITTLE EVIDENCE exists on the EFFECTS of Vitamin D on the Cognitive Development among children and adolescents.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0050787', 'detoxification of mercury ion', 58, 'cognitive development')]
PMC5372327	3/2017	S57-PMC5372327	['ALTHOUGH PRELIMINARY results POINT to IMPORTANCE of early Life exposure, the ROLE of Vitamin D in Cognitive Development during childhood and Adolescence REMAINS LARGELY UNSTUDIED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 38), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 169)]	8	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0050787', 'detoxification of mercury ion', 98, 'cognitive development'), ('GO_0048848', 'neurohypophysis morphogenesis', 141, 'adolescence')]
PMC5372327	3/2017	S59-PMC5372327	['Genome-wide association studies on Vitamin D insufficiency IDENTIFIED a number OF common Genetic variants that INFLUENCE 25-Ohd concentrations and the risk of insufficiency [54].']	[('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 79), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('SO_0001026', 'genome', 0, 'Genome'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('SO_0000704', 'gene', 89, 'genetic'), ('CHEBI_72765', 'verruculogen', 121, '25-OHD')]
PMC5372327	3/2017	S61-PMC5372327	['we have studied gc polymorphisms in RELATION to Vitamin D Metabolism and bone strength in children [55] and OBSERVED differences in s-25-Ohd and pth concentrations between gc genotypes and that variation exists in bmd and bone strength index as well.']	[('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 108)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 48, 'vitamin D metabolism'), ('CHEBI_72765', 'verruculogen', 134, '25-OHD')]
PMC5372327	3/2017	S62-PMC5372327	['the variation in S-25-Ohd between gc genotypes SUGGESTS differences in Vitamin D utilisation.']	[('INCOMPLETE_EVIDENCE', 47)]	1	[('CHEBI_16786', 'vestitone', 17, 'S-'), ('1', 'A1BG (human)', 18, '-'), ('CHEBI_72765', 'verruculogen', 19, '25-OHD'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC5372327	3/2017	S64-PMC5372327	['vdr polymorphisms together with Vitamin D supplementation AFFECT bone Mineral accrual SUGGESTING that Vitamin D supplementation COULD BE used to change the developmental trajectory and induce phenotype with lowered risk for chronic disease or disorder [59,60].']	[('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 128)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_46662', 'mineral', 70, 'mineral'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5372327	3/2017	S68-PMC5372327	['we HYPOTHESISE that a higher Vitamin D supplementation to infants between 2\xa0weeks and 24\xa0months of age will increase bone strength and decrease the frequency of infections.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5372327	3/2017	S100-PMC5372327	['PREVIOUS intervention STUDIES have evaluated the SAFETY of substitution doses of up to 50\xa0μg Vitamin D in infants [61].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 49)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC5372327	3/2017	S123-PMC5372327	['to date, epidemiological studies and randomised intervention trials have DEMONSTRATED CONFLICTING results on, for example, the EFFECT of Vitamin D supplementation on childhood infections and on Neurocognitive functioning.']	[('INCOMPLETE_EVIDENCE', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 194, 'neurocognitive')]
PMC5372327	3/2017	S127-PMC5372327	['results from this study will LIKELY generate NOVEL EVIDENCE-BASED INFORMATION for improving Vitamin D status among the paediatric population worldwide.']	[('PROBABLE_UNDERSTANDING', 29), ('FULL_UNKNOWN', 45), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 66)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC5372327	3/2017	S128-PMC5372327	['by analysis of the IMPACT of Gene polymorphisms on the concentration and efficacy of the given Vitamin D substitution it MAY create the basis for individualised dosage guidelines.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 121)]	2	[('SO_0000704', 'gene', 29, 'gene'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5372327	3/2017	S136-PMC5372327	['in addition, the study is designed to have control over the most common sources of Vitamin D.\nIF the results from the vidi-trial CONFIRM the connections between the increased dose of Vitamin D and the primary outcomes, the health benefits gained by a population-wide supplementation with higher Vitamin D dose — a simple and low-cost INTERVENTION — are obvious.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 94), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 334)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC5485024	3/2017	S75-PMC5485024	['parental smoking, bmi status, or diet (Vitamin D, Omega‐3 Fatty Acids, Omega‐6 Fatty Acids or dietary supplements) at age 8 years DID NOT influence the OBSERVED or and were not included in the final model.']	[('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 152)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_75908', "5'-CTGC-3' dsDNA oligonucleotide", 50, 'omega‐3 fatty acids'), ('CHEBI_75908', "5'-CTGC-3' dsDNA oligonucleotide", 71, 'omega‐6 fatty acids')]
PMC5485024	3/2017	S91-PMC5485024	['significantly lower intakes of Vitamin D were FOUND in children in the highest tertile of dietary tac.']	[('INCOMPLETE_EVIDENCE', 46)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5485024	3/2017	S108-PMC5485024	['after additional adjustment for dietary supplement use and dietary intakes of Omega‐3, Omega‐6 Fatty Acids and Vitamin D at 8 years of age similar results were OBSERVED (oradj0.70, 95% ci 0.55–0.90).']	[('INCOMPLETE_EVIDENCE', 160)]	1	[('CHEBI_30823', 'oleate', 78, 'omega'), ('CHEBI_37972', 'phosphorus-32 atom', 84, '3'), ('CHEBI_30823', 'oleate', 87, 'omega'), ('CHEBI_52026', 'amorpha-4,11-diene', 93, '6'), ('CHEBI_35366', 'fatty acid', 95, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC5485024	3/2017	S139-PMC5485024	['a cumulative EFFECT of Genetic susceptibility in Glutathione S‐Transferase Mu 1 ( Gstm1 ), Gstp1 and Nad(P)H dehydrogenase, Quinone 1 ( Nqo1 ) polymorphisms and low dietary Vitamin C intake HAS BEEN ASSOCIATED with decreased Lung function in asthmatic children28.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 190), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('SO_0000704', 'gene', 23, 'genetic'), ('CHEBI_16856', 'glutathione', 49, 'glutathione'), ('PR_000008320', 'general transcription factor IIH subunit 4', 49, 'glutathione S‐transferase mu 1'), ('PR_000008296', 'glutathione S-transferase A3', 82, 'GSTM1'), ('PR_000008294', 'glutathione S-transferase A1', 91, 'GSTP1'), ('CHEBI_13392', 'NAD(P)H', 101, 'NAD(P)H'), ('PR_000010999', 'N-acetyltransferase 14', 101, 'NAD ...'), ('3', 'A2MP1', 104, '(P'), ('PR_000004770', 'Polycomb complex protein BMI-1', 122, ', quinone 1'), ('CHEBI_36141', 'quinone', 124, 'quinone'), ('PR_000011339', 'RNA-binding protein Nova-1', 136, 'NQO1'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin C'), ('UBERON_0002048', 'lung', 225, 'lung')]
PMC5368580	4/2017	S11-PMC5368580	['acute supplementation EFFECTS were FOUND for Thiamin, riboflavin, and Vitamins B-6 and a at 2–4 h postdosing, with 0.1–6.17% passing into Milk.']	[('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 35)]	2	[('CHEBI_26948', 'vitamin B1', 45, 'thiamin'), ('CHEBI_27300', 'vitamin D', 70, 'vitamins B'), ('UBERON_0001913', 'milk', 138, 'milk')]
PMC5368580	4/2017	S127-PMC5368580	['niacin and Vitamin E both SHOWED significantly lower concentrations on days when supplements were consumed.']	[('INCOMPLETE_EVIDENCE', 26)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin E')]
PMC5368580	4/2017	S128-PMC5368580	['no effects of acute supplementation were FOUND for Vitamin B-12 and efatconcentrations.']	[('INCOMPLETE_EVIDENCE', 41)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 51, 'vitamin B-12')]
PMC5368580	4/2017	S152-PMC5368580	['lower concentrations were FOUND for niacin and Vitamin E, BUT ONLY on day 4.']	[('INCOMPLETE_EVIDENCE', 26), ('ANOMALY_CURIOUS_FINDING', 58)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin E')]
PMC5368580	4/2017	S167-PMC5368580	['(29) FOUND higher amounts of Vitamin B-12 in Hindmilk than in Foremilk, trugo and sardinha (34) FOUND no differences in Vitamin B-12 concentration within Feedings, between Breasts, or over the day.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 96)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 29, 'vitamin B-12'), ('UBERON_0001466', 'pedal digit', 45, 'hindmilk'), ('UBERON_0002386', 'forelimb zeugopod', 62, 'foremilk'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin B'), ('GO_0007631', 'feeding behavior', 154, 'feedings'), ('UBERON_0000310', 'breast', 172, 'breasts')]
PMC5368580	4/2017	S180-PMC5368580	['the acute response of riboflavin and Vitamin B-6 also enabled the ESTIMATE of 1 ) a maximum dose of these Vitamins in the milk during maternal supplementation and, subsequently, 2 ) a maximum amount provided to the infant.']	[('INCOMPLETE_EVIDENCE', 66)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 37, 'vitamin B-6'), ('CHEBI_33277', 'gamma-tocotrienol', 106, 'vitamins')]
PMC5368580	4/2017	S183-PMC5368580	['Water-soluble Vitamins are THOUGHT TO be actively Secreted involving members of the solute carrier (slc) and atp-binding Cassette (abc) family; breast Cancer–Resistant Protein (Bcrp) is ASSOCIATED with riboflavin secretion, Vitamin B-12 uptake MIGHT be PARTLY DEPENDENT on a receptor-mediated system, and Thiamin transporters Thtr1 and Thtr2 MAY BE INVOLVED in Thiamin secretion.']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 186), ('INCOMPLETE_EVIDENCE', 244), ('INCOMPLETE_EVIDENCE', 253), ('SUPERFICIAL_RELATIONSHIP', 260), ('INCOMPLETE_EVIDENCE', 342), ('SUPERFICIAL_RELATIONSHIP', 349)]	7	[('CHEBI_15377', 'water', 0, 'Water'), ('CHEBI_33277', 'gamma-tocotrienol', 14, 'vitamins'), ('GO_0046903', 'secretion', 50, 'secreted'), ('SO_0005853', 'gene_cassette', 121, 'cassette'), ('PR_000005005', 'calnexin', 151, 'cancer–resistant protein'), ('PR_000004760', 'bleomycin hydrolase', 177, 'BCRP'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 224, 'vitamin B-12'), ('CHEBI_26948', 'vitamin B1', 305, 'thiamin'), ('PR_000001959', 'tumor necrosis factor receptor superfamily member 1B', 326, 'THTR1'), ('PR_000001155', 'Toll-like receptor 4', 336, 'THTR2'), ('CHEBI_26948', 'vitamin B1', 361, 'thiamin')]
PMC5368580	4/2017	S188-PMC5368580	['moreover, we FOUND that the acute EFFECTS of maternal supplementation REMAINED significant for riboflavin and Vitamin B-6 in the fasting Milk samples 24 h after supplementation compared with day 1, and that the Vitamins were not Secreted into Milk at the same rate throughout a day during maternal supplementation, resulting in a bolus dose of ≤35% of the adequate intake for Vitamin B-6 during a single Feeding, WHEREAS the bolus dose for riboflavin during a single Feeding only provided ∼11% of the adequate intake.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 110, 'vitamin B-6'), ('UBERON_0001913', 'milk', 137, 'milk'), ('CHEBI_33277', 'gamma-tocotrienol', 211, 'vitamins'), ('GO_0046903', 'secretion', 229, 'secreted'), ('UBERON_0001913', 'milk', 243, 'milk'), ('CHEBI_27300', 'vitamin D', 376, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 376, 'vitamin B-6'), ('GO_0007631', 'feeding behavior', 404, 'feeding'), ('GO_0007631', 'feeding behavior', 467, 'feeding')]
PMC5385921	4/2017	S0-PMC5385921	['Gestational Vitamin D deficiency and autism spectrum disorder\n\nabstract\n\nbackground\nthere is GROWING INTEREST in LINKING Vitamin D deficiency with autism spectrum disorders (asds).']	[('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 113)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC5385921	4/2017	S13-PMC5385921	['within the domain of nutritional exposures, there is GROWING INTEREST in the POSSIBLE LINKS between Gestational Vitamin D deficiency and an INCREASED RISK of asd.3–6this research HAS BEEN inspired BY Birth cohort studies, which have provided EVIDENCE that Prenatal Vitamin D deficiency (as assessed in maternal Sera) is ASSOCIATED with a range of later Brain-related outcomes including impaired Language Development7,8and Cognitive Development in offspring.9,10ALTHOUGH SEVERAL STUDIES HAVE REPORTED that Vitamin D deficiency or insufficiency is MORE COMMON in children with asd compared with controls,11few STUDIES addressed the specific HYPOTHESIS that Vitamin D deficiency during Gestation, a CRUCIAL time point in Neurodevelopment, is RELATED to the risk of subsequent asd.']	[('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 140), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 197), ('INCOMPLETE_EVIDENCE', 242), ('SUPERFICIAL_RELATIONSHIP', 320), ('ANOMALY_CURIOUS_FINDING', 459), ('INCOMPLETE_EVIDENCE', 470), ('INCOMPLETE_EVIDENCE', 486), ('PROBABLE_UNDERSTANDING', 546), ('INCOMPLETE_EVIDENCE', 608), ('INCOMPLETE_EVIDENCE', 639), ('IMPORTANT_CONSIDERATION', 696), ('SUPERFICIAL_RELATIONSHIP', 739)]	16	[('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007567', 'parturition', 200, 'birth'), ('GO_0007565', 'female pregnancy', 256, 'prenatal'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'sera'), ('UBERON_0000955', 'brain', 353, 'brain'), ('GO_0001763', 'morphogenesis of a branching structure', 395, 'language development7'), ('GO_0050787', 'detoxification of mercury ion', 422, 'cognitive development'), ('CHEBI_27300', 'vitamin D', 505, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 655, 'vitamin D'), ('GO_0007565', 'female pregnancy', 683, 'gestation'), ('GO_0007399', 'nervous system development', 718, 'neurodevelopment')]
PMC5385921	4/2017	S14-PMC5385921	['ONE STUDY compared neonatal Vitamin D status in children with asd v. their unaffected siblings ( n =58 sibling pairs).']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5385921	4/2017	S15-PMC5385921	['THIS STUDY REPORTED lower 25-Hydroxyvitamin D (25Ohd) concentrations in neonatal samples from the asd cases compared with their unaffected siblings.6RECENTLY, a chinese asd case–control study ( n =68 cases) compared first trimester (11–13 weeks) maternal 25Ohd concentrations and REPORTED significantly lower concentrations of 25Ohd in the asd cases compared with their gender- and age-matched controls.12\nwe RECENTLY REPORTED an ASSOCIATION between developmental Vitamin D deficiency and a measure of social impairment within the autism spectrum, based on a large dutch Birth cohort.13in this study, Vitamin D was measured at two occasions: at mid-Gestation and at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 280), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 430)]	7	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 26, '25-hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 47, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 255, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 327, '25OHD'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('GO_0007567', 'parturition', 571, 'birth'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0007565', 'female pregnancy', 649, 'gestation'), ('GO_0007567', 'parturition', 666, 'birth')]
PMC5385921	4/2017	S18-PMC5385921	['we had the opportunity to explore the ASSOCIATION between developmental Vitamin D status and risk of asd, based on the same dutch Birth cohort in which we previously reported an ASSOCIATION between low mid-Gestational and neonatal Vitamin D concentrations and autistic traits.13within the cohort, we had access to an extensive set of POTENTIAL CONFOUNDING variables as well as the children’s individual-level Genome-wide genotype data.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 178), ('INCOMPLETE_EVIDENCE', 334), ('PROBLEM_COMPLICATION', 344)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007567', 'parturition', 130, 'birth'), ('GO_0007565', 'female pregnancy', 206, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('SO_0001026', 'genome', 409, 'genome')]
PMC5385921	4/2017	S40-PMC5385921	['ALTHOUGH there is SOME DEBATE about the definition of these strata,21there is no DEBATE that children with 25Ohd concentrations of <25 nmol/l have Vitamin D deficiency (AS defined by an increased risk of rickets and increased Parathyroid hormone).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('PROBABLE_UNDERSTANDING', 169)]	6	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 107, '25OHD'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 226, 'parathyroid')]
PMC5385921	4/2017	S56-PMC5385921	['ancestry information and Genetic relatedness derived from observed common Genetic variants\nethnicity is strongly ASSOCIATED with Vitamin D status (darker skinned Individuals are more PRONE to Vitamin D deficiency and insufficiency).19genome-wide genotype data for the children allow us to build models that are BETTER able to account for variation in ethnic background (compared with register-based or self-ascribed ethnicity) and for Genetic relatedness between cohort members that MAY inflate an association statistic when Genes AFFECT the exposure or outcome variable.']	[('SUPERFICIAL_RELATIONSHIP', 113), ('PROBABLE_UNDERSTANDING', 183), ('INCOMPLETE_EVIDENCE', 311), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 531)]	5	[('SO_0000704', 'gene', 25, 'genetic'), ('SO_0000704', 'gene', 74, 'genetic'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('NCBITaxon_1', 'root', 162, 'individuals'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('SO_0000704', 'gene', 435, 'genetic'), ('SO_0000704', 'gene', 525, 'genes')]
PMC5385921	4/2017	S120-PMC5385921	['ASSUMING that the variables of interest are causally RELATED and that other VARIABLES remain unchanged), optimising Vitamin D status of this sample COULD BE ASSOCIATED with a reduction in the prevalence of asd of APPROXIMATELY 10%.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 213)]	6	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5385921	4/2017	S121-PMC5385921	['the FINDING from THIS STUDY LENDS weight to the GROWING BODY of epidemiological and Animal MODEL-based research LINKING Gestational Vitamin D deficiency and altered Brain Development.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 112)]	6	[('NCBITaxon_33208', 'Metazoa', 84, 'animal'), ('GO_0007565', 'female pregnancy', 120, 'gestational'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007420', 'brain development', 165, 'brain development'), ('UBERON_0000955', 'brain', 165, 'brain')]
PMC5385921	4/2017	S123-PMC5385921	['Rodent MODELS BASED ON transient Prenatal exposure to Vitamin D deficiency have FOUND a range of persistent molecular, neurochemical and behavioural changes of interest to neuropsychiatry.32a number OF STUDIES have LINKED asd with Neuronal Migration.33migration-ASSOCIATED phenotypes such as changes in Neuronal density and volume, aberrant Minicolumns and heterotopias HAVE BEEN detected in patients with asd.34,35as Neuronal Migration starts at 6 weeks Gestation and USUALLY ends around 24 weeks Gestation, the OBSERVED ASSOCIATION between our mid-Gestation samples, which were drawn at ~20 weeks Gestation, and risk of asd CORROBORATES our PREVIOUS FINDINGS LINKING Vitamin D deficiency with abnormal Brain Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 215), ('SUPERFICIAL_RELATIONSHIP', 262), ('INCOMPLETE_EVIDENCE', 370), ('INCOMPLETE_EVIDENCE', 469), ('INCOMPLETE_EVIDENCE', 513), ('SUPERFICIAL_RELATIONSHIP', 522), ('INCOMPLETE_EVIDENCE', 626), ('INCOMPLETE_EVIDENCE', 643), ('SUPERFICIAL_RELATIONSHIP', 661)]	15	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rodent'), ('GO_0007565', 'female pregnancy', 33, 'prenatal'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CL_0000540', 'neuron', 231, 'neuronal'), ('GO_0001764', 'neuron migration', 231, 'neuronal migration'), ('CL_0000540', 'neuron', 303, 'neuronal'), ('UBERON_0016512', 'lumen of duodenum', 341, 'minicolumns'), ('CL_0000540', 'neuron', 418, 'neuronal'), ('GO_0001764', 'neuron migration', 418, 'neuronal migration'), ('GO_0007565', 'female pregnancy', 455, 'gestation'), ('GO_0007565', 'female pregnancy', 498, 'gestation'), ('GO_0007565', 'female pregnancy', 550, 'gestation'), ('GO_0007565', 'female pregnancy', 599, 'gestation'), ('CHEBI_27300', 'vitamin D', 669, 'vitamin D'), ('GO_0007420', 'brain development', 704, 'brain development'), ('UBERON_0000955', 'brain', 704, 'brain')]
PMC5385921	4/2017	S124-PMC5385921	['furthermore, neonatal Vitamin D deficiency HAS been PREVIOUSLY ASSOCIATED with an increased risk of schizophrenia.36asd and schizophrenia are KNOWN to share Genetic risk variants;37our findings provide ADDITIONAL EVIDENCE of the shared risk ARCHITECTURE between these two Neurodevelopmental disorders.']	[('IMPORTANT_CONSIDERATION', 43), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 142), ('FUTURE_WORK', 202), ('INCOMPLETE_EVIDENCE', 213), ('SUPERFICIAL_RELATIONSHIP', 241)]	7	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('SO_0000704', 'gene', 157, 'genetic'), ('GO_0007399', 'nervous system development', 272, 'neurodevelopmental')]
PMC5385921	4/2017	S125-PMC5385921	['for example, the active form of Vitamin D (1,25Ohd) IS KNOWN to AFFECT the function of voltage-gated calcium channels.38variants in Genes coding for subunits of these same calcium channels (e.g.']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 45, '25OHD'), ('SO_0000704', 'gene', 132, 'genes')]
PMC5385921	4/2017	S131-PMC5385921	['in FUTURE STUDIES, it will be OF INTEREST to explore the CRITICAL window during which low Vitamin D MAY CONTRIBUTE to asd RISK – it is FEASIBLE that exposure in the first few years of Life MAY also CONTRIBUTE to adverse Brain outcomes.']	[('FUTURE_WORK', 3), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 104), ('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 135), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 198)]	9	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('UBERON_0000104', 'life cycle', 184, 'life'), ('UBERON_0000955', 'brain', 220, 'brain')]
PMC5385921	4/2017	S141-PMC5385921	['the ASSOCIATION between developmental Vitamin D deficiency and asd MAY have IMPORTANT IMPLICATIONS from a PUBLIC HEALTH perspective.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 76), ('IMPORTANT_CONSIDERATION', 86), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC5385921	4/2017	S142-PMC5385921	['it is FEASIBLE that a SAFE, inexpensive and PUBLICALLY acceptable Vitamin D supplementation in AT-RISK groups MAY reduce the PREVALENCE of this RISK FACTOR.']	[('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 22), ('IMPORTANT_CONSIDERATION', 44), ('IMPORTANT_CONSIDERATION', 95), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 125), ('SUPERFICIAL_RELATIONSHIP', 144)]	7	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5385921	4/2017	S143-PMC5385921	['just as Prenatal Folate supplementation has reduced the incidence of spina bifida, we SPECULATE that Prenatal Vitamin D supplementation MAY reduce the incidence of asd.']	[('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 136)]	2	[('GO_0007565', 'female pregnancy', 8, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 17, 'folate'), ('GO_0007565', 'female pregnancy', 101, 'prenatal'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5405075	4/2017	S1-PMC5405075	['abstract\nthe worldwide increase in asthma PREVALENCE during the last decades and the re-emergence of Vitamin D deficiency in many populations HINTED toward an UNDERLYING ASSOCIATION between these two conditions.']	[('IMPORTANT_CONSIDERATION', 42), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 159), ('SUPERFICIAL_RELATIONSHIP', 170)]	4	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC5405075	4/2017	S2-PMC5405075	['SINCE asthma is presented with high incidence in childhood and neonatal Vitamin D stores DEPEND on maternal Vitamin levels, a POSSIBLE programming EFFECT of maternal Vitamin D status during Gestation was SUGGESTED.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 204)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 108, 'vitamin'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'gestation')]
PMC5405075	4/2017	S5-PMC5405075	['ALTHOUGH, the results of rcts SHOWED a POTENTIAL ASSOCIATION with asthma-RELATED phenotypes RATHER than asthma per se , the low toxicity of Vitamin D supplements make it TEMPTING to SPECULATE that Pregnant women at a high RISK of obtaining a child with asthma MAY BE benefited, ESPECIALLY if they are Vitamin D deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 182), ('IMPORTANT_CONSIDERATION', 222), ('INCOMPLETE_EVIDENCE', 260), ('ANOMALY_CURIOUS_FINDING', 278)]	12	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 197, 'pregnant'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D')]
PMC5405075	4/2017	S6-PMC5405075	['introduction\nepidemiological and experimental data on health IMPACT of “Multitasking” Vitamin D SUPPORT a PROTECTIVE EFFECT of Vitamin D over diseases such as cancer, Cardiovascular, Autoimmune, dementia, and diabetes (1,2).']	[('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 117)]	4	[('GO_0007618', 'mating', 72, 'multitasking'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 167, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 183, 'autoimmune')]
PMC5405075	4/2017	S7-PMC5405075	['RECENTLY, randomized clinical trials HAVE BEEN conducted to determine OPTIMAL Serum concentrations and optimal intake of Vitamin D that MIGHT be beneficial to Human health (3–5).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 70), ('INCOMPLETE_EVIDENCE', 136)]	4	[('UBERON_0001977', 'blood serum', 78, 'serum'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 159, 'human')]
PMC5405075	4/2017	S8-PMC5405075	['the PREVENTION of Asthma Development is one of the MANY POTENTIAL health benefits of Vitamin D (6).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 56)]	3	[('GO_0035801', 'adrenal cortex development', 18, 'asthma development'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5405075	4/2017	S9-PMC5405075	['SINCE asthma is presented with high incidence in childhood, a POSSIBLE programming EFFECT of maternal Vitamin D status during Gestation HAS BEEN PROPOSED.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 145)]	6	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestation')]
PMC5405075	4/2017	S11-PMC5405075	['several OBSERVATIONAL STUDIES explored THIS issue and SUGGESTED a PUTATIVE PROTECTIVE ROLE of Prenatal Vitamin D sufficiency in the development Of Wheezing and Asthma in the offspring [reviewed in ref.']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 66), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 86)]	6	[('GO_0007565', 'female pregnancy', 94, 'prenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0001503', 'ossification', 144, 'of wheezing'), ('GO_0006953', 'acute-phase response', 160, 'asthma')]
PMC5405075	4/2017	S13-PMC5405075	['HOWEVER, it REMAINS UNCLEAR WHETHER maternal Vitamin D deficiency MAY CONTRIBUTE to the development of childhood asthma OR it is the consequence of a GENERALLY altered biochemistry.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 150)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5405075	4/2017	S14-PMC5405075	['in THIS mini-REVIEW ARTICLE, we AIM to present the CURRENT KNOWLEDGE as it EMERGES from studies FOCUSED on the IMPACT of maternal Vitamin D status and Vitamin d supplementation on the Development Of Asthma in early childhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 75), ('QUESTION_ANSWERED_BY_THIS_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 111)]	7	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 151, 'vitamin'), ('GO_0009602', 'detection of symbiont', 184, 'development of asthma')]
PMC5405075	4/2017	S17-PMC5405075	['ALTHOUGH 25(Oh)D circulating levels do not substantially differentiate or MAY BE reduced compared to non-Pregnant women, Serum concentrations of Vitamin D active Metabolite, 1,25(Oh)2D, are significantly elevated from early Pregnancy (13,14).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 74)]	2	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('GO_0007565', 'female pregnancy', 105, 'pregnant'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 162, 'metabolite'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 176, '25(OH)2D'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy')]
PMC5405075	4/2017	S29-PMC5405075	['the IMPACT of Vitamin D exposure in utero\nthe DEPENDENCE of the developing fetus on maternal Vitamin D status TOGETHER with the REPORTED extra Skeletal function of the hormone and Vitamin D deficiency EPIDEMIC during the last years led to FURTHER INVESTIGATION of the CONSEQUENCES of maternal Vitamin D insufficiency on Pregnancy outcomes (6,29,30).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 128), ('IMPORTANT_CONSIDERATION', 201), ('FUTURE_WORK', 239), ('PROBLEM_COMPLICATION', 268)]	7	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('UBERON_0004288', 'skeleton', 143, 'skeletal'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy')]
PMC5405075	4/2017	S31-PMC5405075	['the most cited adverse outcome of maternal Vitamin D deficiency is neonatal rickets, WHILE mild hypovitaminosis D COULD BE more pronounced in exclusively Breast-Fed infants, on the BASIS that Breast Milk constitutes a POOR source of Vitamin D compared with formulas (34–36).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('ANOMALY_CURIOUS_FINDING', 85), ('INCOMPLETE_EVIDENCE', 114), ('PROBABLE_UNDERSTANDING', 181), ('IMPORTANT_CONSIDERATION', 218)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 112, 'D'), ('GO_0007567', 'parturition', 154, 'breast'), ('UBERON_0000310', 'breast', 154, 'breast'), ('GO_0007631', 'feeding behavior', 161, 'fed'), ('UBERON_0001348', 'brown adipose tissue', 192, 'breast milk'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC5405075	4/2017	S32-PMC5405075	['IN THE LIGHT of the POSSIBLE parallel-asthma epidemic, cellular molecular studies along with epidemiological data SUGGEST that Vitamin D deficiency MAY have a programming EFFECT in utero and promote a trajectory to develop asthma in childhood and later in Life (2,37–39).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 171)]	5	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0000104', 'life cycle', 256, 'life')]
PMC5405075	4/2017	S33-PMC5405075	['an immunodulatory ROLE of Vitamin D HAS also BEEN DESCRIBED in both Immune System and Lung Cell Maturation, which occurs MAINLY during fetal and early Extrauterine Life (40–42).']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 50), ('PROBABLE_UNDERSTANDING', 121)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007566', 'embryo implantation', 68, 'immune system'), ('UBERON_0002405', 'immune system', 68, 'immune system'), ('CL_0000175', 'luteal cell', 86, 'lung cell'), ('GO_0060424', 'lung field specification', 86, 'lung cell maturation'), ('UBERON_0002048', 'lung', 86, 'lung'), ('UBERON_0005928', 'external naris', 151, 'extrauterine life')]
PMC5405075	4/2017	S36-PMC5405075	['mainly, the Food-approached studies have SUGGESTED a PROTECTIVE ROLE of Vitamin D Intake on the Development Of Wheezing and Asthma in offspring, with an attenuated effect after adjustment for multiple covariables (43–48).']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 64)]	3	[('CHEBI_33290', 'food', 12, 'food'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007631', 'feeding behavior', 82, 'intake'), ('GO_0098789', 'pre-mRNA cleavage required for polyadenylation', 96, 'development of wheezing'), ('GO_0006953', 'acute-phase response', 124, 'asthma')]
PMC5405075	4/2017	S38-PMC5405075	['CONSEQUENTLY, longitudinal studies measuring 25(Oh)D levels, a POSSIBLE more objective INDICATOR of Vitamin D status, were DESIGNED TO explore the POSSIBLE IMPACT of Vitamin D on asthma-like symptoms or asthma.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 87), ('QUESTION_ANSWERED_BY_THIS_WORK', 123), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 156)]	7	[('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000010220', 'mannose-binding protein C', 47, '('), ('PR_000006444', 'diacylglycerol kinase delta', 51, 'D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC5405075	4/2017	S42-PMC5405075	['INCONSISTENCIES across studies HAVE BEEN ATTRIBUTED to a plethora of FACTORS such as diverse study designs, MISSING significant follow-up, lack OF a clear definition of vitamin d sufficiency in Pregnancy, REMARKABLE fluctuations in populations in different latitudes, Genetic heterogeneity, the diversity of assays employed (69), low repeatability of Serum 25(Oh)D values (37), variety of Vitamin D status DETERMINANTS, multifactorial nature and phenotypical diversity of asthma, as well as imprecision in diagnosing asthma in early Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 69), ('PROBLEM_COMPLICATION', 108), ('ANOMALY_CURIOUS_FINDING', 144), ('ANOMALY_CURIOUS_FINDING', 205), ('SUPERFICIAL_RELATIONSHIP', 406)]	8	[('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('SO_0000704', 'gene', 268, 'genetic'), ('UBERON_0001977', 'blood serum', 351, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 360, 'OH)D'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('UBERON_0000104', 'life cycle', 533, 'life')]
PMC5405075	4/2017	S44-PMC5405075	['OF NOTE, Food base approaches MAY BE ASSUMED AS a better representative of long-term Vitamin D Intake, which MIGHT INFLUENCE the fetus during all stages of Gestation and EVEN ex utero .']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 45), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 115), ('ANOMALY_CURIOUS_FINDING', 170)]	8	[('CHEBI_33290', 'food', 9, 'food'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007631', 'feeding behavior', 95, 'intake'), ('GO_0007565', 'female pregnancy', 156, 'gestation')]
PMC5405075	4/2017	S45-PMC5405075	['the INCONSISTENT body of EVIDENCE with glimmer of positivity from observational prospective cohorts, the RATHER low toxicity of Vitamin D, which is a relative inexpensive CANDIDATE in the attenuation of the asthma’s EPIDEMIC BURDEN on PUBLIC HEALTH, were clearly INDICATIVE of THE NEED to proceed to clinical trials.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('INCOMPLETE_EVIDENCE', 171), ('IMPORTANT_CONSIDERATION', 216), ('IMPORTANT_CONSIDERATION', 235), ('PROBABLE_UNDERSTANDING', 263), ('INCOMPLETE_EVIDENCE', 277)]	8	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5405075	4/2017	S46-PMC5405075	['moreover, both Animal and in vitro experiments have DEMONSTRATED a positive IMPACT of Prenatal Vitamin D exposure on aspects of Lung function and the process of inflammation, which are CONSIDERED to CONTRIBUTE to asthma pathogenesis (70–72).']	[('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('NCBITaxon_33208', 'Metazoa', 15, 'animal'), ('GO_0007565', 'female pregnancy', 86, 'prenatal'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0002048', 'lung', 128, 'lung')]
PMC5405075	4/2017	S51-PMC5405075	['in a RECENT randomized placebo-controlled double-blind trial in new zealand, Vitamin D was administrated in unselected Pregnant women from the 27\u2009weeks of Gestation and subsequently in their infants during the first 6\u2009months of Life (placebo/placebo, 1,000/400\u2009iu, and 2,000/800\u2009iu).']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnant'), ('GO_0007565', 'female pregnancy', 155, 'gestation'), ('UBERON_0000104', 'life cycle', 228, 'life')]
PMC5405075	4/2017	S53-PMC5405075	['besides, a POSSIBLE EFFECT of Vitamin D was depicted on primary care visits, where asthma was diagnosed by physicians (74).']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC5405075	4/2017	S54-PMC5405075	['HOWEVER, these clinical trials were BIASED by many LIMITATIONS, such as SMALL SIZE, Vitamin D administration ONLY in the last Trimester of Pregnancy, POSSIBLY INADEQUATE maternal dose administration, WHILE authors also acknowledged that they were NOT PRIMARY designed to assess the specific outcome.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('PROBLEM_COMPLICATION', 36), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 150), ('IMPORTANT_CONSIDERATION', 159), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('INCOMPLETE_EVIDENCE', 247)]	10	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 126, 'trimester'), ('GO_0007565', 'female pregnancy', 139, 'pregnancy')]
PMC5405075	4/2017	S58-PMC5405075	['caption (table-wrap): table 1\n\nrandomized control trials on Vitamin D supplementation during Pregnancy and asthma/wheezing .referencecountry and enrollment periodstudy populationintervention armsnumber/age of children at outcome assessmentintake of intervention from/untileffect on median Vitamin D levels (ng/ml)outcomes of interestmain FINDINGSGOLDRING et al.']	[('INCOMPLETE_EVIDENCE', 338)]	1	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D')]
PMC5405075	4/2017	S82-PMC5405075	['taken all TOGETHER, Vitamin D SHOWS a POTENTIAL ASSOCIATION RATHER with asthma-RELATED phenotypes than with asthma per se .']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 79)]	6	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
PMC5405075	4/2017	S85-PMC5405075	['additionally, Vitamin D is a marker of uv exposure, which CAN Modulate Immunity via non-Vitamin D RELATED pathways (80,81).']	[('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 98)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'modulate'), ('GO_0007566', 'embryo implantation', 71, 'immunity'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5405075	4/2017	S89-PMC5405075	['moreover, it HAS BEEN PROPOSED that studies SHOULD focus on Vitamin D status in early Pregnancy and supplementary administration SHOULD BE initiated from the first Trimester of Gestation in order to observe the OPTIMAL EFFECT on RISK of childhood asthma, THOUGH EVIDENCE from chawes et al.’s clinical trial DID NOT CONFIRM this NOTION (75).']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('FUTURE_WORK', 44), ('FUTURE_WORK', 129), ('IMPORTANT_CONSIDERATION', 211), ('SUPERFICIAL_RELATIONSHIP', 219), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ANOMALY_CURIOUS_FINDING', 255), ('INCOMPLETE_EVIDENCE', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 307), ('INCOMPLETE_EVIDENCE', 328)]	12	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 164, 'trimester'), ('GO_0007565', 'female pregnancy', 177, 'gestation')]
PMC5405075	4/2017	S93-PMC5405075	['a plethora of environmental and Genetic/epigenetic FACTORS CONTRIBUTE in a COMPLEX manner to a PARTLY understood pathogenesis, WHILE the shifted Vitamin D Metabolism during Pregnancy is also NOT FULLY ELUCIDATED.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 59), ('DIFFICULT_TASK', 75), ('INCOMPLETE_EVIDENCE', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 191)]	6	[('SO_0000704', 'gene', 32, 'genetic'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 145, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
PMC5405075	4/2017	S98-PMC5405075	['moreover, any intervention SHOULD BE individualized to initial maternal Vitamin D status and be followed up, SINCE a u -curve ASSOCIATION between Vitamin D circulating levels and IMPACT on allergy and Human health HAS BEEN also PROPOSED (83,84).']	[('FUTURE_WORK', 27), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 126), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 214), ('INCOMPLETE_EVIDENCE', 228)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 201, 'human')]
PMC5405075	4/2017	S102-PMC5405075	['HOWEVER, given the RATHER low toxicity of such a Supplement, Pregnant women at a high risk of obtaining a child with asthma MAY BE benefited, especially IF they are Vitamin D deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 153)]	4	[('CHEBI_16158', 'steroid sulfate', 49, 'supplement'), ('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
PMC5410409	4/2017	S57-PMC5410409	['three large Birth cohort studies SHOWED CONSISTENT positive ASSOCIATIONS between maternal Intake of Vitamin E in Pregnancy and PREVENTION of childhood asthma or wheeze at 2 years of age [5].']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 40), ('SUPERFICIAL_RELATIONSHIP', 60), ('SUPERFICIAL_RELATIONSHIP', 127)]	5	[('GO_0007567', 'parturition', 12, 'birth'), ('GO_0007631', 'feeding behavior', 90, 'intake'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin E'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
PMC5410409	4/2017	S62-PMC5410409	['SOME REPORTED that high maternal Vitamin D intake during Pregnancy was ASSOCIATED with reduced RISK of wheezing in the child, WHILE SOME SHOWED no effect.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 71), ('IMPORTANT_CONSIDERATION', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 137)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy')]
PMC5410409	4/2017	S63-PMC5410409	['in more RECENT observation STUDIES, high-dose Maternal Intake of Vitamin D was ASSOCIATED with increased atopic diseases such as atopic dermatitis and/or allergic rhinitis [14].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 79)]	2	[('GO_0007618', 'mating', 46, 'maternal'), ('GO_0007631', 'feeding behavior', 55, 'intake'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC5410409	4/2017	S64-PMC5410409	['the CONFLICTING results MAY reflect Genetic variability in the general population in the Metabolism and allergy preventive EFFECTS of Vitamin D supplementation in the child [67].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('SO_0000704', 'gene', 36, 'genetic'), ('GO_0008152', 'metabolic process', 89, 'metabolism'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5410409	4/2017	S194-PMC5410409	['in 1 large Birth cohort STUDY, regular Vitamin D supplementation was ASSOCIATED with the risk of developing atopy (odds ratio [or], 1.66) and allergic rhinitis (or, 1.46) than those who received it irregularly or none at all [75].']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 69)]	2	[('GO_0007567', 'parturition', 11, 'birth'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC5426325	4/2017	S0-PMC5426325	['Prenatal exposure to Vitamin D from fortified Margarine and risk of fractures in late childhood: period and cohort results from 222 000 subjects in the d-tect observational study\n\nabstract:normal\nPrenatal low Vitamin D MAY have CONSEQUENCES for bone health.']	[('INCOMPLETE_EVIDENCE', 219), ('IMPORTANT_CONSIDERATION', 228)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_6784', 'mestranol', 46, 'margarine'), ('GO_0007565', 'female pregnancy', 196, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC5426325	4/2017	S5-PMC5426325	['we ADDRESSED the POTENTIAL modification of the EFFECT of Vitamin D availability by season of Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007567', 'parturition', 93, 'birth')]
PMC5426325	4/2017	S11-PMC5426325	['the study DID NOT PROVIDE EVIDENCE that Prenatal exposure to extra Vitamin D from a mandatory fortification programme of 1·25 µg Vitamin D/100 g Margarine was sufficient to INFLUENCE the risk of fractures in late childhood, REGARDLESS OF season of Birth.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 173), ('INCOMPLETE_EVIDENCE', 224)]	3	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_6784', 'mestranol', 145, 'margarine'), ('GO_0007567', 'parturition', 248, 'birth')]
PMC5426325	4/2017	S13-PMC5426325	['BASED ON Serum 25-Hydroxy Vitamin D3(25(Oh)D3) measurements, STUDIES HAVE SHOWN a pronounced seasonal variation in Vitamin D status in denmark and other countries with latitudes above 35° north and south(1,2), MOST LIKELY RELATED to insufficient actinic Vitamin D Synthesis during the darker part of the year in such countries.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 210), ('SUPERFICIAL_RELATIONSHIP', 222)]	5	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 15, '25-hydroxy'), ('CHEBI_33279', 'vitamin D5', 26, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 26, 'vitamin D3'), ('CHEBI_62946', 'ammonium sulfate', 37, '25(OH)D3'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 254, 'vitamin D synthesis')]
PMC5426325	4/2017	S19-PMC5426325	['the EVIDENCE for LINKING maternal Vitamin D insufficiency to offspring fracture rates is SPARSE and is BASED ON results from Animal studies(5), as well as observational studies SUGGESTING that maternal Vitamin D status INFLUENCES fetal bone growth and mineralisation(6), and PERHAPS also long-term bone health among offspring(7–12).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 219), ('INCOMPLETE_EVIDENCE', 275)]	7	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 125, 'animal'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC5426325	4/2017	S20-PMC5426325	['GIVEN that low bone Mineral density (bmd) is PREDICTIVE of increased fracture risk, AS SHOWN in both case–control and prospective studies – THOUGH principally in Adults(13–20)– maternal Vitamin D insufficiency MAY POTENTIALLY also INFLUENCE fracture RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 84), ('ANOMALY_CURIOUS_FINDING', 140), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 250)]	8	[('CHEBI_46662', 'mineral', 20, 'mineral'), ('UBERON_0007023', 'adult organism', 162, 'adults'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC5426325	4/2017	S23-PMC5426325	['we HYPOTHESISED that Individuals Born during the last 2 years of the mandatory Vitamin D fortification had a reduced risk of sustaining fractures of the Forearm, Wrist or Scaphoid Bone, Clavicle and Ankle in late childhood, compared with those Born 2 years after the termination of Vitamin D fortification, allowing for a washout period after termination.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('NCBITaxon_1', 'root', 21, 'individuals'), ('GO_0007567', 'parturition', 33, 'born'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0002386', 'forelimb zeugopod', 153, 'forearm'), ('UBERON_0004452', 'carpal region', 162, 'wrist'), ('UBERON_0001427', 'radiale', 171, 'scaphoid'), ('UBERON_0001474', 'bone element', 180, 'bone'), ('UBERON_0001105', 'clavicle bone', 186, 'clavicle'), ('UBERON_0004454', 'tarsal region', 199, 'ankle'), ('GO_0007567', 'parturition', 244, 'born'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC5426325	4/2017	S24-PMC5426325	['in addition, it was HYPOTHESISED that the Vitamin D fortification during sun-deprived months of Gestation would be ASSOCIATED with the greatest risk reduction of offspring childhood fractures.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 115)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'gestation')]
PMC5426325	4/2017	S26-PMC5426325	['the d-tect study is based ON the fact that until 1 june 1985 it was mandatory in denmark to fortify all Margarine with Vitamin D. margarine was fortified with 1·25 µg/100 g and APPROXIMATELY 13 % (3–29 %) of all dietary Vitamin D is ESTIMATED to have come from the fortified Margarine(31).']	[('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 177), ('INCOMPLETE_EVIDENCE', 233)]	3	[('CHEBI_6784', 'mestranol', 104, 'margarine'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('CHEBI_6784', 'mestranol', 275, 'margarine')]
PMC5426325	4/2017	S27-PMC5426325	['we DID NOT identify OTHER abrupt societal changes during 1983–1988 that POTENTIALLY COULD INFLUENCE our results, neither in relation to fortification practices in other Food products for Consumption(31,32), nor in relation to Margarine intake in the danish population(33)or in relation to national RECOMMENDATIONS for Vitamin D supplementation to Pregnant women or infants.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 90), ('FUTURE_WORK', 298)]	6	[('CHEBI_33290', 'food', 169, 'food'), ('GO_0007631', 'feeding behavior', 187, 'consumption'), ('CHEBI_6784', 'mestranol', 226, 'margarine'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0007565', 'female pregnancy', 347, 'pregnant')]
PMC5426325	4/2017	S65-PMC5426325	['in a third series of models, we addressed the POTENTIAL modification of the EFFECT of Vitamin D availability by season of Birth, with winter defined as Births in november, december or january.']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007567', 'parturition', 122, 'birth'), ('GO_0007567', 'parturition', 152, 'births')]
PMC5426325	4/2017	S108-PMC5426325	['caption (table-wrap): table 2\n\nage-adjusted facture rate by month of fracture (july is the reference) (rate ratios (rr) and 95 % confidence intervals )boysgirlsmonth of fracturerr95 % cirr95 % cijanuary0·920·86, 0·981·040·96, 1·13february1·040·97, 1·111·141·05, 1·24march1·211·13, 1·281·371·27, 1·48april1·481·40, 1·571·551·43, 1·67may1·671·58, 1·771·711·58, 1·84june1·441·36, 1·531·401·29, 1·51july11august1·731·63, 1·831·571·45, 1·70september1·481·40, 1·571·651·53, 1·78october1·020·96, 1·091·201·11, 1·31november0·930·87, 1·001·171·08, 1·27december0·700·65, 0·760·900·82, 0·98\n\nfracture rates compared between Individuals POTENTIALLY exposed to Vitamin D fortification and non-exposed Individuals\namong girls, the rate ratio for the exposed was 1·15 (95 % ci 1·11, 1·20) compared with the non-exposed.']	[('INCOMPLETE_EVIDENCE', 625)]	1	[('NCBITaxon_1', 'root', 613, 'individuals'), ('CHEBI_27300', 'vitamin D', 648, 'vitamin D'), ('NCBITaxon_1', 'root', 688, 'individuals')]
PMC5426325	4/2017	S117-PMC5426325	['the study DID NOT PROVIDE EVIDENCE that Prenatal exposure to extra Vitamin D from fortification was sufficient to INFLUENCE the risk of fractures in late childhood, REGARDLESS OF season of Birth.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 165)]	3	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 189, 'birth')]
PMC5426325	4/2017	S119-PMC5426325	['THUS, we CANNOT RULE OUT WHETHER the Birth cohort results REFLECT a TRUE adverse EFFECT of Vitamin D on bone; one PREVIOUS STUDY did indeed report borderline significant inverse ASSOCIATIONS between maternal late Pregnancy 25(Oh)D concentrations and offspring Forearm fractures(12).']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 68), ('SUPERFICIAL_RELATIONSHIP', 81), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 178)]	8	[('GO_0007567', 'parturition', 37, 'birth'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 223, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 223, '25(OH)D'), ('UBERON_0002386', 'forelimb zeugopod', 260, 'forearm')]
PMC5426325	4/2017	S121-PMC5426325	['nonetheless, the decreasing TREND MAY have been AFFECTED by INFLUENCES more powerful than the LIKELY IMPACT of Vitamin D in the modest amounts of 1·25 µg vitamin d/100 g Margarine(31).']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 94), ('SUPERFICIAL_RELATIONSHIP', 101)]	6	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_6784', 'mestranol', 170, 'margarine')]
PMC5426325	4/2017	S122-PMC5426325	['by comparing Individuals from entire adjacent Birth cohorts that were, or were not, exposed to extra Vitamin D from Margarine fortification Prenatally only, but all unexposed thereafter, we ASSUME that all POTENTIAL CONFOUNDERS are equally distributed in both groups, and HENCE that control for CONFOUNDING is not NEEDED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('INCOMPLETE_EVIDENCE', 206), ('PROBLEM_COMPLICATION', 216), ('PROBABLE_UNDERSTANDING', 272), ('PROBLEM_COMPLICATION', 295), ('FUTURE_WORK', 314)]	6	[('NCBITaxon_1', 'root', 13, 'individuals'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_6784', 'mestranol', 116, 'margarine'), ('GO_0019230', 'proprioception', 140, 'prenatally')]
PMC5426325	4/2017	S135-PMC5426325	['the RELATIONSHIP between Vitamin D status during fetal Life and long-term bone health has not previously been widely examined, and results from earlier observational studies SHOWED EITHER no association or a direct association.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 55, 'life')]
PMC5426325	4/2017	S146-PMC5426325	['from systematic review and meta-analysis of randomised controlled trials, THERE IS EVIDENCE that Vitamin D-fortified Foods GENERALLY improve Vitamin D status among both children and Adults in a dose-DEPENDENT manner(57–59).']	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 123), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_33290', 'food', 117, 'foods'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('UBERON_0007023', 'adult organism', 182, 'adults')]
PMC5426325	4/2017	S147-PMC5426325	['the danish Margarine fortification programme HAS BEEN SHOWN to account for APPROXIMATELY 0·36–0·57 µg Vitamin D/Person per d(60).']	[('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 75)]	2	[('CHEBI_6784', 'mestranol', 11, 'margarine'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 112, 'person')]
PMC5426325	4/2017	S148-PMC5426325	['these ESTIMATES are BASED ON Food disappearance data (Food availability for Human use), where the average Purchasing of Margarine was ESTIMATED to be 16 000–17 000 g Margarine/person per year during the period 1983–1988(33), which is equal to 44–46 g Margarine/person per d, and the dose-equivalents for Vitamin D from fortified Margarine is on average 0·55–0·57 µg/Person per d(33).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 134)]	3	[('CHEBI_33290', 'food', 29, 'food'), ('CHEBI_33290', 'food', 54, 'food'), ('NCBITaxon_9606', 'Homo sapiens', 76, 'human'), ('GO_0000239', 'pachytene', 106, 'purchasing'), ('CHEBI_6784', 'mestranol', 120, 'margarine'), ('CHEBI_6784', 'mestranol', 166, 'margarine'), ('CHEBI_6784', 'mestranol', 251, 'margarine'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D'), ('CHEBI_6784', 'mestranol', 329, 'margarine'), ('NCBITaxon_10088', 'Mus <genus>', 366, 'person')]
PMC5426325	4/2017	S151-PMC5426325	['IT IS POSSIBLE that this amount was too small to INFLUENCE fracture risk at the population level, EVEN when we CONFINED the analysis to those Pregnancies with habitually low Vitamin D during late trimesters, that is, those Giving Birth during winter months.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 49), ('ANOMALY_CURIOUS_FINDING', 98), ('INCOMPLETE_EVIDENCE', 111)]	4	[('GO_0007565', 'female pregnancy', 142, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0040007', 'growth', 223, 'giving'), ('GO_0007567', 'parturition', 230, 'birth')]
PMC5426325	4/2017	S152-PMC5426325	['UNFORTUNATELY, we LACK INFORMATION on Vitamin D status among danish women in the Reproductive age during the fortification period, BUT for comparision, a study SHOWED that among 850 Pregnant women recruited from the second-largest city in denmark in 1988–1989 (the period without fortification), only 6·3 of the Pregnant women had a Serum 25(Oh)D concentration ≤25 nmol/l(12); the median concentrations of 76·2 (95 % ci 23·0, 152·1) nmol/l were also above the ‘OPTIMAL level’ as STATED by the us Endocrine society(62,63).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 461), ('INCOMPLETE_EVIDENCE', 479)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0000003', 'reproduction', 81, 'reproductive'), ('GO_0007565', 'female pregnancy', 182, 'pregnant'), ('GO_0007565', 'female pregnancy', 312, 'pregnant'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 339, '25(OH)D'), ('UBERON_0005063', 'left ventricular compact myocardium', 496, 'Endocrine')]
PMC5426325	4/2017	S162-PMC5426325	['conclusion\nthe study DID NOT PROVIDE EVIDENCE that Prenatal exposure to extra Vitamin D from a mandatory fortification programme, adding1·25 µg Vitamin D/100 g Margarine, was sufficient to INFLUENCE the risk of fractures in late childhood, REGARDLESS OF season of Birth.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 189), ('INCOMPLETE_EVIDENCE', 240)]	4	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_6784', 'mestranol', 160, 'margarine'), ('GO_0007567', 'parturition', 264, 'birth')]
PMC5452160	4/2017	S140-PMC5452160	['APPROXIMATELY 80% of women had inadequate or marginal Vitamin A status.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A')]
PMC5452160	4/2017	S237-PMC5452160	['CONSIDERING the high prevalence of iron, zinc, Vitamin A, b12, and Folate deficiencies, and PREVIOUSLY presented results on Iodine deficiency in this study population [63], INTERVENTIONS to promote the strengthening of anc, and access and adherence to nutrition and health interventions are URGENTLY NEEDED [64,65].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 173), ('IMPORTANT_CONSIDERATION', 291), ('FUTURE_WORK', 300)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 67, 'folate'), ('CHEBI_24859', 'iodine atom', 124, 'iodine')]
PMC5418719	5/2017	S5-PMC5418719	['Vitamin D intake of 800\xa0iu/day SAFELY achieved an 88% PROBABILITY of Vitamin D sufficiency at 36\xa0weeks Postmenstrual age in vlbw infants with Cord-blood levels of 25(Oh)D\u2009≥\u200910\xa0ng/ml, and 65% PROBABILITY of Vitamin D sufficiency was OBSERVED in infants with 25 Ohd concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 54), ('PROBABLE_UNDERSTANDING', 191), ('INCOMPLETE_EVIDENCE', 232)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0008283', 'cell proliferation', 103, 'postmenstrual'), ('UBERON_0002240', 'spinal cord', 142, 'cord'), ('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 163, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 257, '25 OHD'), ('GO_0007567', 'parturition', 293, 'birth')]
PMC5418719	5/2017	S6-PMC5418719	['conclusion\nCONSIDERING the EFFICACY and SAFETY of Vitamin D supplementation in THIS STUDY, Vitamin D intake of 800\xa0iu/day MAY enhance Vitamin D status during early hospitalization in vlbw infants with 25 Ohd concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('PROBABLE_UNDERSTANDING', 11), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 40), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('INCOMPLETE_EVIDENCE', 122)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 201, '25 OHD'), ('GO_0007567', 'parturition', 237, 'birth')]
PMC5418719	5/2017	S10-PMC5418719	['DUE TO the POTENTIAL IMPACT of Vitamin D on many developmental processes in preterm infants, jobe et al.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5418719	5/2017	S11-PMC5418719	['[1] EMPHASIZED the FUNDAMENTAL BENEFITS of Vitamin D treatment for multiple developmental abnormalities, REFERRING to the high percentage of preterm infants with Blood Vitamin D levels\u2009<\u200920\xa0ng/ml [2].']	[('IMPORTANT_CONSIDERATION', 4), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 105)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0000178', 'blood', 162, 'blood'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC5418719	5/2017	S12-PMC5418719	['HOWEVER, NO CONSENSUS RECOMMENDATION for Vitamin D deficiency was made specifically for preterm infants, BECAUSE FEW DATA on bone mineralization rates in utero are reported.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('FUTURE_WORK', 22), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5418719	5/2017	S15-PMC5418719	['CONSIDERING the high incidence of Vitamin D deficiency/insufficiency in preterm infants that miss the late Gestation period, which builds Vitamin D stores from mother to fetus, a Vitamin D supply MIGHT be NECESSARY and URGENT to compensate the sufficient Vitamin D level.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 196), ('IMPORTANT_CONSIDERATION', 205), ('IMPORTANT_CONSIDERATION', 219)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'gestation'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
PMC5418719	5/2017	S29-PMC5418719	['the total content of daily Vitamin D intake was ESTIMATED and cumulative dose in Human milk fortifier or formula did not exceed 900\xa0iu/day in the present study.']	[('INCOMPLETE_EVIDENCE', 48)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 81, 'human')]
PMC5418719	5/2017	S35-PMC5418719	['the 25(Oh)D cutoff of 30\xa0ng/ml was chosen based on the earlier STUDY, in which this level was considered to be Vitamin D sufficiency [9].']	[('INCOMPLETE_EVIDENCE', 63)]	1	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 10, 'D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC5418719	5/2017	S47-PMC5418719	['statistical analysis\nthe sample size for this study was ESTIMATED based on an earlier STUDY, which OBSERVED the positive outcome on Vitamin D levels in high-dose groups (960\xa0iu/day), with a power of 80% (α\u2009=\u20090.05, δ\u2009=\u20095\xa0iu/l, pooled sd\u2009=\u200912\xa0iu/l, n \u2009=\u200925 infants per group) [5].']	[('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 99)]	3	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5418719	5/2017	S92-PMC5418719	['WHILE the use of 800\xa0iu/d of Vitamin D achieved Serum 25(Oh)D concentrations to the ADEQUATE range of 30–80\xa0ng/ml without toxicity at 36\xa0weeks pma, this dose MAY STILL be too low to restore Vitamin D stores for the MAJORITY of infants with 25(Oh)D concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 84), ('INCOMPLETE_EVIDENCE', 158), ('IMPORTANT_CONSIDERATION', 162), ('PROBABLE_UNDERSTANDING', 215)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 240, '25(OH)D'), ('GO_0007567', 'parturition', 277, 'birth')]
PMC5418719	5/2017	S94-PMC5418719	['RECENT STUDIES DEMONSTRATED that low Vitamin D PREDISPOSE to increased RISK of rickets, Immune dysfunction, asthma, type 1 diabetes and Viral Respiratory Tract infections during infancy [14–17].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 71)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0002405', 'immune system', 88, 'immune'), ('NCBITaxon_1', 'root', 136, 'viral'), ('UBERON_0000065', 'respiratory tract', 142, 'respiratory tract')]
PMC5418719	5/2017	S95-PMC5418719	['the POTENTIAL benefits derived from adequate Vitamin D levels WARRANT assessment the Vitamin D levels in preterm infants.']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_WORK', 62)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5418719	5/2017	S97-PMC5418719	['serial measurements of Serum 25(Oh)D to evaluate Vitamin D status during hospitalization MAY HELP to identify preterm infants AT RISK of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 93), ('IMPORTANT_CONSIDERATION', 126)]	3	[('UBERON_0001977', 'blood serum', 23, 'serum'), ('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 29, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC5418719	5/2017	S98-PMC5418719	['CONSIDERING the high prevalence of Vitamin D deficiency in Pregnant mothers, sufficient Vitamin D supply in preterm infants COULD BE IMPORTANT to quickly correct the fetal low Plasma levels of Vitamin D. a Vitamin D intake of 800\xa0iu to 1000\xa0iu per day during first Months Of Life is RECOMMENDED BASED ON european GUIDELINES [21].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 133), ('FUTURE_WORK', 283), ('PROBABLE_UNDERSTANDING', 295), ('ANOMALY_CURIOUS_FINDING', 301), ('PROBABLE_UNDERSTANDING', 313)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 176, 'plasma'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0005445', 'segment of pes', 265, 'months of life')]
PMC5418719	5/2017	S101-PMC5418719	['preterm infants with radiologic evidence of rickets or high alkaline phosphatase (>800\xa0iu/l) are GENERALLY given the upper intake total of 800\xa0iu/day of Vitamin D. DESPITE Vitamin D supplementation, it is DIFFICULT to maintain the RECOMMENDED daily Vitamin D intake from dietary in preterm infants, and there are FEW EVIDENCE-based data to support Vitamin D supplementation to meet a desired Serum 25(Oh)D ACCORDING to Vitamin D status at Birth in preterm infants.']	[('PROBABLE_UNDERSTANDING', 97), ('ANOMALY_CURIOUS_FINDING', 164), ('DIFFICULT_TASK', 205), ('FUTURE_WORK', 231), ('INCOMPLETE_EVIDENCE', 313), ('SUPERFICIAL_RELATIONSHIP', 406)]	6	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('UBERON_0001977', 'blood serum', 392, 'serum'), ('CHEBI_71657', 'versiconol acetate', 398, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 401, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('GO_0007567', 'parturition', 439, 'birth')]
PMC5418719	5/2017	S102-PMC5418719	['this LACK OF EVIDENCE has resulted in VARYING practices among neonatologists, and CONTROVERSY REMAINS about the thresholds and STRATEGIES for Vitamin D intake of 800\xa0iu among vlbw infants earlier in Life.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 127)]	5	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0000104', 'life cycle', 199, 'life')]
PMC5418719	5/2017	S103-PMC5418719	['CONSISTENT with PREVIOUS reports about a dose-response EFFECT of Vitamin D supplementation [2,23], we OBSERVED that early supplementation with 800\xa0iu Vitamin D safely achieved an 88% PROBABILITY of Vitamin D sufficiency at 36 pma in the MAJORITY of infants with Cord-Blood levels of 25(Oh)D\u2009≥\u200910\xa0ng/ml.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 183), ('PROBABLE_UNDERSTANDING', 237)]	6	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 262, 'cord'), ('UBERON_0000178', 'blood', 267, 'blood'), ('CHEBI_71657', 'versiconol acetate', 283, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 283, '25(OH ... D')]
PMC5418719	5/2017	S104-PMC5418719	['ALTHOUGH a number of Vitamin D deficiency was significantly lower after supplementation than before supplementation in the PRESENT STUDY, supplementation with 800\xa0iu MIGHT not be sufficient to achieve optimal Vitamin D levels in preterm infants with UNDERLYING level of Vitamin D deficiency from Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 123), ('INCOMPLETE_EVIDENCE', 166), ('SUPERFICIAL_RELATIONSHIP', 250)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007567', 'parturition', 296, 'birth')]
PMC5418719	5/2017	S105-PMC5418719	['the DIFFERENT response to Vitamin D supplementation COULD BE EXPLAINED by vdr Gene polymorphism INVOLVED in Vitamin D Receptor, which results in Vitamin D deficiency at 36 pma in SOME babies after supplementation [24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 58), ('PROBABLE_UNDERSTANDING', 61), ('SUPERFICIAL_RELATIONSHIP', 96), ('INCOMPLETE_EVIDENCE', 179)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('SO_0000704', 'gene', 78, 'gene'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 108, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5418719	5/2017	S110-PMC5418719	['a randomized controlled trial in 100 infants with Gestational age between 23 and 27\xa0weeks DEMONSTRATED that the 800\xa0iu/d dose of Vitamin D supplementation PREVENTED Vitamin D deficiency, without toxicity, with concentrations above the desired 25(Oh)D range of 20–60\xa0ng/ml in the majority of infants on day 28 [2].']	[('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 155)]	2	[('GO_0007565', 'female pregnancy', 50, 'gestational'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D')]
PMC5418719	5/2017	S118-PMC5418719	['MANY STUDIES have REVEALED a substantial proportion of Vitamin D deficiency in the middle east, hispanic women, african americans and asian countries during Pregnancy, compared to western countries [7,23,29,30].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnancy')]
PMC5418719	5/2017	S119-PMC5418719	['a RECENT STUDY REVEALING a high prevalence of SEVERE Vitamin D deficiency in the middle east prompted us TO INVESTIGATE the OPTIMAL Vitamin D REQUIREMENT of preterm infants in different geographical locations [7].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 105), ('IMPORTANT_CONSIDERATION', 124), ('IMPORTANT_CONSIDERATION', 142)]	6	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5418719	5/2017	S121-PMC5418719	['[31] IDENTIFIED that the overall prevalence of Vitamin D deficiency (<20\xa0ng/ml) was 77.3% and the prevalence of Vitamin D deficiency (<10\xa0ng/ml) was 28.6% among Pregnant women in korea.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'pregnant')]
PMC5418719	5/2017	S122-PMC5418719	['the POTENTIAL risk of Vitamin D deficiency on Immune status of preterm infants at Birth has attracted much INTEREST RECENTLY [32].']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 107), ('INCOMPLETE_EVIDENCE', 116)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 46, 'immune'), ('GO_0007567', 'parturition', 82, 'birth')]
PMC5418719	5/2017	S125-PMC5418719	['SIMILAR TO PREVIOUS REPORTS [34,35], in the PRESENT STUDY, women with gdm had a significantly INCREASED RISK of deficient Vitamin D status with cord 25(Oh)D concentrations\u2009≤\u200910\xa0ng/ml.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 20), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('IMPORTANT_CONSIDERATION', 94)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 151, '(OH)D')]
PMC5418719	5/2017	S126-PMC5418719	['these results SUGGEST Vitamin D deficiency is RELATED to impaired Glucose tolerance and Insulin resistance.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_17234', 'glucose', 66, 'glucose'), ('PR_000045358', 'insulin family protein', 88, 'insulin')]
PMC5418719	5/2017	S128-PMC5418719	['[36] RECENTLY CONFIRMED that women who had Vitamin D insufficiency during Pregnancy were AT RISK of developing Gestational diabetes and Delivering small for Gestational age infants in a systematic review.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 89)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 111, 'gestational'), ('GO_0006900', 'vesicle budding from membrane', 136, 'delivering'), ('GO_0007565', 'female pregnancy', 157, 'gestational')]
PMC5418719	5/2017	S130-PMC5418719	['preterm infants with these diseases MAY more LIKELY to have low Vitamin D levels INVOLVED in impaired Vitamin D absorption or Metabolism during hospitalization.']	[('INCOMPLETE_EVIDENCE', 36), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0008152', 'metabolic process', 126, 'metabolism')]
PMC5418719	5/2017	S138-PMC5418719	['CONSIDERING the EFFICACY and SAFETY of Vitamin D supplementation in THIS STUDY, Vitamin D intake of 800\xa0iu per day MAY optimize Vitamin D levels during early hospitalization in vlbw infants.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('INCOMPLETE_EVIDENCE', 115)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5418719	5/2017	S139-PMC5418719	['relatively SMALL number of cases and absence of information on maternal Vitamin D and dietary habits for analysis are POTENTIAL limitations of PRESENT STUDY.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 118), ('QUESTION_ANSWERED_BY_THIS_WORK', 143)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5473979	6/2017	S118-PMC5473979	['various Micronutrients, such as Vitamin D, Selenium, zinc, Vitamin B12, Folates and OTHER b Vitamins, HAVE BEEN SUGGESTED as IMPORTANT for the PREVENTION of maternal depression [36].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('INCOMPLETE_EVIDENCE', 102), ('IMPORTANT_CONSIDERATION', 125), ('SUPERFICIAL_RELATIONSHIP', 143)]	4	[('CHEBI_33839', 'macromolecule', 8, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27568', 'selenium atom', 43, 'selenium'), ('CHEBI_33279', 'vitamin D5', 59, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 67, 'B12'), ('CHEBI_72469', 'alpha-Neup5Gc-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc', 72, 'folates'), ('CHEBI_33277', 'gamma-tocotrienol', 92, 'vitamins')]
PMC5474873	6/2017	S0-PMC5474873	['sun exposure and psychotic experiences\n\nabstract:executive-summary\n\nobjective\nsun exposure IS CONSIDERED the single most IMPORTANT source of Vitamin D. Vitamin D deficiency HAS BEEN SUGGESTED to play a ROLE in the etiology of psychotic disorders.']	[('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 121), ('INCOMPLETE_EVIDENCE', 173), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 202)]	5	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 152, 'Vitamin D')]
PMC5474873	6/2017	S15-PMC5474873	['OF PARTICULAR INTEREST is ACCUMULATING EVIDENCE for the ROLE of Vitamin D in the Brain (5,6).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 56)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000955', 'brain', 81, 'brain')]
PMC5474873	6/2017	S16-PMC5474873	['Animal studies HAVE SHOWN that deficiency of Prenatal Vitamin D is ASSOCIATED with persistent changes in Adult Brain structure, neurochemistry, and behavior (5,7).']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('GO_0007565', 'female pregnancy', 45, 'prenatal'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0007023', 'adult organism', 105, 'adult'), ('UBERON_0000955', 'brain', 111, 'brain')]
PMC5474873	6/2017	S17-PMC5474873	['EVIDENCE now LINKS low Vitamin D levels with reduced Cognitive performance (8), INCREASED RISK for cancer, diabetes, Cardiovascular disease, and premature death (9,10).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 80)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0050890', 'cognition', 53, 'cognitive'), ('UBERON_0004535', 'cardiovascular system', 117, 'cardiovascular')]
PMC5474873	6/2017	S22-PMC5474873	['moreover, it HAS BEEN ARGUED that prolonged exposure CAN break down Vitamin D, reducing health BENEFITS and increasing risk of skin cancer (13).']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 53), ('IMPORTANT_CONSIDERATION', 95)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5474873	6/2017	S25-PMC5474873	['reviewed seven STUDIES on Vitamin D and psychosis and CONCLUDED that Individuals with psychosis showed lower Vitamin D levels than healthy controls (16), and a COMPREHENSIVE meta-analysis of observation studies SUGGESTED a strong RELATIONSHIP between Vitamin D deficiency and schizophrenia (17) Vitamin D HAS BEEN FOUND to Modulate Dopamine Neurotransmission (5), and SEVERAL STUDIES REPORTED an ASSOCIATION between early Life Vitamin D deficiency and later psychotic disorder.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 160), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 230), ('INCOMPLETE_EVIDENCE', 305), ('INCOMPLETE_EVIDENCE', 368), ('INCOMPLETE_EVIDENCE', 384), ('SUPERFICIAL_RELATIONSHIP', 396)]	9	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('NCBITaxon_1', 'root', 69, 'individuals'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 295, 'Vitamin D'), ('GO_0065007', 'biological regulation', 323, 'modulate'), ('CHEBI_18243', 'dopamine', 332, 'dopamine'), ('GO_0061527', 'dopamine secretion, neurotransmission', 332, 'dopamine neurotransmission'), ('UBERON_0000104', 'life cycle', 422, 'life'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D')]
PMC5474873	6/2017	S27-PMC5474873	['mcgrath and colleagues REPORTED that “both low and high concentrations of neonatal Vitamin D were ASSOCIATED with INCREASED RISK of schizophrenia.” SIMILARLY, absence of supplementation with Vitamin d before the age of one was FOUND TO BE ASSOCIATED with later schizophrenia in males (19).']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 98), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 148), ('ANOMALY_CURIOUS_FINDING', 227), ('SUPERFICIAL_RELATIONSHIP', 239)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 191, 'vitamin')]
PMC5474873	6/2017	S29-PMC5474873	['WHILE there are MANY STUDIES reporting the ASSOCIATION between Vitamin D levels in the Blood samples (18,19), there is STILL a LACK OF STUDIES on sun exposure, the main source of Vitamin D in most countries.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 43), ('IMPORTANT_CONSIDERATION', 119), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 127)]	6	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC5474873	6/2017	S32-PMC5474873	['THUS, the ASSOCIATION between Vitamin D, sun exposure, and psychosis REMAINS DEBATED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC5474873	6/2017	S40-PMC5474873	['given the LIMITED RESEARCH, the AIM of THIS STUDY is TO INVESTIGATE the ASSOCIATION between Adult Life sun exposure (AS a PROXY for Vitamin D status) and later pes.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 72), ('PROBABLE_UNDERSTANDING', 117), ('SUPERFICIAL_RELATIONSHIP', 122)]	7	[('UBERON_0000113', 'post-juvenile adult stage', 92, 'adult life'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5474873	6/2017	S138-PMC5474873	['discussion\nin the nordic countries, as elsewhere, sun exposure is by far the most IMPORTANT source of Vitamin D. in a population-based cohort of over 30,000 women, we FOUND an ASSOCIATION between cumulative measures of sun exposure at ages 10–39\u2009years and positive pes later in Life.']	[('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0000104', 'life cycle', 278, 'life')]
PMC5474873	6/2017	S140-PMC5474873	['the u-shaped ASSOCIATION is CONSISTENT with PREVIOUS STUDIES on Vitamin D and health outcomes (18).']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 44)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5474873	6/2017	S144-PMC5474873	['using the same cohort of women SHOWED that Vitamin D intake from the diet was statistically significantly ASSOCIATED with a decreased relative risk of both medium and high levels of psychotic symptoms (50).']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 106)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC5474873	6/2017	S145-PMC5474873	['the CONFLICTING FINDING of the PRESENT STUDY COULD POSSIBLY BE ATTRIBUTED to any of the following: (1) DIFFERENT measures were used as PROXIES for Vitamin D—the present study ONLY CONSIDERED the sun exposure variables (and not diet) as a main source for Vitamin D levels (9,13,14); (2) the FOCUS of the PRESENT STUDY was detailed assessment of the entire distribution of the cape scale WHEREAS hedelin et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 290), ('QUESTION_ANSWERED_BY_THIS_WORK', 303), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 386)]	13	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC5474873	6/2017	S151-PMC5474873	['SHOWED a j-shaped ASSOCIATION, with reduced risk for an intermediate Intake of Vitamin D (fish intake) (13).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 18)]	2	[('GO_0007631', 'feeding behavior', 69, 'intake'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5474873	6/2017	S161-PMC5474873	['we had NO biological DATA on Vitamin D levels, which COULD have established a clear LINK to Vitamin D, ALTHOUGH it is WELL KNOWN that sun exposure is the MOST IMPORTANT DETERMINANT of Vitamin D status (9,13).']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 84), ('ANOMALY_CURIOUS_FINDING', 103), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 154), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 169)]	8	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5474873	6/2017	S170-PMC5474873	['another LIMITATION is that there is ONLY a SMALL NUMBER of published studies reporting the ASSOCIATION between questionnaires-based sun exposure and Vitamin D. for example, glanz et al.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC5474873	6/2017	S172-PMC5474873	['FOUND that questionnaire-based reports of sun exposure was CONSIDERED a strong PREDICTOR of Vitamin D (51).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 79)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC5474873	6/2017	S173-PMC5474873	['the same study FURTHER REPORTED that “staying at more southern latitudes during the previous summer was also positively ASSOCIATED with Vitamin D in the Blood” (51) (sun exposure self-reports included in the present study consist of questions related to time spent on sunny holidays in southern latitudes).']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 120)]	3	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0000178', 'blood', 153, 'blood')]
PMC5474873	6/2017	S185-PMC5474873	['PREVIOUS STUDIES HAVE REPORTED ASSOCIATIONS between Vitamin D and INCREASED RISK for health PROBLEMS, such as schizophrenia, as well as clinical symptoms in patients with mental health problems.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 66), ('IMPORTANT_CONSIDERATION', 92)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC5474873	6/2017	S186-PMC5474873	['HOWEVER, there is a LACK OF PREVIOUS STUDIES on HOW sun exposure, the main source of Vitamin D, INFLUENCES psychotic experiences in the general population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 28), ('EXPLICIT_QUESTION', 48), ('SUPERFICIAL_RELATIONSHIP', 96)]	5	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5489519	6/2017	S2-PMC5489519	['WHILE Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (Trail) HAS BEEN IMPLICATED in Cellular growth/Apoptosis, Immune Cell function and Bone-Resorbing Osteoclast formation, the Expression of Trail in Human milk as a function of Vitamin D status in mothers REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 79), ('FULL_UNKNOWN', 265)]	4	[('PR_000000035', 'BMP receptor type-1A', 6, 'tumor necrosis factor-related apoptosis inducing ligand'), ('GO_0006915', 'apoptotic process', 36, 'apoptosis'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 63, 'TRAIL'), ('GO_0006915', 'apoptotic process', 93, 'cellular ... apoptosis'), ('CL_0000738', 'leukocyte', 120, 'immune cell'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('GO_0046849', 'bone remodeling', 145, 'bone-resorbing'), ('CL_0000092', 'osteoclast', 160, 'osteoclast'), ('GO_0010467', 'gene expression', 186, 'expression'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 200, 'TRAIL'), ('NCBITaxon_9606', 'Homo sapiens', 209, 'human'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC5489519	6/2017	S3-PMC5489519	['we HYPOTHESIZED that Vitamin D deficiency alters Trail protein levels in Human Breast Milk and Mammary Epithelial Cells.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 49, 'TRAIL'), ('NCBITaxon_9606', 'Homo sapiens', 73, 'human'), ('UBERON_0001348', 'brown adipose tissue', 79, 'breast milk'), ('CL_0002327', 'mammary gland epithelial cell', 95, 'mammary epithelial cells'), ('UBERON_0006954', 'mammary gland myoepithelium', 95, 'mammary epithelial')]
PMC5489519	6/2017	S5-PMC5489519	['western blot analysis of total cell lysate obtained from normal Human Mammary Epithelial (Hme-1) Cells treated with variable doses (0–20\u2009nm) of Vitamin D for 24\u2009h DEMONSTRATED that low levels (0.5 to 5\u2009nm) significantly increased the Trail Α BUT no change in β Expression.']	[('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 242)]	2	[('NCBITaxon_9606', 'Homo sapiens', 64, 'human'), ('UBERON_0006954', 'mammary gland myoepithelium', 70, 'mammary epithelial'), ('CL_0002295', 'type-6 epithelial cell of thymus', 78, 'epithelial         cells'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 234, 'TRAIL α'), ('GO_0010467', 'gene expression', 261, 'expression')]
PMC5489519	6/2017	S8-PMC5489519	['our results INDICATE that Vitamin D status in mothers Modulates Trail Expression in Breast Milk, which MAY have IMPLICATIONS for both mother and infant health.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 103), ('IMPORTANT_CONSIDERATION', 112)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0065007', 'biological regulation', 54, 'modulates'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 64, 'TRAIL'), ('GO_0010467', 'gene expression', 70, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 84, 'breast milk')]
PMC5489519	6/2017	S10-PMC5489519	['it HAS BEEN SHOWN that Vitamin D Regulates Calcium Uptake, Bone Homeostasis, Mammalian Cell Growth and Division.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0065007', 'biological regulation', 33, 'regulates'), ('GO_0070509', 'calcium ion import', 43, 'calcium uptake'), ('GO_0055064', 'chloride ion homeostasis', 59, 'bone homeostasis'), ('NCBITaxon_40674', 'Mammalia', 77, 'mammalian'), ('GO_0001775', 'cell activation', 87, 'cell growth ... division')]
PMC5489519	6/2017	S15-PMC5489519	['it HAS BEEN REPORTED that Vitamin D is INVOLVED in Mammary Gland Development and Lactation11.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 39)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0060611', 'mammary gland fat development', 51, 'mammary gland development'), ('UBERON_0001911', 'mammary gland', 51, 'mammary gland'), ('GO_0007595', 'lactation', 81, 'lactation11')]
PMC5489519	6/2017	S16-PMC5489519	['studies have SUGGESTED that the Vitamin D status of mother DETERMINES the Vitamin D levels of breastfeeding infant12–14.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5489519	6/2017	S17-PMC5489519	['evidently, randomized controlled clinical trials INDICATED the beneficial ROLE of maternal Vitamin D supplementation on the Vitamin D status of breastfed infants14,15.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC5489519	6/2017	S19-PMC5489519	['it HAS BEEN REPORTED that infants of Vitamin D deficient mothers are PRONE to develop rickets17.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 69)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5489519	6/2017	S26-PMC5489519	['SIMILAR to Vitamin D, Trail HAS BEEN SHOWN to Regulate Immune Cell functions, Bone Remodeling and Cell Growth/Differentiation20,22.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 22, 'TRAIL'), ('GO_0065007', 'biological regulation', 46, 'regulate'), ('CL_0000738', 'leukocyte', 55, 'immune cell'), ('UBERON_0002405', 'immune system', 55, 'immune'), ('GO_0046849', 'bone remodeling', 78, 'bone remodeling'), ('GO_0034614', 'cellular response to reactive oxygen species', 98, 'cell growth ... differentiation20')]
PMC5489519	6/2017	S28-PMC5489519	['THEREFORE, we HYPOTHESIZE that Vitamin D deficiency in mothers alters Trail Expression in Breast Milk.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 70, 'TRAIL'), ('GO_0010467', 'gene expression', 76, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 90, 'breast milk')]
PMC5489519	6/2017	S29-PMC5489519	['in THIS STUDY, we IDENTIFIED that Milk samples collected from Vitamin D deficient mothers contain elevated levels of Trail compared TO the Vitamin D replete group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 132)]	3	[('UBERON_0001913', 'milk', 34, 'milk'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 117, 'TRAIL'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5489519	6/2017	S30-PMC5489519	['furthermore, our experiments REVEALED that Vitamin D levels differentially Regulates Trail Isoform Expression in Mammary Epithelial Cells in vitro .']	[('INCOMPLETE_EVIDENCE', 29)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0065007', 'biological regulation', 75, 'regulates'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 85, 'TRAIL'), ('SO_0001060', 'sequence_variant', 91, 'isoform'), ('GO_0010467', 'gene expression', 99, 'expression'), ('CL_0002327', 'mammary gland epithelial cell', 113, 'mammary epithelial cells'), ('UBERON_0006954', 'mammary gland myoepithelium', 113, 'mammary epithelial')]
PMC5489519	6/2017	S31-PMC5489519	['results\n\nVitamin D deficiency in mothers increases Trail Expression in Breast Milk\nphysiologic levels of Vitamin D HAS BEEN IMPLICATED as an IMPORTANT stimulant for Innate Immunity and Bone Remodeling.']	[('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 124), ('IMPORTANT_CONSIDERATION', 141)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 51, 'TRAIL'), ('GO_0010467', 'gene expression', 57, 'expression'), ('UBERON_0000310', 'breast', 71, 'breast'), ('UBERON_0001913', 'milk', 78, 'milk'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0045087', 'innate immune response', 165, 'innate immunity'), ('GO_0046849', 'bone remodeling', 185, 'bone remodeling')]
PMC5489519	6/2017	S37-PMC5489519	['measurement of total circulating 25(Oh)D concentrations IDENTIFIED seven samples with normal range (>30\u2009ng/ml) and THEREFORE considered Vitamin D-sufficient group.']	[('INCOMPLETE_EVIDENCE', 56), ('PROBABLE_UNDERSTANDING', 115)]	2	[('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 33, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5489519	6/2017	S42-PMC5489519	['2a–c, we IDENTIFIED Trail Α Expression in all the Milk samples obtained from Vitamin D sufficient mother group.']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('PR_000001683', 'vasopressin V2 receptor', 20, 'TRAIL α'), ('GO_0010467', 'gene expression', 28, 'expression'), ('UBERON_0001913', 'milk', 50, 'milk'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC5489519	6/2017	S46-PMC5489519	['these results SUGGEST that Vitamin D status in mothers Modulate Trail Expression levels in Human Breast Milk.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 55, 'modulate'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 64, 'TRAIL'), ('GO_0010467', 'gene expression', 70, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 91, 'human'), ('UBERON_0000310', 'breast', 97, 'breast'), ('UBERON_0001913', 'milk', 104, 'milk')]
PMC5489519	6/2017	S71-PMC5489519	['these results INDICATE that the active form of Vitamin D Regulates Trail Expression in normal Human Breast Epithelial Cells.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0065007', 'biological regulation', 57, 'regulates'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 67, 'TRAIL'), ('GO_0010467', 'gene expression', 73, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 94, 'human'), ('CL_0002327', 'mammary gland epithelial cell', 100, 'breast epithelial cells'), ('UBERON_0008367', 'breast epithelium', 100, 'breast epithelial')]
PMC5489519	6/2017	S84-PMC5489519	['discussion\nTHIS STUDY DEMONSTRATED that Breast Milk from Vitamin D deficient mothers contains high levels of Trail (Α and β) proteins compared to sufficient mother group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 22)]	3	[('UBERON_0001348', 'brown adipose tissue', 40, 'breast milk'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 109, 'TRAIL'), ('PR_000006000', 'carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2', 116, 'α')]
PMC5489519	6/2017	S85-PMC5489519	['further, we IDENTIFIED that low doses of the active form of Vitamin D (0.5 to 5\u2009nm) treatment to hme-1 cells increased the Trail Α but no change in β Expression.']	[('INCOMPLETE_EVIDENCE', 12)]	1	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 123, 'TRAIL α'), ('GO_0010467', 'gene expression', 150, 'expression')]
PMC5489519	6/2017	S87-PMC5489519	['THEREFORE, our results INDICATE that Trail\xa0is Expressed in Breast Milk as a FUNCTION of Vitamin D status in mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 37, 'TRAIL'), ('GO_0010467', 'gene expression', 46, 'expressed'), ('UBERON_0001348', 'brown adipose tissue', 59, 'breast milk'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5489519	6/2017	S89-PMC5489519	['Vitamin D supplementation of mothers results in Vitamin D sufficiency in Breast-Fed infants13, THUS POTENTIALLY Modulating the Immune signature of maternal Breast Milk to her recipient infant.']	[('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0000310', 'breast', 73, 'breast'), ('GO_0007631', 'feeding behavior', 80, 'fed'), ('GO_0065007', 'biological regulation', 112, 'modulating'), ('UBERON_0002405', 'immune system', 127, 'immune'), ('UBERON_0001348', 'brown adipose tissue', 156, 'breast milk')]
PMC5489519	6/2017	S91-PMC5489519	['THUS, OUR FINDINGS that Vitamin D is ASSOCIATED with altered Trail Expression in Breast Milk MAY BE an IMPORTANT LINK to the mother and infant Immune System.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 93), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 113)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 61, 'TRAIL'), ('GO_0010467', 'gene expression', 67, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 81, 'breast milk'), ('UBERON_0002405', 'immune system', 143, 'immune system')]
PMC5489519	6/2017	S92-PMC5489519	['evidence SUGGESTS that Vitamin D deficiency COULD BE carcinogenic to the Brains of offspring in Mouse MODEL30.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 102)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0000955', 'brain', 73, 'brains'), ('NCBITaxon_10088', 'Mus <genus>', 96, 'mouse')]
PMC5489519	6/2017	S94-PMC5489519	['SINCE there is no Trail toxicity demonstrated in vitro and in vivo treatment32,33, IT IS POSSIBLE that Trail Expression in the milk of mothers with Vitamin D deficiency COULD BE a compensatory mechanism to PROTECT infant health.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 206)]	4	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 18, 'TRAIL'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 103, 'TRAIL'), ('GO_0010467', 'gene expression', 109, 'expression'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC5489519	6/2017	S95-PMC5489519	['the functional ROLE of Vitamin D in fetus and infant’s Bone Development has been PREVIOUSLY demonstrated.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 81)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0048539', 'bone marrow development', 55, 'bone development')]
PMC5489519	6/2017	S97-PMC5489519	['mother-offspring group studies HAVE SHOWN that maternal Vitamin D insufficiency LEADS to reduced bone mass during childhood35,36.']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC5489519	6/2017	S99-PMC5489519	['THEREFORE, elevated levels of Trail Expression due to Vitamin D deficiency MAY have a significant IMPACT on both mother and infant bone Growth/Development.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 98)]	3	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 30, 'TRAIL'), ('GO_0010467', 'gene expression', 36, 'expression'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0040007', 'growth', 136, 'growth'), ('GO_0008289', 'lipid binding', 143, 'development')]
PMC5489519	6/2017	S103-PMC5489519	['PREVIOUSLY, it HAS BEEN SHOWN that Vitamin D deficiency during Pregnancy increases genotoxic RISKS in newborns40.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 93)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy')]
PMC5489519	6/2017	S106-PMC5489519	['this evidence SUGGESTS that Vitamin D and Trail Expression in Mammalian cells play a MAJOR ROLE in both mother and infant Immune health.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 85), ('SUPERFICIAL_RELATIONSHIP', 91)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 42, 'TRAIL'), ('GO_0010467', 'gene expression', 48, 'expression'), ('NCBITaxon_40674', 'Mammalia', 62, 'mammalian'), ('UBERON_0002405', 'immune system', 122, 'immune')]
PMC5489519	6/2017	S107-PMC5489519	['THEREFORE, specific modulators of the Trail Signaling axis and Vitamin D analogs MAY lead to the development of randomized clinical trials to rescue from the consequences of Vitamin D deficiency in both mother and infant.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 81)]	2	[('GO_0038008', 'TRAF-mediated signal transduction', 38, 'TRAIL signaling'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 38, 'TRAIL'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC5489519	6/2017	S108-PMC5489519	['also, these studies MAY have IMPLICATIONS regarding Vitamin D supplemention during Lactation.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 29)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007595', 'lactation', 83, 'lactation')]
PMC5489519	6/2017	S112-PMC5489519	['THEREFORE, IT IS POSSIBLE that elevated levels of Trail INFLUENCE Vitamin D Metabolism in Mammary Epithelial Cells45.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 50, 'TRAIL'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 66, 'vitamin D metabolism'), ('CL_0002327', 'mammary gland epithelial cell', 90, 'mammary epithelial cells45'), ('UBERON_0006954', 'mammary gland myoepithelium', 90, 'mammary epithelial')]
PMC5489519	6/2017	S113-PMC5489519	['high dose Vitamin D decreased Trail Expression COMPARED TO basal levels, SUGGESTING that low levels of Vitamin D MAY BE REQUIRED to stimulate Trail Expression in Mammary Epithelial Cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 113), ('IMPORTANT_CONSIDERATION', 120)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 30, 'TRAIL'), ('GO_0010467', 'gene expression', 36, 'expression'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 142, 'TRAIL'), ('GO_0010467', 'gene expression', 148, 'expression'), ('CL_0002327', 'mammary gland epithelial cell', 162, 'mammary epithelial cells'), ('UBERON_0006954', 'mammary gland myoepithelium', 162, 'mammary epithelial')]
PMC5489519	6/2017	S114-PMC5489519	['it is LIKELY that the down-regulation of the Trail-Α and β in response to high doses (>20\u2009nm) of Vitamin D COULD BE a compensatory mechanism to protect the Mammary Cells.']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 107)]	2	[('PR_000001719', 'transient receptor potential cation channel TRPM8', 45, 'TRAIL-α'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CL_0002325', 'mammary alveolar cell', 156, 'mammary cells'), ('UBERON_0002391', 'lymph', 156, 'mammary')]
PMC5489519	6/2017	S115-PMC5489519	['THUS, our results SUGGEST that the Vitamin D modulation of Trail expression in Mammary Epithelial Cells MAY CONTRIBUTE to Trail protein levels in Human Milk, which MAY have IMPLICATIONS for both mother and infant health under Vitamin D deficient and sufficient conditions.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 173)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 59, 'TRAIL'), ('CL_0002327', 'mammary gland epithelial cell', 79, 'mammary epithelial cells'), ('UBERON_0006954', 'mammary gland myoepithelium', 79, 'mammary epithelial'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 122, 'TRAIL'), ('NCBITaxon_9606', 'Homo sapiens', 146, 'human'), ('UBERON_0001913', 'milk', 152, 'milk'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC5510234	7/2017	S72-PMC5510234	['(1994) FOUND a statistically significant CORRELATION between Vitamin A deficiency and mtct rates in 338 hiv-infected women in malawi, SPECULATING that Vitamin A deficiency MAY compromise the Epithelial integrity of Tissues in the Vaginal Mucosa and Mammary Glands.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 134), ('INCOMPLETE_EVIDENCE', 172)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin A'), ('UBERON_0000483', 'epithelium', 191, 'epithelial'), ('UBERON_0000479', 'tissue', 215, 'tissues'), ('UBERON_0004983', 'mucosa of vagina', 230, 'vaginal mucosa'), ('UBERON_0001911', 'mammary gland', 249, 'mammary glands')]
PMC5510234	7/2017	S73-PMC5510234	['this finding SUGGESTS then a LINK between Vitamin A deficiency and an INCREASED RISK of infant exposure to hiv during Vaginal Delivery.48,57later on, this was NOT CONFIRMED by other studies from the developped countries.61,62a cochrane review on Vitamin A supplementation and mtct of hiv was published in 2011, by wiysonge et al .']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin A'), ('UBERON_0001987', 'placenta', 118, 'vaginal'), ('GO_0007567', 'parturition', 126, 'delivery'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin A')]
PMC5510234	7/2017	S78-PMC5510234	['the authors REPORTED that EVEN in regions where Vitamin A deficiency is a PUBLIC HEALTH CONCERN, Vitamin A supplementation for PREVENTION of Prenatal mtct is not RECOMMENDED.58finally a RECENT REVIEW done on the vitamin a supplementation for the reduction of the RISK of mother-to-child transmission of hiv, REPORTED that early observational studies FOUND an ASSOCIATION between Vitamin A deficiency and increased rates of mtct of hiv.']	[('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 26), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 127), ('FUTURE_WORK', 162), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 263), ('INCOMPLETE_EVIDENCE', 308), ('INCOMPLETE_EVIDENCE', 350), ('SUPERFICIAL_RELATIONSHIP', 359)]	10	[('CHEBI_27300', 'vitamin D', 48, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0007565', 'female pregnancy', 141, 'prenatal'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin A')]
PMC5510234	7/2017	S79-PMC5510234	['HOWEVER, another DID NOT FIND a benefit for Vitamin A in decreasing mtct rates.59\nlow maternal Vitamin D level (<32 ng/ml) HAS BEEN SHOWN to be ASSOCIATED with a 50% higher risk of mtct of hiv at 6 weeks in tanzanian women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 144)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5513133	7/2017	S0-PMC5513133	['the ROLE of Vitamin D in pre-eclampsia: a systematic review\n\nabstract\n\nbackground\nthe etiology of pre-eclampsia (pe) is not YET FULLY UNDERSTOOD, THOUGH CURRENT LITERATURE INDICATES an upregulation of Inflammatory Mediators produced by the Placenta AS a POTENTIAL causal mechanism.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 146), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 172), ('PROBABLE_UNDERSTANDING', 249), ('INCOMPLETE_EVIDENCE', 254)]	7	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_64668', 'geranylgeranyl-chlorophyll a', 201, 'inflammatory mediators'), ('UBERON_0001987', 'placenta', 240, 'placenta')]
PMC5513133	7/2017	S4-PMC5513133	['these sources were retrieved, collected, indexed, and ASSESSED for availability of Pregnancy-related data on pe and Vitamin D.\n\nresults\nseveral case-control studies and cross-sectional studies HAVE SHOWN an ASSOCIATION between Vitamin D status and pe, ALTHOUGH EVIDENCE HAS BEEN INCONSISTENT.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 279)]	7	[('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC5513133	7/2017	S5-PMC5513133	['clinical trials TO DATE HAVE BEEN unable to show an INDEPENDENT EFFECT of Vitamin D supplementation in PREVENTING pe.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 64), ('SUPERFICIAL_RELATIONSHIP', 103)]	5	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5513133	7/2017	S6-PMC5513133	['conclusions\nthe included clinical trials do not show an independent effect of Vitamin D supplementation in PREVENTING pe; HOWEVER, ISSUES with dose, timing, and duration of supplementation HAVE NOT BEEN COMPLETELY ADDRESSED.']	[('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('PROBLEM_COMPLICATION', 131), ('IMPORTANT_CONSIDERATION', 189), ('INCOMPLETE_EVIDENCE', 194)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5513133	7/2017	S30-PMC5513133	['WHILE the pathogenesis of pe INVOLVES a number of biological Processes, there are several HYPOTHESES to SUGGEST HOW Vitamin D levels MAY AFFECT these processes (table1).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('INCOMPLETE_EVIDENCE', 104), ('EXPLICIT_QUESTION', 112), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 137)]	7	[('GO_0007565', 'female pregnancy', 61, 'processes'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5513133	7/2017	S32-PMC5513133	['caption (table-wrap): table 1\n\nsummary of effects of increased Vitamin D on the pathogenesis of pre-eclampsia (pe)stage of pecharacteristic of pe↑ Vitamin dstage 1inflammation-linked abnormal Placental Implantation↓ predisposition to pro-inflammatory response [20]↑ Regulation of Genes associated with Placental invasion and normal Implantation [20]stage 2vascular Endothelial dysfunction↑ Vascular structure, elasticity and Intima-Media thickness↓ Blood pressure (Regulation of Renin-angiotension system) [63]↓oxidative stress [24]proteinuria mediated by Renal Vascular Endothelial Growth Factor (Vegf)↑ Vascular Smooth Muscle Cell Proliferation by increasing vegf Gene transcription [19]\n\nbiological PLAUSIBILITY of the ROLE of Vitamin D in pe\nVitamin D3, or Cholecalciferol, is formed endogenously when 7-Dehydrocholesterol in Keratinocytes is converted to a seco-Steroid pro-hormone upon irradiation by uv-b light.']	[('INCOMPLETE_EVIDENCE', 702), ('PROBABLE_UNDERSTANDING', 702), ('SUPERFICIAL_RELATIONSHIP', 722)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 147, 'Vitamin'), ('UBERON_0001987', 'placenta', 192, 'placental'), ('GO_0007566', 'embryo implantation', 202, 'implantation'), ('GO_0007567', 'parturition', 214, '↓'), ('GO_0065007', 'biological regulation', 266, 'Regulation'), ('SO_0000704', 'gene', 280, 'genes'), ('UBERON_0001987', 'placenta', 302, 'placental'), ('GO_0007566', 'embryo implantation', 332, 'implantation'), ('UBERON_0001986', 'endothelium', 365, 'Endothelial'), ('GO_0031674', 'I band', 390, 'Vascular'), ('GO_0005622', 'intracellular anatomical structure', 425, 'intima'), ('UBERON_0009472', 'axilla', 425, 'intima'), ('UBERON_0000951', 'rotator muscle of the vertebral column', 432, 'media'), ('UBERON_0000178', 'blood', 449, 'Blood'), ('GO_0065007', 'biological regulation', 465, 'regulation'), ('PR_000014368', 'RuvB-like 1', 479, 'renin'), ('UBERON_0002113', 'kidney', 556, 'renal'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 562, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 571, 'endothelial'), ('PR_000017279', 'testis-specific basic protein Y 1', 598, 'VEGF'), ('CL_0000359', 'vascular associated smooth muscle cell', 605, 'Vascular smooth muscle cell'), ('UBERON_0006849', 'scapula', 605, 'Vascular'), ('UBERON_0001135', 'smooth muscle tissue', 614, 'smooth muscle'), ('GO_0007601', 'visual perception', 621, 'muscle'), ('GO_0008283', 'cell proliferation', 628, 'cell proliferation'), ('SO_0000704', 'gene', 666, 'gene'), ('CHEBI_27300', 'vitamin D', 730, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 746, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 746, 'Vitamin D3'), ('CHEBI_52550', 'theopalauamide', 761, 'cholecalciferol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 806, '7-dehydrocholesterol'), ('CL_0000312', 'keratinocyte', 830, 'keratinocytes'), ('CHEBI_35341', 'steroid', 867, 'steroid')]
PMC5513133	7/2017	S44-PMC5513133	['african american women of Reproductive age HAVE BEEN FOUND TO BE at PARTICULARLY high RISK for Vitamin D deficiency in the united states [18].']	[('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 59), ('ANOMALY_CURIOUS_FINDING', 68), ('IMPORTANT_CONSIDERATION', 86)]	4	[('GO_0000003', 'reproduction', 26, 'reproductive'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5513133	7/2017	S45-PMC5513133	['clothing with minimal skin exposure [38,39], increased urbanization, skin pigmentation [40], and Vegetarian diets [35] are all BELIEVED to have contributed to a Vitamin D deficiency EPIDEMIC worldwide.']	[('INCOMPLETE_EVIDENCE', 127), ('IMPORTANT_CONSIDERATION', 182)]	2	[('NCBITaxon_7955', 'Danio rerio', 97, 'vegetarian'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC5513133	7/2017	S46-PMC5513133	['during the course of Pregnancy, EVIDENCE from observational studies SHOWS DIVERGENT data on the concentration of Serum 25(Oh)D levels in different Trimesters of Pregnancy, with EITHER decline [41], increase [42], or absence of change in Vitamin D levels with progression [43,44].']	[('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 177)]	4	[('GO_0007565', 'female pregnancy', 21, 'pregnancy'), ('UBERON_0001977', 'blood serum', 113, 'serum'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 119, '25(OH)D'), ('GO_0043033', 'isoamylase complex', 147, 'trimesters'), ('GO_0007565', 'female pregnancy', 161, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC5513133	7/2017	S47-PMC5513133	['it is PLAUSIBLE that a deficiency in Vitamin D and its downstream products CAN play a ROLE in the etiology of pe.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5513133	7/2017	S53-PMC5513133	['role of Vitamin D as an Anti-Inflammatory Agent and Immune modulator\nVitamin D IS THOUGHT TO play a significant ROLE in pe as an Immune modulator [20,50].']	[('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 112)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_67079', 'anti-inflammatory agent', 24, 'anti-inflammatory agent'), ('UBERON_0002405', 'immune system', 52, 'immune'), ('CHEBI_28384', 'vitamin K', 69, 'Vitamin D'), ('UBERON_0002405', 'immune system', 129, 'immune')]
PMC5513133	7/2017	S64-PMC5513133	['in addition to down-regulating the release of anti-Angiogenic factors, Vitamin D HAS BEEN SHOWN to promote Angiogenesis in Endothelial Progenitor Cells, by POSSIBLY increasing vegf Expression and pro-Matrix metalloproteinase (pro-Mmp-2) activity [55].']	[('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 156)]	2	[('GO_0001525', 'angiogenesis', 51, 'angiogenic'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0001525', 'angiogenesis', 107, 'angiogenesis'), ('CL_0000513', 'cardiac muscle myoblast', 123, 'endothelial progenitor cells'), ('UBERON_0001986', 'endothelium', 123, 'endothelial'), ('GO_0010467', 'gene expression', 181, 'expression'), ('GO_0031012', 'extracellular matrix', 200, 'matrix'), ('PR_000010479', '72 kDa type IV collagenase', 230, 'MMP-2')]
PMC5513133	7/2017	S70-PMC5513133	['FOUND that the EFFECT of 1,25(Oh)2D on Vsmc Proliferation is MEDIATED by increased vegf Expression, WHILE others FIND no relation between Vitamin D and pro-Angiogenic factors [15].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_82784', 'PVP38-Ag NP', 25, '1,25(OH)2D'), ('CL_0000359', 'vascular associated smooth muscle cell', 39, 'VSMC'), ('GO_0008283', 'cell proliferation', 44, 'proliferation'), ('GO_0010467', 'gene expression', 88, 'expression'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0001525', 'angiogenesis', 156, 'angiogenic')]
PMC5513133	7/2017	S71-PMC5513133	['there is currently NOT enough data to strongly SUPPORT the HYPOTHESIS that impaired Angiogenesis EXPLAINS the ASSOCIATION between Vitamin D deficiency and pe [60].']	[('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 59), ('PROBABLE_UNDERSTANDING', 97), ('SUPERFICIAL_RELATIONSHIP', 110)]	5	[('GO_0001525', 'angiogenesis', 84, 'angiogenesis'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5513133	7/2017	S72-PMC5513133	['role of Vitamin D and Blood Pressure Regulation\nan inverse RELATIONSHIP between Plasma 1,25(Oh)2D and Plasma Renin activity HAS BEEN OBSERVED.']	[('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 133)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0000178', 'blood', 22, 'blood'), ('GO_0060208', 'proestrus', 28, 'pressure'), ('GO_0065007', 'biological regulation', 37, 'regulation'), ('UBERON_0001969', 'blood plasma', 80, 'plasma'), ('CHEBI_82784', 'PVP38-Ag NP', 87, '1,25(OH)2D'), ('UBERON_0001969', 'blood plasma', 102, 'plasma'), ('PR_000014368', 'RuvB-like 1', 109, 'renin')]
PMC5513133	7/2017	S77-PMC5513133	['Vitamin D Metabolites MAY suppress Renin Gene transcription by a Vitamin D receptor (vdr) dependent pathway [65] or reduce Autoantibodies to the angiotensin ii type i receptor [64].']	[('INCOMPLETE_EVIDENCE', 22)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_25212', 'metabolite', 10, 'metabolites'), ('PR_000014368', 'RuvB-like 1', 35, 'renin'), ('SO_0000704', 'gene', 41, 'gene'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0044308', 'axonal spine', 123, 'autoantibodies')]
PMC5513133	7/2017	S87-PMC5513133	['it is also OBSERVED that calcium sufficiency MAY occur INDEPENDENTLY of Vitamin D sufficiency.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5513133	7/2017	S91-PMC5513133	['given the ROLE of Vitamin D in Modulation of inflammation and Immune function, Placental Implantation, Angiogenesis and adverse Birth outcomes such as low Birth weight and sga, we EXAMINED the EVIDENCE that Vitamin D MAY play a ROLE in the etiology and PREVENTION of pe in this manuscript.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 180), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 217), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 253)]	6	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0065007', 'biological regulation', 31, 'modulation'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('GO_0007565', 'female pregnancy', 79, 'placental'), ('UBERON_0001987', 'placenta', 79, 'placental'), ('GO_0007566', 'embryo implantation', 89, 'implantation'), ('GO_0001525', 'angiogenesis', 103, 'angiogenesis'), ('GO_0007567', 'parturition', 128, 'birth'), ('GO_0007567', 'parturition', 155, 'birth'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5513133	7/2017	S116-PMC5513133	['EVIDENCE to SUPPORT the ROLE of Vitamin D in pe\nSEVERAL cohort and case control studies measuring Vitamin D before the development of pe SHOW an ASSOCIATION between Vitamin D and pe (tables2and3).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 145)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
PMC5513133	7/2017	S117-PMC5513133	['in a large cohort study of 22 057 nulliparous women, no association was FOUND between Vitamin D intake from diet alone and the incidence of pe.']	[('INCOMPLETE_EVIDENCE', 72)]	1	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5513133	7/2017	S120-PMC5513133	['a LIMITATION of this study was that it was unable to adjust for Intake of Long Chain N-3 Fatty Acids, which CORRELATED with Vitamin D intake in a norwegian diet.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 108)]	2	[('GO_0007631', 'feeding behavior', 64, 'intake'), ('CHEBI_25098', 'lyxoside', 74, 'long chain n-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC5513133	7/2017	S121-PMC5513133	['another prospective cohort study of nulliparous women with singleton Pregnancies FOUND no significant association between Vitamin D deficiency in the 1st Trimester and risk for pe; HOWEVER, at 24–26\xa0weeks of Gestation mean maternal 25(Oh)D was significantly lower in women who developed pe COMPARED WITH those who did not ( p \xa0=\xa00.03) [60].']	[('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ANOMALY_CURIOUS_FINDING', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 290)]	4	[('GO_0007565', 'female pregnancy', 69, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 154, 'trimester'), ('GO_0007565', 'female pregnancy', 208, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 232, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 232, '25(OH ... D')]
PMC5513133	7/2017	S132-PMC5513133	['germany, 2–14 [85]↓ 25(Oh)D levels in pe in summer compared to controls, 1,25(Oh)2D ↓ only in winter25(Oh)D: pe:18.2\xa0±\xa017.1; control: 49.2\xa0±\xa029.2\xa0ng/ml, ( p \xa0<\xa00.001); 1,25(Oh)2D: 291\xa0±\xa0217 vs 612.3\xa0±\xa0455\xa0pmol/ml ( p \xa0<\xa00.05)mohaghegh et al., iran, 2015 [89]↓ mean 25(Oh)D in pe compared to Pregnant controls without pe25(Oh)D:Pe: 37.9\xa0±\xa033.9\xa0nmol/lcontrols: 58.2\xa0±\xa038.2\xa0nmol/l( p \xa0=\xa00.001)powe, usa, 2010 [86]↔ women with pe and controls with 25(Oh)D\xa0<\xa015.0\xa0nmol/ladjusted or: 1.3595% ci: 0.40 to 4.50robinson et al., usa, 2010 [25]↑ eospe in women with maternal 25(Oh)D levels <=19.6\xa0nmol/l compared to levels >19.6\xa0nmol/lor: 3.6095% ci: 1.71–7.58( p \xa0<\xa00.001)schneuer et al., australia, 2014 [114]↔ pe or eospe and low 25(Oh)D (< 25\xa0nmol/l)adjusted or- all pe: 0.4695% ci: 0.19–1.10adjusted or- eospe: 1.4095% ci: 0.20 to 9.89singla et al., india, 2015 [87]↓ mean Serum Vitamin D in women with pe vs controlspe: 24.2\xa0±\xa012.4\xa0nmol/l controls: 36.9\xa0±\xa016.7\xa0nmol/l;( p \xa0=\xa00.0001)ullah et al., bangladesh, 2013 [82]↑ pe per 25\xa0nmol/l decrease in 25(Oh)D leveladjusted or: 1.6695% ci: 1.05–3.02wetta et al., uk, 2013 [96]↔ between pe and 25-Oh D\xa0<\xa030\xa0ng/ml and <37.4\xa0nmol/l<30\xa0ng/ml adjusted or: 1.195% ci: 0.6–2.0adjusted or: 1.4 (<37.4\xa0nmol/l)95% ci: 0.7–3.0woodham et al., usa, 2011 [15]↓ severe pe in women with 10\xa0nmol/l increase in maternal 25(Oh)D leveladjusted or: 0.6295% ci: 0.51–0.76xu et al., usa, 2014 [53]↑ pe in women with Vitamin D deficiency (<37.5\xa0nmol/l)or: 4.495% ci: 1.8–10.8yu et al., uk, 2012 [115]↔ Serum Vitamin D raw values in pe and controls25(Oh)D levels: controls: 46.8\xa0nmol/l (27.8–70.0;)early pe: 32.2\xa0nmol/l (22.7–50.4); late pe: 39.2\xa0nmol/l (22.1–63.0) ( p \xa0=\xa00.231)alvarez-fernandez et al., spain, 2014 [90]↑ pe in women with 25(Oh)D levels <50\xa0nmol/l compared TO levels >50\xa0nmol/l after 20\xa0weeks of Gestationor: 4.695% ci:1.4–15( p \xa0=\xa00.010)scholl et al., usa, 2013 [78]↑ pe in women with 25(Oh)D\xa0<\xa049.9\xa0nmol/l and hyperparathyroidismadjusted or: 2.8695% ci: 1.28–6.41burris et al., usa, 2014 [94]↔ Pe and 25(Oh)D levels compared at each 25\xa0nmol/l increase in 25 (Oh)Dadjusted or: 1.1495% ci: 0.77–1.67haugen et al., norway, 2000 [77]↓ pe in women taking 10–15 mcg/d as compared with no supplementsadjusted or: 0.7395% ci: 0.58–0.92shand et al., canada, 2010 [37]↔ pe and 25(Oh)D levels <37.5\xa0nmol/ladjusted or: 0.9195% ci: 0.31–2.62wei et al., canda 2012 [60]↔ Pe and 25(Oh)D\xa0<\xa050\xa0nmol/ladjusted or: 1.2495% ci: 0.58–2.67( p \xa0=\xa00.58)wei, canada, 2013 [14]↑ pe and women with ↓ pigf levels and maternal 25(Oh)d\xa0<\xa050\xa0nmol/ladjusted or: 2.9795% ci: 1.23–7.20zhou, china, 2014 [116]↔ pe and 25(Oh)D levels25(Oh)D levelsgroup a ( n \xa0=\xa013): 41.4\xa0±\xa06.5\xa0nmol/l; group b ( n \xa0=\xa036): 62.1\xa0±\xa07.0\xa0nmol/l; group c ( n \xa0=\xa025): 89.6\xa0±\xa013.0\xa0nmol/l; ( p \xa0=\xa00.900)\na case-cohort study of women from 12 different united states (us) sites whose vitamin D levels were measured at ≤26\xa0weeks of Gestation SHOWED that 25(Oh)D levels greater than 50\xa0nmol/l were ASSOCIATED with a 40% reduction in risk for severe pe (0.65 [95% ci 0.43 to 0.98]), although there was no reduction in absolute and relative risk for the milder clinical subtypes of pe when 25(Oh)D levels were greater than 50\xa0nmol/l [79].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 1791), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2293), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2609), ('INCOMPLETE_EVIDENCE', 2914), ('SUPERFICIAL_RELATIONSHIP', 2969)]	5	[('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('CHEBI_73285', "3-iodo-4-aminobenzyl-5'-N-methylcarboxamidoadenosine", 75, '25(OH)2D ↓'), ('CHEBI_33010', 'chromide(1-)', 102, '(OH)D'), ('CHEBI_82784', 'PVP38-Ag NP', 168, '1,25(OH)2D'), ('CHEBI_71657', 'versiconol acetate', 265, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 265, '25'), ('PR_000011614', 'opioid growth factor receptor', 268, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 271, 'D'), ('GO_0007565', 'female pregnancy', 291, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 322, 'OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 327, 'PE'), ('CHEBI_71657', 'versiconol acetate', 444, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 444, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 566, '(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 725, 'OH)D'), ('UBERON_0001977', 'blood serum', 867, 'serum'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1043, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1043, '25(OH ... D'), ('CHEBI_72765', 'verruculogen', 1134, '25-OH D'), ('CHEBI_71657', 'versiconol acetate', 1343, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1343, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1434, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1519, 'serum'), ('CHEBI_27300', 'vitamin D', 1525, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 1566, '(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 1759, 'OH)D'), ('GO_0007565', 'female pregnancy', 1830, 'gestationOR'), ('CHEBI_71657', 'versiconol acetate', 1920, '25(OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 2030, 'PE'), ('CHEBI_71657', 'versiconol acetate', 2037, '25(OH)D'), ('CHEBI_982', '2-Aceto-2-hydroxybutanoate', 2091, '25 (OH)DAdjusted'), ('CHEBI_71657', 'versiconol acetate', 2303, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 2303, '25(OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 2393, 'PE'), ('CHEBI_71657', 'versiconol acetate', 2400, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 2534, '25(OH'), ('CHEBI_71657', 'versiconol acetate', 2619, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 2635, '(OH)D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 2865, 'D'), ('GO_0007565', 'female pregnancy', 2904, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 2926, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 3159, '25(OH)D')]
PMC5513133	7/2017	S135-PMC5513133	['another nested case control study of 225 women with singleton Pregnancies REPORTED an or of 5.41 for severe pe among women with mid-Gestation Vitamin D deficiency after controlling for multi-parity (95% ci: 2.02–14.52) compared to women with Vitamin D levels of at least 75\xa0nmol/l [80].']	[('INCOMPLETE_EVIDENCE', 74)]	1	[('GO_0007565', 'female pregnancy', 62, 'pregnancies'), ('GO_0007565', 'female pregnancy', 132, 'gestation'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D')]
PMC5513133	7/2017	S138-PMC5513133	['OBSERVATIONAL studies which measured Vitamin D status after the onset of pe [53,82] near Delivery [83] or at Delivery [84,85] SUGGEST an inverse ASSOCIATION with pe.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 145)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007567', 'parturition', 89, 'delivery'), ('GO_0007567', 'parturition', 109, 'delivery')]
PMC5513133	7/2017	S142-PMC5513133	['a RECENT north indian case control STUDY of nulliparous women with pe and singleton Pregnancies REPORTED Serum Vitamin D to be significantly lower among pe cases vs. controls at the time of delivery (24.2 +/− 12.4\xa0nmol/l, 36.9 +/− 16.7\xa0nmol/l, respectively; p \xa0=\xa00.0001).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 96)]	3	[('GO_0007565', 'female pregnancy', 84, 'pregnancies'), ('UBERON_0001977', 'blood serum', 105, 'serum'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 119, 'D')]
PMC5513133	7/2017	S143-PMC5513133	['SIMILAR Vitamin D levels were FOUND in women with mild and severe pe [87].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 30)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D')]
PMC5513133	7/2017	S145-PMC5513133	['ALTHOUGH these STUDIES FIND an inverse ASSOCIATION between Vitamin D levels and pe, this ASSOCIATION MAY BE CONFOUNDED by the Gestational age at Serum collection.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 101), ('DIFFICULT_TASK', 108)]	8	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestational'), ('UBERON_0001977', 'blood serum', 145, 'serum')]
PMC5513133	7/2017	S147-PMC5513133	['CORRELATION between low Serum Vitamin D in women with established pe was also FOUND in studies in which populations had specific RISK factors for Vitamin D deficiency such as race or seasonal sun exposure.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 129)]	3	[('UBERON_0001977', 'blood serum', 24, 'serum'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC5513133	7/2017	S148-PMC5513133	['a nested case control study SHOWED an ASSOCIATION between eospe and Vitamin D deficiency after the diagnosis of eospe.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5513133	7/2017	S157-PMC5513133	['two studies of Vitamin D in pe cases have evaluated the POSSIBLE RELATIONSHIP with Angiogenic FACTORS.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0001525', 'angiogenesis', 83, 'angiogenic')]
PMC5513133	7/2017	S165-PMC5513133	['there HAVE BEEN a SMALL NUMBER OF clinical trials studying ASSOCIATIONS between maternal Vitamin D and hypertensive disorders in Pregnancy (table4).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC5513133	7/2017	S166-PMC5513133	['in a 50-year-old controlled trial of 5644 women, olsen & secher ASSESSED the PREVENTIVE EFFECT of a multi-Vitamin Mineral supplement, which included iron, Calcium, Iodine, manganese, copper, Vitamin B Complex, Vitamin C, and 260\xa0mg/day of calcium and halibut Liver oil containing 2500\xa0iu/g Vitamin D per day.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 88)]	3	[('CHEBI_46674', 'lizardite', 106, 'vitamin mineral'), ('CHEBI_22313', 'alkaline earth metal atom', 155, 'calcium'), ('CHEBI_24859', 'iodine atom', 164, 'iodine'), ('CHEBI_75427', 'deuterated fatty acid', 191, 'vitamin B complex'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin C'), ('UBERON_0002107', 'liver', 259, 'liver'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
PMC5513133	7/2017	S170-PMC5513133	['caption (table-wrap): table 4\n\nASSOCIATION of Vitamin D supplementation and Pregnancy-induced hypertension (pih) outcomes in clinical trialsauthor, location, yearstudy designsubjectsinterventionkey findingsresultsolsen and secher, denmark, 1990 [91]randomized controlled clinical trial5644 Pregnant women2500\xa0iu Vitamin D supplement versus no Supplement at week 20 of Pregnancy↓ pe31.5% reduction in the odds ( p \xa0<\xa00.005)olsen et al., europe, 2000 [98]randomized placebo controlled clinical trial386 women who previously experienced pih2.7\xa0g N-3 Fatty Acids/day given from 33\xa0weeks until Delivery vs Olive Oil placebo↔ pih recurrence riskor\xa0=\xa00.9895% ci: 0.63–1.53\n\nevidence that SUGGESTS no association between maternal Vitamin D deficiency and pe\nWHILE the PRECEDING STUDIES SUPPORT a LINK between Vitamin D deficiency during Pregnancy and risk of pe, SOME STUDIES present CONFLICTING EVIDENCE (tables2and3).']	[('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 681), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('INCOMPLETE_EVIDENCE', 760), ('INCOMPLETE_EVIDENCE', 778), ('SUPERFICIAL_RELATIONSHIP', 788), ('INCOMPLETE_EVIDENCE', 855), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 876), ('INCOMPLETE_EVIDENCE', 888)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('GO_0007565', 'female pregnancy', 290, 'pregnant'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 343, 'supplement'), ('GO_0007565', 'female pregnancy', 368, 'pregnancy'), ('GO_0007567', 'parturition', 377, '↓'), ('CHEBI_30256', 'thiocarbonyl group', 543, 'n-3'), ('CHEBI_35366', 'fatty acid', 547, 'fatty acids'), ('GO_0007567', 'parturition', 589, 'delivery'), ('CHEBI_50695', 'monobactam', 601, 'olive oil'), ('CHEBI_27300', 'vitamin D', 722, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 801, 'vitamin D'), ('GO_0007565', 'female pregnancy', 829, 'pregnancy')]
PMC5513133	7/2017	S171-PMC5513133	['most of these studies were OBSERVATIONAL, and measured maternal Vitamin D concentration before the diagnosis of pe AS OPPOSED TO measuring at the time of diagnosis or Delivery.']	[('INCOMPLETE_EVIDENCE', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007567', 'parturition', 167, 'delivery')]
PMC5513133	7/2017	S177-PMC5513133	['RETROSPECTIVELY ANALYZED Vitamin D status and the risk of pe in 697 nulliparous women with singleton Pregnancies in a randomized, placebo-controlled trial of vitamin c and e supplementation for the PREVENTION of pe.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 198)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancies')]
PMC5513133	7/2017	S178-PMC5513133	['after controlling for smoking, the study SHOWED that in the first trimester (mean 11\xa0weeks), Vitamin D deficiency was not significantly associated with an INCREASED RISK of pe (aor\xa0=\xa01.24 95% ci: 0.58–2.67; p \xa0=\xa00.58) [60].']	[('INCOMPLETE_EVIDENCE', 41), ('IMPORTANT_CONSIDERATION', 155)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC5513133	7/2017	S186-PMC5513133	['SUGGESTED that EARLIER STUDIES have measured total 25(Oh)D AS a Vitamin D/Vitamin D binding protein (vdp) Complex, and not the free vitamin.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 59), ('DIFFICULT_TASK', 106)]	4	[('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 74, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 74, 'Vitamin D'), ('GO_0032991', 'protein-containing complex', 106, 'complex')]
PMC5513133	7/2017	S199-PMC5513133	['discussion\nOBSERVATIONAL studies evaluating the ASSOCIATION between Vitamin D and pe HAVE SHOWN INCONSISTENT results and MUST BE interpreted CAUTIOUSLY.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('IMPORTANT_CONSIDERATION', 121), ('INCOMPLETE_EVIDENCE', 141)]	6	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5513133	7/2017	S200-PMC5513133	['this MAY BE a result of ISSUES with study design and methodology, including LACK OF adjustment of KEY CONFOUNDING variables and methods of measuring Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBLEM_COMPLICATION', 24), ('PROBLEM_COMPLICATION', 76), ('IMPORTANT_CONSIDERATION', 98), ('PROBLEM_COMPLICATION', 102)]	5	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC5513133	7/2017	S204-PMC5513133	['residual CONFOUNDING and differences between groups MAY EXPLAIN the ASSOCIATION between Vitamin D deficiency and pe.']	[('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5513133	7/2017	S209-PMC5513133	['smoking HAS also BEEN LINKED to lower Vitamin D concentrations [37].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 22)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC5513133	7/2017	S210-PMC5513133	['smoking MAY BE an IMPORTANT CONFOUNDER and SHOULD BE CONSIDERED in studies LINKING Vitamin D to pe.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 18), ('PROBLEM_COMPLICATION', 28), ('FUTURE_WORK', 43), ('FUTURE_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 75)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5513133	7/2017	S214-PMC5513133	['seasonality is also CONSIDERED a CONFOUNDER, particularly in studies RELATED to causal EFFECTS of Vitamin D on pe.']	[('INCOMPLETE_EVIDENCE', 20), ('PROBLEM_COMPLICATION', 33), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 87)]	4	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC5513133	7/2017	S221-PMC5513133	['maternal dietary intake of Vitamin D from Foods or supplements MAY also VARY.']	[('INCOMPLETE_EVIDENCE', 63), ('DIFFICULT_TASK', 72)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_33290', 'food', 42, 'foods')]
PMC5513133	7/2017	S231-PMC5513133	['the ROLE of Fish Oils in pe REMAINS UNCERTAIN and SIMILARLY poses a CHALLENGE in determining an isolated EFFECT of Vitamin D supplementation, UNLESS studies are designed such that they CONSIDER this.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 28), ('FULL_UNKNOWN', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('DIFFICULT_TASK', 68), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 185)]	9	[('CHEBI_39279', 'halomethane', 12, 'fish oils'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC5513133	7/2017	S238-PMC5513133	['studies that find a ROLE early in Pregnancy, before the clinical onset of pe, SUGGEST that Vitamin D MAY play a ROLE in the Modulation of a pro-inflammatory response or Regulation of Angiogenic factors.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 101), ('SUPERFICIAL_RELATIONSHIP', 112)]	4	[('GO_0007565', 'female pregnancy', 34, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 124, 'modulation'), ('GO_0065007', 'biological regulation', 169, 'regulation'), ('GO_0001525', 'angiogenesis', 183, 'angiogenic')]
PMC5513133	7/2017	S239-PMC5513133	['IT IS POSSIBLE that BIOMARKERS for pe, such as Angiogenic factors Vegf and Pigf, MAY serve as mediators in the pathway LINKING Vitamin D Metabolites to pe.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('GO_0001525', 'angiogenesis', 47, 'angiogenic'), ('PR_000017279', 'testis-specific basic protein Y 1', 66, 'VEGF'), ('PR_000012702', 'GPI ethanolamine phosphate transferase 3', 75, 'PIGF'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_25212', 'metabolite', 137, 'metabolites')]
PMC5513133	7/2017	S240-PMC5513133	['DESPITE EVIDENCE that low Vitamin D levels increase RISK for pe early in Pregnancy, VERY FEW STUDIES have tried TO RELATE this EFFECT with the Regulation Of Angiogenic or anti-Angiogenic factors.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 84), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 143)]	9	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('GO_0006110', 'regulation of glycolytic process', 143, 'regulation of angiogenic'), ('GO_0001525', 'angiogenesis', 176, 'angiogenic')]
PMC5513133	7/2017	S241-PMC5513133	['ALTHOUGH CURRENT EVIDENCE SUPPORTS an ASSOCIATION between Angiogenic factors and pe, these STUDIES have NOT FOUND an ASSOCIATION between Vitamin D levels and Angiogenic factors [14,15].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('SUPERFICIAL_RELATIONSHIP', 117)]	9	[('GO_0001525', 'angiogenesis', 58, 'angiogenic'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0001525', 'angiogenesis', 158, 'angiogenic')]
PMC5513133	7/2017	S242-PMC5513133	['STUDIES with longitudinal study design carefully controlling for temporal sequences of changes in Vitamin D levels in women with pe ARE NEEDED to identify the ROLE of Vitamin D and any POTENTIAL Mediators in the pathway LINKING Vitamin D to pe.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 132), ('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 220)]	5	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_35222', 'inhibitor', 195, 'mediators'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC5513133	7/2017	S244-PMC5513133	['there is LIMITED DATA on the most efficacious dose of Vitamin D to prevent pre-eclampsia while avoiding toxicity.']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5513133	7/2017	S247-PMC5513133	['RECENTLY, participants in the Vitamin D for antenatal asthma (vdaart) randomized double-blind placebo controlled trial took a daily dose of 4000\xa0iu Vitamin D supplementation plus a multivitamin with 400\xa0iu Vitamin D or placebo (placebo pill plus a multi-Vitamin with 400\xa0iu Vitamin D daily) TO ASSESS the EFFECT of Vitamin D supplementation on the frequency of pe among Pregnant women with a high risk for atopic disease [110].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 291), ('SUPERFICIAL_RELATIONSHIP', 305)]	3	[('CHEBI_28384', 'vitamin K', 30, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 254, 'vitamin'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 315, 'vitamin D'), ('GO_0007565', 'female pregnancy', 370, 'pregnant')]
PMC5513133	7/2017	S249-PMC5513133	['SUGGESTS a POTENTIAL for a ROLE for the frequency and timing of Vitamin D supplementation and risk for pe, given that the total intake greater than 800\xa0iu/day did not reduce RISK.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5513133	7/2017	S254-PMC5513133	['BUT this Vitamin D level was maintained in ONLY 74% of Pregnancies in the supplementation group by weeks 32 to 38 of Gestation, SUGGESTING that supplementation at EVEN earlier time-points or before Pregnancy MAY BE NECESSARY to maintain sufficient Vitamin D levels that are PROTECTIVE against pe.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 43), ('INCOMPLETE_EVIDENCE', 128), ('ANOMALY_CURIOUS_FINDING', 163), ('INCOMPLETE_EVIDENCE', 208), ('IMPORTANT_CONSIDERATION', 215), ('SUPERFICIAL_RELATIONSHIP', 274)]	8	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 55, 'pregnancies'), ('GO_0007565', 'female pregnancy', 117, 'gestation'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D')]
PMC5513133	7/2017	S261-PMC5513133	['replication of findings using a uniform set of definitions for pe and clinical subtypes CAN inform the use of Vitamin D supplementation for the PREVENTION of pe.']	[('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 144)]	2	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5513133	7/2017	S263-PMC5513133	['[25] SUGGEST that Vitamin D deficiency MAY BE a FACTOR in the DISPROPORTIONATE incidence of adverse Pregnancy outcomes in african american women since this group had the lowest Vitamin D levels among the populations they studied.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 48), ('ANOMALY_CURIOUS_FINDING', 62)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC5513133	7/2017	S264-PMC5513133	['WHILE SOME STUDIES HAVE BEEN able to capture an adequate representation of african american women [96], there is a NEED FOR FURTHER RESEARCH on populations with very low Vitamin D levels to understand THIS OBSERVATION and IDENTIFY FACTORS that PREDISPOSE high-risk groups to pe and its more THREATENING clinical subtypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 115), ('FUTURE_WORK', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206), ('QUESTION_ANSWERED_BY_THIS_WORK', 222), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 244), ('IMPORTANT_CONSIDERATION', 291)]	11	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5513133	7/2017	S265-PMC5513133	['DESPITE the clear ASSOCIATION of Serum deficiency with pe, a better understanding of the variable IMPACT of supplementation IS NEEDED to identify POTENTIAL of Genetic and environmental INTERACTIONS, as well as pre-Conception data TO IDENTIFY the CRITICAL time window for therapeutic potential of Vitamin D, if any.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 230), ('IMPORTANT_CONSIDERATION', 246)]	8	[('UBERON_0001977', 'blood serum', 33, 'serum'), ('SO_0000704', 'gene', 159, 'genetic'), ('GO_0007620', 'copulation', 214, 'conception'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D')]
PMC5513133	7/2017	S266-PMC5513133	['conclusion\nthere is CONSISTENT EVIDENCE of an ASSOCIATION between low Vitamin D concentrations and adverse pih outcomes.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5513133	7/2017	S268-PMC5513133	['at this time, our UNDERSTANDING of an IDEAL supplementation dose of Vitamin D to reduce pih REMAINS INCOMPLETE.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 38), ('INCOMPLETE_EVIDENCE', 92)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5521778	7/2017	S11-PMC5521778	['taken TOGETHER, THESE FINDINGS provide the FIRST EVIDENCE that Gcs Regulate Vitamin A (Retinoid) Signaling via inhibition of bco1 Gene Expression in a Pparα-dependent manner.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 43)]	3	[('CL_0000740', 'retinal ganglion cell', 63, 'GCs'), ('GO_0065007', 'biological regulation', 67, 'regulate'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin A'), ('GO_0038094', 'Fc-gamma receptor signaling pathway', 76, 'vitamin A ... signaling'), ('CHEBI_26537', 'retinoid', 87, 'retinoid'), ('GO_0010467', 'gene expression', 130, 'gene expression'), ('SO_0000704', 'gene', 130, 'gene'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 151, 'PPARα')]
PMC5521778	7/2017	S22-PMC5521778	['in parallel fashion, Blood Vitamin A concentrations are OBSERVED to be lower in preterm than in full-term newborns [14] as well as in preterm infants who develop bronchopulmonary dysplasia (bpd) than in those who do not [15].']	[('INCOMPLETE_EVIDENCE', 56)]	1	[('UBERON_0000178', 'blood', 21, 'blood'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin A')]
PMC5521778	7/2017	S42-PMC5521778	['we HYPOTHESIZED that: ( a ) bco1 activity provides a local source for Pulmonary Retinoid Synthesis, and ( b ) gc alters Pulmonary EFFECTS of Vitamin A through Regulating Bco1 Expression.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 130), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('UBERON_0002048', 'lung', 70, 'pulmonary'), ('CHEBI_26537', 'retinoid', 80, 'retinoid'), ('GO_0016063', 'rhodopsin biosynthetic process', 80, 'retinoid synthesis'), ('UBERON_0002048', 'lung', 120, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A'), ('GO_0065007', 'biological regulation', 159, 'regulating'), ('PR_000004693', 'Bcl-2-like protein 10', 170, 'BCO1'), ('GO_0010467', 'gene expression', 175, 'expression')]
PMC5521778	7/2017	S47-PMC5521778	['THIS STUDY PROVIDES the FIRST EVIDENCE that Gcs antagonize Vitamin A Signaling through suppression of Bco1 Expression and defines a Pparα-dependent transcriptional mechanism.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 24)]	3	[('CL_0000740', 'retinal ganglion cell', 44, 'GCs'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin A'), ('GO_0038092', 'nodal signaling pathway', 59, 'vitamin A signaling'), ('PR_000004693', 'Bcl-2-like protein 10', 102, 'BCO1'), ('GO_0010467', 'gene expression', 107, 'expression'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 132, 'PPARα')]
PMC5521778	7/2017	S115-PMC5521778	['results\n\nBco1 Expression in Human Lung Tissue and Pulmonary Alveolar Epithelial (a549) Cells\nBco1 is prominently Expressed in Human Intestine, Liver, and Kidney [20], CONSISTENT with the key enzymatic function converting pro-Vitamin A Carotenoids to Vitamin A.']	[('INCOMPLETE_EVIDENCE', 167)]	1	[('PR_000004693', 'Bcl-2-like protein 10', 9, 'BCO1'), ('GO_0010467', 'gene expression', 14, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 28, 'human'), ('UBERON_0002048', 'lung', 34, 'lung'), ('UBERON_0000479', 'tissue', 39, 'tissue'), ('CL_0002241', 'pulmonary interstitial fibroblast', 50, 'pulmonary'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 50, 'pulmonary alveolar epithelial'), ('CL_0000322', 'pneumocyte', 60, 'alveolar epithelial ... cells'), ('PR_000004693', 'Bcl-2-like protein 10', 93, 'BCO1'), ('GO_0010467', 'gene expression', 113, 'expressed'), ('NCBITaxon_9606', 'Homo sapiens', 126, 'human'), ('UBERON_0000160', 'intestine', 132, 'intestine'), ('UBERON_0002107', 'liver', 143, 'liver'), ('UBERON_0002113', 'kidney', 154, 'kidney'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin A'), ('CHEBI_50815', 'norgestimate', 235, 'carotenoids'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin A')]
PMC5521778	7/2017	S267-PMC5521778	['discussion\nlocal Synthesis Of Vitamin A Isomers From Β-Carotene MAY BE required for certain physiological Processes, especially when Vitamin A is insufficient.']	[('INCOMPLETE_EVIDENCE', 64)]	1	[('GO_0019539', 'hydroxymate-containing siderophore biosynthetic process', 17, 'synthesis of vitamin A ... from ... -carotene'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin A'), ('SO_0001060', 'sequence_variant', 40, 'isomers'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 53, 'β-carotene'), ('GO_0007565', 'female pregnancy', 106, 'processes'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A')]
PMC5521778	7/2017	S272-PMC5521778	['the presence of Bco1 activity in Human Alveolar Epithelial-derived Cells SUGGESTS this enzyme CAN produce Retinoids when Vitamin A sources MAY BE low, e .']	[('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 139)]	3	[('PR_000004693', 'Bcl-2-like protein 10', 16, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 33, 'human'), ('CL_0000322', 'pneumocyte', 39, 'alveolar epithelial- ... cells'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 39, 'alveolar epithelial'), ('CHEBI_26537', 'retinoid', 106, 'retinoids'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin A')]
PMC5523023	7/2017	S82-PMC5523023	['it WAS SHOWN that ba and Airflow limitation are ASSOCIATED with deficiency of various antioxidants, such as Carotenoids, Retinol, coenzyme q10, and Vitamin C, d, and e (17,40–45).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('UBERON_0001005', 'respiratory airway', 25, 'airflow'), ('CHEBI_50815', 'norgestimate', 108, 'carotenoids'), ('CHEBI_26536', 'retinoic acid', 121, 'retinol'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin C')]
PMC5523023	7/2017	S85-PMC5523023	['in SEVERAL STUDIES, the supplementation with a Nutraceutical of Antioxidants and Anti-Inflammatory Compounds (e.g., Curcumin, zinc, Selenium, Vitamin D) was ASSOCIATED with reduction of Airway inflammation, as documented by a decrease in fractional exhaled Nitric Oxide (feno) (48) or prolonged time to exacerbation (49).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 157)]	2	[('CHEBI_50733', 'nutraceutical', 47, 'nutraceutical'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 64, 'antioxidants'), ('CHEBI_22485', 'glucosamine oligosaccharide', 81, 'anti-inflammatory compounds'), ('CHEBI_3962', 'curcumin', 116, 'curcumin'), ('CHEBI_27568', 'selenium atom', 132, 'selenium'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 186, 'airway'), ('CHEBI_16480', 'nitric oxide', 257, 'nitric oxide')]
PMC5524288	7/2017	S0-PMC5524288	['maternal 25(Oh)D concentrations ≥40 ng/ml ASSOCIATED with 60% lower Preterm Birth RISK among general obstetrical patients at an urban medical center\n\nabstract\n\nbackground\nGIVEN the HIGH RATE of Preterm Birth (ptb) nationwide and data from rcts DEMONSTRATING risk reduction with Vitamin D supplementation, the medical university of south carolina (musc) implemented a NEW standard of care for Pregnant women to receive Vitamin D testing and supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 171), ('IMPORTANT_CONSIDERATION', 181), ('INCOMPLETE_EVIDENCE', 244), ('FULL_UNKNOWN', 367)]	6	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 9, '25(OH)D'), ('GO_0007565', 'female pregnancy', 68, 'preterm birth'), ('GO_0007565', 'female pregnancy', 194, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D'), ('GO_0007565', 'female pregnancy', 392, 'pregnant'), ('CHEBI_27300', 'vitamin D', 418, 'vitamin D')]
PMC5524288	7/2017	S17-PMC5524288	['multiple epidemiologic STUDIES have FOUND an ASSOCIATION between higher maternal Serum 25-Hydroxyvitamin D [25(Oh)D] concentration, the physiological measure of Vitamin D status, and lower ptb RISK [4–10].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 45), ('IMPORTANT_CONSIDERATION', 193)]	4	[('UBERON_0001977', 'blood serum', 81, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 87, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 108, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC5524288	7/2017	S21-PMC5524288	['in those clinical trials, 4000 iu/day of Vitamin D was FOUND to SAFELY achieve a concentration of at least 32 ng/ml by early in the second Trimester in a diverse group of Pregnant women [13–15].']	[('INCOMPLETE_EVIDENCE', 55), ('IMPORTANT_CONSIDERATION', 64)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 139, 'trimester'), ('GO_0007565', 'female pregnancy', 171, 'pregnant')]
PMC5524288	7/2017	S24-PMC5524288	['trials, the medical university of south carolina (musc) INITIATED a NEW standard of care for Pregnant women that included routine Vitamin D testing and supplementation in september 2015.']	[('INCOMPLETE_EVIDENCE', 56), ('FULL_UNKNOWN', 68)]	2	[('GO_0007565', 'female pregnancy', 93, 'pregnant'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5524288	7/2017	S39-PMC5524288	['for this analysis, women Pregnant with multiples and those participating in Vitamin D clinical trials at musc were EXCLUDED.']	[('INCOMPLETE_EVIDENCE', 115)]	1	[('GO_0007565', 'female pregnancy', 25, 'pregnant'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5524288	7/2017	S111-PMC5524288	['THESE FINDINGS SHOW that higher Vitamin D status is significantly ASSOCIATED with lower ptb RISK for both ptb subtypes and that Vitamin D plays an IMPORTANT ROLE in the UNDERLYING causes of indicated ptb including maternal hypertension, pre-existing diabetes, and non-reassuring fetal status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 92), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 157), ('SUPERFICIAL_RELATIONSHIP', 169)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5524288	7/2017	S116-PMC5524288	['THESE FINDINGS SUGGEST that IMPROVEMENTS in Vitamin D status MAY decrease the DISPARITY in ptb rates between race/ethnic groups.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('FUTURE_WORK', 28), ('FUTURE_PREDICTION', 61), ('IMPORTANT_CONSIDERATION', 78)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5524288	7/2017	S117-PMC5524288	['additionally, for women with a prior ptb, the substantial decrease in recurrent ptb RISK (80%) for ≥40 ng/ml vs. <20 ng/ml INDICATES that IMPROVING Vitamin D status in this HIGH RISK subgroup COULD sizably reduce ptb rates.']	[('IMPORTANT_CONSIDERATION', 84), ('INCOMPLETE_EVIDENCE', 123), ('FUTURE_WORK', 138), ('IMPORTANT_CONSIDERATION', 173), ('FUTURE_PREDICTION', 192)]	5	[('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC5524288	7/2017	S118-PMC5524288	['among women with initial 25(Oh)D concentrations <40 ng/ml, the significantly lower ptb rate (60%) for those who achieved ≥40 ng/ml COMPARED TO those who did not reach the target concentration on a follow-up test SUGGESTS that maternal Vitamin D status is a MODIFIABLE RISK FACTOR that CAN be addressed during the Prenatal period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 268), ('INCOMPLETE_EVIDENCE', 285)]	5	[('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 25, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007565', 'female pregnancy', 313, 'prenatal')]
PMC5524288	7/2017	S120-PMC5524288	['this INDICATES that IMPROVING the Vitamin D status of non-white women, who are known to have PARTICULARLY low Vitamin D concentrations, COULD DRAMATICALLY decrease racial DISPARITIES in ptb rates.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 20), ('IMPORTANT_CONSIDERATION', 93), ('FUTURE_PREDICTION', 136), ('ANOMALY_CURIOUS_FINDING', 142), ('IMPORTANT_CONSIDERATION', 171)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5524288	7/2017	S126-PMC5524288	['additionally, using Serum 25(Oh)D concentration is a BETTER INDICATOR of Vitamin D status and statistically more powerful than using reported Intake BECAUSE it ACCOUNTS FOR all Vitamin D input sources (sun exposure, Food, and Supplements) and makes provision for inter-Individual VARIABILITY in Vitamin D dose response.']	[('PROBABLE_UNDERSTANDING', 53), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 149), ('INCOMPLETE_EVIDENCE', 160), ('DIFFICULT_TASK', 280)]	5	[('UBERON_0001977', 'blood serum', 20, 'serum'), ('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 28, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 32, 'D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007631', 'feeding behavior', 142, 'intake'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_33290', 'food', 216, 'food'), ('CHEBI_33341', 'titanium atom', 226, 'supplements'), ('NCBITaxon_1', 'root', 269, 'individual'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC5524288	7/2017	S127-PMC5524288	['a LIMITATION of THIS STUDY was that nearly two-thirds of the women (63%) had ONLY one 25(Oh)D test during Pregnancy, which PROHIBITED assessment by Trimester and a more thorough analysis of Vitamin D BENEFIT among those with low initial levels.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 77), ('DIFFICULT_TASK', 123), ('IMPORTANT_CONSIDERATION', 200)]	5	[('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 148, 'trimester'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC5537904	7/2017	S8-PMC5537904	['our data CONFIRM the HYPOTHESIS that Vitamin D exposure in early Life is ASSOCIATED with neonatal body size and composition.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0000104', 'life cycle', 65, 'life')]
PMC5537904	7/2017	S12-PMC5537904	['APPROXIMATELY 33% of Pregnant women in the united states have Vitamin D deficiency, defined as 25-Hydroxyvitamin D (25Ohd) < 50 nmol/l, EVEN THOUGH 73% report using Vitamin D-containing Prenatal supplements [2].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 136)]	2	[('GO_0007565', 'female pregnancy', 21, 'pregnant'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 95, '25-hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 116, '25OHD'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 186, 'prenatal')]
PMC5537904	7/2017	S14-PMC5537904	['Prenatal Vitamin D deficiency HAS BEEN ASSOCIATED with pre-term Birth [4,5], low birthweight [5,6], and small for Gestational age offspring [5,6,7], WHILE Prenatal Vitamin D supplementation HAS BEEN SHOWN to increase offspring Birth weight and length [8].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149), ('INCOMPLETE_EVIDENCE', 190)]	4	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007567', 'parturition', 64, 'birth'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('GO_0007565', 'female pregnancy', 155, 'prenatal'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007567', 'parturition', 227, 'birth')]
PMC5537904	7/2017	S15-PMC5537904	['Prenatal Vitamin D exposure MAY also INFLUENCE offspring adiposity through reduced availability of the biologically active vitamin d metabolite, 1Α, 25-Dihydroxyvitamin D, which inhibits Parathyroid hormone and Intracellular calcium, thereby AFFECTING Lipogenesis and Lipolysis [9,10,11,12,13].']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 242)]	3	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 145, '1α, 25-dihydroxyvitamin D'), ('UBERON_0001132', 'parathyroid gland', 187, 'parathyroid'), ('GO_0005622', 'intracellular anatomical structure', 211, 'intracellular'), ('GO_0008610', 'lipid biosynthetic process', 252, 'lipogenesis'), ('GO_0016042', 'lipid catabolic process', 268, 'lipolysis')]
PMC5537904	7/2017	S16-PMC5537904	['current Human EVIDENCE SUPPORTING the ASSOCIATION between Prenatal Vitamin D intake, neonatal Vitamin D status, and offspring adiposity is MIXED.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	4	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5537904	7/2017	S17-PMC5537904	['WHILE NUMEROUS STUDIES HAVE REPORTED that higher maternal Vitamin D intake (from Food and/or dietary supplements) is ASSOCIATED with increased Prenatal and/or cord Blood 25(Oh)D levels [14,15,16,17], it is NOT CLEAR WHETHER this TRANSLATES TO an EFFECT on neonatal adiposity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 117), ('FULL_UNKNOWN', 206), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216), ('SUPERFICIAL_RELATIONSHIP', 229), ('SUPERFICIAL_RELATIONSHIP', 246)]	8	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 81, 'food'), ('GO_0007565', 'female pregnancy', 143, 'prenatal'), ('UBERON_0000178', 'blood', 164, 'blood'), ('CHEBI_71657', 'versiconol acetate', 170, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 176, 'D')]
PMC5537904	7/2017	S20-PMC5537904	['there is also a notable LACK OF study on body composition during infancy, a time in which Postnatal exposures (infant Vitamin D supplementation, Vitamin D-fortified formula use) MAY also play a PIVOTAL ROLE in Adiposity Development.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 178), ('IMPORTANT_CONSIDERATION', 194), ('SUPERFICIAL_RELATIONSHIP', 202)]	4	[('GO_0007567', 'parturition', 90, 'postnatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0060612', 'adipose tissue development', 210, 'adiposity development')]
PMC5537904	7/2017	S21-PMC5537904	['PRIOR STUDIES VARY strongly in methodology, PARTICULARLY in regard to assessment of Prenatal Vitamin D intake, timing and source of 25(Oh)D measurements, a method for assessing neonatal adiposity, and CONSIDERATION of OTHER contributing factors such as maternal obesity.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('IMPORTANT_CONSIDERATION', 44), ('FUTURE_WORK', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218)]	5	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 138, 'D')]
PMC5537904	7/2017	S23-PMC5537904	['in addition, FEW STUDIES EXAMINED WHETHER Gestational weight gain OR body mass index (bmi) modify the ASSOCIATIONS between Prenatal Vitamin D intake, neonatal Vitamin D status, and offspring adiposity.']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 102)]	4	[('GO_0007565', 'female pregnancy', 42, 'gestational'), ('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC5537904	7/2017	S51-PMC5537904	['using this MODEL, we ESTIMATED usual daily Intake of Vitamin D from Food sources during Pregnancy (iu/day).']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 21)]	2	[('GO_0007631', 'feeding behavior', 43, 'intake'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_33290', 'food', 68, 'food'), ('GO_0007565', 'female pregnancy', 88, 'pregnancy')]
PMC5537904	7/2017	S55-PMC5537904	['dose) for each Supplement, and used manufacturer data on Nutrient composition to ESTIMATE average daily dose of Vitamin D from dietary supplements (iu/day) during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 81)]	1	[('CHEBI_16158', 'steroid sulfate', 15, 'supplement'), ('CHEBI_33284', 'nutrient', 57, 'nutrient'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'pregnancy')]
PMC5537904	7/2017	S68-PMC5537904	['we ESTIMATED weeks of daily Vitamin D supplement use for offspring by summing the weeks of daily Vitamin D use (when reported by the mother as an “other” Supplement) and weeks of daily multivitamin use, AS infant multivitamin supplements typically contain Vitamin D [42].']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 203)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 154, 'supplement'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC5537904	7/2017	S102-PMC5537904	['the FIRST analysis evaluated the ASSOCIATION of maternal oral Intake of Vitamin D during Pregnancy with Cord Blood 25(Oh)D. this model was adjusted for season of Birth, maternal age, pre-Pregnancy bmi, race/ethnicity, household income, gwg, and Gestational age at Birth and considered the following interaction terms: Vitamin D intake × bmi, Vitamin D intake × gwg, Vitamin D intake × race/ethnicity, season × bmi, season × gwg, and season × race/ethnicity.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('GO_0007631', 'feeding behavior', 62, 'intake'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 104, 'cord'), ('UBERON_0000178', 'blood', 109, 'blood'), ('CHEBI_71657', 'versiconol acetate', 115, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 115, '25(OH ... D'), ('GO_0007567', 'parturition', 162, 'birth'), ('GO_0007565', 'female pregnancy', 187, 'pregnancy'), ('GO_0007565', 'female pregnancy', 245, 'gestational'), ('GO_0007567', 'parturition', 264, 'birth'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D')]
PMC5537904	7/2017	S143-PMC5537904	['AS EXPECTED, 25(Oh)D at Birth was PREDICTED by both modifiable (maternal bmi, Prenatal Vitamin D intake) and non-modifiable (race/ethnicity, season of Birth) FACTORS.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 158)]	3	[('CHEBI_71657', 'versiconol acetate', 13, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 19, 'D'), ('GO_0007567', 'parturition', 24, 'birth'), ('GO_0007565', 'female pregnancy', 78, 'prenatal'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007567', 'parturition', 151, 'birth')]
PMC5537904	7/2017	S144-PMC5537904	['randomized clinical trials HAVE SHOWN that Prenatal Vitamin D supplementation increases both maternal 25(Oh)D and offspring birthweight [8].']	[('INCOMPLETE_EVIDENCE', 27)]	1	[('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 105, 'OH ... D')]
PMC5537904	7/2017	S150-PMC5537904	['IT IS POSSIBLE that the differential ASSOCIATIONS between 25(Oh)D and Birthweight according to maternal bmi we OBSERVED are DUE TO VARIATIONS in overall energy intake or OTHER nutritional factors that are concomitant with increased Vitamin D intake and THUS increased 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 111), ('PROBLEM_COMPLICATION', 124), ('DIFFICULT_TASK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('PROBABLE_UNDERSTANDING', 253)]	7	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH)D'), ('GO_0007596', 'blood coagulation', 70, 'birthweight'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D')]
PMC5537904	7/2017	S151-PMC5537904	['OUR finding that the ASSOCIATION between Cord Blood 25(Oh)D and Birthweight varies according to maternal bmi MUST BE REPLICATED in OTHER studies, including intervention trials, TO DETERMINE IF Vitamin D supplementation RECOMMENDATIONS to modify Birthweight SHOULD BE bmi-specific.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('FUTURE_WORK', 219), ('FUTURE_WORK', 257)]	9	[('UBERON_0009472', 'axilla', 41, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 52, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 52, '25(OH)D'), ('GO_0007596', 'blood coagulation', 64, 'birthweight'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007596', 'blood coagulation', 245, 'birthweight')]
PMC5537904	7/2017	S166-PMC5537904	['these data are IN AGREEMENT with results of Prenatal Vitamin D supplementation trials, which REPORTED that EVEN with supplementation, women with non-white race/ethnicity, higher pre-Pregnancy bmis, and winter Deliveries had lower 25(Oh)D levels in Pregnancy [15,61].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 107)]	3	[('GO_0007565', 'female pregnancy', 44, 'prenatal'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy'), ('GO_0007567', 'parturition', 209, 'deliveries'), ('CHEBI_71657', 'versiconol acetate', 230, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 230, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy')]
PMC5537904	7/2017	S170-PMC5537904	['HOWEVER, this dose also exceeds the united states national academy of sciences Food and nutrition board tolerable upper limit of 4000 iu/day of Vitamin D for pregnant women [63], and THEREFORE cannot be RECOMMENDED based SOLELY on the present results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 183), ('FUTURE_WORK', 203), ('INCOMPLETE_EVIDENCE', 221)]	4	[('CHEBI_33290', 'food', 79, 'Food'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC5537904	7/2017	S171-PMC5537904	['IT IS POSSIBLE that VARIATIONS in absorption and specific sources of Vitamin D (D2Versus D3) ACCOUNT FOR our differing ESTIMATE, and THUS should be INTERPRETED with caution.']	[('INCOMPLETE_EVIDENCE', 0), ('DIFFICULT_TASK', 20), ('PROBABLE_UNDERSTANDING', 93), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 133), ('FULL_UNKNOWN', 148)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 80, 'D2versus D3')]
PMC5537904	7/2017	S179-PMC5537904	['we were ONLY able to use crude ESTIMATES of offspring Intake of Vitamin D Postnatally from formula or infant supplements, which MAY have prevented us from detecting ASSOCIATIONS between 25(Oh)D at Birth and 5-month body composition that varied by Postnatal Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 165)]	4	[('GO_0007631', 'feeding behavior', 54, 'intake'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'postnatally'), ('CHEBI_71657', 'versiconol acetate', 186, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 192, 'D'), ('GO_0007567', 'parturition', 197, 'birth'), ('GO_0007567', 'parturition', 247, 'postnatal'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D')]
PMC5537904	7/2017	S180-PMC5537904	['we used season of Birth as a crude measurement of sun exposure because we DID NOT have direct measures of uvb-synthesized Vitamin D, and THUS our results for the relative CONTRIBUTION of Oral Intake versus sun exposure SHOULD BE INTERPRETED with CAUTION.']	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 137), ('SUPERFICIAL_RELATIONSHIP', 171), ('FUTURE_WORK', 219), ('FULL_UNKNOWN', 229), ('INCOMPLETE_EVIDENCE', 246)]	6	[('GO_0007567', 'parturition', 18, 'birth'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('UBERON_0000165', 'mouth', 187, 'oral'), ('GO_0007631', 'feeding behavior', 192, 'intake')]
PMC5540678	7/2017	S73-PMC5540678	["additional separate adjustment for maternal Intake of Vitamin E, zinc, selenium, n-3 Pufas, n-6 Pufas, and total fruits and vegetables in Pregnancy DID NOT substantially alter the main findings (data not shown), nor did additional separate adjustment for child's free Sugar intake at age 3\u2005years (supplementary table e3)."]	[('INCOMPLETE_EVIDENCE', 148)]	1	[('GO_0007631', 'feeding behavior', 44, 'intake'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin E'), ('CHEBI_86926', 'S a S b S', 85, 'PUFAs'), ('CHEBI_86926', 'S a S b S', 96, 'PUFAs'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy'), ('CHEBI_24870', 'ion', 268, 'sugar')]
PMC5539754	8/2017	S0-PMC5539754	['season and Vitamin D status are INDEPENDENTLY ASSOCIATED with Glucose Homeostasis in Pregnancy\n\nabstract\n\nbackground\nVitamin D status and season are intrinsically LINKED, and both have been PROPOSED to be ASSOCIATED with Glucose Homeostasis in Pregnancy, with CONFLICTING results.']	[('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 190), ('SUPERFICIAL_RELATIONSHIP', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_17234', 'glucose', 62, 'glucose'), ('GO_0042593', 'glucose homeostasis', 62, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 117, 'Vitamin D'), ('CHEBI_17234', 'glucose', 221, 'glucose'), ('GO_0042593', 'glucose homeostasis', 221, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 244, 'pregnancy')]
PMC5539754	8/2017	S10-PMC5539754	['our NOVEL FINDINGS IMPLY that seasonal variation in Insulin resistance MAY NOT be fully EXPLAINED by differences in Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 19), ('INCOMPLETE_EVIDENCE', 71), ('PROBABLE_UNDERSTANDING', 88)]	4	[('PR_000045358', 'insulin family protein', 52, 'insulin'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5539754	8/2017	S16-PMC5539754	['the presence of Vitamin D receptors and Expression of 1-α-hydroxylase enzyme in Pancreatic Beta Cells SUGGEST that Vitamin D MAY BE a modulator of Insulin secretion and THUS, INFLUENCE Glucose Homeostasis [6].']	[('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 125), ('PROBABLE_UNDERSTANDING', 169), ('SUPERFICIAL_RELATIONSHIP', 175)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0010467', 'gene expression', 40, 'expression'), ('CL_0000169', 'type B pancreatic cell', 80, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 80, 'pancreatic'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('PR_000045358', 'insulin family protein', 147, 'insulin'), ('CHEBI_17234', 'glucose', 185, 'glucose'), ('GO_0042593', 'glucose homeostasis', 185, 'glucose homeostasis')]
PMC5539754	8/2017	S17-PMC5539754	['in Pregnancy, the ASSOCIATION between low Vitamin D levels and abnormalities in Glucose tolerance is the subject of scientific DEBATE, with SOME STUDIES reporting that maternal Insulin sensitivity, fasting Glucose and Gestational diabetes are not associated with 25ohd [7], WHILE others have FOUND inverse ASSOCIATIONS between 25ohd, fasting Glucose [8] and risk of Gestational diabetes [9].']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('INCOMPLETE_EVIDENCE', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 274), ('INCOMPLETE_EVIDENCE', 292), ('SUPERFICIAL_RELATIONSHIP', 306)]	6	[('GO_0007565', 'female pregnancy', 3, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_17234', 'glucose', 80, 'glucose'), ('PR_000045358', 'insulin family protein', 177, 'insulin'), ('CHEBI_17234', 'glucose', 206, 'glucose'), ('GO_0007565', 'female pregnancy', 218, 'gestational'), ('CHEBI_17234', 'glucose', 342, 'glucose'), ('GO_0007565', 'female pregnancy', 366, 'gestational')]
PMC5539754	8/2017	S23-PMC5539754	['epidemiological data SUGGEST that seasonality in sunlight and Vitamin D are RELATED to mortality and infection rates [18].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC5539754	8/2017	S30-PMC5539754	['due to the seasonal nature of 25Ohd concentrations in many parts of the world [32], and the OBSERVED ASSOCIATIONS between Vitamin D and Insulin resistance, it WOULD seem PRUDENT to HYPOTHESISE that seasonal variation of Glucose Homeostasis MAY BE MEDIATED through 25Ohd.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 101), ('FUTURE_PREDICTION', 159), ('IMPORTANT_CONSIDERATION', 170), ('FUTURE_WORK', 181), ('INCOMPLETE_EVIDENCE', 240), ('SUPERFICIAL_RELATIONSHIP', 247)]	7	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 30, '25OHD'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('PR_000045358', 'insulin family protein', 136, 'insulin'), ('CHEBI_17234', 'glucose', 220, 'glucose'), ('GO_0042593', 'glucose homeostasis', 220, 'glucose homeostasis'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 264, '25OHD')]
PMC5539754	8/2017	S51-PMC5539754	['information about the quantity of Vitamin D within supplements was NOT COLLECTED.']	[('INCOMPLETE_EVIDENCE', 67)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC5539754	8/2017	S105-PMC5539754	['GIVEN that the ASSOCIATION between early Gestation through extended winter and Insulin resistance is INDEPENDENT of Serum 25Ohd <30\xa0nmol/l, our NOVEL FINDINGS IMPLY that seasonal variation in Insulin resistance MAY NOT be fully EXPLAINED by differences in Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 101), ('INCOMPLETE_EVIDENCE', 144), ('PROBABLE_UNDERSTANDING', 159), ('INCOMPLETE_EVIDENCE', 211), ('PROBABLE_UNDERSTANDING', 228)]	7	[('GO_0007565', 'female pregnancy', 41, 'gestation'), ('PR_000045358', 'insulin family protein', 79, 'insulin'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 122, '25OHD'), ('PR_000045358', 'insulin family protein', 192, 'insulin'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC5539754	8/2017	S152-PMC5539754	['HOWEVER, UNLIKE the Hapo trial, we FOUND increased fasting Plasma Glucose in late Pregnancy among those at risk of Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 35)]	3	[('CHEBI_17883', 'hydrogen chloride', 20, 'HAPO'), ('UBERON_0001969', 'blood plasma', 59, 'plasma'), ('CHEBI_17234', 'glucose', 66, 'glucose'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC5539754	8/2017	S153-PMC5539754	['a recent meta-analysis of OBSERVATIONAL studies REPORTED that Vitamin D\xa0<\xa050\xa0nmol/l was ASSOCIATED with an INCREASED RISK (or\xa0=\xa01.53) of developing Gestational diabetes [9].']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 107)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'gestational')]
PMC5539754	8/2017	S155-PMC5539754	['POOR Vitamin D intakes HAVE BEEN REPORTED among Pregnant women living in ireland [5].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 23)]	2	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'pregnant')]
PMC5539754	8/2017	S158-PMC5539754	['at present, there REMAINS a LACK OF CONSENSUS regarding RECOMMENDATIONS for uvb exposure for the Production Of Vitamin D for Pregnant Women [46].']	[('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('FUTURE_WORK', 56)]	3	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 97, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant women')]
PMC5539754	8/2017	S159-PMC5539754	['OUR FINDINGS SUGGEST that women at risk of Vitamin D deficiency in early Pregnancy have altered Glucose Metabolism in later Gestation, BUT the evidence is NOT CONSISTENT for Insulin resistance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_17234', 'glucose', 96, 'glucose'), ('GO_0006006', 'glucose metabolic process', 96, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'gestation'), ('PR_000045358', 'insulin family protein', 174, 'insulin')]
PMC5539754	8/2017	S160-PMC5539754	['thus, RECOMMENDATIONS for Vitamin D supplementation to improve Glucose Homeostasis in Pregnancy CANNOT BE made BASED ON our results.']	[('FUTURE_WORK', 6), ('INCOMPLETE_EVIDENCE', 96), ('PROBABLE_UNDERSTANDING', 111)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_17234', 'glucose', 63, 'glucose'), ('GO_0042593', 'glucose homeostasis', 63, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy')]
PMC5539754	8/2017	S175-PMC5539754	['participants at risk of Vitamin D deficiency at their first Antenatal visit were LIKELY to have increased fasting Glucose at 28\xa0weeks’ Gestation, REGARDLESS OF season.']	[('PROBABLE_UNDERSTANDING', 81), ('INCOMPLETE_EVIDENCE', 146)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007567', 'parturition', 60, 'antenatal'), ('CHEBI_17234', 'glucose', 114, 'glucose'), ('GO_0007565', 'female pregnancy', 135, 'gestation')]
PMC5539754	8/2017	S176-PMC5539754	['WHILE no interaction effect was OBSERVED between season and Vitamin D with regards to Glucose Homeostasis, it is well RECOGNISED that 25Ohd declines in winter, and is a modifiable FACTOR.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 118), ('SUPERFICIAL_RELATIONSHIP', 180)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_17234', 'glucose', 86, 'glucose'), ('GO_0042593', 'glucose homeostasis', 86, 'glucose homeostasis'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 134, '25OHD')]
PMC5546866	8/2017	S0-PMC5546866	['response to antenatal Cholecalciferol supplementation is ASSOCIATED with common Vitamin D–related Genetic variants\n\nabstract\n\ncontext:\nSingle-Nucleotide Polymorphisms (Snps) in Genes RELATED to Vitamin D Metabolism HAVE BEEN ASSOCIATED with Serum 25-Hydroxyvitamin D [25(Oh)D] concentration, BUT these RELATIONSHIPS have NOT BEEN EXAMINED following Antenatal Cholecalciferol supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 183), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 225), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 292), ('SUPERFICIAL_RELATIONSHIP', 302), ('FULL_UNKNOWN', 321)]	7	[('CHEBI_16113', 'cholesterol', 22, 'Cholecalciferol'), ('CHEBI_28384', 'vitamin K', 80, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 80, 'Vitamin D'), ('SO_0000704', 'gene', 98, 'Genetic'), ('SO_0000694', 'SNP', 135, 'Single-nucleotide polymorphisms'), ('SO_0000694', 'SNP', 168, 'SNPs'), ('SO_0000704', 'gene', 177, 'genes'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 202, 'D metabolism'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 247, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D'), ('GO_0007567', 'parturition', 349, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 359, 'cholecalciferol')]
PMC5546866	8/2017	S11-PMC5546866	['conclusions:\nGenetic variation in Dhcr7 , which encodes 7-Dehyrocholesterol reductase in the Epidermal Vitamin D Biosynthesis pathway, APPEARS to modify baseline 25(Oh)D. IN CONTRAST, the response to Antenatal Cholecalciferol supplementation was ASSOCIATED with Snps in Cyp2R1 , which MAY alter 25-hydroxylase activity, and gc , which MAY AFFECT Vitamin D binding Protein Synthesis or Metabolite affinity.']	[('ANOMALY_CURIOUS_FINDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171), ('SUPERFICIAL_RELATIONSHIP', 246), ('INCOMPLETE_EVIDENCE', 285), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 339)]	6	[('SO_0000704', 'gene', 13, 'Genetic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 34, 'DHCR7'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 56, '7-dehyrocholesterol'), ('UBERON_0007376', 'outer epithelium', 93, 'epidermal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 103, 'vitamin D biosynthesis'), ('PR_000006444', 'diacylglycerol kinase delta', 111, 'D'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D'), ('GO_0007567', 'parturition', 200, 'antenatal'), ('CHEBI_52550', 'theopalauamide', 210, 'cholecalciferol'), ('SO_0000694', 'SNP', 262, 'SNPs'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 270, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('GO_0006412', 'translation', 364, 'protein synthesis'), ('CHEBI_39382', 'flufenoxuron', 385, 'metabolite')]
PMC5546866	8/2017	S14-PMC5546866	['antenatal Vitamin D supplementation is now RECOMMENDED for all Pregnant women in many national GUIDELINES (1–3) AS SEVERE maternal Vitamin D deficiency CAN result in symptomatic neonatal hypocalcemia (4).']	[('FUTURE_WORK', 43), ('PROBABLE_UNDERSTANDING', 95), ('PROBABLE_UNDERSTANDING', 112), ('IMPORTANT_CONSIDERATION', 115), ('INCOMPLETE_EVIDENCE', 152)]	5	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnant'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5546866	8/2017	S15-PMC5546866	['furthermore, ASSOCIATIONS between maternal Vitamin D status and obstetric COMPLICATIONS (4) and offspring Musculoskeletal Development (5–7) HAVE BEEN REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBLEM_COMPLICATION', 74), ('INCOMPLETE_EVIDENCE', 140)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0061375', 'mammillotectal axonal tract development', 106, 'musculoskeletal development'), ('UBERON_0002204', 'musculoskeletal system', 106, 'musculoskeletal')]
PMC5546866	8/2017	S19-PMC5546866	['in a PREVIOUS Genome-wide association study (gwas), we DEMONSTRATED that a NUMBER OF Single-Nucleotide Polymorphisms (Snps) in or near to Genes encoding KEY components of the Vitamin D Metabolism pathway are ASSOCIATED with Serum 25(Oh)D level (8).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 153), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('SO_0001026', 'genome', 14, 'genome'), ('SO_0000694', 'SNP', 85, 'single-nucleotide polymorphisms'), ('SO_0000694', 'SNP', 118, 'SNPs'), ('SO_0000704', 'gene', 138, 'genes'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 175, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 224, 'serum'), ('CHEBI_71657', 'versiconol acetate', 230, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 233, 'OH ... D')]
PMC5546866	8/2017	S21-PMC5546866	['several of these Snps have been ASSOCIATED with the Serum 25(Oh)D increase in response to Vitamin D supplementation in SMALL STUDIES (9–11).']	[('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 119)]	2	[('SO_0000694', 'SNP', 17, 'SNPs'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5546866	8/2017	S26-PMC5546866	['CONSIDERING this and the physiological changes to the Vitamin D pathway in Pregnancy, it is THEREFORE POSSIBLE that the Genetic variants ASSOCIATED with baseline Serum 25(Oh)d status and the response to supplementation also differ between the Pregnant and nonpregnant state.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 92), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('SO_0000704', 'gene', 120, 'genetic'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_30778', 'gallic acid', 168, '25(OH)'), ('GO_0007565', 'female pregnancy', 243, 'pregnant')]
PMC5546866	8/2017	S27-PMC5546866	['we THEREFORE undertook THIS STUDY TO DETERMINE WHETHER Snps within the Vitamin D Metabolism pathway KNOWN to modify Vitamin D status are also ASSOCIATED with the response to Antenatal Vitamin d supplementation.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('SO_0000694', 'SNP', 55, 'SNPs'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 71, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 174, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 184, 'vitamin')]
PMC5546866	8/2017	S125-PMC5546866	['(11) (15 to 18 nmol/l) than our cohort (9 to 10 nmol/l), BUT this COULD REFLECT the higher Cholecalciferol doses used in those studies and/or alterations in Vitamin D Metabolism and volume of distribution in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 72)]	3	[('CHEBI_52550', 'theopalauamide', 91, 'cholecalciferol'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 157, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 208, 'pregnancy')]
PMC5546866	8/2017	S127-PMC5546866	['the published gwas (8,22) DID NOT stratify Individuals by Vitamin D supplement usage, which COULD ACCOUNT FOR differing ASSOCIATIONS before and after supplementation in our cohort, or the differing FINDINGS MIGHT REFLECT the LOWER POWER in our study.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 92), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 198), ('INCOMPLETE_EVIDENCE', 207), ('SUPERFICIAL_RELATIONSHIP', 213), ('INCOMPLETE_EVIDENCE', 225)]	8	[('NCBITaxon_1', 'root', 43, 'individuals'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5546866	8/2017	S129-PMC5546866	['the Dhcr7 Gene encodes 7-Dhc reductase, which converts 7-Dhc back to Cholesterol, thereby reducing the availability of 7-Dhc for conversion to previtamin d. the ASSOCIATION of this Snp with only baseline 25(Oh)D is biologically CONSISTENT with the NOTION that the relative proportion of 25(Oh)D obtained from Vitamin D Biosynthesis in the skin AS OPPOSED TO dietary intake is lower following supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 161), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 344)]	4	[('PR_000006474', 'ATP-dependent RNA helicase A', 4, 'DHCR7'), ('SO_0000704', 'gene', 10, 'gene'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 23, '7-DHC'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 55, '7-DHC'), ('CHEBI_16113', 'cholesterol', 69, 'cholesterol'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 119, '7-DHC'), ('SO_0000694', 'SNP', 181, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 204, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 287, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 293, 'D'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 309, 'vitamin D biosynthesis')]
PMC5546866	8/2017	S132-PMC5546866	['we FOUND that the rs10741657 Snp was not associated with baseline 25(Oh)D BUT was ASSOCIATED with the response to Gestational Vitamin D supplementation, THEREFORE SUGGESTING that this Snp ONLY modifies 25(Oh)D status when the substrate is more readily available and that at the baseline measurement, saturation of the enzyme had not been reached.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 82), ('PROBABLE_UNDERSTANDING', 153), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 188)]	6	[('SO_0000694', 'SNP', 29, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 66, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 66, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('SO_0000694', 'SNP', 184, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D')]
PMC5546866	8/2017	S134-PMC5546866	['BECAUSE the g Allele at rs10741657, which was more frequent in our population, was ASSOCIATED with lower 25(Oh)D following supplementation, it COULD BE POSTULATED that this Allele previously conferred an evolutionary advantage to prevent Vitamin D toxicity.']	[('PROBLEM_COMPLICATION', 0), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 152)]	4	[('SO_0001023', 'allele', 14, 'allele'), ('CHEBI_71657', 'versiconol acetate', 105, '25(OH)D'), ('SO_0001023', 'allele', 173, 'allele'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5546866	8/2017	S137-PMC5546866	['we SIMILARLY FOUND that the c Allele was ASSOCIATED with lower achieved 25(Oh)D following Antenatal Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 41)]	3	[('SO_0001023', 'allele', 30, 'allele'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 75, 'OH ... D'), ('GO_0007567', 'parturition', 90, 'antenatal'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5546866	8/2017	S145-PMC5546866	['AS SUCH, CONFIRMATION of THESE FINDINGS in severely Vitamin D–deficient women IS NEEDED AS IT IS POSSIBLE that women with specific genotypes were selectively excluded by this inclusion criterion.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 78), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 91)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC5546866	8/2017	S151-PMC5546866	['OUR FINDINGS SUGGEST that analysis of Snps MAY have an IMPORTANT ROLE in identifying high-risk categories of Individuals who are LIKELY to REQUIRE higher doses of Vitamin D to achieve repletion, and STUDIES ARE NEEDED to establish clinical approaches to Vitamin D supplementation that are centered on individual characteristics.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 129), ('IMPORTANT_CONSIDERATION', 139), ('FUTURE_WORK', 199)]	8	[('SO_0000694', 'SNP', 38, 'SNPs'), ('NCBITaxon_1', 'root', 109, 'individuals'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC5576167	8/2017	S51-PMC5576167	['among all the participants, about 62.2% SELF-REPORTED that they were Vitamin D deficient.']	[('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 45)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5576167	8/2017	S87-PMC5576167	['with regards to OTHER Micronutrients, Vitamin D and Iodine deficiencies HAVE BEEN ASSOCIATED with various fetal and maternal abnormalities [29,30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_33839', 'macromolecule', 22, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 52, 'iodine')]
PMC5576167	8/2017	S88-PMC5576167	['the prevalence of Vitamin D deficiency and insufficiency (50.0 and 43.8%, respectively) HAS BEEN reported among Pregnant saudi women with adequate Vitamin D Intake (≥600\xa0iu/day) among ONLY 8.1% of Pregnant women [14,31,32].']	[('INCOMPLETE_EVIDENCE', 88), ('ANOMALY_CURIOUS_FINDING', 184)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnant'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007631', 'feeding behavior', 157, 'intake'), ('GO_0007565', 'female pregnancy', 197, 'pregnant')]
PMC5579643	8/2017	S24-PMC5579643	['Nutrients, such as zinc and Vitamin D and nutritional factors, such as pre- and Probiotics, CAN INFLUENCE the nature of an Immune Response and are important in ensuring appropriate functioning of the Immune System, as described in the paragraphs below.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('CHEBI_33284', 'nutrient', 0, 'Nutrients'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_26346', 'prostaglandins J', 80, 'probiotics'), ('GO_0006955', 'immune response', 123, 'immune response'), ('UBERON_0002405', 'immune system', 123, 'immune'), ('UBERON_0002405', 'immune system', 200, 'immune system'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 207, 'system')]
PMC5579643	8/2017	S57-PMC5579643	['HOWEVER, over the last decade, the EFFECTS of Vitamin D on the innate and Adaptive Immune System HAVE BEEN investigated and expanded [20].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 97)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0051866', 'general adaptation syndrome', 74, 'adaptive immune system'), ('UBERON_0002405', 'immune system', 83, 'immune system')]
PMC5579643	8/2017	S61-PMC5579643	['NEVERTHELESS, the POTENTIAL EFFECT of Vitamin D on Th1/Th2 Adaptive Immune Response is of INTEREST and RELATED to Food allergy [21,22,23].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 90), ('SUPERFICIAL_RELATIONSHIP', 103)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0042639', 'telogen', 51, 'Th1 ...'), ('GO_0002290', 'gamma-delta T cell activation involved in immune response', 55, 'Th2 adaptive immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('CHEBI_33290', 'food', 114, 'food')]
PMC5579643	8/2017	S63-PMC5579643	['when specifically CONSIDERING a POTENTIAL ROLE for Vitamins in Food allergy, Vitamin D HAS BEEN SHOWN to AFFECT several mechanisms that promote immunologic tolerance, including T Regulatory Cell function and the induction of tolerogenic Dendritic Cells.']	[('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('CHEBI_33290', 'food', 63, 'food'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CL_0000902', 'induced T-regulatory cell', 177, 'T regulatory cell'), ('GO_0065007', 'biological regulation', 179, 'regulatory'), ('CL_0000451', 'dendritic cell', 237, 'dendritic cells')]
PMC5579643	8/2017	S64-PMC5579643	['HOWEVER, clinical trials on Vitamin D supplementation in children and the POSSIBLE ROLE in preventing Food allergy are LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('FULL_UNKNOWN', 119)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_33290', 'food', 102, 'food')]
PMC5579643	8/2017	S65-PMC5579643	['a systematic review of Vitamin D supplementation for the PREVENTION of allergic diseases FOUND NO EVIDENCES about the PROTECTIVE ROLE of this Nutrient in children, but the CURRENTLY available data are poor [24].']	[('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 118), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 172)]	6	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_33284', 'nutrient', 142, 'nutrient')]
PMC5638722	8/2017	S1-PMC5638722	['Vitamin D deficiency MAY play a ROLE in the pathogenesis of infections, and low levels of circulating Vitamin D are STRONGLY ASSOCIATED with infectious diseases.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 116), ('SUPERFICIAL_RELATIONSHIP', 125)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5638722	8/2017	S5-PMC5638722	['results\nsixty-three percent of the infants had deficient levels of Cord Blood Vitamin D (group 1), 24% had insufficient levels (group 2), and 13% were FOUND to have sufficient levels (group 3).']	[('INCOMPLETE_EVIDENCE', 151)]	1	[('UBERON_0002240', 'spinal cord', 67, 'cord'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5638722	8/2017	S11-PMC5638722	['the OBSERVATIONS of the ASSOCIATION between infections and Vitamin D deficiency were FIRST DESCRIBED more than a century ago2).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 91)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC5638722	8/2017	S13-PMC5638722	['RECENT REPORTS have SUPPORTED a ROLE for Vitamin D in promoting normal function of the innate and Adaptive Immune Systems2).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32)]	4	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0019825', 'oxygen binding', 98, 'adaptive immune'), ('UBERON_2000139', 'immature otolith', 107, 'immune systems2')]
PMC5638722	8/2017	S22-PMC5638722	['moreover, there is a MAJORITY of epidemiological EVIDENCE INDICATING that circulating Vitamin D concentrations from Cord Blood CORRELATE indirectly with increased susceptibility to infection in newborns7).']	[('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0009472', 'axilla', 116, 'cord blood')]
PMC5638722	8/2017	S23-PMC5638722	['this FINDING has led to the common HYPOTHESIS that Vitamin D deficiency MAY play a ROLE in the pathogenesis of infections8).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5638722	8/2017	S24-PMC5638722	['there are a FEW STUDIES which REPORTED a LINK between Vitamin D deficiency and neonatal sepsis in term infants9).']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 41)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5638722	8/2017	S25-PMC5638722	['with the results of the FIRST STUDY, it IS SHOWN that maternal and neonatal Vitamin D is in RELATION with early-onset neonatal sepsis (eos).']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 92)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5638722	8/2017	S26-PMC5638722	['the other STUDY REPORTED lower Cord Blood Vitamin D levels in the mature babies with eos.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 16)]	2	[('UBERON_0002240', 'spinal cord', 31, 'cord'), ('UBERON_0000178', 'blood', 36, 'blood'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5638722	8/2017	S28-PMC5638722	['moreover, there is a preponderance of epidemiological EVIDENCE INDICATING that lower Vitamin D concentrations from Cord Blood CORRELATE with INCREASED susceptibility to infections in newborns11).']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 126), ('IMPORTANT_CONSIDERATION', 141)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0009472', 'axilla', 115, 'cord blood')]
PMC5638722	8/2017	S88-PMC5638722	['discussion\nthe AIM of OUR STUDY was TO BETTER EVALUATE the EFFECT of Cord-Blood Vitamin D levels on sepsis, by excluding the babies with known RISK factors for infection and who underwent resuscitation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 143)]	6	[('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0000178', 'blood', 74, 'blood'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC5638722	8/2017	S89-PMC5638722	['the OBSERVATIONS of the ASSOCIATION between infections and Vitamin D deficiency were FIRST DESCRIBED more than a century ago15).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 91)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC5638722	8/2017	S90-PMC5638722	['today, it is well established that Monocytes and Macrophages possess 1-α hydroxylase and, the active Metabolite of Vitamin D CAN also be synthesized in the immune system2).']	[('INCOMPLETE_EVIDENCE', 125)]	1	[('CL_0000576', 'monocyte', 35, 'monocytes'), ('CL_0000235', 'macrophage', 49, 'macrophages'), ('CHEBI_39382', 'flufenoxuron', 101, 'metabolite'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC5638722	8/2017	S91-PMC5638722	['this FINDING has led to the common HYPOTHESIS that Vitamin D deficiency MAY play a ROLE in the pathogenesis of infections, and low levels of circulating Vitamin D have BEEN SHOWN to be strongly ASSOCIATED with infectious diseases816).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 194)]	6	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC5638722	8/2017	S92-PMC5638722	['moreover, there is a preponderance of epidemiological EVIDENCE INDICATING circulating Vitamin D concentrations from Cord Blood CORRELATE.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 116, 'cord'), ('UBERON_0000178', 'blood', 121, 'blood')]
PMC5638722	8/2017	S93-PMC5638722	['ONLY FEW STUDIES in the literature, regarding to the RELATIONSHIP between neonatal Vitamin D levels and early onset sepsis are present.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 53)]	3	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC5638722	8/2017	S94-PMC5638722	['cetinkaya et al.10)HAS SHOWN that, low maternal and neonatal Vitamin D levels are RELATED to eos of the newborn.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5638722	8/2017	S96-PMC5638722	['we concluded that Vitamin D deficiency detected via the Blood taken from the Umbilical Cord MAY BE RELATED to increased rates of neonatal sepsis in preterm infants.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000178', 'blood', 56, 'blood'), ('UBERON_0002331', 'umbilical cord', 77, 'umbilical cord')]
PMC5638722	8/2017	S97-PMC5638722	['with the results of OUR STUDY, we SHOWED that Vitamin D insufficiency is not an independent risk factor for sepsis in premature infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 34)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC5638722	8/2017	S101-PMC5638722	['BECAUSE of this, it is NOT SURPRISING that the results of OUR STUDY DID not SHOW Vitamin D level AS an INDEPENDENT risk FACTOR for neonatal sepsis.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 58), ('ANOMALY_CURIOUS_FINDING', 68), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 97), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 120)]	8	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5638722	8/2017	S105-PMC5638722	['BUT we PROPOSE that, MORE prospective STUDIES regarding to the RELATIONSHIP of Vitamin D and sepsis in premature infants ARE NEEDED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 7), ('ANOMALY_CURIOUS_FINDING', 21), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 63), ('FUTURE_WORK', 121)]	6	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5638722	8/2017	S108-PMC5638722	['BUT ON THE OTHER HAND, SOME STUDIES DID NOT FIND difference between the Vitamin D levels and preeclampsia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 36)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5638722	8/2017	S109-PMC5638722	['the results of our study REVEALED no difference in the incidence of Preeclampsia when the infants are grouped according to their Cord-Blood Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 25)]	1	[('GO_0007128', 'meiotic prophase I', 68, 'preeclampsia'), ('UBERON_0002240', 'spinal cord', 129, 'cord'), ('UBERON_0000178', 'blood', 134, 'blood'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC5638722	8/2017	S111-PMC5638722	['BUT with the results of OUR STUDY, no relation between the Cord-Blood Vitamin D levels and Gestational diabetes incidence is FOUND.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 125)]	3	[('UBERON_0002240', 'spinal cord', 59, 'cord'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'gestational')]
PMC5638722	8/2017	S114-PMC5638722	['DUE TO the absence of Serum Vitamin D levels of the mothers who have premature Deliveries, the results obtained give ONLY INDIRECT DATA about maternal morbidities and Vitamin D. epidemiologic STUDIES ARE NEEDED for investigating the POSSIBLE maternal EFFECTS of low Vitamin D levels during Pregnancy.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 122), ('FUTURE_WORK', 192), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 251)]	6	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007567', 'parturition', 79, 'deliveries'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('GO_0007565', 'female pregnancy', 290, 'pregnancy')]
PMC5638722	8/2017	S117-PMC5638722	['with OUR STUDY, we FOUND that 70% of the infants had deficient Vitamin D levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('INCOMPLETE_EVIDENCE', 19)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5638722	8/2017	S119-PMC5638722	['one of the factors ACCEPTED as a REGULATOR is Vitamin D. in A STUDY, small for Gestational age probability was FOUND TO BE 7.5 fold higher in the babies of the mothers with <15 ng/ml Vitamin D levels23).']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 60), ('ANOMALY_CURIOUS_FINDING', 111)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'gestational'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC5638722	8/2017	S120-PMC5638722	['BUT, ON THE OTHER HAND, there are also studies which DID NOT FIND a RELATIONSHIP between the Pregnancy Vitamin D levels and Birth weight and length.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007567', 'parturition', 124, 'birth')]
PMC5638722	8/2017	S121-PMC5638722	['in a study carried out by javaid et al.24), no relationship between the third trimester Vitamin D levels and neonatal Birth weight, length and Head circumference was FOUND.']	[('INCOMPLETE_EVIDENCE', 166)]	1	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007567', 'parturition', 118, 'birth'), ('UBERON_0000033', 'head', 143, 'head')]
PMC5638722	8/2017	S125-PMC5638722	['secondly, we also DO NOT HAVE data related to OTHER dietary factors which COULD BE INTERFERING with Vitamin D level.']	[('FULL_UNKNOWN', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5638722	8/2017	S127-PMC5638722	['in THE literature, Cord-Blood Vitamin D levels are REPORTED to be MAINLY 20% lower than the maternal Blood levels25).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 51), ('PROBABLE_UNDERSTANDING', 66)]	3	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('UBERON_0000178', 'blood', 24, 'blood'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000178', 'blood', 101, 'blood')]
PMC5638722	8/2017	S130-PMC5638722	['but the maternal Vitamin D intake was FOUND to the SIMILAR in all 3 groups.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC5638722	8/2017	S131-PMC5638722	['and thirdly, with the consideration AS the POSSIBLE EFFECT of seasonal changes in Vitamin D levels on the results, we ONLY included the babies which are Born during the summer period.']	[('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 118)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007567', 'parturition', 153, 'born')]
PMC5638722	8/2017	S132-PMC5638722	['as a CONCLUSION; OUR STUDY is the FIRST to INVESTIGATE the RELATIONSHIP between the Cord-Blood Vitamin D levels and neonatal sepsis in preterm infants.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 34), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('SUPERFICIAL_RELATIONSHIP', 59)]	5	[('UBERON_0002240', 'spinal cord', 84, 'cord'), ('UBERON_0000178', 'blood', 89, 'blood'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5638722	8/2017	S133-PMC5638722	['ACCORDING TO the results of our study, we CONCLUDED that there is no relationship between the Cord-Blood Vitamin D levels and neonatal sepsis in preterm infants.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 42)]	2	[('UBERON_0002240', 'spinal cord', 94, 'cord'), ('UBERON_0000178', 'blood', 99, 'blood'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC5587553	9/2017	S66-PMC5587553	['ON THE OTHER HAND, Antenatal supplementation was FOUND EFFECTIVE when they had iron (n\u2009=\u200910, d 0.05, 95% ci 0.002–0.10, p\u2009=\u20090.04), Vitamins B1, B2, b3, B12(n\u2009=\u200910, d 0.05, 95% ci 0.01–0.10, p\u2009=\u20090.02), and Vitamin C (n\u2009=\u20099, d 0.07, 95% ci 0.02–0.12, p\u2009=\u20090.004).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('GO_0007567', 'parturition', 19, 'antenatal'), ('CHEBI_34993', 'talampicillin hydrochloride', 131, 'vitamins B1'), ('PR_000004693', 'Bcl-2-like protein 10', 140, 'B1'), ('PR_000004693', 'Bcl-2-like protein 10', 144, 'B2'), ('CHEBI_27778', 'abequose', 152, 'B12'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin C')]
PMC5623264	9/2017	S73-PMC5623264	['twenty-two studies ASSESSED the EFFECT of the INTERVENTIONS on ptb.24–43 45 46all systematic reviews included individually\xa0rcts,24–469 cluster-rcts24 30–32 35 36 38 42 45and 10\xa0both rcts and quasi-rcts.24 26 29–32 43–46the number of included trials per review ranged from 241to 61 trials.30the number of included participants in the reviews ranged from 603 participants41to over 310\u2009000 participants.24supplementation with Vitamins was reported in five reviews,24–26 45 46supplementation with Minerals in eight reviews27–34and mmn supplementation was assessed in three reviews.35–37there was one review on protein supplementation and nutritional education38and two reviews REPORTED on marine oil and Fatty Acid supplementation.39 40one review evaluated reduced Salt intake,41one deworming42and two reviews preventive Antimalarial drugs.43 44\n\nmethodological quality of the included reviews\nsixteen reviews were of high quality.24–26 28–33 36 38 39 42 43 45 46six reviews were assessed to be of moderate quality.27 34 37 40 41 44only one included review had a score of three and, therefore, was judged to be of low methodological quality (table 1).35\n\neffects of interventions\n\noral supplementation with Vitamins alone or in combination\nfive systematic reviews INVESTIGATED the EFFECT of oral supplementation with Vitamin A,24vitamin C45Or Vitamin E during Pregnancy46And oral Folic Acid supplementation25 26during the Periconceptional period and Pregnancy (see\xa0onlinesupplementary table 6).']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 673), ('QUESTION_ANSWERED_BY_THIS_WORK', 1260), ('SUPERFICIAL_RELATIONSHIP', 1277)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 423, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 493, 'minerals'), ('CHEBI_35366', 'fatty acid', 700, 'fatty acid'), ('CHEBI_24866', 'salt', 761, 'salt'), ('CHEBI_67261', '(Z)-2,3-dehydroadipyl-CoA(5-)', 817, 'antimalarial'), ('CHEBI_33277', 'gamma-tocotrienol', 1203, 'vitamins'), ('CHEBI_27300', 'vitamin D', 1313, 'vitamin A'), ('CHEBI_528968', '1-O-(alpha-D-galactopyranosyl)-N-(8-phenyloctanoyl)phytosphingosine', 1333, 'C45or'), ('PR_000001309', 'CD70 molecule', 1333, 'C45or'), ('CHEBI_27300', 'vitamin D', 1339, 'vitamin E'), ('GO_0006412', 'translation', 1356, 'pregnancy46and'), ('CHEBI_30751', 'formic acid', 1376, 'folic acid'), ('UBERON_0001844', 'cochlea', 1418, 'periconceptional'), ('GO_0007565', 'female pregnancy', 1446, 'pregnancy')]
PMC5623264	9/2017	S108-PMC5623264	['vitamin a supplementation with other Micronutrients (Iron\xa0+\xa0Folate) compared with Micronutrient supplementation without Vitamin A had a positive EFFECT and reduced the risk of lbw by 33%.24HOWEVER, THESE FINDINGS are from a study involving only hiv-positive women and when comparing Vitamin A supplementation alone versus placebo or no treatment, a reduction of lbw could NOT be OBSERVED.']	[('SUPERFICIAL_RELATIONSHIP', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187), ('INCOMPLETE_EVIDENCE', 198), ('FULL_UNKNOWN', 372)]	4	[('CHEBI_33839', 'macromolecule', 37, 'micronutrients'), ('CHEBI_24870', 'ion', 53, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 60, 'folate'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 82, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin A')]
PMC5623264	9/2017	S121-PMC5623264	['piso et al FOUND that Vitamin C supplementation during Pregnancy increased the RISK of ptb and magnesium supplementation decreased the RISK of ptb, lbw and sga.15HOWEVER, the cochrane reviews from which data were extracted had previously been updated and new studies had been added resulting in changed conclusions.']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 79), ('IMPORTANT_CONSIDERATION', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin C'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy')]
PMC5623264	9/2017	S122-PMC5623264	['currently, there is NO EVIDENCE that magnesium or Vitamin C supplementation during Pregnancy positively or negatively AFFECT the RISK of ptb, lbw or sga.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 118), ('IMPORTANT_CONSIDERATION', 129)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin C'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy')]
PMC5640793	9/2017	S44-PMC5640793	["the lancet 's 2013 maternal and child nutrition series RECOMMENDS ten nutrition-specific INTERVENTIONS, including sufficient and diverse Foods for adolescent girls and women; iron, Folic Acid, and Calcium supplementation in Pregnancy; good infant and young child Feeding practices; Vitamin A, iron, and preventive zinc supplementation for children; and treatment for moderate and severe acute malnutrition.5strikingly HOWEVER, expanding the coverage of these nutrition-specific INTERVENTIONS to 90% of mothers and children would only reduce stunting by an ESTIMATED 20%.5larger reductions than these REQUIRE increasing access to family Planning, health services for Pregnant women and children, investments in Water and sanitation, social safety nets, girls' education, and women's empowerment.6a pragmatic approach to design community STRATEGIES for stunting reduction MIGHT THEREFORE be to prioritise action on immediate determinants (infection control, nutrition, and care in the first 1000 days) while providing an enabling social environment for changes in more distal determinants, for example by sharing information about health, nutrition, and sanitation entitlements, and bolstering women's agency."]	[('FUTURE_WORK', 55), ('SUPERFICIAL_RELATIONSHIP', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('ANOMALY_CURIOUS_FINDING', 418), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 556), ('FUTURE_WORK', 600), ('IMPORTANT_CONSIDERATION', 600), ('FUTURE_WORK', 836), ('INCOMPLETE_EVIDENCE', 870), ('PROBABLE_UNDERSTANDING', 876)]	11	[('CHEBI_33290', 'food', 137, 'foods'), ('CHEBI_30751', 'formic acid', 181, 'folic acid'), ('CHEBI_22313', 'alkaline earth metal atom', 197, 'calcium'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007631', 'feeding behavior', 263, 'feeding'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin A'), ('GO_0006260', 'DNA replication', 636, 'planning'), ('GO_0007565', 'female pregnancy', 666, 'pregnant'), ('CHEBI_15377', 'water', 710, 'water')]
PMC5664622	9/2017	S8-PMC5664622	['introduction\nthe last decade has witnessed a steady stream of REPORTS from all over the world about Vitamin D INSUFFICIENCY in the general population, EVEN in regions with high year-round sun exposure (the so-CALLED “mediterranean paradox”) [1,2].']	[('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 110), ('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 208)]	4	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5664622	9/2017	S9-PMC5664622	['the FIRST REPORTS on Vitamin D insufficiency appeared in the 80s of the previous century but it was not until recently that the PROBLEM gained significant ATTENTION DUE TO the GROWING TENDENCY to stay indoors, avoid sun exposure, and use of sunscreen [2,3].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 10), ('IMPORTANT_CONSIDERATION', 128), ('INCOMPLETE_EVIDENCE', 155), ('PROBLEM_COMPLICATION', 165), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 184)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5664622	9/2017	S13-PMC5664622	['IN LIGHT OF the ONGOING DEBATE on the OPTIMAL Vitamin D concentration in Pregnant women, MOST EXPERTS are of the OPINION that the 25(Oh)D concentration in maternal Blood SHOULD exceed 30 ng/ml [2,8,9].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('IMPORTANT_CONSIDERATION', 38), ('PROBABLE_UNDERSTANDING', 89), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 113), ('FUTURE_WORK', 170), ('IMPORTANT_CONSIDERATION', 170)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC5664622	9/2017	S14-PMC5664622	['HOWEVER, OTHER authors CLAIM that maternal concentration that fully normalizes Vitamin D Metabolism and Calcium Homeostasis is AT LEAST 40 ng/ml [10], and still others that >20 ng/ml is NECESSARY to prevent Vitamin D deficiency in the newborn [11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 127), ('IMPORTANT_CONSIDERATION', 186)]	5	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 79, 'vitamin D metabolism'), ('GO_0055073', 'cadmium ion homeostasis', 104, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5664622	9/2017	S35-PMC5664622	['the content of Vitamin D in Vitamin/Mineral supplements for Pregnant women, as well as single-component Vitamin D preparations, was ESTIMATED on the BASIS of our earlier analysis [14].']	[('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 149)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 28, 'vitamin'), ('CHEBI_46662', 'mineral', 36, 'mineral'), ('GO_0007565', 'female pregnancy', 60, 'pregnant'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC5664622	9/2017	S47-PMC5664622	['multivariate regression analysis REVEALED that mean Vitamin D concentration during summer was higher by approximately 5.8 ng/ml (95% ci = [2.60, 8.93]) as compared to winter ( p< 0.001).']	[('INCOMPLETE_EVIDENCE', 33)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC5664622	9/2017	S55-PMC5664622	['similarly to the maternal values, differences in the distribution structure for Vitamin D concentration between the neonatal groups were OBSERVED (pr = 0.026).']	[('INCOMPLETE_EVIDENCE', 137)]	1	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC5664622	9/2017	S57-PMC5664622	['overall, Vitamin D deficiency was FOUND in >25% of the neonates (figure 1).']	[('INCOMPLETE_EVIDENCE', 34)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC5664622	9/2017	S58-PMC5664622	['no differences in Umbilical Cord Blood Vitamin D concentration were FOUND with regard to gender.']	[('INCOMPLETE_EVIDENCE', 68)]	1	[('UBERON_0002331', 'umbilical cord', 18, 'umbilical cord'), ('UBERON_0000178', 'blood', 33, 'blood'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC5664622	9/2017	S61-PMC5664622	['with a 1 ng/ml increase in the maternal levels, Umbilical Cord Blood Vitamin D concentration increases by APPROXIMATELY 1.26 ng/ml (95% ci = [1.13, 1.40] (r2= 0.78, p< 0.0001).']	[('INCOMPLETE_EVIDENCE', 106)]	1	[('UBERON_0002331', 'umbilical cord', 48, 'umbilical cord'), ('UBERON_0000178', 'blood', 63, 'blood'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5664622	9/2017	S62-PMC5664622	['additionally, we FOUND that the diagnostic value of basing the neonatal prognosis for Vitamin D concentration on the maternal levels was very high (roc area = 0.993) (figure 3).']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5664622	9/2017	S63-PMC5664622	['all neonates with Cord Blood Vitamin D deficiency were Born to mothers with <15.3 ng/ml Venous Blood concentration, WHILE 67 (93%) infants with OPTIMAL levels of Vitamin D were Born to mothers with ≥15.3 ng/ml Venous Blood concentration of that Vitamin, INDICATING that the sensitivity and specificity of the predicted normal Cord Blood levels were 93% and 100%, respectively at the maternal concentration of ≥15.3 ng/ml.']	[('ANOMALY_CURIOUS_FINDING', 116), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 254)]	3	[('UBERON_0002240', 'spinal cord', 18, 'cord'), ('UBERON_0000178', 'blood', 23, 'blood'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007567', 'parturition', 55, 'born'), ('UBERON_0001638', 'vein', 88, 'venous'), ('UBERON_0000178', 'blood', 95, 'blood'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007567', 'parturition', 177, 'born'), ('UBERON_0001638', 'vein', 210, 'venous'), ('UBERON_0000178', 'blood', 217, 'blood'), ('CHEBI_33229', 'vitamin (role)', 245, 'vitamin'), ('UBERON_0002240', 'spinal cord', 326, 'cord'), ('UBERON_0000178', 'blood', 331, 'blood')]
PMC5664622	9/2017	S65-PMC5664622	['other factors RELATED to Serum Vitamin D concentration\nmultivariate regression analysis REVEALED that, apart from the season of the year, Vitamin D concentration was AFFECTED by the following FACTORS: maternal use of Vitamin D supplements, weight gain in Pregnancy, Gestational diabetes mellitus (gdm), and—in case of Cord Blood—also with Maternal age.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 166), ('SUPERFICIAL_RELATIONSHIP', 192)]	4	[('UBERON_0001977', 'blood serum', 25, 'Serum'), ('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 31, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('GO_0007565', 'female pregnancy', 266, 'gestational'), ('UBERON_0002240', 'spinal cord', 318, 'cord'), ('UBERON_0000178', 'blood', 323, 'blood'), ('GO_0007618', 'mating', 339, 'maternal')]
PMC5664622	9/2017	S68-PMC5664622	['excessive weight gain was negatively CORRELATED with Vitamin D concentration in Venous and Cord Blood, and was lower by APPROXIMATELY 4.0 ng/ml (95% ci = [−7.96, −0.02]) in the mothers and by 5.7 ng/ml (95% ci = [−11.02, −0.41]) in their neonates as compared to normal weight gain ( p< 0.05).']	[('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 120)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0001638', 'vein', 80, 'venous'), ('UBERON_0009472', 'axilla', 91, 'cord blood')]
PMC5664622	9/2017	S69-PMC5664622	['also, we FOUND that Vitamin D concentration was higher by APPROXIMATELY 5.4 ng/ml among women with gdm (95% ci = [0.39, 10.34]) as compared to healthy mothers ( p< 0.05), which resulted in elevated levels by APPROXIMATELY 7.2 ng/ml (95% ci = [0.54, 13.84]) also in Neonatal Cord Blood ( p< 0.05).']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 208)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0001759', 'vagus nerve', 265, 'neonatal'), ('UBERON_0002240', 'spinal cord', 274, 'cord'), ('UBERON_0000178', 'blood', 279, 'blood')]
PMC5664622	9/2017	S77-PMC5664622	['our results are CONSISTENT with the FINDINGS of OTHER authors, who have also CONFIRMED Vitamin D deficiency among Pregnant women in poland [3,5,17,18,19], ALTHOUGH REPORTS in the polish literature on better Vitamin D saturation in the summer are LESS UNAMBIGUOUS.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('ANOMALY_CURIOUS_FINDING', 155), ('INCOMPLETE_EVIDENCE', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 246), ('INCOMPLETE_EVIDENCE', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 251)]	10	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'pregnant'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5664622	9/2017	S80-PMC5664622	['who also CONFIRMED season-DEPENDENT variability in Vitamin D levels, with the highest values in summer and the lowest in winter [3,17].']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 26)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC5664622	9/2017	S83-PMC5664622	['reports from OTHER european countries also FOUND a TENDENCY for higher Vitamin D levels among Pregnant women during summer, e.g., in germany which is located at a similar latitude as poland [20], as well as countries with very DIFFERENT geographic location and sun exposure, such as greece [12], or norway [21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnant')]
PMC5664622	9/2017	S84-PMC5664622	['higher maternal Vitamin D concentration during summer resulted in lower rates of mothers with Vitamin D deficiency as compared to the winter group (34% vs. 66%), BUT the scale of Vitamin D insufficiency REMAINS significant.']	[('ANOMALY_CURIOUS_FINDING', 162), ('INCOMPLETE_EVIDENCE', 203)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC5664622	9/2017	S86-PMC5664622	['as far as Vitamin D deficiency is concerned, the situation in poland is COMPARABLE to that SEEN in neighboring countries.']	[('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 91)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC5664622	9/2017	S87-PMC5664622	['the RECOMMENDED levels of Vitamin D were FOUND in ONLY 5% of the Pregnant women in germany [20], and 16.5% in ukraine [22].']	[('FUTURE_WORK', 4), ('INCOMPLETE_EVIDENCE', 41), ('ANOMALY_CURIOUS_FINDING', 50), ('INCOMPLETE_EVIDENCE', 50)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnant')]
PMC5664622	9/2017	S88-PMC5664622	['in OUR STUDY, the high number of women with Vitamin D deficiency MIGHT result from avoidance of sun exposure between 10:00 a.m. and 3:00 p.m. and using sunscreen, which was reported by 46% and 26% of the women from the summer group, respectively.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 65)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5664622	9/2017	S92-PMC5664622	['a study conducted in belgium FOUND that Pregnant women who avoid sun exposure are at a 2-fold higher RISK for severe Vitamin D deficiency [25].']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 101)]	2	[('GO_0007565', 'female pregnancy', 40, 'pregnant'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5664622	9/2017	S94-PMC5664622	['REGARDLESS, DESPITE Vitamin/Mineral supplementation in Pregnancy, maternal intake of Vitamin D REMAINS below the RECOMMENDED levels, MOSTLY BECAUSE 75% of the multi-component Supplements for Pregnant women which are available in poland contain small amount of Vitamin D (5–10 µg) [14], as compared to the recommended dose of 37.5–50 µg [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 95), ('FUTURE_WORK', 113), ('PROBABLE_UNDERSTANDING', 133), ('PROBABLE_UNDERSTANDING', 140)]	6	[('CHEBI_33229', 'vitamin (role)', 20, 'vitamin'), ('CHEBI_46662', 'mineral', 28, 'mineral'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 175, 'supplements'), ('GO_0007565', 'female pregnancy', 191, 'pregnant'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D')]
PMC5664622	9/2017	S100-PMC5664622	['ONLY 15% of the women from this study used single-component preparations, with higher Vitamin D content (mean 25 µg) [14], which automatically resulted in higher maternal and Cord Blood levels.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 175, 'cord'), ('UBERON_0000178', 'blood', 180, 'blood')]
PMC5664622	9/2017	S102-PMC5664622	['THUS, it SEEMS IMPOSSIBLE for it to ever become a significant source of Vitamin D, especially in light of exaggerated media REPORTS on chemical Pollutants absorbed by the fish.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('DIFFICULT_TASK', 15), ('INCOMPLETE_EVIDENCE', 124)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_26199', 'polyprenol', 144, 'pollutants')]
PMC5664622	9/2017	S103-PMC5664622	['in all mother-infant Blood sets, Umbilical Cord Blood Vitamin D concentration was higher by 7.7 ng/ml on average (APPROXIMATELY 40%), as COMPARED TO maternal levels, which is CONSISTENT with MOST studies worldwide, CLAIMING that Cord Blood level was higher than maternal Venous Blood level by 3.9–8.0 ng/ml [7,12,26,32].']	[('INCOMPLETE_EVIDENCE', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 175), ('PROBABLE_UNDERSTANDING', 191), ('PROBABLE_UNDERSTANDING', 215), ('PROBABLE_UNDERSTANDING', 215)]	6	[('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0002331', 'umbilical cord', 33, 'umbilical cord'), ('UBERON_0000178', 'blood', 48, 'blood'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 229, 'cord'), ('UBERON_0000178', 'blood', 234, 'blood'), ('UBERON_0013756', 'venous blood', 271, 'venous blood')]
PMC5664622	9/2017	S107-PMC5664622	['in OUR STUDY, we FOUND that maternal Vitamin D concentration of >15.3 ng/ml, i.e., half the recommended dose, would be sufficient to meet the DEMANDS of the developing fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 142)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5664622	9/2017	S110-PMC5664622	['in OUR STUDY, we CONFIRMED DETRIMENTAL EFFECTS of excessive weight gain in Pregnancy which results in diminished Vitamin D concentration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 27), ('SUPERFICIAL_RELATIONSHIP', 39)]	4	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC5664622	9/2017	S112-PMC5664622	['elevated levels of Vitamin D in mothers with gdm REMAIN a SURPRISE.']	[('INCOMPLETE_EVIDENCE', 49), ('ANOMALY_CURIOUS_FINDING', 58)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC5664622	9/2017	S116-PMC5664622	['the absence of a correlation between Blood Vitamin D levels and its intake from the diet (no supplementation) is MOST PROBABLY a direct result of low Vitamin D Intake (2.1 µg/day), which is CONSISTENT with REPORTS of other authors at a daily Intake of 0.8 µg [12].']	[('PROBABLE_UNDERSTANDING', 113), ('PROBABLE_UNDERSTANDING', 118), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 206)]	4	[('UBERON_0000178', 'blood', 37, 'blood'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('GO_0007631', 'feeding behavior', 160, 'intake'), ('GO_0007631', 'feeding behavior', 242, 'intake')]
PMC5664622	9/2017	S117-PMC5664622	['IN LIGHT OF the current norms in poland [34], adequate Consumption of Vitamin D from dietary sources was REPORTED by ONLY 6% of the investigated women.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 105), ('ANOMALY_CURIOUS_FINDING', 117), ('INCOMPLETE_EVIDENCE', 117)]	4	[('GO_0007631', 'feeding behavior', 55, 'consumption'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5664622	9/2017	S118-PMC5664622	['it SEEMS that the ESTIMATED Vitamin D consumption is a RELIABLE result AS it is CONSISTENT with OTHER REPORTS, which for years have INDICATED a consistently low amount of Vitamin D in the diet of polish Pregnant women (2.6–2.8 µg/day) [13,35].']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 55), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 132)]	8	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnant')]
PMC5664622	9/2017	S119-PMC5664622	['the same HAS BEEN FOUND for young non-Pregnant women, who Consume on average 2.4 µg/day of Vitamin D [36].']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('GO_0007565', 'female pregnancy', 38, 'pregnant'), ('GO_0007631', 'feeding behavior', 58, 'consume'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC5664622	9/2017	S121-PMC5664622	['the ASSOCIATION between Vitamin D consumption and financial status WAS NOT INVESTIGATED, which is one of the LIMITATIONS of OUR STUDY BECAUSE that FACTOR MIGHT have AFFECTED the diet of the investigated population.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 67), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('INCOMPLETE_EVIDENCE', 109), ('QUESTION_ANSWERED_BY_THIS_WORK', 124), ('PROBLEM_COMPLICATION', 134), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 165)]	9	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5664622	9/2017	S126-PMC5664622	['it is CONSISTENT with the national studies, on a representative sample, which have determined the EFFECT of the geographic latitude on Serum Vitamin D concentration to be of minimal IMPORTANCE [37].']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 98), ('IMPORTANT_CONSIDERATION', 182)]	3	[('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC5664622	9/2017	S128-PMC5664622	['we also DID NOT investigate pre-Pregnancy Vitamin D intake, which MAY have had SOME IMPACT on its concentration in the first trimester.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 84)]	4	[('GO_0007565', 'female pregnancy', 32, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5664622	9/2017	S132-PMC5664622	['conclusions\nON THE BASIS OF the FINDINGS of OUR STUDY, conducted among polish Pregnant women, it SEEMS SAFE to conclude that significantly low levels of Vitamin D concentration among Pregnant women in poland MAY in FACT be a common occurrence.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 97), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 208), ('ANOMALY_CURIOUS_FINDING', 215)]	7	[('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'pregnant')]
PMC5664622	9/2017	S133-PMC5664622	['during the summer season, EVEN DESPITE visible improvement, a large group of women STILL REMAINS AT RISK for Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 26), ('ANOMALY_CURIOUS_FINDING', 31), ('ANOMALY_CURIOUS_FINDING', 83), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 97)]	6	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC5664622	9/2017	S135-PMC5664622	['in OUR STUDY, we FOUND that the lowest maternal Vitamin D level should be ≥15.3 ng/ml in order to meet the demands of the fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5716389	9/2017	S10-PMC5716389	['maternal nutritional status, and exposure during fetal Life to an inadequately nurturing environment, COULD THUS IMPACT fetal Immune Development [3,4], in particular, Micronutrients including zinc, iron, Vitamin A and protein energy malnutrition (pem).']	[('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 108), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('UBERON_0000104', 'life cycle', 55, 'life'), ('GO_0001822', 'kidney development', 126, 'immune development'), ('UBERON_0002405', 'immune system', 126, 'immune'), ('CHEBI_33839', 'macromolecule', 167, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A')]
PMC5716389	9/2017	S31-PMC5716389	['Micronutrients\nseveral Micronutrients (Minerals or Vitamins) are KNOWN to be IMPORTANT in Fetal Immune System Development and child Immune Response to vaccines.table 1summarizes findings relevant to Immune functioning (zinc, Vitamin A, d, Folate, Iodine and Iron).']	[('INCOMPLETE_EVIDENCE', 65), ('IMPORTANT_CONSIDERATION', 77)]	2	[('CHEBI_34850', 'milrinone lactate', 0, 'Micronutrients'), ('CHEBI_33839', 'macromolecule', 23, 'micronutrients'), ('CHEBI_46751', 'quinolizidine', 39, 'minerals'), ('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('UBERON_0000922', 'embryo', 90, 'fetal'), ('GO_0002520', 'immune system development', 96, 'immune system development'), ('UBERON_0002405', 'immune system', 96, 'immune system'), ('GO_0006955', 'immune response', 132, 'immune response'), ('UBERON_0002405', 'immune system', 132, 'immune'), ('UBERON_0002405', 'immune system', 199, 'immune'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 239, 'folate'), ('CHEBI_24859', 'iodine atom', 247, 'iodine'), ('CHEBI_24870', 'ion', 258, 'iron')]
PMC5716389	9/2017	S38-PMC5716389	['in fetal development, the ROLE of Vitamin A HAS BEEN RELATED to general Embryonic and fetal survival, Regulation Of Hematopoiesis and fetal growth.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 53)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin A'), ('GO_0007608', 'sensory perception of smell', 72, 'embryonic ...'), ('UBERON_0000922', 'embryo', 72, 'embryonic'), ('GO_1903706', 'regulation of hemopoiesis', 102, 'regulation of hematopoiesis')]
PMC5716389	9/2017	S41-PMC5716389	["FURTHER, Vitamin A IS NEEDED in the Development and functioning Of the Cell-Mediated and humoral Immune Systems, with deficiency at Birth POTENTIALLY reducing the infant's response to vaccines."]	[('FUTURE_WORK', 0), ('FUTURE_WORK', 19), ('INCOMPLETE_EVIDENCE', 138)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0009566', 'fertilization', 36, 'development ... of ...'), ('GO_0007464', 'R3/R4 cell fate commitment', 71, 'cell-mediated ... immune systems'), ('UBERON_0002405', 'immune system', 97, 'immune systems'), ('GO_0007567', 'parturition', 132, 'birth')]
PMC5716389	9/2017	S46-PMC5716389	['fetal Vitamin D stores HAVE BEEN FOUND to be highly DEPENDENT on maternal nutritional levels [32].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC5634437	10/2017	S226-PMC5634437	['THEREFORE, Drugs increasing Dhcr7 Expression COULD inadvertently lower maternal Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 45)]	2	[('CHEBI_23888', 'drug', 11, 'drugs'), ('PR_000006474', 'ATP-dependent RNA helicase A', 28, 'DHCR7'), ('GO_0010467', 'gene expression', 34, 'expression'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC5634437	10/2017	S228-PMC5634437	['THEREFORE, the harmful EFFECTS we OBSERVED for Haloperidol COULD BE due to the elevated 7-Dehydrocholesterol levels and not a reduction in Vitamin D. further mechanism-based STUDIES ARE REQUIRED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 59), ('FUTURE_WORK', 174), ('FUTURE_WORK', 182)]	6	[('CHEBI_5613', 'haloperidol', 47, 'haloperidol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 88, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5634437	10/2017	S274-PMC5634437	['additionally, we FOUND that first trimester exposure to Haloperidol – a Drug that interferes with the Dhcr7 – Cholesterol – Vitamin D pathway increased the risk of fetal loss.']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_5613', 'haloperidol', 56, 'haloperidol'), ('CHEBI_23888', 'drug', 72, 'drug'), ('PR_000006474', 'ATP-dependent RNA helicase A', 102, 'DHCR7'), ('CHEBI_16113', 'cholesterol', 110, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC5634602	10/2017	S12-PMC5634602	['conclusions\nimprovement in 25(Oh)D3Levels at 4 weeks, bone density, and TRENDS towards improvement in linear growth SUPPORT CONSIDERATION of a daily dose of 800 iu of Vitamin D for infants <32 weeks cared for in the nicu.']	[('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 116), ('FUTURE_WORK', 124)]	3	[('CHEBI_51924', 'ethyl 2-cyanoacetoacetate', 27, '25(OH)D3levels'), ('PR_000001895', 'natural cytotoxicity triggering receptor 3', 27, '25(OH)D3levels'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC5634602	10/2017	S14-PMC5634602	['MANY aspects of clinical application of Vitamin D supplementation in the smallest preterm infants NEED additional SUPPORTIVE EVIDENCE.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 98), ('INCOMPLETE_EVIDENCE', 114), ('FUTURE_WORK', 125)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC5634602	10/2017	S18-PMC5634602	['this RECOMMENDATION is BASED, IN PART, off of work by priemel et al evaluating bone mineralization defects and Vitamin D deficiency in Iliac Crest bone of Adults [3].']	[('FUTURE_WORK', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('INCOMPLETE_EVIDENCE', 30)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_4300127', 'nuchal crest', 135, 'iliac crest'), ('UBERON_0007023', 'adult organism', 155, 'adults')]
PMC5634602	10/2017	S19-PMC5634602	['the authors of THIS PAPER HOWEVER, CONCLUDE that doses of supplementation of Vitamin D SHOULD ensure 25(Oh)D levels of 75 nmol/l to maintain Skeletal health.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 35), ('FUTURE_WORK', 87)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 101, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 107, 'D'), ('UBERON_0004288', 'skeleton', 141, 'skeletal')]
PMC5634602	10/2017	S26-PMC5634602	['preterm infants2008[2]Endocrine society healthy infants 0–1 year400–1000 iu>75 nmol/l (for non-Skeletal benefits)0–1 Vitamin D deficient (<50 nmol/l) 2000 iu/D for 6 weeks followed by maintenance dosing2011[9]\nvery LITTLE data is available regarding response to Vitamin D supplementation in the smallest and youngest infants (<1200 grams at Birth), a population that MIGHT see the most BENEFIT from normalized Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 215), ('INCOMPLETE_EVIDENCE', 367), ('IMPORTANT_CONSIDERATION', 386)]	3	[('UBERON_0005063', 'left ventricular compact myocardium', 22, 'Endocrine'), ('UBERON_0004288', 'skeleton', 95, 'skeletal'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('GO_0007567', 'parturition', 341, 'birth'), ('CHEBI_27300', 'vitamin D', 410, 'vitamin D')]
PMC5634602	10/2017	S28-PMC5634602	['another trial evaluating placebo, 200 iu and 800 iu daily Vitamin D supplement evaluated levels at 36 weeks and days of Respiratory support, SHOWING PREVENTION of Vitamin D deficiency with the 800 iu dose, and an improvement in Serum levels with the 200 iu dose as compared to placebo, but no difference in days alive or in Respiratory support [11].']	[('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 149)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 120, 'respiratory'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('UBERON_0001004', 'respiratory system', 324, 'respiratory')]
PMC5634602	10/2017	S30-PMC5634602	['as the ROLE of Vitamin D in Immune function, Respiratory health, allergy and atopic disease, and many other Tissue and Organ functions becomes apparent, adjustments have BEEN SUGGESTED in OPTIMAL Serum level of 25(Oh)D [12–14].']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 170), ('IMPORTANT_CONSIDERATION', 188)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0002405', 'immune system', 28, 'immune'), ('UBERON_0001004', 'respiratory system', 45, 'respiratory'), ('UBERON_0000479', 'tissue', 108, 'tissue'), ('UBERON_0000062', 'organ', 119, 'organ'), ('UBERON_0001977', 'blood serum', 196, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 217, 'D')]
PMC5634602	10/2017	S33-PMC5634602	['MANY STUDIES in the united states and abroad have DOCUMENTED maternal status to be SUBOPTIMAL and have CALLED for national programs to improve maternal Vitamin D status with increased supplementation dose and frequency [18–26].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 103), ('IMPORTANT_CONSIDERATION', 103)]	5	[('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC5634602	10/2017	S34-PMC5634602	['the Fetus relies solely on maternal stores for Vitamin D in utero, and TYPICALLY has Cord Blood levels APPROXIMATELY 50–75% of the maternal value [6,27,28].']	[('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 103)]	2	[('UBERON_0000312', 'inner cambium layer of periosteum', 4, 'fetus'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 85, 'cord'), ('UBERON_0000178', 'blood', 90, 'blood')]
PMC5634602	10/2017	S36-PMC5634602	['IMPORTANTLY, SEVERAL STUDIES have DOCUMENTED an ASSOCIATION with decreasing 25(Oh)D levels and lower Gestational age at Delivery allowing for a situation where preterm infants are a highly vulnerable population at Birth with regards to their Vitamin D status [15,28,30].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 82, 'D'), ('GO_0007565', 'female pregnancy', 101, 'gestational'), ('GO_0007567', 'parturition', 120, 'delivery'), ('GO_0007567', 'parturition', 214, 'birth'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D')]
PMC5634602	10/2017	S40-PMC5634602	['additionally, we will EVALUATE response to supplementation in the subset of infants weighing <1200 grams AS there is MINIMAL information available regarding response to Vitamin D supplementation in this specific high-risk group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('PROBABLE_UNDERSTANDING', 105), ('INCOMPLETE_EVIDENCE', 117)]	3	[('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC5634602	10/2017	S44-PMC5634602	['the study Vitamin D was delivered in a brown Oral syringe (to protect the product from light) and the product was identical in color, volume and smell REGARDLESS OF dose.']	[('INCOMPLETE_EVIDENCE', 151)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0000165', 'mouth', 45, 'oral')]
PMC5634602	10/2017	S84-PMC5634602	['we SHOWED significant improvements in Vitamin D status between the groups supplemented with 400 iu and 800 iu at four weeks of age.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC5634602	10/2017	S95-PMC5634602	['bone health HAS long BEEN the primary ASSOCIATION with Vitamin D in infants and children.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5634602	10/2017	S96-PMC5634602	['INITIAL STUDIES of and RECOMMENDATIONS for Vitamin D intake were designed to PREVENT rickets in term infants targeting a Serum 25(Oh)D level of >50 nmol/l [36,37].']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 127, '25(OH)D')]
PMC5634602	10/2017	S97-PMC5634602	['the preterm population of patients is at high RISK for bone disease of prematurity, and improving Delivery of Vitamin D MAY have a positive IMPACT on bone health.']	[('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 140)]	3	[('GO_0007567', 'parturition', 98, 'delivery'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5634602	10/2017	S115-PMC5634602	['this, coupled with the LACK OF dangerously high levels or clinical side EFFECTS REPORTED with dosing between 400–1600 iu in preterm infants, lead us to argue for CONSIDERATION of and ADDITIONAL EVALUATION of the 800 iu dose of Vitamin D in addition to Vitamin D from diet sources in this high-risk hospitalized patient population.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 80), ('FUTURE_WORK', 162), ('FUTURE_WORK', 183)]	5	[('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D')]
PMC5634602	10/2017	S116-PMC5634602	['reports of clinical EFFECTS from Vitamin D overdose in infants and children are quite RARE.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 86)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5634602	10/2017	S120-PMC5634602	['jones has OUTLINED a mechanism by which this toxicity MAY present ARGUING that 25(Oh)D3At these concentrations displaces 1-alpha,25(Oh)2D from Vitamin D binding protein leading to increased Gene transcription [48].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66)]	3	[('CHEBI_35047', 'xanthomicrol', 79, '25(OH)D3at'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 129, '25(OH)2D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('SO_0000704', 'gene', 190, 'gene')]
PMC5634602	10/2017	S136-PMC5634602	['we were unable to adequately assess maternal Vitamin D intake during Pregnancy in the cohort studied, AS maternal records OFTEN DID NOT report the amount of Vitamin D in the prescribed Prenatal vitamin.']	[('PROBABLE_UNDERSTANDING', 102), ('PROBABLE_UNDERSTANDING', 122), ('INCOMPLETE_EVIDENCE', 128)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007565', 'female pregnancy', 185, 'prenatal')]
PMC5634602	10/2017	S137-PMC5634602	['HOWEVER, given that the MAJORITY of Prenatal Vitamins have 400 iu of Vitamin D and this has not been shown to increase levels in Pregnancy this LIKELY does not have any IMPACT on our DESCRIBED results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 24), ('PROBABLE_UNDERSTANDING', 144), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 183)]	5	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 45, 'vitamins'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC5634602	10/2017	S144-PMC5634602	['EVIDENCE continues to mount in SUPPORT of this supplementation of preterm infants with Vitamin D early in hospitalization [44].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC5634602	10/2017	S145-PMC5634602	['Vitamin D toxicity is a RARE event, and tolerance of EVEN higher doses of Vitamin D HAVE BEEN REPORTED in a variety of populations [9,52].']	[('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 53), ('INCOMPLETE_EVIDENCE', 84)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5634602	10/2017	S146-PMC5634602	['ALTERNATIVELY, the risks of RECOMMENDATION of too low a dose MAY have significant IMPACT on Individual and population health with disease outcomes ASSOCIATED with low Vitamin D status, including hypocalcemic seizures, growth restriction, fractures, and elevation of Serum Parathyroid hormone [53–55].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 28), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 82), ('SUPERFICIAL_RELATIONSHIP', 147)]	5	[('NCBITaxon_1', 'root', 92, 'individual'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('UBERON_0001977', 'blood serum', 266, 'serum'), ('UBERON_0001132', 'parathyroid gland', 272, 'parathyroid')]
PMC5634602	10/2017	S147-PMC5634602	['IN FACT, SOME authors, including heaney, have ARGUED that a physiological reference for optimal Vitamin D status would be between 100 and 130 nmol/l stating that BASED ON physiological outcomes such as normalization of pth and adequate Vitamin D supply in Breast Milk this level is SAFE for disease prevention without ASSOCIATION of toxicity [56].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 162), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 282), ('SUPERFICIAL_RELATIONSHIP', 318)]	7	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 256, 'breast milk')]
PMC5634602	10/2017	S149-PMC5634602	['our results AGREE with PREVIOUS EVIDENCE that SUPPORTS an ASSOCIATION between Vitamin D status, Gestational age, and growth in premature infants.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'gestational')]
PMC5634602	10/2017	S150-PMC5634602	['the OPTIMAL dose of Vitamin D supplementation for preterm infants during the early Neonatal Period WARRANTS FURTHER INVESTIGATION, but it is REASONABLE and SAFE to RECOMMEND daily supplementation in addition to dietary intake with 800 iu of Vitamin D to high-risk preterm infants while hospitalized in the nicu in order to TARGET a level of 25(Oh)D that is >75 nmol/l, AS we HAVE SHOWN this to improve bone health defined by dexa in this AT-RISK population.']	[('IMPORTANT_CONSIDERATION', 4), ('FUTURE_WORK', 99), ('PROBABLE_UNDERSTANDING', 141), ('IMPORTANT_CONSIDERATION', 156), ('FUTURE_WORK', 164), ('FUTURE_WORK', 323), ('PROBABLE_UNDERSTANDING', 369), ('INCOMPLETE_EVIDENCE', 375), ('IMPORTANT_CONSIDERATION', 438)]	9	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0007221', 'neonate stage', 83, 'neonatal period'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 344, 'OH)D')]
PMC5659607	10/2017	S0-PMC5659607	['Prenatal Vitamin D supplementation reduces RISK of asthma/recurrent wheeze in early childhood: a combined analysis of two randomized controlled trials\n\nabstract\n\nbackground\nwe RECENTLY published two independent randomized controlled trials of Vitamin D supplementation during Pregnancy, both INDICATING a >20% reduced risk of asthma/recurrent wheeze in the offspring by 3 years of age.']	[('IMPORTANT_CONSIDERATION', 43), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 292)]	3	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('GO_0007565', 'female pregnancy', 276, 'pregnancy')]
PMC5659607	10/2017	S13-PMC5659607	['conclusions\nthis combined analysis SHOWS that Vitamin D supplementation during Pregnancy results in a significant reduced risk of asthma/recurrent wheeze in the offspring, ESPECIALLY among women with 25(Oh)D level ≥ 30 ng/ml at randomization, where the risk was almost halved.']	[('INCOMPLETE_EVIDENCE', 35), ('ANOMALY_CURIOUS_FINDING', 172)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 200, '25(OH)D')]
PMC5659607	10/2017	S15-PMC5659607	['trial registration\ncopsac2010: clinicaltrials.govnct00856947; vdaart: clinicaltrials.govnct00920621\n\nintroduction\nthere are several REASONS to HYPOTHESIZE that low in utero Vitamin D exposure increases risk of childhood asthma/recurrent wheeze: (1) Genetic studies HAVE SHOWN that polymorphisms in the Vitamin D Receptor are ASSOCIATED with childhood asthma susceptibility[1].']	[('PROBABLE_UNDERSTANDING', 132), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 325)]	4	[('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('SO_0000704', 'gene', 249, 'Genetic'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 302, 'vitamin D receptor')]
PMC5659607	10/2017	S17-PMC5659607	['(3) epidemiological studies HAVE SHOWN that high dietary Vitamin D intake during Pregnancy reduces the risk of asthma/recurrent wheeze in the offspring[4,5].']	[('INCOMPLETE_EVIDENCE', 28)]	1	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC5659607	10/2017	S19-PMC5659607	['THEREFORE, we RECENTLY conducted two independent randomized controlled trials (rcts) of increased Vitamin D supplementation during Pregnancy to prevent childhood asthma/recurrent wheeze in the offspring by age 3 years: the Vitamin D antenatal asthma reduction trial (vdaart[7]) and the copenhagen prospective studies on asthma in childhood 2010 (copsac2010[8]).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14)]	2	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 223, 'Vitamin D')]
PMC5659607	10/2017	S21-PMC5659607	['a recent meta-analysis SUGGESTED that INSUFFICIENT power DUE TO an OVERESTIMATION of the treatment effect MAY HAVE BEEN one of the ISSUES for the non-significance of the FINDINGS[11], BUT we HYPOTHESIZED that maternal 25(Oh)D level at trial entry MAY also have INFLUENCED the EFFECT of the Vitamin D supplementation[12].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 38), ('PROBLEM_COMPLICATION', 38), ('PROBLEM_COMPLICATION', 57), ('PROBLEM_COMPLICATION', 67), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 110), ('PROBLEM_COMPLICATION', 131), ('INCOMPLETE_EVIDENCE', 170), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 247), ('SUPERFICIAL_RELATIONSHIP', 261), ('SUPERFICIAL_RELATIONSHIP', 276)]	14	[('CHEBI_71657', 'versiconol acetate', 218, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 224, 'D'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
PMC5659607	10/2017	S68-PMC5659607	['HOWEVER, a literature search REVEALED one additional trial of Vitamin D supplementation in Pregnancy and subsequent asthma/recurrent wheeze performed by goldring et al., which DIFFERED markedly from our trials by enrolling 180 women at Pregnancy week 27 and randomizing them to either no Vitamin D, 800 iu Ergocalciferol daily until Delivery or a single oral bolus of 200,000 iu Cholecalciferol[22].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin D'), ('CHEBI_4910', 'etomidate', 306, 'ergocalciferol'), ('GO_0007567', 'parturition', 333, 'delivery'), ('CHEBI_52550', 'theopalauamide', 379, 'cholecalciferol')]
PMC5659607	10/2017	S72-PMC5659607	['the Vitamin D intervention resulted in a significant increase in the mothers post-interventional 25(Oh)D levels in both trials (table 1): in vdaart an increase from 23ng/ml to 39ng/ml and in copsac2010an increase from 31ng/ml to 43ng/ml, respectively.10.1371/journal.pone.0186657.t001\n\ncaption (table-wrap): table 1\ncharacteristics of the two trials.trialno.interventionduration of interventionfollow-upinclusion/ exclusion criteria25(Oh)D levels:control group (pre- to post-intervention)25(Oh)D levels: treatment group (pre- to post-intervention)asthma/ wheeze ESTIMATES (95% ci) vdaart, double blinded, multicenter rct, usa (2009) 806active: 4,000 + 400 iu/dplacebo:400 iu/dfrom 10–18 weeks of Gestation until Birth3 years of follow-up by quarterly phone calls andannual visits to the clinicinclusion: parental asthma, allergy or eczemaexclusion: maternal chronic disease23 ng/ml to 27 ng/ml23 ng/ml to 39 ng/mlhr: 0.8 (0.6–1.00)or: 0.72 (0.52–1.00) copsac2010, double blinded, single center rct, denmark (2008) 581active: 2,400 + 400 iu/dplacebo: 400 iu/dfrom 22–26 weeks of Gestation until 1 week Postpartum3 years of follow-up with visits to the clinic at age 1\xa0week, 1, 3, 6, 12, 18, 24, 30, 36 months and at acute Airway symptoms, plus a daily diaryinclusion: no criteriaexclusion: maternal chronic disease31 ng/ml to 29 ng/ml31 ng/ml to 43 ng/mlhr: 0.76 (0.52–1.12)or: 0.77 (0.5–1.18)\nin vdaart, 625 women (78%) had an initial 25(Oh)D level <30 ng/ml (307 received Vitamin d and 318 placebo) and 176 women (22%) had a level ≥30 ng/ml at trial entry (95 received Vitamin D and 81 placebo).']	[('INCOMPLETE_EVIDENCE', 562)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 97, '25(OH ... D'), ('CHEBI_33010', 'chromide(1-)', 434, '(OH)D'), ('CHEBI_71657', 'versiconol acetate', 488, '25(OH)D'), ('GO_0007565', 'female pregnancy', 696, 'gestation'), ('GO_0007567', 'parturition', 712, 'birth3'), ('GO_0007565', 'female pregnancy', 1078, 'gestation'), ('GO_0007565', 'female pregnancy', 1101, 'postpartum3'), ('UBERON_0001005', 'respiratory airway', 1221, 'airway'), ('CHEBI_71657', 'versiconol acetate', 1435, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1435, '25(OH ... D'), ('CHEBI_33229', 'vitamin (role)', 1473, 'vitamin'), ('CHEBI_27300', 'vitamin D', 1570, 'vitamin D')]
PMC5659607	10/2017	S74-PMC5659607	['primary end-point\n\nasthma/recurrent wheeze\na total of 218 (29%) children were diagnosed with asthma/recurrent wheeze in the vdaart trial and 104 (18%) in copsac2010during the first 3 years of Life ( table 2 ).10.1371/journal.pone.0186657.t002\n\ncaption (table-wrap): table 2\nend-points in the two trials at age 0–3 years.end-point:copsac2010(581)vdaart (806)asthma/recurrent wheeze18% (104 of 581)29% (218 of 748)eczema25% (143 of 581)23% (172 of 751)lrti24% (139 of 581)33% (266 of 806)specific Ige ≥ 0.35 kua/l: Milk, egg, Cat, Dog8% (39 of 471)39% (212 of 544)median (iqr) total Ige, ku/l4.56 (2.50–8.79)31.5 (11.5–103)\na combined analysis of the calculated odds-ratios from the separate trials SHOWED a significant 26% reduced risk of asthma/recurrent wheeze in the Vitamin D vs. control group: or = 0.74 (95% ci, 0.57 to 0.96), p = 0.02 (fig 2aandtable 3), with no heterogeneity among the trials: i2= 0%, p = 0.89.10.1371/journal.pone.0186657.g002\n\ncaption (fig): fig 2\nforest plots of the combined analyses of asthma/recurrent wheeze in copsac2010and vdaart.']	[('INCOMPLETE_EVIDENCE', 697)]	1	[('UBERON_0000104', 'life cycle', 192, 'life'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 495, 'IgE'), ('UBERON_0001913', 'milk', 513, 'milk'), ('NCBITaxon_33208', 'Metazoa', 524, 'cat'), ('NCBITaxon_33208', 'Metazoa', 529, 'dog8'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 581, 'IgE'), ('CHEBI_27300', 'vitamin D', 769, 'vitamin D')]
PMC5659607	10/2017	S94-PMC5659607	['an analysis of initial 25(Oh)D level and randomization group, SHOWED a lower risk of asthma/recurrent wheeze in women with 25(Oh)D level ≥ 30ng/ml and randomized to Vitamin D (women with initial 25(Oh)D <30 ng/ml and randomized to Placebo as reference), or = 0.58 (0.37–0.91), p = 0.02, i2= 0%, p = 0.35.']	[('INCOMPLETE_EVIDENCE', 62)]	1	[('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('PR_000010220', 'mannose-binding protein C', 25, '('), ('PR_000006444', 'diacylglycerol kinase delta', 29, 'D'), ('CHEBI_30778', 'gallic acid', 123, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 129, 'D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 195, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 195, '25(OH ... D'), ('CHEBI_26130', 'biological pigment', 231, 'placebo')]
PMC5659607	10/2017	S97-PMC5659607	['SHOWED similar results with a significantly reduced risk of asthma/wheeze at 3 years of age in the Vitamin D intervention group, compared to controls: or = 0.76 (95% ci, 0.59–0.96), p = 0.02 ( fig 3 ), with little variation among the included studies: i2= 0%, p = 0.97.10.1371/journal.pone.0186657.g003\n\ncaption (fig): fig 3\nforest plots of the meta-analysis of asthma/recurrent wheeze in all three published randomized trials of Vitamin D intervention in Pregnancy and subsequent asthma/recurrent wheeze at age 3 years.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 430, 'vitamin D'), ('GO_0007565', 'female pregnancy', 456, 'pregnancy')]
PMC5659607	10/2017	S99-PMC5659607	['the combined analysis of the Vitamin D intervention SHOWED no effect on development of elevated total Ige level (above the median): or = 0.90 (0.71 to 1.16), p = 0.46 ( table 4 ), i2= 0%, p = 0.46.']	[('INCOMPLETE_EVIDENCE', 52)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 102, 'IgE')]
PMC5659607	10/2017	S105-PMC5659607	['the combined analysis SHOWED no effect of the Vitamin D intervention on the risk of developing elevated specific Ige: or = 1.08 (0.69 to 1.67), p = 0.78 ( table 4 ), i2= 35%, p = 0.22.this also applied for analyses restricted to inhalant and Food Allergens (data not shown).']	[('INCOMPLETE_EVIDENCE', 22)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 113, 'IgE'), ('CHEBI_33290', 'food', 242, 'food'), ('CHEBI_33663', 'cyclic hydrocarbon', 247, 'allergens')]
PMC5659607	10/2017	S107-PMC5659607	['the combined analysis SHOWED no effect of the Vitamin D intervention on the risk of developing eczema: or = 0.90 (0.70 to 1.17), p = 0.44 (table 4), i2= 0%, p = 0.88.']	[('INCOMPLETE_EVIDENCE', 22)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC5659607	10/2017	S111-PMC5659607	['these analyses yielded results SIMILAR as the random effects meta-analyses (table 5), with or = 0.75 (0.57 to 0.97), p = 0.03 for development of asthma/recurrent wheeze.10.1371/journal.pone.0186657.t005\n\ncaption (table-wrap): table 5\nmeta-analyses of individual patient data (ipd), of Vitamin D vs. Placebo on the primary and secondary end-points at age 0–3.']	[('INCOMPLETE_EVIDENCE', 31)]	1	[('CHEBI_27300', 'vitamin D', 285, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 299, 'placebo')]
PMC5659607	10/2017	S113-PMC5659607	['Lower Respiratory Tract infections (lrti) are analyzed by poisson regression model.Vitamin D vs.placeboipdor (95% ci)asthma/ recurrent wheeze0.75 (0.57–0.97)p = 0.03total Ige > median0.93 (0.73–1.18)p = 0.43specific Ige > 0.35ku/l1.05 (0.77–1.43)p = 0.78eczema0.91 (0.71–1.18)p = 0.47lrti0.92 (0.75–1.14)p = 0.44\n\ndiscussion\nin THIS combined analysis of the two largest rcts to date of Vitamin D supplementation during Pregnancy, we SHOWED that the supplementation resulted in a significant and clinically IMPORTANT 26% reduced risk of asthma/recurrent wheeze in the offspring until age 3, with a more pronounced 46% reduced risk if the women had 25(Oh)d level ≥30ng/ml at trial entry.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 328), ('INCOMPLETE_EVIDENCE', 433), ('IMPORTANT_CONSIDERATION', 506)]	3	[('UBERON_0004905', 'articulation', 0, 'Lower respiratory tract'), ('CHEBI_28384', 'vitamin K', 83, 'Vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 171, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 216, 'IgE'), ('CHEBI_27300', 'vitamin D', 386, 'vitamin D'), ('GO_0007565', 'female pregnancy', 419, 'pregnancy'), ('CHEBI_63056', 'zinc cation', 647, '25(OH')]
PMC5659607	10/2017	S114-PMC5659607	['these results UNDERLINE that Vitamin D supplementation during Pregnancy MAY BE an IMPORTANT FACTOR in the PREVENTION of childhood asthma.']	[('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 72), ('IMPORTANT_CONSIDERATION', 82), ('SUPERFICIAL_RELATIONSHIP', 92), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy')]
PMC5659607	10/2017	S120-PMC5659607	['DESPITE these DIFFERENCES, the trials SIMILARLY SHOWED that the Vitamin D supplementation resulted in significantly increased post-interventional 25(Oh)D levels in the mothers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 48)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 146, '25(OH ... D')]
PMC5659607	10/2017	S130-PMC5659607	['furthermore, including a third trial of Vitamin D supplementation in the meta-analysis, which intervened at a later Pregnancy stage (week 27) and with a much lower dose (800 iu/day) [22] also SHOWED an overall PROTECTIVE EFFECT of Vitamin D on Development Of Asthma/recurrent Wheeze.']	[('INCOMPLETE_EVIDENCE', 192), ('SUPERFICIAL_RELATIONSHIP', 210), ('SUPERFICIAL_RELATIONSHIP', 221)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0009602', 'detection of symbiont', 244, 'development of asthma'), ('GO_0006386', 'termination of RNA polymerase III transcription', 276, 'wheeze')]
PMC5659607	10/2017	S131-PMC5659607	['INTERPRETATION\nthis combined analysis of our two Vitamin D rcts SHOWED a significant 26% reduced risk of the primary end-point asthma/recurrent wheeze during the first 3 years of Life, which SUGGESTS that the non-significant/borderline significant trial responses OBSERVED in the individual intent-to-treat analyses were PARTLY due to LACK OF power caused by an OVERESTIMATION of the treatment effect, RATHER than lack of an intervention effect.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 321), ('INCOMPLETE_EVIDENCE', 335), ('ANOMALY_CURIOUS_FINDING', 340), ('PROBLEM_COMPLICATION', 362), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 402)]	9	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 179, 'life')]
PMC5659607	10/2017	S132-PMC5659607	['a recent meta-analysis SUPPORTS our finding of a significant reduction in asthma/wheeze from Prenatal Vitamin D supplementation[11].']	[('INCOMPLETE_EVIDENCE', 23)]	1	[('GO_0007565', 'female pregnancy', 93, 'prenatal'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5659607	10/2017	S135-PMC5659607	['to explore that ISSUE, we performed the combined analyses stratified for the women’s 25(Oh)D level at trial entry, which SHOWED that the Vitamin D supplement resulted in a significantly reduced RISK of asthma/recurrent wheeze in the offspring of women with 25(Oh)D ≥ 30 ng/ml, BUT a much SMALLER and statistically non-significant EFFECT among women with 25(Oh)D < 30 ng/ml.']	[('PROBLEM_COMPLICATION', 16), ('INCOMPLETE_EVIDENCE', 121), ('IMPORTANT_CONSIDERATION', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 277), ('INCOMPLETE_EVIDENCE', 288), ('SUPERFICIAL_RELATIONSHIP', 330)]	6	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 257, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 257, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 354, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 354, '25(OH)D')]
PMC5659607	10/2017	S136-PMC5659607	['this FINDING is CONTRARY to what MANY have SUGGESTED that ONLY those who are deficient in Vitamin D would BENEFIT from supplementation.']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 43), ('ANOMALY_CURIOUS_FINDING', 58), ('IMPORTANT_CONSIDERATION', 106)]	6	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5659607	10/2017	S138-PMC5659607	['when the two trials were initiated, IT WAS THOUGHT that the EFFECTS of Vitamin D were confined to the Alveolar stage of Lung Development, occurring in the third Trimester of Pregnancy[28].']	[('ANOMALY_CURIOUS_FINDING', 36), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0003215', 'alveolus', 102, 'alveolar'), ('GO_0030324', 'lung development', 120, 'lung development'), ('UBERON_0002048', 'lung', 120, 'lung'), ('GO_0009294', 'DNA mediated transformation', 161, 'trimester'), ('GO_0007565', 'female pregnancy', 174, 'pregnancy')]
PMC5659607	10/2017	S139-PMC5659607	['HOWEVER, EMERGING EVIDENCE arising from Lung Gene Expression data from our own lab have SUBSEQUENTLY SHOWN that Vitamin D already has EFFECTS at the stage of Branching Morphogenesis of the fetal Lung occurring in the first Trimester of Pregnancy prior to randomization in both these trials[2].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 134)]	4	[('UBERON_0002048', 'lung', 40, 'lung'), ('GO_0010467', 'gene expression', 45, 'gene expression'), ('SO_0000704', 'gene', 45, 'gene'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0001763', 'morphogenesis of a branching structure', 158, 'branching morphogenesis'), ('UBERON_0002048', 'lung', 195, 'lung'), ('GO_0009294', 'DNA mediated transformation', 223, 'trimester'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]
PMC5659607	10/2017	S141-PMC5659607	['in addition, AS Human fertility is also INFLUENCED by Vitamin D[29,30], it MAY EVEN be worthwhile to TARGET supplementation before Conception to optimize Implantation of the Fertilized Egg and assure sufficient Vitamin D for Lung and Immune Development from the very beginning of Life.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 75), ('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 101)]	5	[('NCBITaxon_9606', 'Homo sapiens', 16, 'human'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007620', 'copulation', 131, 'conception'), ('GO_0007566', 'embryo implantation', 154, 'implantation'), ('GO_0009566', 'fertilization', 174, 'fertilized'), ('CL_0000025', 'egg cell', 185, 'egg'), ('UBERON_0007379', 'shelled egg', 185, 'egg'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('GO_0006266', 'DNA ligation', 225, 'lung ...'), ('UBERON_0002048', 'lung', 225, 'lung'), ('GO_0001822', 'kidney development', 234, 'immune development'), ('UBERON_0002405', 'immune system', 234, 'immune'), ('UBERON_0000104', 'life cycle', 280, 'life')]
PMC5659607	10/2017	S142-PMC5659607	['our combined analysis also SUGGESTS that we MAY have used an INSUFFICIENT dosage of Vitamin D in both the trials.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 44), ('IMPORTANT_CONSIDERATION', 61), ('PROBLEM_COMPLICATION', 61)]	4	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC5659607	10/2017	S144-PMC5659607	['we OBSERVED that the Vitamin D supplement resulted in a significant increase in post-interventional maternal 25(Oh)D level in both trials, BUT levels ≥ 30 ng/ml were ONLY achieved in 75% of the supplemented mothers in vdaart and 82% in copsac2010underscoring that too low a dose MAY have attenuated the trial results in both trials but to a greater extent in vdaart POSSIBLY because of the increased african american enrollment.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 139), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 279), ('INCOMPLETE_EVIDENCE', 366)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 109, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 109, '25(OH ... D')]
PMC5659607	10/2017	S145-PMC5659607	['the LACK OF effect of the Vitamin D supplement among women with low 25(Oh)D levels at trial entry also SUGGESTS that the dose MIGHT have been too low to reverse developmental changes caused by insufficient Vitamin D exposure before the supplementation was initiated.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 126)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 68, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 74, 'D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
PMC5659607	10/2017	S148-PMC5659607	['this is CONSISTENT with a RECENT rct SHOWING no effect on Cat specific Ige levels, WHEREAS decreased house-Dust Mite specific Ige was SHOWN in the offspring of mothers supplemented with Vitamin D during Pregnancy[31].']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('INCOMPLETE_EVIDENCE', 134)]	5	[('NCBITaxon_33208', 'Metazoa', 58, 'cat'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 71, 'IgE'), ('NCBITaxon_10088', 'Mus <genus>', 107, 'dust'), ('NCBITaxon_10088', 'Mus <genus>', 112, 'mite'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 126, 'IgE'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC5659607	10/2017	S151-PMC5659607	['combining this KNOWLEDGE with OUR FINDINGS from THIS combined analysis, SHOWING that Vitamin D supplementation has a PROTECTIVE EFFECT on childhood asthma/recurrent wheeze, makes Vitamin D a very PROMISING Nutrient for FUTURE PREVENTION of Immune-mediated disorders.']	[('FUTURE_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 128), ('PROBABLE_UNDERSTANDING', 196), ('FUTURE_WORK', 219), ('SUPERFICIAL_RELATIONSHIP', 226)]	9	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('UBERON_0002405', 'immune system', 240, 'immune')]
PMC5659607	10/2017	S153-PMC5659607	['conclusion\nthis combined analysis SHOWS a significant and clinically IMPORTANT 26% PROTECTIVE EFFECT of Vitamin D supplementation during Pregnancy on the RISK of asthma/recurrent wheeze in the offspring, with a more pronounced risk reduction of 46% in women with 25(Oh)D level ≥ 30 ng/ml at trial entry.']	[('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 69), ('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 94), ('IMPORTANT_CONSIDERATION', 154)]	5	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 263, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 263, '25(OH)D')]
PMC5134748	11/2017	S85-PMC5134748	['we also FOUND lower Consumption of Vitamin C in the women with spontaneous Abortion.']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('GO_0007631', 'feeding behavior', 20, 'consumption'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin C'), ('GO_0007569', 'cell aging', 75, 'abortion')]
PMC5134748	11/2017	S87-PMC5134748	['(25), they have FOUND that antioxidant elements including Vitamin C decreased in case group in comparison with healthy Pregnant women.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('CHEBI_27300', 'vitamin D', 58, 'vitamin C'), ('GO_0007565', 'female pregnancy', 119, 'pregnant')]
PMC5679631	11/2017	S0-PMC5679631	['INFLUENCE of Vitamin D on key bacterial taxa in infant microbiota in the koala Birth cohort study\n\nabstract\nVitamin D has immunomodulatory properties giving it the POTENTIAL to AFFECT Microbial Colonization Of the Intestinal Tract.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 177)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007567', 'parturition', 79, 'Birth'), ('CHEBI_28384', 'vitamin K', 108, 'Vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 184, 'microbial'), ('GO_0042680', 'compound eye cone cell fate determination', 194, 'colonization of ... intestinal tract'), ('UBERON_0001555', 'digestive tract', 214, 'intestinal tract')]
PMC5679631	11/2017	S14-PMC5679631	['these data SUGGEST that Vitamin D INFLUENCES the abundance of several key bacterial taxa within the infant microbiota.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 34)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5679631	11/2017	S15-PMC5679631	['given that Intestinal Microbiotic Homeostasis MAY BE an IMPORTANT FACTOR in the PREVENTION of Immune mediated diseases and that Vitamin D status is a MODIFIABLE FACTOR, FURTHER INVESTIGATION of the IMPACT of Postnatal Vitamin D supplementation SHOULD BE conducted in older infants.']	[('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 150), ('SUPERFICIAL_RELATIONSHIP', 161), ('FUTURE_WORK', 169), ('SUPERFICIAL_RELATIONSHIP', 198), ('FUTURE_WORK', 244)]	9	[('UBERON_0000160', 'intestine', 11, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 22, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 22, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007567', 'parturition', 208, 'postnatal'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC5679631	11/2017	S22-PMC5679631	['in addition, a study of sepsis patients DEMONSTRATED a positive ASSOCIATION between Vitamin D status and Plasma Cathelicidin concentrations [10].']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 105, 'plasma'), ('CHEBI_3364', 'Canthiumine', 112, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 112, 'cathelicidin')]
PMC5679631	11/2017	S26-PMC5679631	['GIVEN that Vitamin D status is a MODIFIABLE FACTOR which MAY INFLUENCE Intestinal Microbiotic Homeostasis, which in turn is INDICATED to be IMPORTANT in the prevention of Immune mediated diseases, we INVESTIGATED WHETHER maternal use of multivitamin supplements containing Vitamin D, maternal Vitamin D status (25 Hydroxyvitamin D (25(Oh)D), OR administration of Vitamin D supplement to the baby INFLUENCES the presence and abundance of several key bacterial taxa of the infant Gut microbiota.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 140), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 342), ('SUPERFICIAL_RELATIONSHIP', 396)]	11	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 82, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 82, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 171, 'immune'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 311, '25 hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 332, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 478, 'gut')]
PMC5679631	11/2017	S36-PMC5679631	['data regarding POSSIBLE CONFOUNDERS and Vitamin D exposure through Supplement use was assessed from questionnaires sent to all parents at 34 weeks of Gestation, the time of Fecal sampling and 3 months Postpartum, respectively.']	[('INCOMPLETE_EVIDENCE', 15), ('PROBLEM_COMPLICATION', 24)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 67, 'supplement'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('UBERON_0000922', 'embryo', 173, 'fecal'), ('GO_0007565', 'female pregnancy', 201, 'postpartum')]
PMC5679631	11/2017	S42-PMC5679631	['diet and sunlight exposure were NOT CONSIDERED AS 25(Oh)D concentrations were measured in mothers providing an estimation of exposure based on all sources and only “yellow fat spreads” were fortified with Vitamin D in the netherlands at the time of the study.']	[('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 47)]	2	[('CHEBI_71657', 'versiconol acetate', 50, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC5679631	11/2017	S69-PMC5679631	['due TO the study design, we tested for POSSIBLE INTERACTION between Vitamin D exposure and recruitment group (conventional/alternative).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5679631	11/2017	S89-PMC5679631	['use of multivitamin supplements containing Vitamin D and maternal obesity were ASSOCIATED with maternal 25(Oh)D level during both low and high seasons, WHILE recruitment group was significantly ASSOCIATED with 25(Oh)D concentration ONLY during the high season.10.1371/journal.pone.0188011.t002\n\ncaption (table-wrap): table 2\nmean maternal 25(Oh)D concentration according to season of Blood sampling and use of multivitamin supplements containing Vitamin D.Blood sampling in high season of cutaneous Vitamin D productionblood sampling in low season of cutaneous Vitamin D production maternal use of multivitamin supplement containing Vitamin Dmaternal Plasma 25(Oh)d nmol/lmaternal Plasma 25(Oh)D nmol/l no (mean (sd))45.2 (17.0)30.1 (13.5)yes (mean (sd))53.3 (17.8)40.9 (16.1)p value&p = 0.000p = 0.000model # beta (95% ci)beta (95% ci) constant52.7 (47.7, 57.7)34.6 (29.5, 39.7)maternal use of multivitamin supplement containing Vitamin D (yes vs .']	[('SUPERFICIAL_RELATIONSHIP', 79), ('ANOMALY_CURIOUS_FINDING', 152), ('SUPERFICIAL_RELATIONSHIP', 194), ('INCOMPLETE_EVIDENCE', 232)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 210, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 210, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 339, '25 ... OH ... D'), ('UBERON_0000178', 'blood', 384, 'blood'), ('CHEBI_27300', 'vitamin D', 446, 'vitamin D'), ('UBERON_0000178', 'blood', 456, 'Blood'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_61716', 'alpha-Kdo-CH2OH-(2->4)-alpha-Kdo', 633, 'vitamin DMaternal'), ('UBERON_0001969', 'blood plasma', 651, 'Plasma'), ('CHEBI_63056', 'zinc cation', 658, '25(OH'), ('UBERON_0001969', 'blood plasma', 681, 'Plasma'), ('CHEBI_71657', 'versiconol acetate', 688, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 930, 'vitamin D')]
PMC5679631	11/2017	S92-PMC5679631	['conventional recruitment group -4.6 (-7.8, -1.4) -3.1 (-6.4, 0.3)\nhigh season = april–october, low season = november–march; overweight = body mass index > 90thpercentile;\n&unpaired t-test;\n#regression coefficients (beta) from multivariable linear regression analysis INDICATE the difference in maternal Plasma 25(Oh)D in nmol/l between the group of mothers taking multivitamin supplement containing Vitamin D and those who did not while controlling for the other factors in the model\n\nmaternal Vitamin D intake through use of multivitamin supplements containing Vitamin d\nmaternal use of multivitamin supplements containing Vitamin D was not associated with the prevalence of any of the bacteria in both the unadjusted and adjusted analyses (data not shown).']	[('INCOMPLETE_EVIDENCE', 267)]	1	[('UBERON_0001969', 'blood plasma', 303, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 310, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 310, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 494, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 562, 'vitamin'), ('CHEBI_27300', 'vitamin D', 624, 'vitamin D')]
PMC5679631	11/2017	S93-PMC5679631	['there was a statistically significant negative linear TREND between categories of maternal Vitamin D supplementation and counts of bifidobacterium spp.']	[('INCOMPLETE_EVIDENCE', 54)]	1	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC5679631	11/2017	S96-PMC5679631	['the trend for bifidobacteria REMAINED statistically significant following correction for multiple testing using the fdr.10.1371/journal.pone.0188011.t003\n\ncaption (table-wrap): table 3\nassociation between maternal use of multivitamin supplements containing Vitamin D and log10colony forming units of bacterial species or groups in infants colonized with the respective bacteria.maternal use of multivitamin supplements containing vitamin dmaternal multivitamin supplementation containing Vitamin dbacteria&nunadjusted b (95% ci)#adjusted b (95% ci)none bifidobacterium spp.']	[('INCOMPLETE_EVIDENCE', 29)]	1	[('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 488, 'vitamin')]
PMC5679631	11/2017	S115-PMC5679631	['discussion\nthe OBJECTIVE of THIS STUDY was TO INVESTIGATE the POTENTIAL of Vitamin D to INFLUENCE the presence and or abundance of several key bacterial taxa within the infant Intestinal microbiota.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 88)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0000160', 'intestine', 176, 'intestinal')]
PMC5679631	11/2017	S116-PMC5679631	['we THEORIZED that Vitamin D COULD IMPACT Intestinal colonization due to its immunomodulatory EFFECTS [17,18]; namely, through its inhibition of Intestinal infections via stimulated Antimicrobial Peptide Production and promotion of anti-Inflammatory Responses by the Immune System.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 3), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 93)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000160', 'intestine', 41, 'intestinal'), ('UBERON_0000160', 'intestine', 144, 'intestinal'), ('CHEBI_65381', 'albizoside C', 181, 'antimicrobial'), ('GO_0001519', 'peptide amidation', 195, 'peptide production'), ('GO_0006888', 'endoplasmic reticulum to Golgi vesicle-mediated transport', 236, 'inflammatory responses'), ('UBERON_0002405', 'immune system', 266, 'immune system')]
PMC5679631	11/2017	S117-PMC5679631	['the abundance of several bacterial taxa in infant Fecal samples at one month after Birth was shown to be ASSOCIATED with pre- or Postnatal Vitamin D exposure, supporting the POSTULATION that Vitamin D CAN INFLUENCE the composition of the Intestinal microbiota.']	[('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 201), ('SUPERFICIAL_RELATIONSHIP', 205)]	4	[('UBERON_0000922', 'embryo', 50, 'fecal'), ('GO_0007567', 'parturition', 83, 'birth'), ('GO_0007567', 'parturition', 129, 'postnatal'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('UBERON_0000160', 'intestine', 238, 'intestinal')]
PMC5679631	11/2017	S122-PMC5679631	['the function of Vitamin D in Regulating Amp Production, THEREFORE, SUGGESTS that Vitamin D status COULD INFLUENCE the composition of the Intestinal microbiota.']	[('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0065007', 'biological regulation', 29, 'regulating'), ('CHEBI_16027', "adenosine 5'-monophosphate", 40, 'AMP'), ('GO_0006754', 'ATP biosynthetic process', 40, 'AMP production'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000160', 'intestine', 137, 'intestinal')]
PMC5679631	11/2017	S128-PMC5679631	['a state of Vitamin D deficiency resulting in a pro-inflammatory state and INCREASED susceptibility to Intestinal infections, THEREFORE, MAY lead to altered microbial colonization known as Dysbiosis or disturbance of the balance between beneficial commensal and pathogenic species [24].']	[('IMPORTANT_CONSIDERATION', 74), ('PROBABLE_UNDERSTANDING', 125), ('INCOMPLETE_EVIDENCE', 136)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000160', 'intestine', 102, 'intestinal'), ('GO_0046067', 'dGDP catabolic process', 188, 'dysbiosis')]
PMC5679631	11/2017	S129-PMC5679631	['in SUMMARY, the ROLE of Vitamin D is MOST LIKELY to Regulate the Immune Response to maintain Immune Homeostasis [25] by balancing activation of tolerance and the innate Immune System.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 16), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 42)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 52, 'regulate'), ('GO_0006955', 'immune response', 65, 'immune response'), ('UBERON_0002405', 'immune system', 65, 'immune'), ('GO_0055090', 'acylglycerol homeostasis', 93, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 93, 'immune'), ('GO_0007566', 'embryo implantation', 169, 'immune'), ('UBERON_0002405', 'immune system', 169, 'immune system')]
PMC5679631	11/2017	S130-PMC5679631	['ALTHOUGH Vitamin D promotes Immune tolerance, adequate Adaptive Immune Response, as measured by Igg Production in response to infection or vaccination, HAS BEEN observed in patients with relatively high Serum 25(Oh)D levels, SUGGESTING that Vitamin D maintains Immune stability by preventing excessive Immune Responses in EITHER direction [26].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 225), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 322)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0002405', 'immune system', 28, 'immune'), ('GO_0002250', 'adaptive immune response', 55, 'adaptive immune response'), ('UBERON_0002405', 'immune system', 64, 'immune'), ('GO_0032608', 'interferon-beta production', 96, 'IgG production'), ('GO_0071735', 'IgG immunoglobulin complex', 96, 'IgG'), ('UBERON_0001977', 'blood serum', 203, 'serum'), ('CHEBI_71657', 'versiconol acetate', 209, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 209, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('UBERON_0002405', 'immune system', 261, 'immune'), ('GO_0006955', 'immune response', 302, 'immune responses'), ('UBERON_0002405', 'immune system', 302, 'immune')]
PMC5679631	11/2017	S131-PMC5679631	['investigations studying the EFFECT of Vitamin D status on the composition of the Intestinal microbiota are FEW; ONE STUDY was performed in Vitamin D deficient Mice and two investigations in Humans examined the ROLE of Vitamin D as secondary questions.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 210)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000160', 'intestine', 81, 'intestinal'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 159, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 190, 'humans'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC5679631	11/2017	S132-PMC5679631	['COMPATIBLE with our PRESENT STUDY, the results of these three investigations SUGGEST that Vitamin D MAY play a ROLE in shaping the Intestinal microbiota.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 111)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('UBERON_0000160', 'intestine', 131, 'intestinal')]
PMC5679631	11/2017	S134-PMC5679631	['in Humans, a study investigating variation in diet and microbial composition of the Intestinal Tract between 52 african americans and 46 caucasian americans FOUND DISCORDANT Vitamin D supplementation practices and differences between the counts of bacteroidetes in the Fecal samples between the two groups [28].']	[('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163)]	2	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('UBERON_0001555', 'digestive tract', 84, 'intestinal tract'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('UBERON_0000922', 'embryo', 269, 'fecal')]
PMC5679631	11/2017	S138-PMC5679631	['the INFLUENCE of direct Vitamin D supplementation of the child DIFFERED between the two recruitment groups SUGGESTING that lifestyle factors are Modulating the ASSOCIATION between Vitamin D and the Intestinal bacterial Taxa.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 145, 'modulating'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('UBERON_0000160', 'intestine', 198, 'intestinal'), ('NCBITaxon_10088', 'Mus <genus>', 219, 'taxa')]
PMC5679631	11/2017	S142-PMC5679631	['g ., health ISSUES leading to the choice of an alternative lifestyle, COULD BE modifying the EFFECT of Vitamin D on the Intestinal bacteria and, THEREFORE, recruitment group was adjusted for in the multivariable analyses.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 93), ('PROBABLE_UNDERSTANDING', 145)]	4	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0000160', 'intestine', 120, 'intestinal')]
PMC5679631	11/2017	S151-PMC5679631	['the number of infants not administered Vitamin D supplementation was low because it is standard PRACTICE to supplement Breast Fed children with Vitamin D, and the lower prevalence of colonization with these bacteria also CONTRIBUTED to this LIMITATION.']	[('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 221), ('INCOMPLETE_EVIDENCE', 241)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007567', 'parturition', 119, 'breast'), ('UBERON_0000310', 'breast', 119, 'breast'), ('GO_0007631', 'feeding behavior', 126, 'fed'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC5679631	11/2017	S159-PMC5679631	['TO OUR KNOWLEDGE, THIS is the FIRST report of a large scale observational study INDICATING that Prenatal Vitamin D exposure, AS measured either by maternal use of multivitamin supplements containing Vitamin D, or 25(Oh)D quintiles, INFLUENCES several IMPORTANT bacterial taxa within the infant Gut.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 80), ('PROBABLE_UNDERSTANDING', 125), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 251)]	7	[('GO_0007565', 'female pregnancy', 96, 'prenatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('UBERON_0001555', 'digestive tract', 294, 'gut')]
PMC5682869	11/2017	S24-PMC5682869	['supplementation of Vitamin A is SUGGESTED to be restricted only to areas where Vitamin A deficiency is a substantial PUBLIC HEALTH PROBLEM.']	[('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 117), ('IMPORTANT_CONSIDERATION', 131), ('PROBLEM_COMPLICATION', 131)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A')]
PMC5682869	11/2017	S46-PMC5682869	['HOWEVER, still a well-balanced ovo-lacto vegetarian diet USUALLY enables good Nutrient status in Pregnancy, when supplemented with Vitamin D, Folic Acid, Iodine, iron, Vitamin B12 and zinc, and, in cases of a fish-free diet, with Dha [19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 57)]	2	[('CHEBI_33284', 'nutrient', 78, 'nutrient'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_30751', 'formic acid', 142, 'folic acid'), ('CHEBI_24859', 'iodine atom', 154, 'iodine'), ('CHEBI_33279', 'vitamin D5', 168, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 176, 'B12'), ('CHEBI_17874', 'dihydrozeatin', 230, 'DHA')]
PMC5682869	11/2017	S76-PMC5682869	['EARLY STUDIES concerning Vitamin D in Pregnancy SHOWED an ASSOCIATION with Preeclampsia and caesarean section but also Glucose tolerance, abnormal foetal Grown pattern, Preterm Birth and Reproductive failure.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 75, 'preeclampsia'), ('CHEBI_17234', 'glucose', 119, 'glucose'), ('GO_0040007', 'growth', 154, 'grown'), ('GO_0007565', 'female pregnancy', 169, 'preterm'), ('GO_0007567', 'parturition', 177, 'birth'), ('GO_0000003', 'reproduction', 187, 'reproductive')]
PMC5706533	11/2017	S0-PMC5706533	['Vitamin D supplementation during Pregnancy: state of the evidence from a systematic review of randomised trials\n\nabstract\nobjectives \xa0TO ESTIMATE the EFFECTS of Vitamin D supplementation during Pregnancy on 11 maternal and 27 neonatal/infant outcomes; TO DETERMINE frequencies at which trial outcome data were missing, unreported, or inconsistently reported; and to project the POTENTIAL contributions of registered ongoing or planned trials.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 134), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 150), ('QUESTION_ANSWERED_BY_THIS_WORK', 252), ('INCOMPLETE_EVIDENCE', 378)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 194, 'pregnancy')]
PMC5706533	11/2017	S10-PMC5706533	['there was STRONG EVIDENCE that Prenatal Vitamin D reduced the risk of offspring wheeze by age 3 years (0.81, 0.67 to 0.98; two comparisons).']	[('INCOMPLETE_EVIDENCE', 10)]	1	[('GO_0007565', 'female pregnancy', 31, 'prenatal'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC5706533	11/2017	S14-PMC5706533	['conclusions \xa0most trials on Prenatal Vitamin D published by september 2017 were SMALL and of low quality.']	[('INCOMPLETE_EVIDENCE', 80)]	1	[('GO_0007565', 'female pregnancy', 28, 'prenatal'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5706533	11/2017	S18-PMC5706533	['beyond its established INFLUENCE on bone growth and Calcium Homeostasis,1vitamin D and its RELATED Metabolites have HYPOTHESISED EFFECTS on the risk of Cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions RELATED to Pregnancy (such as pre-eclampsia, Gestational diabetes), and Birth outcomes.6concern that Vitamin D deficiency is a global PUBLIC HEALTH PROBLEM HAS BEEN sparked by numerous REPORTS of the high proportion of Individuals in studies throughout the world who have relatively low Serum/Plasma concentrations of 25-hydroxyvitamin d (25(Oh)D),7the conventional circulating BIOMARKER of Vitamin D status.8there HAS BEEN particular ATTENTION to the high prevalence of vitamin d deficiency in Pregnant women and newborns.7\nin 2010, dietary reference intakes for Vitamin D for canada and the us from the institute of medicine were based solely on bone health—particularly in young children (for instance, rickets) and older Adults (for instance, osteoporosis).1considerable SKEPTICISM was cast onto the LINK between Vitamin D and Extraskeletal health conditions or the POTENTIAL benefits (versus risks) of intakes larger than the recommended dietary allowance (600 iu/day for MOST children and Adults).1THE institute’s report DID NOT RECOMMEND higher intakes during Pregnancy and Lactation.1a 2016 update of the cochrane collaboration systematic review and meta-analysis of trials of Vitamin D in Pregnancy (versus placebo or no Supplement), HOWEVER, TENTATIVELY CONCLUDED that Prenatal Vitamin D supplementation “MAY reduce the risk of pre-eclampsia, low birthweight and Preterm Birth.”6other RECENT systematic reviews that included trials with active control arms (in which participants received Vitamin D) ACKNOWLEDGED the POTENTIAL EFFECT of Vitamin D on fetal growth910but DID NOT FIND evidence of EFFECTS on OTHER maternal, fetal, or infant outcomes.91011citing the 2016 cochrane review,6the world health organization guidelines for Antenatal care ADVISE against routine Vitamin D supplementation in Pregnancy.12dietary and supplementation RECOMMENDATIONS, HOWEVER, vary widely across other professional organisations (appendix 1), and there REMAINS a LACK OF CONSENSUS on target health outcomes, indications for Prenatal supplementation, or EVIDENCE BASED regimens for supplement dose (or fortification STRATEGIES).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 129), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 362), ('IMPORTANT_CONSIDERATION', 376), ('PROBLEM_COMPLICATION', 376), ('INCOMPLETE_EVIDENCE', 384), ('INCOMPLETE_EVIDENCE', 413), ('SUPERFICIAL_RELATIONSHIP', 606), ('INCOMPLETE_EVIDENCE', 643), ('IMPORTANT_CONSIDERATION', 663), ('INCOMPLETE_EVIDENCE', 663), ('IMPORTANT_CONSIDERATION', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1098), ('PROBABLE_UNDERSTANDING', 1205), ('INCOMPLETE_EVIDENCE', 1231), ('INCOMPLETE_EVIDENCE', 1255), ('FUTURE_WORK', 1263), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1471), ('INCOMPLETE_EVIDENCE', 1480), ('INCOMPLETE_EVIDENCE', 1492), ('INCOMPLETE_EVIDENCE', 1543), ('INCOMPLETE_EVIDENCE', 1623), ('INCOMPLETE_EVIDENCE', 1738), ('PROBABLE_UNDERSTANDING', 1738), ('INCOMPLETE_EVIDENCE', 1755), ('SUPERFICIAL_RELATIONSHIP', 1765), ('INCOMPLETE_EVIDENCE', 1807), ('SUPERFICIAL_RELATIONSHIP', 1832), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1843), ('FUTURE_WORK', 1983), ('FUTURE_WORK', 2075), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2092), ('ANOMALY_CURIOUS_FINDING', 2092), ('INCOMPLETE_EVIDENCE', 2177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2187), ('INCOMPLETE_EVIDENCE', 2187), ('INCOMPLETE_EVIDENCE', 2277), ('FUTURE_WORK', 2339)]	42	[('GO_0055073', 'cadmium ion homeostasis', 52, 'calcium homeostasis'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 81, 'D'), ('CHEBI_25212', 'metabolite', 99, 'metabolites'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'gestational'), ('GO_0007567', 'parturition', 300, 'birth'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('NCBITaxon_1', 'root', 447, 'individuals'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('UBERON_0001969', 'blood plasma', 521, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('GO_0007565', 'female pregnancy', 723, 'pregnant'), ('CHEBI_27300', 'vitamin D', 792, 'vitamin D'), ('UBERON_0007023', 'adult organism', 953, 'adults'), ('CHEBI_27300', 'vitamin D', 1045, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 1059, 'extraskeletal'), ('UBERON_0007023', 'adult organism', 1223, 'adults'), ('GO_0007565', 'female pregnancy', 1295, 'pregnancy'), ('GO_0007595', 'lactation', 1309, 'lactation'), ('CHEBI_27300', 'vitamin D', 1413, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1426, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 1458, 'supplement'), ('GO_0007565', 'female pregnancy', 1507, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1516, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1601, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 1727, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1775, 'vitamin D'), ('GO_0007567', 'parturition', 1968, 'antenatal'), ('CHEBI_27300', 'vitamin D', 2006, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2035, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2248, 'prenatal')]
PMC5706533	11/2017	S19-PMC5706533	['given the numerous trials on Prenatal Vitamin D published since 2015 and the RESTRICTED scope of the 2016 cochrane review, we UNDERTOOK an updated systematic review of Vitamin D in Pregnancy TO ASSESS the current and future state of the evidence from randomised controlled trials.']	[('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('QUESTION_ANSWERED_BY_THIS_WORK', 191), ('QUESTION_ANSWERED_BY_THIS_WORK', 191), ('QUESTION_ANSWERED_BY_THIS_WORK', 194)]	5	[('GO_0007565', 'female pregnancy', 29, 'prenatal'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007565', 'female pregnancy', 181, 'pregnancy')]
PMC5706533	11/2017	S20-PMC5706533	['we SPECIFICALLY AIMED to estimate the EFFECTS of Vitamin D supplementation during Pregnancy on maternal, neonatal, and infant outcomes, taking into consideration the quality of AVAILABLE evidence and heterogeneity across studies; determine frequencies at which relevant outcome variable data were missing, unreported, or inconsistently reported among trials that were otherwise eligible for inclusion; and IDENTIFY ONGOING or PLANNED STUDIES of Vitamin D supplementation during Pregnancy to project the state of EVIDENCE that COULD accrue in the next decade.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 177), ('FUTURE_WORK', 406), ('IMPORTANT_CONSIDERATION', 415), ('FUTURE_WORK', 426), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 526)]	10	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0007565', 'female pregnancy', 478, 'pregnancy')]
PMC5706533	11/2017	S29-PMC5706533	['we EXCLUDED from the systematic review single arm Vitamin D trials (such as pharmacokinetic studies); trials in which the intervention was administered only before Conception or after Delivery; observational cohorts RATHER than parallel group trials (that is, intervention group assignment was based on review of medical records or participant Recall or there was a lack of sufficient evidence in the published report to INDICATE that participants were assigned prospectively to intervention groups); and trials in which differences in cointervention(s) across trial arms prevented inferences specifically about Vitamin D. two independent reviewers screened abstracts and full text articles for inclusion using a web based systematic review platform (covidence).']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216), ('INCOMPLETE_EVIDENCE', 421)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007620', 'copulation', 164, 'conception'), ('GO_0007567', 'parturition', 184, 'delivery'), ('GO_0060033', 'anatomical structure regression', 344, 'recall'), ('CHEBI_27300', 'vitamin D', 612, 'vitamin D')]
PMC5706533	11/2017	S46-PMC5706533	['when multiple comparisons from the same trial were included in the same meta-analysis, we divided the control group sample size corresponding to each comparison by the number of intervention arms to avoid double counting participants.14\nwe conducted subgroup meta-analyses according to a priori defined sources of potential clinical and methodological heterogeneity17: control arm type (Placebo versus Vitamin D containing active control); dosing frequency (regular versus bolus); baseline Vitamin D status categorised as low (mean 25(Oh)D <30 nmol/l) versus sufficient (≥30 nmol/l), based on maternal mean 25(Oh)D in the control group at enrolment (“initial baseline”) or at/near delivery (“modified baseline,” which THEORETICALLY takes into account the effect of active control supplementation); intervention dose (among regular dose trials), defined as low (<2000 iu/day) versus high (≥2000 iu/day).']	[('INCOMPLETE_EVIDENCE', 718)]	1	[('CHEBI_26130', 'biological pigment', 387, 'placebo'), ('CHEBI_27300', 'vitamin D', 402, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 490, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 532, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 538, 'D'), ('CHEBI_71657', 'versiconol acetate', 607, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 613, 'D')]
PMC5706533	11/2017	S77-PMC5706533	['among regular dose trials, effective doses were no higher in populations with lower baseline Vitamin D status, and placebo controlled trials DID NOT consistently use higher effective doses nor were they more LIKELY to be conducted in populations deficient in Vitamin D compared with active control trials (fig 3).']	[('INCOMPLETE_EVIDENCE', 141), ('PROBABLE_UNDERSTANDING', 208)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC5706533	11/2017	S96-PMC5706533	['higher regular dose regimens (≥2000 iu/day) LED TO a greater average increment in Maternal Delivery and Cord 25(Oh)D than lower doses (tables s1 and s2 in appendix 10); HOWEVER, the linear dose-response curves for maternal and Cord Blood INDICATED modest EFFECTS of increasing Vitamin D doses on the increment in 25(Oh)D concentrations (fig s2 and s4 in Appendix 10).']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('INCOMPLETE_EVIDENCE', 238), ('SUPERFICIAL_RELATIONSHIP', 255)]	4	[('GO_0007618', 'mating', 82, 'maternal'), ('GO_0007567', 'parturition', 91, 'delivery'), ('UBERON_0002240', 'spinal cord', 104, 'cord'), ('CHEBI_71657', 'versiconol acetate', 109, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 109, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 227, 'cord'), ('UBERON_0000178', 'blood', 232, 'blood'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 313, '25(OH)D'), ('UBERON_0001154', 'vermiform appendix', 354, 'appendix')]
PMC5706533	11/2017	S105-PMC5706533	['inclusion of all trials irrespective of these criteria, HOWEVER, SUGGESTED that Vitamin D COULD reduce the risk of Gestational diabetes (risk ratio 0.61, 95% confidence interval 0.45 to 0.83; 14 comparisons; 2643 participants) (table s5 and fig s10 in appendix 10).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 90)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestational')]
PMC5706533	11/2017	S107-PMC5706533	['biochemical safety outcomes (hypercalcaemia, hypercalciuria, hypocalcaemia) were RARE; ONLY four trials met our minimum criteria for case definitions and methods of ascertainment based on routine monitoring of maternal Serum calcium (table 2; tables s9-s11in appendix 10), YET ignoring the these criteria did not change the inference that there was no significant EFFECT of Vitamin D supplementation on the RISK of hypercalcaemia, which is a primary INDICATOR of toxicity of Vitamin D supplementation (table s9 and fig s18 in Appendix 10).']	[('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 273), ('SUPERFICIAL_RELATIONSHIP', 364), ('IMPORTANT_CONSIDERATION', 407), ('SUPERFICIAL_RELATIONSHIP', 450)]	6	[('UBERON_0001977', 'blood serum', 219, 'serum'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin D'), ('UBERON_0001154', 'vermiform appendix', 526, 'appendix')]
PMC5706533	11/2017	S109-PMC5706533	['pooling of 37 comparisons INDICATED that Prenatal Vitamin D supplementation (versus low dose, no Vitamin D, or placebo) increased mean Birth weight by an average of 58 g (fig 4).']	[('INCOMPLETE_EVIDENCE', 26)]	1	[('GO_0007565', 'female pregnancy', 41, 'prenatal'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007567', 'parturition', 135, 'birth')]
PMC5706533	11/2017	S115-PMC5706533	['caption (fig)\n\nfig 4 \xa0a: weighted mean differences (wmds) and b: cumulative wmds for effect of Prenatal Vitamin D supplementation on mean Birth weight (g), ESTIMATED with random effects meta-analysis, based on 37 intervention-control comparisons in 30 randomised controlled trials of regular or bolus regimen Vitamin D at any dose in studies published by september 2017\nCONSISTENT with the pooled EFFECT on mean Birth weight—but in a smaller subset of only seven comparisons—vitamin d reduced the risk of small for Gestational age (sga) (table 2; table s14 and fig s30 in appendix 10).']	[('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 370), ('SUPERFICIAL_RELATIONSHIP', 397)]	3	[('GO_0007565', 'female pregnancy', 95, 'prenatal'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007567', 'parturition', 138, 'birth'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D'), ('GO_0007567', 'parturition', 412, 'birth'), ('GO_0007565', 'female pregnancy', 515, 'gestational')]
PMC5706533	11/2017	S121-PMC5706533	['the pooled estimate from two high quality regular dose trials in high income countries (total 1387 participants) INDICATED that Prenatal Vitamin D supplementation significantly decreased the RISK of persistent/recurrent wheeze in offspring by age 3 years (table 2; fig s51 in appendix 10).']	[('INCOMPLETE_EVIDENCE', 113), ('IMPORTANT_CONSIDERATION', 191)]	2	[('GO_0007565', 'female pregnancy', 128, 'prenatal'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC5706533	11/2017	S124-PMC5706533	['two studies REPORTED EFFECTS on neonatal bone Mineral content and bone Mineral density, for which the meta-analysis DID NOT support an effect of Vitamin D (table 3; tables s29-s30 and figs s56-s57 in appendix 10).']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 116)]	3	[('CHEBI_46662', 'mineral', 46, 'mineral'), ('CHEBI_46662', 'mineral', 71, 'mineral'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5706533	11/2017	S125-PMC5706533	['one trial (two comparisons) FOUND that bone Mineral content and density at 12-16 months of age were lower in the Vitamin D groups than in placebo groups (table 3; tables s31-s32 and figs s58-s59 in appendix 10).']	[('INCOMPLETE_EVIDENCE', 28)]	1	[('CHEBI_46662', 'mineral', 44, 'mineral'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC5706533	11/2017	S145-PMC5706533	['discussion\nthough trials of Prenatal Vitamin D supplementation are being published at an ACCELERATING pace, randomised controlled trials published up to 2017 were GENERALLY SMALL, low quality, and RARELY designed to examine clinical outcomes.']	[('IMPORTANT_CONSIDERATION', 89), ('PROBABLE_UNDERSTANDING', 163), ('INCOMPLETE_EVIDENCE', 173), ('INCOMPLETE_EVIDENCE', 197)]	4	[('GO_0007565', 'female pregnancy', 28, 'prenatal'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5706533	11/2017	S146-PMC5706533	['although data COULD BE statistically pooled for several outcomes, irreconcilable heterogeneity between trials (such as variable baseline Vitamin D status) rendered most inferences DIFFICULT to interpret or apply.']	[('INCOMPLETE_EVIDENCE', 14), ('DIFFICULT_TASK', 180)]	2	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC5706533	11/2017	S148-PMC5706533	['THOUGH SOME OBSERVATIONAL STUDIES HAVE SHOWN ASSOCIATIONS between maternal Vitamin D deficiency and Gestational diabetes and pre-eclampsia,22we DID NOT FIND ROBUST corroborating evidence from randomised controlled trials.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 144), ('INCOMPLETE_EVIDENCE', 157)]	8	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'gestational')]
PMC5706533	11/2017	S150-PMC5706533	['most trials reported mean Birth weight, providing a wide distribution of ESTIMATES surrounding the pooled effect of +58 g in the Vitamin D groups.']	[('INCOMPLETE_EVIDENCE', 73)]	1	[('GO_0007567', 'parturition', 26, 'birth'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC5706533	11/2017	S151-PMC5706533	['this COULD BE EVIDENCE of the biological responsiveness of fetal growth to Vitamin D, CONSISTENT with OBSERVATIONAL epidemiological STUDIES2223AND SOME Animal research.2425yet this is also an example of an intangible meta-analysis result that frustrates as much as it illuminates as the EFFECT cannot be attributed to a specific dose or target 25(Oh)d threshold.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 287)]	7	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 152, 'animal'), ('CHEBI_30778', 'gallic acid', 344, '25(OH)')]
PMC5706533	11/2017	S154-PMC5706533	['two trials INDICATED that Vitamin D COULD enhance Postnatal linear growth, an outcome RELATED to growth plates for which a HYPOTHESISED ROLE of Vitamin D is logical,26and which is the primary focus of our AS YET unpublished trial in bangladesh.27in the FEW STUDIES reporting EFFECTS on infant bone mass, results were MIXED; the largest of these trials—the mavidos study in the uk, which excluded women with 25(Oh)D concentrations <25 nmol/l28—has scheduled follow-up of children at age 4 years.29infant rickets was NOT REPORTED in any trials; THOUGH RARE, this is one of the MOST LIKELY paediatric conditions to be directly caused by poor maternal and early infant Vitamin D status.30adverse events were infrequently REPORTED, resulting in unreliable meta-analyses.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 205), ('ANOMALY_CURIOUS_FINDING', 208), ('INCOMPLETE_EVIDENCE', 253), ('SUPERFICIAL_RELATIONSHIP', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 515), ('ANOMALY_CURIOUS_FINDING', 543), ('INCOMPLETE_EVIDENCE', 550), ('PROBABLE_UNDERSTANDING', 575), ('PROBABLE_UNDERSTANDING', 580), ('INCOMPLETE_EVIDENCE', 717)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 407, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 413, 'D'), ('CHEBI_27300', 'vitamin D', 665, 'vitamin D')]
PMC5706533	11/2017	S155-PMC5706533	['for example, Prenatal Vitamin D supplementation in deficient women modifies neonatal Calcium Homeostasis,31BUT clinical CORRELATES (such as symptomatic infant hypocalcaemia) were RARE and infrequently ascertained across trials.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 179)]	3	[('GO_0007565', 'female pregnancy', 13, 'prenatal'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 85, 'calcium homeostasis')]
PMC5706533	11/2017	S156-PMC5706533	['NONETHELESS, there was no EVIDENCE of any specific harms to mothers or fetuses attributable to Vitamin D supplementation within the range of reported doses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 26)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5706533	11/2017	S157-PMC5706533	['one of the most ROBUST FINDINGS in our systematic review—which has been PREVIOUSLY REPORTED32—was the beneficial EFFECT of Prenatal Vitamin D on RISK of persistent/recurrent wheeze (or asthma) in offspring, BASED ON data from two large well conducted trials in which wheeze/asthma was the primary outcome.3334this is broadly CONSISTENT with the POSSIBLY positive EFFECT of Vitamin D on severity of illness in Adults with asthma.5before Prenatal Vitamin D CAN be RECOMMENDED as a routine preventive measure against childhood asthma, HOWEVER, FURTHER WORK IS REQUIRED to CLARIFY the minimum effective dose and longer term follow-up to determine IF OBSERVED early EFFECTS on symptoms TRANSLATE into reductions in the incidence of asthma and improvements in Pulmonary function.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 113), ('IMPORTANT_CONSIDERATION', 145), ('INCOMPLETE_EVIDENCE', 207), ('ANOMALY_CURIOUS_FINDING', 213), ('INCOMPLETE_EVIDENCE', 325), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 363), ('INCOMPLETE_EVIDENCE', 455), ('FUTURE_WORK', 462), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 532), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 557), ('FUTURE_WORK', 569), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('INCOMPLETE_EVIDENCE', 646), ('SUPERFICIAL_RELATIONSHIP', 661), ('SUPERFICIAL_RELATIONSHIP', 681)]	21	[('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('UBERON_0007023', 'adult organism', 409, 'adults'), ('GO_0007565', 'female pregnancy', 436, 'prenatal'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('UBERON_0002048', 'lung', 754, 'pulmonary')]
PMC5706533	11/2017	S159-PMC5706533	['the INTERPRETATION of Micronutrient intervention trials, HOWEVER, is COMPLEX BECAUSE all Individuals have some Vitamin D intake or Endogenous production.35the EFFECT of a given dose depends on the difference between the intervention and control doses (or the difference in mean 25(Oh)D in the intervention versus control group at/near delivery) as well as baseline Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('DIFFICULT_TASK', 69), ('PROBABLE_UNDERSTANDING', 77), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 22, 'micronutrient'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0009790', 'embryo development', 131, 'endogenous'), ('CHEBI_71657', 'versiconol acetate', 278, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 278, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
PMC5706533	11/2017	S160-PMC5706533	['populations without Vitamin D deficiency MIGHT have little to gain from any dose, BUT deficient populations MIGHT require relatively high doses to raise Vitamin D status to an optimal range ASSOCIATED with clinical BENEFITS.35in this FRAMEWORK, the DISTINCTION between placebo versus active control trials is ONLY INFORMATIVE insofar as an active control dose increases the baseline status to which the intervention dose is compared (as such, we considered a “modified” baseline status to be reflected by the mean 25(Oh)d at Delivery in the control group).']	[('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 190), ('IMPORTANT_CONSIDERATION', 215), ('INCOMPLETE_EVIDENCE', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('INCOMPLETE_EVIDENCE', 309), ('INCOMPLETE_EVIDENCE', 314)]	9	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 514, '25(OH)'), ('GO_0007567', 'parturition', 525, 'delivery')]
PMC5706533	11/2017	S161-PMC5706533	['IF a modest dose of Vitamin D (<600 iu/day) readily eliminates deficiency in EVEN the most deficient women, then we MIGHT expect to see benefits ONLY in Placebo control trials conducted in populations where deficiency is common.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 77), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 145)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 153, 'placebo')]
PMC5706533	11/2017	S163-PMC5706533	['MANY of the REPORTED doses, HOWEVER, DID NOT yield EFFECTS on maternal 25(Oh)D that would be expected BASED ON Vitamin D pharmacokinetics.3637the muted dose-25(Oh)D RELATION COULD BE ATTRIBUTED to high baseline 25(Oh)D, low precision of 25(Oh)D assays, low rates of adherence to supplementation regimens, or lower than labeled Vitamin D content of the Supplements.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('ANOMALY_CURIOUS_FINDING', 108), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 183)]	10	[('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 73, '(OH ... D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 157, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 237, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 352, 'supplements')]
PMC5706533	11/2017	S164-PMC5706533	['we CONSIDERED the weak ASSOCIATION between dose and 25(Oh)D to reflect the overall low quality of many of the trials, which TEMPERED expectations of finding dose DEPENDENT EFFECTS of Vitamin D on clinical outcomes.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 172)]	5	[('CHEBI_71657', 'versiconol acetate', 52, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 52, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC5706533	11/2017	S167-PMC5706533	['for example, for the EFFECT of Vitamin D on pre-eclampsia, de-regil and colleagues REPORTED a pooled risk ratio of 0.52 (95% confidence interval 0.25 to 1.05) based on two trials that we included in our review, but neither of which met our minimum criteria for case definitions and methods of ascertainment: one trial ONLY mentioned the exclusion of a participant for “severe pre-eclampsia,”38AND the other REPORTED frequencies of pre-eclampsia but DID NOT mention any screening or diagnostic procedures.39de-regil and colleagues also REPORTED that Vitamin D reduced the RISK of Preterm Birth based on thee trials,6but the current meta-analysis based on 15 comparisons produced REASONABLY strong evidence of a null effect.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 318), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 391), ('INCOMPLETE_EVIDENCE', 407), ('INCOMPLETE_EVIDENCE', 449), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 571), ('PROBABLE_UNDERSTANDING', 678)]	9	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 549, 'vitamin D'), ('GO_0007565', 'female pregnancy', 579, 'preterm birth')]
PMC5706533	11/2017	S170-PMC5706533	['a narrative review of findings of five Vitamin D trials that were considered ineligible did not materially alter any of the inferences from the meta-analyses, SUGGESTING that our conclusions were not biased by overly stringent inclusion criteria.']	[('INCOMPLETE_EVIDENCE', 159)]	1	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC5706533	11/2017	S173-PMC5706533	['although we intend to update this review regularly (the platform for FUTURE real time dissemination is STILL TO BE DETERMINED), we project LIMITED aggregate gains from the 35 MOSTLY SMALL TRIALS of Prenatal Vitamin D supplementation trials that are registered as completed, ongoing, or planned.']	[('FUTURE_WORK', 69), ('FULL_UNKNOWN', 103), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 182)]	5	[('GO_0007565', 'female pregnancy', 198, 'prenatal'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5706533	11/2017	S176-PMC5706533	['in the meantime, we ENDORSE the NOTION that WHENEVER feasible, investigators SHOULD report all clinically IMPORTANT outcomes, EVEN in SMALL trials that are individually UNDERPOWERED to detect EFFECTS on such outcomes.45\njohn ioannidis RECENTLY REMARKED that “systematic reviews MAY SOMETIMES be most helpful IF, INSTEAD of focusing on the summary of the evidence, HIGHLIGHT the BIASES that are INVOLVED and what NEEDS to be done to remedy the state-of-the-EVIDENCE in the given field.”46we conclude that there is currently INSUFFICIENT EVIDENCE to guide RECOMMENDATIONS for Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 77), ('IMPORTANT_CONSIDERATION', 106), ('ANOMALY_CURIOUS_FINDING', 126), ('INCOMPLETE_EVIDENCE', 134), ('PROBLEM_COMPLICATION', 169), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 235), ('ANOMALY_CURIOUS_FINDING', 244), ('ANOMALY_CURIOUS_FINDING', 244), ('INCOMPLETE_EVIDENCE', 278), ('INCOMPLETE_EVIDENCE', 282), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 312), ('INCOMPLETE_EVIDENCE', 364), ('PROBLEM_COMPLICATION', 378), ('SUPERFICIAL_RELATIONSHIP', 394), ('FUTURE_WORK', 412), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 523), ('FUTURE_WORK', 554)]	23	[('GO_0007565', 'female pregnancy', 574, 'prenatal'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D')]
PMC5706533	11/2017	S177-PMC5706533	['cautious PROJECTIONS for the next decade SUGGEST that we will eventually know more about Vitamin D in Pregnancy THAN we do now, BUT in the absence of a coordinated effort and funding to conduct large new trials, SOME of the most CRITICAL QUESTIONS about the effectiveness of Prenatal Vitamin D supplementation will PROBABLY REMAIN unanswered in the foreseeable FUTURE.']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 229), ('EXPLICIT_QUESTION', 238), ('PROBABLE_UNDERSTANDING', 315), ('INCOMPLETE_EVIDENCE', 324), ('FUTURE_WORK', 361)]	11	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 275, 'prenatal'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC5706533	11/2017	S178-PMC5706533	['what is already known on THIS topic\nnumerous randomised trials and systematic reviews of Vitamin D supplementation during Pregnancy HAVE BEEN published, with CONFLICTING results and conclusions\nrecommendations regarding Vitamin D supplementation vary widely among medical and professional organisations, and who currently RECOMMENDS against routine Prenatal Vitamin D supplementation\n\nwhat THIS STUDY adds\nsystematic review and meta-analyses of 43 trials including 8406 participants SHOWED that Prenatal Vitamin D supplementation was ASSOCIATED with increased maternal and cord Serum 25-Hydroxyvitamin D concentrations, increased mean birth weight, reduced the risk of small for Gestational age, reduced the risk of wheeze in offspring, and increased infant length at one year of age\nthere was a LACK OF EVIDENCE OF benefits of Prenatal Vitamin D supplementation for maternal health conditions RELATED to Pregnancy, no effect on other Birth outcomes of PUBLIC HEALTH IMPORTANCE such as Preterm Birth, and SCANT EVIDENCE on safety outcomes\nFEW of the trials were designed to test the EFFECT of Vitamin D on clinical or functional outcomes, and most trials were SMALL and at overall high or UNCERTAIN risk of bias\nthirty five planned or ongoing Prenatal Vitamin D trials COULD contribute an additional 12\u2009530 participants to FUTURE systematic reviews\n\npubmed central:']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('FUTURE_WORK', 322), ('QUESTION_ANSWERED_BY_THIS_WORK', 390), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 534), ('INCOMPLETE_EVIDENCE', 796), ('SUPERFICIAL_RELATIONSHIP', 894), ('IMPORTANT_CONSIDERATION', 953), ('IMPORTANT_CONSIDERATION', 967), ('INCOMPLETE_EVIDENCE', 1005), ('INCOMPLETE_EVIDENCE', 1039), ('SUPERFICIAL_RELATIONSHIP', 1083), ('INCOMPLETE_EVIDENCE', 1160), ('FULL_UNKNOWN', 1189), ('INCOMPLETE_EVIDENCE', 1269), ('FUTURE_WORK', 1323)]	18	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 228, 'D'), ('GO_0007565', 'female pregnancy', 349, 'prenatal'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0007565', 'female pregnancy', 495, 'prenatal'), ('CHEBI_27300', 'vitamin D', 504, 'vitamin D'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 584, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 679, 'gestational'), ('GO_0007565', 'female pregnancy', 828, 'prenatal'), ('CHEBI_27300', 'vitamin D', 837, 'vitamin D'), ('GO_0007565', 'female pregnancy', 905, 'pregnancy'), ('GO_0007567', 'parturition', 935, 'birth'), ('GO_0007565', 'female pregnancy', 986, 'preterm'), ('GO_0007567', 'parturition', 994, 'birth'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1243, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1252, 'vitamin D')]
PMC5707701	11/2017	S130-PMC5707701	['the results from a 24-h Food Intake Recall SHOWED that dietary Vitamin A and total Carotenoids were not associated with all of the Carotenoids in Breast Milk when adjusted with different Cities and Lactation period ( p> 0.05) (table 5).']	[('INCOMPLETE_EVIDENCE', 43)]	1	[('CHEBI_33290', 'food', 24, 'food'), ('GO_0007631', 'feeding behavior', 24, 'food intake'), ('GO_0060033', 'anatomical structure regression', 36, 'recall'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin A'), ('CHEBI_50815', 'norgestimate', 83, 'carotenoids'), ('CHEBI_50815', 'norgestimate', 131, 'carotenoids'), ('UBERON_0000310', 'breast', 146, 'breast'), ('UBERON_0001913', 'milk', 153, 'milk'), ('UBERON_0000978', 'leg', 187, 'cities'), ('GO_0007595', 'lactation', 198, 'lactation')]
PMC5707701	11/2017	S131-PMC5707701	['similarly, no significant associations were FOUND between Vitamin E and Α-Tocopherol intake, and Α- and Γ-Tocopherol in Human milk ( p> 0.05).']	[('INCOMPLETE_EVIDENCE', 44)]	1	[('CHEBI_27300', 'vitamin D', 58, 'vitamin E'), ('CHEBI_27725', 'butin', 72, 'α-tocopherol'), ('CHEBI_16199', 'urea', 97, 'α-'), ('CHEBI_27725', 'butin', 104, 'γ-tocopherol'), ('NCBITaxon_9606', 'Homo sapiens', 120, 'human')]
PMC5707701	11/2017	S164-PMC5707701	['ACCORDING TO the recommendations of the institute of medicine (iom) [62], we ESTIMATED the supply of Vitamin E for infants in the PRESENT STUDY using the average quantity of milk consumed by infants aged 0–6 m (780 ml), and FOUND that the POSSIBLE EFFECT of these milks offered to the infants was 5.0, 3.0, 1.9, 1.6, 1.7, 1.6 mg/day of Vitamin E, respectively.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 130), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 239), ('SUPERFICIAL_RELATIONSHIP', 248)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin E')]
PMC5707701	11/2017	S165-PMC5707701	['OUR FINDINGS SUGGESTED that only Colostrum reached an ai proposal for the infant aged less than six months; therefore, the implementation of procedures to increase Vitamin E concentrations in milk would be IMPORTANT.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 206)]	3	[('UBERON_0001914', 'colostrum', 33, 'colostrum'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin E')]
PMC5707701	11/2017	S166-PMC5707701	['SOME nutritional, obstetric, and socio-economic factors HAVE BEEN IMPLICATED as being ASSOCIATED with the Vitamin A and E concentrations in milk [36,39,60].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 86)]	4	[('CHEBI_27300', 'vitamin D', 106, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 120, 'E')]
PMC5707701	11/2017	S170-PMC5707701	['these inverse CORRELATIONS between SOME of the Carotenoids and current bmi MAY BE due TO the underlying mechanism that an excess of body fat increases the consumption of all antioxidant elements in the diet [63], SO that Lactating women with a higher bmi and more body fat consumed more Vitamins A and E than those with lower bmi, resulting in lower Carotenoids in Human Milk.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 75), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('PROBABLE_UNDERSTANDING', 213)]	5	[('CHEBI_50815', 'norgestimate', 47, 'carotenoids'), ('GO_0007594', 'puparial adhesion', 221, 'lactating'), ('CHEBI_27300', 'vitamin D', 287, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 296, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 302, 'E'), ('CHEBI_50815', 'norgestimate', 350, 'carotenoids'), ('NCBITaxon_9606', 'Homo sapiens', 365, 'human'), ('UBERON_0001913', 'milk', 371, 'milk')]
PMC5707701	11/2017	S171-PMC5707701	['our results were SIMILAR with the PREVIOUS FINDING [37] that the percentage of body fat in the Lactating women was negatively ASSOCIATED to the concentration of Vitamin A in Breast Milk.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 126)]	4	[('GO_0007594', 'puparial adhesion', 95, 'lactating'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin A'), ('UBERON_0001348', 'brown adipose tissue', 174, 'breast milk')]
PMC5707701	11/2017	S176-PMC5707701	['PREVIOUS STUDIES [36,37,66] SUGGESTED Vitamins A and e in Human milk were ASSOCIATED with maternal stores, dietary supplements, fortified foods, and dietary intake.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamins A'), ('NCBITaxon_9606', 'Homo sapiens', 58, 'human')]
PMC5707701	11/2017	S177-PMC5707701	['HOWEVER, our results INDICATED that neither Vitamin A nor E intakes from one 24-h dietary Recall was associated with Vitamin A and E in Human milk, which MAY BE DUE TO the inherent Intake variability of one single 24-h dietary Recall questionnaire, which DID NOT ALLOW for estimations of an Individual’s usual diet, and THEREFORE, it is LIKELY to under- OR overestimate some Nutrient intakes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 154), ('PROBLEM_COMPLICATION', 161), ('DIFFICULT_TASK', 255), ('ANOMALY_CURIOUS_FINDING', 259), ('PROBABLE_UNDERSTANDING', 320), ('PROBABLE_UNDERSTANDING', 337), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 354)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('GO_0060033', 'anatomical structure regression', 90, 'recall'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 131, 'E'), ('NCBITaxon_9606', 'Homo sapiens', 136, 'human'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('GO_0060033', 'anatomical structure regression', 227, 'recall'), ('NCBITaxon_1', 'root', 291, 'individual'), ('CHEBI_33284', 'nutrient', 375, 'nutrient')]
PMC5707701	11/2017	S184-PMC5707701	['thirdly, SINCE our design was a cross-sectional study, we COULD NOT collect DIRECT EVIDENCE about changes in Vitamins A and E with Lactation stages.']	[('PROBLEM_COMPLICATION', 9), ('DIFFICULT_TASK', 58), ('ANOMALY_CURIOUS_FINDING', 64), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 83)]	5	[('CHEBI_27300', 'vitamin D', 109, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 109, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 124, 'E'), ('GO_0007595', 'lactation', 131, 'lactation')]
PMC5707701	11/2017	S187-PMC5707701	['indeed, our results SHOWED that all of these milks, except for colostrum, did not meet an infant’s nutritional REQUIREMENT of Vitamin E. HOWEVER, we COULD NOT ESTIMATE the POSSIBLE supply of Vitamin A to the infant in the present study, DUE TO the LACKING detection of Retinol in Human milk.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('DIFFICULT_TASK', 149), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 237), ('FULL_UNKNOWN', 248)]	8	[('CHEBI_27300', 'vitamin D', 126, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 269, 'retinol'), ('NCBITaxon_9606', 'Homo sapiens', 280, 'human')]
PMC5697969	12/2017	S21-PMC5697969	['the IMPACTS of Micronutrient supplements, such as Iron and Folic Acid (ifa) (7), calcium (8), Vitamin A (9), and zinc (10), on maternal and child health outcomes are well DOCUMENTED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 171)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 15, 'micronutrient'), ('CHEBI_24870', 'ion', 50, 'iron'), ('CHEBI_30751', 'formic acid', 59, 'folic acid'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin A')]
PMC5732505	12/2017	S0-PMC5732505	['maternal Vitamin D status, Gestational diabetes and infant Birth size\n\nabstract\n\nbackground\nmaternal Vitamin D status HAS BEEN ASSOCIATED with both Gestational diabetes mellitus (gdm) and fetal growth restriction, HOWEVER, the EVIDENCE is INCONSISTENT.']	[('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('INCOMPLETE_EVIDENCE', 227), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 27, 'gestational'), ('GO_0007567', 'parturition', 59, 'birth'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'gestational')]
PMC5732505	12/2017	S15-PMC5732505	['a sufficient maternal Vitamin D status, specified AS 25(Oh)D above 50\xa0nmol/l, MAY BE a threshold above which the physiological REQUIREMENTS of Pregnancy are achieved.']	[('PROBABLE_UNDERSTANDING', 50), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 127)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 53, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 59, 'D'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy')]
PMC5732505	12/2017	S26-PMC5732505	['POOR maternal Vitamin D status HAS BEEN RELATED to fetal growth restriction [15] BUT it is UNKNOWN WHETHER maternal Vitamin D status ASSOCIATES with Birth size in infants with normal Birth weight.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 81), ('FULL_UNKNOWN', 91), ('EXPLICIT_QUESTION', 99), ('SUPERFICIAL_RELATIONSHIP', 133)]	7	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 149, 'birth'), ('GO_0007567', 'parturition', 183, 'birth')]
PMC5732505	12/2017	S27-PMC5732505	['MANY of the FINDINGS regarding the RELATIONSHIP between Vitamin D deficiency and gdm are BASED ON case-control STUDIES, which MAY include a POTENTIAL selection BIAS.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 140), ('PROBLEM_COMPLICATION', 160)]	8	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC5732505	12/2017	S28-PMC5732505	['case-control STUDIES OFTEN focus on HIGH-RISK groups, for example women who are overweight and sedentary, which are INDEPENDENT RISK FACTORS for Vitamin D deficiency as well (for example [16]).']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 21), ('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 128)]	5	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5732505	12/2017	S49-PMC5732505	['we DEFINED Vitamin D deficiency AS 25(Oh)D\u2009<\u200950\xa0nmol/l, and Vitamin D sufficiency AS 25(Oh)D\u2009≥\u200950\xa0nmol/l, SINCE a concentration of ≥50\xa0nmol/l IS CONSIDERED sufficient for bone health [17].']	[('PROBABLE_UNDERSTANDING', 3), ('PROBABLE_UNDERSTANDING', 32), ('PROBABLE_UNDERSTANDING', 82), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 142)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 35, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D')]
PMC5732505	12/2017	S50-PMC5732505	['suboptimal Vitamin D status was DEFINED AS 25(Oh)D\u2009<\u200980\xa0nmol/l, and optimal Vitamin D status AS 25(Oh)D\u2009≥\u200980\xa0nmol/l, AS HAS BEEN SUGGESTED BASED ON calcium absorption STUDIES [18].']	[('PROBABLE_UNDERSTANDING', 32), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 93), ('PROBABLE_UNDERSTANDING', 117), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 167)]	7	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 43, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D')]
PMC5732505	12/2017	S104-PMC5732505	['NO DIFFERENCES between the groups were OBSERVED in SEVERAL other characteristics, including gwg, duration of Gestation, and supplemental Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 51)]	3	[('GO_0007565', 'female pregnancy', 109, 'gestation'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC5732505	12/2017	S134-PMC5732505	['ALMOST ALL mother-child pairs (97%) were Vitamin D sufficient [25(Oh)D\u2009≥\u200950\xa0nmol/l], and ABOUT half of the mother-child pairs had optimal Vitamin D status [25(Oh)D\u2009≥\u200980\xa0nmol/l].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 89)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 162, 'D')]
PMC5732505	12/2017	S136-PMC5732505	['INTERESTINGLY, Pregnancy Vitamin D status ASSOCIATED positively with Birth weight, BUT an inverse ASSOCIATION was OBSERVED between newborn Vitamin D status and Head circumference at Birth.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('ANOMALY_CURIOUS_FINDING', 83), ('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 114)]	5	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007567', 'parturition', 69, 'birth'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0000033', 'head', 160, 'head'), ('GO_0007567', 'parturition', 182, 'birth')]
PMC5732505	12/2017	S138-PMC5732505	['(2016) CONCLUDED in their meta-analysis that maternal Vitamin D insufficiency (< 50\xa0nmol/l or <75\xa0nmol/l) was ASSOCIATED with greater RISK of gdm [6].']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 110), ('IMPORTANT_CONSIDERATION', 134)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5732505	12/2017	S141-PMC5732505	['HOWEVER, we OBSERVED that Vitamin D deficiency at Delivery was more PREVALENT in mothers with gdm compared with non-gdm mothers, BUT this was not marked during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 68), ('ANOMALY_CURIOUS_FINDING', 129)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 50, 'delivery'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy')]
PMC5732505	12/2017	S144-PMC5732505	['IN ACCORDANCE with OTHER STUDIES, our results IMPLY that in a Vitamin D sufficient population, the ASSOCIATION between 25(Oh)D and gdm MAY NOT exist [8,21,22].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 99), ('INCOMPLETE_EVIDENCE', 135)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D')]
PMC5732505	12/2017	S148-PMC5732505	['furthermore, SOME of these FACTORS are RELATED to or CO-EXIST with POOR Vitamin D status [24,25], which further increases the CHALLENGE when dissecting INDEPENDENT EFFECT.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 67), ('DIFFICULT_TASK', 126), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 164)]	8	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5732505	12/2017	S151-PMC5732505	['ALTHOUGH a biological mechanism between low Vitamin D status and diabetes is PLAUSIBLE [29], ONLY a FEW INTERVENTIONS have been conducted, and these HAVE NOT proved an EFFECT of Vitamin D supplementation on RISK of gdm [30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 149), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 207)]	8	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC5732505	12/2017	S152-PMC5732505	['maternal Vitamin D status ASSOCIATED with Birth size: Pregnancy 25(Oh)D SHOWED a positive ASSOCIATION towards Birth weight, BUT ucb 25(Oh)D an inverse ASSOCIATION with Head circumference, WHILE ONLY the inverse ASSOCIATION with Head circumference was VERIFIED with linear model.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 90), ('ANOMALY_CURIOUS_FINDING', 124), ('SUPERFICIAL_RELATIONSHIP', 151), ('ANOMALY_CURIOUS_FINDING', 188), ('ANOMALY_CURIOUS_FINDING', 194), ('SUPERFICIAL_RELATIONSHIP', 211), ('INCOMPLETE_EVIDENCE', 251)]	9	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007567', 'parturition', 42, 'birth'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('UBERON_0000033', 'head', 168, 'head'), ('UBERON_0000033', 'head', 228, 'head')]
PMC5732505	12/2017	S154-PMC5732505	['(2014) CONCLUDED that MODEST EVIDENCE exist for a positive RELATION between maternal Vitamin D status and Birth weight [31].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007567', 'parturition', 106, 'birth')]
PMC5732505	12/2017	S155-PMC5732505	['SOME earlier STUDIES HAVE SHOWN that SEVERE maternal Vitamin D deficiency ASSOCIATES with smaller Head circumference at Birth [32,33], YET SOME HAVE NOT [34,35].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 37), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 144)]	7	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000033', 'head', 98, 'head'), ('GO_0007567', 'parturition', 120, 'birth')]
PMC5732505	12/2017	S156-PMC5732505	['IN AGREEMENT with OUR FINDINGS, OTHERS have DISCOVERED that mothers with higher Vitamin D concentration have infants with smaller Head circumference at Birth [36,37].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 44)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0000033', 'head', 130, 'head'), ('GO_0007567', 'parturition', 152, 'birth')]
PMC5732505	12/2017	S157-PMC5732505	['HOWEVER, the clinical RELEVANCE, if any, of the inverse RELATIONSHIP between maternal Vitamin D status and Head circumference at Birth REMAINS UNEXPLAINED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 143)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000033', 'head', 107, 'head'), ('GO_0007567', 'parturition', 129, 'birth')]
PMC5732505	12/2017	S160-PMC5732505	['a POSSIBLE EXPLANATION for this MIGHT be a u-shaped ASSOCIATION between maternal Vitamin D concentration and fetal outcomes in a population with sufficient Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC5732505	12/2017	S163-PMC5732505	['in MANY previous STUDIES, participants had various ethnic backgrounds which COULD AFFECT both Vitamin D status and their RISK of gdm [7,38].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 82), ('IMPORTANT_CONSIDERATION', 121)]	4	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5732505	12/2017	S166-PMC5732505	['a CHALLENGE in PREVIOUS STUDIES on Vitamin D status and gdm HAS BEEN the LACK OF RELEVANT adjustments, for example adjustments for bmi and smoking status [6].']	[('DIFFICULT_TASK', 2), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 60), ('PROBLEM_COMPLICATION', 73), ('IMPORTANT_CONSIDERATION', 81)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC5732505	12/2017	S168-PMC5732505	['the threshold for DEFINING Vitamin D deficiency and the diagnostic criteria for gdm VARY between STUDIES, which MIGHT AFFECT the results and COMPLICATE the comparison of STUDIES.']	[('INCOMPLETE_EVIDENCE', 18), ('DIFFICULT_TASK', 84), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 118), ('DIFFICULT_TASK', 141), ('INCOMPLETE_EVIDENCE', 170)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC5732505	12/2017	S173-PMC5732505	['conclusion\nIN SUMMARY, maternal Vitamin D concentration was SIMILAR in mothers with and without gdm in a Vitamin D sufficient population.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC5736940	12/2017	S111-PMC5736940	['the EFFECTS of a healthy dietary pattern on reducing risk of gdm MAY BE due to a lower dietary energy density and Glycemic load and higher amount of fruits and vegetables rich in antioxidants and Phytochemicals, dietary fiber, and Micronutrients such as magnesium and Vitamin C [22,30].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 65)]	2	[('GO_0006096', 'glycolytic process', 114, 'glycemic'), ('CHEBI_26254', 'prenylnaphthoquinone', 196, 'phytochemicals'), ('CHEBI_33839', 'macromolecule', 231, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin C')]
PMC5738092	12/2017	S123-PMC5738092	['OUR STUDY REVEALED that all the maternal variables EXAMINED, except Vitamin A and Β- Carotene supplement receipt during Pregnancy, were significantly ASSOCIATED with Birth size.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 82, 'β- carotene'), ('GO_0007565', 'female pregnancy', 120, 'pregnancy'), ('GO_0007567', 'parturition', 166, 'birth')]
PMC5738092	12/2017	S142-PMC5738092	['we did NOT FIND any effect of maternal Vitamin A and Β-Carotene supplementation on infant’s size at Birth and which is CONSISTENT with the result found by christian et al.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 119)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 53, 'β-carotene'), ('GO_0007567', 'parturition', 100, 'birth')]
PMC5758521	1/2018	S1-PMC5758521	['we ASSESSED WHETHER Vitamin A and Vitamin E nutritional status MAY AFFECT circulating leptin, adiponectin, Insulin-Like Growth Factor (Igf)-I and Igf-Ii levels in early Life in Humans.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin E'), ('PR_000008929', 'interferon-related developmental regulator 1', 107, 'insulin-like growth factor ...'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 135, 'IGF)-I'), ('PR_000002046', 'interferon regulatory factor 4', 146, 'IGF-II'), ('UBERON_0000104', 'life cycle', 169, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 177, 'humans')]
PMC5758521	1/2018	S13-PMC5758521	['SURPRISINGLY, high-dose Vitamin E (Α-Tocopherol) supplementation HAS BEEN ASSOCIATED with increased risk of low Birth weight8– a condition LINKED to Insulin-Like Growth Factor I (Igf-I) insufficiency9.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 139)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin E'), ('CHEBI_27725', 'butin', 35, 'α-tocopherol'), ('GO_0007567', 'parturition', 112, 'birth'), ('PR_000045358', 'insulin family protein', 149, 'insulin'), ('PR_000009659', 'laminin subunit gamma-2', 157, 'like growth factor I'), ('PR_000008919', 'interferon alpha-6', 179, 'IGF-I')]
PMC5758521	1/2018	S15-PMC5758521	['circulating Vitamin A and E concentrations HAVE BEEN inversely CORRELATED to adiposity and Insulin sensitivity in children11.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 20, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 26, 'E'), ('PR_000045358', 'insulin family protein', 91, 'insulin')]
PMC5758521	1/2018	S19-PMC5758521	['taken TOGETHER, these OBSERVATIONS SUGGEST that Vitamins A and E MAY AFFECT Metabolic health.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 48, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 63, 'E'), ('GO_0008152', 'metabolic process', 76, 'metabolic')]
PMC5758521	1/2018	S20-PMC5758521	['HOWEVER, there is a LACK OF DATA on WHETHER Vitamin A and E nutritional status MAY BE ASSOCIATED with Metabolic health BIOMARKERS in early Life in Humans.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 119)]	7	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('GO_0008152', 'metabolic process', 102, 'metabolic'), ('UBERON_0000104', 'life cycle', 139, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 147, 'humans')]
PMC5758521	1/2018	S22-PMC5758521	['we HYPOTHESIZED that Vitamin A and E nutritional status MAY AFFECT fetal circulating leptin, adiponectin, Igf-I and Igf-Ii levels.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 35, 'E'), ('PR_000008919', 'interferon alpha-6', 106, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 116, 'IGF-II')]
PMC5758521	1/2018	S119-PMC5758521	['these observations SUGGEST that Vitamin E and a nutritional status MAY matter for Metabolic health in early Life in Humans.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 67)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin E'), ('GO_0008152', 'metabolic process', 82, 'metabolic'), ('UBERON_0000104', 'life cycle', 108, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 116, 'humans')]
PMC5758521	1/2018	S128-PMC5758521	['THUS, our OBSERVED negative ASSOCIATIONS of Cord Blood Vitamin E with leptin and adiponectin SUGGEST a POTENTIAL beneficial ROLE of Vitamin E in early Life in preventing the development of childhood obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('UBERON_0009472', 'axilla', 44, 'cord blood'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin E'), ('UBERON_0000104', 'life cycle', 151, 'life')]
PMC5758521	1/2018	S131-PMC5758521	['a RECENT STUDY in Mice SUGGESTS that Vitamin A deficiency MAY AFFECT fetal Islet Development27.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 62)]	4	[('NCBITaxon_10088', 'Mus <genus>', 18, 'mice'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('CL_0000214', 'synovial cell', 75, 'islet'), ('GO_0036165', 'invasive growth in response to heat', 75, 'islet development27'), ('UBERON_0002533', 'post-anal tail bud', 75, 'islet')]
PMC5758521	1/2018	S140-PMC5758521	['MOST STUDIES on Vitamins A and E in Pregnancy HAVE BEEN focused on the ASSOCIATION with fetal growth, and the FINDINGS HAVE BEEN INCONSISTENT33–35.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 25, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 31, 'E'), ('GO_0007565', 'female pregnancy', 36, 'pregnancy')]
PMC5758521	1/2018	S144-PMC5758521	['REPORTED that maternal Α-Tocopherol concentrations were positively ASSOCIATED with Birth weight, BUT poston and colleagues FOUND that Prenatal supplementation with Α-Tocopherol and Vitamin C was ASSOCIATED with elevated risk of low Birth weight8.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 195)]	6	[('CHEBI_27725', 'butin', 23, 'α-tocopherol'), ('GO_0007567', 'parturition', 83, 'birth'), ('GO_0007565', 'female pregnancy', 134, 'prenatal'), ('CHEBI_27725', 'butin', 164, 'α-tocopherol'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin C'), ('GO_0007567', 'parturition', 232, 'birth')]
PMC5758521	1/2018	S147-PMC5758521	['it is NOTEWORTHY that in OUR STUDY, Vitamin A and E measurements were pretty ROBUST (low intra- and inter-assay cvs), and that Birth weight was measured by research nurses using a reliable electronic weighing scale.']	[('ANOMALY_CURIOUS_FINDING', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 50, 'E'), ('GO_0007567', 'parturition', 127, 'birth')]
PMC5758521	1/2018	S155-PMC5758521	['it SHOULD be NOTED that the normal reference values for Vitamins A and E in Cord Blood are NOT AVAILABLE, and our OBSERVED ASSOCIATIONS were MOSTLY moderate.']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 123), ('PROBABLE_UNDERSTANDING', 141)]	6	[('CHEBI_27300', 'vitamin D', 56, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 56, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 71, 'E'), ('UBERON_0009472', 'axilla', 76, 'cord blood')]
PMC5784894	1/2018	S0-PMC5784894	['early Life Vitamin D depletion alters the Postnatal response to Skeletal loading in Growing and mature bone\n\nabstract\nthere is INCREASING EVIDENCE of persistent EFFECTS of early Life Vitamin D exposure on later Skeletal health; LINKING low levels in early Life to smaller bone size in childhood as well as increased fracture risk later in Adulthood, INDEPENDENTLY of later Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 161), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 350)]	4	[('UBERON_0000104', 'life cycle', 6, 'life'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007567', 'parturition', 42, 'postnatal'), ('UBERON_0004288', 'skeleton', 64, 'skeletal'), ('GO_0040007', 'growth', 84, 'growing'), ('UBERON_0000104', 'life cycle', 178, 'life'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('UBERON_0004288', 'skeleton', 211, 'skeletal'), ('UBERON_0000104', 'life cycle', 256, 'life'), ('UBERON_0000113', 'post-juvenile adult stage', 339, 'adulthood'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D')]
PMC5784894	1/2018	S2-PMC5784894	['we TESTED the HYPOTHESIS in an Animal MODEL system that Early Life Vitamin D depletion results in abrogation of the response to mechanical loading, with consequent reduction in bone size, mass and strength during both childhood and Adulthood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 38)]	3	[('NCBITaxon_33208', 'Metazoa', 31, 'animal'), ('UBERON_0001847', 'lobule of pinna', 56, 'early life'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 232, 'adulthood')]
PMC5784894	1/2018	S7-PMC5784894	['THESE FINDINGS SUGGEST early Life Vitamin D status MAY, IN PART, determine the propensity to osteoporosis and fracture that blights later Life in many Individuals.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 56)]	4	[('UBERON_0000104', 'life cycle', 29, 'life'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0000104', 'life cycle', 138, 'life'), ('NCBITaxon_1', 'root', 151, 'individuals')]
PMC5784894	1/2018	S17-PMC5784894	['in a recent prospective randomised controlled STUDY, maternal Vitamin D supplementation increased bone mass at Birth in winter-Born infants.']	[('INCOMPLETE_EVIDENCE', 46)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007567', 'parturition', 111, 'birth'), ('GO_0007567', 'parturition', 127, 'born')]
PMC5784894	1/2018	S18-PMC5784894	['[12] previous epidemiological work SUGGESTS a RELATIONSHIP between season of Birth, and HENCE maternal sunlight exposure and cutaneous Vitamin D Synthesis, and hip fracture risk in older people[13].']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 46), ('PROBABLE_UNDERSTANDING', 88)]	3	[('GO_0007567', 'parturition', 77, 'birth'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 135, 'vitamin D synthesis')]
PMC5784894	1/2018	S20-PMC5784894	['[14]\nconsidered TOGETHER, THESE FINDINGS IMPLY that early Life Vitamin D exposure has EFFECTS that persist into childhood, MAY IMPACT on peak bone mass accrual and INFLUENCE subsequent bone loss, the development of osteoporosis and the risk of Life-limiting fracture.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 26), ('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 164)]	7	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0000104', 'life cycle', 244, 'life')]
PMC5784894	1/2018	S21-PMC5784894	['we HYPOTHESISE that Antenatal Vitamin D status MAY BE RESPONSIBLE for altered bone responsiveness to Postnatal mechanical loading, a major anabolic INFLUENCE on bone size, mass and strength, and thus act as a DETERMINANT of later Skeletal ill-health.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 47), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 148), ('SUPERFICIAL_RELATIONSHIP', 209)]	5	[('GO_0007567', 'parturition', 20, 'antenatal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 101, 'postnatal'), ('UBERON_0004288', 'skeleton', 230, 'skeletal')]
PMC5784894	1/2018	S25-PMC5784894	['IN SUMMARY we HAVE BEEN able to demonstrate that offspring of Vitamin D deplete dams have reduced bone mass and, in response to mechanical loading, accrual of bone mass is further reduced along with a reduction in bone strength.10.1371/journal.pone.0190675.g001\n\ncaption (fig): fig 1\nexperimental design showing the creation of Murine MODEL of dietary Vitamin D deficiency up to culling post mechanical loading.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 335)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('NCBITaxon_39107', 'Murinae', 328, 'murine'), ('CHEBI_27300', 'vitamin D', 352, 'vitamin D')]
PMC5784894	1/2018	S136-PMC5784894	['discussion\nTHIS STUDY REPLICATES the real Life situation of early Life Vitamin D deficiency in the infant who is Born to a Vitamin D deficient mother and then exclusively breast Fed until weaning.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 22)]	2	[('UBERON_0000104', 'life cycle', 42, 'life'), ('UBERON_0000104', 'life cycle', 66, 'life'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007567', 'parturition', 113, 'born'), ('CHEBI_28384', 'vitamin K', 123, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 178, 'fed')]
PMC5784894	1/2018	S137-PMC5784894	['in THIS STUDY we HAVE SHOWN that early Life Vitamin D deficiency LEADS to decreased bone strength and negatively IMPACTS structure in the bone of Growing and mature female Mice.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('UBERON_0000104', 'life cycle', 39, 'life'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0040007', 'growth', 146, 'growing'), ('NCBITaxon_10088', 'Mus <genus>', 172, 'mice')]
PMC5784894	1/2018	S138-PMC5784894	['IMPORTANTLY, and for the FIRST TIME, we have DEMONSTRATED that for those with early Life Vitamin D deficiency, the Anabolic response of bone to mechanical loading is reduced in Growing bone, AFFECTING both Cortical and Trabecular Bone, with the EFFECT on Cortical bone persisting into “Adult” Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 191), ('SUPERFICIAL_RELATIONSHIP', 245)]	5	[('UBERON_0000104', 'life cycle', 84, 'life'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0009057', 'macromolecule catabolic process', 115, 'anabolic'), ('GO_0040007', 'growth', 177, 'growing'), ('UBERON_0001851', 'cortex', 206, 'cortical'), ('UBERON_0002483', 'trabecular bone tissue', 219, 'trabecular bone'), ('UBERON_0001851', 'cortex', 255, 'cortical'), ('UBERON_0007023', 'adult organism', 286, 'adult'), ('UBERON_0000104', 'life cycle', 293, 'life')]
PMC5784894	1/2018	S142-PMC5784894	['we HAVE SHOWN through multiple means that the Bones of the offspring of Vitamin D replete AS OPPOSED TO deplete Mice are intrinsically stronger and better able to respond effectively to mechanical stimulation.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90)]	2	[('UBERON_0001474', 'bone element', 46, 'bones'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 112, 'mice')]
PMC5784894	1/2018	S144-PMC5784894	['that these changes are present in Mice that, following weaning, are Vitamin D replete throughout Life INDICATES that early Life, AS OPPOSED TO current, Vitamin D status is the cause of these differences.']	[('INCOMPLETE_EVIDENCE', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129)]	2	[('NCBITaxon_10088', 'Mus <genus>', 34, 'mice'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('UBERON_0000104', 'life cycle', 123, 'life'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
PMC5784894	1/2018	S147-PMC5784894	['OUR FINDINGS SUGGEST a nutritional programming EFFECT of Vitamin D on Growing and Adult bone.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0040007', 'growth', 70, 'growing'), ('UBERON_0007023', 'adult organism', 82, 'adult')]
PMC5784894	1/2018	S148-PMC5784894	['THESE FINDINGS are CONSISTENT with multiple data sources that LINK early Life Vitamin D status to later bone size[4,8,9,25], structure[6,26], mass[8,9,26,27] and risk of fracture[9].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('UBERON_0000104', 'life cycle', 73, 'life'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5784894	1/2018	S151-PMC5784894	['the EFFECT of maternal Vitamin D deficiency on bone (without loading) HAS BEEN studied in a range of Animal MODELS.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 108)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 101, 'animal')]
PMC5784894	1/2018	S158-PMC5784894	['in a separate study, maternal deficiency until mid Lactation with male pups placed on an obesogenic diet at weaning SHOWED improved Trabecular architecture for those on high compared to low Vitamin D diet but no differences in strength[33].']	[('INCOMPLETE_EVIDENCE', 116)]	1	[('GO_0007595', 'lactation', 51, 'lactation'), ('UBERON_0002363', 'dura mater', 132, 'trabecular'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC5784894	1/2018	S159-PMC5784894	['the mavidos study, a randomised controlled trial of Vitamin D supplementation to Pregnant women RECENTLY REPORTED changes in bmc in babies Born during the winter months.']	[('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 105)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('GO_0007567', 'parturition', 139, 'born')]
PMC5784894	1/2018	S171-PMC5784894	['a further LIMITATION to THIS STUDY is that the diet used creates a MODEL of complete Vitamin D deficiency that is not typical of the Human population.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 67)]	3	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 133, 'human')]
PMC5784894	1/2018	S173-PMC5784894	['we BELIEVE that our data are ROBUST and that our INFERENCES of a reduced EFFECT of loading in offspring of Vitamin D deplete Animals stand BECAUSE the increased compliance of the Bones in the deplete group MEANS that the strain stimulus induced by the load of 10.5n was greater than in the replete group.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 49), ('PROBABLE_UNDERSTANDING', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 139), ('PROBABLE_UNDERSTANDING', 206)]	7	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 125, 'animals'), ('UBERON_0001474', 'bone element', 179, 'bones')]
PMC5784894	1/2018	S184-PMC5784894	['INSTEAD it SHOWS the EFFECT of Vitamin D response before or after Birth on the bone stiffness.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 21)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007567', 'parturition', 66, 'birth')]
PMC5784894	1/2018	S187-PMC5784894	['xue et al IDENTIFIED Dna Methylation changes in 2 generations of offspring from dams exposed to dietary Vitamin D deficiency throughout Gestation and weaning[38].']	[('INCOMPLETE_EVIDENCE', 10)]	1	[('GO_0006306', 'DNA methylation', 21, 'DNA methylation'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'gestation')]
PMC5784894	1/2018	S189-PMC5784894	['identification of specific pathways is being pursued with a VIEW to BETTER UNDERSTANDING the CONTRIBUTION of early Life Vitamin D to bone health in later Life and to identify new pathways that COULD IMPACT on osteoporosis PREVENTION and treatment.']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 222)]	6	[('UBERON_0000104', 'life cycle', 115, 'life'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('UBERON_0000104', 'life cycle', 154, 'life')]
PMC5784894	1/2018	S190-PMC5784894	['THIS is the FIRST STUDY to report the results of mechanical loading of bone in Mice exposed to Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12)]	2	[('NCBITaxon_10088', 'Mus <genus>', 79, 'mice'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5784894	1/2018	S191-PMC5784894	['THIS work THUS establishes Early Life Vitamin D deficiency as a FACTOR that CAN CONTRIBUTE to Adult osteoporosis; offers a POTENTIAL Solution–supplementation of Vitamin D during Pregnancy and infancy; and presents a MODEL system TO IDENTIFY pathways that COULD BE TARGETED in Adult Life to prevent or treat osteoporosis, a GLOBAL health PROBLEM.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 10), ('SUPERFICIAL_RELATIONSHIP', 64), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 216), ('QUESTION_ANSWERED_BY_THIS_WORK', 229), ('INCOMPLETE_EVIDENCE', 255), ('FUTURE_WORK', 264), ('IMPORTANT_CONSIDERATION', 323), ('IMPORTANT_CONSIDERATION', 337)]	12	[('UBERON_0001847', 'lobule of pinna', 27, 'early life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 94, 'adult'), ('CHEBI_75958', 'solution', 133, 'solution'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('UBERON_0000113', 'post-juvenile adult stage', 276, 'adult life')]
PMC5804088	2/2018	S19-PMC5804088	['OTHER STUDIES have FOUND EVIDENCE of ASSOCIATIONS between acute malaria and deficiency of Thiamine [14] and antioxidants including Vitamin E [15], which SUGGESTS they have ROLES in protection against malaria.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 172)]	5	[('CHEBI_26948', 'vitamin B1', 90, 'thiamine'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin E')]
PMC5812027	2/2018	S14-PMC5812027	['THUS, both higher Vitamin D status in late Pregnancy and Gestational Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 124)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('GO_0007565', 'female pregnancy', 57, 'gestational'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'pregnancy')]
PMC5812027	2/2018	S19-PMC5812027	['we have PREVIOUSLY SHOWN that higher Vitamin D status in late Pregnancy and larger increase in Vitamin D status during Pregnancy is ASSOCIATED with lower risk of Preeclampsia [3].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 132)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 162, 'preeclampsia')]
PMC5812027	2/2018	S20-PMC5812027	['ASSOCIATIONS HAVE also BEEN SHOWN between Vitamin D insufficiency (<\u200950\xa0nmol/l) and increased risk of infant small for Gestational age (sga) and low birth weight (lbw) [4].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'gestational')]
PMC5812027	2/2018	S28-PMC5812027	['lower Vitamin D status HAS also BEEN ASSOCIATED with a medical history of recurrent Miscarriage [12] BUT ONLY two prospective studies have INVESTIGATED this, without finding that lower 25Ohd concentrations increases the risk of Pregnancy Loss [5,13].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 37), ('ANOMALY_CURIOUS_FINDING', 101), ('QUESTION_ANSWERED_BY_THIS_WORK', 139)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0046660', 'female sex differentiation', 84, 'miscarriage'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 185, '25OHD'), ('GO_0006508', 'proteolysis', 228, 'pregnancy loss')]
PMC5812027	2/2018	S62-PMC5812027	['season was coded as a binary variable, since this EXPLAINED 30% of Vitamin D status in a PREVIOUS STUDY in Pregnant women at the same latitude [16].']	[('PROBABLE_UNDERSTANDING', 50), ('INCOMPLETE_EVIDENCE', 89)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'pregnant')]
PMC5812027	2/2018	S73-PMC5812027	['tobacco use and Vitamin D supplement use were also INVESTIGATED as POTENTIAL CONFOUNDERS BUT did not show any confounding effect and were THUS not included in the final MODELS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('INCOMPLETE_EVIDENCE', 67), ('PROBLEM_COMPLICATION', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('PROBABLE_UNDERSTANDING', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC5812027	2/2018	S108-PMC5812027	['discussion\nwe FOUND that higher Vitamin D status among women in late, BUT NOT early, Pregnancy was ASSOCIATED with lower probability of sga and lbw.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy')]
PMC5812027	2/2018	S111-PMC5812027	['we also FOUND that lower Vitamin D status in early Pregnancy was RELATED to Pregnancy loss.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC5812027	2/2018	S116-PMC5812027	['we have PREVIOUSLY SHOWN that the DETERMINANTS of season-corrected change in 25Ohd during Pregnancy include origin, sun-exposure and dietary as well as supplementary Vitamin D Intake [18].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 34)]	2	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 77, '25OHD'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007631', 'feeding behavior', 176, 'intake')]
PMC5812027	2/2018	S118-PMC5812027	['AS the results between change in 25Ohd and neonatal Birth size and Preterm Delivery REMAINED after adjustment for season of Conception, origin and Vitamin D supplementation, Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 209), ('SUPERFICIAL_RELATIONSHIP', 229)]	5	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 33, '25OHD'), ('GO_0007567', 'parturition', 52, 'birth'), ('GO_0007565', 'female pregnancy', 67, 'preterm'), ('GO_0007567', 'parturition', 75, 'delivery'), ('GO_0007620', 'copulation', 124, 'conception'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
PMC5812027	2/2018	S121-PMC5812027	['it is also POSSIBLE that the ASSOCIATIONS between fetal growth and maternal Vitamin D status are DUE TO residual CONFOUNDING or REVERSE CAUSATION.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 29), ('PROBLEM_COMPLICATION', 97), ('PROBLEM_COMPLICATION', 113), ('PROBLEM_COMPLICATION', 128)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5812027	2/2018	S127-PMC5812027	['this COULD BE INTERPRETED AS SUPPORT of our finding that late RATHER than early Pregnancy Vitamin D status is the stronger PREDICTOR of fetal growth restriction.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('SUPERFICIAL_RELATIONSHIP', 123)]	5	[('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5812027	2/2018	S130-PMC5812027	['our results COULD also INDICATE that it takes time for changes in Vitamin D Metabolism to manifest as changes in circulating 25Ohd.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 23)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 66, 'vitamin D metabolism'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 125, '25OHD')]
PMC5812027	2/2018	S131-PMC5812027	['we DID NOT SEE a u-shaped ASSOCIATION between early Pregnancy Vitamin D status and sga, as PREVIOUSLY INDICATED [9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 102)]	4	[('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC5812027	2/2018	S136-PMC5812027	['supplementation CAN THEREFORE ONLY PARTLY EXPLAIN the large proportion with high Vitamin D status, and OTHER LIKELY CONTRIBUTORS are Pregnancy associated Endocrine changes and POSSIBLY lifestyle FACTORS.']	[('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 195)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('GO_0006397', 'mRNA processing', 154, 'endocrine')]
PMC5812027	2/2018	S137-PMC5812027	['TO OUR KNOWLEDGE, ours is one of the FIRST studies to find ASSOCIATIONS between Vitamin D status and Pregnancy loss.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC5812027	2/2018	S141-PMC5812027	['one earlier study, from denmark, FOUND that lower Vitamin D status in early Pregnancy was ASSOCIATED with Pregnancy loss in the first trimester [24].']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 90)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy')]
PMC5812027	2/2018	S143-PMC5812027	['AS most women with high Vitamin D status were Born in sweden and THUS more LIKELY to be familiar with the swedish Health-Care System, IT IS POSSIBLE that they registered earlier for Antenatal Care and were more LIKELY to report Pregnancy Loss.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 65), ('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 134), ('PROBABLE_UNDERSTANDING', 211)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007567', 'parturition', 46, 'born'), ('UBERON_0001008', 'renal system', 114, 'health-care system'), ('GO_0007608', 'sensory perception of smell', 182, 'antenatal care'), ('GO_0006508', 'proteolysis', 228, 'pregnancy loss')]
PMC5812027	2/2018	S145-PMC5812027	['DESPITE FEW cases of iufd in the gravid cohort, our results SUGGEST that Vitamin D deficiency in early Pregnancy MAY BE LINKED to iufd.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 120)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy')]
PMC5812027	2/2018	S152-PMC5812027	['in addition, Vitamin D status among women who Terminated the Pregnancy WAS NOT ASSESSED.']	[('INCOMPLETE_EVIDENCE', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 79)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0042778', 'tRNA end turnover', 46, 'terminated'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
PMC5812027	2/2018	S160-PMC5812027	['INTERESTINGLY, Vitamin D status at t1- around the time the maternal Blood flow of the Placenta is fully developed- is ONLY RELATED to Pregnancy loss.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0001987', 'placenta', 86, 'placenta'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy')]
PMC5812027	2/2018	S164-PMC5812027	['both higher late Pregnancy Vitamin D status and Gestational Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 115)]	3	[('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'gestational'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy')]
PMC5827025	2/2018	S0-PMC5827025	['INFLUENT FACTORS of Gestational Vitamin D deficiency and its RELATION to an INCREASED RISK of Preterm Delivery in chinese population\n\nabstract\nGestational Vitamin D deficiency (vdd) HAS BEEN LINKED with adverse Pregnant outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 61), ('IMPORTANT_CONSIDERATION', 76), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 191)]	6	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'preterm'), ('GO_0007567', 'parturition', 102, 'delivery'), ('GO_0007565', 'female pregnancy', 143, 'Gestational'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 211, 'pregnant')]
PMC5827025	2/2018	S13-PMC5827025	['RECENTLY, Vitamin D is well recognized for its non-classical actions including antioxidant activity, modulation of innate Immune response and Adaptive Immune Response2–4.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('GO_0002836', 'positive regulation of response to tumor cell', 142, 'adaptive immune response2'), ('UBERON_0002405', 'immune system', 151, 'immune')]
PMC5827025	2/2018	S15-PMC5827025	['ALTHOUGH SOME POTENTIAL INFLUENT FACTORS for Vitamin D status, such as seasonality, age, smoking, race and ethnicity HAVE BEEN IDENTIFIED in SEVERAL case-control STUDIES6–8, research REPORTS on the INFLUENT FACTORS for Gestational Vitamin D status in a population-based cohort are LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 162), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 198), ('SUPERFICIAL_RELATIONSHIP', 207), ('FULL_UNKNOWN', 281), ('INCOMPLETE_EVIDENCE', 281)]	15	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
PMC5827025	2/2018	S17-PMC5827025	['IN CONTRAST, the reports from randomized controlled trials INDICATE that Gestational Vitamin D supplementation CAN markedly decrease Pregnancy COMPLICATIONS including Preeclampsia and Pregnancy induced hypertension11.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 111), ('PROBLEM_COMPLICATION', 143)]	4	[('GO_0007565', 'female pregnancy', 73, 'gestational'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 167, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
PMC5827025	2/2018	S78-PMC5827025	['a report DEMONSTRATED that socio-economic status INFLUENCES Gestational Vitamin D status26.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('GO_0007565', 'female pregnancy', 60, 'gestational'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5827025	2/2018	S81-PMC5827025	['results SHOW that these factors did not affect Gestational Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('GO_0007565', 'female pregnancy', 47, 'gestational'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC5827025	2/2018	S90-PMC5827025	['SEVERAL STUDIES SHOWED that multivitamin use CAN improve their Vitamin D status29,30.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 45)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5827025	2/2018	S94-PMC5827025	['NUMEROUS STUDIES SHOWED that season is a MAJOR INFLUENT FACTOR for Vitamin D status31,32.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 41), ('SUPERFICIAL_RELATIONSHIP', 47), ('SUPERFICIAL_RELATIONSHIP', 56)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5827025	2/2018	S101-PMC5827025	['follow-up, SEVERAL randomized TRIAL of Vitamin D supplementation FOUND that the rate of Preterm Delivery is significant more lower in Pregnant women with Serum 25(Oh)D ≥40\u2009ng/ml COMPARED TO those with Serum 25(Oh)D ≤20\u2009ng/ml, SUGGESTING higher 25(Oh)D concentration was ASSOCIATED with an decreased risk of Preterm Delivery35–38.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 178), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 270)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 88, 'preterm'), ('GO_0007567', 'parturition', 96, 'delivery'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('UBERON_0001977', 'blood serum', 154, 'serum'), ('CHEBI_63056', 'zinc cation', 160, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 166, 'D'), ('UBERON_0001977', 'blood serum', 201, 'serum'), ('CHEBI_71657', 'versiconol acetate', 207, '25(OH)D'), ('PR_000011614', 'opioid growth factor receptor', 210, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 213, 'D'), ('CHEBI_71657', 'versiconol acetate', 244, '25(OH)D'), ('GO_0007565', 'female pregnancy', 307, 'preterm'), ('GO_0008219', 'cell death', 315, 'delivery35')]
PMC5827025	2/2018	S102-PMC5827025	['the INCONSISTENCY of PAST FINDINGS MAY BE RELATED to following REASONS: first, cohort among Pregnant women with relatively Vitamin D replete, with a history of Preterm Delivery or at high risk for Preeclampsia; second, Gestational Vitamin D status is a LINK to ethnic DISPARITIES in adverse Birth outcomes24.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 253), ('IMPORTANT_CONSIDERATION', 268)]	9	[('GO_0007565', 'female pregnancy', 92, 'pregnant'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'preterm'), ('GO_0007567', 'parturition', 168, 'delivery'), ('GO_0007128', 'meiotic prophase I', 197, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0007567', 'parturition', 291, 'birth')]
PMC5827025	2/2018	S103-PMC5827025	['ALTHOUGH a RECENT STUDY in northeast china DEMONSTRATED that vdd was more PREVALENT in the SEVERE preterm group than in the mildly preterm group and the in-term group, they DID NOT analyze the ASSOCIATION between vdd and an INCREASED RISK of Preterm Delivery BECAUSE Vitamin D status at prior to labor cannot be used to assess risk of Preterm Delivery39.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 74), ('IMPORTANT_CONSIDERATION', 91), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 193), ('IMPORTANT_CONSIDERATION', 224), ('PROBLEM_COMPLICATION', 259)]	10	[('GO_0007565', 'female pregnancy', 242, 'preterm'), ('GO_0007567', 'parturition', 250, 'delivery'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('GO_0007565', 'female pregnancy', 335, 'preterm'), ('GO_0007567', 'parturition', 343, 'delivery39')]
PMC5827025	2/2018	S116-PMC5827025	['INCREASING EVIDENCE DEMONSTRATES that Vitamin D has an anti-inflammatory activity40.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC5827025	2/2018	S117-PMC5827025	['RECENTLY, an Animal report INDICATES that Vitamin D inhibits Placental inflammation through reinforcing physical INTERACTION between Vitamin D Receptor (vdr) and Nf-Κb P65 Subunit17.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('NCBITaxon_33208', 'Metazoa', 13, 'animal'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0001987', 'placenta', 61, 'placental'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 133, 'vitamin D receptor'), ('GO_0071159', 'NF-kappaB complex', 162, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 162, 'NF-κB p65 subunit17')]
PMC5841533	2/2018	S17-PMC5841533	['introduction\nan ESTIMATED 250\u2009million children GLOBALLY are denied the opportunity to reach their full developmental potential DUE TO the combined EFFECTS of poverty and undernutrition.1poor nutrition during Pregnancy CONTRIBUTES to maternal morbidity and mortality, increases the risks of low Birth weight and poor development, and exacerbates the risk of chronic disease in Adulthood.2 3many Pregnant women face Micronutrient deficiencies: an ESTIMATED 15.3% globally lack Vitamin A, 28.5% lack Iodine and 38% have iron-deficiency anaemia.1 4nutritional deprivation in Pregnancy CAN alter neural growth in the fetus and AFFECT Cognitive functioning, hindering children’s chances in school and CONTRIBUTING to the intergenerational transmission of poverty.5–9\nthe world health organisation (who) currently RECOMMENDS Iron and Folic Acid (ifa) supplementation in Pregnancy to improve maternal and Perinatal outcomes, BUT NOT multiple Micronutrient (mmn)supplementation.10–12could Antenatal Micronutrient supplementation improve children’s long-term Cognitive functioning?']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 47), ('PROBLEM_COMPLICATION', 127), ('SUPERFICIAL_RELATIONSHIP', 147), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 445), ('INCOMPLETE_EVIDENCE', 581), ('SUPERFICIAL_RELATIONSHIP', 622), ('SUPERFICIAL_RELATIONSHIP', 695), ('FUTURE_WORK', 807), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 917), ('ANOMALY_CURIOUS_FINDING', 917), ('EXPLICIT_QUESTION', 1070)]	13	[('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007567', 'parturition', 294, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 376, 'adulthood'), ('GO_0007565', 'female pregnancy', 394, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 414, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 475, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 497, 'iodine'), ('GO_0007565', 'female pregnancy', 571, 'pregnancy'), ('GO_0050890', 'cognition', 629, 'cognitive'), ('CHEBI_24870', 'ion', 818, 'Iron'), ('CHEBI_30751', 'formic acid', 827, 'Folic Acid'), ('GO_0007565', 'female pregnancy', 863, 'pregnancy'), ('GO_0036268', 'swimming', 897, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 897, 'perinatal'), ('CHEBI_6956', 'Mitragynine', 934, 'Micronutrient'), ('GO_0007567', 'parturition', 980, 'antenatal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 990, 'micronutrient'), ('GO_0050890', 'cognition', 1049, 'cognitive')]
PMC5841533	2/2018	S19-PMC5841533	['supplementation with single Micronutrients during Pregnancy APPEARS TO have little influence on children’s Cognitive outcomes: 10 trials conducted in high-income, middle-income and low-income settings FOUND no effects of Antenatal iron, zinc, Vitamin A or Choline supplementation on Cognitive functions.13–20supplementation with mmn, on the OTHER HAND, COULD AFFECT children’s Cognitive functions via three RELATED pathways.']	[('ANOMALY_CURIOUS_FINDING', 60), ('INCOMPLETE_EVIDENCE', 201), ('ANOMALY_CURIOUS_FINDING', 341), ('INCOMPLETE_EVIDENCE', 353), ('SUPERFICIAL_RELATIONSHIP', 359), ('SUPERFICIAL_RELATIONSHIP', 407)]	6	[('CHEBI_33839', 'macromolecule', 28, 'micronutrients'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('GO_0050890', 'cognition', 107, 'cognitive'), ('GO_0007567', 'parturition', 221, 'antenatal'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin A'), ('CHEBI_15354', 'choline', 256, 'choline'), ('GO_0050890', 'cognition', 283, 'cognitive'), ('GO_0050890', 'cognition', 377, 'cognitive')]
PMC5831579	3/2018	S104-PMC5831579	['fruits and vegetables, foods that require preparation, protein, Carbohydrate, Nutrients related to One-Carbon Metabolism pathway, Dha, Vitamin D, iron, sodium, Calcium and Caffeine were more strongly CORRELATED to the ‘seasoned vegetables and lean meats,’ which was the dietary pattern that COULD CONTRIBUTE MOST to a healthy pre-Pregnancy nutrition [9,17–20], followed by ‘lentils, whole grains and soups’ pattern.']	[('SUPERFICIAL_RELATIONSHIP', 200), ('INCOMPLETE_EVIDENCE', 291), ('SUPERFICIAL_RELATIONSHIP', 297), ('PROBABLE_UNDERSTANDING', 308)]	4	[('CHEBI_16730', 'chloramphenicol 3-acetate', 64, 'carbohydrate'), ('CHEBI_33284', 'nutrient', 78, 'nutrients'), ('GO_0006730', 'one-carbon metabolic process', 99, 'one-carbon metabolism'), ('CHEBI_17874', 'dihydrozeatin', 130, 'DHA'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 160, 'calcium'), ('CHEBI_27732', 'caffeine', 172, 'caffeine'), ('GO_0007565', 'female pregnancy', 330, 'pregnancy')]
PMC5838372	3/2018	S20-PMC5838372	['the lack of Vitamin D during Pregnancy is the MOST IMPORTANT RISK FACTOR for infantile rickets and MAY also result in POOR fetal growth and Neonatal Development (8,9,10,11).']	[('PROBABLE_UNDERSTANDING', 46), ('IMPORTANT_CONSIDERATION', 51), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 118)]	5	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('GO_0021985', 'neurohypophysis development', 140, 'neonatal development')]
PMC5838372	3/2018	S82-PMC5838372	['the SAFETY dose during Pregnancy is NOT CLEAR, but hollis et al (20) SHOWED that Vitamin D supplementation of 4000 iu/day for achieving adequate levels was SAFE and EFFECTIVE in Pregnant women.']	[('IMPORTANT_CONSIDERATION', 4), ('FULL_UNKNOWN', 36), ('INCOMPLETE_EVIDENCE', 69), ('IMPORTANT_CONSIDERATION', 156), ('SUPERFICIAL_RELATIONSHIP', 165)]	5	[('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnant')]
PMC5838372	3/2018	S86-PMC5838372	['the endocrine society SUGGESTS Vitamin D levels of > 20 ng/ml for sufficiency, 12-20 ng/ml for insufficiency and <12 ng/ml as Vitamin D deficiency (16).']	[('INCOMPLETE_EVIDENCE', 22)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC5838372	3/2018	S88-PMC5838372	['studies REPORTED from different countries HAVE SHOWN a prevalence of Vitamin D deficiency in Pregnant women and in infants ranging from 4% to 60% and from 3% to 86%, respectively (24,25).']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 42)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnant')]
PMC5838372	3/2018	S90-PMC5838372	['in a study from india, it HAS BEEN REPORTED that 84% of Pregnant women had Vitamin D concentrations <22.5 ng/ml (27).']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 35)]	2	[('GO_0007565', 'female pregnancy', 56, 'pregnant'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5838372	3/2018	S91-PMC5838372	['in a national survey from belgium, Vitamin D insufficiency (<30 ng/ml) and deficiency (<20 ng/ml) were FOUND as 74.1% and 44.6% (28).']	[('INCOMPLETE_EVIDENCE', 103)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC5838372	3/2018	S92-PMC5838372	['PREVIOUS STUDIES HAVE SHOWN that Vitamin D deficiency is common in Pregnant women in turkey.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnant')]
PMC5838372	3/2018	S93-PMC5838372	['in 1998, alagöl et al (29) FOUND that Vitamin D levels were low in 66.6% of women of Reproductive age in i̇stanbul.']	[('INCOMPLETE_EVIDENCE', 27)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0000003', 'reproduction', 85, 'reproductive')]
PMC5838372	3/2018	S95-PMC5838372	['in a FURTHER study by ergur et al (2009) (31), ONLY 18.6% of the mothers and 2.9% of the neonates had normal Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 47)]	2	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC5838372	3/2018	S96-PMC5838372	['in 2008, halicioglu et al (32) FOUND that 50.4% of Pregnant women in i̇zmir, a city in a sunny region of turkey, had Blood Vitamin d levels ≤10 ng/ml.']	[('INCOMPLETE_EVIDENCE', 31)]	1	[('GO_0007565', 'female pregnancy', 51, 'pregnant'), ('UBERON_0000178', 'blood', 116, 'blood'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC5838372	3/2018	S101-PMC5838372	['all these data CONFIRM that Vitamin D deficiency continues to be a PROBLEM in Pregnant women and their infants in turkey, DESPITE the introduction of the supplementation programme.']	[('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 67), ('PROBLEM_COMPLICATION', 67), ('ANOMALY_CURIOUS_FINDING', 122)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnant')]
PMC5838372	3/2018	S102-PMC5838372	['ALTHOUGH the ministry of health has RECOMMENDED a Vitamin D intake of 1200 iu/day, we FOUND that 12.4% of mothers never used Vitamin D Supplements and 73.2% used irregular or low doses.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 36), ('INCOMPLETE_EVIDENCE', 86)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 135, 'supplements')]
PMC5838372	3/2018	S105-PMC5838372	['these results SHOW that high dose Vitamin D support is NECESSARY during Pregnancy and that the support program SHOULD BE continued.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 55), ('FUTURE_WORK', 111)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy')]
PMC5838372	3/2018	S106-PMC5838372	['limited sun exposure, regular use of sunscreens, living in northern latitudes, dark skin, obesity, extensive clothing cover, Aging, poor nutritional status, malabsorption syndromes and Medications HAVE BEEN REPORTED as RISK FACTORS for Vitamin D deficiency (1,19).']	[('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 219)]	2	[('GO_0007568', 'aging', 125, 'aging'), ('CHEBI_25441', 'mycothiols', 185, 'medications'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
PMC5838372	3/2018	S107-PMC5838372	['in PREVIOUS STUDIES in turkey, winter season, low socioeconomic status, low educational status and covered clothing style were REPORTED as RISK FACTORS for Vitamin D deficiency in mothers (31,34,35).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC5838372	3/2018	S109-PMC5838372	['SIMILARLY, halicioglu et al (32) and çuhacı-çakır et al (36) REPORTED that covered clothing style was a RISK factor for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC5838372	3/2018	S112-PMC5838372	['THESE FINDINGS SHOW that covered clothing style is an IMPORTANT factor for Vitamin D deficiency in Pregnant women in turkey.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 54)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 99, 'pregnant')]
PMC5838372	3/2018	S115-PMC5838372	['as MIGHT BE EXPECTED PREVIOUS STUDIES HAVE SHOWN a strong CORRELATION between maternal and neonatal levels of Vitamin D (8,9).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC5838372	3/2018	S116-PMC5838372	['ergur et al (31) SUGGESTED that maternal deficiency was the most IMPORTANT FACTOR for Vitamin D deficiency in newborns.']	[('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5838372	3/2018	S118-PMC5838372	['SIMILARLY, we FOUND a strong positive CORRELATION between the mothers’ and their babies’ Vitamin D levels and low level of Vitamin D in mother was an important RISK FACTOR for deficiency in infants.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC5838372	3/2018	S119-PMC5838372	['when we evaluated the RELATIONSHIP between the infants’ Vitamin D level and their mothers’ clothing style, together with daily Vitamin D intake, we FOUND that there were no significant differences with respect to the mothers’ clothing style.']	[('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 148)]	2	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC5838372	3/2018	S120-PMC5838372	['HOWEVER, mothers’ low Vitamin intake was FOUND AS a RISK FACTOR for the infants’ Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 47), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('CHEBI_33229', 'vitamin (role)', 22, 'vitamin'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5941617	5/2018	S1-PMC5941617	['besides its historical Skeletal functions, in the last years it HAS BEEN DEMONSTRATED that Vitamin D directly OR indirectly Regulates up to 1250 Genes, playing so-called Extraskeletal actions.']	[('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110)]	3	[('UBERON_0004288', 'skeleton', 23, 'skeletal'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 124, 'regulates'), ('SO_0000704', 'gene', 145, 'genes'), ('UBERON_0001431', 'distal carpal bone 2', 170, 'extraskeletal')]
PMC5941617	5/2018	S2-PMC5941617	['indeed, RECENT DATA SUGGEST a POSSIBLE ROLE of Vitamin D in the pathogenesis of several pathological conditions, including infectious, allergic and Autoimmune diseases.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 148, 'autoimmune')]
PMC5941617	5/2018	S3-PMC5941617	['THUS, Vitamin D deficiency MAY AFFECT NOT ONLY Musculoskeletal health BUT ALSO a POTENTIALLY WIDE range of acute and chronic conditions.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 38), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93)]	6	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 47, 'musculoskeletal')]
PMC5941617	5/2018	S4-PMC5941617	['AT PRESENT, the prevalence of Vitamin D deficiency is high in italian children and adolescents, and national RECOMMENDATIONS on Vitamin D supplementation during pediatric age are LACKING.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 109), ('FULL_UNKNOWN', 179)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5941617	5/2018	S7-PMC5941617	['besides these classic Skeletal actions, RECENT STUDIES have DEMONSTRATED that Vitamin D exerts OTHER significant Extraskeletal actions, with a POSSIBLE ROLE in the pathogenesis of several pathological conditions, including infectious and Autoimmune diseases [1].']	[('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 152)]	5	[('UBERON_0004288', 'skeleton', 22, 'skeletal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 113, 'extraskeletal'), ('UBERON_0001442', 'skeleton of manus', 238, 'autoimmune')]
PMC5941617	5/2018	S20-PMC5941617	['the main OBJECTIVE is to give RECOMMENDATIONS regarding the PREVENTION and treatment of Vitamin D deficiency in italian children and adolescents (0–18\xa0years), CONSIDERING both the Skeletal and Extra-Skeletal EFFECTS of Vitamin D and POTENTIAL RISK FACTORS in specific subgroups of children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FUTURE_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 208), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 243)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0004288', 'skeleton', 180, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 193, 'extra-skeletal'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC5941617	5/2018	S29-PMC5941617	['in literature, several cut-offs HAVE BEEN PROPOSED for Vitamin D deficiency with respect to Serum 25(Oh)D levels measured with a RELIABLE assay.']	[('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 129)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0001977', 'blood serum', 92, 'serum'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 98, '25(OH)D')]
PMC5941617	5/2018	S32-PMC5941617	['caption (table-wrap): table 2\n\ndefinition of Vitamin D status according to several societies and organizations in the last 10\xa0yearssociety/organizationyearsevere deficiencydeficiencyinsufficiencysufficiency/adequacycanadian pediatric society [8]2007–<\u2009 10\xa0ng/ml10–29\xa0ng/ml≥ 30\xa0ng/mllawson wilkins pediatric Endocrine society [9]2008<\u2009 5\xa0ng/ml5–14\xa0ng/ml15–19\xa0ng/ml≥ 20\xa0ng/mlinstitute of medicine [10]2011–<\u2009 12\xa0ng/ml12–20\xa0ng/mla≥ 20\xa0ng/mlthe Endocrine society [11]2011–<\u2009 20\xa0ng/ml21–29\xa0ng/ml≥ 30\xa0ng/mlbritish paediatric and adolescent bone group [12]2012–<\u200910\xa0ng/ml10–19\xa0ng/ml≥ 20\xa0ng/mlfrench society of paediatrics [13]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlasociación espanola de pediatría (spain) [14]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlfederal commission for nutrition (switzerland) [15]2012<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlnordic nutrition recommendations [16]2012–<\u2009 12\xa0ng/ml12–20\xa0ng/ml≥ 20\xa0ng/mlgerman nutrition society [17]2012–––≥ 20\xa0ng/mlhealth council of the netherlands [18]2012–––≥ 12\xa0ng/mleuropean society for paediatric gastroenterology hepatology and nutrition [19]2013<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlcentral europe [20]2013–< 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlsociety for adolescent health and medicine [21]2013–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlaustralia/new zealand [22]2013<\u2009 5\xa0ng/ml5–11\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mlamerican academy of pediatrics [23]2014–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyb[24]2015–<\u2009 20\xa0ng/ml––scientific advisory committee on nutrition [25]2016–––≥ 10\xa0ng/mleuropean Food safety authority [26]2016–––≥ 20\xa0ng/mlunited arab emirates [27]2016–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlglobal consensus for rickets [28]2016–<\u2009 12\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyc[29]2017–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mleuropean academy of pediatrics [30]2017definition of Vitamin D status is UNCLEAR DUE TO a lack OF consensus\navitamin D inadequacy\nbdiagnostic criteria for rickets\ncassessment criteria for Vitamin D deficiency/insufficiency (authors REPORTED that DIFFERENT criteria MAY BE needed for children)\nsevere Vitamin D deficiency is DEFINED as 25(Oh)d levels <\u200910\xa0ng/ml by SEVERAL authors and societies BECAUSE the risk of rickets is high below this cut-off also in presence of an adequate Calcium intake [31–33] (see chapter “nutritional rickets”).']	[('FULL_UNKNOWN', 1894), ('PROBLEM_COMPLICATION', 1902), ('ANOMALY_CURIOUS_FINDING', 1916), ('ANOMALY_CURIOUS_FINDING', 1916), ('INCOMPLETE_EVIDENCE', 2053), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2067), ('INCOMPLETE_EVIDENCE', 2086), ('PROBABLE_UNDERSTANDING', 2145), ('INCOMPLETE_EVIDENCE', 2185), ('PROBABLE_UNDERSTANDING', 2215)]	10	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 307, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 441, 'Endocrine'), ('CHEBI_46662', 'mineral', 1396, 'Mineral'), ('GO_0009790', 'embryo development', 1420, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1420, 'Endocrine'), ('CHEBI_33290', 'food', 1533, 'Food'), ('CHEBI_46662', 'mineral', 1738, 'Mineral'), ('GO_0009790', 'embryo development', 1762, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1762, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 1874, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1938, 'D'), ('CHEBI_27300', 'vitamin D', 2009, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2121, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 2156, '25(OH)'), ('CHEBI_22313', 'alkaline earth metal atom', 2302, 'calcium')]
PMC5941617	5/2018	S40-PMC5941617	['this COULD BE DUE by an age-dependent more efficient calcium absorption, a compensatory absorption Vitamin D-independent and a higher conversion to Calcitriol [44,51,52].']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 14)]	2	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 148, 'calcitriol')]
PMC5941617	5/2018	S44-PMC5941617	['based ON the above CONSIDERATIONS, we SUGGEST to define Vitamin D status as reported in table\xa03.']	[('ANOMALY_CURIOUS_FINDING', 6), ('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 38)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC5941617	5/2018	S53-PMC5941617	['the standardization, also RETROSPECTIVELY, SHOULD help to develop FUTURE Vitamin D GUIDELINES [59,60].']	[('INCOMPLETE_EVIDENCE', 26), ('FUTURE_WORK', 43), ('FUTURE_WORK', 66), ('PROBABLE_UNDERSTANDING', 83)]	4	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5941617	5/2018	S65-PMC5941617	['LIMITATIONS of the study include the fact that SOME of the studies mainly included children aged 7–11\xa0years, and that Vitamin D supplements, Food fortification or sun awareness campaigns COULD have INFLUENCED the ESTIMATES.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 198), ('INCOMPLETE_EVIDENCE', 213)]	5	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 141, 'food')]
PMC5941617	5/2018	S67-PMC5941617	['other italian data are present in literature, ALTHOUGH they SHOW SOME LIMITATIONS, regarding SMALL populations, analytic methods for 25(Oh)D, the season of recruitment, the prevalence of overweight/obesity, Vitamin D supplements, sunscreens, ethnicity, and uncovered areas of latitude.']	[('ANOMALY_CURIOUS_FINDING', 46), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 70), ('PROBLEM_COMPLICATION', 70), ('INCOMPLETE_EVIDENCE', 93)]	6	[('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 133, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5941617	5/2018	S95-PMC5941617	['CONSIDERING Water REQUIREMENTS, formula Fed infants MAY receive 400\xa0iu/day of Vitamin D, which is adequate for the first year of Life [10], only when they come to weigh 5 to 6 kg.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 52)]	4	[('CHEBI_15377', 'water', 12, 'water'), ('GO_0007631', 'feeding behavior', 40, 'fed'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000104', 'life cycle', 129, 'life')]
PMC5941617	5/2018	S98-PMC5941617	['THUS, dietary sources of Vitamin D SHOULD NOT BE considered significant for Humans except SOME populations living at higher latitudes where fish, fish oil and fish eggs are frequently Consumed [88].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 35), ('INCOMPLETE_EVIDENCE', 90)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 76, 'humans'), ('GO_0007631', 'feeding behavior', 184, 'consumed')]
PMC5941617	5/2018	S103-PMC5941617	['in 2016 the united kingdom scientific advisory committee on nutrition (sacn) reviewed THE EVIDENCE on Vitamin D and health and RECOMMENDED that Serum 25(Oh)D levels of all children and adolescents in the united kingdom SHOULD NOT fall below 10\xa0ng/ml (a so-CALLED “population PROTECTIVE level”) at any time of the year to protect Musculoskeletal health.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('INCOMPLETE_EVIDENCE', 90), ('FUTURE_WORK', 127), ('FUTURE_WORK', 219), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 275)]	6	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001977', 'blood serum', 144, 'serum'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('UBERON_0002204', 'musculoskeletal system', 329, 'musculoskeletal')]
PMC5941617	5/2018	S109-PMC5941617	['caption (table-wrap): table 5\n\ndietary reference values of Vitamin D in infants, children, and adolescents as PROPOSED by various organizations and societiesorganization/societyyearcountry/countriesdietary reference value for Vitamin D0–12\xa0months, iu/day1–18\xa0years, iu/dayeuropean Food safety authority [26]2016europeai400 (7–11\xa0months)600 (1–17\xa0years)scientific advisory committee on nutrition [25]2016united kingdomsafe intake (<\u20094\xa0years)340–400400rni (4–18\xa0years)nordic nutrition recommendations [16]2012denmark, finland, iceland, norway, sweden, faroe islands, greenland, åland islandsri400400german nutrition society [17]2012germany, austria, switzerlandai400 (infants)800a(children)health council of the netherlands [18]2012the netherlandsai400400italian society of nutrition [89]2012italyai (<\u2009 12\xa0months)400 (6–12\xa0months)600pri (1–18\xa0years)institute of medicine [10]2011north america, canadaai (<\u2009 12\xa0months)400600rda (1–18\xa0years)the Endocrine society [11]2011worldwidedaily requirementb400–1000600–1000\nai adequate intake, the average observed daily level of Intake by a population group of apparently healthy People that is ASSUMED to be adequate\nsafe intake , a level or range of intakes considered to pose no risk of deficiency and below a level where there is a risk of undesirable EFFECTS\nrni reference Nutrient intake, the amount of a Nutrient that is LIKELY to meet the needs of 97.5% of the population\nri recommended intake, the amount of a Nutrient that meets the known REQUIREMENT and maintains good nutritional status among practically all (97–98%) healthy Individuals in a particular Life Stage or gender group\npri population reference intake, the level of Nutrient intake sufficient to satisfy the needs of ALMOST all (97.5%) healthy subjects in one specific population group\nrda recommended dietary allowance, the estimated intake capable of satisfying the needs of 97.5% of the population\naadequate intake with missing Endogenous Synthesis Of Vitamin D\nbrecommended REQUIREMENTS for subjects at risk of Vitamin D deficiency\nin accordance with the european society for paediatric gastroenterology hepatology and nutrition [espghan] [19] and the european academy of pediatrics [30], we endorsed tolerable upper intake levels of Vitamin D proposed by efsa in 2012 (1000\xa0iu/day for infants: 2000\xa0iu/day for children ages 1 to 10\xa0years; 4000\xa0iu/day for children and adolescents ages 11 to 17\xa0years) [90].']	[('INCOMPLETE_EVIDENCE', 110), ('PROBABLE_UNDERSTANDING', 1134), ('SUPERFICIAL_RELATIONSHIP', 1295), ('PROBABLE_UNDERSTANDING', 1367), ('IMPORTANT_CONSIDERATION', 1488), ('ANOMALY_CURIOUS_FINDING', 1729), ('IMPORTANT_CONSIDERATION', 1990)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 226, 'vitamin D0'), ('PR_000017299', 'VIP peptides', 226, 'vitamin D0'), ('CHEBI_33290', 'food', 281, 'Food'), ('UBERON_0005063', 'left ventricular compact myocardium', 942, 'Endocrine'), ('GO_0007631', 'feeding behavior', 1068, 'intake'), ('NCBITaxon_10088', 'Mus <genus>', 1119, 'people'), ('CHEBI_33284', 'nutrient', 1317, 'Nutrient'), ('CHEBI_33284', 'nutrient', 1350, 'nutrient'), ('CHEBI_33284', 'nutrient', 1458, 'nutrient'), ('NCBITaxon_1', 'root', 1577, 'individuals'), ('UBERON_0000105', 'life cycle stage', 1605, 'life stage'), ('CHEBI_33284', 'nutrient', 1678, 'nutrient'), ('GO_0009790', 'embryo development', 1943, 'endogenous'), ('GO_0030474', 'spindle pole body duplication', 1954, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1967, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 1975, 'D'), ('CHEBI_27300', 'vitamin D', 2027, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2250, 'vitamin D')]
PMC5941617	5/2018	S112-PMC5941617	['as PREVIOUSLY discussed, Breast Milk [86] and formula Milk [1] contain insufficient amount of Vitamin D to prevent its deficiency.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('UBERON_0001348', 'brown adipose tissue', 25, 'breast milk'), ('UBERON_0001913', 'milk', 54, 'milk'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5941617	5/2018	S114-PMC5941617	['the IMPORTANCE of Vitamin D supplementation during the first year of Life HAS BEEN CONFIRMED by the FINDING that children not receiving supplementation have reduced Serum 25(Oh)d levels, PARTICULARLY if exclusively Breastfed and during winter season [94–96].']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 100), ('ANOMALY_CURIOUS_FINDING', 187)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000104', 'life cycle', 69, 'life'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('GO_0007567', 'parturition', 215, 'breastfed')]
PMC5941617	5/2018	S115-PMC5941617	['SOME STUDIES evaluated the EFFECT of daily Vitamin D supplementation at variable dosages (ranging from 200 to 1600\xa0iu/day) on Vitamin D status in children during the first year of Life [52,62,97–107].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
PMC5941617	5/2018	S119-PMC5941617	['ONLY FEW STUDIES evaluated the EFFICACY and SAFETY of intermittent Vitamin D supplementation during the first year of Life, particularly in cases with low compliance [109–111], THUS AT PRESENT daily supplementation REMAINS PREFERRED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 44), ('PROBABLE_UNDERSTANDING', 177), ('INCOMPLETE_EVIDENCE', 182), ('INCOMPLETE_EVIDENCE', 215), ('PROBABLE_UNDERSTANDING', 223)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
PMC5941617	5/2018	S122-PMC5941617	['the same RECOMMENDATION HAS BEEN worldwide PROPOSED also by an expert position statement on Vitamin D in childhood [1], the department of nutrition for health and development of the world health organization [116], the espghan [19], the european academy of pediatrics [30], and the Vitamin D GUIDELINES for united arab emirates [27] and central europe [20].']	[('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 292)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC5941617	5/2018	S125-PMC5941617	['regarding the PREFERRED form of Vitamin D for supplementation, the national institute for health and care excellence GUIDELINE RECOMMENDED Vitamin D drops in infants and young children [114], WHILE other international scientific societies DID NOT make any SPECIFIC RECOMMENDATION.']	[('PROBABLE_UNDERSTANDING', 14), ('PROBABLE_UNDERSTANDING', 117), ('FUTURE_WORK', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('INCOMPLETE_EVIDENCE', 239), ('FUTURE_WORK', 256), ('FUTURE_WORK', 265)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5941617	5/2018	S134-PMC5941617	['Ketoconazole)• infants Born from mothers with multiple RISK FACTORS for Vitamin D deficiency, particularly in absence of Vitamin D supplementation during Pregnancy\n\npreterm\npreterm infants are AT RISK for Calcium-Phosphorus Metabolism alterations, with POSSIBLE development of osteopenia of prematurity [120].']	[('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 193), ('INCOMPLETE_EVIDENCE', 253)]	3	[('CHEBI_47519', 'ketoconazole', 0, 'ketoconazole'), ('GO_0007567', 'parturition', 23, 'born'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy'), ('CHEBI_30272', 'arsonium', 205, 'calcium-phosphorus'), ('GO_0050655', 'dermatan sulfate proteoglycan metabolic process', 205, 'calcium-phosphorus metabolism')]
PMC5941617	5/2018	S137-PMC5941617	['AT PRESENT, the exact timing and proportion of Vitamin D-dependent absorption of Calcium and Phosphorus in preterm infants is UNKNOWN [122].']	[('INCOMPLETE_EVIDENCE', 0), ('FULL_UNKNOWN', 126)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 81, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 93, 'phosphorus')]
PMC5941617	5/2018	S139-PMC5941617	['in addition to optimize bone mineralization during fetal Life, Vitamin D status HAS BEEN ASSOCIATED with acute Respiratory morbidity in preterm infants Born <\u200932\xa0weeks Gestation [124].']	[('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('UBERON_0000104', 'life cycle', 57, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 111, 'respiratory'), ('GO_0007567', 'parturition', 152, 'born'), ('GO_0007565', 'female pregnancy', 168, 'gestation')]
PMC5941617	5/2018	S141-PMC5941617	['in 2013 the aap RECOMMENDED a daily Vitamin D intake of 200–400\xa0iu for vlbw infants, AS their smaller size MAY LEAD TO a lower need for Vitamin D to ensure adequate Serum 25(Oh)D levels.']	[('FUTURE_WORK', 16), ('PROBABLE_UNDERSTANDING', 85), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 111)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_71657', 'versiconol acetate', 171, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 177, 'D')]
PMC5941617	5/2018	S144-PMC5941617	['OTHER authors and GUIDELINES for central europe RECOMMENDED Vitamin D supplementation in preterm infants at higher dosages (400–1000\xa0iu/day) THAN those SUGGESTED for healthy term newborns [1,9,20,126], BUT such an intake SHOULD NOT BE prolonged over the THEORETICAL term (40\xa0weeks of post-Conceptional age) due to the POTENTIAL risk of Vitamin D intoxication [126].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 18), ('FUTURE_WORK', 48), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('FUTURE_WORK', 221), ('INCOMPLETE_EVIDENCE', 254), ('INCOMPLETE_EVIDENCE', 318)]	10	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007620', 'copulation', 289, 'conceptional'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D')]
PMC5941617	5/2018	S145-PMC5941617	['preterm infants MAY receive Vitamin D from various sources, such as parenteral nutrition, fortified Human milk or preterm infant formula, but it HAS BEEN calculated that without supplementation they do not receive 400\xa0iu/day of Vitamin D until reaching a weight of 2–2.5 kg [123] or only 4\xa0weeks after Birth [127].']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 145)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 100, 'human'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('GO_0007567', 'parturition', 302, 'birth')]
PMC5941617	5/2018	S147-PMC5941617	['SOME STUDIES evaluated the EFFECT of Vitamin D supplementation at DIFFERENT doses in preterm infants of various Gestational age and Birth weight [124,128–146].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'gestational'), ('GO_0007567', 'parturition', 132, 'birth')]
PMC5941617	5/2018	S152-PMC5941617	['RECENTLY RECOMMENDED Vitamin D supplementation at 800\xa0iu/day to enhance Vitamin D status during early hospitalization in vlbw infants with Serum 25(Oh)D levels <\u200910\xa0ng/ml at Birth [142].']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 9)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_71657', 'versiconol acetate', 145, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 145, '25 ... OH ... D'), ('GO_0007567', 'parturition', 174, 'birth')]
PMC5941617	5/2018	S157-PMC5941617	['SUGGESTED for extremely low Gestational age newborns an initial Vitamin D supplementation at 800\xa0iu/day for 1–2\xa0weeks to restore Serum 25(Oh)D levels followed by a lower dosage (200\xa0iu/day) [143].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('GO_0007565', 'female pregnancy', 28, 'gestational'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0001977', 'blood serum', 129, 'serum'), ('CHEBI_71657', 'versiconol acetate', 135, '25(OH)D')]
PMC5941617	5/2018	S159-PMC5941617	['1–18\xa0years\nthe promotion of an adequate Vitamin D status is IMPORTANT for older children and adolescents, AS nutritional rickets MAY develop during the entire pediatric age [28] and Vitamin D deficiency MAY negatively AFFECT bone health [25,26].']	[('IMPORTANT_CONSIDERATION', 60), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 218)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC5941617	5/2018	S160-PMC5941617	['VARIOUS STUDIES evaluated DIFFERENT regimens of Vitamin D supplementation, BUT comparison of results is COMPLEX DUE TO HETEROGENEITY in Vitamin D administration (dose, interval, and length of supplementation) and population enrolled (age, gender, ethnicity, body mass index, latitude of the country of residence, season of enrolment, and basal Vitamin D status).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('PROBLEM_COMPLICATION', 75), ('DIFFICULT_TASK', 104), ('PROBLEM_COMPLICATION', 112), ('DIFFICULT_TASK', 119)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D')]
PMC5941617	5/2018	S162-PMC5941617	['supplementation at 400\xa0iu/day for variable length (up to 12\xa0months) was USUALLY INSUFFICIENT in raising Serum 25(Oh)D levels >\u200930\xa0ng/ml [78,147–149,151–153,160–162], particularly in subjects with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 72), ('PROBLEM_COMPLICATION', 80)]	2	[('UBERON_0001977', 'blood serum', 104, 'serum'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 110, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC5941617	5/2018	S163-PMC5941617	['a RECENT rct performed during winter SHOWED that a Vitamin D intake up to 800\xa0iu/day was REQUIRED by white danish children (4–8\xa0years) to maintain Serum 25(Oh)D\u2009>\u200920\xa0ng/ml.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 89)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0001977', 'blood serum', 147, 'serum'), ('CHEBI_71657', 'versiconol acetate', 153, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 153, '25(OH)D')]
PMC5941617	5/2018	S165-PMC5941617	['another rct DEMONSTRATED that white uk adolescents (14–18\xa0years) REQUIRED higher intake of Vitamin D (up to 1200\xa0iu/day) during winter to achieve 25(Oh)D concentration\u2009>\u200920\xa0ng/ml in 97.5% of cases.']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 65)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 146, '25(OH ... D')]
PMC5941617	5/2018	S168-PMC5941617	['intermittent Vitamin D administration MAY BE CONSIDERED in case of reduced compliance with daily supplementation, BUT ACTUAL EVIDENCE IS INSUFFICIENT to RECOMMEND a PREFERRED doses and interval.']	[('INCOMPLETE_EVIDENCE', 38), ('FUTURE_WORK', 45), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 118), ('PROBLEM_COMPLICATION', 137), ('FUTURE_WORK', 153), ('PROBABLE_UNDERSTANDING', 165)]	8	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC5941617	5/2018	S172-PMC5941617	['CONSIDERING the italian child health care system organization, family pediatricians MAY anamnestically evaluate Vitamin D intake of children and POSSIBLE RISK FACTORS for deficiency during periodic health check-ups [176].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 154)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC5941617	5/2018	S174-PMC5941617	['following the publication of sacn review of the EVIDENCE on Vitamin D and health [25], public health england advised that uk children aged 1 to 4\xa0years should receive Vitamin D supplementation at 400\xa0iu/day, and older children and adolescents SHOULD take a daily supplement containing 400\xa0iu of Vitamin D in autumn and winter to PROTECT bone and muscle health because it is DIFFICULT to meet this intake from dietary sources.']	[('INCOMPLETE_EVIDENCE', 48), ('FUTURE_WORK', 243), ('SUPERFICIAL_RELATIONSHIP', 329), ('DIFFICULT_TASK', 374)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC5941617	5/2018	S180-PMC5941617	['regarding italy (latitude 35°29′24″-47°5′31″), an in vitro study SHOWED that no Vitamin D is produced AS a result of sun exposure at the latitude of pisa (43°43’n) from november to february [179], CONFIRMING that sunlight-derived Vitamin D production is ineffective for at least 1\xa0month during the year in countries placed between 23.5° and 66.5° of latitude [180].']	[('INCOMPLETE_EVIDENCE', 65), ('PROBABLE_UNDERSTANDING', 102), ('PROBABLE_UNDERSTANDING', 197), ('PROBABLE_UNDERSTANDING', 197)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D')]
PMC5941617	5/2018	S181-PMC5941617	['subsequent italian cross sectional studies enrolling children and adolescents living in the north-western area of tuscany, central italy (latitude between 43°n and 44°n) not receiving Vitamin D supplementation CONFIRMED seasonal variability in Serum 25(Oh)D levels, with lower concentrations during late winter-early spring months (february–april), with negligible amount of Vitamin D obtained from diet [50,79], ACCORDING TO OTHER italian pediatric studies [70,76–78,83].']	[('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 413), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 426)]	3	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0001977', 'blood serum', 244, 'serum'), ('CHEBI_71657', 'versiconol acetate', 250, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 250, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D')]
PMC5941617	5/2018	S182-PMC5941617	['these data SUGGEST that wintry Vitamin D status DEPENDS ON the amount of Vitamin D produced and stored during the previous summer [181].']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5941617	5/2018	S183-PMC5941617	['finally, a RECENT cross sectional STUDY SHOWED high prevalence of Vitamin D deficiency and insufficiency (40.3% and 33.5%, respectively) among internationally adopted children at their first clinical evaluation in italy [182].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 40)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5941617	5/2018	S188-PMC5941617	['CONSIDERING the results of italian studies, we SUGGEST Vitamin D supplementation from the end of fall to the beginning of spring (november–april) in children and adolescents with reduced sun exposure during summer.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 47)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5941617	5/2018	S191-PMC5941617	['as REPORTED for infants in the first years of Life, we RECOMMEND against using Vitamin D Metabolites and their analogs (Calcifediol, Alfacalcidol, Calcitriol, and Dihydrotachysterol) for the routine Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 55)]	2	[('UBERON_0000104', 'life cycle', 46, 'life'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_25212', 'metabolite', 89, 'metabolites'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 120, 'calcifediol'), ('CHEBI_31186', 'alfacalcidol', 133, 'alfacalcidol'), ('CHEBI_17823', 'calcitriol', 147, 'calcitriol'), ('CHEBI_4657', 'disopyramide', 163, 'dihydrotachysterol'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D')]
PMC5941617	5/2018	S196-PMC5941617	['Ketoconazole)\nAT PRESENT, population screening for Vitamin D deficiency in healthy Individuals is not RECOMMENDED.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 102)]	2	[('CHEBI_47519', 'ketoconazole', 0, 'ketoconazole'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_1', 'root', 83, 'individuals')]
PMC5941617	5/2018	S197-PMC5941617	['indeed, Serum 25(Oh)D evaluation SHOULD BE reserved to subjects AT RISK for Vitamin D deficiency, BUT INDICATIONS for 25(Oh)D measurement significantly VARY among different societies (table\xa08) [9,11,13,15,20–23,27,30].']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 102), ('DIFFICULT_TASK', 152)]	5	[('UBERON_0001977', 'blood serum', 8, 'serum'), ('CHEBI_71657', 'versiconol acetate', 14, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D')]
PMC5941617	5/2018	S198-PMC5941617	['we RECOMMEND against routine 25(Oh)D testing in children and adolescents, SUGGESTING to limit Serum 25(Oh)D levels evaluation in children and adolescents with multiple RISK FACTORS for Vitamin D deficiency.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 168)]	3	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 35, 'D'), ('UBERON_0001977', 'blood serum', 94, 'serum'), ('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC5941617	5/2018	S208-PMC5941617	['children of immigrants living in industrialized countries are at INCREASED RISK of rickets BECAUSE they USUALLY present several RISK FACTORS for Vitamin D deficiency such as prolonged breastfeeding without vitamin d supplementation, increased skin pigmentation, reduced sun exposure due to cultural habits (i.e.']	[('IMPORTANT_CONSIDERATION', 65), ('PROBABLE_UNDERSTANDING', 91), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5941617	5/2018	S211-PMC5941617	['a RECENT GLOBAL CONSENSUS RECOMMENDATIONS on prevention and management of nutritional rickets DEFINED Vitamin D deficiency AS Serum 25(Oh)D\u2009<\u2009\xa012\xa0ng/ml, CONSIDERING the increased incidence of rickets with Serum 25(Oh)D levels under this THRESHOLD [28].']	[('INCOMPLETE_EVIDENCE', 2), ('IMPORTANT_CONSIDERATION', 9), ('PROBABLE_UNDERSTANDING', 16), ('FUTURE_WORK', 26), ('INCOMPLETE_EVIDENCE', 94), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 123), ('IMPORTANT_CONSIDERATION', 153), ('PROBABLE_UNDERSTANDING', 237)]	9	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001977', 'blood serum', 126, 'serum'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('UBERON_0001977', 'blood serum', 205, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 211, '25(OH ... D')]
PMC5941617	5/2018	S217-PMC5941617	['particularly, adolescents MAY develop non-specific symptoms, such as Lower Limb pain or difficulties in climbing stairs, BECAUSE of proximal myopathy secondary to Vitamin D deficiency [189].']	[('INCOMPLETE_EVIDENCE', 26), ('PROBABLE_UNDERSTANDING', 121)]	2	[('UBERON_0002103', 'hindlimb', 69, 'lower limb'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC5941617	5/2018	S219-PMC5941617	['moreover, Vitamin D deficiency MAY determine hypocalcaemia that MAY BE asymptomatic, latent or symptomatic POSSIBLY with acute onset (seizures, syncope, laryngospasm, bronchospasm, tetanus, paresthesia, tremors, muscular cramps, dilated cardiomyopathy) [188].']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 107)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
PMC5941617	5/2018	S226-PMC5941617	['the global CONSENSUS on nutritional rickets RECOMMENDED the administration of 2000\xa0iu/day of Vitamin D in patients aged less than 1\xa0year, 3000–6000\xa0iu/day in patients aged 1 to 12\xa0years and 6000\xa0iu/day in patients older than 12\xa0years for a minimum of 3\xa0months, EVEN IF some children MAY require a longer treatment duration [28].']	[('PROBABLE_UNDERSTANDING', 11), ('FUTURE_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 261), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 266), ('INCOMPLETE_EVIDENCE', 283)]	5	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC5941617	5/2018	S227-PMC5941617	['intermittent administration of Vitamin D MAY BE a reliable ALTERNATIVE to daily administration, PARTICULARLY in cases with low compliance.']	[('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('ANOMALY_CURIOUS_FINDING', 96)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5941617	5/2018	S232-PMC5941617	['the administration of a single large dose of Vitamin D\u2009>\u2009300000\xa0iu is not RECOMMENDED, BECAUSE MAY cause high risk of Vitamin D intoxication with hypercalciuria and hypercalcemia, AS CONFIRMED by RECENT STUDIES [191–195].']	[('FUTURE_WORK', 74), ('PROBLEM_COMPLICATION', 87), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 180), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 196)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC5941617	5/2018	S236-PMC5941617	['RECOMMENDED oral Calcium administration of 500\xa0mg/day in conjunction with Vitamin D REGARDLESS OF age or weight [28], WHILE misra et al.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	3	[('CHEBI_22313', 'alkaline earth metal atom', 17, 'calcium'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5941617	5/2018	S241-PMC5941617	['particularly, the use of 1Α-Hydroxylated Metabolites of Vitamin D does not restore Vitamin D levels, and MAY determine supraphysiological levels of 1,25(Oh)2d with increased risk of hypercalcemia [183,188].']	[('INCOMPLETE_EVIDENCE', 105)]	1	[('CHEBI_37983', 'sulfur-35 atom', 25, '1α'), ('CHEBI_24669', 'hydroxy carboxylic acid', 28, 'hydroxylated'), ('CHEBI_25212', 'metabolite', 41, 'metabolites'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_78907', "1,2-dioleoyl-sn-glycero-3-phospho-(1'-sn-glycerol-3'-phosphate)(3-)", 148, '1,25(OH')]
PMC5941617	5/2018	S242-PMC5941617	['the administration of 1α-Hydroxylated Metabolites of Vitamin D MAY BE CONSIDERED in nutritional rickets ASSOCIATED with acute hypocalcemia or hypocalcemic cardiomyopathy [9,183].']	[('INCOMPLETE_EVIDENCE', 63), ('FUTURE_WORK', 70), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('CHEBI_24669', 'hydroxy carboxylic acid', 25, 'hydroxylated'), ('CHEBI_25212', 'metabolite', 38, 'metabolites'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC5941617	5/2018	S250-PMC5941617	['a FEW STUDIES evaluated the RELATIONSHIP between Vitamin D status and bone mass during this period of Life [52,62,97,104,201–203].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 102, 'life')]
PMC5941617	5/2018	S251-PMC5941617	['among these, three italian STUDIES assessed bone Mineral status in infants using quantitative ultrasound [201–203], SUGGESTING that Vitamin D supplementation is IMPORTANT to provide an adequate Bone Development, PARTICULARLY in exclusively breastfed infants.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 116), ('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 212), ('IMPORTANT_CONSIDERATION', 212)]	5	[('CHEBI_46662', 'mineral', 49, 'mineral'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0048539', 'bone marrow development', 194, 'bone development')]
PMC5941617	5/2018	S253-PMC5941617	['moreover, studies comparing supplementation with placebo or different regimens of Vitamin D supplementation (up to 1600\xa0iu/day) did not FIND any difference in infant bone mass at 3\xa0months [104], 6\xa0months [97], 1\xa0year [62] or 3\xa0years of Life [204].']	[('INCOMPLETE_EVIDENCE', 136)]	1	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0000104', 'life cycle', 236, 'life')]
PMC5941617	5/2018	S256-PMC5941617	['SEVERAL STUDIES evaluated the ASSOCIATION between Vitamin D status and bone mass in children and adolescents, USUALLY SEARCHING for a CORRELATION between actual Serum 25(Oh)D levels and bone mass.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 134)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0001977', 'blood serum', 161, 'serum'), ('CHEBI_71657', 'versiconol acetate', 167, '25(OH)D')]
PMC5941617	5/2018	S257-PMC5941617	['results of these studies are HETEROGENEOUS, because SOME DEMONSTRATED that Vitamin D status was significantly RELATED to bone mass [41,42,54,206–208] WHILE others DID NOT FIND any association [44,209–211].']	[('DIFFICULT_TASK', 29), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 163)]	6	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5941617	5/2018	S261-PMC5941617	['moreover, Vitamin D status was DEMONSTRATED to be a significant DETERMINANT of pbm in young Adults [214,215].']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0007023', 'adult organism', 92, 'adults')]
PMC5941617	5/2018	S263-PMC5941617	['overall, meta-analysis SHOWED a non-significant EFFECT of Vitamin D supplementation on bmd at any site.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5941617	5/2018	S264-PMC5941617	['HOWEVER, the EFFECT of supplementation became significant on total body bmc and Lumbar Spine bmd by dividing the sample into two groups, depending on Vitamin D status [25(Oh)D levels <\u200914\xa0ng/ml vs. ≥ 14\xa0ng/ml], SUGGESTING that Vitamin D supplementation MAY result in a clinically significant increase in bone mass in subjects with Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 211), ('INCOMPLETE_EVIDENCE', 253)]	4	[('UBERON_0006074', 'lumbar region of vertebral column', 80, 'lumbar spine'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 168, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D')]
PMC5941617	5/2018	S265-PMC5941617	['in 2016 the national osteoporosis foundation applied an EVIDENCE based grading system to describe the strength of AVAILABLE EVIDENCE on modifiable lifestyle factors that MAY INFLUENCE the acquisition of pbm, reporting MODERATE EVIDENCE (grade b) for Vitamin D [220].']	[('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 170), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 218)]	5	[('CHEBI_27300', 'vitamin D', 250, 'vitamin D')]
PMC5941617	5/2018	S268-PMC5941617	['particularly, 4 rcts PROVIDE EVIDENCE for a beneficial EFFECT of Vitamin D supplementation on bone Mineral accrual [148,166,216,224], mainly in subjects with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 55)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_46662', 'mineral', 99, 'mineral'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC5941617	5/2018	S270-PMC5941617	['INTERESTINGLY, a RECENT STUDY showed that the beneficial EFFECT of Vitamin D on Hip bone mass in lebanese adolescent girls persisted 1\xa0year after discontinuation of supplementation [226].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0001464', 'hip', 80, 'hip')]
PMC5941617	5/2018	S271-PMC5941617	['at PRESENT, SOME UNANSWERED QUESTIONS REMAIN [CRITICAL times during which supplementation MAY BE most EFFECTIVE, regimen and length of supplementation (continuous or intermittent), gender difference] [227], THUS Vitamin D supplementation to optimize bone mass acquisition SHOULD BE reserved for children AT RISK for deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 17), ('EXPLICIT_QUESTION', 28), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 102), ('PROBABLE_UNDERSTANDING', 207), ('FUTURE_WORK', 272), ('IMPORTANT_CONSIDERATION', 304)]	11	[('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC5941617	5/2018	S272-PMC5941617	['maternal Vitamin D status during Pregnancy MAY significantly INFLUENCE fetal and neonatal bone mass, as RECENTLY CONFIRMED by the sacn [25].']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 113)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy')]
PMC5941617	5/2018	S275-PMC5941617	['these results CONFIRMED that maternal Vitamin D status MAY AFFECT bone Mineral accrual during the Intrauterine Period and INFLUENCE bone size [230].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_46662', 'mineral', 71, 'mineral'), ('UBERON_0006351', 'principal vein of forelimb', 98, 'intrauterine period')]
PMC5941617	5/2018	S276-PMC5941617	['moreover, Postnatal Vitamin D supplementation (follow-up 14\xa0months) MAY ONLY PARTLY eliminate the differences in bone variables induced by maternal Vitamin D status during the Fetal Period [231].']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 77)]	3	[('GO_0007567', 'parturition', 10, 'postnatal'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('UBERON_0002375', 'cricoid cartilage', 176, 'fetal period')]
PMC5941617	5/2018	S277-PMC5941617	['RECENTLY an english rct (mavidos) failed to demonstrate an EFFECT of maternal Vitamin D supplementation (1000\xa0iu/day from 14\xa0week of Gestation until Delivery) on offspring bone mass assessed within 2\xa0weeks of Birth by dxa.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'gestation'), ('GO_0007567', 'parturition', 149, 'delivery'), ('GO_0007567', 'parturition', 209, 'birth')]
PMC5941617	5/2018	S282-PMC5941617	['several variables MAY justify this DISCREPANCY, such as DIFFERENT enrolled populations, various regimens of Vitamin D supplementation, and age at bone mass assessment.']	[('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56)]	3	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC5941617	5/2018	S283-PMC5941617	['HOWEVER, the most RECENT STUDY SUGGESTED that Vitamin D status during childhood MIGHT be more RELEVANT for bone health that maternal 25(Oh)D levels during fetal Life [237].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 80), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('UBERON_0000104', 'life cycle', 161, 'life')]
PMC5941617	5/2018	S285-PMC5941617	['a RELATIONSHIP between Vitamin D status and the incidence or the severity of Respiratory infections in children HAS BEEN FOUND in MANY observational STUDIES, most with a case-control or cross sectional design, both in developing and in westernized countries.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 130)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 77, 'respiratory')]
PMC5941617	5/2018	S289-PMC5941617	['OTHER than pneumonia, SOME data also INDICATE that Vitamin D deficiency MIGHT be a risk factor also for undifferentiated Viral infections [246], recurrent pharyngotonsillitis [247], otitis media [248], bronchiolitis [249] and viral wheezing [250].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 72)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('NCBITaxon_1', 'root', 121, 'viral')]
PMC5941617	5/2018	S290-PMC5941617	['SOME authors also POSTULATED that the lower Vitamin D production in winter MIGHT CONTRIBUTE to the marked seasonality of epidemic influenza [251].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5941617	5/2018	S291-PMC5941617	['OBVIOUSLY, the more ROBUST EVIDENCES on the ASSOCIATION between Vitamin D deficiency and Respiratory infections stem from prospective studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 89, 'respiratory')]
PMC5941617	5/2018	S292-PMC5941617	['camargo et al., after adjusting for season of Birth, FOUND that newborns with Vitamin D Cord Blood levels <\u200910\xa0ng/ml had a two-fold (odds ratio: 2.16; 95% ci 1.35–3.46) increased risk of Respiratory infections by 3\xa0months of age as COMPARED TO newborns with 25(Oh)D concentrations >\u200930\xa0ng/ml [252].']	[('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232)]	2	[('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('UBERON_0001004', 'respiratory system', 187, 'respiratory'), ('CHEBI_71657', 'versiconol acetate', 258, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 258, '25(OH)D')]
PMC5941617	5/2018	S294-PMC5941617	['also DEMONSTRATED that Cord Blood Vitamin D levels <\u200920\xa0ng/ml were ASSOCIATED with a sixfold (95% ci: 1.6–24.9) increased risk of Respiratory syncytial Virus lower Respiratory Tract infections in the first year of Life as compared with concentrations ≥30\xa0ng/ml [249].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('UBERON_0002240', 'spinal cord', 23, 'cord'), ('UBERON_0000178', 'blood', 28, 'blood'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 130, 'respiratory'), ('NCBITaxon_1', 'root', 152, 'virus'), ('UBERON_0000065', 'respiratory tract', 164, 'respiratory tract'), ('UBERON_0000104', 'life cycle', 214, 'life')]
PMC5941617	5/2018	S297-PMC5941617	['OTHER STUDIES have FOUND an inverse ASSOCIATION between Vitamin D concentrations in Pregnancy and the RISK of Respiratory infections in newborns or children during the first 3\xa0years of life [253,254].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 102)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('UBERON_0001004', 'respiratory system', 110, 'respiratory')]
PMC5941617	5/2018	S299-PMC5941617	['for example, no relationship has been FOUND in children and Adults between baseline Vitamin D concentrations and Influenza Virus infection [256].']	[('INCOMPLETE_EVIDENCE', 38)]	1	[('UBERON_0007023', 'adult organism', 60, 'adults'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('NCBITaxon_1', 'root', 113, 'influenza virus')]
PMC5941617	5/2018	S300-PMC5941617	['taken TOGETHER, all these data INDICATE that Vitamin D status MIGHT have SOME INFLUENCE on conditioning the incidence and severity of SOME but not all type of Respiratory infections and that more information are REQUIRED before drawing any firm conclusion on THIS topic.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 134), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('QUESTION_ANSWERED_BY_THIS_WORK', 259)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 159, 'respiratory')]
PMC5941617	5/2018	S301-PMC5941617	['a RECENT LITERATURE REVIEW SUPPORTS a ROLE for Vitamin D deficiency ONLY for tuberculosis, recurrent acute otitis media and SEVERE bronchiolitis [242].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 68), ('IMPORTANT_CONSIDERATION', 124)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5941617	5/2018	S302-PMC5941617	['furthermore, SOME ROLE from vdr polymorphisms or OTHER Genetic factors MIGHT play a ROLE in determining the INFLUENCE of Vitamin D status on Respiratory morbidity [257,258].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 84), ('SUPERFICIAL_RELATIONSHIP', 108)]	6	[('SO_0000704', 'gene', 55, 'genetic'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 141, 'respiratory')]
PMC5941617	5/2018	S303-PMC5941617	['SEVERAL STUDIES, mostly in Adults, have also addressed the QUESTION WHETHER Vitamin D supplementation CAN PREVENT OR reduce the severity of upper or lower Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 0), ('EXPLICIT_QUESTION', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('EXPLICIT_QUESTION', 68), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	7	[('UBERON_0007023', 'adult organism', 27, 'adults'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]
PMC5941617	5/2018	S306-PMC5941617	['all BUT two [259,261] of the aforementioned reviews concluded that published studies do not INDICATE a PROTECTIVE EFFECT of Vitamin D supplementation on the PREVENTION of acute Respiratory infections in healthy Individuals.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 177, 'respiratory'), ('NCBITaxon_1', 'root', 211, 'individuals')]
PMC5941617	5/2018	S308-PMC5941617	['HOWEVER, a well conducted study, not included in the above cited meta-analysis, on a selected population of otitis prone children, FOUND that Vitamin D administration (1000\xa0iu/day) reduces the RISK of uncomplicated acute otitis [267].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 131), ('IMPORTANT_CONSIDERATION', 193)]	3	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5941617	5/2018	S309-PMC5941617	['a RECENT meta-analysis of 25 rcts (total 11,321 participants, aged 0–95\xa0years) SHOWED that Vitamin D supplementation was SAFE and protected against acute Respiratory Tract infections overall (adjusted odds ratio 0.88).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 121)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 154, 'respiratory tract')]
PMC5941617	5/2018	S311-PMC5941617	['indeed, a more RECENT canadian rct SHOWED that daily administration of 2000\xa0iu of Vitamin D did not reduce overall wintertime Upper Respiratory Tract infections among healthy children aged 1–5\xa0years compared with supplementation with 400\xa0iu/day.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 35)]	2	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001557', 'upper respiratory tract', 126, 'upper respiratory tract')]
PMC5941617	5/2018	S312-PMC5941617	['THUS, the results of this study do not SUPPORT the routine use of high-dose Vitamin D supplementation in children for the PREVENTION of Viral Upper Respiratory Tract infections [271].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 122)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('NCBITaxon_1', 'root', 136, 'viral'), ('UBERON_0001557', 'upper respiratory tract', 142, 'upper respiratory tract')]
PMC5941617	5/2018	S313-PMC5941617	['finally, LIMITED DATA are available on Vitamin D supplementation in Pregnancy and the RISK of Respiratory infections in the offspring [272,273].']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 86)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('UBERON_0001004', 'respiratory system', 94, 'respiratory')]
PMC5941617	5/2018	S317-PMC5941617	['in an usa study a SIMILAR ASSOCIATION was OBSERVED between skin or soft Tissue infections by staphylococcus aureus strains and Vitamin D levels [25(Oh)D\u2009<\u200930\xa0ng/ml] in 202 children [276].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 42)]	4	[('UBERON_0000479', 'tissue', 72, 'tissue'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 145, '25(OH)D')]
PMC5941617	5/2018	S319-PMC5941617	['HOWEVER, it is UNCLEAR WHETHER the OBSERVED Vitamin D deficiency/insufficiency is TO BE CONSIDERED a consequence of the infection itself OR IF it plays a ROLE in determining susceptibility to infections or the severity of the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140), ('SUPERFICIAL_RELATIONSHIP', 154)]	8	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5941617	5/2018	S321-PMC5941617	['FEW REPORTS exist regarding the BENEFIT of Vitamin D supplementation in children with specific infections.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 32)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC5941617	5/2018	S322-PMC5941617	['in a large randomized study in afghanistan involving 3000 children with acute diarrhea Vitamin D supplementation HAS BEEN ASSOCIATED with improvement in clinical parameters [283].']	[('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC5941617	5/2018	S324-PMC5941617	['the Vitamin D status CAN be INFLUENCED by the infection itself but also by Antiretroviral therapy.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('CHEBI_65417', '(+)-aplysinillin', 75, 'antiretroviral')]
PMC5941617	5/2018	S326-PMC5941617	['evaluated more than 900 infected children and OBSERVED that Vitamin D-RELATED host Genetic variants MAY alter the availability and activity of Vitamin D and are ASSOCIATED with risk of hiv disease progression in children [284].']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 161)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('SO_0000704', 'gene', 83, 'genetic'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC5941617	5/2018	S333-PMC5941617	['an italian rct was performed TO TEST WHETHER Vitamin D3Supplementation (oral 100000\xa0iu every 3\xa0months for 4 doses) COULD improve Vitamin D status and AFFECT the t-Cell phenotype in hiv-infected patients aged 8 to 26\xa0years with Serum 25(Oh) D\u2009<\u200930\xa0ng/ml.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('CHEBI_52915', 'phosphatediyl group', 45, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CL_0000622', 'acinar cell', 162, '-cell'), ('UBERON_0001977', 'blood serum', 227, 'serum'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 233, '25(OH) D')]
PMC5941617	5/2018	S340-PMC5941617	['SEVERAL STUDIES investigated a POSSIBLE RELATIONSHIP between Vitamin D deficiency and tuberculosis infection in children [295], BUT literature results are DISCORDANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5941617	5/2018	S341-PMC5941617	['significant ASSOCIATION between active tuberculosis and Vitamin D deficiency [25(Oh)D levels <\u200920\xa0ng/ml] HAS BEEN EVIDENCED in an australian study including 91 children with latent or active tuberculosis and 236 controls [296], SIMILARLY TO one uk study [297].']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 105), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 228)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 78, '25(OH)D')]
PMC5941617	5/2018	S344-PMC5941617	['moreover, a large meta-analysis FAILED TO demonstrate that Vitamin D supplementation MAY BE beneficial in children with tubercular infection [300].']	[('ANOMALY_CURIOUS_FINDING', 32), ('DIFFICULT_TASK', 32), ('INCOMPLETE_EVIDENCE', 85)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC5941617	5/2018	S346-PMC5941617	['DID NOT FIND an ASSOCIATION between tubercular infection and Vitamin D status in a large population of internationally adopted children, although results DEMONSTRATED a high prevalence (about 75%) of hypovitaminosis d in this population [182].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 154)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5941617	5/2018	S348-PMC5941617	['the same authors had PREVIOUSLY DEMONSTRATED a RELATION between tubercular disease and Vitamin D status [301].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC5941617	5/2018	S354-PMC5941617	['RECENTLY, litonjua SHOWED that Vitamin D has both in utero and post-Natal EFFECTS on Lung Development and Immune System Development and function [304].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007567', 'parturition', 68, 'natal'), ('GO_0030324', 'lung development', 85, 'lung development'), ('UBERON_0002048', 'lung', 85, 'lung'), ('GO_0002520', 'immune system development', 106, 'immune system development'), ('UBERON_0002405', 'immune system', 106, 'immune system')]
PMC5941617	5/2018	S357-PMC5941617	['SEVERAL STUDIES SHOWED that Vitamin D deficiency in utero and in early Life was ASSOCIATED with an increase in Th2 Lymphocyte Cells and a reduction in T Regulatory Cells and Production Of Interleukin (Il)-10, which subsequently MAY activate pro-inflammatory Cytokine Production through Macrophages and Dendritic Cells [306–308].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 228)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('CL_0000546', 'T-helper 2 cell', 111, 'Th2 lymphocyte cells'), ('CL_0000902', 'induced T-regulatory cell', 151, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 153, 'regulatory'), ('GO_0030154', 'cell differentiation', 174, 'production of interleukin ... IL ... 10'), ('PR_000001470', 'interleukin-28B', 188, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 201, 'IL)-10'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 258, 'cytokine production'), ('CL_0000235', 'macrophage', 286, 'macrophages'), ('CL_0000451', 'dendritic cell', 302, 'dendritic cells')]
PMC5941617	5/2018	S358-PMC5941617	['CONSEQUENTLY, SEVERAL STUDIES in vivo and in vitro SHOWED that Vitamin D supplementation inhibits the th2 Expression contrasting allergic diseases [309–314].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 51)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0010467', 'gene expression', 106, 'expression')]
PMC5941617	5/2018	S359-PMC5941617	['furthermore, PREVIOUS STUDIES focused on the ASSOCIATION between Serum 25(Oh)D levels and the Expression of Genes INVOLVED in the Proliferation and Cells Differentiation, showing an anti-proliferative activity of Vitamin D with CONSEQUENTLY remodeling inhibition [309–312].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 228)]	4	[('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 77, 'D'), ('GO_0010467', 'gene expression', 94, 'expression'), ('SO_0000704', 'gene', 108, 'genes'), ('GO_0007565', 'female pregnancy', 130, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 148, 'cells differentiation'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC5941617	5/2018	S361-PMC5941617	['about the ROLE of Vitamin D in the immunopathogenesis of allergic skin diseases, Vitamin D induces the production of Antimicrobial Peptides, as Beta-Defensin and Cathelicidin, causing a reduction of the bacterial infections that MAY exacerbate asthma and atopic dermatitis (ad) [316,317].']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 229)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_65381', 'albizoside C', 117, 'antimicrobial'), ('GO_0007565', 'female pregnancy', 131, 'peptides'), ('PR_000006033', 'cathepsin S', 144, 'beta-defensin'), ('PR_000006009', 'alpha-catulin', 162, 'cathelicidin')]
PMC5941617	5/2018	S362-PMC5941617	['not YET FULLY UNDERSTOOD is the ROLE of Vitamin D on Eosinophilic Airway inflammation.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CL_0000771', 'eosinophil', 53, 'eosinophilic'), ('UBERON_0001005', 'respiratory airway', 66, 'airway')]
PMC5941617	5/2018	S366-PMC5941617	['OBSERVATIONAL studies on the RELATIONSHIP between Vitamin D in Pregnancy and wheezing, asthma, and allergies Development in early Life SHOWED UNCLEAR results.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 135), ('FULL_UNKNOWN', 142)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('GO_0048513', 'animal organ development', 109, '... development'), ('UBERON_0000104', 'life cycle', 130, 'life')]
PMC5941617	5/2018	S370-PMC5941617	['in 966 children DEMONSTRATED that Vitamin D deficiency [Serum 25(Oh)D\u2009<\u2009\xa020\xa0ng/ml] was the MAJOR PREDICTIVE factor of asthma RISK [327], and gale et al.']	[('INCOMPLETE_EVIDENCE', 16), ('IMPORTANT_CONSIDERATION', 91), ('SUPERFICIAL_RELATIONSHIP', 97), ('IMPORTANT_CONSIDERATION', 125)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001977', 'blood serum', 56, 'serum'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 62, '25(OH ... D')]
PMC5941617	5/2018	S377-PMC5941617	['a meta-analysis SHOWED a significant ASSOCIATION between Vitamin D supplementation and reduction of asthma exacerbations (17% vs. 46%, p \u2009<\u20090.029) [334].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC5941617	5/2018	S378-PMC5941617	['RECENTLY, three studies SHOWED a positive CORRELATION between Vitamin D supplementation and the improvement of asthma Control [335–337], accordingly with two RECENT meta-analyses.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 158)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0065007', 'biological regulation', 118, 'control')]
PMC5941617	5/2018	S382-PMC5941617	['about the EFFECTS of Vitamin D on Lung function, a RECENT meta-analysis DEMONSTRATED a difference of 0.54\xa0l/s in Forced Expiratory volume in the 1st second (fev1) values after the treatment with Vitamin D [334].']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 72)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0002048', 'lung', 34, 'lung'), ('GO_0007629', 'flight behavior', 113, 'forced expiratory'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5941617	5/2018	S383-PMC5941617	['in another STUDY high doses of Vitamin D (100,000\xa0iu as first dose and 50,000\xa0iu/week for 6\xa0months) were administered to 130 patients (children and Adults).']	[('INCOMPLETE_EVIDENCE', 11)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0007023', 'adult organism', 148, 'adults')]
PMC5941617	5/2018	S384-PMC5941617	['after 28\xa0weeks the authors SHOWED an increase (20%) in fev1 values in the patients treated with Vitamin D and Corticosteroids in comparison with an increase of 7% in the control group [341].']	[('INCOMPLETE_EVIDENCE', 27)]	1	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_50850', 'etabonate ester', 110, 'corticosteroids')]
PMC5941617	5/2018	S386-PMC5941617	['two STUDIES in vitro SHOWED the IMPORTANCE of Vitamin D supplementation in patients affected by Corticosteroid-resistant asthma [315,343] BUT two other STUDIES DEMONSTRATED in vivo that lower 25(Oh)D levels were ASSOCIATED with an increase in Corticosteroids use and an IMPAIRED Lung function [344,345].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 212), ('IMPORTANT_CONSIDERATION', 270)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_36916', 'cation', 96, 'corticosteroid'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH)D'), ('CHEBI_50850', 'etabonate ester', 243, 'corticosteroids'), ('UBERON_0002048', 'lung', 279, 'lung')]
PMC5941617	5/2018	S390-PMC5941617	['the EVIDENCES for a pathogenetic ROLE for Vitamin D in ad are STILL CONFLICTING EVEN THOUGH data in favour of such CORRELATION are increasingly stronger with MORE STUDIES in favour BUT OTHERS OPPOSING THIS HYPOTHESIS.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 115), ('FUTURE_WORK', 158), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206)]	11	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5941617	5/2018	S391-PMC5941617	['HOWEVER, at LEAST two longitudinal STUDIES have CORRELATED the Vitamin D Cord Blood low levels to the development of ad in the offsprings, FINDING that low levels in the Cord Blood significantly increased the risk to develop the disease [347,348].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 139)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('UBERON_0009472', 'axilla', 170, 'cord blood')]
PMC5941617	5/2018	S394-PMC5941617	['a RECENT large STUDY FOUND NO EVIDENCE that Genetically determined reduction in 25(Oh)D levels conferred an increased risk for ad, SUGGESTING that EFFORTS to increase Vitamin D are UNLIKELY to reduce risks of the atopic disease [349].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 131), ('FUTURE_WORK', 147), ('PROBABLE_UNDERSTANDING', 181)]	6	[('SO_0000704', 'gene', 44, 'genetically'), ('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC5941617	5/2018	S395-PMC5941617	['HOWEVER, there are also two reviews and meta-analyses, considering ad patients of all ages, SHOWING that Vitamin D supplementation is capable of a higher mean difference in severity of ad symptoms [350,351].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 92)]	2	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC5941617	5/2018	S397-PMC5941617	['in pediatric population there is SOME EVIDENCE about a favourable EFFECT of administration of Vitamin D on several aspects of ad, but results are STILL CONFLICTING.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152)]	4	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5941617	5/2018	S398-PMC5941617	['FOR THESE REASONS AT PRESENT Vitamin D supplementation as adjunctive standard therapy for ad cannot be RECOMMENDED in all the affected children [351].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 18), ('FUTURE_WORK', 103)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5941617	5/2018	S400-PMC5941617	['HOWEVER, it HAS BEEN SUGGESTED that in patients with a more SEVERE ad, unresponsive to common therapy and with low Serum 25(Oh)D levels, a trial of Vitamin D supplementation CAN BE CONSIDERED [352].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 60), ('FUTURE_WORK', 174), ('FUTURE_WORK', 181)]	5	[('UBERON_0001977', 'blood serum', 115, 'serum'), ('CHEBI_71657', 'versiconol acetate', 121, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 127, 'D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC5941617	5/2018	S402-PMC5941617	['again, we NEED clinical data SHOWING that restoring normal levels of Vitamin D one CAN obtain significant variation in severity especially IF evaluated by standardized methods (symptom score, scoring atopic dermatitis or equivalent).']	[('FUTURE_WORK', 10), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5941617	5/2018	S403-PMC5941617	['the SO-called ecological studies SUGGEST the RELATIONSHIP between latitude, the consequent level of sun exposure, Vitamin D Production and subsequent Serum 25(Oh)D levels and the prevalence and severity of allergic diseases.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006272', 'leading strand elongation', 122, 'D production'), ('UBERON_0001977', 'blood serum', 150, 'serum'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D')]
PMC5941617	5/2018	S405-PMC5941617	['furthermore, the use of Vitamin D supplementation for primary PREVENTION of allergic diseases REMAINS an attractive AREA OF STUDY, BUT CURRENT KNOWLEDGE and EVIDENCE DOES NOT ALLOW to RECOMMEND it in routine use.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 157), ('DIFFICULT_TASK', 166), ('FUTURE_WORK', 184)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5941617	5/2018	S406-PMC5941617	['DATA from ongoing intervention trials ARE WARRANTED to establish the extent of Vitamin D POTENTIALLY preventive EFFECT, along with the best timing and dose of an intervention.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 89), ('SUPERFICIAL_RELATIONSHIP', 112)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5941617	5/2018	S407-PMC5941617	['also in Food allergies the ROLE of Vitamin D REMAINS CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53)]	3	[('CHEBI_33290', 'food', 8, 'food'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC5941617	5/2018	S408-PMC5941617	['there are studies SUGGESTING that both lower and higher levels of Vitamin D are ASSOCIATED with elevated Ige concentrations, with a u-shaped RELATIONSHIP [354].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 80), ('SUPERFICIAL_RELATIONSHIP', 141)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 105, 'IgE')]
PMC5941617	5/2018	S411-PMC5941617	['negative results were obtained in term of primary PREVENTION by Vitamin D supplementation in a RECENT meta-analysis and conclusions were that the EFFECTS of Vitamin D supplementation REMAIN UNCERTAIN [353].']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 146), ('INCOMPLETE_EVIDENCE', 183), ('FULL_UNKNOWN', 190)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC5941617	5/2018	S412-PMC5941617	['there is THE NEED for rcts to validate these HYPOTHESES and to evaluate the POSSIBILITY of primary prevention and treatment of Food allergies with Vitamin D [355–357].']	[('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('INCOMPLETE_EVIDENCE', 76)]	4	[('CHEBI_33290', 'food', 127, 'food'), ('GO_0007631', 'feeding behavior', 127, 'food'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 155, 'D')]
PMC5941617	5/2018	S413-PMC5941617	['type 1 diabetes mellitus\nseveral epidemiological studies SUGGESTED that type 1 diabetes mellitus (t1dm) is ASSOCIATED with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 107)]	2	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC5941617	5/2018	S420-PMC5941617	['a meta-analysis of six case-control studies and two cohort-studies SHOWED a reduction of the RISK of t1dm in later Life (odds ratio: 0.71; 95% ci 0.51–0.98) in infants who were supplemented with Vitamin D compared with controls, ALTHOUGH the needed time of supplementation and the dose are STILL UNCLEAR [377–379].']	[('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 93), ('ANOMALY_CURIOUS_FINDING', 229), ('FULL_UNKNOWN', 290)]	4	[('UBERON_0000104', 'life cycle', 115, 'life'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5941617	5/2018	S422-PMC5941617	['IF data of OBSERVATIONAL studies in general population in infancy are ENCOURAGING, in the daisy study, conducted in subjects at higher RISK, the Vitamin D nutritional intake in the first years of Life as well as the Serum 25(Oh)D levels at 9\xa0months of age were not associated with the development of Autoantibodies or with the progression to t1dm [381].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('FUTURE_WORK', 70), ('IMPORTANT_CONSIDERATION', 135)]	4	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0000104', 'life cycle', 196, 'life'), ('UBERON_0001977', 'blood serum', 216, 'serum'), ('CHEBI_71657', 'versiconol acetate', 222, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 222, '25 ... OH ... D'), ('GO_0044308', 'axonal spine', 300, 'autoantibodies')]
PMC5941617	5/2018	S427-PMC5941617	['the imdiab xi study in which new onset t1dm children were given in the Vitamin D group Calcitriol at 0.25\xa0μg/2\xa0days or Nicotinamide at 25\xa0mg/kg/day REPORTED a reduction of Insulin requirements in the Vitamin D group [384].']	[('INCOMPLETE_EVIDENCE', 148)]	1	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 87, 'calcitriol'), ('CHEBI_17154', 'nicotinamide', 119, 'nicotinamide'), ('PR_000045358', 'insulin family protein', 172, 'insulin'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC5941617	5/2018	S431-PMC5941617	['ALTHOUGH SOME SUGGESTIVE and encouraging data on epidemiological observational studies and pilot clinical studies of intervention, the LACK OF EVIDENCE deriving by rcts DOES NOT ALLOW to ENCOURAGE treatment with Cholecalciferol or other Vitamin D Metabolites in patients with t1dm or subjects at higher RISK.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 135), ('DIFFICULT_TASK', 169), ('FUTURE_WORK', 187), ('IMPORTANT_CONSIDERATION', 303)]	8	[('CHEBI_52550', 'theopalauamide', 212, 'cholecalciferol'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_25212', 'metabolite', 247, 'metabolites')]
PMC5941617	5/2018	S435-PMC5941617	['a recent meta-analysis SHOWED that patients with crohn’s disease ( n \u2009=\u2009129808, age 11–48\xa0years) had lower Serum 25(Oh)D concentrations compared with healthy controls, with an overall prevalence of Vitamin D deficiency [25(Oh)D\u2009<\u2009\xa020\xa0ng/ml] of 57.7% and an inverse CORRELATION between Serum 25(Oh)D levels and the severity of disease [399].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 265)]	2	[('UBERON_0001977', 'blood serum', 107, 'serum'), ('CHEBI_63056', 'zinc cation', 113, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 119, 'D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 220, '25(OH)D'), ('UBERON_0001977', 'blood serum', 285, 'serum'), ('CHEBI_71657', 'versiconol acetate', 291, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 291, '25(OH ... D')]
PMC5941617	5/2018	S444-PMC5941617	['AT PRESENT the IDEAL dosing regimen to treat Vitamin D deficiency and to maintain sufficiency in ibd patients is STILL DEBATED [406].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 15), ('IMPORTANT_CONSIDERATION', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5941617	5/2018	S449-PMC5941617	['FOUND that two regimens of weekly Vitamin D3Administration (5000\xa0iu/10 kg/week, maximum weekly dose of 25000\xa0iu and maximum cumulative dose of 150000\xa0iu vs. 10000\xa0iu/10 kg/week, maximum weekly dose of 50000\xa0iu and maximum cumulative dose of 300000\xa0iu) for 6\xa0weeks were SAFE and EFFECTIVE in normalizing Vitamin D status in ibd children and adolescents with hypovitaminosis D [411].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 269), ('SUPERFICIAL_RELATIONSHIP', 278)]	3	[('CHEBI_63455', 'tetronic acid derivative', 34, 'vitamin D3administration'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 34, 'vitamin D3administration'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 373, 'D')]
PMC5941617	5/2018	S450-PMC5941617	['finally, a single age DEPENDENT high-dose oral Vitamin D3(the SO-CALLED stoss therapy; <\u20093\xa0years: 200000\xa0iu; 4–12\xa0years 400000\xa0iu; >\u200912\xa0years 800000\xa0iu) was SAFE and efficacious in achieving and maintaining Serum 25(Oh)D levels >\u200920\xa0ng/ml during a 6-month period in ibd children with Vitamin D deficiency [412].']	[('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 157)]	3	[('CHEBI_33279', 'vitamin D5', 47, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 47, 'vitamin D3'), ('UBERON_0001977', 'blood serum', 207, 'serum'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 213, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC5941617	5/2018	S452-PMC5941617	['Vitamin D supplementation at 800–1000\xa0iu/day is SUGGESTED to maintain optimal Vitamin D status [403].']	[('INCOMPLETE_EVIDENCE', 48)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5941617	5/2018	S457-PMC5941617	['particularly, large rcts ARE NEEDED to BETTER investigate the ROLE of Vitamin D in disease remission and Control.']	[('FUTURE_WORK', 25), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0065007', 'biological regulation', 105, 'control')]
PMC5941617	5/2018	S459-PMC5941617	['it HAS BEEN SUGGESTED that early-Life Vitamin D deficiency MAY CONTRIBUTE to the pathogenesis of childhood-onset cd by determining inappropriate Immune Responses, abnormal Intestinal Mucosal integrity and impaired local Defence against Microbial agents [413].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0000104', 'life cycle', 33, 'life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0006955', 'immune response', 145, 'immune responses'), ('UBERON_0002405', 'immune system', 145, 'immune'), ('UBERON_0001262', 'wall of intestine', 172, 'intestinal mucosal'), ('GO_0006952', 'defense response', 220, 'defence'), ('NCBITaxon_10088', 'Mus <genus>', 236, 'microbial')]
PMC5941617	5/2018	S464-PMC5941617	['indeed, Small Intestinal Mucosal damage MAY AFFECT Intestinal absorption of Calcium and Vitamin D, and chronic Intestinal inflammation MAY lead to release of proinflammatory cytokines with subsequent increased bone loss [424].']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 135)]	3	[('UBERON_0001206', 'serosa of small intestine', 8, 'small intestinal mucosal'), ('UBERON_0000160', 'intestine', 51, 'intestinal'), ('CHEBI_22313', 'alkaline earth metal atom', 76, 'calcium'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0000160', 'intestine', 111, 'intestinal')]
PMC5941617	5/2018	S470-PMC5941617	['spontaneous recovery of Vitamin D status following gluten free diet HAS BEEN SUGGESTED [417], BUT it is still DEBATED.']	[('INCOMPLETE_EVIDENCE', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5941617	5/2018	S471-PMC5941617	['strict adherence to gluten free diet itself MAY REPRESENTS a DETERMINANT of Vitamin D status, BECAUSE it HAS BEEN DEMONSTRATED that sweden cd children on gluten free diet had low Vitamin D intake compared with nordic nutrition recommendation and lower Nutrient density of Vitamin D than healthy children [431].']	[('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 105), ('INCOMPLETE_EVIDENCE', 114)]	7	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_33284', 'nutrient', 252, 'nutrient'), ('CHEBI_27300', 'vitamin D', 272, 'vitamin D')]
PMC5941617	5/2018	S472-PMC5941617	['AS Vitamin D is an IMPORTANT KEY DETERMINANT of bone mass acquisition, SOME authors RECOMMENDED Vitamin D supplementation during winter and spring in all cd children and adolescents to optimize bone recovery [432].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 71), ('FUTURE_WORK', 84)]	6	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC5941617	5/2018	S473-PMC5941617	['nice GUIDELINES ADVICE that People with cd MAY NEED to receive Calcium and Vitamin D supplementation if their dietary intake is insufficient [433].']	[('PROBABLE_UNDERSTANDING', 5), ('FUTURE_WORK', 16), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 47)]	4	[('NCBITaxon_10088', 'Mus <genus>', 28, 'people'), ('CHEBI_22313', 'alkaline earth metal atom', 63, 'calcium'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5941617	5/2018	S474-PMC5941617	['other authors REINFORCE that Vitamin D supplementation SHOULD BE offered to cd patients AT LEAST during the first years of gluten free diet [423].']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 55), ('PROBABLE_UNDERSTANDING', 88)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5941617	5/2018	S480-PMC5941617	['two meta-analyses CONFIRMED that Vitamin D deficiency was ASSOCIATED with obesity in children, adolescents and Adults irrespective of age, latitude, and cut-offs used to define deficiency [439,440].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adults')]
PMC5941617	5/2018	S482-PMC5941617	['a RECENT meta-analysis of 4 rcts and 11 non-rcts, ONLY 1 enrolling children [442], SHOWED that weight loss marginally improved Vitamin D in comparison with weight maintenance under similar Vitamin D intake [443], CONFIRMING that increased adiposity causes SUBOPTIMAL Serum 25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 83), ('PROBABLE_UNDERSTANDING', 213), ('IMPORTANT_CONSIDERATION', 256)]	5	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('UBERON_0001977', 'blood serum', 267, 'serum'), ('CHEBI_71657', 'versiconol acetate', 273, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 273, '25(OH ... D')]
PMC5941617	5/2018	S483-PMC5941617	['ON THE CONTRARY, two meta-analyses enrolling MAINLY Adults SHOWED that Vitamin D supplementation did not decrease adiposity [444,445].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 45), ('INCOMPLETE_EVIDENCE', 59)]	3	[('UBERON_0007023', 'adult organism', 52, 'adults'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC5941617	5/2018	S484-PMC5941617	['Animal models and in vitro studies report that Vitamin D MAY INFLUENCE both Pancreatic Insulin secretion and Insulin sensitivity in Skeletal muscle [446,447].']	[('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0001264', 'pancreas', 76, 'pancreatic'), ('PR_000045358', 'insulin family protein', 87, 'insulin'), ('PR_000045358', 'insulin family protein', 109, 'insulin'), ('UBERON_0004288', 'skeleton', 132, 'skeletal')]
PMC5941617	5/2018	S485-PMC5941617	['THUS, several authors have SUGGESTED that Vitamin D deficiency COULD play a ROLE in worsening the comorbidities of pediatric obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5941617	5/2018	S491-PMC5941617	['REPORTED no correlation between Insulin sensitivity and Vitamin D levels, EVEN after weight loss [442].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 74)]	2	[('PR_000045358', 'insulin family protein', 32, 'insulin'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC5941617	5/2018	S493-PMC5941617	['SHOWED no difference in Vitamin D status between obese with or without impaired Glucose Homeostasis [450].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_17234', 'glucose', 80, 'glucose'), ('GO_0042593', 'glucose homeostasis', 80, 'glucose homeostasis')]
PMC5941617	5/2018	S495-PMC5941617	['several rcts HAVE BEEN conducted to evaluate the efficacy of Vitamin D supplementation as a POTENTIAL therapy for each component of Metabolic syndrome.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 92)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0008152', 'metabolic process', 132, 'metabolic')]
PMC5941617	5/2018	S496-PMC5941617	['in a 16-week rct with 2000\xa0iu/day of Vitamin D authors REPORTED that therapy was able to reduce Arterial stiffness in black obese adolescents [151].']	[('INCOMPLETE_EVIDENCE', 55)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0001637', 'artery', 96, 'arterial')]
PMC5941617	5/2018	S497-PMC5941617	['other papers DESCRIBE a significant reduction of Insulin resistance index after Vitamin D supplementation [454,455].']	[('INCOMPLETE_EVIDENCE', 13)]	1	[('PR_000045358', 'insulin family protein', 49, 'insulin'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC5941617	5/2018	S499-PMC5941617	['more RECENT FINDINGS have reported no influence of DIFFERENT Vitamin D supplementation schedules on Serum Lipid levels, Glucose Homeostasis, glycated hemoglobin and Pancreatic Insulin secretion [457–459].']	[('INCOMPLETE_EVIDENCE', 5), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_18059', 'lipid', 106, 'lipid'), ('CHEBI_17234', 'glucose', 120, 'glucose'), ('GO_0042593', 'glucose homeostasis', 120, 'glucose homeostasis'), ('UBERON_0001264', 'pancreas', 165, 'pancreatic'), ('PR_000045358', 'insulin family protein', 176, 'insulin')]
PMC5941617	5/2018	S500-PMC5941617	['a RECENT italian rct SHOWED that supplementation with Vitamin D (800\xa0iu/day) plus Docosahexanoic Acid IMPROVED Insulin-resistance, Lipid profile, aminotransferases levels, and activity score in obese children with non alcoholic fatty Liver disease and Vitamin D deficiency [460].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 102)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_36006', 'icosapentaenoic acid', 82, 'docosahexanoic acid'), ('PR_000045358', 'insulin family protein', 111, 'insulin'), ('CHEBI_18059', 'lipid', 131, 'lipid'), ('UBERON_0002107', 'liver', 234, 'liver'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D')]
PMC5941617	5/2018	S501-PMC5941617	['finally, two RECENT meta-analyses SHOWED that Vitamin D supplementation had no significant effect on Glucose and Insulin Metabolism [461] and on changes in the concentrations of inflammatory BIOMARKERS (C-Reactive Protein, tumor necrosis factor alpha, Il-6) in obese and overweight adolescents and Adults [462].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 191)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17234', 'glucose', 101, 'glucose'), ('GO_0007369', 'gastrulation', 101, 'glucose ...'), ('GO_1901142', 'insulin metabolic process', 113, 'insulin metabolism'), ('PR_000045358', 'insulin family protein', 113, 'insulin'), ('PR_000005890', 'crooked neck-like protein 1', 203, 'C-reactive protein'), ('PR_000001470', 'interleukin-28B', 252, 'IL-6'), ('UBERON_0007023', 'adult organism', 298, 'adults')]
PMC5941617	5/2018	S505-PMC5941617	['DIFFERENT Vitamin D dose regimens HAVE BEEN PROPOSED in obese children and adolescents for both Vitamin D supplementation and treatment of deficiency [463–467].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 44)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC5941617	5/2018	S506-PMC5941617	['the Endocrine society clinical practice guideline SUGGESTED in obese children Vitamin D supplementation at doses 2–3 times higher than those recommended for age to satisfy their body’s Vitamin D REQUIREMENT.']	[('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 195)]	2	[('UBERON_0005063', 'left ventricular compact myocardium', 4, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC5941617	5/2018	S510-PMC5941617	['more RECENTLY, united arab emirates GUIDELINES also RECOMMENDED Vitamin D supplementation in obese children and adolescents (1200–2000\xa0iu/day DEPENDING ON severity of obesity, season and sun exposure) throughout the year IF sufficient Skin Synthesis if Vitamin D is not ensured during winter [27].']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 36), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0009697', 'salicylic acid biosynthetic process', 235, 'skin synthesis'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC5941617	5/2018	S511-PMC5941617	['DIFFERENTLY, sacn CONFIRMED that obese People are AT RISK of low Serum 25(Oh)D concentrations, but HIGHLIGHTED that CURRENTLY EVIDENCE is INSUFFICIENT to RECOMMEND for obese Individuals different reference Nutrient intake of Vitamin D from that PROPOSED for the general uk population [25].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 50), ('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 138), ('FUTURE_WORK', 154), ('INCOMPLETE_EVIDENCE', 245)]	9	[('NCBITaxon_10088', 'Mus <genus>', 39, 'people'), ('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 71, '25(OH ... D'), ('NCBITaxon_1', 'root', 174, 'individuals'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC5941617	5/2018	S513-PMC5941617	['in CONCLUSION, obese children have higher RISK of Vitamin D deficiency and insufficiency.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 42)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC5941617	5/2018	S517-PMC5941617	['AT PRESENT, CONSIDERING that obese italian children have higher prevalence of Vitamin D deficiency and insufficiency then normal weight Individuals, we SUGGEST in obese children and adolescents vitamin D supplementation at higher doses THAN those RECOMMENDED for age (1000–1500\xa0iu/day) from the end of fall to the beginning of spring (november–april) to ensure an adequate Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('FUTURE_WORK', 247)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_1', 'root', 136, 'individuals'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 202, 'D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D')]
PMC5941617	5/2018	S521-PMC5941617	['several OBSERVATIONAL STUDIES have LINKED autism spectrum disorders and low Serum 25(Oh)D levels during Pregnancy because of Vitamin D pleiotropic activity [469–476].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 88, 'D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC5941617	5/2018	S523-PMC5941617	['particularly, a RECENT meta-analysis SHOWED that Serum 25(Oh)D levels in children and adolescents (age 2–16\xa0years) with autism spectrum disorders were significantly lower than controls, SUGGESTING that lower Vitamin D levels MIGHT be a risk factor for autism [480].']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 186), ('INCOMPLETE_EVIDENCE', 225)]	4	[('UBERON_0001977', 'blood serum', 49, 'serum'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 55, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D')]
PMC5941617	5/2018	S524-PMC5941617	['FEW STUDIES or case reports SUGGESTED that Vitamin D supplementation CAN improve autism symptoms [481–484].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 69)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC5941617	5/2018	S525-PMC5941617	['NEVERTHELESS, a RECENT rct enrolled 42 children with autism spectrum disorders showing that Vitamin D supplementation (2000\xa0iu/day of Vitamin D3For 20\xa0weeks) had no EFFECT on the primary outcome (the stereotypic behaviour subscale from the aberrant behaviour checklist) in comparison with placebo [485].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 165)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27364', 'zinc molecular entity', 134, 'vitamin D3for')]
PMC5941617	5/2018	S533-PMC5941617	['FOUND no differences in Vitamin D status and bone density among adolescents AFFECTED by major depression and healthy controls [493].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5941617	5/2018	S537-PMC5941617	['AS literature SHOWS CONTRASTING results because of DIFFERENT methods and study designs, MORE STUDIES ARE NEEDED to define the ROLE of Vitamin D in pathogenesis and severity of depression, particularly in the pediatric age.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('ANOMALY_CURIOUS_FINDING', 88), ('FUTURE_WORK', 93), ('SUPERFICIAL_RELATIONSHIP', 126)]	7	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5941617	5/2018	S538-PMC5941617	['Pregnancy and breastfeeding\nthe high prevalence of Vitamin D deficiency in Pregnant women is a worldwide health PROBLEM REGARDLESS OF latitude, Food Intake or socio-economic status [93].']	[('IMPORTANT_CONSIDERATION', 112), ('INCOMPLETE_EVIDENCE', 120)]	2	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnant'), ('CHEBI_33290', 'food', 144, 'food'), ('GO_0007631', 'feeding behavior', 144, 'food intake')]
PMC5941617	5/2018	S539-PMC5941617	['data about Vitamin D intake and status in Pregnant women are relatively SCARCE but CONFIRM THIS scenario.']	[('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 83), ('QUESTION_ANSWERED_BY_THIS_WORK', 91)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnant')]
PMC5941617	5/2018	S542-PMC5941617	['semi-quantitative Food questionnaires SHOWED that the average dietary Vitamin D Intake is 136\u2009±\u200968\xa0iu, significantly lower than the institute of medicine recommended amount (600\xa0iu) [10].']	[('INCOMPLETE_EVIDENCE', 38)]	1	[('CHEBI_33290', 'food', 18, 'food'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007631', 'feeding behavior', 80, 'intake')]
PMC5941617	5/2018	S551-PMC5941617	['moreover, maternal Vitamin D deficiency HAS BEEN ASSOCIATED with INCREASED risk of several obstetrics diseases (spontaneous Pregnancy Loss, Preterm and/or small-for-Gestational age Birth, Gestational diabetes pre-eclampsia) [502–506].']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 65)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0006508', 'proteolysis', 124, 'pregnancy loss'), ('GO_0007565', 'female pregnancy', 140, 'preterm'), ('GO_0007565', 'female pregnancy', 165, 'gestational'), ('GO_0007567', 'parturition', 181, 'birth'), ('GO_0007565', 'female pregnancy', 188, 'gestational')]
PMC5941617	5/2018	S552-PMC5941617	['in addition, Vitamin D deficiency during Pregnancy MAY negatively AFFECT long-term offspring Extraskeletal health outcomes, with INCREASED risk of infant Respiratory Tract infections, asthma, wheeze, and eczema [273,380,507,508].']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 129)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('UBERON_0001431', 'distal carpal bone 2', 93, 'extraskeletal'), ('UBERON_0000065', 'respiratory tract', 154, 'respiratory tract')]
PMC5941617	5/2018	S554-PMC5941617	['supplementing Pregnant women with Vitamin D in a single or continued dose increases Serum 25(Oh)D at term and MAY reduce the RISK of Preeclampsia, low Birth weight and Preterm Birth.']	[('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 125)]	2	[('GO_0007565', 'female pregnancy', 14, 'pregnant'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001977', 'blood serum', 84, 'serum'), ('CHEBI_71657', 'versiconol acetate', 90, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 93, 'OH ... D'), ('GO_0007128', 'meiotic prophase I', 133, 'preeclampsia'), ('GO_0007567', 'parturition', 151, 'birth'), ('GO_0007565', 'female pregnancy', 168, 'preterm'), ('GO_0007567', 'parturition', 176, 'birth')]
PMC5941617	5/2018	S558-PMC5941617	['indeed, Vitamin D supplementation with 400\xa0iu/day HAS BEEN REPORTED insufficient in Pregnancy, PARTICULARLY for women at higher RISK of Vitamin D deficiency [512,513].']	[('INCOMPLETE_EVIDENCE', 50), ('ANOMALY_CURIOUS_FINDING', 95), ('IMPORTANT_CONSIDERATION', 128)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5941617	5/2018	S560-PMC5941617	['SUGGESTED that a Vitamin D intake of AT LEAST 4000\xa0iu/day SHOULD BE CONSIDERED in all Pregnant women to maintain Serum 25(Oh)D levels ≥40\xa0ng/ml [513,514].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 37), ('FUTURE_WORK', 58), ('FUTURE_WORK', 68)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnant'), ('UBERON_0001977', 'blood serum', 113, 'serum'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 119, '25(OH)D')]
PMC5941617	5/2018	S568-PMC5941617	['we do not RECOMMEND routine screening of Serum 25(Oh)D levels in all Pregnant and breastfeeding women, BUT we SUGGEST to CONSIDER Vitamin D testing in women with multiple RISK FACTORS for Vitamin D deficiency, PARTICULARLY if not receiving Vitamin D supplementation.']	[('FUTURE_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 110), ('FUTURE_WORK', 121), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 210), ('IMPORTANT_CONSIDERATION', 210)]	7	[('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_71657', 'versiconol acetate', 47, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 47, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC5941617	5/2018	S570-PMC5941617	['management of asymptomatic Vitamin D deficiency and insufficiency\nin RECENT YEARS SOME international societies and committees PROPOSED various regimens to treat of Vitamin D deficiency [9,11,20–23].']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 126)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC5941617	5/2018	S571-PMC5941617	['the aap RECOMMENDED to treat Vitamin D deficiency administering 2000\xa0iu/day or 50,000\xa0iu/week of Vitamin D2Or D3(independent of weight) for 6\xa0week in infants (0–12\xa0months) and for 6–8\xa0weeks in children and adolescents (1–18\xa0years), SUGGESTING that Vitamin D3May be more potent than Vitamin D2[23].']	[('FUTURE_WORK', 8), ('INCOMPLETE_EVIDENCE', 232)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_72759', 'N-(pentadecanoyl)sphinganine-1-phosphocholine', 97, 'vitamin D2or D3'), ('PR_000017050', 'UDP-glucuronosyltransferase 1A3', 97, 'vitamin D2or D3'), ('CHEBI_64367', 'N-ethyl-L-asparagine', 248, 'vitamin D3may'), ('CHEBI_28934', 'vitamin D2', 282, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 282, 'vitamin D2')]
PMC5941617	5/2018	S574-PMC5941617	['relatively FEW STUDIES evaluated the efficacy of DIFFERENT regimens with Vitamin D2Or Vitamin D3For the treatment of Vitamin D deficiency in otherwise healthy children.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49)]	2	[('CHEBI_27329', 'xanthosine phosphate', 73, 'vitamin D2or'), ('PR_000017209', 'utrophin', 73, 'vitamin D2or'), ('CHEBI_27364', 'zinc molecular entity', 86, 'vitamin D3for'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 94, 'D3for'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5941617	5/2018	S576-PMC5941617	['a RECENT RCT in children (2–5\xa0years) with Vitamin D deficiency SHOWED that treatment with oral 4000\xa0iu/day or 30000\xa0iu/week for 12\xa0weeks or a single intramuscular dose of 300000\xa0iu of Vitamin D3Followed by a maintenance dose of 400\xa0iu/day increased and maintained Serum 25(Oh)D concentration\u2009>\u200930\xa0ng/ml after 1\xa0year [516].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 63)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_83261', 'pyribencarb', 184, 'vitamin D3followed'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 184, 'vitamin D3followed'), ('UBERON_0001977', 'blood serum', 264, 'serum'), ('CHEBI_30778', 'gallic acid', 270, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 276, 'D')]
PMC5941617	5/2018	S582-PMC5941617	['a RECENT 1-year-RCT compared three different regimens for asymptomatic children and adolescents with Vitamin D deficiency and insufficiency (400\xa0iu/day, 45000\xa0iu weekly for 2\xa0months then 400\xa0iu daily, 2000\xa0iu/day for 3\xa0months then 1000\xa0iu/day), SUGGESTING that low loading dose with high maintenance dose is PREFERRED to achieve steady increase in Serum 25(Oh)D levels avoiding hypercalcemic side effects [521].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 245), ('PROBABLE_UNDERSTANDING', 308)]	3	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0001977', 'blood serum', 348, 'serum'), ('CHEBI_71657', 'versiconol acetate', 354, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 354, '25(OH)D')]
PMC5941617	5/2018	S593-PMC5941617	['on the CONTRARY a stoss therapy (Oral single-dose of 10000\xa0iu/kg or 300000\xa0iu of Vitamin D3) HAS BEEN DEMONSTRATED EFFECTIVE and SAFE in the treatment of Vitamin D deficiency in older children (mean age 10.6\u2009±\u20094.4\xa0years) without rickets [523].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 115), ('IMPORTANT_CONSIDERATION', 129)]	4	[('UBERON_0000165', 'mouth', 33, 'oral'), ('CHEBI_33279', 'vitamin D5', 81, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 81, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5941617	5/2018	S594-PMC5941617	['HOWEVER, at PRESENT safety data in both the short- and the long-term of monthly or OTHER Vitamin D regimens LACK DUE TO the nature of the studies, especially in young children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 113)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5941617	5/2018	S595-PMC5941617	['different dose regimens HAVE BEEN PROPOSED in conditions and diseases KNOWN to be a risk for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 70)]	3	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC5941617	5/2018	S598-PMC5941617	['FOUND that in children infected with hiv and Vitamin D insufficiency a daily intake ≥1600\xa0iu/day of Vitamin D3Vitamin D MAY BE REQUIRED to achieve Serum 25(Oh)D levels >\u200930\xa0ng/ml [524].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 120), ('IMPORTANT_CONSIDERATION', 127)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_70326', 'guttiferone A, (rel-(+))-', 100, 'vitamin D3vitamin D'), ('UBERON_0001977', 'blood serum', 147, 'serum'), ('CHEBI_33010', 'chromide(1-)', 155, '(OH)D')]
PMC5941617	5/2018	S604-PMC5941617	['AT PRESENT there is NO STRONG EVIDENCE about WHETHER to treat asymptomatic children with Vitamin D insufficiency [23].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5941617	5/2018	S608-PMC5941617	['nutritional rickets cases are STILL REPORTED in italy, THUS adequate national STRATEGIES to prevent Vitamin D deficiency ARE NEEDED.']	[('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 36), ('PROBABLE_UNDERSTANDING', 55), ('FUTURE_WORK', 78), ('FUTURE_WORK', 121)]	5	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5941617	5/2018	S609-PMC5941617	['moreover, the RECENTLY SUGGESTED ROLE of Vitamin D in the development of other non-Skeletal diseases reinforced the interest in the promotion of an adequate Vitamin D status during pediatric age.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC5941617	5/2018	S616-PMC5941617	['evaluation of Vitamin D status\n\nthe isotope dilution- lc-ms/ms is CONSIDERED the PREFERRED method for measuring Serum 25(Oh)D levels, especially in the Neonatal Period.']	[('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 81)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0001977', 'blood serum', 112, 'serum'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 118, '25(OH ... D'), ('UBERON_0007221', 'neonate stage', 152, 'neonatal period')]
PMC5941617	5/2018	S628-PMC5941617	['we SUGGEST to measure Serum 25(Oh)D levels in infants with multiple RISK FACTORS for Vitamin D deficiency (table\xa06).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 68)]	2	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_71657', 'versiconol acetate', 28, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 34, 'D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5941617	5/2018	S629-PMC5941617	['preterm infants\n\nwe SUGGEST for vlbw infants a Vitamin D intake of 200–400\xa0iu/day (including the amount administered through parenteral nutrition, fortified Breast milk, or preterm infant formula).']	[('INCOMPLETE_EVIDENCE', 20)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0000310', 'breast', 157, 'breast')]
PMC5941617	5/2018	S630-PMC5941617	['when vlbw infants reach a weight\u2009≥\u20091500\xa0g and full enteral nutrition we SUGGEST Vitamin D supplementation at 400–800\xa0iu/day.']	[('INCOMPLETE_EVIDENCE', 72)]	1	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC5941617	5/2018	S640-PMC5941617	['we SUGGEST Vitamin D supplementation from the end of fall to the beginning of spring (november–april) in children and adolescents with reduced sun exposure during summer.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D')]
PMC5941617	5/2018	S641-PMC5941617	['we SUGGEST continuous Vitamin D supplementation in cases of permanent RISK FACTORS for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC5941617	5/2018	S643-PMC5941617	['we endorsed as tolerable upper intake levels of Vitamin D those PROPOSED by efsa in 2012 (1000\xa0iu/day for infants; 2000\xa0iu/day for children ages 1 to 10\xa0years; 4000\xa0iu/day for children and adolescents ages 11 to 17\xa0years).']	[('INCOMPLETE_EVIDENCE', 64)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 56, 'D')]
PMC5941617	5/2018	S647-PMC5941617	['we SUGGEST to measure Serum 25(Oh)D levels in presence of multiple RISK FACTORS for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_71657', 'versiconol acetate', 28, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 28, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC5941617	5/2018	S649-PMC5941617	['Skeletal actions of Vitamin D\n\nnutritional rickets\n\nchildren of immigrants living in industrialized countries are at INCREASED RISK of nutritional rickets BECAUSE they USUALLY present several risk FACTORS for vitamin d deficiency such as prolonged breastfeeding without Vitamin D supplementation, increased skin pigmentation, reduced sun exposure due to cultural habits (i.e.']	[('IMPORTANT_CONSIDERATION', 117), ('PROBABLE_UNDERSTANDING', 155), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 197)]	4	[('UBERON_0004288', 'skeleton', 0, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC5941617	5/2018	S655-PMC5941617	['intermittent administration of Vitamin D MAY BE CONSIDERED in children and adolescents with POOR compliance with daily treatment (i.e.']	[('INCOMPLETE_EVIDENCE', 41), ('FUTURE_WORK', 48), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 92), ('PROBLEM_COMPLICATION', 92)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC5941617	5/2018	S660-PMC5941617	['AVAILABLE EVIDENCE SUGGESTS a positive EFFECT of Vitamin D supplementation on bone mass acquisition in children and adolescents with Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 39)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC5941617	5/2018	S661-PMC5941617	['RECENT STUDIES SUGGEST a RELATIONSHIP between maternal Vitamin D status during Pregnancy and bone mass of the fetus and the newborn.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy')]
PMC5941617	5/2018	S663-PMC5941617	['Extraskeletal actions of Vitamin D\n\nrespiratory infections\n\nRECENT STUDIES SUGGEST an ASSOCIATION between Vitamin D deficiency and the severity or the incidence of Respiratory infections in children.']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('UBERON_0001431', 'distal carpal bone 2', 0, 'Extraskeletal'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 164, 'respiratory')]
PMC5941617	5/2018	S664-PMC5941617	['HOWEVER, BECAUSE CURRENT EVIDENCE IS WEAK, we SUGGEST against Vitamin D administration as a therapy for Respiratory infections, beyond the correction of a DOCUMENTED Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 104, 'respiratory'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC5941617	5/2018	S665-PMC5941617	['NO DEFINITIVE EVIDENCE exists to RECOMMEND Vitamin D supplementation for PREVENTION of Respiratory infections (non-associated with wheezing) or recurrent Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 87, 'respiratory'), ('UBERON_0001004', 'respiratory system', 154, 'respiratory')]
PMC5941617	5/2018	S668-PMC5941617	['a single rct SUGGESTED that Vitamin D supplementation MAY help in preventing non complicated acute otitis media.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 54)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC5941617	5/2018	S672-PMC5941617	['we SUGGEST the evaluation of Vitamin D status ONLY in patients affected by tuberculosis or hiv infection, AS they MAY BENEFIT from Vitamin D supplementation, in particular due to concomitant treatments that INFLUENCE Vitamin D Metabolism.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 207)]	7	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0008152', 'metabolic process', 227, 'metabolism')]
PMC5941617	5/2018	S674-PMC5941617	['HOWEVER, as FEW STUDIES SHOWED that Vitamin D supplementation improves clinical parameters in patients with active tuberculosis or hiv infection, MORE rigorous and extensive STUDIES ARE NEEDED to EVALUATE the ROLE of Vitamin D supplementation in infectious diseases, CONSIDERING also the setting of care, children’s age and nutritional status, POTENTIAL co-infections and compliance with Anti-infective therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 146), ('FUTURE_WORK', 174), ('QUESTION_ANSWERED_BY_THIS_WORK', 196), ('SUPERFICIAL_RELATIONSHIP', 209), ('IMPORTANT_CONSIDERATION', 267), ('INCOMPLETE_EVIDENCE', 344)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('CHEBI_59132', 'antigen', 388, 'anti')]
PMC5941617	5/2018	S678-PMC5941617	['recent meta-analyses SUGGEST that supplementation with Vitamin D (500–2000\xa0iu/day) MAY reduce the RISK of asthma exacerbation.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 83), ('IMPORTANT_CONSIDERATION', 98)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5941617	5/2018	S683-PMC5941617	['Serum 25(Oh)D evaluation MAY BE CONSIDERED in children with SEVERE ad unresponsive to common therapy and multiple RISK FACTORS for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 32), ('IMPORTANT_CONSIDERATION', 32), ('IMPORTANT_CONSIDERATION', 60), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5941617	5/2018	S684-PMC5941617	['in pediatric population there is LIMITED EVIDENCE regarding a POSSIBLE favourable EFFECT of Vitamin D supplementation on several aspects of ad.']	[('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC5941617	5/2018	S685-PMC5941617	['a short trial of Vitamin D supplementation CAN be CONSIDERED in patients with SEVERE ad unresponsive to common therapy, especially in the late winter-early spring period.']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC5941617	5/2018	S691-PMC5941617	['at PRESENT, there is NO EVIDENCE that Vitamin D supplementation MAY delay the development of t1dm or MAY ameliorate its clinical features.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 101)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC5941617	5/2018	S692-PMC5941617	['HOWEVER, we RECOMMEND to maintain Vitamin D intake for age and to treat Vitamin D deficiency IF FOUND.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 96)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5941617	5/2018	S700-PMC5941617	['we SUGGEST against further 25(Oh)D evaluations in case of sufficient 25(Oh)D levels or documented normalization of Vitamin D status and strict adherence to the gluten-free diet.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC5941617	5/2018	S703-PMC5941617	['obesity and Metabolic syndrome\n\nepidemiological studies SHOWED that obese children and adolescents are at high RISK for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 111)]	2	[('GO_0008152', 'metabolic process', 12, 'metabolic'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC5941617	5/2018	S705-PMC5941617	['it is UNCERTAIN IF Vitamin D deficiency MAY worsen Metabolic profile of obese children and adolescents.']	[('FULL_UNKNOWN', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 40)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0008152', 'metabolic process', 51, 'metabolic')]
PMC5941617	5/2018	S706-PMC5941617	['we SUGGEST against Vitamin D administration to improve obesity-related COMPLICATIONS, given INCONSISTENT results and the SMALL NUMBER OF STUDIES.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 121)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC5941617	5/2018	S707-PMC5941617	['we SUGGEST Vitamin D supplementation at higher doses THAN those RECOMMENDED for age (1000–1500\xa0iu/day) from the end of fall to the beginning of spring (november–april) in obese children and adolescents to ensure an adequate Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('FUTURE_WORK', 64)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D')]
PMC5941617	5/2018	S711-PMC5941617	['if an obese Individual does not receive Vitamin D supplementation and has a sedentary indoor lifestyle with consequent reduced sun exposure, Serum 25(Oh)D evaluation MAY BE CONSIDERED to confirm Vitamin D deficiency and start adequate treatment.']	[('INCOMPLETE_EVIDENCE', 166), ('ANOMALY_CURIOUS_FINDING', 170), ('FUTURE_WORK', 173), ('IMPORTANT_CONSIDERATION', 173)]	4	[('NCBITaxon_1', 'root', 12, 'individual'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('CHEBI_71657', 'versiconol acetate', 147, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 147, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC5941617	5/2018	S715-PMC5941617	['we RECOMMEND against Vitamin D treatment to improve patient’s performance CONSIDERING the LIMITED and CONFLICTING AVAILABLE EVIDENCE.']	[('FUTURE_WORK', 3), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 114)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5941617	5/2018	S720-PMC5941617	['we SUGGEST to CONSIDER serum 25(Oh)D testing in women with multiple RISK FACTORS for Vitamin D deficiency, PARTICULARLY if not receiving Vitamin D supplementation, and/or with specific conditions POSSIBLY AFFECTING Pregnancy course (table\xa09).']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 68), ('ANOMALY_CURIOUS_FINDING', 107), ('IMPORTANT_CONSIDERATION', 107), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 205)]	7	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 35, 'D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy')]
PMC5941617	5/2018	S729-PMC5941617	['CONSIDERING AVAILABLE EVIDENCE, PARTICULARLY the LACK OF italian studies, at PRESENT we DO NOT RECOMMEND OTHER modalities DIFFERENT from daily or weekly administration of Vitamin D to treat asymptomatic Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 77), ('FULL_UNKNOWN', 88), ('FUTURE_WORK', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	10	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 211, 'D')]
PMC5952272	5/2018	S11-PMC5952272	['SIMILAR TREND was FOUND with respect to Vitamins E, d, a, and Folic Acid.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 18)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamins E'), ('CHEBI_30751', 'formic acid', 62, 'folic acid')]
PMC5952272	5/2018	S14-PMC5952272	['approximately 1 in 68 children aged 8\u2009years living in sites participating in the addm network surveillance areas (usa) met the asd case criteria for the 2012 surveillance year.1some HYPOTHESES were SUGGESTED to explain this increase, such as an increased awareness, improved detection, expanding definition, or an actual increase in incidence or a combination of these FACTORS.2ALTHOUGH both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function–RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.3SEVERAL RECENT STUDIES have put FORWARD hypotheses to explain the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 369), ('ANOMALY_CURIOUS_FINDING', 377), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 440), ('INCOMPLETE_EVIDENCE', 476), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 554), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 634), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 668), ('INCOMPLETE_EVIDENCE', 677), ('FUTURE_WORK', 701), ('SUPERFICIAL_RELATIONSHIP', 748)]	15	[('SO_0000704', 'gene', 392, 'genetic'), ('UBERON_0002405', 'immune system', 538, 'immune'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D'), ('CHEBI_30751', 'formic acid', 594, 'folic acid'), ('GO_0008152', 'metabolic process', 610, 'metabolic'), ('CHEBI_30751', 'formic acid', 773, 'folic acid'), ('CHEBI_27300', 'vitamin D', 788, 'vitamin D')]
PMC5952272	5/2018	S16-PMC5952272	['there is also a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK for autism.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0000104', 'life cycle', 105, 'life')]
PMC5952272	5/2018	S82-PMC5952272	['THUS, Vitamin E status CAN be considered AS quite satisfactory.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 41)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin E')]
PMC5952272	5/2018	S94-PMC5952272	['this level was achieved ONLY by ABOUT 2.7% of the Lactating women from the west bank and none in the gaza strip, whereas 36% and 24% of Lactating women from the respective provinces were Vitamin D deficient.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 32)]	2	[('GO_0007594', 'puparial adhesion', 50, 'lactating'), ('GO_0007594', 'puparial adhesion', 136, 'lactating'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC5952272	5/2018	S107-PMC5952272	['anaemia and intellectual abilities\niron, Folate, Vitamin B12, Vitamin A, zinc, and other Micronutrient deficiencies CAN CONTRIBUTE to anaemia.5iron-deficiency anaemia is a MAJOR PUBLIC HEALTH nutritional PROBLEM AFFECTING People of all ages.']	[('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 172), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 204), ('SUPERFICIAL_RELATIONSHIP', 212)]	6	[('CHEBI_30863', '5-azaorotic acid', 41, 'folate'), ('CHEBI_33279', 'vitamin D5', 49, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 89, 'micronutrient'), ('NCBITaxon_10088', 'Mus <genus>', 222, 'people')]
PMC5952272	5/2018	S141-PMC5952272	['methionine MAY then be activated by methionine adenosyltransferase to form S-Adenosylmethionine (sam), the primary Methyl Donor for most cellular methyltransferase reactions, including the methylation of dna, rna, proteins, Phospholipids, and Neurotransmitters.34\n\nVitamin D status as a risk factor for autism\nthe main source of Vitamin D is the solar uv-b radiation–RELATED Conversion Of 7-Dehydrocholesterol to Previtamin D3 in the skin and a lesser amount of Vitamin D from Food.35there is a GROWING BODY of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a risk of autism.36moreover, epidemiologic EVIDENCE SUPPORTS the ROLE of maternal Vitamin D deficiency AS a RISK FACTOR for the development of infantile autism.37maternal status of Vitamin D IS CONSIDERED INSUFFICIENT not ONLY in countries where solar radiation is low but also in very sunny places such saudi arabia, uae, iran, and jordan.38\nVitamin D functions in the body have been extensively studied by researchers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 367), ('INCOMPLETE_EVIDENCE', 495), ('INCOMPLETE_EVIDENCE', 525), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 572), ('INCOMPLETE_EVIDENCE', 589), ('INCOMPLETE_EVIDENCE', 639), ('INCOMPLETE_EVIDENCE', 648), ('SUPERFICIAL_RELATIONSHIP', 661), ('PROBABLE_UNDERSTANDING', 699), ('SUPERFICIAL_RELATIONSHIP', 704), ('INCOMPLETE_EVIDENCE', 787), ('PROBLEM_COMPLICATION', 801), ('INCOMPLETE_EVIDENCE', 818)]	15	[('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 75, 'S-adenosylmethionine'), ('CHEBI_81933', 'methasulfocarb', 115, 'methyl donor'), ('CHEBI_16247', 'phospholipid', 224, 'phospholipids'), ('CHEBI_25512', 'neurotransmitter', 243, 'neurotransmitters'), ('CHEBI_28384', 'vitamin K', 265, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('GO_0048669', 'collateral sprouting in absence of injury', 375, 'conversion of ... dehydrocholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 389, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 413, 'previtamin D3'), ('CHEBI_29238', 'tritium atom', 424, 'D3'), ('CHEBI_27300', 'vitamin D', 462, 'vitamin D'), ('CHEBI_33290', 'food', 477, 'food'), ('CHEBI_27300', 'vitamin D', 539, 'vitamin D'), ('UBERON_0000104', 'life cycle', 584, 'life'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 777, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 939, 'Vitamin D')]
PMC5952272	5/2018	S143-PMC5952272	['IN fact, it is the most potent Steroid Hormone in the Human body INTERACTING with 2.5% of the Human Genome or some 1000 Genes (a large NUMBER of which AFFECT Brain Development and function) and working like a master on-off switch.35\nthe LINK between Vitamin D and autism are based on 4 observational data:\nthe low concentrations of Serotonin in the Brain and its elevated concentrations in Tissues outside the Blood-Brain Barrier;\nlow Plasma concentrations of the Vitamin D hormone precursor 25-Hydroxyvitamin D (25(Oh) D3);\nhigh male incidence;\npresence of maternal Antibodies to foetal Brain Tissue.35,36\nthe level of Serotonin in the Brain DEPENDS ON the Blood levels of tryptophan, which, UNLIKE Serotonin, crosses the Blood-Brain Barrier.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 151), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 643), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 693)]	7	[('CHEBI_26764', 'steroid hormone', 31, 'steroid hormone'), ('NCBITaxon_9606', 'Homo sapiens', 54, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 94, 'human'), ('SO_0001026', 'genome', 100, 'genome'), ('SO_0000704', 'gene', 120, 'genes'), ('GO_0007420', 'brain development', 158, 'brain development'), ('UBERON_0000955', 'brain', 158, 'brain'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_28790', 'serotonin', 332, 'serotonin'), ('UBERON_0000955', 'brain', 349, 'brain'), ('UBERON_0000479', 'tissue', 390, 'tissues'), ('UBERON_0000120', 'blood brain barrier', 410, 'blood-brain barrier'), ('UBERON_0001969', 'blood plasma', 435, 'plasma'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 492, '25-hydroxyvitamin D'), ('CHEBI_62946', 'ammonium sulfate', 513, '25(OH) D3'), ('GO_0042571', 'immunoglobulin complex, circulating', 567, 'antibodies'), ('UBERON_0000955', 'brain', 588, 'brain'), ('UBERON_0000479', 'tissue', 594, 'tissue'), ('CHEBI_28790', 'serotonin', 620, 'serotonin'), ('UBERON_0000955', 'brain', 637, 'brain'), ('UBERON_0000178', 'blood', 658, 'blood'), ('CHEBI_28790', 'serotonin', 700, 'serotonin'), ('UBERON_0000178', 'blood', 723, 'blood'), ('UBERON_0000052', 'fornix of brain', 729, 'brain barrier')]
PMC5952272	5/2018	S146-PMC5952272	['it is IMPORTANT TO MENTION in this context that the PREVALENCE of autism in somali children Born in sweden was FOUND TO BE 3 to 4 times higher than in the non-somali group (0.7% vs 0.19%).39as somalis have high levels of Melanin, during migration to northern latitudes, such as sweden, they would REQUIRE 5 to 10 times more uv-b exposure than light-skinned Individuals OR an ALTERNATIVE Vitamin D source, such as from the diet or supplementation.40moreover, saad et al41reported that 57% Vitamin D deficient and 30% insufficient patients who received Vitamin D3 (300\u2009iu/kg/day not to exceed 5000\u2009iu/day) for 3\u2009months SHOWED significant improved outcomes (80.72 %), which were MAINLY in the sections of the childhood autism rating scale (cars) and aberrant behaviour checklist subscales that measure behaviour, stereotypy, Eye contact, and attention span.']	[('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 52), ('ANOMALY_CURIOUS_FINDING', 111), ('FUTURE_WORK', 297), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 369), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 375), ('INCOMPLETE_EVIDENCE', 617), ('PROBABLE_UNDERSTANDING', 676)]	8	[('GO_0007567', 'parturition', 92, 'born'), ('CHEBI_25179', 'melanins', 221, 'melanin'), ('NCBITaxon_1', 'root', 357, 'individuals'), ('CHEBI_27300', 'vitamin D', 387, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 488, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 551, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 551, 'vitamin D3'), ('UBERON_0000970', 'eye', 822, 'eye')]
PMC5952272	5/2018	S147-PMC5952272	['experiment on Animal models SHOWED that 1,25 Dihydroxyvitamin D3 Prenatal supplementations were PROTECTIVE for offsprings against induced Maternal Immune Activation (mia).42maternal Immune Activation in experimental Animals Reproduces asd-like symptoms via significant increase of proinflammatory cytokines; however, administration of Vitamin D has blocked the emergence of asd-relevant deficits in social INTERACTION, stereotyped behaviour, and emotional Learning and Memory.42RECENTLY, sotodehasl et al43have reviewed 80 articles LINKING autism and Vitamin D. the authors found no significant DIFFERENCES between children with asd and neurotypical developed children.43this was also SUPPORTED by a canadian prospective cohort study that included 3852 children.44forty-one children were diagnosed with asd, who have no difference in the level of Vitamin D in their Serum compared with non-asd children.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 406), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 476), ('SUPERFICIAL_RELATIONSHIP', 532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 685)]	7	[('NCBITaxon_33208', 'Metazoa', 14, 'animal'), ('CHEBI_63912', '19-hydroxyprostaglandin H2', 40, '1,25 dihydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 62, 'D3'), ('GO_0007565', 'female pregnancy', 65, 'prenatal'), ('GO_0007618', 'mating', 138, 'maternal'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 147, 'immune activation'), ('UBERON_0002405', 'immune system', 147, 'immune'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 182, 'immune activation'), ('UBERON_0002405', 'immune system', 182, 'immune'), ('NCBITaxon_33208', 'Metazoa', 216, 'animals'), ('GO_0000003', 'reproduction', 224, 'reproduces'), ('CHEBI_27300', 'vitamin D', 335, 'vitamin D'), ('GO_0007612', 'learning', 456, 'learning'), ('GO_0007613', 'memory', 469, 'memory'), ('CHEBI_27300', 'vitamin D', 551, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 847, 'vitamin D'), ('UBERON_0001977', 'blood serum', 866, 'serum')]
PMC5952272	5/2018	S151-PMC5952272	['on the community level, it was NOTICED that diet plays a MAJOR ROLE in the manifestation of anaemia and Vitamin E and D deficiency; HOWEVER, OTHER factors MAY interfere to make such a deficiency multifactorial.']	[('ANOMALY_CURIOUS_FINDING', 31), ('IMPORTANT_CONSIDERATION', 57), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin E'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 118, 'D')]
PMC5956785	5/2018	S1-PMC5956785	['WHILE the ROLES of Vitamin D in OTHER Autoimmune diseases HAVE BEEN investigated, less is known about the ROLE of Vitamin D in chronic childhood arthritis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 38, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5956785	5/2018	S6-PMC5956785	['conclusion\nthe data INDICATE SUBOPTIMAL Vitamin D status in children with chronic arthritis.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 29)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC5956785	5/2018	S14-PMC5956785	['Vitamin D status is POTENTIALLY GOVERNED by these same FACTORS; Vitamin D receptor genotype, ethnically RELATED skin tone and clothing, environmental variations in exposure to ultraviolet b radiation RELATING to the latitude of residence and season, and Vitamin D nutritional intake are FACTORS that Modulate Vitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 200), ('SUPERFICIAL_RELATIONSHIP', 287)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0065007', 'biological regulation', 300, 'modulate'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D')]
PMC5956785	5/2018	S21-PMC5956785	['CONSEQUENTLY, low Vitamin D concentrations are ASSOCIATED with an increase in pro-Inflammatory Mediators and more active disease [6,10] CONSISTENT, for example, with the OBSERVATION that low Serum 25(Oh)D is ASSOCIATED with increased disease activity in rheumatoid arthritis [11].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 136), ('ANOMALY_CURIOUS_FINDING', 170), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_64664', '(2-nitrophenyl)azo group', 81, '-inflammatory mediators'), ('UBERON_0001977', 'blood serum', 191, 'serum'), ('CHEBI_71657', 'versiconol acetate', 197, '25(OH)D')]
PMC5956785	5/2018	S24-PMC5956785	['an updated, systematic analysis of pertinent literature SHOULD help to FURTHER REFINE understanding of the RELATIONSHIPS between Vitamin D and juvenile arthritis, contribute to optimizing management of vitamin d status in children with arthritis, and CLARIFY Vitamin D’s POTENTIAL ROLE in MEDIATING disease pathogenesis.']	[('FUTURE_WORK', 56), ('FUTURE_WORK', 71), ('SUPERFICIAL_RELATIONSHIP', 107), ('FUTURE_WORK', 251), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 281), ('SUPERFICIAL_RELATIONSHIP', 289)]	7	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC5956785	5/2018	S30-PMC5956785	['HERE we report the results of a Vitamin D- jia scoping review that summarizes, synthesizes, evaluates, and interprets pertinent EVIDENCE from the literature to address the following research questions: 1) WHAT is the RELATIONSHIP between Vitamin D status and the occurrence of jia?']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 128), ('EXPLICIT_QUESTION', 205), ('SUPERFICIAL_RELATIONSHIP', 217), ('EXPLICIT_QUESTION', 280)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5956785	5/2018	S62-PMC5956785	['defining Vitamin D status\nvitamin D deficiency is DEFINED AS a Serum 25(Oh)D concentration less than 30\xa0nmol/l, a 25(Oh)D concentration between 30 and 50\xa0nmol/l IS CONSIDERED insufficient, greater than 50\xa0nmol/l IS CONSIDERED sufficient and a 25(Oh)D status greater than 125\xa0nmol/l IS CONSIDERED AT RISK of adverse EFFECTS [19].']	[('PROBABLE_UNDERSTANDING', 50), ('PROBABLE_UNDERSTANDING', 58), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 212), ('INCOMPLETE_EVIDENCE', 282), ('IMPORTANT_CONSIDERATION', 296), ('SUPERFICIAL_RELATIONSHIP', 315)]	7	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 34, 'D'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 114, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 120, 'D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D')]
PMC5956785	5/2018	S64-PMC5956785	['in the most RECENT review of Vitamin D REQUIREMENTS, the iom CONCLUDED that there was INADEQUATE INFORMATION to make intake RECOMMENDATIONS in RELATION to OTHER biologic ROLES of vitamin d [19].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 86), ('PROBLEM_COMPLICATION', 86), ('INCOMPLETE_EVIDENCE', 97), ('FUTURE_WORK', 124), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 170)]	10	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5956785	5/2018	S75-PMC5956785	['THIS PRESENT REVIEW summarizes ACCUMULATED EVIDENCE on Vitamin D and chronic childhood arthritis by disease activity and latitude.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('INCOMPLETE_EVIDENCE', 31)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5956785	5/2018	S108-PMC5956785	['reviewsuggests severe jra has an INFLUENCE on bone mass POSSIBLY MEDIATED by a decrease in active Vitamin D Metabolites.study duration one year, controls ONLY measured at baseline 25(Oh)D 92\u2009±\u200917.5\xa0nmol/l n \u2009=\u200920huddinge, sweden johansson et al.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 154)]	4	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_25212', 'metabolite', 108, 'metabolites'), ('CHEBI_71657', 'versiconol acetate', 180, '25(OH)D')]
PMC5956785	5/2018	S123-PMC5956785	['age, ethnicity, season, bmi ASSOCIATED with 25(Oh)D BUT NOT Vitamin D deficiency.no association with whole sample; SMALL negative ASSOCIATION for new onset jia; mean time since onset 28\xa0months.helinski, finland markula-patjas et al.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 52), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 130)]	4	[('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 46, '(OH ... D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC5956785	5/2018	S134-PMC5956785	['ONLY nine children had acceptable Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC5956785	5/2018	S140-PMC5956785	['the 2013, systematic literature review of 19 childhood arthritis STUDIES REPORTED Vitamin D status (14 reporting 25(Oh)D and 11 reporting 1,25(Oh)D) SUGGESTED that at that time there was NO CLEAR LINK between Vitamin D status and children with chronic arthritis [12].']	[('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 149), ('FULL_UNKNOWN', 187), ('SUPERFICIAL_RELATIONSHIP', 196)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 113, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 116, 'OH ... D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 143, 'OH)D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC5956785	5/2018	S141-PMC5956785	['the review also contained a meta-analysis comprising three studies that REPORTED the prevalence of Vitamin D insufficiency to be 82% in jia [12].']	[('INCOMPLETE_EVIDENCE', 72)]	1	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC5956785	5/2018	S183-PMC5956785	['ONE STUDY (26.3%) SHOWED the OPPOSITE RELATIONSHIP; those with active disease had higher Vitamin D concentrations than those with inactive disease [34].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('SUPERFICIAL_RELATIONSHIP', 38)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5956785	5/2018	S185-PMC5956785	['except for one STUDY conducted in turkey [21], all other studies conducted in europe that explored disease activity REPORTED an inverse ASSOCIATION between Vitamin D and disease activity.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 136)]	3	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC5956785	5/2018	S186-PMC5956785	['long-term cohort STUDIES CAN FURTHER CLARIFY the RELATIONSHIP between Vitamin D concentration and disease duration or frequency of relapse.']	[('FUTURE_WORK', 17), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 29), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5956785	5/2018	S189-PMC5956785	['the authors QUESTIONED WHETHER jia patients with more SEVERE disease REQUIRE higher supplementation of Vitamin D to maintain normal 25(Oh) D concentrations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('IMPORTANT_CONSIDERATION', 54), ('IMPORTANT_CONSIDERATION', 69)]	5	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH) D')]
PMC5956785	5/2018	S192-PMC5956785	['to date, the EVIDENCE TO SUPPORT a RELATIONSHIP between Vitamin D and disease activity with Autoimmune diseases in Humans is CORRELATIVE and not causative [71].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 125)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 92, 'autoimmune'), ('NCBITaxon_9606', 'Homo sapiens', 115, 'humans')]
PMC5956785	5/2018	S194-PMC5956785	['POTENTIAL REQUIREMENTS of Vitamin D intake\nVitamin D intake was ONLY measured in seven studies [23,26,31,37,38,43,44].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 10), ('INCOMPLETE_EVIDENCE', 64)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 43, 'Vitamin D')]
PMC5956785	5/2018	S195-PMC5956785	['all of THESE STUDIES REPORTED a mean or median Vitamin D intake that was less than the estimated average requirement (ear) of 400\xa0iu per day set by the Iom [19].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 21)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0001137', 'dorsum', 152, 'IOM')]
PMC5956785	5/2018	S199-PMC5956785	['two studies REPORTED Intake of Vitamin D supplements by study participants but neither had a mean 25(Oh)D that reached the OPTIMAL concentration [38,44].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 123)]	2	[('GO_0007631', 'feeding behavior', 21, 'intake'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 104, 'D')]
PMC5956785	5/2018	S205-PMC5956785	['REPORTED SIMILAR intake of Vitamin D and higher 25(Oh)D in controls, and in the study REPORTED by dey et al.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 86)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D')]
PMC5956785	5/2018	S207-PMC5956785	['it HAS BEEN THEORIZED that there MAY BE an increased utilization of Vitamin D during active inflammation, POSSIBLY caused by \\the presence of Vitamin D receptor polymorphisms in patients with Autoimmune diseases [6,72].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 106)]	6	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 192, 'autoimmune')]
PMC5956785	5/2018	S209-PMC5956785	['understanding this RELATIONSHIP will be IMPORTANT in the use of Vitamin D as a POTENTIAL adjunct therapy.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('IMPORTANT_CONSIDERATION', 40), ('INCOMPLETE_EVIDENCE', 79)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5956785	5/2018	S210-PMC5956785	['additionally, IMPROVED UNDERSTANDING of Vitamin D NEEDS in children with chronic arthritis will HELP TO CLARIFY the ROLE of Vitamin D in the UNDERLYING disease processes so that therapies that target specific Vitamin D responsive Immune pathways CAN be developed.']	[('FUTURE_WORK', 14), ('FUTURE_WORK', 23), ('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 50), ('FUTURE_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 141), ('FUTURE_WORK', 246), ('INCOMPLETE_EVIDENCE', 246)]	9	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('UBERON_0002405', 'immune system', 230, 'immune')]
PMC5956785	5/2018	S211-PMC5956785	['by exploring the factors that INFLUENCE Vitamin D status (genetics, environment, and nutrition), we will be BETTER able to discern an ASSOCIATION between Vitamin D and jia.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5956785	5/2018	S214-PMC5956785	['the authors CAUTIONED that providing large doses of Vitamin D CAN result in providing “too much of a good thing” and that studies comparing children with rheumatic diseases to healthy children are REQUIRED.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 197)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC5956785	5/2018	S226-PMC5956785	['the authors HYPOTHESIZED that the REASON their patients’ 25(Oh)D concentrations were so high was that their PREVIOUS RESEARCH had FOUND low concentrations of 25(Oh)D and they were encouraging their patients to consume Vitamin D fortified Foods and to spend time in the sun [53].']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 34), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 130)]	4	[('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 57, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 60, 'OH ... D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 161, 'OH)D'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D'), ('CHEBI_33290', 'food', 238, 'foods')]
PMC5956785	5/2018	S229-PMC5956785	['they FOUND that the MAJORITY of pediatric rheumatologists are RECOMMENDING Vitamin D for patients who were on long-term Corticosteroids [76].']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 20), ('FUTURE_WORK', 62)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_50850', 'etabonate ester', 120, 'corticosteroids')]
PMC5956785	5/2018	S230-PMC5956785	['the ROLE of Vitamin D in MEDIATING bone health, especially in RELATION to Corticosteroids, HAS BEEN established [75].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 91)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_50850', 'etabonate ester', 74, 'corticosteroids')]
PMC5956785	5/2018	S238-PMC5956785	['WHILE THIS REVIEW FOCUSED on Vitamin D status in children with jia, Vitamin D MAY BE INVOLVED in both disease development and subsequent disease activity status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 85)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5956785	5/2018	S239-PMC5956785	['exploring elements of Vitamin D status that MAY have a ROLE in disease development such as early Life and Gestational Vitamin D status as well as Genes in the Vitamin D pathway will help TO CLARIFY the ROLE of Vitamin D.\nseason of Birth HAS BEEN SUGGESTED to have an IMPACT on the risk of developing a number of Autoimmune diseases such as multiple sclerosis, type 1 diabetes and celiac disease [78].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 55), ('FUTURE_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('SO_0000704', 'gene', 146, 'genes'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007567', 'parturition', 231, 'birth'), ('UBERON_0001442', 'skeleton of manus', 312, 'autoimmune')]
PMC5956785	5/2018	S244-PMC5956785	['season of Birth MAY BE a MARKER for Vitamin D status in utero with children Born in the non-Vitamin D synthesizing periods being exposed to less Vitamin D during their time in utero THAN those who are Born during the Vitamin D synthesizing seasons.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	3	[('GO_0007567', 'parturition', 10, 'birth'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007567', 'parturition', 76, 'born'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0007567', 'parturition', 201, 'born'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
PMC5956785	5/2018	S250-PMC5956785	['certain vdr Gene polymorphisms MAY BE ASSOCIATED with different biologic response to Vitamin D. the cdx2 polymorphism of the Vdr Gene specifically the gg genotype, HAVE BEEN SUGGESTED to be more represented in patients with jia COMPARED TO healthy controls who more OFTEN have the ga genotype [82].']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('PROBABLE_UNDERSTANDING', 266)]	6	[('SO_0000704', 'gene', 12, 'gene'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 125, 'VDR'), ('SO_0000704', 'gene', 129, 'gene')]
PMC5956785	5/2018	S251-PMC5956785	['RECENTLY THE IDEA of investigating epistasis (Gene-Gene interactions) amongst Genes in the inflammatory and Vitamin D pathway and HOW their INTERACTIONS CONTRIBUTE to jia risk was explored by ellis et al.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 13), ('EXPLICIT_QUESTION', 130), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 153)]	6	[('SO_0000704', 'gene', 46, 'gene'), ('SO_0000704', 'gene', 51, 'gene'), ('SO_0000704', 'gene', 78, 'genes'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC5956785	5/2018	S254-PMC5956785	['their work FOUND EVIDENCE of epistasis amongst Tyrosine-Protein Phosphatase Non-Receptor Type 2 (Ptpn2) Gene and the Vitamin D Binding Protein Gene in contributing to the risk of jia [86].']	[('INCOMPLETE_EVIDENCE', 11)]	1	[('PR_000016775', 'thiosulfate sulfurtransferase', 47, 'tyrosine-protein phosphatase non-receptor type 2'), ('PR_000013453', 'tyrosine-protein phosphatase non-receptor type 18', 97, 'PTPN2'), ('SO_0000704', 'gene', 104, 'gene'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 117, 'vitamin D binding protein'), ('SO_0000704', 'gene', 143, 'gene')]
PMC5956785	5/2018	S257-PMC5956785	['INVESTIGATING Genetic, nutritional and environmental factors that INFLUENCE Vitamin D in jia COULD HELP inform ways in which Vitamin D status INFLUENCES the occurrence and activity of jia.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 93), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC5956785	5/2018	S261-PMC5956785	['this first step is IMPORTANT for the development of FUTURE STUDIES leading to the exploration of POTENTIAL OPTIMAL target concentrations of Vitamin D for the reduction of inflammation in children with chronic arthritis.']	[('IMPORTANT_CONSIDERATION', 19), ('FUTURE_WORK', 52), ('INCOMPLETE_EVIDENCE', 97), ('IMPORTANT_CONSIDERATION', 107)]	4	[('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC5956785	5/2018	S265-PMC5956785	['these variables CAN make it DIFFICULT to interpret the RELATIONSHIP between Vitamin D and disease activity in RELATION to both inflammation status and risk of relapse.']	[('INCOMPLETE_EVIDENCE', 16), ('DIFFICULT_TASK', 28), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5956785	5/2018	S272-PMC5956785	['conclusion\nTHIS is the FIRST scoping review to summarize research RELATING to Vitamin D and jia in the context of Vitamin D status, latitude, disease activity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5956785	5/2018	S279-PMC5956785	['thus far, we KNOW that there is a ROLE for Vitamin D in the inflammatory pathways, a high prevalence of 25(Oh)D insufficiency among children with jia, and an established LINK of Vitamin D with other Autoimmune diseases.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 199, 'autoimmune')]
PMC5956785	5/2018	S284-PMC5956785	['being able to SUGGEST specific TARGETS for Vitamin D status AS a POTENTIAL adjunct therapy in the treatment of jia and understanding HOW Genetic variants increase the RISK of disease development will enhance the quality of Life of patients and their families.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 31), ('PROBABLE_UNDERSTANDING', 60), ('INCOMPLETE_EVIDENCE', 65), ('EXPLICIT_QUESTION', 133), ('IMPORTANT_CONSIDERATION', 167)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('SO_0000704', 'gene', 137, 'genetic'), ('UBERON_0000104', 'life cycle', 223, 'life')]
PMC5958072	5/2018	S21-PMC5958072	['several HYPOTHESES HAVE BEEN PROPOSED in the literature, including increased Perinatal influenza infection for those Born in the winter in new york city or decreased Perinatal Vitamin D exposure10,11.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 29)]	3	[('GO_0036268', 'swimming', 77, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 77, 'perinatal'), ('GO_0007567', 'parturition', 117, 'born'), ('GO_0036268', 'swimming', 166, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 166, 'perinatal'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D')]
PMC5995352	6/2018	S22-PMC5995352	['hypovitaminosis D MAY BE defined as Vitamin D deficiency or insufficiency (Serum-25-Hydroxyvitamin D (25Ohd) < 25 nmol/l and 25–50 nmol/l, respectively) [3], ALTHOUGH the most APPROPRIATE cut points are STILL UNDER DEBATE [4,5].']	[('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('IMPORTANT_CONSIDERATION', 176), ('IMPORTANT_CONSIDERATION', 203), ('IMPORTANT_CONSIDERATION', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 215)]	6	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 16, 'D'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 81, '25-hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 102, '25OHD')]
PMC5995352	6/2018	S28-PMC5995352	['this leaves the infant more SUSCEPTIBLE to developing Vitamin D deficiency rickets if not receiving adequate Vitamin D supplementation, AS the lower inborn Vitamin D stores will decrease to severely insufficient levels sooner IN ACCORDANCE WITH the half-life of 25Ohd.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 226)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 262, '25OHD')]
PMC5995352	6/2018	S29-PMC5995352	['inborn rickets due to Vitamin D deficiency, however, is very RARE, but MAY BE seen in children of mothers with SEVERE Vitamin D deficiency, osteomalacia and low s-calcium during Pregnancy [11].']	[('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 111)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy')]
PMC5995352	6/2018	S31-PMC5995352	['low foetal Vitamin D stores MAY THEREFORE further decrease to CRITICAL levels soon after Birth, in the absence of infant Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 28), ('PROBABLE_UNDERSTANDING', 32), ('IMPORTANT_CONSIDERATION', 62)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007567', 'parturition', 89, 'birth'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC5995352	6/2018	S33-PMC5995352	['a danish study FOUND Vitamin D deficiency rickets to be diagnosed between 0.3 to 3.6 years of age with a median age at diagnosis of 1.4 years [17].']	[('INCOMPLETE_EVIDENCE', 15)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5995352	6/2018	S38-PMC5995352	['IF low maternal or Cord 25Ohd is LINKED to diminished infant growth, especially of the Long Bones, DESPITE Vitamin D supplementation RECOMMENDATIONS, an IMPORTANT POTENTIAL for enforced PREVENTION STRATEGIES is SUGGESTED, EVEN in populations with low incidence of Vitamin D deficiency rickets.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('ANOMALY_CURIOUS_FINDING', 99), ('FUTURE_WORK', 133), ('IMPORTANT_CONSIDERATION', 153), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 186), ('FUTURE_WORK', 197), ('INCOMPLETE_EVIDENCE', 211), ('ANOMALY_CURIOUS_FINDING', 222)]	10	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 24, '25OHD'), ('UBERON_0002495', 'long bone', 87, 'long bones'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D')]
PMC5995352	6/2018	S64-PMC5995352	['dietary Intake of Calcium and Vitamin D intake were ESTIMATED by multiplying the frequency of self-reported Consumed Food with standard portion sizes [29] and information obtained from danish Food composition tables [30] the Intake of supplementary Vitamin D was calculated based on self-reported data on type and frequency of Supplements, and a database of all registered Supplements in denmark provided by the danish veterinary and Food administration [31].']	[('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 98)]	2	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 18, 'calcium'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007631', 'feeding behavior', 108, 'consumed'), ('CHEBI_33290', 'food', 117, 'food'), ('CHEBI_33290', 'food', 192, 'food'), ('GO_0007631', 'feeding behavior', 225, 'intake'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 327, 'supplements'), ('CHEBI_33341', 'titanium atom', 373, 'supplements'), ('CHEBI_33290', 'food', 434, 'Food')]
PMC5995352	6/2018	S145-PMC5995352	['covariates\nCord 25Ohd was RELATED with season of Birth, maternal ethnicity, pre-Gestational bmi, parity, maternal Vitamin D supplementation and smoking in Pregnancy, which is CONSISTENT with the literature [33–35].']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 175)]	2	[('UBERON_0000948', 'heart', 11, 'Cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 16, '25OHD'), ('GO_0007567', 'parturition', 49, 'birth'), ('GO_0007565', 'female pregnancy', 80, 'gestational'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'pregnancy')]
PMC5995352	6/2018	S147-PMC5995352	['Breastfed infants MAY BE at a higher RISK of rickets [36], BUT this DID NOT apply to our cohort with a general high Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('INCOMPLETE_EVIDENCE', 68)]	4	[('UBERON_0001224', 'renal pelvis', 0, 'Breastfed'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5995352	6/2018	S148-PMC5995352	['IN KEEPING WITH our results, longitudinal growth trajectories at age seven months were SIMILAR in Breast vs. formula Fed infants in an american cohort studying maternal Vitamin D supplementation during Lactation [37].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 87)]	2	[('UBERON_0000310', 'breast', 98, 'breast'), ('GO_0007631', 'feeding behavior', 117, 'fed'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('GO_0007595', 'lactation', 202, 'lactation')]
PMC5995352	6/2018	S152-PMC5995352	['this was IN KEEPING WITH OUR FINDINGS, SUPPORTING that early Pregnancy Vitamin D status does not affect offspring linear growth.']	[('INCOMPLETE_EVIDENCE', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 39)]	3	[('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC5995352	6/2018	S162-PMC5995352	['AS s-Igf-I, promoting growth by Proliferation of the Growth Plate, is inhibited by active Vitamin D as DEMONSTRATED in Animal and in vitro studies [39–43], we SPECULATE IF higher Vitamin D levels MAY restrict infant linear growth through inhibition of Igf-I, which has higher Serum concentrations in boys than in girls.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 159), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('INCOMPLETE_EVIDENCE', 196)]	5	[('PR_000008919', 'interferon alpha-6', 5, 'IGF-I'), ('GO_0008283', 'cell proliferation', 32, 'proliferation'), ('UBERON_0002516', 'epiphyseal plate', 53, 'growth plate'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 119, 'animal'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('PR_000008919', 'interferon alpha-6', 252, 'IGF-I'), ('UBERON_0001977', 'blood serum', 276, 'serum')]
PMC5995352	6/2018	S163-PMC5995352	['ALTERNATIVE explanations MAY BE searched in the Expression of Genes encoding for the inactive c3-epimer Vitamin D, vdr, Vitamin D binding protein, etc.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 25)]	2	[('GO_0010467', 'gene expression', 48, 'expression'), ('SO_0000704', 'gene', 62, 'genes'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC6011374	6/2018	S1-PMC6011374	['hence, there is CONTINUING INTEREST in determining HOW Vitamin D INFLUENCES Pregnancy health.']	[('INCOMPLETE_EVIDENCE', 16), ('EXPLICIT_QUESTION', 51), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
PMC6011374	6/2018	S10-PMC6011374	['a POSSIBLE ASSOCIATION between fetal sex, Vitamin D status and gdm provides FURTHER QUESTIONS and ENCOURAGES continual RESEARCH and discussion into the ROLE of Vitamin D in Pregnancy, particularly in Vitamin D replete populations.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 76), ('EXPLICIT_QUESTION', 84), ('FUTURE_WORK', 98), ('SUPERFICIAL_RELATIONSHIP', 152)]	6	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC6011374	6/2018	S12-PMC6011374	['background\nwith an increasing prevalence of Vitamin D deficiency and insufficiency reported both in australia and new zealand, as well as worldwide [1], there is CONTINUING INTEREST in determining HOW Vitamin D deficiency MAY INFLUENCE health in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 162), ('EXPLICIT_QUESTION', 197), ('INCOMPLETE_EVIDENCE', 222), ('SUPERFICIAL_RELATIONSHIP', 226)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy')]
PMC6011374	6/2018	S13-PMC6011374	['evidence SUGGESTS that Vitamin D deficiency is ASSOCIATED with a number of Pregnancy COMPLICATIONS including Preeclampsia (pe), Gestational diabetes mellitus (gdm) and spontaneous Preterm Birth (Sptb) [2–4].']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 47), ('PROBLEM_COMPLICATION', 85)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 109, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 128, 'gestational'), ('GO_0007565', 'female pregnancy', 180, 'preterm birth'), ('PR_000015390', 'sterol O-acyltransferase 2', 195, 'sPTB')]
PMC6011374	6/2018	S15-PMC6011374	['this MAY BE explained, IN PART, by INADEQUATE control of RELATED risk factors and CONFOUNDERS in statistical analyses, VARIATIONS between assays that measure Vitamin D and significant HETEROGENEITY between studied populations [6].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 23), ('PROBLEM_COMPLICATION', 35), ('SUPERFICIAL_RELATIONSHIP', 57), ('PROBLEM_COMPLICATION', 82), ('DIFFICULT_TASK', 119), ('DIFFICULT_TASK', 184)]	7	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC6011374	6/2018	S21-PMC6011374	['reports from lower-risk groups have INDICATED that Vitamin D deficiency occurs in 25–55% of Pregnant women [11–13].']	[('INCOMPLETE_EVIDENCE', 36)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 92, 'pregnant')]
PMC6011374	6/2018	S22-PMC6011374	['there are numerous studies which HAVE SHOWN that Vitamin D deficiency is ASSOCIATED with adverse Pregnancy outcomes (most recent: [14–17]), particularly in populations that reside at higher latitudes.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy')]
PMC6011374	6/2018	S24-PMC6011374	['PREVIOUS STUDIES on Pregnant australian and new zealand women have reported that WHILE circulating 25(Oh)D was significantly lower in women with pe, Sptb, gdm and those who Delivered a small-for Gestational age (sga) infant, no association between Vitamin D deficiency and these Pregnancy complications was found after adjusting for covariates [18–20].']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81)]	2	[('GO_0007565', 'female pregnancy', 20, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000015390', 'sterol O-acyltransferase 2', 149, 'sPTB'), ('GO_0007567', 'parturition', 173, 'delivered'), ('GO_0007565', 'female pregnancy', 195, 'gestational'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D'), ('GO_0007565', 'female pregnancy', 279, 'pregnancy')]
PMC6011374	6/2018	S45-PMC6011374	['UNLIKE the PREVIOUSLY published data on Vitamin D in the auckland cohort [20], Serum 25(Oh)D was measured using the ids-isys chemiluminescent-based assay (abacus, als) as per the manufacturer’s instructions.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001977', 'blood serum', 79, 'serum'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 85, '25(OH ... D')]
PMC6011374	6/2018	S63-PMC6011374	['HOWEVER, after adjusting for maternal age, bmi, sei, smoking status and Alcohol consumption at 15\u2009±\u20091\xa0weeks’ Gestation, ethnicity, recreational walking and season, the women recruited in adelaide STILL had significantly lower Serum 25(Oh)D when compared with those in auckland (adelaide: 58.4\u2009±\u200950.3 vs. auckland: 70.2\u2009±\u200954.5\xa0nmol/l, p\u2009<\u20090.001) INDICATING the INFLUENCE of OTHER CONFOUNDERS not measured as part of the study on Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 196), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 373), ('PROBLEM_COMPLICATION', 379)]	6	[('CHEBI_30879', 'alcohol', 72, 'alcohol'), ('GO_0007565', 'female pregnancy', 109, 'gestation'), ('UBERON_0001977', 'blood serum', 226, 'serum'), ('CHEBI_71657', 'versiconol acetate', 232, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 232, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
PMC6011374	6/2018	S64-PMC6011374	['caption (table-wrap): table 1\n\nparticipant characteristics and comparison of characteristics between women recruited at the adelaide and auckland scope centresall women (n = 2800)adelaide (n = 1156)auckland (n = 1644) p value*age yrs , mean (sd)28 (6)23.73 (5.11)30.44 (4.82)<0.0001bmi kg/m2, mean (sd)25.8 (5.44)27.04 (6.56)24.88 (4.26)<0.0001ethnicity<0.0001\u2003caucasian2449 (87)1060 (92)1389 (84)\u2003non caucasian351 (13)96 (8)255 (16)smoking status, n (%)<0.0001\u2003no2152 (77)704 (61)1448 (88)\u2003quit during Pregnancy306 (11)175 (15)131 (8)\u2003smoking342 (12)277 (24)65 (4)Alcohol consumption, n (%)<0.0001\u2003no1480 (53)708 (61)772 (47)\u2003stopped during pregnancy1185 (42)397 (34)788 (48)\u2003consuming Alcohol135 (5)51 (4)84 (5)fruit intake, n (%)<0.0001\u2003≥1x per day2032 (73)586 (51)1446 (88)\u20033-6x per week405 (14)272 (24)133 (8)\u20031-2x per week223 (8)181 (16)42 (3)\u20031-3x per month or less140 (5)117 (10)23 (1)recreational walking<0.0001\u2003never428 (15)265 (23)163 (10)\u20031-3 times/week1773 (63)668 (58)1105 (68)\u2003≥4 times/week590 (22)221 (19)369 (23)time watching tv<0.0001\u2003<5 hours per day2404 (86)901 (78)1503 (92)\u2003≥5 hours per day387 (14)253 (22)134 (8)season Serum was sampled0.3213\u2003summer636 (23)278 (24)358 (22)\u2003autumn705 (25)273 (24)432 (26)\u2003winter727 (26)300 (26)427 (26)\u2003spring732 (26)305 (26)427 (26)Serum 25(Oh)D nmol/l , mean (sd)68.09 (27.14)60.06 (23.68)73.74 (27.99)<0.0001vitamin D status<0.0001\u2003<25 nmol/l99 (4)48 (4)51 (3)\u200325-50 nmol/l673 (24)375 (32)298 (18)\u200350-75 nmol/l928 (33)422 (37)506 (31)\u2003>75 nmol/l1098 (39)311 (27)787 (48)\n* p values for continuous variables were determined using a welch’s t-test and categorical variables a fisher’s exact test comparing adelaide and auckland women\n\nstandardising Serum 25(Oh)D based on seasonal variation\nAS EXPECTED, there was a seasonal INFLUENCE on Serum 25(Oh)D and THUS, “standardised” Vitamin D concentrations were calculated to account for the month of Serum collection.']	[('INCOMPLETE_EVIDENCE', 1748), ('SUPERFICIAL_RELATIONSHIP', 1782), ('PROBABLE_UNDERSTANDING', 1813)]	3	[('GO_0007602', 'phototransduction', 503, 'pregnancy306'), ('CHEBI_30879', 'alcohol', 565, 'Alcohol'), ('CHEBI_78635', 'fatty alcohol 16:1', 687, 'alcohol135'), ('UBERON_0001977', 'blood serum', 1142, 'serum'), ('UBERON_0001977', 'blood serum', 1289, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 1295, '25(OH)D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1375, 'D'), ('UBERON_0001977', 'blood serum', 1706, 'serum'), ('CHEBI_71657', 'versiconol acetate', 1712, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1712, '25(OH)D'), ('UBERON_0001977', 'blood serum', 1795, 'serum'), ('CHEBI_71657', 'versiconol acetate', 1801, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1801, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1834, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1903, 'serum')]
PMC6011374	6/2018	S79-PMC6011374	['ALTHOUGH, the point estimates INDICATED a marginal increased risk for developing any Pregnancy complication with severe (<\u200925\xa0nmol/l) Vitamin D deficiency compared to those who had levels between 50 and 75\xa0nmol/l (arr: 1.10; 95% ci: 0.89, 1.36).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30)]	2	[('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC6011374	6/2018	S80-PMC6011374	['caption (table-wrap): table 2\n\nadjusted relative risks (arr) of Pregnancy complications from any complication, Preeclampsia (pe), Gestational hypertension (gh), Gestational diabetes mellitus (gdm), spontaneous Preterm Birth (sptb) and small-for-Gestational age (sga) according to Vitamin D status categorised based on standardised quartiles and clinical definitions of Vitamin D statuspregnancy complicationsall womenany complicationpeghgdmsptbsga n (%) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci)standardised quartiles**\u2003low711 (25)328 (46)0.95 (0.85, 1.07)46 (6)1.02 (0.66, 1.57))57 (8)0.97 (0.67, 1.42)28 (4)0.79 (0.47, 1.30)36 (5)0.83 (0.54, 1.29)84 (12)1.02 (0.75, 1.39)\u2003low-moderate755 (27)318 (42)1.00 (0.90, 1.12)42 (6)1.07 (0.69, 1.64)65 (9)1.06 (0.74, 1.52)25 (3)0.67 (0.39, 1.16)33 (4)0.87 (0.56, 1.3572 (10)0.98 (0.73, 1.32)\u2003moderate-high702 (25)309 (44)1.0†37 (5)1.0†50 (7)1.0†28 (4)1.0†39 (6)1.0†81 (12)1.0†\u2003high630 (23)258 (41)0.93 (0.82, 1.06)†35 (6)1.24 (0.78, 1.96)40 (6)0.87 (0.58, 1.30)10 (2) 0.47(0.23, 0.96) 30 (5)0.77 (0.48, 1.25)60 (10)0.80 (0.57, 1.11)Vitamin d status\u2003<25 nmol/l99 (4)51 (52)1.10 (0.89, 1.36)8 (8)1.44 (0.68, 3.03))6 (6)0.70 (0.32, 1.52)5 (5)0.98 (0.38, 2.52)7 (7)1.44 (0.68, 3.04)13 (13)1.15 (0.66, 2.01)\u200325-50 nmol/l673 (24)301 (45)0.93 (0.83, 1.03)45 (7)1.18 (0.80, 1.75)59 (9)0.97 (0.71, 1.34)26 (4)0.89 (0.54, 1.47)29 (4)0.75 (0.48, 1.16)74 (11)0.93 (0.69, 1.24)\u2003>50-75 nmol/l928 (33)428 (46)1.0†48 (5)1.0†80 (9)1.0†35 (4)1.0†52 (6)1.0†107 (12)1.0†\u2003>75 nmol/l1098 (39)435 (40)0.95 (0.86, 1.04)60 (5)1.28 (0.87, 1.87)67 (6)0.82 (0.59, 1.12)†26 (2)0.78 (0.48, 1.28)51 (5)0.86 (0.59, 1.26)104 (9)0.86 (0.67, 1.12)\n*relative risks compared to all women were adjusted for age, maternal body mass index, ethnicity (non caucasian vs. caucasian), smoking status at 15\u2009±\u20091\xa0weeks’ Gestation (no vs. yes), Alcohol consumption at 15\u2009±\u20091\xa0weeks’ (no vs yes), recreational walking (1-3×/week and\u2009≥\u20094×/week vs. never) and recruitment site (auckland vs. adelaide)\n**Serum 25(Oh)D was standardised for month that Serum was sampled based as previously described [34]\n†reference category\n\nSerum 25(Oh)D, Pregnancy outcome and fetal sex\nas THERE IS EVIDENCE to SUGGEST that Vitamin D Metabolism within the Placenta MAY DIFFER with respect to fetal sex [35] THUS, we ASSESSED the EFFECT of “standardised” Vitamin D status on Pregnancy outcome stratified by fetal sex (table\xa03).']	[('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2251), ('INCOMPLETE_EVIDENCE', 2305), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2309), ('PROBABLE_UNDERSTANDING', 2347), ('QUESTION_ANSWERED_BY_THIS_WORK', 2356), ('SUPERFICIAL_RELATIONSHIP', 2369)]	7	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 111, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('GO_0007565', 'female pregnancy', 161, 'gestational'), ('GO_0007565', 'female pregnancy', 210, 'preterm birth'), ('GO_0007565', 'female pregnancy', 245, 'gestational'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 1141, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1882, 'gestation'), ('CHEBI_30879', 'alcohol', 1906, 'alcohol'), ('UBERON_0001977', 'blood serum', 2060, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 2066, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 2066, '25(OH)D'), ('UBERON_0001977', 'blood serum', 2106, 'serum'), ('UBERON_0001977', 'blood serum', 2180, 'Serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 2189, 'OH)D'), ('GO_0007565', 'female pregnancy', 2195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2264, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 2264, 'vitamin D metabolism'), ('UBERON_0001987', 'placenta', 2296, 'placenta'), ('CHEBI_27300', 'vitamin D', 2394, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2414, 'pregnancy')]
PMC6011374	6/2018	S86-PMC6011374	['caption (table-wrap): table 3\n\nadjusted relative risks (arr) of Pregnancy complications from any complication, Preeclampsia (pe), Gestational hypertension (gh), Gestational diabetes mellitus (gdm), spontaeous Preterm Birth (sptb) and small-for-Gestational age (sga) according to Vitamin D status and stratified by fetal sexpregnancy complicationsall womenany complicationpeghgdmsptbsga n (%) n (%)arr* (95% ci) n (%)arr* (95% ci) n (%)arr* (95% ci) n (%)arr* (95% ci) n (%)arr* (95% ci) n (%)arr* (95% ci)standardised quartiles**males\u2003low367 (26)173 (47)1.00 (0.85, 1.18)24 (7)1.24 (0.65, 2.34)31 (8)1.11 (0.64, 1.94)18 (5)1.25 (0.58, 2.68)22 (6)1.09 (0.60, 1.98)43 (12)1.14 (0.73, 1.79)\u2003low-moderate364 (26)163 (45)1.01 (0.86, 1.19))20 (5)1.11 (0.58, 2.12)32 (9)1.25 (0.73, 2.13)13 (4)1.06 (0.48, 2.38)18 (5)0.93 (0.49, 1.76)45 (12)1.23 (0.80, 1.88)\u2003moderate-high359 (25)152 (42)1.0†16 (4)1.0†23 (6)1.0†11 (3)1.0†18 (5)1.0†35 (10)1.0†\u2003high325 (23)111 (34)0.86 (0.71, 1.04)15 (5)1.18 (0.59, 2.36)17 (5)0.90 (0.50, 1.62)4 (1)0.45 (0.15, 1.38)15 (5)0.97 (0.50, 1.88)26 (8)0.77 (0.47, 1.26)females\u2003low380 (28)169 (44)0.91 (0.77, 1.06)23 (6)0.85 (0.47, 1.55)30 (8)0.87 (0.52, 1.45)13 (3)0.51 (0.25, 1.04)14 (4)0.61 (0.31, 1.18)45 (12)0.88 (0.58, 1.35)\u2003low-moderate353 (26)168 (48)0.99 (0.85, 1.15)24 (7)1.03 (0.57, 1.85)31 (9)0.92 (0.57, 1.50)9 (3) 0.44(0.20, 0.97) 18 (5)0.79 (0.43, 1.45)33 (9)0.74 (0.48, 1.13)\u2003moderate-high334 (24)149 (45)1.0†19 (6)1.0†28 (8)1.0†17 (5)1.0†21 (6)1.0†31 (9)1.0†\u2003high314 (23)128 (41)1.00 (0.84, 1.19)19 (6)1.29 (0.70, 2.35)20 (6)0.85 (0.49, 1.46)6 (2)0.48 (0.19, 1.23)12 (4)0.60 (0.30, 1.21)29 (9)0.82 (0.53, 1.28)\n*relative risks compared to all women were adjusted for age, maternal body mass index, ethnicity (non caucasian vs. caucasian), smoking status at 15\u2009±\u20091\xa0weeks’ Gestation (no vs. yes), Alcohol consumption at 15\u2009±\u20091\xa0weeks’ (no vs yes), recreational walking (1-3×/week and\u2009≥\u20094×/week vs. never) and recruitment site (auckland vs. adelaide)\n**Serum 25(Oh)D was standardised for month that serum was sampled based as previously described [34]\n†reference category\n\ndiscussion\nthis study ADDS TO THE current body of LITERATURE on Vitamin D status in a population of Pregnant australian and new zealand women and provides INSIGHT into normal circulating levels of 25(Oh)D in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 2125), ('INCOMPLETE_EVIDENCE', 2258)]	2	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 111, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('GO_0007565', 'female pregnancy', 161, 'gestational'), ('GO_0007565', 'female pregnancy', 209, 'preterm birth'), ('GO_0007565', 'female pregnancy', 244, 'gestational'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1805, 'gestation'), ('CHEBI_30879', 'alcohol', 1829, 'alcohol'), ('UBERON_0001977', 'blood serum', 1983, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 1989, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1989, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 2167, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2203, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 2300, '25(OH)D'), ('GO_0007565', 'female pregnancy', 2317, 'pregnancy')]
PMC6011374	6/2018	S87-PMC6011374	['it is the largest prospective cohort study TO ASSESS Vitamin D status within the international scope cohort, comparing and combining two distinct populations of Pregnant women living at similar latitude and provides a GREATER UNDERSTANDING of Vitamin D deficiency and the risk of adverse Pregnancy outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('INCOMPLETE_EVIDENCE', 218)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'pregnant'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('GO_0007565', 'female pregnancy', 288, 'pregnancy')]
PMC6011374	6/2018	S91-PMC6011374	['furthermore, there MAY BE POSSIBLE fetal sex specific DIFFERENCES in Vitamin D status WORTH CONSIDERING in FUTURE STUDIES.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54), ('IMPORTANT_CONSIDERATION', 86), ('FUTURE_WORK', 107)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC6011374	6/2018	S94-PMC6011374	['PREVIOUS STUDIES HAVE SHOWN a positive ASSOCIATION between socioeconomic status and Vitamin D in both Pregnant and non-Pregnant women [36,37].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 39)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnant'), ('GO_0007565', 'female pregnancy', 119, 'pregnant')]
PMC6011374	6/2018	S97-PMC6011374	['HOWEVER, after adjusting for factors shown to be ASSOCIATED with Vitamin D status including bmi and recreational walking, serum 25(Oh)D remained significantly lower in the women recruited in adelaide SUGGESTING the INFLUENCE of OTHER factors not measured as part of scope for example, hours spent outside in the sun.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 215), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 130, '(OH ... D')]
PMC6011374	6/2018	S98-PMC6011374	['as INDICATED by the seasonal variation in Serum 25(Oh)D, amongst women recruited in adelaide, Vitamin D status declined significantly from february to april WHILST in the women recruited in auckland, Serum 25(Oh)D in march and april remained elevated before declining.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157)]	2	[('UBERON_0001977', 'blood serum', 42, 'serum'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 48, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 206, '25(OH)D')]
PMC6011374	6/2018	S101-PMC6011374	['THEREFORE, the protective ROLE of high 25(Oh)D 15\u2009±\u20091\xa0weeks’ Gestation against gdm, as seen with a decreased risk of gdm in women within the ‘high’ quartile of standardised Vitamin D compared to moderate-high, is CONSISTENT with knowledge about Vitamin D and diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 213)]	3	[('CHEBI_71657', 'versiconol acetate', 39, '25(OH)D'), ('GO_0007565', 'female pregnancy', 61, 'gestation'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC6011374	6/2018	S102-PMC6011374	['this is also CONSISTENT with another study that observed an increased risk of gdm with Vitamin D deficiency in early Pregnancy (aor: 3.40; 95% ci: 2.03–4.98 [17]) and offers POTENTIAL physiological CONNECTIONS between Vitamin D status and the progression of Insulin resistance in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 198)]	3	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D'), ('PR_000045358', 'insulin family protein', 258, 'insulin'), ('GO_0007565', 'female pregnancy', 280, 'pregnant')]
PMC6011374	6/2018	S103-PMC6011374	['furthermore, studies HAVE SHOWN that Vitamin D supports early Placental Development [44,45] in which, abnormal Placentation CAN be a characteristic of a number of Pregnancy complications including gdm, pe, Sptb and sga [46].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 124)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0001890', 'placenta development', 62, 'placental development'), ('UBERON_0001987', 'placenta', 62, 'placental'), ('GO_0001890', 'placenta development', 111, 'placentation'), ('GO_0007565', 'female pregnancy', 163, 'pregnancy'), ('PR_000015390', 'sterol O-acyltransferase 2', 206, 'sPTB')]
PMC6011374	6/2018	S110-PMC6011374	['this is similar to that which has PREVIOUSLY been shown in the RELATIONSHIP between Vitamin D status at ≤26\xa0weeks’ Gestation and Placental pathology in Pregnancy [51] SUGGESTING that male and female fetuses respond differently to maternal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 167)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestation'), ('UBERON_0001987', 'placenta', 129, 'placental'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D')]
PMC6011374	6/2018	S111-PMC6011374	['lack of statistically significant associations with other Pregnancy complications MAY reflect the fact that this was a largely Vitamin D-replete population (>\u200972% with Serum 25(Oh)D\u2009>\u200950\xa0nmol/l) LIKELY DUE TO their residence latitude as low Serum 25(Oh)D was found in the scope ireland cohort [52].']	[('INCOMPLETE_EVIDENCE', 82), ('PROBABLE_UNDERSTANDING', 195), ('PROBLEM_COMPLICATION', 202)]	3	[('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0001977', 'blood serum', 168, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 177, 'OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 180, 'D'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 247, '25(OH)D')]
PMC6011374	6/2018	S112-PMC6011374	['indeed many of the studies that have assessed the ASSOCIATION between Vitamin D status and adverse Pregnancy outcome that have reported statistically significant differences HAVE BEEN in populations with higher rates of Vitamin D deficiency [2,4].']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 174)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC6011374	6/2018	S116-PMC6011374	['INCONSISTENCIES in the literature MAY also reflect OTHER causative factors in which Vitamin D is a mediator.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC6011374	6/2018	S119-PMC6011374	['THEREFORE, Vitamin D status MAY BE IMPORTANT in populations where dietary Calcium intake is low which is UNLIKELY in the population of women studied HERE.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 35), ('PROBABLE_UNDERSTANDING', 105), ('QUESTION_ANSWERED_BY_THIS_WORK', 149)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 74, 'calcium')]
PMC6011374	6/2018	S121-PMC6011374	['HOWEVER, DIFFERENCES in Vitamin D status between the women recruited in adelaide and those recruited in auckland reflect obvious DIFFICULTIES in studying HOW Vitamin D MAY support healthy Pregnancies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('DIFFICULT_TASK', 129), ('EXPLICIT_QUESTION', 154), ('INCOMPLETE_EVIDENCE', 168)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnancies')]
PMC6011374	6/2018	S122-PMC6011374	['a POSSIBLE CONNECTION between fetal sex, Vitamin D status and Pregnancy complications REVEALS FURTHER QUESTIONS and ENCOURAGES continual RESEARCH and discussion into the ROLE of Vitamin D in Pregnancy, particularly in Vitamin D replete populations.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 86), ('FUTURE_WORK', 94), ('FUTURE_WORK', 116), ('SUPERFICIAL_RELATIONSHIP', 170)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC6039335	7/2018	S156-PMC6039335	['nutritional factors\nseveral nutritional factors including Fat Metabolism, fat Digestion and absorption, Glucose/Starch availability, roughage vs. concentrate ratio, dietary energy and protein levels, Vitamins A, d, and c levels, fetal nutritional programming, and stage-specific Feeding systems CAN AFFECT imf deposition.']	[('INCOMPLETE_EVIDENCE', 295), ('SUPERFICIAL_RELATIONSHIP', 299)]	2	[('GO_0006631', 'fatty acid metabolic process', 58, 'fat metabolism'), ('GO_0007586', 'digestion', 78, 'digestion'), ('CHEBI_17234', 'glucose', 104, 'glucose'), ('CHEBI_28017', 'starch', 112, 'starch'), ('CHEBI_27300', 'vitamin D', 200, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 209, 'A'), ('GO_0007631', 'feeding behavior', 279, 'feeding')]
PMC6039335	7/2018	S256-PMC6039335	['SEVERAL STUDIES HAVE SHOWN that restricting Vitamin A in the diet, or low Beta-Carotene (a precursor of Vitamin A) Intake, increases body fat, including imf, deposition.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_17579', 'beta-carotene', 74, 'beta-carotene'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin A'), ('GO_0007631', 'feeding behavior', 115, 'intake')]
PMC6039335	7/2018	S260-PMC6039335	['the appropriate age for, and duration of, Vitamin A deple tion or supplementation have been SUGGESTED as IMPORTANT factors that AFFECT ms. oka et al [134] reported that restricting Vitamin A in 15-month-old cattle until the final finishing phase (29 months of age) increased ms, but not in 23-month-old cattle prior to finishing.']	[('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 128)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin A')]
PMC6039335	7/2018	S261-PMC6039335	['they SUGGESTED that Serum Vitamin A level AFFECTS the Lm ms during the early fattening stage and that restricting Vitamin A during the later stages of growth AFFECTS growth rate.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 158)]	3	[('UBERON_0001977', 'blood serum', 20, 'serum'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin A'), ('UBERON_0016551', 'subdivision of spinal cord ventral column', 54, 'LM'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin A')]
PMC6039335	7/2018	S263-PMC6039335	['continuous dietary Vitamin A restriction during the late fattening phase is not RECOMMENDED because prolonged Vitamin A restriction MAY lead to health PROBLEMS and retard growth rate [130].']	[('FUTURE_WORK', 80), ('INCOMPLETE_EVIDENCE', 132), ('PROBLEM_COMPLICATION', 151)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin A')]
PMC6039335	7/2018	S265-PMC6039335	['a continuous supply of normal levels of dietary Vitamin A during the entire growth period MAY also result in poor marbling and qg, EVEN IF the growth rate were normal and no health PROBLEMS occurred.']	[('INCOMPLETE_EVIDENCE', 90), ('ANOMALY_CURIOUS_FINDING', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('PROBLEM_COMPLICATION', 181)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin A')]
PMC6039335	7/2018	S266-PMC6039335	['kawachi [137] described that the number of Adipocytes increases in muscle between 13 and 19 months of age, so Feeding a Vitamin A-deficient diet during this stage MAY stimulate marbling.']	[('INCOMPLETE_EVIDENCE', 163)]	1	[('CL_0000136', 'fat cell', 43, 'adipocytes'), ('GO_0007631', 'feeding behavior', 110, 'feeding'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A')]
PMC6039335	7/2018	S275-PMC6039335	['they concluded that the tt genotype of adh1c c.-64t>c is RELATED to greater imf than the cc genotype when Vitamin A is restricted, and adh1c c.-64t>c COULD BE a Genetic marker for enhancing marbling in feedlot steers.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 150)]	2	[('CHEBI_27300', 'vitamin D', 106, 'vitamin A'), ('SO_0000704', 'gene', 161, 'genetic')]
PMC6039335	7/2018	S279-PMC6039335	['wang et al [144] SUGGESTED that the Vitamin D receptor (vdr) competes with Pparg for binding to the Retinoid X Receptor (rxr).']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 75, 'PPARG'), ('CHEBI_69517', 'rubiarbonol L', 100, 'retinoid X'), ('PR_000001658', 'prostaglandin E2 receptor EP2 subtype', 100, 'retinoid X receptor')]
PMC6039335	7/2018	S281-PMC6039335	['FEW in vivo STUDIES HAVE BEEN performed on the EFFECT of Vitamin D on beef marbling.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC6039335	7/2018	S289-PMC6039335	['in addition, Vitamin C MAY help to Regulate Adipogenesis.']	[('INCOMPLETE_EVIDENCE', 23)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin C'), ('GO_0065007', 'biological regulation', 35, 'regulate'), ('GO_0060612', 'adipose tissue development', 44, 'adipogenesis')]
PMC6043562	7/2018	S8-PMC6043562	['we IDENTIFIED a POTENTIAL synergistic INTERACTION (p\u2009=\u20090.02) between Vitamin E (Food\u2009+\u2009supplements) and Pm2.5; this exposure combination was ASSOCIATED with further increases in Feno levels.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 141)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin E'), ('CHEBI_33290', 'food', 80, 'food'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 104, 'PM2'), ('CHEBI_32035', 'potassium hydroxide', 178, 'FeNO')]
PMC6043562	7/2018	S15-PMC6043562	['OTHER STUDIES have FOUND PROTECTIVE ASSOCIATIONS of maternal Antenatal Vitamin D or antioxidant Nutrient intake with later allergic or Respiratory outcomes8–12, THOUGH their findings have NOT always been reproducible13–16.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 161), ('ANOMALY_CURIOUS_FINDING', 161), ('ANOMALY_CURIOUS_FINDING', 188)]	8	[('GO_0007567', 'parturition', 61, 'antenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_33284', 'nutrient', 96, 'nutrient'), ('UBERON_0001004', 'respiratory system', 135, 'respiratory')]
PMC6043562	7/2018	S56-PMC6043562	['Prenatal Vitamin D intake from Foods showed a TREND toward decreased feno measures in Adolescence (table\xa03).']	[('INCOMPLETE_EVIDENCE', 46)]	1	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33290', 'food', 31, 'foods'), ('GO_0048848', 'neurohypophysis morphogenesis', 86, 'adolescence')]
PMC6043562	7/2018	S106-PMC6043562	['IN KEEPING WITH our HYPOTHESIS, we OBSERVED that higher Prenatal intakes of N-3 polyunsaturated Fatty Acids (a POTENTIAL immunomodulatory agent), Vitamin D (an antioxidant and Immunomodulatory Agent) and Folate were ASSOCIATED with lower levels of allergic disease BIOMARKERS.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 216), ('SUPERFICIAL_RELATIONSHIP', 265)]	6	[('GO_0007565', 'female pregnancy', 56, 'prenatal'), ('CHEBI_30256', 'thiocarbonyl group', 76, 'n-3'), ('CHEBI_35366', 'fatty acid', 96, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('CHEBI_35476', 'antipsychotic agent', 176, 'immunomodulatory agent'), ('CHEBI_30863', '5-azaorotic acid', 204, 'folate')]
PMC6043562	7/2018	S107-PMC6043562	['IN CONTRAST with OTHER Nutrients, total Vitamin E intake in Pregnancy APPEARED TO amplify the adverse EFFECT of Prenatal exposure to Pm2.5on Feno measured in adolescence, SUGGESTING a synergy between these two exposures.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('ANOMALY_CURIOUS_FINDING', 70), ('SUPERFICIAL_RELATIONSHIP', 102), ('INCOMPLETE_EVIDENCE', 171)]	6	[('CHEBI_33284', 'nutrient', 23, 'nutrients'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin E'), ('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('GO_0007565', 'female pregnancy', 112, 'prenatal'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 133, 'PM2'), ('CHEBI_32035', 'potassium hydroxide', 141, 'FeNO')]
PMC6043562	7/2018	S119-PMC6043562	['in project viva, we have PREVIOUSLY REPORTED a lower risk of mid childhood atopy and allergic rhinitis with more Vitamin D intake in Pregnancy30.']	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 36)]	2	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0006915', 'apoptotic process', 133, 'pregnancy30')]
PMC6043562	7/2018	S160-PMC6043562	['IN SUMMARY, we FOUND that greater maternal intakes of Vitamin D, Folate, and N-3 Fatty Acids were ASSOCIATED with less Airway inflammation in adolescence, WHILE other Nutrients (Vitamin E), and air Pollutants were ASSOCIATED with higher inflammation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 214)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 65, 'folate'), ('CHEBI_35418', 'N-acetylneuraminate', 77, 'n-3 fatty acids'), ('UBERON_0001005', 'respiratory airway', 119, 'airway'), ('CHEBI_33284', 'nutrient', 167, 'nutrients'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin E'), ('CHEBI_26199', 'polyprenol', 198, 'pollutants')]
PMC6043562	7/2018	S161-PMC6043562	['Prenatal exposure INTERACTIONS MAY play an IMPORTANT ROLE, AS EVIDENCED by the POTENTIAL synergy between Vitamin E and Pm2.5.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 59), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 79)]	7	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin E'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 119, 'PM2')]
PMC6043562	7/2018	S225-PMC6043562	['we MODELLED all Nutrients in the same exposure group except Vitamin E and Β-Carotene, which DEMONSTRATED ASSOCIATIONS with Feno in the direction OPPOSITE to that observed for other Nutrients.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 145)]	4	[('CHEBI_33284', 'nutrient', 16, 'nutrients'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin E'), ('CHEBI_28660', '(-)-alpha-pinene', 74, 'β-Carotene'), ('CHEBI_32035', 'potassium hydroxide', 123, 'FeNO'), ('CHEBI_33284', 'nutrient', 181, 'nutrients')]
PMC6056931	7/2018	S21-PMC6056931	['the Nutrients MOST STUDIED during Pregnancy include b-vitamins (particularly Folic Acid), Vitamin D, iron, Long-Chain polyunsaturated Fatty Acids (particularly N-3 Fatty Acids) and Iodine [8,10].']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_33284', 'nutrient', 4, 'nutrients'), ('GO_0007565', 'female pregnancy', 34, 'pregnancy'), ('CHEBI_30751', 'formic acid', 77, 'folic acid'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_28911', 'cob(III)alamin', 107, 'long-chain'), ('CHEBI_35366', 'fatty acid', 134, 'fatty acids'), ('31', 'ACACA (human)', 160, 'n'), ('CHEBI_35366', 'fatty acid', 164, 'fatty acids'), ('CHEBI_24859', 'iodine atom', 181, 'iodine')]
PMC6056931	7/2018	S22-PMC6056931	['HOWEVER, adequate maternal intakes of zinc and Vitamin A MAY also be IMPORTANT for optimal Pregnancy outcomes, as well as for maternal and offspring health [11–13].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 69)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin A'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy')]
PMC5741981	12/2018	S40-PMC5741981	['when Prenatal Vitamins were REPORTED, we considered them as multivitamins designed for Pregnant women containing more and/or other Vitamins than Folic Acid and Vitamin D.\nwomen were asked if they obtained information about medication before and during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 28)]	1	[('GO_0007565', 'female pregnancy', 5, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 14, 'vitamins'), ('GO_0007565', 'female pregnancy', 87, 'pregnant'), ('CHEBI_33277', 'gamma-tocotrienol', 131, 'vitamins'), ('CHEBI_30751', 'formic acid', 145, 'folic acid'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 252, 'pregnancy')]
